[["Besides the relief of symptoms, the main purpose of any treatment must be to ensure a better quality of life (QOL).", {"entities": []}], ["Mere recording of symptoms reveals their severity and frequency, but gives scant information on its effect on QOL.", {"entities": []}], ["The study was designed to assess QOL in Indian patients with chronic urticaia (CU).", {"entities": []}], ["We used the validated CU-QOL by Bairadani et al ., consisting of five domains and each domain consisting of several items.", {"entities": []}], ["Each item was scored from 1 to 5 (score 5 = most affected, score 1 = not affected).", {"entities": []}], ["Patients having symptoms of rash and pruritis on most of the days for at least 6 weeks were enrolled.", {"entities": []}], ["If the individuals had CU secondary to any other disease, they were excluded.", {"entities": []}], ["We enrolled 48 patients.", {"entities": []}], ["The means of the domains, the items, and the frequency of occurrence of an item were tabulated.", {"entities": []}], ["The highest mean scores were in the domains of symptoms, followed by sleep disturbances, life activities, looks, and limits.", {"entities": []}], ["The highest mean scores for the items were for pruritis and wheals followed by sleep disturbances, mood changes, nervousness, embarrassment, fatigue, loss of concentration, reduced work, and social relationships.", {"entities": []}], ["We also observed a significant relationship among individual items.", {"entities": []}], ["It is possible that they may have an additive effect.", {"entities": []}], ["Even though CU significantly affected many items, patients were rarely aware of them.", {"entities": []}], ["There was a significant inter-item correlation, suggesting that items might be aggravating each other.", {"entities": []}], ["It is important to address the issues regarding QOL along with symptoms for better management of CU.", {"entities": []}], ["Madurella mycetomatis is the most prevalent causative agent of eumycetoma in Sudan, an infection characterized by the formation of grains.", {"entities": []}], ["Many patients are exposed to the causative agent, however only a small number develop infection.", {"entities": []}], ["mycetomatis contains chitin in its cell wall, which can trigger the human immune system.", {"entities": []}], ["Polymorphisms in the genes encoding for the chitin-degrading enzymes chitotriosidase and AMCase were described, resulting in altered chitinase activity.", {"entities": []}], ["We investigated the association between 4 of these polymorphisms and the incidence of M .", {"entities": []}], ["mycetomatis mycetoma in a Sudanese population.", {"entities": []}], ["Polymorphisms studied in 112 eumycetoma patients and 103 matched controls included a 24-bp insertion in the chitotriosidase gene (rs3831317), resulting in impaired chitinase activity and single nucleotide polymorphism (SNP) in the AMCase gene (rs61756687), resulting in decreased AMCase activity.", {"entities": []}], ["Also, a SNP (rs41282492) and a 10-bp insertion in the 5\u2019UTR region of the AMCase gene (rs143789088) were studied, both resulting in increased AMCase activity.", {"entities": []}], ["DNA was isolated from blood and genotypes were determined using PCR-RFLP.", {"entities": []}], ["Histological staining proved the presence of chitin in the fungal grain.", {"entities": []}], ["The polymorphism resulting in decreased chitotriosidase activity was associated with increased odds of eumycetoma (odds ratio 2.9; p = 0.004).", {"entities": []}], ["No association was found for the polymorphisms in the genes for AMCase (all p>0.05).", {"entities": []}], ["Decreased chitotriosidase activity was associated with increased risk of M .", {"entities": []}], ["mycetomatis mycetoma.", {"entities": []}], ["Madurella mycetomatis mycetoma is a chronic fungal infection, resulting frequently in mutilating lesions.", {"entities": []}], ["The causative agents are found in soil, however, many people are exposed but most do not develop mycetoma.", {"entities": []}], ["Characteristic for mycetoma is that the fungus organizes itself in a grain once inside the body.", {"entities": []}], ["Here we showed that this grain contains chitin.", {"entities": []}], ["The immune system of the host will try to eliminate the grains by producing cytokines and enzymes, including the chitin-degrading chitinases.", {"entities": []}], ["We showed that both human chitinases AMCase and chitotriosidase bind to fungal chitin in the grain.", {"entities": []}], ["We also investigated 4 polymorphisms in the genes for these chitinases, and we found that a polymorphism in the gene for chitotriosidase, resulting in enzyme inactivity, was associated with increased risk for mycetoma.", {"entities": []}], ["Based on these findings, we hypothesized that chitotriosidase is important in the pathogen-eliminating immune response, resulting in clearance of the infection.", {"entities": []}], ["We assumed that absence of chitotriosidase results in increased AMCase production and thus in grain formation.", {"entities": []}], ["In this study we identified a risk factor for the development of M .", {"entities": []}], ["mycetomatis mycetoma, however the disease is multifactorial and other factors also play a role.", {"entities": []}], ["Surfactant proteins (SPs) are important lipoprotein complex components, expressed in alveolar epithelial cells type II (AEC-II), and playing an essential role in maintenance of alveolar integrity and host defence.", {"entities": []}], ["Because expressions of SPs are regulated by cyclic adenosine monophosphate (cAMP), we hypothesized that phosphodiesterase (PDE) inhibitors, influence SP expression and release.", {"entities": []}], ["Analysis of PDE activity of our AEC-II preparations revealed that PDE4 is the major cAMP hydrolysing PDE in human adult AEC-II.", {"entities": []}], ["Thus, freshly isolated human AEC-II were stimulated with two different concentrations of the PDE4 inhibitor roflumilast-N-oxide (3 nM and 1 \u00b5M) to investigate the effect on SP expression.", {"entities": []}], ["SP mRNA levels disclosed a large inter-individual variation.", {"entities": []}], ["Therefore, the experiments were grouped by the basal SP expression in low and high expressing donors.", {"entities": []}], ["AEC-II stimulated with Roflumilast-N-oxide showed a minor increase in SP-A1, SP-C and SP-D mRNA mainly in low expressing preparations.", {"entities": []}], ["To overcome the effects of different basal levels of intracellular cAMP, cyclooxygenase was blocked by indomethacin and cAMP production was reconstituted by prostaglandin E2 (PGE2).", {"entities": []}], ["Under these conditions SP-A1, SP-A2, SP-B and SP-D are increased by roflumilast-N-oxide in low expressing preparations.", {"entities": []}], ["Roflumilast-N-oxide fosters the expression of SPs in human AEC-II via increase of intracellular cAMP levels potentially contributing to improved alveolar host defence and enhanced resolution of inflammation.", {"entities": []}], ["Novel engineered nanoparticles (NPs), nanomaterial (NM) products and composites, are continually emerging worldwide.", {"entities": [[32, 35, "GENE"]]}], ["Many potential benefits are expected from their commercial applications; however, these benefits should always be balanced against risks.", {"entities": []}], ["Potential toxic effects of NM exposure have been highlighted, but, as there is a lack of understanding about potential interactions of nanomaterials (NMs) with biological systems, these side effects are often ignored.", {"entities": [[150, 153, "GENE"]]}], ["NPs are able to translocate to the bloodstream, cross body membrane barriers effectively, and affect organs and tissues at cellular and molecular levels.", {"entities": [[0, 3, "GENE"]]}], ["NPs may pass the blood\u2013brain barrier (BBB) and gain access to the brain.", {"entities": [[0, 3, "GENE"]]}], ["The interactions of NPs with biological milieu and resulted toxic effects are significantly associated with their small size distribution, large surface area to mass ratio (SA/MR), and surface characteristics.", {"entities": [[20, 23, "GENE"]]}], ["NMs are able to cross tissue and cell membranes, enter into cellular compartments, and cause cellular injury as well as toxicity.", {"entities": [[0, 3, "GENE"]]}], ["The extremely large SA/MR of NPs is also available to undergo reactions.", {"entities": [[29, 32, "GENE"]]}], ["An increased surface area of the identical chemical will increase surface reactivity, adsorption properties, and potential toxicity.", {"entities": []}], ["This review explores biological pathways of NPs, their toxic potential, and underlying mechanisms responsible for such toxic effects.", {"entities": [[44, 47, "GENE"]]}], ["The necessity of toxicological risk assessment to human health should be emphasised as an integral part of NM design and manufacture.", {"entities": []}], ["Influenza hospitalizations result in substantial morbidity and mortality each year.", {"entities": [[0, 9, "DISEASE"]]}], ["Little is known about the association between influenza hospitalization and census tract\u2010based socioeconomic determinants beyond the effect of individual factors.", {"entities": [[46, 55, "DISEASE"]]}], ["To evaluate whether census tract\u2010based determinants such as poverty and household crowding would contribute significantly to the risk of influenza hospitalization above and beyond individual\u2010level determinants.", {"entities": [[137, 146, "DISEASE"]]}], ["We analyzed 33\u00a0515 laboratory\u2010confirmed influenza\u2010associated hospitalizations that occurred during the 2009\u20102010 through 2013\u20102014 influenza seasons using a population\u2010based surveillance system at 14 sites across the United States.", {"entities": [[40, 49, "DISEASE"], [131, 140, "DISEASE"]]}], ["Using a multilevel regression model, we found that individual factors were associated with influenza hospitalization with the highest adjusted odds ratio ( AOR ) of 9.20 (95% CI 8.72\u20109.70) for those \u226565 vs 5\u201017\u00a0years old.", {"entities": [[91, 100, "DISEASE"]]}], ["African Americans had an AOR of 1.67 (95% CI 1.60\u20101.73) compared to Whites, and Hispanics had an AOR of 1.21 (95% CI 1.16\u20101.26) compared to non\u2010Hispanics.", {"entities": []}], ["Among census tract\u2010based determinants, those living in a tract with \u226520% vs <5% of persons living below poverty had an AOR of 1.31 (95% CI 1.16\u20101.47), those living in a tract with \u22655% vs <5% of persons living in crowded conditions had an AOR of 1.17 (95% CI 1.11\u20101.23), and those living in a tract with \u226540% vs <5% female heads of household had an AOR of 1.32 (95% CI 1.25\u20101.40).", {"entities": []}], ["Census tract\u2010based determinants account for 11% of the variability in influenza hospitalization.", {"entities": [[70, 79, "DISEASE"]]}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the upper airways frequently associated with asthma.", {"entities": [[132, 138, "DISEASE"]]}], ["Bacterial infection is a feature of CRSwNP that can aggravate the disease and the response to glucocorticoid treatment.", {"entities": []}], ["We examined whether the bacterial product lipopolysaccharide (LPS) reduces glucocorticoid receptor (GR) function in control nasal mucosa (NM) fibroblasts and in nasal polyp (NP) fibroblasts from patients with CRSwNP and asthma.", {"entities": [[220, 226, "DISEASE"]]}], ["NP (n = 12) and NM fibroblasts (n = 10) were in vitro pre-incubated with LPS (24 hours) prior to the addition of dexamethasone.", {"entities": []}], ["Cytokine/chemokine secretion was measured by ELISA and Cytometric Bead Array.", {"entities": []}], ["GR\u03b1, GR\u03b2, mitogen-activated protein-kinase phosphatase-1 (MKP-1) and glucocorticoid-induced leucine zipper (GILZ) expression was measured by RT-PCR and immunoblotting, GR\u03b1 nuclear translocation by immunocytochemistry, and GR\u03b2 localization by immunoblotting.", {"entities": []}], ["The role of MKP-1 and GILZ on dexamethasone-mediated cytokine inhibition was analyzed by small interfering RNA silencing.", {"entities": []}], ["Pre-incubation of nasal fibroblasts with LPS enhanced the secretion of IL-6, CXCL8, RANTES, and GM-CSF induced by FBS.", {"entities": []}], ["FBS-induced CXCL8 secretion was higher in NP than in NM fibroblasts.", {"entities": []}], ["LPS effects on IL-6 and CXCL8 were mediated via activation of p38\u03b1/\u03b2 MAPK and IKK/NF-\u03baB pathways.", {"entities": []}], ["Additionally, LPS pre-incubation: 1) reduced dexamethasone\u2019s capacity to inhibit FBS-induced IL-6, CXCL8 and RANTES, 2) reduced dexamethasone-induced GR\u03b1 nuclear translocation (only in NM fibroblasts), 3) did not alter GR\u03b1/GR\u03b2 expression, 4) decreased GILZ expression, and 5) did not affect dexamethasone\u2019s capacity to induce MKP-1 and GILZ expression.", {"entities": []}], ["MKP-1 knockdown reduced dexamethasone\u2019s capacity to suppress FBS-induced CXCL8 release.", {"entities": []}], ["The bacterial product LPS negatively affects GR function in control NM and NP fibroblasts by interfering with the capacity of the activated receptor to inhibit the production of pro-inflammatory mediators.", {"entities": []}], ["This study contributes to the understanding of how bacterial infection of the upper airways may limit the efficacy of glucocorticoid treatment.", {"entities": []}], ["Elderly patients with coronary artery disease (CAD) frequently complicated with more cardiovascular risk factors, but received fewer evidence-based medications (EBMs).", {"entities": []}], ["This study explored the association of EBMs compliance in different age groups and the risk of long-term death.", {"entities": []}], ["A retrospective analysis was conducted from a single registered database.", {"entities": []}], ["2830 consecutive patients with CAD were enrolled and grouped into 3 categories by age.", {"entities": []}], ["The primary end point was all-cause mortality and secondary endpoint is cardiovascular mortality.", {"entities": []}], ["The mean follow-up time was 30.25\u2009\u00b1\u200911.89\u00a0months and death occurred in 270 cases,including 150 cases of cardiac death.", {"entities": []}], ["Cumulative survival curves indicated that the incidence rates of all-cause death and cardiovascular death increased with age (older than 75\u00a0years old vs. 60 to 75\u00a0years old vs. younger than 60\u00a0years old, mortality: 18.7% vs. 9.6% vs. 4.1%, p \u2009<\u20090.001; cardiovascular mortality: 10.3% vs. 5.1% vs. 2.7%, p\u2009<\u20090.001).", {"entities": []}], ["The percentage of elderly patients using no EBMs was significantly higher than the percentages in the other age group (7.7% vs. 4.6% vs. 2.2%, p \u2009<\u20090.05).", {"entities": []}], ["Cox regression analysis revealed the benefit of combination EBMs (all-cause mortality: hazard ratio [HR] 0.15, 95% CI 0.08\u20130.27; cardiac mortality: HR 0.08, 95% CI 0.04\u20130.19) for older CAD patients.", {"entities": [[101, 103, "GENE"], [148, 150, "GENE"], [101, 103, "GENE"], [148, 150, "GENE"]]}], ["Similar trends were found about different kinds of EBMs in elderly patients.", {"entities": []}], ["Elderly patients with CAD had higher risk of death but a lower degree of compliance with EBMs usage.", {"entities": []}], ["Elderly CAD patients could receive more clinical benefits by using EBMs.", {"entities": []}], ["The online version of this article (10.1186/s12889-018-5049-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Adverse childhood experiences (ACE) have been previously linked to quality of life, health conditions, and life expectancy in adulthood.", {"entities": []}], ["Less is known about the potential mechanisms which mediate these associations.", {"entities": []}], ["This study examined how ACE influences adult health-related quality of life (HRQoL) in a low-income community in Florida.", {"entities": []}], ["A community-based participatory needs assessment was conducted from November 2013 to March 2014 with 201 residents of Tampa, Florida, USA.", {"entities": []}], ["HRQoL was measured by an\u00a0excessive number of\u00a0unhealthy days experienced during the previous 30-day\u00a0window.", {"entities": []}], ["Mediation analyses for dichotomous outcomes were conducted with logistic regression.", {"entities": []}], ["Bootstrapped confidence intervals were generated for both\u00a0total and specific indirect effects.", {"entities": []}], ["Most participants reported \u2018good to excellent health\u2019 (76\u00a0%) and about a fourth reported \u2018fair to poor health\u2019 (24\u00a0%).", {"entities": []}], ["The mean of total unhealthy days was 9\u00a0days per month (SD \u00b110.5).", {"entities": []}], ["Controlling for demographic and neighborhood covariates, excessive unhealthy days was associated with ACE (AOR\u2009=\u20091.23; 95\u00a0% CI: 1.06, 1.43), perceived stress (AOR\u2009=\u20091.07; 95\u00a0% CI: 1.03, 1.10), and sleep disturbance (AOR\u2009=\u20098.86; 3.61, 21.77).", {"entities": []}], ["Mediated effects were significant for stress (\u03b2\u2009=\u20090.08) and sleep disturbances (\u03b2\u2009=\u20090.11) as they related to\u00a0 the relationship between ACE and excessive unhealthy days.", {"entities": []}], ["ACE is linked to adult HRQoL.", {"entities": []}], ["Stress and sleep disturbances may represent later consequences of childhood adversity that modulate adult quality of life.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-015-0323-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Clonorchis sinensis ( C. sinensis, Cs ) is a trematode parasite that often causes chronic cumulative infections in the hepatobiliary ducts of the host and can lead to pathological changes by continuously released excretory/secretory proteins (ESPs).", {"entities": [[35, 37, "GENE"]]}], ["A T2 ribonuclease in trematode ESPs, has been identified as a potent regulator of dendritic cell (DCs) modulation.", {"entities": []}], ["We wondered whether there was a counterpart present in Cs ESPs with similar activity.", {"entities": [[55, 57, "GENE"]]}], ["To gain a better understanding of Cs ESPs associated immune responses, we identified and characterized RNASET2 of C. sinensis ( Cs RNASET2) in this paper.", {"entities": [[34, 36, "GENE"], [128, 130, "GENE"], [103, 110, "GENE"], [131, 138, "GENE"], [34, 36, "GENE"], [128, 130, "GENE"], [103, 110, "GENE"], [131, 138, "GENE"]]}], ["We expressed Cs RNASET2 in Pichia pastoris and identified its molecular characteristics using bioinformatic analysis and experimental approaches.", {"entities": [[13, 15, "GENE"], [16, 23, "GENE"]]}], ["The immune modulation activities of Cs RNASET2 were confirmed by evaluating cytokine production and surface markers of recombinant Cs RNASET2 (r Cs RNASET2) co-cultured DCs, and monitoring levels of IgG isotypes from r Cs RNASET2 administered BALB/c mice.", {"entities": [[36, 38, "GENE"], [131, 133, "GENE"], [145, 147, "GENE"], [219, 221, "GENE"], [39, 46, "GENE"], [134, 141, "GENE"], [148, 155, "GENE"], [222, 229, "GENE"], [36, 38, "GENE"], [131, 133, "GENE"], [145, 147, "GENE"], [219, 221, "GENE"], [39, 46, "GENE"], [134, 141, "GENE"], [148, 155, "GENE"], [222, 229, "GENE"], [36, 38, "GENE"], [131, 133, "GENE"], [145, 147, "GENE"], [219, 221, "GENE"], [39, 46, "GENE"], [134, 141, "GENE"], [148, 155, "GENE"], [222, 229, "GENE"], [36, 38, "GENE"], [131, 133, "GENE"], [145, 147, "GENE"], [219, 221, "GENE"], [39, 46, "GENE"], [134, 141, "GENE"], [148, 155, "GENE"], [222, 229, "GENE"]]}], ["Cs RNASET2 appeared to be a glycoprotein of T2 ribonuclease family harboring conserved CAS motifs and rich in B-cell epitopes .", {"entities": [[0, 2, "GENE"], [3, 10, "GENE"]]}], ["Furthermore, Cs RNASET2 was present in Cs ESPs and was able to modulate cytokine production of DCs.", {"entities": [[13, 15, "GENE"], [39, 41, "GENE"], [16, 23, "GENE"], [13, 15, "GENE"], [39, 41, "GENE"]]}], ["In addition, r Cs RNASET2 could significantly suppress the expression of lipopolysaccharide-induced DCs maturation markers.", {"entities": [[15, 17, "GENE"], [18, 25, "GENE"]]}], ["In addition, when subcutaneously administered with r Cs RNASET2 there was a marked effect on IgG isotypes in mouse sera.", {"entities": [[53, 55, "GENE"], [56, 63, "GENE"]]}], ["Collectively, we revealed that Cs RNASET2, a T2 ribonuclease present in Cs ESPs, could modulate DCs maturation and might play an important role in C. sinensis associated immune regulation in the host.", {"entities": [[31, 33, "GENE"], [72, 74, "GENE"], [34, 41, "GENE"], [31, 33, "GENE"], [72, 74, "GENE"]]}], ["Evidence of the adverse health effects attributable to second-hand smoke (SHS) exposure is available.", {"entities": []}], ["This study aims to quantify the impact of SHS exposure on ischaemic heart diseases (IHD), chronic obstructive pulmonary diseases (COPD), and stroke in Germany.", {"entities": []}], ["Therefore, this study estimated and forecasted the morbidity for the three outcomes in the German population.", {"entities": []}], ["Furthermore, a health impact assessment was performed using DYNAMO-HIA, which is a generic software tool applying a Markov model.", {"entities": []}], ["Overall 687,254 IHD cases, 231,973 COPD cases, and 288,015 stroke cases were estimated to be attributable to SHS exposure in Germany for 2014.", {"entities": []}], ["Under the assumption that the population prevalence of these diseases and the prevalence of SHS exposure remain constant, the total number of cases will increase due to demographic aging.", {"entities": []}], ["Assuming a total eradication of SHS exposure beginning in 2014 leads to an estimated reduction of 50% in cases, compared to the reference scenario in 2040 for all three diseases.", {"entities": []}], ["The results highlight the relevance of SHS exposure because it affects several chronic disease conditions and has a major impact on the population\u2019s health.", {"entities": []}], ["Therefore, public health campaigns to protect non-smokers are urgently needed.", {"entities": []}], ["Non-specific lipid transfer proteins (LTPs) are a family of lipid-binding molecules that are widely distributed across flowering plant species, many of which have been identified as allergens.", {"entities": []}], ["They are highly resistant to simulated gastroduodenal proteolysis, a property that may play a role in determining their allergenicity and it has been suggested that lipid binding may further increase stability to proteolysis.", {"entities": []}], ["It is demonstrated that LTPs from wheat and peach bind a range of lipids in a variety of conditions, including those found in the gastroduodenal tract.", {"entities": []}], ["Both LTPs are initially cleaved during gastroduodenal proteolysis at three major sites between residues 39\u201340, 56\u201357 and 79\u201380, with wheat LTP being more resistant to cleavage than its peach ortholog.", {"entities": []}], ["The susceptibility of wheat LTP to proteolyic cleavage increases significantly upon lipid binding.", {"entities": []}], ["This enhanced digestibility is likely to be due to the displacement of Tyr79 and surrounding residues from the internal hydrophobic cavity upon ligand binding to the solvent exposed exterior of the LTP, facilitating proteolysis.", {"entities": []}], ["Such knowledge contributes to our understanding as to how resistance to digestion can be used in allergenicity risk assessment of novel food proteins, including GMOs.", {"entities": []}], ["Chronic spontaneous urticaria (CSU) is considered in a subset of patients to be an autoimmune disorder.", {"entities": [[20, 29, "DISEASE"]]}], ["Interleukin(IL)-17, IL-31, and IL-33 are involved in some immune response.", {"entities": []}], ["The aim of this study was to quantify plasma IL-17, IL-31, and IL-33 levels in CSU patients and to examine their relationships with disease severity.", {"entities": []}], ["Plasma IL-17, IL-31, and IL-33 concentration were measured in 51 CSU patients and 20 healthy subjects (HCs).", {"entities": []}], ["Plasma IL-17 ( P \u2009<\u20090.001), IL-31 ( P \u2009<\u20090.001), and IL-33 ( P \u2009<\u20090.001) concentrations were significantly higher in CSU patients when compared with those of HCs.", {"entities": []}], ["Concerning UAS7, severe group of CSU patients had significantly higher IL-17 levels than the moderate and mild groups ( P \u2009=\u20090.028 and 0.007, respectively), and significantly higher IL-33 concentrations than the mild group ( P \u2009=\u20090.026).", {"entities": []}], ["Regarding only pruritus, severe group of patients had significantly higher IL-31 levels than the mild group ( P \u2009=\u20090.003).", {"entities": []}], ["The IL-33 levels in the total IgE positive group were significantly higher than that of negative group ( P \u2009=\u20090.010).", {"entities": []}], ["Our results showed higher plasma levels of IL-17, IL-31, and IL-33 among CSU patients which may highlight a functional role of these cytokines in the pathogenesis of CSU.", {"entities": []}], ["Gene expression analyses are used to investigate signaling pathways involved in diseases.", {"entities": []}], ["In asthma, they have been primarily derived from the analysis of bronchial biopsies harvested from mild to moderate asthmatic subjects and controls.", {"entities": [[3, 9, "DISEASE"]]}], ["Due to ethical considerations, there is currently limited information on the transcriptome profile of the peripheral lung tissues in asthma.", {"entities": [[133, 139, "DISEASE"]]}], ["To identify genes contributing to chronic inflammation and remodeling in the peripheral lung tissue of horses with heaves, a naturally occurring asthma-like condition.", {"entities": [[145, 151, "DISEASE"]]}], ["Eleven adult horses (6 heaves-affected and 5 controls) were studied while horses with heaves were in clinical remission (Pasture), and during disease exacerbation induced by a 30-day natural antigen challenge during stabling (Challenge).", {"entities": []}], ["Large peripheral lung biopsies were obtained by thoracoscopy at both time points.", {"entities": []}], ["Using suppression subtractive hybridization (SSH), lung cDNAs of controls (Pasture and Challenge) and asymptomatic heaves-affected horses (Pasture) were subtracted from cDNAs of horses with heaves in clinical exacerbation (Challenge).", {"entities": []}], ["The differential expression of selected genes of interest was confirmed using quantitative PCR assay.", {"entities": []}], ["Horses with heaves, but not controls, developed airway obstruction when challenged.", {"entities": []}], ["Nine hundred and fifty cDNA clones isolated from the subtracted library were screened by dot blot array and 224 of those showing the most marked expression differences were sequenced.", {"entities": []}], ["The gene expression pattern was confirmed by quantitative PCR in 15 of 22 selected genes.", {"entities": []}], ["Novel genes and genes with an already defined function in asthma were identified in the subtracted cDNA library.", {"entities": [[58, 64, "DISEASE"]]}], ["Genes of particular interest associated with asthmatic airway inflammation and remodeling included those related to PPP3CB/NFAT, RhoA, and LTB4/GPR44 signaling pathways.", {"entities": [[129, 133, "GENE"]]}], ["Pathways representing new possible targets for anti-inflammatory and anti-remodeling therapies for asthma were identified.", {"entities": [[99, 105, "DISEASE"]]}], ["The findings of genes previously associated with asthma validate this equine model for gene expression studies.", {"entities": [[49, 55, "DISEASE"]]}], ["The ability of phagocytes to clear pathogens is an essential attribute of the innate immune response.", {"entities": []}], ["The role of signaling lipid molecules such as phosphoinositides is well established, but the role of membrane sphingolipids in phagocytosis is largely unknown.", {"entities": []}], ["Using a genetic approach and small molecule inhibitors, we show that phagocytosis of Candida albicans requires an intact sphingolipid biosynthetic pathway.", {"entities": []}], ["Blockade of serine-palmitoyltransferase (SPT) and ceramide synthase-enzymes involved in sphingolipid biosynthesis- by myriocin and fumonisin B1, respectively, impaired phagocytosis by phagocytes.", {"entities": []}], ["We used CRISPR/Cas9-mediated genome editing to generate Sptlc2-deficient DC2.4 dendritic cells, which lack serine palmitoyl transferase activity.", {"entities": []}], ["Supplementing the growth media with GM1, the major ganglioside present at the cell surface, restored phagocytic activity of Sptlc2 in vitro data, compromised sphingolipid biosynthesis in mice sensitizes the animal to C .", {"entities": [[124, 130, "GENE"]]}], ["albicans infection.", {"entities": []}], ["Sphingolipid biosynthesis is therefore critical for phagocytosis and in vivo clearance of C .", {"entities": []}], ["The fungus Candida albicans is not only a commensal of the digestive system, but also a common cause of human opportunistic infections.", {"entities": []}], ["Macrophages and dendritic cells can eliminate C .", {"entities": []}], ["albicans by phagocytosis, a complex process that involves extensive membrane reorganization at the cell surface.", {"entities": []}], ["The extent to which membrane lipids, including sphingolipids, contribute to the proper execution of phagocytosis remains largely unknown.", {"entities": []}], ["Pharmacological blockade of sphingolipid biosynthesis by the small molecule inhibitors myriocin and fumonisin B1 impairs phagocytosis of C .", {"entities": []}], ["DC2.4 dendritic cells genetically deficient in Sptlc2, the enzyme that catalyzes the first and rate-limiting step in the sphingolipid biosynthetic pathway, are likewise defective in phagocytosis of C .", {"entities": [[47, 53, "GENE"]]}], ["albicans , but overall membrane transport and protein secretion remained functional.", {"entities": []}], ["Sptlc2-deficient cells express reduced levels of the receptors Dectin-1 and TLR2 at the cell surface, and are unable to form a normal phagocytic cup.", {"entities": [[76, 80, "GENE"]]}], ["Exogenous addition of the major ganglioside GM1 restored phagocytic ability of Sptlc2 in vivo treatment with fumonisin B1 fail to eradicate C .", {"entities": [[79, 85, "GENE"]]}], ["albicans , consistent with the in vitro results.", {"entities": []}], ["Sphingolipids are thus essential for clearance of fungal infection through phagocytosis, and hence indispensable for the proper functioning of the innate immune system.", {"entities": []}], ["Newly discovered cell penetration peptides derived from human eosinophil cationic proteins (CPPecp) have the characteristic of cell internalization, but the effect of CPPecp on immunomodulation has not been clarified.", {"entities": []}], ["House dust mite (HDM) major allergen, Der p 2, can induce proinflammatory cytokine production which contributes to airway inflammation and allergic asthma.", {"entities": [[139, 154, "DISEASE"], [148, 154, "DISEASE"]]}], ["However, the mechanism of Der p 2 on NLRP3 inflammasome activation remains unclear.", {"entities": [[37, 42, "GENE"]]}], ["The aim of this study was to investigate the immunomodulatory effect of CPPecp on inhibition of Der p 2 induced inflammasome activation.", {"entities": []}], ["We showed that proinflammatory cytokines IL-1\u03b2, IL-6 and IL-8 were significantly upregulated in peripheral blood mononuclear cells (PBMCs) derived from HDM allergic patients after Der p 2 stimulation.", {"entities": []}], ["Expression of NLRP3, ASC, Caspase-1, IL-1\u03b2 and Caspase-1 activity was upregulated in THP-1 cells after Der p 2 stimulation.", {"entities": [[14, 19, "GENE"]]}], ["Proinflammatory cytokine production, NLRP3 inflammasome activation and caspase-1 activity were downregulated in THP-1 cells and CD14+ cells co-cultured with Der p 2 and CPPecp.", {"entities": [[37, 42, "GENE"]]}], ["The immunomodulatory effect of CPPecp was through upregulation of IFN-\u03b1 production but not induction of autophagy.", {"entities": []}], ["These results suggested Der p 2 plays an important role in NLRP3 inflammasome activation and CPPecp has the potential to be a novel anti-inflammatory agent for allergic inflammation treatment in the future.", {"entities": [[59, 64, "GENE"]]}], ["The use of extracorporeal membrane oxygenation is a new approach to rewarming patients with severe hypothermia and hemodynamic instability.", {"entities": []}], ["There are, however, many questions regarding qualification for this technique in case of suspected or confirmed trauma.", {"entities": []}], ["A male with confirmed accidental hypothermia (25\u00b0C) and after successful cardiopulmonary resuscitation from in-hospital cardiac arrest was subjected to a protocol of extracorporeal rewarming from profound hypothermia.", {"entities": []}], ["Because of unclear history, a full trauma computed tomography was performed that showed pericerebral hematoma and signs of previously undergone right craniotomy, multiple right-sided rib fractures and the presence of intraperitoneal fluid.", {"entities": []}], ["Based on repeated imaging and specialist consultation, no life-threatening injuries were identified and rewarming with extracorporeal membrane oxygenation was safely performed.", {"entities": []}], ["In a year follow-up, the patient was found to be alive, with no neurologic deficits.", {"entities": []}], ["Although this case highlights the first successful utilization of extracorporeal rewarming in a trauma patient at our center there are several limitations to its widespread use", {"entities": []}], ["Introduction : Asthma is a multifactorial disease and a serious public health problem.", {"entities": [[15, 21, "DISEASE"]]}], ["Environmental factors and poverty are the main determinants of this disease.", {"entities": []}], ["Objective : To describe the spatial and temporal distribution of asthma-related hospitalizations and identify the areas with the highest prevalence of and vulnerability to severe asthma in a major Brazilian city.", {"entities": [[65, 71, "DISEASE"], [179, 185, "DISEASE"]]}], ["Methods : An ecological study of hospitalizations for asthma from 2002 to 2012, in children and adolescents under 15 years of age, living in Belo Horizonte, Southeast Brazil.", {"entities": [[54, 60, "DISEASE"]]}], ["All events were geocoded by residence address using Hospital Information System data.", {"entities": []}], ["The socioeconomic vulnerability of residence address was ranked using the Health Vulnerability Index.", {"entities": []}], ["Raster surfaces were generated and time-series plots were constructed to determine spatial and time trends in the frequency of asthma-related hospitalizations, respectively.", {"entities": [[127, 133, "DISEASE"]]}], ["Results : Asthma-related hospitalization rates were highest in children aged 0\u20134 years and in boys.", {"entities": [[10, 16, "DISEASE"]]}], ["There was a decreasing trend in the number of asthma-related hospitalizations across the study period.", {"entities": [[46, 52, "DISEASE"]]}], ["Approximately 48% of all hospitalizations were children living in health vulnerable areas.", {"entities": []}], ["Seasonal trends showed a hospitalization peak in March, April, and May, coinciding with the post-rainy period.", {"entities": []}], ["Conclusion : Our findings suggest that social and environmental factors may be determinants of disparities in severe asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["Interactions between two or more toxic agents can produce lung damage by chemical-chemical interactions, chemical-receptor interactions or by modification, by a first agent, of the cell and tissue response to a second agent.", {"entities": []}], ["Interactions may occur by simultaneous exposure and if exposure to the two agents is separated in time.", {"entities": []}], ["Chemical-chemical interactions have been mostly studied in the toxicology of air pollutants, where it was shown that the untoward effect of certain oxidants may be enhanced in the presence of other aerosols.", {"entities": []}], ["Interactions at the receptor site have been found in isolated perfused lung experiments.", {"entities": []}], ["Oxygen tolerance may be an example, when pre-exposure to one concentration of oxygen mitigates later exposure to 100% oxygen by modifying cellular and enzymatic composition of the lung.", {"entities": []}], ["Damage of the alveolar zone by the antioxidant butylated hydroxytoluene (BHT) can be greatly enhanced by subsequent exposure to oxygen concentration which, otherwise, would have little if any demonstrable effect.", {"entities": []}], ["The synergistic interaction between BHT and oxygen results in a resulting interstitial pulmonary fibrosis.", {"entities": [[87, 105, "DISEASE"]]}], ["Acute or chronic lung disease may then be caused not only by one agent, but very likely in many instances by the interaction of several agents.", {"entities": [[17, 29, "DISEASE"]]}], ["Neutrophil gelatinase\u2013associated lipocalin (NGAL) is a protein that is used in human medicine as a real\u2010time indicator of acute kidney injury (AKI).", {"entities": []}], ["Dogs with AKI have significantly higher plasma NGAL concentration and urine NGAL\u2010to\u2010creatinine ratio (UNCR) compared with healthy dogs and dogs with chronic kidney disease (CKD).", {"entities": [[157, 171, "DISEASE"]]}], ["18 healthy control dogs, 17 dogs with CKD, and 48 dogs with AKI.", {"entities": []}], ["Over a period of 1 year, all dogs with renal azotemia were prospectively included.", {"entities": []}], ["Urine and plasma samples were collected during the first 24 hours after presentation or after development of renal azotemia.", {"entities": []}], ["Plasma and urine NGAL concentrations were measured with a commercially available canine NGAL Elisa Kit (Bioporto\u00ae Diagnostic) and UNCR was calculated.", {"entities": []}], ["A single\u2010injection plasma inulin clearance was performed in the healthy dogs.", {"entities": []}], ["Median (range) NGAL plasma concentration in healthy dogs, dogs with CKD, and AKI were 10.7 ng/mL (2.5\u201321.2), 22.0 ng/mL (7.7\u201362.3), and 48.3 ng/mL (5.7\u2013469.0), respectively.", {"entities": []}], ["UNCR was 2\u00a0\u00d7\u00a010 P \u00a0<\u00a0.0001 for both).", {"entities": []}], ["Plasma NGAL concentration was significantly higher in dogs with AKI compared with dogs with CKD ( P \u00a0=\u00a0.027).", {"entities": []}], ["Plasma NGAL could be helpful to differentiate AKI from CKD in dogs with renal azotemia.", {"entities": []}], ["It has been reported that there is a difference in drug prescription between males and females.", {"entities": []}], ["Even after adjustment for multi-morbidity, females tend to use more prescription drugs compared to males.", {"entities": []}], ["In this study, we wanted to analyse whether the gender difference in drug treatment could be explained by gender-related morbidity.", {"entities": []}], ["Data was collected on all individuals 20\u00a0years and older in the county of \u00d6sterg\u00f6tland in Sweden.", {"entities": []}], ["The Johns Hopkins ACG Case-Mix System was used to calculate individual level of multi-morbidity.", {"entities": []}], ["A report from the Swedish National Institute of Public Health using the WHO term DALY was the basis for gender-related morbidity.", {"entities": []}], ["Prescription drugs used to treat diseases that mainly affect females were excluded from the analyses.", {"entities": []}], ["The odds of having prescription drugs for males, compared to females, increased from 0.45 (95% confidence interval (CI) 0.44-0.46) to 0.82 (95% CI 0.81-0.83) after exclusion of prescription drugs that are used to treat diseases that mainly affect females.", {"entities": []}], ["Gender-related morbidity and the use of anti-conception drugs may explain a large part of the difference in prescription drug use between males and females but still there remains a difference between the genders at 18%.", {"entities": []}], ["This implicates that it is of importance to take the gender-related morbidity into consideration, and to exclude anti-conception drugs, when performing studies regarding difference in drug use between the genders.", {"entities": []}], ["To evaluate outcomes of the Clinical Chronic obstructive pulmonary disease (COPD) Questionnaire (CCQ) in patients with advanced COPD admitted for a post-acute pulmonary rehabilitation (PR) programme and to relate (change in) health status to lung function, degree of dyspnoea and (change in) functional capacity.", {"entities": []}], ["This is a prospective observational study in patients with advanced COPD admitted for a post-acute PR programme in a skilled nursing facility.", {"entities": []}], ["Health status (CCQ) and functional capacity were measured before and after rehabilitation.", {"entities": []}], ["Health status measured by the CCQ was severely impaired and showed significant and clinically relevant improvement during the post-acute PR programme.", {"entities": []}], ["Moderate to strong correlations were found between CCQ scores and functional capacity on admission and at discharge.", {"entities": []}], ["Moderate correlations were found between improvement in CCQ scores and improvement in functional capacity.", {"entities": []}], ["No correlation was found between CCQ scores and lung function (forced expiratory volume in 1\u2009s % predicted).", {"entities": []}], ["Health status measured by the CCQ improves following a post-acute PR programme in patients with advanced COPD and correlates with improvement in functional capacity.", {"entities": []}], ["These results suggest that the CCQ is sensitive to change in response to PR in this specific group of patients.", {"entities": []}], ["This paper presents the first quantitative ethnobotanical study of the flora in Toli Peer National Park of Azad Jammu and Kashmir, Pakistan.", {"entities": []}], ["Being a remote area, there is a strong dependence by local people on ethnobotanical practices.", {"entities": []}], ["Thus, we attempted to record the folk uses of the native plants of the area with a view to acknowledging and documenting the ethnobotanical knowledge.", {"entities": []}], ["The aims of the study were to compile an inventory of the medicinal plants in the study area and to record the methods by which herbal drugs were prepared and administered.", {"entities": []}], ["Information on the therapeutic properties of medicinal plants was collected from 64 local inhabitants and herbalists using open ended and semi-structured questionnaires over the period Aug 2013-Jul 2014.", {"entities": []}], ["The data were recorded into a synoptic table comprising an ethnobotanical inventory of plants, the parts used, therapeutic indications and modes of application or administration.", {"entities": []}], ["Different ethnobotanical indices i.e.", {"entities": []}], ["relative frequencies of citation (RFC), relative importance (RI), use value (UV) and informant consensus factor (Fic), were calculated for each of the recorded medicinal plants.", {"entities": []}], ["In addition, a correlation analysis was performed using SPSS ver.", {"entities": []}], ["16 to check the level of association between use value and relative frequency of citation.", {"entities": []}], ["A total of 121 species of medicinal plants belonging to 57 families and 98 genera were recorded.", {"entities": []}], ["The study area was dominated by herbaceous species (48%) with leaves (41%) as the most exploited plant part.", {"entities": []}], ["The Lamiaceae and Rosaceae (9% each) were the dominant families in the study area.", {"entities": []}], ["Among different methods of preparation, the most frequently used method was decoction (26 species) of different plant parts followed by use as juice and powder (24 species each), paste (22 species), chewing (16 species), extract (11 species), infusion (10 species) and poultice (8 species).", {"entities": []}], ["The maximum Informant consensus factor (Fic) value was for gastro-intestinal, parasitic and hepatobiliary complaints (0.90).", {"entities": []}], ["Berberis lycium Ajuga bracteosa , Prunella vulgaris , Adiantum capillus-veneris , Desmodium polycarpum , Pinus roxburgii , Albizia lebbeck , Cedrella serrata , Rosa brunonii , Punica granatum , Jasminum mesnyi and Zanthoxylum armatum were the most valuable plants with the highest UV, RFC and relative importance values.", {"entities": []}], ["The Pearson correlation coefficient between UV and RFC (0.881) reflects a significant positive correlation between the use value and relative frequency of citation.", {"entities": []}], ["The coefficient of determination indicated that 77% of the variability in UV could be explained in terms of RFC.", {"entities": []}], ["Systematic documentation of the medicinal plants in the Toli Peer National Park shows that the area is rich in plants with ethnomedicinal value and that the inhabitants of the area have significant knowledge about the use of such plants with herbal drugs commonly used to cure infirmities.", {"entities": []}], ["The results of this study indicate that carrying out subsequent pharmacological and phytochemical investigations in this part of Pakistan could lead to new drug discoveries.", {"entities": []}], ["Testing for marginal associations between numerous genetic variants and disease may miss complex relationships among variables (e.g., gene-gene interactions).", {"entities": []}], ["Bayesian approaches can model multiple variables together and offer advantages over conventional model building strategies, including using existing biological evidence as modeling priors and acknowledging that many models may fit the data well.", {"entities": []}], ["With many candidate variables, Bayesian approaches to variable selection rely on algorithms to approximate the posterior distribution of models, such as Markov-Chain Monte Carlo (MCMC).", {"entities": []}], ["Unfortunately, MCMC is difficult to parallelize and requires many iterations to adequately sample the posterior.", {"entities": []}], ["We introduce a scalable algorithm called PEAK that improves the efficiency of MCMC by dividing a large set of variables into related groups using a rooted graph that resembles a mountain peak.", {"entities": []}], ["Our algorithm takes advantage of parallel computing and existing biological databases when available.", {"entities": []}], ["By using graphs to manage a model space with more than 500,000 candidate variables, we were able to improve MCMC efficiency and uncover the true simulated causal variables, including a gene-gene interaction.", {"entities": []}], ["We applied PEAK to a case-control study of childhood asthma with 2,521 genetic variants.", {"entities": [[53, 59, "DISEASE"]]}], ["We used an informative graph for oxidative stress derived from Gene Ontology and identified several variants in ERBB4 , OXR1 , and BCL2 with strong evidence for associations with childhood asthma.", {"entities": [[189, 195, "DISEASE"], [112, 117, "GENE"], [120, 124, "GENE"], [131, 135, "GENE"]]}], ["We introduced an extremely flexible analysis framework capable of efficiently performing Bayesian variable selection on many candidate variables.", {"entities": []}], ["The PEAK algorithm can be provided with an informative graph, which can be advantageous when considering gene-gene interactions, or a symmetric graph, which simply divides the model space into manageable regions.", {"entities": []}], ["The PEAK framework is compatible with various model forms, allowing for the algorithm to be configured for different study designs and applications, such as pathway or rare-variant analyses, by simple modifications to the model likelihood and proposal functions.", {"entities": []}], ["Background: Easyhaler in vitro-in vivo correlation (IVIVC) modeling.", {"entities": []}], ["Methods: Four PK studies were performed to compare the lung deposition and total systemic exposure of budesonide and formoterol after administration of budesonide/formoterol Easyhaler and the reference product, Symbicort Turbuhaler.", {"entities": []}], ["The products were administered concomitantly with oral charcoal (lung deposition) and in two of the studies also without charcoal (total systemic exposure).", {"entities": []}], ["Demonstration of BE for lung deposition (surrogate marker for efficacy) and non-inferiority for systemic exposure (surrogate marker for safety) were considered a proof of therapeutic equivalence.", {"entities": []}], ["In addition, IVIVC models were constructed to predict study outcomes with different reference product fine particle doses (FPDs).", {"entities": []}], ["Results: In the first pivotal study, the exposure and lung dose via Easyhaler were higher compared to the reference product (mean comparison estimates between 1.07 and 1.28) as the FPDs of the reference product batch were low.", {"entities": []}], ["In the following studies, reference product batches with higher FPDs were utilized.", {"entities": []}], ["In the second pivotal study, non-inferiority of Easyhaler compared to Turbuhaler was shown in safety and BE in efficacy for all other parameters except the formoterol AUC t .", {"entities": []}], ["In the fourth study where two reference batches were compared to each other and Easyhaler, budesonide/formoterol Easyhaler was bioequivalent with one reference batch but not with the other having the highest FPDs amongst the 28 reference batches studied.", {"entities": []}], ["In the IVIVC based study outcome predictions, the test product was bioequivalent with great proportion of the reference batches.", {"entities": []}], ["For the test product and the median FPD reference product BE was predicted.", {"entities": []}], ["Conclusions: Equivalence regarding both safety and efficacy between budesonide/formoterol Easyhaler and Symbicort Turbuhaler was shown based on totality of evidence from the PK studies and IVIVC analyses, and therefore, therapeutic equivalence between the products can be concluded.", {"entities": []}], ["The results of the PK studies are likely dependent on the variability of FPDs of the reference product batches.", {"entities": []}], ["Multi-morbidity is common in patients with chronic obstructive pulmonary disease and low levels of physical activity are hypothesized to be an important risk factor.", {"entities": [[43, 80, "DISEASE"]]}], ["The current study aimed to assess the longitudinal association between physical activity and risk of seven categories of comorbidity in chronic obstructive pulmonary disease patients.", {"entities": [[136, 173, "DISEASE"]]}], ["The study included 409 patients from primary care practice in the Netherlands and Switzerland.", {"entities": []}], ["We assessed physical activity using the Longitudinal Ageing Study Amsterdam Physical Activity Questionnaire at baseline and followed patients for up to 5 years.", {"entities": []}], ["During follow-up, patients reported their comorbidities (cardiovascular, neurological, endocrine, musculoskeletal, malignant, and infectious diseases) and completed the Hospital Anxiety and Depression Scale questionnaire for mental health assessment.", {"entities": []}], ["We implemented multinomial logistic regression (an approximation to discrete time survival model using death as a competing risk) for our analysis.", {"entities": []}], ["Study results did not suggest a statistically significant association of baseline physical activity with the development of seven categories of comorbidity.", {"entities": []}], ["However, when we focused on depression and anxiety symptoms, we found that higher levels of physical activity at baseline were associated with a lower risk for depression (adjusted hazard ratio, 0.85; 0.75\u20130.95; p \u2009=\u20090.005) and anxiety (adjusted hazard ratio, 0.89; 0.79\u20131.00; p \u2009=\u20090.045).", {"entities": []}], ["In chronic obstructive pulmonary disease patients, those with high physical activity are less likely to develop depression or anxiety symptoms over time.", {"entities": [[3, 40, "DISEASE"]]}], ["Increasing physical activity in chronic obstructive pulmonary disease patients may be an approach for testing to lower the burden from incident depression and anxiety.", {"entities": [[32, 69, "DISEASE"]]}], ["Patients with chronic lung disease who stay physically active could reduce their chances of depression and anxiety.", {"entities": [[22, 34, "DISEASE"]]}], ["Milo Puhan at the University of Zurich, Switzerland, and co-workers assessed the association between physical activity and the risk of developing various co-existing diseases in 409 patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[196, 233, "DISEASE"]]}], ["Co-morbidities such as cardiovascular diseases, diabetes and depression are prevalent in patients with COPD, but the reasons why are not clear.", {"entities": []}], ["Puhan\u2019s team assessed patients\u2019 activity levels using an existing questionnaire, and administered another questionnaire to assess mental health.", {"entities": []}], ["They followed the cohort for 5 years.", {"entities": []}], ["Results indicated weak associations between physical activity levels and most physical illnesses, but there were significant links between higher levels of physical activity and a reduced risk of depression and anxiety.", {"entities": []}], ["The results could inform novel COPD treatment programs.", {"entities": []}], ["Family health history reflects the effects of genetic, environmental, and behavioral factors and is an important risk factor for a variety of disorders including coronary heart disease, cancer, and diabetes.", {"entities": [[171, 184, "DISEASE"], [162, 184, "DISEASE"], [186, 192, "DISEASE"]]}], ["In 2004, the Centers for Disease Control and Prevention developed Family Healthware, a new interactive, Web-based tool that assesses familial risk for 6 diseases (coronary heart disease, stroke, diabetes, and colorectal, breast, and ovarian cancer) and provides a \"prevention plan\" with personalized recommendations for\u00a0lifestyle changes and\u00a0screening.", {"entities": [[172, 185, "DISEASE"], [163, 185, "DISEASE"], [233, 247, "DISEASE"], [241, 247, "DISEASE"]]}], ["The tool collects data on health behaviors, screening tests, and disease history of a person's first- and second-degree relatives.", {"entities": []}], ["Algorithms in the software analyze the family history data and assess familial risk based on the number of relatives affected, their age at disease onset, their sex, how closely related the relatives are to each other and to the user, and the combinations of diseases in the family.", {"entities": []}], ["A second set of algorithms uses the data on familial risk level, health behaviors, and screening to generate personalized prevention messages.", {"entities": []}], ["Qualitative and quantitative formative research on lay understanding of family history and genetics helped shape the tool's content, labels, and messages.", {"entities": []}], ["Lab-based usability testing helped refine messages and tool navigation.", {"entities": []}], ["The tool is being evaluated by 3 academic centers by using a network of primary care practices to determine whether personalized prevention messages tailored to familial risk will motivate people at risk to change their lifestyles or screening behaviors.", {"entities": []}], ["Particulate pollutants cause adverse health effects through the generation of oxidative stress.", {"entities": []}], ["A key question is whether these effects are mediated by the particles or their chemical compounds.", {"entities": []}], ["In this article we show that aliphatic, aromatic, and polar organic compounds, fractionated from diesel exhaust particles (DEPs), exert differential toxic effects in RAW 264.7 cells.", {"entities": []}], ["Cellular analyses showed that the quinone-enriched polar fraction was more potent than the polycyclic aromatic hydrocarbon (PAH)\u2013enriched aromatic fraction in O 2", {"entities": []}], ["Amyloid-beta protein (A\u03b2) deposition is a pathological hallmark of Alzheimer\u2019s disease (AD).", {"entities": []}], ["A\u03b2 deposition triggers both pro-neuroinflammatory microglial activation and neurofibrillary tangle formation.", {"entities": []}], ["Cromolyn sodium is an asthma therapeutic agent previously shown to reduce A\u03b2 levels in transgenic AD mouse brains after one-week of treatment.", {"entities": [[22, 28, "DISEASE"]]}], ["Here, we further explored these effects as well as the mechanism of action of cromolyn, alone, and in combination with ibuprofen in APP", {"entities": [[132, 135, "GENE"]]}], ["Introduction: Sphingosine-1-phosphate (S1P) regulates the migration of follicular B cells (B2 cells) and directs the positioning of Marginal zone B cells (MZ B cells) within the spleen.", {"entities": []}], ["The function of S1P signalling in the third B cell lineage, B1 B cells, mainly present in the pleural and peritoneal cavity, has not yet been determined.", {"entities": []}], ["Methods: S1P receptor expression was analysed in peritoneal B cells by real-time polymerase chain reaction (qPCR).", {"entities": []}], ["The chemotactic response to S1P was studied in vitro.", {"entities": []}], ["The role of S1P signalling was further explored in a s1p 4 Results: Peritoneal B cells expressed considerable amounts of the S1P receptors 1 and 4 (S1P 1 and S1P 4 , respectively).", {"entities": []}], ["S1P 1 showed differential expression between the distinct peritoneal B cell lineages.", {"entities": []}], ["While B2 cells showed no chemotactic response to S1P, B1 B cells showed a migration response to S1P.", {"entities": []}], ["s1p 4 Discussion: S1P signalling influences peritoneal B1 B cell migration.", {"entities": []}], ["S1P 4 deficiency alters the composition of peritoneal B cell populations and reduces secretory IgA levels.", {"entities": []}], ["These findings suggest that S1P signalling may be a target to modulate B cell function in inflammatory intestinal pathologies.", {"entities": []}], ["In cancer, proteoglycans have been found to play roles in facilitating the actions of growth factors, and effecting matrix invasion and remodeling.", {"entities": [[3, 9, "DISEASE"]]}], ["However, little is known regarding the genetic and functional importance of glycan chains displayed by proteoglycans on dendritic cells (DCs) in cancer immunity.", {"entities": [[145, 151, "DISEASE"]]}], ["In lung carcinoma, among other solid tumors, tumor-associated DCs play largely subversive/suppressive roles, promoting tumor growth and progression.", {"entities": [[8, 17, "DISEASE"], [3, 17, "DISEASE"]]}], ["Herein, we show that targeting of DC glycan sulfation through mutation in the heparan sulfate biosynthetic enzyme N-deacetylase/N-sulfotransferase-1 (Ndst1) in mice increased DC maturation and inhibited trafficking of DCs to draining lymph nodes.", {"entities": [[150, 155, "GENE"]]}], ["Lymphatic-driven DC migration and chemokine (CCL21)-dependent activation of a major signaling pathway required for DC migration (as measured by phospho-Akt) were sensitive to Ndst1 mutation in DCs.", {"entities": [[45, 50, "GENE"], [175, 180, "GENE"]]}], ["Lewis lung carcinoma tumors in mice deficient in Ndst1 were reduced in size.", {"entities": [[11, 20, "DISEASE"], [6, 20, "DISEASE"], [49, 54, "GENE"]]}], ["Purified CD11c\u00a0+ cells from the tumors, which contain the tumor-infiltrating DC population, showed a similar phenotype in mutant cells.", {"entities": []}], ["These features were replicated in mice deficient in syndecan-4, the major heparan sulfate proteoglycan expressed on the DC surface: Tumors were growth-impaired in syndecan-4\u2013deficient mice and were characterized by increased infiltration by mature DCs.", {"entities": []}], ["Tumors on the mutant background also showed greater infiltration by NK cells and NKT cells.", {"entities": []}], ["These findings indicate the genetic importance of DC heparan sulfate proteoglycans in tumor growth and may guide therapeutic development of novel strategies to target syndecan-4 and heparan sulfate in cancer.", {"entities": [[201, 207, "DISEASE"]]}], ["Individuals from different backgrounds, social groups, and countries enjoy different levels of health.", {"entities": []}], ["This article defines and distinguishes between unavoidable health inequalities and unjust and preventable health inequities.", {"entities": []}], ["We describe the dimensions along which health inequalities are commonly examined, including across the global population, between countries or states, and within geographies, by socially relevant groupings such as race/ethnicity, gender, education, caste, income, occupation, and more.", {"entities": []}], ["Different theories attempt to explain group-level differences in health, including psychosocial, material deprivation, health behavior, environmental, and selection explanations.", {"entities": []}], ["Concepts of relative versus absolute; dose\u2013response versus threshold; composition versus context; place versus space; the life course perspective on health; causal pathways to health; conditional health effects; and group-level versus individual differences are vital in understanding health inequalities.", {"entities": []}], ["We close by reflecting on what conditions make health inequalities unjust, and to consider the merits of policies that prioritize the elimination of health disparities versus those that focus on raising the overall standard of health in a population.", {"entities": []}], ["Supplemental Digital Content is available in the text The safety and efficacy of different drugs in treatment of gestational diabetes mellitus (GDM) patients who could not maintain normal glucose level only through diet and exercise remains to be debated.", {"entities": [[113, 133, "DISEASE"], [125, 142, "DISEASE"]]}], ["We performed this network meta-analysis (NAM) to compare and rank different antidiabetic drugs in glucose level control and pregnancy outcomes in GDM patients.", {"entities": []}], ["We searched PubMed, Cochrane Library, Web of Science, and Embase up to December 31, 2016.", {"entities": []}], ["Randomized controlled trials (RCTs) related to different drugs in the treatment of GDM patients were enrolled.", {"entities": []}], ["We extracted the relevant information and assessed the risk of bias with the Cochrane risk of bias tool.", {"entities": []}], ["We did pair-wise meta-analyses using the fixed-effects model or random-effects model and then adopted random-effects NAM combining both direct and indirect evidence within a Bayesian framework, to calculate the odds ratio (OR) or standardized mean difference (SMD) and to draw a surface under the cumulative ranking curve of the neonatal and maternal outcomes of different treatments in GDM patients.", {"entities": []}], ["Thirty-two randomized controlled trials (RCTs) were included in this NAM, including 6 kinds of treatments (metformin, metformin plus insulin, insulin, glyburide, acarbose, and placebo).", {"entities": []}], ["The results of the NAM showed that regarding the incidence of macrosomia and LGA, metformin had lower incidence than glyburide (OR, 0.5411 and 0.4177).", {"entities": []}], ["In terms of the incidence of admission to the NICU, insulin had higher incidence compared with glyburide (OR, 1.844).", {"entities": []}], ["As for the incidence of neonatal hypoglycemia, metformin had lower incidence than insulin and glyburide (OR, 0.6331 and 0.3898), and insulin was lower than glyburide (OR, 0.6236).", {"entities": [[33, 45, "DISEASE"]]}], ["For mean birth weight, metformin plus insulin was lower than insulin (SMD, -0.5806), glyburide (SMD, -0.7388), and placebo (SMD, -0.6649).", {"entities": []}], ["Besides, metformin was observed to have lower birth weight than glyburide (SMD, 0.2591).", {"entities": []}], ["As for weight gain, metformin and metformin plus insulin were lower than insulin (SMD, -0.9166, -1.53).", {"entities": []}], ["Ranking results showed that glyburide might be the optimum treatment regarding average glucose control, and metformin is the fastest in glucose control for GDM patients; glyburide have the highest incidence of macrosomia, preeclampsia, hyperbilirubinemia, neonatal hypoglycemia, shortest gestational age at delivery, and lowest mean birth weight; metformin (plus insulin when required) have the lowest incidence of macrosomia, PIH, LGA, RDS, low gestational age at delivery, and low birth weight.", {"entities": [[265, 277, "DISEASE"]]}], ["Besides, insulin had the highest incidence of NICU admission, acarbose had the lowest risk of neonatal hypoglycemia.", {"entities": [[103, 115, "DISEASE"]]}], ["Our study concluded that metformin is fastest in glucose control, with a more favorable pregnancy outcomes\u2014would be a better option, but its rate of glucose control is the lowest.However, glyburide is the optimumtreatment regarding the rate of glucose control, but withmore adverse outcomes.", {"entities": []}], ["This NAMbased on 32 RCTs will strongly help to guide further development of management for GDM patients, clinicians should carefully balance the risk\u2013benefit profile of different treatments according to various situations.", {"entities": []}], ["The relationship between dyspnea and incident heart failure (HF) and myocardial infarction (MI) among patients without previously diagnosed cardiopulmonary disease is unclear.", {"entities": [[69, 90, "DISEASE"]]}], ["We studied the prognostic relevance of self-reported dyspnea for cardiovascular outcomes and all-cause mortality in persons without previously diagnosed cardiopulmonary disease.", {"entities": []}], ["We studied 10 881 community-dwelling participants (mean age 57\u00b16, 56% women, 25% black) who were free of prevalent cardiopulmonary disease from Atherosclerosis Risk in Communities Study.", {"entities": []}], ["Dyspnea status at study entry using the modified Medical Research Council (mMRC) scale.", {"entities": []}], ["The primary outcomes were time to HF, MI or all-cause death.", {"entities": []}], ["Dyspnea prevalence was 22%, and was mild (mMRC grade 1 or 2) in 21% and moderate-to-severe (mMRC 3 or 4) in 1%.", {"entities": []}], ["The main correlates of dyspnea were older age, female sex, higher BMI and active smoking.", {"entities": []}], ["Over a follow-up of 19\u00b15 years, greater self-reported dyspnea severity was associated with worse prognosis.", {"entities": []}], ["Mild dyspnea was associated with significantly heightened risk of HF (adjusted Hazard Ratio, HR,1.30; 95% CI: 1.16\u20131.46), MI (adjusted HR 1.34; 95%CI: 1.20\u20131.50), and death (adjusted HR 1.16; 95%CI: 1.06\u20131.26), with moderate/severe dyspnea associated with an even greater risk (adjusted HR 2.14, 95%CI: 1.59\u20132.89; 1.93, 95%CI: 1.41\u20132.56; 1.96, 95%CI: 1.55\u20132.48, respectively).", {"entities": [[93, 95, "GENE"], [135, 137, "GENE"], [183, 185, "GENE"], [287, 289, "GENE"], [93, 95, "GENE"], [135, 137, "GENE"], [183, 185, "GENE"], [287, 289, "GENE"], [93, 95, "GENE"], [135, 137, "GENE"], [183, 185, "GENE"], [287, 289, "GENE"]]}], ["In community-dwelling persons free of previously diagnosed cardiopulmonary disease, self-reported dyspnea is common and, even when of mild intensity, it is independently associated with a greater risk of incident HF, MI, and death.", {"entities": []}], ["Our data emphasize the prognostic importance of even mild self-reported dyspnea for cardiovascular outcomes.", {"entities": []}], ["Anxiety is the most common mental health disorders in the general population.", {"entities": []}], ["This study aimed to determine the prevalence of anxiety, its associated factors and the predictors of anxiety among adults in the community of Selangor, Malaysia.", {"entities": []}], ["A cross sectional study was carried out in three districts in Selangor, Malaysia.", {"entities": []}], ["The inclusion criteria of this study were Malaysian citizens, adults aged 18\u00a0years and above, and living in the selected living quarters based on the list provided by the Department of Statistics Malaysia (DOS).", {"entities": []}], ["Participants completed a set of questionnaires, including the validated Malay version of Generalized Anxiety Disorder 7 (GAD 7) to detect anxiety.", {"entities": []}], ["Of the 2512 participants who were approached, 1556 of them participated in the study (61.90\u00a0%).", {"entities": []}], ["Based on the cut-off point of 8 and above in the GAD-7, the prevalence of anxiety was 8.2\u00a0%.", {"entities": []}], ["Based on the initial multiple logistic regression analysis, the predictors of anxiety were depression, serious problems at work, domestic violence and high perceived stress.", {"entities": []}], ["When reanalyzed again after removing depression, low self-esteem and high perceived stress, six predictors that were identified are cancer, serious problems at work, domestic violence, unhappy relationship with family, non-organizational religious activity and intrinsic religiosity.", {"entities": [[132, 138, "DISEASE"]]}], ["This study reports the prevalence of anxiety among adults in the community of Selangor, Malaysia and also the magnitude of the associations between various factors and anxiety.", {"entities": []}], ["Introduction .", {"entities": []}], ["The aim of the study was to compare treatment of sarcoidosis with antifungal or corticosteroid medication.", {"entities": [[49, 60, "DISEASE"]]}], ["In patients with sarcoidosis antifungal medication ( n = 29), corticosteroids ( n = 21) or a combination ( n = 27) was given.", {"entities": [[17, 28, "DISEASE"]]}], ["Nine patients allotted to antifungal medication were later given corticosteroids because of the lack of regression of the disease.", {"entities": []}], ["X-ray scores for the severity of granuloma infiltration were determined.", {"entities": []}], ["Chitotriosidase and angiotensin converting enzyme were determined.", {"entities": []}], ["The time in months till remission was observed as well as the number of recurrences.", {"entities": []}], ["Macrophage infiltration is a hallmark feature of viral myocarditis.", {"entities": [[55, 66, "DISEASE"]]}], ["As studies have shown that microRNA-155 regulates the differentiation of macrophages, we aimed to investigate the role of microRNA-155 in VM.", {"entities": []}], ["We report that silencing microRNA-155 protects mice from coxsackievirus B3 induced myocarditis.", {"entities": [[83, 94, "DISEASE"]]}], ["We found that microRNA-155 expression was upregulated and localized primarily in heart-infiltrating macrophages and CD4", {"entities": [[116, 119, "GENE"]]}], ["Respiratory effort belt measurement is a widely used method to monitor respiration.", {"entities": []}], ["Signal waveforms of respiratory volume and flow may indicate pathological signs of several diseases and, thus, it would be highly desirable to predict them accurately.", {"entities": []}], ["Calibrated effort belts are sufficiently accurate for estimating respiratory rate, but the respiratory volume and flow prediction accuracies degrade considerably with changes in the subject\u2019s body position and breathing style.", {"entities": []}], ["An improved calibration method of respiratory effort belts is presented in this paper.", {"entities": []}], ["It is based on an optimally trained FIR (Finite Impulse Response) filter bank constructed as a MISO system (Multiple-Input Single-Output) between respiratory effort belt signals and the spirometer in order to reduce waveform errors.", {"entities": []}], ["Ten healthy adult volunteers were recruited.", {"entities": []}], ["Breathing was varied between the following styles: metronome-guided controlled breathing rate of 0.1 Hz, 0.15 Hz, 0.25 Hz and 0.33 Hz, and a free rate that was felt normal by each subject.", {"entities": []}], ["Body position was varied between supine, sitting and standing.", {"entities": []}], ["The proposed calibration method was tested against these variations and compared with the state-of-the-art methods from the literature.", {"entities": []}], ["Relative waveform error decreased 60-70% when predicting airflow under changing breathing styles.", {"entities": []}], ["The coefficient of determination R Results show that not only the respiratory volume can be computed more precisely from the predicted airflow, but also the flow waveforms are very accurate with the proposed method.", {"entities": []}], ["The method is robust to breathing style changes and body position changes improving greatly the accuracy of the calibration of respiratory effort belts over the standard method.", {"entities": []}], ["The enhanced accuracy of the belt calibration offers interesting opportunities, e.g.", {"entities": []}], ["in pulmonary and critical care medicine when objective measurements are required.", {"entities": []}], ["Larva migrans syndrome (LMS) caused by Toxocara and Ascaris roundworms is generally believed to be more common in children, while a report from Japan suggests that it is more common in adults.", {"entities": [[14, 22, "DISEASE"]]}], ["We conducted a large-scale retrospective study to confirm these findings and to clarify what caused the difference between Japan and other countries, to reveal overlooked aspects of this disease.", {"entities": []}], ["The clinical information of 911 cases which we diagnosed as Toxocara or Ascaris LMS during 2001 and 2015 was analysed.", {"entities": []}], ["Information used included age, sex, address (city or county), chief complaint, present history, dietary history, overseas travelling history, medical imaging findings and laboratory data (white blood cell count, peripheral blood eosinophil number and total IgE).", {"entities": []}], ["The sex ratio of the disease was 2.37 (male/female\u2009=\u2009641/270).", {"entities": []}], ["The number of patients not younger than 20\u00a0years old were 97.8 and 95.1\u00a0% among males and females, respectively.", {"entities": []}], ["Major disease types were visceral, ocular, neural and asymptomatic.", {"entities": []}], ["The visceral type was more prevalent in older patients, while younger patients were more vulnerable to ocular symptoms.", {"entities": []}], ["More than two-thirds of the patients whose dietary habits were recorded had a history of ingesting raw or undercooked animal meat.", {"entities": []}], ["LMS caused by Toxocara or Ascaris is primarily a disease of adult males in Japan, who probably acquired infections by eating raw or undercooked animal meat/liver.", {"entities": []}], ["Healthcare specialists should draw public attention to the risk of raw or undercooked animal meat in Europe as well.", {"entities": []}], ["The peptide HsTX1[R14A] is a potent and selective blocker of the voltage-gated potassium channel Kv1.3, which is a highly promising target for the treatment of autoimmune diseases and other conditions.", {"entities": []}], ["In order to assess the biodistribution of this peptide, it was conjugated with NOTA and radiolabelled with copper-64.", {"entities": []}], ["[ in vitro and in vivo .", {"entities": []}], ["The biodistribution and PET studies after intravenous and subcutaneous injections showed similar patterns and kinetics.", {"entities": []}], ["The hydrophilic peptide was rapidly distributed, showed low accumulation in most of the organs and tissues, and demonstrated high molecular stability in vitro and in vivo .", {"entities": []}], ["The most prominent accumulation occurred in the epiphyseal plates of trabecular bones.", {"entities": []}], ["The high stability and bioavailability, low normal-tissue uptake of [ in vitro and in vivo demonstrate that HsTX1[R14A] represents a valuable lead for conditions treatable by blockade of the voltage-gated potassium channel Kv1.3.", {"entities": []}], ["The pharmacokinetics shows that both intravenous and subcutaneous applications are viable routes for the delivery of this potent peptide.", {"entities": []}], ["Asthma and chronic obstructive pulmonary disease (COPD) are characterized by airway obstruction and airflow limitation and pose a huge burden to society.", {"entities": [[11, 48, "DISEASE"], [0, 6, "DISEASE"]]}], ["These obstructive lung diseases impact the lung physiology across multiple biological scales.", {"entities": []}], ["Environmental stimuli are introduced via inhalation at the organ scale, and consequently impact upon the tissue, cellular and sub-cellular scale by triggering signaling pathways.", {"entities": []}], ["These changes are propagated upwards to the organ level again and vice versa.", {"entities": []}], ["In order to understand the pathophysiology behind these diseases we need to integrate and understand changes occurring across these scales and this is the driving force for multiscale computational modeling.", {"entities": []}], ["There is an urgent need for improved diagnosis and assessment of obstructive lung diseases.", {"entities": []}], ["Standard clinical measures are based on global function tests which ignore the highly heterogeneous regional changes that are characteristic of obstructive lung disease pathophysiology.", {"entities": [[144, 168, "DISEASE"], [156, 168, "DISEASE"]]}], ["Advances in scanning technology such as hyperpolarized gas MRI has led to new regional measurements of ventilation, perfusion and gas diffusion in the lungs, while new image processing techniques allow these measures to be combined with information from structural imaging such as Computed Tomography (CT).", {"entities": []}], ["However, it is not yet known how to derive clinical measures for obstructive diseases from this wealth of new data.", {"entities": []}], ["Computational modeling offers a powerful approach for investigating this relationship between imaging measurements and disease severity, and understanding the effects of different disease subtypes, which is key to developing improved diagnostic methods.", {"entities": []}], ["Gaining an understanding of a system as complex as the respiratory system is difficult if not impossible via experimental methods alone.", {"entities": []}], ["Computational models offer a complementary method to unravel the structure-function relationships occurring within a multiscale, multiphysics system such as this.", {"entities": []}], ["Here we review the current state-of-the-art in techniques developed for pulmonary image analysis, development of structural models of the respiratory system and predictions of function within these models.", {"entities": []}], ["We discuss application of modeling techniques to obstructive lung diseases, namely asthma and emphysema and the use of models to predict response to therapy.", {"entities": [[83, 89, "DISEASE"]]}], ["Finally we introduce a large European project, AirPROM that is developing multiscale models to investigate structure-function relationships in asthma and COPD.", {"entities": [[143, 149, "DISEASE"]]}], ["Food allergy prevalence is increasing in US children.", {"entities": [[0, 12, "DISEASE"]]}], ["Presently, the primary means of preventing potentially fatal reactions are avoidance of allergens, prompt recognition of food allergy reactions, and knowledge about food allergy reaction treatments.", {"entities": [[121, 133, "DISEASE"], [165, 177, "DISEASE"]]}], ["Focus groups were held as a preliminary step in the development of validated survey instruments to assess food allergy knowledge, attitudes, and beliefs of parents, physicians, and the general public.", {"entities": [[106, 118, "DISEASE"]]}], ["Eight focus groups were conducted between January and July of 2006 in the Chicago area with parents of children with food allergy (3 groups), physicians (3 groups), and the general public (2 groups).", {"entities": [[117, 129, "DISEASE"]]}], ["A constant comparative method was used to identify the emerging themes which were then grouped into key domains of food allergy knowledge, attitudes, and beliefs.", {"entities": [[115, 127, "DISEASE"]]}], ["Parents of children with food allergy had solid fundamental knowledge but had concerns about primary care physicians' knowledge of food allergy, diagnostic approaches, and treatment practices.", {"entities": [[25, 37, "DISEASE"], [131, 143, "DISEASE"]]}], ["The considerable impact of children's food allergies on familial quality of life was articulated.", {"entities": []}], ["Physicians had good basic knowledge of food allergy but differed in their approach to diagnosis and advice about starting solids and breastfeeding.", {"entities": [[39, 51, "DISEASE"]]}], ["The general public had wide variation in knowledge about food allergy with many misconceptions of key concepts related to prevalence, definition, and triggers of food allergy.", {"entities": [[57, 69, "DISEASE"], [162, 174, "DISEASE"]]}], ["Appreciable food allergy knowledge gaps exist, especially among physicians and the general public.", {"entities": [[12, 24, "DISEASE"]]}], ["The quality of life for children with food allergy and their families is significantly affected.", {"entities": [[38, 50, "DISEASE"]]}], ["Eosinophils contribute to immune regulation and wound healing/fibrosis in various diseases including asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["Growing appreciation for the role of activin A in such processes led us to hypothesize that eosinophils are a source of this TGF-\u03b2 superfamily member.", {"entities": []}], ["TNF\u03b1 (TNF) induces activin A by other cell types and is often present at the site of allergic inflammation along with the eosinophil activating common \u03b2 (\u03b2c) chain-signaling cytokines (IL-5, IL-3, GM-CSF).", {"entities": [[6, 9, "GENE"]]}], ["Previously, we established that the combination of TNF plus a \u03b2c chain-signaling cytokine synergistically induces eosinophil synthesis of the remodeling enzyme MMP-9.", {"entities": [[51, 54, "GENE"]]}], ["Therefore, eosinophils were stimulated ex vivo by these cytokines and in vivo through an allergen-induced airway inflammatory response.", {"entities": []}], ["In contrast to IL-5+TNF or GM-CSF+TNF, the combination of IL-3+TNF synergistically induced activin A synthesis and release by human blood eosinophils.", {"entities": []}], ["IL-3+TNF enhanced activin A mRNA stability, which required sustained signaling of pathways downstream of p38 and ERK MAP kinases.", {"entities": []}], ["In vivo , following segmental airway allergen challenge of subjects with mild allergic asthma, activin A mRNA was upregulated in airway eosinophils compared to circulating eosinophils, and ex vivo , circulating eosinophils tended to release activin A in response to IL-3+TNF.", {"entities": [[78, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["These data provide evidence that eosinophils release activin A and that this function is enhanced when eosinophils are present in an allergen-induced inflammatory environment.", {"entities": []}], ["Moreover, these data provide the first evidence for post-transcriptional control of activin A mRNA.", {"entities": []}], ["We propose that, an environment rich in IL-3+TNF will lead to eosinophil\u2013derived activin A, which plays an important role in regulating inflammation and/or fibrosis.", {"entities": []}], ["Inbred mouse strains are used in different models of respiratory diseases but the variation of critical respiratory leukocyte subpopulations across different strains is unknown.", {"entities": []}], ["By using multiparameter flow cytometry we have quantitated respiratory leukocyte subsets including dendritic cells subpopulations, macrophages, classical T and B cells, natural killer cells, \u03b3\u03b4TCR+ T cells and lineage-negative leukocytes in the five most common inbred mouse strains BALB/c, C57BL/6, DBA/2, 129SV and C3H.", {"entities": []}], ["To minimize confounding environmental factors, age-matched animals were received from the same provider and were housed under identical specific-pathogen-free conditions.", {"entities": []}], ["Results revealed significant strain differences with respect to respiratory neutrophils (p=0.005; up to 1.4 fold differences versus C57BL/6 mice), eosinophils (p=0.029; up to 2.7 fold), certain dendritic cell subsets (p\u22640.0003; up to 3.4 fold), T (p<0.001; up to 1.6 fold) and B lymphocyte subsets (p=0.005; up to 0.4 fold), \u03b3\u03b4 T lymphocytes (p=0.003; up to 1.6 fold), natural killer cells (p<0.0001; up to 0.6 fold) and lineage-negative innate leukocytes (p\u22640.007; up to 3.6 fold).", {"entities": []}], ["In contrast, total respiratory leukocytes, macrophages, total dendritic cells and bronchoalveolar lavage leukocytes did not differ significantly.", {"entities": []}], ["Stimulation of respiratory leukocytes via Toll-like receptor 4 and 9 as well as CD3/CD28 revealed significant strain differences of TNF-\u03b1 and IL-10 production.", {"entities": []}], ["Our study demonstrates significant strain heterogeneity of respiratory leukocyte subsets that may impact respiratory immunity in different disease models.", {"entities": []}], ["Additionally, the results may help identification of optimal strains for purification of rare respiratory leukocyte subsets for ex vivo analyses.", {"entities": []}], ["The BioBank Japan (BBJ) Project was launched in 2003 with the aim of providing evidence for the implementation of personalized medicine by constructing a large, patient-based biobank (BBJ).", {"entities": []}], ["This report describes the study design and profile of BBJ participants who were registered during the first 5-year period of the project.", {"entities": []}], ["The BBJ is a registry of patients diagnosed with any of 47 target common diseases.", {"entities": []}], ["Patients were enrolled at 12 cooperative medical institutes all over Japan from June 2003 to March 2008.", {"entities": []}], ["Clinical information was collected annually via interviews and medical record reviews until 2013.", {"entities": []}], ["We collected DNA from all participants at baseline and collected annual serum samples until 2013.", {"entities": []}], ["In addition, we followed patients who reported a history of 32 of the 47 target diseases to collect survival data, including cause of death.", {"entities": []}], ["During the 5-year period, 200,000 participants were registered in the study.", {"entities": []}], ["The total number of cases was 291,274 at baseline.", {"entities": []}], ["Baseline data for 199,982 participants (53.1% male) were available for analysis.", {"entities": []}], ["The average age at entry was 62.7 years for men and 61.5 years for women.", {"entities": []}], ["Follow-up surveys were performed for participants with any of 32 diseases, and survival time data for 141,612 participants were available for analysis.", {"entities": []}], ["The BBJ Project has constructed the infrastructure for genomic research for various common diseases.", {"entities": []}], ["This clinical information, coupled with genomic data, will provide important clues for the implementation of personalized medicine.", {"entities": []}], ["\u2022 The BioBank Japan Project (BBJ) enrolled 200,000 patients with 47 target diseases.", {"entities": []}], ["\u2022 The BBJ is one of the largest patient-based biobanks in the world.", {"entities": []}], ["\u2022 The BBJ may allow for personalized medicine in the future.", {"entities": []}], ["The BioBank Japan Project (BBJ) enrolled 200,000 patients with 47 target diseases.", {"entities": []}], ["The BBJ is one of the largest patient-based biobanks in the world.", {"entities": []}], ["The BBJ may allow for personalized medicine in the future.", {"entities": []}], ["Matrix metalloproteinases (MMPs) are known to play an important role in the degradation of the extracellular matrix and the pathological progression of osteoarthritis (OA).", {"entities": [[152, 166, "DISEASE"]]}], ["The natural polyphenolic compound rosmarinic acid (Ros.", {"entities": []}], ["A) has been shown to suppress the inhibitory activity of matrix metalloproteinases (MMPs).", {"entities": []}], ["However, the effects of Ros.", {"entities": []}], ["A on OA have not been investigated.", {"entities": []}], ["In the current study, primary articular chondrocytes were cultured from rabbit articular cartilage and treated with Ros.", {"entities": []}], ["A. Phenotypic characterization was performed by western blotting to assess specific markers, prostaglandin E 2 (PGE 2 ) assays, and alcian blue staining to measure sulfated-proteoglycan production.", {"entities": []}], ["We report that in rabbit articular chondrocytes, Ros.", {"entities": []}], ["A increased type II collagen, sulfated-proteoglycan, cyclooxygenase-2 (COX-2), and PGE 2 production in a dose- and time-dependent manner.", {"entities": []}], ["Furthermore, Ros.", {"entities": []}], ["A suppressed the expression of MMP-13.", {"entities": []}], ["In addition, treatment with Ros A activated extracellular signal-regulated kinase (ERK)-1/2 and p38 kinase signaling pathways.", {"entities": []}], ["Inhibition of MMP-13 enhanced Ros.", {"entities": []}], ["A-induced type II collagen expression and sulfated-proteoglycan synthesis but COX-2 and PGE 2 production were unchanged.", {"entities": []}], ["A-mediated up-regulation of ERK phosphorylation was abolished by the MEK inhibitor, PD98059, which prevented induction of the associated inflammatory response.", {"entities": []}], ["Inhibition of p38 kinase with SB203580 enhanced the increase in type II collagen expression via Ros.", {"entities": []}], ["A-mediated down-regulation of MMP-13.", {"entities": []}], ["Results suggest that ERK-1/2 regulates Ros.", {"entities": []}], ["A-induced inflammation and that p38 regulates differentiation by inhibiting MMP-13 in rabbit articular chondrocytes.", {"entities": []}], ["Caffeine is a commonly used food additive found naturally in many products.", {"entities": []}], ["In addition to potently stimulating the central nervous system caffeine is able to affect various systems within the body including the cardiovascular and respiratory systems.", {"entities": []}], ["Importantly, caffeine is used clinically to treat apnoea and bronchopulmonary dysplasia in premature babies.", {"entities": []}], ["Recently, caffeine has been shown to exhibit antifibrotic effects in the liver in part through reducing collagen expression and deposition, and reducing expression of the profibrotic cytokine TGF\u03b2.", {"entities": []}], ["The potential antifibrotic effects of caffeine in the lung have not previously been investigated.", {"entities": []}], ["Using a combined in vitro and ex vivo approach we have demonstrated that caffeine can act as an antifibrotic agent in the lung by acting on two distinct cell types, namely epithelial cells and fibroblasts.", {"entities": []}], ["Caffeine inhibited TGF\u03b2 activation by lung epithelial cells in a concentration-dependent manner but had no effect on TGF\u03b2 activation in fibroblasts.", {"entities": []}], ["Importantly, however, caffeine abrogated profibrotic responses to TGF\u03b2 in lung fibroblasts.", {"entities": []}], ["It inhibited basal expression of the \u03b1-smooth muscle actin gene and reduced TGF\u03b2-induced increases in profibrotic genes.", {"entities": []}], ["Finally, caffeine reduced established bleomycin-induced fibrosis after 5\u2005days treatment in an ex vivo precision-cut lung slice model.", {"entities": []}], ["Together, these findings suggest that there is merit in further investigating the potential use of caffeine, or its analogues, as antifibrotic agents in the lung.", {"entities": []}], ["This study evaluated the adherence to influenza vaccination among medical students in 2010 and 2011.", {"entities": [[38, 47, "DISEASE"]]}], ["From August to December 2011, a questionnaire was used to record the influenza vaccination in 2010 and 2011, reasons for acceptance of the influenza vaccine and knowledge of healthcare workers about the influenza vaccine recommendation.", {"entities": [[69, 78, "DISEASE"], [139, 148, "DISEASE"], [203, 212, "DISEASE"]]}], ["One hundred and forty-four students from the 2", {"entities": []}], ["Heredity as well as external factors influences the development of allergic rhinitis.", {"entities": [[67, 84, "DISEASE"], [76, 84, "DISEASE"]]}], ["The aim of this study was to analyse early risk factors and protective factors for allergic rhinitis at school age.", {"entities": [[83, 100, "DISEASE"], [92, 100, "DISEASE"]]}], ["This is a prospective, longitudinal study of children born in western Sweden in 2003 where 50% of the birth cohort was randomly selected.", {"entities": []}], ["The parents answered questionnaires at 6\u00a0months, 12\u00a0months, 4.5\u00a0yr and 8\u00a0yr. At 8\u00a0yr, 5044 questionnaires were distributed.", {"entities": []}], ["Of these, 4051 responded, that is, 80.3%.", {"entities": []}], ["Current allergic rhinitis was defined as symptoms and use of medication during the past 12\u00a0months.", {"entities": [[8, 25, "DISEASE"], [17, 25, "DISEASE"]]}], ["Current allergic rhinitis at 8\u00a0yr was reported by 10.9%.", {"entities": [[8, 25, "DISEASE"], [17, 25, "DISEASE"]]}], ["Mean onset age was 5.7\u00a0yr, and 61.9% were boys.", {"entities": []}], ["In a multivariate analysis, antibiotics in the first week of life increased the risk of allergic rhinitis (adjusted odds ratio 1.75, 95% confidence interval (1.03, 2.97)).", {"entities": [[88, 105, "DISEASE"], [97, 105, "DISEASE"]]}], ["Increased risk was also seen with parental allergic rhinitis (aOR 2.73 (2.12, 3.52)), food allergy first year (aOR 2.45 (1.61, 3.73)), eczema first year (aOR 1.97 (1.50, 2.59)) and male gender (aOR 1.35 (1.05, 1.74)).", {"entities": [[43, 60, "DISEASE"], [52, 60, "DISEASE"], [86, 98, "DISEASE"]]}], ["Living on a farm at 4.5\u00a0yr reduced the risk (aOR 0.31 (0.13, 0.78)).", {"entities": []}], ["Antibiotics in the first week of life increased the risk of allergic rhinitis at school age, while living on a farm at preschool age reduced the risk.", {"entities": [[60, 77, "DISEASE"], [69, 77, "DISEASE"]]}], ["Both findings are compatible with the hygiene hypothesis.", {"entities": []}], ["Propionic acid (PPA) is a ubiquitous short-chain fatty acid, which is a major fermentation product of the enteric microbiome.", {"entities": []}], ["PPA is a normal intermediate of metabolism and is found in foods, either naturally or as a preservative.", {"entities": []}], ["PPA and its derivatives have been implicated in both health and disease.", {"entities": []}], ["Whereas PPA is an energy substrate and has many proposed beneficial effects, it is also associated with human disorders involving mitochondrial dysfunction, including propionic acidemia and autism spectrum disorders (ASDs).", {"entities": [[167, 185, "DISEASE"]]}], ["We aimed to investigate the dichotomy between the health and disease effects of PPA by measuring mitochondrial function in ASD and age- and gender-matched control lymphoblastoid cell lines (LCLs) following incubation with PPA at several concentrations and durations both with and without an in vitro increase in reactive oxygen species (ROS).", {"entities": []}], ["Mitochondrial function was optimally increased at particular exposure durations and concentrations of PPA with ASD LCLs, demonstrating a greater enhancement.", {"entities": []}], ["In contrast, increasing ROS negated the positive PPA effect with the ASD LCLs, showing a greater detriment.", {"entities": []}], ["These data demonstrate that enteric microbiome metabolites such as PPA can have both beneficial and toxic effects on mitochondrial function, depending on concentration, exposure duration and microenvironment redox state with these effects amplified in LCLs derived from individuals with ASD.", {"entities": []}], ["As PPA, as well as enteric bacteria, which produce PPA, have been implicated in a wide variety of diseases, including ASD, diabetes, obesity and inflammatory diseases, insight into this metabolic modulator from the host microbiome may have wide applications for both health and disease.", {"entities": [[133, 140, "DISEASE"]]}], ["Air pollution exposure may contribute to rhinoconjunctivitis morbidity in children with underlying airways disease.", {"entities": []}], ["Prior studies have not assessed rhinoconjunctivitis-related quality of life (QOL) in children with asthma chronically exposed to air pollution.", {"entities": [[99, 105, "DISEASE"]]}], ["Children ages 9\u201319 years with asthma from peri-urban Peru, self-reporting rhinoconjunctivitis symptoms (n = 484), were administered the Rhinoconjunctivitis QOL Questionnaire (RQLQ) at repeated intervals over one year, with scores dichotomized into bothered (>0) and not bothered (= 0).", {"entities": [[30, 36, "DISEASE"]]}], ["Individual weekly exposures to particulate matter<2.5\u03bcm (PM 2.5 ) and its black carbon (BC) component were estimated by inverse distance weighted methods.", {"entities": []}], ["Generalized estimating equations, adjusting for covariates, estimated associations of PM 2.5 and BC with QOL.", {"entities": []}], ["Participants were on average 13 years old, 55% female, and majority were atopic (77%).", {"entities": []}], ["Mean (SD) PM 2.5 and BC concentrations were 21(3.2) \u03bcg/m3 and 4.4(1.5) \u03bcg/m3, respectively.", {"entities": []}], ["In adjusted multi-pollutant models, each 10\u03bcg/m3 increase in PM 2.5 was associated with increased odds of worse rhinoconjunctivitis QOL (OR;[95% CI]: 1.83;[1.33,2.52]).", {"entities": []}], ["A 10% increase in the BC proportion was associated with higher rhinitis burden (OR;[95% CI]: 1.80;[1.22,2.66]), while increases in the non-BC component of PM did not significantly impact rhinoconjunctivitis QOL.", {"entities": [[63, 71, "DISEASE"]]}], ["Associations were similar regardless of atopy.", {"entities": []}], ["Higher PM2.5 and BC exposure is associated with worse rhinitis QOL among asthmatic children.", {"entities": [[54, 62, "DISEASE"]]}], ["Obesity is a major global epidemic and a burden to society and health systems.", {"entities": [[0, 7, "DISEASE"]]}], ["It is well known risk factor for a number of chronic medical conditions with high morbidity and mortality.", {"entities": []}], ["This study aimed to provide an estimate of the direct costs associated to outpatient and inpatient care of overweight and obesity related diseases in the perspective of the Brazilian Health System (SUS).", {"entities": [[122, 129, "DISEASE"]]}], ["Population attributable risk (PAR) was calculated for selected diseases related to overweight and obesity and with the following parameters: Relative risk (RR)\u2009\u2265\u20091.20 or RR \u22651.10 and\u2009<\u20091.20, but important problem of public health due its high prevalence.", {"entities": [[98, 105, "DISEASE"]]}], ["After a broad search in the literature, two meta-analysis were selected to provide RR for PAR calculation.", {"entities": []}], ["The prevalence rates of overweight and obesity in Brazilians with \u226518\u2009years were obtained from large national survey.", {"entities": [[39, 46, "DISEASE"]]}], ["The national health database (DATASUS) was used to estimate the annual cost of the Brazilian Unified Health System (SUS) with the diseases included in the analysis.", {"entities": []}], ["The extracted values were stratified by sex, type of service (inpatient or outpatient care) and year.", {"entities": []}], ["Data were collected from 2008 to 2010 and the results reflect the average of 3\u2009years.", {"entities": []}], ["Brazilian costs were converted into US dollars during the analysis using a purchasing power parity basis (2010).", {"entities": []}], ["The estimated total costs in one year with all diseases related to overweight and obesity are US$ 2,1 billion; US$ 1,4 billion (68.4% of total costs) due to hospitalizations and US$ 679 million due to ambulatory procedures.", {"entities": [[82, 89, "DISEASE"]]}], ["Approximately 10% of these cost is attributable to overweight and obesity.", {"entities": [[66, 73, "DISEASE"]]}], ["The results confirm that overweight and obesity carry a great economic burden for Brazilian health system and for the society.", {"entities": [[40, 47, "DISEASE"]]}], ["The knowledge of these costs will be useful for future economic analysis of preventive and treatment interventions.", {"entities": []}], ["Alternating ibuprofen and acetaminophen for the treatment of febrile children is a prevalent practice among physicians and parents, despite the lack of evidence on effectiveness or safety.", {"entities": []}], ["This randomized, double-blind and placebo-controlled clinical trial aims at comparing the antipyretic effectiveness and safety of a single administration of alternating ibuprofen and acetaminophen doses to that of ibuprofen mono-therapy in febrile children.", {"entities": []}], ["Seventy febrile children were randomly allocated to receive either a single oral dose of 10 mg/kg ibuprofen and 15 mg/kg oral acetaminophen after 4 hours, or a similar dose of ibuprofen and placebo at 4 hours.", {"entities": []}], ["Rectal temperature was measured at baseline, 4, 5, 6, 7 and 8 hours later.", {"entities": []}], ["Endpoints included proportions of afebrile children at 6, 7 and 8 hours, maximum decline in temperature, time to recurrence of fever, and change in temperature from baseline at each time point.", {"entities": []}], ["Intent-to-treat analysis was planned with statistical significance set at P < 0.05.", {"entities": []}], ["A higher proportion of subjects in the intervention group (83.3%) became afebrile at 6 hours than in the control group (57.6%); P = 0.018.", {"entities": []}], ["This difference was accentuated at 7 and 8 hours (P < 0.001) with a significantly longer time to recurrence of fever in the intervention group (mean \u00b1 SD of 7.4 \u00b1 1.3 versus 5.7 \u00b1 2.2 hours), P < 0.001.", {"entities": []}], ["Odds ratios (95%CI) for defervescence were 5.6 (1.3; 23.8), 19.5 (3.5; 108.9) and 15.3 (3.4; 68.3) at 6, 7 and 8 hours respectively.", {"entities": []}], ["Two-way ANOVA with repeated measures over time revealed a significantly larger decline in temperature in the intervention group at times 7 (P = 0.026) and 8 (P = 0.002) hours.", {"entities": []}], ["A single dose of alternating ibuprofen and acetaminophen appears to be a superior antipyretic regimen than ibuprofen mono-therapy.", {"entities": []}], ["Further studies are needed to confirm these findings.", {"entities": []}], ["Epidemiological studies of community populations are highly relevant to the process of setting national ambient air quality primary standards, as criteria for those standards are the protection of human populations against adverse effects on health.", {"entities": []}], ["Nevertheless, because of the difficulties of performing adequate community population studies of a quality commensurate with the needs of standard setting, the use of data derived from studies is problematic.", {"entities": []}], ["This paper addresses the important issues of appropriate exposure assessment and health assessment, and discusses the problems of multiplex variables and colinearity as they are critical in assessments of exposure-effect relationships.", {"entities": []}], ["It is concluded that a major problem in the use of data from such studies for standard setting is not necessarily one of scientific reliability or validity, but arises from the attempt of translating adequate science into policy decisions.", {"entities": []}], ["Excessive oxidative stress has been reported to be generated in inflamed tissues and contribute to the pathogenesis of inflammatory lung diseases, exacerbations of which induced by viral infections are associated with toll-like receptor (TLR) activation.", {"entities": []}], ["Among these receptors, TLR8 has been reported as a key receptor that recognizes single-strand RNA virus.", {"entities": [[23, 27, "GENE"]]}], ["However, it remains unknown whether TLR8 signaling is potentiated by oxidative stress.", {"entities": [[36, 40, "GENE"]]}], ["The aim of this study is to examine whether oxidative stress modulates TLR8 signaling in vitro.", {"entities": [[71, 75, "GENE"]]}], ["Human peripheral blood neutrophils were obtained from healthy non-smokers and stimulated with TLR 7/8 agonist imidazoquinoline resiquimod (R848) in the presence or absence of hydrogen peroxide (H 2 O 2 ).", {"entities": []}], ["Neutrophilic responses including cytokine release, superoxide production and chemotaxis were examined, and the signal transduction was also analyzed.", {"entities": []}], ["Activation of TLR8, but not TLR7, augmented IL-8 release.", {"entities": [[14, 18, "GENE"], [28, 32, "GENE"]]}], ["The R848-augmented IL-8 release was significantly potentiated by pretreatment with H 2 O 2 (p < 0.01), and N-acetyl- L -cysteine reversed this potentiation.", {"entities": []}], ["The combination of H 2 O 2 and R848 significantly potentiated NF-kB phosphorylation and IkB\u03b1 degradation.", {"entities": []}], ["The H 2 O 2 -potentiated IL-8 release was suppressed by MG-132, a proteosome inhibitor, and by dexamethasone.", {"entities": []}], ["The expressions of TLR8, myeloid differentiation primary response gene 88 (MyD88), and tumor necrosis factor receptor-associated factor 6 (TRAF6) were not affected by H 2 O 2 .", {"entities": [[19, 23, "GENE"], [75, 80, "GENE"], [139, 144, "GENE"]]}], ["TLR8-mediated neutrophilic responses were markedly potentiated by oxidative stress, and the potentiation was mediated by enhanced NF-kB activation.", {"entities": []}], ["These results suggest that oxidative stress might potentiate the neutrophilic inflammation during viral infection.", {"entities": []}], ["Ambient particulate matter (PM) has an adverse effect on respiratory morbidity.", {"entities": []}], ["Desert dust outbreaks contribute to increased PM levels but the toxicity of desert dust mixed with anthropogenic pollutants needs clarification.", {"entities": []}], ["We identified 132\u00a0days with desert dust episodes and 177 matched days by day of the week, season, temperature and humidity between 2001 and 2006 in Athens, Greece.", {"entities": []}], ["We collected data on regulated pollutants and daily emergency outpatient visits and admissions for respiratory causes.", {"entities": []}], ["We applied Poisson regression models adjusting for confounding effects of seasonality, meteorology, holidays and influenza epidemics.", {"entities": [[113, 122, "DISEASE"]]}], ["We evaluated the sensitivity of our results to co-pollutant exposures and effect modification by age and sex.", {"entities": []}], ["A 10\u00a0\u03bcg/m 10 concentration was associated with 1.95% (95% confidence interval (CI): 0.02%, 3.91%) increase in respiratory emergency room visits.", {"entities": []}], ["No significant interaction with desert dust episodes was observed.", {"entities": []}], ["Compared with non-dust days, there was a 47% (95% CI: 29%, 68%) increase in visits in dust days not adjusting for PM 10 .", {"entities": []}], ["Desert dust days were associated with higher numbers of emergency room visits for asthma, chronic obstructive pulmonary disease and respiratory infections with increases of 38%, 57% and 60%, respectively ( p \u00a0<\u00a00.001 for all comparisons).", {"entities": [[90, 127, "DISEASE"], [82, 88, "DISEASE"]]}], ["Analyses of respiratory hospital admissions provided similar results.", {"entities": []}], ["PM 10 effects decreased when adjusting for desert dust days and were further confounded by co-pollutants.", {"entities": []}], ["Desert dust episode days are associated with higher respiratory emergency room visits and hospital admissions.", {"entities": []}], ["This effect is insufficiently explained by increased PM 10 levels.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0281-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent advances in animal models of glioma have facilitated a better understanding of biological mechanisms underlying gliomagenesis and glioma progression.", {"entities": []}], ["The limitations of existing therapy, including surgery, chemotherapy, and radiotherapy, have prompted numerous investigators to search for new therapeutic approaches to improve quantity and quality of survival from these aggressive lesions.", {"entities": []}], ["One of these approaches involves triggering a tumor specific immune response.", {"entities": []}], ["However, a difficulty in this approach is the the scarcity of animal models of primary CNS neoplasms which faithfully recapitulate these tumors and their interaction with the host's immune system.", {"entities": []}], ["In this article, we review the existing methods utilized to date for modeling gliomas in rodents, with a focus on the known as well as potential immunological aspects of these models.", {"entities": []}], ["As this review demonstrates, many of these models have inherent immune system limitations, and the impact of these limitations on studies on the influence of pre-clinical therapeutics testing warrants further attention.", {"entities": []}], ["Live attenuated influenza vaccine (LAIV) is an intranasal vaccine recently incorporated into the United Kingdom immunization schedule.", {"entities": [[16, 25, "DISEASE"]]}], ["However, it contains egg protein and, in the absence of safety data, is contraindicated in patients with egg allergy.", {"entities": [[105, 116, "DISEASE"]]}], ["Furthermore, North American guidelines recommend against its use in asthmatic children.", {"entities": []}], ["We sought to assess the safety of LAIV in children with egg allergy.", {"entities": [[56, 67, "DISEASE"]]}], ["We performed a prospective, multicenter, open-label, phase IV intervention study involving 11 secondary/tertiary centers in the United Kingdom.", {"entities": []}], ["Children with egg allergy (defined as a convincing clinical reaction to egg within the past 12 months and/or >95% likelihood of clinical egg allergy as per published criteria) were recruited.", {"entities": [[14, 25, "DISEASE"], [137, 148, "DISEASE"]]}], ["LAIV was administered under medical supervision, with observation for 1 hour and telephone follow-up 72 hours later.", {"entities": []}], ["Four hundred thirty-three doses were administered to 282 children with egg allergy (median, 4.9 years; range, 2-17 years); 115 (41%) had experienced prior anaphylaxis to egg.", {"entities": [[71, 82, "DISEASE"]]}], ["A\u00a0physician's diagnosis of asthma/recurrent wheezing was noted in 67%, and 51% were receiving regular preventer therapy.", {"entities": [[27, 33, "DISEASE"]]}], ["There were no systemic allergic reactions (upper 95% CI for population, 1.3%).", {"entities": []}], ["Eight children experienced mild self-limiting symptoms, which might have been due an IgE-mediated allergic reaction.", {"entities": []}], ["Twenty-six (9.4%; 95% CI for population, 6.2% to 13.4%) children experienced lower respiratory tract symptoms within 72 hours, including 13 with parent-reported wheeze.", {"entities": []}], ["None of these episodes required medical intervention beyond routine treatment.", {"entities": []}], ["In contrast to current recommendations, LAIV appears to be safe for use in children with egg allergy.", {"entities": [[89, 100, "DISEASE"]]}], ["Furthermore, the vaccine appears to be well tolerated in\u00a0children with a diagnosis of asthma or recurrent wheeze.", {"entities": [[86, 92, "DISEASE"]]}], ["Herpes zoster is rare in healthy children, but immunocompromised persons have an increased risk of herpes zoster and severe diseases.", {"entities": [[0, 13, "DISEASE"], [99, 112, "DISEASE"]]}], ["Considering the very limited information on herpes zoster in children with cancer, we performed a nationwide population-based cohort study to estimate the incidence of herpes zoster in children with cancer and to explore the association between the 2 diseases.", {"entities": [[75, 81, "DISEASE"], [199, 205, "DISEASE"], [44, 57, "DISEASE"], [168, 181, "DISEASE"]]}], ["Data were obtained from the National Health Research Institutes Database in Taiwan.", {"entities": []}], ["A total of 4432 children with newly diagnosed cancer between 2000 and 2007 were identified as the cancer cohort, and 17,653 children without cancer frequency-matched by sex and age at entry were considered the noncancer cohort.", {"entities": [[46, 52, "DISEASE"], [98, 104, "DISEASE"], [141, 147, "DISEASE"]]}], ["The association between herpes zoster and childhood cancer was determined.", {"entities": [[52, 58, "DISEASE"], [24, 37, "DISEASE"]]}], ["Children with cancer had a higher risk of herpes zoster.", {"entities": [[14, 20, "DISEASE"], [42, 55, "DISEASE"]]}], ["The incidence rate of herpes zoster was higher in the cancer cohort than in the noncancer cohort (20.7 vs 2.4 per 10,000 person-years; IRR\u200a=\u200a8.6; 95% CI\u200a=\u200a4.8\u201315.6).", {"entities": [[54, 60, "DISEASE"], [22, 35, "DISEASE"]]}], ["The cumulative incidence was significantly higher in the cancer cohort ( P \u200a<\u200a0.0001).", {"entities": [[57, 63, "DISEASE"]]}], ["Leukemia, lymphoma, and solid tumor were all associated with the increased risk, and leukemia had the highest magnitude of strength of association.", {"entities": [[10, 18, "DISEASE"], [0, 8, "DISEASE"], [85, 93, "DISEASE"]]}], ["This nationwide population-based cohort study demonstrated that children with cancer were associated with an increased risk of herpes zoster.", {"entities": [[78, 84, "DISEASE"], [127, 140, "DISEASE"]]}], ["In addition to early antiviral treatment, vaccination with heat-treated zoster vaccine or adjuvanted subunit vaccine could be an appropriate policy to decrease the incidence in children with cancer.", {"entities": [[191, 197, "DISEASE"]]}], ["Obstructive sleep apnea (OSA) is becoming increasingly prevalent in North America and has been described in association with specific chronic diseases, particularly cardiovascular diseases.", {"entities": []}], ["In primary care, where the prevalence of co-occurring chronic conditions is very high, the potential association with OSA is unknown.", {"entities": []}], ["The purpose of this study was to explore the association between OSA and 1) the presence and severity of multimorbidity (multiple co-occurring chronic conditions), and 2) subcategories of multimorbidity.", {"entities": []}], ["A cluster sampling technique was used to recruit 120 patients presenting with OSA of various severities from the records of a sleep laboratory in 2008.", {"entities": []}], ["Severity of OSA was based on the results of the polysomnography.", {"entities": []}], ["Patients invited to participate received a mail questionnaire including questions on sociodemographic characteristics and the Disease Burden Morbidity Assessment (DBMA).", {"entities": []}], ["They also consented to give access to their medical records.", {"entities": []}], ["The DBMA was used to provide an overall multimorbidity score and sub-score of diseases affecting various systems.", {"entities": []}], ["Bivariate analysis did not demonstrate an association between OSA and multimorbidity (r\u2009=\u20090.117; p \u2009=\u20090.205).", {"entities": []}], ["However, severe OSA was associated with multimorbidity (adjusted odds ratio\u2009=\u20097.33 [1.67-32.23], p \u2009=\u20090.05).", {"entities": []}], ["OSA was moderately correlated with vascular (r\u2009=\u20090.26, p \u2009=\u20090.01) and metabolic syndrome (r\u2009=\u20090.26, p \u2009=\u20090.01) multimorbidity sub-scores.", {"entities": [[80, 88, "DISEASE"]]}], ["This study showed that severe OSA is associated with severe multimorbidity and sub-scores of multimorbidity.", {"entities": []}], ["These results do not allow any causal inference.", {"entities": []}], ["More research is required to confirm these associations.", {"entities": []}], ["However, primary care providers should be aware of these potential associations and investigate OSA when deemed appropriate.", {"entities": []}], ["Biochemical tests have been the basis for investigations of disorders affecting steroid hormones.", {"entities": []}], ["In recent years it has been possible however to study the genes that determine functional enzymes, cofactors, receptors, transcription factors and signaling systems that are involved in the process.", {"entities": []}], ["Analyses of mutations are available as a diagnostic service for only a few of these genes although research laboratories may be able to provide a service.", {"entities": []}], ["Both biochemical and genetic research have brought to light new disorders.", {"entities": []}], ["Some genes for transcription factors involved in the development of the endocrine organs have also been identified and patients with defects in these processes have been found.", {"entities": []}], ["This paper will review general aspects of adrenal disorders with emphasis on clinical and laboratory findings.", {"entities": []}], ["As with all endocrine investigations there are few single measurements that provide a definitive answer to a diagnosis.", {"entities": []}], ["Timing of samples in relation to age, gender and time of day needs to be considered.", {"entities": []}], ["Conflict of interest: None declared.", {"entities": []}], ["The disaccharide motif fucose-\u03b1(1-2)-galactose (Fuc\u03b1(1-2)Gal) is involved in many important physiological processes, such as learning and memory, inflammation, asthma, and tumorigenesis.", {"entities": [[160, 166, "DISEASE"]]}], ["However, the size and structural complexity of Fuc\u03b1(1-2)Gal-containing glycans have posed a significant challenge to their detection.", {"entities": []}], ["We report a new chemoenzymatic strategy for the rapid, sensitive detection of Fuc\u03b1(1-2)Gal glycans.", {"entities": []}], ["We demonstrate that the approach is highly selective for the Fuc\u03b1(1-2)Gal motif, detects a variety of complex glycans and glycoproteins, and can be used to profile the relative abundance of the motif on live cells, discriminating malignant from normal cells.", {"entities": []}], ["This approach represents a new potential strategy for biomarker detection and expands the technologies available for understanding the roles of this important class of carbohydrates in physiology and disease.", {"entities": []}], ["Background : The Asia-Pacific Economic Cooperation (APEC) meeting was held from 5 November to 11 November 2014 in Beijing, and comprehensive emission control measures were implemented.", {"entities": []}], ["The efficiency of these measures on particulate matter-related health impacts and economic cost need to be evaluated.", {"entities": []}], ["Methods : The influences of emission control measures during APEC on particulate matter were evaluated, and health economic effects were assessed.", {"entities": []}], ["Results : Average concentrations of PM 2.5 and PM 10 during APEC were reduced by 57.0%, and 50.6% respectively, compared with pre-APEC period.", {"entities": []}], ["However, the concentrations of particulate matter rebounded after APEC.", {"entities": []}], ["Compared with the pre-APEC and post-APEC periods, the estimated number of deaths caused by non-accidental, cardiovascular and respiratory diseases that could be attributed to PM 2.5 and PM 10 during the APEC were the lowest.", {"entities": []}], ["The economic cost associated with mortality caused by PM 2.5 and PM 10 during the APEC were reduced by (61.3% and 66.6%) and (50.3% and 60.8%) respectively, compared with pre-APEC and post-APEC.", {"entities": []}], ["Conclusions : The emission control measures were effective in improving short term air quality and reducing health risks and medical expenses during 2014 APEC, but more efforts is needed for long term and continuous air quality improvement and health protection.", {"entities": []}], ["Audit and feedback is one of the most widely used and promising interventions in implementation research, yet also one of the most variably effective.", {"entities": []}], ["Understanding this variability has been limited in part by lack of attention to the theoretical and conceptual basis underlying audit and feedback.", {"entities": []}], ["Examining the extent of theory use in studies of audit and feedback will yield better understanding of the causal pathways of audit and feedback effectiveness and inform efforts to optimize this important intervention.", {"entities": []}], ["A total of 140 studies in the 2012 Cochrane update on audit and feedback interventions were independently reviewed by two investigators.", {"entities": []}], ["Variables were extracted related to theory use in the study design, measurement, implementation or interpretation.", {"entities": []}], ["Theory name, associated reference, and the location of theory use as reported in the study were extracted.", {"entities": []}], ["Theories were organized by type ( e.g ., education, diffusion, organization, psychology), and theory utilization was classified into seven categories (justification, intervention design, pilot testing, evaluation, predictions, post hoc, other).", {"entities": []}], ["A total of 20 studies (14%) reported use of theory in any aspect of the study design, measurement, implementation or interpretation.", {"entities": []}], ["In only 13 studies (9%) was a theory reportedly used to inform development of the intervention.", {"entities": []}], ["A total of 18 different theories across educational, psychological, organizational and diffusion of innovation perspectives were identified.", {"entities": []}], ["Rogers\u2019 Diffusion of Innovations and Bandura\u2019s Social Cognitive Theory were the most widely used (3.6% and 3%, respectively).", {"entities": []}], ["The explicit use of theory in studies of audit and feedback was rare.", {"entities": []}], ["A range of theories was found, but not consistency of theory use.", {"entities": []}], ["Advancing our understanding of audit and feedback will require more attention to theoretically informed studies and intervention design.", {"entities": []}], ["Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension.", {"entities": [[174, 186, "DISEASE"]]}], ["Multicenter randomized clinical trial.", {"entities": []}], ["Eligible patients had 2 systolic blood pressure (SBP) measures \u2265180 mmHg and no contraindications to nicardipine or labetalol.", {"entities": []}], ["Before randomization, the physician specified a target SBP \u00b1 20 mmHg (the target range: TR).", {"entities": []}], ["The primary endpoint was the percent of subjects meeting TR during the initial 30 minutes of treatment.", {"entities": []}], ["Of 226 randomized patients, 110 received nicardipine and 116 labetalol.", {"entities": []}], ["End organ damage preceded treatment in 143 (63.3%); 71 nicardipine and 72 labetalol patients.", {"entities": []}], ["Median initial SBP was 212.5 (IQR 197, 230) and 212 mmHg (IQR 200,225) for nicardipine and labetalol patients ( P = 0.68), respectively.", {"entities": []}], ["Within 30 minutes, nicardipine patients more often reached TR than labetalol (91.7 vs. 82.5%, P = 0.039).", {"entities": []}], ["Of 6 BP measures (taken every 5 minutes) during the study period, nicardipine patients had higher rates of five and six instances within TR than labetalol (47.3% vs. 32.8%, P = 0.026).", {"entities": []}], ["Rescue medication need did not differ between nicardipine and labetalol (15.5 vs. 22.4%, P = 0.183).", {"entities": []}], ["Labetalol patients had slower heart rates at all time points ( P < 0.01).", {"entities": []}], ["Multivariable modeling showed nicardipine patients were more likely in TR than labetalol patients at 30 minutes (OR 2.73, P = 0.028; C stat for model = 0.72) Patients treated with nicardipine are more likely to reach the physician-specified SBP target range within 30 minutes than those treated with labetalol.", {"entities": []}], ["ClinicalTrials.gov: NCT00765648", {"entities": []}], ["To create and validate a frailty assessment tool for community-dwelling adults aged \u226575\u2005years.", {"entities": []}], ["Longitudinal, population-based study.", {"entities": []}], ["The Survey of Health, Ageing and Retirement in Europe (SHARE).", {"entities": []}], ["4001 women and 3057 men aged \u226575\u2005years from the second wave of SHARE.", {"entities": []}], ["3325 women and 2587 men had complete information for the frailty indicators: fatigue, low appetite, weakness, observed gait (walking without help, walking with help, chairbound/bedbound, unobserved) and low physical activity.", {"entities": []}], ["The internal validity of the frailty indicators was tested with latent class analysis, by modelling an underlying variable with three ordered categories.", {"entities": []}], ["The predictive validity of the frailty classification was tested against 2-year mortality and 4-year disability.", {"entities": []}], ["The mortality prediction of SHARE-FI75+ was compared with that of previously operationalised frailty scales in SHARE (SHARE-FI, 70-item index, phenotype, FRAIL).", {"entities": []}], ["In both genders, all frailty indicators significantly aggregated into a three-category ordinal latent variable.", {"entities": []}], ["After adjusting for baseline age, comorbidity and basic activities of daily living (BADL) disability, the frail had an OR for 2-year mortality of 2.2 (95% CI 1.2 to 3.8) in women and 4.2 (2.6 to 6.8) in men.", {"entities": []}], ["The mortality prediction of SHARE-FI75+ was similar to that of the other SHARE frailty scales.", {"entities": []}], ["By wave 4, 49% of frail women (78 of 159) had at least one more limitation with BADL (compared with 18% of non-frail, 125 of 684; p<0.001); in men, these proportions were 39% (26 of 66) and 18% (110 of 621), respectively (p<0.001).", {"entities": []}], ["A calculator is supplied for point-of-care use, which automatically replicates the frailty classification for any given measurements.", {"entities": []}], ["SHARE-FI75+ could help frailty case finding in primary care and provide a focus for personalised community interventions.", {"entities": []}], ["Further validation in trials and clinical programmes is needed.", {"entities": []}], ["Increased airway wall thickness (AWT) and parenchymal lung destruction both contribute to airflow limitation.", {"entities": []}], ["Advances in computed tomography (CT) post-processing imaging allow to quantify these features.", {"entities": []}], ["The aim of this Dutch population study is to assess the relationships between AWT, lung function, emphysema and respiratory symptoms.", {"entities": []}], ["AWT and emphysema were assessed by low-dose CT in 500 male heavy smokers, randomly selected from a lung cancer screening population.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["AWT was measured in each lung lobe in cross-sectionally reformatted images with an automated imaging program at locations with an internal diameter of 3.5\u2009mm, and validated in smaller cohorts of patients.", {"entities": []}], ["The 15 Median AWT in airways with an internal diameter of 3.5\u2009mm (AWT 3.5 ) was 0.57 (0.44 - 0.74) mm.", {"entities": []}], ["Median AWT in subjects without symptoms was 0.52 (0.41-0.66) and in those with dyspnea and/or wheezing 0.65 (0.52-0.81) mm (p<0.001).", {"entities": []}], ["In the multivariate analysis only AWT 3.5 and emphysema independently explained 31.1%and 9.5%of the variance in FEV 1 %predicted, respectively, after adjustment for smoking behavior.", {"entities": [[112, 115, "GENE"]]}], ["Post processing standardization of airway wall measurements provides a reliable and useful method to assess airway wall thickness.", {"entities": []}], ["Increased airway wall thickness contributes more to airflow limitation than emphysema in a smoking male population even after adjustment for smoking behavior.", {"entities": []}], ["Rates of chronic disease are escalating around the world.", {"entities": []}], ["To date health service evaluations have focused on interventions for single chronic diseases.", {"entities": []}], ["However, evaluations of the effectiveness of new intervention strategies that target single chronic diseases as well as multimorbidity are required, particularly in areas outside major metropolitan centres where access to services, such as specialist care, is difficult and where the retention and recruitment of health professionals affects service provision.", {"entities": []}], ["This study is a longitudinal investigation with a baseline and three follow-up assessments comparing the health and health costs of people with chronic disease before and after intervention at a chronic disease clinic, in regional Australia.", {"entities": []}], ["The clinic is led by students under the supervision of health professionals.", {"entities": []}], ["The study will provide preliminary evidence regarding the effectiveness of the intervention, and evaluate the influence of a range of factors on the health outcomes and costs of the patients attending the clinic.", {"entities": []}], ["Patients will be evaluated at baseline (intake to the service), and at 3-, 6-, and 12-months after intake to the service.", {"entities": []}], ["Health will be measured using the SF-36 and health costs will be measured using government and medical record sources.", {"entities": []}], ["The intervention involves students and health professionals from multiple professions working together to treat patients with programs that include education and exercise therapy programs for back pain, and Healthy Lifestyle programs; as well as individual consultations involving single professions.", {"entities": []}], ["Understanding the effect of a range of factors on the health state and health costs of people attending an interdisciplinary clinic will inform health service provision for this clinical group and will determine which factors need to be controlled for in future observational studies.", {"entities": []}], ["Preliminary evidence regarding changes in health and health costs associated with the intervention will be a platform for future clinical trials of intervention effectiveness.", {"entities": []}], ["The results will be of interest to teams investigating new chronic disease programs particularly for people with multimorbidity, and in areas outside major metropolitan centres.", {"entities": []}], ["Australia and New Zealand Clinical Trials Registry: ACTRN12611000724976", {"entities": []}], ["Dengue causes considerable morbidity and mortality in Sri Lanka.", {"entities": []}], ["Inflammatory mediators such as cytokines, contribute to its evolution from an asymptotic infection to severe forms of dengue.", {"entities": []}], ["The majority of previous studies have analysed the association of individual cytokines with clinical disease severity.", {"entities": []}], ["In contrast, we view evolution to Dengue Haemorrhagic Fever as the behaviour of a complex dynamic system.", {"entities": []}], ["We therefore, analyse the combined effect of multiple cytokines that interact dynamically with each other in order to generate a mathematical model to predict occurrence of Dengue Haemorrhagic Fever.", {"entities": []}], ["We expect this to have predictive value in detecting severe cases and improve outcomes.", {"entities": []}], ["Platelet activating factor (PAF), Sphingosine 1- Phosphate (S1P), IL-1\u03b2, TNF\u03b1 and IL-10 are used as the parameters for the model.", {"entities": []}], ["Hierarchical clustering is used to detect factors that correlated with each other.", {"entities": []}], ["Their interactions are mapped using Fuzzy Logic mechanisms with the combination of modified Hamacher and OWA operators.", {"entities": []}], ["Trapezoidal membership functions are developed for each of the cytokine parameters and the degree of unfavourability to attain Dengue Haemorrhagic Fever is measured.", {"entities": []}], ["The accuracy of this model in predicting severity level of dengue is 71.43% at 96\u00a0h from the onset of illness, 85.00% at 108\u00a0h and 76.92% at 120\u00a0h. A region of ambiguity is detected in the model for the value range 0.36 to 0.51.", {"entities": []}], ["Sensitivity analysis indicates that this is a robust mathematical model.", {"entities": []}], ["The results show a robust mathematical model that explains the evolution from dengue to its serious forms in individual patients with high accuracy.", {"entities": []}], ["However, this model would have to be further improved by including additional parameters and should be validated on other data sets.", {"entities": []}], ["The online version of this article (doi:10.1186/s12918-017-0415-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Two recent Phase III clinical trials to investigate an intravaginal ring for preventing HIV infection demonstrated that adherence to prescribed device use was a primary driver of efficacy.", {"entities": []}], ["Surrogate methods for determining adherence in the studies were limited in their inability to monitor temporal patterns of use and allow deconvolution of the effects of adherence and device efficacy on HIV infection rates.", {"entities": []}], ["To address this issue, we have developed functionality in an intravaginal ring to continuously monitor when the device is being used and maintain a log of adherence that can be accessed by clinicians after it is removed.", {"entities": []}], ["An electronic module fabricated with common, inexpensive electronic components was encapsulated in a silicone intravaginal ring.", {"entities": []}], ["The device uses temperature as a surrogate measure of periods of device insertion and removal, and stores a record of the data for subsequent retrieval.", {"entities": []}], ["The adherence-monitoring intravaginal ring accurately recorded the device status over 33 simulated IN-OUT cycles and more than 1000 measurement cycles in vitro .", {"entities": []}], ["Following initial in vitro testing in a temperature-controlled chamber, the device was evaluated in vivo in sheep using a predetermined insertion/removal pattern to simulate intravaginal ring use.", {"entities": []}], ["After insertion into the vaginal cavity of a sheep, the logged data correctly indicated the device status over 29 hours of continuous measurement including three cycles of insertion and removal.", {"entities": []}], ["The device described here is a promising, low-cost method for real-time adherence assessment in clinical trials involving medicated intravaginal rings or other intravaginal devices.", {"entities": []}], ["Lipids are essential for physiological processes such as maintaining membrane integrity, providing a source of energy and acting as signalling molecules to control processes including cell proliferation, metabolism, inflammation and apoptosis.", {"entities": []}], ["Disruption of lipid homeostasis can promote pathological changes that contribute towards biological ageing and age-related diseases.", {"entities": []}], ["Several age-related diseases have been associated with altered lipid metabolism and an elevation in highly damaging lipid peroxidation products; the latter has been ascribed, at least in part, to mitochondrial dysfunction and elevated ROS formation.", {"entities": []}], ["In addition, senescent cells, which are known to contribute significantly to age-related pathologies, are also associated with impaired mitochondrial function and changes in lipid metabolism.", {"entities": []}], ["Therapeutic targeting of dysfunctional mitochondrial and pathological lipid metabolism is an emerging strategy for alleviating their negative impact during ageing and the progression to age-related diseases.", {"entities": []}], ["Such therapies could include the use of drugs that prevent mitochondrial uncoupling, inhibit inflammatory lipid synthesis, modulate lipid transport or storage, reduce mitochondrial oxidative stress and eliminate senescent cells from tissues.", {"entities": []}], ["In this review, we provide an overview of lipid structure and function, with emphasis on mitochondrial lipids and their potential for therapeutic targeting during ageing and age-related disease.", {"entities": []}], ["Underdiagnosis of COPD is a relevant issue, and most frequently involves patients at early stages of the disease.", {"entities": []}], ["Physicians do not routinely recommend smokers to undergo spirometry, unless they are symptomatic.", {"entities": []}], ["To investigate the effectiveness of voluntary lung function screening in bringing to light patients with previously unknown COPD and to evaluate the relationships among symptoms, smoking status, and airway obstruction.", {"entities": []}], ["A voluntary screening study for COPD was conducted during two editions of the annual Fiera del Levante (2014 and 2015), an international trade fair in Bari.", {"entities": []}], ["Subjects were eligible for the study if they fulfilled the following inclusion criteria: age \u226535 years, smoker/ex-smoker \u22655 pack-years (PYs), or at least one chronic respiratory symptom (cough, sputum production, shortness of breath, and wheezing).", {"entities": []}], ["A free post-\u03b2 2 -agonist spirometry test was performed by trained physicians for each participant using portable spirometers.", {"entities": []}], ["Post-\u03b2 2 -agonist forced expiratory volume in 1 second (FEV 1 ):forced vital capacity ratio <0.7 was chosen to establish the diagnosis of COPD.", {"entities": [[56, 59, "GENE"]]}], ["Sensitivity, specificity, and negative and positive predictive values (NPVs and PPVs) of symptoms for the presence of obstruction were calculated.", {"entities": []}], ["A total of 1,920 individuals were eligible for the study; 188 subjects (9.8%) met COPD criteria.", {"entities": []}], ["There was a 10.4% prevalence of COPD in subjects with one or more symptoms who had never smoked or smoked \u22645 PYs.", {"entities": []}], ["Among COPD patients, prevalence of symptoms increased in the presence of FEV 1 <80%.", {"entities": [[73, 76, "GENE"]]}], ["COPD smokers were more symptomatic than smokers without COPD.", {"entities": []}], ["Sensitivity and specificity in all subjects with one or more symptoms were 87% and 32%, respectively, whereas in smoker subgroups, sensitivity and specificity were 71% and 41% (\u22655 PYs) and 74% and 35% (\u226510 PYs), respectively.", {"entities": []}], ["In all subjects, the presence of at least one symptom was associated with a low PPV for COPD of 11%, but a very high NPV (96%).", {"entities": []}], ["These data did not change if the analysis was limited to smokers.", {"entities": []}], ["Voluntary public lung function screening programs in Italy are effective, and may detect a large number of undiagnosed subjects with COPD in early stages.", {"entities": []}], ["In our population, COPD symptoms had low specificity and PPV, even considering smokers only.", {"entities": []}], ["With the increasing use of the internet and the spread of smartphones, health information seekers obtain considerable information through the internet.", {"entities": []}], ["As the amount of online health information increases, the need for quality management of health information has been emphasized.", {"entities": []}], ["The purpose of this study was to investigate the factors affecting the intention of using accredited online health information by applying the extended technology acceptance model (Extended-TAM).", {"entities": []}], ["An online survey was conducted from September 15, 2016 to October 3, 2016, on 500 men and women aged 19\u201369 years.", {"entities": []}], ["The results showed that the greatest factor influencing the acceptance of the accredited health information was perceived usefulness, and the expectation for the quality of the accreditation system was the most important mediator variable.", {"entities": []}], ["In order to establish the health information accreditation system as a means to provide easy and useful information to the consumers, it is necessary to carry out quality management and promote the system through the continuous monitoring of the accreditation system.", {"entities": []}], ["Background .", {"entities": []}], ["The use of a squalene-containing (AS03) pandemic vaccine for high-risk groups in England allowed vaccine effectiveness (VE) of such novel oil-in-water adjuvanted vaccine to be evaluated.", {"entities": []}], ["Cases of laboratory-confirmed pandemic (H1N1)2009 influenza in England between November 2009 and January 2010 were followed up for history of pandemic (H1N1)2009 or 2009/10 seasonal influenza vaccination and relevant comorbidities.", {"entities": [[50, 59, "DISEASE"], [182, 191, "DISEASE"]]}], ["Controls were patients similarly tested but negative for the virus.", {"entities": []}], ["We estimated pandemic (H1N1)2009 VE from the relative reduction in the odds of confirmed pandemic (H1N1)2009 infection between vaccinated and unvaccinated individuals after adjustment for confounders.", {"entities": []}], ["A total of 933 cases and 1220 controls were analyzed.", {"entities": []}], ["VE from \u226514 days was 62% (95% CI 33% to 78%) with protection from 7 to 13 days post-vaccination (59%, 95% CI 12% to 81%).", {"entities": []}], ["VE from \u226514 days differed by age ( P =.03) being 77% (11% to 94%) in children <10 years, 100% (80% to 100%) in 10\u201324-year olds, 22% (-153% to 76%) in 25\u201349-year olds, and 41% (-71% to 80%) in 50-plus-year-olds.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Use of oil-in-water adjuvant contributed to a high VE with reduced antigen dosage in children and young adults.", {"entities": []}], ["Our VE estimate supports the serological correlates of protection used for licensure in these age groups.", {"entities": []}], ["However, the immunological basis of disappointing VE in older adults merits investigation.", {"entities": []}], ["We aimed to determine whether average and trimester-specific exposures to ambient measures of nitrogen dioxide (NO 2 ) and particular matter (PM 2.5 ) were associated with elevated cord blood concentrations of immunoglobulin E (IgE) and two epithelial cell produced cytokines: interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP).", {"entities": [[334, 338, "GENE"]]}], ["This study utilized data and biospecimens from the Maternal-Infant Research on Environmental Chemicals (MIREC) Study.", {"entities": []}], ["There were 2001 pregnant women recruited between 2008 and 2011 from 10 Canadian cities.", {"entities": []}], ["Maternal exposure to NO 2 and PM 2.5 was estimated using land use regression and satellite-derived models.", {"entities": []}], ["We observed statistically significant associations between maternal NO 2 exposure and elevated cord blood concentrations of both IL-33 and TSLP among girls but not boys.", {"entities": [[139, 143, "GENE"]]}], ["Maternal NO 2 exposure may impact the development of the newborn immune system as measured by cord blood concentrations of two cytokines.", {"entities": []}], ["To identify different types of models used in economic evaluations of smoking cessation, analyse the quality of the included models examining their attributes and ascertain their transferability to a new context.", {"entities": []}], ["A systematic review of the literature on the economic evaluation of smoking cessation interventions published between 1996 and April 2015, identified via Medline, EMBASE, National Health Service (NHS) Economic Evaluation Database (NHS EED), Health Technology Assessment (HTA).", {"entities": [[196, 199, "GENE"], [231, 234, "GENE"], [196, 199, "GENE"], [231, 234, "GENE"], [235, 238, "GENE"], [271, 274, "GENE"]]}], ["The checklist\u2010based quality of the included studies and transferability scores was based on the European Network of Health Economic Evaluation Databases (EURONHEED) criteria.", {"entities": []}], ["Studies that were not in smoking cessation, not original research, not a model\u2010based economic evaluation, that did not consider adult population and not from a high\u2010income country were excluded.", {"entities": []}], ["Among the 64 economic evaluations included in the review, the state\u2010transition Markov model was the most frequently used method ( n \u00a0=\u00a030/64), with quality adjusted life years (QALY) being the most frequently used outcome measure in a life\u2010time horizon.", {"entities": []}], ["A small number of the included studies (13 of 64) were eligible for EURONHEED transferability checklist.", {"entities": []}], ["The overall transferability scores ranged from 0.50 to 0.97, with an average score of 0.75.", {"entities": []}], ["The average score per section was 0.69 (range\u00a0=\u00a00.35\u20130.92).", {"entities": []}], ["The relative transferability of the studies could not be established due to a limitation present in the EURONHEED method.", {"entities": []}], ["All existing economic evaluations in smoking cessation lack in one or more key study attributes necessary to be fully transferable to a new context.", {"entities": []}], ["Optimal functioning of the immune system is crucial to human health, and nutrition is one of the major exogenous factors modulating different aspects of immune function.", {"entities": []}], ["Currently, no single marker is available to predict the effect of a dietary intervention on different aspects of immune function.", {"entities": []}], ["To provide further guidance on the assessment and interpretation of the modulation of immune functions due to nutrition in the general population, International Life Sciences Institute Europe commissioned a group of experts from academia, government and the food industry to prepare a guidance document.", {"entities": []}], ["A draft of this paper was refined at a workshop involving additional experts.", {"entities": []}], ["First, the expert group defined criteria to evaluate the usefulness of immune function markers.", {"entities": []}], ["Over seventy-five markers were scored within the context of three distinct immune system functions: defence against pathogens; avoidance or mitigation of allergy; control of low-grade (metabolic) inflammation.", {"entities": []}], ["The most useful markers were subsequently classified depending on whether they by themselves signify clinical relevance and/or involvement of immune function.", {"entities": []}], ["Next, five theoretical scenarios were drafted describing potential changes in the values of markers compared with a relevant reference range.", {"entities": []}], ["Finally, all elements were combined, providing a framework to aid the design and interpretation of studies assessing the effects of nutrition on immune function.", {"entities": []}], ["This stepwise approach offers a clear rationale for selecting markers for future trials and provides a framework for the interpretation of outcomes.", {"entities": []}], ["A similar stepwise approach may also be useful to rationalise the selection and interpretation of markers for other physiological processes critical to the maintenance of health and well-being.", {"entities": []}], ["Tools to predict death or spontaneous survival are necessary to inform liver transplantation (LTx) decisions in pediatric acute liver failure (PALF), but such tools are not available.", {"entities": []}], ["Recent data suggest that immune/inflammatory dysregulation occurs in the setting of acute liver failure.", {"entities": []}], ["We hypothesized that specific, dynamic, and measurable patterns of immune/inflammatory dysregulation will correlate with outcomes in PALF.", {"entities": []}], ["We assayed 26 inflammatory mediators on stored serum samples obtained from a convenience sample of 49 children in the PALF study group (PALFSG) collected within 7 days after enrollment.", {"entities": []}], ["Outcomes were assessed within 21 days of enrollment consisting of spontaneous survivors, non-survivors, and LTx recipients.", {"entities": []}], ["Data were subjected to statistical analysis, patient-specific Principal Component Analysis (PCA), and Dynamic Bayesian Network (DBN) inference.", {"entities": []}], ["Raw inflammatory mediator levels assessed over time did not distinguish among PALF outcomes.", {"entities": []}], ["However, DBN analysis did reveal distinct interferon-gamma-related networks that distinguished spontaneous survivors from those who died.", {"entities": []}], ["The network identified in LTx patients pre-transplant was more like that seen in spontaneous survivors than in those who died, a finding supported by PCA.", {"entities": []}], ["The application of DBN analysis of inflammatory mediators in this small patient sample appears to differentiate survivors from non-survivors in PALF.", {"entities": []}], ["Patterns associated with LTx pre-transplant were more like those seen in spontaneous survivors than in those who died.", {"entities": []}], ["DBN-based analyses might lead to a better prediction of outcome in PALF, and could also have more general utility in other complex diseases with an inflammatory etiology.", {"entities": []}], ["Respiratory syncytial virus (RSV)-bronchiolitis is a major cause of infant morbidity and mortality and a risk factor for subsequent asthma.", {"entities": [[132, 138, "DISEASE"], [34, 47, "DISEASE"]]}], ["We showed previously that toll-like receptor (TLR)7 in plasmacytoid dendritic cells (pDCs) is critical for protection against bronchiolitis and asthma in mice infected with pneumonia virus of mice (PVM), the mouse homolog of RSV.", {"entities": [[173, 182, "DISEASE"], [144, 150, "DISEASE"], [126, 139, "DISEASE"]]}], ["This lack of redundancy was unexpected as interferon-\u03b2 promotor stimulator-1 (IPS-1) signalling, downstream of RIG-I-like receptor (RLR) and not TLR7 activation, contributes to host defence in hRSV-inoculated adult mice.", {"entities": [[145, 149, "GENE"]]}], ["To further clarify the role of IPS-1 signalling, we inoculated IPS-1", {"entities": []}], ["Fibrous dysplasia is a benign tumour of the bones and is a disease of unknown aetiology.", {"entities": [[0, 17, "DISEASE"]]}], ["This report discusses a case of proptosis and visual deterioration with associated bony mass involving the right orbit.", {"entities": []}], ["A 32-year-old Nigerian man of Yoruba ethnic origin presented to the eye clinic of our hospital with right-eye proptosis and visual deterioration of 7-year duration.", {"entities": []}], ["Presentation was preceded by a history of trauma.", {"entities": []}], ["Proptosis was preceded by trauma but was non-pulsatile with no thrill or bruit but was associated with bony orbital mass.", {"entities": []}], ["The patient reported no weight loss.", {"entities": []}], ["Examination of his right eye showed visual acuity of 6/60 with relative afferent pupillary defect.", {"entities": []}], ["Fundal examination revealed optic atrophy.", {"entities": [[28, 41, "DISEASE"]]}], ["Computed tomography showed an expansile bony mass involving all the walls of the orbit.", {"entities": []}], ["The bony orbital mass was diagnosed histologically as fibrous dysplasia.", {"entities": [[54, 71, "DISEASE"]]}], ["Treatment included orbital exploration and orbital shaping to create room for the globe and relieve pressure on the optic nerve.", {"entities": []}], ["Fibrous dysplasia should be considered in the differential diagnosis of slowly developing proptosis with associated visual loss in young adults.", {"entities": [[0, 17, "DISEASE"]]}], ["Previous population-based studies have found that delusional-like experiences (DLE) are prevalent in the community, and are associated with a wide range of mental health disorders including substance use.", {"entities": []}], ["The aim of the study was to explore the association between DLE and three commonly used substances - tobacco, alcohol and cannabis.", {"entities": []}], ["Subjects were drawn from the Australian National Survey of Mental Health and Wellbeing 2007.", {"entities": []}], ["The Composite International Diagnostic Interview was used to identify DLE, common psychiatric disorders, and substance use.", {"entities": []}], ["We examined the relationship between the variables of interest using logistic regression, adjusting for potential confounding factors.", {"entities": []}], ["Of 8 773 participants, 8.4% (n = 776) subjects endorsed one or more DLE.", {"entities": []}], ["With respect to tobacco use, compared to nonusers, DLE were more common in those who (a) had daily use, (b) commenced usage aged 15 years or less, and (c) those who smoked heavily (23 or more cigarettes per day).", {"entities": []}], ["Participants with cannabis use disorders were more likely to endorse DLE; this association was most prominent in those with an onset of 16 years or younger.", {"entities": []}], ["In contrast, the pattern of association between DLE versus alcohol use or dependence was less consistent, however those with early onset alcohol use disorders were more likely to endorse DLE probe items.", {"entities": []}], ["While cannabis use disorders have been previously linked with DLE, our findings linking alcohol and tobacco use and DLE suggest that the influence of these substances on psychosis-related outcomes warrants closer scrutiny in longitudinal prospective studies.", {"entities": []}], ["Multimorbidity increases with age and is generally more common in women, but little is known about sex effects on the \u201ctypology\u201d of multimorbidity.", {"entities": []}], ["We have characterized multimorbidity in a large nationally representative primary care dataset in terms of sex in ten year age groups from 25 years to 75 years and over, in a cross-sectional analysis of multimorbidity type (physical-only, mental-only, mixed physical and mental; and commonest conditions) for 1,272,685 adults in Scotland.", {"entities": []}], ["Our results show that women had more multimorbidity overall in every age group, which was most pronounced in the 45\u201354 years age group (women 26.5% vs. men 19.6%; difference 6.9 (95% CI 6.5 to 7.2).", {"entities": []}], ["From the age of 45, physical-only multimorbidity was consistently more common in men, and physical-mental multimorbidity more common in women.", {"entities": []}], ["The biggest difference in physical-mental multimorbidity was found in the 75 years and over group (women 30.9% vs. men 21.2%; difference 9.7 (95% CI 9.1 to 10.2).", {"entities": []}], ["The commonest condition in women was depression until the age of 55 years, thereafter hypertension.", {"entities": [[86, 98, "DISEASE"]]}], ["In men, drugs misuse had the highest prevalence in those aged 25\u201334 years, depression for those aged 35\u201344 years, and hypertension for 45 years and over.", {"entities": [[118, 130, "DISEASE"]]}], ["Depression, pain, irritable bowel syndrome and thyroid disorders were more common in women than men across all age groups.", {"entities": [[18, 42, "DISEASE"], [34, 42, "DISEASE"]]}], ["We conclude that the higher overall prevalence of multimorbidity in women is mainly due to more mixed physical and mental health problems.", {"entities": []}], ["The marked difference between the sexes over 75 years especially warrants further investigation.", {"entities": []}], ["The significant roles of genetic variants in myasthenia gravis (MG) pathogenesis have been demonstrated in many studies, and recently it has been revealed that aberrant level/regulation of microRNAs (miRNAs) might contribute to the initiation and progression of MG.", {"entities": [[45, 62, "DISEASE"]]}], ["However, the dysfunction of miRNA associated with single nucleotide polymorphisms (miRSNPs) has not been well investigated in MG.", {"entities": []}], ["In this study, we created a contemporary catalog of 89 MG risk genes via manual literature-mining.", {"entities": []}], ["Based on this risk gene catalog, we obtained 18 MG risk pathways.", {"entities": []}], ["Furthermore, we identified 93 miRNAs that target MG risk pathways and revealed the miRSNPs \u2018switches\u2019 in miRNA regulation in the MG risk pathways by integrating the database information of miRSNPs.", {"entities": []}], ["We also constructed a miRNA-mediated SNP switching pathway network (MSSPN) to intuitively analyze miRNA regulation of MG risk pathways and the relationship of the polymorphism \u2018switch\u2019 with these changes in regulation.", {"entities": []}], ["Moreover, we carried out in-depth dissection on the correlation between hsa05200 (pathway in cancer) and MG development, and elaborated the significance of 4 high-risk genes.", {"entities": [[93, 99, "DISEASE"]]}], ["By network analysis and literature mining, we proposed a potential mechanism of miRSNPs\u2192gene\u2192pathway effects on MG pathogenesis, especially for rs28457673 (miR-15/16/195/424/497 family)\u2192 IGF1R \u2192hsa05200 (pathway in cancer).", {"entities": [[215, 221, "DISEASE"], [187, 192, "GENE"]]}], ["Therefore, our studies have revealed a functional role for genetic modulators in MG pathogenesis at a systemic level, which could be informative for further miRNA and miRSNPs studies in MG.", {"entities": []}], ["Alopecia areata (AA), a prevalent inflammatory cause of hair loss, lacks FDA-approved therapeutics for extensive cases, which are associated with very poor rates of spontaneous hair regrowth and major psychological distress.", {"entities": []}], ["Current treatments for severe cases include broad immune-suppressants, which are associated with significant adverse effects, precluding long-term use, with rapid hair loss following treatment termination.", {"entities": []}], ["As a result of the extent of the disease in severe cases, topical contact sensitizers and intralesional treatments are of limited use.", {"entities": []}], ["The pathogenesis of AA is not yet fully understood, but recent investigations of the immune activation in AA skin reveal Th1/IFN-\u03b3, as well as Th2, PDE4, IL-23, and IL-9 upregulations.", {"entities": []}], ["Tissue analyses of both animal models and human lesions following broad-acting and cytokine-specific therapeutics (such as JAK inhibitors and ustekinumab, respectively) provide another opportunity for important insights into the pathogenesis of AA.", {"entities": []}], ["As reviewed in this paper, numerous novel therapeutics are undergoing clinical trials for AA, emphasizing the potential transformation of the clinical practice of AA, which is currently lacking.", {"entities": []}], ["Dermatologists are already familiar with the revolution in disease management of psoriasis, stemming from better understanding of immune dysregulations, and atopic dermatitis will soon follow a similar path.", {"entities": [[81, 90, "DISEASE"], [157, 174, "DISEASE"], [164, 174, "DISEASE"]]}], ["In light of these recent developments, the therapeutic arena of AA treatments is finally getting more exciting.", {"entities": []}], ["AA will join the lengthening list of dermatologic diseases with mechanism-targeted drugs, thus changing the face of AA.", {"entities": []}], ["The pathophysiological role of human chitinases and chitinase-like proteins (CLPs) is not fully understood.", {"entities": [[77, 81, "GENE"]]}], ["We aimed to determine the levels of neutrophil-derived chitotriosidase (CHIT1), acidic mammalian chitinase (AMCase) and chitinase 3-like protein 1 (YKL-40) in patients with type 2 diabetes (T2D) and verify their association with metabolic and clinical conditions of these patients.", {"entities": [[72, 77, "GENE"]]}], ["Neutrophils were obtained from the whole blood by gradient density centrifugation from 94 T2D patients and 40 control subjects.", {"entities": []}], ["The activities of CHIT1 and AMCase as well as leukocyte elastase (LE) were measured fluorometrically and concentration of YKL-40 immunoenzymatically.", {"entities": [[18, 23, "GENE"]]}], ["Also, routine laboratory parameters in serum/plasma were determined by standard methods.", {"entities": []}], ["The levels of all three examined proteins were about 2-times higher in diabetic patients in comparison to control subjects.", {"entities": []}], ["They were significantly correlated with the activity of LE and increased progressively across tertiles of LE activity.", {"entities": []}], ["Moreover, the activities of CHIT1 and AMCase were significantly correlated with each other.", {"entities": [[28, 33, "GENE"]]}], ["Metabolic compensation of diabetes did not influence the levels of these proteins.", {"entities": []}], ["In the subgroup of patients with inflammatory evidence only YKL-40 concentration was significantly higher compared to those without inflammation.", {"entities": []}], ["The highest levels of all three proteins were observed in patients with macroangiopathies.", {"entities": []}], ["Insulin therapy was associated with lower levels of examined proteins.", {"entities": []}], ["We revealed that neutrophils may be an important source of the increased levels of chitinases and CLPs in T2D, and these proteins may participate in inflammatory mechanisms in the course of the disease and consequent development of diabetic angiopathies.", {"entities": [[98, 102, "GENE"]]}], ["Prior studies addressing the impacts of regular physical activity or sedentary habits on the immune system have been conducted in adults and laboratory settings.", {"entities": []}], ["Thus, it is practically unknown how a healthy active lifestyle could affect low-grade inflammation processes, infections or allergies in young persons.", {"entities": []}], ["The AFINOS Study was designed to determine the relationship between the regular physical activity levels of adolescents and overweight, infection, and allergies along with the presence of metabolic and immunological biomarkers of a deteriorated health status.", {"entities": []}], ["A further objective of the AFINOS Study is to assess the health status and lifestyle habits of an adolescent population in an effort to identify any protective factors that could be used as preventive measures, since many chronic diseases and their associated co-morbidities often persist from adolescence into adulthood.", {"entities": []}], ["This study was conducted as three separate sub-studies in three different populations as follows: (a) Study 1 was performed on a population sample of adolescents; (b) Study 2 on the adolescents' parents; and (c) Study 3 on a subset of the adolescents from Study 1.", {"entities": []}], ["Study 1 assessed health and lifestyle indicators through a questionnaire administered to a representative sample of adolescents from the Madrid Region (n = 2400) aged 13 to 16 years.", {"entities": []}], ["In Study 2, the parents of the teenagers participating in Study 1 were required to fill out a questionnaire.", {"entities": []}], ["Finally in Study 3, body composition, physical activity, health-related physical fitness, and blood measurements were determined in a subset (n = 200) of the individuals included in Study 1.", {"entities": []}], ["This paper describes the rationale, design, and methodologies used in the AFINOS Study.", {"entities": []}], ["This multidisciplinary, multicenter study seeks to evaluate several aspects of existing relationships between routine physical activity/sedentary behaviour and several health status markers, specifically those related to the immune system.", {"entities": []}], ["The results of this cross-sectional study will serve for comparisons with the available data obtained in laboratory settings and in adults.", {"entities": []}], ["In addition, knowledge regarding the health status and lifestyle habits of Spanish adolescents and their parents will be useful for designing preventive measures.", {"entities": []}], ["Chronic eczema is commonly encountered in the Indian set up.", {"entities": []}], ["So also is atopic dermatitis.", {"entities": [[11, 28, "DISEASE"], [18, 28, "DISEASE"]]}], ["House dust mites (Dermatophagoides) are implicated in various diseases like atopic dermatitis, asthma, and perennial rhinitis.", {"entities": [[76, 93, "DISEASE"], [117, 125, "DISEASE"], [95, 101, "DISEASE"], [83, 93, "DISEASE"]]}], ["It has also been proven that patch testing with Dermatophagoides pteronyssinus (DP) is important for detection of contact sensitization in chronic dermatitis.", {"entities": [[147, 157, "DISEASE"]]}], ["To study clinical characteristics of DP mix positive patients with regards to chronic dermatitis and atopic dermatitis.", {"entities": [[101, 118, "DISEASE"], [86, 96, "DISEASE"], [108, 118, "DISEASE"]]}], ["Dermatology outpatients presenting to the department of Skin and STD of Kasturba Medical College (KMC), with clinically diagnosed atopic dermatitis and chronic eczema were chosen for the study.", {"entities": [[130, 147, "DISEASE"], [137, 147, "DISEASE"]]}], ["Inclusion and exclusion criteria were well demarked.", {"entities": []}], ["Eighty six randomly selected patients of dermatitis were subjected to patch testing with standard series and DP mix.", {"entities": [[41, 51, "DISEASE"]]}], ["Of the 86, 50 (58%) showed positive reaction to DP mix.", {"entities": []}], ["Among these positive patients, chronic dermatitis was seen in 42 (84%) with involvement of exposed parts in 37 (74%).", {"entities": [[39, 49, "DISEASE"]]}], ["Atopic dermatitis was seen in 19 patients (38%) from DP positive group whereas it was observed in 4 patients (17%) from the other group.", {"entities": [[0, 17, "DISEASE"], [7, 17, "DISEASE"]]}], ["Dermatophagoides mix positivity was statistically significant in chronic eczema as well as atopic dermatitis.", {"entities": [[91, 108, "DISEASE"], [98, 108, "DISEASE"]]}], ["Patch testing is an important tool to detect delayed type allergy to house dust mite.", {"entities": []}], ["Cancer patients show large individual variation in their response to chemotherapeutic agents.", {"entities": []}], ["Gemcitabine (dFdC) and AraC, two cytidine analogues, have shown significant activity against a variety of tumors.", {"entities": []}], ["We previously used expression data from a lymphoblastoid cell line-based model system to identify genes that might be important for the two drug cytotoxicity.", {"entities": []}], ["In the present study, we used that same model system to perform a genome-wide association (GWA) study to test the hypothesis that common genetic variation might influence both gene expression and response to the two drugs.", {"entities": []}], ["Specifically, genome-wide single nucleotide polymorphisms (SNPs) and mRNA expression data were obtained using the Illumina 550K\u00ae HumanHap550 SNP Chip and Affymetrix U133 Plus 2.0 GeneChip, respectively, for 174 ethnically-defined \u201cHuman Variation Panel\u201d lymphoblastoid cell lines.", {"entities": []}], ["Gemcitabine and AraC cytotoxicity assays were performed to obtain IC 50 values for the cell lines.", {"entities": []}], ["We then performed GWA studies with SNPs, gene expression and IC 50 of these two drugs.", {"entities": []}], ["This approach identified SNPs that were associated with gemcitabine or AraC IC 50 values and with the expression regulation for 29 genes or 30 genes, respectively.", {"entities": []}], ["One SNP in IQGAP2 (rs3797418) was significantly associated with variation in both the expression of multiple genes and gemcitabine and AraC IC 50 .", {"entities": [[11, 17, "GENE"]]}], ["A second SNP in TGM3 (rs6082527) was also significantly associated with multiple gene expression and gemcitabine IC50.", {"entities": [[16, 20, "GENE"]]}], ["To confirm the association results, we performed siRNA knock down of selected genes with expression that was associated with rs3797418 and rs6082527 in tumor cell and the knock down altered gemcitabine or AraC sensitivity, confirming our association study results.", {"entities": []}], ["These results suggest that the application of GWA approaches using cell-based model systems, when combined with complementary functional validation, can provide insights into mechanisms responsible for variation in cytidine analogue response.", {"entities": []}], ["Pneumococcal diseases remain a major cause of morbidity and mortality worldwide.", {"entities": []}], ["Updated data on drug-resistance from different populations may be important to recognize changes in disease patterns.", {"entities": []}], ["This study assessed current levels of penicilin resistance among Streptococcus Pneumoniae causing pneumonia in Spanish middle age and older adults.", {"entities": [[98, 107, "DISEASE"]]}], ["Antimicrobial susceptibility was tested for 104 consecutive isolates of Streptococcus pneumoniae recovered from patients 50 years or older with radiographically confirmed pneumonia in the region of Tarragona (Spain) between 2002 and 2007.", {"entities": [[171, 180, "DISEASE"]]}], ["According to the minimum inhibitory concentration of tested antimicrobials (penicillin, erythromycin, cefotaxime and levofloxacin) strains were classified as susceptible or resistant.", {"entities": []}], ["Antimicrobial resistance was determined for early cases (2002\u20132004) and contemporary cases (2005\u20132007).", {"entities": []}], ["Twenty-seven (25.9%) were penicillin-resistant strains (19 strains with intermediate resistance and 8 strains with high resistance).", {"entities": []}], ["Penicillin-resistance was higher in 2002\u20132004 than in 2005\u20132007 (39.5% vs 18.2%, p = 0.017).", {"entities": []}], ["Of 27 penicillin-resistant strains, 10 (37%) were resistant to erythromycin, 8 (29.6%) to cefotaxime, 2 (7.4%) to levofloxacin, and 4 (14.8%) were identified as multidrug resistant.", {"entities": []}], ["Case-fatality rate was higher among those patients who had an infection caused by any penicillin susceptible strain (16.9%) than in those with infections due to penicillin-resistant strains.", {"entities": []}], ["Resistance to penicillin among Streptococcus pneumoniae remains high, but such resistance does not result in increased mortality in patients with pneumococcal pneumonia.", {"entities": [[159, 168, "DISEASE"]]}], ["The final analysis of this 2-year, randomized, crossover study showed that postmenopausal women with osteoporosis were more adherent, compliant, and persistent with subcutaneous denosumab injections every 6\u00a0months than with once-weekly alendronate tablets.", {"entities": [[101, 113, "DISEASE"]]}], ["After receiving both treatments, women reported greater satisfaction with injectable denosumab and preferred it over oral alendronate.", {"entities": []}], ["Osteoporosis patients who are non-compliant or non-persistent with therapy may have suboptimal clinical outcomes.", {"entities": [[0, 12, "DISEASE"]]}], ["This 2-year, randomized, open-label, crossover study compared treatment adherence between subcutaneous denosumab, 60\u00a0mg every 6\u00a0months, and oral alendronate, 70\u00a0mg once weekly.", {"entities": []}], ["Postmenopausal women at 25 centers in the USA and Canada with bone mineral density T-scores \u22124.0 to \u22122.0 and no prior bisphosphonate use received alendronate then denosumab, or denosumab then alendronate, over successive 12-month periods.", {"entities": []}], ["Adherence required both compliance (denosumab injections 6\u00a0months apart or \u226580% of alendronate tablets) and persistence (both denosumab injections or \u22652 alendronate doses in the last month and completion of the treatment period).", {"entities": []}], ["Of the 250 women enrolled (124 alendronate, 126 denosumab), 221 entered the second year (106 denosumab, 115 alendronate).", {"entities": []}], ["Denosumab was associated with less non-adherence than alendronate (first year, 11.9% vs 23.4%; second year, 7.5% vs 36.5%).", {"entities": []}], ["Risk ratios for non-adherence, non-compliance, and non-persistence favored denosumab in both years ( p \u2009<\u20090.05).", {"entities": []}], ["Of 198 subjects expressing treatment preference, 183 (92.4%) preferred the injections over the oral therapy.", {"entities": []}], ["BMD improved further when subjects received denosumab after alendronate and remained stable when they received alendronate after denosumab.", {"entities": []}], ["Based on the final results of this crossover study after women had received each treatment for up to 1\u00a0year, postmenopausal women with osteoporosis were more adherent, compliant, and persistent with subcutaneous denosumab injections every 6\u00a0months than with once-weekly alendronate tablets and reported increased treatment preference and satisfaction with injectable denosumab over oral alendronate.", {"entities": [[135, 147, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s00198-011-1780-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To examine the media response to severe acute respiratory syndrome, we reviewed New Zealand's major newspaper (261 articles for 3 months).", {"entities": [[58, 66, "DISEASE"], [33, 66, "DISEASE"]]}], ["While important accurate health messages were frequently included, some were missed (e.g., hand washing in only 2% of articles).", {"entities": []}], ["No incorrect information was identified, and health spokespersons were accurately quoted.", {"entities": []}], ["As studies uncover the breadth of microbes associated with human life, opportunities will emerge to manipulate and augment their functions in ways that improve health and longevity.", {"entities": []}], ["From involvement in the complexities of reproduction and fetal/infant development, to delaying the onset of disease, and indeed countering many maladies, microbes offer hope for human well-being.", {"entities": []}], ["Evidence is emerging to suggest that microbes may play a beneficial role in body sites traditionally viewed as being sterile.", {"entities": []}], ["Although further evidence is required, we propose that much of medical dogma is about to change significantly through recognition and understanding of these hitherto unrecognized microbe\u2013host interactions.", {"entities": []}], ["A meeting of the International Scientific Association for Probiotics and Prebiotics held in Aberdeen, Scotland (June 2014), presented new views and challenged established concepts on the role of microbes in reproduction and health of the mother and infant.", {"entities": []}], ["This article summarizes some of the main aspects of these discussions.", {"entities": []}], ["The American Thoracic Society/European Respiratory Society (ATS/ERS) Task Force acknowledged the multi-faceted nature of asthma in its recent definition of asthma control as a summary term capturing symptoms, reliever use, frequency/severity of exacerbations, lung function, and future risk and the Global Initiative for Asthma (GINA) defines the clinical manifestations (well established markers of asthma severity) of asthma to include symptoms, sleep disturbances, limitations of daily activity, impairment of lung function, and use of rescue medications.", {"entities": [[121, 127, "DISEASE"], [156, 162, "DISEASE"], [321, 327, "DISEASE"], [400, 406, "DISEASE"], [420, 426, "DISEASE"]]}], ["The objectives of this qualitative work were to identify symptoms and markers of symptom severity relevant to patients with moderate to severe asthma and to evaluate the content validity of the asthma symptom diary (ASD).", {"entities": [[143, 149, "DISEASE"], [194, 200, "DISEASE"]]}], ["A qualitative interview study was conducted using a purposive sample of symptomatic adult and adolescent (\u226512\u00a0years) subjects with asthma.", {"entities": [[131, 137, "DISEASE"]]}], ["Concept elicitation (CE) interviews (n\u2009=\u200950) were conducted to identify core asthma symptoms and symptom-related clinical markers, followed by cognitive interviews (n\u2009=\u200924) to ensure patient comprehension of the items, instructions and response options.", {"entities": [[77, 83, "DISEASE"]]}], ["CE interviews were coded using ATLAS.ti for content analysis.", {"entities": []}], ["The study sample had a diverse range of symptom severity, level of symptom control, sociodemographic and socioeconomic status.", {"entities": []}], ["The most frequently reported symptoms in adults were chest tightness (n\u2009=\u200933/34; 97.1%), wheezing (n\u2009=\u200931; 91.2%), coughing (n\u2009=\u200930; 88.2%), and shortness of breath (n\u2009=\u200925; 73.5%); in adolescents they were wheezing (n\u2009=\u200914/16; 87.5%), coughing (n\u2009=\u200913; 81.3%), and chest tightness (n\u2009=\u200911; 68.8%).", {"entities": []}], ["Adults identified chest tightness followed by shortness of breath as their most severe symptoms; while adolescents reported coughing and chest tightness as their most severe symptoms.", {"entities": []}], ["Sleep awakenings and limitations in day-to-day activities were frequent symptom-related clinical markers.", {"entities": []}], ["Day-to-day variability and differences between daytime and nighttime symptom experiences reported by subjects resulted in the need for the ASD to be administered twice daily.", {"entities": []}], ["Cognitive interviews indicated that subjects found the revised ASD items clear and easy to understand.", {"entities": []}], ["This study supports the content validity of the revised ASD, showing it to be consistent with patient experiences and ready for further psychometric testing.", {"entities": []}], ["Body composition is an important parameter for patients with chronic obstructive pulmonary disease (COPD) whereas the association between asthma and obesity is not fully understood.", {"entities": [[61, 98, "DISEASE"], [149, 156, "DISEASE"], [138, 144, "DISEASE"]]}], ["The impact of severe refractory asthma (SRA) on fat free mass (FFM) has not been investigated.", {"entities": [[32, 38, "DISEASE"]]}], ["213 subjects (70 healthy smokers, 71 COPD patients and 72 asthma patients) without significant comorbidities were included in the study.", {"entities": [[58, 64, "DISEASE"]]}], ["In all patients, body composition assessment (using bioelectrical impendance analysis, skinfold and anthropometric measurements) and spirometry were performed.", {"entities": []}], ["Differences in fat free mass index (FFMI) between groups were assessed and determinants of FFMI in asthma were evaluated.", {"entities": [[99, 105, "DISEASE"]]}], ["Patients with SRA had lower values of FFMI compared to patients with mild-to-moderate asthma [18.0(17.3\u201318.3)\u201319.5(18.4\u201321.5), p<0.001], despite the fact that they were more obese.", {"entities": [[86, 92, "DISEASE"]]}], ["The levels of FFMI in SRA were lower than those of GOLD stage I\u2013III COPD and comparable to those of stage IV COPD patients [18.0(17.3\u201318.3)\u201318.8(17.8\u201320.1), p\u200a=\u200ans].", {"entities": []}], ["These differences were present even after proper adjustments for sex, age, smoking status, daily dose of inhaled corticosteroids (ICS) and daily use of oral corticosteroids (OCS).", {"entities": []}], ["In multivariate analysis, independent predictors of FFMI in asthmatic patients were age, use of OCS and the presence of SRA, but not smoking, sex or cumulative dose of ICS used.", {"entities": []}], ["SRA is related to the presence of low FFMI that is comparable to that of GOLD stage IV COPD.", {"entities": []}], ["The impact of this observation on asthma mechanisms and outcomes should be further investigated in large prospective studies.", {"entities": [[34, 40, "DISEASE"]]}], ["Sepsis is now the leading cause of death in the non-cardiovascular intensive care unit (ICU).", {"entities": []}], ["Recent research suggests that sepsis is likely to be due to an interaction between genetic and environmental factors.", {"entities": []}], ["Genetic mutations of toll-like receptor 4 ( TLR4 ) and cluster of differentiation 14 ( CD14 ) genes are involved in the immune and (or) inflammatory response.", {"entities": [[44, 48, "GENE"], [87, 91, "GENE"]]}], ["These may contribute to the susceptibility to sepsis in patients.", {"entities": []}], ["This study was designed to evaluate whether the TLR4 and cluster CD14 gene polymorphisms are associated with susceptibility to sepsis.", {"entities": [[48, 52, "GENE"], [65, 69, "GENE"]]}], ["The single nucleotide polymorphisms (SNPs) of TLR4 (rs10759932, rs11536889, rs7873784, rs12377632, rs1927907, rs1153879) and CD14 (rs2569190 and rs2563298) in patients with sepsis and control subjects in the Guangxi Province were analyzed by using the polymerase chain reaction-single base extension (PCR-SBE) and DNA sequencing methods.", {"entities": [[46, 50, "GENE"], [125, 129, "GENE"]]}], ["The rs11536889 polymorphism in TLR4 and rs2563298 polymorphism in CD14 were significantly associated with the risk of sepsis when compared to the control group.", {"entities": [[31, 35, "GENE"], [66, 70, "GENE"]]}], ["The frequencies of rs11536889 and rs2563298 polymorphisms in the group with sepsis were higher than that in the control group ( OR \u2009=\u20091.430, 9 5% CI , 1.032-1.981, P< 0.05; O R\u2009=\u20092.454, 95% CI , 1.458-4.130, P <0.05, respectively).", {"entities": []}], ["Followed up haplotype analysis suggested that there were two haplotypes in which increased risk factors for sepsis were indicated.", {"entities": []}], ["The rs11536889 polymorphism in TLR4 and rs2563298 polymorphism in CD14 , and two haplotypes were associated with increased susceptibility to sepsis.", {"entities": [[31, 35, "GENE"], [66, 70, "GENE"]]}], ["Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective medical therapies.", {"entities": [[11, 29, "DISEASE"]]}], ["Recent research has focused on identifying the biological processes essential to the development and progression of fibrosis, and on the mediators driving these processes.", {"entities": []}], ["Lysophosphatidic acid (LPA), a biologically active lysophospholipid, is one such mediator.", {"entities": [[23, 26, "GENE"]]}], ["LPA has been found to be elevated in bronchoalveolar lavage (BAL) fluid of IPF patients, and through interaction with its cell surface receptors, it has been shown to drive multiple biological processes implicated in the development of IPF.", {"entities": [[0, 3, "GENE"]]}], ["Accordingly, the first clinical trial of an LPA receptor antagonist in IPF has recently been initiated.", {"entities": [[44, 47, "GENE"]]}], ["In addition to being a therapeutic target, LPA also has potential to be a biomarker for IPF.", {"entities": [[43, 46, "GENE"]]}], ["There is increasing interest in exhaled breath condensate (EBC) analysis as a non-invasive method for biomarker detection in lung diseases, but to what extent LPA is present in EBC is not known.", {"entities": [[159, 162, "GENE"]]}], ["In this study, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to assess for the presence of LPA in the EBC and plasma from 11 IPF subjects and 11 controls.", {"entities": [[111, 114, "GENE"]]}], ["A total of 9 different LPA species were detectable in EBC.", {"entities": [[23, 26, "GENE"]]}], ["Of these, docosatetraenoyl (22:4) LPA was significantly elevated in the EBC of IPF subjects when compared to controls (9.18 pM vs. 0.34 pM; p =\u20090.001).", {"entities": [[34, 37, "GENE"]]}], ["A total of 13 different LPA species were detectable in the plasma, but in contrast to the EBC, there were no statistically significant differences in plasma LPA species between IPF subjects and controls.", {"entities": [[24, 27, "GENE"], [157, 160, "GENE"], [24, 27, "GENE"], [157, 160, "GENE"]]}], ["These results demonstrate that multiple LPA species are detectable in EBC, and that 22:4 LPA levels are elevated in the EBC of IPF patients.", {"entities": [[40, 43, "GENE"], [89, 92, "GENE"], [40, 43, "GENE"], [89, 92, "GENE"]]}], ["Further research is needed to determine the significance of this elevation of 22:4 LPA in IPF EBC, as well as its potential to serve as a biomarker for disease severity and/or progression.", {"entities": [[83, 86, "GENE"]]}], ["Porcine acellular dermal matrices (ADM) have been widely used in experimental and clinical research for abdominal wall repair.", {"entities": [[35, 38, "GENE"]]}], ["Compared to porcine small intestinal submucosa (SIS), the effect of these matrices on the regenerative capacity of blood vessels is still not ideal.", {"entities": []}], ["Multi-walled carbon nanotubes (MWNTs) can more effectively transport VEGF to cells or tissues because of their large specific surface area and interior cavity.", {"entities": []}], ["In this study, we explored the safety and efficacy of implanted VEGF-loaded MWNT composite scaffolds in vitro and vivo to repair abdominal wall defects.", {"entities": []}], ["VEGF-loaded MWNTs were prepared by a modified plasma polymerization treatment.", {"entities": []}], ["Four composite scaffolds were evaluated for cytotoxicity, proliferation, and release dynamics.", {"entities": []}], ["We created 3 cm\u00d74 cm abdominal wall defects in 43 Sprague-Dawley rats.", {"entities": []}], ["After implantation times of 2, 4, 8, and 12 weeks, the scaffolds and the surrounding tissues were collected and examined by gross inspection, biomechanical testing, and histological examination.", {"entities": []}], ["A 5\u201310 nm poly(lactic-co-glycolic acid) (PLGA) film was evenly distributed on MWNTs.", {"entities": []}], ["The 3% MWNT composite group showed lower cytotoxicity and appropriate release performance, and it was thus tested in vivo .", {"entities": []}], ["In rats with the 3% composite implanted, host cells were prevented from migrating to the ADM at 2 weeks, vascularization was established more rapidly at 12 weeks, and the values for both the maximum load and the elastic modulus were significantly lower than in the ADM-alone group (p<0.01).", {"entities": [[89, 92, "GENE"], [265, 268, "GENE"]]}], ["Histological staining revealed that the MWNT was still not completely eliminated 12 weeks after implantation.", {"entities": []}], ["MWNTs were able to carry VEGF to cells or tissues, and the 3% MWNT composite material showed lower cytotoxicity and had an appropriate release performance, which prompted faster vascularization of the ADM than other scaffolds.", {"entities": [[201, 204, "GENE"]]}], ["Nevertheless, the MWNTs induced harmful effects that should be carefully considered in biomedical studies.", {"entities": []}], ["We see patients who present with spirometry airflow limitation despite their forced expiratory volume in one second (FEV 1 ) as well as forced vital capacity (FVC) to be supernormal (FEV 1 /FVC\u2009<\u200970%, both the %FEV 1 and the %FVC \u2267100%) in asymptomatic healthy non-smokers.", {"entities": [[117, 120, "GENE"], [183, 186, "GENE"], [211, 214, "GENE"], [117, 120, "GENE"], [183, 186, "GENE"], [211, 214, "GENE"], [117, 120, "GENE"], [183, 186, "GENE"], [211, 214, "GENE"]]}], ["Based on previous studies, we hypothesized these spirometry conditions (results measured with spirometry) could be suitably used as a practical surrogate marker of pulmonary dysanapsis: the condition of disproportionate but physiologically normal growth between airways and lung parenchyma.", {"entities": []}], ["We compared the conventional surrogate marker of dysanapsis, maximum mid-expiratory flow to FVC (MMF/FVC), in SUBJECTS (FEV 1 /FVC\u2009<\u200970%, both the %FEV 1 and the %FVC \u2267100% in healthy non-smokers) (n\u2009=\u200925), in EMPHYSEMA (CT confirmed pulmonary emphysema, same spirometry results with SUBJECTS) (n\u2009=\u200955), and in CONTROLS (age- and height- matched, normal spirometry results) (n\u2009=\u200925).", {"entities": [[234, 253, "DISEASE"], [120, 123, "GENE"], [148, 151, "GENE"], [120, 123, "GENE"], [148, 151, "GENE"]]}], ["Next we added imaging analysis to evaluate the relationship between the cross sectional airway luminal area (X-Ai) and the lung volume results among the three groups.", {"entities": []}], ["The MMF/FVC was significantly lower in SUBJECTS and in EMPHYSEMA compared to CONTROLS.", {"entities": []}], ["However, percent predicted peak expiratory flow (%PEFR) was significantly lower only in SUBJECTS and not in EMPHYSEMA compared to CONTROLS.", {"entities": []}], ["The ratio of the X-Ai of the trachea and right apical bronchus to lung volume was significantly lower in SUBJECTS compared to CONTROLS.", {"entities": []}], ["The simple spirometry conditions in SUBJECTS are highly suggestive of practical surrogate marker of pulmonary dysanapsis.", {"entities": []}], ["Awareness of this concept would help to attenuate the risk of overdiagnosis of obstructive pulmonary disease.", {"entities": []}], ["Cationic amino acid transporters (CAT) are important regulators of NOS2 and ARG1 activity because they regulate L-arginine availability.", {"entities": [[67, 71, "GENE"], [76, 80, "GENE"]]}], ["However, their role in the development of Th1/Th2 effector functions following infection has not been investigated.", {"entities": []}], ["Here we dissect the function of CAT2 by studying two infectious disease models characterized by the development of polarized Th1 or Th2-type responses.", {"entities": []}], ["We show that CAT2 Toxoplasma gondii .", {"entities": []}], ["Although T. gondii infected CAT2 Schistosoma mansoni displayed no change in susceptibility to infection, although they succumbed to schistosomiasis at an accelerated rate.", {"entities": [[132, 147, "DISEASE"]]}], ["Granuloma formation and fibrosis, pathological features regulated by Th2 cytokines, were also exacerbated even though their Th2 response was reduced.", {"entities": []}], ["Finally, while IL-13 blockade was highly efficacious in wild-type mice, the development of fibrosis in CAT2 Recent studies conducted with amino transporter Slc7a2 -deficient mice (CAT2) demonstrated that NOS2 activity in macrophages is regulated by CAT2.", {"entities": [[156, 162, "GENE"], [204, 208, "GENE"]]}], ["NOS2, which synthesizes nitric oxide, regulates numerous important activities, including resistance to infectious organisms, tumor development, and autoimmune diseases.", {"entities": [[0, 4, "GENE"]]}], ["It also competes with the enzyme Arginase-1 (Arg1) for the common substrate L-arginine.", {"entities": [[45, 49, "GENE"]]}], ["However, the role CAT2 in the regulation of Arg1 activity has not been previously examined.", {"entities": [[44, 48, "GENE"]]}], ["Therefore, we infected CAT2-deficient mice with the helminth parasite Schistosoma mansoni or with the protozoan pathogen Toxoplasma gondii , two organisms that trigger highly divergent host immune responses.", {"entities": []}], ["Strikingly, following infection with S. mansoni , CAT2 T. gondii infection, demonstrating that CAT2 is critical for the development of protective cell-mediated immunity.", {"entities": []}], ["Thus, these studies identify CAT2 as a powerful regulator of host immune responses, which may have major implications for a variety of infectious, inflammatory, and autoimmune diseases.", {"entities": []}], ["Anaphylaxis is difficult to diagnose in the absence of skin or mucosal signs and symptoms.", {"entities": []}], ["We report two cases of anaphylaxis under general anesthesia, in which the initial presentation was in the form of respiratory signs, followed by skin manifestations 10\u201315\u00a0min later.", {"entities": []}], ["Diagnosis of anaphylaxis was delayed because skin symptoms were absent early on in the presentation.", {"entities": []}], ["In the first case, a 23-year-old male patient with jaw deformity was scheduled to undergo maxillary alveolar osteotomy.", {"entities": []}], ["After intubation, auscultation indicated a sudden decrease in breath sounds, together with severe hypotension.", {"entities": []}], ["Approximately 10\u00a0min later, flushing of the skin and urticaria on the thigh appeared and spread widely throughout the body.", {"entities": [[53, 62, "DISEASE"]]}], ["In the second case, a 21-year-old female patient with jaw deformity was scheduled to undergo maxillomandibular osteotomy.", {"entities": []}], ["Twenty minutes after the start of dextran infusion, her lungs suddenly became difficult to ventilate, and oxygen saturation decreased to 90%.", {"entities": []}], ["Approximately 15\u00a0min later, flushing of the skin and urticaria were observed.", {"entities": [[53, 62, "DISEASE"]]}], ["In both cases, there was a time lag between the appearance of respiratory and skin symptoms, which resulted in a delay in the diagnosis, and hence, treatment of anaphylaxis.", {"entities": []}], ["Our experience highlights the fact that it is difficult to diagnose anaphylaxis under general anesthesia.", {"entities": []}], ["The Acute Physiology and Chronic Health Evaluation System (APACHE II) was used in 451 patients admitted to the intensive care unit, Belfast City Hospital, in 1988 and 1989.", {"entities": []}], ["Mortality in the patients studied was 15.5% which is slightly less than that predicted for patients with equal severity of disease (18.8%).", {"entities": []}], ["Within the limitations discussed the APACHE II system has valuable potential both in terms of predictive power and as a means of audit.", {"entities": []}], ["An Nrf2-dependent response is a central protective mechanism against oxidative stress.", {"entities": []}], ["We propose that particular genetic variants of the Nrf2 gene may be associated with a rapid forced expiratory volume in one second (FEV 1 ) decline induced by cigarette smoking.", {"entities": [[132, 135, "GENE"]]}], ["We conducted a retrospective cohort study of 915 Japanese from a general population.", {"entities": []}], ["Values of annual decline in FEV 1 were computed for each individual using a linear mixed-effect model.", {"entities": [[28, 31, "GENE"]]}], ["Multiple clinical characteristics were assessed to identify associations with annual FEV 1 decline.", {"entities": [[85, 88, "GENE"]]}], ["Tag single-nucleotide polymorphisms (SNPs) in the Nrf2 gene (rs2001350, rs6726395, rs1962142, rs2364722) and one functional SNP (rs6721961) in the Nrf2 promoter region were genotyped to assess interactions between the Nrf2 polymorphisms and smoking status on annual FEV 1 decline.", {"entities": [[266, 269, "GENE"]]}], ["Annual FEV 1 decline was associated with smoking behavior and inversely correlated with FEV 1 /FVC and FEV 1 % predicted.", {"entities": [[7, 10, "GENE"], [88, 91, "GENE"], [103, 106, "GENE"], [7, 10, "GENE"], [88, 91, "GENE"], [103, 106, "GENE"], [7, 10, "GENE"], [88, 91, "GENE"], [103, 106, "GENE"]]}], ["The mean annual FEV 1 declines in individuals with rs6726395 G/G, G/A, or A/A were 26.2, 22.3, and 20.8 mL/year, respectively, and differences in these means were statistically significant (p corr = 0.016).", {"entities": [[16, 19, "GENE"]]}], ["We also found a significant interaction between rs6726395 genotype and smoking status on the FEV 1 decline (p for interaction = 0.011).", {"entities": [[93, 96, "GENE"]]}], ["The haplotype rs2001350T/rs6726395A/rs1962142A/rs2364722A/rs6721961T was associated with lower annual decline in FEV 1 (p = 0.004).", {"entities": [[113, 116, "GENE"]]}], ["This study indicated that an Nrf2-dependent response to exogenous stimuli may affect annual FEV 1 decline in the general population.", {"entities": [[92, 95, "GENE"]]}], ["It appears that the genetic influence of Nrf2 is modified by smoking status, suggesting the presence of a gene-environment interaction in accelerated decline in FEV 1 .", {"entities": [[161, 164, "GENE"]]}], ["The human high affinity receptor for IgE (Fc\u025bRI) is a cell surface structure critical for the pathology of allergic reactions.", {"entities": []}], ["Human Fc\u025bRI is expressed as a tetramer (\u03b1\u03b2\u03b3 2 ) on basophils or mast cells and as trimeric (\u03b1\u03b3 2 ) complex on antigen-presenting cells.", {"entities": []}], ["Expression of the human \u03b1 subunit can be down-regulated by a splice variant of Fc\u025bRI\u03b2 (\u03b2 var ).", {"entities": []}], ["We demonstrate that Fc\u025bRI\u03b1 is the core subunit with which the other subunits assemble strictly cotranslationally.", {"entities": []}], ["In addition to \u03b1\u03b2\u03b3 2 and \u03b1\u03b3 2 , we demonstrate the presence of \u03b1\u03b2 and \u03b1\u03b2 var \u03b3 2 complexes that are stable in the detergent Brij 96.", {"entities": []}], ["The role of individual Fc\u025bRI subunits for the formation of functional, immunoglobulin E\u2013binding Fc\u025bRI complexes during endoplasmic reticulum (ER) assembly can be defined as follows: \u03b2 and \u03b3 support ER insertion, signal peptide cleavage and proper N-glycosylation of \u03b1, whereas \u03b2 var allows accumulation of \u03b1 protein backbone.", {"entities": []}], ["We show that assembly of Fc\u025bRI in the ER is a key step for the regulation of surface expression of Fc\u025bRI.", {"entities": []}], ["The ER quality control system thus regulates the quantity of functional Fc\u025bRI, which in turn controls onset and persistence of allergic reactions.", {"entities": []}], ["Background: Bisphenol A (BPA) is a well-known endocrine disruptor that imperfectly mimics the effects of physiologic estrogens via membrane-bound estrogen receptors (mER\u03b1, mER\u03b2, and GPER/GPR30), thereby initiating nongenomic signaling.", {"entities": []}], ["Bisphenol S (BPS) is an alternative to BPA in plastic consumer products and thermal paper.", {"entities": []}], ["Objective: To characterize the nongenomic activities of BPS, we examined signaling pathways it evoked in GH 3 /B 6 /F 10 rat pituitary cells alone and together with the physiologic estrogen estradiol (E 2 ).", {"entities": []}], ["Extracellular signal-regulated kinase (ERK)\u2013 and c-Jun-N-terminal kinase (JNK)\u2013specific phosphorylations were examined for their correlation to three functional responses: proliferation, caspase activation, and prolactin (PRL) release.", {"entities": [[222, 225, "GENE"]]}], ["Methods: We detected ERK and JNK phosphorylations by fixed-cell immunoassays, identified the predominant mER initiating the signaling with selective inhibitors, estimated cell numbers by crystal violet assays, measured caspase activity by cleavage of fluorescent caspase substrates, and measured PRL release by radioimmunoassay.", {"entities": [[296, 299, "GENE"]]}], ["Results: BPS phosphoactivated ERK within 2.5 min in a nonmonotonic dose-dependent manner (10 2 , the physiologic estrogen\u2019s ERK response was attenuated.", {"entities": []}], ["BPS could not activate JNK, but it greatly enhanced E 2 -induced JNK activity.", {"entities": []}], ["BPS induced cell proliferation at low concentrations (femtomolar to nanomolar), similar to E 2.", {"entities": []}], ["Combinations of both estrogens reduced cell numbers below those of the vehicle control and also activated caspases.", {"entities": []}], ["Earlier activation of caspase 8 versus caspase 9 demonstrated that BPS initiates apoptosis via the extrinsic pathway, consistent with activation via a membrane receptor.", {"entities": []}], ["BPS also inhibited rapid (\u2264 1 min) E 2 -induced PRL release.", {"entities": [[48, 51, "GENE"]]}], ["Conclusion: BPS, once considered a safe substitute for BPA, disrupts membrane-initiated E 2 -induced cell signaling, leading to altered cell proliferation, cell death, and PRL release.", {"entities": [[172, 175, "GENE"]]}], ["The organic chemicals present in Asian sand dust (ASD) might contribute to the aggravation of lung eosinophila.", {"entities": []}], ["Therefore, the aggravating effects of the Tar fraction from ASD on ovalbumin (OVA)-induced lung eosinophilia were investigated.", {"entities": [[96, 108, "DISEASE"]]}], ["The Tar fraction was extracted from ASD collected from the atmosphere in Fukuoka, Japan.", {"entities": []}], ["ASD collected from the Gobi desert was heated at 360\u00b0C to inactivate toxic organic substances (H-ASD).", {"entities": []}], ["ICR mice were instilled intratracheally with 12 different test samples prepared with Tar (1\u00a0\u03bcg and 5\u00a0\u03bcg), H-ASD, and OVA in a normal saline solution containing 0.02% Tween 80.", {"entities": []}], ["The lung pathology, cytological profiles in the bronchoalveolar lavage fluid (BALF), inflammatory cytokines/chemokines in BALF and OVA-specific immunoglobulin in serum were investigated.", {"entities": []}], ["Several kinds of polycyclic aromatic hydrocarbons (PAHs) were detected in the Tar sample.", {"entities": []}], ["H-ASD\u2009+\u2009Tar 5\u00a0\u03bcg induced slight neutrophilic lung inflammation.", {"entities": []}], ["In the presence of OVA, Tar 5\u00a0\u03bcg increased the level of eosinophils slightly and induced trace levels of Th2 cytokines IL-5 and IL-13 in BALF.", {"entities": []}], ["Also mild to moderate goblet cell proliferation and mild infiltration of eosinophils in the submucosa of airway were observed.", {"entities": []}], ["These pathological changes caused by H-ASD\u2009+\u2009OVA were relatively small.", {"entities": []}], ["However, in the presence of OVA and H-ASD, Tar, at as low a level as 1\u00a0\u03bcg, induced severe eosinophil infiltration and proliferation of goblet cells in the airways and significantly increased Th2 cytokines IL-5 and IL-13 in BALF.", {"entities": []}], ["The mixture showed an adjuvant effect on OVA-specific IgG1 production.", {"entities": []}], ["These results indicate that H-ASD with even low levels of Tar exacerbates OVA-induced lung eosinophilia via increases of Th2-mediated cytokines.", {"entities": [[91, 103, "DISEASE"]]}], ["These results suggest that ASD-bound PAHs might contribute to the aggravation of lung eosinophila.", {"entities": []}], ["The science of syndromic surveillance is still very much in its infancy.", {"entities": []}], ["While a number of syndromic surveillance systems are being evaluated in the US, very few have had success thus far in predicting an infectious disease event.", {"entities": []}], ["Furthermore, to date, the majority of syndromic surveillance systems have been based primarily in emergency department settings, with varying levels of enhancement from other data sources.", {"entities": []}], ["While research has been done on the value of telephone helplines on health care use and patient satisfaction, very few projects have looked at using a telephone helpline as a source of data for syndromic surveillance, and none have been attempted in Canada.", {"entities": []}], ["The notable exception to this statement has been in the UK where research using the national NHS Direct system as a syndromic surveillance tool has been conducted.", {"entities": [[93, 96, "GENE"]]}], ["The purpose of our proposed study is to evaluate the effectiveness of Ontario's telephone nursing helpline system as a real-time syndromic surveillance system, and how its implementation, if successful, would have an impact on outbreak event detection in Ontario.", {"entities": []}], ["Using data collected retrospectively, all \"reasons for call\" and assigned algorithms will be linked to a syndrome category.", {"entities": [[105, 113, "DISEASE"]]}], ["Using different analytic methods, normal thresholds for the different syndromes will be ascertained.", {"entities": []}], ["This will allow for the evaluation of the system's sensitivity, specificity and positive predictive value.", {"entities": []}], ["The next step will include the prospective monitoring of syndromic activity, both temporally and spatially.", {"entities": []}], ["As this is a study protocol, there are currently no results to report.", {"entities": []}], ["However, this study has been granted ethical approval, and is now being implemented.", {"entities": []}], ["It is our hope that this syndromic surveillance system will display high sensitivity and specificity in detecting true outbreaks within Ontario, before they are detected by conventional surveillance systems.", {"entities": []}], ["Future results will be published in peer-reviewed journals so as to contribute to the growing body of evidence on syndromic surveillance, while also providing an non US-centric perspective.", {"entities": []}], ["The present study establishes poly(ADP-ribose)polymerase's (PARP's) role in chronic asthma, demonstrates that it is activated in human asthma, increases the clinical relevance of targeting PARP for blocking or preventing chronic asthma in humans and presents olaparib as a likely candidate drug.", {"entities": [[84, 90, "DISEASE"], [135, 141, "DISEASE"], [229, 235, "DISEASE"]]}], ["Our laboratory established a role for poly(ADP-ribose)polymerase (PARP) in asthma.", {"entities": [[75, 81, "DISEASE"]]}], ["To increase the clinical significance of our studies, it is imperative to demonstrate that PARP is actually activated in human asthma, to examine whether a PARP inhibitor approved for human testing such as olaparib blocks already-established chronic asthma traits in response to house dust mite (HDM), a true human allergen, in mice and to examine whether the drug modulates human cluster of differentiation type 4 (CD4 gata-3)/IL-4 expression while moderately affecting T-cell proliferation.", {"entities": [[127, 133, "DISEASE"], [250, 256, "DISEASE"], [416, 419, "GENE"]]}], ["PARP inhibition inconsistently increased IL-17\u00a0in HDM-exposed mice and CD3/CD28-stimulated CD4", {"entities": [[91, 94, "GENE"]]}], ["The molecular mechanisms underlying autistic behaviors remain to be elucidated.", {"entities": []}], ["Mutations in genes linked to autism adversely affect molecules regulating dendritic spine formation, function and plasticity, and some increase the mammalian target of rapamycin, mTOR, a regulator of protein synthesis at spines.", {"entities": [[179, 183, "GENE"]]}], ["Here, we investigated whether the Akt/mTOR pathway is disrupted in idiopathic autism and in rats exposed to valproic acid, an animal model exhibiting autistic-like behavior.", {"entities": []}], ["Components of the mTOR pathway were assayed by Western blotting in postmortem fusiform gyrus samples from 11 subjects with idiopathic autism and 13 controls and in valproic acid versus saline-exposed rat neocortex.", {"entities": [[18, 22, "GENE"]]}], ["Additionally, protein levels of brain-derived neurotrophic factor receptor (TrkB) isoforms and the postsynaptic organizing molecule PSD-95 were measured in autistic versus control subjects.", {"entities": []}], ["Full-length TrkB, PI3K, Akt, phosphorylated and total mTOR, p70S6 kinase, eIF4B and PSD-95 were reduced in autistic versus control fusiform gyrus.", {"entities": [[54, 58, "GENE"], [74, 79, "GENE"]]}], ["Similarly, phosphorylated and total Akt, mTOR and 4E-BP1 and phosphorylated S6 protein were decreased in valproic acid- versus saline-exposed rats.", {"entities": [[41, 45, "GENE"]]}], ["However, no changes in 4E-BP1 or eIF4E were found in autistic brains.", {"entities": [[33, 38, "GENE"]]}], ["In contrast to some monogenic disorders with high rates of autism, our data demonstrate down-regulation of the Akt/mTOR pathway, specifically via p70S6K/eIF4B, in idiopathic autism.", {"entities": []}], ["These findings suggest that disruption of this pathway in either direction is widespread in autism and can have adverse consequences for synaptic function.", {"entities": []}], ["The use of valproic acid, a histone deacetylase inhibitor, in rats successfully modeled these changes, implicating an epigenetic mechanism in these pathway disruptions.", {"entities": []}], ["Chronic serum sickness leads to the formation of glomerular immune complexes; however, C57BL/6 mice do not develop glomerulonephritis unless complement factor H (CFH) is absent from the plasma.", {"entities": [[115, 133, "DISEASE"], [162, 165, "GENE"]]}], ["Here we studied the role for C5a receptor (R) in this setting.", {"entities": []}], ["The exaggerated humoral immune response in CFH", {"entities": [[43, 46, "GENE"]]}], ["Asthma susceptibility genes are mapped to a region on human chromosome 5q31-q33, which contains a cluster of proinflammatory cytokine genes such as interleukin-13 (IL-13), which is associated with asthma.", {"entities": [[0, 6, "DISEASE"], [197, 203, "DISEASE"]]}], ["This study investigated the allele frequencies of two single nucleotide polymorphisms (SNPs) (\u22121111C>T and 4257C>A) in the IL-13 gene between asthmatics and healthy volunteers as well as the relationship between these SNPs and IL-13 production.", {"entities": []}], ["DNA extracted from buffy coat of asthmatic and control subjects was genotyped using the PCR-RFLP method.", {"entities": []}], ["Amount of IL-13 produced by mitogen-stimulated peripheral blood leucocytes PBLs (PBLs) was determined by ELISA.", {"entities": []}], ["The frequencies of the \u22121111C and 4257G wild-type alleles were 0.52 and 0.55 in asthmatics and were 0.67 and 0.56 in controls.", {"entities": []}], ["A significant ( P < 0.05) association was found between genotype and allele frequencies of SNP at position \u22121111C>T between asthmatic and control groups (OR, 1.810; 95% CI\u2009=\u20091.184 to 2.767; P < 0.05).", {"entities": []}], ["The mitogen-stimulated PBLs from asthmatics produced higher amounts of IL-13 production ( P < 0.001).", {"entities": []}], ["The 4257GA heterozygous and 4257AA homozygous mutant alleles were associated with higher IL-13 production in asthmatics ( P < 0.05).", {"entities": []}], ["Our results show that the \u22121111T mutant allele are associated with asthma and the 4257A mutant alleles are associated with elevated IL-13 production.", {"entities": [[67, 73, "DISEASE"]]}], ["Genetic isolates with a history of a small founder population, long-lasting isolation and population bottlenecks represent exceptional resources in the identification of disease genes.", {"entities": []}], ["In these populations the disease allele reveals Linkage Disequilibrium (LD) with markers over significant genetic intervals, therefore facilitating disease locus identification.", {"entities": []}], ["In a previous study we examined the LD extension on the Xq13 region in three Corsican sub-populations from the inner mountainous region of the island.", {"entities": []}], ["On the basis of those previous results we have proposed a multistep procedure to carry out studies aimed at the identification of genes involved in complex diseases in Corsica.", {"entities": []}], ["A prerequisite to carry out the proposed multi-step procedure was the presence of different degrees of LD on the island and a common genetic derivation of the different Corsican sub-populations.", {"entities": []}], ["In order to evaluate the existence of these conditions in the present paper we extended the analysis to the Corsican coastal populations.", {"entities": []}], ["Samples were analyzed using seven dinucleotide microsatellite markers on chromosome Xq13-21: DXS983, DXS986, DXS8092, DXS8082, DXS1225, DXS8037 and DXS995 spanning approximately 4.0 cM (13.3 Mb).", {"entities": [[191, 193, "GENE"]]}], ["We have also investigated the distribution of the DXS1225-DXS8082 haplotype which has been recently proposed as a good marker of population genetic history due to its low recombination rate.", {"entities": []}], ["the results obtained indicate a decrease of LD on the island from the central mountainous toward the coastal sub-populations.", {"entities": []}], ["In addition the analysis of the DXS1225-DXS8082 haplotype revealed: 1) the presence of a particular haplotype with high frequency; 2) the derivation from a common genetic pool of the sub-populations examined in the present study.", {"entities": []}], ["These results indicate the Corsican sub-populations useful for the fine mapping of genes contributing to complex diseases.", {"entities": []}], ["Vitamin D is an important micronutrient for health.", {"entities": []}], ["Hypovitaminosis D is thought to play a role in the seasonality of a number of diseases and adverse health conditions.", {"entities": []}], ["To refine hypotheses about the links between vitamin D and seasonal diseases, good estimates of the cyclicality of serum vitamin D are necessary.", {"entities": []}], ["The objective of this study is to describe quantitatively the cyclicality of 25-hydroxyvitamin D (25OHD) in the United States.", {"entities": []}], ["We provide a statistical analysis with weekly time resolution, in comparison to the quarterly (winter/spring/summer/fall) estimates already in the literature.", {"entities": []}], ["We analyzed time series data on 25OHD, spanning 287 consecutive weeks.", {"entities": []}], ["The pooled data set comes from 3.44 million serum samples from the United States.", {"entities": []}], ["We statistically analyzed the proportion of sera that were vitamin D sufficient, defined as 25OHD ng/mL, as a function of date.", {"entities": []}], ["In the United States, serum 25OHD follows a lagged pattern relative to the astronomical seasons, peaking in late summer (August) and troughing in late winter (February).", {"entities": []}], ["Airmass, which is a function of solar altitude, fits the 25OHD data very well when lagged by 8 weeks.", {"entities": []}], ["Serum vitamin D levels can be modeled as a function of date, working through a double-log transformation of minimal solar airmass (easily calculated from solar altitude, retrievable from an online solar altitude/azimuth table).", {"entities": []}], ["Interventions to improve care for persons with chronic medical conditions often use quality of life (QOL) outcomes.", {"entities": []}], ["These outcomes may be affected by coexisting (comorbid) chronic conditions as well as the index condition of interest.", {"entities": []}], ["A subjective measure of comorbidity that incorporates an assessment of disease severity may be particularly useful for assessing comorbidity for these investigations.", {"entities": []}], ["A survey including a list of 25 common chronic conditions was administered to a population of HMO members age 65 or older.", {"entities": []}], ["Disease burden (comorbidity) was defined as the number of self-identified comorbid conditions weighted by the degree (from 1 to 5) to which each interfered with their daily activities.", {"entities": []}], ["We calculated sensitivities and specificities relative to chart review for each condition.", {"entities": []}], ["We correlated self-reported disease burden, relative to two other well-known comorbidity measures (the Charlson Comorbidity Index and the RxRisk score) and chart review, with our primary and secondary QOL outcomes of interest: general health status, physical functioning, depression screen and self-efficacy.", {"entities": []}], ["156 respondents reported an average of 5.9 chronic conditions.", {"entities": []}], ["Median sensitivity and specificity relative to chart review were 75% and 92% respectively.", {"entities": []}], ["QOL outcomes correlated most strongly with disease burden, followed by number of conditions by chart review, the Charlson Comorbidity Index and the RxRisk score.", {"entities": []}], ["Self-report appears to provide a reasonable estimate of comorbidity.", {"entities": []}], ["For certain QOL assessments, self-reported disease burden may provide a more accurate estimate of comorbidity than existing measures that use different methodologies, and that were originally validated against other outcomes.", {"entities": []}], ["Investigators adjusting for comorbidity in studies using QOL outcomes may wish to consider using subjective comorbidity measures that incorporate disease severity.", {"entities": []}], ["A close relationship between Metabolic Syndrome (MetS) and Chronic Obstructive Pulmonary Disease (COPD) has been described, but the exact nature of this link remains unclear.", {"entities": []}], ["Current epidemiological data refer exclusively to the MetS prevalence among patients with COPD and data about the prevalence of COPD in MetS patients are still unavailable.", {"entities": []}], ["To analyse and compare risk factors, clinical and metabolic characteristics, as well as the main respiratory function parameters, among patients affected by MetS, COPD or both diseases.", {"entities": []}], ["We recruited 59 outpatients with MetS and 76 outpatients with COPD.", {"entities": []}], ["After medical history collection, physical examination, blood sampling for routine analysis, spirometric evaluation, they were subdivided into MetS (n = 46), MetS+COPD (n = 60), COPD (n = 29).", {"entities": []}], ["A MetS diagnosis was assigned to 62% of COPD patients recruited in the COPD Outpatients Clinic of the Pneumology Department, while the COPD prevalence in MetS patients enrolled in the Internal Medicine Metabolic Disorders Outpatients Clinic was 22%.", {"entities": []}], ["More than 60% of subjects enrolled in each Department were unaware that they suffered from an additional disease.", {"entities": []}], ["MetS+COPD patients exhibited significantly higher C-peptide levels.", {"entities": []}], ["We also found a positive relation between C-peptide and pack-years in all subjects and a negative correlation between C-peptide and vitamin D only in current smokers.", {"entities": []}], ["Finally, a negative association emerged between smoking and vitamin D. We have estimated, for the first time, the COPD prevalence in MetS and suggest a potential role of smoking in inducing insulin resistance.", {"entities": []}], ["Moreover, a direct effect of smoking on vitamin D levels is proposed as a novel mechanism, which may account for both insulin resistance and COPD development.", {"entities": []}], ["We previously reported that alveolar macrophages from patients with chronic obstructive pulmonary disease (COPD) are defective in their ability to phagocytose apoptotic cells, with a similar defect in response to cigarette smoke.", {"entities": [[68, 105, "DISEASE"]]}], ["The exact mechanisms for this defect are unknown.", {"entities": []}], ["Sphingolipids including ceramide, sphingosine and sphingosine-1-phosphate (S1P) are involved in diverse cellular processes and we hypothesised that a comprehensive analysis of this system in alveolar macrophages in COPD may help to delineate the reasons for defective phagocytic function.", {"entities": []}], ["We compared mRNA expression of sphingosine kinases ( SPHK1/2 ), S1P receptors (S1PR1-5) and S1P-degrading enzymes ( SGPP1 , SGPP2 , SGPL1 ) in bronchoalveolar lavage-derived alveolar macrophages from 10 healthy controls, 7 healthy smokers and 20 COPD patients (10 current- and 10 ex-smokers) using Real-Time PCR.", {"entities": [[116, 121, "GENE"], [124, 129, "GENE"], [132, 137, "GENE"]]}], ["Phagocytosis of apoptotic cells was investigated using flow cytometry.", {"entities": []}], ["Functional associations were assessed between sphingosine signalling system components and alveolar macrophage phagocytic ability in COPD.", {"entities": []}], ["To elucidate functional effects of increased S1PR5 on macrophage phagocytic ability, we performed the phagocytosis assay in the presence of varying concentrations of suramin, an antagonist of S1PR3 and S1PR5 .", {"entities": [[45, 50, "GENE"], [202, 207, "GENE"], [192, 197, "GENE"], [45, 50, "GENE"], [202, 207, "GENE"]]}], ["The effects of cigarette smoking on the S1P system were investigated using a THP-1 macrophage cell line model.", {"entities": []}], ["We found significant increases in SPHK1/2 (3.4- and 2.1-fold increases respectively), S1PR2 and 5 (4.3- and 14.6-fold increases respectively), and SGPL1 (4.5-fold increase) in COPD vs. controls.", {"entities": [[86, 91, "GENE"], [147, 152, "GENE"]]}], ["S1PR5 and SGPL1 expression was unaffected by smoking status, suggesting a COPD \u201cdisease effect\u201d rather than smoke effect per se .", {"entities": [[0, 5, "GENE"], [10, 15, "GENE"]]}], ["Significant associations were noted between S1PR5 and both lung function and phagocytosis.", {"entities": [[44, 49, "GENE"]]}], ["Cigarette smoke extract significantly increased mRNA expression of SPHK1 , SPHK2 , S1PR2 and S1PR5 by THP-1 macrophages, confirming the results in patient-derived macrophages.", {"entities": [[67, 72, "GENE"], [75, 80, "GENE"], [83, 88, "GENE"], [93, 98, "GENE"]]}], ["Antagonising SIPR5 significantly improved phagocytosis.", {"entities": []}], ["Our results suggest a potential link between the S1P signalling system and defective macrophage phagocytic function in COPD and advise therapeutic targets.", {"entities": []}], ["Human metapneumovirus (hMPV) and the Netherlands human coronavirus (HCoV-NL63) have been isolated from children with respiratory tract infection.", {"entities": []}], ["The prevalence of these viruses has not been reported from Saudi Arabia.", {"entities": []}], ["We sought to determine whether hMPV and HCoV-NL63 are responsible for acute respiratory illness and also to determine clinical features and severity of illness in the hospitalized pediatric patient population.", {"entities": []}], ["Prospective hospital-based study from July 2007 to November 2008.", {"entities": []}], ["Nasopharyngeal specimens from children less than 16 years old who were suffering from acute respiratory diseases were tested for hMPV and HCoV-NL63 by reverse transcriptase\u2013polymerase chain reaction.", {"entities": []}], ["Samples were collected from July 2007 to November 2008.", {"entities": []}], ["Both viruses were found among Saudi children with upper and lower respiratory tract diseases during the autumn and winter of 2007 and 2008, contributing to 11.1% of all viral diagnoses, with individual incidences of 8.3% (hMPV) and 2.8% (HCoV-NL63) among 489 specimens.", {"entities": []}], ["Initial symptoms included fever, cough, and nasal congestion.", {"entities": []}], ["Lower respiratory tract disease occurs in immunocompromised individuals and those with underlying conditions.", {"entities": [[0, 31, "DISEASE"]]}], ["Clinical findings of respiratory failure and culture-negative shock were established in 7 children infected with hMPV and having hematologic malignancies, myelofibrosis, Gaucher disease, and congenital immunodeficiency; 2 of the 7 patients died with acute respiratory failure.", {"entities": [[155, 168, "DISEASE"], [21, 40, "DISEASE"], [256, 275, "DISEASE"]]}], ["All children infected with HCoV-NL63 had underlying conditions; 1 of the 4 patients developed respiratory failure.", {"entities": [[94, 113, "DISEASE"]]}], ["hMPV and HCoV-NL63 are important causes of acute respiratory illness among hospitalized Saudi children.", {"entities": []}], ["hMPV infection in the lower respiratory tract is associated with morbidity and mortality in immunocompromised children.", {"entities": []}], ["HCoV-NL63 may cause severe lower respiratory disease with underlying conditions.", {"entities": []}], ["In resource-poor countries access to essential medicines, suboptimal prescribing and use of medicines are major problems.", {"entities": []}], ["Health workers lack updated medical information and treatment support.", {"entities": []}], ["Information and Communication Technology (ICT) could help tackle this.", {"entities": []}], ["The impact of ICT on health systems in resource-poor countries is likely to be significant and transform the practice of medicine just as in high-income countries.", {"entities": []}], ["However, research for finding the best way of doing this is needed.", {"entities": []}], ["We aimed to assess current approaches to and use of ICT among health workers in two rural districts of Tanzania in relation to the current drug distribution practices, drug stock and continuing medical information (CME), as well as assessing the feasibility of using ICT to improve ordering and use of medicines.", {"entities": []}], ["This pilot study was conducted in 2010\u20132011, mapping the drug distribution chain in Tanzania, including problems and barriers.", {"entities": []}], ["The study was conducted in Bunda and Serengeti districts, both part of the ICT4RD (ICT for rural development) project.", {"entities": []}], ["Health workers involved in drug procurement and use at 13 health facilities were interviewed on use and knowledge of ICT, and their attitudes to its use in their daily work.", {"entities": []}], ["They were also shown and interviewed about their thoughts on an android tablet application prototype for drug stock inventory and drug ordering, based on the Tanzanian Medical Stores Department (MSD) current paper forms.", {"entities": []}], ["The main challenge was a stable supply of essential medicines.", {"entities": []}], ["Drug supplies were often delayed and incomplete, resulting in stock-outs.", {"entities": []}], ["All 20 interviewed health workers used mobile phones, 8 of them Smartphones with Internet connection.", {"entities": []}], ["The Health workers were very positive to the tablet application and saw its potential in reducing drug stock-outs.", {"entities": []}], ["They also expressed a great need and wish for CME by distance.", {"entities": []}], ["The tablet application was easily used and appreciated by health workers, and thus has the potential to save time and effort, reduce transportation costs and minimise drug stock-outs.", {"entities": []}], ["Furthermore, the android tablet could be used to reach out with CME programs to health care workers at remote health facilities, as well as those in towns.", {"entities": []}], ["Monthly doses of palivizumab, an RSV-specific monoclonal antibody, reduce RSV-related hospitalizations (RSVH) in high-risk children; however, no specific palivizumab level has been correlated with disease severity in humans.", {"entities": []}], ["A post hoc analysis of a previous randomized, placebo-controlled trial evaluated the relationship between serum palivizumab level at the time of RSVH and disease severity.", {"entities": []}], ["Pediatric intensive care unit (PICU) admission was the primary severity marker.", {"entities": []}], ["Relationships were evaluated between disease severity and gestational age, age at enrollment, age at RSVH, presence of bronchopulmonary dysplasia, sex, race, multiple birth, household smoking, daycare attendance, sibling(s), family history of atopy, duration between most recent palivizumab dose and RSVH, and palivizumab level at RSVH.", {"entities": []}], ["Forty-two (87.5%) of 48 palivizumab recipients with RSVH had palivizumab levels drawn; 11 were admitted to the PICU.", {"entities": []}], ["Mean palivizumab levels were lower in PICU-admitted subjects (47.2\u00a0\u03bcg/mL) vs. non-PICU subjects (98.7\u00a0\u03bcg/mL; P < 0.0001); there were no statistically significant differences in other variables examined.", {"entities": []}], ["The probability of PICU admission declined with higher palivizumab levels; there were no PICU admissions with levels \u2265 92\u00a0\u03bcg/mL.", {"entities": []}], ["In multivariate analyses, palivizumab level was the only independent predictor of PICU admission ( P = 0.009).", {"entities": []}], ["Palivizumab level also correlated with duration of RSVH and PICU stay, supplemental oxygen use and duration, and mechanical ventilation use and duration ( P < 0.05).", {"entities": []}], ["Higher palivizumab level was associated with decreased disease severity in high-risk infants with RSVH.", {"entities": []}], ["Findings suggest that palivizumab level has clinical relevance, and adherence to timely monthly dosing may confer additional protection among high-risk children receiving palivizumab.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a common and deadly disease.", {"entities": []}], ["One of the hallmarks of COPD is an accelerated decline in lung function, as measured by spirometry.", {"entities": []}], ["Inflammation, oxidative stress and other pathways are hypothesized to be important in this deterioration.", {"entities": []}], ["Because progressive airflow obstruction is associated with considerable morbidity and mortality, a major goal of COPD treatment has been to slow or prevent the accelerated decline in lung function.", {"entities": []}], ["Until recently, the only known effective intervention was smoking cessation.", {"entities": []}], ["However, newly reported large clinical trials have shown that commonly used medications may help slow the rate of lung function decline.", {"entities": []}], ["The effect of these medications is modest (and thus required such large, expensive trials) and to be of clinical benefit, therapy would likely need to start early in the course of disease and be prolonged.", {"entities": []}], ["Such a treatment strategy aimed at preservation of lung function would need to be balanced against the side effects and costs of prolonged therapy.", {"entities": []}], ["A variety of newer classes of medications may help target other pathophysiologically important pathways, and could be used in the future to prevent lung function decline in COPD.", {"entities": []}], ["We examined prevalence of diagnosed autism spectrum disorder (ASD) and age at diagnosis according to child\u2019s race/ethnicity and primary household language.", {"entities": [[36, 60, "DISEASE"]]}], ["From the 2009\u20132010 National Survey of Children with Special Health Care Needs, we identified 2729 3\u201317-year-old US children whose parent reported a current ASD diagnosis.", {"entities": []}], ["We compared ASD prevalence, mean diagnosis age, and percentage with later diagnoses (\u22655\u00a0years) across racial/ethnic/primary household language groups: non-Hispanic-white, any language (NHW); non-Hispanic-black, any language (NHB); Hispanic-any-race, English (Hispanic-English); and Hispanic-any-race, other language (Hispanic-Other).", {"entities": []}], ["We assessed findings by parent-reported ASD severity level and adjusted for family sociodemographics.", {"entities": []}], ["ASD prevalence estimates were 15.3 (NHW), 10.4 (NHB), 14.1 (Hispanic-English), and 5.2 (Hispanic-Other) per 1000 children.", {"entities": []}], ["Mean diagnosis age was comparable across racial/ethnic/language groups for 3\u20134-year-olds.", {"entities": []}], ["For 5\u201317-year-olds, diagnosis age varied by race/ethnicity/language and also by ASD severity.", {"entities": []}], ["In this group, NHW children with mild/moderate ASD had a significantly higher proportion (50.8\u00a0%) of later diagnoses than NHB (33.5\u00a0%) or Hispanic-Other children (18.0\u00a0%).", {"entities": []}], ["However, NHW children with severe ASD had a comparable or lower (albeit non-significant) proportion (16.4\u00a0%) of later diagnoses than NHB (37.8\u00a0%), Hispanic-English (30.8\u00a0%), and Hispanic-Other children (12.0\u00a0%).", {"entities": []}], ["While NHW children have comparable ASD prevalence and diagnosis age distributions as Hispanic-English children, they have both higher prevalence and proportion of later diagnoses than NHB and Hispanic-Other children.", {"entities": []}], ["The diagnosis age findings were limited to mild/moderate cases only.", {"entities": []}], ["Thus, the prevalence disparity might be primarily driven by under-representation (potentially under-identification) of older children with mild/moderate ASD in the two minority groups.", {"entities": []}], ["Monitoring respiratory status using end tidal CO 2 (EtCO 2 ), which reliably reflects arterial PaCO 2 in intubated patients under general anesthesia, has often proven both inaccurate and inadequate when monitoring non-intubated and spontaneously breathing patients.", {"entities": []}], ["This is particularly important in patients undergoing procedural sedation (e.g., endoscopy, colonoscopy).", {"entities": []}], ["This can be undertaken in the operating theater, but is also often delivered outside the operating room by non-anesthesia providers.", {"entities": []}], ["In this study we evaluated the ability for conventional EtCO 2 monitoring to reflect changes in ventilation in non-intubated surgical patients undergoing monitored anesthesia care and compared and contrasted these findings to both intubated patients under general anesthesia and spontaneously breathing volunteers.", {"entities": []}], ["Minute Ventilation (MV), tidal volume (TV), and respiratory rate (RR) were continuously collected from an impedance-based Respiratory Volume Monitor (RVM) simultaneously with capnography data in 160 patients from three patient groups: non-intubated surgical patients managed using spinal anesthesia and Procedural Sedation (n = 58); intubated surgical patients under General Anesthesia (n = 54); and spontaneously breathing Awake Volunteers (n = 48).", {"entities": []}], ["EtCO 2 instrument sensitivity was calculated for each patient as the slope of a Deming regression between corresponding measurements of EtCO 2 and MV and expressed as angle from the x-axis (\u03b8).", {"entities": []}], ["All data are presented as mean \u00b1 SD unless otherwise indicated.", {"entities": []}], ["While, as expected, EtCO 2 and MV measurements were negatively correlated in most patients, we found gross systematic differences across the three cohorts.", {"entities": []}], ["In the General Anesthesia patients, small changes in MV resulted in large changes in EtCO 2 (high sensitivity, \u03b8 = -83.6 \u00b1 9.9\u00b0).", {"entities": []}], ["In contrast, in the Awake Volunteers patients, large changes in MV resulted in insignificant changes in EtCO 2 (low sensitivity, \u03b8 = -24.7 \u00b1 19.7\u00b0, p < 0.0001 vs General Anesthesia).", {"entities": []}], ["In the Procedural Sedation patients, EtCO 2 sensitivity showed a bimodal distribution, with an approximately even split between patients showing high EtCO 2 instrument sensitivity, similar to those under General Anesthesia, and patients with low EtCO 2 instrument sensitivity, similar to the Awake Volunteers.", {"entities": []}], ["When monitoring non-intubated patients undergoing procedural sedation, EtCO 2 often provides inadequate instrument sensitivity when detecting changes in ventilation.", {"entities": []}], ["This suggests that augmenting standard patient care with EtCO 2 monitoring is a less than optimal solution for detecting changes in respiratory status in non-intubated patients.", {"entities": []}], ["Instead, adding direct monitoring of MV with an RVM may be preferable for continuous assessment of adequacy of ventilation in non-intubated patients.", {"entities": []}], ["Cancer immunotherapy has shown impressive results, but most patients do not respond.", {"entities": []}], ["We hypothesized that the effector response in the tumour could be visualized as a complex network of interacting gene products and that by mapping this network we could predict effective pharmacological interventions.", {"entities": []}], ["Here, we provide proof of concept for the validity of this approach in a murine mesothelioma model, which displays a dichotomous response to anti-CTLA4 immune checkpoint blockade.", {"entities": []}], ["Network analysis of gene expression profiling data from responding versus non-responding tumours was employed to identify modules associated with response.", {"entities": []}], ["Targeting the modules via selective modulation of hub genes or alternatively by using repurposed pharmaceuticals selected on the basis of their expression perturbation signatures dramatically enhanced the efficacy of CTLA4 blockade in this model.", {"entities": [[217, 222, "GENE"]]}], ["Our approach provides a powerful platform to repurpose drugs, and define contextually relevant novel therapeutic targets.", {"entities": []}], ["A Complex Chronic Disease (CCD) is a condition involving multiple morbidities that requires the attention of multiple health care providers or facilities and possibly community (home)-based care.", {"entities": []}], ["A patient with CCD presents to the health care system with unique needs, disabilities, or functional limitations.", {"entities": []}], ["The literature on how to best support self-management efforts in those with CCD is lacking.", {"entities": []}], ["With this paper, the authors present the case of an individual with diabetes and end-stage renal disease who is having difficulty with self-management.", {"entities": []}], ["The case is discussed in terms of intervention effectiveness in the areas of prevention, addiction, and self-management of single diseases.", {"entities": []}], ["Implications for research are discussed.", {"entities": []}], ["Resistance to the intestinal parasitic helminth Trichuris muris requires T-helper 2 (T H 2) cellular and associated IgG1 responses, with expulsion typically taking up to 4 weeks in mice.", {"entities": []}], ["Here, we show that the time-of-day of the initial infection affects efficiency of worm expulsion, with strong T H 2 bias and early expulsion in morning-infected mice.", {"entities": []}], ["Conversely, mice infected at the start of the night show delayed resistance to infection, and this is associated with feeding-driven metabolic cues, such that feeding restriction to the day-time in normally nocturnal-feeding mice disrupts parasitic expulsion kinetics.", {"entities": []}], ["We deleted the circadian regulator BMAL1 in antigen-presenting dendritic cells (DCs) in vivo and found a loss of time-of-day dependency of helminth expulsion.", {"entities": []}], ["RNAseq analyses revealed that IL-12 responses to worm antigen by circadian-synchronised DCs were dependent on BMAL1.", {"entities": []}], ["Therefore, we find that circadian machinery in DCs contributes to the T H 1/T H 2 balance, and that environmental, or genetic perturbation of the DC clock results in altered parasite expulsion kinetics.", {"entities": []}], ["Global Initiative Strategy for Asthma Management (GINA) is poorly applied in undeveloped and developing countries.", {"entities": [[31, 37, "DISEASE"]]}], ["The current study examined the effects of applying GINA guidelines on treatment efficacy in asthmatic patients in Iran.", {"entities": []}], ["Twenty four asthmatic patients (usual care group) were treated as usual and 26 patients (intervention group) according to the GINA for 2 months.", {"entities": []}], ["Asthma symptom score, asthma severity, frequency of symptoms/week and wheezing were recorded at the beginning (first visit), one month after treatment (second visit), and at the end of the study (third visit).", {"entities": [[0, 6, "DISEASE"], [22, 28, "DISEASE"]]}], ["Pulmonary function tests (PFTs) were performed by spirometry, and the patients' use of asthma drugs and their symptoms were evaluated, at each visit.", {"entities": [[87, 93, "DISEASE"]]}], ["Asthma symptoms, frequency of symptoms/week, chest wheezing, and PFT values were significantly improved in the intervention group at the second and third visits compared to first visit (p < 0.001 for all measures).", {"entities": [[0, 6, "DISEASE"]]}], ["In addition, exercise induced cough and wheeze were significant improved in the third visit compared to the second visit in this group (p < 0.01 for both measures).", {"entities": []}], ["In the second and third visits all symptoms were significantly lower, and PFT values higher, in the intervention group compared to the usual care group (p < 0.005 to p < 0.001).", {"entities": []}], ["In the usual care group, there were only small improvements in some parameters in just the second visit (p < 0.01 for all measures).", {"entities": []}], ["The use of asthma drugs was unchanged in the usual care group and significantly reduced in the intervention group (p < 0.01) by the end of the study.", {"entities": [[11, 17, "DISEASE"]]}], ["Adoption of GINA guidelines improves asthma symptoms and pulmonary function in asthmatic patients in Iran.", {"entities": [[37, 43, "DISEASE"]]}], ["Anti- N -methyl- d -aspartate (Anti-NMDA) receptor encephalitis is an acute autoimmune neurological disorder.", {"entities": [[51, 63, "DISEASE"]]}], ["The cause of this disease is often unknown, and previous studies revealed that it might be caused by a virus, vaccine or tumor.", {"entities": []}], ["It occurs more often in females than in males.", {"entities": []}], ["Several cases were reported to be related to vaccination such as the H1N1 vaccine and tetanus/diphtheria/pertussis and polio vaccines.", {"entities": [[94, 104, "DISEASE"], [86, 93, "DISEASE"], [105, 114, "DISEASE"]]}], ["In this study, we reported an anti-NMDA receptor encephalitis case that may be caused by Japanese encephalitis vaccination.", {"entities": [[49, 61, "DISEASE"], [98, 110, "DISEASE"]]}], ["To investigate the association between anti-NMDA receptor encephalitis and vaccination, we analyzed the phylogenetic relationship of the microRNAs, which significantly regulate these vaccine viruses or bacteria, and the phylogenetic relationship of these viruses and bacteria.", {"entities": [[58, 70, "DISEASE"]]}], ["This reveals that anti-NMDA receptor encephalitis may be caused by Japanese encephalitis vaccination, as well as H1N1 vaccination or tetanus/diphtheria/pertussis and polio vaccinations, from the phylogenetic viewpoint.", {"entities": [[141, 151, "DISEASE"], [133, 140, "DISEASE"], [152, 161, "DISEASE"], [37, 49, "DISEASE"], [76, 88, "DISEASE"]]}], ["Granting dispensing pharmacists the authority to prescribe has significant implications for pharmaceutical and health human resources policy, and quality of care.", {"entities": []}], ["Despite the growing number of jurisdictions that have given pharmacists such privileges, there are few rigorous evaluations of these policy changes.", {"entities": []}], ["This study will examine a January 2009 policy change in British Columbia (BC), Canada that allowed pharmacists to independently adapt and renew prescriptions.", {"entities": []}], ["We hypothesize this policy increased drug utilization and drug costs, increased patient adherence to medication, and reduced total healthcare resource use.", {"entities": []}], ["We will study a population-based cohort of approximately 4 million BC residents from 2004 through 2010.", {"entities": []}], ["We will use data from BC PharmaNet on all of the prescriptions obtained by this cohort during the study period, and link it to administrative billings from physicians and hospital discharges.", {"entities": []}], ["Using interrupted time series analysis, we will study longitudinal changes in drug utilization and costs, medication adherence, and short-term health care use.", {"entities": []}], ["Further, using hierarchical modelling, we will examine the factors at the regional, pharmacy, patient, and prescription levels that are associated with prescription adaptations and renewals.", {"entities": []}], ["In a recent survey of Canadian policymakers, many respondents ranked the issue of prescribing privileges as one of their most pressing policy questions.", {"entities": []}], ["No matter the results of our study, they will be important for policymakers, as our data will make policy decisions surrounding pharmacist prescribing more evidence-based.", {"entities": []}], ["In the present study, the cytotoxic and apoptogenic properties of hydroalcoholic extract and ethyl acetate (EtOAc), n -butanol, and water fractions (0\u2013800\u2009 \u03bc g/mL) of Viola tricolor were investigated in Neuro2a mouse neuroblastoma and MCF-7 human breast cancer cells.", {"entities": [[247, 260, "DISEASE"], [217, 230, "DISEASE"], [254, 260, "DISEASE"]]}], ["In addition, antiangiogenic effect of EtOAc fraction was evaluated on chicken chorioallantoic membrane (CAM).", {"entities": []}], ["The quality of EtOAc fraction was also characterized using high performance liquid chromatography (HPLC) fingerprint.", {"entities": []}], ["Cytotoxicity assay revealed that EtOAc fraction was the most potent among all fractions with maximal effect on MCF-7 and minimal toxicity against normal murine fibroblast L929 cells.", {"entities": []}], ["Apoptosis induction by EtOAc fraction was confirmed by increased sub-G1 peak of propidium iodide (PI) stained cells.", {"entities": []}], ["This fraction triggered the apoptotic pathway by increased Bax/Bcl-2 ratio and cleaved caspase-3 level.", {"entities": []}], ["Moreover, treatment with EtOAc fraction significantly decreased the diameter of vessels on CAM, while the number of newly formed blood vessels was not suppressed significantly.", {"entities": []}], ["Analysis of quality of EtOAc fraction using HPLC fingerprint showed six major peaks with different retention times.", {"entities": []}], ["The results of the present study suggest that V. tricolor has potential anticancer property by inducing apoptosis and inhibiting angiogenesis.", {"entities": []}], ["Clinical characteristics and outcome among dengue patients with and without human immunodeficiency virus (HIV) infection remain elusive.", {"entities": []}], ["A total of 10 dengue virus (DENV)\u2013HIV Chinese patients were compared with 40 Chinese dengue patients without HIV, who were matched for age, gender, type of care received, methods, and year of dengue diagnosis from 2005 to 2008.", {"entities": []}], ["Univariate and multivariate conditional logistics regression were applied.", {"entities": []}], ["DENV-HIV patients were significantly associated with the World Health Organization (WHO) 2009 severe dengue (conditional odds ratio [COR] = 5.72; 95% confidence interval [CI] = 1.01\u201332.64) but not with the WHO 1997 dengue hemorrhagic fever/dengue shock syndrome (COR = 0.40; 95% CI = 0.09\u20131.71).", {"entities": [[253, 261, "DISEASE"], [240, 261, "DISEASE"], [215, 239, "DISEASE"]]}], ["This is mainly due to severe plasma leakage and the lack of hemorrhagic manifestations.", {"entities": []}], ["Hospitalization duration was longer for DENV-HIV patients (10.5 days; interquartile range [IQR] = 5.5\u201326.3 days) compared with dengue patients (5 days; IQR = 4\u20136 days).", {"entities": []}], ["There were no significant differences in presentation of clinical warning signs and symptoms at admission and during hospitalization, except for rash (adjusted COR [ACOR] = 0.06; 95% CI = 0.03\u20130.92).", {"entities": []}], ["DENV-HIV patients were associated with higher pulse rate (ACOR = 1.13; 95% CI = 1.02\u20131.25), eosinophils proportion (ACOR = 3.07; 95% CI = 1.12\u20138.41) and lower hematocrit level (ACOR = 0.79; 95% CI = 0.64\u20130.98) compared with dengue patients.", {"entities": []}], ["Even though DENV-HIV patients may present similarly to dengue patients, they may be more likely to have severe dengue outcome.", {"entities": []}], ["Hence, close monitoring of DENV-HIV patients is highly recommended as part of dengue clinical care and management.", {"entities": []}], ["Appropriate expression and regulation of the transcriptome, which mainly comprise of mRNAs and lncRNAs, are important for all biological and cellular processes including the physiological activities of bone microvascular endothelial cells (BMECs).", {"entities": []}], ["Through an intricate intracellular signaling systems, the transcriptome regulates the pharmacological response of the cells.", {"entities": []}], ["Although studies have elucidated the impact of glucocorticoids (GCs) cell-specific gene expression signatures, it remains necessary to comprehensively characterize the impact of lncRNAs to transcriptional changes.", {"entities": []}], ["BMECs were divided into two groups.", {"entities": []}], ["One was treated with GCs and the other left untreated as a paired control.", {"entities": []}], ["Differential expression was analyzed with GeneSpring software V12.0 (Agilent, Santa Clara, CA, USA) and hierarchical clustering was conducted using Cluster 3.0 software.", {"entities": []}], ["The Gene Ontology (GO) analysis was performed with Molecular Annotation System provided by CapitalBio Corporation.", {"entities": []}], ["Our results highlight the involvement of genes implicated in development, differentiation and apoptosis following GC stimulation.", {"entities": [[114, 116, "GENE"]]}], ["Elucidation of differential gene expression emphasizes the importance of regulatory gene networks induced by GCs.", {"entities": []}], ["We identified 73 up-regulated and 166 down-regulated long noncoding RNAs, the expression of 107 of which significantly correlated with 172 mRNAs induced by hydrocortisone.", {"entities": []}], ["Transcriptome analysis of BMECs from human samples was performed to identify specific gene networks induced by GCs.", {"entities": []}], ["Our results identified complex RNA crosstalk underlying the pathogenesis of steroid-induced necrosis of femoral head.", {"entities": []}], ["Royal Jelly (RJ) is widely consumed in diets throughout the world due to its beneficial effects: antioxidant, antitumor and anti-inflammatory.", {"entities": []}], ["We have investigated the role of RJ in the development of TNBS colitis in mice.", {"entities": []}], ["Colitis was induced by a rectal instillation of TNBS at 0.1\u2009mL per mouse.", {"entities": []}], ["Intestine samples of the animals orally treated with RJ (100, 150, and 200\u2009mg/kg) were collected for antioxidant assays (GSH and GSH-Px), proinflammatory protein quantification (COX-2 and NF- \u03ba B), and histological analyses.", {"entities": []}], ["RJ 100\u2009mg/kg maintained GSH levels and increased the activity of GSH-Px, downregulated key inflammatory mediators (COX-2 and NF- \u03ba B), and decreased the lesions caused by TNBS as shown by the histological analyses.", {"entities": []}], ["In conclusion, RJ showed anti-inflammatory and antioxidant properties in experimental colitis, resulting in the amelioration of the macroscopic and histological analyses.", {"entities": []}], ["These results corroborate with the RJ supplementation in diets.", {"entities": []}], ["While tuberculosis susceptibility has historically been ascribed to failed inflammation, it is now known that an excess of leukotriene A 4 hydrolase (LTA4H), which catalyzes the final step in leukotriene B 4 (LTB 4 ) synthesis, produces a hyperinflammatory state and tuberculosis susceptibility.", {"entities": [[6, 18, "DISEASE"], [267, 279, "DISEASE"], [150, 155, "GENE"], [209, 212, "GENE"]]}], ["Here we show that the LTB 4 -inactivating enzyme leukotriene B 4 dehydrogenase/prostaglandin reductase 1 (LTB4DH/PTGR1) restricts inflammation and independently confers resistance to tuberculous infection.", {"entities": [[22, 25, "GENE"]]}], ["LTB4DH overexpression counters the susceptibility resulting from LTA4H excess while ltb4dh -deficient animals can be rescued pharmacologically by LTB 4 receptor antagonists.", {"entities": [[65, 70, "GENE"], [146, 149, "GENE"]]}], ["These data place LTB4DH as a key modulator of TB susceptibility and suggest new tuberculosis therapeutic strategies.", {"entities": [[80, 92, "DISEASE"]]}], ["Exposure to ambient fine particulate matter (PM 2.5 ) increases risks for cardiovascular disorders (CVD).", {"entities": []}], ["However, the mechanisms and components responsible for the effects are poorly understood.", {"entities": []}], ["Based on our previous murine exposure studies, a translational pilot study was conducted in female residents of Jinchang and Zhangye, China, to test the hypothesis that specific chemical component of PM 2.5 is responsible for PM 2.5 associated CVD.", {"entities": []}], ["Daily ambient and personal exposures to PM 2.5 and 35 elements were measured in the two cities.", {"entities": []}], ["A total of 60 healthy nonsmoking adult women residents were recruited for measurements of inflammation biomarkers.", {"entities": []}], ["In addition, circulating endothelial progenitor cells (CEPCs) were also measured in 20 subjects.", {"entities": []}], ["The ambient levels of PM 2.5 were comparable between Jinchang and Zhangye (47.4 and 54.5\u00b5g/m 2.5 -induced cardiovascular effects and that the reduced capacity of endothelial repair may play a critical role.", {"entities": []}], ["Motivation: Many microarray datasets are available online with formalized standards describing the probe sequences and expression values.", {"entities": []}], ["Unfortunately, the description, conditions and parameters of the experiments are less commonly formalized and often occur as natural language text.", {"entities": []}], ["This hinders searching, high-throughput analysis, organization and integration of the datasets.", {"entities": []}], ["Results: We use the lexical resources and software tools from the Unified Medical Language System (UMLS) to extract concepts from text.", {"entities": []}], ["We then link the UMLS concepts to classes in open biomedical ontologies.", {"entities": []}], ["The result is accessible and clear semantic annotations of gene expression experiments.", {"entities": []}], ["We applied the method to 595 expression experiments from Gemma, a resource for re-use and meta-analysis of gene expression profiling data.", {"entities": []}], ["We evaluated and corrected all stages of the annotation process.", {"entities": []}], ["The majority of missed annotations were due to a lack of cross-references.", {"entities": []}], ["The most error-prone stage was the extraction of concepts from phrases.", {"entities": []}], ["Final review of the annotations in context of the experiments revealed 89% precision.", {"entities": []}], ["A naive system, lacking the phrase to concept corrections is 68% precise.", {"entities": []}], ["We have integrated this annotation pipeline into Gemma.", {"entities": []}], ["Availability: The source code, documentation and Supplementary Materials are available at http://www.chibi.ubc.ca/GEOMMTX .", {"entities": []}], ["The results of the manual evaluations are provided as Supplementary Material .", {"entities": []}], ["Both manual and predicted annotations can be viewed and searched via the Gemma website at http://www.chibi.ubc.ca/Gemma .", {"entities": []}], ["The complete set of predicted annotations is available as a machine readable resource description framework graph.", {"entities": []}], ["Contact: paul@chibi.ubc.ca", {"entities": []}], ["Recommendations for acceptable emergency department (ED) length of stay (LOS) vary internationally with\u2009\u2264\u20098\u2009h generally considered acceptable.", {"entities": []}], ["Protracted ED LOS may place critically ill patients requiring mechanical ventilation at increased risk of adverse events as most EDs are not resourced for longitudinal delivery of critical care.", {"entities": []}], ["Our objective was to quantify the ED LOS for mechanically ventilated patients (invasive and/or non-invasive ventilation [NIV]) and to explore patient and system level predictors of prolonged ED LOS.", {"entities": []}], ["Additionally, we aimed to describe delivery and monitoring of ventilation in the ED.", {"entities": []}], ["Prospective observational study of ED LOS for all patients receiving mechanical ventilation at four metropolitan EDs in Toronto, Canada over two six-month periods in 2009 and 2010.", {"entities": []}], ["We identified 618 mechanically ventilated patients which represented 0.5% (95% CI 0.4%\u20130.5%) of all ED visits.", {"entities": []}], ["Of these, 484 (78.3%) received invasive ventilation, 118 (19.1%) received NIV; 16 received both during the ED stay.", {"entities": []}], ["Median Kaplan-Meier estimated duration of ED stay for all patients was 6.4\u2009h (IQR 2.8\u201314.6).", {"entities": []}], ["Patients with trauma diagnoses had a shorter median (IQR) LOS, 2.5\u2009h (1.3\u20135.1), compared to ventilated patients with non-trauma diagnoses, 8.5\u2009h (3.3\u201314.0) ( p <0.001).", {"entities": []}], ["Patients requiring NIV had a longer ED stay (16.6\u2009h, 8.2\u201327.9) compared to those receiving invasive ventilation exclusively (4.6\u2009h, 2.2\u201311.1) and patients receiving both (15.4\u2009h, 6.4\u201332.6) ( p <0.001).", {"entities": []}], ["Longer ED LOS was associated with ED site and lower priority triage scores.", {"entities": []}], ["Shorter ED LOS was associated with intubation at another ED prior to transfer.", {"entities": []}], ["While patients requiring mechanical ventilation represent a small proportion of overall ED visits these critically ill patients frequently experienced prolonged ED stay especially those treated with NIV, assigned lower priority triage scores at ED presentation, and non-trauma patients.", {"entities": []}], ["Background The Patient-Oriented Eczema Measure (POEM) is a validated, patient-derived assessment measure for monitoring atopic eczema severity, although further information on how different POEM scores translate into disease severity categories is needed for clinical trials, epidemiological research and audit.", {"entities": []}], ["Objectives We sought to determine the relationship between Patient-Oriented Eczema Measure (POEM) scores (range 0\u201328) and two Global Questions (GQ1 and 2) concerning patients\u2019/parents\u2019 views of the overall severity of their/their child's atopic eczema, in order to stratify POEM scores into five severity bands.", {"entities": []}], ["Methods POEM scores and GQs were completed by 300 patients from general practice and 700 patients from dermatology outpatient clinics, including 300 adults aged \u2265\u200316\u2003years and 700 children.", {"entities": []}], ["Results The mean POEM score was 13\u00b76 (range 0\u201328), and standard deviation (SD) was 7\u00b72.", {"entities": []}], ["Mean GQ1/GQ2 scores were 2\u00b71/2\u00b71, respectively (range 0\u20134 and SD 1\u00b71 for both).", {"entities": []}], ["The mean, mode and median of the GQ scores for each POEM score were used to devise possible POEM bandings.", {"entities": []}], ["The proposed banding for POEM scores are: 0\u20132 (clear/almost clear); 3\u20137 (mild); 8\u201316 (moderate); 17\u201324 (severe); 25\u201328 (very severe), kappa coefficient 0\u00b746.", {"entities": []}], ["Conclusions Severity banding of the POEM will allow more clinically meaningful use in everyday clinical practice and as a core outcome measure in future atopic eczema research.", {"entities": []}], ["Because the human population is biologically diverse and genetically heterogeneous, it is not surprising that differences in susceptibility to disease among individuals with or without exposure to environmental agents exist.", {"entities": []}], ["Individuals vary greatly in their susceptibility to disease.", {"entities": []}], ["This is true of adults and children.", {"entities": []}], ["The etiologies of many diseases of childhood are due to a combination of factors, including genetic susceptibility and environmental exposures during vulnerable periods of development.", {"entities": []}], ["Genes regulate cellular growth and development, DNA replication and repair, the metabolism of endogenous agents in the body, and the metabolism and excretion of exogenous agents that the body comes in contact with in the environment.", {"entities": []}], ["This regulation varies over the life span, contributing to the cellular consequences of the environmental exposures.", {"entities": []}], ["This paper summarizes the contributions of genetics in understanding the etiology of environmentally induced diseases in children.", {"entities": []}], ["The use of biomarkers of genetic susceptibility in the study of these diseases will be discussed.", {"entities": []}], ["Future research needs for expanding our knowledge of the interactions between genetic and environmental components of childhood diseases will be presented.", {"entities": []}], ["Chronic mast cell activation is a characteristic feature of asthma.", {"entities": [[60, 66, "DISEASE"]]}], ["BEAS-2B human airway epithelial cells (AEC) profoundly inhibit both constitutive and IgE-dependent human lung mast cell (HLMC) histamine release.", {"entities": []}], ["The aim of this study was to examine the regulation of HLMC degranulation by primary AEC from healthy and asthmatic subjects, and investigate further the inhibitory mechanism.", {"entities": []}], ["HLMC were co-cultured with both BEAS-2B and primary AEC grown as monolayers or air-liquid interface (ALI) cultures.", {"entities": []}], ["Both constitutive and IgE-dependent HLMC histamine release were attenuated by BEAS-2B, primary AEC monolayers and ALI cultures.", {"entities": []}], ["This occurred in the absence of HLMC-AEC contact indicating the presence of a soluble factor.", {"entities": []}], ["Unlike healthy ALI AEC, asthmatic ALI-AEC did not significantly reduce constitutive histamine release.", {"entities": []}], ["AEC inhibitory activity was transferable in primary AEC monolayer supernatant, but less active than with Transwell co-culture, suggesting that the inhibitory factor was labile.", {"entities": []}], ["The AEC inhibitory effects were attenuated by both AEC wounding and pertussis toxin, indicating the involvement of a G 0 /G i receptor coupled mechanism.", {"entities": [[68, 77, "DISEASE"]]}], ["Solid phase extraction of lipids (<10 kDa) removed the AEC inhibitory activity.", {"entities": []}], ["The lipid derivatives resolvin D1 and D2 and lipoxin A 4 attenuated HLMC histamine release in a dose-dependent fashion but were not detectable in co-culture supernatants.", {"entities": []}], ["Primary AEC suppress HLMC constitutive and IgE-dependent histamine secretion through the release of a soluble, labile lipid mediator(s) that signals through the G 0 /G i receptor coupled mechanism.", {"entities": []}], ["Manipulation of this interaction may have a significant therapeutic role in asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["The peripheral Foxp3 in vitro , and memory CD4 in vitro , such Foxp3 in vitro are lack suppressive functions.", {"entities": [[15, 20, "GENE"], [63, 68, "GENE"], [43, 46, "GENE"], [15, 20, "GENE"], [63, 68, "GENE"]]}], ["Our data about the suppressive functions of CD4", {"entities": [[44, 47, "GENE"]]}], ["Incidence of attention deficit hyperactivity disorder (ADHD) in children and adolescents has been increasing.", {"entities": [[13, 53, "DISEASE"]]}], ["The disorder results in high societal costs.", {"entities": []}], ["Policymakers increasingly use health economic evaluations to inform decisions on competing treatments of ADHD.", {"entities": []}], ["Yet, health economic evaluations of first-choice medication of ADHD in children and adolescents are scarce and generally do not include broader societal effects.", {"entities": []}], ["This study presents a probabilistic model and analysis of methylphenidate osmotic-release oral system (OROS) versus methylphenidate immediate-release (IR).", {"entities": []}], ["We investigate and include relevant societal aspects in the analysis so as to provide cost-effectiveness estimates based on a broad societal perspective.", {"entities": []}], ["We enhanced an existing Markov model and determined the cost effectiveness of OROS versus IR for children and adolescents responding suboptimally to treatment with IR.", {"entities": []}], ["Enhancements included screening of a broad literature base, updated utility values, inclusion of costs and effects on caregivers and a change of the model type from deterministic to probabilistic.", {"entities": []}], ["The base case scenario resulted in lower incremental costs (\u20ac\u22125815) of OROS compared with IR and higher incremental quality-adjusted life-year (QALY) gains (0.22).", {"entities": []}], ["Scenario analyses were performed to determine sensitivity to changes in transition rates, utility of caregivers, medical costs of caregivers and daily medication dose.", {"entities": []}], ["The results indicate that, for children responding suboptimally to treatment with IR, the beneficial effect of OROS on compliance may be worth the additional costs of medication.", {"entities": []}], ["The presented model adds to the health economic information available for policymakers and to considerations on a broader perspective in cost-effectiveness analyses.", {"entities": []}], ["Although approximately 82 percent of the US population was covered by some form of law that restricted smoking in public establishments as of 2014, most research examining the relationship between smoke-free laws and health has been focused at the state level.", {"entities": []}], ["To examine the effect of county workplace smoke-free laws over and above the effect of other (restaurant or bar) smoke-free laws on adult asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["The study estimated the effect of rates of adult asthma discharges before and after the implementation of county nonhospitality workplace smoke-free laws and county restaurant and bar smoke-free laws.", {"entities": [[49, 55, "DISEASE"]]}], ["Data were from 2002 to 2009, and all analyses were performed in 2011 through 2013.", {"entities": []}], ["A statistically significant relationship (\u22125.43, p < .05) was found between county restaurant or bar smoke-free laws and reductions in working age adult asthma discharges.", {"entities": [[153, 159, "DISEASE"]]}], ["There was no statistically significant effect of nonhospitality workplace smoke-free laws over and above the effect of county restaurant or bar laws.", {"entities": []}], ["This study suggests that further gains in preventable asthma-related hospitalizations in the US are more likely to be made by focusing on smoke-free laws in bars or restaurants rather than in nonhospitality workplaces.", {"entities": [[54, 60, "DISEASE"]]}], ["The main soluble form of the receptor for advanced glycation end-products (sRAGE) is elevated during acute respiratory distress syndrome (ARDS).", {"entities": [[128, 136, "DISEASE"]]}], ["However other RAGE isoforms and multiple ligands have been poorly reported in the clinical setting, and their respective contribution to RAGE activation during ARDS remains unclear.", {"entities": []}], ["Our goal was therefore to describe main RAGE isoforms and ligands levels during ARDS.", {"entities": []}], ["30 ARDS patients and 30 mechanically ventilated controls were prospectively included in this monocenter observational study.", {"entities": []}], ["Arterial, superior vena cava and alveolar fluid levels of sRAGE, endogenous-secretory RAGE (esRAGE), high mobility group box-1 protein (HMGB1), S100A12 and advanced glycation end-products (AGEs) were measured in duplicate ELISA on day 0, day 3 and day 6.", {"entities": [[136, 141, "GENE"], [144, 151, "GENE"]]}], ["In patients with ARDS, baseline lung morphology was assessed with computed tomography.", {"entities": []}], ["ARDS patients had higher arterial, central venous and alveolar levels of sRAGE, HMGB1 and S100A12, but lower levels of esRAGE and AGEs, than controls.", {"entities": [[80, 85, "GENE"], [90, 97, "GENE"]]}], ["Baseline arterial sRAGE, HMGB1 and S100A12 were correlated with nonfocal ARDS (AUC 0.79, 0.65 and 0.63, respectively).", {"entities": [[25, 30, "GENE"], [35, 42, "GENE"]]}], ["Baseline arterial sRAGE, esRAGE, S100A12 and AGEs were associated with severity as assessed by PaO 2 /FiO 2 .", {"entities": [[33, 40, "GENE"]]}], ["This is the first kinetics study of levels of RAGE main isoforms and ligands during ARDS.", {"entities": []}], ["Elevated sRAGE, HMGB1 and S100A12, with decreased esRAGE and AGEs, were found to distinguish patients with ARDS from those without.", {"entities": [[16, 21, "GENE"], [26, 33, "GENE"]]}], ["Our findings should prompt future studies aimed at elucidating RAGE/HMGB1/S100A12 axis involvement in ARDS.", {"entities": []}], ["clinicaltrials.gov Identifier: NCT01270295.", {"entities": []}], ["Inhaled corticosteroid/long-acting \u03b2 2 -agonist combination therapy is recommended in chronic obstructive pulmonary disease (COPD) patients at high risk of exacerbations.", {"entities": [[86, 123, "DISEASE"]]}], ["The EFFECT (Efficacy of Fluticasone propionate/FormotErol in COPD Treatment) trial is a Phase III, 52-week, randomized, double-blind study to evaluate the efficacy and safety of two doses of fluticasone propionate/formoterol compared to formoterol monotherapy in COPD patients with FEV 1 \u226550% predicted and a history of exacerbations.", {"entities": [[282, 285, "GENE"]]}], ["The primary endpoint is the annualized rate of moderate and severe exacerbations.", {"entities": []}], ["Secondary endpoints include pre-dose FEV 1 , EXACT-PRO (EXAcerbations of Chronic pulmonary disease Tool \u2013 Patient-Reported Outcome)-defined exacerbations, St George\u2019s Respiratory Questionnaire for COPD, COPD Assessment Test, and EXACT-Respiratory Symptoms total score.", {"entities": [[37, 40, "GENE"]]}], ["Lung-specific biomarkers (surfactant protein D and CC chemokine ligand-18) will be measured in a subset of patients to explore their relationship to other clinical indices in COPD and their predictive utility.", {"entities": []}], ["Pneumonia will be diagnosed per criteria defined by the British Thoracic Society community acquired pneumonia guideline, primarily by radiological confirmation and, additionally, using clinical criteria when a chest radiograph cannot be obtained.", {"entities": [[0, 9, "DISEASE"], [100, 109, "DISEASE"]]}], ["Serial measurements of serum potassium, vital signs and electrocardiograms, 24-hour Holter monitoring, and 24-hour urinary cortisol measurement will be performed in a subset of patients in addition to conventional safety assessments.", {"entities": []}], ["Controversy exists as to whether obesity constitutes a risk-factor or a protective-factor for the development of nosocomial Infection (NI).", {"entities": [[33, 40, "DISEASE"]]}], ["According to the obesity-paradox, there is evidence that moderate obesity is a protective-factor.", {"entities": [[17, 24, "DISEASE"], [66, 73, "DISEASE"]]}], ["In Mexico few studies have focused on the nutritional status (NS) distribution in the hospital setting.", {"entities": []}], ["The aim of this study was to estimate the distribution of NS and the prevalence of nosocomial infection NI among adult elective surgery (ES) patients and to compare the clinical and anthropometric characteristics and length of stays (LOS) between obese and non-obese patients and between patients with and without NI.", {"entities": []}], ["We conducted a cross-sectional study with a sample (n = 82) adult ES patients (21\u201359 years old) who were recruited from a tertiary-care hospital.", {"entities": []}], ["The prevalences of each NS category and NI were estimated, the assessments were compared between groups (Mann-Whitney, Chi-squared or the Fisher's-exact-test), and the association between preoperative risk-factors and NI was evaluated using odds ratios.", {"entities": []}], ["The distribution of subjects by NS category was: underweight (3.66%), normal-weight (28.05%), overweight (35.36%), and obese (32.93%).", {"entities": []}], ["The prevalence of NI was 14.63%.", {"entities": []}], ["The LOS was longer (p<0.001) for the patients who developed NI.", {"entities": []}], ["The percentages of NI were: 33.3% in underweight, 18.52% in obese, 17.39% in normal-weight, and 6.90% in overweight patients.", {"entities": []}], ["The prevalence of overweight and obesity in adult ES patients is high.", {"entities": [[33, 40, "DISEASE"]]}], ["The highest prevalence of NI occurred in the underweight and obese patients.", {"entities": []}], ["The presence of NI considerably increased the LOS, resulting in higher medical care costs.", {"entities": []}], ["Trends in climate suggest that extreme weather events such as heat waves will become more common.", {"entities": []}], ["High levels of the gaseous pollutant ozone are associated with elevated temperatures.", {"entities": []}], ["Ozone has been associated with respiratory diseases as well as cardiovascular morbidity and mortality and can reduce lung function and alter systemic markers of fibrinolysis.", {"entities": []}], ["The interaction between ozone and temperature is unclear.", {"entities": []}], ["Sixteen healthy volunteers were exposed in a randomized crossover study to 0.3 ppm ozone and clean air for 2 hr at moderate (22\u00b0C) temperature and again at an elevated temperature (32.5\u00b0C).", {"entities": [[109, 111, "GENE"]]}], ["In each case lung function was performed and blood taken before and immediately after exposure and the next morning.", {"entities": []}], ["Ozone exposure at 22\u00b0C resulted in a decrease in markers of fibrinolysis the next day.", {"entities": []}], ["There was a 51.8% net decrease in PAI-1 (plasminogen activator inhibitor-1), a 12.1% net decrease in plasminogen, and a 17.8% net increase in D -dimer.", {"entities": []}], ["These significantly differed from the response at 32.5\u00b0C, where there was a 44.9% ( p = 0.002) and a 27.9% ( p = 0.001) increase in PAI-1 and plasminogen, respectively, and a 12.5% ( p = 0.042) decrease in D -dimer.", {"entities": []}], ["In contrast, decrements in lung function following ozone exposure were comparable at both moderate and elevated temperatures (forced expiratory volume in 1 sec, \u201312.4% vs. \u20137.5%, p > 0.05).", {"entities": []}], ["No changes in systemic markers of inflammation were observed for either temperature.", {"entities": []}], ["Ozone-induced systemic but not respiratory effects varied according to temperature.", {"entities": []}], ["Our study suggests that at moderate temperature ozone may activate the fibrinolytic pathway, while at elevated temperature ozone may impair it.", {"entities": []}], ["These findings provide a biological basis for the interaction between temperature and ozone on mortality observed in some epidemiologic studies.", {"entities": []}], ["Kahle JJ, Neas LM, Devlin RB, Case MW, Schmitt MT, Madden MC, Diaz-Sanchez D. 2015.", {"entities": []}], ["Interaction effects of temperature and ozone on lung function and markers of systemic inflammation, coagulation, and fibrinolysis: a crossover study of healthy young volunteers.", {"entities": []}], ["Environ Health Perspect 123:310\u2013316;\u2002 http://dx.doi.org/10.1289/ehp.1307986", {"entities": []}], ["Decorin, a member of the small leucine-rich proteoglycan gene family, exists and functions wholly within the tumor microenvironment to suppress tumorigenesis by directly targeting and antagonizing multiple receptor tyrosine kinases, such as the EGFR and Met.", {"entities": [[245, 249, "GENE"]]}], ["This leads to potent and sustained signal attenuation, growth arrest, and angiostasis.", {"entities": []}], ["We thus sought to evaluate the tumoricidal benefits of systemic decorin on a triple-negative orthotopic breast carcinoma xenograft model.", {"entities": [[111, 120, "DISEASE"], [104, 120, "DISEASE"]]}], ["To this end, we employed a novel high-density mixed expression array capable of differentiating and simultaneously measuring gene signatures of both Mus musculus (stromal) and Homo sapiens (epithelial) tissue origins.", {"entities": []}], ["We found that decorin protein core modulated the differential expression of 374 genes within the stromal compartment of the tumor xenograft.", {"entities": []}], ["Further, our top gene ontology classes strongly suggests an unexpected and preferential role for decorin protein core to inhibit genes necessary for immunomodulatory responses while simultaneously inducing expression of those possessing cellular adhesion and tumor suppressive gene properties.", {"entities": []}], ["Rigorous verification of the top scoring candidates led to the discovery of three genes heretofore unlinked to malignant breast cancer that were reproducibly found to be induced in several models of tumor stroma.", {"entities": [[121, 134, "DISEASE"], [128, 134, "DISEASE"]]}], ["Collectively, our data provide highly novel and unexpected stromal gene signatures as a direct function of systemic administration of decorin protein core and reveals a fundamental basis of action for decorin to modulate the tumor stroma as a biological mechanism for the ascribed anti-tumorigenic properties.", {"entities": []}], ["Pollen forecasts are in use everywhere to inform therapeutic decisions for patients with allergic rhinoconjunctivitis (ARC).", {"entities": []}], ["We exploited data derived from Twitter in order to identify tweets reporting a combination of symptoms consistent with a case definition of ARC and those reporting the name of an antihistamine drug.", {"entities": []}], ["In order to increase the sensitivity of the system, we applied an algorithm aimed at automatically identifying jargon expressions related to medical terms.", {"entities": []}], ["We compared weekly Twitter trends with National Allergy Bureau weekly pollen counts derived from US stations, and found a high correlation of the sum of the total pollen counts from each stations with tweets reporting ARC symptoms (Pearson\u2019s correlation coefficient: 0.95) and with tweets reporting antihistamine drug names (Pearson\u2019s correlation coefficient: 0.93).", {"entities": []}], ["Longitude and latitude of the pollen stations affected the strength of the correlation.", {"entities": []}], ["Twitter and other social networks may play a role in allergic disease surveillance and in signaling drug consumptions trends.", {"entities": []}], ["Paracetamol is commonly used to control mild-to-moderate pain or to reduce opioid exposure as part of multimodal analgesia, and is the only compound recommended to treat fever in neonates.", {"entities": []}], ["Paracetamol clearance is lower in neonates than in children and adults.", {"entities": []}], ["After metabolic conversion, paracetamol is subsequently eliminated by the renal route.", {"entities": []}], ["The main metabolic conversions are conjugation with glucuronic acid and with sulphate.", {"entities": []}], ["In the urine of neonates sulphated paracetamol concentration is higher than the glucuronidated paracetamol level, suggesting that sulfation prevails over glucuronidation in neonates.", {"entities": []}], ["A loading dose of 20 mg/kg followed by 10 mg/kg every 6 hours of intravenous paracetamol is suggested to achieve a compartment concentration of 11 mg/L in late preterm and term neonates.", {"entities": []}], ["Aiming for the same target concentration, oral doses are similar with rectal administration of 25 to 30 mg/kg/d in preterm neonates of 30 weeks\u2019 gestation, 45 mg/kg/d in preterm infants of 34 weeks\u2019 gestation, and 60 mg/kg/d in term neonates are suggested.", {"entities": []}], ["The above-mentioned paracetamol doses for these indications (pain, fever) are well tolerated in neonates, but do not result in a significant increase in liver enzymes, and do not affect blood pressure and have limited effects on heart rate.", {"entities": []}], ["In contrast, the higher doses suggested in extreme preterm neonates to induce closure of the patent ductus arteriosus have not yet been sufficiently evaluated regarding efficacy or safety.", {"entities": [[93, 117, "DISEASE"]]}], ["Moreover, focussed pharmacovigilance to explore the potential causal association between paracetamol exposure during perinatal life and infancy and subsequent atopy is warranted.", {"entities": []}], ["This study compared the economic value of pediatric immunisation programmes for influenza to those for rotavirus (RV), meningococcal disease (MD), pneumococcal disease (PD), human papillomavirus (HPV), hepatitis B (Hep B), and varicella reported in recent (2000 onwards) cost-effectiveness (CE) studies identified in a systematic review of PubMed, health technology, and vaccination databases.", {"entities": [[80, 89, "DISEASE"], [202, 211, "DISEASE"]]}], ["The systematic review yielded 51 economic evaluation studies of pediatric immunisation \u2014 10 (20%) for influenza and 41 (80%) for the other selected diseases.", {"entities": [[102, 111, "DISEASE"]]}], ["The quality of the eligible articles was assessed using Drummond's checklist.", {"entities": []}], ["Although inherent challenges and limitations exist when comparing economic evaluations of immunisation programmes, an overall comparison of the included studies demonstrated cost-effectiveness/cost saving for influenza from a European-Union-Five (EU5) and United States (US) perspective; point estimates for cost/quality-adjusted life-years (QALY) from dominance (cost-saving with more effect) to \u226445,444 were reported.", {"entities": [[209, 218, "DISEASE"]]}], ["The economic value of influenza programmes was comparable to the other vaccines of interest, with cost/QALY in general considerably lower than RV, Hep B, MD and PD.", {"entities": [[22, 31, "DISEASE"]]}], ["Independent of the perspective and type of analysis, the economic impact of a pediatric influenza immunisation program was influenced by vaccine efficacy, immunisation coverage, costs, and most significantly by herd immunity.", {"entities": [[88, 97, "DISEASE"]]}], ["This review suggests that pediatric influenza immunisation may offer a cost effective strategy when compared with HPV and varicella and possibly more value compared with other childhood vaccines (RV, Hep B, MD and PD).", {"entities": [[36, 45, "DISEASE"]]}], ["This cross-sectional study examined the relationships between household smoking restrictions and intentions to quit smoking among Korean American male smokers in California.", {"entities": []}], ["We used data from the California Korean American Tobacco Use Survey (CKATUS), which was conducted in 2004 using computer-assisted telephone interviewing.", {"entities": []}], ["Among the 2,545 respondents who participated in the CKATUS, the 387 male smokers who answered a question assessing their intention to quit smoking were included in the final analyses.", {"entities": []}], ["In univariable analyses, smokers who reported having household smoking restrictions were more likely to intend to quit smoking as compared with those who did not ( P <0.01).", {"entities": []}], ["Other independent correlates of having an intention to quit smoking were being less than 50 yr of age, having spent more than 50% of one's life in the US, being assimilated, and having other smokers in the household.", {"entities": []}], ["In a multiple logistic regression analysis, the significant correlates of having an intention to quit smoking were household smoking restrictions (complete or partial restriction vs. no restriction on smoking; odds ratio, 2.54; 95% confidence interval, 1.22-5.28) and absence of other smokers in the household.", {"entities": []}], ["In conclusion, smoking restrictions in the household are associated with an intention to quit smoking among Korean American male smokers in California.", {"entities": []}], ["Although sedation is often required for agitated patients undergoing noninvasive ventilation (NIV), reports on its practical use have been few.", {"entities": []}], ["This study aimed to evaluate the efficacy and safety of sedation for agitated patients undergoing NIV in clinical practice in a single hospital.", {"entities": []}], ["We retrospectively reviewed sedated patients who received NIV due to acute respiratory failure from May 2007 to May 2012.", {"entities": [[75, 94, "DISEASE"]]}], ["Sedation level was controlled according to the Richmond Agitation Sedation Scale (RASS).", {"entities": []}], ["Clinical background, sedatives, failure rate of sedation, and complications were evaluated by 1) sedative methods (intermittent only, switched to continuous, or initially continuous) and 2) code status (do-not-intubate [DNI] or non-DNI).", {"entities": []}], ["Of 3506 patients who received NIV, 120 (3.4\u00a0%) consecutive patients were analyzed.", {"entities": []}], ["Sedation was performed only intermittently in 72 (60\u00a0%) patients, was switched to continuously in 37 (31\u00a0%) and was applied only continuously in 11 (9\u00a0%).", {"entities": []}], ["Underlying diseases in 48\u00a0% were acute respiratory distress syndrome/acute lung injury/severe pneumonia or acute exacerbation of interstitial pneumonia.", {"entities": [[94, 103, "DISEASE"], [142, 151, "DISEASE"], [60, 68, "DISEASE"]]}], ["In non-DNI patients ( n \u2009=\u200939), no patient required intubation due to agitation with continuous sedation, and in DNI patients ( n \u2009=\u200981), 96\u00a0% of patients could continue NIV treatment.", {"entities": []}], ["PaCO 2 level changes (6.7\u2009\u00b1\u200915.1\u00a0mmHg vs. -2.0\u2009\u00b1\u20097.7\u00a0mmHg, P \u2009=\u20090.028) and mortality in DNI patients (81\u00a0% vs. 57\u00a0%, P \u2009=\u20090.020) were significantly greater in the continuous use group than in the intermittent use group.", {"entities": []}], ["According to RASS scores, sedation during NIV in proficient hospitals may be favorably used to potentially avoid NIV failure in agitated patients, even in those having diseases with poor evidence of the usefulness of NIV.", {"entities": []}], ["However, with continuous use, we must be aware of an increased hypercapnic state and the possibility of increased mortality.", {"entities": []}], ["Larger controlled studies are needed to better clarify the role of sedation in improving NIV outcomes in intolerant patients.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-015-0072-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["T cell-associated inflammation, particularly type 2 inflammation, has an important role in asthma pathogenesis, which is suppressed by regulatory T cells (Tregs).", {"entities": [[91, 97, "DISEASE"]]}], ["Proviral integration site for Moloney murine leukemia virus 2 (PIM2), a member off the serine/threonine kinase family, promotes the growth and survival of T cells and influences the function of Treg cells.", {"entities": [[45, 53, "DISEASE"], [63, 67, "GENE"]]}], ["However, whether PIM2 affects asthma pathogenesis remains unclear.", {"entities": [[30, 36, "DISEASE"], [17, 21, "GENE"]]}], ["Peripheral blood mononuclear cells and Treg cells from asthmatic and healthy subjects were obtained, and the expression level of PIM2 was measured by reverse transcription-quantitative polymerase chain reaction and immunocytochemistry.", {"entities": [[129, 133, "GENE"]]}], ["In addition, BALB/c female mice sensitized and challenged by ovalbumin were used as an asthma model, and PIM2 inhibitor was injected during the challenge period to observe the effect of PIM2 on asthma.", {"entities": [[87, 93, "DISEASE"], [194, 200, "DISEASE"], [105, 109, "GENE"], [186, 190, "GENE"], [105, 109, "GENE"], [186, 190, "GENE"]]}], ["The asthma symptoms were recorded, and airway hyper-responsiveness (AHR), expression levels of cytokines in the serum or bronchoalveolar lavage fluid (BALF), and the number of BALF leukocytes were evaluated.", {"entities": [[4, 10, "DISEASE"], [68, 71, "GENE"]]}], ["In addition, hematoxylin and eosin staining and immunohistochemistry of lung tissues was performed.", {"entities": []}], ["The results demonstrated that PIM2 was overexpressed in patients with asthma in natural Treg cells.", {"entities": [[70, 76, "DISEASE"], [30, 34, "GENE"]]}], ["Inhibition of PIM2 attenuated asthma symptoms, and improved AHR and airway inflammation compared with asthmatic mice without inhibition of PIM2.", {"entities": [[30, 36, "DISEASE"], [14, 18, "GENE"], [139, 143, "GENE"], [60, 63, "GENE"], [14, 18, "GENE"], [139, 143, "GENE"]]}], ["In addition, expression levels of interleukin (IL)-10 and forkhead box protein 3 (FOXP3) in BALF were increased following PIM2 inhibition (IL-10, 470.3\u00b121.78 vs. 533.7\u00b125.55 pg/ml, P<0.05; FOXP3, 259\u00b14.68 vs. 279.3\u00b13.68 pg/ml; asthma and PIM2 inhibition groups, respectively; P<0.05).", {"entities": [[227, 233, "DISEASE"], [82, 87, "GENE"], [189, 194, "GENE"], [122, 126, "GENE"], [238, 242, "GENE"], [82, 87, "GENE"], [189, 194, "GENE"], [122, 126, "GENE"], [238, 242, "GENE"]]}], ["In conclusion, PIM2 may exhibit an important role in asthma pathogenesis and exacerbate AHR, airway inflammation and asthma symptoms.", {"entities": [[53, 59, "DISEASE"], [117, 123, "DISEASE"], [15, 19, "GENE"], [88, 91, "GENE"]]}], ["These effects of PIM2 may be dependent on Treg cells and the secretion of IL-10 by Tregs.", {"entities": [[17, 21, "GENE"]]}], ["The results of the present study suggest that PIM2 may be a potential target molecule for asthma treatment.", {"entities": [[90, 96, "DISEASE"], [46, 50, "GENE"]]}], ["Documentation of unexplained geographic variations in medical practices and use of inappropriate interventions has led to the proliferation of clinical practice guidelines.", {"entities": []}], ["With increased enthusiasm for guidelines, evidence exists that clinical practice guidelines often influence clinical practices or health outcomes.", {"entities": []}], ["Their successful implementation may improve the quality of care by decreasing in appropriate variation and expediting the application of effective advances to healthcare practices.", {"entities": []}], ["In Korea, physicians and healthcare professionals have begun to take interests in clinical practice guidelines.", {"entities": []}], ["Currently, over 50 practice guidelines have been developed through professional academic organizations or via other routes; however, the quality of the guidelines is unsatisfactory, implementation in clinical settings is incomplete, and there is insufficient infrastructure to develop clinical practice guidelines.", {"entities": []}], ["Korea must develop policies and invest resources to enhance the development and implementation of clinical practice guidelines.", {"entities": []}], ["Some grass species are richer in coumarin and thus more sweetly scented than others.", {"entities": []}], ["These have been eagerly sought after in parts of Norway, but the tradition has been weakly documented, both in terms of the species collected, their vernacular names, and uses.", {"entities": []}], ["Based on literature data and a substantial body of information collected during my own ethnobotanical field work, artefacts and voucher specimens, the grass species are identified, and their uses clarified.", {"entities": []}], ["In Norwegian literature, the tradition of collecting and using scented grasses has received little attention, and past authors largely refer it to Anthoxanthum spp.", {"entities": []}], ["The tradition\u2019s concentration to the S\u00e1mi strongholds of northernmost Norway, and most authors\u2019 lacking knowledge of the S\u00e1mi language, have contributed to the weak and misleading coverage in previous publications.", {"entities": []}], ["Coumarin-rich grass species are well known in folk tradition in northernmost Norway, as luktegress (Norwegian, \u201cscent grass\u201d), h\u00e1issasuoidni (North S\u00e1mi, \u201cscent grass\u201d), hajuhein\u00e4 (Finnish, \u201cscent grass\u201d), or similar terms.", {"entities": []}], ["They have been (and still are) frequently collected, and used as perfume, for storing with clothes, and a number of other purposes.", {"entities": []}], ["Despite literature records identifying the species used as Anthoxanthum odoratum coll.", {"entities": []}], ["(including A. nipponicum), the main source utilized in North Norway is Hierochlo\u00eb odorata , both ssp.", {"entities": []}], ["arctica and ssp.", {"entities": []}], ["Anthoxanthum nipponicum and Milium effusum are alternative, but infrequently used sources of material, depending on local tradition and availability.", {"entities": []}], ["By far the most important grass species hiding behind the \u201cscented grass\u201d tradition in Norway is Hierochlo\u00eb odorata.", {"entities": []}], ["Anthoxanthum nipponicum is also used, but much less frequently, and only a single record confirms the use of Milium effusum .", {"entities": []}], ["Only the foliage of Hierochlo\u00eb provides suitable material for making traditional braids.", {"entities": []}], ["The three major ethnic groups in Norway have all utilized scented grasses as perfume and for storing with clothes, but the tradition\u2019s geographical concentration to the far north of Norway (Finnmark and NE Troms), suggests that it has originally mainly been a S\u00e1mi tradition, adopted by their neighbours.", {"entities": []}], ["Late-life depression is an important public health problem because of its devastating consequences.", {"entities": []}], ["The study aims to investigate the prevalence and associated factors of self-reported symptom-based depression in a national sample of older South Africans who participated in the Study of Global Ageing and Adult Health (SAGE wave 1) in 2008.", {"entities": []}], ["We conducted a national population-based cross-sectional study with a probability sample of 3,840 individuals aged 50 years or above in South Africa in 2008.", {"entities": []}], ["The questionnaire included socio-demographic characteristics, health variables, anthropometric and blood pressure measurements as well as questions on depression symptoms in the past 12 months.", {"entities": []}], ["Multivariable regression analysis was performed to assess the association of socio-demographic factors, health variables, and depression.", {"entities": []}], ["The overall prevalence of symptom-based depression in the past 12 months was 4.0%.", {"entities": []}], ["In multivariable analysis, functional disability, lack of quality of life, and chronic conditions (angina, asthma, arthritis, and nocturnal sleep problems) were associated with self-reported depression symptoms in the past 12 months.", {"entities": [[115, 124, "DISEASE"], [107, 113, "DISEASE"]]}], ["Self-reported depression in older South Africans seems to be a public health problem calling for appropriate interventions to reduce occurrence.", {"entities": []}], ["Factors identified to be associated with depression, including functional disability, lack of quality of life, and chronic conditions (angina, asthma, arthritis, and nocturnal sleep problems), can be used to guide interventions.", {"entities": [[151, 160, "DISEASE"], [143, 149, "DISEASE"]]}], ["The identified protective and risk factors can help in formulating public health care policies to improve quality of life among older adults.", {"entities": []}], ["Data is lacking on comorbid personality disorders (PD) and fibromyalgia syndrome (FMS) in terms of prevalence, and associated healthcare and societal costs.", {"entities": [[72, 80, "DISEASE"], [59, 71, "DISEASE"]]}], ["The main aim of this study was to assess the prevalence of PD in FMS patients and to analyse whether the presence of comorbid PD is related to worse functional impairment and greater healthcare (medical visits, drug consumption, and medical tests) and societal costs.", {"entities": []}], ["A cross-sectional study was performed using the baseline data of 216 FMS patients participating in a randomized, controlled trial carried out in three primary health care centres situated in the region of Barcelona, Spain.", {"entities": []}], ["Measurement instruments included the International Personality Disorder Examination - Screening Questionnaire (IPDE-SQ), the Fibromyalgia Impact Questionnaire (FIQ), the Client Service Receipt Inventory (CSRI), and a socio-demographic questionnaire.", {"entities": [[51, 71, "DISEASE"], [125, 137, "DISEASE"]]}], ["Most patients (65\u00a0%) had a potential PD according to the IPDE-SQ.", {"entities": []}], ["The most prevalent PD were the avoidant (41.4\u00a0%), obsessive-compulsive (33.1\u00a0%), and borderline (27\u00a0%).", {"entities": []}], ["We found statistically significant differences in functional impairment (FIQ scores) between FMS patients with potential PD vs non-PD (59.2 vs 51.1; p \u2009<\u20090.001).", {"entities": []}], ["Multivariate regression analyses revealed that higher FIQ total scores and the presence of potential PD were related to more healthcare costs (primary and specialised care visits).", {"entities": []}], ["As expected, PD are frequent comorbid conditions in patients with FMS.", {"entities": []}], ["Our results suggest that the screening of comorbid PD in patients with FMS might be recommendable in order to detect potential frequent attenders to primary and specialised care.", {"entities": []}], ["Low body mass index has been associated with increased mortality in severe COPD.", {"entities": []}], ["The impact of body composition earlier in the disease remains unclear.", {"entities": []}], ["We studied the impact of body composition on the risk of functional limitation in COPD.", {"entities": []}], ["We used bioelectrical impedance to estimate body composition in a cohort of 355 younger adults with COPD who had a broad spectrum of severity.", {"entities": []}], ["Among women, a higher lean-to-fat ratio was associated with a lower risk of self-reported functional limitation after controlling for age, height, pulmonary function impairment, race, education, and smoking history (OR 0.45 per 0.50 increment in lean-to-fat ratio; 95% CI 0.28 to 0.74).", {"entities": []}], ["Among men, a higher lean-to-fat ratio was associated with a greater distance walked in 6 minutes (mean difference 40 meters per 0.50 ratio increment; 95% CI 9 to 71 meters).", {"entities": []}], ["In women, the lean-to-fat ratio was associated with an even greater distance walked (mean difference 162 meters per 0.50 increment; 95% CI 97 to 228 meters).", {"entities": []}], ["In women, higher lean-to-fat ratio was also associated with better Short Physical Performance Battery Scores.", {"entities": []}], ["In further analysis, the accumulation of greater fat mass, and not the loss of lean mass, was most strongly associated with functional limitation among both sexes.", {"entities": []}], ["Body composition is an important non-pulmonary impairment that modulates the risk of functional limitation in COPD, even after taking pulmonary function into account.", {"entities": []}], ["Body composition abnormalities may represent an important area for screening and preventive intervention in COPD.", {"entities": []}], ["Sex-related differences in lipid availability and fatty acid composition during swine foetal development were investigated.", {"entities": []}], ["Plasma cholesterol and triglyceride concentrations in the mother were strongly related to the adequacy or inadequacy of foetal development and concomitant activation of protective growth in some organs (brain, heart, liver and spleen).", {"entities": []}], ["Cholesterol and triglyceride availability was similar in male and female offspring, but female foetuses showed evidence of higher placental transfer of essential fatty acids and synthesis of non-essential fatty acids in muscle and liver.", {"entities": []}], ["These sex-related differences affected primarily the neutral lipid fraction (triglycerides), which may lead to sex-related postnatal differences in energy partitioning.", {"entities": []}], ["These results illustrate the strong influence of the maternal lipid profile on foetal development and homeorhesis, and they confirm and extend previous reports that female offspring show better adaptive responses to maternal malnutrition than male offspring.", {"entities": []}], ["These findings may help guide dietary interventions to ensure adequate fatty acid availability for postnatal development.", {"entities": []}], ["Cumulative exposure to lead is associated with cardiovascular outcomes.", {"entities": []}], ["Polymorphisms in the \u03b4-aminolevulinic acid dehydratase ( ALAD ), hemochromatosis ( HFE ), heme oxygenase-1 ( HMOX1 ), vitamin D receptor ( VDR ), glutathione S-transferase ( GST ) supergene family ( GSTP1 , GSTT1 , GSTM1 ), apolipoprotein E ( APOE ),angiotensin II receptor-1 ( AGTR1 ) and angiotensinogen ( AGT ) genes, are believed to alter toxicokinetics and/or toxicodynamics of lead.", {"entities": [[65, 80, "DISEASE"], [57, 61, "GENE"], [83, 86, "GENE"], [109, 114, "GENE"], [139, 142, "GENE"], [199, 204, "GENE"], [207, 212, "GENE"], [215, 220, "GENE"], [243, 247, "GENE"], [278, 283, "GENE"], [308, 311, "GENE"]]}], ["We assessed possible effect modification by genetic polymorphisms in ALAD , HFE , HMOX1 , VDR , GSTP1 , GSTT1 , GSTM1 , APOE , AGTR1 and AGT individually and as the genetic risk score (GRS) on the association between cumulative lead exposure and incident coronary heart disease (CHD) events.", {"entities": [[264, 277, "DISEASE"], [255, 277, "DISEASE"], [69, 73, "GENE"], [76, 79, "GENE"], [82, 87, "GENE"], [90, 93, "GENE"], [96, 101, "GENE"], [104, 109, "GENE"], [112, 117, "GENE"], [120, 124, "GENE"], [127, 132, "GENE"], [137, 140, "GENE"]]}], ["We used K-shell-X-ray fluorescence to measure bone lead levels.", {"entities": []}], ["GRS was calculated on the basis of 22 lead-related loci.", {"entities": []}], ["We constructed Cox proportional hazard models to compute adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CHD.", {"entities": []}], ["We applied inverse probability weighting to account for potential selection bias due to recruitment into the bone lead sub-study.", {"entities": []}], ["Significant effect modification was found by VDR , HMOX1 , GSTP1 , APOE , and AGT genetic polymorphisms when evaluated individually.", {"entities": [[45, 48, "GENE"], [51, 56, "GENE"], [59, 64, "GENE"], [67, 71, "GENE"], [78, 81, "GENE"]]}], ["Further, the bone lead-CHD associations became larger as GRS increases.", {"entities": []}], ["After adjusting for potential confounders, a HR of CHD was 2.27 (95%CI: 1.50\u20133.42) with 2-fold increase in patella lead levels, among participants in the top tertile of GRS.", {"entities": [[45, 47, "GENE"]]}], ["We also detected an increasing trend in HRs across tertiles of GRS (p-trend = 0.0063).", {"entities": []}], ["Our findings suggest that lead-related loci as a whole may play an important role in susceptibility to lead-related CHD risk.", {"entities": []}], ["These findings need to be validated in a separate cohort containing bone lead, lead-related genetic loci and incident CHD data.", {"entities": []}], ["Complementary therapies are widespread but controversial.", {"entities": []}], ["We aim to provide a comprehensive collection and a summary of systematic reviews of clinical trials in three major complementary therapies (acupuncture, herbal medicine, homeopathy).", {"entities": []}], ["This article is dealing with acupuncture.", {"entities": []}], ["Potentially relevant reviews were searched through the register of the Cochrane Complementary Medicine Field, the Cochrane Library, Medline, and bibliographies of articles and books.", {"entities": []}], ["To be included articles had to review prospective clinical trials of acupuncture; had to describe review methods explicitly; had to be published; and had to focus on treatment effects.", {"entities": []}], ["Information on conditions, interventions, methods, results and conclusions was extracted using a pretested form and summarized descriptively.", {"entities": []}], ["From a total of 48 potentially relevant reviews preselected in a screeening process 39 met the inclusion criteria.", {"entities": []}], ["22 were on various pain syndromes or rheumatic diseases.", {"entities": []}], ["Other topics addressed by more than one review were addiction, nausea, asthma and tinnitus.", {"entities": [[71, 77, "DISEASE"]]}], ["Almost unanimously the reviews state that acupuncture trials include too few patients.", {"entities": []}], ["Often included trials are heterogeneous regarding patients, interventions and outcome measures, are considered to have insufficient quality and contradictory results.", {"entities": []}], ["Convincing evidence is available only for postoperative nausea, for which acupuncture appears to be of benefit, and smoking cessation, where acupuncture is no more effective than sham acupuncture.", {"entities": []}], ["A large number of systematic reviews on acupuncture exists.", {"entities": []}], ["What is most obvious from these reviews is the need for (the funding of) well-designed, larger clinical trials.", {"entities": []}], ["In recent years there has been a major change on the part of funders, particularly in North America, so that data sharing is now considered to be the norm rather than the exception.", {"entities": []}], ["We believe that data sharing is a good idea.", {"entities": []}], ["However, we also believe that it is inappropriate to prescribe exactly when or how researchers should preserve and share data, since these issues are highly specific to each study, the nature of the data collected, who is requesting it, and what they intend to do with it.", {"entities": []}], ["The level of ethical concern will vary according to the nature of the information, and the way in which it is collected - analyses of anonymised hospital admission records may carry a quite different ethical burden than analyses of potentially identifiable health information collected directly from the study participants.", {"entities": []}], ["It is striking that most discussions about data sharing focus almost exclusively on issues of ownership (by the researchers or the funders) and efficiency (on the part of the funders).", {"entities": []}], ["There is usually little discussion of the ethical issues involved in data sharing, and its implications for the study participants.", {"entities": []}], ["Obtaining prior informed consent from the participants does not solve this problem, unless the informed consent process makes it completely clear what is being proposed, in which case most study participants would not agree.", {"entities": []}], ["Thus, the undoubted benefits of data sharing does not remove the obligations and responsibilities that the original investigators hold for the people they invited to participate in the study.", {"entities": []}], ["It has been proposed that the redox activity of particles may represent a major determinant of their toxicity.", {"entities": []}], ["We measured the in vitro ability of ambient fine particles [particulate matter with aerodynamic diameters \u22642.5 \u03bcm (PM 2.5 )] to form hydroxyl radicals ( Gravimetric PM 2.5 samples ( n = 716) collected over 1 year from 20 centers participating in the European Community Respiratory Health Survey were available.", {"entities": []}], ["Light absorbance of these filters was measured with reflectometry.", {"entities": []}], ["PM suspensions were recovered from filters by vortexing and sonication before dilution to a standard concentration.", {"entities": []}], ["The oxidative activity of these particle suspensions was then assessed by measuring their ability to generate N -oxide as spin trap, or by establishing their capacity to deplete antioxidants from a synthetic model of the RTLF.", {"entities": []}], ["PM oxidative activity varied significantly among European sampling sites.", {"entities": []}], ["Correlations between oxidative activity and all other characteristics of PM were low, both within centers (temporal correlation) and across communities (annual mean).", {"entities": []}], ["Thus, no single surrogate measure of PM redox activity could be identified.", {"entities": []}], ["Because these novel measures are suggested to reflect crucial biologic mechanisms of PM, their use may be pertinent in epidemiologic studies.", {"entities": []}], ["Therefore, it is important to define the appropriate methods to determine oxidative activity of PM.", {"entities": []}], ["Concerning the different effects of essential oils from Nepeta genus on the central nervous system including pain killing effect, this study was designed to evaluate the antinociceptive and anti-inflammatory effects of essential oil of Nepeta pogonosperma Jamzad et Assadi (NP) , a recently identified species.", {"entities": []}], ["Air-dried aerial parts of NP were hydrodistillated and GC-MS analysis of obtained essential oil was conducted.", {"entities": []}], ["Total 24 male Wister rats weighing 225\u2009\u00b1\u200925 gm were studied.", {"entities": []}], ["Essential oil of NP was administered intraperitoneally at the doses of 50\u2009mg/kg, 100\u2009mg/kg and 200\u2009mg/kg for the experimental groups.", {"entities": []}], ["Control rats received equal volume (2\u2009ml/kg) of normal saline.", {"entities": []}], ["Antinociception was assessed by tail flick test (after 30 minutes) and formalin test (for further 60 minutes).", {"entities": []}], ["Then the animal was sacrificed and the paw edema was measured using a water plethysmometer.", {"entities": []}], ["4a\u03b1,7\u03b1,7a\u03b2-nepetalactone and 1,8-cineole were found as the main concentrated components of NP essential oil.", {"entities": []}], ["All the doses of NP showed antinociception.", {"entities": []}], ["NP 200\u2009mg/kg reduced the pain sensation in tail flick (p <0.01) and formalin test (p <0.001 in both phases).", {"entities": []}], ["In paw edema test, NP 100 and 200\u2009mg/kg significantly reduced the inflammation (p <0.01 and p <0.05).", {"entities": []}], ["This study reveals that the essential oil of NP may minimize both the acute and chronic forms of nociception and may have potent role against inflammation, but the dose should be maintained precisely to obtain the intended effect.", {"entities": []}], ["This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work.", {"entities": []}], ["We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda.", {"entities": []}], ["We find that youth commonly use SMS as over 90% of this study\u2019s youths knew how to read, write and send messages and almost three-fourths of them had phones.", {"entities": [[32, 35, "GENE"]]}], ["Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status.", {"entities": []}], ["Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth.", {"entities": []}], ["Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support.", {"entities": []}], ["Youths\u2019 suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.", {"entities": []}], ["Clinical studies investigating medicinal products need to comply with laws concerning good clinical practice (GCP) and good manufacturing practice (GMP) to guarantee the quality and safety of the product, to protect the health of the participating individual and to assure proper performance of the study.", {"entities": []}], ["However, there are no specific regulations or guidelines for non-Medicinal Investigational Products (non-MIPs) such as allergens, enriched food supplements, and air pollution components.", {"entities": []}], ["As a consequence, investigators will avoid clinical research and prefer preclinical models or in vitro testing for e.g.", {"entities": []}], ["toxicology studies.", {"entities": []}], ["1) briefly review the current guidelines and regulations for Investigational Medicinal Products; 2) present a standardised approach to ensure the quality and safety of non-MIPs in human in vivo research; and 3) discuss some lessons we have learned.", {"entities": []}], ["We propose a practical line of approach to compose a clarifying product dossier (PD), comprising the description of the production process, the analysis of the raw and final product, toxicological studies, and a thorough risk-benefit-analysis.", {"entities": []}], ["This is illustrated by an example from a human in vivo research model to study exposure to air pollutants, by challenging volunteers with a suspension of carbon nanoparticles (the component of ink cartridges for laser printers).", {"entities": []}], ["With this novel risk-based approach, the members of competent authorities are provided with standardised information on the quality of the product in relation to the safety of the participants, and the scientific goal of the study.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0413-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Plasminogen activator inhibitor-1 (PAI-1) and soluble urokinase-type plasminogen activator receptor (suPAR) participate in inflammation and tissue remolding in various diseases, but their roles in chronic obstructive pulmonary disease (COPD) are not yet clear.", {"entities": [[197, 234, "DISEASE"]]}], ["This study aimed to investigate if PAI-1 and suPAR were involved in systemic inflammation and small airway obstruction (SAO) in COPD.", {"entities": []}], ["Demographic and clinical characteristics, spirometry examination, and blood samples were obtained from 84 COPD patients and 51 healthy volunteers.", {"entities": []}], ["Serum concentrations of PAI-1, suPAR, tissue inhibitor of metalloproteinase-1 (TIMP-1), Matrix metalloproteinase-9 (MMP-9), and C-reactive protein (CRP) were detected with Magnetic Luminex Screening Assay.", {"entities": [[148, 151, "GENE"]]}], ["Differences between groups were statistically analyzed using one-way analysis of variance or chi-square test.", {"entities": []}], ["Pearson\u2019s partial correlation test (adjusted for age, sex, body mass index, cigarette status, and passive smoke exposure) and multivariable linear analysis were used to explore the relationships between circulating PAI-1 and indicators of COPD.", {"entities": []}], ["First, we found that serum PAI-1 levels but not suPAR levels were significantly increased in COPD patients compared with healthy volunteers (125.56\u00b151.74 ng/mL versus 102.98\u00b136.62 ng/mL, P =0.007).", {"entities": []}], ["Then, the correlation analysis showed that circulating PAI-1 was inversely correlated with pulmonary function parameters including the ratio of forced expiratory volume in 1 second to forced vital capacity (FEV 1 /FVC), FEV 1 /Pre (justified r =\u22120.308, P <0.001; justified r =\u22120.295, P =0.001, respectively) and SAO indicators such as FEV 3 /FVC, MMEF25\u201375/Pre (justified r =\u22120.289, P =0.001; justified r =\u22120.273, P =0.002, respectively), but positively related to the inflammatory marker CRP (justified r =0.351, P <0.001), the small airway remolding biomarker TIMP-1, and MMP-9 (justified r =0.498, P <0.001; justified r =0.267, P =0.002, respectively).", {"entities": [[207, 210, "GENE"], [220, 223, "GENE"], [335, 338, "GENE"], [207, 210, "GENE"], [220, 223, "GENE"], [335, 338, "GENE"], [207, 210, "GENE"], [220, 223, "GENE"], [335, 338, "GENE"], [489, 492, "GENE"]]}], ["Besides, multivariable linear analysis showed that FEV 1 /FVC, CRP, and TIMP-1 were independent parameters associated with PAI-1.", {"entities": [[51, 54, "GENE"], [63, 66, "GENE"]]}], ["Our findings first illustrate that elevated serum PAI-1 levels are related to the lung function decline, systemic inflammation, and SAO in COPD, suggesting that PAI-1 may play critical roles in the pathogenesis of COPD.", {"entities": []}], ["Depression and anxiety are highly prevalent in patients with epilepsy (PWE), with prevalence rates ranging from 20% to 55%.", {"entities": []}], ["The cause of this increased rate is multifactorial.", {"entities": []}], ["Depression and epilepsy are thought to share the same pathogenic mechanism.", {"entities": []}], ["Anxiety, on the other hand, seems to have a prevalence rate among PWE comparable to, or even higher than, those reported for depression, and it is closely linked to epilepsy.", {"entities": []}], ["To test this hypothesis, we screened for depression and anxiety 186 and 160 patients attending the epilepsy and MS clinics, respectively, using standardized screening tools to determine the rates of both depression and anxiety, comparing these rates to 186 age, sex matched controls.", {"entities": []}], ["Among the three groups, only patients with epilepsy were at increased risk of having depression (OR = 1.9), whereas anxiety was not.", {"entities": []}], ["This finding could point to the shared pathogenic mechanisms hypothesis between depression and epilepsy.", {"entities": []}], ["Pilocarpine-induced saliva of the tick, Ixodes dammini, inhibited platelet aggregation triggered by ADP and collagen, as well as platelet- aggregation factor.", {"entities": []}], ["In addition, we found apyrase activity (which degrades ATP and ADP to AMP and orthophosphate) and an anticoagulant.", {"entities": []}], ["We showed the presence of prostaglandin E2 (PGE2) by bioassay and radioimmunoassay.", {"entities": []}], ["This saliva inhibited interleukin 2 production by T cell hybridomas, an activity consistent with that of PGE2.", {"entities": []}], ["A kininase was demonstrated, and this may counteract the algesia- and edema- promoting properties of PGE2.", {"entities": []}], ["Together, these salivary components produce antihemostatic, antiinflammatory, and immunosuppressive effects that may facilitate feeding, as well as transmission of tick-borne pathogens.", {"entities": []}], ["to evaluate the reliability and discriminant validity of Arabic translation of the Medication Adherence Report Scale (MARS) and the Beliefs about Medication Questionnaire-specific (BMQ-specific).", {"entities": [[118, 122, "GENE"]]}], ["Having developed Arabic translations of the study instruments, a cross-sectional study was carried out between March and October 2015 in two multidisciplinary governmental hospitals in Jordan.", {"entities": []}], ["An expert panel monitored the forward and backward translation of the MARS and BMQ.", {"entities": [[70, 74, "GENE"]]}], ["Standard Arabic was used (with no specific dialect inclusion) to allow greater generalisability across Arabic speaking countries.", {"entities": []}], ["Once the Arabic translations of the questionnaires were developed they were tested for consistency, validity and reliability on a group of children with chronic diseases and their parents.", {"entities": []}], ["A total of 258 parents and 208 children were included in the study.", {"entities": []}], ["The median age of participated children and parents was 15 years and 42 years respectively.", {"entities": []}], ["Principle component analysis of all questionnaires indicated that all had good construct validity as they clearly measured one construct.", {"entities": []}], ["The questionnaires were deemed reliable based on the results of Cronbach alpha coefficient.", {"entities": []}], ["Furthermore, reliability of the questionnaires was demonstrated by test-retest intraclass correlation coefficients (ICC) which ranged from good to excellent for all scales (ICC>0.706).", {"entities": []}], ["The Pearson correlation coefficient ranged from 0.546\u20130.805 for the entire sample which indicated a significant moderate to strong positive correlation between MARS and BMQ items at time 1 and 2.", {"entities": [[160, 164, "GENE"]]}], ["Reported adherence was greater than 59% using MARS-children and MARS-parents scales, and was correlated with beliefs in necessity and independent of the concerns regarding medications.", {"entities": []}], ["The Arabic translations of both BMQ and MARS for use in children and their parents have good internal consistency and proved to be valid and reliable tools that can be used by researchers in clinical practice to measure adherence and beliefs about medications in Arabic speaking patient populations.", {"entities": [[40, 44, "GENE"]]}], ["Adolescents with extreme obesity, who have undergone bariatric surgery, must adhere to many lifestyle and nutritional recommendations, including multivitamin therapy.", {"entities": [[25, 32, "DISEASE"]]}], ["Little is know about multivitamin adherence following adolescent bariatric surgery.", {"entities": []}], ["The present study aims to document self-reported and electronically-monitored adherence to multivitamins, determine convergence between self-report and electronic monitoring adherence for multivitamins, and identify barriers to multivitamin adherence for adolescents who have undergone bariatric surgery.", {"entities": []}], ["The study used a prospective, longitudinal observational design to assess subjective (self-reported) and objective (electronic monitors) multivitamin adherence in a cohort of 41 adolescents (Mean age = 17.1\u00b11.5; range=13\u201319) who have undergone bariatric surgery at Cincinnati Children's Hospital Medical Center.", {"entities": []}], ["Mean adherence as derived from electronic monitoring for the entire 6-month study period was 29.8% \u00b1 23.9.", {"entities": []}], ["Self-reported adherence was significantly higher than electronically monitored adherence across both the 1 and 6-month assessment points (z = 4.5, p < 0.000 and z = 4.0, p < 0.0001, respectively).", {"entities": []}], ["Forgetting and difficulty swallowing multivitamins were the two primary barriers identified.", {"entities": []}], ["While there are no established data regarding best practice for multivitamins following bariatric surgery, high rates of non-adherence to multivitamin therapy were observed in adolescents who had undergone bariatric surgery with forgetting and difficulty swallowing pills as reported barriers to adherence.", {"entities": []}], ["These high rates of non-adherence to multivitamin therapy should be considered when devising treatment and family education pathways for adolescents considering weight loss surgery.", {"entities": []}], ["Mutations of forkhead box p3 ( FOXP3 ), the master gene for naturally occurring regulatory T cells (nTregs), are responsible for the impaired function of nTregs, resulting in an autoimmune disease known as the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.", {"entities": [[281, 289, "DISEASE"], [31, 36, "GENE"]]}], ["The relevance of other peripheral tolerance mechanisms, such as the presence and function of type 1 regulatory T (Tr1) cells, the major adaptive IL-10-producing Treg subset, in patients with IPEX syndrome remains to be clarified.", {"entities": [[196, 204, "DISEASE"]]}], ["FOXP3 FOXP3 mutations did not impair their function.", {"entities": [[0, 5, "GENE"], [6, 11, "GENE"], [0, 5, "GENE"], [6, 11, "GENE"]]}], ["Furthermore, we isolated Tr1 cell clones from the peripheral blood of one FOXP3", {"entities": [[74, 79, "GENE"]]}], ["Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, gut, liver and lung.", {"entities": []}], ["Both pro- and anti-inflammatory properties have been reported for IL-22 depending on the tissue and disease model.", {"entities": []}], ["In a murine model of allergic airway inflammation, we found that IL-22 is predominantly produced by innate lymphoid cells in the inflamed lungs, rather than TH cells.", {"entities": []}], ["To determine the impact of IL-22 on airway inflammation, we used allergen-sensitized IL-22-deficient mice and found that they suffer from significantly higher airway hyperreactivity upon airway challenge.", {"entities": []}], ["IL-22-deficiency led to increased eosinophil infiltration lymphocyte invasion and production of CCL17 (TARC), IL-5 and IL-13 in the lung.", {"entities": [[96, 101, "GENE"]]}], ["Mice treated with IL-22 before antigen challenge displayed reduced expression of CCL17 and IL-13 and significant amelioration of airway constriction and inflammation.", {"entities": [[81, 86, "GENE"]]}], ["We conclude that innate IL-22 limits airway inflammation, tissue damage and clinical decline in allergic lung disease.", {"entities": [[105, 117, "DISEASE"]]}], ["Bile stones represent a highly prevalent condition and abnormalities of the biliary tree predispose to stone recurrence due to development of biliary stasis.", {"entities": []}], ["In our study, we assessed the importance of an altered bile duct course for stone formation.", {"entities": []}], ["1,307 patients with choledocholithiasis in the absence of any associated hepatobiliary disease who underwent endoscopic retrograde cholangiopancreatography (ERCP) between 2002 and 2009 were analysed.", {"entities": [[73, 94, "DISEASE"], [20, 39, "DISEASE"]]}], ["The angle enclosed between the horizontal portion of the common bile duct (CBD) and the horizontal plane was measured (angle \u03b1).", {"entities": []}], ["Oblique common bile duct (OCBD) was defined as a CBD with angle \u03b1<45\u00b0.", {"entities": []}], ["103 patients (7.9%) were found to harbour OCBD and these were compared to 104 randomly selected control subjects.", {"entities": []}], ["Compared to controls, OCBD patients were (i) significantly older (72\u00b113 vs. 67\u00b113, p<0.00001); (ii) more frequently underwent a cholecystectomy (p\u200a=\u200a0.02) and biliary surgery (p\u200a=\u200a0.003) prior to the diagnosis and (iii) more often developed chronic pancreatitis (p\u200a=\u200a0.04) as well as biliary fistulae (p\u200a=\u200a0.03).", {"entities": [[249, 261, "DISEASE"]]}], ["Prior to and after ERCP, OCBD subjects displayed significantly elevated cholestatic parameters and angle \u03b1 negatively correlated with common bile duct diameter (r\u200a=\u200a-0.29, p\u200a=\u200a0.003).", {"entities": []}], ["OCBD subjects more often required multiple back-to-back ERCP sessions to remove bile stones (p\u200a=\u200a0.005) as well as more ERCPs later on due to recurrent stone formation (p<0.05).", {"entities": []}], ["OCBD defines a novel variant of the biliary tree, which is associated with chronic cholestasis, hampers an efficient stone removal and predisposes to recurrence of bile duct stones.", {"entities": [[83, 94, "DISEASE"]]}], ["Non-cystic fibrosis bronchiectasis is characterised by sputum production, exercise limitation and recurrent infections.", {"entities": [[20, 34, "DISEASE"], [4, 19, "DISEASE"]]}], ["Although pulmonary rehabilitation is advocated for this patient group, its effects are unclear.", {"entities": []}], ["The aims of this study are to determine the short and long term effects of pulmonary rehabilitation on exercise capacity, cough, quality of life and the incidence of acute pulmonary exacerbations.", {"entities": []}], ["This randomised controlled trial aims to recruit 64 patients with bronchiectasis from three tertiary institutions.", {"entities": [[66, 80, "DISEASE"]]}], ["Participants will be randomly allocated to the intervention group (supervised, twice weekly exercise training with regular review of airway clearance therapy) or a control group (twice weekly telephone support).", {"entities": []}], ["Measurements will be taken at baseline, immediately following the intervention and at six and 12 months following the intervention period by a blinded assessor.", {"entities": []}], ["Exercise capacity will be measured using the incremental shuttle walk test and the six-minute walk test.", {"entities": []}], ["Quality of life and health status will be measured using the Chronic Respiratory Questionnaire, Leicester Cough Questionnaire, Assessment of Quality of Life Questionnaire and the Hospital Anxiety and Depression Scale.", {"entities": []}], ["The rate of hospitalisation will be captured as well as the incidence of acute pulmonary exacerbations using a daily symptom diary.", {"entities": []}], ["Results from this study will help to determine the efficacy of supervised twice-weekly pulmonary rehabilitation upon exercise capacity and quality of life in patients with bronchiectasis and will contribute to clinical practice guidelines for physiotherapists in the management of this population.", {"entities": [[172, 186, "DISEASE"]]}], ["This study protocol is registered with ClinicalTrials.gov (NCT00885521).", {"entities": []}], ["Objective .", {"entities": []}], ["To analyse drug use in early pregnancy with special focus on socio-demographic factors associated with psychotropic and analgesic drug use.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Setting and subjects .", {"entities": []}], ["A total of 1765 women were invited via their local health care centres, and 1111 participated at 11\u201316 weeks of pregnancy by filling out a postal questionnaire concerning socio-demographic and obstetric background, stressful life events, and drug use.", {"entities": []}], ["Main outcome measures .", {"entities": []}], ["Drug use prior to and early on in pregnancy, socio-demographic factors, smoking, and adverse life events were investigated.", {"entities": []}], ["Drug categories screened for were psychotropics (collective term for antidepressants, relaxants, and sleep medication), analgesics, hormones, nicotine, vitamins/minerals, and homeopathic medicine.", {"entities": []}], ["Drug use from the aforementioned drug categories, excluding vitamins/minerals and homeopathic medicine, was reduced by 18% during early pregnancy, compared with six months prior to conception (49% vs. 60%).", {"entities": []}], ["Psychotropic drug use during early pregnancy was associated with elementary maternal education (p < 0.5), being unemployed (p < 0.001), being single/divorced/separated (p < 0.01), smoking prior to or during pregnancy (p < 0.01), forced to change job/move house (p < 0.001), and psychotropic drug use six months prior to pregnancy (p < 0.001).", {"entities": []}], ["No items on the stressful life events scale were associated with increased analgesic use, which increased only with multiparity.", {"entities": []}], ["Conclusions.", {"entities": []}], ["Use of analgesics and psychotropic drugs seems common in pregnancy.", {"entities": []}], ["Our results indicate that lack of a support network, stressful life events, and lower status in society may predispose women to more drug use.", {"entities": []}], ["GPs and midwives responsible for maternity care could take this into account when evaluating risk and gain for women and foetuses in the primary care setting.", {"entities": []}], ["Inflammation and its resolution are central to vascular injury and repair.", {"entities": []}], ["Maresins comprise a new family of bioactive lipid mediators synthesized from docosahexaenoic acid, an \u03c9-3 polyunsaturated fatty acid.", {"entities": []}], ["They have been found to exert anti-inflammatory and pro-resolving responses in macrophages, neutrophils and bronchial epithelial cells and impart beneficial actions in murine models of peritonitis and colitis.", {"entities": [[185, 196, "DISEASE"]]}], ["We investigated the impact of maresin-1 (MaR1) on tumor necrosis factor alpha (TNF-\u03b1) induced inflammatory responses in human vascular endothelial (EC) and smooth muscle cells (VSMC).", {"entities": []}], ["Primary cultures of human saphenous vein EC and VSMC were employed.", {"entities": []}], ["We tested the naturally occurring MaR1 as modulator of TNF-\u03b1 effects, with examination of monocyte adhesion, oxidant stress, and intracellular inflammatory signaling pathways.", {"entities": []}], ["MaR1 attenuated TNF-\u03b1 induced monocyte adhesion and reactive oxygen species (ROS) generation in both EC and VSMC, associated with down-regulated expression (cell surface) of the adhesion molecule E-selectin (in EC) and NADPH-oxidases (NOX4, NOX1, NOX2).", {"entities": [[235, 239, "GENE"], [241, 245, "GENE"]]}], ["MaR1 attenuated TNF-\u03b1 induced release of pro-inflammatory mediators by EC and VSMC.", {"entities": []}], ["MaR1 caused an attenuation of TNF-\u03b1 induced NF-\u03baB activation in both cell types associated with inhibition of I-\u03ba Kinase (IKK) phosphorylation, I\u03baB-\u03b1 degradation and nuclear translocation of the NF- \u03baB p65 subunit.", {"entities": []}], ["MaR1 also caused a time-dependent increase in intracellular cyclic AMP (cAMP) in both naive and TNF-\u03b1 stimulated VSMC and EC.", {"entities": []}], ["MaR1 has broad anti-inflammatory actions on EC and VSMC, which may be partly mediated through up-regulation of cAMP and down-regulation of the transcription factor NF-\u03baB.", {"entities": []}], ["The results suggest that the pro-resolving lipid mediator MaR1 exerts homeostatic actions on vascular cells that counteract pro-inflammatory signals.", {"entities": []}], ["These findings may have direct relevance for acute and chronic states of vascular inflammation.", {"entities": []}], ["Harmful algal blooms (HABs) of the toxic dinoflagellate, Karenia brevis , produce red tide toxins, or brevetoxins.", {"entities": []}], ["Significant health effects associated with red tide toxin exposure have been reported in sea life and in humans, with brevetoxins documented within immune cells from many species.", {"entities": []}], ["The objective of this research was to investigate potential immunotoxic effects of brevetoxins using a leukemic T cell line (Jurkat) as an in vitro model system.", {"entities": []}], ["Viability, cell proliferation, and apoptosis assays were conducted using brevetoxin congeners PbTx-2, PbTx-3, and PbTx-6.", {"entities": []}], ["The effects of in vitro brevetoxin exposure on cell viability and cellular metabolism or proliferation were determined using trypan blue and MTT (1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan), respectively.", {"entities": []}], ["Using MTT, cellular metabolic activity was decreased in Jurkat cells exposed to 5 \u2013 10 \u03bcg/ml PbTx-2 or PbTx-6.", {"entities": []}], ["After 3 h, no significant effects on cell viability were observed with any toxin congener in concentrations up to 10 \u03bcg/ml.", {"entities": []}], ["Viability decreased dramatically after 24 h in cells treated with PbTx-2 or -6.", {"entities": []}], ["Apoptosis, as measured by caspase-3 activity, was significantly increased in cells exposed to PbTx-2 or PbTx-6.", {"entities": []}], ["In summary, brevetoxin congeners varied in effects on Jurkat cells, with PbTx-2 and PbTx-6 eliciting greater cellular effects compared to PbTx-3.", {"entities": []}], ["Genome reduction is a hallmark of obligate intracellular pathogens such as Chlamydia, where adaptation to intracellular growth has resulted in the elimination of genes encoding biosynthetic enzymes.", {"entities": []}], ["Accordingly, chlamydiae rely heavily on the host cell for nutrients yet their specific source is unclear.", {"entities": []}], ["Interestingly, chlamydiae grow within a pathogen-defined vacuole that is in close apposition to lysosomes.", {"entities": []}], ["Metabolically-labeled uninfected host cell proteins were provided as an exogenous nutrient source to chlamydiae-infected cells, and uptake and subsequent labeling of chlamydiae suggested lysosomal degradation as a source of amino acids for the pathogen.", {"entities": []}], ["Indeed, Bafilomycin A1 (BafA1), an inhibitor of the vacuolar H C. trachomatis and C. pneumoniae , and these effects are especially profound in C. pneumoniae .", {"entities": []}], ["BafA1 induced the marked accumulation of material within the lysosomal lumen, which was due to the inhibition of proteolytic activities, and this response inhibits chlamydiae rather than changes in lysosomal acidification per se , as cathepsin inhibitors also inhibit the growth of chlamydiae.", {"entities": []}], ["Finally, the addition of cycloheximide, an inhibitor of eukaryotic protein synthesis, compromises the ability of lysosomal inhibitors to block chlamydial growth, suggesting chlamydiae directly access free amino acids in the host cytosol as a preferred source of these nutrients.", {"entities": []}], ["Thus, chlamydiae co-opt the functions of lysosomes to acquire essential amino acids.", {"entities": []}], ["Controversy exists about the human health risk of environmental exposure to bisphenol A (BPA).", {"entities": []}], ["Telomerase activity is emerging both as biomarker and contributing factor for age-related diseases.", {"entities": []}], ["The effects of BPA exposure at 1\u20131000\u2009nM on telomerase, DNA integrity and cell proliferation were investigated in PBMC from human donors.", {"entities": []}], ["Telomerase activity was determined by TRAP-ELISA assay and mRNA expression by qRT-PCR.", {"entities": []}], ["Mechanistic studies were carried out on the ER/GPR30-ERK pathway using specific inhibitors/antagonists, the comet assay to quantify DNA damage and flow cytometry for cell proliferation.", {"entities": []}], ["24\u2009h BPA exposure inhibited telomerase in a non-monotonic pattern with a peak inhibition of 32% at 1\u2009nM ( p \u2009\u2264\u20090.01).", {"entities": []}], ["A significant telomerase inhibition was evident at 1\u2009h after exposure with a minimum at 6\u2009h. Elevated levels of DNA damage frequency and decrease in cell proliferation were evident upon long-term exposure.", {"entities": []}], ["The results further demonstrate that BPA triggered rapidly an ER/GPR30-ERK transduction pathway that leads to decreased telomerase activity in human PBMC.", {"entities": []}], ["This is the first study to demonstrate adverse impact of BPA at levels of current human exposure on telomerase in normal cells, mediated by ER/GPR30-ERK.", {"entities": []}], ["The results suggest a potentially harmful influence of BPA on immune cells and should be addressed in future studies.", {"entities": []}], ["The study aims to explore the effects of TLR-2/NF-\u03baB signaling pathway on the occurrence of degenerative knee osteoarthritis (OA).", {"entities": [[110, 124, "DISEASE"]]}], ["Degenerative knee OA and normal cartilage samples were collected from patients with degenerative knee OA receiving total knee arthroplasty and amputation.", {"entities": []}], ["Expressions of TLR-2, NF-\u03baB and MMP-13 were determined by qRT-PCR and immunochemistry.", {"entities": []}], ["The chondrocytes were divided into control, IL-1\u03b2, IL-1\u03b2 + anti-TLR-2 and IL-1\u03b2 + PDTC groups.", {"entities": []}], ["MTT assay and flow cytometry were performed to determine proliferation and apoptosis of the chondrocytes.", {"entities": []}], ["Expressions of TLR-2, NF-\u03baB and MMP-13 were measured by Western blotting.", {"entities": []}], ["ELISA was conducted to detect the expressions of related inflammatory factors.", {"entities": []}], ["The positive expressions of TLR, NF-\u03baB and MMP13 were associated with body mass index (BMI), family history, exercise, and WOMAC scores of OA patients.", {"entities": [[43, 48, "GENE"]]}], ["Logistic regression analysis showed that OA influencing factors were TLR, NF-\u03baB, MMP13, BMI, family history and exercise.", {"entities": [[81, 86, "GENE"]]}], ["Compared with normal chondrocytes, the expressions of TLR-2, NF-\u03baB, MMP-13 and related inflammatory factors increased in degenerative knee OA.", {"entities": []}], ["The chondrocytes in the IL-1\u03b2 + anti-TLR-2 and IL-1\u03b2 + PDTC groups showed lower apoptosis rates than those in the IL-1\u03b2 group.", {"entities": []}], ["Compared with the control group, increased expressions of TLR-2, NF-\u03baB, phosphorylated-NF-\u03baB (p-NF-\u03baB), MMP-13, IL-1, IL-6 and TNF-\u03b1 were found in the IL-1\u03b2 group.", {"entities": []}], ["In the IL-1\u03b2 + anti-TLR-2 and IL-1\u03b2 + PDTC groups, decreased expressions of NF-\u03baB, p-NF-\u03baB, MMP-13, IL-1, IL-6 and TNF-\u03b1 were found compared with those in the IL-1\u03b2 group.", {"entities": []}], ["TLR-2/NF-\u03baB signaling pathway contributes to the occurrence of degenerative knee OA.", {"entities": []}], ["The lymphatic endothelial receptor LYVE-1 has been implicated in both uptake of hyaluronan (HA) from tissue matrix and in facilitating transit of leukocytes and tumor cells through lymphatic vessels based largely on in vitro studies with recombinant receptor in transfected fibroblasts.", {"entities": []}], ["Curiously, however, LYVE-1 in lymphatic endothelium displays little if any binding to HA in vitro , and this has led to the conclusion that the native receptor is functionally silenced, a feature that is difficult to reconcile with its proposed in vivo functions.", {"entities": []}], ["Nonetheless, as we reported recently, LYVE-1 can function as a receptor for HA-encapsulated Group A streptococci and mediate lymphatic dissemination in mice.", {"entities": []}], ["Here we resolve these paradoxical findings and show that the capacity of LYVE-1 to bind HA is strictly dependent on avidity, demanding appropriate receptor self-association and/or HA multimerization.", {"entities": []}], ["In particular, we demonstrate the prerequisite of a critical LYVE-1 threshold density and show that HA binding may be elicited in lymphatic endothelium by surface clustering with divalent LYVE-1 mAbs.", {"entities": []}], ["In addition, we show that cross-linking of biotinylated HA in streptavidin multimers or supramolecular complexes with the inflammation-induced protein TSG-6 enables binding even in the absence of LYVE-1 cross-linking.", {"entities": []}], ["Finally, we show that endogenous HA on the surface of macrophages can engage LYVE-1, facilitating their adhesion and transit across lymphatic endothelium.", {"entities": []}], ["These results reveal LYVE-1 as a low affinity receptor tuned to discriminate between different HA configurations through avidity and establish a new mechanistic basis for the functions ascribed to LYVE-1 in matrix HA binding and leukocyte trafficking in vivo .", {"entities": []}], ["Self-management support is seen as a cornerstone of good diabetes care and many countries are currently engaged in initiatives to integrate self-management support in primary care.", {"entities": []}], ["Concerning the organisation of these programs, evidence is growing that engagement of health care professionals, in particular of GPs, is critical for successful application.", {"entities": []}], ["This paper reports on a study exploring why a substantial number of GPs was (initially) reluctant to refer patients to a self-management education program in Belgium.", {"entities": []}], ["Qualitative analysis of semi-structured face-to-face interviews with a purposive sample of 20 GPs who were not regular users of the service.", {"entities": []}], ["The Greenhalgh diffusion of innovation framework was used as background and organising framework.", {"entities": []}], ["Several barriers, linked to different components of the Greenhalgh model, emerged from the interview data.", {"entities": []}], ["One of the most striking ones was the limited readiness for innovation among GPs.", {"entities": []}], ["Feelings of fear of further fragmentation of diabetes care and frustration and insecurity regarding their own role in diabetes care prevented them from engaging in the innovation process.", {"entities": []}], ["GPs needed time to be reassured that the program respects their role and has an added value to usual care.", {"entities": []}], ["Once GPs considered referring patients, it was not clear enough which of their patients would benefit from the program.", {"entities": []}], ["Some GPs expressed the need for training in motivational skills, so that they could better motivate their patients to participate.", {"entities": []}], ["A practical but often mentioned barrier was the distance to the centre where the program was delivered.", {"entities": []}], ["Further, uncertainty about continuity interfered with the uptake of the offer.", {"entities": []}], ["The study results contribute to a better understanding of the reasons why GPs hesitate to refer patients to a self-management education program.", {"entities": []}], ["First of all, the role of GPs and other health care providers in diabetes care needs to be clarified before introducing new functions.", {"entities": []}], ["Feelings of security and a basic trust of providers in the health system are a prerequisite for participation in care innovation.", {"entities": []}], ["Moreover, some important lessons regarding the implementation of an education program in primary care have been learned from the study.", {"entities": []}], ["Sequentially ordered multivariate failure time or recurrent event duration data are commonly observed in biomedical longitudinal studies.", {"entities": []}], ["In general, standard hazard regression methods cannot be applied because of correlation between recurrent failure times within a subject and induced dependent censoring.", {"entities": []}], ["Multiplicative and additive hazards models provide the two principal frameworks for studying the association between risk factors and recurrent event durations for the analysis of multivariate failure time data.", {"entities": []}], ["Using emergency department visits data, we illustrated and compared the additive and multiplicative hazards models for analysis of recurrent event durations under (i) a varying baseline with a common coefficient effect and (ii) a varying baseline with an order-specific coefficient effect.", {"entities": []}], ["The analysis showed that both additive and multiplicative hazards models, with varying baseline and common coefficient effects, gave similar results with regard to covariates selected to remain in the model of our real dataset.", {"entities": []}], ["The confidence intervals of the multiplicative hazards model were wider than the additive hazards model for each of the recurrent events.", {"entities": []}], ["In addition, in both models, the confidence interval gets wider as the revisit order increased because the risk set decreased as the order of visit increased.", {"entities": []}], ["Due to the frequency of multiple failure times or recurrent event duration data in clinical and epidemiologic studies, the multiplicative and additive hazards models are widely applicable and present different information.", {"entities": []}], ["Hence, it seems desirable to use them, not as alternatives to each other, but together as complementary methods, to provide a more comprehensive understanding of data.", {"entities": []}], ["The response of S-phase cells labelled with bromodeoxyuridine (BrdU) in sheep airways undergoing repair in response to endobronchial brush biopsy was investigated in this study.", {"entities": []}], ["Separate sites within the airway tree of anaesthetised sheep were biopsied at intervals prior to pulse labelling with BrdU, which was administered one hour prior to euthanasia.", {"entities": []}], ["Both brushed and spatially disparate unbrushed (control) sites were carefully mapped, dissected, and processed to facilitate histological analysis of BrdU labelling.", {"entities": []}], ["Our study indicated that the number and location of BrdU-labelled cells varied according to the age of the repairing injury.", {"entities": []}], ["There was little evidence of cell proliferation in either control airway tissues or airway tissues examined six hours after injury.", {"entities": []}], ["However, by days 1 and 3, BrdU-labelled cells were increased in number in the airway wall, both at the damaged site and in the regions flanking either side of the injury.", {"entities": []}], ["Thereafter, cell proliferative activity largely declined by day 7 after injury, when consistent evidence of remodelling in the airway wall could be appreciated.", {"entities": []}], ["This study successfully demonstrated the effectiveness of in vivo pulse labelling in tracking cell proliferation during repair which has a potential value in exploring the therapeutic utility of stem cell approaches in relevant lung disease models.", {"entities": [[228, 240, "DISEASE"]]}], ["In our study we characterised the immunophenotype of monocytes that migrated through an endothelial cell (EC) monolayer in vitro .", {"entities": []}], ["We found that monocyte migration led to an enhanced expression of CD11a, CD33, CD45RO, CD54 [intercellular cell-adhesion molecule (ICAM)-1] and human leucocyte antigen-DR.", {"entities": [[73, 77, "GENE"]]}], ["The most striking increase was observed for ICAM-1 when ECs were activated with tumour necrosis factor-\u03b1 and interleukin-1\u03b1.", {"entities": []}], ["The results of our study indicate the following: (1) there is a characteristic immunophenotype on the surface of monocytes after transendothelial migration; (2) this phenotype seems to be induced by interactions between monocytes and ECs; and (3) this change is enhanced by the pretreatment of ECs with cytokines.", {"entities": []}], ["Taken together, the results suggest that local cytokine production activating ECs is sufficient to enhance monocyte migration and that this, in turn, can induce changes consistent with an activated phenotype known to be interactive between antigen-presenting cells and T cells.", {"entities": []}], ["These results have implications for our pathogenetic insights into rheumatoid arthritis.", {"entities": [[67, 87, "DISEASE"], [78, 87, "DISEASE"]]}], ["Neutrophils are well known for their role in infection and inflammatory disease and are first responders at sites of infection or injury.", {"entities": []}], ["Platelets have an established role in hemostasis and thrombosis and are first responders at sites of vascular damage.", {"entities": []}], ["However, neutrophils are increasingly recognized for their role in thrombosis, while the immunemodulatory properties of platelets are being increasingly studied.", {"entities": []}], ["Platelets and neutrophils interact during infection, inflammation and thrombosis and modulate each other\u2019s functions.", {"entities": []}], ["This review will discuss the consequences of platelet\u2013neutrophil interactions in infection, thrombosis, atherosclerosis and tissue injury and repair.", {"entities": [[104, 119, "DISEASE"]]}], ["Maternal obesity increases adult offspring risk for cardiovascular disease; however the role of offspring adiposity in mediating this association remains poorly characterized.", {"entities": [[9, 16, "DISEASE"]]}], ["To investigate the associations of maternal pre-pregnant body mass index (maternal BMI) and gestational weight gain (GWG) with neonatal cardio-metabolic markers independent of fetal growth and neonatal adiposity.", {"entities": []}], ["A total of 753 maternal-infant pairs from the Healthy Start study, a large multi-ethnic pre-birth observational cohort were used.", {"entities": []}], ["Neonatal cardio-metabolic markers included cord blood glucose, insulin, glucose-to-insulin ratio (Glu/Ins), total and high-density lipoprotein cholesterol (HDL-c), triglycerides, free fatty acids and leptin.", {"entities": []}], ["Maternal BMI was abstracted from medical records or self-reported.", {"entities": []}], ["GWG was calculated as the difference between the first pre-pregnant weight and the last weight measurement before delivery.", {"entities": []}], ["Neonatal adiposity (percent fat mass) was measured within 72 hours of delivery using whole body air displacement plethysmography.", {"entities": []}], ["In covariate adjusted models, maternal BMI was positively associated with cord blood insulin (p=0.01) and leptin (p<0.001) levels and inversely associated with cord blood HDL-c (p=0.05) and Glu/Ins (p=0.003).", {"entities": []}], ["Adjustment for fetal growth or neonatal adiposity attenuated the effect of maternal BMI on neonatal insulin, rendering the association non-significant.", {"entities": []}], ["However, maternal BMI remained associated with higher leptin (p<0.0011), lower HDL-c (p=0.02) and Glu/Ins (p=0.05), independent of neonatal adiposity.", {"entities": []}], ["GWG was positively associated with neonatal insulin (p=0.02), glucose (p=0.03) and leptin levels (p<0.001) and negatively associated with Glu/Ins (p=0.006).", {"entities": []}], ["After adjusting for neonatal adiposity, GWG remained associated with higher neonatal glucose (p=0.02) and leptin levels (p=0.02) and lower Glu/Ins (p=0.048).", {"entities": []}], ["Maternal weight prior and/or during pregnancy is associated with neonatal cardio-metabolic makers including leptin, glucose, and HDL-c at delivery, independent of neonatal adiposity.", {"entities": []}], ["Our results suggest that intrauterine exposure to maternal obesity influences metabolic processes beyond fetal growth and fat accretion.", {"entities": [[59, 66, "DISEASE"]]}], ["Anxiety symptoms are frequently present in patients with late-life depression.", {"entities": []}], ["The designation \u201canxious depression\u201d has been used to describe major depressive disorder (MDD) accompanied by clinically significant but subsyndromal anxiety symptoms.", {"entities": [[63, 88, "DISEASE"]]}], ["MDD may also present comorbid with diagnosable anxiety disorders, although this presentation is less common in late life.", {"entities": []}], ["Diagnosis of anxious depression in the elderly is complicated by several factors (eg, their tendency to experience and report psychiatric symptoms as somatic illness) and is associated with a more severe clinical presentation, increased risk for suicidal ideation, increased disability, and poorer prognosis.", {"entities": []}], ["Standard pharmacotherapy for depression may be sufficient but for many patients must be modified or augmented.", {"entities": []}], ["Psychosocial interventions may also be an important component in the treatment of these patients, although no specific psychosocial treatments have been developed for late-life anxious depression.", {"entities": []}], ["The incidence and severity of dengue in Latin America has increased substantially in recent decades and data from Puerto Rico suggests an increase in severe cases.", {"entities": []}], ["Successful clinical management of severe dengue requires early recognition and supportive care.", {"entities": []}], ["Fatal cases were identified among suspected dengue cases reported to two disease surveillance systems and from death certificates.", {"entities": []}], ["To be included, fatal cases had to have specimen submitted for dengue diagnostic testing including nucleic acid amplification for dengue virus (DENV) in serum or tissue, immunohistochemical testing of tissue, and immunoassay detection of anti-DENV IgM from serum.", {"entities": []}], ["Medical records from laboratory-positive dengue fatal case-patients were reviewed to identify possible determinants for death.", {"entities": []}], ["Among 10,576 reported dengue cases, 40 suspect fatal cases were identified, of which 11 were laboratory-positive, 14 were laboratory-negative, and 15 laboratory-indeterminate.", {"entities": []}], ["The median age of laboratory-positive case-patients was 26 years (range 5 months to 78 years), including five children aged <15 years; 7 sought medical care at least once prior to hospital admission, 9 were admitted to hospital and 2 died upon arrival.", {"entities": []}], ["The nine hospitalized case-patients stayed a mean of 15 hours (range: 3\u201348 hours) in the emergency department (ED) before inpatient admission.", {"entities": []}], ["Five of the nine case-patients received intravenous methylprednisolone and four received non-isotonic saline while in shock.", {"entities": []}], ["Eight case-patients died in the hospital; five had their terminal event on the inpatient ward and six died during a weekend.", {"entities": []}], ["Dengue was listed on the death certificate in only 5 instances.", {"entities": []}], ["During a dengue epidemic in an endemic area, none of the 11 laboratory-positive case-patients who died were managed according to current WHO Guidelines.", {"entities": []}], ["Management issues identified in this case-series included failure to recognize warning signs for severe dengue and shock, prolonged ED stays, and infrequent patient monitoring.", {"entities": []}], ["Dengue is a major public health problem in the tropics and subtropics; an estimated 50 million cases occur annually and 40 percent of the world's population lives in areas with dengue virus (DENV) transmission.", {"entities": []}], ["Dengue has a wide range of clinical presentations from an undifferentiated acute febrile illness, classic dengue fever, to severe dengue (i.e., dengue hemorrhagic fever or dengue shock syndrome).", {"entities": [[185, 193, "DISEASE"], [172, 193, "DISEASE"], [144, 168, "DISEASE"]]}], ["About 5% of patients develop severe dengue, which is more common with second or subsequent infections.", {"entities": []}], ["No vaccines are available to prevent dengue, and there are no specific antiviral treatments for patients with dengue.", {"entities": []}], ["However, early recognition of shock and intensive supportive therapy can reduce risk of death from \u223c10% to less than 1% among severe dengue cases.", {"entities": []}], ["Reviewing dengue deaths is one means to identify issues in clinical management.", {"entities": []}], ["These findings can be used to develop healthcare provider education to minimize dengue morbidity and mortality.", {"entities": []}], ["Pseudomonas aeruginosa ( PA ) is a ubiquitous opportunistic pathogen that is capable of causing highly problematic, chronic infections in cystic fibrosis and chronic obstructive pulmonary disease patients.", {"entities": [[158, 195, "DISEASE"], [138, 153, "DISEASE"]]}], ["With the increased prevalence of multi-drug resistant PA , the conventional \u201cone gene, one drug, one disease\u201d paradigm is losing effectiveness.", {"entities": []}], ["Network pharmacology, on the other hand, may hold the promise of discovering new drug targets to treat a variety of PA infections.", {"entities": []}], ["However, given the urgent need for novel drug target discovery, a PA protein-protein interaction (PPI) network of high accuracy and coverage, has not yet been constructed.", {"entities": []}], ["In this study, we predicted a genome-scale PPI network of PA by integrating various genomic features of PA proteins/genes by a machine learning-based approach.", {"entities": []}], ["A total of 54,107 interactions covering 4,181 proteins in PA were predicted.", {"entities": []}], ["A high-confidence network combining predicted high-confidence interactions, a reference set and verified interactions that consist of 3,343 proteins and 19,416 potential interactions was further assembled and analyzed.", {"entities": []}], ["The predicted interactome network from this study is the first large-scale PPI network in PA with significant coverage and high accuracy.", {"entities": []}], ["Subsequent analysis, including validations based on existing small-scale PPI data and the network structure comparison with other model organisms, shows the validity of the predicted PPI network.", {"entities": []}], ["Potential drug targets were identified and prioritized based on their essentiality and topological importance in the high-confidence network.", {"entities": []}], ["Host-pathogen protein interactions between human and PA were further extracted and analyzed.", {"entities": []}], ["In addition, case studies were performed on protein interactions regarding anti-sigma factor MucA, negative periplasmic alginate regulator MucB, and the transcriptional regulator RhlR.", {"entities": []}], ["A web server to access the predicted PPI dataset is available at http://research.cchmc.org/PPIdatabase/ .", {"entities": []}], ["In recent years, it is recognized that acquired immunity is controlled by regulatory T cell (Treg).", {"entities": []}], ["Since fundamental pathophysiological changes of allergy are mainly caused by hyperresponsiveness of immune system to allergens that acquires after birth, Tregs likely play key roles in the pathogenesis of allergy, particularly during the sensitization phase.", {"entities": []}], ["However, accumulated information indicate that there are several distinctive subtypes of Tregs in man, and each of them seems to play different role in controlling immune system, which complicates the involvement of Tregs in allergy.", {"entities": []}], ["The aim of the present study is to attempt to classify subtypes of Tregs and summarize their roles in allergy.", {"entities": []}], ["Tregs should include natural Tregs (nTreg) including inducible costimulator (ICOS)(+) Tregs, inducible/adaptive Tregs (iTreg), interleukin (IL)-10-producing type 1 Tregs (Tr1 cells), CD8(+) Tregs and IL-17-producing Tregs.", {"entities": [[77, 81, "GENE"]]}], ["These cells share some common features including expression of Foxp3 (except for Tr1 cells), and secretion of inhibitory cytokine IL-10 and/or TGF-\u03b2.", {"entities": [[63, 68, "GENE"]]}], ["Furthermore, it is noticeable that Tregs likely contribute to allergic disorders such as dermatitis and airway inflammation, and play a crucial role in the treatment of allergy through their actions on suppression of effector T cells and inhibition of activation of mast cells and basophils.", {"entities": [[89, 99, "DISEASE"]]}], ["Modulation of functions of Tregs may provide a novel strategy to prevent and treat allergic diseases.", {"entities": []}], ["The Patient-Centered Medical Home (PCMH) is a widely endorsed model of delivery system reform that emphasizes primary care.", {"entities": []}], ["Pilot demonstration projects are underway in many states, sponsored by Medicare, Medicaid, major health plans and multi-payer coalitions.", {"entities": []}], ["In this paper we consider the development of a long-term policy-relevant research agenda on outcomes of the PCMH.", {"entities": []}], ["We provide an overview of potential measures of PCMH impact, identify measurement challenges and recommend areas for further study.", {"entities": []}], ["Although the PCMH should not be expected to solve every problem in the health care system, developing a research agenda for measuring outcomes of delivery system innovations such as the PCMH should be considered in the context of the larger effort to improve the US health care system, with the ultimate goal to improve population health.", {"entities": []}], ["As a framework for our discussion, we have chosen the Institute of Medicine\u2019s six specific aims for 21st century health care: (1) safe, (2) effective, (3) patient-centered, (4) timely, (5) efficient and (6) equitable.", {"entities": []}], ["In addition, we include potential areas of PCMH outcomes that do not easily fall under this framework and consider unintended consequences.", {"entities": []}], ["Multi-stakeholder involvement will be essential in developing a long-term policy-relevant research agenda for outcomes of the PCMH.", {"entities": []}], ["The prevalence of low vitamin D status in the elderly population of subtropical area and the potential risk/protective factors have not been addressed.", {"entities": []}], ["This cross-sectional questionnaire-based study, which collected demographic/anthropometric data and information on diet habit and sun exposure, recruited 170 subjects with mean age 70.9\u00b15.6 in rural areas of southern Taiwan.", {"entities": []}], ["Serum 25-OH vitamin D, calcium, and intact parathyroid hormone were also measured.", {"entities": []}], ["Using cut-off level of 30 ng/mL, subjects were divided into low (n = 95) and normal (n = 75) serum vitamin D groups.", {"entities": []}], ["The results demonstrated a low vitamin D status in 30.6% of men and 57.7% of women.", {"entities": []}], ["Dietary vitamin D intake was another factor associated with vitamin D status (p = 0.02).", {"entities": []}], ["Logistic regression identified inadequate intake of vitamin D-rich food as the only risk factor for low vitamin D status in men (OR = 4.55, p = 0.01), whereas inadequate sun exposure was the only predictable risk with dose-response relationship in women (low vs. high sun exposure, OR = 6.84, p = 0.018; moderate vs. high sun exposure, OR = 6.67, p = 0.005).", {"entities": []}], ["In conclusion, low vitamin D status was common in the elderly of subtropical rural areas.", {"entities": []}], ["Low sun exposure and inadequate dietary vitamin D consumption were associated with a low vitamin D status in females and males, respectively.", {"entities": []}], ["The legal framework and funding mechanisms of the national health research system were recently reformed in Mexico.", {"entities": []}], ["A study of the resource allocation for health research is still missing.", {"entities": []}], ["We identified the health research areas funded by the National Council on Science and Technology (CONACYT) and examined whether research funding has been aligned to national health problems.", {"entities": []}], ["We collected the information to create a database of research grant projects supported through the three main Sectoral Funds managed by CONACYT between 2003 and 2010.", {"entities": []}], ["The health-related projects were identified and classified according to their methodological approach and research objective.", {"entities": []}], ["A correlation analysis was carried out to evaluate the association between disease-specific funding and two indicators of disease burden.", {"entities": []}], ["From 2003 to 2010, research grant funding increased by 32% at a compound annual growth rate of 3.5%.", {"entities": []}], ["By research objective, the budget fluctuated annually resulting in modest increments or even decrements during the period under analysis.", {"entities": []}], ["The basic science category received the largest share of funding (29%) while the less funded category was violence and accidents (1.4%).", {"entities": []}], ["The number of deaths (\u03c1\u200a=\u200a0.51; P<0.001) and disability-adjusted life years (DALYs; \u03c1\u200a=\u200a0.33; P\u200a=\u200a0.004) were weakly correlated with the funding for health research.", {"entities": []}], ["Considering the two indicators, poisonings and infectious and parasitic diseases were among the most overfunded conditions.", {"entities": []}], ["In contrast, congenital anomalies, road traffic accidents, cerebrovascular disease, and chronic obstructive pulmonary disease were the most underfunded conditions.", {"entities": [[59, 82, "DISEASE"], [88, 125, "DISEASE"]]}], ["Although the health research funding has grown since the creation of CONACYT sectoral funds, the financial effort is still low in comparison to other Latin American countries with similar development.", {"entities": []}], ["Furthermore, the great diversity of the funded topics compromises the efficacy of the investment.", {"entities": []}], ["Better mechanisms of research priority-setting are required to adjust the research portfolio to the new health panorama of Mexican population.", {"entities": []}], ["Multi-morbidity among elderly is increasingly recognized as a major public health challenge in most of the developing countries.", {"entities": []}], ["However, information on the size of population suffering from multi-morbidity and socio-economic differentials of multi-morbidity is scarce.", {"entities": []}], ["The objectives of this paper are twofold; first, to assess the prevalence of various chronic conditions and morbidity among rural elderly and second, to examine the socio-economic and demographic factors that have a significant effect on the morbidity.", {"entities": []}], ["A cross-sectional survey has been done using multi-stage random sampling procedure that was conducted among elderly (60+ years) in Bargarh District of Odisha during October 2011-February 2012.", {"entities": []}], ["The survey was conducted among 310 respondents including 153 males and 157 females.", {"entities": []}], ["Descriptive analyses were performed to assess the pattern of multi-morbidity.", {"entities": []}], ["Logistic regression analyses were used to see the adjusted effect of various socio-economic and demographic covariates of multi-morbidity.", {"entities": []}], ["The overall prevalence of multi-morbidity is 57% among rural elderly in Bargarh District of Odisha.", {"entities": []}], ["The most common diseases in rural areas are: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), High Blood Pressure and Cataract.", {"entities": []}], ["Results from the logistic regression analyses show that age, state of economic independence and life style indicators are the most important measured predictors of multi-morbidity.", {"entities": []}], ["Unlike earlier studies, wealth index and education have a marginal impact on multi-morbidity rate.", {"entities": []}], ["Moreover, the occurrence of multi-morbidity is higher for elderly males compared to their female counterparts, though the difference is not significant.", {"entities": []}], ["The high prevalence of morbidity observed in the present study suggests that there is an urgent need to develop geriatric health care services in a developing country like India.", {"entities": []}], ["Any effort to reorganize primary care for elderly people should also consider the high prevalence of multi-morbidity among rural elderly in India.", {"entities": []}], ["Since its cloning in 1994, leptin has emerged in the literature as a pleiotropic hormone whose actions extend from immune system homeostasis to reproduction and angiogenesis.", {"entities": []}], ["Recent investigations have identified the lung as a leptin responsive and producing organ, while extensive research has been published concerning the role of leptin in the respiratory system.", {"entities": []}], ["Animal studies have provided evidence indicating that leptin is a stimulant of ventilation, whereas researchers have proposed an important role for leptin in lung maturation and development.", {"entities": []}], ["Studies further suggest a significant impact of leptin on specific respiratory diseases, including obstructive sleep apnoea-hypopnoea syndrome, asthma, COPD and lung cancer.", {"entities": [[161, 172, "DISEASE"], [134, 142, "DISEASE"], [144, 150, "DISEASE"], [166, 172, "DISEASE"]]}], ["However, as new investigations are under way, the picture is becoming more complex.", {"entities": []}], ["The scope of this review is to decode the existing data concerning the actions of leptin in the lung and provide a detailed description of leptin's involvement in the most common disorders of the respiratory system.", {"entities": []}], ["Cystic echinococcosis (CE) is a near cosmopolitan zoonosis caused by the larval stage of the dog tapeworm Echinococcus granulosus.", {"entities": [[7, 21, "DISEASE"]]}], ["E. granulosus infection induces a polarized T-helper type 2 (Th2) systematic immune response in its intermediate hosts.", {"entities": []}], ["However, it is not known whether the infection modulates lung inflammation by regulating local immune response.", {"entities": []}], ["In this study, we examined the effects of E. granulosus infection on mouse ovalbumin (OVA)-induced asthma model.", {"entities": [[99, 105, "DISEASE"]]}], ["BALB/c mice were intraperitoneally transplanted with 50 small E. granulosus cysts cultured in vitro .", {"entities": []}], ["At 3\u00a0months post-inoculation, the mice were sensitized and challenged with ovalbumin (OVA).", {"entities": []}], ["For histopathological studies, hematoxylin eosin and periodic acid schiff staining was used to examine the inflammatory cells infiltration and goblet cells hyperplasia, respectively.", {"entities": []}], ["Cytokine levels were measured by mouse cytometric bead array (CBA) Kit and quantitative RT-PCR and other molecular biological approaches.", {"entities": []}], ["Airway hyperresponsiveness was assessed in response to increasing doses of methacholine.", {"entities": []}], ["Serum immunoglobulins were determined by ELISA.", {"entities": []}], ["E. granulosus infection significantly increased Th2 and Treg cytokine levels in serum and lung tissues, but down-regulated the expression of IL-5 in the lungs and IL-17A in serum and lung tissues of asthmatic mice sensitized and challenged with OVA.", {"entities": []}], ["Histological staining of lung tissues showed that E. granulosus infection significantly reduced the severity of OVA-induced airway inflammation including reduction of eosinophil cell infiltration and mucus production.", {"entities": []}], ["The E. granulosus infection also reduced eosinophil accumulation induced by OVA in bronchoalveolar lavage fluid (BALF) and also ameliorated airway hyperresponsiveness, a hallmark symptom of asthma.", {"entities": [[190, 196, "DISEASE"]]}], ["E. granulosus infection remarkably reduces the severity of OVA-induced airway inflammation likely through enhancing IL-10 and down-regulation of IL-5 and IL-17A.", {"entities": []}], ["The online version of this article (doi:10.1186/s13071-014-0522-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["COPD is a significant cause of morbidity and mortality.", {"entities": []}], ["In some patients with COPD, eosinophils contribute to inflammation that promotes airway obstruction; approximately a third of stable COPD patients have evidence of eosinophilic inflammation.", {"entities": []}], ["Although the eosinophil threshold associated with clinical relevance in patients with COPD is currently subject to debate, eosinophil counts hold potential as biomarkers to guide therapy.", {"entities": []}], ["In particular, eosinophil counts may be useful in assessing which patients may benefit from inhaled corticosteroid therapy, particularly regarding exacerbation prevention.", {"entities": []}], ["In addition, several therapies targeting eosinophilic inflammation are available or in development, including monoclonal antibodies targeting the IL5 ligand, the IL5 receptor, IL4, and IL13.", {"entities": [[146, 149, "GENE"], [162, 165, "GENE"], [146, 149, "GENE"], [162, 165, "GENE"], [176, 179, "GENE"], [185, 189, "GENE"]]}], ["The goal of this review was to describe the biologic characteristics of eosinophils, their role in COPD during exacerbations and stable disease, and their use as biomarkers to aid treatment decisions.", {"entities": []}], ["We also propose an algorithm for inhaled corticosteroid use, taking into consideration eosinophil counts and pneumonia history, and emerging eosinophil-targeted therapies in COPD.", {"entities": [[109, 118, "DISEASE"]]}], ["The Modification of Diet in Renal Disease (MDRD) formula is widely used in clinical practice to assess the correct drug dose.", {"entities": []}], ["This formula is based on serum creatinine levels which might be influenced by chronic diseases itself or the effects of the chronic diseases.", {"entities": []}], ["We conducted a systematic review to determine the validity of the MDRD formula in specific patient populations with renal impairment: elderly, hospitalized and obese patients, patients with cardiovascular disease, cancer, chronic respiratory diseases, diabetes mellitus, liver cirrhosis and human immunodeficiency virus.", {"entities": [[271, 286, "DISEASE"], [214, 220, "DISEASE"], [252, 269, "DISEASE"]]}], ["We searched for articles in Pubmed published from January 1999 through January 2014.", {"entities": []}], ["Selection criteria were (1) patients with a glomerular filtration rate (GFR) < 60 ml/min (/1.73m 30 % of 80% or higher were indicators of the validity of the MDRD formula.", {"entities": []}], ["In total we included 27 studies.", {"entities": []}], ["The number of patients included ranged from 8 to 1831.", {"entities": []}], ["The gold standard and measurement method used varied across the studies.", {"entities": []}], ["For none of the specific patient populations the studies provided sufficient evidence of validity of the MDRD formula regarding the three parameters.", {"entities": []}], ["For patients with diabetes mellitus and liver cirrhosis, hospitalized patients and elderly with moderate to severe renal impairment we concluded that the MDRD formula is not valid.", {"entities": [[40, 55, "DISEASE"], [18, 35, "DISEASE"]]}], ["Limitations of the review are the lack of considering the method of measuring serum creatinine levels and the type of gold standard used.", {"entities": []}], ["In several specific patient populations with renal impairment the use of the MDRD formula is not valid or has uncertain validity.", {"entities": []}], ["This multi-center, randomized, double-blind, placebo-controlled, two-way crossover study was designed to characterize the safety, tolerability, pharmacokinetic, and pharmacodynamic profile of single and once-daily repeat doses of vilanterol 25\u2009\u00b5g in children aged 5\u201311 years.", {"entities": []}], ["Twenty-eight children with persistent asthma received a single inhaled dose of vilanterol 25\u2009\u00b5g or placebo via the ELLIPTA\u2122 dry powder inhaler (DPI) on Day 1, followed 7 days later by once-daily treatment for 7 days.", {"entities": [[38, 44, "DISEASE"]]}], ["Nine (33%) subjects reported adverse events (AEs) with vilanterol 25\u2009\u00b5g and 6 (23%) with placebo.", {"entities": []}], ["No serious or drug-related AEs were reported; 3 subjects experienced upper respiratory tract infection (URTI) with vilanterol 25\u2009\u00b5g versus none with placebo.", {"entities": []}], ["Similar pharmacokinetic profiles of vilanterol 25\u2009\u00b5g were observed irrespective of age or gender.", {"entities": []}], ["No clinically relevant changes in heart rate, Fridericia's correction (QTcF), maximum glucose or minimum potassium parameters were observed during treatment with vilanterol 25\u2009\u00b5g compared with placebo treatment.", {"entities": []}], ["Vilanterol was well-tolerated and no long-acting \u00df 2 -agonist (LABA)-mediated AEs were observed.", {"entities": []}], ["The pharmacokinetic profile of vilanterol 25\u2009\u00b5g suggests exposure is similar regardless of age or gender in a pediatric population aged 5\u201311 years.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease associated with substantial morbidity and mortality.", {"entities": [[11, 29, "DISEASE"], [0, 29, "DISEASE"], [70, 82, "DISEASE"]]}], ["The objective of this study was to determine whether there is a peripheral blood protein signature in IPF and whether components of this signature may serve as biomarkers for disease presence and progression.", {"entities": []}], ["We analyzed the concentrations of 49 proteins in the plasma of 74 patients with IPF and in the plasma of 53 control individuals.", {"entities": []}], ["We identified a combinatorial signature of five proteins\u2014MMP7, MMP1, MMP8, IGFBP1, and TNFRSF1A\u2014that was sufficient to distinguish patients from controls with a sensitivity of 98.6% (95% confidence interval [CI] 92.7%\u2013100%) and specificity of 98.1% (95% CI 89.9%\u2013100%).", {"entities": [[63, 67, "GENE"], [69, 73, "GENE"], [75, 81, "GENE"]]}], ["Increases in MMP1 and MMP7 were also observed in lung tissue and bronchoalveolar lavage fluid obtained from IPF patients.", {"entities": [[13, 17, "GENE"], [22, 26, "GENE"]]}], ["MMP7 and MMP1 plasma concentrations were not increased in patients with chronic obstructive pulmonary disease or sarcoidosis and distinguished IPF compared to subacute/chronic hypersensitivity pneumonitis, a disease that may mimic IPF, with a sensitivity of 96.3% (95% CI 81.0%\u2013100%) and specificity of 87.2% (95% CI 72.6%\u201395.7%).", {"entities": [[72, 109, "DISEASE"], [113, 124, "DISEASE"], [0, 4, "GENE"], [9, 13, "GENE"]]}], ["We verified our results in an independent validation cohort composed of patients with IPF, familial pulmonary fibrosis, subclinical interstitial lung disease (ILD), as well as with control individuals.", {"entities": [[132, 157, "DISEASE"], [100, 118, "DISEASE"], [145, 157, "DISEASE"]]}], ["MMP7 and MMP1 concentrations were significantly higher in IPF patients compared to controls in this cohort.", {"entities": [[0, 4, "GENE"], [9, 13, "GENE"]]}], ["Furthermore, MMP7 concentrations were elevated in patients with subclinical ILD and negatively correlated with percent predicted forced vital capacity (FVC%) and percent predicted carbon monoxide diffusing capacity (DL CO %).", {"entities": [[13, 17, "GENE"]]}], ["Our experiments provide the first evidence for a peripheral blood protein signature in IPF to our knowledge.", {"entities": []}], ["The two main components of this signature, MMP7 and MMP1, are overexpressed in the lung microenvironment and distinguish IPF from other chronic lung diseases.", {"entities": [[43, 47, "GENE"], [52, 56, "GENE"]]}], ["Additionally, increased MMP7 concentration may be indicative of asymptomatic ILD and reflect disease progression.", {"entities": [[24, 28, "GENE"]]}], ["Naftali Kaminski and colleagues find increased levels of specific proteins in the bloodstream of individuals with idiopathic pulmonary fibrosis, and suggest that these proteins may ultimately provide a biomarker for the disease.", {"entities": [[125, 143, "DISEASE"], [114, 143, "DISEASE"]]}], ["Idiopathic pulmonary fibrosis (IPF) is a serious disease in which the lungs become progressively scarred or thickened for unknown reasons.", {"entities": [[11, 29, "DISEASE"], [0, 29, "DISEASE"]]}], ["In healthy people, air is taken in through the mouth or nose and travels down the windpipe into tubes in the lungs called the airways.", {"entities": []}], ["Each airway has many small branches that end in alveoli, tiny air sacs with thin walls that are surrounded by small blood vessels called capillaries.", {"entities": [[66, 70, "GENE"]]}], ["When air reaches the alveoli, the oxygen in it passes into the bloodstream and is taken to the organs of the body to keep them working.", {"entities": []}], ["In IPF, the alveoli and the space around them (the \u201cinterstitial\u201d area) gradually become scarred and thickened, which stops oxygen's movement into the bloodstream.", {"entities": []}], ["When only small areas of the lung are scarred, IPF may cause no symptoms.", {"entities": []}], ["But, as more of the lung becomes damaged, IPF eventually causes breathlessness, even when resting.", {"entities": []}], ["There is no effective treatment for IPF, although steroids and drugs that suppress the body's immune system are often tried in an attempt to slow its progression.", {"entities": []}], ["On average, half of the people with IPF die within three years of diagnosis, often from respiratory or heart failure.", {"entities": []}], ["It can be difficult to diagnose IPF\u2014there are many lung diseases with similar symptoms, including numerous other interstitial lung diseases\u2014and currently, physicians can only follow the progression of IPF by repeatedly testing their patients' lung function or by doing multiple chest X-rays.", {"entities": []}], ["If proteins could be identified whose level in blood indicated disease activity (so-called \u201cperipheral blood biomarkers\u201d), it would be easier to diagnose and monitor patients.", {"entities": []}], ["In addition, the identification of such biomarkers might suggest new drug targets for the treatment of IPF.", {"entities": []}], ["In this study, the researchers look for peripheral blood biomarkers in IPF by using a \u201cmultiplex analysis\u201d system to measure the level of several proteins in patient blood samples simultaneously.", {"entities": []}], ["The researchers measured the levels of 49 plasma proteins (plasma is the fluid part of blood) in 74 patients with IPF and 53 healthy people (controls) and used a technique called \u201crecursive partitioning\u201d to define a five-protein signature that distinguished patients from unaffected study participants (controls).", {"entities": []}], ["Matrix metalloproteinase 7 (MMP7) and MMP1\u2014the two plasma proteins whose levels were most increased in patients with IPF compared to controls\u2014were key components of this signature.", {"entities": [[28, 32, "GENE"]]}], ["Concentrations of MMP7 and MMP1 were higher in bronchoalveolar lavage samples (fluid obtained by washing out the lungs with saline) and in lung tissue samples from patients with IPF than in similar samples taken from healthy individuals.", {"entities": [[18, 22, "GENE"], [27, 31, "GENE"]]}], ["Plasma concentrations of MMP7 and MMP1 were significantly higher in patients with IPF than in patients with hypersensitivity pneumonitis, an interstitial lung disease that mimics IPF, but not increased in patients with chronic obstructive pulmonary disease or sarcoidosis, two other lung diseases.", {"entities": [[219, 256, "DISEASE"], [141, 166, "DISEASE"], [260, 271, "DISEASE"], [154, 166, "DISEASE"], [25, 29, "GENE"], [34, 38, "GENE"]]}], ["In an independent validation group, patients with IPF and familial pulmonary fibrosis had increased plasma concentrations of MMP7 and MMP1 that correlated with the severity of their disease.", {"entities": [[67, 85, "DISEASE"], [125, 129, "GENE"], [134, 138, "GENE"]]}], ["In addition, MMP7 concentrations were raised in close relatives of people with familial pulmonary fibrosis who had normal lung function tests but some lung scarring.", {"entities": [[88, 106, "DISEASE"], [13, 17, "GENE"]]}], ["These findings provide evidence for a protein signature in the blood for IPF and suggest MMP1 and MMP7 may be useful as biomarkers for IPF.", {"entities": [[89, 93, "GENE"], [98, 102, "GENE"]]}], ["These two matrix metalloproteinases have previously been suggested to be involved in the development of IPF.", {"entities": []}], ["However, additional work is probably needed to confirm that increased plasma concentrations MMP7 and MMP1 are specific for IPF, since it may be that these markers will not distinguish IPF from other interstitial lung diseases.", {"entities": [[92, 96, "GENE"], [101, 105, "GENE"]]}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0050093 .", {"entities": []}], ["Read a related PLoS Medicine Perspective article The MedlinePlus Encyclopedia has a page on idiopathic pulmonary fibrosis (in English and Spanish) and on pulmonary fibrosis The US National Heart Lung and Blood Institute and the British Lung Foundation also provide information on IPF for patients and relatives Some of the researchers involved in this study provide more details about what might go wrong in IPF in a recent PLoS Medicine article", {"entities": [[103, 121, "DISEASE"], [154, 172, "DISEASE"], [92, 121, "DISEASE"]]}], ["In the absence of established guidelines for hospitalization of patients with pandemic (H1N1) 2009, we studied emergency department patients to identify clinical parameters that predict need for hospitalization.", {"entities": []}], ["Independent predictors of hospitalization include multiple high-risk medical conditions, dyspnea, and hypoxia.", {"entities": []}], ["These findings are easily applicable, with a 79% positive predictive value for hospitalization.", {"entities": []}], ["This paper examines the traditional use of medicinal plants in Northern Peru and Southern Ecuador, with special focus on the Departments of Piura, Lambayeque, La Libertad, Cajamarca, and San Martin, and in Loja province, with special focus on the development since the early colonial period.", {"entities": []}], ["Northern Peru represents the locus of the old Central Andean \"Health Axis.\"", {"entities": []}], ["The roots of traditional healing practices in this region go as far back as the Cupisnique culture early in the first millennium BC.", {"entities": []}], ["Northern Peru and Southern Ecuador share the same cultural context and flora but show striking differences in plant use and traditional knowledge.", {"entities": []}], ["Two hundred fifteen plant species used for medicinal purposes in Ecuador and 510 plant species used for medicinal purposes in Peru were collected, identified,.", {"entities": []}], ["and their vernacular names, traditional uses, and applications recorded.", {"entities": []}], ["This number of species indicates that the healers, market vendors, and members of the public interviewed in Peru still have a very high knowledge of plants in their surroundings, which can be seen as a reflection of the knowledge of the population in general.", {"entities": []}], ["In Ecuador much of the original plant knowledge has already been lost.", {"entities": []}], ["In Peru, 433 (85%) were Dicotyledons, 46 (9%) Monocotyledons, 21 (4%) Pteridophytes, and 5 (1%) Gymnosperms.", {"entities": []}], ["Three species of Giartina (Algae) and one species of the Lichen genus Siphula were used.", {"entities": []}], ["The families best represented were Asteraceae with 69 species, Fabaceae (35), Lamiaceae (25), and Solanaceae (21).", {"entities": []}], ["Euphorbiaceae had 12 species, and Poaceae and Apiaceae each accounted for 11 species.", {"entities": []}], ["In Ecuador the families best represented were Asteraceae (32 species), Euphorbiaceae, Lamiaceae, and Solanaceae (11 species each), and Apiaceae, Fabaceae, Lycopodiaceae (9 species each).", {"entities": []}], ["One hundred eighty-two (85%) of the species used were Dicotyledons, 20 Monocotyledons (9.3%), 12 ferns (5.5%), and one unidentified lichen was used.", {"entities": []}], ["Most of the plants used (83%) were native to Peru and Ecuador.", {"entities": []}], ["Fresh plants, often collected wild, were used in two thirds of all cases in Peru, but in almost 95% of the cases in Ecuador.", {"entities": []}], ["The most common applications included the ingestion of herb decoctions or the application of plant material as poultices.", {"entities": []}], ["Although about 50% of the plants in use in the colonial period have disappeared from the popular pharmacopoeia, the overall number of plant species used medicinally has increased in Northern Peru, while Southern Ecuador shows a decline of plant knowledge since colonial times.", {"entities": []}], ["C-reactive protein (CRP) is widely used to detect bacterial infection in children.", {"entities": [[20, 23, "GENE"]]}], ["We investigated the impact of CRP test results on decision-making and summarized the evidence base (EB) of CRP testing.", {"entities": [[30, 33, "GENE"], [107, 110, "GENE"], [30, 33, "GENE"], [107, 110, "GENE"]]}], ["We collected information from the hospital records of 91 neonates with suspected sepsis and of 152 febrile children with suspected infection on the number of ordered CRP tests, the number of EB-CRP tests, and the impact of the test results on decision-making.", {"entities": [[166, 169, "GENE"], [194, 197, "GENE"]]}], ["CRP diagnostic accuracy studies focusing on pediatric infections were reviewed critically.", {"entities": [[0, 3, "GENE"]]}], ["The main outcomes were the proportion of CRP tests that were EB and the proportion of tests that affected decision-making.", {"entities": [[41, 44, "GENE"]]}], ["A secondary outcome was the overall one-year expenditure on CRP testing.", {"entities": [[60, 63, "GENE"]]}], ["The current EB for CRP testing in pediatric infections is weak and suggests that CRP is of low diagnostic value.", {"entities": [[19, 22, "GENE"], [81, 84, "GENE"], [19, 22, "GENE"], [81, 84, "GENE"]]}], ["Approximately 54.8% of tests performed for suspected neonatal sepsis and 28% of tests performed for other infections were EB; however, the results of only 12.9% of neonatal sepsis tests and of 29.9% of tests on children with other infections informed decision-making.", {"entities": []}], ["The one-year overall cost for CRP testing and related health care was $26,715.9.", {"entities": [[30, 33, "GENE"]]}], ["The routine ordering of CRP for children with infections is based on weak evidence.", {"entities": [[24, 27, "GENE"]]}], ["The impact of the CRP test results on decision-making is rather small, and CRP ordering may contribute to unnecessary health care expenditures.", {"entities": [[18, 21, "GENE"], [75, 78, "GENE"], [18, 21, "GENE"], [75, 78, "GENE"]]}], ["Better quality research is needed to definitively determine the diagnostic accuracy of CRP levels in children with infections.", {"entities": [[87, 90, "GENE"]]}], ["Clinical practice guidelines (CPGs) are systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific clinical circumstances.", {"entities": []}], ["There is a limited number of studies on guidelines in Turkey.", {"entities": []}], ["The quality of Ministry of Health guidelines have formerly been assessed whereas there is no information on the other guidelines developed in the country.", {"entities": []}], ["This study aims to assess the quality of CPGs that are developed by professional societies that work for the health sector in Turkey, and compare the findings with international guidelines.", {"entities": []}], ["Professional societies that work for the health sector were determined by using the data obtained from the Ministry of Internal Affairs.", {"entities": []}], ["Inclusion and exclusion criteria were defined for selecting the CPGs.", {"entities": []}], ["Guidelines containing recommendations about disease management to the doctors, accessible online, developed within the past 5 years, citing references for recommendations, about the diseases over 1% prevalence according to the \u201cStatistical Yearbook of Turkey 2012\u201d were included in the study.", {"entities": []}], ["The quality of CPGs were assessed with the AGREE II instrument, which is an internationally recognized tool for this purpose.", {"entities": []}], ["Four independent reviewers, who did not participate in the development of the selected guidelines and were trained in CPG appraisal, used the AGREE instrument for assessment of the selected guidelines.", {"entities": []}], ["47 professional societies were defined which provided access to CPGs in their websites; 3 of them were only open to members so these could not be reached.", {"entities": []}], ["8 CPGs from 7 societies were selected from a total of 401 CPGs from 44 societies.", {"entities": []}], ["The mean scores of the domains of the guidelines which were assessed by the AGREE II tool were; Scope and purpose: 64%, stakeholder involvement: 37.9%, rigour of development: 35.3%, clarity and presentation: 77.9%, applicability: 49.0% and editorial independence: 46.0%.", {"entities": []}], ["This is the first study in Turkey regarding quality appraisal of guidelines developed by the local professional societies.", {"entities": []}], ["It adds to the limited amount of information in the literature that comes from Turkey as well as other developing countries.", {"entities": []}], ["We provide a comprehensive classification of the proteoglycan gene families and respective protein cores.", {"entities": []}], ["This updated nomenclature is based on three criteria: Cellular and subcellular location, overall gene/protein homology, and the utilization of specific protein modules within their respective protein cores.", {"entities": []}], ["These three signatures were utilized to design four major classes of proteoglycans with distinct forms and functions: the intracellular, cell-surface, pericellular and extracellular proteoglycans.", {"entities": []}], ["The proposed nomenclature encompasses forty-three distinct proteoglycan-encoding genes and many alternatively-spliced variants.", {"entities": []}], ["The biological functions of these four proteoglycan families are critically assessed in development, cancer and angiogenesis, and in various acquired and genetic diseases where their expression is aberrant.", {"entities": [[101, 107, "DISEASE"]]}], ["Multimorbidity is common in the older population, but the impact of combinations of chronic conditions on disability and quality of life (QoL) is not well known.", {"entities": []}], ["This analysis explores the effect of specific combinations of chronic diseases on disability, QoL and self-rated health (SRH).", {"entities": []}], ["We used data from two population representative cross-sectional studies, the Northern Ireland Health and Social Wellbeing Survey (NIHSWS) 2005 and the Survey of Lifestyle, Attitudes and Nutrition (SLAN) 2007 (conducted in the Republic of Ireland).", {"entities": []}], ["Randomly selected community-living participants were interviewed at home.", {"entities": []}], ["A total of 6159 participants aged 50\u2005years and older were included in the analysis.", {"entities": []}], ["Chronic conditions were classified as cardiovascular disease, chronic pain, diabetes or respiratory disease.", {"entities": []}], ["Interaction terms estimated by logistic regression were used to examine the effects of multiple chronic conditions on disability, SRH and QoL.", {"entities": []}], ["Each chronic condition group was correlated with each of the others after adjusting for sociodemographic factors.", {"entities": []}], ["Those from Northern Ireland were more likely to report a limitation in daily activities (45%) compared to those from the Republic of Ireland (21%).", {"entities": []}], ["Each condition had an independent effect on disability, SRH and QoL, and those with multiple chronic conditions reported the worst outcomes.", {"entities": []}], ["However, there were no statistically significant positive interactions between chronic condition groups with respect to any outcome.", {"entities": []}], ["Chronic conditions affect individuals largely independent of each other with respect to their effect on disability, SRH and QoL.", {"entities": []}], ["However, a significant proportion of the population aged 50\u2005years and over across the island of Ireland lives with multimorbidity, and this group is at the highest risk of disability, poor SRH and poor QoL.", {"entities": []}], ["The manufacturing process of a new intravenous immune globulin (IVIG) 10% liquid product incorporates two dedicated pathogen safety steps: solvent/detergent (S/D) treatment and nanofiltration (20\u00a0nm).", {"entities": []}], ["Ion-exchange chromatography (IEC) during protein purification also contributes to pathogen safety.", {"entities": []}], ["The ability of these three process steps to inactivate/remove viruses and prions was evaluated.", {"entities": []}], ["The objective of this study was to evaluate the virus and prion safety of the new IVIG 10% liquid.", {"entities": []}], ["Bovine viral diarrhea virus (BVDV), human immunodeficiency virus type 1 (HIV-1), mouse encephalomyelitis virus (MEV), porcine parvovirus (PPV), and pseudorabies virus (PRV) were used as models for common human viruses.", {"entities": [[13, 21, "DISEASE"], [87, 104, "DISEASE"]]}], ["The hamster-adapted scrapie strain 263K (HAS\u00a0263K) was used for transmissible spongiform encephalopathies.", {"entities": [[20, 27, "DISEASE"]]}], ["Virus clearance capacity and robustness of virus reduction were determined for the three steps.", {"entities": []}], ["Abnormal prion protein (PrP S/D treatment and nanofiltration inactivated/removed enveloped viruses to below detection limits.", {"entities": []}], ["IEC supplements viral safety and nanofiltration was highly effective in removing non-enveloped viruses and HAS\u00a0263K.", {"entities": []}], ["Overall virus reduction factors were: \u22659.4\u00a0log 10 (HIV-1), \u226513.2\u00a0log 10 (PRV), \u22658.2\u00a0log 10 (BVDV), \u226511.7\u00a0log 10 (MEV), \u226511.6\u00a0log 10 (PPV), and \u226510.4\u00a0log 10 (HAS\u00a0263K).", {"entities": []}], ["Two dedicated and one supplementing steps in the manufacturing process of the new IVIG 10% liquid provide a high margin of pathogen safety.", {"entities": []}], ["Laurie Glimcher is a physician-scientist with a true passion for research.", {"entities": []}], ["In this interview, she discusses her early career, key issues in successful clinical translation and her move to become Dean of Weill Cornell Medical College in Manhattan.", {"entities": []}], ["Chest radiographic abnormalities were common in HIV-infected individuals in the pre-combination antiretroviral therapy era, but findings may differ now due to a changing spectrum of pulmonary complications.", {"entities": []}], ["Cross-sectional study of radiographic abnormalities in an HIV-infected outpatient population during the antiretroviral therapy era.", {"entities": []}], ["Demographics, chest computed tomography, and pulmonary function tests were obtained in HIV-infected volunteers without acute respiratory illness from the University of Pittsburgh HIV/AIDS clinic.", {"entities": []}], ["Overall prevalence of radiographic abnormalities and potential risk factors for having any abnormality, nodules, or emphysema were evaluated using univariate and multivariable analyses.", {"entities": []}], ["A majority of the 121 participants (55.4%) had a radiographic abnormality with the most common being emphysema (26.4%), nodules (17.4%), and bronchiectasis (10.7%).", {"entities": [[141, 155, "DISEASE"]]}], ["In multivariate models, age (odds ratio [OR] per year \u200a=\u200a1.07, 95% confidence interval [CI] 1.04\u20131.14, p<0.001), pneumonia history (OR \u200a=\u200a3.60, 95% CI \u200a=\u200a1.27\u201310.20, p\u200a=\u200a0.016), and having ever smoked (OR \u200a=\u200a3.66, p\u200a=\u200a0.013, 95% CI \u200a=\u200a1.31\u201310.12) were significant predictors of having any radiographic abnormality.", {"entities": [[113, 122, "DISEASE"]]}], ["Use of antiretroviral therapy, CD4 cell count, and HIV viral load were not associated with presence of abnormalities.", {"entities": [[31, 34, "GENE"]]}], ["Individuals with radiographic emphysema were more likely to have airway obstruction on pulmonary function tests.", {"entities": []}], ["Only 85.8% participants with nodules had follow-up imaging resulting in 52.4% having stable nodules, 23.8% resolution of their nodules, 4.8% development of a new nodule, and 4.8% primary lung cancer.", {"entities": [[187, 198, "DISEASE"], [192, 198, "DISEASE"]]}], ["Radiographic abnormalities remain common in HIV-infected individuals with emphysema, nodules, and bronchiectasis being the most common.", {"entities": [[98, 112, "DISEASE"]]}], ["Age, smoking, and pneumonia were associated with radiographic abnormalities, but HIV-associated factors did not seem to predict risk.", {"entities": [[18, 27, "DISEASE"]]}], ["Inflammation is central to the development of chronic obstructive pulmonary disease (COPD), a pulmonary disorder characterized by chronic bronchitis, chronic airway obstruction, emphysema, associated to progressive and irreversible decline of lung function.", {"entities": [[46, 83, "DISEASE"], [138, 148, "DISEASE"]]}], ["Emerging genetic and pharmacological evidence suggests that IL-1-like cytokines are highly detected in the sputum and broncho-alveolar lavage (BAL) of COPD patients, implying the involvement of the multiprotein complex inflammasome.", {"entities": []}], ["So far, scientific evidence has focused on nucleotide-binding oligomerization domain-like receptors protein 3 (NLRP3) inflammasome, a specialized inflammatory signaling platform that governs the maturation and secretion of IL-1-like cytokines through the regulation of caspase-1-dependent proteolytic processing.", {"entities": [[111, 116, "GENE"]]}], ["Some studies revealed that it is involved during airway inflammation typical of COPD.", {"entities": []}], ["Based on the influence of cigarette smoke in various respiratory diseases, including COPD, in this view we report its effects in inflammatory and immune responses in COPD mouse models and in human subjects affected by COPD.", {"entities": []}], ["In sharp contrast to what reported on experimental and clinical studies, randomized clinical trials show that indirect inflammasome inhibitors did not have any beneficial effect in moderate to severe COPD patients.", {"entities": []}], ["Studies determining the development of a wide variety of different comorbid disorders in inflammatory arthritis (IA) patients are scarce, however, this knowledge could be helpful in optimising preventive care in IA patients.", {"entities": [[102, 111, "DISEASE"]]}], ["The aim of this study is to establish the risk that new chronic comorbid disorders in newly diagnosed patients with IA in a primary care setting are developed.", {"entities": []}], ["This is a nested-case\u2013control study from 2001\u20132010 using data from electronic medical patient records in general practice.", {"entities": []}], ["In total, 3,354 patients with newly diagnosed IA were selected.", {"entities": []}], ["Each patient was matched with two control patients of the same age and sex in the same general practice.", {"entities": []}], ["The development of 121 chronic comorbid disorders of index and control patients was compared using Cox regression.", {"entities": []}], ["After a median follow-up period of 2.8 years, 56% of the IA-patients had developed at least one chronic comorbid disorder after the onset of IA, compared to 46% of the control patients (p\u2009<\u20090.05).", {"entities": []}], ["The most frequent developed comorbid disorders after the onset of IA were of cardiovascular (23%), and musculoskeletal (17%) origin.", {"entities": []}], ["The highest hazard ratios (HRs) were found for anaemia (HR 2.0 [95% CI: 1.4-2.7]) osteoporosis (HR 1.9 [1.4-2.4]), and COPD (HR 1.8 [1.4-2.3]).", {"entities": [[82, 94, "DISEASE"], [56, 58, "GENE"], [96, 98, "GENE"], [125, 127, "GENE"], [56, 58, "GENE"], [96, 98, "GENE"], [125, 127, "GENE"], [56, 58, "GENE"], [96, 98, "GENE"], [125, 127, "GENE"]]}], ["Patients with IA developed more chronic comorbid disorders after the onset of IA than one might expect based on age and sex.", {"entities": []}], ["Since comorbidity has a large impact on the disease course, quality of life, and possibly on treatment itself, prevention of comorbidity should be one of the main targets in the treatment of IA patients.", {"entities": []}], ["Streptococcus pneumoniae is a common cause of pneumonia and infective exacerbations of chronic lung disease, yet there are few data on how adaptive immunity can specifically prevent S. pneumoniae lung infection.", {"entities": [[46, 55, "DISEASE"], [95, 107, "DISEASE"]]}], ["We have used a murine model of nasopharyngeal colonization by the serotype 19F S. pneumoniae strain EF3030 followed by lung infection to investigate whether colonization protects against subsequent lung infection and the mechanisms involved.", {"entities": []}], ["EF3030 colonization induced systemic and local immunoglobulin G against a limited number of S. pneumoniae protein antigens rather than capsular polysaccharide.", {"entities": []}], ["During lung infection, previously colonized mice had increased early cytokine responses and neutrophil recruitment and reduced bacterial colony-forming units in the lungs and bronchoalveolar lavage fluid compared with control mice.", {"entities": []}], ["Colonization-induced protection was lost when experiments were repeated in B-cell- or neutrophil-deficient mice.", {"entities": []}], ["Furthermore, the improved interleukin (IL)-17 response to infection in previously colonized mice was abolished by depletion of CD4+ cells, and prior colonization did not protect against lung infection in mice depleted of CD4+ cells or IL17.", {"entities": []}], ["Together these data show that naturally acquired protective immunity to S. pneumoniae lung infection requires both humoral and cell-mediated immune responses, providing a template for the design of improved vaccines that can specifically prevent pneumonia or acute bronchitis.", {"entities": [[246, 255, "DISEASE"], [265, 275, "DISEASE"]]}], ["This bacterium is an underappreciated cause of lung disease and infection rates appear to be increasing.", {"entities": [[47, 59, "DISEASE"]]}], ["The prevalence and trends of pulmonary nontuberculous mycobacteria (NTM)\u2013associated hospitalizations in the United States were estimated using national hospital discharge data.", {"entities": [[68, 71, "GENE"]]}], ["Records were extracted for all persons with a pulmonary NTM International Classification of Diseases code (031.0) hospitalized in the 11 states with continuous data available from 1998 through 2005.", {"entities": [[56, 59, "GENE"]]}], ["Prevalence was calculated using US census data.", {"entities": []}], ["Pulmonary NTM hospitalizations (031.0) increased significantly with age among both sexes: relative prevalence for persons 70\u201379 years of age compared with those 40\u201349 years of age was 15/100,000 for women (9.4 vs. 0.6) and 9/100,000 for men (7.6 vs. 0.83).", {"entities": [[10, 13, "GENE"]]}], ["Annual prevalence increased significantly among men and women in Florida (3.2%/year and 6.5%/year, respectively) and among women in New York (4.6%/year) with no significant changes in California.", {"entities": []}], ["The prevalence of pulmonary NTM\u2013associated hospitalizations is increasing in selected geographic areas of the United States.", {"entities": []}], ["The use of noninvasive positive-pressure mechanical ventilation (NPPV) has been investigated in several acute respiratory failure situations.", {"entities": [[110, 129, "DISEASE"]]}], ["Questions remain about its benefits when used in weaning patients from invasive mechanical ventilation (IMV).", {"entities": []}], ["The objective of this study was to evaluate the use of bi-level NPPV for patients who fail weaning from IMV.", {"entities": []}], ["This experimental randomized clinical trial followed up patients undergoing IMV weaning, under ventilation for more than 48 hours, and who failed a spontaneous breathing T-piece trial.", {"entities": []}], ["Patients with contraindications to NPPV were excluded.", {"entities": []}], ["Before T-piece placement, arterial gases, maximal inspiratory pressure, and other parameters of IMV support were measured.", {"entities": []}], ["During the trial, respiratory rate, tidal volume, minute volume, rapid shallow breathing index, heart rate, arterial blood pressure, and peripheral oxygen saturation were measured at 1 and 30 minutes.", {"entities": []}], ["After failing a T-piece trial, patients were randomly divided in two groups: (a) those who were extubated and placed on NPPV and (b) those who were returned to IMV.", {"entities": []}], ["Group results were compared using the Student t test and the chi-square test.", {"entities": []}], ["Of 65 patients who failed T-piece trials, 28 were placed on NPPV and 37 were placed on IMV.", {"entities": []}], ["The ages of patients in the NPPV and IMV groups were 67.6 \u00b1 15.5 and 59.7 \u00b1 17.6 years, respectively.", {"entities": []}], ["Heart disease, post-surgery respiratory failure, and chronic pulmonary disease aggravation were the most frequent causes of IMV use.", {"entities": [[28, 47, "DISEASE"]]}], ["In both groups, ventilation time before T-piece trial was 7.3 \u00b1 4.1 days.", {"entities": []}], ["Heart and respiratory parameters were similar for the two groups at 1 and 30 minutes of T-piece trial.", {"entities": []}], ["The percentage of complications in the NPPV group was lower (28.6% versus 75.7%), with lower incidences of pneumonia and tracheotomy.", {"entities": [[107, 116, "DISEASE"]]}], ["Length of stay in the intensive care unit and mortality were not statistically different when comparing the groups.", {"entities": []}], ["The results suggest that NPPV is a good alternative for ventilation of patients who fail initial weaning attempts.", {"entities": []}], ["NPPV reduces the incidence of pneumonia associated with mechanical ventilation and the need for tracheotomy.", {"entities": [[30, 39, "DISEASE"]]}], ["CEP HCPA (02\u2013114).", {"entities": []}], ["Background: Although ambient fine particulate matter (PM 2.5 ; particulate matter \u2264 2.5 \u00b5m in aerodynamic diameter) has been linked to adverse human health effects, the chemical constituents that cause harm are unknown.", {"entities": []}], ["To our knowledge, the health effects of PM 2.5 constituents have not been reported for a developing country.", {"entities": []}], ["Objectives: We examined the short-term association between PM 2.5 constituents and daily mortality in Xi\u2019an, a heavily polluted Chinese city.", {"entities": []}], ["Methods: We obtained daily mortality data and daily concentrations of PM 2.5 , organic carbon (OC), elemental carbon (EC), and 10 water-soluble ions for 1 January 2004 through 31 December 2008.", {"entities": []}], ["We also measured concentrations of fifteen elements 1 January 2006 through 31 December 2008.", {"entities": []}], ["We analyzed the data using over-dispersed generalized linear Poisson models.", {"entities": []}], ["Results: During the study period, the mean daily average concentration of PM 2.5 in Xi\u2019an was 182.2 \u00b5g/m 2.5 mass included OC, EC, sulfate, nitrate, and ammonium.", {"entities": []}], ["After adjustment for PM 2.5 mass, we found significant positive associations of total, cardiovascular, or respiratory mortality with OC, EC, ammonium, nitrate, chlorine ion, chlorine, and nickel for at least 1 lag day.", {"entities": []}], ["Nitrate demonstrated stronger associations with total and cardiovascular mortality than PM 2.5 mass.", {"entities": []}], ["For a 1-day lag, interquartile range increases in PM 2.5 mass and nitrate (114.9 and 15.4 \u00b5g/m Conclusions: Our findings suggest that PM 2.5 constituents from the combustion of fossil fuel may have an appreciable influence on the health effects attributable to PM 2.5 in Xi\u2019an.", {"entities": []}], ["Sohar industrial zone (SIZ), Oman, which started operating in 2006, contains many industries that potentially affect the health of the local population.", {"entities": []}], ["This study's aim was to evaluate the health effects in a young population living near SIZ.", {"entities": []}], ["Patient visits to state health clinics for acute respiratory diseases (ARD), asthma, conjunctivitis and dermatitis were obtained for the period of 2006 to 2010, for children ages <20 years old, for two large provinces around SIZ.", {"entities": [[85, 99, "DISEASE"], [77, 83, "DISEASE"], [104, 114, "DISEASE"]]}], ["Three exposure zones were defined on the basis of the distance from SIZ determined as: \u22645, >5 to 10, \u226520\u2005km to represent high, intermediate and control exposure zones, respectively.", {"entities": []}], ["Age-specific and gender-specific monthly counts of visits were modelled using generalised additive models controlling for time trends.", {"entities": []}], ["The high and intermediate exposure zones were later combined together due to the similarity of associations.", {"entities": []}], ["Exposure effect modification by age, gender and socioeconomic status (SES) was also tested.", {"entities": []}], ["Living within 10\u2005km from SIZ showed a greater association with ARD (risk ratio (RR)=2.5; 95% CI=2.3 to 2.7), asthma (RR=3.7; 95% CI=3.1 to 4.5), conjunctivitis (RR=3.1; 95% CI=2.9 to 3.5) and dermatitis (RR=2.7; 95% CI=2.5 to 3.0) when compared with the control zone.", {"entities": [[145, 159, "DISEASE"], [109, 115, "DISEASE"], [192, 202, "DISEASE"]]}], ["No differences in associations were found for gender and SES groups; greater effects were noticed in the \u226414-year-old group for asthma.", {"entities": [[128, 134, "DISEASE"]]}], ["This is the first study conducted in Oman to examine the health effects of a young population living near an industrial park.", {"entities": []}], ["We hope that these findings will contribute in future developments of environmental health policies in Oman.", {"entities": []}], ["We compared phagocytic and metabolic activities of multinucleated giant cells (MGC) and macrophages derived from human monocytes after 9-14 d in culture.", {"entities": []}], ["Phagocytosis of sheep erythrocytes (E) coated with IgG, of E coated with IgM and complement, and of Candida albicans was comparable in MGC and macrophages.", {"entities": []}], ["The same percentage of ingested fungi was killed by MGC (24 +/- 4%) and macrophages (21 +/- 5%).", {"entities": []}], ["Approximately 70% of MGC and macrophages exhibited superoxide-dependent reduction of nitroblue tetrazolium during stimulation.", {"entities": []}], ["Ia antigen was present on approximately 75% of both cell types.", {"entities": []}], ["Analysis of cell populations separated by nuclear fluorescence indicated that beta- glucosaminidase, acid phosphatase, and beta-glucuronidase activity per cell was higher in MGC, but specific activity of these enzymes was greater in macrophages.", {"entities": []}], ["These results suggest that MGC have the capacity to function like macrophages in host defense against infection.", {"entities": []}], ["This paper attempts to clarify the nature of chemical sensitivity by proposing a theory of disease that unites the disparate clinical observations associated with the condition.", {"entities": []}], ["Sensitivity to chemicals appears to be the consequence of a two-step process: loss of tolerance in susceptible persons following exposure to various toxicants, and subsequent triggering of symptoms by extremely small quantities of previously tolerated chemicals, drugs, foods, and food and drug combinations including caffeine and alcohol.", {"entities": []}], ["Although chemical sensitivity may be the consequence of this process, a term that may more clearly describe the observed process is toxicant-induced loss of tolerance.", {"entities": []}], ["Features of this yet-to-be-proven mechanism or theory of disease that affect the design of human exposure studies include the stimulatory and withdrawallike nature (resembling addiction) of symptoms reported by patients and masking.", {"entities": []}], ["Masking, which may blunt or eliminate responses to chemical challenges, appears to have several components: apposition, which is the overlapping of the effects of closely timed exposures, acclimatization or habituation, and addiction.", {"entities": []}], ["A number of human challenge studies in this area have concluded that there is no physiological basis for chemical sensitivity.", {"entities": []}], ["However, these studies have failed to address the role of masking.", {"entities": []}], ["To ensure reliable and reproducible responses to challenges, future studies in which subjects are evaluated in an environmental medical unit, a hospital-based facility in which background chemical exposures are reduced to the lowest levels practicable, may be necessary.", {"entities": []}], ["A set of postulates is offered to determine whether there is a causal relationship between low-level chemical exposures and symptoms using an environmental medical unit.", {"entities": []}], ["To investigate a possible role for human rhinovirus C in respiratory exacerbations of children with cystic fibrosis, we conducted microbiologic testing on respiratory specimens from 103 such patients in S\u00e3o Paulo, Brazil, during 2006\u20132007.", {"entities": [[100, 115, "DISEASE"]]}], ["A significant association was found between the presence of human rhinovirus C and respiratory exacerbations.", {"entities": []}], ["Several clinical studies show that individuals with HIV are at an increased risk for worsened lung function and for the development of COPD, although the mechanism underlying this increased susceptibility is poorly understood.", {"entities": []}], ["The airway epithelium, situated at the interface between the external environment and the lung parenchyma, acts as a physical and immunological barrier that secretes mucins and cytokines in response to noxious stimuli which can contribute to the pathobiology of chronic obstructive pulmonary disease (COPD).", {"entities": [[262, 299, "DISEASE"]]}], ["We sought to determine the effects of HIV on the lung epithelium.", {"entities": []}], ["We grew primary normal human bronchial epithelial (NHBE) cells and primary lung epithelial cells isolated from bronchial brushings of patients to confluence and allowed them to differentiate at an air- liquid interface (ALI) to assess the effects of HIV on the lung epithelium.", {"entities": []}], ["We assessed changes in monolayer permeability as well as the expression of E-cadherin and inflammatory modulators to determine the effect of HIV on the lung epithelium.", {"entities": []}], ["We measured E-cadherin protein abundance in patients with HIV compared to normal controls.", {"entities": []}], ["Cell associated HIV RNA and DNA were quantified and the p24 viral antigen was measured in culture supernatant.", {"entities": []}], ["Surprisingly, X4, not R5, tropic virus decreased expression of E-cadherin and increased monolayer permeability.", {"entities": []}], ["While there was some transcriptional regulation of E-cadherin, there was significant increase in lysosome-mediated protein degradation in cells exposed to X4 tropic HIV.", {"entities": []}], ["Interaction with CXCR4 and viral fusion with the epithelial cell were required to induce the epithelial changes.", {"entities": [[17, 22, "GENE"]]}], ["X4 tropic virus was able to enter the airway epithelial cells but not replicate in these cells, while R5 tropic viruses did not enter the epithelial cells.", {"entities": []}], ["Significantly, X4 tropic HIV induced the expression of intercellular adhesion molecule-1 (ICAM-1) and activated extracellular signal-regulated kinase (ERK).", {"entities": []}], ["We demonstrate that HIV can enter airway epithelial cells and alter their function by impairing cell-cell adhesion and increasing the expression of inflammatory mediators.", {"entities": []}], ["These observed changes may contribute local inflammation, which can lead to lung function decline and increased susceptibility to COPD in HIV patients.", {"entities": []}], ["Aggressive periodontitis is characterized by a rapid and severe periodontal destruction in young systemically healthy subjects.", {"entities": [[0, 24, "DISEASE"], [11, 24, "DISEASE"]]}], ["A greater prevalence is reported in Africans and African descendent groups than in Caucasians and Hispanics.", {"entities": []}], ["We first fine mapped the interval 1q24.2 to 1q31.3 suggested as containing an aggressive periodontitis locus.", {"entities": [[78, 102, "DISEASE"], [89, 102, "DISEASE"]]}], ["Three hundred and eighty-nine subjects from 55 pedigrees were studied.", {"entities": []}], ["Saliva samples were collected from all subjects, and DNA was extracted.", {"entities": []}], ["Twenty-one single nucleotide polymorphisms were selected and analyzed by standard polymerase chain reaction using TaqMan chemistry.", {"entities": []}], ["Non-parametric linkage and transmission distortion analyses were performed.", {"entities": []}], ["Although linkage results were negative, statistically significant association between two markers, rs1935881 and rs1342913, in the FAM5C gene and aggressive periodontitis (p\u200a=\u200a0.03) was found.", {"entities": [[146, 170, "DISEASE"], [157, 170, "DISEASE"], [131, 136, "GENE"]]}], ["Haplotype analysis showed an association between aggressive periodontitis and the haplotype A-G (rs1935881-rs1342913; p\u200a=\u200a0.009).", {"entities": [[49, 73, "DISEASE"], [60, 73, "DISEASE"]]}], ["Sequence analysis of FAM5C coding regions did not disclose any mutations, but two variants in conserved intronic regions of FAM5C , rs57694932 and rs10494634, were found.", {"entities": [[21, 26, "GENE"], [124, 129, "GENE"], [21, 26, "GENE"], [124, 129, "GENE"]]}], ["However, these two variants are not associated with aggressive periodontitis.", {"entities": [[52, 76, "DISEASE"], [63, 76, "DISEASE"]]}], ["Secondly, we investigated the pattern of FAM5C expression in aggressive periodontitis lesions and its possible correlations with inflammatory/immunological factors and pathogens commonly associated with periodontal diseases.", {"entities": [[61, 85, "DISEASE"], [72, 85, "DISEASE"], [41, 46, "GENE"]]}], ["FAM5C mRNA expression was significantly higher in diseased versus healthy sites, and was found to be correlated to the IL-1\u03b2 , IL-17A , IL-4 and RANKL mRNA levels.", {"entities": [[0, 5, "GENE"]]}], ["No correlations were found between FAM5C levels and the presence and load of red complex periodontopathogens or Aggregatibacter actinomycetemcomitans .", {"entities": [[35, 40, "GENE"]]}], ["This study provides evidence that FAM5C contributes to aggressive periodontitis.", {"entities": [[55, 79, "DISEASE"], [66, 79, "DISEASE"], [34, 39, "GENE"]]}], ["Aquagenic pruritus (AP) occurs during or after contact of the skin with water such as occurs in bathing.", {"entities": []}], ["This study aims to describe the prevalence of aquagenic pruritus in a young adult population and describe the circumstances of bathing.", {"entities": []}], ["A Population-based cross sectional study involving administration of Questionnaires to young adult Nigerians on the occurrence of pruritus associated with bathing.", {"entities": []}], ["The prevalence of bathing pruritus among respondents in this study was 23.8%.", {"entities": []}], ["The commonest type of water respondents itch to was rain water (23%) followed by cold water (19%).", {"entities": []}], ["8.33% of respondents feels like avoiding bathing because of these.", {"entities": []}], ["Bathing pruritus is a common finding among young adult Nigerians in the general population.", {"entities": []}], ["Systemic mast cell activation disease (MCAD) is characterized by an enhanced release of mast cell-derived mediators, including eicosanoids, which induce a broad spectrum of clinical symptoms.", {"entities": []}], ["Accordingly, the diagnostic algorithm of MCAD presupposes the proof of increased mast cell mediator release, but only a few mediators are currently established as routine laboratory parameters.", {"entities": []}], ["We thus initiated an explorative study to evaluate in vitro typing of individual eicosanoid pattern of peripheral blood leukocytes (PBLs) as a new diagnostic tool in MCAD.", {"entities": []}], ["Using the \u201cfunctional eicosanoid testing and typing\u201d (FET) assay, we investigated the balance (i.e.", {"entities": []}], ["the complex pattern of formation, release and mutual interaction) of prostaglandin E 2 (PGE 2 ) and peptido-leukotrienes (pLT) release from PBLs of 22 MCAD patients and 20 healthy individuals.", {"entities": []}], ["FET algorithms thereby consider both basal and arachidonic acid (AA)-, acetylsalicylic acid (ASA)-, and substance P (SP)-triggered release of PGE 2 and pLT.", {"entities": []}], ["The FET assay was further supplemented by analyzing prostaglandin D 2 (PGD 2 ), as mast cell-specific eicosanoid.", {"entities": [[71, 74, "GENE"]]}], ["We observed marked PGE 2 -pLT imbalances for PBLs of MCAD patients, as indicated by a markedly enhanced mean FET value of 1.75\u2009\u00b1\u20090.356 (range: 1.14\u20132.36), compared to 0.53\u2009\u00b1\u20090.119 (range: 0.36-0.75) for healthy individuals.", {"entities": []}], ["In addition, mean PGD 2 release from PBLs of MCAD patients was significantly, 6.6-fold higher than from PBLs of healthy individuals (946\u2009\u00b1\u2009302.2\u00a0pg/ml versus 142\u2009\u00b1\u200947.8\u00a0pg/ml; P \u2009<\u20090.001).", {"entities": [[18, 21, "GENE"]]}], ["In contrast to healthy individuals, PGD 2 release from PBLs of MCAD patients was markedly triggered by SP (mean: 1896\u2009\u00b1\u2009389.7\u00a0pg/ml; P \u2009<\u20090.001), whereas AA and ASA caused individually varying effects on both PGD 2 and pLT release.", {"entities": [[36, 39, "GENE"], [209, 212, "GENE"], [36, 39, "GENE"], [209, 212, "GENE"]]}], ["The new in-vitro FET assay, supplemented with analysis of PGD 2 , demonstrated that the individual patterns of eicosanoid release from PBLs can unambiguously distinguish MCAD patients from healthy individuals.", {"entities": [[58, 61, "GENE"]]}], ["Notably, in our analyses, the FET value and both basal and triggered PGD 2 levels were not significantly affected by MCAD-specific medication.", {"entities": [[69, 72, "GENE"]]}], ["Thus, this approach may serve as an in-vitro diagnostic tool to estimate mast cell activity and to support individualized therapeutic decision processes for patients suffering from MCAD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12967-014-0213-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In a biphasic, ovalbumin (OVA)-induced murine asthma model where allergic airway disease is followed by resolution and the development of local inhalational tolerance (LIT), TGF\u03b2-expressing CD5 in vitro .", {"entities": [[46, 52, "DISEASE"], [190, 193, "GENE"]]}], ["Diabetic nephropathy (DN) is a serious diabetic complication with renal hypertrophy and expansion of extracellular matrices in renal fibrosis.", {"entities": []}], ["Epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells may be involved in the main mechanism.", {"entities": []}], ["Berberine (BBR) has been shown to have antifibrotic effects in liver, kidney and lung.", {"entities": []}], ["However, the mechanism of cytoprotective effects of BBR in DN is still unclear.", {"entities": []}], ["In this study, we investigated the curative effects of BBR on tubulointerstitial fibrosis in streptozotocin (STZ)-induced diabetic mice and the high glucose (HG)-induced EMT in NRK 52E cells.", {"entities": [[177, 180, "GENE"]]}], ["We found that BBR treatment attenuated renal fibrosis by activating the nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway in the diabetic kidneys.", {"entities": []}], ["Further revealed that BBR abrogated HG-induced EMT and oxidative stress in relation not only with the activation of Nrf2 and two Nrf2-targeted antioxidative genes (NQO-1 and HO-1), but also with the suppressing the activation of TGF-\u03b2/Smad signaling pathway.", {"entities": []}], ["Importantly, knockdown Nrf2 with siRNA not only abolished the BBR-induced expression of HO-1 and NQO-1 but also removed the inhibitory effect of BBR on HG-induced activation of TGF-\u03b2/Smad signaling as well as the anti-fibrosis effects.", {"entities": []}], ["The data from present study suggest that BBR can ameliorate tubulointerstitial fibrosis in DN by activating Nrf2 pathway and inhibiting TGF-\u03b2/Smad/EMT signaling activity.", {"entities": []}], ["To evaluate the clinical evolution and the association between nutritional status and severity of asthma in children and adolescents enrolled in Primary Health Care.", {"entities": [[98, 104, "DISEASE"]]}], ["A retrospective cohort study of 219 asthmatic patients (3-17 years old) enrolled in Primary Care Services (PCSs) in Embu das Artes (SP), from 2007 to 2011.", {"entities": []}], ["Secondary data: gender, age, diagnosis of asthma severity, other atopic diseases, family history of atopy, and body mass index.", {"entities": [[42, 48, "DISEASE"]]}], ["To evaluate the clinical outcome of asthma, data were collected on number of asthma exacerbations, number of emergency room consultations and doses of inhaled corticosteroids at follow-up visits in the 6th and 12th months.", {"entities": [[36, 42, "DISEASE"], [77, 83, "DISEASE"]]}], ["The statistical analysis included chi-square and Kappa agreement index, with 5% set as the significance level.", {"entities": []}], ["50.5% of patients started wheezing before the age of 2 years, 99.5% had allergic rhinitis and 65.2% had a positive family history of atopy.", {"entities": [[72, 89, "DISEASE"], [81, 89, "DISEASE"]]}], ["Regarding severity, intermittent asthma was more frequent (51.6%) and, in relation to nutritional status, 65.8% of patients had normal weight.", {"entities": [[33, 39, "DISEASE"]]}], ["There was no association between nutritional status and asthma severity ( p =0.409).", {"entities": [[56, 62, "DISEASE"]]}], ["After 1 year of follow-up, 25.2% of patients showed reduction in exacerbations and emergency room consultations, and 16.2% reduced the amount of inhaled corticosteroids.", {"entities": []}], ["The monitoring of asthmatic patients in Primary Care Services showed improvement in clinical outcome, with a decreased number of exacerbations, emergency room consultations and doses of inhaled corticosteroids.", {"entities": []}], ["No association between nutritional status and asthma severity was observed in this study.", {"entities": [[46, 52, "DISEASE"]]}], ["Avaliar a evolu\u00e7\u00e3o cl\u00ednica e a associa\u00e7\u00e3o entre o estado nutricional e a gravidade da asma em crian\u00e7as e adolescentes matriculados em Unidades B\u00e1sicas de Sa\u00fade (UBS).", {"entities": []}], ["Estudo de coorte retrospectiva com 219 pacientes asm\u00e1ticos (3-17 anos), matriculados em UBS do munic\u00edpio de Embu das Artes (SP), de 2007 a 2011.", {"entities": []}], ["Dados secund\u00e1rios: sexo, idade, diagn\u00f3stico de gravidade da asma, outras atopias, antecedentes familiares de atopia, \u00edndice de massa corporal.", {"entities": []}], ["Para avaliar a evolu\u00e7\u00e3o da asma foram coletados n\u00famero de crises de asma, n\u00famero de atendimentos de urg\u00eancia e doses de corticoide inalat\u00f3rio no 6\u00b0 e 12\u00b0 m\u00eas de acompanhamento.", {"entities": []}], ["A an\u00e1lise estat\u00edstica incluiu testes de qui-quadrado e \u00edndice de concord\u00e2ncia Kappa, com n\u00edvel de signific\u00e2ncia de 5%.", {"entities": []}], ["Dos pacientes, 50,5% iniciaram a sibil\u00e2ncia antes dos dois anos; 99,5% apresentaram rinite al\u00e9rgica e 65,2% antecedente familiar para atopia positivo.", {"entities": []}], ["Quanto \u00e0 gravidade, a asma intermitente foi mais frequente (51,6%); em rela\u00e7\u00e3o ao estado nutricional, 65,8% dos pacientes eram eutr\u00f3ficos.", {"entities": []}], ["N\u00e3o houve associa\u00e7\u00e3o entre o estado nutricional e a gravidade da asma ( p =0,409).", {"entities": []}], ["Ap\u00f3s um ano de acompanhamento, 25,2% dos pacientes reduziram as exacerba\u00e7\u00f5es e os atendimentos nas urg\u00eancias e 16,2% reduziram a quantidade de corticoide inalat\u00f3rio.", {"entities": []}], ["O acompanhamento dos pacientes asm\u00e1ticos em UBS demonstrou melhoria da evolu\u00e7\u00e3o com redu\u00e7\u00e3o do n\u00famero de exacerba\u00e7\u00f5es, dos atendimentos nas urg\u00eancias e das doses de corticoide inalat\u00f3rio.", {"entities": []}], ["N\u00e3o houve associa\u00e7\u00e3o entre o estado nutricional e gravidade da asma.", {"entities": []}], ["The apparent high number of deaths in Argentina during the 2009 pandemic led to concern that the influenza A H1N1pdm disease was different there.", {"entities": [[97, 106, "DISEASE"]]}], ["We report the characteristics and risk factors for influenza A H1N1pdm fatalities.", {"entities": [[51, 60, "DISEASE"]]}], ["We identified laboratory-confirmed influenza A H1N1pdm fatalities occurring during June-July 2009.", {"entities": [[35, 44, "DISEASE"]]}], ["Physicians abstracted data on age, sex, time of onset of illness, medical history, clinical presentation at admission, laboratory, treatment, and outcomes using standardize questionnaires.", {"entities": []}], ["We explored the characteristics of fatalities according to their age and risk group.", {"entities": []}], ["Of 332 influenza A H1N1pdm fatalities, 226 (68%) were among persons aged <50 years.", {"entities": [[7, 16, "DISEASE"]]}], ["Acute respiratory failure was the leading cause of death.", {"entities": [[6, 25, "DISEASE"]]}], ["Of all cases, 249 (75%) had at least one comorbidity as defined by Advisory Committee on Immunization Practices.", {"entities": []}], ["Obesity was reported in 32% with data and chronic pulmonary disease in 28%.", {"entities": []}], ["Among the 40 deaths in children aged <5 years, chronic pulmonary disease (42%) and neonatal pathologies (35%) were the most common co-morbidities.", {"entities": []}], ["Twenty (6%) fatalities were among pregnant or postpartum women of which only 47% had diagnosed co-morbidities.", {"entities": []}], ["Only 13% of patients received antiviral treatment within 48 hours of symptom onset.", {"entities": []}], ["None of children aged <5 years or the pregnant women received antivirals within 48 h of symptom onset.", {"entities": []}], ["As the pandemic progressed, the time from symptom-onset to medical care and to antiviral treatment decreased significantly among case-patients who subsequently died (p<0.001).", {"entities": []}], ["Persons with co-morbidities, pregnant and who received antivirals late were over-represented among influenza A H1N1pdm deaths in Argentina, though timeliness of antiviral treatment improved during the pandemic.", {"entities": [[99, 108, "DISEASE"]]}], ["Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto\u2010sino\u2010pulmonary disease in both children and adults.", {"entities": [[70, 82, "DISEASE"]]}], ["Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods.", {"entities": []}], ["Thus far, all therapies used for PCD are unproven through large clinical trials.", {"entities": []}], ["This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years.", {"entities": []}], ["These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long\u2010term therapeutics in PCD patients.", {"entities": []}], ["Pediatr Pulmonol.", {"entities": []}], ["2016;51:115\u2013132 .", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Pediatric Pulmonology Published by Wiley Periodicals, Inc.", {"entities": []}], ["We evaluated the effects of previous pulmonary tuberculosis (TB) on the risk of obstructive lung disease.", {"entities": [[80, 104, "DISEASE"], [47, 59, "DISEASE"], [37, 59, "DISEASE"], [92, 104, "DISEASE"]]}], ["We analyzed population-based, the Second Korea National Health and Nutrition Examination Survey 2001.", {"entities": []}], ["Participants underwent chest X-rays (CXR) and spirometry, and qualified radiologists interpreted the presence of TB lesion independently.", {"entities": []}], ["A total of 3,687 underwent acceptable spirometry and CXR.", {"entities": []}], ["Two hundreds and ninty four subjects had evidence of previous TB on CXR with no subjects having evidence of active disease.", {"entities": []}], ["Evidence of previous TB on CXR were independently associated with airflow obstruction (adjusted odds ratios [OR] = 2.56 [95% CI 1.84-3.56]) after adjustment for sex, age and smoking history.", {"entities": []}], ["Previous TB was still a risk factor (adjusted OR = 3.13 [95% CI 1.86-5.29]) with exclusion of ever smokers or subjects with advanced lesion on CXR.", {"entities": []}], ["Among never-smokers, the proportion of subjects with previous TB on CXR increased as obstructive lung disease became more severe.", {"entities": [[85, 109, "DISEASE"], [97, 109, "DISEASE"]]}], ["Previous TB is an independent risk factor for obstructive lung disease, even if the lesion is minimal and TB can be an important cause of obstructive lung disease in never-smokers.", {"entities": [[46, 70, "DISEASE"], [138, 162, "DISEASE"], [58, 70, "DISEASE"], [150, 162, "DISEASE"]]}], ["Effort on prevention and control of TB is crucial in reduction of obstructive lung disease, especially in countries with more than intermediate burden of TB.", {"entities": [[66, 90, "DISEASE"], [78, 90, "DISEASE"]]}], ["Macrophages are essential to maintaining lung homoeostasis and recent work has demonstrated that influenza-infected lung macrophages downregulate their expression of the scavenger receptor CD36.", {"entities": [[97, 106, "DISEASE"], [189, 193, "GENE"]]}], ["This receptor has also been shown to be involved in phagocytosis of Streptococcus pneumoniae , a primary agent associated with pneumonia secondary to viral infection.", {"entities": [[127, 136, "DISEASE"]]}], ["The aim of this study was to investigate the role of CD36 in the effects of viral infection on macrophage phagocytic function.", {"entities": [[53, 57, "GENE"]]}], ["Human monocyte-derived macrophages (MDM) were exposed to H3N2 X31 influenza virus, M37 respiratory syncytial virus (RSV) or UV-irradiated virus.", {"entities": [[66, 75, "DISEASE"]]}], ["No infection of MDM was seen upon exposure to UV-irradiated virus but incubation with live X31 or M37 resulted in significant levels of viral detection by flow cytometry or RT-PCR respectively.", {"entities": []}], ["Infection resulted in significantly diminished uptake of S .", {"entities": []}], ["pneumoniae by MDM and significantly decreased expression of CD36 at both the cell surface and mRNA level.", {"entities": [[60, 64, "GENE"]]}], ["Concurrently, there was a significant increase in IFN\u03b2 gene expression in response to infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFN\u03b2.", {"entities": [[177, 181, "GENE"]]}], ["Knockdown of CD36 by siRNA resulted in decreased phagocytosis, but this was mimicked by transfection reagent alone.", {"entities": [[13, 17, "GENE"]]}], ["When MDM were incubated with CD36 blocking antibodies no effect on phagocytic ability was observed.", {"entities": [[29, 33, "GENE"]]}], ["These data indicate that autologous IFN\u03b2 production by virally-infected cells can inhibit bacterial phagocytosis, but that decreased CD36 expression by these cells does not play a major role in this functional deficiency.", {"entities": [[133, 137, "GENE"]]}], ["Variations in gene expression level might lead to phenotypic diversity across individuals or populations.", {"entities": []}], ["Although many human genes are found to have differential mRNA levels between populations, the extent of gene expression that could vary within and between populations largely remains elusive.", {"entities": []}], ["To investigate the dynamic range of gene expression, we analyzed the expression variability of \u223c18, 000 human genes across individuals within HapMap populations.", {"entities": []}], ["Although \u223c20% of human genes show differentiated mRNA levels between populations, our results show that expression variability of most human genes in one population is not significantly deviant from another population, except for a small fraction that do show substantially higher expression variability in a particular population.", {"entities": []}], ["By associating expression variability with sequence polymorphism, intriguingly, we found SNPs in the untranslated regions (5\u2032 and 3\u2032UTRs) of these variable genes show consistently elevated population heterozygosity.", {"entities": []}], ["We performed differential expression analysis on a genome-wide scale, and found substantially reduced expression variability for a large number of genes, prohibiting them from being differentially expressed between populations.", {"entities": []}], ["Functional analysis revealed that genes with the greatest within-population expression variability are significantly enriched for chemokine signaling in HIV-1 infection, and for HIV-interacting proteins that control viral entry, replication, and propagation.", {"entities": []}], ["This observation combined with the finding that known human HIV host factors show substantially elevated expression variability, collectively suggest that gene expression variability might explain differential HIV susceptibility across individuals.", {"entities": []}], ["Many human genes have population-specific expression levels, which are linked to population-specific polymorphisms and copy-number variations.", {"entities": []}], ["However, it is unclear whether human genes show similar dynamic range of expression between populations.", {"entities": []}], ["In this work we analyzed HapMap gene expression compendium, and quantified the between-population and within-population expression variability for \u223c18,000 human transcripts.", {"entities": []}], ["We first concluded that the majority of the human genes have similar levels of within-population variability.", {"entities": []}], ["However, a small fraction (\u223c4%) does show much higher expression variability in one population, and the deviation is consistently associated with increased SNP heterozygosity in their UTR regulatory regions.", {"entities": []}], ["We further showed that genes with the greatest within-population expression variability are significantly enriched for chemokine signaling associated with HIV-1 infection.", {"entities": []}], ["Combined with the finding that human HIV-1 host factors tend to have increased expression variability within populations, our analysis may explain, at least in part, different susceptibility to HIV infection within the human population.", {"entities": []}], ["This work provides a fresh angle for analyzing gene expression variations in populations.", {"entities": []}], ["This study evaluated the safety and efficacy of onabotulinumtoxinA in Japanese subjects with crow\u2019s feet lines (CFL).", {"entities": []}], ["This phase 3, multicenter, double-blind, randomized study included 2 treatment periods: 6-month placebo-controlled period followed by a 7-month open-label period.", {"entities": []}], ["In period 1, subjects with moderate to severe CFL received onabotulinumtoxinA 24 U ( n \u00a0 = \u00a0104) or 12 U ( n \u00a0 = \u00a099), or placebo ( n \u00a0 = \u00a097).", {"entities": []}], ["In period 2, placebo subjects switched to onabotulinumtoxinA 24 U or 12 U (double-blind dose).", {"entities": []}], ["Up to 5 total treatments were permitted for subjects meeting re-treatment criteria.", {"entities": []}], ["The primary efficacy measure was the proportion of investigator-assessed responders (achieving CFL severity of none or mild at maximum smile using the Facial Wrinkle Scale with Asian Photonumeric Guide [FWS-A] at day 30 of treatment 1).", {"entities": []}], ["Additional endpoints included other responders (achieving at least 1-grade improvement at maximum smile and at rest using the FWS-A at day 30), responders at other time points, duration of effect, subject-reported outcomes, and safety.", {"entities": []}], ["All efficacy endpoints were met.", {"entities": []}], ["At day 30, the proportion of subjects achieving none or mild severity at maximum smile was significantly greater ( P \u00a0<\u00a00.001) in the onabotulinumtoxinA 24 and 12 U groups (68.3 and 56.6%, respectively) compared with the placebo group (8.2%).", {"entities": []}], ["Efficacy results were consistent over repeated treatments, and subjects\u2019 self-assessed outcomes were similar to investigator-assessed results.", {"entities": []}], ["Treatment with onabotulinumtoxinA 24 and 12 U improved the appearance of CFL in Japanese subjects and was well tolerated, with no new safety findings.", {"entities": []}], ["This journal requires that authors assign a level of evidence to each article.", {"entities": []}], ["For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .", {"entities": []}], ["Many studies have found an increased risk of venous thromboembolism (VTE) associated with the use of combined hormonal contraceptives, but various methodologies have been used in the study design relating to definition of VTE event and the selection of appropriate cases for analysis.", {"entities": []}], ["This study will focus on common oral hormonal contraceptives, including compositions with cyproterone because of their contraceptive effect and will perform a number of sensitivity analyses to compare findings with previous studies.", {"entities": []}], ["2 nested case\u2013control studies will be based on the general population using records from UK general practices within the QResearch and Clinical Practice Research Datalink databases.", {"entities": []}], ["Cases will be female patients aged 15\u201349 with primary VTE diagnosed between 2001 and 2013.", {"entities": []}], ["Each case will be matched by age, year of birth and practice to five female controls, who are alive and registered with the practice at the time of diagnosis of the case (index date).", {"entities": []}], ["Exposure to different hormonal contraceptives will be defined as at least one prescription for that contraceptive in the year before the index date.", {"entities": []}], ["The effects of duration and the length of any gap since last use will also be investigated.", {"entities": []}], ["Conditional logistic regression will be applied to calculate ORs adjusted for smoking, ethnicity, comorbidities and use of other medications.", {"entities": []}], ["Possible indications for prescribing hormonal contraceptives, such as menstrual disorders, acne or hirsutism will be included in the analyses as confounding factors.", {"entities": [[91, 95, "DISEASE"]]}], ["A number of sensitivity analyses will be carried out.", {"entities": []}], ["The initial protocol has been reviewed and approved by ISAC (Independent Scientific Advisory Committee) for Medicine and Healthcare Products Regulatory Agency Database Research.", {"entities": []}], ["The project has also been reviewed by QResearch and meets the requirements of the Trent Research Ethics Committee.", {"entities": []}], ["The results will be published in a peer-reviewed journal.", {"entities": []}], ["Macrophages are among the most abundant cells in the respiratory tract, and they can have strikingly different phenotypes within this environment.", {"entities": []}], ["Our knowledge of the different phenotypes and their functions in the lung is sketchy at best, but they appear to be linked to the protection of gas exchange against microbial threats and excessive tissue responses.", {"entities": []}], ["Phenotypical changes of macrophages within the lung are found in many respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.", {"entities": [[109, 146, "DISEASE"], [159, 177, "DISEASE"], [101, 107, "DISEASE"]]}], ["This paper will give an overview of what macrophage phenotypes have been described, what their known functions are, what is known about their presence in the different obstructive and restrictive respiratory diseases (asthma, COPD, pulmonary fibrosis), and how they are thought to contribute to the etiology and resolution of these diseases.", {"entities": [[232, 250, "DISEASE"], [218, 224, "DISEASE"]]}], ["This study is motivated by National Household Surveys that collect genetic data, in which complex samples (e.g.", {"entities": []}], ["stratified multistage cluster sample), partially from the same family, are selected.", {"entities": []}], ["In addition to the differential selection probabilities of selecting households and persons within the sampled households, there are two levels of correlations of the collected genetic data in National Genetic Household Surveys (NGHS).", {"entities": []}], ["The first level of correlation is induced by the hierarchical geographic clustered sampling of households and the second level of correlation is induced by biological inheritances from individuals sampled in the same household.", {"entities": []}], ["To test for Hardy-Weinberg Equilibrium (HWE) in NGHS, two test statistics, the CCS method [1] and the QS method [2], appear to be the only existing methods that take account of both correlations.", {"entities": [[79, 82, "GENE"]]}], ["In this paper, I evaluate both methods in terms of the test size and power under a variety of complex designs with different weighting schemes and varying magnitudes of the two correlation effects.", {"entities": []}], ["Both methods are applied to a real data example from the Hispanic Health and Nutrition Examination Survey with simulated genotype data.", {"entities": []}], ["The QS method maintains the nominal size well and consistently achieves higher power than the CCS method in testing HWE under a variety of sample designs, and therefore is recommended for testing HWE of genetic survey data with complex designs.", {"entities": [[94, 97, "GENE"]]}], ["Past research has suggested significant relationships between symptoms and health outcomes among patients with COPD.", {"entities": []}], ["However, these studies have generally focused on a broad COPD sample and may have included those not receiving proper treatment.", {"entities": []}], ["As a result, the aim of this study was to document the burden of COPD symptoms among those who are currently treated with the standard-of-care (SOC) medications in both the US and Western Europe.", {"entities": []}], ["Data from the 2013 US (N=75,000) and 2011 (N=57,512)/2013 (N=62,000) European (France, Germany, Italy, Spain, and UK; 5EU) National Health and Wellness Survey (NHWS) were used.", {"entities": []}], ["The NHWS is a health survey administered to a demographically representative sample of the adult population in each country.", {"entities": []}], ["A total of 1,666 and 2,006 patients with self-reported physician diagnosis of COPD in the 5EU and US, respectively, were being treated with the appropriate SOC (based on self-reported medication use) and were included in the analyses.", {"entities": []}], ["Symptoms (eg, dyspnea, coughing, wheezing) were reported descriptively and summed to create a symptom score (with higher score indicating more frequent symptoms).", {"entities": []}], ["The relationships between the symptom score and patient outcomes (eg, health status using the Short Form-36 version 2 [SF-36v2], work productivity and activity impairment [WPAI], and self-reported health care resource use) were explored using regression modeling.", {"entities": []}], ["Nearly all patients (99.7% and 99.8% in the 5EU and US, respectively) reported experiencing symptoms and >80% reported experiencing at least one symptom \u201coften\u201d.", {"entities": []}], ["Increasing symptom scores were associated with poorer health status (unstandardized beta [ b ] =\u22120.87 and \u22120.78 for mental component summary and physical component summary, respectively, in the US and b =\u22120.67 and \u22120.79 in the 5EU, respectively; all P <0.05).", {"entities": []}], ["Increasing symptom scores were also associated with greater work impairment ( b =0.09 and 0.06 for the US and 5EU, respectively), activity impairment ( b =0.05 and 0.06, respectively), and health care resource utilization (eg, hospitalizations: b =0.05 and 0.06, respectively) (all P <0.05).", {"entities": []}], ["Approximately 70% of patients reported some level of non-adherence.", {"entities": []}], ["Greater non-adherence was significantly associated with more frequent symptoms, poorer health status, and greater work impairment and health care resource use (all P <0.05).", {"entities": []}], ["Patients with COPD who are using the appropriate SOC still experience symptoms, which have a significant effect on both humanistic and economic outcomes.", {"entities": []}], ["The purpose of this study is to investigate and analyze the traditional knowledge of medicinal plants used by residents in Gayasan National Park in order to obtain basic data regarding the sustainable conservation of its natural plant ecosystem.", {"entities": []}], ["Data was collected using participatory observations and in-depth interviews, as the informants also become investigators themselves through attending informal meetings, open and group discussions, and overt observations with semi-structured questionnaires.", {"entities": []}], ["Quantitative analyses were accomplished through the informant consensus factor (ICF), fidelity level, and inter-network analysis (INA).", {"entities": [[130, 133, "GENE"]]}], ["In total, 200 species of vascular plants belonging to 168 genera and 87 families were utilized traditionally in 1,682 ethnomedicianal practices.", {"entities": []}], ["The representative families were Rosaceae (6.5%) followed by Asteraceae (5.5%), Poaceae (4.5%), and Fabaceae (4.0%).", {"entities": []}], ["On the whole, 27 kinds of plant-parts were used and prepared in 51 various ways by the residents for medicinal purposes.", {"entities": []}], ["The ICF values in the ailment categories were muscular-skeletal disorders (0.98), pains (0.97), respiratory system disorders (0.97), liver complaints (0.97), and cuts and wounds (0.96).", {"entities": []}], ["In terms of fidelity levels, 57 plant species showed fidelities levels of 100%.", {"entities": []}], ["Regarding the inter-network analysis (INA) between ailments and medicinal plants within all communities of this study, the position of ailments is distributed into four main groups.", {"entities": [[38, 41, "GENE"]]}], ["The results of the inter-network analysis will provide a suitable plan for sustainable preservation of the national park through a continued study of the data.", {"entities": []}], ["Particular species of medicinal plants need to be protected for a balanced plant ecosystem within the park.", {"entities": []}], ["Consequently, through further studies using these results, proper steps need to be established for preparing a wise alternative to create a sustainable natural plant ecosystem for Gayasan National Park and other national parks.", {"entities": []}], ["To evaluate the technical feasibility, performance, and interobserver agreement of a computer-aided classification (CAC) system for regional ventilation at two-phase xenon-enhanced CT in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[201, 238, "DISEASE"]]}], ["Thirty-eight patients with COPD underwent two-phase xenon ventilation CT with resulting wash-in (WI) and wash-out (WO) xenon images.", {"entities": []}], ["The regional ventilation in structural abnormalities was visually categorized into four patterns by consensus of two experienced radiologists who compared the xenon attenuation of structural abnormalities with that of adjacent normal parenchyma in the WI and WO images, and it served as the reference.", {"entities": []}], ["Two series of image datasets of structural abnormalities were randomly extracted for optimization and validation.", {"entities": []}], ["The proportion of agreement on a per-lesion basis and receiver operating characteristics on a per-pixel basis between CAC and reference were analyzed for optimization.", {"entities": []}], ["Thereafter, six readers independently categorized the regional ventilation in structural abnormalities in the validation set without and with a CAC map.", {"entities": []}], ["Interobserver agreement was also compared between assessments without and with CAC maps using multirater \u03ba statistics.", {"entities": []}], ["Computer-aided classification maps were successfully generated in 31 patients (81.5%).", {"entities": []}], ["The proportion of agreement and the average area under the curve of optimized CAC maps were 94% (75/80) and 0.994, respectively.", {"entities": []}], ["Multirater \u03ba value was improved from moderate (\u03ba = 0.59; 95% confidence interval [CI], 0.56-0.62) at the initial assessment to excellent (\u03ba = 0.82; 95% CI, 0.79-0.85) with the CAC map.", {"entities": []}], ["Our proposed CAC system demonstrated the potential for regional ventilation pattern analysis and enhanced interobserver agreement on visual classification of regional ventilation.", {"entities": []}], ["Aspergillus spp .", {"entities": []}], ["can lead to allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitisation and Aspergillus bronchitis in CF.", {"entities": [[38, 51, "DISEASE"], [12, 51, "DISEASE"], [102, 112, "DISEASE"]]}], ["The relative frequencies of these entities have recently been ascertained in a large UK adult CF cohort.", {"entities": []}], ["We have used this data to estimate the burden of aspergillosis and ABPA cases in adult CF patients in 30 countries reporting CF.", {"entities": [[49, 62, "DISEASE"]]}], ["National and international CF registry data was accessed and assessed for completeness and age distribution.", {"entities": []}], ["Published proportions of ABPA (17.7%), Aspergillus sensitisation (14.6%) and Aspergillus bronchitis (30%) in CF were applied to those >18 years and compared with notified ABPA cases.", {"entities": [[89, 99, "DISEASE"]]}], ["Of the 76,201 estimated CF patients worldwide (not including India), 37,714 were >18 years.", {"entities": []}], ["The proportion of adults to children varied from 63% in Norway to 20% in Brazil.", {"entities": []}], ["ABPA caseload in adults is anticipated to be 6,675 cases of which only 2,221 cases (33%) are currently recorded, indicating substantial underdiagnosis.", {"entities": []}], ["The ABPA diagnosis rate compared with estimated rates varies by country from 101% (France) to 14.5% (Greece), although genetic variation could account for genuine differences compared with the UK.", {"entities": []}], ["Aspergillus bronchitis is not currently recognised or recorded in CF registries but there are an anticipated 10,988 adult cases.", {"entities": [[12, 22, "DISEASE"]]}], ["Aspergillus sensitisation, associated with increased bronchiectasis and reduced FEV1, affects an anticipated 5,506 patients without ABPA or Aspergillus bronchitis.", {"entities": [[53, 67, "DISEASE"], [152, 162, "DISEASE"]]}], ["Together ABPA and Aspergillus bronchitis are estimated to affect 17,989 adults, 47.7% of the adult CF population.", {"entities": [[30, 40, "DISEASE"]]}], ["ABPA also occurs in children and teenagers and 984 cases were documented in registries.", {"entities": []}], ["Diagnosed ABPA rates by age were available for the ECFS registry, USA, UK, Ireland, Belgium and Netherlands.", {"entities": []}], ["The rate was <1% under 4 years, and increased throughout childhood and adolescence, with marked variation between countries.", {"entities": []}], ["Newly published diagnostic criteria and methods should facilitate better recognition of aspergillosis in CF, allowing better CF disease control.", {"entities": [[88, 101, "DISEASE"]]}], ["Bcl I in the promoter polymorphism observed within h - GR/NR3C1 gene may play an important role in the development of bronchial asthma and resistance to GCs in the severe bronchial asthma.", {"entities": [[128, 134, "DISEASE"], [181, 187, "DISEASE"]]}], ["The aim of the investigation was to study the correlation between this h - GR/NR3C1 gene polymorphism and occurrence of asthma in the population of Polish asthmatics.", {"entities": [[120, 126, "DISEASE"]]}], ["Peripheral blood was obtained from 70 healthy volunteers and 59 asthma patients.", {"entities": [[64, 70, "DISEASE"]]}], ["Structuralized anamnesis, spirometry and allergy skin prick tests were performed in all participants.", {"entities": []}], ["Genotyping was carried out with PCR\u2013RFLP method.", {"entities": []}], ["In healthy, non-atopic population variants of Bcl I : GG, GC, CC were found with frequency 0.129/0.471/0.400, respectively.", {"entities": [[58, 60, "GENE"]]}], ["In asthma patients Bcl I: GG, GC, CC occurred with respective frequencies of 0.410/0.462/0.128.", {"entities": [[3, 9, "DISEASE"], [30, 32, "GENE"]]}], ["Chi-square analysis revealed a significantly different ( P \u00a0<\u00a00.05) distribution between cases and controls for the Bcl I polymorphism.", {"entities": []}], ["The Bcl I polymorphism of h - GR/NR3C1 gene is significantly associated with bronchial asthma, susceptibility to the development of severe form and resistance to GCs in Polish population.", {"entities": [[87, 93, "DISEASE"]]}], ["Meat is considered as a major source of polyunsaturated fatty acid (PUFA) which is essential for humans, therefore its lipid level and fatty acid composition have drawn great attention.", {"entities": []}], ["As no clinical sign can be found in chicks subclinically infected by Clostridium perfringens (CP), the meat may be purchased and eaten.", {"entities": [[94, 96, "GENE"]]}], ["The objective of the present study was to determine whether Lactobacillus johnsonii (LJ) can control the CP-caused impact on growth, lipid levels, fatty acid composition and other flavor or nutritional quality in the meat.", {"entities": []}], ["480 one-day-old chicks were divided into four groups and fed with basal diet (control and CP group).", {"entities": [[90, 92, "GENE"]]}], ["Supplemented with 1\u2009\u00d7\u200910 LJ-treated chickens were free from negative influences on growth performance and significant decrease of abdominal fat deposit., LJ inhibited CP-caused shearing force and drip loss increase and pH\u00a040\u00a0min and 24\u00a0h decrease after sacrifice.", {"entities": []}], ["In addition, LJ exhibited a positive effect on muscle lipid peroxidation by significantly increasing SOD, CAT and GSH-Px activity and decreasing MDA level.", {"entities": []}], ["Besides, LJ attenuated the decrease of intramuscular fat, total cholesterol and triglyceride contents caused by CP infection.", {"entities": [[112, 114, "GENE"]]}], ["However, levels of total protein and most of amino acids were not changed.", {"entities": []}], ["CP infection decreased C18:3n-3 (\u03b1-LA), C20:4n-6, C20:5n-3(EPA), C22:4n-6, C22:5n-3, C22:6n-3(DHA), total PUFA, n-3 PUFA and PUFA:SFA ratio and increased C14:0, total SFA and n-6:n-3 ratio.", {"entities": [[0, 2, "GENE"]]}], ["LJ was found to protect the muscle from these changes.", {"entities": []}], ["Meanwhile, the 28-day gut permeability level was higher in CP group.", {"entities": [[59, 61, "GENE"]]}], ["These findings suggest that CP may affect the growth performance of chicks and negatively influence lipid content and fatty acid composition in chicken meat.", {"entities": [[28, 30, "GENE"]]}], ["Meanwhile, LJ treatment may be effective in controlling these changes by reducing the increased gut permeability caused by CP subclinical infection.", {"entities": [[123, 125, "GENE"]]}], ["To guide clinicians in selecting treatment options for esophageal squamous cell carcinoma (ESCC) patients, reliable markers predictive of clinical outcome are desirable.", {"entities": [[80, 89, "DISEASE"], [66, 89, "DISEASE"]]}], ["This study analyzed the correlation of cyclophilin A (CypA) and matrix metalloproteinase 9 (MMP9) in ESCC and their relationships to clinicopathological features and survival.", {"entities": [[92, 96, "GENE"]]}], ["We immunohistochemically investigated 70 specimens of ESCC tissues using CypA and MMP9 antibodies.", {"entities": [[82, 86, "GENE"]]}], ["Then, the correlations between CypA and MMP9 expression and clinicopathological features and its prognostic relevance were determined.", {"entities": [[40, 44, "GENE"]]}], ["Significant correlations were only found in high level of CypA and MMP9 expression with tumor differentiation and lymph node status.", {"entities": [[67, 71, "GENE"]]}], ["Significant positive correlations were found between the expression status of CypA and that of MMP9.", {"entities": [[95, 99, "GENE"]]}], ["Overexpression of CypA and metastasis were significantly associated with shorter progression free survival times in univariate analysis.", {"entities": []}], ["Multivariate analysis confirmed that CypA expression was an independent prognostic factor.", {"entities": []}], ["CypA might be correlated with the differentiation, and its elevated expression may be an adverse prognostic indicator for the patients of ESCC.", {"entities": []}], ["CypA/MMP9 signal pathway may be attributed to the malignant transformation of ESCC, and attention should be paid to a possible target for therapy.", {"entities": []}], ["The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1166551968105508 .", {"entities": []}], ["Most heart diseases are associated with and reflected by the sounds that the heart produces.", {"entities": []}], ["Heart auscultation, defined as listening to the heart sound, has been a very important method for the early diagnosis of cardiac dysfunction.", {"entities": []}], ["Traditional auscultation requires substantial clinical experience and good listening skills.", {"entities": []}], ["The emergence of the electronic stethoscope has paved the way for a new field of computer-aided auscultation.", {"entities": []}], ["This article provides an in-depth study of (1) the electronic stethoscope technology, and (2) the methodology for diagnosis of cardiac disorders based on computer-aided auscultation.", {"entities": []}], ["The paper is based on a comprehensive review of (1) literature articles, (2) market (state-of-the-art) products, and (3) smartphone stethoscope apps.", {"entities": []}], ["It covers in depth every key component of the computer-aided system with electronic stethoscope, from sensor design, front-end circuitry, denoising algorithm, heart sound segmentation, to the final machine learning techniques.", {"entities": []}], ["Our intent is to provide an informative and illustrative presentation of the electronic stethoscope, which is valuable and beneficial to academics, researchers and engineers in the technical field, as well as to medical professionals to facilitate its use clinically.", {"entities": []}], ["The paper provides the technological and medical basis for the development and commercialization of a real-time integrated heart sound detection, acquisition and quantification system.", {"entities": []}], ["The pathophysiology of diverticulitis is poorly understood.", {"entities": [[23, 37, "DISEASE"]]}], ["Factors such as physical inactivity, constipation, obesity, smoking, and the use of nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with an increased risk of diverticular disease.", {"entities": [[37, 49, "DISEASE"], [51, 58, "DISEASE"]]}], ["To evaluate whether patients exhibiting long-term steroid use are at increased risk of colonic diverticulitis.", {"entities": [[95, 109, "DISEASE"]]}], ["We conducted a population-based, nested case\u2013control study.", {"entities": []}], ["Data were retrospectively collected from the National Health Insurance Research Database.", {"entities": []}], ["The study cohort comprised patients diagnosed with diverticulitis, identified using inpatient discharge records using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes (562.11 and 562.13), and those who were administered one or more prescriptions for corticosteroids for systemic use.", {"entities": [[51, 65, "DISEASE"]]}], ["Control patients were matched to cases by age, sex, NSAID use, laxative drug use, and index date.", {"entities": []}], ["We enrolled 690 patients with colonic diverticulitis and 2760 in the control group.", {"entities": [[38, 52, "DISEASE"]]}], ["The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression.", {"entities": []}], ["Compared with steroid nonusers, the adjusted ORs were 0.60 (95% CI\u2009=\u20090.35\u20131.06) and 0.80 (95% CI\u2009=\u20090.64\u20131.008) in current steroid users and previous steroid users, respectively.", {"entities": []}], ["In addition, the adjusted ORs were 0.55 (95% CI\u2009=\u20090.31\u20130.98), 0.57 (95% CI\u2009=\u20090.31\u20130.98), and 0.44 (95% CI\u2009=\u20090.22\u20130.86) for steroid use duration more than half time by an exposure period of 90 days, 180 days, and 365 days before the claim date of colonic diverticulitis, respectively.", {"entities": [[254, 268, "DISEASE"]]}], ["The results indicated that long-term steroid use within one year is associated with lower risk of colonic diverticulitis.", {"entities": [[106, 120, "DISEASE"]]}], ["Strong evidence supports the existence of Health Barriers to Learning (HBLs)\u2014health conditions that when untreated or unmanaged can interfere with a child\u2019s ability to learn and succeed in school.", {"entities": []}], ["These HBLs include vision and hearing deficits, uncontrolled asthma, mental and behavioral problems, dental pain, persistent hunger, and the effects of lead exposure.", {"entities": [[61, 67, "DISEASE"]]}], ["However, 19% of US children aged 6 to 11 did not receive their annual checkup in the past year.", {"entities": []}], ["School requirements for health screenings can help identify children with HBLs.", {"entities": []}], ["This study explores which states require health screening for children in elementary school, and the extent to which the 7 HBLs are included.", {"entities": []}], ["Investigators reviewed websites of state departments of health and education, and legislation for all 50 states and DC.", {"entities": []}], ["For states with mandated screenings and a required form, investigators applied structured analysis to assess HBL inclusion.", {"entities": []}], ["No state mandated that schools require screening for all 7 HBLs.", {"entities": []}], ["Less than half (49%) required comprehensive school health examinations and only 12 states plus DC required a specific form.", {"entities": []}], ["Of these, 12 of the forms required documentation of vision screening, 11 of hearing screening, and 12 of dental screening.", {"entities": []}], ["Ten forms asked about asthma and 9 required documentation of lead testing.", {"entities": [[22, 28, "DISEASE"]]}], ["Seven asked about general well-being, emotional problems, or mental health.", {"entities": []}], ["None addressed hunger.", {"entities": []}], ["When including states without comprehensive school health examination requirements, the most commonly required HBL screenings were for vision (80% of states; includes DC), hearing (75% of states; includes DC) and dental (24% of state; includes DC).", {"entities": []}], ["The lack of state mandated requirements for regular student health screening represents a missed opportunity to identify children with HBLs.", {"entities": []}], ["Without state mandates, accompanying comprehensive forms, and protocols, children continue to be at risk of untreated health conditions that can undermine their success in school.", {"entities": []}], ["The objective of this study is to provide details on probiotic supplement use among young children in Taiwan.", {"entities": []}], ["This study is based on the Taiwan Birth Cohort Study database.", {"entities": []}], ["We used questionnaires to collect information on probiotic supplement use among young children from birth to 18 months of age, while also considering their demographic characteristics and other covariates.", {"entities": []}], ["Low-birth-weight infants, preterm infants, those with birth defects, and those with caregivers who returned incomplete questionnaires were excluded.", {"entities": []}], ["The final valid sample comprised 16,991 cases.", {"entities": []}], ["Approximately half the children received probiotic supplements before the age of 18 months.", {"entities": []}], ["Only 6.3% of the children received probiotic supplements during the two periods of birth to 6 months and 7 to 18 months.", {"entities": []}], ["Firstborn children, native mothers, mothers with higher educational levels, higher family income, and parents who lead healthy lifestyles were positively related to probiotic supplement use among children.", {"entities": []}], ["Young children who were breastfed, with eczema, or with gastrointestinal tract problems were significantly positively associated with probiotic supplement use.", {"entities": []}], ["The findings show that probiotic supplement usage among young children is associated with a more socially advantaged circumstance and certain child health factors, such as eczema, diarrhea, and constipation.", {"entities": [[194, 206, "DISEASE"], [180, 188, "DISEASE"]]}], ["Parents might use probiotic supplements for prevention or treatment of child diseases.", {"entities": []}], ["The findings of this research could serve as a baseline for future studies, and provide insight into probiotic supplement use behavior for health professionals caring for infants and young children.", {"entities": []}], ["Atopic dermatitis (AD) is a chronic inflammatory skin disorder caused by complex interaction of genetic and environmental factors.", {"entities": [[7, 17, "DISEASE"]]}], ["Besides mutations in the filaggrin gene, leading to impaired skin barrier function, variation in genes encoding additional skin proteins has been suggested to contribute to disease risk.", {"entities": []}], ["Laminin 5, playing an important role in skin integrity, is composed of three subunits encoded by the LAMA3 , LAMB3 and LAMC2 genes in which biallelic mutations cause epidermolysis bullosa junctionalis.", {"entities": [[166, 187, "DISEASE"], [101, 106, "GENE"], [109, 114, "GENE"], [119, 124, "GENE"]]}], ["We aimed at evaluating the role of variation in the LAMA3 , LAMB3 and LAMC2 genes for AD pathogenesis.", {"entities": [[52, 57, "GENE"], [60, 65, "GENE"], [70, 75, "GENE"]]}], ["29 single nucleotide polymorphisms (SNPs) were genotyped in the three genes in a German AD case\u2013control cohort comprising 470 unrelated AD patients and 320 non-atopic controls by means of restriction enzyme digestion.", {"entities": []}], ["Allele, genotype and haplotype frequencies were compared between cases and controls using chi-square testing and the Haploview software.", {"entities": []}], ["Several SNPs in the LAMA3 gene showed significant association with AD in our cohort (p <0.01), while we did not detect association with variations in the LAMB3 and LAMC2 genes.", {"entities": [[20, 25, "GENE"], [154, 159, "GENE"], [164, 169, "GENE"]]}], ["Haplotype analysis additionally revealed several significantly associated haplotypes in the LAMA3 gene.", {"entities": [[92, 97, "GENE"]]}], ["Due to extensive linkage disequilibrium, though, we were not able to further differentiate the specific disease causing variation(s) in this region.", {"entities": []}], ["We established the LAMA3 gene as novel potential susceptibility gene for AD.", {"entities": [[19, 24, "GENE"]]}], ["Additional studies in independent cohorts are needed to replicate these results.", {"entities": []}], ["Medically Unexplained Symptoms (MUS) are frequently encountered in general practice.", {"entities": []}], ["However, little is known whether MUS affects labor market participation.", {"entities": []}], ["We investigated the prospective association between MUS at baseline and risk of long-term sickness absence (LTSA), unemployment, and disability pensioning in a 5-year-follow-up study.", {"entities": []}], ["In the Danish Work Environment Cohort Study 2005, 8187 randomly selected employees from the Danish general population answered a questionnaire on work and health.", {"entities": []}], ["Responses were linked with national registers on prescribed medication and hospital treatment.", {"entities": []}], ["Participants were classified with MUS if they: a) had reported three or more symptoms during the last month, and b) did not have a chronic condition, neither in the self-reported nor the register data.", {"entities": []}], ["We assessed LTSA, unemployment, and disability pensioning by linking our data with National registers of social transfer payments.", {"entities": []}], ["Of the 8187 participants, 272 (3.3\u00a0%) were categorized with MUS.", {"entities": []}], ["Compared to healthy participants, participants with MUS had an increased risk of LTSA (Rate ratio (RR)\u2009=\u20091.76, 95\u00a0% CI\u2009=\u20091.28\u20132.42), and of unemployment (RR\u2009=\u20091.48, 95\u00a0% CI\u2009=\u20091.02\u20132.15) during follow-up.", {"entities": []}], ["MUS participants also showed an elevated RR with regard to risk of disability pensioning, however this association was not statistically significant (RR\u2009=\u20092.06, 95\u00a0% CI\u2009=\u20090.77\u20135.52).", {"entities": []}], ["MUS seem to have a negative effect on labor market participation defined by LTSA and unemployment, whereas it is more uncertain whether MUS affects risk of disability pensioning.", {"entities": []}], ["To determine whether the neurokinin-1 receptor (NK1R) plays a role in the activation of RBL-2H3 mast cells after Fc\u03b5R\u0399 aggregation.", {"entities": []}], ["NK1R expression in RBL-2H3 cells was inhibited by small hairpin RNA (shRNA) against NK1R, and determined by western blotting.", {"entities": []}], ["For activation, both NK1R knockdown and control RBL-2H3 cells were sensitized by dinitrophenol (DNP)-specific IgE and stimulated with the antigen DNP-bovine serum albumin (BSA).", {"entities": []}], ["Following the activation of RBL-2H3 cells, monocyte chemoattractant protein (MCP-1) production and intracellular calcium flux were monitored by ELISA and confocal microscopy assay, respectively.", {"entities": []}], ["For investigation of the signaling mechanism, phosphorylation of mitogen-activated protein kinases (MAPKs) after RBL-2H3 cell activation was assessed by western blotting.", {"entities": []}], ["shRNA-NK1R mediated an effective inhibition of NK1R expression in RBL-2H3 cells.", {"entities": []}], ["Protein production of MCP-1 was reduced by more than 55\u00a0% in NK1R knockdown RBL-2H3 cells compared with control RBL-2H3 cells.", {"entities": []}], ["In addition, both calcium mobilization and phosphorylation levels of MAPKs (Erk1/2, JNK, and p38) after DNP-BSA stimulation (via Fc\u03b5R\u0399) were decreased due to the inhibition of NK1R expression.", {"entities": []}], ["NK1R is required for the activation of RBL-2H3 cells following Fc\u03b5R\u0399 engagement and involved in the regulation of MAPK signaling pathways.", {"entities": []}], ["The online version of this article (doi:10.1007/s00011-012-0523-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Atopy-related illnesses such as atopic dermatitis and asthma are chronic illnesses, and children suffering from such illnesses are subjected to frequent absenteeism from school.", {"entities": [[32, 49, "DISEASE"], [54, 60, "DISEASE"], [39, 49, "DISEASE"]]}], ["Studies have shown that the performance of children with asthma was comparable to their healthy counterparts despite their absenteeism at school, in contrast to findings in other chronic illnesses like epilepsy.", {"entities": [[57, 63, "DISEASE"]]}], ["In the present study, we investigated the association between atopy and intelligence quotient (IQ) scores in a group of Nigerian children in Ibadan, a city in southwestern Nigeria.", {"entities": []}], ["This is a cross-sectional study of children in an urban elementary school.", {"entities": []}], ["Questionnaires to ascertain the presence of atopy-associated conditions such as hay fever, atopic dermatitis, asthma, allergic rhinitis, and allergic conjunctivitis were administered to the parents of 128 pupils in the 3 Out of the children studied, 26.6% were found to have atopy and after adjusting for factors such as age and sex, the IQ scores in this atopic group were not found to be statistically different from the scores in the nonatopic group (r = 2.122872, P = 0.009).", {"entities": [[118, 135, "DISEASE"], [91, 108, "DISEASE"], [127, 135, "DISEASE"], [141, 164, "DISEASE"], [150, 164, "DISEASE"], [110, 116, "DISEASE"], [98, 108, "DISEASE"]]}], ["IQ scores were not statistically significantly different for children with and without atopy.", {"entities": []}], ["Thus, the presence of atopy does not appear to be associated with low IQ scores and hence, may not be related to poor school performance.", {"entities": []}], ["Frequent emergency department (ED) users contribute to a disproportionate number of ED visits that consume a substantial amount of medical resources.", {"entities": []}], ["Additionally, people with frequent ED visits may be at greater risks of illnesses and injury and are vulnerable to even more severe health events.", {"entities": []}], ["We conducted, based on a nationally representative sample, a population-based study to estimate the prevalence of frequent ED users among all ED users, and to explore factors associated with frequent ED visits.", {"entities": []}], ["This is a population-based cross-sectional study.", {"entities": []}], ["Data of 1 million people randomly selected from all beneficiaries of Taiwan's National Health Insurance claim database in 2010 were analyzed to estimate the distribution of ED visit among ED users.", {"entities": []}], ["Multivariate logistic regression was employed to calculate the independent associations of factors with prevalence of frequent (4-12 ED visits per year) and highly frequent (>12 ED visits per year) ED visits.", {"entities": []}], ["Of the 1 million beneficiaries 170,475 subjects used ED service in 2010 and 103,111 (60.5%), 37,964 (22.3%), 14,881 (8.7%), 14,041 (8.2%), and 460 (0.3%) subjects had 1, 2, 3, 4 to 12, and more than 12 ED visits, respectively.", {"entities": []}], ["ED users with 4 to 12 visits and those with >12 visits disproportionally accounted for 24.1% and 3.0%, respectively, of all ED visits in 2010.", {"entities": []}], ["We noted significant associations of frequent ED visit with a number of factors including socio-demographics, health care utilization, and comorbidity.", {"entities": []}], ["Among them, the most increased adjusted odds ratio (AOR) was noted for hospitalization during the past year (AOR\u200a=\u200a1.85) and younger ages (1\u20136 years) (AOR\u200a=\u200a1.84).", {"entities": []}], ["On the contrary, the significant predictors for highly frequent ED visit with greater AOR included hospitalization during the past year (AOR\u200a=\u200a3.95), >12 outpatient visits during the past year (AOR\u200a=\u200a2.66), and a history of congestive heart failure (AOR\u200a=\u200a2.64) and psychiatric disorders (AOR\u200a=\u200a2.35).", {"entities": [[224, 248, "DISEASE"]]}], ["People admitted and with frequent outpatient visits were at greater risk of frequent ED visit.", {"entities": []}], ["Because people with a history of various comorbidities were also vulnerable to become frequent ED users, careful management of those comorbidities by clinicians may help further reduce the likelihood of frequent ED visit.", {"entities": []}], ["Gut flora are important immunomodulators that may be disrupted in individuals with atopic conditions.", {"entities": []}], ["Probiotic bacteria have been suggested as therapeutic modalities to mitigate or prevent food allergic manifestations.", {"entities": []}], ["We wished to investigate whether perinatal factors known to disrupt gut flora increase the risk of IgE-mediated food allergies.", {"entities": []}], ["Birth records obtained from 192 healthy children and 99 children diagnosed with food allergies were reviewed retrospectively.", {"entities": []}], ["Data pertaining to delivery method, perinatal antibiotic exposure, neonatal nursery environment, and maternal variables were recorded.", {"entities": []}], ["Logistic regression analysis was used to assess the association between variables of interest and subsequent food allergy diagnosis.", {"entities": [[109, 121, "DISEASE"]]}], ["Retrospective investigation did not find perinatal antibiotics, NICU admission, or cesarean section to be associated with increased risk of food allergy diagnosis.", {"entities": [[140, 152, "DISEASE"]]}], ["However, associations between food allergy diagnosis and male gender (66 vs. 33; p=0.02) were apparent in this cohort.", {"entities": [[30, 42, "DISEASE"]]}], ["Additionally, increasing maternal age at delivery was significantly associated with food allergy diagnosis during childhood (OR, 1.05; 95% CI, 1.017 to 1.105; p=0.005).", {"entities": [[84, 96, "DISEASE"]]}], ["Gut flora are potent immunomodulators, but their overall contribution to immune maturation remains to be elucidated.", {"entities": []}], ["Additional understanding of the interplay between immunologic, genetic, and environmental factors underlying food allergy development need to be clarified before probiotic therapeutic interventions can routinely be recommended for prevention or mitigation of food allergies.", {"entities": [[109, 121, "DISEASE"]]}], ["Such interventions may be well-suited in male infants and in infants born to older mothers.", {"entities": []}], ["In patients with bronchial obstruction, pulmonary function tests may not change significantly after intervention.", {"entities": []}], ["The airflow asynchrony in both lungs due to unilateral bronchial obstruction may be applicable as a physiological indicator.", {"entities": []}], ["The airflow asynchrony is reflected by the difference in the left and right lung sound development at tidal breathing.", {"entities": []}], ["To investigate the usefulness of left and right lung asynchrony due to unilateral bronchial obstruction as a physiological indicator for interventional bronchoscopy.", {"entities": []}], ["Fifty cases with central airway obstruction were classified into three groups: tracheal, bronchial and extensive obstruction.", {"entities": []}], ["The gap index was defined as the absolute value of the average of gaps between the left and right lung sound intensity peaks for a 12-second duration.", {"entities": []}], ["Before interventional bronchoscopy, the gap index was significantly higher in the bronchial (p<0.05) and extensive obstruction groups (p<0.05) than in the tracheal group.", {"entities": []}], ["The gap index in cases with unilateral bronchial obstruction of at least 80% (0.18\u00b10.04 seconds) was significantly higher than in cases with less than 80% obstruction (0.02\u00b10.01 seconds, p<0.05).", {"entities": []}], ["After intervention for bronchial obstruction, the dyspnea scale (p<0.001) and gap index significantly improved (p<0.05), although no significant improvements were found in spirometric assessments.", {"entities": []}], ["The responder rates for dyspnea were 79.3% for gap indexes over 0.06 seconds and 55.6% for gap indexes of 0.06 seconds or under.", {"entities": []}], ["Assessment of left and right lung asynchrony in central airway obstruction with bronchial involvement may provide useful physiological information for interventional bronchoscopy.", {"entities": []}], ["Asthma is the most common chronic condition affecting Aboriginal youth aged 8 to 12 years in Canada.", {"entities": [[0, 6, "DISEASE"]]}], ["Research investigating psychosocial challenges associated with asthma is limited.", {"entities": [[63, 69, "DISEASE"]]}], ["This study examines support resources, support-seeking strategies, support and education needs, and intervention preferences of Aboriginal youth with asthma and their caregivers in an effort to encourage community-wide, health-promoting behaviors.", {"entities": [[150, 156, "DISEASE"]]}], ["We employed a community-based participatory research design to conduct interviews with 21 youths aged 8 to 12 years and 17 caregivers from 5 Mi\u2019kmaq communities in Unama\u2019ki (Cape Breton) Nova Scotia, Canada.", {"entities": []}], ["After conducting interviews that explored existing and desired social, educational, and health support in participating communities, we held a 2-day asthma camp to engage participants in asthma education, social support networking, and cultural activities.", {"entities": [[149, 155, "DISEASE"], [187, 193, "DISEASE"]]}], ["At the camp, we collected data through participant observation, sharing circles, focus groups, and youth drawings of their experiences living with asthma.", {"entities": [[147, 153, "DISEASE"]]}], ["Our study yielded 4 key findings: 1) asthma triggers included household mold, indoor smoking, pets, season change, strenuous exercise, extreme cold, and humidity; 2) social and educational support is lacking in Mi\u2019kmaq communities despite a strong desire for these services; 3) cultural, linguistic, and geographic barriers to accessing support exist; and 4) family members are primary support resources.", {"entities": [[37, 43, "DISEASE"]]}], ["Improved support and educational resources are needed to foster effective Mi\u2019kmaq asthma support networks.", {"entities": [[82, 88, "DISEASE"]]}], ["Future asthma interventions for marginalized populations must be culturally meaningful and linguistically accessible to those using and providing asthma support.", {"entities": [[7, 13, "DISEASE"], [146, 152, "DISEASE"]]}], ["Background : Children placed in out-of-home care (OHC) have exceedingly high rates of health problems.", {"entities": []}], ["Their poor health tends to persist across adolescence and into young adulthood, resulting in increased risks of mortality.", {"entities": []}], ["Yet, very little is known about this group\u2019s mortality risks later in life.", {"entities": []}], ["The aim of this study was to investigate whether OHC was associated with the risk of all-cause mortality across adulthood, and whether these risks varied across different placement characteristics.", {"entities": []}], ["Moreover, the study addressed potential confounding by including two comparison groups with children who grew up under similarly adverse living conditions but did not experience placement.", {"entities": []}], ["Methods : Data were derived from a 60-year follow-up of a Stockholm cohort born in 1953 ( n = 15\u00a0048), of whom around 9% have had experiences of OHC.", {"entities": []}], ["The associations between OHC and subsequent all-cause mortality were analysed by means of Cox\u2019s proportional hazards regression models.", {"entities": []}], ["Results : Individuals who were placed in OHC at any point during their formative years had increased mortality risks across ages 20 to 56 years.", {"entities": []}], ["Elevated risk of mortality was particularly pronounced among those who were placed in adolescence and/or because of their own behaviours.", {"entities": []}], ["Children who were exposed to OHC had increased risks of mortality also when compared with those who grew up under similar living conditions but did not experience placement.", {"entities": []}], ["Conclusions : Children in OHC constitute a high-risk group for subsequent mortality.", {"entities": []}], ["In order to narrow the mortality gap, interventions may need to monitor not only health aspects but also to target the cognitive and social development of these children.", {"entities": []}], ["To investigate the anticonvulsant and muscle relxant activity of ethanolic extract of stems of Dendrophthoe falcata in mice.", {"entities": []}], ["The ethanolic extract of stems of D. falcata (100, 300 and 500 mg/kg, p.o.)", {"entities": []}], ["was studied for its anticonvulsant effect on maximal electroshock-induced seizures and muscle relaxant activity at the same dose level using rota rod and traction test in mice.", {"entities": []}], ["Preliminary phytochemical analysis revealed presence of proteins, carbohydrates, glycosides, steroids, triterpenes, flavonoids, tannins and phenolic compounds.", {"entities": []}], ["D. falcata ethanolic extract (DFEE) (100, 300 and 500 mg/kg, p.o.)", {"entities": []}], ["significantly ( P <0.001) inhibited seizures induced by MES, reduced the duration of Hind limb tonic extensor phase (HLTE) and a decline in motor coordination.", {"entities": []}], ["The ethanolic extract possesses anticonvulsant activity and muscle relaxant activity.", {"entities": []}], ["Some anti-epileptic drugs (AED) have well-known teratogenic effects.", {"entities": []}], ["The aim of the present study was to elucidate the effect of prenatal exposure to AED and the risk of enamel defects in the primary and permanent dentition.", {"entities": []}], ["A total of 38 exposed and 129 non-exposed children, 6\u201310 years of age, were recruited from the Aarhus Birth Cohort and the Department of Neurology, Viborg Regional Hospital, Denmark.", {"entities": []}], ["Medication during pregnancy was confirmed by the Danish Prescription Database.", {"entities": []}], ["All children had their teeth examined and outcomes in terms of enamel opacities and enamel hypoplasia were recorded.", {"entities": []}], ["Children prenatally exposed to AED have an increased prevalence of enamel hypoplasia (11% vs .", {"entities": []}], ["4%, odds ratio (OR)\u200a=\u200a3.6 [95% confidence interval (CI): 0.9 to 15.4]), diffuse opacities (18% vs .", {"entities": []}], ["7%, OR\u200a=\u200a3.0; [95% CI: 1.0 to 8.7, p<0.05]), and numerous (>3) white opacities (18% vs .", {"entities": []}], ["10%, OR\u200a=\u200a2.2; [95% CI: 0.8 to 6.1]) in the primary dentition.", {"entities": []}], ["In the permanent dentition, an increased risk of numerous (>3) white opacities (34% vs. 12%, OR\u200a=\u200a3.3; [95% CI: 1.3 to 8.4]) was found.", {"entities": []}], ["The present study shows that children prenatally exposed to AED have an increased risk of developing numerous teeth with white opacities in their primary and permanent dentition.", {"entities": []}], ["In addition, they also have an increased risk of developing diffuse opacities and enamel hypoplasia in their primary teeth.", {"entities": []}], ["Item response theory (IRT) is extensively used to develop adaptive instruments of health-related quality of life (HRQoL).", {"entities": []}], ["However, each IRT model has its own function to estimate item and category parameters, and hence different results may be found using the same response categories with different IRT models.", {"entities": []}], ["The present study used the Rasch rating scale model (RSM) to examine and reassess the psychometric properties of the Persian version of the PedsQL The PedsQL The CTT method showed that the scaling success rate for convergent and discriminant validity were 100% in all domains with the exception of physical health in the child self-report.", {"entities": []}], ["Moreover, confirmatory factor analysis supported a four-factor model similar to its original version.", {"entities": []}], ["The RSM showed that 22 out of 23 items had acceptable infit and outfit statistics (<1.4, >0.6), person reliabilities were low, item reliabilities were high, and item difficulty ranged from -1.01 to 0.71 and -0.68 to 0.43 for child self-report and parent proxy-report, respectively.", {"entities": []}], ["Also the RSM showed that successive response categories for all items were not located in the expected order.", {"entities": []}], ["This study revealed that, in all domains, the five response categories did not perform adequately.", {"entities": []}], ["It is not known whether this problem is a function of the meaning of the response choices in the Persian language or an artifact of a mostly healthy population that did not use the full range of the response categories.", {"entities": []}], ["The response categories should be evaluated in further validation studies, especially in large samples of chronically ill patients.", {"entities": []}], ["Increasing severe vegetation fires worldwide has been attributed to both global environmental change and land management practices.", {"entities": []}], ["However there is little evidence concerning the population health effects of outdoor air pollution derived from biomass fires.", {"entities": []}], ["Frequent seasonal bushfires near Darwin, Australia provide an opportunity to examine this issue.", {"entities": []}], ["We examined the relationship between atmospheric particle loadings <10 microns in diameter (PM 10 ), and emergency hospital admissions for cardio-respiratory conditions over the three fire seasons of 2000, 2004 and 2005.", {"entities": []}], ["In addition we examined the differential impacts on Indigenous Australians, a high risk population subgroup.", {"entities": []}], ["We conducted a case-crossover analysis of emergency hospital admissions with principal ICD10 diagnosis codes J00\u2013J99 and I00\u2013I99.", {"entities": []}], ["Conditional logistic regression models were used to calculate odds ratios for admission with 10 \u03bcg/m 10 .", {"entities": []}], ["These were adjusted for weekly influenza rates, same day mean temperature and humidity, the mean temperature and humidity of the previous three days, days with rainfall > 5 mm, public holidays and holiday periods.", {"entities": [[31, 40, "DISEASE"]]}], ["PM 10 ranged from 6.4 \u2013 70.0 \u03bcg/m 10 and admissions for all respiratory conditions (OR 1.08 95%CI 0.98\u20131.18) with a larger magnitude in the Indigenous subpopulation (OR1.17 95% CI 0.98\u20131.40).", {"entities": []}], ["While there was no relationship between PM 10 and cardiovascular admissions overall, there was a positive association with ischaemic heart disease in Indigenous people, greatest at a lag of 3 days (OR 1.71 95%CI 1.14\u20132.55).", {"entities": [[133, 146, "DISEASE"]]}], ["PM10 derived from vegetation fires was predominantly associated with respiratory rather than cardiovascular admissions.", {"entities": []}], ["This outcome is consistent with the few available studies of ambient biomass smoke pollution.", {"entities": []}], ["Indigenous people appear to be at higher risk of cardio-respiratory hospital admissions associated with exposure to PM10.", {"entities": []}], ["Improvements in the quality of health care services are often measured using data present in medical records.", {"entities": []}], ["Electronic Medical Records (EMRs) contain potentially valuable new sources of health data.", {"entities": []}], ["However, data quality in EMRs may not be optimal and should be assessed.", {"entities": []}], ["Data reliability (are the same data elements being measured over time?)", {"entities": []}], ["is a prerequisite for data validity (are the data accurate?).", {"entities": []}], ["Our objective was to measure the reliability of data for preventive services in primary care EMRs during the transition to EMR.", {"entities": []}], ["Our data sources were randomly selected eligible patients\u2019 medical records and data obtained from provincial administrative datasets.", {"entities": []}], ["Eighteen community-based family physicians in Toronto, Ontario that implemented EMRs starting in 2006 participated in this study.", {"entities": []}], ["We measured the proportion of patients eligible for a service (Pap smear, screening mammogram or influenza vaccination) that received the service.", {"entities": [[97, 106, "DISEASE"]]}], ["We compared the change in rates of selected preventive services calculated from the medical record audits with the change in administrative datasets.", {"entities": []}], ["In the first year of EMR use (2006) services decreased by 8.7% more (95% CI \u221211.0%\u2013\u2009\u2212\u20096.4%, p \u2009<\u20090.0001) when measured through medical record audits as compared with administrative datasets.", {"entities": []}], ["Services increased by 2.4% more (95% CI 0%\u20134.9%, p \u2009=\u20090.05) in the medical record audits during the second year of EMR use (2007).", {"entities": []}], ["There were differences between the change measured through medical record audits and administrative datasets.", {"entities": []}], ["Problems could include difficulties with organizing new data entry processes as well as continued use of both paper and EMRs.", {"entities": []}], ["Data extracted from EMRs had limited reliability during the initial phase of EMR implementation.", {"entities": []}], ["Unreliable data interferes with the ability to measure and improve health care quality", {"entities": []}], ["Cold hypersensitivity in the hands and feet (CHHF) is a common symptom in Korea and patients with CHHF complain of coldness in the hands and feet in an environment that is not considered cold by unaffected people.", {"entities": []}], ["In traditional East Asian medicine, CHHF is believed to be accompanied by various diseases and symptoms, and is considered a symptom that needs active treatment.", {"entities": []}], ["CHHF is used for pattern identification in the cold pattern, yang deficiency, and constitution.", {"entities": []}], ["This study aimed to examine the differences in frequencies of chronic diseases with respect to the presence of CHHF.", {"entities": []}], ["Disease history, CHHF, body measurements, and blood test survey data from 6149 patients collected by 25 medical institutes in Korea were obtained from the Korean Medicine Data Center.", {"entities": []}], ["The participants were divided into CHHF ( n \u2009=\u20091909) and non-CHHF groups ( n \u2009=\u20093017) according to the CHHF survey.", {"entities": []}], ["The differences in frequencies of 18 diseases were analysed using chi-square tests, and the odds ratios (ORs) for each disease according to CHHF status were examined via logistic regression with adjustment for age, sex, and body mass index (BMI).", {"entities": []}], ["Based on chi-square test results, the CHHF group showed a higher frequency of the following diseases: anaemia, hypotension, chronic gastritis, reflux oesophagitis, chronic rhinitis, dysmenorrhoea, and gastroduodenal ulcer.", {"entities": [[132, 141, "DISEASE"], [172, 180, "DISEASE"], [164, 180, "DISEASE"]]}], ["Diseases found in lower frequencies were as follows: hypertension, diabetes mellitus, impaired fasting glucose, dyslipidaemia, stroke, fatty liver, and angina pectoris.", {"entities": [[53, 65, "DISEASE"], [67, 84, "DISEASE"]]}], ["In addition, from the logistic regression with adjustment for age, sex, and BMI, the CHHF group showed a lower OR in diabetes mellitus and dyslipidaemia than the non-CHHF group, but a higher OR in degenerative arthritis, chronic gastritis, gastroduodenal ulcer, reflux oesophagitis, and chronic rhinitis.", {"entities": [[229, 238, "DISEASE"], [295, 303, "DISEASE"], [287, 303, "DISEASE"], [210, 219, "DISEASE"], [117, 134, "DISEASE"]]}], ["This study showed that CHHF is associated with chronic disease.", {"entities": []}], ["Further large-scale prospective studies are needed to validate these associations.", {"entities": []}], ["A variety of cardiovascular, neurological, and neoplastic conditions have been associated with oxidative stress, i.e., conditions under which levels of reactive oxygen species (ROS) are elevated over significant periods.", {"entities": []}], ["Nuclear factor erythroid 2-related factor (Nrf2) regulates the transcription of several gene products involved in the protective response to oxidative stress.", {"entities": []}], ["The transcriptional regulatory and signaling relationships linking gene products involved in the response to oxidative stress are, currently, only partially resolved.", {"entities": []}], ["Microarray data constitute RNA abundance measures representing gene expression patterns.", {"entities": []}], ["In some cases, these patterns can identify the molecular interactions of gene products.", {"entities": []}], ["They can be, in effect, proxies for protein\u2013protein and protein\u2013DNA interactions.", {"entities": []}], ["Traditional techniques used for clustering coregulated genes on high-throughput gene arrays are rarely capable of distinguishing between direct transcriptional regulatory interactions and indirect ones.", {"entities": []}], ["In this study, newly developed information-theoretic algorithms that employ the concept of mutual information were used: the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNE), and Context Likelihood of Relatedness (CLR).", {"entities": []}], ["These algorithms captured dependencies in the gene expression profiles of the mouse lung, allowing the regulatory effect of Nrf2 in response to oxidative stress to be determined more precisely.", {"entities": []}], ["In addition, a characterization of promoter sequences of Nrf2 regulatory targets was conducted using a Support Vector Machine classification algorithm to corroborate ARACNE and CLR predictions.", {"entities": []}], ["Inferred networks were analyzed, compared, and integrated using the Collective Analysis of Biological Interaction Networks (CABIN) plug-in of Cytoscape.", {"entities": []}], ["Using the two network inference algorithms and one machine learning algorithm, a number of both previously known and novel targets of Nrf2 transcriptional activation were identified.", {"entities": []}], ["Genes predicted as novel Nrf2 targets include Atf1, Srxn1, Prnp, Sod2, Als2, Nfkbib, and Ppp1r15b.", {"entities": [[46, 50, "GENE"], [52, 57, "GENE"], [59, 63, "GENE"], [65, 69, "GENE"], [71, 75, "GENE"], [77, 83, "GENE"], [89, 97, "GENE"]]}], ["Furthermore, microarray and quantitative RT-PCR experiments following cigarette-smoke-induced oxidative stress in Nrf2 A variety of conditions including certain cancers and heart diseases, diabetes mellitus, and rheumatoid arthritis have been associated with the generation of high levels of highly reactive molecular species under conditions known as \u201coxidative stress.\u201d A number of protein molecules have been identified as participants in an elaborate response to oxidative stress.", {"entities": [[212, 232, "DISEASE"], [223, 232, "DISEASE"], [189, 206, "DISEASE"]]}], ["Sustained elevated generation of reactive species can overwhelm this response and lead to disease conditions.", {"entities": []}], ["In these studies, we make use of data generated from over 250 studies (microarrays) in which messenger RNA levels of the gene precursors of mouse lung proteins have been examined collectively.", {"entities": []}], ["We have made use of computational approaches to help identify the key regulatory relationships among the proteins that respond to oxidative stress.", {"entities": []}], ["Nrf2, a protein known as a master regulator of oxidative stress response, was a principal focus of our studies.", {"entities": []}], ["Among the novel regulatory targets of Nrf2 we identified is Als2, a protein involved in amyotrophic lateral sclerosis (Lou Gehrig's disease).", {"entities": [[88, 117, "DISEASE"], [100, 117, "DISEASE"], [60, 64, "GENE"]]}], ["We also identify important candidate three-party regulatory relationships, one of which involves the recently discovered Srxn1, an antioxidant protein that reverses S-glutathionylation, a common posttranslational modification associated with diseases such as Parkinson's disease, diabetes, hyperlipidemia, Friedreich's ataxia, renal cell carcinoma, and HIV/AIDS.", {"entities": [[338, 347, "DISEASE"], [327, 347, "DISEASE"], [121, 126, "GENE"]]}], ["These studies demonstrate the utility of network inference algorithms and affirm that Nrf2 has a direct regulatory role over the expression of other genes responding to oxidative stress.", {"entities": []}], ["Knowledge of differences in the cellular physiology of malignant and non-malignant cells is a prerequisite for the development of cancer treatments that effectively kill cancer without damaging normal cells.", {"entities": [[130, 136, "DISEASE"], [170, 176, "DISEASE"]]}], ["Calcium is a ubiquitous signal molecule that is involved in the control of proliferation and apoptosis.", {"entities": []}], ["We aimed to investigate if the endoplasmic reticulum (ER) Ca The intracellular Ca In a Small Cell Lung Cancer (H1339) and an Adeno Carcinoma Lung Cancer (HCC) cell line but not in a Squamous Cell Lung Cancer (EPLC) and a Large Cell Lung Cancer (LCLC) cell line the ER Ca 3 R releasing calcium from the ER, and a reduced expression of calreticulin buffering calcium within the ER.", {"entities": [[103, 109, "DISEASE"], [146, 152, "DISEASE"], [201, 207, "DISEASE"], [237, 243, "DISEASE"]]}], ["Lowering the ER Ca The significant differences in Ca", {"entities": []}], ["For single-cell experiments, it is important to accurately count the number of viable cells in a nanoliter well.", {"entities": []}], ["We used a deep learning-based convolutional neural network (CNN) on a large amount of digital data obtained as microscopic images.", {"entities": []}], ["The training set consisted of 103 019 samples, each representing a microscopic grayscale image.", {"entities": []}], ["After extensive training, the CNN was able to classify the samples into four categories, i.e., 0, 1, 2, and more than 2 cells per well, with an accuracy of 98.3% when compared to determination by two trained technicians.", {"entities": []}], ["By analyzing the samples for which judgments were discordant, we found that the judgment by technicians was relatively correct although cell counting was often difficult by the images of discordant samples.", {"entities": []}], ["Based on the results, the system was further enhanced by introducing a new algorithm in which the highest outputs from CNN were used, increasing the accuracy to higher than 99%.", {"entities": []}], ["Our system was able to classify the data even from wells with a different shape.", {"entities": []}], ["No other tested machine learning algorithm showed a performance higher than that of our system.", {"entities": []}], ["The presented CNN system is expected to be useful for various single-cell experiments, and for high-throughput and high-content screening.", {"entities": []}], ["Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health.", {"entities": []}], ["Assessment of the strengths and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results.", {"entities": []}], ["The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the STrengthening the Reporting of OBservational Studies in Epidemiology (STROBE) Statement and provides additions to 12 of the 22 items on the STROBE checklist.", {"entities": []}], ["The additions concern population stratification, genotyping errors, modelling haplotype variation, Hardy\u2013Weinberg equilibrium, replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative traits, statistical methods, relatedness, reporting of descriptive and outcome data and the volume of data issues that are important to consider in genetic association studies.", {"entities": []}], ["The STREGA recommendations do not prescribe or dictate how a genetic association study should be designed, but seek to enhance the transparency of its reporting, regardless of choices made during design, conduct or analysis.", {"entities": []}], ["There is a bidirectional relationship between depression and chronic medical disorders.", {"entities": []}], ["The adverse health risk behaviors and psychobiological changes associated with depression increase the risk for chronic medical disorders, and biological changes and complications associated with chronic medical disorders may precipitate depressive episodes.", {"entities": []}], ["Comorbid depression is associated with increased medical symptom burden, functional impairment, medical costs, poor adherence to self-care regimens, and increased risk of morbidity and mortality in patients with chronic medical disorders.", {"entities": []}], ["Depression may worsen the course of medical disorders because of its effect on proinflammatory factors, hypothalamic-pituitary axis, autonomic nervous system, and metabolic factors, in addition to being associated with a higher risk of obesity, sedentary lifestyle, smoking, and poor adherence to medical regimens.", {"entities": [[236, 243, "DISEASE"]]}], ["Both evidence-based psychotherapies and antidepressant medication are efficacious treatments for depression.", {"entities": []}], ["Collaborative depression care has been shown to be an effective way to deliver these treatments to large primary care populations with depression and chronic medical illness.", {"entities": []}], ["The economic crisis in Greece has substantially affected patients with COPD.", {"entities": []}], ["The reduction of disposable income has its consequences on patients\u2019 ability to afford their medication.", {"entities": []}], ["The aim of the study is to evaluate the cost of treatment for patients with COPD and the influence of the financial crisis to the patients.", {"entities": []}], ["Data were collected from 189 patients (male: 178, mean age: 70.1\u00b18.4) who visited the outpatient department of University Hospital of Larissa in 2014 and 2015.", {"entities": []}], ["The pharmacological cost of treatment was calculated based on national pharmaceutical formulary prices.", {"entities": []}], ["COPD patients were classified into four stages according to Global Initiative for Chronic Obstructive Lung Disease (GOLD): 7.4% were in stage I, 43.4% in stage II, 34.4% in stage III, and 14.8% in stage IV.", {"entities": []}], ["Patients were graded as per GOLD as follows: 18% as grade A, 14.3% as B, 23.3% as C, and 44.4% as D. The annual cost of COPD maintenance treatment per patient was \u20ac952.92 (\u00b1398.01), of which \u20ac239.91 were patients\u2019 expenses.", {"entities": []}], ["The annual treatment cost for stable disease ranged from \u20ac615.44 to \u20ac1302.03 depending on disease stages (GOLD stages I\u2013IV) and from \u20ac715.01 to \u20ac1101.05 depending on GOLD grades (grades A\u2013D).", {"entities": []}], ["The cost of maintenance medication was statistically and significantly higher for patients with advanced disease (GOLD stages III\u2013IV) and for patients at high risk (GOLD grades C\u2013D [ P =0.000]).", {"entities": []}], ["The pharmacological cost of treatment for COPD patients seems to be considerably high, in all disease stages.", {"entities": []}], ["As the average income is decreased, patients face difficulties to afford inhaled medication.", {"entities": []}], ["Acute infectious diseases are major causes of short periods of days off from work, day care and school.", {"entities": []}], ["These diseases are mainly caused by viruses and hands have a key role in their transmission.", {"entities": []}], ["Thus, hypothetically, they can be controlled with means of intensified hand hygiene.", {"entities": []}], ["In this study we aim to elucidate the effect of acute infectious diseases on the work contribution in common office work and study the influence of improved hand hygiene on possible reduction of infectious disease episodes and days off from work due to acute infectious diseases.", {"entities": []}], ["The voluntary participants have been recruited from six companies in the Helsinki region.", {"entities": []}], ["The designated 21 study clusters were identified as operationally distinct working units each containing at least 50 people.", {"entities": []}], ["The clusters were matched and randomized based on results of a pre-trial contagion risk survey.", {"entities": []}], ["Improved hand hygiene is being executed with guided hand-washing with soap and water in one intervention arm and with alcohol based hand rubbing disinfectant in the other.", {"entities": []}], ["Participants in both arms have received guidance on how to avoid infections and how to implement contagion stopping habits.", {"entities": []}], ["A control arm is acting as before regarding hand hygiene.", {"entities": []}], ["Data collection for evaluation of the efficacy of the interventions is based on self-reporting through weekly electronic reports.", {"entities": []}], ["The questionnaire is enquiring about possible respiratory or gastrointestinal symptoms during the preceding week, and requests a daily report of presence of symptoms and working capacity.", {"entities": []}], ["Etiology of the symptoms is not searched for individually, but contribution of different viruses is evaluated by sentinel surveillance, where occupational health clinics located in the premises of the participating companies collect specimens from employees visiting the clinic.", {"entities": []}], ["Common causative agents of the diseases are being searched for using real-time PCR techniques.", {"entities": []}], ["The duration of the intervention will be 16 months.", {"entities": []}], ["Primary endpoints of the study are the number of reported infection episodes in a cluster within a time frame of 100 reporting weeks and the number of reported sick leave episodes in a cluster within a time frame of 100 reporting weeks.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT00821509", {"entities": []}], ["Pakistan is highly vulnerable to climate change due to its geographic location, high dependence on agriculture and water resources, low adaptive capacity of its people, and weak system of emergency preparedness.", {"entities": []}], ["This paper is the first ever attempt to rank the agro-ecological zones in Pakistan according to their vulnerability to climate change and to identify the potential health repercussions of each manifestation of climate change in the context of Pakistan.", {"entities": []}], ["A climate change vulnerability index is constructed as an un-weighted average of three sub-indices measuring (a) the ecological exposure of each region to climate change, (b) sensitivity of the population to climate change and (c) the adaptive capacity of the population inhabiting a particular region.", {"entities": []}], ["The regions are ranked according to the value of this index and its components.", {"entities": []}], ["Since health is one of the most important dimensions of human wellbeing, this paper also identifies the potential health repercussions of each manifestations of climate change and links it with the key manifestations of climate change in the context of Pakistan.", {"entities": []}], ["The results indicate that Balochistan is the most vulnerable region with high sensitivity and low adaptive capacity followed by low-intensity Punjab (mostly consisting of South Punjab) and Cotton/Wheat Sindh.", {"entities": []}], ["The health risks that each of these regions face depend upon the type of threat that they face from climate change.", {"entities": []}], ["Greater incidence of flooding, which may occur due to climate variability, poses the risk of diarrhoea and gastroenteritis; skin and eye Infections; acute respiratory infections; and malaria.", {"entities": [[183, 190, "DISEASE"], [107, 122, "DISEASE"]]}], ["Exposure to drought poses the potential health risks in the form of food insecurity and malnutrition; anaemia; night blindness; and scurvy.", {"entities": [[132, 138, "DISEASE"], [117, 126, "DISEASE"], [111, 126, "DISEASE"]]}], ["Increases in temperature pose health risks of heat stroke; malaria; dengue; respiratory diseases; and cardiovascular diseases.", {"entities": [[59, 66, "DISEASE"]]}], ["The study concludes that geographical zones that are more exposed to climate change in ecological and geographic terms- such as Balochistan, Low-Intensity Punjab, and Cotton-Wheat Sindh -also happen to be the most deprived regions in Pakistan in terms of socio-economic indicators, suggesting that the government needs to direct its efforts to the socio-economic uplift of these lagging regions to reduce their vulnerability to the adverse effects of climate change.", {"entities": []}], ["At steady state, plasma histamine levels exhibit circadian variations with nocturnal peaks, which is implicated in the nighttime exacerbation of allergic symptoms.", {"entities": []}], ["However, the regulatory mechanisms are largely unexplored.", {"entities": []}], ["This study determined how steady-state plasma histamine levels are regulated and affected by environmental factors.", {"entities": []}], ["We found that plasma histamine levels decreased in mast cell\u2013deficient mice and their circadian variations were lost in mast cell\u2013deficient mice reconstituted with bone marrow\u2013derived mast cells (BMMCs) harboring a mutation in the circadian gene Clock.", {"entities": []}], ["Clock temporally regulates expression of organic cation transporter 3 (OCT3), which is involved in histamine transport, in mast cells; OCT inhibition abolished circadian variations in plasma histamine levels.", {"entities": []}], ["Mice housed under aberrant light/dark conditions or suffering from restraint stress exhibited de-synchronization of the mast cell clockwork, concomitant with the loss of circadian variations in OCT3 expression and plasma histamine levels.", {"entities": []}], ["The degree of compound 48/80\u2013induced plasma extravasation in mice was correlated with plasma histamine levels.", {"entities": []}], ["Collectively, the mast cell clock mediates circadian regulation of plasma histamine levels at steady state, in part by controlling OCT3 expression, which can be modulated by stress.", {"entities": []}], ["Additionally, we propose that plasma histamine levels potentiate mast cell\u2013mediated allergic reactions.", {"entities": []}], ["Asthma is a chronic inflammatory disease that can be difficult to treat due to its complex pathophysiology.", {"entities": [[0, 6, "DISEASE"]]}], ["Most current drugs focus on controlling the inflammatory process, but are unable to revert the changes of tissue remodeling.", {"entities": []}], ["Human mesenchymal stromal cells (MSCs) are effective at reducing inflammation and tissue remodeling; nevertheless, no study has evaluated the therapeutic effects of extracellular vesicles (EVs) obtained from human adipose tissue-derived MSCs (AD-MSC) on established airway remodeling in experimental allergic asthma.", {"entities": [[300, 315, "DISEASE"], [309, 315, "DISEASE"]]}], ["C57BL/6 female mice were sensitized and challenged with ovalbumin (OVA).", {"entities": []}], ["Control (CTRL) animals received saline solution using the same protocol.", {"entities": [[9, 13, "GENE"]]}], ["One day after the last challenge, each group received saline, 10 In OVA animals, AD-MSCs and EVs acted differently on static lung elastance and on BALF regulatory T cells, CD3 In this immunocompetent mouse model of allergic asthma, human AD-MSCs and EVs effectively reduced eosinophil counts in lung tissue and BALF and modulated airway remodeling, but their effects on T cells differed in lung and thymus.", {"entities": [[215, 230, "DISEASE"], [224, 230, "DISEASE"]]}], ["EVs may hold promise for asthma; however, further studies are required to elucidate the different mechanisms of action of AD-MSCs versus their EVs.", {"entities": [[25, 31, "DISEASE"]]}], ["Childhood pneumonia and bronchiolitis is a leading cause of illness and death in young children worldwide with Respiratory Syncytial Virus (RSV) as the main viral cause.", {"entities": [[10, 19, "DISEASE"], [24, 37, "DISEASE"]]}], ["RSV has been associated with annual respiratory disease outbreaks and bacterial co-infection has also been reported.", {"entities": []}], ["This study is the first RSV epidemiological study in young children hospitalized with community-acquired pneumonia (CAP) in Bel\u00e9m city, Par\u00e1 (Northern Brazil).", {"entities": [[105, 114, "DISEASE"]]}], ["With the objective of determining the prevalence of RSV infection and evaluating the patients\u2019 clinical and epidemiological features, we conducted a prospective study across eight hospitals from November 2006 to October 2007.", {"entities": []}], ["In this study, 1,050 nasopharyngeal aspirate samples were obtained from hospitalized children up to the age of three years with CAP, and tested for RSV antigen by direct immunofluorescence assay and by Reverse Transcription Polymerase Chain Reaction (RT-PCR) for RSV Group identification.", {"entities": []}], ["RSV infection was detected in 243 (23.1%) children.", {"entities": []}], ["The mean age of the RSV-positive group was lower than the RSV-negative group (12.1\u2009months vs 15.5\u2009months, p <0.001) whereas gender distribution was similar.", {"entities": []}], ["The RSV-positive group showed lower means of C-reactive protein (CRP) in comparison to the RSV-negative group (15.3 vs 24.0\u2009mg/dL, p <0.05).", {"entities": [[65, 68, "GENE"]]}], ["Radiological findings showed that 54.2% of RSV-positive group and 50.3% of RSV-negative group had interstitial infiltrate.", {"entities": []}], ["Bacterial infection was identified predominantly in the RSV-positive group (10% vs 4.5%, p<0.05).", {"entities": []}], ["Rhinorrhea and nasal obstruction were predominantly observed in the RSV-positive group.", {"entities": []}], ["A co-circulation of RSV Groups A and B was identified, with a predominance of Group B (209/227).", {"entities": []}], ["Multivariate analysis revealed that age under 1\u2009year ( p <0.015), CRP levels under 48\u2009mg/dL ( p <0.001) and bacterial co-infection ( p <0.032) were independently associated with the presence of RSV and, in the analyze of symptoms, nasal obstruction were independently associated with RSV-positive group ( p <0.001).", {"entities": [[66, 69, "GENE"]]}], ["The present study highlights the relevance of RSV infection in hospitalized cases of CAP in our region; our findings warrant the conduct of further investigations which can help design strategies for controlling the disease.", {"entities": []}], ["Depression is a common comorbidity among patients with Chronic Obstructive Pulmonary Disease (COPD) and has a significant impact on the course of the disease.", {"entities": []}], ["The aim of this study is to determine association between COPD Assessment Test (CAT) and major depression among clinically stable out-patient COPD subjects with mild hypoxemia.", {"entities": []}], ["Case\u2013control study.", {"entities": []}], ["Cases were 30 patients with major depression and controls were 30 patients without depression.", {"entities": []}], ["Major depression was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders criteria by a psychiatric evaluation.", {"entities": []}], ["All possible predictive variables were included in a multivariate logistic regression model to assess the association between major depression and each independent variable, while controlling for the sleep parameters.", {"entities": []}], ["CAT score >20 was associated with major depression (OR 7.88; 95% CI 1.96 - 31.7; p\u2009=\u20090.004).", {"entities": []}], ["CAT score >20 was associated with major depression, suggesting CAT as a predictor variable of major depression among COPD patients with mild hypoxemia, and indicating that an additional specific evaluation for the presence of major depression should be done.", {"entities": []}], ["Cough is frequently self-limiting, but may persist longer in certain individuals.", {"entities": []}], ["Most of previous studies on the epidemiology of chronic cough have only measured period prevalence, and thus have afforded limited information on the burden and natural course.", {"entities": []}], ["We aimed to investigate the epidemiology of chronic cough by using a point prevalence measure in a large-scale general population.", {"entities": []}], ["We analyzed cross-sectional data collected from 18,071 adults who participated in the Korean National Health and Nutrition Examination Survey 2010\u20132012.", {"entities": []}], ["Presence and duration of current cough was ascertained by structured questionnaires, and cough was classified into acute (<3 weeks), subacute (3\u20138 weeks), or chronic cough (\u22658 weeks).", {"entities": []}], ["Demographic and clinical parameters were examined in relation to chronic cough.", {"entities": []}], ["The point prevalences of acute, subacute, and chronic cough were 2.5\u200a\u00b1\u200a0.2%, 0.8\u200a\u00b1\u200a0.1% and 2.6\u200a\u00b1\u200a0.2%, respectively.", {"entities": []}], ["The proportion of current cough showed a steep decrease after 1 week of duration.", {"entities": []}], ["However, 2 peaks in the prevalence of current cough were revealed; cough durations of less than 1 week and longer than 1 year were most common (31.1% and 27.7% of current cough, respectively).", {"entities": []}], ["Subacute and chronic cough were more prevalent in the elderly (\u226565 years); the positive associations with older age were independent of other confounders, including current smoking and comorbidities.", {"entities": []}], ["This is the first report on the epidemiology of cough using a point prevalence measure in a nationally representative population sample.", {"entities": []}], ["Our findings indicate a high burden of chronic cough among adults with current cough in the community.", {"entities": []}], ["The dual-peak of cough duration suggested that the pathophysiology of acute and chronic cough may differ.", {"entities": []}], ["The preponderance of elderly people in the prevalence of chronic cough warrants further investigation.", {"entities": []}], ["In addition, more sophistication and validation of tools to define chronic cough will help our understanding of the epidemiology.", {"entities": []}], ["Fingolimod is an oral sphingosine\u20101\u2010phospate (S1P) receptor modulator for the treatment of relapsing\u2010remitting multiple sclerosis ( RRMS ).", {"entities": [[111, 129, "DISEASE"]]}], ["In addition to therapeutic effects on lymphoid and neural tissue, fingolimod influences cardiovascular system by specific S1P\u2010receptor modulation.", {"entities": []}], ["The effects of S1P\u2010receptor modulation on the endogenous circadian pattern of cardiac autonomic regulation ( CAR ), however, are not known.", {"entities": []}], ["We examined the effects of fingolimod on the circadian pattern of CAR .", {"entities": []}], ["Ambulatory 24\u2010h ECG recordings were undertaken in 27 RRMS patients before fingolimod (baseline), at the day of fingolimod initiation (1D) and after 3\u00a0months of fingolimod treatment (3M).", {"entities": []}], ["The mean time between two consecutive R\u2010peaks ( RR \u2010interval) and mean values for measures of heart rate variability ( HRV ) in time\u2010 and frequency domain were calculated from ECG recording at daytime and nighttime.", {"entities": []}], ["The mean night:day\u2010ratio of RR \u2010interval was 1.23\u00a0\u00b1\u00a00.12 at baseline, decreased temporarily at 1D (1.16\u00a0\u00b1\u00a00.12; P\u00a0 < \u00a0 0.01) and was higher at 3M (1.32\u00a0\u00b1\u00a00.11; P\u00a0 < \u00a0 0.001) than at baseline.", {"entities": []}], ["The night:day\u2010ratio of HRV parameters reflecting parasympathetic cardiac regulation ( pNN 50, rMSSD , HF nu) decreased at 1D but recovered back to baseline at 3M ( P\u00a0 < \u00a0 0.05 for all).", {"entities": [[86, 89, "GENE"]]}], ["On the other hand, the night:day\u2010ratio of TP , a parameter reflecting overall HRV gradually decreased and was lower at 3M than at baseline ( P\u00a0 < \u00a0 0.05).", {"entities": []}], ["Our findings suggest that physiological relation between the circadian pattern of RR \u2010interval and overall HRV as well as parasympathetic cardiac regulation becomes uncoupled during fingolimod treatment.", {"entities": []}], ["In addition, fingolimod shifts the circadian equilibrium of CAR toward greater daytime dominance of overall HRV .", {"entities": []}], ["Accordingly, S1P\u2010receptor modulation influences circadian pattern of CAR.", {"entities": []}], ["The 5-year retrospective study of the association between temperature and emergency department (ED) visits for asthma with mean ambient ozone levels between 10:00 and 15:00 was conducted in central New Jersey during the summer months.", {"entities": [[111, 117, "DISEASE"]]}], ["An association was identified in each of the years (1986-1990).", {"entities": []}], ["Between 8 and 34% of the total variance in ED visits for asthma was explained by the two environmental variables in the step-wise multiple regression analysis.", {"entities": [[57, 63, "DISEASE"]]}], ["ED visits occurred 28% more frequently when the mean ozone levels were > 0.06 ppm than when they were < 0.06 ppm.", {"entities": []}], ["This result was statistically significant in a covariance analysis.", {"entities": []}], ["An evaluation of the effects of ozone on asthmatics reported in the literature was completed to determine if, as proposed by Bates, the results from different types of studies were coherent among the health metrics.", {"entities": []}], ["A consistency in the magnitude of reported effects and the time lag between exposure and response for four different health indices (symptom reports, decrements in expiratory flow, ED visits, and hospital admissions) was identified and indicates a coherence between ozone and respiratory response to ozone exposure.", {"entities": []}], ["This supports a proposition that ozone adversely affects asthmatics at levels below the current U.S. standard.", {"entities": []}], ["The \u2018hygiene hypothesis\u2019 as originally formulated by Strachan, proposes that a cause of the recent rapid rise in atopic disorders could be a lower incidence of infection in early childhood, transmitted by unhygienic contact with older siblings.", {"entities": []}], ["Use of the term \u2018hygiene hypothesis\u2019 has led to several interpretations, some of which are not supported by a broader survey of the evidence.", {"entities": []}], ["The increase in allergic disorders does not correlate with the decrease in infection with pathogenic organisms, nor can it be explained by changes in domestic hygiene.", {"entities": []}], ["A consensus is beginning to develop round the view that more fundamental changes in lifestyle have led to decreased exposure to certain microbial or other species, such as helminths, that are important for the development of immunoregulatory mechanisms.", {"entities": []}], ["Although this review concludes that the relationship of the hypothesis to hygiene practice is not proven, it lends strong support to initiatives seeking to improve hygiene practice.", {"entities": []}], ["It would however be helpful if the hypothesis were renamed, e.g.", {"entities": []}], ["as the \u2018microbial exposure\u2019 hypothesis, or \u2018microbial deprivation\u2019 hypothesis, as proposed for instance by Bjorksten.", {"entities": []}], ["Avoiding the term \u2018hygiene\u2019 would help focus attention on determining the true impact of microbes on atopic diseases, while minimizing risks of discouraging good hygiene practice.", {"entities": []}], ["Stigma and discrimination constitute one of the greatest barriers to dealing effectively with the HIV epidemic, underlying a range of human rights violations and hindering access to prevention, care, treatment and support.", {"entities": []}], ["There is some existing protection against HIV-based discrimination under international law, but the extent of states' obligations to address such discrimination has not been comprehensively addressed in an international instrument.", {"entities": []}], ["The United Nations Convention on the Rights of Persons with Disabilities entered into force in May 2008.", {"entities": []}], ["As countries ratify the convention, they are required to amend national laws and policies to give greater protection to the human rights of people with disabilities, including abolishing disability-based discrimination by the state and protecting persons against such discrimination by others.", {"entities": []}], ["The Disability Convention addresses many of the issues faced by people living with HIV (PLHIV) but does not explicitly include HIV or AIDS within its open-ended definition of \"disability\".", {"entities": []}], ["Therefore, the advent of the Disability Convention prompts us to consider the links between HIV and disability and, specifically, to consider the opportunities it and other legal mechanisms, international or domestic, may afford for advancing the human rights of PLHIV facing human rights infringements.", {"entities": []}], ["We do so in the belief that the movement for human rights is stronger when constituencies with so many common and overlapping interests are united, and that respectful and strategic collaboration ultimately strengthens both the disability rights and the AIDS movements.", {"entities": []}], ["In this article, we first examine the links between HIV and disability.", {"entities": []}], ["We then provide a brief overview of how international human rights law has treated both disability and HIV/AIDS.", {"entities": []}], ["We note some of the different ways in which national anti-discrimination laws have reflected the links between HIV and disability, illustrated with representative examples from a number of countries.", {"entities": []}], ["Finally, we offer some conclusions and recommendations about ways forward for collaboration between HIV and disability rights advocates in advancing human rights at the international level, including the use of the new tool that is the Disability Convention.", {"entities": []}], ["We hope these reflections will promote further discussion across movements, ultimately to the benefit of all persons with disabilities and/or HIV.", {"entities": []}], ["Bipolar affective disorder (BP) is a common, highly heritable psychiatric disorder characterized by periods of depression and mania.", {"entities": []}], ["Using dense SNP genotype data, we characterized CNVs in 388 members of an Old Order Amish Pedigree with bipolar disorder.", {"entities": [[104, 120, "DISEASE"]]}], ["We identified CNV regions arising from common ancestral mutations by utilizing the pedigree information.", {"entities": []}], ["By combining this analysis with whole genome sequence data in the same individuals, we also explored the role of compound heterozygosity.", {"entities": []}], ["Here we describe 541 inherited CNV regions, of which 268 are rare in a control population of European origin but present in a large number of Amish individuals.", {"entities": []}], ["In addition, we highlight a set of CNVs found at higher frequencies in BP individuals, and within genes known to play a role in human development and disease.", {"entities": []}], ["As in prior reports, we find no evidence for an increased burden of CNVs in BP individuals, but we report a trend towards a higher burden of CNVs in known Mendelian disease loci in bipolar individuals (BPI and BPII, p\u2009=\u20090.06).", {"entities": [[202, 205, "GENE"]]}], ["We conclude that CNVs may be contributing factors in the phenotypic presentation of mood disorders and co-morbid medical conditions in this family.", {"entities": []}], ["These results reinforce the hypothesis of a complex genetic architecture underlying BP disorder, and suggest that the role of CNVs should continue to be investigated in BP data sets.", {"entities": []}], ["The online version of this article (doi:10.1186/s12863-015-0184-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["No longitudinal studies exist on the natural history of food hypersensitivity and IgE sensitisation to food allergens in adults.", {"entities": []}], ["To examine the natural history of food hypersensitivity, the natural history of IgE sensitisation to food allergens and to investigate the risk factors for new onset food hypersensitivity.", {"entities": []}], ["Food hypersensitivity was questionnaire-assessed in 2307 individuals (aged 20\u201345 years) from Iceland and Sweden during the European Community Respiratory Health Survey both at baseline and follow-up 9 years later.", {"entities": []}], ["IgE food and aeroallergen sensitisation were assessed in a subgroup of these individuals (n\u200a=\u200a807).", {"entities": []}], ["Values of 0.35 kU/L and above were regarded as positive sensitisation.", {"entities": []}], ["Food hypersensitivity was reported by 21% of the subjects and this proportion remained unchanged at follow-up (p\u200a=\u200a0.58).", {"entities": []}], ["Fruits, nuts and vegetables were the three most common causes of food hypersensitivity, with a similar prevalence at baseline and follow-up.", {"entities": []}], ["The prevalence IgE sensitisation to food allergens decreased in general by 56% (p<0.001) and IgE sensitisation to peanut decreased in particular by 67% (p\u200a=\u200a0.003).", {"entities": []}], ["The prevalence of timothy grass IgE sensitisation decreased by 15% (p\u200a=\u200a0.003) while cat, mite and birch IgE sensitisation did not decrease significantly.", {"entities": []}], ["Female sex, rhinitis, eczema and presence of IgE sensitisation to aeroallergens were independently associated with new onset food hypersensitivity.", {"entities": [[12, 20, "DISEASE"]]}], ["The prevalence of food hypersensitivity remained unchanged while the prevalence of IgE sensitisation to food allergens decreased in adults over a 9-year follow-up period.", {"entities": []}], ["The decrease in prevalence of IgE sensitisation to food allergens was considerably larger than the change in prevalence of IgE sensitisation to aeroallergens.", {"entities": []}], ["To evaluate the risk of depressive disorders among non-alcoholic patients by using the Taiwan National Health Insurance Research Database (NHIRD).", {"entities": []}], ["We conducted a retrospective study of a matched cohort of 52 725 participants (10 545 non-alcoholic cirrhotic patients and 42 180 control patients) who were selected from the NHIRD.", {"entities": []}], ["Patients were observed for a maximum of 11 years to determine the rates of newly onset depressive disorders, and Cox regression was used to identify the risk factors associated with depressive disorders in cirrhotic patients.", {"entities": []}], ["During the 11-year follow-up period, 395 (3.75%) non-alcoholic cirrhotic patients and 1 183 (2.80%) control patients were diagnosed with depressive disorders.", {"entities": []}], ["The incidence risk ratio of depressive disorders between non-alcoholic cirrhotic patients and control patients was 1.76 (95% CI, 1.57\u20131.98, P <.001).", {"entities": []}], ["After adjusting for age, sex, and comorbidities, non-alcoholic cirrhotic patients were 1.75 times more likely to develop depressive disorders (95% CI, 1.56\u20131.96, P <.001) compared with the control patients.", {"entities": []}], ["The hazard ratios for patients younger than 60 years old (1.31) and female (1.25) indicated that each is an independent risk factor for depressive disorders in non-alcoholic cirrhotic patients.", {"entities": []}], ["The likelihood of developing depressive disorders is greater among non-alcoholic cirrhotic patients than among patients without cirrhosis.", {"entities": []}], ["Symptoms of depression should be sought in patients with cirrhosis.", {"entities": []}], ["Epidemiologic studies investigating the differences in respiratory outcomes between asthma\u2013chronic obstructive pulmonary disease overlap syndrome (ACOS) and chronic obstructive pulmonary disease (COPD) in an Asian population are lacking.", {"entities": [[91, 128, "DISEASE"], [157, 194, "DISEASE"], [137, 145, "DISEASE"], [84, 90, "DISEASE"]]}], ["We conducted a population-based cohort study to compare the incidence of acute respiratory events between ACOS and COPD cohorts in Taiwan.", {"entities": []}], ["This study investigated the incidence of acute respiratory events, namely, pneumonia, acute exacerbation, acute respiratory failure, and cardiopulmonary arrest, in 8571 patients with physician-diagnosed ACOS between 2000 and 2007 from the Longitudinal Health Insurance Database.", {"entities": [[112, 131, "DISEASE"], [75, 84, "DISEASE"]]}], ["The comparison cohort comprised 17,088 COPD patients, frequency-matched according to age, sex, and the index-year.", {"entities": []}], ["The duration of follow-up was measured for each patient from the index date to 5 years thereafter.", {"entities": []}], ["We used univariable and multivariable Poisson regression models to analyze the risk of acute respiratory events by including the variables of sex, age, and comorbidity.", {"entities": []}], ["The overall prevalence of ACOS was approximately 17.4% in patients with COPD.", {"entities": []}], ["The prevalence of ACOS increased with age.", {"entities": []}], ["During the 5-year follow-up, a greater incidence of acute respiratory events was observed in the ACOS cohort than in the COPD cohort (11.5 and 4.62, per 100 person-years, respectively) with an adjusted incidence rate ratio (IRR) of 1.72 (95% confidence interval [CI]\u200a=\u200a1.63\u20131.81).", {"entities": []}], ["Compared with the COPD cohort, the ACOS patients had a 1.13-fold adjusted IRR of pneumonia (95% CI\u200a=\u200a1.07\u20131.20) and a 2.58-fold adjusted IRR of acute exacerbation (95% CI\u200a=\u200a2.43\u20132.74).", {"entities": [[81, 90, "DISEASE"]]}], ["Clinicians should be aware of frequent exacerbation of ACOS and prescribe appropriate treatment.", {"entities": []}], ["To evaluate the sensitivity, specificity and predictive values of spirometry for the diagnosis of chronic obstructive pulmonary disease (COPD) and asthma in patients suspected of suffering from an obstructive airway disease (OAD) in primary care.", {"entities": [[98, 135, "DISEASE"], [147, 153, "DISEASE"]]}], ["Cross sectional diagnostic study of 219 adult patients attending 10 general practices for the first time with complaints suspicious for OAD.", {"entities": []}], ["All patients underwent spirometry and structured medical histories were documented.", {"entities": []}], ["All patients received whole-body plethysmography (WBP) in a lung function laboratory.", {"entities": []}], ["The reference standard was the Tiffeneau ratio (FEV 1 /VC) received by the spirometric maneuver during examination with WBP.", {"entities": [[48, 51, "GENE"]]}], ["In the event of inconclusive results, bronchial provocation was performed to determine bronchial hyper-responsiveness (BHR).", {"entities": []}], ["Asthma was defined as a PC 20 fall after inhaling methacholine concentration \u2264 16 mg/ml.", {"entities": [[0, 6, "DISEASE"], [24, 26, "GENE"]]}], ["90 (41.1%) patients suffered from asthma, 50 (22.8%) suffered from COPD, 79 (36.1%) had no OAD.", {"entities": [[34, 40, "DISEASE"]]}], ["The sensitivity for diagnosing airway obstruction in COPD was 92% (95%CI 80\u201397); specificity was 84% (95%CI 77\u201389).", {"entities": []}], ["The positive predictive value (PPV) was 63% (95%CI 51\u201373); negative predictive value (NPV) was 97% (95%CI 93\u201399).", {"entities": []}], ["The sensitivity for diagnosing airway obstruction in asthma was 29% (95%CI 21\u201339); specificity was 90% (95%CI 81\u201395).", {"entities": [[53, 59, "DISEASE"]]}], ["PPV was 77% (95%CI 60\u201388); NPV was 53% (95%CI 45\u201361).", {"entities": []}], ["COPD can be estimated with high diagnostic accuracy using spirometry.", {"entities": []}], ["It is also possible to rule in asthma with spirometry.", {"entities": [[31, 37, "DISEASE"]]}], ["However, asthma can not be ruled out only using spirometry.", {"entities": [[9, 15, "DISEASE"]]}], ["This diagnostic uncertainty leads to an overestimation of asthma presence.", {"entities": [[58, 64, "DISEASE"]]}], ["Patients with inconclusive spirometric results should be referred for nitric oxide (NO) \u2013 measurement and/or bronchial provocation if possible to guarantee accurate diagnosis.", {"entities": []}], ["Mast cells originate from pluripotent hematopoietic stem cells.", {"entities": []}], ["Two mast cell specific antibodies, mAbsAA4 and BGD6, have previously been used to identify and study committed mast cell precursors (MCcps) in the bone marrow of adult mice and rats.", {"entities": []}], ["However, the embryonic origin of MCcps is still not known.", {"entities": []}], ["In the present study, we identified MCcps in rat embryos using these previously characterized mast cell specific antibodies.", {"entities": []}], ["The MCcps were found in the AGM (aorta-gonad-mesonephros) region of rat embryos at E11.5.", {"entities": []}], ["These cells were BGD6+, CD34 In vitro , the MCcps differentiated into metachromatic mast cells.", {"entities": [[24, 28, "GENE"]]}], ["With age of gestation the percent of MCcps diminished while the percent of mast cell progenitors increased.", {"entities": []}], ["An increased knowledge of the biology and embryonic origin of mast cells may contribute to a greater understanding of allergy, asthma, and other mast cell related diseases.", {"entities": [[127, 133, "DISEASE"]]}], ["Atherosclerosis and its complications are major causes of\u00a0death all over the world.", {"entities": [[0, 15, "DISEASE"]]}], ["One of the major risks\u00a0of atherosclerosis is hypercholesterolemia.", {"entities": [[26, 41, "DISEASE"]]}], ["During atherosclerosis, oxidized low density lipoprotein (oxLDL) regulates CD36-mediated activation of c-jun amino terminal kinase-1 (JNK1) and modulates matrix metalloproteinase (MMP) induction which stimulates inflammation with an invasion of monocytes.", {"entities": [[7, 22, "DISEASE"]]}], ["Additionally, inhibition of proteasome leads to an accumulation of c-jun and phosphorylated c-jun and activation of activator protein-1 (AP-1) related increase of MMP expression.", {"entities": []}], ["We have previously reported a significant increase in cluster of differentiation 36 (CD36) mRNA levels in hypercholesterolemic rabbits and shown that vitamin E treatment prevented the cholesterol induced increase in CD36 mRNA expression.", {"entities": [[85, 89, "GENE"], [216, 220, "GENE"], [85, 89, "GENE"], [216, 220, "GENE"]]}], ["In the present study, our aim is to identify the signaling molecules/transcription factors involved in the progression of atherosclerosis following CD36 activation in an in vivo model of hypercholesterolemic (induced by 2% cholesterol containing diet) rabbits.", {"entities": [[122, 137, "DISEASE"], [148, 152, "GENE"]]}], ["In this direction, proteasomal activities by fluorometry and c-jun, phospo c-jun, JNK1, MMP-9 expressions by quantitative RT-PCR and immunoblotting were tested in aortic tissues.", {"entities": []}], ["The effects of vitamin E on these changes were also investigated in this model.", {"entities": []}], ["As a result, c-jun was phosphorylated following decreased proteasomal degradation in hypercholesterolemic group.", {"entities": []}], ["MMP-9 expression was also increased in cholesterol group rabbits contributing to the development of atherosclerosis.", {"entities": [[100, 115, "DISEASE"]]}], ["In addition, vitamin E showed its effect by decreasing MMP-9 levels and phosphorylation of c-jun.", {"entities": []}], ["\u2022 Signaling mechanisms are examined in hypercholesterolemic rabbits.", {"entities": []}], ["\u2022 Hypercholesterolemia mediated proteasome inhibition modulates c-jun degradation.", {"entities": []}], ["\u2022 Phosphorylated c-jun is thought to be involved in matrix metalloproteinase expression.", {"entities": []}], ["\u2022 Vitamin E shows its beneficial effect by decreasing JNK1 and phospho c-jun levels.", {"entities": []}], ["Signaling mechanisms are examined in hypercholesterolemic rabbits.", {"entities": []}], ["Hypercholesterolemia mediated proteasome inhibition modulates c-jun degradation.", {"entities": []}], ["Phosphorylated c-jun is thought to be involved in matrix metalloproteinase expression.", {"entities": []}], ["Vitamin E shows its beneficial effect by decreasing JNK1 and phospho c-jun levels.", {"entities": []}], ["Quality of life (QoL) in patients with chronic disease is impaired and cannot be solely explained by disease severity.", {"entities": []}], ["We explored whether genetic variability and activity contributes to QoL in patients with Marfan syndrome (MFS), a genetic connective tissue disorder.", {"entities": [[96, 104, "DISEASE"]]}], ["In 121 MFS patients, patient characteristics (i.e.", {"entities": []}], ["demographics and MFS-related symptoms) were assessed.", {"entities": []}], ["Patients completed the SF-36 to measure QoL.", {"entities": []}], ["In addition, transcriptome wide gene expression and 484 Single Nucleotide Polymorphysms (SNPs) in cytokine genes were available.", {"entities": []}], ["QoL was first analyzed and associated with patient characteristics.", {"entities": []}], ["Patients\u2019 physical QoL was impaired and weakly related with age and scoliosis, whereas mental quality of life (MCS) was normal.", {"entities": []}], ["To explain a largely lacking correlation between disease severity and QoL, we related genome wide gene expression to QoL.", {"entities": []}], ["Patients with lower MCS scores had high expression levels of CXCL9 and CXCL11 cytokine-related genes ( p \u200a=\u200a0.001; p \u200a=\u200a0.002); similarly, patients with low vitality scores had high expression levels of CXCL9, CXCL11 and IFNA6 cytokine-related genes ( p \u200a=\u200a0.02 ; p \u200a=\u200a0.02; p \u200a=\u200a0.04), independent of patient characteristics.", {"entities": [[61, 66, "GENE"], [203, 208, "GENE"], [71, 77, "GENE"], [210, 216, "GENE"], [61, 66, "GENE"], [203, 208, "GENE"], [71, 77, "GENE"], [210, 216, "GENE"], [221, 226, "GENE"]]}], ["Subsequently, we associated cytokine related SNPs to mental QoL (MCS and vitality).", {"entities": []}], ["SNP-cluster in the IL4R gene showed a weak association with MCS and vitality (strongest association p \u200a=\u200a0.0017).", {"entities": [[19, 23, "GENE"]]}], ["Although overall mental QoL was normal, >10% of patients had low scores for MCS and vitality.", {"entities": []}], ["Post-hoc analysis of systemic inflammatory mediators showed that patients with lowest MCS and vitality scores had high levels of CCL11 cytokine ( p \u200a=\u200a0.03; p \u200a=\u200a0.04).", {"entities": [[129, 134, "GENE"]]}], ["Variation in the cytokine genetic pathway and its activation is related to mental QoL.", {"entities": []}], ["These findings might allow us to identify and, ultimately, treat patients susceptible to poor QoL.", {"entities": []}], ["Specific strains of Lactobacillus have been found to be beneficial in treating some types of diarrhea and vaginosis.", {"entities": [[93, 101, "DISEASE"]]}], ["However, a high mortality rate results from underlying immunosuppressive conditions in patients with Lactobacillus casei bacteremia.", {"entities": []}], ["Cyclic AMP (cAMP) is a small second messenger molecule that mediates signal transduction.", {"entities": []}], ["The onset and progression of inflammatory responses are sensitive to changes in steady-state cAMP levels.", {"entities": []}], ["L. casei cell wall extract (LCWE) develops arteritis in mice through Toll-like receptor-2 signaling.", {"entities": []}], ["The purpose of this study was to investigate whether intracellular cAMP affects LCWE-induced pathological signaling.", {"entities": []}], ["LCWE was shown to induce phosphorylation of the nuclear factor \u03ba B (NF- \u03ba B) and mitogen-activated protein kinase (MAPK) signaling pathways and cell proliferation in mice fibroblast cells.", {"entities": []}], ["Theophylline and phosphodiesterase inhibitor increased intracellular cAMP and inhibited LCWE-induced cell proliferation as well as phosphorylation of NF- \u03ba B and MAPK.", {"entities": []}], ["Protein kinase A inhibitor H89 prevented cAMP-induced MAPK inhibition, but not cAMP-induced NF- \u03ba B inhibition.", {"entities": []}], ["An exchange protein activated by cAMP (Epac) agonist inhibited NF- \u03ba B activation but not MAPK activation.", {"entities": []}], ["These results indicate that an increase in intracellular cAMP prevents LCWE induction of pathological signaling pathways dependent on PKA and Epac signaling.", {"entities": []}], ["Rheumatoid arthritis (RA) associates with excessive cardiovascular morbidity and mortality, attributed to both traditional and novel cardiovascular risk factors.", {"entities": [[11, 20, "DISEASE"]]}], ["The metabolic syndrome, a cluster of classical cardiovascular risk factors, including hypertension, obesity, glucose intolerance, and dyslipidaemia, is highly prevalent in RA.", {"entities": [[86, 98, "DISEASE"], [109, 128, "DISEASE"], [100, 107, "DISEASE"], [14, 22, "DISEASE"]]}], ["Reports suggest that long-term glucocorticoid (GC) use may exacerbate individual cardiovascular risk factors, but there have been no studies in RA to assess whether it associates with the metabolic syndrome.", {"entities": [[198, 206, "DISEASE"], [47, 49, "GENE"]]}], ["We examined whether GC exposure associates with the presence of metabolic syndrome in patients with RA.", {"entities": [[74, 82, "DISEASE"], [20, 22, "GENE"]]}], ["RA patients (n = 398) with detailed clinical and laboratory assessments were categorised into three groups according to GC exposure: no/limited (<3 months) exposure (NE), low-dose (<7.5 mg/day) long-term exposure (LE), and medium-dose (greater than or equal to 7.5 mg to 30 mg/day) long-term exposure (ME).", {"entities": [[120, 122, "GENE"]]}], ["The metabolic syndrome was defined using the National Cholesterol Education Programme III guidelines.", {"entities": [[14, 22, "DISEASE"]]}], ["The association of GC exposure with the metabolic syndrome was evaluated using binary logistic regression.", {"entities": [[50, 58, "DISEASE"], [19, 21, "GENE"]]}], ["The metabolic syndrome was present in 40.1% of this population and its prevalence did not differ significantly between the GC exposure groups (NE 37.9% versus LE 40.7% versus ME 50%, P = 0.241).", {"entities": [[14, 22, "DISEASE"], [123, 125, "GENE"]]}], ["Binary logistic regression did not demonstrate any increased odds for the metabolic syndrome when comparing ME with LE (odds ratio = 1.64, 95% confidence interval 0.92 to 2.92, P = 0.094) and remained non significant after adjusting for multiple potential confounders.", {"entities": [[84, 92, "DISEASE"]]}], ["Long-term GC exposure does not appear to associate with a higher prevalence of the metabolic syndrome in patients with RA.", {"entities": [[93, 101, "DISEASE"], [10, 12, "GENE"]]}], ["The components of the metabolic syndrome may already be extensively modified by other processes in RA (including chronic inflammation and treatments other than GCs), leaving little scope for additive effects of GCs.", {"entities": [[32, 40, "DISEASE"]]}], ["Hypoxemia is the most common adverse event that happened during gastrointestinal endoscopy.", {"entities": []}], ["To estimate risk of hypoxemia prior to endoscopy, American Society of Anesthesiology (ASA) classification scores were used as a major predictive factor.", {"entities": []}], ["But the accuracy of ASA scores for predicting hypoxemia incidence was doubted here, considering that the classification system ignores much information about general health status and fitness of patient that may contribute to hypoxemia.", {"entities": []}], ["In this retrospective review of clinical data collected prospectively, the data on 4904 procedures were analyzed.", {"entities": []}], ["The Pearson\u2019s chi-square test or the Fisher exact test was employed to analyze variance of categorical factors.", {"entities": []}], ["Continuous variables were statistically evaluated using t-tests or Analysis of variance (ANOVA).", {"entities": []}], ["As a result, only 245 (5.0%) of the enrolled 4904 patients were found to present hypoxemia during endoscopy.", {"entities": []}], ["Multivariable logistic regressions revealed that independent risk factors for hypoxemia include high BMI (BMI 30 versus 20, Odd ratio: 1.52, 95% CI: 1.13\u20132.05; P\u200a=\u200a0.0098), hypertension (Odd ratio: 2.28, 95% CI: 1.44\u20133.60; P\u200a=\u200a0.0004), diabetes (Odd ratio: 2.37, 95% CI: 1.30\u20134.34; P\u200a=\u200a0.005), gastrointestinal diseases (Odd ratio: 1.77, 95% CI: 1.21\u20132.60; P\u200a=\u200a0.0033), heart diseases (Odd ratio: 1.97, 95% CI: 1.06\u20133.68; P\u200a=\u200a0.0325) and the procedures that combined esophagogastroduodenoscopy (EGD) and colonoscopy (Odd ratio: 4.84, 95% CI: 1.61\u201315.51; P\u200a=\u200a0.0292; EGD as reference).", {"entities": [[173, 185, "DISEASE"]]}], ["It is noteworthy that ASA classification scores were not included as an independent predictive factor, and susceptibility of youth to hypoxemia during endoscopy was as high as old subjects.", {"entities": []}], ["In conclusion, some certain pre-existing diseases of patients were newly identified as independent risk factors for hypoxemia during GI endoscopy.", {"entities": []}], ["High ASA scores are a confounding predictive factor of pre-existing diseases.", {"entities": []}], ["We thus recommend that youth (\u226418 yrs), obese patients and those patients with hypertension, diabetes, heart diseases, or GI diseases should be monitored closely during sedation endoscopy.", {"entities": [[79, 91, "DISEASE"]]}], ["There is only limited accurate data on the epidemiology of rhinosinusitis in primary care.", {"entities": []}], ["This study was conducted to assess the incidence of acute and chronic rhinosinusitis by analysing data from two Dutch general practice registration projects.", {"entities": []}], ["Several patient characteristics and diseases are related to the diagnosis rhinosinusitis.", {"entities": []}], ["The Continuous Morbidity Registration (CMR) and the Transitionproject (TP) are used to analyse the data on rhinosinusitis in primary practice.", {"entities": []}], ["Both registries use codes to register diagnoses.", {"entities": []}], ["In the CMR 3244 patients are registered with rhinosinusitis and in the TP 5424 CMR: The absolute incidence of (acute) rhinosinusitis is 5191 (18.8 per 1000 patient years).", {"entities": []}], ["Regarding an odds ratio of 5.58, having nasal polyps is strongest related to rhinosinusitis compared to the other evaluated comorbidities.", {"entities": []}], ["A separate code for chronic rhinosinusitis exists, but is not in use.", {"entities": []}], ["TP: Acute and chronic rhinosinusitis are coded as one diagnosis.", {"entities": []}], ["The incidence of rhinosinusitis is 5574 or 28.7 per 1000 patient years.", {"entities": []}], ["Patients who visit their general practitioner with \u201csymptoms/complaints of sinus\u201d, allergic rhinitis and \u201cother diseases of the respiratory system\u201d have the highest chances to be diagnosed with rhinosinusitis.", {"entities": [[83, 100, "DISEASE"], [92, 100, "DISEASE"]]}], ["Medication is prescribed in 90.6\u00a0% of the cases.", {"entities": []}], ["Rhinosinusitis is a common diagnosis in primary practice.", {"entities": []}], ["In the used registries no difference could be made between acute and chronic rhinosinusitis, but they give insight in comorbidity and interventions taken by the GP in case of rhinosinusitis.", {"entities": []}], ["Most western countries have disability benefit schemes ostensibly based upon requiring (1) a work inhibiting functional limitation that (2) can be attributed to a diagnosable condition, injury or disease.", {"entities": []}], ["The present paper examines to what extent current practice matches the core premises of this model by examining how much poorer the perceived health of disability benefit recipients is, compared to the employed and the unemployed, and further to examine to what extent any poorer perceived health among benefit recipients can be attributed to mental or somatic illness and symptoms.", {"entities": []}], ["Information on disability benefit recipiency was obtained from Norwegian registry data, and merged with health information from the Hordaland Health Study (HUSK) in Western Norway, 1997\u201399.", {"entities": []}], ["Participants (N = 14 946) aged 40\u201347 were assessed for perceived physical and mental health (Short Form-12), somatic symptoms, mental health, and self reported somatic conditions and diseases treated with medication.", {"entities": []}], ["Differences associated with employment status were tested in chi-square and t-tests, as well as multivariate and univariate regression models to adjust for potential confounders.", {"entities": []}], ["Recipients of disability benefits (n = 1 351) had poorer perceived physical and mental health than employees (n = 13 156); group differences were 1.86 and 0.74 pooled standard deviations respectively.", {"entities": []}], ["Self reported somatic diagnoses, mental health and symptoms accounted for very little of this difference in perceived health.", {"entities": []}], ["The unemployed (n = 439) were comparable to the employed rather than the recipients of disability benefits.", {"entities": []}], ["Recipients of disability benefits have poor perceived health compared to both the employed and the unemployed.", {"entities": []}], ["Surprisingly little of this difference can be ascribed to respondents' descriptions of their illnesses and symptoms.", {"entities": []}], ["Even allowing for potential underascertainment of condition severity, this finding supports the increasing focus on non-disease oriented contributing factors.", {"entities": []}], ["Rehabilitation efforts aiming at return to work should have a strong focus on the patients' perceptions of their health in addition to symptom relief and social factors.", {"entities": []}], ["Despite a potentially effective therapy for adult respiratory failure, a general agreement on venovenous extracorporeal membrane oxygenation (VV-ECMO) has not been reached among institutions due to its invasiveness and high resource usage.", {"entities": [[50, 69, "DISEASE"]]}], ["To establish consensus on the timing of intervention, large ECMO organizations have published the respiratory extracorporeal membrane oxygenation survival prediction (RESP) score and the ECMOnet score, which allow users to predict hospital mortality for candidates with their pre-ECMO presentations.", {"entities": []}], ["This study was aimed to test the predictive powers of these published scores in a medium-sized cohort enrolling adults treated with VV-ECMO for acute respiratory failure, and develop an institutional prediction model under the framework of the 3 scores if a superior predictive power could be achieved.", {"entities": [[150, 169, "DISEASE"]]}], ["This retrospective study included 107 adults who received VV-ECMO for severe acute respiratory failure (a P a O 2 /FiO 2 ratio <70\u200amm Hg) in a tertiary referral center from 2007 to 2015.", {"entities": [[83, 102, "DISEASE"]]}], ["Essential demographic and clinical data were collected to calculate the RESP score, the ECMOnet score, and the sequential organ failure assessment (SOFA) score before VV-ECMO.", {"entities": []}], ["The predictive power of hospital mortality of each score was presented as the area under receiver-operating characteristic curve (AUROC).", {"entities": []}], ["The multivariate logistic regression was used to develop an institutional prediction model.", {"entities": []}], ["The surviving to discharge rate was 55% (n\u200a=\u200a59).", {"entities": []}], ["All of the 3 published scores had a real but poor predictive power of hospital mortality in this study.", {"entities": []}], ["The AUROCs of RESP score, ECMOnet score, and SOFA score were 0.662 ( P \u200a=\u200a0.004), 0.616 ( P \u200a=\u200a0.04), and 0.667 ( P \u200a=\u200a0.003), respectively.", {"entities": []}], ["An institutional prediction model was established from these score parameters and presented as follows: hospital mortality ( Y )\u200a=\u200a\u22123.173\u200a+\u200a0.208\u200a\u00d7\u200a(pre-ECMO SOFA score)\u200a+\u200a0.148\u200a\u00d7\u200a(pre-ECMO mechanical ventilation day)\u200a+\u200a1.021\u200a\u00d7\u200a(immunocompromised status).", {"entities": []}], ["Compared with the 3 scores, the institutional model had a significantly higher AUROC (0.779; P \u200a<\u200a0.001).", {"entities": []}], ["The 3 published scores provide valuable information about the poor prognostic factors for adult respiratory ECMO.", {"entities": []}], ["Among the score parameters, duration of mechanical ventilation, immunocompromised status, and severity of organ dysfunction may be the most important prognostic factors of VV-ECMO used for adult respiratory failure.", {"entities": [[195, 214, "DISEASE"]]}], ["The pathological increase in the levels of reactive oxygen species (ROS) in the retinal pigment epithelium (RPE), is implicated in the development of age-related macular degeneration (AMD).", {"entities": [[162, 182, "DISEASE"], [108, 111, "GENE"]]}], ["The discovery of drug candidates to effectively protect RPE cells from oxidative damage is required to resolve the pathological aspects and modify the process of AMD.", {"entities": [[56, 59, "GENE"]]}], ["In this study, a FDA-approved anti-malaria drug, Artemisinin was found to suppress hydrogen peroxide (H 2 O 2 )-induced cell death in human RPE cell-D407 cells.", {"entities": [[35, 42, "DISEASE"], [140, 143, "GENE"]]}], ["Further study showed that Artemisinin significantly suppressed H 2 O 2 2 O 2 -induced cytotoxicity and the increase of caspase 3/7 activity in the presence of the ERK inhibitor PD98059.", {"entities": []}], ["Taken together, these results suggest that Artemisinin is a potential protectant with the pro-survival effects against H 2 O 2 insult through activation of the ERK/CREB pathway.", {"entities": []}], ["fx1 \u2022 Artemisinin modulates \u25b3\u03c8m and caspase 3 apoptotic pathways.", {"entities": []}], ["\u2022 Artemisinin induces ERK/CREB signaling pathway.", {"entities": []}], ["\u2022 Artemisinin protects RPE cells against H 2 O 2 -induced oxidative stress.", {"entities": [[23, 26, "GENE"]]}], ["\u2022 Artemisinin suppresses H 2 O 2 -induced the increase of ROS in RPE cells.", {"entities": [[65, 68, "GENE"]]}], ["Artemisinin modulates \u25b3\u03c8m and caspase 3 apoptotic pathways.", {"entities": []}], ["Artemisinin induces ERK/CREB signaling pathway.", {"entities": []}], ["Artemisinin protects RPE cells against H 2 O 2 -induced oxidative stress.", {"entities": [[21, 24, "GENE"]]}], ["Artemisinin suppresses H 2 O 2 -induced the increase of ROS in RPE cells.", {"entities": [[63, 66, "GENE"]]}], ["Procalcitonin (PCT) is activated during cardiopulmonary bypass (CPB) and may be a predictor of acute respiratory distress syndrome (ARDS).", {"entities": [[122, 130, "DISEASE"]]}], ["The objective of this study is to determine whether patients with different serum PCT concentrations exhibit different rates of developing moderate to severe ARDS.", {"entities": []}], ["This is a prospective, single centre, observational cohort study.", {"entities": []}], ["All patients admitted to the cardiosurgery department for cardiac surgery with CPB were screened for study eligibility.", {"entities": []}], ["All eligible patients received a CPB procedure.", {"entities": []}], ["Blood samples were obtained to determine white cell counts as well as N-terminal pro-B-type natriuretic peptide, C reactive protein and PCT levels.", {"entities": []}], ["Patients were assigned to the PCT elevated cohort or the control cohort based on serum PCT concentrations on the first postoperative day with a cut-off value of 7.0\u2005ng/mL.", {"entities": []}], ["Data, including baseline, perioperative and outcome data, were collected daily for 7\u2005days.", {"entities": []}], ["The primary end point was the incidence of moderate to severe ARDS, which was diagnosed according to the Berlin definition.", {"entities": []}], ["The study was approved by the Institutional Review Board of Fujian Provincial Hospital.", {"entities": []}], ["Study findings are disseminated through peer-reviewed publications and conference presentations.", {"entities": []}], ["Chinese Clinical Trial Registry (ChiCTR-OCH-14005076).", {"entities": []}], ["Atherosclerosis and COPD are both systemic inflammatory diseases that may influence each other.", {"entities": []}], ["The aim of the present study was to determine the prevalence of COPD in patients with cerebral and/or peripheral artery disease and to assess factors associated with the presence of COPD.", {"entities": []}], ["Following the diagnosis of cerebral and/or peripheral artery disease by means of duplex sonography, 166 consecutive patients underwent body plethysmography with capillary blood gas analysis.", {"entities": []}], ["Thereafter, blood tests with determination of different parameters such as lipid profile, inflammatory and coagulation markers were conducted in remaining 136 patients who fulfilled inclusion criteria of the study.", {"entities": []}], ["Thirty-six out of 136 patients suffered from COPD, mostly in early stages of the disease.", {"entities": []}], ["Residual volume indicating emphysema was increased (162.9%\u00b155.9% vs 124.5%\u00b137.0%, p <0.05) and diffusion capacity was decreased (55.1%\u00b119.5% vs 75.3%\u00b118.6%, p <0.05) in COPD patients vs non-COPD group.", {"entities": []}], ["In capillary blood gas analysis, COPD patients had lower partial pressure of oxygen (70.9\u00b111.5 vs 75.2\u00b111.0 mmHg, p <0.05) and higher partial pressure of carbon dioxide (36.8\u00b17.5 vs 34.4\u00b14.4 mmHg, p <0.05) compared with non-COPD individuals.", {"entities": []}], ["Presence of COPD was associated with predominance of diabetes mellitus, interleukin-8-related systemic neutrophilic inflammation and anemia.", {"entities": [[133, 139, "DISEASE"], [53, 70, "DISEASE"]]}], ["In conclusion, COPD is highly prevalent in patients with atherosclerotic artery disease.", {"entities": []}], ["A strong inverse relationship of functional limitation and socioeconomic status has been established in western ageing society.", {"entities": []}], ["Functional limitation can be related to chronic diseases, disuse, cognitive decline, and ageing.", {"entities": []}], ["Among chronic diseases in the Thai population, cerebrovascular diseases, diabetes, and arthritis are common.", {"entities": [[87, 96, "DISEASE"]]}], ["These factors are known to contribute to disability and poor quality of life in the elder population.", {"entities": []}], ["Neuropsychiatric problems, cognitive decline, dementia, and cultural issues in elderly people also can alter the quality of life of the elderly.", {"entities": [[46, 54, "DISEASE"]]}], ["The Dementia and Disability Project in Thai Elderly (DDP) aims at comprehensively assessing community dwelling Thai elderly to understand the relationship between disability and motor function, neuropsychiatric symptoms, cognitive function, and chronic diseases.", {"entities": [[4, 12, "DISEASE"]]}], ["The DDP is the first study to look at the prevalence and etiology of dementia and of mild cognitive impairment (MCI) in Thai elders and to explore the relationship of cognition, disability, small vessel diseases and cortical degeneration with neuroimaging in Thai elderly people.", {"entities": [[69, 77, "DISEASE"]]}], ["1998 Thai elders were screened in 2004\u20132006 and diagnosed as having MCI or dementia.", {"entities": [[75, 83, "DISEASE"]]}], ["223 elders with MCI or dementia and cognitively normal elderly had brain magnetic resonance imaging (MRI) or at baseline.", {"entities": [[23, 31, "DISEASE"]]}], ["319 elders from the 3 groups had blood tests to investigate the risks and possible etiologies of dementia including genotyping at baseline.", {"entities": [[97, 105, "DISEASE"]]}], ["The mean age of elders in this study is 69.51(SD=6.71, min=60, max=95) years.", {"entities": []}], ["689(34.9%) are men and 1284(65.1%) are women.", {"entities": []}], ["Mean body weight was 58.36(SD=11.20) kgs.", {"entities": []}], ["The regression model reveals that performance on gait and balance and serum triglyceride predicts activity of daily living performance (adjusted r The large and comprehensive set of measurements in DDP allows a wide-ranging explanation of the functional and clinical features to be investigated in relation to white matter lesions or cortical atrophy of the brain in Thai elderly population.", {"entities": []}], ["An almost 2 year follow up was made available to those with MCI and dementia and some of the cognitively normal elderly.", {"entities": [[68, 76, "DISEASE"]]}], ["The longitudinal design will provide great understanding of the possible contributors to disability in the elderly and to the progression of cognitive decline in Thai elders.", {"entities": []}], ["Many patients with chronic obstructive pulmonary disease (COPD) continue to suffer exacerbations, even when treated with maximum recommended therapy (eg, inhaled combinations of long-acting \u03b2 2 -agonist and high dose inhaled corticosteroids, with or without a long-acting anticholinergic [long-acting muscarinic antagonist]).", {"entities": [[19, 56, "DISEASE"]]}], ["Roflumilast is approved to treat severe COPD in patients with chronic bronchitis \u2013 and a history of frequent exacerbations \u2013 as an add-on to bronchodilators.", {"entities": [[70, 80, "DISEASE"]]}], ["The REACT (Roflumilast in the Prevention of COPD Exacerbations While Taking Appropriate Combination Treatment) study (identification number RO-2455-404-RD, clinicaltrials.", {"entities": []}], ["gov identifier NCT01329029) will investigate whether roflumilast further reduces exacerbations when added to inhaled combination therapy in patients still suffering from frequent exacerbations.", {"entities": []}], ["REACT is a 1-year randomized, double-blind, multicenter, phase III/IV study of roflumilast 500 \u03bcg once daily or placebo on top of a fixed long-acting \u03b2 2 -agonist/inhaled corticosteroid combination.", {"entities": []}], ["A concomitant long-acting muscarinic antagonist will be allowed at stable doses.", {"entities": []}], ["The primary outcome is the rate of moderate or severe COPD exacerbations.", {"entities": []}], ["Using a Poisson regression model with a two-sided significance level of 5%, a sample size of 967 patients per treatment group is needed for 90% power.", {"entities": []}], ["COPD patients with severe to very severe airflow limitation, symptoms of chronic bronchitis, and at least two exacerbations in the previous year will be recruited.", {"entities": [[81, 91, "DISEASE"]]}], ["It is hypothesized that because roflumilast (a phosphodiesterase-4 inhibitor) has a different mode of action to bronchodilators and inhaled corticosteroids, it may provide additional benefits when added to these treatments in frequent exacerbators.", {"entities": []}], ["REACT will be important to determine the role of roflumilast in COPD management.", {"entities": []}], ["Here, the design and rationale for this important study is described.", {"entities": []}], ["Sensory hyperreactivity (SHR) is one explanation for airway symptoms induced by chemicals and scents.", {"entities": []}], ["Little is known about health-related quality of life (HRQOL) and coping, in this group of patients.", {"entities": []}], ["A study was done in patients with SHR to (1) compare the Nottingham Health Profile (NHP) and the Short-Form 36 Health Survey (SF-36) in regard to their suitability, validity, reliability, and acceptability; (2) evaluate how the patients cope with the illness; (3) assess whether there are differences between women and men with respect to HRQOL and coping; and (4) assess whether there are differences between patients and normative data with respect to HRQOL and coping.", {"entities": []}], ["A total of 115 patients (91 women) with SHR were asked to answer five questionnaires: a study-specific questionnaire, the Chemical Sensitivity Scale for Sensory Hyperreactivity (CSS-SHR), the NHP, the SF-36, and the Jalowiec Coping Scale-60.", {"entities": []}], ["Eighty-three patients (72%; 70 women) completed all questionnaires.", {"entities": []}], ["The SF-36 scores were less skewed and more homogeneously distributed and showed fewer floor and ceiling effects than the NHP scores.", {"entities": []}], ["The SF-36 was also discriminated better between patients with high and low CSS-SHR scores.", {"entities": []}], ["The reliability standard for both questionnaires was satisfactory.", {"entities": []}], ["There were no gender differences in HRQOL.", {"entities": []}], ["Patients with SHR had significantly lower HRQOL scores than the normative data in comparable domains of the NHP and the SF-36: emotional reactions/mental health, energy/vitality, physical mobility/functioning, and pain/bodily pain.", {"entities": []}], ["In social isolation/functioning, the results were different; the NHP scores were similar to the normative data and the SF-36 scores were lower.", {"entities": []}], ["The most commonly used coping styles were optimistic, self-reliant, and confrontational.", {"entities": []}], ["Women used optimistic coping more than men.", {"entities": []}], ["Compared with the normative group, patients with SHR used confrontational and optimistic coping more and emotive coping less.", {"entities": []}], ["The current findings showed that both the NHP and the SF-36 were reliable instruments; but the results suggest that the SF-36 is a more sensitive instrument than the NHP for elucidating HRQOL in patients with SHR.", {"entities": []}], ["Patients with SHR experienced a poor HRQOL and they followed the Western tradition of preferring problem-focused coping strategies to palliative and emotive strategies.", {"entities": []}], ["The role of vascular endothelial growth factor (VEGF)-induced 3 different nitric oxide synthase (NOS) isoforms in lung development and injury in the newborn (NB) lung are not known.", {"entities": []}], ["We hypothesized that VEGF-induced specific NOS pathways are critical regulators of lung development and injury.", {"entities": []}], ["We studied NB wild type (WT), lung epithelial cell-targeted VEGF165 doxycycline-inducible overexpressing transgenic (VEGFTG), VEGFTG treated with a NOS1 inhibitor (L-NIO), VEGFTG x NOS2 VEGF overexpression in RA led to increased chord length and vascular markers at PN7, which were significantly decreased to control values in VEGFTG x NOS2 Our data showed that the complete absence of NOS2 and partial deficiency of NOS3 confers protection against VEGF-induced pathologic lung vascular and alveolar developmental changes, as well as injury markers.", {"entities": [[148, 152, "GENE"], [181, 185, "GENE"], [336, 340, "GENE"], [386, 390, "GENE"], [181, 185, "GENE"], [336, 340, "GENE"], [386, 390, "GENE"], [181, 185, "GENE"], [336, 340, "GENE"], [386, 390, "GENE"], [417, 421, "GENE"]]}], ["Inhibition of NOS1 does not have any modulating role on VEGF-induced changes in the NB lung.", {"entities": [[14, 18, "GENE"]]}], ["Overall, our data suggests that there is a significant differential regulation in the NOS-mediated effects of VEGF overexpression in the developing mouse lung.", {"entities": []}], ["Loss of integrity of the epithelial and endothelial barriers is thought to be a prominent feature of ventilator-induced lung injury (VILI).", {"entities": []}], ["Based on its function in vascular integrity, we hypothesize that the angiopoietin (Ang)-Tie2 system plays a role in the development of VILI.", {"entities": [[83, 86, "GENE"]]}], ["The present study was designed to examine the effects of mechanical ventilation on the Ang-Tie2 system in lung tissue.", {"entities": []}], ["Moreover, we evaluated whether treatment with Ang-1, a Tie2 receptor agonist, protects against inflammation, vascular leakage and impaired gas exchange induced by mechanical ventilation.", {"entities": []}], ["Mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with either an inspiratory pressure of 10 cmH 2 O (\u2018low\u2019 tidal volume \u223c7.5 ml/kg; LV T ) or 18 cmH 2 O (\u2018high\u2019 tidal volume \u223c15 ml/kg; HV T ).", {"entities": []}], ["At initiation of HV T -ventilation, recombinant human Ang-1 was intravenously administered (1 or 4 \u00b5g per animal).", {"entities": []}], ["Non-ventilated mice served as controls.", {"entities": []}], ["HV T -ventilation influenced the Ang-Tie2 system in lungs of healthy mice since Ang-1, Ang-2 and Tie2 mRNA were decreased.", {"entities": []}], ["Treatment with Ang-1 increased Akt-phosphorylation indicating Tie2 signaling.", {"entities": []}], ["Ang-1 treatment reduced infiltration of granulocytes and expression of keratinocyte-derived chemokine (KC), macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1 and interleukin (IL)-1\u03b2 caused by HV T -ventilation.", {"entities": [[141, 144, "GENE"]]}], ["Importantly, Ang-1 treatment did not prevent vascular leakage and impaired gas exchange in HV T -ventilated mice despite inhibition of inflammation, vascular endothelial growth factor (VEGF) and Ang-2 expression.", {"entities": []}], ["Ang-1 treatment downregulates pulmonary inflammation, VEGF and Ang-2 expression but does not protect against vascular leakage and impaired gas exchange induced by HV T -ventilation.", {"entities": []}], ["Depression is twice as common in diabetes mellitus (DM) as the general population and is associated with adverse health outcomes, but access to evidence-based therapies such as cognitive behavioral therapy (CBT) is limited in routine diabetes care.", {"entities": [[33, 50, "DISEASE"]]}], ["Past research has shown that generic Internet-based cognitive behavioral therapy (iCBT) is an effective treatment for depression in the general population, but it has never been evaluated in people with comorbid depression and DM.", {"entities": []}], ["The aim of our study was to examine the efficacy of a generic 6-lesson iCBT delivered over 10 weeks in people with major depressive disorder (MDD) and DM.", {"entities": [[115, 140, "DISEASE"]]}], ["Participants with comorbid MDD and DM (type 1 or 2) were recruited online and randomized to an iCBT program with therapist support provided by phone and email (n=42) or a treatment as usual (TAU, n=49) control group.", {"entities": []}], ["Outcomes were assessed through Web-based self-report questionnaires and the trial was Web-based with no face-to-face components.", {"entities": []}], ["Primary outcomes were self-reported depression (patient health questionnaire-9, PHQ-9), diabetes-related distress (problem areas in diabetes, PAID), and self-reported glycemic control (hemoglobin A1c, HbA1c).", {"entities": []}], ["Secondary outcomes were general distress (Kessler 10-item psychological distress scale, K-10) and disability (short form 12-item, SF-12), generalized anxiety (generalized anxiety disorder 7-item, GAD-7), and somatization (PHQ-15).", {"entities": [[159, 187, "DISEASE"], [171, 187, "DISEASE"]]}], ["The iCBT group was assessed at 3 months.", {"entities": []}], ["A total of 27 participants (66%; 27/41) completed the iCBT program.", {"entities": []}], ["Analyses indicated between-group superiority of iCBT over TAU at posttreatment on PHQ-9 ( g =0.78), PAID ( g =0.80), K-10 ( g =1.06), GAD-7 ( g =0.72), and SF-12 mental well-being scores ( g =0.66), but no significant differences in self-reported HbA1c levels ( g =0.14), SF-12 physical well-being, or PHQ-15 scores ( g =0.03-0.21).", {"entities": []}], ["Gains were maintained at 3-month follow-up in the iCBT group, and the 87% (27/31) of iCBT participants who were interviewed no longer met criteria for MDD.", {"entities": []}], ["Clinically significant change following iCBT on PHQ-9 scores was 51% (21/41) versus 18% (9/49) in TAU.", {"entities": []}], ["iCBT for depression is an efficacious, accessible treatment option for people with diabetes.", {"entities": []}], ["Future studies should explore whether tailoring of iCBT programs improves acceptability and adherence, and evaluate the long-term outcomes following iCBT.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry (ACTRN): 12613001198718; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365208&isReview=true (Archived by WebCite at http://www.webcitation.org/6qCR8Fi9V)", {"entities": []}], ["The objective of the study was to assess the association between the quality of drug prescribing based on three indicator types derived from the DU90% method and different levels of functioning in pharmacotherapy audit meetings (PTAMs).", {"entities": []}], ["The level of functioning in PTAMs in 2004 was assessed by a standard questionnaire.", {"entities": []}], ["Data on prescriptions in 2004 by the GPs participating in the included PTAMs were extracted from the database of the Foundation for Pharmaceutical Statistics.", {"entities": []}], ["Three types of DU90% indicators were computed for the seven mostly prescribed drug classes.", {"entities": []}], ["With univariate and multivariate analyses of variance, differences in the results of three types of indicators for each of the seven drug classes were assessed according to the levels of PTAMs.", {"entities": []}], ["For 84 PTAMs with varying levels of functioning, we found no association between the level of PTAM and the quality of prescribing for any of the indicators within the seven drug classes.", {"entities": []}], ["In general, results gained of all PTAMs seemed to be high in quality for the aspects measured.", {"entities": []}], ["It is difficult to define indicators based on the DU90% method, which can readily distinguish differences in the quality of drug prescribing between PTAMs with different levels of functioning.", {"entities": []}], ["Indicators for prescribing should specifically meet relevant items in the quality of prescribing for certain drug classes.", {"entities": []}], ["Items for classification of PTAM levels may need some reconsideration.", {"entities": []}], ["The present research was carried out to investigate pharmacological properties of Buxus papillosa C.K.", {"entities": []}], ["(Buxaceae).", {"entities": []}], ["Buxus papillosa extracts of leaves (BpL), stem (BpS), roots (BpR) and BpL fractions: hexane (BpL-H), aqueous (BpL-A) also plant constituent, cyclomicrobuxine effect were studied in jejunum, atria, aorta and tracheal preparations from rabbit and guine-peg.", {"entities": []}], ["Ca Our results reveal that Buxus papillosa possesses gut, airways and cardiovascular inhibitory actions.", {"entities": []}], ["Acute lung injury (ALI) is a life-threatening hypoxemic respiratory disorder with high incidence and mortality.", {"entities": []}], ["ALI usually manifests as widespread inflammation and lung fibrosis with the accumulation of pro-inflammatory and pro-fibrotic factors and collagen.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) has a significant role in regulation of inflammation but little is known about its roles in lung fibrosis or ALI.", {"entities": [[30, 34, "GENE"]]}], ["This study aimed to define the role and possible regulatory mechanism of TSLP in lung fibrosis.", {"entities": [[73, 77, "GENE"]]}], ["We cultured human lung fibroblast MRC-5 cells and overexpressed or inhibited TSLP by the vector or small interfering RNA transfection.", {"entities": [[77, 81, "GENE"]]}], ["Then, the pro-fibrotic factors skeletal muscle actin alpha (\u03b1-SMA) and collagen I, and the 4 mitogen-activated protein kinases (MAPKs) \u2013 MAPK7, p38, extracellular signal-regulated kinase 1 (ERK1), and c-Jun N-terminal kinase 1 (JNK1) \u2013 were detected by Western blot.", {"entities": [[137, 142, "GENE"]]}], ["Results showed that TSLP promoted the production of \u03b1-SMA and collagen I ( P <0.001), suggesting that it can accelerate MRC-5 cell fibrosis.", {"entities": [[20, 24, "GENE"]]}], ["It also activated the expression of MAPK7, p-p38, p-ERK1, and p-JNK1, but the total MAPK7, p-38, ERK1, and JNK1 protein levels were mostly unchanged, indicating the activated MAPK pathways that might contribute to the promotion of cell fibrosis.", {"entities": [[36, 41, "GENE"], [84, 89, "GENE"], [36, 41, "GENE"], [84, 89, "GENE"]]}], ["This study shows the pro-fibrotic role of TSLP in MRC-5 cells, suggesting TSLP is a potential therapeutic target for treating lung fibrosis in ALI.", {"entities": [[42, 46, "GENE"], [74, 78, "GENE"], [42, 46, "GENE"], [74, 78, "GENE"]]}], ["It possibly functions via activating MAPKs.", {"entities": []}], ["These findings add to our understanding of the mechanism of fibrosis.", {"entities": []}], ["A large number of chemicals are used on a regular basis in modern society.", {"entities": []}], ["Thousands of new chemicals are added each year, many of which may have toxic properties constituting potential health hazards.", {"entities": []}], ["Rapid assessment of the risk associated with the use of these chemicals is therefore essential to protect people from exposure to potentially harmful substances.", {"entities": []}], ["Exposures to chemicals (and physical agents) are typically unevenly distributed geographically as well as temporally.", {"entities": []}], ["Disease occurrence also shows geographically varying patterns.", {"entities": []}], ["Geographic information systems (GIS) may be used to produce maps of exposure and/or disease to reveal spatial patterns.", {"entities": []}], ["Exposure mapping using advanced GIS modeling may enhance exposure assessment in environmental epidemiology studies.", {"entities": []}], ["Disease maps can be valuable tools in risk assessment to explore changes in disease patterns potentially associated with changes in environmental exposures.", {"entities": []}], ["Spatial variations in risk and trends related to distance from pollution sources may be studied using software tools such as the Rapid Inquiry Facility, developed by the U.K. Small Area Health Statistics Unit and enhanced in the European Health and Environment Information System project, for an initial quick evaluation of any potential health hazards associated with an environmental pollutant.", {"entities": []}], ["L'atteinte cardiovasculaire repr\u00e9sente le facteur pronostique majeur de la dr\u00e9panocytose.", {"entities": []}], ["C\u2019\u00e9tait une \u00e9tude transversale et descriptive dans le service de cardiologie du centre hospitalier et universitaire de Pointe-\u00e0-Pitre.", {"entities": []}], ["Nous avons inclus 82 patients, 23 hommes (28%) et 59 femmes (72%), \u00e2g\u00e9s en moyenne de 40,0\u00b112 ans.", {"entities": []}], ["On avait 39 patients porteurs d'h\u00e9moglobinose SS (49,4%) et 40 porteurs d'h\u00e9moglobinose SC (50,6%).", {"entities": []}], ["Le taux d'h\u00e9moglobine de base \u00e9tait en moyenne de 9,8\u00b11,8 g/dl et celui de l'h\u00e9moglobine f\u0153tale \u00e9tait en moyenne de 5,5\u00b15,3 g/dl.", {"entities": []}], ["La fraction de raccourcissement \u00e9tait de 36\u00b14,9% en moyenne, la FeVG moyenne \u00e9tait de 65\u00b15,9%.", {"entities": []}], ["On avait 68 patients avec un profil mitral normal (82,9%) et 14 patients avec un profil pseudo normal (17,1%).", {"entities": []}], ["On avait une dilatation ventriculaire gauche chez 26 patients (31,7%), ventriculaire droite chez 14 patients (17.1%), une dilatation auriculaire gauche chez 36 patients (43.9%), auriculaire droite chez 11 patients (13.4%).", {"entities": []}], ["On avait une hypertrophie ventriculaire gauche chez 13 patients soit 15.9%.", {"entities": []}], ["L'hypertension art\u00e9rielle pulmonaire a \u00e9t\u00e9 retrouv\u00e9e chez 43 patients soit 52,4%.", {"entities": [[2, 14, "DISEASE"]]}], ["Apr\u00e8s r\u00e9gression logistique, les facteurs suivants ont \u00e9t\u00e9 associ\u00e9s \u00e0 la pr\u00e9sence d'une HTAP: \u00e2ge (p=0,0024), le taux h\u00e9moglobine de base (p=0,032), le taux d'h\u00e9moglobine f\u0153tale (p=0,011), le type SS (p=0,040), la dilatation de l'oreillette gauche (p=0,0012) et la dilatation de ventricule droit (p=0,047).", {"entities": []}], ["Apr\u00e8s comparaison, L'h\u00e9moglobinose SS s\u2019\u00e9tait av\u00e9r\u00e9e plus s\u00e9v\u00e8re.", {"entities": []}], ["La dr\u00e9panocytose est une pathologie s\u00e9v\u00e8re dont le pronostic est aggrav\u00e9 par l'atteinte cardiaque.", {"entities": []}], ["Prostaglandin D 2 (PGD 2 ) released by degranulating mast cells is believed to play a key role in orchestrating mechanisms of inflammation in allergies and asthma.", {"entities": [[156, 162, "DISEASE"], [19, 22, "GENE"]]}], ["The biological effects of PGD 2 are mediated by D-prostanoid (DP1), CRTH2 (DP2), and thromboxane prostanoid (TP) receptors.", {"entities": [[26, 29, "GENE"]]}], ["The CRTH2 receptor is involved in induction of migration and activation of T helper type 2 (Th 2 ) lymphocytes, eosinophils, and basophils; up-regulation of adhesion molecules; and promotion of pro-inflammatory Th 2 -type cytokines (interleukin [IL]-4, 5, 13), whereas the DP receptor is associated with relaxation of smooth muscles, vasodilation, inhibition of cell migration, and apoptosis of eosinophils.", {"entities": []}], ["A number of CRTH2/PGD 2 receptor antagonists have been investigated in asthma and allergic diseases.", {"entities": [[71, 77, "DISEASE"]]}], ["The CRTH2 antagonist (OC000459) or dual CRTH2 and TP receptor antagonist (ramatroban) were effective in reducing eosinophilia, nasal mucosal swelling, and clinical symptoms of allergic rhinitis, with the latter drug registered for clinical use in this indication.", {"entities": [[176, 193, "DISEASE"], [185, 193, "DISEASE"], [113, 125, "DISEASE"]]}], ["OC000459 and setipiprant reduced the late but not early phase of response in an allergen challenge in atopic asthmatics.", {"entities": []}], ["In persistent asthma, some molecules induced limited improvement in lung function, quality of life, and asthma symptoms (OC000459, BI671800), but in other trials with AMG 853 and AZ1981 these findings were not confirmed.", {"entities": [[14, 20, "DISEASE"], [104, 110, "DISEASE"]]}], ["The clear discrepancy between animal studies and clinical efficacy of CRTH2 antagonism in allergic rhinitis, and lack of efficacy in a general cohort of asthmatics, highlight the issue of patient phenotyping.", {"entities": [[90, 107, "DISEASE"], [99, 107, "DISEASE"]]}], ["There is no doubt that the PGD 2 /CATH2/DP1 pathway plays a key role in allergic inflammation and further studies with selective or combined antagonisms in well defined cohorts of patients are needed.", {"entities": [[27, 30, "GENE"]]}], ["Periostin (PN) epithelial and stromal overexpression in tumor pathology has been studied according to tumor growth, angiogenesis, invasiveness, and metastasis, but a limited number of studies address PN in thyroid tumors.", {"entities": []}], ["Our study aimed to analyze PN expression in different histological variants of PTC and to correlate its expression with the clinicopathological prognostic factors.", {"entities": []}], ["PN expression has been immunohistochemically assessed in 50 cases of PTC (conventional, follicular, oncocytic, macrofollicular, and tall cell variants), in tumor epithelial cells and intratumoral stroma.", {"entities": []}], ["The association between PN expression and clinicopathological characteristics has been evaluated.", {"entities": []}], ["Our results show that PTC presented different patterns of PN immunoreaction, stromal PN being significantly associated with advanced tumor stage and extrathyroidal extension.", {"entities": []}], ["No correlations were found between PN overexpression in tumor epithelial cells and clinicopathological features, except for specific histological variants, the highest risk of poor outcome being registered for the conventional subtype in comparison to the oncocytic type.", {"entities": []}], ["Our study demonstrates differences in PN expression in histological subtypes of PTC.", {"entities": []}], ["Our results plead in favor of a dominant protumorigenic role of stromal PN, while the action of epithelial PN is less noticeable.", {"entities": []}], ["Ambient air particulate matter (PM) is increasingly considered to be a causal factor evoking severe adverse health effects.", {"entities": []}], ["People spend the majority of their time indoors, which should be taken into account especially in future risk assessments, when the role of outdoor air particles transported into indoor air is considered.", {"entities": []}], ["Therefore, there is an urgent need for characterization of possible sources seasonally for harmful health outcomes both indoors and outdoors.", {"entities": []}], ["In this study, we collected size-segregated (PM 10\u20132.5 , PM 2.5\u20130.2 ) particulate samples with a high volume cascade impactor (HVCI) simultaneously both indoors and outdoors of a new single family detached house at four different seasons.", {"entities": []}], ["The chemical composition of the samples was analyzed as was the presence of microbes.", {"entities": []}], ["Mouse macrophages were exposed to PM samples for 24 hours.", {"entities": []}], ["Thereafter, the levels of the proinflammatory cytokines, NO-production, cytotoxicity and changes in the cell cycle were investigated.", {"entities": []}], ["The putative sources of the most toxic groups of constituents were resolved by using the principal component analysis (PCA) and pairwise dependencies of the variables were detected with Spearman correlation.", {"entities": []}], ["Source-related toxicological responses clearly varied according to season.", {"entities": []}], ["The role of outdoor sources in indoor air quality was significant only in the warm seasons and the significance of outdoor microbes was also larger in the indoor air.", {"entities": []}], ["During wintertime, the role of indoor sources of the particles was more significant, as was also the case for microbes.", {"entities": []}], ["With respect to the outdoor sources, soil-derived particles during a road dust episode and local wood combustion in wintertime were the most important factors inducing toxicological responses.", {"entities": []}], ["Even though there were clear seasonal differences in the abilities of indoor and outdoor air to induce inflammatory and cytotoxic responses, there were relatively small differences in the chemical composition of the particles responsible of those effects.", {"entities": []}], ["Outdoor sources have only a limited effect on indoor air quality in a newly built house with a modern ventilation system at least in a low air pollution environment.", {"entities": []}], ["The most important sources for adverse health related toxicological effects were related to soil-derived constituents, local combustion emissions and microbes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-014-0060-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Zoonoses account for the most commonly reported emerging and re-emerging infectious diseases in Sub-Saharan Africa.", {"entities": []}], ["However, there is limited knowledge on how pastoral communities perceive zoonoses in relation to their livelihoods, culture and their wider ecology.", {"entities": []}], ["This study was carried out to explore local knowledge and perceptions on zoonoses among pastoralists in Tanzania.", {"entities": []}], ["This study involved pastoralists in Ngorongoro district in northern Tanzania and Kibaha and Bagamoyo districts in eastern Tanzania.", {"entities": []}], ["Qualitative methods of focus group discussions, participatory epidemiology and interviews were used.", {"entities": []}], ["A total of 223 people were involved in the study.", {"entities": []}], ["Among the pastoralists, there was no specific term in their local language that describes zoonosis.", {"entities": []}], ["Pastoralists from northern Tanzania possessed a higher understanding on the existence of a number of zoonoses than their eastern districts' counterparts.", {"entities": []}], ["Understanding of zoonoses could be categorized into two broad groups: a local syndromic framework, whereby specific symptoms of a particular illness in humans concurred with symptoms in animals, and the biomedical framework, where a case definition is supported by diagnostic tests.", {"entities": []}], ["Some pastoralists understand the possibility of some infections that could cross over to humans from animals but harm from these are generally tolerated and are not considered as threats.", {"entities": []}], ["A number of social and cultural practices aimed at maintaining specific cultural functions including social cohesion and rites of passage involve animal products, which present zoonotic risk.", {"entities": []}], ["These findings show how zoonoses are locally understood, and how epidemiology and biomedicine are shaping pastoralists perceptions to zoonoses.", {"entities": []}], ["Evidence is needed to understand better the true burden and impact of zoonoses in these communities.", {"entities": []}], ["More studies are needed that seek to clarify the common understanding of zoonoses that could be used to guide effective and locally relevant interventions.", {"entities": []}], ["Such studies should consider in their approaches the pastoralists\u2019 wider social, cultural and economic set up.", {"entities": []}], ["Zoonoses are diseases transmissible between animals and humans.", {"entities": []}], ["Risk factors include animal slaughter, the handling and preparing food of animal origin and particularly the consumption of such food when raw or undercooked.", {"entities": []}], ["Pastoralists are daily in contact with their livestock and are likely to be more frequently exposed to zoonotic pathogens.", {"entities": []}], ["However, very few studies have focused on the understanding of zoonoses and related risk factors among pastoralists of Tanzania.", {"entities": []}], ["This was striking considering pastoralists\u2019 close bond with and reliance on livestock for their nutritional needs and livelihoods.", {"entities": []}], ["Our study was implemented in pastoral communities located in two different ecological zones of Tanzania.", {"entities": []}], ["In all ten communities visited no local term for zoonoses existed, yet participants recognised there are some symptoms that appear in both animals and humans.", {"entities": []}], ["However, these were not thought to be harmful to humans and people did not perceive the animal products from which they originate to be dangerous.", {"entities": []}], ["Other zoonoses were known because community members received a diagnosis from a health facility.", {"entities": []}], ["We also learnt that cultural practices relating to the preparation and consumption of food of animal origin were considered more important to the community than the risk of infection.", {"entities": []}], ["The findings of this study highlight the gaps in knowledge of zoonoses among pastoralists in Tanzania and the importance of social and cultural practices.", {"entities": []}], ["Therefore, we propose that interventions to control zoonoses should be informed by research of peoples\u2019 behaviours related to handling of animals and consumption of animal source foods.", {"entities": []}], ["Diabetes prevalence is increasing and current methods of management are unsustainable.", {"entities": []}], ["Effective approaches to supporting self-management are required.", {"entities": []}], ["The aim of this randomized controlled trial is to establish whether supported telemetric monitoring of glycemic control and blood pressure results in reductions in glycosylated hemoglobin (HbA1c; the primary outcome of a measure of long-term glycemic control) and secondary outcomes of blood pressure and weight among people with poorly controlled diabetes compared to a control group receiving usual care.", {"entities": []}], ["Design: multi-center, randomized controlled trial with embedded qualitative study.", {"entities": []}], ["Setting: primary care in Lothian, Kent, Glasgow and Borders regions in the UK.", {"entities": []}], ["Participants: people with type 2 diabetes and confirmed HbA1c >7.5% (58\u00a0mmol/mol).", {"entities": []}], ["Intervention/comparison: randomization to intervention or control groups will be performed by the Edinburgh Clinical Trials Unit.", {"entities": []}], ["Participants in the intervention group will be shown how to use blood glucose and blood pressure monitors and weighing scales which use Bluetooth wireless technology to transmit readings via modem to a remote server.", {"entities": []}], ["These participants will be asked to provide at least twice weekly measurements of morning and evening blood glucose and weekly measurements of weight and blood pressure.", {"entities": []}], ["Measurements will be checked at least weekly by practice nurses who will contact the patients to adjust therapy according to guidelines and reinforce lifestyle advice.", {"entities": []}], ["Participants in the control group will receive usual care.", {"entities": []}], ["All participants will receive an individual education session.", {"entities": []}], ["Follow-up: measurements will be performed at practices 9 months after randomization by research nurses blinded to allocation.", {"entities": []}], ["The primary outcome measure is HbA1c and secondary outcomes measure are daytime systolic and diastolic blood pressure, weight and cost per quality-adjusted life year.", {"entities": []}], ["Analysis: intention-to-treat analyses will be performed.", {"entities": []}], ["The sample size of 320 participants allows for 20% drop-out and has 80% power at 5% significance to detect a 0.5% absolute (6 mmol/mol) fall in HbA1c in the intervention group.", {"entities": []}], ["The qualitative study will explore the experiences of patients and professionals using the intervention.", {"entities": []}], ["Trial registration number ISRCTN71674628", {"entities": []}], ["Inflammation is a part of the complex biological responses of a tissue to injury that protect the organ by removing injurious stimuli and initiating the healing process, and is considered as a mechanism of innate immunity.", {"entities": []}], ["To identify biologically active compounds against pathogenic inflammatory and immune responses, we fractionated water, aqueous methanol and n -hexane layers from nine kinds of leguminosae and examined anti-inflammatory activity of the fractions in human keratinocytes and mouse skin.", {"entities": []}], ["Among the fractions, rf3 and rf4, isolated from the aqueous methanol layer of Astragalus sinicus L., exhibited the strongest reactive oxygen species (ROS)-scavenging and anti-inflammatory activities as measured by inhibition of the intracellular ROS production, nuclear factor-kappaB (NF-\u03baB), janus kinase (JAK)/signal transducer and activator of transcription (STAT), and phosphatidylinositol 3-kinase/Akt signaling in cytokine-stimulated human keratinocytes, as well as by effects on T-cell differentiation in mouse CD4 Astragalus sinicus L. may ameliorate chronic inflammatory skin diseases due to its antioxidant and anti-inflammatory activities via regulation of the intracellular ROS production, NF-\u03baB, JAK/STAT and PI3/Akt signaling cascades as well as immune responses, and these results are the first report that Astragalus sinicus L. exhibits pharmacological activity.", {"entities": [[518, 521, "GENE"]]}], ["Exhaled breath condensate (EBC) has been increasingly studied as a noninvasive research method for sampling the alveolar and airway space and is recognized as a promising source of biomarkers of lung diseases.", {"entities": []}], ["Substances measured in EBC include oxidative stress and inflammatory mediators, such as arachidonic acid derivatives, reactive oxygen/nitrogen species, reduced and oxidized glutathione, and inflammatory cytokines.", {"entities": []}], ["Although EBC has great potential as a source of biomarkers in many lung diseases, the low concentrations of compounds within the EBC present challenges in sample collection and analysis.", {"entities": []}], ["Although EBC is viewed as a noninvasive method for sampling airway lining fluid (ALF), validation is necessary to confirm that EBC truly represents the ALF.", {"entities": []}], ["Likewise, a dilution factor for the EBC is needed in order to compare across subjects and determine changes in the ALF.", {"entities": []}], ["The aims of this paper are to address the characteristics of EBC; strategies to standardize EBC sample collection and review available analytical techniques for EBC analysis.", {"entities": []}], ["Asymmetric and symmetric dimethylarginine (ADMA and SDMA, respectively) are toxic, non-proteinogenic amino acids formed by post-translational modification and are uremic toxins that inhibit nitric oxide (NO) production and play multifunctional roles in many human diseases.", {"entities": []}], ["Both ADMA and SDMA have emerged as strong predictors of cardiovascular events and death in a range of illnesses.", {"entities": []}], ["Major progress has been made in research on ADMA-lowering therapies in animal studies; however, further studies are required to fill the translational gap between animal models and clinical trials in order to treat human diseases related to elevated ADMA/SDMA levels.", {"entities": []}], ["Here, we review the reported impacts of ADMA and SDMA on human health and disease, focusing on the synthesis and metabolism of ADMA and SDMA; the pathophysiological roles of these dimethylarginines; clinical conditions and animal models associated with elevated ADMA and SDMA levels; and potential therapies against ADMA and SDMA.", {"entities": []}], ["There is currently no specific pharmacological therapy for lowering the levels and counteracting the deleterious effects of ADMA and SDMA.", {"entities": []}], ["A better understanding of the mechanisms underlying the impact of ADMA and SDMA on a wide range of human diseases is essential to the development of specific therapies against diseases related to ADMA and SDMA.", {"entities": []}], ["Influencing the general public response to pandemics is a public health priority.", {"entities": []}], ["There is a prevailing view, however, that the general public is resistant to communications on pandemic influenza and that behavioural responses to the 2009/10 H1N1 pandemic were not sufficient.", {"entities": [[104, 113, "DISEASE"]]}], ["Using qualitative methods, this paper investigates how members of the general public respond to pandemic influenza and the hygiene, social isolation and other measures proposed by public health.", {"entities": [[105, 114, "DISEASE"]]}], ["Going beyond the commonly deployed notion that the general public is resistant to public health communications, this paper examines how health individualism, gender and real world constraints enable and limit individual action.", {"entities": []}], ["In-depth interviews (n = 57) and focus groups (ten focus groups; 59 individuals) were conducted with community samples in Melbourne, Sydney and Glasgow.", {"entities": []}], ["Participants were selected according to maximum variation sampling using purposive criteria, including: 1) pregnancy in 2009/2010; 2) chronic illness; 3) aged 70 years and over; 4) no disclosed health problems.", {"entities": []}], ["Verbatim transcripts were subjected to inductive, thematic analysis.", {"entities": []}], ["Respondents did not express resistance to public health communications, but gave insight into how they interpreted and implemented guidance.", {"entities": []}], ["An individualistic approach to pandemic risk predominated.", {"entities": []}], ["The uptake of hygiene, social isolation and vaccine strategies was constrained by seeing oneself \u2018at risk\u2019 but not \u2018a risk\u2019 to others.", {"entities": []}], ["Gender norms shape how members of the general public enact hygiene and social isolation.", {"entities": []}], ["Other challenges pertained to over-reliance on perceived remoteness from risk, expectation of recovery from infection and practical constraints on the uptake of vaccination.", {"entities": []}], ["Overall, respondents were engaged with public health advice regarding pandemic influenza, indicating that the idea of public resistance has limited explanatory power.", {"entities": [[79, 88, "DISEASE"]]}], ["Public communications are endorsed, but challenges persist.", {"entities": []}], ["Individualistic approaches to pandemic risk inhibit acting for the benefit of others and may deepen divisions in the community according to health status.", {"entities": []}], ["Public communications on pandemics are mediated by gender norms that may overburden women and limit the action of men.", {"entities": []}], ["Social research on the public response to pandemics needs to focus on the social structures and real world settings and relationships that shape the action of individuals.", {"entities": []}], ["This review aims to give an overview of available published evidence concerning the association between physical activity and asthma in children, adolescents and adults.", {"entities": [[126, 132, "DISEASE"]]}], ["We included all original articles in which both physical activity and asthma were assessed in case-control, cross-sectional or longitudinal (cohort) studies.", {"entities": [[70, 76, "DISEASE"]]}], ["Excluded were studies concerning physical fitness, studies in athletes, therapeutic or rehabilitation intervention studies such as physical training or exercise in asthma patients.", {"entities": [[164, 170, "DISEASE"]]}], ["Methodological quality of the included articles was assessed according to the Newcastle-Ottawa Scale (NOS).", {"entities": []}], ["A literature search was performed until June 2011 and resulted in 6,951 publications derived from PubMed and 1,978 publications from EMBASE.", {"entities": []}], ["In total, 39 studies met the inclusion criteria: 5 longitudinal studies (total number of subjects n\u200a=\u200a85,117) with physical activity at baseline as exposure, and asthma incidence as outcome.", {"entities": [[162, 168, "DISEASE"]]}], ["Thirty-four cross-sectional studies (n\u200a=\u200a661,222) were included.", {"entities": []}], ["Pooling of the longitudinal studies showed that subjects with higher physical activity levels had lower incidence of asthma (odds ratio 0.88 (95% CI: 0.77\u20131.01)).", {"entities": [[117, 123, "DISEASE"]]}], ["When restricting pooling to the 4 prospective studies with moderate to good study quality (defined as NOS\u22655) the pooled odds ratio only changed slightly (0.87 (95% CI: 0.77\u20130.99)).", {"entities": []}], ["In the cross-sectional studies, due to large clinical variability and heterogeneity, further statistical analysis was not possible.", {"entities": []}], ["The available evidence indicates that physical activity is a possible protective factor against asthma development.", {"entities": [[96, 102, "DISEASE"]]}], ["The heterogeneity suggests that possible relevant effects remain hidden in critical age periods, sex differences, or extremes of levels of physical activity (e.g.", {"entities": []}], ["sedentary).", {"entities": []}], ["Future longitudinal studies should address these issues.", {"entities": []}], ["Noninvasive mechanical ventilation (NIV) is a front-line therapy for the management of acute respiratory failure (ARF) in the intensive care units.", {"entities": [[93, 112, "DISEASE"]]}], ["However, the data on factors and outcomes associated with the use of NIV in ARF patients is lacking.", {"entities": []}], ["Therefore, we aimed to determine the utilization of NIV for ARF in a population-based study.", {"entities": []}], ["We conducted a populated-based retrospective cohort study, where in all consecutively admitted adults (\u226518\u2009years) with ARF from Olmsted County, Rochester, MN, at the Mayo Clinic medical and surgical ICUs, during 2006 were included.", {"entities": []}], ["Patients without research authorization or on chronic NIV use for sleep apnea were excluded.", {"entities": []}], ["Out of 1461 Olmsted County adult residents admitted to the ICUs in 2006, 364 patients developed ARF, of which 146 patients were initiated on NIV.", {"entities": []}], ["The median age in years was 75 (interquartile range, 60\u201384), 48% females and 88.7% Caucasians.", {"entities": []}], ["Eighteen patients (12%) were on Continuous Positive Airway Pressure (CPAP) mode and 128 (88%) were on noninvasive intermittent positive-pressure ventilation (NIPPV) mode.", {"entities": []}], ["Forty-six (10%) ARF patients were put on NIV for palliative strategy to alleviate dyspnea.", {"entities": []}], ["Seventy-six ARF patients without treatment limitation were given a trial of NIV and 49 patients succeeded, while 27 had to be intubated.", {"entities": []}], ["Mortality was similar between the patients initially supported with NIV versus invasive mechanical ventilation (33% vs 22%, P=0.289).", {"entities": []}], ["In the multivariate analysis, the development of acute respiratory distress syndrome (ARDS) and higher APACHE III scores were associated with the failure of initial NIV treatment.", {"entities": [[76, 84, "DISEASE"]]}], ["Our results have important implications for a future planning of NIV in a suburban US community with high access to critical care services.", {"entities": []}], ["The higher APACHE III scores and the development of ARDS are associated with the failure of initial NIV treatment.", {"entities": []}], ["Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide.", {"entities": []}], ["It has been suggested as an important risk factor of chronic obstructive pulmonary disease (COPD), which is also a major cause of morbidity and mortality.", {"entities": [[53, 90, "DISEASE"]]}], ["This study investigated the impact of pulmonary TB and anti-TB treatment on the risk of developing COPD.", {"entities": []}], ["This cohort study used the National Health Insurance Database of Taiwan, particularly the Longitudinal Health Insurance Database 2005 to obtain 3,176 pulmonary TB cases and 15,880 control subjects matched in age, sex, and timing of entering the database.", {"entities": []}], ["Hazard ratios of potential risk factors of COPD, especially pulmonary TB and anti-TB treatment.", {"entities": []}], ["The mean age of pulmonary TB cases was 51.9\u00b119.2.", {"entities": []}], ["The interval between the initial study date and commencement of anti-TB treatment (delay in anti-TB treatment) was 75.8\u00b165.4 days.", {"entities": []}], ["Independent risk factors for developing COPD were age, male, low income, and history of pulmonary TB (hazard ratio 2.054 [1.768\u20132.387]), while diabetes mellitus was protective.", {"entities": [[143, 160, "DISEASE"]]}], ["The impact of TB persisted for six years after TB diagnosis and was significant in women and subjects aged >70 years.", {"entities": []}], ["Among TB patients, delay in anti-TB treatment had a dose-response relationship with the risk of developing COPD.", {"entities": []}], ["Some cases of COPD may be preventable by controlling the TB epidemic, early TB diagnosis, and prompt initiation of appropriate anti-TB treatment.", {"entities": []}], ["Follow-up care and early intervention for COPD may be necessary for treated TB patients.", {"entities": []}], ["Lung epithelial and endothelial cell death accompanied by inflammation contributes to hyperoxia-induced acute lung injury (ALI).", {"entities": []}], ["Impaired resolution of ALI can promote and/or perpetuate lung pathogenesis, including fibrosis.", {"entities": []}], ["Previously, we have shown that the transcription factor Nrf2 induces cytoprotective gene expression and confers protection against hyperoxic lung injury, and that Nrf2-mediated signaling is also crucial for the restoration of lung homeostasis post-injury.", {"entities": []}], ["Although we have reported that PI3K/AKT signaling is required for Nrf2 activation in lung epithelial cells, significance of the PI3K/AKT-Nrf2 crosstalk during hyperoxic lung injury and repair remains unclear.", {"entities": []}], ["Thus, we evaluated this aspect using Nrf2 knockout ( Nrf2 Nrf2 Nrf2 Nrf2 Nrf2 Nrf2", {"entities": []}], ["FoxP3-deficient mice are rescued from tissue and organ destruction and subsequent lethal autoimmune disease by the combined absence of OX40 and CD30 signals.", {"entities": []}], ["Our previous studies have implicated signaling through the tumor necrosis family receptors OX40 and CD30 as critical for maintaining CD4 memory responses.", {"entities": [[133, 136, "GENE"]]}], ["We show that signals through both molecules are also required for CD4 effector-mediated autoimmune tissue damage.", {"entities": [[66, 69, "GENE"]]}], ["Under normal circumstances, male mice deficient in the forkhead transcription factor FoxP3, which lack regulatory CD4 T cells, develop lethal autoimmune disease in the first few weeks of life.", {"entities": [[85, 90, "GENE"], [114, 117, "GENE"]]}], ["However, in the combined absence of OX40 and CD30, FoxP3-deficient mice develop normally and breed successfully.", {"entities": []}], ["The extensive tissue infiltration and organ destruction characteristic of FoxP3 disease does not appear in these mice, and their mortality is not associated with autoimmunity.", {"entities": [[74, 79, "GENE"]]}], ["Although the absence of OX40 plays the dominant role, FoxP3-deficient mice sufficient in CD30 but deficient in OX40 signals still eventually develop lethal disease.", {"entities": []}], ["This result was supported by the observation that blocking antibodies to OX40 and CD30 ligands also abrogated disease mediated by FoxP3-deficient T cells.", {"entities": []}], ["These observations identify OX40 and CD30 signals as essential for the development of clinically relevant CD4-dependent autoimmunity and suggest that combination therapies that abrogate these signals might be used to treat established human autoimmune diseases.", {"entities": []}], ["Mycoplasma pneumoniae is a significant cause of respiratory illness worldwide.", {"entities": []}], ["Despite a minimal and highly conserved genome, genetic diversity within the species may impact disease.", {"entities": []}], ["We performed whole genome sequencing (WGS) analysis of 107 M .", {"entities": []}], ["pneumoniae isolates, including 67 newly sequenced using the Pacific BioSciences RS II and/or Illumina MiSeq sequencing platforms.", {"entities": []}], ["Comparative genomic analysis of 107 genomes revealed >3,000 single nucleotide polymorphisms (SNPs) in total, including 520 type-specific SNPs.", {"entities": []}], ["Population structure analysis supported the existence of six distinct subgroups, three within each type.", {"entities": []}], ["We developed a predictive model to classify an isolate based on whole genome SNPs called against the reference genome into the identified subtypes, obviating the need for genome assembly.", {"entities": []}], ["This study is the most comprehensive WGS analysis for M .", {"entities": []}], ["pneumoniae to date, underscoring the power of combining complementary sequencing technologies to overcome difficult-to-sequence regions and highlighting potential differential genomic signatures in M .", {"entities": []}], ["pneumoniae .", {"entities": []}], ["Heliox is a mixture of oxygen and helium which reduces airway resistance in patients with airway obstruction.", {"entities": []}], ["In clinical practice, patients breathing spontaneously receive heliox via an open circuit.", {"entities": []}], ["Recently, a semi-closed circuit for heliox administration has been proposed which minimizes consumption of heliox and therefore cost of the heliox therapy; although, the semi-closed circuit is associated with additional costs.", {"entities": []}], ["The aim of the study is to conduct an economical analysis comparing total cost of heliox therapy using an open versus a semi-closed circuit in spontaneously breathing patients with airway obstruction.", {"entities": []}], ["Four different systems for heliox administration were analyzed: an open circuit and three alternatives of a semi-closed circuit involving a custom made semi-closed circuit and two standard anesthesia machines.", {"entities": []}], ["Total costs of heliox therapy were calculated for all the systems.", {"entities": []}], ["For calculation of gas consumption, the clinical procedures limiting continuous heliox therapy including the aerosol therapy, personal hygiene and nutrition were taken into account.", {"entities": []}], ["A sensitivity analysis was conducted for main input variables that may influence the results of the study.", {"entities": []}], ["Price of gases consumed by a semi-closed system represents less than 20\u00a0% of price of gases when a standard open circuit is used.", {"entities": []}], ["This represents a saving of approximately 540 EUR per patient.", {"entities": []}], ["The initial cost of the custom-made semi-closed circuit recuperates after treatment of 18 patients.", {"entities": []}], ["The corresponding number of patients is 32 when a low-cost anesthesia machine is initially acquired and rises to 69 when a highly advanced anesthesia machine is considered.", {"entities": []}], ["Heliox therapy in spontaneously breathing patients using a semi-closed circuit becomes more cost-effective compared to the open circuit, currently used in clinical practice, when applied in a sufficient number of cases.", {"entities": []}], ["The impact of finding a cheaper way of heliox administration on the clinical practice needs to be ascertained.", {"entities": []}], ["We propose a Green Mind Theory (GMT) to link the human mind with the brain and body, and connect the body into natural and social environments.", {"entities": []}], ["The processes are reciprocal: environments shape bodies, brains, and minds; minds change body behaviours that shape the external environment.", {"entities": []}], ["GMT offers routes to improved individual well-being whilst building towards greener economies.", {"entities": []}], ["It builds upon research on green exercise and nature-based therapies, and draws on understanding derived from neuroscience and brain plasticity, spiritual and wisdom traditions, the lifeways of original cultures, and material consumption behaviours.", {"entities": []}], ["We set out a simple metaphor for brain function: a bottom brain stem that is fast-acting, involuntary, impulsive, and the driver of fight and flight behaviours; a top brain cortex that is slower, voluntary, the centre for learning, and the driver of rest and digest.", {"entities": []}], ["The bottom brain reacts before thought and directs the sympathetic nervous system.", {"entities": []}], ["The top brain is calming, directing the parasympathetic nervous system.", {"entities": []}], ["Here, we call the top brain blue and the bottom brain red; too much red brain is bad for health.", {"entities": []}], ["In modern high-consumption economies, life has often come to be lived on red alert.", {"entities": []}], ["An over-active red mode impacts the gastrointestinal, immune, cardiovascular, and endocrine systems.", {"entities": []}], ["We develop our knowledge of nature-based interventions, and suggest a framework for the blue brain-red brain-green mind.", {"entities": []}], ["We show how activities involving immersive-attention quieten internal chatter, how habits affect behaviours across the lifecourse, how long habits take to be formed and hard-wired into daily practice, the role of place making, and finally how green minds could foster prosocial and greener economies.", {"entities": []}], ["We conclude with observations on twelve research priorities and health interventions, and ten calls to action.", {"entities": []}], ["The present study investigates the neuroprotective activity of ethanol extract of Tinospora cordifolia aerial parts against 6-hydroxy dopamine (6-OHDA) lesion rat model of Parkinson's disease (PD).", {"entities": []}], ["T. cordifolia ethanol extract (TCEE) was standardized with high performance thin layer chromatography using berberine.", {"entities": []}], ["Experimental PD was induced by intracerebral injection of 6-OHDA (8 \u03bcg).", {"entities": []}], ["Animals were divided into five groups: sham operated, negative control, positive control (levodopa 6 mg/kg) and two experimental groups ( n = 6/group).", {"entities": []}], ["Experimental groups received 200 and 400 mg/kg of TCEE once daily for 30 days by oral gavage.", {"entities": []}], ["Biochemical parameters including dopamine level, oxidative stress, complex I activity and brain iron asymmetry ratio and locomotor activity including skeletal muscle co-ordination and degree of catatonia were assessed.", {"entities": []}], ["TCEE exhibited significant neuroprotection by increasing the dopamine levels (1.96 \u00b1 0.20 and 2.45 \u00b1 0.40 ng/mg of protein) and complex I activity (77.14 \u00b1 0.89 and 78.50 \u00b1 0.96 nmol/min/mg of protein) at 200 and 400 mg/kg respectively when compared with negative control group.", {"entities": []}], ["Iron asymmetry ratio was also significantly attenuated by TCEE at 200 (1.57 \u00b1 0.18) and 400 mg/kg (1.11 \u00b1 0.15) when compared with negative control group.", {"entities": []}], ["Neuroprotection by TCEE was further supported by reduced oxidative stress and restored locomotor activity in treatment groups.", {"entities": []}], ["Results show that TCEE possess significant neuroprotection in 6-OHDA induced PD by protecting dopaminergic neurons and reducing the iron accumulation.", {"entities": []}], ["Interferon-gamma release assays have emerged as a more specific alternative to the tuberculin skin test (TST) for detection of tuberculosis (TB) infection, especially in Bacille Calmette-Gu\u00e9rin (BCG) vaccinated people.", {"entities": [[127, 139, "DISEASE"]]}], ["We determined the prevalence of Mycobacterium tuberculosis infection by TST and QuantiFERON 163 HIV-negative childhood household contacts under 16\u00a0years of age were enrolled for TST, QFT-GIT and chest X-ray (CXR).", {"entities": [[46, 58, "DISEASE"]]}], ["Follow-up was performed at six and 12\u00a0months.", {"entities": []}], ["Factors associated with TST and QFT-GIT positivity were studied using generalized estimation equations logistic regression models.", {"entities": []}], ["At baseline, the proportion of TST positive children was similar to the proportion of children with a positive QFT-GIT (47% vs. 42%, p\u2009=\u20090.12).", {"entities": []}], ["Overall concordance between QFT-GIT and TST was substantial (kappa 0.76, 95% CI 0.46-1.06).", {"entities": []}], ["Previous BCG vaccination was not associated with significantly increased positivity in either test (OR 0.68, 95% CI 0.32-1.5 for TST and OR 0.51, 95% CI 0.14-1.9 for QFT-GIT).", {"entities": []}], ["Eleven children were diagnosed with active TB at baseline.", {"entities": []}], ["QFT-GIT had a higher sensitivity for active TB (88%, 95% CI 47-98%) than TST (55%, 95% CI 24-83%) while specificities were similar (respectively 58% and 55%).", {"entities": []}], ["Five initially asymptomatic childhood contacts progressed to active TB disease during follow-up.", {"entities": []}], ["Replacement of TST by the QFT-GIT for detection of M. tuberculosis infection is not recommended in this resource-constrained setting as test results showed substantial concordance and TST positivity was not affected by previous BCG vaccination.", {"entities": [[54, 66, "DISEASE"]]}], ["The QFT-GIT had a higher sensitivity than the TST for the detection of TB disease.", {"entities": []}], ["However, the value of the QFT-GIT as an adjunct in diagnosing TB disease is limited by a high variability in QFT-GIT results over time.", {"entities": []}], ["Identifying patients at risk of exacerbations and managing them appropriately to reduce this risk represents an important clinical challenge.", {"entities": []}], ["Numerous treatments have been assessed for the prevention of exacerbations and their efficacy may differ by patient phenotype.", {"entities": []}], ["Given their centrality in the treatment of COPD, there is strong rationale for maximizing bronchodilation as an initial strategy to reduce exacerbation risk irrespective of patient phenotype.", {"entities": []}], ["Therefore, in patients assessed as frequent exacerbators (>1 exacerbation/year) we propose initial bronchodilator treatment with a long-acting muscarinic antagonist (LAMA)/ long-acting \u03b2 2 -agonist (LABA).", {"entities": []}], ["For those patients who continue to experience >1 exacerbation/year despite maximal bronchodilation, we advocate treating according to patient phenotype.", {"entities": []}], ["Based on currently available data on adding inhaled corticosteroids (ICS) to a LABA, ICS might be added to a LABA/LAMA combination in exacerbating patients who have an asthma-COPD overlap syndrome or high blood eosinophil counts, while in exacerbators with chronic bronchitis, consideration should be given to treating with a phosphodiesterase (PDE)-4 inhibitor (roflumilast) or high-dose mucolytic agents.", {"entities": [[188, 196, "DISEASE"], [168, 174, "DISEASE"], [265, 275, "DISEASE"]]}], ["For those patients who experience frequent bacterial exacerbations and/or bronchiectasis, addition of mucolytic agents or a macrolide antibiotic (e.g.", {"entities": [[74, 88, "DISEASE"]]}], ["azithromycin) should be considered.", {"entities": []}], ["In all patients at risk of exacerbations, pulmonary rehabilitation should be included as part of a comprehensive management plan.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0425-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["An appreciable number of patients with toluene diisocyanate (TDI)-induced asthma have high serum levels of specific IgE (sIgE) antibody to TDI-human serum albumin conjugate (HSA).", {"entities": [[74, 80, "DISEASE"]]}], ["A recent investigation suggested a role of specific IgG (sIgG) in the development of TDI asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["We observed the changes in the levels of specific IgE and IgG antibodies to TDIHSA conjugate in TDI-induced asthmatic patients during seven years avoidance.", {"entities": []}], ["Six subjects with high sIgE and five with high sIgG were enrolled.", {"entities": []}], ["All of them had taken anti-asthmatic medications with complete avoidance.", {"entities": []}], ["Serum levels of sIgE and sIgG to TDI-HSA conjugate were detected by ELISA.", {"entities": []}], ["The level of sIgE continued to decline up to 7 years and the mean half-life was 3.9 years.", {"entities": []}], ["The mean half-life of sIgG was 4.5 yrs.", {"entities": []}], ["These findings suggest that both sIgE and sIgG to TDI-HSA conjugate may persist for several years after the last exposure to TDI.", {"entities": []}], ["Lack of sleep is a modifiable risk factor for adverse health in humans.", {"entities": []}], ["Short sleep duration and poor sleep quality are common in the pediatric population; the largest decline in sleep duration over the past decades has been seen in children and adolescents.", {"entities": []}], ["The objective of the present narrative review was to provide for the first time an overview of the literature on sleep and its association with type 2 diabetes mellitus (T2D) biomarkers in children and adolescents.", {"entities": [[151, 168, "DISEASE"], [144, 168, "DISEASE"]]}], ["For this narrative review, 23 studies were retained (21 observational and 2 experimental studies).", {"entities": []}], ["Notwithstanding the conflicting results found in these studies and despite being attenuated by adiposity level, maturity, sex and age, there is still some compelling evidence for an association between sleep duration (for both objective or subjective measurements of duration) and architecture with one or more T2D biomarkers in children and adolescents.", {"entities": []}], ["The majority of the studies reviewed did focus on sleep duration and one or more T2D biomarkers in children and adolescents, but sleep architecture, more precisely the suppression of slow wave sleep and rapid eye movement sleep, has also been shown to be associated with insulin resistance.", {"entities": []}], ["Only two studies looked at sleep quality, and the association between sleep quality and insulin resistance was not independent of level of adiposity.", {"entities": []}], ["Future experimental studies will help to better understand the mechanisms linking insufficient sleep with T2D.", {"entities": []}], ["Work also needs to be carried out on finding novel and effective strategies aimed at improving sleep hygiene and health outcomes of children and adolescents.", {"entities": []}], ["Balloon kyphoplasty provides symptomatic relief of vertebral compression fractures in elderly patients.", {"entities": []}], ["Peri-operative complications are rare; however, they can potentially be devastating.", {"entities": []}], ["To the best of our knowledge, complications during balloon kyphoplasty have not been described previously in published case reports.", {"entities": []}], ["A 66-year-old man who was a farmer of Caucasian origin presented with a 6-month history of back pain after a fall.", {"entities": []}], ["We discovered a significant T12 wedge compression fracture, so we performed a T12 balloon kyphoplasty.", {"entities": []}], ["Approximately 2\u00a0weeks after being discharged from our hospital, the patient presented with increasing back pain.", {"entities": []}], ["He presented for a second time with excruciating pain on the left side of his thoracolumbar region, so he was admitted to our ward.", {"entities": []}], ["X-rays did not show any further fractures or compromise, but magnetic resonance imaging showed extensive edema in the T11 and L1 vertebral bodies as well as fluid tracking from the T11-T12 disc into the vertebral body.", {"entities": []}], ["Nine days after being discharged, the patient presented to the outpatient clinic with severe back pain.", {"entities": []}], ["Magnetic resonance imaging at that visit showed edema at the levels above and below the T11/T12 disc.", {"entities": []}], ["He was put into a brace and given 300mg of morphine, which did not provide any pain resolution.", {"entities": []}], ["Posterior instrumentation from T9 to L2 (pedicle fixation of T9-T10 as well as L1-L2, rods in between and a crosslink above T11-T12) was performed as the final treatment, and the patient was discharged uneventfully.", {"entities": []}], ["Patients presenting with residual pain over a previous balloon kyphoplasty level should raise high suspicion for a fracture or complication involving the levels above and/or below the balloon kyphoplasty.", {"entities": []}], ["The best way to treat fractures that develop after a failed balloon kyphoplasty is to instrument and fuse posteriorly.", {"entities": []}], ["Our present case report shows that a high level of suspicion for possible new fractures should be maintained for all similar cases.", {"entities": []}], ["To reach global and national goals for maternal and child mortality, countries must identify vulnerable populations, which includes sex workers and their children.", {"entities": []}], ["The objective of this study was to identify and describe maternal deaths of female sex workers in Cambodia and causes of death among their children.", {"entities": []}], ["A convenience sample of female sex workers were recruited by local NGOs that provide support to sex workers.", {"entities": []}], ["We modified the maternal mortality section of the 2010 Cambodia Demographic and Health Survey and collected reports of all deaths of female sex workers.", {"entities": []}], ["For each death we ask the \u2018sisterhood\u2019 methodology questions to identify maternal deaths.", {"entities": []}], ["For child deaths we asked each mother who reported the death of a child about the cause of death.", {"entities": []}], ["We also asked all participants about the cause of deaths of children of other female sex workers.", {"entities": []}], ["We interviewed 271 female sex workers in the four largest Cambodian cities between May and September 2013.", {"entities": []}], ["Participants reported 32 deaths of other female sex workers that met criteria for maternal death.", {"entities": []}], ["The most common reported causes of maternal deaths were abortion ( n \u2009=\u200913;40%) and HIV ( n \u2009=\u20095;16%).", {"entities": []}], ["Participants report deaths of 8 of their children and 50 deaths of children of other female sex workers.", {"entities": []}], ["HIV was the reported cause of death for 13 (36%) children under age five.", {"entities": []}], ["This is the first report of maternal deaths of sex workers in Cambodia or any other country.", {"entities": []}], ["This modification of the sisterhood methodology has not been validated and did not allow us to calculate maternal mortality rates so the results are not generalizable, however these deaths may represent unrecognized maternal deaths in Cambodia.", {"entities": []}], ["The results also indicate that children of sex workers in Cambodia are at risk of HIV and may not be accessing treatment.", {"entities": []}], ["These issues require additional studies but in the meantime we must assure that sex workers in Cambodia and their children have access to quality health services.", {"entities": []}], ["Inflammatory disease management poses challenges due to the complexity of inflammation and inherent patient variability, thereby necessitating patient-specific therapeutic interventions.", {"entities": []}], ["Theranostics, which integrate therapeutic and imaging functionalities, can be used for simultaneous imaging and treatment of inflammatory diseases.", {"entities": []}], ["Theranostics could facilitate assessment of safety, toxicity and real-time therapeutic efficacy leading to personalized treatment strategies.", {"entities": []}], ["Macrophages are an important cellular component of inflammatory diseases, participating in varied roles of disease exacerbation and resolution.", {"entities": []}], ["The inherent phagocytic nature, abundance and disease homing properties of macrophages can be targeted for imaging and therapeutic purposes.", {"entities": []}], ["This review discusses the utility of theranostics in macrophage ablation, phenotype modulation and inhibition of their inflammatory activity leading to resolution of inflammation in several diseases.", {"entities": []}], ["The incidence of skin and soft-tissue infections (SSTIs) has rapidly increased among children in primary care settings since the emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).", {"entities": []}], ["Recent treatment recommendations emphasize CA-MRSA as the primary cause, performing incision and drainage (I&D) as the primary therapy, and not prescribing antibiotics for uncomplicated cases.", {"entities": []}], ["It is unknown how this epidemic has impacted primary care pediatricians in terms of their practice patterns and barriers they face to providing recommended therapies.", {"entities": []}], ["3 Focus groups among 29 primary care pediatricians in the San Francisco Bay Area were conducted.", {"entities": []}], ["Transcripts were reviewed and coded into major themes by two investigators using modified grounded theory.", {"entities": []}], ["Substantial changes in clinical practice have occurred since the emergence of CA-MRSA.", {"entities": []}], ["These include increased office visits for SSTIs, patients with multiple recurrences and transmission within households.", {"entities": []}], ["Additionally, our participants reported increased visits for mild skin problems due to media reports contributing to fears about CA-MRSA.", {"entities": []}], ["Participants routinely prescribed antibiotics for SSTIs, however, few performed I&D.", {"entities": []}], ["Few were aware of recent SSTI treatment recommendations.", {"entities": []}], ["Barriers to prescribing antibiotics with CA-MRSA activity included concerns about side-effects and lack of local epidemiologic data showing that it is the primary etiology.", {"entities": []}], ["Barriers to performing I&D included lack of training, resources and skepticism about its necessity.", {"entities": []}], ["Important clinical challenges included increased time demands for follow-up visits and patient education along with the lack of evidence-based strategies for preventing recurrent inections and household transmission.", {"entities": []}], ["CA-MRSA has influenced the presentation and treatment of SSTIs especially in terms of case numbers and recurrences.", {"entities": []}], ["Barriers to providing recommended therapies can be addressed through improved dissemination of treatment guidelines and epidemiologic data.", {"entities": []}], ["Studies are urgently needed toimprove theevidence-base for treatment and prevention strategies.", {"entities": []}], ["Data on genome damage, lipid peroxidation, and levels of glutathione peroxidase (GPX) in newborns after transplacental exposure to xenobiotics are rare and insufficient for risk assessment.", {"entities": []}], ["The aim of the current study was to analyze, in an animal model, transplacental genotoxicity, lipid peroxidation, and detoxification disturbances caused by the following drugs commonly prescribed to pregnant women: paracetamol, fluconazole, 5-nitrofurantoin, and sodium valproate.", {"entities": []}], ["Genome damage in dams and their newborn pups transplacentally exposed to these drugs was investigated using the in vivo micronucleus (MN) assay.", {"entities": []}], ["The drugs were administered to dams intraperitoneally in three consecutive daily doses between days 12 and 14 of pregnancy.", {"entities": []}], ["The results were correlated, with detoxification capacity of the newborn pups measured by the levels of GPX in blood and lipid peroxidation in liver measured by malondialdehyde (HPLC-MDA) levels.", {"entities": []}], ["Sodium valproate and 5-nitrofurantoin significantly increased MN frequency in pregnant dams.", {"entities": []}], ["A significant increase in the MN frequency of newborn pups was detected for all drugs tested.", {"entities": []}], ["This paper also provides reference levels of MDA in newborn pups, according to which all drugs tested significantly lowered MDA levels of newborn pups, while blood GPX activity dropped significantly only after exposure to paracetamol.", {"entities": []}], ["The GPX reduction reflected systemic oxidative stress, which is known to occur with paracetamol treatment.", {"entities": []}], ["The reduction of MDA in the liver is suggested to be an unspecific metabolic reaction to the drugs that express cytotoxic, in particular hepatotoxic, effects associated with oxidative stress and lipid peroxidation.", {"entities": []}], ["Despite a burgeoning interest in using interprofessional approaches to promote effective collaboration in health care, systematic reviews find scant evidence of benefit.", {"entities": []}], ["This protocol describes the first cluster randomized controlled trial (RCT) to design and evaluate an intervention intended to improve interprofessional collaborative communication and patient-centred care.", {"entities": []}], ["The objective is to evaluate the effects of a four-component, hospital-based staff communication protocol designed to promote collaborative communication between healthcare professionals and enhance patient-centred care.", {"entities": []}], ["The study is a multi-centre mixed-methods cluster randomized controlled trial involving twenty clinical teaching teams (CTTs) in general internal medicine (GIM) divisions of five Toronto tertiary-care hospitals.", {"entities": []}], ["CTTs will be randomly assigned either to receive an intervention designed to improve interprofessional collaborative communication, or to continue usual communication practices.", {"entities": []}], ["Non-participant naturalistic observation, shadowing, and semi-structured, qualitative interviews were conducted to explore existing patterns of interprofessional collaboration in the CTTs, and to support intervention development.", {"entities": []}], ["Interviews and shadowing will continue during intervention delivery in order to document interactions between the intervention settings and adopters, and changes in interprofessional communication.", {"entities": []}], ["The primary outcome is the rate of unplanned hospital readmission.", {"entities": []}], ["Secondary outcomes are length of stay (LOS); adherence to evidence-based prescription drug therapy; patients' satisfaction with care; self-report surveys of CTT staff perceptions of interprofessional collaboration; and frequency of calls to paging devices.", {"entities": []}], ["Outcomes will be compared on an intention-to-treat basis using adjustment methods appropriate for data from a cluster randomized design.", {"entities": []}], ["Pre-intervention qualitative analysis revealed that a substantial amount of interprofessional interaction lacks key core elements of collaborative communication such as self-introduction, description of professional role, and solicitation of other professional perspectives.", {"entities": []}], ["Incorporating these findings, a four-component intervention was designed with a goal of creating a culture of communication in which the fundamentals of collaboration become a routine part of interprofessional interactions during unstructured work periods on GIM wards.", {"entities": []}], ["Registered with National Institutes of Health as NCT00466297.", {"entities": []}], ["Heart failure is characterized by the inability of the cardiovascular system to maintain oxygen (O 2 ) delivery (i.e., muscle blood flow in non-hypoxemic patients) to meet O 2 demands.", {"entities": []}], ["The resulting increase in fractional O 2 extraction can be non-invasively tracked by deoxygenated hemoglobin concentration (deoxi-Hb) as measured by near-infrared spectroscopy (NIRS).", {"entities": []}], ["We aimed to establish a simplified approach to extract deoxi-Hb-based indices of impaired muscle O 2 delivery during rapidly-incrementing exercise in heart failure.", {"entities": []}], ["We continuously probed the right vastus lateralis muscle with continuous-wave NIRS during a ramp-incremental cardiopulmonary exercise test in 10 patients (left ventricular ejection fraction <35%) and 10 age-matched healthy males.", {"entities": []}], ["Deoxi-Hb is reported as % of total response (onset to peak exercise) in relation to work rate.", {"entities": []}], ["Patients showed lower maximum exercise capacity and O 2 uptake-work rate than controls (P<0.05).", {"entities": []}], ["The deoxi-Hb response profile as a function of work rate was S-shaped in all subjects, i.e., it presented three distinct phases.", {"entities": []}], ["Increased muscle deoxygenation in patients compared to controls was demonstrated by: i) a steeper mid-exercise deoxi-Hb-work rate slope (2.2\u00b11.3 vs 1.0\u00b10.3% peak/W, respectively; P<0.05), and ii) late-exercise increase in deoxi-Hb, which contrasted with stable or decreasing deoxi-Hb in all controls.", {"entities": []}], ["Steeper deoxi-Hb-work rate slope was associated with lower peak work rate in patients (r=\u20130.73; P=0.01).", {"entities": []}], ["This simplified approach to deoxi-Hb interpretation might prove useful in clinical settings to quantify impairments in O 2 delivery by NIRS during ramp-incremental exercise in individual heart failure patients.", {"entities": []}], ["Our objective in this study was to evaluate the mortality of workers exposed to sulfur dioxide in the pulp and paper industry.", {"entities": []}], ["The cohort included 57,613 workers employed for at least 1 year in the pulp and paper industry in 12 countries.", {"entities": []}], ["We assessed exposure to SO(2) at the level of mill and department, using industrial hygiene measurement data and information from company questionnaires; 40,704 workers were classified as exposed to SO(2).", {"entities": []}], ["We conducted a standardized mortality ratio (SMR) analysis based on age-specific and calendar period-specific national mortality rates.", {"entities": []}], ["We also conducted a Poisson regression analysis to determine the dose-response relations between SO(2) exposure and cancer mortality risks and to explore the effect of potential confounding factors.", {"entities": [[116, 122, "DISEASE"]]}], ["The SMR analysis showed a moderate deficit of all causes of death [SMR = 0.89; 95% confidence interval (CI), 0.87-0.96] among exposed workers.", {"entities": []}], ["Lung cancer mortality was marginally increased among exposed workers (SMR = 1.08; 95% CI, 0.98-1.18).", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"]]}], ["After adjustment for occupational coexposures, the lung cancer risk was increased compared with unexposed workers (rate ratio = 1.49; 95% CI, 1.14-1.96).", {"entities": [[51, 62, "DISEASE"], [56, 62, "DISEASE"]]}], ["There was a suggestion of a positive relationship between weighted cumulative SO(2) exposure and lung cancer mortality (p-value of test for linear trend = 0.009 among all exposed workers; p = 0.3 among workers with high exposure).", {"entities": [[97, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["Neither duration of exposure nor time since first exposure was associated with lung cancer mortality.", {"entities": [[79, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["Mortality from non-Hodgkin lymphoma and from leukemia was increased among workers with high SO(2) exposure; a dose-response relationship with cumulative SO(2) exposure was suggested for non-Hodgkin lymphoma.", {"entities": [[27, 35, "DISEASE"], [198, 206, "DISEASE"], [45, 53, "DISEASE"]]}], ["For the other causes of death, there was no evidence of increased mortality associated with exposure to SO(2).", {"entities": []}], ["Although residual confounding may have occurred, our results suggest that occupational exposure to SO(2) in the pulp and paper industry may be associated with an increased risk of lung cancer.", {"entities": [[180, 191, "DISEASE"], [185, 191, "DISEASE"]]}], ["Inhaled corticosteroids are the most effective treatment currently available for asthma, but their beneficial effect against airway remodeling is limited.", {"entities": [[81, 87, "DISEASE"]]}], ["The tyrosine kinase inhibitor nilotinib has inhibitory activity against c-kit and the platelet-derived growth factor receptor.", {"entities": []}], ["We compared the effects of fluticasone and nilotinib on airway remodeling in a chronic asthma model.", {"entities": [[87, 93, "DISEASE"]]}], ["We also examined whether co-treatment with nilotinib and fluticasone had any synergistic effect in preventing airway remodeling.", {"entities": []}], ["We developed a mouse model of airway remodeling, including smooth muscle thickening, in which ovalbumin (OVA)-sensitized female BALB/c-mice were repeatedly exposed to intranasal OVA administration twice per week for 3 months.", {"entities": []}], ["Mice were treated with fluticasone and/or nilotinib intranasally during the OVA challenge.", {"entities": []}], ["Mice chronically exposed to OVA developed eosinophilic airway inflammation and showed features of airway remodeling, including thickening of the peribronchial smooth muscle layer.", {"entities": []}], ["Both fluticasone and nilotinib attenuated airway smooth muscle thickening.", {"entities": []}], ["However, only nilotinib suppressed fibrotic changes, demonstrating inhibition of collagen deposition.", {"entities": []}], ["Fluticasone reduced pro-inflammatory cells, such as eosinophils, and several cytokines, such as interleukin 4 (IL-4), IL-5, and IL-13, induced by repeated OVA challenges.", {"entities": []}], ["On the other hand, nilotinib reduced transforming growth factor \u03b21 levels in bronchoalveolar lavage fluid and inhibited fibroblast proliferation significantly.", {"entities": []}], ["These results suggest that fluticasone and nilotinib suppressed airway remodeling in this chronic asthma model through anti-inflammatory and anti-fibrotic pathways, respectively.", {"entities": [[98, 104, "DISEASE"]]}], ["Background: Prospective birth cohort studies comprising follow up of children from pregnancy or birth over a long period of time, and collecting various biological samples at different times through the life-course offer a promising approach to enhance etiologic knowledge of various diseases.", {"entities": []}], ["Especially for those where early lifetime exposures and conditions are thought to play an important role.", {"entities": []}], ["The collection and storage of biological samples is a critical component in epidemiological studies, notably for research regarding prenatal exposures to various environmental factors as well as for DNA extraction.", {"entities": []}], ["Our feasibility study for a birth cohort within the scope of etiology of childhood leukemia with prospective sampling of mothers and their future newborns aimed to investigate the willingness of pregnant women to participate in a birth cohort study involving collection of blood and umbilical cord blood samples.", {"entities": [[83, 91, "DISEASE"], [73, 91, "DISEASE"]]}], ["The overall aim was to develop practice-based research recommendations for a possible German birth cohort study.", {"entities": []}], ["Methods: The study was conducted in Bremen, Germany, between January 2012 and March 2013.", {"entities": []}], ["Pregnant women were eligible for recruitment if (i) their expected date of delivery was during the study recruitment phase (September 2012\u2013February 2013), (ii) they planned to give birth at the cooperating hospital\u2019s obstetric unit and (iii) their knowledge of the German language was sufficient to understand study materials, details of participation and to fill out the prenatal self-administered questionnaire.", {"entities": []}], ["Maternal blood and umbilical cord blood samples to be used for later research activities were collected and stored at a stem cell bank already collaborating with the hospital.", {"entities": []}], ["22 primary care gynecologists were invited to enroll pregnant women for the study and cooperation with one hospital was established.", {"entities": []}], ["Expectant women were recruited during the last trimester of pregnancy, either during one of their prenatal care visits at their primary care gynecologist or later on in hospital by the attending obstetricians or project staff.", {"entities": []}], ["Results: Of the 22 invited primary care gynecologists requested to enroll pregnant women for the study, 8 gynecologists actually collaborated.", {"entities": []}], ["A total of 200 eligible women were invited to participate in the study, 48 (24%) of whom agreed.", {"entities": []}], ["34 women were enrolled by primary care gynecologists, with one gynecologist enrolling 26 women.", {"entities": []}], ["Twelve of 14 women recruited via hospitals were enrolled by study staff.", {"entities": []}], ["A total of 41 women consented to the collection of umbilical cord blood and maternal blood samples, and samples could be stored for 54% of them.", {"entities": []}], ["Reason for non-participation were the uncertainty whether or not the full study would be conducted and the fact that the participants were not willing to decide for their children whether or not genetic information (cord blood) can be stored for research purposes.", {"entities": []}], ["Conclusion: Enrolling parents in a birth cohort study that includes biosampling is a challenge, but participation can be improved through close collaboration with primary care gynecologists and maternity hospitals.", {"entities": []}], ["Cord blood collection may impede participation, especially when maternity hospitals offer an alternative option for cord blood donation.", {"entities": []}], ["To investigate the association of vitamin D status with all-cause mortality in a Norwegian population and the potential influences of existing chronic diseases on the association.", {"entities": []}], ["A population-based prospective cohort study.", {"entities": []}], ["Nord-Tr\u00f8ndelag County, Norway.", {"entities": []}], ["A random sample (n=6613) of adults aged 20 years or older in a cohort.", {"entities": []}], ["Serum 25-hydroxyvitamin D (25(OH)D) levels were measured in blood samples collected at baseline (n=6377).", {"entities": []}], ["Mortality was ascertained from the Norwegian National Registry.", {"entities": []}], ["Cox regression models were applied to estimate the HRs with 95% CIs for all-cause mortality in association with serum 25(OH)D levels after adjustment for a wide spectrum of confounding factors as well as chronic diseases at baseline.", {"entities": []}], ["The median follow-up time was 18.5 years, during which 1539 subjects died.", {"entities": []}], ["The HRs for all-cause mortality associated with the first quartile level of 25(OH)D (<34.5 nmol/L) as compared with the fourth quartile (\u226558.1 nmol/L) before and after adjustment for chronic diseases at baseline were 1.30 (95% CI 1.11 to 1.51) and 1.27 (95% CI 1.09 to 1.48), respectively.", {"entities": []}], ["In the subjects without chronic diseases at baseline and with further exclusion of the first 3 years of follow-up, the corresponding adjusted HR was 1.34 (95% CI 1.09 to 1.66).", {"entities": [[142, 144, "GENE"]]}], ["Low serum 25(OH)D level was associated with increased all-cause mortality in a general Norwegian population.", {"entities": []}], ["The association was not notably influenced by existing chronic diseases.", {"entities": []}], ["The aim of this study was to explore the prevalence and relationship of anticipated chronic illness stigma among patients diagnosed with a variety of chronic diseases in three Southeast Asian countries (Cambodia, Myanmar and Vietnam).", {"entities": []}], ["A cross-sectional survey was conducted in 4,803 adult chronic disease patients (mean age 49.3 years; SD=16.5) recruited systematically from health facilities.", {"entities": []}], ["Overall, the results indicate that 20.7% of patients reported that for any of the 12 stigma items, they anticipated they were likely or very likely to experience chronic disease stigma.", {"entities": []}], ["A multivariate analysis of sociodemographics revealed the following were associated with anticipated chronic disease stigma: older versus younger age, OR (odds ratio) = 0.71; 95% Confidence Interval (CI) [0.58, 0.87]; higher versus lower education, OR = 2.23; 95% CI [1.81, 2.75]; origin from Myanmar or Vietnam, being single, divorced or widowed, rural residence, and health status (having three or more chronic conditions versus having one chronic condition), OR = 1.93; 95% CI [1.58, 2.35]; lower versus higher quality of life, OR = 0.73; 95% CI [0.63, 0.85]); health risk behavior (physical inactivity, poor diet, current smoking, and problem drinking) and low versus medium or high medication adherence (OR = 0.69; 95% CI [0.55,0.86]).", {"entities": []}], ["This study demonstrated the possible consequences of anticipated stigma on the health and behavior of people living with chronic diseases, and several factors for chronic disease stigma were identified that can help guide interventions to reduce chronic illness stigma in this population.", {"entities": []}], ["TRPM8 (transient receptor potential M8) and TRPA1 (transient receptor potential A1) are cold-temperature-sensitive nociceptors expressed in sensory neurons but their behaviour in neuronal cells is poorly understood.", {"entities": [[0, 5, "GENE"], [44, 49, "GENE"]]}], ["Therefore DNA expression constructs containing human TRPM8 or TRPA1 cDNAs were transfected into HEK (human embryonic kidney cells)-293 or SH-SY5Y neuroblastoma cells and G418 resistant clones analysed for effects of agonists and antagonists on intracellular Ca N -(3-Aminopropyl)-2-[(3-methylphenyl)methoxy]- N -(2-thienylmethyl)benzamide]}.", {"entities": [[146, 159, "DISEASE"], [53, 58, "GENE"], [62, 67, "GENE"]]}], ["SNP (single nucleotide polymorphism) variants in TRPA1 ICL-1 (R797T, S804N) and TRPA1 fusion protein containing C-terminal (His) 10 retained sensitivity to agonists (cinnamaldehyde, allyl-isothiocyanate, carvacrol, eugenol) and antagonists (HC-030031, A967079).", {"entities": [[49, 54, "GENE"], [80, 85, "GENE"], [49, 54, "GENE"], [80, 85, "GENE"]]}], ["One SNP variant, 797T, possessed increased sensitivity to agonists.", {"entities": []}], ["TRPA1 became repressed in SH-SY5Y clones but was rapidly rescued by Src-family inhibitor PP2 [4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4- d ]pyrimidine].", {"entities": [[0, 5, "GENE"]]}], ["Conversely, TRPM8\u00a0in SH-SY5Y cells was inhibited by PP2.", {"entities": [[12, 17, "GENE"]]}], ["Further studies utilizing SH-SY5Y may identify structural features of TRPA1 and TRPM8 involved in conferring differential post-translational regulation.", {"entities": [[70, 75, "GENE"], [80, 85, "GENE"]]}], ["Transient receptor potential channels M8 and A1 sense the cellular environment and activate entry of Ca", {"entities": []}], ["Bronchiolitis caused by the respiratory syncytial virus (RSV) and its related complications are common in infants born prematurely, with severe congenital heart disease, or bronchopulmonary dysplasia, as well as in immunosuppressed infants.", {"entities": [[155, 168, "DISEASE"]]}], ["There is a rich literature on the different aspects of RSV infection with a focus, for the most part, on specific risk populations.", {"entities": []}], ["However, there is a need for a systematic global analysis of the impact of RSV infection in terms of use of resources and health impact on both children and adults.", {"entities": []}], ["With this aim, we performed a systematic search of scientific evidence on the social, economic, and health impact of RSV infection.", {"entities": []}], ["A systematic search of the following databases was performed: MEDLINE, EMBASE, Spanish Medical Index, MEDES-MEDicina in Spanish, Cochrane Plus Library, and Google without time limits.", {"entities": []}], ["We selected 421 abstracts based on the 6,598 articles identified.", {"entities": []}], ["From these abstracts, 4 RSV experts selected the most relevant articles.", {"entities": []}], ["They selected 65 articles.", {"entities": []}], ["After reading the full articles, 23 of their references were also selected.", {"entities": []}], ["Finally, one more article found through a literature information alert system was included.", {"entities": []}], ["The information collected was summarized and organized into the following topics: 1.", {"entities": []}], ["Impact on health (infections and respiratory complications, mid- to long-term lung function decline, recurrent wheezing, asthma, other complications such as otitis and rhino-conjunctivitis, and mortality; 2.", {"entities": [[174, 188, "DISEASE"], [121, 127, "DISEASE"]]}], ["Impact on resources (visits to primary care and specialists offices, emergency room visits, hospital admissions, ICU admissions, diagnostic tests, and treatments); 3.", {"entities": []}], ["Impact on costs (direct and indirect costs); 4.", {"entities": []}], ["Impact on quality of life; and 5.", {"entities": []}], ["Strategies to reduce the impact (interventions on social and hygienic factors and prophylactic treatments).", {"entities": []}], ["We concluded that 1.", {"entities": []}], ["The health impact of RSV infection is relevant and goes beyond the acute episode phase; 2.", {"entities": []}], ["The health impact of RSV infection on children is much better documented than the impact on adults; 3.", {"entities": []}], ["Further research is needed on mid- and long-term impact of RSV infection on the adult population, especially those at high-risk; 4.", {"entities": []}], ["There is a need for interventions aimed at reducing the impact of RSV infection by targeting health education, information, and prophylaxis in high-risk populations.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-014-0544-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to evaluate risk factors in patients with macular telangiectasia (MacTel) 2A in an Asian population.", {"entities": []}], ["This was a hospital-based case\u2013control study.", {"entities": []}], ["We reviewed the case records of patients in our hospital, diagnosed as MacTel 2A over a 3-year period from April 2011 to March 2014.", {"entities": []}], ["Controls were selected from patients seen in the hospital at the same time for visual defects after matching for age and sex.", {"entities": []}], ["A multivariate logistic regression model was constructed using the variables that showed a statistically significant association ( P < 0.05) with MacTel 2A in the univariate analysis.", {"entities": []}], ["The mean age of the patients with MacTel 2A was 58.63 years.", {"entities": []}], ["A majority (76; 73.8%) of the patients were female.", {"entities": []}], ["Of the patients with MacTel 2A, 61 (59.2%) patients had diabetes mellitus, and 50 (48.5%) revealed hypertension.", {"entities": [[99, 111, "DISEASE"], [56, 73, "DISEASE"]]}], ["Multivariate logistic regression analysis revealed the presence of diabetes mellitus to be the risk factor with the highest odds ratio (OR) of 5.7 followed by hypertension with an OR of 2.6.", {"entities": [[159, 171, "DISEASE"], [67, 84, "DISEASE"]]}], ["Binary logistic regression showed hypermetropia to have a greater risk factor compared to emmetropia, OR 2.64.", {"entities": []}], ["Our case\u2013control study revealed that MacTel 2A is significantly associated with systemic diseases.", {"entities": []}], ["Diabetes mellitus was found to have the strongest association with MacTel 2A, showing a high OR of 5.7.", {"entities": [[0, 17, "DISEASE"]]}], ["Systemic hypertension followed by an OR of 2.6.", {"entities": [[9, 21, "DISEASE"]]}], ["Compared to emmetropia, hypermetropia was significantly associated with MacTel 2A.", {"entities": []}], ["There could be a genetic link between the two.", {"entities": []}], ["Determining risk factors draws us close to the goal of identifying the etiopathogenesis of MacTel 2A.", {"entities": []}], ["Complex diseases are defined to be determined by multiple genetic and environmental factors alone as well as in interactions.", {"entities": []}], ["To analyze interactions in genetic data, many statistical methods have been suggested, with most of them relying on statistical regression models.", {"entities": []}], ["Given the known limitations of classical methods, approaches from the machine-learning community have also become attractive.", {"entities": []}], ["From this latter family, a fast-growing collection of methods emerged that are based on the Multifactor Dimensionality Reduction (MDR) approach.", {"entities": []}], ["Since its first introduction, MDR has enjoyed great popularity in applications and has been extended and modified multiple times.", {"entities": []}], ["Based on a literature search, we here provide a systematic and comprehensive overview of these suggested methods.", {"entities": []}], ["The methods are described in detail, and the availability of implementations is listed.", {"entities": []}], ["Most recent approaches offer to deal with large-scale data sets and rare variants, which is why we expect these methods to even gain in popularity.", {"entities": []}], ["Some studies have shown that nasally administered immunobiotics had the potential to improve the outcome of influenza virus infection.", {"entities": [[108, 117, "DISEASE"]]}], ["However, the capacity of immunobiotics to improve protection against respiratory syncytial virus (RSV) infection was not investigated before.", {"entities": []}], ["The aims of this study were: a) to evaluate whether the nasal administration of Lactobacillus rhamnosus CRL1505 (Lr05) and L. rhamnosus CRL1506 (Lr06) are able to improve respiratory antiviral defenses and beneficially modulate the immune response triggered by TLR3/RIG-I activation; b) to investigate whether viability of Lr05 or Lr06 is indispensable to modulate respiratory immunity and; c) to evaluate the capacity of Lr05 and Lr06 to improve the resistance of infant mice against RSV infection.", {"entities": []}], ["Nasally administered Lr05 and Lr06 differentially modulated the TLR3/RIG-I-triggered antiviral respiratory immune response.", {"entities": []}], ["Lr06 administration significantly modulated the production of IFN-\u03b1, IFN-\u03b2 and IL-6 in the response to poly(I:C) challenge, while nasal priming with Lr05 was more effective to improve levels of IFN-\u03b3 and IL-10.", {"entities": []}], ["Both viable Lr05 and Lr06 strains increased the resistance of infant mice to RSV infection while only heat-killed Lr05 showed a protective effect similar to those observed with viable strains.", {"entities": []}], ["The present work demonstrated that nasal administration of immunobiotics is able to beneficially modulate the immune response triggered by TLR3/RIG-I activation in the respiratory tract and to increase the resistance of mice to the challenge with RSV.", {"entities": []}], ["Comparative studies using two Lactobacillus rhamnosus strains of the same origin and with similar technological properties showed that each strain has an specific immunoregulatory effect in the respiratory tract and that they differentially modulate the immune response after poly(I:C) or RSV challenges, conferring different degree of protection and using distinct immune mechanisms.", {"entities": []}], ["We also demonstrated in this work that it is possible to beneficially modulate the respiratory defenses against RSV by using heat-killed immunobiotics.", {"entities": []}], ["The effectiveness of intermittent montelukast for wheeze in young children is unclear.", {"entities": []}], ["We aimed to assess whether intermittent montelukast is better than placebo for treatment of wheeze in this age group.", {"entities": []}], ["Because copy numbers of the Sp1-binding motif in the arachidonate 5-lipoxygenase ( ALOX5 ) gene promoter (either 5/5, 5/x, or x/x, where x does not equal 5) modifies response to montelukast in adults, we stratified by this genotype.", {"entities": [[83, 88, "GENE"]]}], ["We did this multicentre, parallel-group, randomised, placebo-controlled trial between Oct 1, 2010, and Dec 20, 2013, at 21 primary care sites and 41 secondary care sites in England and Scotland.", {"entities": []}], ["Children aged 10 months to 5 years with two or more wheeze episodes were allocated to either a 5/5 or 5/x+x/x ALOX5 promoter genotype stratum, then randomly assigned (1:1) via a permuted block schedule (size ten), to receive intermittent montelukast or placebo given by parents at each wheeze episode over a 12 month period.", {"entities": [[110, 115, "GENE"]]}], ["Clinical investigators and parents were masked to treatment group and genotype strata.", {"entities": []}], ["The primary outcome was number of unscheduled medical attendances for wheezing episodes.", {"entities": []}], ["Analysis was by intention to treat.", {"entities": []}], ["This trial is registered with ClinicalTrials.gov , number NCT01142505 .", {"entities": []}], ["We randomly assigned 1358 children to receive montelukast (n=669) or placebo (n=677).", {"entities": []}], ["Consent was withdrawn for 12 (1%) children.", {"entities": []}], ["Primary outcome data were available for 1308 (96%) children.", {"entities": []}], ["There was no difference in unscheduled medical attendances for wheezing episodes between children in the montelukast and placebo groups (mean 2\u00b70 [SD 2\u00b76] vs 2\u00b73 [2\u00b77]; incidence rate ratio [IRR] 0\u00b788, 95% CI: 0\u00b777\u20131\u00b701; p=0\u00b706).", {"entities": []}], ["Compared with placebo, unscheduled medical attendances for wheezing episodes were reduced in children given montelukast in the 5/5 stratum (2\u00b70 [2\u00b77] vs 2\u00b74 [3\u00b70]; IRR 0\u00b780, 95% CI 0\u00b768\u20130\u00b795; p=0\u00b701), but not in those in the 5/x+x/x stratum (2\u00b70 [2\u00b75] vs 2\u00b70 [2\u00b73]; 1\u00b703, 0\u00b783\u20131\u00b729; p=0\u00b779, p interaction =0\u00b708).", {"entities": []}], ["We recorded one serious adverse event, which was a skin reaction in a child allocated to placebo.", {"entities": []}], ["Our findings show no clear benefit of intermittent montelukast in young children with wheeze.", {"entities": []}], ["However, the 5/5 ALOX5 promoter genotype might identify a montelukast-responsive subgroup.", {"entities": [[17, 22, "GENE"]]}], ["Medical Research Council (UK) and National Institute for Health Research.", {"entities": []}], ["This study aimed to assess the patient-rated level of discomfort during point-of-care ultrasonography (POCUS) of the heart, lungs and deep veins in a population of patients admitted to an ED with respiratory symptoms and to what extent the patients would accept being assessed by the use of POCUS if they had to be examined for possible disease.", {"entities": []}], ["A questionnaire-based observational study was conducted in an ED.", {"entities": []}], ["Inclusion criteria were one or more of the following: respiratory rate\u2009>\u200920/min, oxygen saturation\u2009<\u200995\u00a0%, oxygen therapy initiated, dyspnoea, cough or chest pain.", {"entities": []}], ["Patients were examined by the use of POCUS of the heart, lungs and deep veins.", {"entities": []}], ["Patient-rated level of discomfort and acceptance were assessed using a standardised questionnaire.", {"entities": []}], ["The median duration of the sonographic examinations was 12\u00a0min (IQR 11\u201313, range 9\u201323).", {"entities": []}], ["The median patient-rated level of discomfort for all three types of POCUS was 1 (IQR 1\u20131, range 1\u20138) on a scale from 1 to 10.", {"entities": []}], ["All but one patient (99.6\u00a0% (95 % CI: 98.9-100\u00a0%)), would accept being examined by the use of POCUS as a part of routine ED diagnostics.", {"entities": []}], ["The patient-rated level of discomfort during POCUS of the heart, lungs and deep veins is very low and the vast majority of patients would accept being assessed by the use of POCUS if the patients once again had to be examined for possible disease .", {"entities": []}], ["The online version of this article (doi:10.1186/s13049-015-0127-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma has been associated with the atherosclerosis risk, but not clear of peripheral artery disease (PAD).", {"entities": [[36, 51, "DISEASE"], [0, 6, "DISEASE"]]}], ["We attempted to examine the risk of PAD in patients with asthma.", {"entities": [[57, 63, "DISEASE"]]}], ["From the insurance claims data of Taiwan, we identified 28,158 newly diagnosed asthma patients in 2000 to 2005 and 56,316 persons without asthma randomly selected into the comparison cohort, frequency matched by sex, age, and the date of diagnosis.", {"entities": [[79, 85, "DISEASE"], [138, 144, "DISEASE"]]}], ["Both cohorts were followed up until the end of 2011 to estimate the incident PAD.", {"entities": []}], ["Adjusted hazard ratios (aHRs) of PAD were estimated using the Cox proportional hazards model after controlling for sex, age, and comorbidities.", {"entities": []}], ["The incidence of PAD was 1.46 times higher in the asthma cohort than in the comparison cohort, with an aHR of 1.34 [95% confidence interval (CI)\u200a=\u200a1.24\u20131.45].", {"entities": [[50, 56, "DISEASE"], [103, 106, "GENE"]]}], ["Incidence of PAD was higher in men, the aged, and those with comorbidities in both cohorts.", {"entities": []}], ["The aHRs of PAD remained significant for the asthma cohort in all subgroups of sex, age, and the presence of comorbidity.", {"entities": [[45, 51, "DISEASE"]]}], ["The aHRs of PAD were 14.1 (95% CI\u200a=\u200a8.18\u201324.5) in asthma patients with multiple emergency visits and 22.3 (95% CI\u200a=\u200a15.6\u201331.9) for those with multiple hospitalizations.", {"entities": [[50, 56, "DISEASE"]]}], ["Although smoking is a potential confounding factor, this study suggests patients with asthma have a significantly higher risk of developing PAD than the general population.", {"entities": [[86, 92, "DISEASE"]]}], ["The results also support the notion that poor control of asthma status is a key factor in subsequent PAD development.", {"entities": [[57, 63, "DISEASE"]]}], ["The aim of this study was to evaluate whether the difference in the degree of collateral ventilation between canine and swine models of bronchial obstruction could be detected by using xenon-enhanced dynamic dual-energy CT.", {"entities": []}], ["Eight mongrel dogs and six pigs underwent dynamic dual-energy scanning of 64-slice dual-source CT at 12-second interval for 2-minute wash-in period (60% xenon) and at 24-second interval for 3-minute wash-out period with segmental bronchus occluded.", {"entities": []}], ["Ventilation parameters of magnitude (A value), maximal slope, velocity (K value), and time-to-peak (TTP) enhancement were calculated from dynamic xenon maps using exponential function of Kety model.", {"entities": []}], ["A larger difference in A value between parenchyma was observed in pigs than in dogs (absolute difference, -33.0 \u00b1 5.0 Hounsfield units [HU] vs. -2.8 \u00b1 7.1 HU, p = 0.001; normalized percentage difference, -79.8 \u00b1 1.8% vs. -5.4 \u00b1 16.4%, p = 0.0007).", {"entities": []}], ["Mean maximal slopes in both periods in the occluded parenchyma only decreased in pigs (all p < 0.05).", {"entities": []}], ["K values of both periods were not different ( p = 0.892) in dogs.", {"entities": []}], ["However, a significant ( p = 0.027) difference was found in pigs in the wash-in period.", {"entities": []}], ["TTP was delayed in the occluded parenchyma in pigs ( p = 0.013) but not in dogs ( p = 0.892).", {"entities": []}], ["Xenon-ventilation CT allows the quantification of collateral ventilation and detection of differences between canine and swine models of bronchial obstruction.", {"entities": []}], ["The importance of tyrosine kinases in airway smooth muscle (ASM) contraction is not fully understood.", {"entities": []}], ["The aim of this study was to investigate the role of Src\u2010family kinases (SrcFK) and focal adhesion kinase (FAK) in GPCR\u2010mediated ASM contraction and associated signalling events.", {"entities": []}], ["Contraction was recorded in intact or \u03b1\u2010toxin permeabilized rat bronchioles.", {"entities": []}], ["Phosphorylation of SrcFK, FAK, myosin light\u2010chain\u201020 (MLC 20 ) and myosin phosphatase targeting subunit\u20101 (MYPT\u20101) was evaluated in cultured human ASM cells (hASMC).", {"entities": []}], ["[Ca i was evaluated in Fura\u20102 loaded hASMC.", {"entities": []}], ["Responses to carbachol (CCh) and bradykinin (BK) and the contribution of SrcFK and FAK to these responses were determined.", {"entities": []}], ["Contractile responses in intact bronchioles were inhibited by antagonists of SrcFK, FAK and Rho\u2010kinase, while after \u03b1\u2010toxin permeabilization, they were sensitive to inhibition of SrcFK and Rho\u2010kinase, but not FAK.", {"entities": []}], ["CCh and BK increased phosphorylation of MYPT\u20101 and MLC 20 and auto\u2010phosphorylation of SrcFK and FAK.", {"entities": []}], ["MYPT\u20101 phosphorylation was sensitive to inhibition of Rho\u2010kinase and SrcFK, but not FAK.", {"entities": []}], ["Contraction induced by SR Ca i responses in hASMC were sensitive to inhibition of both SrcFK and FAK, while depolarization\u2010induced contraction was sensitive to FAK inhibition only.", {"entities": []}], ["SrcFK auto\u2010phosphorylation was partially FAK\u2010dependent, while FAK auto\u2010phosphorylation was SrcFK\u2010independent.", {"entities": []}], ["SrcFK mediates Ca", {"entities": []}], ["Asthma is a common chronic condition with an economic burden of almost $56 billion annually in the US.", {"entities": [[0, 6, "DISEASE"]]}], ["Biologic markers like blood eosinophils, that help predict the risk of exacerbation could help guide more optimal treatment plans and reduce cost.", {"entities": []}], ["The purpose of this study was to determine whether healthcare resource use and expenditures vary by eosinophil level among patients with asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["Patients with a diagnosis of asthma defined by ICD-9-CM code 493.xx between January 2004 and July 2011 were extracted from EMRClaims\u2009+\u2009database (eMAX Health, White Plains NY).", {"entities": [[29, 35, "DISEASE"]]}], ["Patients were classified as mild, moderate, or severe by medication use following diagnosis, based on recommendations of National Institutes of Health Expert Panel Report 3.", {"entities": []}], ["Patients were classified as those with elevated eosinophils (\u2265400 cells/\u03bcL) and normal eosinophil level (<400 cells/\u03bcL).", {"entities": []}], ["Patients were followed for resource use, defined as hospitalizations, ER visits and outpatient visit and associated costs were calculated to assess whether an economic difference exists between eosinophil groups.", {"entities": []}], ["Non-parametric tests were used to compare resource use and associated cost between elevated and normal eosinophil groups.", {"entities": []}], ["Multivariate modeling was performed to assess the contribution of eosinophil level on the likelihood of study outcomes among patients with severe asthma.", {"entities": [[146, 152, "DISEASE"]]}], ["Among the 2,164 patients meeting eligibility criteria, 1,144 had severity designations.", {"entities": []}], ["Of these, 179(16\u00a0%) of patients had severe asthma of which 20\u00a0% ( n \u2009=\u200935) had elevated eosinophils.", {"entities": [[43, 49, "DISEASE"]]}], ["Seventeen percent of patients with elevated eosinophils were admitted to the hospital during the follow-up period, significantly greater than patients with normal eosinophil levels (12\u00a0%; p \u2009=\u20090.011).", {"entities": []}], ["Overall, compared to patients with normal eosinophil levels ( n \u2009=\u20091734), patients with elevated eosinophil levels ( n \u2009=\u2009430) had significantly greater mean annual hospital admissions (0.51 vs. 0.21/year, p \u2009=\u20090.006) and hospital costs (2,536 vs. $1,091, p \u2009=\u20090.011).", {"entities": []}], ["Logistic regressions showed that elevated eosinophil level was associated with 5.14 times increased odds of all cause admissions (95\u00a0% CI:1.76\u201314.99, p \u2009=\u20090.003) and 4.07 times increased odds of asthma related admissions (95\u00a0% CI: 1.26\u201313.12, p \u2009=\u20090.019).", {"entities": [[195, 201, "DISEASE"]]}], ["Eosinophil elevation was associated with greater healthcare resource use in patients with asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["The polyamine system has been implicated in a number of psychiatric conditions, which display both alterations in polyamine levels and altered expression of genes related to polyamine metabolism.", {"entities": []}], ["Studies have identified associations between genetic variants in spermidine/spermine N1-acetyltransferase (SAT1) and both anxiety and suicide, and several polymorphisms appear to play important roles in determining gene expression.", {"entities": [[107, 111, "GENE"]]}], ["We genotyped 63 polymorphisms, spread across four polyaminergic genes (SAT1, spermine synthase (SMS), spermine oxidase (SMOX), and ornithine aminotransferase like-1 (OATL1)), in 1255 French-Canadian individuals who have been followed longitudinally for 22 years.", {"entities": [[71, 75, "GENE"], [96, 99, "GENE"], [120, 124, "GENE"]]}], ["We assessed univariate associations with anxiety, mood disorders, and attempted suicide, as assessed during early adulthood.", {"entities": []}], ["We also investigated the involvement of gene-environment interactions in terms of childhood abuse, and assessed internalizing and externalizing symptoms as endophenotypes mediating these interactions.", {"entities": []}], ["Overall, each gene was associated with at least one main outcome: anxiety (SAT1, SMS), mood disorders (SAT1, SMOX), and suicide attempts (SAT1, OATL1).", {"entities": [[75, 79, "GENE"], [103, 107, "GENE"], [138, 142, "GENE"], [81, 84, "GENE"], [75, 79, "GENE"], [103, 107, "GENE"], [138, 142, "GENE"], [109, 113, "GENE"], [75, 79, "GENE"], [103, 107, "GENE"], [138, 142, "GENE"]]}], ["Several SAT1 polymorphisms displayed disease-specific risk alleles, and polymorphisms in this gene were involved in gene-gene interactions with SMS to confer risk for anxiety disorders, as well as gene-environment interactions between childhood physical abuse and mood disorders.", {"entities": [[8, 12, "GENE"], [144, 147, "GENE"]]}], ["Externalizing behaviors demonstrated significant mediation with regards to the association between OATL1 and attempted suicide, however there was no evidence that externalizing or internalizing behaviors were appropriate endophenotypes to explain the associations with mood or anxiety disorders.", {"entities": []}], ["Finally, childhood sexual abuse did not demonstrate mediating influences on any of our outcomes.", {"entities": []}], ["These results demonstrate that genetic variants in polyaminergic genes are associated with psychiatric conditions, each of which involves a set of separate and distinct risk alleles.", {"entities": []}], ["As several of these polymorphisms are associated with gene expression, these findings may provide mechanisms to explain the alterations in polyamine metabolism which have been observed in psychiatric disorders.", {"entities": []}], ["Treatment burden is the workload of healthcare experienced by those with long-term conditions and the impact that this has on well-being.", {"entities": []}], ["Treatment burden can negatively impact on quality of life and adherence to treatments.", {"entities": []}], ["Individuals are likely to differ in their ability to manage health problems and follow treatments, defined as patient capacity.", {"entities": []}], ["This has been under investigated in stroke.", {"entities": []}], ["The aim of this paper is to create a conceptual model of treatment burden and patient capacity for people who have had a stroke through exploration of their experiences of healthcare.", {"entities": []}], ["Interviews were conducted at home with 29 individuals who have had a stroke.", {"entities": []}], ["These were recorded and transcribed verbatim.", {"entities": []}], ["Fifteen explored treatment burden and were analysed by framework analysis underpinned by Normalisation Process Theory (NPT).", {"entities": []}], ["Fourteen explored patient capacity and were analysed by thematic analysis.", {"entities": []}], ["Taxonomies of treatment burden and patient capacity were created and a conceptual model produced.", {"entities": []}], ["Mean age was 68\u00a0years.", {"entities": []}], ["Sixteen were men and 13 women.", {"entities": []}], ["The following broad areas of treatment burden were identified: making sense of stroke management and planning care; interacting with others including health professionals, family and other stroke patients; enacting management strategies; and reflecting on management.", {"entities": []}], ["Treatment burdens were identified as arising from either: the workload of healthcare; or the endurance of care deficiencies.", {"entities": []}], ["Six factors were identified that influence patient capacity: personal attributes and skills; physical and cognitive abilities; support network; financial status; life workload, and environment.", {"entities": []}], ["Healthcare workload and the presence of care deficiencies can influence and be influenced by patient capacity.", {"entities": []}], ["The quality and configuration of health and social care services has considerable influence on treatment burden and patient capacity.", {"entities": []}], ["Findings have important implications for the design of clinical guidelines and healthcare delivery, highlighting issues such as the importance of good care co-ordination.", {"entities": []}], ["The online version of this article (10.1186/s12875-017-0691-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and significantly impact on patients\u2019 quality of life, exacerbation frequency, and survival.", {"entities": [[30, 67, "DISEASE"]]}], ["There is increasing evidence that certain diseases occur in greater frequency amongst patients with COPD than in the general population, and that these comorbidities significantly impact on patient outcomes.", {"entities": []}], ["Although the mechanisms are yet to be defined, many comorbidities likely result from the chronic inflammatory state that is present in COPD.", {"entities": []}], ["Common problems in the clinical management of COPD include recognizing new comorbidities, determining the impact of comorbidities on patient symptoms, the concurrent treatment of COPD and comorbidities, and accurate prognostication.", {"entities": []}], ["The majority of comorbidities in COPD should be treated according to usual practice, and specific COPD management is infrequently altered by the presence of comorbidities.", {"entities": []}], ["Unfortunately, comorbidities are often under-recognized and under-treated.", {"entities": []}], ["This review focuses on the epidemiology of ten major comorbidities in patients with COPD.", {"entities": []}], ["Further, we emphasize the clinical impact upon prognosis and management considerations.", {"entities": []}], ["This review will highlight the importance of comorbidity identification and management in the practice of caring for patients with COPD.", {"entities": []}], ["Whether perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS), two widely used and biopersistent synthetic chemicals, are immunotoxic in humans is unclear.", {"entities": []}], ["Accordingly, this article systematically and critically reviews the epidemiologic evidence on the association between exposure to PFOA and PFOS and various immune-related health conditions in humans.", {"entities": []}], ["Twenty-four epidemiologic studies have reported associations of PFOA and/or PFOS with immune-related health conditions, including ten studies of immune biomarker levels or gene expression patterns, ten studies of atopic or allergic disorders, five studies of infectious diseases, four studies of vaccine responses, and five studies of chronic inflammatory or autoimmune conditions (with several studies evaluating multiple endpoints).", {"entities": []}], ["Asthma, the most commonly studied condition, was evaluated in seven studies.", {"entities": []}], ["With few, often methodologically limited studies of any particular health condition, generally inconsistent results, and an inability to exclude confounding, bias, or chance as an explanation for observed associations, the available epidemiologic evidence is insufficient to reach a conclusion about a causal relationship between exposure to PFOA and PFOS and any immune-related health condition in humans.", {"entities": []}], ["When interpreting such studies, an immunodeficiency should not be presumed to exist when there is no evidence of a clinical abnormality.", {"entities": []}], ["Large, prospective studies with repeated exposure assessment in independent populations are needed to confirm some suggestive associations with certain endpoints.", {"entities": []}], ["An analysis of pregnancy data for the whole of Scotland demonstrates a reduction in small-for-gestational-age births and preterm delivery since the introduction of legislation banning smoking in enclosed public spaces.", {"entities": []}], ["Both active smoking and environmental tobacco smoke exposure are associated with pregnancy complications.", {"entities": []}], ["In March 2006, Scotland implemented legislation prohibiting smoking in all wholly or partially enclosed public spaces.", {"entities": []}], ["The aim of this study was to determine the impact of this legislation on preterm delivery and small for gestational age.", {"entities": []}], ["We conducted logistic regression analyses using national administrative pregnancy data covering the whole of Scotland.", {"entities": []}], ["Of the two breakpoints tested, 1 January 2006 produced a better fit than the date when the legislation came into force (26 March 2006), suggesting an anticipatory effect.", {"entities": []}], ["Among the 716,941 eligible women who conceived between August 1995 and February 2009 and subsequently delivered a live-born, singleton infant between 24 and 44 wk gestation, the prevalence of current smoking fell from 25.4% before legislation to 18.8% after legislation ( p <0.001).", {"entities": []}], ["Three months prior to the legislation, there were significant decreases in small for gestational age (\u22124.52%, 95% CI \u22128.28, \u22120.60, p \u200a=\u200a0.024), overall preterm delivery (\u221211.72%, 95% CI \u221215.87, \u22127.35, p <0.001), and spontaneous preterm labour (\u221211.35%, 95% CI \u221217.20, \u22125.09, p \u200a=\u200a0.001).", {"entities": []}], ["In sub-group analyses, significant reductions were observed among both current and never smokers.", {"entities": []}], ["Reductions were observed in the risk of preterm delivery and small for gestational age 3 mo prior to the introduction of legislation, although the former reversed partially following the legislation.", {"entities": []}], ["There is growing evidence of the potential for tobacco control legislation to have a positive impact on health.", {"entities": []}], ["Please see later in the article for the Editors' Summary The risks of smoking during pregnancy, both on mother and fetus, are well established: women who smoke during pregnancy are more likely to have a miscarriage.", {"entities": []}], ["Smoking can cause placental problems, such as placental abruption, which can result in heavy bleeding during pregnancy, which is dangerous for both mother and baby.", {"entities": [[46, 65, "DISEASE"]]}], ["Other dangers of smoking during pregnancy include the baby being born too early (premature birth), the baby being below average weight (small for gestational age), birth defects, and infant death.", {"entities": []}], ["Because of the serious damage to health caused by smoking, in 2005, under the auspices of the World Health Organization, countries adopted the Framework Convention on Tobacco Control to protect present and future generations from the devastating health, social, environmental, and economic consequences of tobacco consumption and exposure to tobacco smoke.", {"entities": []}], ["Article 8 of the treaty obliges member states who have ratified the treaty\u2014168 so far\u2014to protect all people from exposure to tobacco smoke in indoor workplaces, public transport, and indoor public places.", {"entities": []}], ["As a result, many countries around the world have banned smoking in public places.", {"entities": []}], ["Scotland was the first country in the United Kingdom to ban smoking in public places, which was implemented as part of the Smoking, Health and Social Care (Scotland) Bill on 26 March 2006.", {"entities": []}], ["Previous studies have shown that the introduction of the legislation led directly to a reduction in smoking and also a reduction in environmental tobacco smoke exposure in adults and children.", {"entities": []}], ["Furthermore, the Scottish legislation has been accompanied by significant reductions in both cardiovascular and respiratory disease.", {"entities": []}], ["Because of the known risks of smoking during pregnancy, the researchers wanted to investigate whether the change in policy on smoking in public places had positive benefits on the health of mothers and babies.", {"entities": []}], ["They evaluated this by measuring the rates of preterm delivery and small for gestational age before and after the Scottish legislation went into effect.", {"entities": []}], ["The researchers collected information on preterm delivery and small for gestational age in all single babies born live at 22\u201344 weeks gestation between 1 January 1996 and 31 December 2009 by using the Scottish Morbidity Record (SMR2), which collects relevant information on all women discharged from Scottish maternity hospitals, including maternal and infant characteristics and pregnancy complications.", {"entities": []}], ["The researchers categorized preterm delivery into mild, moderate, and extreme depending on how much before 37 weeks the baby was born.", {"entities": []}], ["They defined small for gestational age as the smallest 10% (below the 10th centile) for sex-specific birth weight at delivery, and very small for gestational age as the smallest 3% (below the 3rd centile), for all deliveries in Scotland over the study period.", {"entities": []}], ["As some people may have stopped smoking in anticipation of the smoking ban, in their statistical model, the researchers included two possible breakpoints for the effect of the legislation\u2014the actual date of implementation and 1 January 2006.", {"entities": []}], ["The researchers found that of the 716,968 pregnancies (the number eligible for inclusion in the study), 99.9% of women had their smoking status recorded, and among these 23.9% were current smokers, 57.6% never smokers, and 8.7% former smokers.", {"entities": []}], ["However, following implementation of the legislation the researchers noted that there was a significant reduction in current smokers to 18.8%.", {"entities": []}], ["In their statistical model, the researchers found that following 1 January 2006, there was a significant drop in overall preterm deliveries, which remained after adjustment for potential confounding factors.", {"entities": []}], ["Likewise, there was a significant decrease in the number of infants born small, and very small, for gestational age after 1 January 2006.", {"entities": []}], ["Furthermore, the researchers found that these significant reductions occurred in both mothers who smoked and those who had never smoked.", {"entities": []}], ["These findings suggest that the introduction of national, comprehensive smoke-free legislation in Scotland was associated with significant reductions in preterm delivery and babies being born small for gestational age.", {"entities": []}], ["These findings are plausible and add to the growing evidence of the wide-ranging health benefits of smoke-free legislation, and support the adoption of such legislation in other countries that have yet to implement smoking bans.", {"entities": []}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001175 .", {"entities": []}], ["More information is available on the World Health Organization's Framework Convention for Tobacco Control More information on the Smoking, Health and Social Care (Scotland) Bill is available The US Centers for Disease Control and Prevention has more information about the risks of smoking in pregnancy , as does the UK National Health Service's smokefree web page NHS Health Scotland has a website that summarises all the studies to date evaluating the Scottish smoke-free legislation", {"entities": [[364, 367, "GENE"]]}], ["Daily changes in ambient concentrations of particulate matter, nitrogen oxides and ozone are associated with increased cardiopulmonary morbidity and mortality, with the lungs and their function being a vulnerable target.", {"entities": []}], ["To evaluate the association between daily changes in air pollution and lung function in healthy adults we obtained annual lung function measurements from a routine worker health surveillance program not designed for research purposes.", {"entities": []}], ["Forced Vital Capacity (FVC), Forced Expiratory Volume in the first second (FEV1), FEV1/FVC and Peak Expiratory flow (PEF) from a cohort of 2449 employees were associated with daily measurements of PM 10 , NO 2 and ozone at a nearby monitoring station in the North of Belgium.", {"entities": []}], ["Repeated measures were available for the period 2011\u20132015.", {"entities": []}], ["The mean (SD) PM 10 concentration on the day of the lung function test was 24.9 (15.5) \u03bcg/m 10 /m p \u00a0<\u00a00.0001), 12.8\u00a0ml lower FEV1 (\u221219.1 to \u22126.5; p \u00a0<\u00a00.0001), and a 51.4\u00a0ml/s lower PEF (\u221275.0 to \u221227.0; p \u00a0<\u00a00.0001).", {"entities": []}], ["The FEV1/FVC-ratio showed no associations.", {"entities": []}], ["An increase of 10 \u03bcgNO 2 /m p \u00a0<\u00a00.001)) on the day of the examination.", {"entities": []}], ["We found negative associations between daily variations in ambient air pollution and FVC, FEV1 and PEF in healthy adults.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0271-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The increasing prevalence of abnormal body mass index (BMI), mainly obesity, is becoming a significant public health problem.", {"entities": [[68, 75, "DISEASE"]]}], ["This cross-sectional study aimed to provide a comprehensive view of secular trends of BMI, and the associated socio-demographic variables and comorbidities among adolescents with abnormal BMI.", {"entities": []}], ["Individuals of the study population were born mainly between 1970 and 1993, and were examined at 16 to 19 years of age during the years 1987 to 2010, at 1 conscription center in the northern district of Israel.", {"entities": []}], ["The study population included 113,694 adolescents.", {"entities": []}], ["Univariate and multivariable logistic regression models were used to investigate the associations between BMI categories, socio-demographic variables, and medical conditions.", {"entities": []}], ["A downward trend in the prevalence of normal BMI among both male and female adolescents was obtained, while trends of overweight and obesity (in both genders) and underweight (only among females) rose.", {"entities": [[133, 140, "DISEASE"]]}], ["Socio-demographic variables such as religion, education, family-related parameters, residential environment, country of birth, and origin were all associated with different risks for abnormal BMI.", {"entities": []}], ["Obesity was associated with higher risk for hyperlipidemia, endocrine disorders (only in males), knee disorders, and hypertension type I + II (in both genders).", {"entities": [[117, 129, "DISEASE"], [0, 7, "DISEASE"]]}], ["Overweight was associated with knee disorders (only in females).", {"entities": []}], ["Underweight, exclusively in males, was associated with increased risk for endocrine disorders, proteinuria, and cardiac disorders.", {"entities": [[95, 106, "DISEASE"]]}], ["Hierarchical clustering analysis revealed the intricate relations between gender, BMI, and medical signatures.", {"entities": []}], ["It brought to light novel clusters of diseases that were abundant among populations having above-normal BMI or underweight males.", {"entities": []}], ["Furthermore, above-normal BMI was associated with a lower rate of cardiac anomalies and scoliosis/kyphosis, whereas being underweight was associated with a lower risk for hypertension and flat foot.", {"entities": [[171, 183, "DISEASE"]]}], ["This study provides a reliable and in-depth view of secular trends in height, weight, and BMI of male and female adolescents.", {"entities": []}], ["It supports previous associations between abnormal BMI and demographic variables and comorbidities, while uncovering novel associations, mainly regarding medical signatures of each gender\u2013BMI group.", {"entities": []}], ["This might lead to better monitoring, early detection, prevention, and treatment of various conditions associated to abnormal BMI categories and gender groups.", {"entities": []}], ["Polymorphisms in the endotoxin-mediated TLR4 pathway genes have been associated with asthma and atopy.", {"entities": [[85, 91, "DISEASE"], [40, 44, "GENE"]]}], ["We aimed to examine how genetic polymorphisms in innate immunity pathways interact with endotoxin to influence asthma risk in children.", {"entities": [[111, 117, "DISEASE"]]}], ["In a previous analysis of 372 children from the Boston Home Allergens and the Connecticut Childhood Asthma studies, 7 SNPs in 6 genes (CARD15, TGFB1, LY96, ACAA1, DEFB1 and IFNG) involved in innate immune pathways were associated with asthma, and 5 SNPs in 3 genes (CD80, STAT4, IRAK2) were associated with eczema.", {"entities": [[100, 106, "DISEASE"], [235, 241, "DISEASE"], [143, 148, "GENE"], [150, 154, "GENE"], [156, 161, "GENE"], [163, 168, "GENE"], [173, 177, "GENE"], [266, 270, "GENE"], [272, 277, "GENE"], [279, 284, "GENE"]]}], ["We tested these SNPs for interaction with early life endotoxin exposure (n = 291), in models for asthma and eczema by age 6.", {"entities": [[97, 103, "DISEASE"]]}], ["We found a significant interaction between endotoxin and a SNP (rs156265) in ACAA1 (p = 0.0013 for interaction).", {"entities": [[77, 82, "GENE"]]}], ["Increased endotoxin exposure (by quartile) showed protective effects for asthma in individuals with at least one copy of the minor allele (OR = 0.39 per quartile increase in endotoxin, 95% CI 0.15 to 1.01).", {"entities": [[73, 79, "DISEASE"]]}], ["Endotoxin exposure did not reduce the risk of asthma in children homozygous for the major allele.", {"entities": [[46, 52, "DISEASE"]]}], ["Our findings suggest that protective effects of endotoxin exposure on asthma may vary depending upon the presence or absence of a polymorphism in ACAA1.", {"entities": [[70, 76, "DISEASE"], [146, 151, "GENE"]]}], ["To describe the characteristics, access, utilization, satisfaction, and outcomes of Healthy Start participants in eight selected sites, a survey of Healthy Start participants with infants ages 6\u201312-months-old at time of interview was conducted between October 2006 and January 2007.", {"entities": []}], ["The response rate was 66% ( n \u00a0=\u00a0646), ranging from 37% in one site to >70% in seven sites.", {"entities": []}], ["Healthy Start participants\u2019 outcomes were compared to two national benchmarks.", {"entities": []}], ["Healthy Start participants reported that they were satisfied with the program (>90% on five measures).", {"entities": []}], ["Level of unmet need was 6% or less for most services, except for dental appointments (11%), housing (13%), and child care (11%).", {"entities": []}], ["Infants had significantly better access to medical care than did their mothers, with higher rates of insurance coverage, medical homes, and checkups, and fewer unmet needs for health care.", {"entities": []}], ["Healthy Start participants\u2019 rates of ever breastfeeding (72%) and putting infants to sleep on their backs (70%) were at or near the Healthy People 2010 objectives, and considerably higher than rates among low-income mothers in the ECLS.", {"entities": []}], ["The high rate of health education (>90%) may have contributed to these outcomes.", {"entities": []}], ["Elimination of smoking among Healthy Start participants (46%) fell short of the Healthy People 2010 objective (99%).", {"entities": []}], ["The low-birth weight (LBW) rate among Black Healthy Start participants (14%) was three times higher than the rate for Whites and Hispanics (5% each).", {"entities": []}], ["Overall, the LBW rate in the eight sites (7.5%) was similar to the rate for low-income mothers in the ECLS, but both rates were above the Healthy People 2010 objective (5%).", {"entities": []}], ["Challenges remain in reducing disparities in maternal and child health outcomes.", {"entities": []}], ["Further attention to risk factors associated with LBW (especially smoking) may help close the gaps.", {"entities": []}], ["The life course theory suggests that improved outcomes may require longer-term investments.", {"entities": []}], ["Healthy Start\u2019s emerging focus on interconception care has the potential to address longer-term needs of participants.", {"entities": []}], ["It has been reported that equine recurrent airway obstruction (RAO) is a state of oxidative stress.", {"entities": []}], ["Oxidant-antioxidant imbalance is known to increase the conversion of deoxyguanosine to 8-hydroxy-2-deoxyguanosine (8-OHdG) in DNA.", {"entities": []}], ["8-OHdG can easily be measured using ELISA tests in serum or urine samples.", {"entities": []}], ["In this study, we analysed serum 8-OHdG levels in horses with recurrent airway obstruction and in healthy controls.", {"entities": []}], ["The study material consisted of seven healthy horses and seven horses with symptomatic RAO.", {"entities": []}], ["All horses were exposed to moldy hay and straw for 48\u00a0h to induce clinical exacerbation of RAO.", {"entities": []}], ["The serum 8-OHdG levels were determined using the ELISA Highly Sensitive 8-OHdG kit.", {"entities": []}], ["The difference between the levels of 8-OHdG in healthy and RAO-affected horses was significant.", {"entities": []}], ["The median level of 8-OHdG was 0.044\u00a0ng/ml in the healthy controls versus 0.498\u00a0ng/ml in RAO horses ( P \u00a0=\u00a00.0021).", {"entities": []}], ["The results of the study strongly suggest that DNA damage coexists in the course of equine RAO.", {"entities": []}], ["We therefore propose that future research should aim at the development of new drugs that target pro-inflammatory molecules, since DNA damage appears to be the result of chronic inflammation.", {"entities": []}], ["ABO discrepancy refers to an inconsistency between red cell and serum typings and has various causes, including hypogammaglobulinemia.", {"entities": [[0, 3, "GENE"]]}], ["IgM deficiency is a rare disorder that may accompany several conditions such as infection and autoimmune disorders.", {"entities": []}], ["Here, we describe a case of IgM deficiency discovered during the evaluation of an ABO discrepancy in a 16-yr-old Korean boy.", {"entities": [[82, 85, "GENE"]]}], ["ABO blood grouping showed that while his cell type was O+, serum typing detected only anti-A (3+).", {"entities": [[0, 3, "GENE"]]}], ["Anti-B was not detectable at room temperature but was graded at 1+ at 4\u2103.", {"entities": []}], ["ABO genotyping revealed an O/O genotype.", {"entities": [[0, 3, "GENE"]]}], ["His serum IgG, IgA, and IgM concentrations were 770 mg/dL (reference range: 800-1,700 mg/dL), 244 mg/dL (reference range: 100-490 mg/dL), and 13.5 mg/dL (reference range: 50-320 mg/dL), respectively.", {"entities": []}], ["He was diagnosed with acute osteomyelitis on the basis of clinical presentation and imaging studies.", {"entities": [[28, 41, "DISEASE"]]}], ["The symptoms gradually improved within 3 weeks of treatment.", {"entities": []}], ["However, the ABO discrepancy and IgM deficiency persisted even 6 months after recovery and lymphocyte subset analysis revealed CD19+ B cell deficiency.", {"entities": [[13, 16, "GENE"]]}], ["To the best of our knowledge, IgM deficiency detected by ABO discrepancy in a patient with acute osteomyelitis has not been reported before.", {"entities": [[97, 110, "DISEASE"], [57, 60, "GENE"]]}], ["Steady-state bone marrow (SS-BM) and granulocyte colony-stimulating growth factor-primed BM/peripheral blood stem-cell (G-BM/G-PBSC) are the main stem-cell sources used in allogeneic hematopoietic stem-cell transplantation.", {"entities": []}], ["Here, we evaluated the treatment effects of SS-BM and G-BM/G-PBSC in human leucocyte antigen (HLA)-identical sibling transplantation.", {"entities": [[94, 97, "GENE"]]}], ["A total of 226 patients (acute myelogenous leukemia-complete remission 1, chronic myelogenous leukemia-chronic phase 1) received SS-BM, G-BM, or G-PBSC from an HLA-identical sibling.", {"entities": [[43, 51, "DISEASE"], [94, 102, "DISEASE"]]}], ["Clinical outcomes (graft-versus-host disease [GVHD], overall survival, transplant-related mortality [TRM], and leukemia-free survival [LFS]) were analyzed.", {"entities": [[111, 119, "DISEASE"]]}], ["When compared to SS-BM, G-BM gave faster recovery time to neutrophil or platelet ( P < 0.05).", {"entities": []}], ["Incidence of grade III-IV acute GVHD and extensive chronic GVHD (cGVHD) was lower than seen with SS-BM ( P < 0.05) and similar to G-PBSC.", {"entities": []}], ["Although the incidence of cGVHD in the G-BM group was similar to SS-BM, both were lower than G-PBSC ( P < 0.05).", {"entities": []}], ["G-BM and G-PBSC exhibited similar survival, LFS, and TRM, but were significantly different from SS-BM ( P < 0.05).", {"entities": []}], ["There were no significant differences in leukemia relapse rates among the groups ( P > 0.05).", {"entities": [[41, 49, "DISEASE"]]}], ["G-CSF-primed bone marrow shared the advantages of G-PBSC and SS-BM.", {"entities": []}], ["We conclude that G-BM is an excellent stem-cell source that may be preferable to G-PBSC or SS-BM in patients receiving HLA-identical sibling hematopoietic stem-cell transplantation.", {"entities": []}], ["T-Bet (T-box protein expressed in T cells, also called as TBX21) was originally cloned as a key transcription factor involved in the commitment of T helper (Th) cells to the Th1 lineage.", {"entities": [[58, 63, "GENE"]]}], ["T-Bet directly activates IFN- \u03b3 gene transcription and enhances development of Th1 cells.", {"entities": []}], ["T-Bet simultaneously modulates IL-2 and Th2 cytokines in an IFN- \u03b3 -independent manner, resulting in an attenuation of Th2 cell development.", {"entities": []}], ["Numerous studies have demonstrated that T-bet plays multiple roles in many subtypes of immune cells, including B cell, dendritic cells, natural killer (NK) cells, NK T cells, and innate lymphoid cells.", {"entities": []}], ["Therefore, T-bet is crucial for the development and coordination of both innate and adaptive immune responses.", {"entities": []}], ["To fulfill these multiple roles, T-bet undergoes several posttranslational protein modifications, such as phosphorylation at tyrosine, serine, and threonine residues, and ubiquitination at lysine residues, which affect lineage commitment during Th cell differentiation.", {"entities": []}], ["This review presents a current overview of the progress made in understanding the roles of various types of T-bet protein modifications in the regulation of cytokine production during Th cell differentiation.", {"entities": []}], ["Enhanced proliferation of pulmonary arterial vascular smooth muscle cells (PASMCs) is a key pathological component of vascular remodeling in hypoxia-induced pulmonary hypertension (HPH).", {"entities": [[167, 179, "DISEASE"], [157, 179, "DISEASE"]]}], ["Mammalian targeting of rapamycin (mTOR) signaling has been shown to play a role in protein translation and participate in the progression of pulmonary hypertension.", {"entities": [[151, 163, "DISEASE"], [141, 163, "DISEASE"], [34, 38, "GENE"]]}], ["Eukaryotic translation initiation factor-2\u03b1 (eIF2\u03b1) is a key factor in regulation of cell growth and cell cycle, but its role in mTOR signaling and PASMCs proliferation remains unknown.", {"entities": [[129, 133, "GENE"]]}], ["Pulmonary hypertension (PH) rat model was established by hypoxia.", {"entities": [[10, 22, "DISEASE"], [0, 22, "DISEASE"]]}], ["Rapamycin was used to treat rats as an mTOR inhibitor.", {"entities": [[39, 43, "GENE"]]}], ["Proliferation of primarily cultured rat PASMCs was induced by hypoxia, rapamycin and siRNA of mTOR and eIF2\u03b1 were used in loss-of-function studies.", {"entities": [[94, 98, "GENE"]]}], ["The expression and activation of eIF2\u03b1, mTOR and c-myc were analyzed.", {"entities": [[40, 44, "GENE"]]}], ["Results showed that mTOR/eIF2\u03b1 signaling was significantly activated in pulmonary arteries from hypoxia exposed rats and PASMCs cultured under hypoxia condition.", {"entities": []}], ["Treatment with mTOR inhibitor for 21 days attenuated vascular remodeling, suppressed mTOR and eIF2\u03b1 activation, inhibited c-myc expression in HPH rats.", {"entities": [[15, 19, "GENE"], [85, 89, "GENE"], [15, 19, "GENE"], [85, 89, "GENE"]]}], ["In hypoxia-induced PASMCs, rapamycin and knockdown of mTOR and eIF2\u03b1 by siRNA significantly abolished proliferation and increased c-myc expression.", {"entities": [[54, 58, "GENE"]]}], ["These results suggest a critical role of the mTOR/eIF2\u03b1pathway in hypoxic vascular remodeling and PASMCs proliferation of HPH.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by expiratory flow limitation, causing air trapping and lung hyperinflation.", {"entities": []}], ["Hyperinflation leads to reduced exercise tolerance and poor quality of life in COPD patients.", {"entities": []}], ["Total lung capacity (TLC) is an indicator of hyperinflation particularly in subjects with moderate-to-severe airflow obstruction.", {"entities": []}], ["The aim of our study was to identify genetic variants associated with TLC in COPD.", {"entities": []}], ["We performed genome-wide association studies (GWASs) in white subjects from three cohorts: the COPDGene Study; the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE); and GenKOLS (Bergen, Norway).", {"entities": []}], ["All subjects were current or ex-smokers with at least moderate airflow obstruction, defined by a ratio of forced expiratory volume in 1 second to forced vital capacity (FEV 1 /FVC) <0.7 and FEV 1 \u2009<\u200980% predicted on post-bronchodilator spirometry.", {"entities": [[169, 172, "GENE"], [190, 193, "GENE"], [169, 172, "GENE"], [190, 193, "GENE"]]}], ["TLC was calculated by using volumetric computed tomography scans at full inspiration (TLC CT ).", {"entities": []}], ["Genotyping in each cohort was completed, with statistical imputation of additional markers.", {"entities": []}], ["To find genetic variants associated with TLC CT , linear regression models were used, with adjustment for age, sex, pack-years of smoking, height, and principal components for genetic ancestry.", {"entities": []}], ["Results were summarized using fixed-effect meta-analysis.", {"entities": []}], ["Analysis of a total of 4,543 COPD subjects identified one genome-wide significant locus on chromosome 5p15.2 (rs114929486, \u03b2\u2009=\u20090.42L, P \u2009=\u20094.66\u2009\u00d7\u200910 In COPD, TLC CT was associated with a SNP in dynein, axonemal, heavy chain 5 ( DNAH5 ), a gene in which genetic variants can cause primary ciliary dyskinesia.", {"entities": [[280, 306, "DISEASE"], [228, 233, "GENE"]]}], ["DNAH5 could have an effect on hyperinflation in COPD.", {"entities": [[0, 5, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-014-0097-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Physicians have noted dyspnea in severely ill asthmatic patients to be associated with fright or panic; in more stable patients dyspnea may reflect characteristics including lung function, personality and behavioral traits.", {"entities": []}], ["This study evaluates the symptom of dyspnea in 32 asthmatic patients twice: first when acutely ill and again after an initial response to therapy.", {"entities": []}], ["Spirometry was performed, dyspnea quantified (Borg scale), and panic assessed with a specialized measure of acute panic (the acute panic inventory (API)) in the 32 patients before and again after treatment.", {"entities": []}], ["After treatment, questionnaires to evaluate somatization and panic disorder were also administered.", {"entities": [[61, 75, "DISEASE"]]}], ["When acutely ill, both the API and all spirometric measures (PEFR; FEV1; IC) correlated with dyspnea.", {"entities": []}], ["Multiple linear regression showed that measures of the API, the peak expiratory flow rate, and female sex taken together accounted for 41% of dyspnea in acute asthma.", {"entities": [[159, 165, "DISEASE"]]}], ["After treatment, the API again predicted dyspnea while spirometric data did not.", {"entities": []}], ["Those subjects who described themselves as having chronic panic disorder reported high grades of dyspnea after treatment also.", {"entities": [[58, 72, "DISEASE"]]}], ["We conclude that interpretations of the self-report of asthma differ between acutely ill and stable asthmatic patients.", {"entities": [[55, 61, "DISEASE"]]}], ["Interleukin 4 (IL-4) and IL-13 are critical for responses against parasitic helminthes.", {"entities": []}], ["Here we used genetically engineered reporter mice to assess the temporal and spatial production of these cytokine in vivo .", {"entities": []}], ["In lymph nodes, IL-4 was confined to T follicular helper (T FH ) cells, however these cells did not make IL-13.", {"entities": [[60, 62, "GENE"]]}], ["In contrast, tissue type 2 helper T T H 2 cells produce both cytokines.", {"entities": []}], ["Divergent IL-4 and IL-13 production also occurred among innate immune cells, where basophils produced IL-4, while innate helper type 2 (Ih2) cells produced IL-13.", {"entities": []}], ["IL-13 production by T H 2 and Ih2 cells was dependent on high GATA-3 levels, in contrast to low GATA-3 levels in T FH cells and basophils.", {"entities": [[115, 117, "GENE"]]}], ["Distinct localization and cellular expression of IL-4 and IL-13 explains their unique roles during allergic immunity.", {"entities": []}], ["Patients with primary immunodeficiency (PID) often suffer from frequent respiratory tract infections.", {"entities": []}], ["Despite standard treatment with IgG-substitution and antibiotics many patients do not improve significantly.", {"entities": []}], ["Therefore, we hypothesized that additional immune deficits may be present among these patients.", {"entities": []}], ["To investigate if PID patients exhibit impaired production of antimicrobial peptides (AMPs) in nasal fluid and a possible link between AMP-expression and Th17-cells.", {"entities": []}], ["Nasal fluid, nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs) were collected from patients and healthy controls.", {"entities": []}], ["AMP levels were measured in nasal fluid by Western blotting.", {"entities": []}], ["Nasal swabs were cultured for bacteria.", {"entities": []}], ["PBMCs were stimulated with antigen and the supernatants were assessed for IL-17A release by ELISA.", {"entities": []}], ["In healthy controls and most patients, AMP levels in nasal fluid were increased in response to pathogenic bacteria.", {"entities": []}], ["However, this increase was absent in patients with common variable immunodeficiency (CVID) and Hyper-IgE syndrome (HIES), despite the presence of pathogenic bacteria.", {"entities": [[51, 83, "DISEASE"], [105, 113, "DISEASE"]]}], ["Furthermore, stimulation of PBMCs revealed that both HIES and CVID patients exhibited an impaired production of IL-17A.", {"entities": []}], ["CVID and HIES patients appear to have a dysregulated AMP response to pathogenic bacteria in the upper respiratory tract, which could be linked to an aberrant Th17 cell response.", {"entities": []}], ["The low prevalence of allergic disease in the rural tropics has been attributed to the protective effects of chronic helminth infections.", {"entities": []}], ["There is concern that treatment-based control programmes for these parasites may lead to an increase in the prevalence of allergic diseases.", {"entities": []}], ["We measured the impact of 15\u201317 years of anthelmintic treatment with ivermectin on the prevalence of allergen skin test reactivity and allergic symptoms in school-age children.", {"entities": []}], ["The prevalence of allergen skin test reactivity, exercise-induced bronchospasm and allergic symptoms was compared between school-age children living in communities that had received community-based treatments with ivermectin (for onchocerciasis control) for a period of 15\u201317 years with those living in geographically adjacent communities that had received no ivermectin.", {"entities": [[230, 244, "DISEASE"]]}], ["The prevalence of allergen skin test reactivity was double in children living in treated communities compared with those in untreated communities (16.7% vs. 8.7%, adjusted OR 2.10, 95% CI 1.50\u20132.94, P <0.0001), and the effect was mediated partly by a reduced prevalence of Trichuris trichiura among treated children.", {"entities": []}], ["Ivermectin treatments were associated with an increased prevalence of recent eczema symptoms (adjusted OR 2.24, 95% CI 1.05\u20134.78, P =0.04) but not symptoms of asthma or rhino-conjunctivitis.", {"entities": [[175, 189, "DISEASE"], [159, 165, "DISEASE"]]}], ["The effect on eczema symptoms was not associated with reductions in geohelminth infections.", {"entities": []}], ["Long-term periodic treatments with ivermectin were associated with an increased prevalence of allergen skin test reactivity.", {"entities": []}], ["There was some evidence that treatment was associated with an increased prevalence of recent eczema symptoms but not those of asthma or rhino-conjunctivitis.", {"entities": [[142, 156, "DISEASE"], [126, 132, "DISEASE"]]}], ["Cite this as : P. Endara, M. Vaca, M. E. Chico, S. Erazo, G. Oviedo, I. Quinzo, A. Rodriguez R. Lovato, A.-L. Moncayo, M. L. Barreto, L. C. Rodrigues and P. J. Cooper, Clinical & Experimental Allergy , 2010 (40) 1669\u20131677.", {"entities": []}], ["Genome-wide association studies can provide novel insights into diseases of interest, as well as to the responsiveness of an individual to specific treatments.", {"entities": []}], ["In such studies, it is very important to correct for population stratification, which refers to allele frequency differences between cases and controls due to systematic ancestry differences.", {"entities": []}], ["Population stratification can cause spurious associations if not adjusted properly.", {"entities": []}], ["The principal component analysis (PCA) method has been relied upon as a highly useful methodology to adjust for population stratification in these types of large-scale studies.", {"entities": []}], ["Recently, the linear mixed model (LMM) has also been proposed to account for family structure or cryptic relatedness.", {"entities": []}], ["However, neither of these approaches may be optimal in properly correcting for sample structures in the presence of subject outliers.", {"entities": []}], ["We propose to use robust PCA combined with k-medoids clustering to deal with population stratification.", {"entities": []}], ["This approach can adjust for population stratification for both continuous and discrete populations with subject outliers, and it can be considered as an extension of the PCA method and the multidimensional scaling (MDS) method.", {"entities": []}], ["Through simulation studies, we compare the performance of our proposed methods with several widely used stratification methods, including PCA and MDS.", {"entities": []}], ["We show that subject outliers can greatly influence the analysis results from several existing methods, while our proposed robust population stratification methods perform very well for both discrete and admixed populations with subject outliers.", {"entities": []}], ["We illustrate the new method using data from a rheumatoid arthritis study.", {"entities": [[47, 67, "DISEASE"], [58, 67, "DISEASE"]]}], ["We demonstrate that subject outliers can greatly influence the analysis result in GWA studies, and propose robust methods for dealing with population stratification that outperform existing population stratification methods in the presence of subject outliers.", {"entities": []}], ["It has been proposed that vitamin D deficiency may be responsible for an increase in the prevalence of allergic diseases and asthma worldwide.", {"entities": [[125, 131, "DISEASE"]]}], ["Human ability to generate physiologically required quantities of vitamin D through sun exposure is decreasing with increasing geographical latitude.", {"entities": []}], ["Considering that vitamin D deficiency is usually due to lack of outdoor sun exposure, this study is designed to test the hypothesis that a higher prevalence of asthma should be expected at high relative to low geographical latitudes.", {"entities": [[160, 166, "DISEASE"]]}], ["Linear regression analyses are performed on asthma prevalence in the U.S. adult population vs. geographical latitude, insolation, air temperature, and air pollution (PM 2.5 ) for 97 major metropolitan/micropolitan statistical areas of the continental United States of America and on general population asthma prevalence vs. geographical latitude in eight metropolitan areas of Australia.", {"entities": [[44, 50, "DISEASE"], [302, 308, "DISEASE"]]}], ["A 10\u00b0 change in geographical latitude from southern to northern regions of the Eastern Seaboard is associated with a 2% increase in adult asthma prevalence ( p <0.001).", {"entities": [[138, 144, "DISEASE"]]}], ["Total insolation in winter months is almost as strong as latitude in its ability to explain the observed spatial variation in the prevalence of asthma (r p <0.001).", {"entities": [[144, 150, "DISEASE"]]}], ["Similar results are obtained using the Australian data (r The results of this study suggest that, as a known modulator of the immune response closely linked with the geographical latitude and erythemal UV irradiation, vitamin D may play an important role in the development/exacerbation of asthma.", {"entities": [[290, 296, "DISEASE"]]}], ["The 2008 Beijing Olympic Games provided a unique case study to investigate the effect of source control measures on the reduction in air pollution, and associated inhalation cancer risk, in a Chinese megacity.", {"entities": [[174, 180, "DISEASE"]]}], ["We measured 17 carcinogenic polycyclic aromatic hydrocarbons (PAHs) and estimated the lifetime excess inhalation cancer risk during different periods of the Beijing Olympic Games, to assess the effectiveness of source control measures in reducing PAH-induced inhalation cancer risks.", {"entities": [[113, 119, "DISEASE"], [270, 276, "DISEASE"]]}], ["PAH concentrations were measured in samples of particulate matter \u2264 2.5 \u03bcm in aerodynamic diameter (PM 2.5 ) collected during the Beijing Olympic Games, and the associated inhalation cancer risks were estimated using a point-estimate approach based on relative potency factors.", {"entities": [[183, 189, "DISEASE"]]}], ["We estimated the number of lifetime excess cancer cases due to exposure to the 17 carcinogenic PAHs [12 priority pollutant PAHs and five high-molecular-weight (302 Da) PAHs (MW 302 PAHs)] to range from 6.5 to 518 per million people for the source control period concentrations and from 12.2 to 964 per million people for the nonsource control period concentrations.", {"entities": [[43, 49, "DISEASE"]]}], ["This would correspond to a 46% reduction in estimated inhalation cancer risk due to source control measures, if these measures were sustained over time.", {"entities": [[65, 71, "DISEASE"]]}], ["Benzo[ b ]fluoranthene, dibenz[ a , h ]anthracene, benzo[ a ]pyrene, and dibenzo[ a , l ]pyrene were the most carcinogenic PAH species evaluated.", {"entities": []}], ["Total excess inhalation cancer risk would be underestimated by 23% if we did not include the five MW 302 PAHs in the risk calculation.", {"entities": [[24, 30, "DISEASE"]]}], ["Source control measures, such as those imposed during the 2008 Beijing Olympics, can significantly reduce the inhalation cancer risk associated with PAH exposure in Chinese megacities similar to Beijing.", {"entities": [[121, 127, "DISEASE"]]}], ["MW 302 PAHs are a significant contributor to the estimated overall inhalation cancer risk.", {"entities": [[78, 84, "DISEASE"]]}], ["Architects and engineers are beginning to consider a new dimension of indoor air: the structure and composition of airborne microbial communities.", {"entities": []}], ["A first step in this emerging field is to understand the forces that shape the diversity of bioaerosols across space and time within the built environment.", {"entities": []}], ["In an effort to elucidate the relative influences of three likely drivers of indoor bioaerosol diversity \u2013 variation in outdoor bioaerosols, ventilation strategy, and occupancy load \u2013 we conducted an intensive temporal study of indoor airborne bacterial communities in a high-traffic university building with a hybrid HVAC (mechanically and naturally ventilated) system.", {"entities": []}], ["Indoor air communities closely tracked outdoor air communities, but human-associated bacterial genera were more than twice as abundant in indoor air compared with outdoor air.", {"entities": []}], ["Ventilation had a demonstrated effect on indoor airborne bacterial community composition; changes in outdoor air communities were detected inside following a time lag associated with differing ventilation strategies relevant to modern building design.", {"entities": []}], ["Our results indicate that both occupancy patterns and ventilation strategies are important for understanding airborne microbial community dynamics in the built environment.", {"entities": []}], ["Allergic and other immune-mediated diseases are complex disease states determined by interplay between host genetics and environmental factors.", {"entities": []}], ["Environmental changes such as fewer infections and reduced exposure to microbial products have been suggested to have led to insufficient regulation of Th1 and Th2 immune responses, causing an increased incidence of inflammatory diseases.", {"entities": []}], ["The objective of the present study was to investigate the effect of poor living environmental conditions on mitogen-induced production of cytokines (Th1 and Th2) by peripheral blood leukocytes in children living in urban Brazil and investigate the role of IL-10 in modifying this effect.", {"entities": []}], ["Our data showed that the proportion of children producing Th1 and Th2 cytokines was lower among those with poor living conditions and that this finding was stronger in children producing IL-10.", {"entities": []}], ["These results provide a possible biologic explanation for the temporal trends of increasing risk of inflammatory diseases observed in populations living in affluent countries.", {"entities": []}], ["The gut microbiota is increasingly considered as a symbiotic partner for the maintenance of health.", {"entities": []}], ["The homeostasis of the gut microbiota is dependent on host characteristics (age, gender, genetic background\u2026), environmental conditions (stress, drugs, gastrointestinal surgery, infectious and toxic agents\u2026).", {"entities": []}], ["Moreover, it is dependent on the day-to-day dietary changes.", {"entities": []}], ["Experimental data in animals, but also observational studies in obese patients, suggest that the composition of the gut microbiota is a factor characterizing obese versus lean individuals, diabetic versus non diabetic patients, or patients presenting hepatic diseases such as non alcoholic steatohepatitis.", {"entities": []}], ["Interestingly, the changes in the gut microbes can be reversed by dieting and related weight loss.", {"entities": []}], ["The qualitative and quantitative changes in the intake of specific food components (fatty acids, carbohydrates, micronutrients, prebiotics, probiotics), have not only consequences on the gut microbiota composition, but may modulate the expression of genes in host tissues such as the liver, adipose tissue, intestine, muscle.", {"entities": []}], ["This in turn may drive or lessen the development of fat mass and metabolic disturbances associated with the gut barrier function and the systemic immunity.", {"entities": []}], ["The relevance of the prebiotic or probiotic approaches in the management of obesity in humans is supported by few intervention studies in humans up to now, but the experimental data obtained with those compounds help to elucidate novel potential molecular targets relating diet with gut microbes.", {"entities": [[76, 83, "DISEASE"]]}], ["The metagenomic and integrative metabolomic approaches could help elucidate which bacteria, among the trillions in human gut, or more specifically which activities/genes, could participate to the control of host energy metabolism, and could be relevant for future therapeutic developments.", {"entities": []}], ["Developing thymocytes require pre-TCR signalling to differentiate from CD4\u2212CD8\u2212 double negative to CD4+CD8+ double positive cell.", {"entities": []}], ["Here we followed the transcriptional response to pre-TCR signalling in a synchronised population of differentiating double negative thymocytes.", {"entities": []}], ["This time series analysis revealed a complex transcriptional response, in which thousands of genes were up and down-regulated before changes in cell surface phenotype were detected.", {"entities": []}], ["Genome-wide measurement of RNA degradation of individual genes showed great heterogeneity in the rate of degradation between different genes.", {"entities": []}], ["We therefore used time course expression and degradation data and a genome wide transcriptional modelling (GWTM) strategy to model the transcriptional response of genes up-regulated on pre-TCR signal transduction.", {"entities": []}], ["This analysis revealed five major temporally distinct transcriptional activities that up regulate transcription through time, whereas down-regulation of expression occurred in three waves.", {"entities": []}], ["Our model thus placed known regulators in a temporal perspective, and in addition identified novel candidate regulators of thymocyte differentiation.", {"entities": []}], ["The extracellular domains of cytokine receptors are released during inflammation, but little is known about the shedding of Toll-like receptors (TLR) and whether they can be used as diagnostic biomarkers.", {"entities": []}], ["The release of sTLR2 and sTLR4 was studied in in-vitro stimulations, as well as in-vivo during experimental human endotoxemia (n\u2009=\u200911, 2\u00a0ng/kg LPS), and in plasma of 394 patients with infections (infectious mononucleosis, measles, respiratory tract infections, bacterial sepsis and candidemia) or non-infectious inflammation (Crohn\u2019s disease, gout, rheumatoid arthritis, autoinflammatory syndromes and pancreatitis).", {"entities": [[222, 229, "DISEASE"], [349, 369, "DISEASE"], [196, 220, "DISEASE"], [402, 414, "DISEASE"], [360, 369, "DISEASE"], [343, 347, "DISEASE"]]}], ["Using C-statistics, the value of sTLR2 and sTLR4 levels for discrimination between infections and non-infectious inflammatory diseases, as well as between viral and bacterial infections was analyzed.", {"entities": []}], ["In-vitro, peripheral blood mononuclear cells released sTLR2 and sTLR4 by exposure to microbial ligands.", {"entities": []}], ["During experimental human endotoxemia, plasma concentrations peaked after 2\u00a0hours (sTLR4) and 4\u00a0hours (sTLR2).", {"entities": []}], ["sTLR4 did not correlate with cytokines, but sTLR2 correlated positively with TNF\u03b1 (r s \u2009=\u20090.80, P\u2009<\u20090.05), IL-6 (r s \u2009=\u20090.65, P\u2009<\u20090.05), and IL-1Ra (r s \u2009=\u20090.57, P\u2009=\u20090.06), and negatively with IL-10 (r s \u2009=\u2009-0.58, P\u2009=\u20090.06), respectively.", {"entities": []}], ["sTLR4 had a similar area under the ROC curve [AUC] for differentiating infectious and non-infectious inflammation compared to CRP: 0.72 (95% CI 0.66-0.79) versus 0.74 (95% CI 0.69-0.80) [P\u2009=\u20090.80], while sTLR2 had a lower AUC: 0.60 (95% CI 0.54-0.66) [P\u2009=\u20090.0004].", {"entities": [[126, 129, "GENE"]]}], ["CRP differentiated bacterial infections better from viral infections than sTLR2 and sTLR4: AUC 0.94 (95% CI 0.90-0.96) versus 0.58 (95% CI 0.51-0.64) and 0.75 (95% CI 0.70-0.80), respectively [P\u2009<\u20090.0001 for both].", {"entities": [[0, 3, "GENE"]]}], ["sTLRs are released into the circulation, and suggest the possibility to use sTLRs as diagnostic tool in inflammatory conditions.", {"entities": []}], ["Vitamin D (VD) is implicated in multiple aspects of human physiology and vitamin D receptor ( VDR ) polymorphisms are associated with a variety of neuropsychiatric disorders.", {"entities": [[94, 97, "GENE"]]}], ["Although VD deficiency is highly prevalent in epilepsy patients and converging evidence indicates a role for VD in the development of epilepsy, no data is available on the possible relationship between epilepsy and genetic variations of VDR .", {"entities": [[237, 240, "GENE"]]}], ["In this study, 150 controls and 82 patients with temporal lobe epilepsy (TLE) were genotyped for five common VDR polymorphisms (Cdx-2, FokI, BsmI, ApaI and TaqI) by the polymerase chain reaction-ligase detection reaction method.", {"entities": [[49, 71, "DISEASE"], [109, 112, "GENE"]]}], ["Our results revealed that the frequency of FokI AC genotype was significantly higher in the control group than in the patients ( p = 0.003, OR = 0.39, 95% CI = 0.21\u20130.73), whereas the AA genotype of ApaI SNP was more frequent in patients than in controls ( p = 0.018, OR = 2.92, 95% CI = 1.2\u20137.1).", {"entities": []}], ["However, no statistically significant association was found between Cdx-2, BsmI and TaqI polymorphisms and epilepsy.", {"entities": []}], ["Additionally, in haplotype analysis, we found the haplotype GAT (BsmI/ApaI/TaqI) conferred significantly increased risk for developing TLE ( p = 0.039, OR = 1.62, 95% CI = 1.02\u20132.56).", {"entities": []}], ["As far as we know, these results firstly underline the importance of VDR polymorphisms for the genetic susceptibility to epilepsy.", {"entities": [[69, 72, "GENE"]]}], ["Despite the widespread use of curcumin for centuries in Eastern medicine as an anti-inflammatory agent, its molecular actions and therapeutic viability have only recently been explored.", {"entities": []}], ["While curcumin does have potential therapeutic efficacy, both solubility and bioavailability must be improved before it can be more successfully translated to clinical care.", {"entities": []}], ["We have previously reported a novel formulation of nano-emulsion curcumin (NEC) that achieves significantly greater plasma concentrations in mice after oral administration.", {"entities": []}], ["Here, we confirm the immunosuppressive effects of NEC in vivo and further examine its molecular mechanisms to better understand therapeutic potential.", {"entities": []}], ["Using transgenic mice harboring an NF\u03baB-luciferase reporter gene, we demonstrate a novel application of this in vivo inflammatory model to test the efficacy of NEC administration by bioluminescent imaging and show that LPS-induced NF\u03baB activity was suppressed with NEC compared to an equivalent amount of curcumin in aqueous suspension.", {"entities": []}], ["Administration of NEC by oral gavage resulted in a reduction of blood monocytes, decreased levels of both TLR4 and RAGE expression, and inhibited secretion of MCP-1.", {"entities": [[106, 110, "GENE"]]}], ["Mechanistically, curcumin blocked LPS-induced phosphorylation of the p65 subunit of NF\u03baB and I\u03baB\u03b1 in murine macrophages.", {"entities": []}], ["In a mouse model of peritonitis, NEC significantly reduced macrophage recruitment, but not T-cell or B-cell levels.", {"entities": [[20, 31, "DISEASE"]]}], ["In addition, curcumin treatment of monocyte derived cell lines and primary human macrophages in vitro significantly inhibited cell migration.", {"entities": []}], ["These data demonstrate that curcumin can suppress inflammation by inhibiting macrophage migration via NF\u03baB and MCP-1 inhibition and establish that NEC is an effective therapeutic formulation to increase the bioavailability of curcumin in order to facilitate this response.", {"entities": []}], ["The resistance of T lymphocytes to Fas-mediated apoptosis is an important feature of atopic asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["The only effective causative treatment of atopic diseases is immunotherapy.", {"entities": []}], ["Clinical efficacy of sublingual immunotherapy (SLIT) has been already proven, but there is still limited number of studies on its influence on lymphocytes function.", {"entities": []}], ["The aim of the study was to evaluate whether SLIT could restore the sensitivity of asthmatic T cells to undergo Fas-mediated apoptosis.", {"entities": []}], ["Peripheral blood was collected from 12 patients aged 8 \u00b1 2 years suffering from atopic asthma and undergoing sublingual specific immunotherapy.", {"entities": [[87, 93, "DISEASE"]]}], ["To evaluate sensitivity to Fas-mediated apoptosis, the blood was transmitted to sterile tubes and mixed with purified monoclonal antibody anti-CD95.", {"entities": []}], ["After incubation, leukocytes were stained with Annexin V, propidium iodide, and monoclonal antibody against CD2 conjugated with phycoerythrincyanin 5.1, and then analyzed with flow cytometry.", {"entities": [[108, 111, "GENE"]]}], ["The procedure was repeated for each patient after 12 months of SLIT.", {"entities": []}], ["Stimulation with anti-CD95 of T lymphocytes from patients with atopic asthma before treatment increased the number of early apoptotic cells (from 19.5 \u00b1 16.7% before stimulation to 26.6 \u00b1 16.7% Annexin V positive cells after stimulation).", {"entities": [[70, 76, "DISEASE"]]}], ["After one year of SLIT anti-CD95 still caused an increase of the early apoptotic cells ratio in the lymphocyte population (from 12.4 \u00b1 7.4% before stimulation to 24.7 \u00b1 15.4% Annexin V positive T cells after CD95 stimulation).", {"entities": []}], ["Although an increasing trend could be observed, differences between the analyzed groups were not statistically significant.", {"entities": []}], ["A year of SLIT does not change the sensitivity of T lymphocytes from peripheral blood of children suffering from atopic asthma to Fas-mediated apoptosis.", {"entities": [[120, 126, "DISEASE"]]}], ["Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angiogenesis and metastasis.", {"entities": []}], ["In normoxic condition, PHD2 triggers the degradation of hypoxia-inducible factor 1 (HIF-1\u03b1) that induces the expression of hypoxia response genes.", {"entities": []}], ["Therefore the correct function of PHD2 would inhibit angiogenesis and consequent metastasis of tumor cells in normoxic condition.", {"entities": []}], ["PHD2 mutations were reported in some common cancers.", {"entities": []}], ["However, high levels of HIF-1\u03b1 protein were observed even in normoxic metastatic tumors with normal expression of wild type PHD2.", {"entities": []}], ["PHD2 malfunctions due to protein misfolding may be the underlying reason of metastasis and invasion in such cases.", {"entities": []}], ["In this study, we scrutinize the unfolding pathways of the PHD2 catalytic domain\u2019s possible species and demonstrate the properties of their unfolding states by computational approaches.", {"entities": []}], ["Our study introduces the possibility of aggregation disaster for the prominent species of PHD2 during its partial unfolding.", {"entities": []}], ["This may justify PHD2 inability to regulate HIF-1\u03b1 level in some normoxic tumor types.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is common among both men and women, and guidelines recommend the same therapy for both sexes.", {"entities": []}], ["While previous studies have identified gender differences in other chronic disease management, few studies have examined how implementation of COPD guidelines differs between men and women.", {"entities": []}], ["We performed a cross-sectional study of veterans admitted to Veterans Affairs (VA) hospitals for COPD during October 1, 2008, to September 30, 2011.", {"entities": []}], ["We collected information on baseline COPD medications during the 6 months prior to hospitalization and categorized therapies as \u201cappropriate\u201d or \u201cinappropriate\u201d based on current guidelines.", {"entities": []}], ["We used multivariable logistic regression to examine the differences in COPD medications between men and women, after controlling for baseline patient characteristics.", {"entities": []}], ["We also examined the differences in hospital outcomes, including length of stay and hospital readmission.", {"entities": []}], ["We identified 33,558 veterans, including 1149 women and 32,409 men who were admitted to 130 VA hospitals.", {"entities": []}], ["Women were significantly less likely to have received inhaler therapies prior to admission, with lower rates of short-acting beta agonists, short-acting muscarinic antagonists, long-acting beta agonists, and long-acting muscarinic antagonists compared to men.", {"entities": []}], ["Women also received fewer appropriate inhaler combinations (odds ratio [OR] = 0.83, 95% confidence interval [CI] 0.74\u20130.93) and more inappropriate combinations (OR = 1.33, 95% CI 1.17\u20131.51).", {"entities": []}], ["Women and men were prescribed similar rates of inhaled steroid and oral steroids.", {"entities": []}], ["Hospital outcomes were also similar between the two groups.", {"entities": []}], ["These findings highlight a potential gender disparity in appropriate outpatient COPD therapy.", {"entities": []}], ["Improving the quality of care for patients with COPD should include equitable implementation of guideline-based COPD management.", {"entities": []}], ["Acute bronchiolitis is the commonest cause for hospitalisation in infancy.", {"entities": [[6, 19, "DISEASE"]]}], ["Supportive care remains the cornerstone of current management and no other therapy has been shown to influence the course of the disease.", {"entities": []}], ["It has been suggested that adding nebulised hypertonic saline to usual care may shorten the duration of hospitalisation.", {"entities": []}], ["To determine whether hypertonic saline does have beneficial effects we undertook an open, multi-centre parallel-group, pragmatic RCT in ten UK hospitals.", {"entities": []}], ["Infants admitted to hospital with a clinical diagnosis of acute bronchiolitis and requiring oxygen therapy were randomised to receive usual care alone or nebulised 3% hypertonic saline (HS) administered 6-hourly.", {"entities": [[64, 77, "DISEASE"]]}], ["Randomisation was within 4 h of admission.", {"entities": []}], ["The primary outcome was time to being assessed as \u2018fit\u2019 for discharge with secondary outcomes including time to discharge, incidence of adverse events together with follow up to 28 days assessing patient centred health related outcomes.", {"entities": []}], ["A total of 317 infants were recruited to the study.", {"entities": []}], ["158 infants were randomised to HS (141 analysed) and 159 to standard care (149 analysed).", {"entities": []}], ["There was no difference between the two arms in time to being declared fit for discharge (hazard ratio: 0\u221295, 95% CI: 0.75\u22121.20) nor to actual discharge (hazard ratio: 0.97, 95% CI: 0.76\u22121.23).", {"entities": []}], ["There was no difference in adverse events.", {"entities": []}], ["One infant in the HS group developed bradycardia with desaturation.", {"entities": []}], ["This study does not support the use of nebulised HS in the treatment of acute bronchiolitis over usual care with minimal handlings.", {"entities": [[78, 91, "DISEASE"]]}], ["NCT01469845.", {"entities": []}], ["Humans may acquire infection from potable water.", {"entities": []}], ["Mycobacterium lentiflavum , a slow-growing nontuberculous mycobacterium, is a rare cause of human disease.", {"entities": []}], ["It has been isolated from environmental samples worldwide.", {"entities": []}], ["To assess the clinical significance of M. lentiflavum isolates reported to the Queensland Tuberculosis Control Centre, Australia, during 2001\u20132008, we explored the genotypic similarity and geographic relationship between isolates from humans and potable water in the Brisbane metropolitan area.", {"entities": []}], ["A total of 47 isolates from 36 patients were reported; 4 patients had clinically significant disease.", {"entities": []}], ["M. lentiflavum was cultured from 13 of 206 drinking water sites.", {"entities": []}], ["These sites overlapped geographically with home addresses of the patients who had clinically significant disease.", {"entities": []}], ["Automated repetitive sequence\u2013based PCR genotyping showed a dominant environmental clone closely related to clinical strains.", {"entities": []}], ["This finding suggests potable water as a possible source of M. lentiflavum infection in humans.", {"entities": []}], ["Plasma is the component of blood from which lead is free to cross cell membranes and cause organ toxicity.", {"entities": []}], ["Plasma lead levels, however, are extremely low and difficult to measure.", {"entities": []}], ["Urinary lead originates from plasma lead that has been filtered at the glomerular level; thus, urinary lead adjusted for glomerular filtration rate serves as a proxy for plasma lead levels.", {"entities": []}], ["In this investigation we examined the interrelationships of lead levels in whole blood corrected by hematocrit [i.e., erythrocyte lead (EPb)], trabecular bone (TBoPb), cortical bone (CBoPb), and urine excreted over 24 hr (UPb); all samples were obtained from 71 middle-aged and elderly men with no known occupational lead exposures.", {"entities": [[218, 220, "GENE"]]}], ["Lead was measured by graphite furnace atomic absorption spectroscopy (blood), K-X-ray fluorescence (bone), and inductively coupled plasma mass spectroscopy (urine).", {"entities": []}], ["Lead levels were generally low, with mean EPb, TBoPb, and CBoPb values of 13.8, 31.1, and 21.7 microg/g, respectively, and a median UPb value of 6.15 microg/day.", {"entities": []}], ["In generalized additive models adjusted for body weight and creatinine clearance rate, both EPb and bone lead variables remained independently and significantly associated with UPb.", {"entities": []}], ["This finding suggests that bone influences plasma lead in a manner that is independent of the influence of erythrocytic lead on plasma lead.", {"entities": []}], ["Thus, the superiority of bone lead over blood lead in predicting some chronic forms of toxicity may be mediated through bone's influence on plasma lead.", {"entities": []}], ["In addition, this study suggests that measurement of urinary lead might be useful as a proxy for plasma lead levels in studies of lead toxicity.", {"entities": []}], ["Seizure duration in electroconvulsive therapy (ECT) is positively related with patients\u2019 outcome.", {"entities": []}], ["This study sought to investigate the impact of anesthetic management on seizure duration, and the impact of selected drugs (theophylline, remifentanil, S-ketamine) on seizure duration.", {"entities": []}], ["Retrospective analysis of all patients undergoing ECT at our institution from January 2011 to April 2012 was performed based on electronic medical chart and review of existing quality improvement data.", {"entities": []}], ["Patient data ( N \u00a0=\u00a078), including gender, age, height, weight, and administered drugs, energy levels, and electroencephalic seizure duration were analyzed.", {"entities": []}], ["Statistical analysis was performed using a generalized linear model.", {"entities": []}], ["A total of 78 patients (male\u00a0=\u00a039, female\u00a0=\u00a039, age 51\u00a0\u00b1\u00a012\u00a0years) were included.", {"entities": []}], ["Average number of session was 10\u00a0\u00b1\u00a06 (1\u201330).", {"entities": []}], ["In our patient population, theophylline administration was the only parameter, which significantly prolonged seizure duration, whereas S-ketamine, remifentanil, thiopental, age, sex, session or energy level had no significant effect.", {"entities": []}], ["Theophylline can be a useful adjunct for patients with inadequate seizure duration.", {"entities": []}], ["If there is a concomitant beneficial effect on patients\u2019 outcome needs to be investigated in further studies.", {"entities": []}], ["Short-term exposure to outdoor fine particulate matter (particles with a median aerodynamic diameter <2.5 \u03bcm (PM 2 .", {"entities": []}], ["5 )) air pollution has been associated with adverse health effects.", {"entities": []}], ["Existing literature reviews have been limited in size and scope.", {"entities": []}], ["We conducted a comprehensive, systematic review and meta-analysis of 110 peer-reviewed time series studies indexed in medical databases to May 2011 to assess the evidence for associations between PM 2 .", {"entities": []}], ["5 and daily mortality and hospital admissions for a range of diseases and ages.", {"entities": []}], ["We stratified our analyses by geographical region to determine the consistency of the evidence worldwide and investigated small study bias.", {"entities": []}], ["Based upon 23 estimates for all-cause mortality, a 10\u2005\u00b5g/m 2 .", {"entities": []}], ["5 was associated with a 1.04% (95% CI 0.52%\u00a0to 1.56%) increase in the risk of death.", {"entities": []}], ["Worldwide, there was substantial regional variation (0.25% to 2.08%).", {"entities": []}], ["Associations for respiratory causes of death were larger than for cardiovascular causes, 1.51% (1.01% to 2.01%) vs 0.84% (0.41% to 1.28%).", {"entities": []}], ["Positive associations with mortality for most other causes of death and for cardiovascular and respiratory hospital admissions were also observed.", {"entities": []}], ["We found evidence for small study bias in single-city mortality studies and in multicity studies of cardiovascular disease.", {"entities": []}], ["The consistency of the evidence for adverse health effects of short-term exposure to PM 2 .", {"entities": []}], ["5 across a range of important health outcomes and diseases supports policy measures to control PM 2 .", {"entities": []}], ["5 concentrations.", {"entities": []}], ["However, reasons for heterogeneity in effect estimates in different regions of the world require further investigation.", {"entities": []}], ["Small study bias should also be considered in assessing and quantifying health risks from PM 2 .", {"entities": []}], ["Volatile organic compounds (VOCs) in concentrations found in both the work and home environments may influence lung function.", {"entities": []}], ["We investigated the prevalence of airway responsiveness in workers exposed to VOCs.", {"entities": []}], ["We used allergic skin tests, nonspecific airway hyperresponsiveness testing and questionnaires to study twenty exposed workers and twenty-seven control subjects.", {"entities": []}], ["Atopy was defined as a reactor who showed >3+ response to one or more allergens on the skin prick tests.", {"entities": []}], ["Airway hyperresponsiveness (BRindex) was defined as log [% fall of FEV 1 / log (last concentration of methacholine) +10].", {"entities": [[67, 70, "GENE"]]}], ["The VOC exposed workers, in comparison with the control subjects, tended to have a higher BRindex (1.19\u00b10.07 vs. 1.15\u00b10.08, respectively).", {"entities": []}], ["Workers exposed to VOCs with atopy or smoker, as compared with the workers exposed to VOCs with non-atopy and who were non-smokers and the control subjects with non-atopy and who were non-smokers, had a significantly higher BRindex (1.20\u00b10.05 vs. 1.14\u00b10.06 vs. 1.10\u00b10.03, respectively p <0.05).", {"entities": []}], ["The BRindex was not correlated with atopy, the smoking status or the duration of VOC exposure.", {"entities": []}], ["These findings suggest that VOCs may act as a contributing factor of airway hyperresponsiveness in workers exposed to VOCs.", {"entities": []}], ["SLCO2B1, also known as OATP2B1 (Organic Anion Transporter) or OATP-B or SLC21A9, is an organic anion uptake transporter that is encoded by the SLCO2B1 gene.", {"entities": [[0, 7, "GENE"], [143, 150, "GENE"], [0, 7, "GENE"], [143, 150, "GENE"]]}], ["In this study we assessed the frequencies of SLCO2B1 polymorphisms in a Korean population using newly developed pyrosequencing methods and compared their frequencies with those in other ethnic groups.", {"entities": [[45, 52, "GENE"]]}], ["We developed pyrosequencing methods to identify the following six SLCO2B1 non-synonymous polymorphisms: c.1175C\u00a0>\u00a0T (rs1621378), c.1457C\u00a0>\u00a0T (rs2306168), c.43C\u00a0>\u00a0T (rs56837383), c.935G\u00a0>\u00a0A (rs12422149), c.601G\u00a0>\u00a0A (rs35199625) and c.644A\u00a0>\u00a0T (rs72559740).", {"entities": [[66, 73, "GENE"]]}], ["The allele frequencies of these polymorphisms were analyzed in 227 Korean subjects.", {"entities": []}], ["The allele frequencies of SLCO2B1 polymorphisms in the population tested were as follows: 0.0 for c.1175C\u00a0>\u00a0T, c.43C\u00a0>\u00a0T and c.644A\u00a0>\u00a0T; 0.2687 for c.1457C\u00a0>\u00a0T; 0.4273 for c.935G\u00a0>\u00a0A; and 0.0727 for c. 601G\u00a0>\u00a0A.", {"entities": [[26, 33, "GENE"]]}], ["Even though the allele frequencies of the c.1175C\u00a0>\u00a0T and c.1457C\u00a0>\u00a0T polymorphisms were comparable to those in Japanese subjects, the frequencies in this Korean population differed from those in other ethnic groups.", {"entities": []}], ["The developed pyrosequencing methods are rapid and reliable for detecting non-synonymous SLCO2B1 polymorphisms.", {"entities": [[89, 96, "GENE"]]}], ["Large ethnic differences in the frequency of SLCO2B1 genetic polymorphisms were noted among ethnic groups.", {"entities": [[45, 52, "GENE"]]}], ["The SLCO2B1 polymorphisms at c.1175C\u00a0>\u00a0T, c.43C\u00a0>\u00a0T and c.644A\u00a0>\u00a0T were not found in the Korean population while c.1457C\u00a0>\u00a0T, c.935G\u00a0>\u00a0A and c.601G\u00a0>\u00a0A exhibited mostly higher frequencies in Koreans compared with Finnish, Caucasian and African-American populations.", {"entities": [[4, 11, "GENE"]]}], ["We report a study of genome-wide, dense SNP (\u223c900K) and copy number polymorphism data of indigenous southern Africans.", {"entities": []}], ["We demonstrate the genetic contribution to southern and eastern African populations, which involved admixture between indigenous San, Niger-Congo-speaking and populations of Eurasian ancestry.", {"entities": []}], ["This finding illustrates the need to account for stratification in genome-wide association studies, and that admixture mapping would likely be a successful approach in these populations.", {"entities": []}], ["We developed a strategy to detect the signature of selection prior to and following putative admixture events.", {"entities": []}], ["Several genomic regions show an unusual excess of Niger-Kordofanian, and unusual deficiency of both San and Eurasian ancestry, which were considered the footprints of selection after population admixture.", {"entities": []}], ["Several SNPs with strong allele frequency differences were observed predominantly between the admixed indigenous southern African populations, and their ancestral Eurasian populations.", {"entities": []}], ["Interestingly, many candidate genes, which were identified within the genomic regions showing signals for selection, were associated with southern African-specific high-risk, mostly communicable diseases, such as malaria, influenza, tuberculosis, and human immunodeficiency virus/AIDs.", {"entities": [[222, 231, "DISEASE"], [233, 245, "DISEASE"], [213, 220, "DISEASE"]]}], ["This observation suggests a potentially important role that these genes might have played in adapting to the environment.", {"entities": []}], ["Additionally, our analyses of haplotype structure, linkage disequilibrium, recombination, copy number variation and genome-wide admixture highlight, and support the unique position of San relative to both African and non-African populations.", {"entities": []}], ["This study contributes to a better understanding of population ancestry and selection in south-eastern African populations; and the data and results obtained will support research into the genetic contributions to infectious as well as non-communicable diseases in the region.", {"entities": []}], ["Genome-wide analysis of human populations is useful in shedding light on the evolutionary history of the human genome, with a wide range of applications from reconstructing past associations between different population histories to disease mapping.", {"entities": []}], ["In this manuscript we report on the application of genome-wide data to southern African populations and the identification of genome-wide signatures of selection pre- and post-admixture.", {"entities": []}], ["Several signals of selection, before and after admixture, were identified, some of which involved loci associated with human diseases, including malaria, influenza, tuberculosis and HIV/AIDS.", {"entities": [[154, 163, "DISEASE"], [165, 177, "DISEASE"], [145, 152, "DISEASE"]]}], ["These results may reflect adaptations of southern African populations to infectious diseases.", {"entities": []}], ["Consistent with previous studies, this study highlights the significance of the San in the genetics of human populations, as they are distinct from the other populations in many respects i.e.", {"entities": []}], ["haplotype structure, locations of recombination hotspots, copy number and population structure.", {"entities": []}], ["Furthermore, our study demonstrates the admixture of the San, Bantu-speaking populations and populations of Eurasian ancestry in some of the southern and eastern African populations.", {"entities": []}], ["It illustrates the value in correcting for this stratification in future genome-wide association studies, and suggests that a future admixture mapping in these populations would likely be warranted and successful.", {"entities": []}], ["In this study a systematic attempt has been made to integrate various approaches in order to predict allergenic proteins with high accuracy.", {"entities": []}], ["The dataset used for testing and training consists of 578 allergens and 700 non-allergens obtained from A. K. Bjorklund, D. Soeria-Atmadja, A. Zorzet, U. Hammerling and M. G. Gustafsson (2005) Bioinformatics , 21 , 39\u201350.", {"entities": []}], ["First, we developed methods based on support vector machine using amino acid and dipeptide composition and achieved an accuracy of 85.02 and 84.00%, respectively.", {"entities": []}], ["Second, a motif-based method has been developed using MEME/MAST software that achieved sensitivity of 93.94 with 33.34% specificity.", {"entities": []}], ["Third, a database of known IgE epitopes was searched and this predicted allergenic proteins with 17.47% sensitivity at specificity of 98.14%.", {"entities": []}], ["Fourth, we predicted allergenic proteins by performing BLAST search against allergen representative peptides.", {"entities": []}], ["Finally hybrid approaches have been developed, which combine two or more than two approaches.", {"entities": []}], ["The performance of all these algorithms has been evaluated on an independent dataset of 323 allergens and on 101 725 non-allergens obtained from Swiss-Prot.", {"entities": []}], ["A web server AlgPred has been developed for the predicting allergenic proteins and for mapping IgE epitopes on allergenic proteins ( ).", {"entities": []}], ["AlgPred is available at .", {"entities": []}], ["Thrombotic risk is increased in eosinophil-mediated disorders, and several hypotheses have been proposed to link eosinophilia and thrombosis.", {"entities": [[113, 125, "DISEASE"]]}], ["In particular, eosinophils have been described as source of tissue factor (TF), the main initiator of blood coagulation; however, this aspect is still controversial.", {"entities": [[75, 77, "GENE"]]}], ["This study was aimed to evaluate whether TF expression varies in eosinophils isolated from normal subjects and patients with different hypereosinophilic conditions.", {"entities": [[41, 43, "GENE"]]}], ["Eosinophils were immunologically purified from peripheral blood samples of 9 patients with different hypereosinophilic conditions and 9 normal subjects.", {"entities": []}], ["Western blot analysis and real-time polymerase chain reaction (RT-PCR) were performed to test eosinophil TF expression.", {"entities": [[105, 107, "GENE"]]}], ["For comparison, TF expression was evaluated in monocytes from blood donors and in human endothelial (ECV304) and fibroblast (IMR90) cell lines.", {"entities": [[16, 18, "GENE"]]}], ["Western blot analysis revealed a major band of 47,000 corresponding to native TF in homogenates of purified eosinophils with a higher intensity in the 9 patients than in the 9 controls (p<0.0001).", {"entities": [[78, 80, "GENE"]]}], ["According to RT-PCR cycle threshold (Ct), TF gene expression was higher in eosinophils from patients than in those from controls, median (range) 35.10 (19.45\u201336.50) vs 37.17 (35.33\u201337.87) (p\u200a=\u200a0.002), and was particularly abundant in one patient with idiopathic hypereosinophilic syndrome and ischemic heart attacks (Ct: 19.45).", {"entities": [[280, 288, "DISEASE"], [42, 44, "GENE"]]}], ["TF gene expression was moderate in monocytes, Ct: 31.32 (29.82\u201333.49) and abundant in endothelial cells, Ct: 28.70 (27.79\u201329.57) and fibroblasts, Ct: 22.77 (19.22\u201325.05).", {"entities": [[0, 2, "GENE"]]}], ["Our results indicate that human blood eosinophils contain variable amounts of TF.", {"entities": [[78, 80, "GENE"]]}], ["The higher TF expression in patients with hypereosinophilic disorders may contribute to increase the thrombotic risk.", {"entities": [[11, 13, "GENE"]]}], ["Asthma self-management remains poorly implemented in clinical practice despite overwhelming evidence of improved healthcare outcomes, reflected in guideline recommendations over three decades.", {"entities": [[0, 6, "DISEASE"]]}], ["To inform delivery in routine care, we synthesised evidence from implementation studies of self-management support interventions.", {"entities": []}], ["We systematically searched eight electronic databases (1980 to 2012) and research registers, and performed snowball and manual searches for studies evaluating implementation of asthma self-management in routine practice.", {"entities": [[177, 183, "DISEASE"]]}], ["We included, and adapted systematic review methodology to reflect, a broad range of implementation study designs.", {"entities": []}], ["We extracted data on study characteristics, process measures (for example, action plan ownership), asthma control (for example, patient reported control questionnaires, days off school/work, symptom-free days) and use of health services (for example, admissions, emergency department attendances, unscheduled consultations).", {"entities": [[99, 105, "DISEASE"]]}], ["We assessed quality using the validated Downs and Black checklist, and conducted a narrative synthesis informed by Kennedy\u2019s whole systems theoretical approach (considering patient, practitioner and organisational components and the interaction between these).", {"entities": []}], ["We included 18 studies (6 randomised trials, 2 quasi-experimental studies, 8 with historical controls and 3 with retrospective comparators) from primary, secondary, community and managed care settings serving a total estimated asthma population of 800,000 people in six countries.", {"entities": [[227, 233, "DISEASE"]]}], ["In these studies, targeting professionals (n = 2) improved process, but had no clinically significant effect on clinical outcomes.", {"entities": []}], ["Targeting patients (n = 6) improved some process measures, but had an inconsistent impact on clinical outcomes.", {"entities": []}], ["Targeting the organisation (n = 3) improved process measures, but had little/no effect on clinical outcomes.", {"entities": []}], ["Interventions that explicitly addressed patient, professional and organisational factors (n = 7) showed the most consistent improvement in both process and clinical outcomes.", {"entities": []}], ["Authors highlighted the importance of health system commitment, skills training for professionals, patient education programmes supported by regular reviews, and on-going evaluation of implementation effectiveness.", {"entities": []}], ["Our methodology offers an exemplar of reviews synthesising the heterogeneous implementation literature.", {"entities": []}], ["Effective interventions combined active engagement of patients, with training and motivation of professionals embedded within an organisation in which self-management is valued.", {"entities": []}], ["Healthcare managers should consider how they can promote a culture of actively supporting self-management as a normal, expected, monitored and remunerated aspect of the provision of care.", {"entities": []}], ["PROSPERO (registration number: CRD42012002898 ) Accessed 24 May 2015 The online version of this article (doi:10.1186/s12916-015-0361-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Epidemiologic studies usually use database diagnoses or patient self-report to identify disease cohorts, but no previous research has examined the extent to which self-report of chronic disease agrees with database diagnoses in a Veterans Affairs (VA) health care setting.", {"entities": []}], ["All veterans who had a medical care visit from October 1, 1996, through May 31, 1998, at any of the Veterans Integrated Service Network 13 facilities were surveyed about physician diagnosis of chronic obstructive pulmonary disease (COPD)/asthma, depression, diabetes, and heart disease.", {"entities": [[272, 285, "DISEASE"], [193, 230, "DISEASE"], [238, 244, "DISEASE"]]}], ["Four administrative case definitions (data from VA databases) consisting of combinations of International Classification of Diseases, Ninth Revision, codes and disease-specific medication data were compared with self-report of each disease to assess sensitivity, specificity, positive and negative predictive values, area under receiver operating characteristics curve, and \u03ba statistic.", {"entities": []}], ["Sensitivity for administrative definitions compared with self-report of physician diagnosis was 24% to 54% for COPD/asthma, 25% to 47% for depression, 27% to 59% for heart disease, and 64% to 78% for diabetes.", {"entities": [[166, 179, "DISEASE"], [116, 122, "DISEASE"]]}], ["Specificity was 88% to 100% for all diseases.", {"entities": []}], ["The \u03ba statistic showed fair agreement for COPD/asthma, depression, and heart disease and substantial agreement for diabetes.", {"entities": [[71, 84, "DISEASE"], [47, 53, "DISEASE"]]}], ["Diagnoses identified from databases agree with self-report for diabetes but not COPD/asthma, depression, or heart disease in a VA health care setting.", {"entities": [[108, 121, "DISEASE"], [85, 91, "DISEASE"]]}], ["Cross\u2010sectional studies suggested that allergy prevalence in childhood is higher in boys compared to girls, but it remains unclear whether this inequality changes after puberty.", {"entities": []}], ["We examined the sex\u2010specific prevalence of asthma and rhinitis as single and as multimorbid diseases before and after puberty onset in longitudinal cohort data.", {"entities": [[54, 62, "DISEASE"], [43, 49, "DISEASE"]]}], ["In six European population\u2010based birth cohorts of MeDALL, we assessed the outcomes: current rhinitis, current asthma, current allergic multimorbidity (ie, concurrent asthma and rhinitis), puberty status and allergic sensitization by specific serum antibodies (immunoglobulin E) against aero\u2010allergens.", {"entities": [[92, 100, "DISEASE"], [177, 185, "DISEASE"], [110, 116, "DISEASE"], [166, 172, "DISEASE"]]}], ["With generalized estimating equations, we analysed the effects of sex, age, puberty (yes/no) and possible confounders on the prevalence of asthma and rhinitis, and allergic multimorbidity in each cohort separately and performed individual participant data meta\u2010analysis.", {"entities": [[150, 158, "DISEASE"], [139, 145, "DISEASE"]]}], ["We included data from 19\u00a0013 participants from birth to age 14\u201020\u00a0years.", {"entities": []}], ["Current rhinitis only affected girls less often than boys before and after puberty onset: adjusted odds ratio for females vs males 0.79 (95%\u2010confidence interval 0.73\u20100.86) and 0.86 (0.79\u20100.94), respectively (sex\u2010puberty interaction P \u00a0=\u00a0.089).", {"entities": [[8, 16, "DISEASE"]]}], ["Similarly, for current asthma only, females were less often affected than boys both before and after puberty onset: 0.71, 0.63\u20100.81 and 0.81, 0.64\u20101.02, respectively (sex\u2010puberty interaction P \u00a0=\u00a0.327).", {"entities": [[23, 29, "DISEASE"]]}], ["The prevalence of allergic multimorbidity showed the strongest sex effect before puberty onset (female\u2010male\u2010OR 0.55, 0.46\u20100.64) and a considerable shift towards a sex\u2010balanced prevalence after puberty onset (0.89, 0.74\u20101.04); sex\u2010puberty interaction: P \u00a0<\u00a0.001.", {"entities": []}], ["The male predominance in prevalence before puberty and the \u201csex\u2010shift\u201d towards females after puberty onset were strongest in multimorbid patients who had asthma and rhinitis concurrently.", {"entities": [[165, 173, "DISEASE"], [154, 160, "DISEASE"]]}], ["Neuroendocrine tumors (NETs) arise from disseminated neuroendocrine cells and express general and specific neuroendocrine markers.", {"entities": []}], ["Neuropeptide S receptor 1 (NPSR1) is expressed in neuroendocrine cells and its ligand neuropeptide S (NPS) affects cell proliferation.", {"entities": [[27, 32, "GENE"], [102, 105, "GENE"]]}], ["Our aim was to study whether NPS/NPSR1 could be used as a biomarker for neuroendocrine neoplasms and to identify the gene pathways affected by NPS/NPSR1.", {"entities": []}], ["We collected a cohort of NETs comprised of 91 samples from endocrine glands, digestive tract, skin, and lung.", {"entities": []}], ["Tumor type was validated by immunostaining of chromogranin-A and synaptophysin expression and tumor grade was analyzed by Ki-67 proliferation index.", {"entities": []}], ["NPS and NPSR1 expression was quantified by immunohistochemistry using polyclonal antibodies against NPS and monoclonal antibodies against the amino-terminus and carboxy-terminus of NPSR1 isoform A (NPSR1-A).", {"entities": [[0, 3, "GENE"], [100, 103, "GENE"], [8, 13, "GENE"], [181, 186, "GENE"], [198, 203, "GENE"], [0, 3, "GENE"], [100, 103, "GENE"], [8, 13, "GENE"], [181, 186, "GENE"], [198, 203, "GENE"]]}], ["The effects of NPS on downstream signaling were studied in a human SH-SY5Y neuroblastoma cell line which overexpresses NPSR1-A and is of neuroendocrine origin.", {"entities": [[75, 88, "DISEASE"], [15, 18, "GENE"]]}], ["NPSR1 and NPS were expressed in most NET tissues, with the exception of adrenal pheochromocytomas in which NPS/NPSR1 immunoreactivity was very low.", {"entities": [[0, 5, "GENE"], [111, 116, "GENE"], [10, 13, "GENE"], [107, 110, "GENE"]]}], ["Transcriptome analysis of NPSR1-A overexpressing cells revealed that mitogen-activated protein kinase (MAPK) pathways, circadian activity, focal adhesion, transforming growth factor beta, and cytokine\u2013cytokine interactions were the most altered gene pathways after NPS stimulation.", {"entities": [[265, 268, "GENE"]]}], ["Our results show that NETs are a source of NPS and NPSR1, and that NPS affects cancer-related pathways.", {"entities": [[79, 85, "DISEASE"], [43, 46, "GENE"], [67, 70, "GENE"], [51, 56, "GENE"], [43, 46, "GENE"], [67, 70, "GENE"]]}], ["The online version of this article (doi:10.1007/s00428-014-1602-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Interferon- (IFN-) \u03bb 1 is regarded as a potent bio-active molecule in innate immunity.", {"entities": []}], ["However, little is known about its role in chronic spontaneous urticaria (CSU).", {"entities": [[63, 72, "DISEASE"]]}], ["We therefore investigated expression of IFN- \u03bb 1 in CSU, its cellular location, and its influence on inflammatory cell accumulation by using flow cytometry analysis, skin tissue dispersion, immunohistochemical stain, and a mouse peritoneal inflammation model.", {"entities": []}], ["The results showed that level of IFN- \u03bb 1 was 2.0-fold higher in plasma of the patients with CSU than the level in healthy control (HC) subjects.", {"entities": []}], ["Among leukocytes examined, only CD8 \u03bb 1 in CSU blood.", {"entities": []}], ["Double labeling immunohistochemical staining revealed that IFN- \u03bb 1 \u03bb 1.", {"entities": []}], ["IFN- \u03bb 1 induced a dose-dependent increase in number of eosinophils, lymphocytes, mast cells, macrophages, and neutrophils in the peritoneum of mice at 6\u2009h following injection, which was inhibited by pretreatment of the animals with anti-intercellular adhesion molecule- (ICAM-) 1 and/or anti-L-selectin antibodies.", {"entities": []}], ["In conclusion, IFN- \u03bb 1 is likely to play a role in the pathogenesis of CSU.", {"entities": []}], ["Blocking IFN- \u03bb 1 production may help to reduce the accumulation of inflammatory cells in the involved CSU skin.", {"entities": []}], ["A universal mechanism to turn off a biological response is receptor desensitization, where the ability of a physiological trigger to activate a cell is lost despite the continued presence of the stimulus.", {"entities": []}], ["Receptor desensitization of G protein-coupled receptors involves uncoupling of the receptor from its G protein/second messenger pathway, followed by receptor internalization Desensitization of these receptors arises predominantly from protein kinase C-dependent phosphorylation of three serine residues in the receptor C-terminus 4 evoke repetitive cytoplasmic Ca", {"entities": []}], ["The skin immune system harbors a complex network of dendritic cells (DCs).", {"entities": []}], ["Recent studies highlight a diverse functional specialization of skin DC subsets.", {"entities": []}], ["In addition to generating cellular and humoral immunity against pathogens, skin DCs are involved in tolerogenic mechanisms to ensure the maintenance of immune homeostasis, as well as in pathogenesis of chronic inflammation in the skin when excessive immune responses are initiated and unrestrained.", {"entities": []}], ["Harnessing DCs by directly targeting DC-derived molecules or selectively modulate DC subsets is a convincing strategy to tackle inflammatory skin diseases.", {"entities": []}], ["In this review we discuss recent advances underlining the functional specialization of skin DCs and discuss the potential implication for future DC-based therapeutic strategies.", {"entities": []}], ["We aimed to investigate the effect of a carbohydrate-rich diet on detrusor contractility in rats.", {"entities": []}], ["Sprague-Dawley rats were randomized into two groups.", {"entities": []}], ["The control group received regular food and water.", {"entities": []}], ["The study group received carbohydrate-rich diet for six weeks.", {"entities": []}], ["The rats' detrusor muscle was isolated for pharmacological and histopathological examinations.", {"entities": []}], ["In the control and study groups, mean body weights were 431.5 \u00b1 27.6\u2009g and 528.0 \u00b1 36.2\u2009g, respectively ( p < 0.001).", {"entities": []}], ["Electrical stimulation of the detrusor strips of the control group resulted in gradual contraction.", {"entities": []}], ["A decreased contractile response was shown in the study group.", {"entities": []}], ["Acetylcholine in 10-7-10-3 molar concentration produced a decreased contractile response in the study group, compared to the control group ( p < 0.01).", {"entities": []}], ["The study group showed marked subepithelial and intermuscular fibrosis in the bladder.", {"entities": []}], ["Carbohydrate-rich diet causes marked subepithelial and extracellular fibrosis and changes in contractility in the detrusor within a six-week period.", {"entities": []}], ["Changes have higher costs in therapeutic choices and correction of these changes remains difficult.", {"entities": []}], ["Putting an end to carbohydrate-rich diet would seem to be more cost-effective than dealing with the effects of consuming it in high proportions which should be the national policy worldwide.", {"entities": []}], ["Vitamin D is hypothesized to have a beneficial effect on lung function and respiratory infections.", {"entities": []}], ["The aim of this study was to assess the relationship of serum 25-hydroxyvitamin D (25(OH)D) concentrations with lung function, airway inflammation and common colds.", {"entities": []}], ["We performed a cross-sectional analysis in the Netherlands Epidemiology of Obesity (NEO) study, a population-based cohort study.", {"entities": []}], ["We included participants with measurements of serum 25(OH)D, Forced Expiratory Volume in 1 s (FEV 1 ), Forced Vital Capacity (FVC), Fractional Exhaled Nitric Oxide (Fe NO ), and data on self-reported common colds ( n = 6138).", {"entities": [[94, 97, "GENE"]]}], ["In crude associations, serum 25(OH)D was positively associated with FEV 1 and FVC, and negatively with Fe NO and the occurrence of a common cold.", {"entities": [[133, 144, "DISEASE"], [68, 71, "GENE"]]}], ["After adjustment for confounders, however, these associations disappeared.", {"entities": []}], ["Stratified analyses showed that Body Mass Index (BMI) was an effect modifier in the relationship between serum 25(OH)D and FEV 1 , FVC and Fe NO .", {"entities": [[123, 126, "GENE"]]}], ["In obese participants (BMI \u2265 30 kg/m 1 (95% Confidence Interval: 0.17 to 0.75), 0.46% predicted higher FVC (0.18 to 0.74), and 0.24 ppb lower Fe NO (\u22120.43 to \u22120.04).", {"entities": []}], ["Thus, in the total study population, 25(OH)D concentrations were not associated with lung function, airway inflammation and common colds.", {"entities": []}], ["In obese participants, however, higher 25(OH)D concentrations were associated with a better lung function and lower airway inflammation.", {"entities": []}], ["Molecular epidemiological research suggests that interleukin-10 (IL-10) polymorphisms may be associated with an increased risk of head and neck cancer (HNC), but results remain controversial.", {"entities": [[144, 150, "DISEASE"]]}], ["To derive a more precise evaluation, we performed a meta-analysis focused on genetic polymorphisms of IL-10.", {"entities": []}], ["PubMed, Embase, CNKI and Wanfang databases were searched for studies that examined the relationship between IL-10 polymorphisms or haplotypes and HNC risk.", {"entities": []}], ["The odds ratio (OR) and 95% confidence interval (CI) were applied to assess the relationship strength.", {"entities": []}], ["Publication bias, sensitivity and cumulative analyses were conducted to measure the robustness of our findings.", {"entities": []}], ["Overall, nine related studies involving 2,258 patients and 2,887 control samples were analyzed.", {"entities": []}], ["Significant associations between the IL-10-1082A\u2009>\u2009G polymorphism and HNC risk were observed (G vs. A: OR\u2009=\u20091.56, 95% CI\u2009=\u20091.27\u20131.92, P\u2009<\u20090.01, I", {"entities": []}], ["Tenascin-C (TNC), a large extracellular matrix glycoprotein, has been reported to be associated with metastasis and poor prognosis in pancreatic cancer.", {"entities": [[134, 151, "DISEASE"], [145, 151, "DISEASE"], [12, 15, "GENE"]]}], ["However, the effects and mechanisms of TNC in pancreatic cancer metastasis largely remain unclear.", {"entities": [[46, 63, "DISEASE"], [57, 63, "DISEASE"], [39, 42, "GENE"]]}], ["We performed Transwell assays to investigate the effects of TNC on Capan-2, AsPC-1 and PANC-1 cells.", {"entities": [[60, 63, "GENE"]]}], ["In addition, western blot and RT-qPCR assays were used to examine potential TNC metastasis-associated targets, such as JNK/c-Jun, Paxillin/FAK, E-cadherin, N-cadherin, Vimentin, and MMP9/2.", {"entities": [[76, 79, "GENE"]]}], ["Lastly, we utilized a variety of methods, such as immunofluorescence, gelatin zymography and immunoprecipitation, to determine the molecular mechanisms of TNC in pancreatic cancer cell motility.", {"entities": [[162, 179, "DISEASE"], [173, 179, "DISEASE"], [155, 158, "GENE"]]}], ["The present study showed that TNC induced migration and invasion in pancreatic cancer cells and regulated a number of metastasis-associated proteins, including the EMT markers, MMP9 and Paxillin.", {"entities": [[68, 85, "DISEASE"], [79, 85, "DISEASE"], [30, 33, "GENE"], [177, 181, "GENE"]]}], ["Moreover, our data showed that TNC induced pancreatic cancer cells to generate an EMT phenotype and acquire motility potential through the activation of JNK/c-Jun signalling.", {"entities": [[43, 60, "DISEASE"], [54, 60, "DISEASE"], [31, 34, "GENE"]]}], ["In addition, TNC increased the DNA binding activity of c-Jun to the MMP9 promoter, an action likely resulting in increased MMP9 expression and activity.", {"entities": [[13, 16, "GENE"], [68, 72, "GENE"], [123, 127, "GENE"], [68, 72, "GENE"], [123, 127, "GENE"]]}], ["TNC/JNK also markedly induced the phosphorylation of Paxillin on serine 178, which is critical for the association between FAK and Paxillin and promoted the formation of focal adhesions.", {"entities": []}], ["TNC/JNK initiates cell migration and invasion of pancreatic cancer cells through the promotion of EMT, the transactivation of MMP9 and the phosphorylation of Paxillin on serine 178.", {"entities": [[49, 66, "DISEASE"], [60, 66, "DISEASE"], [126, 130, "GENE"]]}], ["TNC may be a potential therapeutic target for treating pancreatic cancer metastasis.", {"entities": [[55, 72, "DISEASE"], [66, 72, "DISEASE"], [0, 3, "GENE"]]}], ["The aim of this study is to explore how people in contemporary society may apply music in their everyday life to improve their health and well-being.", {"entities": []}], ["Through a series of qualitative interviews, informants gave their narratives about how music had become a part of their health practice.", {"entities": []}], ["Six narratives concerning this type of everyday musical self-care are presented, and the following questions are sought to be answered: What kinds of musical practices do people apply in order to regulate their health and promote their sense of well-being?", {"entities": []}], ["What kind of generative health mechanism can we observe or theorize when people use music to enhance their well-being?", {"entities": []}], ["What kinds of rituals, contextual circumstances and personal health beliefs are operating in these situations?", {"entities": []}], ["The findings suggests that some people may sing, participate in a choir, dance to music, compose songs, play precomposed music, or play in a band as part of a reflexive strategy to improve their health and well-being.", {"entities": []}], ["Further analysis also identified six generative factors that may contribute to the immunogen functions of music: A pragmatic concept of music, music as a social and emotional resource, music as a supportive self object, musical competency, rituals, and locus of control.", {"entities": []}], ["These findings may have implication for the field of music therapy as it will fill the gap between the clinical use of music done by professional music therapists and the everyday \u201cmusicking\u201d performed by people outside the institutional practice.", {"entities": []}], ["Patients with inflammatory rheumatic diseases have expressed a need for more frequent measurement of relevant outcomes, due to the variations in their symptoms during the day and from day to day.", {"entities": []}], ["At present, patient-reported outcomes are extensively collected with questionnaires completed with pen and paper.", {"entities": []}], ["However, as a measurement tool in frequent data collection the questionnaires are impractical.", {"entities": []}], ["In contrast, text messages on mobile phones are suitable for frequent data collection.", {"entities": []}], ["The aim of this study was two-fold; to compare daily registrations of patient-reported outcomes assessed with text-messages on mobile phones (SMS) or with questionnaires completed with pen and paper (P&P), with regard to scores and variation of scores, and to examine feasibility of the SMS method in a multicentre clinical study.", {"entities": [[142, 145, "GENE"], [287, 290, "GENE"], [142, 145, "GENE"], [287, 290, "GENE"]]}], ["To compare scores, 21 patients with an inflammatory, rheumatic disease performed daily assessments of pain, fatigue, stiffness and ability to carry out daily activities on a numeric rating scale (NRS).", {"entities": [[53, 70, "DISEASE"]]}], ["The patients were asked to assess the variables every other day with the SMS method and every other day with the P&P method for 28 consecutive days.", {"entities": [[73, 76, "GENE"]]}], ["In total each participant had to answer 14 P&P forms and 14 SMS messages.", {"entities": [[60, 63, "GENE"]]}], ["Mean scores and variation, expressed as the pooled standard deviation or as the average range between the maximum and minimum scores for the two methods, were compared using paired sample t-tests or Wilcoxon Signed Rank Test.", {"entities": []}], ["To examine feasibility, 36 patients with an inflammatory, rheumatic disease assessed the same four variables with SMS twice a week for 35\u00a0weeks.", {"entities": [[58, 75, "DISEASE"], [114, 117, "GENE"]]}], ["Feasibility of the SMS method was expressed as mean response-rate (%) in the total group and per centre.", {"entities": [[19, 22, "GENE"]]}], ["Mean scores, standard deviation of mean scores and mean range scores did not differ significantly between the two methods (p\u2009>\u20090.05).", {"entities": []}], ["Response-rate with the SMS method was 97.9% for the whole group and for the three centres 97.1%, 98.3% and 98.4%, respectively.", {"entities": [[23, 26, "GENE"]]}], ["Outcomes assessed on numeric rating scales and reported with text-messages on mobile phones or with questionnaires completed with pen and paper provide comparable scores.", {"entities": []}], ["Further, the SMS method provided high response rates (> 97%) in a multicentre setting.", {"entities": [[13, 16, "GENE"]]}], ["Our results encourage the use of text messages on mobile phones in studies requiring frequent data collection and real-time assessment, as in fluctuating diseases such inflammatory, rheumatic diseases.", {"entities": []}], ["We investigated the genetic diversity, the circulation patterns, and risk for hospital admission of human respiratory syncytial virus (HRSV) strains in Japan between 2012 through 2015.", {"entities": []}], ["During the study period, 744 HRSV-positive cases were identified by rapid diagnostic test.", {"entities": []}], ["Of these, 572 samples were positive by real-time PCR; 400 (69.9%) were HRSV-A, and 172 (30.1%) were HRSV-B.", {"entities": []}], ["HRSV-A and -B alternated as the dominant strain in the subsequent seasons.", {"entities": []}], ["Phylogenetic tree analysis of the second hyper-variable region of the G protein classified the HRSV-A specimens into NA1 (n = 242) and ON1 (n = 114) genotypes and the HRSV-B specimens into BA9 (n = 60), and BA10 (n = 27).", {"entities": []}], ["The ON1 genotype, containing a 72-nucleotide duplication in the G protein\u2019s second hyper-variable region, was first detected in the 2012\u20132013 season but it predominated and replaced the older NA1 HRSV-A in the 2014\u20132015 season, which also coincided with a record number of HRSV cases reported to the National Infectious Disease Surveillance in Japan.", {"entities": []}], ["The risk of hospitalization was 6.9 times higher for the ON1 genotype compared to NA1.", {"entities": []}], ["In conclusion, our data showed that the emergence and predominance of the relatively new ON1 genotype in Japan was associated with a record high number of cases and increased risk for hospitalization.", {"entities": []}], ["Antipsychotic medications are routinely prescribed in nursing homes to address the behavioral and psychological symptoms of dementia.", {"entities": [[124, 132, "DISEASE"]]}], ["Unfortunately, inappropriate prescribing of antipsychotic medications is common and associated with increased morbidity, adverse drug events, and hospitalizations.", {"entities": []}], ["Multifaceted interventions can achieve a 12\u201320\u00a0% reduction in antipsychotic prescribing levels in nursing homes.", {"entities": []}], ["Effective interventions have featured educational outreach and ongoing performance feedback.", {"entities": []}], ["This pragmatic, cluster-randomized control trial and embedded process evaluation seeks to determine the effect of adding academic detailing to audit and feedback on prescribing of antipsychotic medications in nursing homes, compared with audit and feedback alone.", {"entities": []}], ["Nursing homes within pre-determined regions of Ontario, Canada, are eligible if they express an interest in the intervention.", {"entities": []}], ["The academic detailing intervention will be delivered by registered health professionals following an intensive training program including relevant clinical issues and techniques to support health professional behavior change.", {"entities": []}], ["Physicians in both groups will have the opportunity to access confidential reports summarizing their prescribing patterns for antipsychotics in comparison to the local and provincial average.", {"entities": []}], ["Participating homes will be allocated to one of the two arms of the study (active/full intervention versus standard audit and feedback) in two waves, with a 2:1 allocation ratio.", {"entities": []}], ["Homes will be randomized after stratifying for geography, baseline antipsychotic prescription rates, and size, to ensure a balance of characteristics.", {"entities": []}], ["The primary outcome is antipsychotic dispensing in nursing homes, measured 6\u00a0months after allocation; secondary outcomes include clinical outcomes and healthcare utilization.", {"entities": []}], ["Policy-makers and the public have taken note that antipsychotics are used in nursing homes in Ontario far more than other jurisdictions.", {"entities": []}], ["Academic detailing can be an effective technique to address challenges in appropriate prescribing in nursing homes, but effect sizes vary widely.", {"entities": []}], ["This opportunistic, policy-driven evaluation, embedded within a government-initiated demonstration project, was designed to ensure policy-makers receive the best evidence possible regarding whether and how to scale up the intervention.", {"entities": []}], ["ClinicalTrials.gov NLM Identifier: NCT02604056 .", {"entities": []}], ["To examine the associations between sleep duration and a variety of demographic and clinical variables in a sample of Saudi adults.", {"entities": []}], ["A cross-sectional study among 2,095 participants was conducted at King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia, between May and October 2014.", {"entities": []}], ["A questionnaire was administered to collect data related to clinical health outcomes and demographic characteristics.", {"entities": []}], ["Participants were asked to report their average sleep duration per night in hours.", {"entities": []}], ["One-third (33.8%) reported short sleep duration of less than 7 hours/night.", {"entities": []}], ["Short sleep duration was more prevalent in females (37.3% versus 31.4%, p =0.004).", {"entities": []}], ["The most common medical problems reported were obesity with body mass index of >30 Kg/m p =0.011) and hypertension (54.2%, p =0.001).", {"entities": [[102, 114, "DISEASE"], [47, 54, "DISEASE"]]}], ["The linear regression model tend to reduce their sleep duration by roughly 22 minutes in female gender, 66 minutes in participants with hyperlipidemia, and 70 minutes in participants with poor sleep quality.", {"entities": []}], ["Short sleep duration per night was prevalent, it affects one in every 3 Saudi adults.", {"entities": []}], ["Long sleep duration of more than 9 hours was associated with increased comorbid conditions.", {"entities": []}], ["Tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, is clinically effective against rheumatoid arthritis (RA), and several reports have indicated how TCZ influences a number of mechanisms underlying RA pathogenesis.", {"entities": [[92, 112, "DISEASE"], [103, 112, "DISEASE"]]}], ["However, it is still unclear whether TCZ affects inflammatory cells in peripheral blood and whether any such changes are associated with clinical response.", {"entities": []}], ["We evaluated associations between proportions of subsets of peripheral immune cells and clinical response in patients with RA treated with TCZ.", {"entities": []}], ["Thirty-nine consecutive patients with RA who started to receive TCZ as their first biologic between March 2010 and April 2012 were enrolled.", {"entities": []}], ["The proportions of several subsets of peripheral cells with their levels of expression of differentiation markers, activation markers and costimulatory molecules were measured sequentially from baseline to week 52 by flow cytometry analysis.", {"entities": []}], ["Clinical Disease Activity Index (CDAI) remission was achieved in 53.8% of patients at week 52 of TCZ therapy.", {"entities": []}], ["The proportions of CD4 reg ) and HLA-DR reg cells significantly increased with TCZ therapy ( P \u2009<\u20090.001 and P \u2009<\u20090.001, respectively), whereas proportions of CD3 P \u2009<\u20090.001, P \u2009<\u20090.001, P \u2009<\u20090.001 and P \u2009<\u20090.001, respectively).", {"entities": [[19, 22, "GENE"]]}], ["Among them, only the change in T reg cells was inversely correlated with the change in CDAI score (\u03c1\u2009=\u2009\u22120.40, P \u2009=\u20090.011).", {"entities": []}], ["The most dynamic increase in T reg cells was observed in the CDAI remission group ( P \u2009<\u20090.001).", {"entities": []}], ["This study demonstrates that TCZ affected proportions of circulating immune cells in patients with RA.", {"entities": []}], ["The proportion of T reg cells among CD4 The online version of this article (doi:10.1186/s13075-015-0526-4) contains supplementary material, which is available to authorized users.", {"entities": [[36, 39, "GENE"]]}], ["Some patients visit a hospital\u2019s emergency department (ED) for reasons other than an urgent medical condition.", {"entities": []}], ["There is evidence that this practice may differ among patients from different backgrounds.", {"entities": []}], ["The objective of this study was to examine the reasons why patients from a non-English speaking background (NESB) and patients with an English speaking background but not born in Australia (ESB-NBA) visit the ED, as compared to patients from English-speaking backgrounds but born in Australia (ESB-BA).", {"entities": []}], ["A cross-sectional survey was conducted at the ED of a tertiary hospital in metropolitan Brisbane, Queensland, Australia.", {"entities": []}], ["Over a four-month period patients who were assigned an Australasian Triage Scale score of 3, 4 or 5 were surveyed.", {"entities": []}], ["Pearson chi-square test and multivariate logistic regression analyses were performed to examine the differences between the ESB and NESB patients\u2019 reported reasons for attending the ED.", {"entities": []}], ["A total of 828 patients participated in this study.", {"entities": []}], ["Compared to ESB-BA patients NESB patients were less likely to consider contacting a general practitioner (GP) before attending the ED (Odds Ratios (OR) 0.6 (95% Confidence Interval (CI) 0.4\u20130.8, p\u2009<\u2009.05) While ESB-NBA were more likely to consider contacting a GP 1.7 (1.1\u20132.5, p\u2009<\u2009.05).", {"entities": []}], ["Both the NESB patients and the ESB-NBA patients were far more likely than ESB-BA patients to report that they had visited the ED either because they do not have a GP (OR 7.9, 95% CI 4.7\u201313.4, p\u2009<\u2009.001) and 2.2 (95% CI 1.1\u20134.4, p\u2009<\u2009.05) respectively and less likely to think that the ED could deal with their problem better than a GP (OR 0.5 (95% CI 0.3\u20130.8, p\u2009<\u2009.05) and 0.7 (0.3\u20130.9, p\u2009<\u2009.05) respectively.", {"entities": []}], ["The NESB patients also thought it would take too long to make an appointment to consult a GP (OR 6.2, 95% CI 3.7\u201310.4, p\u2009<\u20090.001).", {"entities": []}], ["NESB patients were the least likely to consider contacting a GP before attending hospital EDs.", {"entities": []}], ["Educational interventions may help direct NESB people to the appropriate health services and therefore reduce the burden on tertiary hospitals ED.", {"entities": []}], ["The online version of this article (doi:10.1186/s12873-015-0031-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It is well established that the ingestion of the omega-3 (N3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) positively benefit a variety of health indices.", {"entities": []}], ["Despite these benefits the actual intake of fish derived N3 is relatively small in the United States.", {"entities": []}], ["The primary aim of our study was to examine a technology capable of delivering omega-3 fatty acids in common foods via microencapsulation (MicroN3) in young, healthy, active participants who are at low risk for cardiovascular disease.", {"entities": []}], ["Accordingly, we randomized 20 participants (25.4 \u00b1 6.2 y; 73.4 \u00b1 5.1 kg) to receive the double blind delivery of a placebo-matched breakfast meal (~2093 kJ) containing MicroN3 (450\u2013550 mg EPA/DHA) during a 2-week pilot trial.", {"entities": []}], ["Overall, we observed no differences in overall dietary macronutrient intake other than the N3 delivery during our treatment regimen.", {"entities": []}], ["Post-test ANOVA analysis showed a significant elevation in mean (SE) plasma DHA (91.18 \u00b1 9.3 vs. 125.58 \u00b1 11.3 u mol/L; P < 0.05) and a reduction in triacylglycerols (89.89 \u00b1 12.8 vs. 80.78 \u00b1 10.4 mg/dL; P < 0.05) accompanying the MicroN3 treatment that was significantly different from placebo (P < 0.05).", {"entities": []}], ["In post study interviews, participants reported that the ingested food was well-tolerated, contained no fish taste, odor or gastrointestinal distress accompanying treatment.", {"entities": []}], ["The use of MicroN3 foods provides a novel delivery system for the delivery of essential fatty acids.", {"entities": []}], ["Our study demonstrates that MicroN3 foods promote the absorption of essential N3, demonstrate bioactivity within 2 weeks of ingestion and are well tolerated in young, active participants who are at low risk for cardiovascular disease.", {"entities": []}], ["Symptoms of theophylline toxicity and factors that augment the risk of developing it are well documented in the literature.", {"entities": []}], ["However these appear to be poorly considered in clinical practice.", {"entities": []}], ["This case underlines the challenges in recognising and managing theophylline toxicity; moreover the requirement for improved application of knowledge of its pharmacokinetics to our practice.", {"entities": []}], ["In this case we observe how theophylline toxicity can be overlooked due to the presence of non-specific symptoms and lack of a structured system to mitigate error in detection, in both hospital medicine and general practice.", {"entities": []}], ["Here, the initial theophylline concentration measurement was documented as 59.3\u00a0mg/l in a patient taking the medication long-term, with the previous concentration being recorded one year prior.", {"entities": []}], ["Management consisted of suspension of theophylline along with best supportive care, however in the process other conditions were exacerbated and the patient ultimately died in hospital.", {"entities": []}], ["Congestive cardiac failure, congestive liver disease and polypharmacy were factors isolated from this case that expedited the patients\u2019 development of theophylline toxicity.", {"entities": [[39, 52, "DISEASE"]]}], ["This was perpetuated by delay in diagnosis due to presentation with generalised symptoms including tachycardia, vomiting and neurological symptoms.", {"entities": []}], ["Findings from this case necessitate a requirement for more stringent monitoring of theophylline when taken chronically in those who demonstrate risk factors for toxicity.", {"entities": []}], ["This would aim to prevent accumulation of the drug, toxicity onset and subsequent acute presentation to hospital.", {"entities": []}], ["Intervention, through charcoal haemoperfusion may provide a means of enhanced recovery to reduce sequelae of toxicity.", {"entities": []}], ["The genetic factors underlying female infertility in humans are only partially understood.", {"entities": [[38, 49, "DISEASE"]]}], ["Here, we performed a genome-wide association study of female infertility in 25 inbred mouse strains by using publicly available SNP data.", {"entities": [[61, 72, "DISEASE"]]}], ["As a result, a total of four SNPs were identified after chromosome-wise multiple test correction.", {"entities": []}], ["The first SNP rs29972765 is located in a gene desert on chromosome\u00a018, about 72\u00a0kb upstream of Skor2 (SKI family transcriptional corepressor\u00a02).", {"entities": [[95, 100, "GENE"]]}], ["The second SNP rs30415957 resides in the intron of Plce1 (phospholipase C epsilon 1).", {"entities": [[51, 56, "GENE"]]}], ["The remaining two SNPs (rs30768258 and rs31216810) are close to each other on chromosome\u00a019, in the vicinity of Sorbs1 (sorbin and SH3 domain containing 1).", {"entities": [[112, 118, "GENE"]]}], ["Using quantitative RT-PCR, we found that Sorbs1 is highly expressed in the mouse uterus during embryo implantation.", {"entities": [[41, 47, "GENE"]]}], ["Knockdown of Sorbs1 by siRNA attenuates the induction of differentiation marker gene Prl8a2 (decidual prolactin-related protein) in an in vitro model of decidualization using mouse endometrial stromal cells, suggesting that Sorbs1 may be a potential candidate gene for female infertility in mice.", {"entities": [[276, 287, "DISEASE"], [13, 19, "GENE"], [224, 230, "GENE"], [13, 19, "GENE"], [224, 230, "GENE"]]}], ["Our results may represent an opportunity to further understand female infertility in humans.", {"entities": [[70, 81, "DISEASE"]]}], ["Hepatocyte growth factor (HGF) promotes lung epithelial repair after injury.", {"entities": [[26, 29, "GENE"]]}], ["Because prior studies established that human neutrophil proteases inactivate HGF in vitro, we predicted that HGF levels decrease in lungs infiltrated with neutrophils and that injury is less severe in lungs lacking HGF-inactivating proteases.", {"entities": [[77, 80, "GENE"], [109, 112, "GENE"], [215, 218, "GENE"], [77, 80, "GENE"], [109, 112, "GENE"], [215, 218, "GENE"]]}], ["After establishing that mouse neutrophil elastase cleaves mouse HGF in vitro, we tested our predictions in vivo by examining lung pathology and HGF in mice infected with Mycoplasma pulmonis , which causes neutrophilic tracheobronchitis and pneumonia.", {"entities": [[240, 249, "DISEASE"], [64, 67, "GENE"], [144, 147, "GENE"], [64, 67, "GENE"], [144, 147, "GENE"]]}], ["Unexpectedly, pneumonia severity was similar in wild type and dipeptidylpeptidase I-deficient ( Dppi ) mice lacking neutrophil serine protease activity.", {"entities": [[14, 23, "DISEASE"]]}], ["To assess how this finding related to our prediction that Dppi-activated proteases regulate HGF levels, we measured HGF in serum, bronchoalveolar lavage fluid, and lung tissue from Dppi and Dppi mice.", {"entities": [[92, 95, "GENE"], [116, 119, "GENE"], [92, 95, "GENE"], [116, 119, "GENE"]]}], ["Contrary to prediction, HGF levels were higher in lavage fluid from infected mice.", {"entities": [[24, 27, "GENE"]]}], ["However, serum and tissue concentrations were not different in infected and uninfected mice, and HGF lung transcript levels did not change.", {"entities": [[97, 100, "GENE"]]}], ["Increased HGF correlated with increased albumin in lavage fluid from infected mice, and immunostaining failed to detect increased lung tissue expression of HGF in infected mice.", {"entities": [[10, 13, "GENE"], [156, 159, "GENE"], [10, 13, "GENE"], [156, 159, "GENE"]]}], ["These findings are consistent with trans-alveolar flux rather than local production as the source of increased HGF in lavage fluid.", {"entities": [[111, 114, "GENE"]]}], ["However, levels of intact HGF from infected mice, normalized for albumin concentration, were two-fold higher in Dppi versus Dppi lavage fluid, suggesting regulation by Dppi-activated proteases.", {"entities": [[26, 29, "GENE"]]}], ["Consistent with the presence of active HGF, increased expression of activated receptor c-Met was observed in infected tissues.", {"entities": [[39, 42, "GENE"]]}], ["These data suggest that HGF entering alveoli from the bloodstream during pneumonia compensates for destruction by Dppi-activated inflammatory proteases to allow HGF to contribute to epithelial repair.", {"entities": [[73, 82, "DISEASE"], [24, 27, "GENE"], [161, 164, "GENE"], [24, 27, "GENE"], [161, 164, "GENE"]]}], ["In this study we investigated the distribution of self-reported health care utilisation by education and household income in a county population in Norway, in a universal public health care system based on ideals of equal access for all according to need, and not according to wealth.", {"entities": []}], ["The study included 24,147 women and 20,608 men aged 20 years and above in the third Nord-Tr\u00f8ndelag Health Survey (HUNT 3) of 2006\u20132008.", {"entities": []}], ["Income-related horizontal inequity was estimated through concentration indexes, and inequity by both education and income was estimated as risk ratios through conventional regression.", {"entities": []}], ["We found no overall pro-rich or pro-educated socioeconomic gradient in needs-adjusted utilisation of general practitioner or inpatient care.", {"entities": []}], ["However, we found overall pro-rich and pro-educated inequity in utilisation of both private medical specialists and hospital outpatient care.", {"entities": []}], ["For these services there were large differences in levels of inequity between younger and older men and women.", {"entities": []}], ["In contrast with recent studies from Norway, we found pro-rich and pro-educated social inequalities in utilisation of hospital outpatient services and not only private medical specialists.", {"entities": []}], ["Utilisation of general practitioner and inpatient services, which have low access threshold or are free of charge, we found to be equitable.", {"entities": []}], ["Acute severe asthma is one of the most common medical emergency situations in childhood, and physicians caring for acutely ill children are regularly faced with this condition.", {"entities": [[13, 19, "DISEASE"]]}], ["In this article we present a summary of the pathophysiology as well as guidelines for the treatment of acute severe asthma in children.", {"entities": [[116, 122, "DISEASE"]]}], ["The cornerstones of the management of acute asthma in children are rapid administration of oxygen, inhalations with bronchodilators and systemic corticosteroids.", {"entities": [[44, 50, "DISEASE"]]}], ["Inhaled bronchodilators may include selective b2-agonists, adrenaline and anticholinergics.", {"entities": []}], ["Additional treatment in selected cases may involve intravenous administration of theophylline, b2-agonists and magnesium sulphate.", {"entities": []}], ["Both non-invasive and invasive ventilation may be options when medical treatment fails to prevent respiratory failure.", {"entities": [[98, 117, "DISEASE"]]}], ["It is important that relevant treatment algorithms exist, applicable to all levels of the treatment chain and reflecting local considerations and circumstances.", {"entities": []}], ["IL-10-differentiated dendritic cells (DC10) can reverse the asthma phenotype in mice, but how they suppress the asthmatic B cell response is unclear.", {"entities": [[60, 66, "DISEASE"]]}], ["Herein we assessed the mechanism(s) by which DC10 and DC10-induced Treg affect IgG1 production in asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["We observed a rapid decline in lung-resident OVA-specific IgG1-secreting B cells on cessation of airway allergen challenge, and intraperitoneal DC10 therapy did not amplify that (p>0.05).", {"entities": []}], ["It did however increase the loss of IgG1-B cells from the bone marrow (by 45+/-7.2%; p\u22640.01) and spleen (by 65+/-17.8%; p\u22640.05) over 2 wk.", {"entities": []}], ["Delivery of OVA-loaded DC10 directly into the airways of asthmatic mice decreased the lung IgG1 B cell response assessed 2 dy later by 33+/-9.7% (p\u22640.01), while their co-culture with asthmatic lung cell suspensions reduced the numbers of IgG1-secreting cells by 56.5+/-9.7% (p\u22640.01).", {"entities": []}], ["This effect was dependent on the DC10 carrying intact allergen on their cell surface; DC10 that had phagocytosed and fully processed their allergen were unable to suppress B cell responses, although they did suppress asthmatic Th2 cell responses.", {"entities": []}], ["We had shown that therapeutic delivery of DC10-induced Treg can effectively suppress asthmatic T and B cell (IgE and IgG1) responses; herein CD4 in vitro B cell IgG1 production by 52.2+/-8.7% (p\u22640.001) or 44.6+/-12.2% (p\u22640.05), respectively, but delivery of DC10-induced Treg directly into the airways of asthmatic mice had no discernible impact over 2 dy on the numbers of lung IgG1-secreting cells (p\u22650.05).", {"entities": [[141, 144, "GENE"]]}], ["In summary, DC10 treatment down-regulates OVA-specific B cell responses of asthmatic mice.", {"entities": []}], ["While DC10 that carry intact allergen on their cell surface can dampen this response, DC10-induced Treg are critical for full realization of this outcome.", {"entities": []}], ["This suggests that infectious tolerance is an essential element in regulatory DC control of the B cell response in allergic asthma.", {"entities": [[115, 130, "DISEASE"], [124, 130, "DISEASE"]]}], ["Developmental programming studies indicate that glucocorticoids modify fetal development.", {"entities": []}], ["We hypothesized that administration of the synthetic glucocorticoid (sGC) betamethasone to pregnant baboons at doses and stages of fetal life equivalent to human obstetric practice to decrease premature offspring morbidity and mortality, programs lipid metabolism.", {"entities": []}], ["In 10-year-old male baboons (human equivalent 40) exposed in fetal life to betamethasone or saline, we quantified pericardial fat and hepatic lipid content with magnetic resonance imaging and spectroscopy.", {"entities": []}], ["sGC offspring delivered at term as do most sGC exposed human neonates.", {"entities": []}], ["Pericardial fat thickness (7.7 \u00b1 3.6 mm vs. 3.1 \u00b1 1.1 mm, M \u00b1 SD; p = 0.022; n=5) and hepatic fatty acids (13.3 \u00b1 11.0 % vs. 2.5 \u00b1 2.2 %; p = 0.046; n=5) increased following sGC without birth weight or current body morphometric differences.", {"entities": []}], ["Our results indicate that antenatal sGC therapy caused abnormal fat deposition and adult body composition in mid-life primate offspring.", {"entities": []}], ["The concern raised is that this degree of pericardial and hepatic lipid accumulation can lead to harmful local lipotoxicity.", {"entities": []}], ["In summary, developmental programing by sGC produces a mid-life metabolically obese but normal weight phenotype.", {"entities": []}], ["Prior studies show sexually dimorphic responses to some programming challenges thus female studies are necessary.", {"entities": []}], ["Colorectal cancer (CRC) survivors who remain fatigued during long-term follow-up are at risk for worse health outcomes and need relevant interventions most.", {"entities": [[11, 17, "DISEASE"]]}], ["The aim of this study is to prospectively assess cancer-related fatigue (CRF) and four categories of CRF correlates (clinical characteristics, demographic characteristics, behavior/well-being, functional status).", {"entities": [[49, 55, "DISEASE"]]}], ["CRC survivors diagnosed between 2000 and 2009, as registered in the population-based Eindhoven Cancer Registry, completed the Fatigue Assessment Scale at three annual time points.", {"entities": [[95, 101, "DISEASE"]]}], ["Linear mixed models were used to assess the course of CRF and identify its correlates.", {"entities": []}], ["CRF levels were relatively stable over time.", {"entities": []}], ["Being female, young (\u226465\u00a0years of age), and single; having a low educational level; treatment with chemotherapy; and having one or more comorbid conditions were associated with higher CRF scores.", {"entities": []}], ["Years since diagnosis, radiotherapy, and disease stage were not related to CRF over time.", {"entities": []}], ["Significant between- and within-subject effects were found for all well-being factors (social, emotional, and cognitive functioning, and global quality of life), symptoms (anxiety, depression, pain, and insomnia), and functional status (physical and role functioning, physical activity levels) in relation to CRF.", {"entities": []}], ["The differences in CRF levels could, for a large part, be attributed to differences in behavior/well-being (59\u00a0%), functional status (37\u00a0%), and, to a lesser extent, to sociodemographic (4\u00a0%) and clinical characteristics (8\u00a0%).", {"entities": []}], ["This study showed that sociodemographic and clinical factors were associated with CRF levels over time among CRC survivors; however, behavior/well-being and functional status explained a larger part of the variance in levels of CRF.", {"entities": []}], ["Standardized doctor\u2019s orders are replacing traditional order writing in teaching hospitals.", {"entities": []}], ["The impact of this shift in practice on medical education is unknown.", {"entities": []}], ["It is possible that preprinted orders interfere with knowledge acquisition and retention by not requiring active decision-making.", {"entities": []}], ["The objective of the study was to evaluate the impact of standardized admission orders on disease-specific knowledge among undergraduate medical trainees.", {"entities": []}], ["This prospective cohort study enrolled Year 3 (n\u2009=\u2009121) and Year 4 (n\u2009=\u200954) medical students at two academic hospitals in Toronto (Ontario, Canada) during their general internal medicine rotation.", {"entities": []}], ["We used standardized orders for patient admissions for alcohol withdrawal (AW) and for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) as the intervention and manual order writing as the control.", {"entities": [[110, 147, "DISEASE"]]}], ["Educational outcomes were assessed through end-of-rotation questionnaires assessing disease-specific knowledge of AW and AECOPD.", {"entities": []}], ["Of 175 students, 105 had exposure to patients with alcohol withdrawal during their rotation, and 68 students wrote admission orders.", {"entities": []}], ["Among these 68 students, 48 used standardized orders (intervention, n\u2009=\u200948) and 20 used manual order writing (control, n\u2009=\u200920).", {"entities": []}], ["Only 3 students used standardized orders for AECOPD, precluding analysis.", {"entities": []}], ["There was no significant difference found in mean total score of questionnaires between those who used AW standardized orders and those who did not (11.8 vs. 11.0, p\u2009=\u20090.4).", {"entities": []}], ["Students who had direct clinical experience had significantly higher mean total scores (11.6 vs. 9.0, p\u2009<\u20090.0001 for AW; 13.8 vs. 12.6, p\u2009=\u20090.02 for AECOPD) compared to students who did not.", {"entities": []}], ["When corrected for overall knowledge, this difference only persisted for AW.", {"entities": []}], ["No significant differences were found in total scores between students who used standardized admission orders and traditional manual order writing.", {"entities": []}], ["Clinical exposure was associated with increase in disease-specific knowledge.", {"entities": []}], ["In a previous study we determined that BcA86 mice, a strain belonging to a panel of AcB/BcA recombinant congenic strains, have an airway responsiveness phenotype resembling mice from the airway hyperresponsive A/J strain.", {"entities": []}], ["The majority of the BcA86 genome is however from the hyporesponsive C57BL/6J strain.", {"entities": []}], ["The aim of this study was to identify candidate regions and genes associated with airway hyperresponsiveness (AHR) by quantitative trait locus (QTL) analysis using the BcA86 strain.", {"entities": [[110, 113, "GENE"]]}], ["Airway responsiveness of 205 F2 mice generated from backcrossing BcA86 strain to C57BL/6J strain was measured and used for QTL analysis to identify genomic regions in linkage with AHR.", {"entities": [[29, 31, "GENE"], [180, 183, "GENE"]]}], ["Consomic mice for the QTL containing chromosomes were phenotyped to study the contribution of each chromosome to lung responsiveness.", {"entities": []}], ["Candidate genes within the QTL were selected based on expression differences in mRNA from whole lungs, and the presence of coding non-synonymous mutations that were predicted to have a functional effect by amino acid substitution prediction tools.", {"entities": []}], ["One QTL for AHR was identified on Chromosome 12 with its 95% confidence interval ranging from 54.6 to 82.6 Mbp and a maximum LOD score of 5.11 ( p \u200a=\u200a3.68\u00d710 Foxa1 , and genes with expression differences, such as Mettl21d and Snapc1, were selected as possible candidates for the AHR phenotype.", {"entities": [[12, 15, "GENE"], [279, 282, "GENE"], [107, 110, "GENE"], [158, 163, "GENE"], [226, 232, "GENE"], [12, 15, "GENE"], [279, 282, "GENE"]]}], ["Overall, through QTL analysis of a recombinant congenic strain, microarray analysis and coding variant analysis we identified Chromosome 12 and three potential candidate genes to be in linkage with airway responsiveness.", {"entities": []}], ["Genome mining facilitated by heterologous systems is an emerging approach to access the chemical diversity encoded in basidiomycete genomes.", {"entities": []}], ["In this study, three sesquiterpene synthase genes, GME3634, GME3638, and GME9210, which were highly expressed in the sclerotium of the medicinal mushroom Lignosus rhinocerotis , were cloned and heterologously expressed in a yeast system.", {"entities": []}], ["Metabolite profile analysis of the yeast culture extracts by GC\u2013MS showed the production of several sesquiterpene alcohols (C 15 H 26 O), including cadinols and germacrene D-4-ol as major products.", {"entities": []}], ["Other detected sesquiterpenes include selina-6-en-4-ol, \u03b2-elemene, \u03b2-cubebene, and cedrene.", {"entities": []}], ["Two purified major compounds namely (+)-torreyol and \u03b1-cadinol synthesised by GME3638 and GME3634 respectively, are stereoisomers and their chemical structures were confirmed by 50 value of 3.5\u00a0\u00b1\u00a00.58\u00a0\u03bcg/ml while \u03b1-cadinol is less active (IC 50 \u00a0=\u00a018.0\u00a0\u00b1\u00a03.27\u00a0\u03bcg/ml).", {"entities": []}], ["This demonstrates that yeast-based genome mining, guided by transcriptomics, is a promising approach for uncovering bioactive compounds from medicinal mushrooms.", {"entities": []}], ["The online version of this article (doi:10.1186/s12934-017-0713-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Confusion between look-alike and sound-alike (LASA) medication names (such as mercaptamine and mercaptopurine) accounts for up to one in four medication errors, threatening patient safety.", {"entities": []}], ["Error reduction strategies include computerized physician order entry interventions, and \u2018Tall Man\u2019 lettering.", {"entities": []}], ["The purpose of this study is to explore the medication name designation process, to elucidate properties that may prime the risk of confusion.", {"entities": []}], ["We analysed the formal and semantic properties of 7,987 International Non-proprietary Names (INNs), in relation to naming guidelines of the World Health Organization (WHO) INN programme, and have identified potential for errors.", {"entities": []}], ["We explored: their linguistic properties, the underlying taxonomy of stems to indicate pharmacological interrelationships, and similarities between INNs.", {"entities": []}], ["We used Microsoft Excel for analysis, including calculation of Levenshtein edit distance (LED).", {"entities": []}], ["Compliance with WHO naming guidelines was inconsistent.", {"entities": []}], ["Since the 1970s there has been a trend towards compliance in formal properties, such as word length, but longer names published in the 1950s and 1960s are still in use.", {"entities": []}], ["The stems used to show pharmacological interrelationships are not spelled consistently and the guidelines do not impose an unequivocal order on them, making the meanings of INNs difficult to understand.", {"entities": []}], ["Pairs of INNs sharing a stem (appropriately or not) often have high levels of similarity (<5 LED), and thus have greater potential for confusion.", {"entities": []}], ["We have revealed a tension between WHO guidelines stipulating use of stems to denote meaning, and the aim of reducing similarities in nomenclature.", {"entities": []}], ["To mitigate this tension and reduce the risk of confusion, the stem system should be made clear and well ordered, so as to avoid compounding the risk of confusion at the clinical level.", {"entities": []}], ["The interplay between the different WHO INN naming principles should be further examined, to better understand their implications for the problem of LASA errors.", {"entities": []}], ["Living with HIV makes considerable demands on a person in terms of self-management, especially as regards adherence to treatment and coping with adverse side-effects.", {"entities": []}], ["The online HIV Treatment, Virtual Nursing Assistance and Education (Virus de I\u2019immunod\u00e9ficience Humaine\u2013Traitement Assistance Virtuelle Infirmi\u00e8re et Enseignement; VIH-TAVIE\u2122) intervention was developed to provide persons living with HIV (PLHIV) with personalized follow-up and real-time support in managing their medication intake on a daily basis.", {"entities": []}], ["An online randomized controlled trial (RCT) will be conducted to evaluate the efficacy of this intervention primarily in optimizing adherence to combination anti-retroviral therapy (ART) among PLHIV.", {"entities": []}], ["A convenience sample of 232 PLHIV will be split evenly and randomly between an experimental group that will use the web application, and a control group that will be handed a list of websites of interest.", {"entities": []}], ["Participants must be aged 18 years or older, have been on ART for at least 6 months, and have internet access.", {"entities": []}], ["The intervention is composed of four interactive computer sessions of 20 to 30 minutes hosted by a virtual nurse who engages the PLHIV in a skills-learning process aimed at improving self-management of medication intake.", {"entities": []}], ["Adherence constitutes the principal outcome, and is defined as the intake of at least 95% of the prescribed tablets.", {"entities": []}], ["The following intermediary measures will be assessed: self-efficacy and attitude towards antiretroviral medication, symptom-related discomfort, and emotional support.", {"entities": []}], ["There will be three measurement times: baseline (T0), after 3 months (T3) and 6 months (T6) of baseline measurement.", {"entities": []}], ["The principal analyses will focus on comparing the two groups in terms of treatment adherence at the end of follow-up at T6.", {"entities": []}], ["An intention-to-treat (ITT) analysis will be carried out to evaluate the true value of the intervention in a real context.", {"entities": []}], ["Carrying out this online RCT poses various challenges in terms of recruitment, ethics, and data collection, including participant follow-up over an extended period.", {"entities": []}], ["Collaboration between researchers from clinical disciplines (nursing, medicine), and experts in behavioral sciences information technology and media will be crucial to the development of innovative solutions to supplying and delivering health services.", {"entities": []}], ["CE 11.184 / NCT 01510340", {"entities": []}], ["To assess the associations of P16 methylation status with low-grade squamous intra-epithelial lesion (LSIL), high-grade squamous intra-epithelial lesion (HSIL), cervical cancer (CC) and their clinicopathological features, a meta-analysis with 29 eligible studies was conducted.", {"entities": [[170, 176, "DISEASE"], [161, 176, "DISEASE"]]}], ["Pooled odds ratios (ORs) with their 95% confidence intervals (CIs) were estimated to assess the strength of the associations.", {"entities": []}], ["Heterogeneity, sensitivity of pooled results and publication bias were also evaluated.", {"entities": []}], ["Overall, there was an increasing trend of P16 hypermethylation rates among LSIL (21.4%), HSIL (30.9%) and CC (35.0%) specimens.", {"entities": []}], ["P16 hypermethylation was significantly associated with the increased risk of LSIL, HSIL and CC, with the pooled ORs of 3.26 (95% CI: 1.86-5.71), 5.80 (95% CI: 3.80-8.84) and 12.17 (95% CI: 5.86-25.27), respectively.", {"entities": []}], ["A significant association was also found between P16 hypermethylation and smoking habit (OR = 3.88, 95% CI: 2.13-7.08).", {"entities": []}], ["Taken together, meta-analysis results support P16 hypermethylation as an epigenetic marker for the progression of cervical carcinogenesis.", {"entities": []}], ["Pulmonary fibrosis has high rates of mortality and morbidity; however, no effective pharmacological therapy has been established.", {"entities": [[0, 18, "DISEASE"]]}], ["C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, selectively binds to the transmembrane guanylyl cyclase (GC)-B receptor and exerts anti-inflammatory and anti-fibrotic effects in various organs through vascular endothelial cells and fibroblasts that have a cell-surface GC-B receptor.", {"entities": [[28, 31, "GENE"], [135, 137, "GENE"], [299, 301, "GENE"]]}], ["Given the pathophysiological importance of fibroblast activation in pulmonary fibrosis, we hypothesized that the anti-fibrotic and anti-inflammatory effects of exogenous CNP against bleomycin (BLM)-induced pulmonary fibrosis were exerted in part by the effect of CNP on pulmonary fibroblasts.", {"entities": [[68, 86, "DISEASE"], [206, 224, "DISEASE"], [170, 173, "GENE"], [263, 266, "GENE"], [193, 196, "GENE"], [170, 173, "GENE"], [263, 266, "GENE"]]}], ["C57BL/6 mice were divided into two groups, CNP-treated (2.5\u00a0\u03bcg/kg/min) and vehicle, to evaluate BLM-induced (1\u00a0mg/kg) pulmonary fibrosis and inflammation.", {"entities": [[118, 136, "DISEASE"]]}], ["A periostin-CNP transgenic mouse model exhibiting CNP overexpression in fibroblasts was generated and examined for the anti-inflammatory and anti-fibrotic effects of CNP via fibroblasts in vivo.", {"entities": [[12, 15, "GENE"], [50, 53, "GENE"], [166, 169, "GENE"], [12, 15, "GENE"], [50, 53, "GENE"], [166, 169, "GENE"]]}], ["Additionally, we assessed CNP attenuation of TGF-\u03b2-induced differentiation into myofibroblasts by using immortalized human lung fibroblasts stably expressing GC-B receptors.", {"entities": [[26, 29, "GENE"]]}], ["Furthermore, to investigate whether CNP acts on human lung fibroblasts in a clinical setting, we obtained primary-cultured fibroblasts from surgically resected lungs of patients with lung cancer and analyzed levels of GC-B mRNA transcription.", {"entities": [[183, 194, "DISEASE"], [188, 194, "DISEASE"], [36, 39, "GENE"]]}], ["CNP reduced mRNA levels of the profibrotic cytokines interleukin (IL)-1\u03b2 and IL-6, as well as collagen deposition and the fibrotic area in lungs of mice with bleomycin-induced pulmonary fibrosis.", {"entities": [[176, 194, "DISEASE"], [0, 3, "GENE"]]}], ["Furthermore, similar CNP effects were observed in transgenic mice exhibiting fibroblast-specific CNP overexpression.", {"entities": [[21, 24, "GENE"], [97, 100, "GENE"], [21, 24, "GENE"], [97, 100, "GENE"]]}], ["In cultured-lung fibroblasts, CNP treatment attenuated TGF-\u03b2\u2013induced phosphorylation of Smad2 and increased mRNA and protein expression of \u03b1-smooth muscle actin and SM22\u03b1, indicating that CNP suppresses fibroblast differentiation into myofibroblasts.", {"entities": [[30, 33, "GENE"], [188, 191, "GENE"], [88, 93, "GENE"], [30, 33, "GENE"], [188, 191, "GENE"]]}], ["Furthermore, human lung fibroblasts from patients with or without interstitial lung disease substantially expressed GC-B receptor mRNA.", {"entities": [[66, 91, "DISEASE"], [79, 91, "DISEASE"]]}], ["These data suggest that CNP ameliorates bleomycin-induced pulmonary fibrosis by suppressing TGF-\u03b2 signaling and myofibroblastic differentiation in lung fibroblasts.", {"entities": [[58, 76, "DISEASE"], [24, 27, "GENE"]]}], ["Therefore, we propose consideration of CNP for clinical application to pulmonary fibrosis treatment.", {"entities": [[71, 89, "DISEASE"], [39, 42, "GENE"]]}], ["Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental and occupational toxicants, which are a major human health concern in the U.S. and abroad.", {"entities": []}], ["Previous research has focused on the genotoxic events caused by high molecular weight PAHs, but not on non-genotoxic events elicited by low molecular weight PAHs.", {"entities": []}], ["We used an isomeric pair of low molecular weight PAHs, namely 1-Methylanthracene (1-MeA) and 2-Methylanthracene (2-MeA), in which only 1-MeA possessed a bay-like region, and hypothesized that 1-MeA, but not 2-MeA, would affect non-genotoxic endpoints relevant to tumor promotion in murine C10 lung cells, a non-tumorigenic type II alveolar pneumocyte and progenitor cell type of lung adenocarcinoma.", {"entities": [[384, 398, "DISEASE"], [379, 398, "DISEASE"]]}], ["The non-genotoxic endpoints assessed were dysregulation of gap junction intercellular communication function and changes in the major pulmonary connexin protein, connexin 43, using fluorescent redistribution and immunoblots, activation of mitogen activated protein kinases (MAPK) using phosphospecific MAPK antibodies for immunoblots, and induction of inflammatory genes using quantitative RT-PCR.", {"entities": []}], ["2-MeA had no effect on any of the endpoints, but 1-MeA dysregulated gap junctional communication in a dose and time dependent manner, reduced connexin 43 protein expression, and altered membrane localization.", {"entities": []}], ["1-MeA also activated ERK1/2 and p38 MAP kinases.", {"entities": []}], ["Inflammatory genes, such as cyclooxygenase 2, and chemokine ligand 2 (macrophage chemoattractant 2), were also upregulated in response to 1-MeA only.", {"entities": []}], ["These results indicate a possible structure-activity relationship of these low molecular weight PAHs relevant to non-genotoxic endpoints of the promoting aspects of cancer.", {"entities": [[165, 171, "DISEASE"]]}], ["Therefore, our novel findings may improve the ability to predict outcomes for future studies with additional toxicants and mixtures, identify novel targets for biomarkers and chemotherapeutics, and have possible implications for future risk assessment for these PAHs.", {"entities": []}], ["Pre-event Quality of Life (QOL) reflects the true social circumstances in which people live prior to the onset of myocardial infarctions.", {"entities": []}], ["It is believed to be a predictor of the post-event QOL.", {"entities": []}], ["The aim of this study was to describe the pre-event QOL and its influence on the post-event Quality of Life among patients with ST elevation (STEMI) and Non-ST elevation myocardial infarctions (NSTEMI) using Short Form-36 (SF-36), a generic QOL tool with 8 domains.", {"entities": []}], ["Documented literature is rare in this regard in Sri Lanka, which is a lower-middle-income country.", {"entities": []}], ["A cross-sectional study with a 28-day post-discharge follow-up was carried out in 13 hospitals.", {"entities": []}], ["Three hundred and forty-four patients who were diagnosed with STEMI or NSTEMI were recruited during the hospital stay.", {"entities": []}], ["The pre-event QOL was measured using an interviewer-administered questionnaire which included the SF-36 QOL tool and medical details.", {"entities": []}], ["Follow-up QOL was gathered using a questionnaire that was filled and posted back by participants.", {"entities": []}], ["Of the recruited sample, 235 responded for the follow-up component.", {"entities": []}], ["Analysis was conducted for associations between pre- and post-discharge QOL.", {"entities": []}], ["Furthermore, comparisons were made between the STEMI and NSTEMI groups.", {"entities": []}], ["Mann Whiney U test, Wilcoxon signed rank test and chi square test were used in the analysis.", {"entities": []}], ["The post-event QOL was lower in seven out of eight domains than the pre-event QOL ( p \u00a0<\u00a00.05).", {"entities": []}], ["The NSTEMI group had more risk factors and a significantly lower pre-event QOL for seven domains ( p \u00a0<\u00a00.05), when compared to the STEMI group.", {"entities": []}], ["For seven domains, the post-discharge QOL was not significantly different ( p \u00a0>\u00a00.05) between the STEMI and NSTEMI groups.", {"entities": []}], ["Post-discharge general-health QOL domain score was higher than the pre-MI score ( p \u00a0=\u00a00.028) and was higher in the STEMI group compared to the NSTEMI group ( p \u00a0=\u00a00.042).", {"entities": []}], ["Regression analysis showed a significant beta coefficient between pre- and post-QOL for five domains in STEMI and for all domains in NSTEMI groups when adjusted for the disease severity.", {"entities": []}], ["The R square values ranged from 12.3 to 62.3% for STEMI and 7.3 to 64.8% for NSTEMI.", {"entities": []}], ["Pre-event QOL is lower in the NSTEMI group compared to the STEMI group.", {"entities": []}], ["Patients do not regain the previous QOL within one month post-discharge.", {"entities": []}], ["Post-discharge QOL can be predicted by the pre-event QOL for most domains.", {"entities": []}], ["Diabetes has already become a threat to the nation and the individual due to its high prevalence rates and high medical expenses.", {"entities": []}], ["Therefore, preventing diabetes at an earlier stage is very important.", {"entities": []}], ["Despite advances in antidiabetic agents, we have not yet achieved any satisfying results in treating diabetes.", {"entities": []}], ["Among various treatments, medicinal herbs and supplements for diabetes are reported to show generally good efficacy and safety data.", {"entities": []}], ["In particular, PURIAM110, a compound from orange fruits and mulberry leaves, is supposed to prevent the progress of type II diabetes mellitus and improve diabetic symptoms.", {"entities": [[124, 141, "DISEASE"]]}], ["This is the first reported pilot study about the protective effect of the orange fruits and mulberry leaves mixture against pre-diabetes on Korean adults.", {"entities": []}], ["Based on these positive results of herb-derived components, extended studies of dietary supplements have to be done to suggest confirmative evidences.", {"entities": []}], ["The efficacy and safety study of PURIAM110 is a double-blinded, placebo-controlled, randomized, and multi-center clinical trial.", {"entities": []}], ["A total of 45 subjects will participate in this study for 6 weeks.", {"entities": []}], ["The present protocol will confirm the efficacy and safety of PURIAM110 for pre-diabetes, suggesting more basic knowledge to conduct further randomized controlled trials (RCT).", {"entities": []}], ["In addition, PURIAM110 can be an alternative dietary supplemental remedy for diabetes patients.", {"entities": []}], ["ISRCTN: ISRCTN44779824", {"entities": []}], ["Recent studies have shown that adverse drug reactions (ADRs) are underreported.", {"entities": []}], ["This may be particularly true of ADRs associated with complementary and alternative medicine (CAM).", {"entities": []}], ["Data on CAM-related ADRs, however, are sparse.", {"entities": []}], ["Objective was to evaluate the impact of an educational intervention and monitoring programme designed to improve physician reporting of ADRs in a primary care setting.", {"entities": []}], ["A prospective multicentre study with 38 primary care practitioners specialized in CAM was conducted from January 2004 through June 2007.", {"entities": []}], ["After 21 month all physicians received an educational intervention in terms of face-to-face training to assist them in classifying and reporting ADRs.", {"entities": []}], ["The study centre monitored the quantity and quality of ADR reports and analysed the results.", {"entities": []}], ["To measure changes in the ADR reporting rate, the median number of ADR reports and interquartile range (IQR) were calculated before and after the educational intervention.", {"entities": []}], ["The pre-intervention and post-intervention quality of the reports was assessed in terms of changes in the completeness of data provided for obligatory items.", {"entities": []}], ["Interrater reliability between the physicians and the study centre was calculated using Cohen's kappa with a 95% confidence interval (CI).", {"entities": []}], ["We used Mann Whitney U-test for testing continuous data and chi-square test was used for categorical data.", {"entities": []}], ["The level of statistical significance was set at P < 0.05.", {"entities": []}], ["A total of 404 ADRs were reported during the complete study period.", {"entities": []}], ["An initial 148% increase ( P = 0.001) in the number of ADR reports was observed after the educational intervention.", {"entities": []}], ["Compared to baseline the postinterventional number of ADR reportings was statistically significant higher (P < 0.005) through the first 16 months after the intervention but not significant in the last 4-month period (median: 8.00 (IQR [2.75; 8.75]; P = 0.605).", {"entities": []}], ["The completeness of the ADR reports increased from 80.3% before to 90.7% after the intervention.", {"entities": []}], ["The completeness of the item for classifying ADRs as serious or non-serious increased significantly ( P < 0.001) after the educational intervention.", {"entities": []}], ["The quality of ADR reports increased from kappa 0.15 (95% CI: 0.08; 0.29) before to 0.43 (95% CI: 0.23; 0.63) after the intervention.", {"entities": []}], ["The results of the present study demonstrate that an educational intervention can increase physician awareness of ADRs.", {"entities": []}], ["Participating physicians were able to incorporate the knowledge they had gained from face-to-face training into their daily clinical practice.", {"entities": []}], ["However, the effects of the intervention were temporary.", {"entities": []}], ["Data for earthquake-related alterations in physique among young children in developed countries is lacking.", {"entities": []}], ["The Great East Japan Earthquake caused severe damage in Iwate, Miyagi, and Fukushima Prefectures in northeastern Japan.", {"entities": []}], ["We retrospectively obtained anthropometric measurements in nursery school from 40,046 (cohort 1, historical control) and 53,492 (cohort 2) children aged 3.5\u20134.5 years without overweight in October 2008, and in October 2010, respectively.", {"entities": []}], ["At the time of the earthquake in March, 2011, children in cohort 1 had already graduated from nursery school; however, children in cohort 2 were still enrolled in nursery school at this time.", {"entities": []}], ["We compared the onset of overweight at 1 year after the baseline between children enrolled in their school located in one of the three target prefectures versus those in other prefectures using a logistic regression model, with adjustment for sex, age, history of disease, and obesity index at baseline.", {"entities": [[277, 284, "DISEASE"]]}], ["Overweight was defined as an obesity index of >+15%, which was calculated as (weight minus sex- and height-specific standard weight)/sex- and height-specific standard weight.", {"entities": [[29, 36, "DISEASE"]]}], ["The odds ratio (OR) for the onset of overweight in the three target prefectures was significant in cohort 2 (OR 1.25; 95% confidence interval [CI], 1.01\u20131.55) but not in cohort 1.", {"entities": []}], ["When the two cohort were pooled (n\u00a0=\u00a093,538), the OR of the interaction term for school location\u00a0\u00d7\u00a0cohort was significant (OR 1.56; 95% CI, 1.09\u20132.23).", {"entities": []}], ["Incident overweight in young children was significantly more common in the three prefectures affected by the Great East Japan Earthquake than in other prefectures after the disaster.", {"entities": []}], ["\u2022 We obtained anthropometric data from 93,538 children aged 3.5\u20134.5 years.", {"entities": []}], ["\u2022 Anthropometric data were measured before and after the Great East Japan Earthquake.", {"entities": []}], ["\u2022 We compared the data in Iwate, Miyagi, and Fukushima vs. the other prefectures.", {"entities": []}], ["\u2022 Incident overweight was higher in the three prefectures than the other prefectures.", {"entities": []}], ["We obtained anthropometric data from 93,538 children aged 3.5\u20134.5 years.", {"entities": []}], ["Anthropometric data were measured before and after the Great East Japan Earthquake.", {"entities": []}], ["We compared the data in Iwate, Miyagi, and Fukushima vs. the other prefectures.", {"entities": []}], ["Incident overweight was higher in the three prefectures than the other prefectures.", {"entities": []}], ["Health-Related Quality of Life (HRQOL) has received much attention in recent years.", {"entities": []}], ["HRQOL indicators have been used to track population trends, identify health disparities, and monitor progress in achieving national health objectives for 2010.", {"entities": []}], ["Prior studies have examined health risks and HRQOL at the national level as well as at the state level.", {"entities": []}], ["This paper examines multiple indicators of HRQOL by demographic characteristics and selected health behaviors for Rhode Island adults.", {"entities": []}], ["Data from Rhode Island's 2002 Behavioral Risk Factor Surveillance System (BRFSS), a random digit dialled telephone survey, were used for this study.", {"entities": []}], ["The state wide sample contained a total of 3,843 respondents ages 18 and older.", {"entities": []}], ["Multiple Imputation (MI) was applied to handle missing data, and data were modelled for each of 10 HRQOL indicators using multivariable logistic regression.", {"entities": []}], ["By examining HRQOL through a multivariable approach we identified the strongest predictors for multiple indicators of poor HRQOL as well as predictors for specific indicators of poor HRQOL.", {"entities": []}], ["Predictors for multiple indicators of poor HRQOL were: disability, inability to work, unemployment, lower income, lack of exercise, asthma, and smoking (specifically associated with poor mental health).", {"entities": [[132, 138, "DISEASE"]]}], ["Using multiple measures of HRQOL can help to assess the burden of poor health in a population, identify subgroups with unmet HRQOL needs, inform the development of targeted interventions, and monitor changes in a population's HRQOL over time.", {"entities": []}], ["Use of these HRQOL measures in longitudinal and intervention studies is needed to increase our understanding of the causal relationships between demographics, health risk behaviors, and HRQOL.", {"entities": []}], ["Fine particulate matter [aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 )] has been associated with autonomic dysregulation.", {"entities": []}], ["We hypothesized that PM 2.5 influences postural changes in systolic blood pressure (\u0394SBP) and in diastolic blood pressure (\u0394DBP) and that this effect is modified by genes thought to be related to chronic lung disease.", {"entities": [[204, 216, "DISEASE"]]}], ["We measured blood pressure in participants every 3\u20135 years.", {"entities": []}], ["\u0394SBP and \u0394DBP were calculated as sitting minus standing SBP and DBP.", {"entities": [[64, 67, "GENE"]]}], ["We averaged PM 2.5 over 48 hr before study visits and analyzed 202 single nucleotide polymorphisms (SNPs) in 25 genes.", {"entities": [[27, 29, "GENE"]]}], ["To address multiple comparisons, data were stratified into a split sample.", {"entities": []}], ["In the discovery cohort, the effects of SNP \u00d7 PM 2.5 interactions on \u0394SBP and \u0394DBP were analyzed using mixed models with subject-specific random intercepts.", {"entities": []}], ["We defined positive outcomes as p < 0.1 for the interaction; we analyzed only these SNPs in the replicate cohort and confirmed them if p < 0.025 with the same sign.", {"entities": []}], ["Confirmed associations were analyzed within the full cohort in models adjusted for anthropometric and lifestyle factors.", {"entities": []}], ["Nine hundred forty-five participants were included in our analysis.", {"entities": []}], ["One interaction with rs9568232 in PHD finger protein 11 ( PHF11 ) was associated with greater \u0394DBP.", {"entities": [[58, 63, "GENE"]]}], ["Interactions with rs1144393 in matrix metalloprotease 1 ( MMP1 ) and rs16930692, rs7955200, and rs10771283 in inositol 1,4,5-triphosphate receptor, type 2 ( ITPR2 ) were associated with significantly greater \u0394SBP.", {"entities": [[58, 62, "GENE"], [157, 162, "GENE"]]}], ["Because SNPs associated with \u0394SBP in our analysis are in genes along the renin\u2013angiotensin pathway, we then examined medications affecting that pathway and observed significant interactions for angiotensin receptor blockers but not angiotensin-converting enzyme inhibitors with PM 2.5 .", {"entities": []}], ["PM 2.5 influences blood pressure and autonomic function.", {"entities": []}], ["This effect is modified by genes and drugs that also act along this pathway.", {"entities": []}], ["Since most clinical guidelines address single diseases, treatment of patients with multimorbidity, the co-occurrence of multiple (chronic) diseases within one person, can become complicated.", {"entities": []}], ["Information on highly prevalent combinations of diseases can set the agenda for guideline development on multimorbidity.", {"entities": []}], ["With this systematic review we aim to describe the prevalence of disease combinations (i.e.", {"entities": []}], ["disease clusters) in older patients with multimorbidity, as assessed in available studies.", {"entities": []}], ["In addition, we intend to acquire information that can be supportive in the process of multimorbidity guideline development.", {"entities": []}], ["We searched MEDLINE, Embase and the Cochrane Library for all types of studies published between January 2000 and September 2012.", {"entities": []}], ["We included empirical studies focused on multimorbidity or comorbidity that reported prevalence rates of combinations of two or more diseases.", {"entities": []}], ["Our search yielded 3070 potentially eligible articles, of which 19 articles, representing 23 observational studies, turned out to meet all our quality and inclusion criteria after full text review.", {"entities": []}], ["These studies provided prevalence rates of 165 combinations of two diseases (i.e.", {"entities": []}], ["disease pairs).", {"entities": []}], ["Twenty disease pairs, concerning 12 different diseases, were described in at least 3 studies.", {"entities": []}], ["Depression was found to be the disease that was most commonly clustered, and was paired with 8 different diseases, in the available studies.", {"entities": []}], ["Hypertension and diabetes mellitus were found to be the second most clustered diseases, both with 6 different diseases.", {"entities": [[0, 12, "DISEASE"], [17, 34, "DISEASE"]]}], ["Prevalence rates for each disease combination varied considerably per study, but were highest for the pairs that included hypertension, coronary artery disease, and diabetes mellitus.", {"entities": [[122, 134, "DISEASE"], [165, 182, "DISEASE"]]}], ["Twenty disease pairs were assessed most frequently in patients with multimorbidity.", {"entities": []}], ["These disease combinations could serve as a first priority setting towards the development of multimorbidity guidelines, starting with the diseases with the highest observed prevalence rates and those with potential interacting treatment plans.", {"entities": []}], ["Acute viral infection causes damages to the host due to uncontrolled viral replication but even replication deficient viral vectors can induce systemic inflammatory responses.", {"entities": []}], ["Indeed, overactive host innate immune responses to viral vectors have led to devastating consequences.", {"entities": []}], ["Macrophages are important innate immune cells that recognize viruses and induce inflammatory responses at the early stage of infection.", {"entities": []}], ["However, tissue resident macrophages are not easily activated by the mere presence of virus suggesting that their activation requires additional signals from other cells in the tissue in order to trigger inflammatory responses.", {"entities": []}], ["Previously, we have shown that the cross-talk between epithelial cells and macrophages generates synergistic inflammatory responses during adenoviral vector infection.", {"entities": []}], ["Here, we investigated whether ATP is involved in the activation of macrophages to induce inflammatory responses during an acute adenoviral infection.", {"entities": []}], ["Using a macrophage-epithelial cell co-culture system we demonstrated that ATP signaling through P2X 7 receptor (P2X 7 R) is required for induction of inflammatory mediators.", {"entities": []}], ["We also showed that ATP-P2X 7 R signaling regulates inflammasome activation as inhibition or deficiency of P2X 7 R as well as caspase-1 significantly reduced IL-1\u03b2 secretion.", {"entities": []}], ["Furthermore, we found that intranasal administration of replication deficient adenoviral vectors in mice caused a high mortality in wild-type mice with symptoms of acute respiratory distress syndrome but the mice deficient in P2X 7 R or caspase-1 showed increased survival.", {"entities": [[191, 199, "DISEASE"]]}], ["In addition, wild-type mice treated with apyrase or inhibitors of P2X 7 R or caspase-1 showed higher rates of survival.", {"entities": []}], ["The improved survival in the P2X 7 R deficient mice correlated with diminished levels of IL-1\u03b2 and IL-6 and reduced neutrophil infiltration in the early phase of infection.", {"entities": []}], ["These results indicate that ATP, released during viral infection, is an important inflammatory regulator that activates the inflammasome pathway and regulates inflammatory responses.", {"entities": []}], ["PU.1 is a hematopoietic cell-specific transcription factor.", {"entities": []}], ["In the current study, we investigated the role of PU.1 in the gene expression and the function of mouse mast cells (MCs) in vitro and in vivo .", {"entities": []}], ["When PU.1 siRNA was introduced into bone marrow-derived MCs (BMMCs), IgE-mediated activation was reduced, and the Syk and Fc\u03b5RI\u03b2 mRNA levels were significantly decreased.", {"entities": [[114, 117, "GENE"]]}], ["As the regulatory mechanism of the Syk gene is largely unknown, we performed promoter analysis and found that PU.1 transactivated the Syk promoter through direct binding to a cis -element in the 5\u2032-untranslated region.", {"entities": [[35, 38, "GENE"], [134, 137, "GENE"], [35, 38, "GENE"], [134, 137, "GENE"]]}], ["The involvement of PU.1 in the Syk promoter was also observed in mouse dendritic cells and human MCs, suggesting that the relationship between PU.1 and Syk is common in mammals and in hematopoietic lineages.", {"entities": [[31, 34, "GENE"], [152, 155, "GENE"], [31, 34, "GENE"], [152, 155, "GENE"]]}], ["When antigen was administrated intravenously after the transfusion of siRNA-transfected BMMCs in the mouse footpad, the footpad thickening was significantly suppressed by PU.1 knockdown.", {"entities": []}], ["Finally, administration of the immunomodulator pomalidomide suppressed passive systemic anaphylaxis of mice.", {"entities": []}], ["Taken together, these results indicate that PU.1 knockdown might be an efficacious strategy for the prevention of MC-mediated allergic diseases.", {"entities": []}], ["The prevention of overweight and obesity during infancy is a highly relevant public health topic given the significant impact of childhood obesity on acute and chronic diseases, general health, and well-being in later stages of life.", {"entities": [[33, 40, "DISEASE"], [139, 146, "DISEASE"]]}], ["Apart from the family setting, daycare facilities (DFs) represent a key setting for health promotion among children under the age of six years.", {"entities": []}], ["\u201cJolinchenKids \u2013 Fit and Healthy in Daycare\u201d is a multi-component program promoting physical activity (PA), healthy eating, and mental well-being in 3- to 6-year-old preschoolers at DFs, originally designed by the German health insurance AOK.", {"entities": []}], ["To evaluate program effectiveness, a cluster-controlled trial involving 68 DFs is currently conducted.", {"entities": []}], ["The objective of this article is to describe the background, study design, and aims of this trial.", {"entities": []}], ["Sixty-eight DFs across Germany will be recruited to take part in the study, half of them serving as intervention DFs and half of them as delayed intervention control DFs (which receive the program upon completion of the study).", {"entities": []}], ["At each DF, height, weight, and body composition, as well as motor skills, will be assessed in twenty 3- to 6-year-old children.", {"entities": []}], ["Children\u2019s eating and PA habits, and mental well-being will be assessed via parental questionnaires.", {"entities": []}], ["A subsample of children (i.e., at 24 DFs which are randomly selected within a geographic region) will be asked to wear accelerometers at their wrists to objectively measure PA over the course of seven days.", {"entities": []}], ["To compare changes in body composition, motor skills, eating and PA habits, and mental well-being of children at intervention DFs with those observed among children at delayed intervention control DFs over one year, all measurements will take place at baseline and twelve months after the launch of the program at all DFs.", {"entities": []}], ["This study investigates the influence of a health promotion program in the daycare setting on various outcomes, including body composition and objectively measured PA, in a nationwide sample of 3- to 6-year-old preschoolers.", {"entities": []}], ["This study will provide evidence regarding the effectiveness of a multi-component program for health promotion in this setting and may provide insights into new strategies for preventing obesity in early life.", {"entities": [[187, 194, "DISEASE"]]}], ["German Clinical Trials Register DRKS00011065 (Date of registration 16\u201309-2016).", {"entities": []}], ["Diabetic kidney disease (DKD) is a widespread chronic microvascular complication of diabetes mellitus (DM), affects almost 30\u201350% of patients, and represents a leading cause of death of DM.", {"entities": [[9, 23, "DISEASE"], [84, 101, "DISEASE"]]}], ["Serotonin or 5-hydroxytryptamine (5-HT) is a multifunctional bioamine that has crucial roles in many physiological pathways.", {"entities": []}], ["Recently, emerging evidence from experimental and clinical studies has demonstrated that 5-HT is involved in the pathogenesis of diabetic vascular complications.", {"entities": []}], ["The 5-HT receptor (5-HTR) antagonists exert renoprotective effects by suppressing oxidative stress, suggesting that 5-HTR can be used as a potential target for treating DKD.", {"entities": []}], ["In this review, therefore, we summarize the published information available for the involvement of 5-HT and 5-HTR antagonists in the pathogenesis of various diabetic complications with a particular focus of DKD.", {"entities": []}], ["We conclude that 5-HTR is a potential therapeutic target for treating DKD, as it has been successfully applied in animal models and has currently being investigated in randomized and controlled clinical trials.", {"entities": []}], ["While research on school children's health has mainly focused on risk factors and illness, few studies have examined aspects of health promotion.", {"entities": []}], ["Thus, this study focuses on health promotional factors including general self-efficacy (GSE) and health-related quality of life (HRQOL).", {"entities": []}], ["GSE refers to a global confidence in coping ability across a wide range of demanding situations, and is related to health.", {"entities": []}], ["The purpose of this study was to examine associations between GSE and HRQOL, and associations between HRQOL and socio-demographic characteristics.", {"entities": []}], ["Knowledge of these associations in healthy school children is currently lacking.", {"entities": []}], ["During 2006 and 2007, 279 school children in the seventh grade across eastern Norway completed a survey assessing their GSE and HRQOL.", {"entities": []}], ["The children were from schools that had been randomly selected using cluster sampling.", {"entities": []}], ["T-tests were computed to compare mean subscale values between HRQOL and socio-demographic variables.", {"entities": []}], ["Single and multiple regression analyses were performed to explore associations among GSE, HRQOL and socio-demographic variables.", {"entities": []}], ["Regression analyses showed a significant relationship between increasing degrees of GSE and increasing degrees of HRQOL.", {"entities": []}], ["In analyses adjusted for socio-demographic variables, boys scored higher than girls on self-esteem.", {"entities": []}], ["School children from single-parent families had lower scores on HRQOL than those from two-parent families, and children who had relocated within the last five years had lower scores on HRQOL than those who had not relocated.", {"entities": []}], ["The strong relationship between GSE and HRQOL indicates that GSE might be a resource for increasing the HRQOL for school children.", {"entities": []}], ["Interest in the health effects of extremely low/high ambient temperature and the diurnal temperature range (DTR) on mortality as representative indices of temperature variability is growing.", {"entities": []}], ["Although numerous studies have reported on these indices independently, few studies have provided the attributes of ambient temperature and DTR related to mortality, concurrently.", {"entities": []}], ["In this study, we aimed to investigate and compare the mortality risk attributable to ambient temperature and DTR.", {"entities": []}], ["The study included data of 63 cities in five East-Asian countries/regions during various periods between 1972 and 2013.", {"entities": []}], ["The attributable risk of non-accidental death to ambient temperature was 9.36% (95% confidence interval [CI]: 8.98\u20139.69%) and to DTR was 0.59% (95% CI: 0.53\u20130.65%).", {"entities": []}], ["The attributable cardiovascular mortality risks to ambient temperature (15.63%) and DTR (0.75%) are higher than the risks to non-accidental/respiratory-related mortality.", {"entities": []}], ["We verified that ambient temperature plays a larger role in temperature-associated mortality, and cardiovascular mortality is susceptible to ambient temperature and DTR.", {"entities": []}], ["\u2022 Effects on immunobiochemical pathways of TiO 2 materials were investigated in vitro .", {"entities": []}], ["\u2022 TiO 2 bulk and nanomaterial stimulated neopterin production in human PBMC.", {"entities": []}], ["\u2022 There was no stimulatory influence of particles on tryptophan breakdown.", {"entities": []}], ["\u2022 At high particles concentrations, tryptophan breakdown was suppressed.", {"entities": []}], ["\u2022 Results suggest that the total effect of particles is even stronger pro-inflammatory.", {"entities": []}], ["Effects on immunobiochemical pathways of TiO 2 materials were investigated in vitro .", {"entities": []}], ["TiO 2 bulk and nanomaterial stimulated neopterin production in human PBMC.", {"entities": []}], ["There was no stimulatory influence of particles on tryptophan breakdown.", {"entities": []}], ["At high particles concentrations, tryptophan breakdown was suppressed.", {"entities": []}], ["Results suggest that the total effect of particles is even stronger pro-inflammatory.", {"entities": []}], ["Nanomaterials are increasingly produced and used throughout recent years.", {"entities": []}], ["Consequently the probability of exposure to nanoparticles has risen.", {"entities": []}], ["Because of their small 1\u2013100\u00a0nm size, the physicochemical properties of nanomaterials may differ from standard bulk materials and may pose a threat to human health.", {"entities": []}], ["Only little is known about the effects of nanoparticles on the human immune system.", {"entities": []}], ["In this study, we investigated the effects of TiO 2 nanoparticles and bulk material in the in vitro model of human peripheral blood mononuclear cells (PBMC) and cytokine-induced neopterin formation and tryptophan breakdown was monitored.", {"entities": []}], ["Both biochemical processes are closely related to the course of diseases like infections, atherogenesis and neurodegeneration.", {"entities": []}], ["OCTi60 (25\u00a0nm diameter) TiO 2 nanoparticles and bulk material increased neopterin production in unstimulated PBMC and stimulated cells significantly, the effects were stronger for OCTi60 compared to bulk material, while P25 TiO 2 (25\u00a0nm diameter) nanoparticles had only little influence.", {"entities": []}], ["No effect of TiO 2 nanoparticles on tryptophan breakdown was detected in unstimulated cells, whereas in stimulated cells, IDO activity and IFN-\u03b3 production were suppressed but only at the highest concentrations tested.", {"entities": []}], ["Because neopterin was stimulated and tryptophan breakdown was suppressed in parallel, data suggests that the total effect of particles would be strongly pro-inflammatory.", {"entities": []}], ["Prior microrheologic assessments of selected, microlitre plugs of cystic fibrosis (CF) sputum suggest no intrinsic rheologic abnormality.", {"entities": [[66, 81, "DISEASE"]]}], ["However, such analyses may not be representative of CF sputum as a whole.", {"entities": []}], ["We therefore reassessed this question using whole sputum macrorheology.", {"entities": []}], ["Additionally, we wished to further explore the relationships between sputum rheology, inflammation and infection.", {"entities": []}], ["Dynamic oscillatory macrorheometry was performed on whole expectorated sputum from stable adults with CF (n = 18) and COPD (n = 12) and induced sputum from normal controls (n = 7).", {"entities": []}], ["Concomitant sputum inflammatory mediator levels were measured in CF and COPD samples.", {"entities": []}], ["Sputum collected from CF subjects (n = 6) at commencement and completion of intravenous antibiotic therapy for an infective exacerbation was also assessed.", {"entities": []}], ["CF sputum neutrophil elastase activity (NE) was significantly related to degree of sputum purulence (p = 0.049) and correlated significantly with measures of sputum viscoelasticity (r = 0.696, p = 0.008 for storage modulus G' at 9 Hz).", {"entities": []}], ["There were significant differences in viscoelasticity between subject groups when samples were compared irrespective of appearance/degree of sputum purulence.", {"entities": []}], ["However, the macrorheology of mucoid CF sputum did not differ from normal sputum (eg median (range) G' at 9 Hz 2.25 (0.79, 3.26) vs 2.04 (1.4,4.6) Pa, p = 1).", {"entities": []}], ["In contrast, mucoid COPD samples demonstrated significantly greater viscoelasticity (G' at 9 Hz 4.5 (2.4, 23) Pa) than sputum from both CF (p = 0.048) & normal subjects (p = 0.009).", {"entities": []}], ["Antibiotic therapy during exacerbations was associated with significant reductions in CF sputum viscoelasticity, with mean (SD) G' at 9 Hz decreasing from 28.5 (11.5) Pa at commencement to 6.4 (4.6) Pa on day 7 (p = 0.01).", {"entities": []}], ["The macrorheologic properties of whole, mucoid CF sputum are not different from normal, confirming the results of prior microrheologic studies.", {"entities": []}], ["Instead, CF sputum viscoelasticity is related to secondary infection, decreases with intravenous antibiotic therapy and correlates with inflammation.", {"entities": []}], ["In contrast, COPD sputum demonstrates inherently greater viscoelasticity, providing a novel target for potential therapeutic interventions.", {"entities": []}], ["Background: Until now, cytokine-induced killer (CIK) cells were assumed to be part of the type I natural killer T (NKT) cell population, but it was not yet investigated if this is correct.", {"entities": []}], ["Methods: For analysis, CIK cells were generated by various culture conditions.", {"entities": []}], ["Human type I NKT cells express a T cell receptor (TCR) composed of an invariant V\u03b124-J\u03b1Q chain combined with one of several V\u03b2 chains.", {"entities": []}], ["The V\u03b124 is a reliable marker for the presence of these TCRs.", {"entities": []}], ["Results: While comparing cultures stimulated with different substances, we observed the lack of any V\u03b124 on the surface of CIK culture cells.", {"entities": []}], ["Conclusion: We conclude that CIK cells do not belong to the type I NKT cells.", {"entities": []}], ["Despite a large amount of microRNAs (miRNAs) have been validated to play crucial roles in human biology and disease, there is little systematic insight into the nature and scale of the potential synergistic interactions executed by miRNAs themselves.", {"entities": []}], ["Here we established an integrated parameter synergy score to determine miRNA synergy, by combining the two mechanisms for miRNA-miRNA interactions, miRNA-mediated gene co-regulation and functional association between target gene products, into one single parameter.", {"entities": []}], ["Receiver operating characteristic (ROC) analysis indicated that synergy score accurately identified the gene ontology-defined miRNA synergy (AUC\u200a=\u200a0.9415, p <0.001).", {"entities": []}], ["Only a very small portion of the random miRNA-miRNA combinations generated potent synergy, implying poor expectancy of widespread synergy.", {"entities": []}], ["However, targeting more key genes made two miRNAs more likely to act synergistically.", {"entities": []}], ["Compared to other miRNAs, miR-21 was a highly exceptional case due to frequent appearance in the top synergistic miRNA pairs.", {"entities": [[26, 32, "GENE"]]}], ["This result highlighted its essential role in coordinating or strengthening physiological and pathological functions of other miRNAs.", {"entities": []}], ["The synergistic effect of miR-21 and miR-1 were functionally validated for their significant influences on myocardial apoptosis, cardiac hypertrophy and fibrosis.", {"entities": [[26, 32, "GENE"]]}], ["The novel approach established in this study enables easy and effective identification of condition-restricted potent miRNA synergy simply by concentrating the available protein interactomics and miRNA-target interaction data into a single parameter synergy score.", {"entities": []}], ["Our results may be important for understanding synergistic gene regulation by miRNAs and may have significant implications for miRNA combination therapy of cardiovascular disease.", {"entities": []}], ["Supported self-management for asthma helps people adjust their treatment in response to symptom changes.", {"entities": [[30, 36, "DISEASE"]]}], ["This improves day-to-day control and reduces the risk of asthma attacks and the need for emergency healthcare.", {"entities": [[57, 63, "DISEASE"]]}], ["However, implementation remains poor in routine clinical practice.", {"entities": []}], ["This systematic review is part of a programme of work developing an intervention to help primary care practice teams embed self-management support into routine asthma care.", {"entities": [[160, 166, "DISEASE"]]}], ["The aim of the review is to synthesise the evidence regarding the effectiveness of educational interventions for professionals supporting self-management in people with asthma or diabetes (type 1 and type 2).", {"entities": [[169, 175, "DISEASE"]]}], ["These two conditions have the most robust evidence base for the effectiveness of implementing supported self-management.", {"entities": []}], ["Electronic searches will be conducted in CENTRAL, MEDLINE, EMBASE, ISI Web of Science, CINAHL, PsycINFO, AMED, Global Health, WHO Global Health Library, ERIC, BNI, RDRB/CME and Google Scholar.", {"entities": []}], ["Eligible studies are randomised controlled trials or controlled clinical trials published between 1990 and 2016 which evaluated professional education interventions facilitating asthma or diabetes supported self-management.", {"entities": [[178, 184, "DISEASE"]]}], ["Further relevant work will be identified from trial registries, citation searching and through contact with authors of included studies.", {"entities": []}], ["This will be supplemented by scoping potentially relevant educational packages described in English language policy literature or health service websites.", {"entities": []}], ["Screening, data extraction and risk of bias assessment (using the Cochrane Risk of Bias Tool) will be completed by two independent reviewers, with a third reviewer arbitrating where necessary.", {"entities": []}], ["We plan a theoretically informed narrative synthesis of the aggregated data as heterogeneity is likely to preclude meta-analysis.", {"entities": []}], ["Ethical approval is not required for this systematic review.", {"entities": []}], ["The results will be described in a paper submitted for peer-reviewed publication and will inform the development of an implementation intervention.", {"entities": []}], ["PROSPERO CRD42016032922.", {"entities": []}], ["Genome-wide association studies aim to correlate genotype with phenotype.", {"entities": []}], ["Many common diseases including Type II diabetes, Alzheimer\u2019s, Parkinson\u2019s and Chronic Obstructive Pulmonary Disease (COPD) are complex genetic traits with hundreds of different loci that are associated with varied disease risk.", {"entities": []}], ["Identifying common features in the genes associated with each disease remains a challenge.", {"entities": []}], ["Furthermore, the role of post-transcriptional regulation, and in particular alternative splicing, is still poorly understood in most multigenic diseases.", {"entities": []}], ["We therefore compiled comprehensive lists of genes associated with Type II diabetes, Alzheimer\u2019s, Parkinson\u2019s and COPD in an attempt to identify common features of their corresponding mRNA transcripts within each gene set.", {"entities": []}], ["The SERPINA1 gene is a well-recognized genetic risk factor of COPD and it produces 11 transcript variants, which is exceptional for a human gene.", {"entities": [[4, 12, "GENE"]]}], ["This led us to hypothesize that other genes associated with COPD, and complex disorders in general, are highly transcriptionally diverse.", {"entities": []}], ["We found that COPD-associated genes have a statistically significant enrichment in transcript complexity stemming from a disproportionately high level of alternative splicing, however, Type II Diabetes, Alzheimer\u2019s and Parkinson\u2019s disease genes were not significantly enriched.", {"entities": []}], ["We also identified a subset of transcriptionally complex COPD-associated genes (~40%) that are differentially expressed between mild, moderate and severe COPD.", {"entities": []}], ["Although the genes associated with other lung diseases are not extensively documented, we found preliminary data that idiopathic pulmonary disease genes, but not cystic fibrosis modulators, are also more transcriptionally complex.", {"entities": [[162, 177, "DISEASE"]]}], ["Interestingly, complex COPD transcripts are more often the product of alternative acceptor site usage.", {"entities": []}], ["To verify the biological importance of these alternative transcripts, we used RNA-sequencing analyses to determine that COPD-associated genes are frequently expressed in lung and liver tissues and are regulated in a tissue-specific manner.", {"entities": []}], ["Additionally, many complex COPD-associated genes are spliced differently between COPD and non-COPD patients.", {"entities": []}], ["Our analysis therefore suggests that post-transcriptional regulation, particularly alternative splicing, is an important feature specific to COPD disease etiology that warrants further investigation.", {"entities": []}], ["Increased levels of particulate air pollution are associated with increased respiratory and cardiovascular mortality and morbidity.", {"entities": []}], ["Some epidemiologic and toxicologic research suggests ultrafine particles (UFPs) (< 100 nm) to be more harmful per unit mass than larger particles.", {"entities": []}], ["Our study was aimed at a quantitative comparison of acute adverse effects of different types of carbonaceous UFPs at a dose range that causes a moderate inflammatory response in lungs.", {"entities": []}], ["We used six different particle types (primary particle size 10\u201350 nm, specific surface area 30\u2013800 m", {"entities": []}], ["Cell wall mycolic acids (MA) from Mycobacterium tuberculosis ( M.tb ) are CD1b presented antigens that can be used to detect antibodies as surrogate markers of active TB, even in HIV coinfected patients.", {"entities": [[48, 60, "DISEASE"], [74, 78, "GENE"]]}], ["The use of the complex mixtures of natural MA is complicated by an apparent antibody cross-reactivity with cholesterol.", {"entities": []}], ["Here firstly we report three recombinant monoclonal scFv antibody fragments in the chicken germ-line antibody repertoire, which demonstrate the possibilities for cross-reactivity: the first recognized both cholesterol and mycolic acids, the second mycolic acids but not cholesterol, and the third cholesterol but not mycolic acids.", {"entities": []}], ["Secondly, MA structure is experimentally interrogated to try to understand the cross-reactivity.", {"entities": []}], ["Unique synthetic mycolic acids representative of the three main functional classes show varying antigenicity against human TB patient sera, depending on the functional groups present and on their stereochemistry.", {"entities": []}], ["Oxygenated (methoxy- and keto-) mycolic acid was found to be more antigenic than alpha-mycolic acids.", {"entities": []}], ["Synthetic methoxy-mycolic acids were the most antigenic, one containing a trans -cyclopropane apparently being somewhat more antigenic than the natural mixture.", {"entities": []}], ["Trans -cyclopropane-containing keto- and hydroxy-mycolic acids were also found to be the most antigenic among each of these classes.", {"entities": []}], ["However, none of the individual synthetic mycolic acids significantly and reproducibly distinguished the pooled serum of TB positive patients from that of TB negative patients better than the natural mixture of MA.", {"entities": []}], ["This argues against the potential to improve the specificity of serodiagnosis of TB with a defined single synthetic mycolic acid antigen from this set, although sensitivity may be facilitated by using a synthetic methoxy-mycolic acid.", {"entities": []}], ["Prior studies reporting that bariatric surgery (including laparoscopic adjustable gastric band (LAGB) and [laparoscopic Roux-en-Y] Gastric Bypass (LRYGB)) is cost-saving relied on a comparison sample of those with a morbid obesity (MO) diagnosis code, a high cost group who may not be reflective of those who opt for the procedures.", {"entities": [[223, 230, "DISEASE"], [216, 230, "DISEASE"]]}], ["We re-estimate net costs and time to breakeven using an alternative sample that does not rely on this code.", {"entities": []}], ["Non-randomized case-control study using medical claims data from a commercial database in the USA.", {"entities": []}], ["LAGB and LRYGB claimants were propensity score matched to two control samples: one restricted to those with a MO diagnosis code and one without this restriction.", {"entities": []}], ["When using the MO sample, costs for LAGB and LRYGB are recovered in 1.5 (Confidence Interval [CI]: 1.45 to 1.55) and 2.25 years (CI: 2.07 to 2.43), and 5 year savings are $78,980 (CI: 62,320 to 100,550) for LAGB and $61,420 (CI: 44,710 to 82,870) for LRYGB.", {"entities": []}], ["Without the MO requirement, time to breakeven for LAGB increases to 5.25 (CI: 4.25 to 10+) years with a 5 year net cost of $690 (CI: 6,800 to 8.400).", {"entities": []}], ["For LRYGB, time to breakeven exceeds 10 years and 5 year net costs are $18,940 (CI: 10,390 to 26,740).", {"entities": []}], ["The net costs and time to breakeven resulting from bariatric surgery are likely less favorable than has been reported in prior studies, and especially for LRYGB, with a time to breakeven of more than twice the 5.25 year estimate for LAGB.", {"entities": []}], ["Lifestyles profoundly determine the quality of an individual\u2019s health and life since his childhood.", {"entities": []}], ["Many diseases in adulthood are avoidable if health-risk behaviors are identified and improved at an early stage of life.", {"entities": []}], ["The aim of the present research was to characterize a cohort of children aged 6\u20138 years selected in order to perform an epidemiological molecular study (the MAPEC_LIFE study), investigate lifestyles of the children that could have effect on their health status, and assess possible association between lifestyles and socio-cultural factors.", {"entities": []}], ["A questionnaire composed of 148 questions was administered in two different seasons to parents of children attending 18 primary schools in five Italian cities (Torino, Brescia, Pisa, Perugia and Lecce) to obtain information regarding the criteria for exclusion from the study, demographic, anthropometric and health information on the children, as well as some aspects on their lifestyles and parental characteristics.", {"entities": []}], ["The results were analyzed in order to assess the frequency of specific conditions among the different seasons and cities and the association between lifestyles and socio-economic factors.", {"entities": []}], ["The final cohort was composed of 1,164 children (50.9 boys, 95.4% born in Italy).", {"entities": []}], ["Frequency of some factors appeared different in terms of the survey season (physical activity in the open air, the ways of cooking certain foods) and among the various cities (parents\u2019 level of education and rate of employment, sport, traffic near the home, type of heating, exposure to passive smoking, ways of cooking certain foods).", {"entities": []}], ["Exposure to passive smoking and cooking fumes, obesity, residence in areas with heavy traffic, frequency of outdoor play and consumption of barbecued and fried foods were higher among children living in families with low educational and/or occupational level while children doing sports and consuming toasted bread were more frequent in families with high socio-economic level.", {"entities": [[47, 54, "DISEASE"]]}], ["The socio-economic level seems to affect the lifestyles of children enrolled in the study including those that could cause health effects.", {"entities": []}], ["Many factors are linked to the geographical area and may depend on environmental, cultural and social aspects of the city of residence.", {"entities": []}], ["Asthma is a chronic inflammatory disorder of the airway and is characterized by airway remodeling, hyperresponsiveness, and shortness of breath.", {"entities": [[0, 6, "DISEASE"]]}], ["Modified Kushen Gancao Formula (mKG), derived from traditional Chinese herbal medicines (TCM), has been demonstrated to have good therapeutic effects on experimental allergic asthma.", {"entities": [[166, 181, "DISEASE"], [175, 181, "DISEASE"]]}], ["However, its anti-asthma mechanism remains currently unknown.", {"entities": [[18, 24, "DISEASE"]]}], ["In the present work, metabolomics studies of biochemical changes in the lung tissue and plasma of ovalbumin (OVA)-induced allergic asthma mice with mKG treatment were performed using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS).", {"entities": [[122, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Partial least squares\u2013discriminate analysis (PLS\u2212DA) indicated that the metabolic perturbation induced by OVA was reduced after mKG treatment.", {"entities": []}], ["A total of twenty-four metabolites involved in seven metabolic pathways were identified as potential biomarkers in the development of allergic asthma.", {"entities": [[134, 149, "DISEASE"], [143, 149, "DISEASE"]]}], ["Among them, myristic acid ( L3 or P2 ), sphinganine ( L6 or P4 ), and lysoPC(15:0) ( L12 or P16 ) were detected both in lung tissue and plasma.", {"entities": []}], ["Additionally, l -acetylcarnitine ( L1 ), thromboxane B2 ( L2 ), 10-HDoHE ( L10 ), and 5-HETE ( L11 ) were first reported to be potential biomarkers associated with allergic asthma.", {"entities": [[164, 179, "DISEASE"], [173, 179, "DISEASE"]]}], ["The treatment of mKG mediated all of those potential biomarkers except lysoPC(15:0) ( P16 ).", {"entities": []}], ["The anti-asthma mechanism of mKG can be achieved through the comprehensive regulation of multiple perturbed biomarkers and metabolic pathways.", {"entities": [[9, 15, "DISEASE"]]}], ["This cross-sectional epidemiological study collected health data for 2,470 school children between 5 and 14 years of age (89% of eligible children) who had lived most of their lives in either one of two counties strongly impacted by industrial pollution (Bitterfeld and Hettstedt) or in a neighboring county without any sources of industrial pollution (Zerbst).", {"entities": []}], ["The objective of the study was to examine whether regional differences--with respect to the occurrence of childhood respiratory diseases and symptoms or allergies--exist and, if such differences are found, whether they persist when we adjust for the effects of known risk factors such as medical and sociodemographic factors or factors related to the indoor environment.", {"entities": []}], ["Controlling for medical, sociodemographic, and indoor factors, according to parental reports, children residing in Hettstedt have about a 50% increased lifetime prevalence for physician-diagnosed allergies, eczema, and bronchitis compared to children from Zerbst and about twice the number of respiratory symptoms such as wheeze, shortness of breath, and cough without cold.", {"entities": [[219, 229, "DISEASE"]]}], ["Sensitization to common aeroallergens according to skin prick tests [odds ratio (OR) = 1.38; 95% confidence interval (CI), 1.02-1.86] and specific IgE levels (OR = 1.75; CI, 1.31-2.33) was more common for children from Hettstedt than children from the nonpolluted county.", {"entities": []}], ["Bitterfeld children, on the other hand, more often received a diagnosis of asthma and eczema than children residing in Zerbst and also showed slightly increased sensitization rates.", {"entities": [[75, 81, "DISEASE"]]}], ["In conclusion, industrial pollution related to mining and smelting operations in the county of Hettstedt were associated with a higher lifetime prevalence of respiratory disorders and an increased rate of allergic sensitization in children between the ages of 5 and 14 years.", {"entities": []}], ["Further studies are needed to determine what role the high dust content of heavy metals plays in Hettstedt.", {"entities": []}], ["The Wisconsin Upper Respiratory Symptom Survey (WURSS) is a self-administered questionnaire developed in the United States to evaluate the severity of the common cold and its reliability has been validated.", {"entities": [[155, 166, "DISEASE"]]}], ["We developed a Korean language version of this questionnaire by using a sequential forward and backward translation approach.", {"entities": []}], ["The purpose of this study was to validate the Korean version of the Wisconsin Upper Respiratory Symptom Survey (WURSS-K) in Korean patients with common cold.", {"entities": [[145, 156, "DISEASE"]]}], ["This multicenter prospective study enrolled 107 participants who were diagnosed with common cold and consented to participate in the study.", {"entities": [[85, 96, "DISEASE"]]}], ["The WURSS-K includes 1 global illness severity item, 32 symptom-based items, 10 functional quality-of-life (QOL) items, and 1 item assessing global change.", {"entities": []}], ["The SF-8 was used as an external comparator.", {"entities": []}], ["The participants were 54 women and 53 men aged 18 to 42 years.", {"entities": []}], ["The WURSS-K showed good reliability in 10 domains, with Cronbach\u2019s alphas ranging from 0.67 to 0.96 (mean: 0.84).", {"entities": []}], ["Comparison of the reliability coefficients of the WURSS-K and WURSS yielded a Pearson correlation coefficient of 0.71 ( P = 0.02).", {"entities": []}], ["Validity of the WURSS-K was evaluated by comparing it with the SF-8, which yielded a Pearson correlation coefficient of \u22120.267 ( P < 0.001).", {"entities": []}], ["The Guyatt\u2019s responsiveness index of the WURSS-K ranged from 0.13 to 0.46, and the correlation coefficient with the WURSS was 0.534 ( P < 0.001), indicating that there was close correlation between the WURSS-K and WURSS.", {"entities": []}], ["The WURSS-K is a reliable, valid, and responsive disease-specific questionnaire for assessing symptoms and QOL in Korean patients with common cold.", {"entities": [[135, 146, "DISEASE"]]}], ["Early-life nutrition is an important modifiable determinant in the development of a child\u2019s immune system, and may thereby influence the risk of allergic sensitization and atopic diseases.", {"entities": []}], ["However, associations between overall dietary patterns and atopic diseases in childhood remain unclear.", {"entities": []}], ["We examined associations of diet quality in early life with allergic sensitization, self-reported physician-diagnosed inhalant and food allergies, eczema, and asthma among 5225 children participating in a population-based cohort in the Netherlands.", {"entities": [[159, 165, "DISEASE"]]}], ["Diet was assessed during pregnancy, infancy, and childhood using validated food-frequency questionnaires.", {"entities": []}], ["We calculated food-based diet quality scores (0\u201310 or 0\u201315), reflecting adherence to dietary guidelines.", {"entities": []}], ["At age 10 years, allergic sensitization was assessed with skin prick tests.", {"entities": []}], ["Information on physician-diagnosed inhalant and food allergies, eczema, and asthma was obtained with questionnaires.", {"entities": [[76, 82, "DISEASE"]]}], ["We observed no associations between diet quality during pregnancy and allergic sensitization (odds ratio (OR) = 1.05 per point in the diet score, 95% confidence interval (CI): 0.99, 1.13), allergies (0.96, 95% CI: 0.88, 1.04), eczema (0.99, 95% CI: 0.93, 1.06), or asthma (0.93, 95% CI: 0.85, 1.03) in childhood.", {"entities": [[265, 271, "DISEASE"]]}], ["Also, diet quality in infancy or childhood were not associated with atopic outcomes in childhood.", {"entities": []}], ["Our findings do not support our hypothesis that a healthy dietary pattern in early life is associated with a lower risk of allergic sensitization or atopic diseases in childhood.", {"entities": []}], ["Tourette Syndrome (TS) is a neurological condition presenting chronic motor and phonic tics, and important degree of comorbidity.", {"entities": []}], ["Considered an uncommon illness, it first becomes apparent during childhood.", {"entities": []}], ["Current standard treatment only achieves partial control of the condition, and provokes frequent, and sometimes severe, side effects.", {"entities": []}], ["Main aim: To show that, with respect to placebo treatment, the combination of 0.5 mEq/Kg magnesium and 2 mg/Kg vitamin B 6 reduces motor and phonic tics and incapacity in cases of exacerbated TS among children aged 7\u201314 years, as measured on the Yale Global Tic Severity Scale (YGTSS).", {"entities": []}], ["Secondary aims: Assess the safety of the treatment.", {"entities": []}], ["Describe metabolic changes revealed by PET.", {"entities": []}], ["Measure the impact of the experimental treatment on family life.", {"entities": []}], ["Randomized, blinded clinical trials.", {"entities": []}], ["Phase IV study (new proposal for treatment with magnesium and vitamin B 6 ).", {"entities": []}], ["Scope: children in the geographic area of the study group.", {"entities": []}], ["Recruitment of subjects: to include patients diagnosed with TS, in accordance with DSM-IV criteria (307.23), during a period of exacerbation, and provided none of the exclusion criteria are met.", {"entities": []}], ["Instrumentation: clinical data and the YGTSS score will be obtained at the outset of a period of exacerbation (t0).", {"entities": []}], ["The examinations will be made after 15 (t1), 30 (t2), 60 (t3) and 90 days (t4).", {"entities": []}], ["PET will be performed at the t0 and t4.", {"entities": []}], ["We evaluated decrease in the overall score (t0, t1, t2, t3, t4), PET variations, and impact made by the treatment on the patient's life (Psychological General Well-Being Index).", {"entities": []}], ["Few clinical trials have been carried out on children with TS, but they are necessary, as current treatment possibilities are insufficient and often provoke side effects.", {"entities": []}], ["The difficulty of dealing with an uncommon illness makes designing such a study all the more complicated.", {"entities": []}], ["The present study seeks to overcome possible methodological problems by implementing a prior, phase II study, in order to calculate the relevant statistical parameters and to determine the safety of the proposed treatment.", {"entities": []}], ["Providing a collateral treatment with magnesium and vitamin B 6 could improve control of the illness and help reduce side effects.", {"entities": []}], ["This protocol was approved by the Andalusian Government Committee for Clinical Trials (Spain).", {"entities": []}], ["This study was funded by the Health Department of the Andalusian Regional Government and by the Healthcare Research Fund of the Carlos III Healthcare Institute (Spanish Ministry of Health).", {"entities": []}], ["Current Controlled Trials ISRCTN41082378", {"entities": []}], ["The number of subjects that can be recruited in immunological studies and the number of immunological parameters that can be measured has increased rapidly over the past decade and is likely to continue to expand.", {"entities": []}], ["Large and complex immunological datasets can now be used to investigate complex scientific questions, but to make the most of the potential in such data and to get the right answers sophisticated statistical approaches are necessary.", {"entities": []}], ["Such approaches are used in many other scientific disciplines, but immunological studies on the whole still use simple statistical techniques for data analysis.", {"entities": []}], ["The paper provides an overview of the range of statistical methods that can be used to answer different immunological study questions.", {"entities": []}], ["We discuss specific aspects of immunological studies and give examples of typical scientific questions related to immunological data.", {"entities": []}], ["We review classical bivariate and multivariate statistical techniques (factor analysis, cluster analysis, discriminant analysis) and more advanced methods aimed to explore causal relationships (path analysis/structural equation modelling) and illustrate their application to immunological data.", {"entities": []}], ["We show the main features of each method, the type of study question they can answer, the type of data they can be applied to, the assumptions required for each method and the software that can be used.", {"entities": []}], ["This paper will help the immunologist to choose the correct statistical approach for a particular research question.", {"entities": []}], ["Introduction .", {"entities": []}], ["Primary spontaneous pneumothorax (PSP) is a disorder commonly encountered in healthy young individuals.", {"entities": [[20, 32, "DISEASE"]]}], ["There is no differentiation between PSP and secondary pneumothorax (SP) in the current version of the International Classification of Diseases (ICD-10).", {"entities": [[54, 66, "DISEASE"]]}], ["This complicates the conduct of epidemiological studies on the subject.", {"entities": []}], ["Objective .", {"entities": []}], ["To validate the accuracy of an algorithm that identifies cases of PSP from administrative databases.", {"entities": []}], ["The charts of 150 patients who consulted the emergency room (ER) with a recorded main diagnosis of pneumothorax were reviewed to define the type of pneumothorax that occurred.", {"entities": [[99, 111, "DISEASE"], [148, 160, "DISEASE"]]}], ["The corresponding hospital administrative data collected during previous hospitalizations and ER visits were processed through the proposed algorithm.", {"entities": []}], ["The results were compared over two different age groups.", {"entities": []}], ["There were 144 cases of pneumothorax correctly coded (96%).", {"entities": [[24, 36, "DISEASE"]]}], ["The results obtained from the PSP algorithm demonstrated a significantly higher sensitivity (97% versus 81%, p = 0.038) and positive predictive value (87% versus 46%, p < 0.001) in patients under 40 years of age than in older patients.", {"entities": []}], ["Conclusions .", {"entities": []}], ["The proposed algorithm is adequate to identify cases of PSP from administrative databases in the age group classically associated with the disease.", {"entities": []}], ["This makes possible its utilization in large population-based studies.", {"entities": []}], ["Chronic rhinosinusitis (CRS) is a highly prevalent inflammatory disease with significant impacts on patient quality of life and daily productivity.", {"entities": []}], ["Evaluating the volume of research on CRS, relative to similar chronic diseases, may provide insight into current disparities in research prioritization.", {"entities": []}], ["A systematic review was performed using Ovid MEDLINE (R) (1970 \u2013 December 31st, 2014) to define the volume of research publications for CRS, asthma, and diabetes mellitus (DM).", {"entities": [[141, 147, "DISEASE"], [153, 170, "DISEASE"]]}], ["Primary outcomes were overall volume of research publications and volume of publications per year.", {"entities": []}], ["A subgroup analysis was performed using chi-square (\u03c72) omnibus test with 2\u00d73 contingency tables to identify significant differences in the proportion of total randomized controlled trials, systematic reviews, meta-analyses, and economic evaluation publications between CRS, asthma, and DM groups.", {"entities": [[275, 281, "DISEASE"]]}], ["There were substantial disparities in the volume of research published over the last 45\u00a0years for CRS (n\u2009=\u20097,962), asthma (n\u2009=\u2009136,652), and DM (n\u2009=\u2009337,411).", {"entities": [[115, 121, "DISEASE"]]}], ["Although the volume of research for CRS in increasing, the disparities in the annual publication volumes between CRS, asthma, and DM appeared consistent over the last 45\u00a0years.", {"entities": [[118, 124, "DISEASE"]]}], ["Outcomes from this review have demonstrated a large disparity in the volume of published research for CRS compared to asthma and DM.", {"entities": [[118, 124, "DISEASE"]]}], ["Given the similarities in prevalence rates, impact on quality of life and economic burden, the relative under supply of CRS research should prompt efforts to increase research prioritization for this chronic disease.", {"entities": []}], ["The airway epithelium forms a barrier against infection but also produces antimicrobial peptides (AMPs) and other inflammatory mediators to activate the immune system.", {"entities": []}], ["It has been shown that in allergic disorders, Th2 cytokines may hamper the antimicrobial activity of the epithelium.", {"entities": []}], ["However, the presence of Th2 cytokines also affects the composition of the epithelial layer which may alter its function.", {"entities": []}], ["Therefore, we investigated whether exposure of human primary bronchial epithelial cells (PBEC) to Th2 cytokines during mucociliary differentiation affects expression of the human cathelicidin antimicrobial protein (hCAP18)/LL-37 and human beta defensins (hBD), and antimicrobial activity.", {"entities": [[255, 258, "GENE"]]}], ["PBEC were cultured at an air-liquid interface (ALI) for two weeks in the presence of various concentrations of IL-4 or IL-13.", {"entities": []}], ["Changes in differentiation and in expression of various AMPs and the antimicrobial proteinase inhibitors secretory leukocyte protease inhibitor (SLPI) and elafin were investigated as well as antimicrobial activity.", {"entities": [[145, 149, "GENE"]]}], ["IL-4 and IL-13 increased mRNA expression of hCAP18/LL-37 and hBD-2.", {"entities": []}], ["Dot blot analysis also showed an increase in hCAP18/LL-37 protein in apical washes of IL-4-treated ALI cultures, whereas Western Blot analysis showed expression of a protein of approximately 4.5 kDa in basal medium of IL-4-treated cultures.", {"entities": []}], ["Using sandwich ELISA we found that also hBD-2 in apical washes was increased by both IL-4 and IL-13.", {"entities": []}], ["SLPI and elafin levels were not affected by IL-4 or IL-13 at the mRNA or protein level.", {"entities": [[0, 4, "GENE"]]}], ["Apical wash obtained from IL-4- and IL-13-treated cultures displayed increased antimicrobial activity against Pseudomonas aeruginosa compared to medium-treated cultures.", {"entities": []}], ["In addition, differentiation in the presence of Th2 cytokines resulted in increased MUC5AC production as has been shown previously.", {"entities": []}], ["These data suggest that prolonged exposure to Th2 cytokines during mucociliary differentiation contributes to antimicrobial defence by increasing the expression and release of selected antimicrobial peptides and mucus.", {"entities": []}], ["The unique hazard posed to the pleural mesothelium by asbestos has engendered concern in potential for a similar risk from high aspect ratio nanoparticles (HARN) such as carbon nanotubes.", {"entities": []}], ["In the course of studying the potential impact of HARN on the pleura we have utilised the existing hypothesis regarding the role of the parietal pleura in the response to long fibres.", {"entities": []}], ["This review seeks to synthesise our new data with multi-walled carbon nanotubes (CNT) with that hypothesis for the behaviour of long fibres in the lung and their retention in the parietal pleura leading to the initiation of inflammation and pleural pathology such as mesothelioma.", {"entities": []}], ["We describe evidence that a fraction of all deposited particles reach the pleura and that a mechanism of particle clearance from the pleura exits, through stomata in the parietal pleura.", {"entities": []}], ["We suggest that these stomata are the site of retention of long fibres which cannot negotiate them leading to inflammation and pleural pathology including mesothelioma.", {"entities": []}], ["We cite thoracoscopic data to support the contention, as would be anticipated from the preceding, that the parietal pleura is the site of origin of pleural mesothelioma.", {"entities": []}], ["This mechanism, if it finds support, has important implications for future research into the mesothelioma hazard from HARN and also for our current view of the origins of asbestos-initiated pleural mesothelioma and the common use of lung parenchymal asbestos fibre burden as a correlate of this tumour, which actually arises in the parietal pleura.", {"entities": []}], ["Previous studies have indicated that the downstream proteins in a key pathway can be potential drug targets and that the pathway can play an important role in the action of drugs.", {"entities": []}], ["So pathways could be considered as targets of small molecules.", {"entities": []}], ["A link map between small molecules and pathways was constructed using gene expression profile, pathways, and gene expression of cancer cell line intervened by small molecules and then we analysed the topological characteristics of the link map.", {"entities": [[128, 134, "DISEASE"]]}], ["Three link patterns were identified based on different drug discovery implications for breast, liver, and lung cancer.", {"entities": [[106, 117, "DISEASE"], [111, 117, "DISEASE"]]}], ["Furthermore, molecules that significantly targeted the same pathways tended to treat the same diseases.", {"entities": []}], ["These results can provide a valuable reference for identifying drug candidates and targets in molecularly targeted therapy.", {"entities": []}], ["Horses develop recurrent airway obstruction (RAO) that resembles human bronchial asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["Differentiated primary equine bronchial epithelial cells (EBEC) in culture that closely mimic the airway cells in vivo would be useful to investigate the contribution of bronchial epithelium in inflammation of airway diseases.", {"entities": []}], ["However, because isolation and characterization of EBEC cultures has been limited, we modified and optimized techniques of generating and culturing EBECs from healthy horses to mimic in vivo conditions.", {"entities": []}], ["Large numbers of EBEC were obtained by trypsin digestion and successfully grown for up to 2 passages with or without serum.", {"entities": []}], ["However, serum or ultroser G proved to be essential for EBEC differentiation on membrane inserts at ALI.", {"entities": []}], ["A pseudo-stratified muco-ciliary epithelium with basal cells was observed at differentiation.", {"entities": []}], ["Further, transepithelial resistance (TEER) was more consistent and higher in P 1 cultures compared to P 0 cultures while ciliation was delayed in P 1 cultures.", {"entities": []}], ["This study provides an efficient method for obtaining a high-yield of EBECs and for generating highly differentiated cultures.", {"entities": []}], ["These EBEC cultures can be used to study the formation of tight junction or to identify epithelial-derived inflammatory factors that contribute to lung diseases such as asthma.", {"entities": [[169, 175, "DISEASE"]]}], ["Angiogenesis is a complex process finely regulated by the balance between angiogenesis stimulators and inhibitors.", {"entities": []}], ["As a result of proangiogenic factors overexpression, it plays a crucial role in cancer development.", {"entities": [[80, 86, "DISEASE"]]}], ["Although initially mast cells (MCs) role has been defined in hypersensitivity reactions and in immunity, it has been discovered that MCs have a crucial interplay on the regulatory function between inflammatory and tumor cells through the release of classical proangiogenic factors (e.g., vascular endothelial growth factor) and nonclassical proangiogenic mediators granule-associated (mainly tryptase).", {"entities": []}], ["In fact, in several animal and human malignancies, MCs density is highly correlated with tumor angiogenesis.", {"entities": []}], ["In particular, tryptase, an agonist of the proteinase-activated receptor-2 (PAR-2), represents one of the most powerful angiogenic mediators released by human MCs after c-Kit receptor activation.", {"entities": []}], ["This protease, acting on PAR-2 by its proteolytic activity, has angiogenic activity stimulating both human vascular endothelial and tumor cell proliferation in paracrine manner, helping tumor cell invasion and metastasis.", {"entities": []}], ["Based on literature data it is shown that tryptase may represent a promising target in cancer treatment due to its proangiogenic activity.", {"entities": [[87, 93, "DISEASE"]]}], ["Here we focused on molecular mechanisms of three tryptase inhibitors (gabexate mesylate, nafamostat mesylate, and tranilast) in order to consider their prospective role in cancer therapy.", {"entities": [[172, 178, "DISEASE"]]}], ["Traditional patient-reported physical function instruments often poorly differentiate patients with mild-to-moderate disability.", {"entities": []}], ["We describe the development and psychometric evaluation of a generic item bank for measuring everyday activity limitations in outpatient populations.", {"entities": []}], ["Seventy-two items generated from patient interviews and mapped to the International Classification of Functioning, Disability and Health (ICF) domestic life chapter were administered to 1128 adults representative of the Dutch population.", {"entities": []}], ["The partial credit model was fitted to the item responses and evaluated with respect to its assumptions, model fit, and differential item functioning (DIF).", {"entities": [[151, 154, "GENE"]]}], ["Measurement performance of a computerized adaptive testing (CAT) algorithm was compared with the SF-36 physical functioning scale (PF-10).", {"entities": []}], ["A final bank of 41 items was developed.", {"entities": []}], ["All items demonstrated acceptable fit to the partial credit model and measurement invariance across age, sex, and educational level.", {"entities": []}], ["Five- and ten-item CAT simulations were shown to have high measurement precision, which exceeded that of SF-36 physical functioning scale across the physical function continuum.", {"entities": []}], ["Floor effects were absent for a 10-item empirical CAT simulation, and ceiling effects were low (13.5%) compared with SF-36 physical functioning (38.1%).", {"entities": []}], ["CAT also discriminated better than SF-36 physical functioning between age groups, number of chronic conditions, and respondents with or without rheumatic conditions.", {"entities": []}], ["The Rasch assessment of everyday activity limitations (REAL) item bank will hopefully prove a useful instrument for assessing everyday activity limitations.", {"entities": []}], ["T-scores obtained using derived measures can be used to benchmark physical function outcomes against the general Dutch adult population.", {"entities": []}], ["The online version of this article (doi:10.1007/s11136-017-1627-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Identifying patients who are potential placebo responders has major implications for clinical practice and trial design.", {"entities": []}], ["Catechol-O-methyltransferase (COMT), an important enzyme in dopamine catabolism plays a key role in processes associated with the placebo effect such as reward, pain, memory and learning.", {"entities": [[30, 34, "GENE"]]}], ["We hypothesized that the COMT functional val158met polymorphism, was a predictor of placebo effects and tested our hypothesis in a subset of 104 patients from a previously reported randomized controlled trial in irritable bowel syndrome (IBS).", {"entities": [[212, 236, "DISEASE"], [228, 236, "DISEASE"], [25, 29, "GENE"]]}], ["The three treatment arms from this study were: no-treatment (\u201cwaitlist\u201d), placebo treatment alone (\u201climited\u201d) and, placebo treatment \u201caugmented\u201d with a supportive patient-health care provider interaction.", {"entities": []}], ["The primary outcome measure was change from baseline in IBS-Symptom Severity Scale (IBS-SSS) after three weeks of treatment.", {"entities": []}], ["In a regression model, the number of methionine alleles in COMT val158met was linearly related to placebo response as measured by changes in IBS-SSS (p\u200a=\u200a.035).", {"entities": [[59, 63, "GENE"]]}], ["The strongest placebo response occurred in met/met homozygotes treated in the augmented placebo arm.", {"entities": []}], ["A smaller met/met associated effect was observed with limited placebo treatment and there was no effect in the waitlist control.", {"entities": []}], ["These data support our hypothesis that the COMT val158met polymorphism is a potential biomarker of placebo response.", {"entities": [[43, 47, "GENE"]]}], ["The generation of acinar and ductal cells from human pluripotent stem cells (PSCs) is a poorly studied process, although various diseases arise from this compartment.", {"entities": []}], ["We designed a straightforward approach to direct human PSCs towards pancreatic organoids resembling acinar and ductal progeny.", {"entities": []}], ["Extensive phenotyping of the organoids not only shows the appropriate marker profile but also ultrastructural, global gene expression and functional hallmarks of the human pancreas in the dish.", {"entities": []}], ["Upon orthotopic transplantation into immunodeficient mice, these organoids form normal pancreatic ducts and acinar tissue resembling fetal human pancreas without evidence of tumour formation or transformation.", {"entities": []}], ["Finally, we implemented this unique phenotyping tool as a model to study the pancreatic facets of cystic fibrosis (CF).", {"entities": [[98, 113, "DISEASE"]]}], ["For the first time, we provide evidence that in vitro , but also in our xenograft transplantation assay, pancreatic commitment occurs generally unhindered in CF.", {"entities": []}], ["Importantly, cystic fibrosis transmembrane conductance regulator (CFTR) activation in mutated pancreatic organoids not only mirrors the CF phenotype in functional assays but also at a global expression level.", {"entities": [[13, 28, "DISEASE"], [66, 70, "GENE"]]}], ["We also conducted a scalable proof-of-concept screen in CF pancreatic organoids using a set of CFTR correctors and activators, and established an mRNA-mediated gene therapy approach in CF organoids.", {"entities": [[95, 99, "GENE"]]}], ["Taken together, our platform provides novel opportunities to model pancreatic disease and development, screen for disease-rescuing agents and to test therapeutic procedures.", {"entities": []}], ["To explore clinicians views of the barriers and facilitators to use of C-reactive protein (CRP) point-of-care tests (POCT) in US family medicine clinics for the management of acute respiratory tract infections (ARTIs) in adults.", {"entities": [[91, 94, "GENE"]]}], ["Five family medicine clinics across two US states.", {"entities": []}], ["30 clinicians including 18 physicians, 9 physician residents, 2 physician assistants and 1 nurse practitioner, took part in the study.", {"entities": []}], ["A qualitative study using a grounded theory approach to thematically analyse focus group interviews.", {"entities": []}], ["These clinicians had limited access to diagnostic tests for patients with ARTI, and very little knowledge of CRP POCT.", {"entities": [[109, 112, "GENE"]]}], ["Three major themes were identified and included the potential clinical role of CRP POCT, concerns related to implementing CRP POCT and evidence needed prior to wider adoption in family medicine.", {"entities": [[79, 82, "GENE"], [122, 125, "GENE"], [79, 82, "GENE"], [122, 125, "GENE"]]}], ["Clinicians believed CRP POCT could support decision-making for some presentations of ARTIs and patient populations when used in conjunction with clinical criteria.", {"entities": [[20, 23, "GENE"]]}], ["Clinicians had concerns about possible overuse and inaccuracy of CRP POCT which they believed might increase antibiotic prescribing rates.", {"entities": [[65, 68, "GENE"]]}], ["Other concerns identified included integration of the test with clinic workflows and cost-effectiveness.", {"entities": []}], ["Clinicians stand at the forefront of antibiotic stewardship efforts, but have few diagnostic tests to help them confidently manage ARTIs.", {"entities": []}], ["CRP POCT may facilitate some aspects of clinical practice.", {"entities": [[0, 3, "GENE"]]}], ["Incorporating CRP POCT with clinical guidelines may strengthen utility of this test, when there is diagnostic uncertainty.", {"entities": [[14, 17, "GENE"]]}], ["N363S and ER22/23EK polymorphisms observed within glucocorticoid receptor gene (NR3C1) may play an important role in the development of bronchial asthma.", {"entities": [[146, 152, "DISEASE"], [80, 85, "GENE"]]}], ["NR3C1 gene is associated with an altered sensitivity to GCs.", {"entities": [[0, 5, "GENE"]]}], ["The aim of the research project was to study the correlation between this NR3C1 gene polymorphisms and occurrence of asthma in the population of Polish asthmatics.", {"entities": [[117, 123, "DISEASE"], [74, 79, "GENE"]]}], ["Peripheral blood was obtained from 207 healthy volunteers and 221 asthma patients.", {"entities": [[66, 72, "DISEASE"]]}], ["Genotyping was carried out with PCR-RFLP method.", {"entities": []}], ["In the groups of patients with uncontrolled moderate asthma and uncontrolled severe disease, the genotype distribution for the investigated polymorphisms was as follows: N363S-AA, AG, GG occurring with 0.881/0.073/0.046 frequency and ER22/23EK-GG, GA, AA occurring with 0.963/0.037/0.000 frequency.", {"entities": [[53, 59, "DISEASE"]]}], ["Chi-square analysis revealed a significantly different ( P \u00a0<\u00a00.05) distribution between cases and controls for the N363S polymorphisms.", {"entities": []}], ["The N363S polymorphism of NR3C1 gene is significantly associated with bronchial asthma, susceptibility to the development of moderate to severe form of uncontrolled bronchial asthma.", {"entities": [[80, 86, "DISEASE"], [175, 181, "DISEASE"], [26, 31, "GENE"]]}], ["Autism spectrum disorder (ASD) has been associated with mitochondrial dysfunction but few studies have examined the relationship between mitochondrial function and ASD symptoms.", {"entities": []}], ["We measured Complex I and IV and citrate synthase activities in 76 children with ASD who were not receiving vitamin supplementation or medication.", {"entities": []}], ["We also measured language using the Preschool Language Scales or Clinical Evaluation of Language Fundamentals, adaptive behavior using the Vineland Adaptive Behavioral Scale, social function using the Social Responsiveness Scale and behavior using Aberrant Behavior Checklist, Childhood Behavior Checklist and the Ohio Autism Clinical Impression Scale.", {"entities": []}], ["Children with ASD demonstrated significantly greater variation in mitochondrial activity compared to controls with more than expected ASD children having enzyme activity outside of the normal range for Citrate Synthase (24%), Complex I (39%) and Complex IV (11%).", {"entities": []}], ["Poorer adaptive skills were associated with Complex IV activity lower or higher than average and lower Complex I activity.", {"entities": []}], ["Poorer social function and behavior was associated with relatively higher Citrate Synthase activity.", {"entities": []}], ["Similar to previous studies we find both mitochondrial underactivity and overactivity in ASD.", {"entities": []}], ["This study confirms an expanded variation in mitochondrial activity in ASD and demonstrates, for the first time, that such variations are related to ASD symptoms.", {"entities": []}], ["Using data from the Continuing to Confront COPD International Physician and Patient Surveys, this paper describes physicians\u2019 attitudes and beliefs regarding chronic obstructive pulmonary disease (COPD) prognosis, and compares physician and patient perceptions with respect to COPD.", {"entities": [[158, 195, "DISEASE"]]}], ["In 12 countries worldwide, 4,343 patients with COPD were identified through systematic screening of population samples, and 1,307 physicians who regularly saw patients with COPD were sampled from in-country professional databases.", {"entities": []}], ["Both patients and physicians completed surveys about their COPD knowledge, beliefs, and perceptions; physicians answered further questions about diagnostic methods and treatment choices for COPD.", {"entities": []}], ["Most physicians (79%) responded that the long-term health outlook for patients with COPD has improved over the past decade, largely attributed to the introduction of better medications.", {"entities": []}], ["However, patient access to medication remains an issue in many countries, and some physicians (39%) and patients (46%) agreed/strongly agreed with the statement \u201cthere are no truly effective treatments for COPD\u201d.", {"entities": []}], ["There was strong concordance between physicians and patients regarding COPD management practices, including the use of spirometry (86% of physicians and 76% of patients reporting they used/had undergone a spirometry test) and smoking cessation counseling (76% of physicians reported they counseled their smoking patients at every clinic visit, and 71% of smoking patients stated that they had received counseling in the past year).", {"entities": []}], ["However, the groups differed in their perception about the role of smoking in COPD, with 78% of physicians versus 38% of patients strongly agreeing with the statement \u201csmoking is the cause of most cases of COPD\u201d.", {"entities": []}], ["The Continuing to Confront COPD International Surveys demonstrate that while physicians and patients largely agreed about COPD management practices and the need for more effective treatments for COPD, a gap exists about the causal role of smoking in COPD.", {"entities": []}], ["To describe mechanisms by which glucocorticoids cause osteoporosis, with fracture risk, combining this learning with a possible professional behavior change.", {"entities": [[54, 66, "DISEASE"]]}], ["A systematic search on SciELO, PubMed, Scopus, and Medline databases was carried out for consensus, review articles, including systematic reviews and meta-analysis, which were published in English, between 2000 and 2016.", {"entities": []}], ["Keywords used on the search were the following: glucocorticoids, fractures, osteoporosis, bone health, vitamin D, children, and adolescents.", {"entities": [[76, 88, "DISEASE"]]}], ["The review was divided into four topics: 1) introduction, with a brief focus on pediatric fractures; 2) osteoporosis in children and adolescents, highlighting it as a silent cause of fractures; 3) glucocorticoids and secondary bone disease, describing deleterious mechanisms of this steroids group on bone structure; 4) molecular effects of glucocorticoids excess on bone, with details about the harmful mechanisms on bone molecular level.", {"entities": [[104, 116, "DISEASE"], [227, 239, "DISEASE"]]}], ["Glucocorticoids excess determines early bone disease, favoring the occurrence of fractures.", {"entities": [[40, 52, "DISEASE"]]}], ["Thus, a child or an adolescent who uses glucocorticoids, especially systemically and chronically, but also repeats cycles at high cumulative doses of the medication, needs care and guidance related to bone health at the onset of treatment.", {"entities": []}], ["On the other hand, the presence of fractures, even if related to trauma, can be a sign of underlying and unknown bone fragility, which may be secondary to the use of glucocorticoids and/or vitamin D deficiency.", {"entities": []}], ["Traditionally, health systems in sub\u2010Saharan Africa have focused on acute conditions.", {"entities": []}], ["Few data exist on the readiness of African health facilities ( HF s) to address the growing burden of chronic diseases ( CD s), specifically chronic, non\u2010communicable diseases ( NCD s).", {"entities": []}], ["A stratified random sample of 28 urban and rural Ugandan HF s was surveyed to document the burden of selected CD s by analysing the service statistics, service availability and service readiness using a modified WHO Service Availability and Readiness Assessment questionnaire.", {"entities": []}], ["Knowledge, skills and practice in the management of CD s of 222 health workers were assessed through a self\u2010completed questionnaire.", {"entities": []}], ["Among adult outpatient visits at hospitals, 33% were for CD s including HIV vs .", {"entities": []}], ["14% and 4% at medium\u2010sized and small health centres, respectively.", {"entities": []}], ["Many HF s lacked guidelines, diagnostic equipment and essential medicines for the primary management of CD s; training and reporting systems were weak.", {"entities": []}], ["Lower\u2010level facilities routinely referred patients with hypertension and diabetes.", {"entities": [[56, 68, "DISEASE"]]}], ["HIV services accounted for most CD visits and were stronger than NCD services.", {"entities": []}], ["Systems were weaker in lower \u2010 level HF s. Non\u2010doctor clinicians and nurses lacked knowledge and experience in NCD care.", {"entities": []}], ["Compared with higher level HF s, lower\u2010level ones are less prepared and little used for CD care.", {"entities": []}], ["Health systems in Uganda, particularly lower \u2010 level HF s, urgently need improvement in managing common NCD s to cope with the growing burden.", {"entities": []}], ["This should include the provision of standard guidelines, essential diagnostic equipment and drugs, training of health workers, supportive supervision and improved referral systems.", {"entities": []}], ["Substantially better HIV basic service readiness demonstrates that improved NCD care is feasible.", {"entities": []}], ["Nowadays, treatment of food allergy only considered the avoidance of the specific food.", {"entities": [[23, 35, "DISEASE"]]}], ["However, the possibility of cross-reactivity makes this practice not very effective.", {"entities": []}], ["Immunotherapy may exhibit as a good alternative to food allergy treatment.", {"entities": [[51, 63, "DISEASE"]]}], ["The use of hypoallergenic molecules with reduced IgE binding capacity but with ability to stimulate the immune system is a promising tool which could be developed for immunotherapy.", {"entities": []}], ["In this study, three mutants of Pru p 3, the principal allergen of peach, were produced based on the described mimotope and T cell epitopes, by changing the specific residues to alanine, named as Pru p 3.01, Pru p 3.02 , and Pru p 3.03 .", {"entities": []}], ["Pru p 3.01 showed very similar allergenic activity as the wild type by in vitro assays.", {"entities": []}], ["However, Pru p 3.02 and Pru p 3.03 presented reduced IgE binding with respect to the native form, by in vitro , ex vivo, and in vivo assays.", {"entities": []}], ["In addition, Pru p 3.03 had affected the IgG4 binding capacity and presented a random circular dichroism, which was reflected in the nonrecognition by specific antibodies anti-Pru p 3.", {"entities": []}], ["Nevertheless, both Pru p 3.02 and Pru p 3.03 maintained the binding to IgG1 and their ability to activate T lymphocytes.", {"entities": []}], ["Thus, Pru p 3.02 and Pru p 3.03 could be good candidates for potential immunotherapy in peach-allergic patients.", {"entities": []}], ["There is current interest in the role of perinatal factors in the aetiology of diseases that occur later in life.", {"entities": []}], ["Infectious mononucleosis (IM) can follow late primary infection with Epstein-Barr virus (EBV), and has been shown to increase the risk of multiple sclerosis and Hodgkin's disease.", {"entities": [[138, 156, "DISEASE"]]}], ["Little is known about maternal or perinatal factors associated with IM or its sequelae.", {"entities": []}], ["We investigated perinatal risk factors for hospitalised IM using a prospective record-linkage study in a population in the south of England.", {"entities": []}], ["The dataset used, the Oxford record linkage study (ORLS), includes abstracts of birth registrations, maternities and in-patient hospital records, including day case care, for all subjects in a defined geographical area.", {"entities": []}], ["From these sources, we identified cases of hospitalised IM up to the age of 30 years in people for whom the ORLS had a maternity record; and we compared perinatal factors in their pregnancy with those in the pregnancy of children who had no hospital record of IM.", {"entities": []}], ["Our data showed a significant association between hospitalised IM and lower social class (p = 0.02), a higher risk of hospitalised IM in children of married rather than single mothers (p < 0.001), and, of marginal statistical significance, an association with singleton birth (p = 0.06).", {"entities": []}], ["The ratio of observed to expected cases of hospitalised IM in each season was 0.95 in winter, 1.02 in spring, 1.02 in summer and 1.00 in autumn.", {"entities": []}], ["The chi-square test for seasonality, with a value of 0.8, was not significant.", {"entities": []}], ["Other factors studied, including low birth weight, short gestational age, maternal smoking, late age at motherhood, did not increase the risk of subsequent hospitalised IM.", {"entities": []}], ["Because of the increasing tendency of women to postpone childbearing, it is useful to know that older age at motherhood is not associated with an increased risk of hospitalised IM in their children.", {"entities": []}], ["We have no explanation for the finding that children of married women had a higher risk of IM than those of single mothers.", {"entities": []}], ["Though highly significant, it may nonetheless be a chance finding.", {"entities": []}], ["We found no evidence that such perinatal factors as birth weight and gestational age, or season of birth, were associated with the risk of hospitalised IM.", {"entities": []}], ["We hypothesized that a substantial proportion of the subjectively experienced variance in pain in fibromyalgia patients would be explained by psychological factors alone, but that a combined model, including neuroendocrine and autonomic factors, would give the most parsimonious explanation of variance in pain.", {"entities": [[98, 110, "DISEASE"]]}], ["Psychometric assessment included McGill Pain Questionnaire, General Health Questionnaire, Hospital Anxiety and Depression Rating Scale, Eysenck personality Inventory, Neuroticism and Lie subscales, Toronto Alexithymia Scale, and Multidimensional Health Locus of Control Scale and was performed in 42 female patients with fibromyalgia and 48 female age matched random sample population controls.", {"entities": [[321, 333, "DISEASE"]]}], ["A subgroup of the original sample (22 fibromyalgia patients and 13 controls) underwent a pharmacological challenge test with buspirone to assess autonomic and adrenocortical reactivity to serotonergic challenge.", {"entities": [[38, 50, "DISEASE"]]}], ["Although fibromyalgia patients scored high on neuroticism, anxiety, depression and general distress, only a minor part of variance in pain was explained by psychological factors alone.", {"entities": [[9, 21, "DISEASE"]]}], ["High pain score was associated with high neuroticism, low baseline cortisol level and small drop in systolic blood pressure after buspirone challenge test.", {"entities": []}], ["This model explained 41.5% of total pain in fibromyalgia patients.", {"entities": [[44, 56, "DISEASE"]]}], ["In population controls, psychological factors alone were significant predictors for variance in pain.", {"entities": []}], ["Fibromyalgia patients may have reduced reactivity in the central sympathetic system or perturbations in the sympathetic-parasympathetic balance.", {"entities": [[0, 12, "DISEASE"]]}], ["This study shows that a biopsychosocial model, including psychological factors as well as factors related to perturbations of the autonomic nervous system and hypothalamic-pituitary-adrenal axis, is needed to explain perceived pain in fibromyalgia patients.", {"entities": [[235, 247, "DISEASE"]]}], ["Recent studies have described the burden of disease in South Africa.", {"entities": []}], ["However these studies do not tell us which of these conditions commonly present to primary care providers, how these conditions may present and how providers make sense of them in terms of their diagnoses.", {"entities": []}], ["Clinical nurse practitioners are the main primary care providers and need to be better prepared for this role.", {"entities": []}], ["This study aimed to determine the range and prevalence of reasons for encounter and diagnoses found among ambulatory patients attending public sector primary care facilities in South Africa.", {"entities": []}], ["The study was a multi-centre prospective cross-sectional survey of consultations in primary care in four provinces of South Africa: Western Cape, Limpopo, Northern Cape and North West.", {"entities": []}], ["Consultations were coded prior to analysis by using the International Classification of Primary Care-Version 2 in terms of reasons for encounter (REF) and diagnoses.", {"entities": []}], ["Altogether 18856 consultations were included in the survey and generated 31451 reasons for encounter (RFE) and 24561 diagnoses.", {"entities": []}], ["Women accounted for 12526 (66.6%) and men 6288 (33.4%).", {"entities": []}], ["Nurses saw 16238 (86.1%) and doctors 2612 (13.9%) of patients.", {"entities": []}], ["The top 80 RFE and top 25 diagnoses are reported and ongoing care for hypertension was the commonest RFE and diagnosis.", {"entities": [[70, 82, "DISEASE"]]}], ["The 20 commonest RFE and diagnoses by age group are also reported.", {"entities": []}], ["Ambulatory primary care is dominated by non-communicable chronic diseases.", {"entities": []}], ["HIV/AIDS and TB are common, but not to the extent predicted by the burden of disease.", {"entities": []}], ["Pneumonia and gastroenteritis are commonly seen especially in children.", {"entities": [[14, 29, "DISEASE"]]}], ["Women's health issues such as family planning and pregnancy related visits are also common.", {"entities": []}], ["Injuries are not as common as expected from the burden of disease.", {"entities": []}], ["Primary care providers did not recognise mental health problems.", {"entities": []}], ["The results should guide the future training and assessment of primary care providers.", {"entities": []}], ["Aims of this cross-sectional study were to assess health status and care dependency in patients with advanced chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF) and to identify correlates of an impaired health status.", {"entities": [[110, 147, "DISEASE"]]}], ["The following outcomes were assessed in outpatients with advanced COPD ( n \u00a0=\u00a0105) or CHF ( n \u00a0=\u00a080): clinical characteristics; general health status (EuroQol-5 Dimensions (EQ-5D); Assessment of Quality of Life instrument (AQoL); Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)); disease-specific health status (St. Georges Respiratory Questionnaire (SGRQ), Minnesota Living with Heart Failure Questionnaire (MLHFQ)); physical mobility (timed \u2018Up and Go\u2019 test); and care dependency (Care Dependency Scale).", {"entities": []}], ["Patients with advanced COPD or CHF have an impaired health status and may be confronted with care dependency.", {"entities": []}], ["Multiple regression analyses have shown that physical and psychological symptoms, care dependency and number of drugs were correlated with impaired health status in advanced COPD or CHF, while demographic and clinical characteristics like age, gender, disease severity and co-morbidities were not correlated.", {"entities": []}], ["Clinical care should regularly assess symptom burden and care dependency to identify patients with advanced COPD or CHF at risk for an impaired health status.", {"entities": []}], ["A study on the native uses of ethnobotanical species was carried out in the south Surguja district of Chhattisgarh state in India with the major objective of identifying different food and medicinal plant species and also to understand their ongoing management and conservation.", {"entities": []}], ["Through questionnaire and personal interviews, a total of 73 ethnobotanical species used by tribal and non-tribal communities were documented, of these 36 species were used in curing different types of diseases and 22 were used as edible food plants.", {"entities": []}], ["This rich traditional knowledge of local people has an immense potential for pharmacological studies.", {"entities": []}], ["The outside forces, at present, were mainly blamed to change the traditional system of harvesting and management of ethnobotanical species.", {"entities": []}], ["The destructive harvesting practices have damaged the existing populations of many ethnobotanical species viz ., Asparagus racemosus, Dioscorea bulbifera, Boswellia serrata, Buchnania lanzan, Sterculia urens and Anogeissus latifolia .", {"entities": []}], ["The sustainable harvesting and management issues of ethnobotanical species are discussed in view of their conservation and management.", {"entities": []}], ["The endocrine disruptor bisphenol A (BPA) and the pharmaceutical 17\u03b1-ethinyl estradiol (EE) are synthetic chemicals with estrogen-like activities.", {"entities": []}], ["Despite ubiquitous human exposure to BPA, and the wide-spread clinical use of EE as oral contraceptive adjuvant, the impact of these estrogenic endocrine disrupting chemicals (EDCs) on the immune system is unclear.", {"entities": []}], ["Here we report results of in vivo dose response studies that analyzed the histology and microstructural changes in the spleen of adult male and female CD-1 mice exposed to 4 to 40,000\u2009\u03bcg/kg/day BPA or 0.02 to 2\u2009\u03bcg/kg/day EE from conception until 12\u201314 weeks of age.", {"entities": []}], ["Results of that analysis indicate that both BPA and EE have dose- and sex-specific impacts on the cellular and microanatomical structures of the spleens that reveal minor alterations in immunomodulatory and hematopoietic functions.", {"entities": []}], ["These findings support previous studies demonstrating the murine immune system as a sensitive target for estrogens, and that oral exposures to BPA and EE can have estrogen-like immunomodulatory affects in both sexes.", {"entities": []}], ["Because of a limited number of reports, we aimed to investigate the clinical characteristics of patients with Legionella pneumonia due to non- Legionella pneumophila serogroup 1 and the diagnostic usefulness of the six-point scoring system for such patients compared with patients with pneumonia caused by L. pneumophila serogroup 1.", {"entities": [[121, 130, "DISEASE"], [286, 295, "DISEASE"]]}], ["We retrospectively analysed patients diagnosed with Legionella pneumonia due to non- L. pneumophila serogroup 1 between March 2001 and June 2016.", {"entities": [[63, 72, "DISEASE"]]}], ["We examined the clinical characteristics, including symptoms, laboratory findings, radiologic findings, pneumonia severity, initial treatment and prognosis.", {"entities": [[104, 113, "DISEASE"]]}], ["We also calculated scores using the six-point scoring system in these patients.", {"entities": []}], ["Furthermore, we compared the clinical characteristics and six-point scores between non- L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients among hospitalized community-acquired pneumonia patients enrolled prospectively between October 2010 and July 2016.", {"entities": [[202, 211, "DISEASE"]]}], ["Eleven patients had pneumonia due to non- L. pneumophila serogroup 1; their median age was 66\u00a0years and 8 patients (72.7%) were male.", {"entities": [[20, 29, "DISEASE"]]}], ["The most common pathogen was L. pneumophila serogroup 3 (6/11), followed by L. pneumophila serogroup 9 (3/11), L. pneumophila serogroup 6 (1/11) and L. longbeachae (1/11).", {"entities": []}], ["Non-specific symptoms, such as fever and cough, were common.", {"entities": []}], ["Six patients (54.5%) had liver enzyme elevation, but no patient developed hyponatraemia at <130\u00a0mEq/L.", {"entities": []}], ["Nine patients (81.8%) showed lobar pneumonia and 7 patients (63.6%) manifested with consolidation and ground-glass opacity.", {"entities": [[35, 44, "DISEASE"]]}], ["Patients with mild to moderate severity comprised 10 (90.9%) by CURB-65 and 5 (45.5%) by the Pneumonia Severity Index.", {"entities": [[93, 102, "DISEASE"]]}], ["Of all patients, 4 were admitted to the intensive care unit and 3 died despite appropriate empiric therapy.", {"entities": []}], ["The clinical characteristics were not significantly different between non- L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients ( n \u2009=\u200923).", {"entities": []}], ["At a cut-off value of \u2265\u20092 points, the sensitivity of the six-point scoring system was 54.5% (6/11) for non- L. pneumophila serogroup 1 patients and 95.7% (22/23) for L. pneumophila serogroup 1 patients.", {"entities": []}], ["Cases of non- L. pneumophila serogroup 1 pneumonia varied in severity from mild to severe and the clinical characteristics were often non-specific.", {"entities": [[41, 50, "DISEASE"]]}], ["The six-point scoring system was not useful in predicting such Legionella pneumonia cases.", {"entities": [[74, 83, "DISEASE"]]}], ["The online version of this article (10.1186/s12890-017-0559-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To evaluate how the rating of the severity of sickness \u2013 as performed by the physician, nurse and patient \u2013 is associated with hospitalisation and acute morbidity.", {"entities": []}], ["Prospective observational study, performed in the emergency department of a tertiary hospital.", {"entities": []}], ["Patients, physicians and nurses were interviewed separately after the first contact from 21 October through to 11 November 2013.", {"entities": []}], ["Of 2426 presenting patients, 1861 were screened, and 1196 were included.", {"entities": []}], ["A total of 299 (25%) were hospitalised, 504 (42%) suffered acute morbidity.", {"entities": []}], ["In the univariate analysis, the physician's, nurse's and patient's rating of severity of sickness, expressed on a scale from 0 to 10, was significantly associated with hospitalisation (physicians: OR 1.61, 95% CI 1.50\u20131.73; nurses: OR 1.52, 1.41\u20131.64; patients: OR 1.16, 1.10\u20131.22), and with acute morbidity ( OR 1.49, 1.40\u20131.59; OR 1.39, 1.30\u20131.48 and OR 1.05, 1.003\u20131.09 respectively).", {"entities": []}], ["The area under the curve of the receiver operating characteristic curves was 0.77, 0.72 and 0.61 for hospitalisation, and 0.72, 0.68 and 0.54 for acute morbidity.", {"entities": []}], ["The interrater reliability was estimated by the intraclass correlation, which was 0.49 for physician/nurse, 0.17 for nurse/patient and 0.07 for physician/patient.", {"entities": []}], ["In a multivariable analysis model consisting of age, male sex, ethnic origin, ratings of severity of sickness, symptoms, ability to go home and hospitalisation during the preceding 12\u00a0months, only age, and the physician's and nurses' rating of severity of sickness remained significantly associated with both outcomes.", {"entities": []}], ["The first impression of severity of sickness was associated with hospitalisation and morbidity.", {"entities": []}], ["Pulmonary fibrosis is a progressive and lethal disorder.", {"entities": [[0, 18, "DISEASE"]]}], ["Although the precise mechanisms of pulmonary fibrosis are not fully understood, oxidant/antioxidant and Th1/Th2 balances may play an important role in many of the processes of inflammation and fibrosis.", {"entities": [[35, 53, "DISEASE"]]}], ["The transcription factor Nrf2 acts as a critical regulator for various inflammatory and immune responses by controlling oxidative stress.", {"entities": []}], ["We therefore investigated the protective role of Nrf2 against the development of pulmonary fibrosis.", {"entities": [[81, 99, "DISEASE"]]}], ["To generate pulmonary fibrosis, both wild-type C57BL/6 mice and Nrf2-deficient mice of the same background were administered bleomycin intratracheally.", {"entities": [[12, 30, "DISEASE"]]}], ["The survival of Nrf2-deficient mice after bleomycin administration was significantly lower than that of wild-type mice.", {"entities": []}], ["The degree of bleomycin-induced initial pulmonary inflammation and pulmonary fibrosis was much more severe in Nrf2-deficient mice than in wild-type mice.", {"entities": [[67, 85, "DISEASE"]]}], ["The expression of antioxidant enzymes and phase II detoxifying enzymes was significantly reduced in the lungs of Nrf2-deficient mice, concomitant with an elevation of lung 8-isoprostane level, compared with wild-type mice.", {"entities": []}], ["The expression of Th2 cytokines, such as interleukin-4 and interleukin-13, was significantly elevated in the lungs of Nrf2-deficient mice with an increase in the number of Th2 cells that express GATA-binding protein 3.", {"entities": []}], ["The results indicated that Nrf2 protects against the development of pulmonary fibrosis by regulating the cellular redox level and lung Th1/Th2 balance.", {"entities": [[68, 86, "DISEASE"]]}], ["Thus, Nrf2 might be an important genetic factor in the determination of susceptibility to pulmonary fibrosis.", {"entities": [[90, 108, "DISEASE"]]}], ["Zerumbone (ZER) is a naturally occurring dietary compound, present in many natural foods consumed today.", {"entities": []}], ["The compound derived from several plant species of the Zingiberaceae family that has been found to possess multiple biomedical properties, such as antiproliferative, antioxidant, anti-inflammatory, and anticancer activities.", {"entities": []}], ["However, evidence of efficacy is sparse, pointing to the need for a more systematic review for assessing scientific evidence to support therapeutic claims made for ZER and to identify future research needs.", {"entities": []}], ["This review provides an updated overview of in vitro and in vivo investigations of ZER, its cancer chemopreventive properties, and mechanisms of action.", {"entities": [[92, 98, "DISEASE"]]}], ["Therapeutic effects of ZER were found to be scientifically plausible and could be explained partially by in vivo and in vitro pharmacological activities.", {"entities": []}], ["Much of the research outlined in this paper will serve as a foundation to explain ZER anticancer bioactivity, which will open the door for the development of strategies in the treatment of malignancies using ZER.", {"entities": []}], ["Experience suggests that patients with alcohol and other drug use disorders (AOD) are commonly cared for in our intensive care units (ICU's) and require more sedation.", {"entities": []}], ["We sought to determine the impact of AOD on sedation requirement and mechanical ventilation (MV) duration.", {"entities": []}], ["Retrospective review of randomly selected records of adult patients undergoing MV in the medical ICU.", {"entities": []}], ["Diagnoses of AOD were identified using strict criteria in Diagnostic and Statistical Manual of Mental Disorders, and through review of medical records and toxicology results.", {"entities": []}], ["Of the 70 MV patients reviewed, 27 had AOD (39%).", {"entities": []}], ["Implicated substances were alcohol in 22 patients, cocaine in 5, heroin in 2, opioids in 2, marijuana in 2.", {"entities": []}], ["There was no difference between AOD and non-AOD patients in age, race, or reason for MV, but patients with AOD were more likely to be male (21 versus 15, p < 0.0001) and had a lower mean Acute Physiology and Chronic Health Evaluation II (22 versus 26, p = 0.048).", {"entities": []}], ["While AOD patients received more lorazepam equivalents (0.5 versus 0.2 mg/kg.day, p = 0.004), morphine equivalents (0.5 versus 0.1 mg/kg.day, p = 0.03) and longer duration of infusions (16 versus 10 hours/day.", {"entities": []}], ["medication, p = 0.002), they had similar sedation levels (Richmond Agitation-Sedation Scale (RASS) -2 versus -2, p = 0.83), incidence of agitation (RASS \u2265 3: 3.0% versus 2.4% of observations, p = 0.33), and duration of MV (3.6 versus 3.9 days, p = 0.89) as those without AOD.", {"entities": []}], ["The prevalence of AOD among medical ICU patients undergoing MV is high.", {"entities": []}], ["Patients with AOD receive higher doses of sedation than their non-AOD counterparts to achieve similar RASS scores but do not undergo longer duration of MV.", {"entities": []}], ["Helminth parasites are highly prevalent in many low- and middle-income countries, in which inflammatory bowel disease and other immunopathologies are less frequent than in the developed world.", {"entities": [[91, 117, "DISEASE"]]}], ["Many of the most common helminths establish themselves in the gastrointestinal tract and can exert counter-inflammatory influences on the host immune system.", {"entities": []}], ["For these reasons, interest has arisen as to how parasites may ameliorate intestinal inflammation and whether these organisms, or products they release, could offer future therapies for immune disorders.", {"entities": []}], ["In this review, we discuss interactions between helminth parasites and the mucosal immune system, as well as the progress being made toward identifying mechanisms and molecular mediators through which it may be possible to attenuate pathology in the intestinal tract.", {"entities": []}], ["Forty to 70 % of medical devices and equipment in low- and middle-income countries are broken, unused or unfit for purpose; this impairs service delivery to patients and results in lost resources.", {"entities": []}], ["Undiscerning procurement processes are at the heart of this issue.", {"entities": []}], ["We conducted a systematic review of the literature to August 2013 with no time or language restrictions to identify what product selection or prioritization methods are recommended or used for medical device and equipment procurement planning within low- and middle-income countries.", {"entities": []}], ["We explore the factors/evidence-base proposed for consideration within such methods and identify prioritization criteria.", {"entities": []}], ["We included 217 documents (corresponding to 250 texts) in the narrative synthesis.", {"entities": []}], ["Of these 111 featured in the meta-summary.", {"entities": []}], ["We identify experience and needs-based methods used to reach procurement decisions.", {"entities": []}], ["Equipment costs (including maintenance) and health needs are the dominant issues considered.", {"entities": []}], ["Extracted data suggest that procurement officials should prioritize devices with low- and middle-income country appropriate technical specifications \u2013 i.e.", {"entities": []}], ["devices and equipment that can be used given available human resources, infrastructure and maintenance capacity.", {"entities": []}], ["Suboptimal device use is directly linked to incomplete costing and inadequate consideration of maintenance services and user training during procurement planning.", {"entities": []}], ["Accurate estimation of life-cycle costing and careful consideration of device servicing are of crucial importance.", {"entities": []}], ["The online version of this article (doi:10.1186/s12992-017-0280-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Early-life exposure to p,p \u2032-DDT [2,2-bis( p -chlorophenyl)-1,1,1-trichloroethane] is associated with a decrease in cognitive skills among preschoolers at 4 years of age.", {"entities": []}], ["We hypothesized that genetic variability in glutathione S -transferase (GST) genes ( GSTP1 , GSTM1 , and GSTT1 ) could influence the effects of prenatal exposure to p,p \u2032 - DDT.", {"entities": [[85, 90, "GENE"], [93, 98, "GENE"], [105, 110, "GENE"]]}], ["We used data from 326 children assessed in a prospective population-based birth cohort at the age of 4 years.", {"entities": []}], ["In that study, the McCarthy Scales of Children\u2019s Abilities were administrated by psychologists, organochlorine compounds were measured in cord serum, and genotyping was conducted for the coding variant Ile105Val from GSTP1 and for null alleles from GSTM1 and GSTT1 .", {"entities": [[217, 222, "GENE"], [249, 254, "GENE"], [259, 264, "GENE"]]}], ["We used linear regression models to measure the association between organochlorines and neurodevelopmental scores by GST polymorphisms.", {"entities": []}], ["p,p \u2032 - DDT cord serum concentration was inversely associated with general cognitive, memory, quantitative, and verbal skills, as well as executive function and working memory, in children who had any GSTP1 Val-105 allele.", {"entities": [[201, 206, "GENE"]]}], ["GSTP1 polymorphisms and prenatal p,p \u2032 - DDT exposure showed a statistically significant interaction for general cognitive skills ( p = 0.05), quantitative skills ( p = 0.02), executive function ( p = 0.01), and working memory ( p = 0.02).", {"entities": [[0, 5, "GENE"]]}], ["There were no significant associations between p,p \u2032 - DDT and cognitive functioning at 4 years of age according to GSTM1 and GSTT1 polymorphisms.", {"entities": [[116, 121, "GENE"], [126, 131, "GENE"]]}], ["Results indicate that children with GSTP1 Val-105 allele were at higher risk of the adverse cognitive functioning effects of prenatal p,p \u2032 - DDT exposure.", {"entities": [[36, 41, "GENE"]]}], ["Sensitization and exposure to the allergenic fungus Alternaria alternata has been associated with increased risk of asthma and asthma exacerbations.", {"entities": [[116, 122, "DISEASE"], [127, 133, "DISEASE"]]}], ["The first cells to encounter inhaled allergens are epithelial cells at the airway mucosal surface.", {"entities": []}], ["Epithelial barrier function has previously been reported to be defective in asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["This study investigated the contribution of proteases from Alternaria alternata on epithelial barrier function and inflammatory responses and compared responses of in vitro cultures of differentiated bronchial epithelial cells derived from severely asthmatic donors with those from non-asthmatic controls.", {"entities": []}], ["Polarised 16HBE cells or air-liquid interface (ALI) bronchial epithelial cultures from non-asthmatic or severe asthmatic donors were challenged apically with extracts of Alternaria and changes in inflammatory cytokine release and transepithelial electrical resistance (TER) were measured.", {"entities": []}], ["Protease activity in Alternaria extracts was characterised and the effect of selectively inhibiting protease activity on epithelial responses was examined using protease inhibitors and heat-treatment.", {"entities": []}], ["In 16HBE cells, Alternaria extracts stimulated release of IL-8 and TNF\u03b1, with concomitant reduction in TER; these effects were prevented by heat-treatment of the extracts.", {"entities": []}], ["Examination of the effects of protease inhibitors suggested that serine proteases were the predominant class of proteases mediating these effects.", {"entities": []}], ["ALI cultures from asthmatic donors exhibited a reduced IL-8 response to Alternaria relative to those from healthy controls, while neither responded with increased thymic stromal lymphopoietin (TSLP) release.", {"entities": [[193, 197, "GENE"]]}], ["Only cultures from asthmatic donors were susceptible to the barrier-weakening effects of Alternaria .", {"entities": []}], ["Therefore, the bronchial epithelium of severely asthmatic individuals may be more susceptible to the deleterious effects of Alternaria .", {"entities": []}], ["The aim of study is to determine whether chronic osteomyelitis (COM) is linked to an increased risk of head and neck cancer (HNC).", {"entities": [[49, 62, "DISEASE"], [117, 123, "DISEASE"]]}], ["We identify 17,033 patients with osteomyelitis and 68,125 subjects without osteomyelitis during 1996 to 2010 periods.", {"entities": [[33, 46, "DISEASE"], [75, 88, "DISEASE"]]}], ["Multivariable Cox proportional hazards regression analysis was used to measure the hazard ratio (HR) of head and neck cancer for the osteomyelitis cohort compared with the comparison cohort.", {"entities": [[133, 146, "DISEASE"], [118, 124, "DISEASE"], [97, 99, "GENE"]]}], ["A total of 99 patients in the COM and 228 patients in the comparison cohort developed HNC during an average 5.12 years of follow-up period.", {"entities": []}], ["The incidence rate of HNC in the COM cohort was 1.51-fold (95% confidence interval [CI]: 1.17\u20131.95) higher than that in the comparison cohort after adjusting gender, age, urbanization level, monthly income, and comorbidities.", {"entities": []}], ["In subgroup analysis, younger (less than 45 years-old) and patients without comorbidities have greater risks (adjusted HR: 2.29 [95% CI:1.43-3.66] and 1.74 [95% CI:1.28-2.38] respectively).", {"entities": [[119, 121, "GENE"]]}], ["This study results suggested the association between COM and HNC, particularly in younger population and patients without comorbidities.", {"entities": []}], ["The article discussed the immanent problems of meta-analyses selecting a number of independent trials in homeopathy, within which, the purpose was to examine the effectiveness of homeopathic treatment.", {"entities": []}], ["Our focus lied in clarifying that the complex effects of homeopathic treatment known from history and day-to-day practice have not been respected so far.", {"entities": []}], ["The examination of most of the homeopathic trials showed that studies rarely account for homeopathic principles, in order to assess the effectiveness of the treatment.", {"entities": []}], ["The main flaw was that trials reflect the point of view that the treatment with a specific remedy could be administered in a particular disease.", {"entities": []}], ["However, homeopathy aims to treat the whole person, rather than the diseases and each case has to be treated individually with an individualized remedy.", {"entities": []}], ["Furthermore, the commonly known events during the course of homeopathic treatment, such as \u201cinitial aggravation\u201d and \u201csymptom-shift\u201d were not considered in almost all the studies.", {"entities": []}], ["Thus, only few trials were eligible for meta-analyses, if at all.", {"entities": []}], ["These and other factors were discussed and certain homeopathic principles were suggested to be respected in further trials.", {"entities": []}], ["It is expected, that a better understanding of homeopathic principles would provide guidelines for homeopathic research, which are more acceptable to both homeopathy and conventional medicine.", {"entities": []}], ["Pulmonary accumulation of neutrophils is typical for active smokers who are also predisposed to multiple inflammatory and infectious lung diseases.", {"entities": []}], ["We show that human neutrophil exposure to cigarette smoke extract (CSE) leads to an atypical cell death sharing features of apoptosis, autophagy and necrosis.", {"entities": []}], ["Accumulation of tar-like substances in autophagosomes is also apparent.", {"entities": []}], ["Before detection of established cell death markers, CSE-treated neutrophils are effectively recognized and non-phlogistically phagocytosed by monocyte-derived macrophages.", {"entities": []}], ["Blockade of LOX-1 and scavenger receptor A, but not MARCO or CD36, as well as pre-incubation with oxLDL, inhibited phagocytosis, suggesting that oxLDL-like structures are major phagocytosis signals.", {"entities": [[61, 65, "GENE"]]}], ["Specific lipid ( \u03b2 -carotene and quercetin), but not aqueous, antioxidants increased the pro-phagocytic effects of CSE.", {"entities": []}], ["In contrast to non-phlogistic phagocytosis, degranulation of secondary granules, as monitored by lactoferrin release, was apparent on CSE exposure, which is likely to promote pulmonary inflammation and tissue degradation.", {"entities": []}], ["Furthermore, CSE-exposed neutrophils exhibited a compromised ability to ingest the respiratory pathogen, Staphylococcus aureus , which likely contributes to bacterial persistence in the lungs of smokers and is likely to promote further pulmonary recruitment of neutrophils.", {"entities": []}], ["These data provide mechanistic insight into the lack of accumulation of apoptotic neutrophil populations in the lungs of smokers and their increased susceptibility to degradative pulmonary diseases and bacterial infections.", {"entities": []}], ["In this study the reliability and validity of generic and disease-specific questionnaires has been assessed focusing on responsiveness.", {"entities": []}], ["This is part of a study on the effects of recurrent acute otitis media (rAOM) on functional health status (FHS) and health-related quality of life (HRQoL) in 383 children with rAOM participating in a randomized clinical trial.", {"entities": [[58, 70, "DISEASE"]]}], ["The following generic questionnaires were studied: 1.", {"entities": []}], ["RAND general health rating index, 2.", {"entities": []}], ["Functional Status Questionnaire (FSQ Generic and FSQ Specific), 3.", {"entities": []}], ["TNO-AZL Infant Quality of Life (TAIQOL), and the following disease-specific questionnaires: 1.", {"entities": []}], ["Otitis Media-6 (OM-6), 2.", {"entities": [[0, 12, "DISEASE"]]}], ["Numerical rating scales (NRS) for child and caregiver (NRS Child and NRS Caregiver), and 3. a new Family Functioning Questionnaire (FFQ).", {"entities": []}], ["Reliability was good to excellent (Cronbach\u2019s \u03b1 range 0.80\u20130.90, intraclass correlation coefficient range 0.76\u20130.93).", {"entities": []}], ["Moderate to strong correlations were found between the questionnaires as well as between questionnaires and relevant clinical indicators ( r \u00a0=\u00a00.29\u20130.49), demonstrating construct validity.", {"entities": []}], ["Discriminant validity for children with few versus frequent episodes of acute otitis media per year was good for most questionnaires ( P \u00a0<\u00a00.004) but poor for the otitis media-related subscales of the TAIQOL ( P \u00a0=\u00a00.10\u20130.97) and both NRS ( P \u00a0=\u00a00.22 and 0.48).", {"entities": [[78, 90, "DISEASE"], [164, 176, "DISEASE"]]}], ["Except for the TAIQOL subscales, change scores were significant ( P \u00a0<\u00a00.003) for generic and disease-specific questionnaires.", {"entities": []}], ["Effect sizes were somewhat higher for disease-specific compared to generic questionnaires (0.55\u20130.95 versus 0.32\u20130.60) except for the TAIQOL subscales, which showed very poor sensitivity to change.", {"entities": []}], ["Anchor-based methods resulted in a somewhat larger range of estimates of MCID than distribution-based methods.", {"entities": []}], ["Combining distribution-based and anchor-based methods resulted in similar ranges for the minimally clinical important differences for generic and disease-specific questionnaires: 2\u201315 points on a 0\u2013100 scale.", {"entities": []}], ["Apart from the generic TAIQOL subscales, both generic and disease-specific questionnaires used in this study showed good psychometric qualities and responsiveness for use in clinical studies on children with rAOM.", {"entities": []}], ["This study aimed to estimate the prevalence of respiratory symptoms and to assess respiratory health risks associated with Particulate Matter (PM) exposure among the residents of Windhoek, Namibia.", {"entities": []}], ["Objectives: To measure particulate pollution concentration in Windhoek through monitoring of particulate matter concentration and to identify any associations between particulate pollution, individual location, and respiratory health among the Windhoek resident\u2019s.", {"entities": []}], ["Methods: an adapted standardized self-administered questionnaire was used to collect respiratory health related data as well as previous exposure, while PM monitoring was done using the ASTM (American Standard Test Method) D1739 reference method.", {"entities": []}], ["Results: A high prevalence was observed for cough (43%), breathlessness (25%), and asthma (11.2%).", {"entities": [[83, 89, "DISEASE"]]}], ["PM was found to be a significant risk factor for episodes of coughing and phlegm, while high PM exposure category had an increased odds ratio (OR) for episodes of phlegm and cough (OR: 2.5, 95% CI (95% confidence intervals): 0.8\u20138.0).", {"entities": []}], ["No association was observed between location and respiratory health outcomes.", {"entities": []}], ["Conclusions: The study found high levels of PM concentration across all Windhoek suburbs which were above the German, American, and Environmental Protection Agency (EPA).", {"entities": []}], ["Enactment of legislation relating to the control and monitoring of PM related emissions at the point of generation is required at both a country and city level.", {"entities": []}], ["Previous studies have found that smoking cessation is associated with a short-term increase in health-care use.", {"entities": []}], ["This may be because \u2018sicker\u2019 smokers are more likely to stop smoking.", {"entities": []}], ["The current study assessed the association between smoking cessation and health-care use, adjusting for pre-cessation physical and mental health conditions.", {"entities": []}], ["Data came from the ATTEMPT cohort, a multi-national prospective survey of smokers in the United States, Canada, United Kingdom, France and Spain, that lasted 18 months (with follow-ups every 3 months).", {"entities": []}], ["A total of 3645 smokers completed the baseline questionnaire.", {"entities": []}], ["All participants smoked at least five cigarettes per day, intended to quit smoking within the next 3 months and were between 35 and 65 years of age.", {"entities": []}], ["Participants were asked questions about their socio-demographic and smoking characteristics, as well previous smoking-related morbidities.", {"entities": []}], ["Participants were also asked to report their health-care use in the previous 3 months i.e.", {"entities": []}], ["emergency room (ER) visits, hospitalization, whether hospitalization required surgery, and health-care appointments.", {"entities": []}], ["A total of 8252, 4779 and 1954 baseline episodes of smoking were available for 3, 6 and 12 months, respectively.", {"entities": []}], ["Of these, 2.8% ( n = 230), 0.9% ( n = 40) and 0.7% ( n = 14) were followed by 3, 6 and 12 months of abstinence.", {"entities": []}], ["No significant differences were found among 3, 6 or 12 months of abstinence and ER visits, hospitalization and whether hospitalization required surgery or health-care visits.", {"entities": []}], ["However, 6-month smoking cessation episodes were associated with higher odds of reporting an appointment with a dietician.", {"entities": []}], ["Smoking cessation does not appear to be associated with a substantial short-term increase or decrease in health-care use after adjusting for pre-cessation morbidities.", {"entities": []}], ["We sought to elucidate the long-term association of tobacco use and respiratory health in designated pollution victims with and without obstructive pulmonary defects.", {"entities": []}], ["A retrospective cross-sectional study.", {"entities": []}], ["The register of pollution victims in Kurashiki, Japan.", {"entities": []}], ["730 individuals over 65\u2005years of age previously diagnosed with pollution-related respiratory disease.", {"entities": []}], ["Patients were classified into four groups according to their smoking status and whether they had obstructive pulmonary disease.", {"entities": []}], ["We then compared the prevalence of respiratory symptoms and lung function over time between groups.", {"entities": []}], ["Spirometry was performed and a respiratory health questionnaire completed in the same season each year for up to 30\u2005years.", {"entities": []}], ["Rates of smoking and respiratory disease were high in our sample.", {"entities": []}], ["Although respiratory function in non-smoking patients did not completely recover, the annual rate of change in lung function was within the normal range (p<0.01).", {"entities": []}], ["However, smokers had worse lung function and were more likely to report more severe pulmonary symptoms (p<0.01).", {"entities": []}], ["Patients\u2019 respiratory function did not fully recover despite improved air quality.", {"entities": []}], ["Our results suggest that, in the context of exposure to air pollution, tobacco use causes additional loss of lung function and exacerbates respiratory symptoms.", {"entities": []}], ["In some diseases, a very important role is played by the ability of bacteria to form multi-dimensional complex structure known as biofilm.", {"entities": []}], ["The most common disease of the oral cavity, known as dental caries, is a top leader.", {"entities": [[53, 66, "DISEASE"]]}], ["Streptococcus mutans , one of the many etiological factors of dental caries, is a microorganism which is able to acquire new properties allowing for the expression of pathogenicity determinants determining its virulence in specific environmental conditions.", {"entities": [[62, 75, "DISEASE"]]}], ["Through the mechanism of adhesion to a solid surface, S. mutans is capable of colonizing the oral cavity and also of forming bacterial biofilm.", {"entities": []}], ["Additional properties enabling S. mutans to colonize the oral cavity include the ability to survive in an acidic environment and specific interaction with other microorganisms colonizing this ecosystem.", {"entities": []}], ["This review is an attempt to establish which characteristics associated with biofilm formation\u2014virulence determinants of S. mutans \u2014are responsible for the development of dental caries.", {"entities": [[171, 184, "DISEASE"]]}], ["In order to extend the knowledge of the nature of Streptococcus infections, an attempt to face the following problems will be made: Biofilm formation as a complex process of protein\u2013bacterium interaction.", {"entities": []}], ["To what extent do microorganisms of the cariogenic flora exemplified by S. mutans differ in virulence determinants \u201cexpression\u201d from microorganisms of physiological flora?", {"entities": []}], ["How does the environment of the oral cavity and its microorganisms affect the biofilm formation of dominant species?", {"entities": []}], ["How do selected inhibitors affect the biofilm formation of cariogenic microorganisms?", {"entities": []}], ["Many innovations in the development and use of air sampling devices have occurred in plant pathology since the first description of the Hirst spore trap.", {"entities": []}], ["These include improvements in capture efficiency at relatively high air-volume collection rates, methods to enhance the ease of sample processing with downstream diagnostic methods and even full automation of sampling, diagnosis and wireless reporting of results.", {"entities": []}], ["Other innovations have been to mount air samplers on mobile platforms such as UAVs and ground vehicles to allow sampling at different altitudes and locations in a short space of time to identify potential sources and population structure.", {"entities": []}], ["Geographical Information Systems and the application to a network of samplers can allow a greater prediction of airborne inoculum and dispersal dynamics.", {"entities": []}], ["This field of technology is now developing quickly as novel diagnostic methods allow increasingly rapid and accurate quantifications of airborne species and genetic traits.", {"entities": []}], ["Sampling and interpretation of results, particularly action-thresholds, is improved by understanding components of air dispersal and dilution processes and can add greater precision in the application of crop protection products as part of integrated pest and disease management decisions.", {"entities": []}], ["The applications of air samplers are likely to increase, with much greater adoption by growers or industry support workers to aid in crop protection decisions.", {"entities": []}], ["The same devices are likely to improve information available for detection of allergens causing hay fever and asthma or provide valuable metadata for regional plant disease dynamics.", {"entities": [[110, 116, "DISEASE"]]}], ["Neutrophils represent the front-line defence cells in protecting organisms against infection and play an irreplaceable role in the proper performance of the immune system.", {"entities": []}], ["As early as within the first minutes of stimulation, neutrophilic NADPH oxidase is activated, and cells release large quantities of highly toxic reactive oxygen species (ROS).", {"entities": []}], ["These oxidants can be highly toxic not only for infectious agents but also for neighboring host tissues.", {"entities": []}], ["Since flavonoids exhibit antioxidant and anti-inflammatory effects, they are subjects of interest for pharmacological modulation of ROS production.", {"entities": []}], ["The present paper summarizes contemporary knowledge on the effects of various flavonoids on the respiratory burst of mammalian neutrophils.", {"entities": []}], ["It can be summarized that the inhibitory effects of flavonoids on the respiratory burst of phagocytes are mediated via inhibition of enzymes involved in cell signaling as well as via modulation of redox status.", {"entities": []}], ["However, the effects of flavonoids are even more complex, and several sites of action, depending upon the flavonoid structure and way of application, are included.", {"entities": []}], ["With recognition of the important roles of Vitamin D (VitD) in various physiological processes, increasing attention has been drawn to the status of VitD in early life.", {"entities": []}], ["However, the VitD status of young children and the related factors in rural areas of Southwestern China remain unclear.", {"entities": []}], ["This study aimed to explore VitD status and its seasonal variation in 18-month-old children living in rural Southwestern China.", {"entities": []}], ["The association of VitD with biochemical and anthropometric variables was also investigated.", {"entities": []}], ["A total of 177 18-month-old children in a rural area of Yunnan Province, Southwestern China, were enrolled.", {"entities": []}], ["Serum concentrations of 25-hydroxy Vitamin D (25(OH)D) were measured through high-performance liquid chromatogram-tandem mass spectrometry.", {"entities": []}], ["Parathyroid hormone (PTH) levels were measured with a chemiluminescence assay.", {"entities": [[21, 24, "GENE"]]}], ["Serum concentrations of calcium, phosphorus, and alkaline phosphatase (ALP) were also measured.", {"entities": []}], ["Anthropometric data and the outdoor activity time of each participant were collected.", {"entities": []}], ["The serum 25(OH)D concentration was 26.61 \u00b1 7.26 ng/ml; concentrations lower than 30 ng/ml accounted for 70.6% of the participants and concentrations lower than 20 ng/ml accounted for 16.4%.", {"entities": []}], ["The level of serum 25(OH)D was not significantly different among four seasons ( P >0.05).", {"entities": []}], ["A positive relationship was found between 25(OH)D concentration and the time of outdoor activities ( r = 0.168, P < 0.05).", {"entities": []}], ["Serum PTH concentration was negatively correlated with 25(OH)D concentration ( r = \u22120.163, P < 0.05).", {"entities": [[6, 9, "GENE"]]}], ["A positive relationship was found between the serum concentrations of 25(OH)D and calcium ( r = 0.154, P < 0.05).", {"entities": []}], ["No significant association was observed between 25(OH)D and ALP, phosphorus, or anthropometric variables.", {"entities": []}], ["The prevalence of VitD insufficiency is high among young children in the rural Southwestern China regardless of the seasons.", {"entities": []}], ["VitD supplementation is still essential to maintain VitD sufficiency for children living in rural area.", {"entities": []}], ["Ideal biomarkers used for disease diagnosis should display deviating levels in affected individuals only and be robust to factors unrelated to the disease.", {"entities": []}], ["Here we show the impact of genetic, clinical and lifestyle factors on circulating levels of 92 protein biomarkers for cancer and inflammation, using a population-based cohort of 1,005 individuals.", {"entities": [[118, 124, "DISEASE"]]}], ["For 75% of the biomarkers, the levels are significantly heritable and genome-wide association studies identifies 16 novel loci and replicate 2 previously known loci with strong effects on one or several of the biomarkers with P -values down to 4.4 \u00d7 10 Protein biomarkers could play an important role in the diagnosis and management of diseases.", {"entities": []}], ["Here the authors investigate the impact of genetic, clinical and lifestyle factors on 92 protein biomarkers for cancer and inflammation and suggest that personalized biomarker thresholds should be used in cancer management.", {"entities": [[112, 118, "DISEASE"], [205, 211, "DISEASE"]]}], ["Cytokines have always been of great interest due to their vast potential and participation in the progression and pathogenesis of various ailments.", {"entities": []}], ["Interleukin-32 (IL-32) is a recently identified cytokine, whose gene is located on human chromosome 16 p13.3, with eight exons and six splice variants (IL-32\u03b1 to IL-32\u03b6).", {"entities": []}], ["IL-32\u03b1, the most abundant form, is secreted by different types of cells including T cells, natural killer (NK) cells, monocytes, endothelial cells and epithelial cells.", {"entities": []}], ["It acts as a preferential mediator and effector of abnormal immune responses to multiple inflammatory and auto immune diseases including rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), etc.", {"entities": [[205, 231, "DISEASE"], [137, 157, "DISEASE"], [159, 196, "DISEASE"], [148, 157, "DISEASE"]]}], ["It was found to stimulate the induction of various chemokines, pro-inflammatory cytokines including IL-1\u03b2, IL-6, IL-8, TNF-\u03b1 and macrophage inflammatory protein-2 (MIP-2).", {"entities": []}], ["Hence, IL-32 mediates the crucial interplay among immune system and body cells during pathogenesis of various insults.", {"entities": []}], ["The aim of the present effort is to summarize the role, mechanism of pathogenesis and potential therapeutic applications of IL-32 in different systemic infections and diseased conditions.", {"entities": []}], ["To determine the prevalence and the severity of wheezing in the first year of life for infants who live in Santo Andr\u00e9, S\u00e3o Paulo, Brazil.", {"entities": []}], ["Cross sectional study with the administration of the Estudio Internacional de Sibilancias en Lactantes (EISL), which is a standardized and validated written questionnaire applied to parents and/or guardians of infants aged 12-24 months treated at primary health units, vaccination centers, day care centers, or kindergartens.", {"entities": []}], ["The questionnaire consisted of questions regarding demographic characteristics, presence of wheezing, respiratory infections, and risk factors.", {"entities": []}], ["Results were analyzed using the SPSS for Windows, 20.0 (SPSS Inc. - Chicago, Il, United States).", {"entities": []}], ["Logistic regression was applied to verify variables associated to recurrent wheezing.", {"entities": []}], ["Among the 1,028 infants studied, 48.5% had one or more episodes of wheezing during the first 12 months of life (wheezing once), and 23.9% had three or more episodes (recurrent wheezing).", {"entities": []}], ["Nocturnal symptoms, severe breathing difficulty, and visits to the emergency room were observed in 67.3%, 42.4%, and 60.7% of infants, respectively.", {"entities": []}], ["Among the studied infants, 19.4% were hospitalized, and 11.0% had a medical diagnosis of asthma in the first year of life.", {"entities": [[89, 95, "DISEASE"]]}], ["Use of \u03b22-agonists, inhaled corticosteroids, oral corticosteroids, and leukotriene receptor antagonists were observed in 88.8%, 21.0%, 54.9%, and 3.2% of children with wheezing, respectively.", {"entities": []}], ["Use of oral corticosteroids, perception of breathlessness by parents, diagnosis of asthma, pneumonia, and hospitalization for pneumonia were more frequent among infants with recurrent wheezing ( p <0.001).", {"entities": [[91, 100, "DISEASE"], [126, 135, "DISEASE"], [83, 89, "DISEASE"]]}], ["In the city of Santo Andr\u00e9, approximately half of infants had at least one episode of wheezing in the first year of life, and almost 25% had recurrent wheezing.", {"entities": []}], ["Wheezing disorders in Santo Andr\u00e9 have early onset and high morbidity.", {"entities": []}], ["Verificar a preval\u00eancia e a gravidade da sibil\u00e2ncia no primeiro ano de vida em lactentes no munic\u00edpio de Santo Andr\u00e9.", {"entities": []}], ["Estudo transversal com aplica\u00e7\u00e3o de question\u00e1rio escrito, padronizado e validado do estudo EISL (do espanhol: Estudio Internacional de Sibilancias en Lactantes) aos pais e/ou respons\u00e1veis por lactentes de 12 a 24 meses de idade, em unidades b\u00e1sicas de sa\u00fade, durante campanhas de vacina\u00e7\u00e3o em creches e escolas maternais.", {"entities": [[188, 191, "GENE"]]}], ["O question\u00e1rio consiste de quest\u00f5es sobre caracter\u00edsticas demogr\u00e1ficas, presen\u00e7a de sibil\u00e2ncia, infec\u00e7\u00f5es respirat\u00f3rias e fatores de risco.", {"entities": []}], ["Os dados obtidos foram analisados com o Statistical Package for the Social Sciences for Windows, vers\u00e3o 20.0 (SPSS inc., Chicago, Il, EUA).", {"entities": []}], ["A regress\u00e3o log\u00edstica foi aplicada para analisar as vari\u00e1veis associadas \u00e0 presen\u00e7a de sibilos recorrentes.", {"entities": []}], ["Do total de 1.028 lactentes estudados, 48,5% apresentaram um ou mais epis\u00f3dios de sibil\u00e2ncia nos primeiros 12 meses de vida (sibil\u00e2ncia alguma vez) e 23,9%, tr\u00eas ou mais epis\u00f3dios (sibil\u00e2ncia recorrente).", {"entities": []}], ["Sintomas noturnos, dificuldade intensa para respirar e visitas \u00e0 emerg\u00eancia estiveram presentes em 67,3%, 42,4% e 60,7% dos lactentes, respectivamente, sendo que 19,4% foram hospitalizados e 11,0% tiveram diagn\u00f3stico m\u00e9dico de asma.", {"entities": []}], ["O uso de \u03b22-agonistas, corticoides inalat\u00f3rios, corticoides orais e antagonistas do receptor de leucotrienos foram observados em 88,8%, 21,0%, 54,9% e 3,2% das crian\u00e7as com sibil\u00e2ncia, respectivamente.", {"entities": []}], ["Uso de corticoide oral, percep\u00e7\u00e3o de falta de ar pelos pais, diagn\u00f3stico de asma, pneumonia e hospitaliza\u00e7\u00e3o por pneumonia foram mais frequentes entre os sibilantes recorrentes ( p <0,001).", {"entities": [[82, 91, "DISEASE"], [113, 122, "DISEASE"], [109, 112, "GENE"]]}], ["No munic\u00edpio de Santo Andr\u00e9, cerca da metade dos lactentes estudados apresentava pelo menos um epis\u00f3dio de sibil\u00e2ncia no primeiro ano de vida, e metade deles apresentou sibil\u00e2ncia recorrente, com in\u00edcio precoce e alta morbidade.", {"entities": [[81, 85, "GENE"]]}], ["Cumulative risk assessment has been proposed as an approach to evaluate the health risks associated with simultaneous exposure to multiple chemical and non-chemical stressors.", {"entities": []}], ["Physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models can allow for the inclusion and evaluation of multiple stressors, including non-chemical stressors, but studies have not leveraged PBPK/PD models to jointly consider these disparate exposures in a cumulative risk context.", {"entities": []}], ["In this study, we focused on exposures to organophosphate (OP) pesticides for children in urban low-income environments, where these children would be simultaneously exposed to other pesticides (including pyrethroids) and non-chemical stressors that may modify the effects of these exposures (including diet).", {"entities": []}], ["We developed a methodological framework to evaluate chemical and non-chemical stressor impacts on OPs, utilizing an existing PBPK/PD model for chlorpyrifos.", {"entities": []}], ["We evaluated population-specific stressors that would influence OP doses or acetylcholinesterase (AChE) inhibition, the relevant PD outcome.", {"entities": []}], ["We incorporated the impact of simultaneous exposure to pyrethroids and dietary factors on OP dose through the compartments of metabolism and PD outcome within the PBPK model, and simulated combinations of stressors across multiple exposure ranges and potential body weights.", {"entities": []}], ["Our analyses demonstrated that both chemical and non-chemical stressors can influence the health implications of OP exposures, with up to 5-fold variability in AChE inhibition across combinations of stressor values for a given OP dose.", {"entities": []}], ["We demonstrate an approach for modeling OP risks in the presence of other population-specific environmental stressors, providing insight about co-exposures and variability factors that most impact OP health risks and contribute to children\u2019s cumulative health risk from pesticides.", {"entities": []}], ["More generally, this framework can be used to inform cumulative risk assessment for any compound impacted by chemical and non-chemical stressors through metabolism or PD outcomes.", {"entities": []}], ["Fertilized soils have large potential for production of soil nitrogen oxide (NO x =NO+NO 2 ), however these emissions are difficult to predict in high-temperature environments.", {"entities": []}], ["Understanding these emissions may improve air quality modelling as NO x contributes to formation of tropospheric ozone (O 3 ), a powerful air pollutant.", {"entities": []}], ["Here we identify the environmental and management factors that regulate soil NO x emissions in a high-temperature agricultural region of California.", {"entities": []}], ["We also investigate whether soil NO x emissions are capable of influencing regional air quality.", {"entities": []}], ["We report some of the highest soil NO x emissions ever observed.", {"entities": []}], ["Emissions vary nonlinearly with fertilization, temperature and soil moisture.", {"entities": []}], ["We find that a regional air chemistry model often underestimates soil NO x emissions and NO x at the surface and in the troposphere.", {"entities": []}], ["Adjusting the model to match NO x observations leads to elevated tropospheric O 3 .", {"entities": []}], ["Our results suggest management can greatly reduce soil NO x emissions, thereby improving air quality.", {"entities": []}], ["Soil NO x emissions can significantly impact air quality in agricultural regions, particularly high temperature fertilized systems.", {"entities": []}], ["Here, the authors investigate NO x emissions in one such system in California and suggest that the NO x emissions are the highest ever observed, with implications for air quality.", {"entities": []}], ["Background: Carrier screening for autosomal recessive disorders aims to facilitate reproductive decision-making by identifying couples with a 1-in-4 risk in every pregnancy of having an affected child.", {"entities": []}], ["Except for a few countries or regions, carrier screening is not widely offered and is mostly ancestry-based.", {"entities": []}], ["Technological advances enable carrier screening for multiple diseases simultaneously allowing universal screening regardless of ancestry (population-based expanded carrier screening).", {"entities": []}], ["It is important to study how this can be successfully implemented.", {"entities": []}], ["This study therefore aims to identify critical factors involved in successful implementation, from a user perspective, by learning from already implemented initiatives.", {"entities": []}], ["Methods: Factors associated with successful implementation were identified by: (i) a literature review and (ii) two case studies; studying experiences with carrier screening in two high-risk communities (a Dutch founder population and the Ashkenazi Jewish population), including a survey among community members.", {"entities": []}], ["Results: Factors identified were familiarity with (specific) genetic diseases and its availability, high perceived benefits of screening (e.g.", {"entities": []}], ["screening avoids much suffering), acceptance of reproductive options, perceived risk of being a carrier and low perceived social barriers (e.g.", {"entities": []}], ["stigmatization).", {"entities": []}], ["In contrast to the Jewish community, the initial demand for screening in the Dutch founder population did not entirely come from the community itself.", {"entities": []}], ["However, the large social cohesion of the community facilitated the implementation process.", {"entities": []}], ["Conclusion: To ensure successful implementation of population-based expanded carrier screening, efforts should be made to increase knowledge about genetic diseases, create awareness and address personal benefits of screening in a non-directive way.", {"entities": []}], ["We conducted a time-series analysis of daily hospital visits and air pollution data to assess acute effects of air pollution on daily unscheduled outpatient visits to internal medicine, pediatric, and emergency departments in the No.", {"entities": []}], ["3 Affiliated Hospital of Beijing Medical University in Beijing, China.", {"entities": []}], ["Sulfur dioxide was marginally significantly associated with total outpatient visits (beta = 41.5, SE = 24.2) and significantly associated with internal medicine (beta = 14.6, SE = 6.7), pediatric (beta = 12.7, SE = 3.7), and emergency room visits (beta = 6.8, SE = 2.7).", {"entities": []}], ["Total suspended particulates (TSP) was a significant predictor for total outpatient (beta = 21.1, SE = 7.7) and pediatric visits (beta = 3.4, SE = 1.3) and a marginally significant predictor of internal medicine visits (beta = 4.2, SE = 2.2).", {"entities": []}], ["In a season-specific analysis, SO2 was a significant predictor for total hospital outpatient visits in summer, although the mean daily SO2 concentration was only 17 micrograms/m3 (maximum = 51 micrograms/m3).", {"entities": []}], ["In winter, SO2 was significantly associated with internal medicine, pediatric, and emergency room visits, and TSP was associated with total outpatient visits.", {"entities": []}], ["This study suggests an exposure-response relationship between TSP and SO2 and hospital outpatient visits, both at high air pollution levels and at levels well below air quality standards recommended by the World Health Organization.", {"entities": []}], ["Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function.", {"entities": [[8, 23, "DISEASE"], [17, 23, "DISEASE"]]}], ["However, the initiating factor that links airway inflammation to remodeling is unknown.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP), an epithelium-derived cytokine, can strongly activate lung dendritic cells (DCs) through the TSLP-TSLPR and OX40L-OX40 signaling pathways to promote Th2 differentiation.", {"entities": [[30, 34, "GENE"], [130, 134, "GENE"]]}], ["To determine whether TSLP is the underlying trigger of airway remodeling in chronic allergen-induced asthma, we induced allergic airway inflammation in mice by intranasal administration of house dust mite (HDM) extracts for up to 5 consecutive weeks.", {"entities": [[101, 107, "DISEASE"], [21, 25, "GENE"]]}], ["We showed that repeated respiratory exposure to HDM caused significant airway eosinophilic inflammation, peribronchial collagen deposition, goblet cell hyperplasia, and airway hyperreactivity (AHR) to methacholine.", {"entities": [[193, 196, "GENE"]]}], ["These effects were accompanied with a salient Th2 response that was characterized by the upregulation of Th2-typed cytokines, such as IL-4 and IL-13, as well as the transcription factor GATA-3.", {"entities": []}], ["Moreover, the levels of TSLP and transforming growth factor beta 1 (TGF-\u03b21) were also increased in the airway.", {"entities": [[24, 28, "GENE"]]}], ["We further demonstrated, using the chronic HDM-induced asthma model, that the inhibition of Th2 responses via neutralization of TSLP with an anti-TSLP mAb reversed airway inflammation, prevented structural alterations, and decreased AHR to methacholine and TGF-\u03b21 level.", {"entities": [[55, 61, "DISEASE"], [128, 132, "GENE"], [146, 150, "GENE"], [233, 236, "GENE"]]}], ["These results suggest that TSLP plays a pivotal role in the initiation and persistence of airway inflammation and remodeling in the context of chronic allergic asthma.", {"entities": [[151, 166, "DISEASE"], [160, 166, "DISEASE"], [27, 31, "GENE"]]}], ["The 65-item Functional Performance Inventory (FPI), developed to quantify functional performance in patients with chronic obstructive pulmonary disease (COPD), has been shown to be reliable and valid.", {"entities": [[114, 151, "DISEASE"]]}], ["The purpose of this study was to create a shorter version of the FPI while preserving the integrity and psychometric properties of the original.", {"entities": []}], ["Secondary analyses were performed on qualitative and quantitative data used to develop and validate the FPI long form.", {"entities": []}], ["Seventeen men and women with COPD participated in the qualitative work, while 154 took part in the mail survey; 54 completed 2-week reproducibility assessment, and 40 relatives contributed validation data.", {"entities": []}], ["Following a systematic process of item reduction, performance properties of the 32-item short form (FPI-SF) were examined.", {"entities": []}], ["The FPI-SF was internally consistent (total scale \u03b1 = 0.93; subscales: 0.76\u20130.89) and reproducible ( r = 0.88; subscales: 0.69\u20130.86).", {"entities": []}], ["Validity was maintained, with significant ( P < 0.001) correlations between the FPI-SF and the Functional Status Questionnaire (activities of daily living, r = 0.71; instrumental activities of daily living, r = 0.73), Duke Activity Status Index ( r = 0.65), Bronchitis-Emphysema Symptom Checklist ( r = \u22120.61), Basic Need Satisfaction Inventory ( r = 0.61) and Cantril\u2019s Ladder of Life Satisfaction ( r = 0.63), and Katz Adjustment Scale for Relatives (socially expected activities, r = 0.51; free-time activities, r = \u22120.49, P < 0.01).", {"entities": []}], ["The FPI-SF differentiated patients with an FEV l % predicted greater than and less than 50% ( t = 4.26, P < 0.001), and those with severe and moderate levels of perceived severity and activity limitation ( t = 9.91, P < 0.001).", {"entities": [[43, 46, "GENE"]]}], ["Results suggest the FPI-SF is a viable alternative to the FPI for situations in which a shorter instrument is desired.", {"entities": []}], ["Further assessment of the instrument\u2019s performance properties in new samples of patients with COPD is warranted.", {"entities": []}], ["The reticular basement membrane (Rbm) in smokers and especially smokers with COPD is fragmented with \"clefts\" containing cells staining for the collagenase matrix-metalloproteinase-9 (MMP-9) and fibroblast protein, S100A4.", {"entities": [[33, 36, "GENE"], [215, 221, "GENE"]]}], ["These cells are also present in the basal epithelium.", {"entities": []}], ["Such changes are likely hallmarks of epithelial mesenchymal transition (EMT).", {"entities": []}], ["We aimed to confirm the epithelial origin of these Rbm cells, and to exclude potential confounding by infiltrating inflammatory cells.", {"entities": [[51, 54, "GENE"]]}], ["Endobronchial biopsy sections from 17 COPD current smokers, with documented Rbm splitting and cellularity were stained for neutrophil elastase (neutrophil marker), CD68 (macrophage/mature fibroblasts), CD4+/CD8+ T lymphocytes, CD19 (B-cells), CD11c (dendritic cells/inflammatory cells), and S100 (Langerhans cells).", {"entities": [[76, 79, "GENE"], [164, 168, "GENE"], [227, 231, "GENE"]]}], ["The number of cells in the Rbm and epithelium staining for these \"inflammatory\" cell markers were then compared to numbers staining for S100A4, \"a documented EMT epitope\".", {"entities": [[27, 30, "GENE"], [136, 142, "GENE"]]}], ["Slides were double stained for S100A4 and cytokeratin(s).", {"entities": [[31, 37, "GENE"]]}], ["In the basal epithelium significantly more cells stained for S100A4 compared to infiltrating macrophages, fibroblasts or immune cells: median, 26 (21.3 - 37.3) versus 0 (0 - 9.6) per mm, p < 0.003.", {"entities": [[61, 67, "GENE"]]}], ["Markedly more S100A4 staining cells were also observed in the Rbm compared to infiltrating macrophages, neutrophils, fibroblasts or immune cells or any sub-type: 58 (37.3 - 92.6) versus 0 (0 - 4.8) cells/mm Rbm, p < 0.003.", {"entities": [[14, 20, "GENE"], [62, 65, "GENE"], [207, 210, "GENE"], [62, 65, "GENE"], [207, 210, "GENE"]]}], ["Cells in the basal epithelium 26 (21.3 - 37.3) per mm) and Rbm (5.9 (2.3 - 13.8) per mm) frequently double stained for both cytokeratin and S100A4.", {"entities": [[59, 62, "GENE"], [140, 146, "GENE"]]}], ["These data provide additional support for active EMT in COPD airways.", {"entities": []}], ["Obesity has some genetic basis but requires interaction with environmental factors for phenotypic expression.", {"entities": [[0, 7, "DISEASE"]]}], ["We examined contributions of gender-specific parental adiposity and smoking to adiposity and related cardiovascular risk in adult offspring.", {"entities": []}], ["Cross-sectional general population survey.", {"entities": []}], ["1456 of the 1477 first generation families in the Midspan Family Study: 2912 parents (aged 45\u201364\u2005years surveyed between 1972 and 1976) who had 1025 sons and 1283 daughters, aged 30\u201359\u2005years surveyed in 1996.", {"entities": []}], ["Offspring body mass index (BMI), waist circumference (WC), cardiometabolic risk (lipids, blood pressure and glucose) and cardiovascular disease as outcome measures, and parental BMI and smoking as determinants.", {"entities": []}], ["All analyses adjusted for age, socioeconomic status and family clustering and offspring birth weight.", {"entities": []}], ["Regression coefficients for BMI associations between father\u2013son (0.30) and mother\u2013daughter (0.33) were greater than father\u2013daughter (0.23) or mother\u2013son (0.22).", {"entities": []}], ["Regression coefficient for the non-genetic, shared-environment or assortative-mating relationship between BMIs of fathers and mothers was 0.19.", {"entities": []}], ["Heritability estimates for BMI were greatest among women with mothers who had BMI either <25 or \u226530\u2005kg/m There are modest genetic/epigenetic influences on the environmental factors behind adverse adiposity.", {"entities": []}], ["Maternal smoking appears a specific hazard on obesity and metabolic syndrome.", {"entities": [[46, 53, "DISEASE"], [68, 76, "DISEASE"]]}], ["A possible epigenetic mechanism linking maternal smoking to obesity and metabolic syndrome in offspring is proposed.", {"entities": [[60, 67, "DISEASE"], [82, 90, "DISEASE"]]}], ["Individuals with family histories of obesity should be targeted from an early age to prevent obesity and complications.", {"entities": [[37, 44, "DISEASE"], [93, 100, "DISEASE"]]}], ["Background .", {"entities": []}], ["The quantification of tumor heterogeneity with molecular images, by analyzing the local or global variation in the spatial arrangements of pixel intensity with texture analysis, possesses a great clinical potential for treatment planning and prognosis.", {"entities": []}], ["To address the lack of available software for computing the tumor heterogeneity on the public domain, we develop a software package, namely, Chang-Gung Image Texture Analysis (CGITA) toolbox, and provide it to the research community as a free, open-source project.", {"entities": []}], ["With a user-friendly graphical interface, CGITA provides users with an easy way to compute more than seventy heterogeneity indices.", {"entities": []}], ["To test and demonstrate the usefulness of CGITA, we used a small cohort of eighteen locally advanced oral cavity (ORC) cancer patients treated with definitive radiotherapies.", {"entities": [[119, 125, "DISEASE"]]}], ["In our case study of ORC data, we found that more than ten of the current implemented heterogeneity indices outperformed SUV mean for outcome prediction in the ROC analysis with a higher area under curve (AUC).", {"entities": []}], ["Heterogeneity indices provide a better area under the curve up to 0.9 than the SUV mean and TLG (0.6 and 0.52, resp.).", {"entities": []}], ["Conclusions .", {"entities": []}], ["CGITA is a free and open-source software package to quantify tumor heterogeneity from molecular images.", {"entities": []}], ["CGITA is available for free for academic use at http://code.google.com/p/cgita .", {"entities": []}], ["Obesity comorbidities are closely associated with chronic low-grade adipose tissue inflammation.", {"entities": [[0, 7, "DISEASE"]]}], ["A number of SNPs associated with inflammation has been identified, underscoring the impact of genetic determinants on this process.", {"entities": []}], ["Here, we screened SNPs in genes with pro-inflammatory (IL-1\u03b2, IL-6, STAT3 and JAK2), anti-inflammatory (IL-10 and SOCS3) and pro-resolving (ERV1/ChemR23) properties in 101 obese and 99 non-obese individuals.", {"entities": [[68, 73, "GENE"], [78, 82, "GENE"], [114, 119, "GENE"]]}], ["Among the SNPs analyzed, we identified that individuals carrying a C allele in the rs1878022 polymorphism of the ERV1/ChemR23 gene, which encodes for the receptor of the pro-resolving mediator RvE1, had increased ERV1/ChemR23 protein expression and reduced levels of the inflammatory cytokine IL-6 in adipose tissue.", {"entities": []}], ["Moreover, patients carrying the C allele in homozygosity had lower plasma levels of IL-6, IFN-\u03b12, IL-15, IL-1ra, IL-10, GM-CSF, G-CSF and VEGF and enhanced leukocyte responsiveness to RvE1.", {"entities": []}], ["C-carriers also exhibited decreased TAG to HDL ratio, a surrogate marker of insulin resistance and a predictor of incident fatty liver.", {"entities": []}], ["Finally, we confirmed in vivo that the ERV1/ChemR23 receptor regulates systemic and tissue inflammation since mice lacking ERV1/ChemR23 expression showed increased IL-6 levels in adipose tissue and peritoneal macrophages.", {"entities": []}], ["Together, our study identified an ERV1/ChemR23 variant that protects patients with obesity from excessive inflammatory burden.", {"entities": [[83, 90, "DISEASE"]]}], ["Guidelines recommend inhaled corticosteroids (ICS) for patients with severe chronic obstructive pulmonary disease (COPD).", {"entities": [[76, 113, "DISEASE"]]}], ["Most COPD patients are managed in primary care and receive ICS long-term and irrespective of severity.", {"entities": []}], ["The effect of withdrawing ICS from COPD patients in primary care is unknown.", {"entities": []}], ["In a pragmatic randomised, double-blind, placebo-controlled trial in 31 practices, 260 COPD patients stopped their usual ICS (median duration of use 8 years) and were allocated to 500 mcg fluticasone propionate twice daily (n = 128), or placebo (n = 132).", {"entities": []}], ["Follow-up assessments took place at three monthly intervals for a year at the patients' practice.", {"entities": []}], ["Our primary outcome was COPD exacerbation frequency.", {"entities": []}], ["Secondary outcomes were time to first COPD exacerbation, reported symptoms, peak expiratory flow rate and reliever inhaler use, and lung function and health related quality of life.", {"entities": []}], ["In patients randomised to placebo, COPD exacerbation risk over one year was RR: 1.11 (CI: 0.91\u20131.36).", {"entities": []}], ["Patients taking placebo were more likely to return to their usual ICS following exacerbation, placebo: 61/128 (48%); fluticasone: 34/132 (26%), OR: 2.35 (CI: 1.38\u20134.05).", {"entities": []}], ["Exacerbation risk whilst taking randomised treatment was significantly raised in the placebo group 1.48 (CI: 1.17\u20131.86).", {"entities": []}], ["Patients taking placebo exacerbated earlier (median time to first exacerbation: placebo (days): 44 (CI: 29\u201359); fluticasone: 63 (CI: 53\u201374), log rank 3.81, P = 0.05) and reported increased wheeze.", {"entities": []}], ["In a post-hoc analysis, patients with mild COPD taking placebo had increased exacerbation risk RR: 1.94 (CI: 1.20\u20133.14).", {"entities": []}], ["Withdrawal of long-term ICS in COPD patients in primary care increases risk of exacerbation shortens time to exacerbation and causes symptom deterioration.", {"entities": []}], ["Patients with mild COPD may be at increased risk of exacerbation after withdrawal.", {"entities": []}], ["ClinicalTrials.gov NCT00440687", {"entities": []}], ["Current techniques used to obtain lung samples have significant limitations and do not provide reproducible biomarkers of inflammation.", {"entities": []}], ["We have developed a novel technique that allows multiple sampling methods from the same area (or multiple areas) of the lung under direct bronchoscopic vision.", {"entities": []}], ["It allows collection of mucosal lining fluid and bronchial brushing from the same site; biopsy samples may also be taken.", {"entities": []}], ["The novel technique takes the same time as standard procedures and can be conducted safely.", {"entities": []}], ["Eight healthy smokers aged 40\u201365 years were included in this study.", {"entities": []}], ["An absorptive filter paper was applied to the bronchial mucosa under direct vision using standard bronchoscopic techniques.", {"entities": []}], ["Further samples were obtained from the same site using bronchial brushings.", {"entities": []}], ["Bronchoalveolar lavage (BAL) was obtained using standard techniques.", {"entities": []}], ["Chemokine (C-C Motif) Ligand 20 (CCL20), CCL4, CCL5, Chemokine (C-X-C Motif) Ligand 1 (CXCL1), CXCL8, CXCL9, CXCL10, CXCL11, Interleukin 1 beta (IL-1\u03b2), IL-6, Vascular endothelial growth factor (VEGF), Matrix metalloproteinase 8 (MMP-8) and MMP-9 were measured in exudate and BAL.", {"entities": [[33, 38, "GENE"], [41, 45, "GENE"], [47, 51, "GENE"], [87, 92, "GENE"], [102, 107, "GENE"], [109, 115, "GENE"], [117, 123, "GENE"]]}], ["mRNA was collected from the bronchial brushings for gene expression analysis.", {"entities": []}], ["A greater than 10 fold concentration of all the biomarkers was detected in lung exudate in comparison to BAL.", {"entities": []}], ["High yield of good quality RNA with RNA integrity numbers (RIN) between 7.6 and 9.3 were extracted from the bronchial brushings.", {"entities": []}], ["The subset of genes measured were reproducible across the samples and corresponded to the inflammatory markers measured in exudate and BAL.", {"entities": []}], ["The bronchoabsorption technique as described offers the ability to sample lung fluid direct from the site of interest without the dilution effects caused by BAL.", {"entities": []}], ["Using this method we were able to successfully measure the concentrations of biomarkers present in the lungs as well as collect high yield mRNA samples for gene expression analysis from the same site.", {"entities": []}], ["This technique demonstrates superior sensitivity to standard BAL for the measurement of biomarkers of inflammation.", {"entities": []}], ["It could replace BAL as the method of choice for these measurements.", {"entities": []}], ["This method provides a systems biology approach to studying the inflammatory markers of respiratory disease progression.", {"entities": []}], ["NHS Health Research Authority ( 13/LO/0256 ).", {"entities": [[0, 3, "GENE"]]}], ["This study was undertaken to determine whether there was an association between fine particle (PM 2.5 ) levels and daily clinic visits for migraine in Taipei, Taiwan.", {"entities": [[139, 147, "DISEASE"]]}], ["Daily clinic visits for migraine and ambient air pollution data for Taipei were obtained for the period from 2006\u20132011.", {"entities": [[24, 32, "DISEASE"]]}], ["The odds ratio of clinic visits was estimated using a case-crossover approach, controlling for weather variables, day of the week, seasonality, and long-term time trends.", {"entities": []}], ["Generally, no significant associations between PM 2.5 levels and migraine visits were observed on cool days.", {"entities": [[65, 73, "DISEASE"]]}], ["On warm days, however, for the single pollutant model (without adjustment for other pollutants), increased clinic visits for migraine were significantly associated with PM 2.5 levels, with an interquartile range (IQR) rise associated with a 13% (95% CI = 8%\u201319%) elevation in number of migraine visits.", {"entities": [[125, 133, "DISEASE"], [286, 294, "DISEASE"]]}], ["In bi-pollutant model, PM 2.5 remained significant after the inclusion of sulfur dioxide (SO 2 ) or ozone (O 3 ) on warm days.", {"entities": []}], ["This study provides evidence that higher levels of PM 2.5 increase the risk of clinic visits for migraine in Taipei, Taiwan.", {"entities": [[97, 105, "DISEASE"]]}], ["Skin has gained substantial attention as a vaccine target organ due to its immunological properties, which include a high density of professional antigen presenting cells (APCs).", {"entities": [[172, 176, "GENE"]]}], ["Previous studies have demonstrated the effectiveness of this vaccination route not only in animal models but also in adults.", {"entities": []}], ["Young children represent a population group that is at high risk from influenza infection.", {"entities": [[70, 79, "DISEASE"]]}], ["As a result, this group could benefit significantly from influenza vaccine delivery approaches through the skin and the improved immune response it can induce.", {"entities": [[57, 66, "DISEASE"]]}], ["In this study, we compared the immune responses in young BALB/c mice upon skin delivery of influenza vaccine with vaccination by the conventional intramuscular route.", {"entities": [[91, 100, "DISEASE"]]}], ["Young mice that received 5\u03bcg of H1N1 A/Ca/07/09 influenza subunit vaccine using MN demonstrated an improved serum antibody response (IgG1 and IgG2a) when compared to the young IM group, accompanied by higher numbers of influenza-specific antibody secreting cells (ASCs) in the bone marrow.", {"entities": [[48, 57, "DISEASE"], [219, 228, "DISEASE"]]}], ["In addition, we observed increased activation of follicular helper T cells and formation of germinal centers in the regional lymph nodes in the MN immunized group, rapid clearance of the virus from their lungs as well as complete survival, compared with partial protection observed in the IM-vaccinated group.", {"entities": []}], ["Our results support the hypothesis that influenza vaccine delivery through the skin would be beneficial for protecting the high-risk young population from influenza infection.", {"entities": [[40, 49, "DISEASE"], [155, 164, "DISEASE"]]}], ["Comorbidities are common in COPD, but quantifying their burden is difficult.", {"entities": []}], ["Currently there is a COPD-specific comorbidity index to predict mortality and another to predict general quality of life.", {"entities": []}], ["We sought to develop and validate a COPD-specific comorbidity score that reflects comorbidity burden on patient-centered outcomes.", {"entities": []}], ["Using the COPDGene study (GOLD II-IV COPD), we developed comorbidity scores to describe patient-centered outcomes employing three techniques: 1) simple count, 2) weighted score, and 3) weighted score based upon statistical selection procedure.", {"entities": []}], ["We tested associations, area under the Curve (AUC) and calibration statistics to validate scores internally with outcomes of respiratory disease-specific quality of life (St. George's Respiratory Questionnaire, SGRQ), six minute walk distance (6MWD), modified Medical Research Council (mMRC) dyspnea score and exacerbation risk, ultimately choosing one score for external validation in SPIROMICS.", {"entities": []}], ["Associations between comorbidities and all outcomes were comparable across the three scores.", {"entities": []}], ["All scores added predictive ability to models including age, gender, race, current smoking status, pack-years smoked and FEV 1 (p<0.001 for all comparisons).", {"entities": [[121, 124, "GENE"]]}], ["Area under the curve (AUC) was similar between all three scores across outcomes: SGRQ (range 0\u00b77624\u20130\u00b77676), MMRC (0\u00b77590\u20130\u00b77644), 6MWD (0\u00b77531\u20130\u00b77560) and exacerbation risk (0\u00b76831\u20130\u00b76919).", {"entities": []}], ["Because of similar performance, the comorbidity count was used for external validation.", {"entities": []}], ["In the SPIROMICS cohort, the comorbidity count performed well to predict SGRQ (AUC 0\u00b77891), MMRC (AUC 0\u00b77611), 6MWD (AUC 0\u00b77086), and exacerbation risk (AUC 0\u00b77341).", {"entities": []}], ["Quantifying comorbidity provides a more thorough understanding of the risk for patient-centered outcomes in COPD.", {"entities": []}], ["A comorbidity count performs well to quantify comorbidity in a diverse population with COPD.", {"entities": []}], ["Pertussis (whooping cough) is frequently complicated by concomitant infections with respiratory viruses.", {"entities": [[0, 9, "DISEASE"]]}], ["Here we report the effect of Bordetella pertussis infection on subsequent influenza virus (PR8) infection in mouse models and the role of pertussis toxin (PT) in this effect.", {"entities": [[74, 83, "DISEASE"], [40, 49, "DISEASE"], [138, 147, "DISEASE"]]}], ["BALB/c mice infected with a wild-type strain of B. pertussis (WT) and subsequently (up to 14 days later) infected with PR8 had significantly increased pulmonary viral titers, lung pathology and mortality compared to mice similarly infected with a PT-deficient mutant strain (\u0394PT) and PR8.", {"entities": [[51, 60, "DISEASE"]]}], ["Substitution of WT infection by intranasal treatment with purified active PT was sufficient to replicate the exacerbating effects on PR8 infection in BALB/c and C57/BL6 mice, but the effects of PT were lost when toxin was administered 24 h after virus inoculation.", {"entities": []}], ["PT had no effect on virus titers in primary cultures of murine tracheal epithelial cells (mTECs) in vitro, suggesting the toxin targets an early immune response to increase viral titers in the mouse model.", {"entities": []}], ["However, type I interferon responses were not affected by PT.", {"entities": []}], ["Whole genome microarray analysis of gene expression in lung tissue from PT-treated and control PR8-infected mice at 12 and 36 h post-virus inoculation revealed that PT treatment suppressed numerous genes associated with communication between innate and adaptive immune responses.", {"entities": []}], ["In mice depleted of alveolar macrophages, increase of pulmonary viral titers by PT treatment was lost.", {"entities": []}], ["PT also suppressed levels of IL-1\u03b2, IL-12, IFN-\u03b3, IL-6, KC, MCP-1 and TNF-\u03b1 in the airways after PR8 infection.", {"entities": []}], ["Furthermore PT treatment inhibited early recruitment of neutrophils and NK cells to the airways.", {"entities": []}], ["Together these findings demonstrate that infection with B. pertussis through PT activity predisposes the host to exacerbated influenza infection by countering protective innate immune responses that control virus titers.", {"entities": [[125, 134, "DISEASE"], [59, 68, "DISEASE"]]}], ["The Keap1-Nrf2 system protects animals from oxidative and electrophilic stresses.", {"entities": []}], ["Nrf2 is a transcription factor that induces the expression of genes essential for detoxifying reactive oxygen species (ROS) and cytotoxic electrophiles.", {"entities": []}], ["Keap1 is a stress sensor protein that binds to and ubiquitinates Nrf2 under unstressed conditions, leading to the rapid proteasomal degradation of Nrf2.", {"entities": [[0, 5, "GENE"]]}], ["Upon exposure to stress, Keap1 is modified and inactivated, which allows Nrf2 to accumulate and activate the transcription of a battery of cytoprotective genes.", {"entities": [[25, 30, "GENE"]]}], ["Antioxidative and detoxification activities are important for many types of cells to avoid DNA damage and cell death.", {"entities": []}], ["Accumulating lines of recent evidence suggest that Nrf2 is also required for the primary functions of myeloid cells, which include phagocytosis, inflammation regulation, and ROS generation for bactericidal activities.", {"entities": []}], ["In fact, results from several mouse models have shown that Nrf2 expression in myeloid cells is required for the proper regulation of inflammation, antitumor immunity, and atherosclerosis.", {"entities": [[171, 186, "DISEASE"]]}], ["Moreover, several molecules generated upon inflammation activate Nrf2.", {"entities": []}], ["Although ROS detoxification mediated by Nrf2 is assumed to be required for anti-inflammation, the entire picture of the Nrf2-mediated regulation of myeloid cell primary functions has yet to be elucidated.", {"entities": []}], ["In this review, we describe the Nrf2 inducers characteristic of myeloid cells and the contributions of Nrf2 to diseases.", {"entities": []}], ["Epidemiological evidence supports the association between exposure to ambient particulate matter (PM) and cardiovascular diseases.", {"entities": []}], ["Chronic exposure to ultrafine particles (UFP; D p <100 nm) is reported to promote atherosclerosis in ApoE knockout mice.", {"entities": [[82, 97, "DISEASE"], [101, 105, "GENE"]]}], ["Atherogenesis-prone factors induce endothelial dysfunction that contributes to the initiation and progression of atherosclerosis.", {"entities": [[113, 128, "DISEASE"]]}], ["We previously demonstrated that UFP induced oxidative stress via c-Jun N-terminal Kinases (JNK) activation in endothelial cells.", {"entities": []}], ["In this study, we investigated pro-inflammatory responses of human aortic endothelial cells (HAEC) exposed to UFP emitted from a diesel truck under an idling mode (UFP1) and an urban dynamometer driving schedule (UFP2), respectively.", {"entities": []}], ["We hypothesize that UFP1 and UFP2 with distinct chemical compositions induce differential pro-inflammatory responses in endothelial cells.", {"entities": []}], ["UFP2 contained a higher level of redox active organic compounds and metals on a per PM mass basis than UFP1.", {"entities": []}], ["While both UFP1 and UFP2 induced superoxide production and up-regulated stress response genes such as heme oxygenease-1 (HO-1), OKL38, and tissue factor (TF), only UFP2 induced the expression of pro-inflammatory genes such as IL-8 (2.8 \u00b1 0.3-fold), MCP-1 (3.9 \u00b1 0.4-fold), and VCAM (6.5 \u00b1 1.1-fold) (n = 3, P < 0.05).", {"entities": [[154, 156, "GENE"]]}], ["UFP2-exposed HAEC also bound to a higher number of monocytes than UFP1-exposed HAEC (Control = 70 \u00b1 7.5, UFP1 = 106.7 \u00b1 12.5, UFP2 = 137.0 \u00b1 8.0, n = 3, P < 0.05).", {"entities": []}], ["Adenovirus NF-\u03baB Luciferase reporter assays revealed that UFP2, but not UFP1, significantly induced NF-\u03baB activities.", {"entities": []}], ["NF-\u03baB inhibitor, CAY10512, significantly abrogated UFP2-induced pro-inflammatory gene expression and monocyte binding.", {"entities": []}], ["While UFP1 induced higher level of oxidative stress and stress response gene expression, only UFP2, with higher levels of redox active organic compounds and metals, induced pro-inflammatory responses via NF-\u03baB signaling.", {"entities": []}], ["Thus, UFP with distinct chemical compositions caused differential response patterns in endothelial cells.", {"entities": []}], ["Cost-utility models are frequently used to compare treatments intended to prevent or delay the onset of cardiovascular events.", {"entities": []}], ["Most published utilities represent post-event health states without incorporating the disutility of the event or reporting the time between the event and utility assessment.", {"entities": []}], ["Therefore, this study estimated health state utilities representing cardiovascular conditions while distinguishing between acute impact including the cardiovascular event and the chronic post-event impact.", {"entities": []}], ["Health states were drafted and refined based on literature review, clinician interviews, and a pilot study.", {"entities": []}], ["Three cardiovascular conditions were described: stroke, acute coronary syndrome (ACS), and heart failure.", {"entities": [[71, 79, "DISEASE"]]}], ["One-year acute health states represented the event and its immediate impact, and post-event health states represented chronic impact.", {"entities": []}], ["UK general population respondents valued the health states in time trade-off tasks with time horizons of one year for acute states and ten years for chronic states.", {"entities": []}], ["A total of 200 participants completed interviews (55% female; mean age\u2009=\u200946.6 y).", {"entities": []}], ["Among acute health states, stroke had the lowest utility (0.33), followed by heart failure (0.60) and ACS (0.67).", {"entities": []}], ["Utility scores for chronic health states followed the same pattern: stroke (0.52), heart failure (0.57), and ACS (0.82).", {"entities": []}], ["For stroke and ACS, acute utilities were significantly lower than chronic post-event utilities (difference\u2009=\u20090.20 and 0.15, respectively; both p\u2009<\u20090.0001).", {"entities": []}], ["Results add to previously published utilities for cardiovascular events by distinguishing between chronic post-event health states and acute health states that include the event and its immediate impact.", {"entities": []}], ["Findings suggest that acute versus chronic impact should be considered when selecting scores for use in cost-utility models.", {"entities": []}], ["Thus, the current utilities provide a unique option that may be used to represent the acute and chronic impact of cardiovascular conditions in economic models comparing treatments that may delay or prevent the onset of cardiovascular events.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-0772-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To determine the mechanisms by which blockade of adenosine A 2B receptors (A 2B Rs) reduces insulin resistance.", {"entities": []}], ["We investigated the effects of deleting or blocking the A 2B R on insulin sensitivity using glucose tolerance tests (GTTs) and hyperinsulinemic-euglycemic clamps in mouse models of type 2 diabetes.", {"entities": []}], ["The effects of diabetes on A 2B R transcription and signaling were measured in human and mouse macrophages and mouse endothelial cells.", {"entities": []}], ["In addition, tag single nucleotide polymorphisms (SNPs) in \u223c42 kb encompassing the A 2B R gene, ADORA2B , were evaluated for associations with markers of diabetes and inflammation.", {"entities": [[96, 103, "GENE"]]}], ["Treatment of mice with the nonselective adenosine receptor agonist 5\u2032- N -ethylcarboxamidoadensoine (NECA) increased fasting blood glucose and slowed glucose disposal during GTTs.", {"entities": []}], ["These responses were inhibited by A 2B R deletion or blockade and minimally affected by deletion of A 1 Rs or A 2A Rs.", {"entities": []}], ["During hyperinsulinemic-euglycemic clamp of diabetic KKA 2B R antagonism increased glucose infusion rate, reduced hepatic glucose production, and increased glucose uptake into skeletal muscle and brown adipose tissue.", {"entities": []}], ["Diabetes caused a four- to sixfold increase in A 2B R mRNA in endothelial cells and macrophages and resulted in enhanced interleukin (IL)-6 production in response to NECA due to activation of protein kinases A and C. Five consecutive tag SNPs in ADORA2B were highly correlated with IL-6 and C-reactive protein (CRP).", {"entities": [[246, 253, "GENE"], [311, 314, "GENE"]]}], ["Diabetes had a highly significant independent effect on variation in inflammatory markers.", {"entities": []}], ["The strength of associations between several ADORA2B SNPs and inflammatory markers was increased when accounting for diabetes status.", {"entities": [[45, 52, "GENE"]]}], ["Diabetes affects the production of adenosine and the expression of A 2B Rs that stimulate IL-6 and CRP production, insulin resistance, and the association between ADORA2B SNPs and inflammatory markers.", {"entities": [[99, 102, "GENE"], [163, 170, "GENE"]]}], ["We hypothesize that increased A 2B R signaling in diabetes increases insulin resistance in part by elevating proinflammatory mediators.", {"entities": []}], ["Selective A 2B R blockers may be useful to treat insulin resistance.", {"entities": []}], ["Consensus on how to adequately measure patient satisfaction with health care is limited, and has led to the development of many questionnaires with various methodological problems.", {"entities": []}], ["The objective of this study was to develop a liver disease- and care-specific patient satisfaction instrument on the basis of previously tested methodology in patient satisfaction measurement, the so called QUOTE- series: Quality Of health care services Through the patients' Eyes.", {"entities": [[45, 58, "DISEASE"]]}], ["QUOTE methodology aims to standardise the measurement of satisfaction as the discrepancy between patients' needs, and the extent to which these needs are being met.", {"entities": []}], ["As part of the QUOTE methodology routine, 11 Patients with chronic liver disease from the Erasmus MC (Rotterdam, the Netherlands) participated in focus-group meetings on patient satisfaction with the provided service at the outpatient hepatology clinic.", {"entities": [[67, 80, "DISEASE"]]}], ["Twenty-eight other patients were invited to rank the items generated during the focus-group meetings according to importance.", {"entities": []}], ["With this information, the QUOTE-Liver was constructed.", {"entities": []}], ["Face validity, construct validity, content validity, and reliability of the newly developed questionnaire were assessed in a test sample of 152 patients with chronic liver disease.", {"entities": [[166, 179, "DISEASE"]]}], ["Two liver-disease specific, and the 18 items ranked as most important were included in the QUOTE-Liver.", {"entities": []}], ["Face validity and content validity were acceptable: neither patients (n = 152) nor psychologists (n = 3) or a hepatologist suggested any extra items to be included.", {"entities": []}], ["Construct validity was good: the overall score correlated significantly with the Visual Analogue Scale (VAS) measuring overall satisfaction (r = 0.69, p < 0.01).", {"entities": []}], ["The reliability of the QUOTE-Liver was excellent (\u03b1 = 0.90).", {"entities": []}], ["The QUOTE-Liver is an easy to complete instrument based on standardized state-of-the-art satisfaction measurement methodology.", {"entities": []}], ["Preliminary evidence for its validity and reliability was demonstrated.", {"entities": []}], ["The QUOTE-liver covers those aspects of satisfaction that CLD patients consider to be important when visiting the outpatient department of hepatology.", {"entities": []}], ["Even though further substantiating of the favourable psychometric findings is desirable, it seems to be a useful instrument that can be used to identify those aspects of care that need improvement in order to optimise the provision of health care for patients with chronic liver disease.", {"entities": [[273, 286, "DISEASE"]]}], ["Nitric oxide (NO) is involved in eating behavior and inflammatory response.", {"entities": []}], ["Moreover, there is evidence that NO production is altered in patients with anorexia nervosa (AN).", {"entities": []}], ["To assess whether the overproduction of NO in AN can affect NO level in exhaled air.", {"entities": []}], ["Exhaled NO level was studied in 23 girls with AN and compared with that of healthy age- and gender-matched nonatopic controls.", {"entities": []}], ["Exhaled NO levels were significantly higher in girls with AN compared with healthy age-matched controls.", {"entities": []}], ["It appears that anorexia nervosa was accompanied by a higher level of exhaled NO, likely resulting from a systemic increase in NO production because of the severe catabolic state.", {"entities": []}], ["Gastroesophageal reflux disease (GORD) can cause respiratory disease in children from recurrent aspiration of gastric contents.", {"entities": []}], ["GORD can be defined in several ways and one of the most common method is presence of reflux oesophagitis.", {"entities": []}], ["In children with GORD and respiratory disease, airway neutrophilia has been described.", {"entities": []}], ["However, there are no prospective studies that have examined airway cellularity in children with GORD but without respiratory disease.", {"entities": []}], ["The aims of the study were to compare (1) BAL cellularity and lipid laden macrophage index (LLMI) and, (2) microbiology of BAL and gastric juices of children with GORD (G+) to those without (G-).", {"entities": []}], ["In 150 children aged <14-years, gastric aspirates and bronchoscopic airway lavage (BAL) were obtained during elective flexible upper endoscopy.", {"entities": []}], ["GORD was defined as presence of reflux oesophagitis on distal oesophageal biopsies.", {"entities": []}], ["BAL neutrophil% in G- group (n = 63) was marginally but significantly higher than that in the G+ group (n = 77), (median of 7.5 and 5 respectively, p = 0.002).", {"entities": []}], ["Lipid laden macrophage index (LLMI), BAL percentages of lymphocyte, eosinophil and macrophage were similar between groups.", {"entities": []}], ["Viral studies were negative in all, bacterial cultures positive in 20.7% of BALs and in 5.3% of gastric aspirates.", {"entities": []}], ["BAL cultures did not reflect gastric aspirate cultures in all but one child.", {"entities": []}], ["In children without respiratory disease, GORD defined by presence of reflux oesophagitis, is not associated with BAL cellular profile or LLMI abnormality.", {"entities": []}], ["Abnormal microbiology of the airways, when present, is not related to reflux oesophagitis and does not reflect that of gastric juices.", {"entities": []}], ["Although public health is often conceptualized only as the prevention of physical illness, recent data suggest that mental illnesses are increasingly relevant to the mission of disease prevention and health promotion.", {"entities": []}], ["Projections are that by 2020, depression will be second only to heart disease in its contribution to the global burden of disease as measured by disability-adjusted life years.", {"entities": [[64, 77, "DISEASE"]]}], ["Also, as the population ages, successive cohorts of older adults will account for increasingly larger segments of the U.S. population.", {"entities": []}], ["We present the diagnostic criteria for, prevalence of, and risk factors for depressive disorders among older adults; the challenges of recognizing and treating depression in this population; the cost-effectiveness of relevant public health interventions; and the public health implications of these disorders.", {"entities": []}], ["In mice, along with the assessment of eosinophils, lung function measurements, most commonly carried out by plethysmography, are essential to monitor the course of allergic airway inflammation, to examine therapy efficacy and to correlate animal with patient data.", {"entities": []}], ["To date, plethysmography techniques either use intubation and/or restraining of the mice and are thus invasive, or are limited in their sensitivity.", {"entities": []}], ["We present a novel unrestrained lung function method based on low-dose planar cinematic x-ray imaging (X-Ray Lung Function, XLF) and demonstrate its performance in monitoring OVA induced experimental allergic airway inflammation in mice and an improved assessment of the efficacy of the common treatment dexamethasone.", {"entities": []}], ["We further show that XLF is more sensitive than unrestrained whole body plethysmography (UWBP) and that conventional broncho-alveolar lavage and histology provide only limited information of the efficacy of a treatment when compared to XLF.", {"entities": []}], ["Our results highlight the fact that a multi-parametric imaging approach as delivered by XLF is needed to address the combined cellular, anatomical and functional effects that occur during the course of asthma and in response to therapy.", {"entities": [[202, 208, "DISEASE"]]}], ["The aim of the present prospective multicenter cohort study was to examine the prevalence of sleep disturbance and its relation to the patient's reported health-related quality of life after intensive care.", {"entities": []}], ["We also assessed the possible underlying causes of sleep disturbance, including factors related to the critical illness.", {"entities": []}], ["Between August 2000 and November 2003 we included 1,625 consecutive patients older than 17 years of age admitted for more than 24 hours to combined medical and surgical intensive care units (ICUs) at three hospitals in Sweden.", {"entities": []}], ["Conventional intensive care variables were prospectively recorded in the unit database.", {"entities": []}], ["Six months and 12 months after discharge from hospital, sleep disturbances and the health-related quality of life were evaluated using the Basic Nordic Sleep Questionnaire and the Medical Outcomes Study 36-item Short-form Health Survey, respectively.", {"entities": []}], ["As a nonvalidated single-item assessment, the quality of sleep prior to the ICU period was measured.", {"entities": []}], ["As a reference group, a random sample (n = 10,000) of the main intake area of the hospitals was used.", {"entities": []}], ["The prevalence of self-reported quality of sleep did not change from the pre-ICU period to the post-ICU period.", {"entities": []}], ["Intensive care patients reported significantly more sleep disturbances than the reference group ( P < 0.01).", {"entities": []}], ["At both 6 and 12 months, the main factor that affected sleep in the former hospitalised patients with an ICU stay was concurrent disease.", {"entities": []}], ["No effects were related to the ICU period, such as the Acute Physiology and Chronic Health Evaluation score, the length of stay or the treatment diagnosis.", {"entities": []}], ["There were minor correlations between the rate and extent of sleep disturbance and the health-related quality of life.", {"entities": []}], ["There is little change in the long-term quality of sleep patterns among hospitalised patients with an ICU stay.", {"entities": []}], ["This applies both to the comparison before and after critical care as well as between 6 and 12 months after the ICU stay.", {"entities": []}], ["Furthermore, sleep disturbances for this group are common.", {"entities": []}], ["Concurrent disease was found to be most important as an underlying cause, which emphasises that it is essential to include assessment of concurrent disease in sleep-related research in this group of patients.", {"entities": []}], ["Worldwide, chronic obstructive pulmonary disease (COPD) is the fourth cause of death.", {"entities": [[11, 48, "DISEASE"]]}], ["Exacerbations have a negative impact on the prognosis of COPD and the frequency and severity of these episodes are associated with a higher patient mortality.", {"entities": []}], ["Exacerbations are the first cause of decompensation, hospital admission and death in COPD.", {"entities": []}], ["The incidence of exacerbations has mainly been estimated in populations of patients with moderate-severe COPD requiring hospital care.", {"entities": []}], ["However, little is known regarding the epidemiology of exacerbations in patients with less severe COPD forms.", {"entities": []}], ["It is therefore possible that a high number of these less severe forms of exacerbations are underdiagnosed and may, in the long-term, have certain prognostic importance for the COPD evolution.", {"entities": []}], ["The aim of this study was to know the incidence and risk factors associated with exacerbations in patients with COPD in primary care.", {"entities": []}], ["A prospective, observational, 3-phase, multicentre study will be performed involving: baseline evaluation, follow up and final evaluation.", {"entities": []}], ["A total of 685 smokers or ex-smokers from 40 to 80 years of age with COPD, without acute respiratory disease or any other long-term respiratory disease will be randomly selected among the population assigned to 21 primary care centres.", {"entities": []}], ["The diagnosis of COPD and its severity will be confirmed by spirometry.", {"entities": []}], ["Information regarding the baseline situation, quality of life and exposure to contaminants or other factors potentially related to exacerbations will be collected.", {"entities": []}], ["A group of 354 patients with confirmed COPD of varying severity will be followed for one year through monthly telephone calls and daily reporting of symptoms with the aim of detecting all the exacerbations which occur.", {"entities": []}], ["These patients will be evaluated again at the end of the study and the incidence of exacerbations and associated relative risks will be estimated by negative binomial regression.", {"entities": []}], ["The results will be relevant to provide knowledge about natural history of the initial phases of the COPD and the impact and incidence of the exacerbations on the patients with mild-moderate forms of the disease.", {"entities": []}], ["These data may be important to know the milder forms of exacerbation wich are often silent or very little expressed clinically.", {"entities": []}], ["To describe the demand for emergency medical assistance during the largest outbreak of thunderstorm asthma reported globally, which occurred on 21 November 2016.", {"entities": [[100, 106, "DISEASE"]]}], ["A time series analysis was conducted of emergency medical service caseload between 1 January 2015 and 31 December 2016.", {"entities": []}], ["Demand during the thunderstorm asthma event was compared to historical trends for the overall population and across specific subgroups.", {"entities": [[31, 37, "DISEASE"]]}], ["Victoria, Australia.", {"entities": []}], ["Number of overall cases attended by emergency medical services, and within patient subgroups.", {"entities": []}], ["On 21 November 2016, the emergency medical service received calls for 2954 cases, which was 1014 more cases than the average over the historical period.", {"entities": []}], ["Between 6 pm and midnight, calls for 1326 cases were received, which was 2.5 times higher than expected.", {"entities": []}], ["A total of 332 patients were assessed by paramedics as having acute respiratory distress on 21 November, compared with a daily average of 52 during the historical period.", {"entities": []}], ["After adjustment for temporal trends, thunderstorm asthma was associated with a 42% (95% confidence interval 40% to 44%) increase in overall caseload for the emergency medical service and a 432% increase in emergency medical attendances for acute respiratory distress symptoms.", {"entities": [[51, 57, "DISEASE"]]}], ["Emergency transports to hospital increased by 17% (16% to 19%) and time critical referrals from general practitioners increased by 47% (21% to 80%).", {"entities": []}], ["Large increases in demand were seen among patients with a history of asthma and bronchodilator use.", {"entities": [[69, 75, "DISEASE"]]}], ["The incidence of out-of-hospital cardiac arrest increased by 82% (67% to 99%) and pre-hospital deaths by 41% (29% to 55%).", {"entities": []}], ["An unprecedented outbreak of thunderstorm asthma was associated with substantial increase in demand for emergency medical services and pre-hospital cardiac arrest.", {"entities": [[42, 48, "DISEASE"]]}], ["The health impact of future events may be minimised through use of preventive measures by patients and predictive early warning systems.", {"entities": []}], ["Background: Inhalation of airborne particulate matter (PM) derived from urban traffic is associated with pathology in the arteries, heart, and lung; effects on brain are also indicated but are less documented.", {"entities": []}], ["Objective: We evaluated rodent brain responses to urban nanoscale (< 200 nm) PM (nPM).", {"entities": []}], ["Methods: Ambient nPM collected near an urban freeway was transferred to aqueous suspension and reaerosolized for 10-week inhalation exposure of mice or directly applied to rat brain cell cultures.", {"entities": []}], ["Results: Free radicals were detected by electron paramagnetic resonance in the nPM 30 days after initial collection.", {"entities": []}], ["Chronic inhalation of reaerosolized nPM altered selected neuronal and glial activities in mice.", {"entities": []}], ["The neuronal glutamate receptor subunit (GluA1) was decreased in hippocampus, whereas glia were activated and inflammatory cytokines were induced [interleukin-1\u03b1 (IL-1\u03b1), tumor necrosis factor-\u03b1 (TNF\u03b1)] in cerebral cortex.", {"entities": []}], ["Two in vitro models showed effects of nPM suspensions within 24\u201348 hr of exposure that involved glutamatergic functions.", {"entities": [[67, 69, "GENE"]]}], ["In hippocampal slice cultures, nPM increased the neurotoxicity of NMDA ( N -methyl- d -aspartic acid), a glutamatergic agonist, which was in turn blocked by the NMDA antagonist AP5 [(2 R )-amino-5-phosphonopentanoate].", {"entities": []}], ["In embryonic neuron cultures, nPM impaired neurite outgrowth, also blocked by AP5.", {"entities": []}], ["Induction of IL-1\u03b1 and TNF\u03b1 in mixed glia cultures required higher nPM concentrations than did neuronal effects.", {"entities": []}], ["Because conditioned media from nPM-exposed glia also impaired outgrowth of embryonic neurites, nPM can act indirectly, as well as directly, on neurons in vitro .", {"entities": []}], ["Conclusions: nPM can affect embryonic and adult neurons through glutamatergic mechanisms.", {"entities": []}], ["The interactions of nPM with glutamatergic neuronal functions suggest that cerebral ischemia, which involves glutamatergic excitotoxicity, could be exacerbated by nPM.", {"entities": [[84, 92, "DISEASE"]]}], ["Pulmonary hypertension is characterized by increased pulmonary artery pressure and carries an increased mortality.", {"entities": [[10, 22, "DISEASE"], [0, 22, "DISEASE"]]}], ["Population-based studies into pulmonary hypertension are scarce and little is known about its prevalence in the general population.", {"entities": [[40, 52, "DISEASE"], [30, 52, "DISEASE"]]}], ["We aimed to describe the distribution of echocardiographically-assessed pulmonary artery systolic pressure (ePASP) in the general population, to estimate the prevalence of pulmonary hypertension, and to identify associated factors.", {"entities": [[182, 194, "DISEASE"], [172, 194, "DISEASE"]]}], ["Participants (n = 3381, mean age 76.4 years, 59% women) from the Rotterdam Study, a population-based cohort, underwent echocardiography.", {"entities": []}], ["Echocardiographic pulmonary hypertension was defined as ePASP>40 mmHg.", {"entities": [[28, 40, "DISEASE"], [18, 40, "DISEASE"]]}], ["Mean ePASP was 26.3 mmHg (SD 7.0).", {"entities": []}], ["Prevalence of echocardiographic pulmonary hypertension was 2.6% (95%CI: 2.0; 3.2).", {"entities": [[42, 54, "DISEASE"], [32, 54, "DISEASE"]]}], ["Prevalence was higher in older participants compared to younger ones (8.3% in those over 85 years versus 0.8% in those between 65 and 70), and in those with underlying disorders versus those without (5.9% in subjects with COPD versus 2.3%; 9.2% in those with left ventricular systolic dysfunction versus 2.3%; 23.1% in stages 3 or 4 left ventricular diastolic dysfunction versus 1.9% in normal or stage 1).", {"entities": []}], ["Factors independently associated with higher ePASP were older age, higher BMI, left ventricular diastolic dysfunction, COPD and systemic hypertension.", {"entities": [[137, 149, "DISEASE"]]}], ["In this large population-based study, we show that pulmonary hypertension as measured by echocardiography has a low prevalence in the overall general population in the Netherlands, but estimates may be higher in specific subgroups, especially in those with underlying diseases.", {"entities": [[61, 73, "DISEASE"], [51, 73, "DISEASE"]]}], ["Increased pulmonary arterial pressure is likely to gain importance in the near future due to population aging and the accompanying prevalences of underlying disorders.", {"entities": []}], ["Suppressor of cytokine signaling (SOCS) proteins are key regulators of innate and adaptive immunity.", {"entities": []}], ["There is no described biological role for SOCS4, despite broad expression in the hematopoietic system.", {"entities": [[42, 47, "GENE"]]}], ["We demonstrate that mice lacking functional SOCS4 protein rapidly succumb to infection with a pathogenic H1N1 influenza virus (PR8) and are hypersusceptible to infection with the less virulent H3N2 (X31) strain.", {"entities": [[110, 119, "DISEASE"], [44, 49, "GENE"]]}], ["In SOCS4-deficient animals, this led to substantially greater weight loss, dysregulated pro-inflammatory cytokine and chemokine production in the lungs and delayed viral clearance.", {"entities": []}], ["This was associated with impaired trafficking of influenza-specific CD8 T cells to the site of infection and linked to defects in T cell receptor activation.", {"entities": [[49, 58, "DISEASE"]]}], ["These results demonstrate that SOCS4 is a critical regulator of anti-viral immunity.", {"entities": [[31, 36, "GENE"]]}], ["The suppressor of cytokine signaling proteins are key regulators of immunity.", {"entities": []}], ["As yet there is no described biological role for SOCS4, despite its broad expression in cells of the immune system.", {"entities": [[49, 54, "GENE"]]}], ["Given the important role of other SOCS proteins in controlling the immune response, we have generated SOCS4-mutant mice and used a mouse influenza infection model to investigate the biological function of SOCS4.", {"entities": [[137, 146, "DISEASE"], [102, 107, "GENE"], [205, 210, "GENE"]]}], ["We demonstrate that mice lacking SOCS4 rapidly succumb to infection with a pathogenic H1N1 influenza virus and are hypersusceptible to infection with the less virulent H3N2 strain.", {"entities": [[91, 100, "DISEASE"], [33, 38, "GENE"]]}], ["This is the first demonstration of a functional phenotype in SOCS4-deficient mice.", {"entities": []}], ["Our study reveals that in SOCS4-deficient animals, there is a dysregulated pro-inflammatory cytokine and chemokine production in the lungs and delayed viral clearance.", {"entities": []}], ["This is associated with impaired trafficking of virus-specific CD8 T cells to the site of infection and linked to defects in T cell receptor activation.", {"entities": []}], ["These results demonstrate that SOCS4 is a critical regulator of anti-viral immunity.", {"entities": [[31, 36, "GENE"]]}], ["Understanding the regulation of the inflammatory response to influenza is particularly relevant given the current climate concerning pandemic influenza outbreaks.", {"entities": [[61, 70, "DISEASE"], [142, 151, "DISEASE"]]}], ["Retinoic acid-inducible gene I (RIG-I) plays important roles in pathogen recognition and antiviral signalling transduction.", {"entities": []}], ["Here we show that syndecan-4 (SDC4) is a RIG-I-interacting partner identified in a yeast two-hybrid screen.", {"entities": [[30, 34, "GENE"]]}], ["We find that SDC4 negatively regulates the RIG-I-mediated antiviral signalling in a feedback-loop control manner.", {"entities": [[13, 17, "GENE"]]}], ["The genetic evidence obtained by using knockout mice further emphasizes this biological role of SDC4 in antiviral signalling.", {"entities": [[96, 100, "GENE"]]}], ["Mechanistically, we show that SDC4 interacts with both RIG-I and deubiquitinase CYLD via its carboxyl-terminal intracellular region.", {"entities": [[30, 34, "GENE"], [80, 84, "GENE"]]}], ["SDC4 likely promotes redistribution of RIG-I and CYLD in a perinuclear pattern post viral infection, and thus enhances the RIG-I\u2013CYLD interaction and potentiates the K63-linked deubiquitination of RIG-I.", {"entities": [[0, 4, "GENE"], [49, 53, "GENE"], [129, 133, "GENE"]]}], ["Collectively, our findings uncover a mechanism by which SDC4 antagonizes the activation of RIG-I in a CYLD-mediated deubiquitination-dependent process, thereby balancing antiviral signalling to avoid deleterious effects on host cells.", {"entities": [[56, 60, "GENE"]]}], ["Syndecans are transmembrane proteoglycans implicated in diverse cellular activities.", {"entities": []}], ["Here the authors show that Syndecan-4 via its cytosolic domain negatively regulates antiviral immunity by enhancing RIG-I interaction with a deubiquitinating enzyme CYLD, thus inhibiting the activating K63-linked RIG-I ubiquitination.", {"entities": [[165, 169, "GENE"]]}], ["Motivational interviewing is a collaborative conversational style intended to strengthen motivation to change.", {"entities": []}], ["It has been shown to be effective in addressing many different lifestyle problems as well as in chronic disease management, and many disease prevention guidelines promote use of motivational interviewing.", {"entities": []}], ["The aim of the present study was twofold: to assess to what extent the primary care nurses in the study perform motivational interviewing according to the Motivational Interviewing Treatment Integrity Code and to investigate how the participating primary care nurses rated their own performance in motivational interviewing.", {"entities": []}], ["The study was based on twelve primary care nurses\u2019 audio-recorded motivational interviewing sessions with patients (total 32 sessions).", {"entities": []}], ["After each session, the nurses completed a questionnaire regarding their experience of their own performance in motivational interviewing.", {"entities": []}], ["The audio-recorded sessions were analyzed using Motivational Interviewing Integrity Code 3.1.1.", {"entities": []}], ["None of the nurses achieved beginning proficiency in all parts of any motivational interviewing sessions and two nurses did not achieve beginning proficiency in any parts or sessions.", {"entities": []}], ["Making more complex than simple reflections was the specific verbal behavior/summary score that most nurses achieved.", {"entities": []}], ["Beginning proficiency/competency in \u201cpercent open questions\u201d was the summary score that fewest achieved.", {"entities": []}], ["Primary care nurses did not achieve beginning proficiency/competency in all aspects of motivational interviewing in their recorded sessions with patients, where lifestyle change was discussed.", {"entities": []}], ["This indicates a need for improvement and thus additional training, feedback and supervision in clinical practice with motivational interviewing.", {"entities": []}], ["Sudden cardiac death (SCD) represents about 25% of deaths in clinical cardiology.", {"entities": [[22, 25, "GENE"]]}], ["The identification of risk factors for SCD is the philosopher's stone of cardiology and the identification of non-invasive markers of risk of SCD remains one of the most important goals for the scientific community.", {"entities": [[39, 42, "GENE"], [142, 145, "GENE"], [39, 42, "GENE"], [142, 145, "GENE"]]}], ["The aim of this review is to analyze the state of the art around the heart rate variability (HRV) as a predictor factor for SCD.", {"entities": [[124, 127, "GENE"]]}], ["HRV is probably the most analyzed index in cardiovascular risk stratification technical literature, therefore an important number of models and methods have been developed.", {"entities": []}], ["Nowadays, low HRV has been shown to be independently predictive of increased mortality in post- myocardial infarction patients, heart failure patients, in contrast with the data of the general population.", {"entities": [[96, 117, "DISEASE"]]}], ["Contrariwise, the relationship between HRV and SCD has received scarce attention in low-risk cohorts.", {"entities": [[47, 50, "GENE"]]}], ["Furthermore, in general population the attributable risk is modest and the cost/benefit ratio is not always convenient.", {"entities": []}], ["The HRV evaluation could become an important tool for health status in risks population, even though the use of HRV alone for risk stratification of SCD is limited and further studies are needed.", {"entities": [[149, 152, "GENE"]]}], ["Findings regarding the prevalence of vascular comorbidities in multiple sclerosis (MS) are conflicting.", {"entities": [[63, 81, "DISEASE"]]}], ["The objective of this review is to estimate the incidence and prevalence of vascular comorbidities and predisposing comorbidities in persons with MS and to assess the quality of the included studies.", {"entities": []}], ["The PubMed, EMBASE, SCOPUS and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles were searched.", {"entities": []}], ["One reviewer abstracted data using a standardized data collection form, while the second reviewer verified the abstraction.", {"entities": []}], ["Included studies were assessed qualitatively.", {"entities": []}], ["Quantitatively, we assessed studies using the I The prevalence of hypertension and hyperlipidemia exceeded 10% in the MS population and increased with age.", {"entities": [[66, 78, "DISEASE"]]}], ["While the prevalence of ischemic heart disease, congestive heart failure, and stroke were less than 5% overall, the prevalence of these conditions exceeded expectations when compared to the general population.", {"entities": [[48, 72, "DISEASE"], [24, 46, "DISEASE"], [33, 46, "DISEASE"]]}], ["Cardiac valvular disease, however, affected the MS population less often than expected.", {"entities": []}], ["Problems with study quality were common.", {"entities": []}], ["Despite the relatively high prevalence of some vascular comorbidities in the MS population, important gaps exist in our understanding of their epidemiology.", {"entities": []}], ["Most of our knowledge is based on studies conducted in a small number of regions.", {"entities": []}], ["B7-H3 is a cell surface molecule in the immunoglobulin superfamily that is frequently upregulated in response to autoantigens and pathogens during host T cell immune responses.", {"entities": []}], ["However, B7-H3's role in the differential regulation of T cell subsets remains largely unknown.", {"entities": []}], ["Therefore, we constructed a new B7-H3 deficient mouse strain (B7-H3 KO) and evaluated the functions of B7-H3 in the regulation of Th1, Th2, and Th17 subsets in experimental autoimmune encephalomyelitis (EAE), experimental asthma, and collagen-induced arthritis (CIA); these mouse models were used to predict human immune responses in multiple sclerosis, asthma, and rheumatoid arthritis, respectively.", {"entities": [[334, 352, "DISEASE"], [366, 386, "DISEASE"], [251, 260, "DISEASE"], [377, 386, "DISEASE"], [222, 228, "DISEASE"], [354, 360, "DISEASE"], [184, 201, "DISEASE"]]}], ["Here, we demonstrate that B7-H3 KO mice have significantly less inflammation, decreased pathogenesis, and limited disease progression in both EAE and CIA mouse models when compared with littermates; these results were accompanied by a decrease in IFN-\u03b3 and IL-17 production.", {"entities": []}], ["In sharp contrast, B7-H3 KO mice developed severe ovalbumin (OVA)-induced asthma with characteristic infiltrations of eosinophils in the lung, increased IL-5 and IL-13 in lavage fluid, and elevated IgE anti-OVA antibodies in the blood.", {"entities": [[74, 80, "DISEASE"]]}], ["Our results suggest B7-H3 has a costimulatory function on Th1/Th17 but a coinhibitory function on Th2 responses.", {"entities": []}], ["Our studies reveal that B7-H3 could affect different T cell subsets which have important implications for regulating pathogenesis and disease progression in human autoimmune disease.", {"entities": []}], ["The association between immunity and neurodevelopmental disorders has been extensively investigated in autism, suggesting a potential involvement of both cellular and humoral immunity in the establishment of synaptic connectivity modulation during development.", {"entities": []}], ["A similar link has been proposed also for Tourette syndrome (TS), a complex, multifactorial disorder, in which the interplay between genetic, environmental, hormonal and immunological factors might be relevant.", {"entities": [[51, 59, "DISEASE"]]}], ["Lymphocyte subpopulation analysis in TS suggests a possible systemic activation of several T- and B-cell subtypes, whereas the observed decreased numbers of T regulatory lymphocytes might predispose to autoimmunity.", {"entities": []}], ["Genes related to both cell- and antibody-mediated immune responses may be over-expressed at specific ages in youngsters with TS.", {"entities": []}], ["Data from cytokine measurements and transcriptomics profiles in TS patients are coherent with the systemic immune activation detected by studies on lymphocyte subpopulations.", {"entities": []}], ["Moreover, TS patients have exhibited IgG3 and IgA dysgammaglobulinemia, which might predispose to recurrent infections and autoimmunity.", {"entities": [[50, 70, "DISEASE"]]}], ["To date, the association between TS and autoantibodies has not been demonstrated.", {"entities": []}], ["Interestingly, however, there is a higher degree of maternal family history of autoimmune diseases among TS patients.", {"entities": []}], ["Finally, TS patients could be prone to allergic illnesses (asthma, atopic dermatitis, rhinitis, conjunctivitis), but more work is needed in this area.", {"entities": [[67, 84, "DISEASE"], [86, 94, "DISEASE"], [96, 110, "DISEASE"], [59, 65, "DISEASE"], [74, 84, "DISEASE"]]}], ["Renewable energy demands have increased the need for new wind farms.", {"entities": []}], ["In turn, concerns have been raised about potential adverse health effects on nearby residents.", {"entities": []}], ["A case definition has been proposed to diagnose \u201cAdverse Health Effects in the Environs of Industrial Wind Turbines\u201d (AHE/IWT); initially in 2011 and then with an update in 2014.", {"entities": []}], ["The authors invited commentary and in turn, we assessed its scientific merits by quantitatively evaluating its proposed application.", {"entities": []}], ["We used binomial coefficients to quantitatively assess the potential of obtaining a diagnosis of AHE/IWT.", {"entities": []}], ["We also reviewed the methodology and process of the development of the case definition by contrasting it with guidelines on case definition criteria of the USA Institute of Medicine .", {"entities": []}], ["The case definition allows at least 3,264 and up to 400,000 possibilities for meeting second- and third-order criteria, once the limited first-order criteria are met.", {"entities": []}], ["IOM guidelines for clinical case definitions were not followed.", {"entities": []}], ["The case definition has virtually no specificity and lacks scientific support from peer-reviewed literature.", {"entities": []}], ["If applied as proposed, its application will lead to substantial potential for false-positive assessments and missed diagnoses.", {"entities": []}], ["Virtually any new illness that develops or any prevalent illness that worsens after the installation of wind turbines within 10 km of a residence could be considered AHE/IWT if the patient feels better away from home.", {"entities": []}], ["The use of this case definition in the absence of a thorough medical evaluation with appropriate diagnostic studies poses risks to patients in that treatable disorders would be overlooked.", {"entities": []}], ["The case definition has significant potential to mislead patients and its use cannot be recommended for application in any health-care or decision-making setting.", {"entities": []}], ["The aim of this study was to assess outcomes of laparoscopic sleeve gastrectomy (LSG) as a stand-alone bariatric operation according to the Bariatric Analysis and Reporting Outcome System (BAROS).", {"entities": []}], ["Out of 112 patients included and operated on initially, 84 patients (F/M, 63:21) were followed up for 14\u201356\u00a0months (mean 22\u2009\u00b1\u20096.75).", {"entities": []}], ["Patients lost to follow-up did not attend scheduled follow-up visits or they have withdrawn their consent.", {"entities": []}], ["Mean age was 39\u00a0years (range 17\u201367; SD\u2009\u00b1\u200912.09) with mean initial BMI 44.62\u00a0kg/m p \u2009<\u20090.05 level.", {"entities": []}], ["Mean operative time was 61\u00a0min (30\u2013140\u00a0min) with mean hospital stay of 1.37\u00a0days (0\u20134; SD\u2009\u00b1\u20090.77).", {"entities": []}], ["Excellent global BAROS outcome was achieved in 13% of patients, very good in 30%, good in 34.5%, fair 9.5% and failure in 13% patients 12\u00a0months after surgery.", {"entities": []}], ["Females achieved significantly better outcomes than males with the mean 46.5% of excess weight loss (EWL) versus 35.3% of EWL at 12\u00a0months ( p \u2009=\u20090.02).", {"entities": []}], ["The mean percentage of excess weight loss (%EWL) was 43.6% at 12\u00a0months and 46.6% at 24\u00a0months.", {"entities": []}], ["Major surgical complication rate was 7.1%; minor surgical complication rate 8.3%.", {"entities": []}], ["There was one conversion (1.2%) due to the massive bleeding.", {"entities": []}], ["Comorbidities improved or resolved in numerous patients: arterial hypertension in 62%, diabetes mellitus in 68.3%, respectively.", {"entities": [[66, 78, "DISEASE"], [87, 104, "DISEASE"]]}], ["Presented LSG series shows that the LSG as a stand-alone procedure provides acceptable %EWL and good global BAROS outcomes.", {"entities": []}], ["It significantly improves comorbidities as well.", {"entities": []}], ["Accumulating evidence suggests that, independent of physical activity levels, sedentary behaviours are associated with increased risk of cardio-metabolic disease, all-cause mortality, and a variety of physiological and psychological problems.", {"entities": []}], ["Therefore, the purpose of this systematic review is to determine the relationship between sedentary behaviour and health indicators in school-aged children and youth aged 5-17 years.", {"entities": []}], ["Online databases (MEDLINE, EMBASE and PsycINFO), personal libraries and government documents were searched for relevant studies examining time spent engaging in sedentary behaviours and six specific health indicators (body composition, fitness, metabolic syndrome and cardiovascular disease, self-esteem, pro-social behaviour and academic achievement).", {"entities": [[255, 263, "DISEASE"]]}], ["232 studies including 983,840 participants met inclusion criteria and were included in the review.", {"entities": []}], ["Television (TV) watching was the most common measure of sedentary behaviour and body composition was the most common outcome measure.", {"entities": []}], ["Qualitative analysis of all studies revealed a dose-response relation between increased sedentary behaviour and unfavourable health outcomes.", {"entities": []}], ["Watching TV for more than 2 hours per day was associated with unfavourable body composition, decreased fitness, lowered scores for self-esteem and pro-social behaviour and decreased academic achievement.", {"entities": []}], ["Meta-analysis was completed for randomized controlled studies that aimed to reduce sedentary time and reported change in body mass index (BMI) as their primary outcome.", {"entities": []}], ["In this regard, a meta-analysis revealed an overall significant effect of -0.81 (95% CI of -1.44 to -0.17, p = 0.01) indicating an overall decrease in mean BMI associated with the interventions.", {"entities": []}], ["There is a large body of evidence from all study designs which suggests that decreasing any type of sedentary time is associated with lower health risk in youth aged 5-17 years.", {"entities": []}], ["In particular, the evidence suggests that daily TV viewing in excess of 2 hours is associated with reduced physical and psychosocial health, and that lowering sedentary time leads to reductions in BMI.", {"entities": []}], ["Mycobacterium tuberculosis infects nearly 1/3 of the world population and this reservoir forms the largest pool from which new cases arise.", {"entities": [[14, 26, "DISEASE"]]}], ["Among the cytokines, IFN-\u03b3 is a key determinant in protection against tuberculosis.", {"entities": [[70, 82, "DISEASE"]]}], ["Single nucleotide polymorphisms (SNPs) in IFN-\u03b3 gene (+874 T/A) which determine TT high ( IFN -\u03b3 gene combinations with other IFN -\u03b3 regulating cytokine genes ( IL-10 , TNF \u2013\u03b1 , IL-6 ) to see the effect of gene- combinations on disease severity outcome in pulmonary tuberculosis.", {"entities": [[266, 278, "DISEASE"], [256, 278, "DISEASE"], [169, 172, "GENE"]]}], ["Study groups comprised of pulmonary TB patients stratified according to lung tissue involvement into mild (Pmd\u200a=\u200a74) or advance (Pad\u200a=\u200a23) lung disease and compared with healthy controls (TBNA\u200a=\u200a166).", {"entities": [[139, 151, "DISEASE"]]}], ["Genotype analysis was carried out using amplification refractory mutation system-PCR (ARMS-PCR).", {"entities": []}], ["IFN-\u03b3 gene (+874 T/A) functional SNP combinations in TNF\u03b1 (\u2212308 G/A), IL-10 (\u22121082 A/G) and IL-6 (\u2212174 G/C) were analyzed.", {"entities": []}], ["Single gene analysis (Pearson \u03c7 IFN-\u03b3 IL-10 IFN-\u03b3 IL-6 IFN-\u03b3 IL-6 Our results show that a limited number of IFN-\u03b3 gene combinations with other cytokine functional SNPs determine the outcome of disease severity in tuberculosis.", {"entities": [[213, 225, "DISEASE"]]}], ["Adoptive therapy with tumour-infiltrating lymphocytes (TILs) induces durable complete responses (CR) in \u223c20% of patients with metastatic melanoma.", {"entities": [[137, 145, "DISEASE"]]}], ["The recruitment of T cells through CXCR3/CCR5 chemokine ligands is critical for immune-mediated rejection.", {"entities": []}], ["We postulated that polymorphisms and/or expression of CXCR3/CCR5 in TILs and the expression of their ligands in tumour influence the migration of TILs to tumours and tumour regression.", {"entities": []}], ["Tumour-infiltrating lymphocytes from 142 metastatic melanoma patients enrolled in adoptive therapy trials were genotyped for CXCR3 rs2280964 and CCR5 -\u039432 deletion, which encodes a protein not expressed on the cell surface.", {"entities": [[52, 60, "DISEASE"], [125, 130, "GENE"], [145, 149, "GENE"]]}], ["Expression of CXCR3/CCR5 in TILs and CXCR3/CCR5 and ligand genes in 113 available parental tumours was also assessed.", {"entities": []}], ["Tumour-infiltrating lymphocyte data were validated by flow cytometry ( N =50).", {"entities": []}], ["The full gene expression/polymorphism model, which includes CXCR3 and CCR5 expression data, CCR5 -\u039432 polymorphism data and their interaction, was significantly associated with both CR and overall response (OR; P =0.0009, and P =0.007, respectively).", {"entities": [[60, 65, "GENE"], [70, 74, "GENE"], [92, 96, "GENE"], [70, 74, "GENE"], [92, 96, "GENE"]]}], ["More in detail, the predicted underexpression of both CXCR3 and CCR5 according to gene expression and polymorphism data (protein prediction model, PPM) was associated with response to therapy (odds ratio=6.16 and 2.32, for CR and OR, respectively).", {"entities": [[54, 59, "GENE"], [64, 68, "GENE"]]}], ["Flow cytometric analysis confirmed the PPM.", {"entities": []}], ["Coordinate upregulation of CXCL9, CXCL10, CXCL11, and CCL5 in pretreatment tumour biopsies was associated with OR.", {"entities": [[27, 32, "GENE"], [34, 40, "GENE"], [42, 48, "GENE"], [54, 58, "GENE"]]}], ["Coordinate overexpression of CXCL9, CXCL10, CXCL11, and CCL5 in pretreatment tumours was associated with responsiveness to treatment.", {"entities": [[29, 34, "GENE"], [36, 42, "GENE"], [44, 50, "GENE"], [56, 60, "GENE"]]}], ["Conversely, CCR5 -\u039432 polymorphism and CXCR3/CCR5 underexpression influence downregulation of the corresponding receptors in TILs and were associated with likelihood and degree of response.", {"entities": [[12, 16, "GENE"], [45, 49, "GENE"]]}], ["Vitamin A is a critical micronutrient for regulating immunity in many organisms.", {"entities": []}], ["Our previous study demonstrated that gestational or early-life vitamin A deficiency decreases the number of immune cells in offspring.", {"entities": []}], ["The present study aims to test whether vitamin A supplementation can restore lymphocyte pools in vitamin A-deficient rats and thereby improve the function of their intestinal mucosa; furthermore, the study aimed to identify the best time frame for vitamin A supplementation.", {"entities": []}], ["Vitamin A-deficient pregnant rats or their offspring were administered a low-dose of vitamin A daily for 7 days starting on gestational day 14 or postnatal day 1, day 14 or day 28.", {"entities": []}], ["Serum retinol concentrations increased significantly in all four groups that received vitamin A supplementation, as determined by high-performance liquid chromatography.", {"entities": []}], ["The intestinal levels of secretory immunoglobulin A and polymeric immunoglobulin receptor increased significantly with lipopolysaccharide challenge in the rats that received vitamin A supplementation starting on postnatal day 1.", {"entities": []}], ["The rats in this group had higher numbers of CD8 C", {"entities": []}], ["A novel plasma-driven catalysis (PDC) reactor with special structure was proposed to remove vehicle exhaust gas.", {"entities": [[33, 36, "GENE"]]}], ["The PDC reactor which consisted of three quartz tubes and two copper electrodes was a coaxial dielectric barrier discharge (DBD) reactor.", {"entities": [[4, 7, "GENE"]]}], ["The inner and outer electrodes firmly surrounded the outer surface of the corresponding dielectric barrier layer in a spiral way, respectively.", {"entities": []}], ["Nano-titanium dioxide (TiO 2 ) film prepared by radiofrequency (RF) magnetron sputtering was coated on the outer wall of the middle quartz tube, separating the catalyst from the high voltage electrode.", {"entities": []}], ["The spiral electrodes were designed to avoid overheating of microdischarges inside the PDC reactor.", {"entities": [[87, 90, "GENE"]]}], ["Continuous operation tests indicated that stable performance without deterioration of catalytic activity could last for more than 25 h. To verify the effectiveness of the PDC reactor, a non-thermal plasma(NTP) reactor was employed, which has the same structure as the PDC reactor but without the catalyst.", {"entities": [[171, 174, "GENE"], [268, 271, "GENE"], [171, 174, "GENE"], [268, 271, "GENE"]]}], ["The real vehicle exhaust gas was introduced into the PDC reactor and NTP reactor, respectively.", {"entities": [[53, 56, "GENE"]]}], ["After the treatment, compared with the result from NTP, the concentration of HC in the vehicle exhaust gas treated by PDC reactor reduced far more obviously while that of NO decreased only a little.", {"entities": [[118, 121, "GENE"]]}], ["Moreover, this result was explained through optical emission spectrum.", {"entities": []}], ["The O emission lines can be observed between 870 nm and 960 nm for wavelength in PDC reactor.", {"entities": [[81, 84, "GENE"]]}], ["Together with previous studies, it could be hypothesized that O derived from catalytically O 3 destruction by catalyst might make a significant contribution to the much higher HC removal efficiency by PDC reactor.", {"entities": [[201, 204, "GENE"]]}], ["A series of complex chemical reactions caused by the multi-components mixture in real vehicle exhaust reduced NO removal efficiency.", {"entities": []}], ["A controllable system with a real-time feedback module for the PDC reactor was proposed to further improve the ability of removing real vehicle exhaust gas.", {"entities": [[63, 66, "GENE"]]}], ["Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality.", {"entities": [[13, 24, "DISEASE"]]}], ["However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited.", {"entities": [[66, 77, "DISEASE"]]}], ["Here, we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and -2, two key pattern recognition receptors for sensing Candida albicans , and their downstream kinase SYK, thus inhibiting dectin-1/2-mediated innate immune responses.", {"entities": [[45, 49, "GENE"], [194, 197, "GENE"]]}], ["CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of Candida albicans , and deficiency of dectin-1, -2, or both, in Cblb Cblb gene in vivo protects mice from lethal systemic Candida albicans infection.", {"entities": [[0, 4, "GENE"], [155, 159, "GENE"], [160, 164, "GENE"], [0, 4, "GENE"], [155, 159, "GENE"], [160, 164, "GENE"], [0, 4, "GENE"], [155, 159, "GENE"], [160, 164, "GENE"]]}], ["Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and -2.", {"entities": [[21, 25, "GENE"]]}], ["Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.", {"entities": [[108, 119, "DISEASE"], [28, 32, "GENE"]]}], ["Chronic pulmonary aspergillosis (CPA) has recently been recognized as a significant global health burden.", {"entities": [[18, 31, "DISEASE"]]}], ["In China, the diagnosis of CPA is still unfamiliar to most doctors.", {"entities": []}], ["The aim of this study was to demonstrate the clinical manifestations and diagnoses of CPA in China.", {"entities": []}], ["A multidisciplinary team of doctors retrospectively screened 690 records of patients diagnosed with pulmonary aspergillosis from January 2000 to December 2016 at Peking Union Medical College Hospital, Beijing, China.", {"entities": [[110, 123, "DISEASE"]]}], ["Of these, 69 patients were diagnosed with CPA.", {"entities": []}], ["The patients\u2019 clinical characteristics were then retrieved and analyzed.", {"entities": []}], ["Demographic, laboratory, and radiological data for these patients were compared by CPA type.", {"entities": []}], ["Of the 69 patients diagnosed with CPA, 10 patients were diagnosed with chronic cavitary pulmonary aspergillosis (CCPA), 15 patients with semi-invasive aspergillosis (SAIA), 41 patients with simple aspergilloma, and 3 patients with Aspergillus nodule.", {"entities": [[98, 111, "DISEASE"], [151, 164, "DISEASE"], [142, 164, "DISEASE"]]}], ["Further, 53.3% of the SAIA patients were obviously immunocompromised, and 60% of the CCPA patients, 26.7% of the SAIA patients, 7.3% of the simple aspergilloma cases were mildly immunocompromised.", {"entities": []}], ["Previous underlying lung abnormalities were observed in 20% of CCPA patients, 53.3% of SAIA patients, and 80.5% of simple aspergilloma patients.", {"entities": []}], ["The most common symptoms in the CPA patients were cough (92.8%), hemoptysis (63.8%), chronic sputum (23.2%), and fever (17.4%).", {"entities": []}], ["The most common computerized tomography abnormalities were cavities (94.2%), nodule (84.1%), consolidation (4.3%), pleural thickening (2.9%), and infiltration (2.9%).", {"entities": []}], ["CCPA, SAIA and simple aspergilloma patients were significantly different with respect to their course before diagnosis, constitutional symptoms, fever, hemoptysis, breathlessness, white blood cell count, erythrocyte sedimentation rate, high-sensitivity C-reactive protein count, presence of nodule, and presence of a solitary lesion (all P \u200a<\u200a.05).", {"entities": []}], ["Furthermore, SAIA patients had a significantly shorter course before diagnosis and a significantly higher white blood cell count compared with CCPA patients (both P \u200a<\u200a.01).", {"entities": []}], ["In China, underlying systemic immunocompromising conditions and lung diseases with mechanical impediments contribute to CPA.", {"entities": []}], ["Simple aspergillosis was the most common diagnosis in CPA patients.", {"entities": [[7, 20, "DISEASE"]]}], ["The imaging characteristics of simple aspergillosis and Aspergillus nodules were quite discriminable, while CCPA, and SAIA were similar in their clinical and radiological features.", {"entities": [[38, 51, "DISEASE"]]}], ["Distinguishing between CCPA and SAIA depends mainly on the physician's clinical judgment.", {"entities": []}], ["Injury to the kidney epithelial barrier is a characteristic feature of acute kidney injury (AKI).", {"entities": []}], ["Serum surfactant protein-D (SP-D), a known biomarker of damaged alveolar epithelium, is also secreted by renal tubular epithelial cells.", {"entities": []}], ["Therefore, the aim of this study was to examine the possible association of SP-D with AKI susceptibility and prognosis.", {"entities": []}], ["In this study, 159 AKI patients and 120 healthy individuals were included.", {"entities": []}], ["SP-D polymorphisms Thr11Met and Thr160Ala, AKI patient serum SP-D levels at days 1, 3 and 7 and urine KIM-1 levels in both AKI patients and controls were examined.", {"entities": []}], ["The obtained results were correlated with the AKI stage, duration of renal replacement therapy (RRT) and prognosis.", {"entities": []}], ["Serum SP-D level in AKI patients was higher than controls ( p \u2009<\u20090.01).", {"entities": []}], ["SP-D 11Thr/Thr genotype was more frequent in AKI patients than in controls ( p \u2009<\u20090.01).", {"entities": []}], ["Furthermore, AKI patients with SP-D 11Thr/Thr genotype had significantly higher serum SP-D levels ( p \u2009<\u20090.05) compared to other genotypes.", {"entities": []}], ["Serum SP-D levels corrected to the progression of AKI with a peak at day 3.", {"entities": []}], ["Furthermore, the SP-D 11Thr/Thr genotype frequency and baseline serum SP-D level were higher in patients who subsequently died.", {"entities": []}], ["Baseline serum SP-D levels positively correlated with the urine KIM-1 levels, AKI stage and RRT duration.", {"entities": []}], ["In our study, elevated serum SP-D was associated with worse AKI clinical outcomes and patients with SP-D 11Thr/Thr genotype were more susceptible to AKI.", {"entities": []}], ["Collectively, these findings suggest that SP-D may be useful as a biomarker of AKI susceptibility and prognosis.", {"entities": []}], ["To rapidly quantify total immunoglobulin E levels in human serum, we developed a novel quantum-dot-based immunochromatographic assay that employs digital recording of fluorescence.", {"entities": []}], ["It can detect IgE levels of 5\u20131000 kU/L, with a coefficient of variation ranging from 2.0 to 9.5%.", {"entities": []}], ["The assay can be processed in 10 min.", {"entities": []}], ["The developed assay was tested on 95 serum samples.", {"entities": []}], ["The correlation coefficient between the IgE values obtained by the proposed assay and those obtained by a commercial ELISA kit was 0.9884.", {"entities": []}], ["Our assay thus shows promise as a new diagnostic tool for IgE detection.", {"entities": []}], ["Respiratory syncytial virus (RSV) infects nearly all children by age 2 years, and it causes considerable illness and death in certain high-risk pediatric populations.", {"entities": []}], ["Historically, treatment for RSV has been symptomatic, and developing a safe and effective vaccine has been a challenge.", {"entities": []}], ["Therefore, research efforts have turned to passive immunization as the best option to control RSV.", {"entities": []}], ["Palivizumab, a genetically engineered humanized monoclonal antibody, has been shown to reduce RSV-related hospitalizations significantly, with few adverse effects.", {"entities": []}], ["It was approved for use in high-risk children in the USA in 1998 and in Europe in 1999; it is now approved for use in more than 45 countries.", {"entities": []}], ["The efficacy and safety of palivizumab continue to be supported by both clinical trial and outcomes data.", {"entities": []}], ["Disabling respiratory symptoms and rapid decline of lung function may occur in susceptible tobacco smokers.", {"entities": []}], ["Bronchial hyperresponsiveness (BHR) elicited by direct challenge methods predicts worse lung function outcomes.", {"entities": []}], ["The aim of this study was to evaluate whether BHR to isocapnic hyperventilation of dry air (IHDA) was associated with rapid deterioration in airway status and respiratory symptoms.", {"entities": []}], ["One hundred twenty-eight smokers and 26 age- and sex-matched healthy individuals with no history of smoking were investigated.", {"entities": []}], ["All subjects completed a questionnaire.", {"entities": []}], ["Spirometry and impulse oscillometry (IOS) measurements were recorded before and after 4\u00a0min of IHDA.", {"entities": []}], ["The tests were repeated after 3\u00a0years in 102 smokers and 11 controls.", {"entities": []}], ["Eighty-five smokers (66\u00a0%) responded to the challenge with a \u22652.4-Hz increase in resonant frequency ( F res ), the cutoff limit defining BHR, as recorded by IOS.", {"entities": []}], ["They had higher F res at baseline compared to nonresponding smokers [12.8\u00a0\u00b1\u00a03.2 vs. 11.5\u00a0\u00b1\u00a03.4\u00a0Hz ( p \u00a0<\u00a00.05)] and lower FEV 1 [83\u00a0\u00b1\u00a013 vs. 89\u00a0\u00b1\u00a013 % predicted (p\u00a0<\u00a00.05)].", {"entities": [[122, 125, "GENE"]]}], ["Multivariable logistic regression analysis indicated that wheezing (odds ratio\u00a0=\u00a03.7, p \u00a0<\u00a00.01) and coughing (odds ratio\u00a0=\u00a08.1, p \u00a0<\u00a00.05) were significantly associated with hyperresponsiveness.", {"entities": []}], ["An increase in F res was recorded after 3\u00a0years in responding smokers but not in nonresponders or controls.", {"entities": []}], ["The difference remained when subjects with COPD were excluded.", {"entities": []}], ["The proportion of hyperresponsive smokers was unexpectedly high and there was a close association between wheezing and coughing and BHR.", {"entities": []}], ["Only BHR could discriminate smokers with rapid deterioration of airway status from others.", {"entities": []}], ["Counselling on health-related lifestyles is key to the prevention and management of chronic diseases.", {"entities": []}], ["After comprehensive study of determinants of its delivery in general practice and strategies to improve, we composed a tailored improvement program, which included communication skills training, online patient information, and a clinical protocol for managing depressive symptoms.", {"entities": []}], ["Our aim was to assess the effectiveness of this program on professional performance and outcomes in cardiovascular patients.", {"entities": []}], ["A two-arm cluster randomized trial in 34 general practices involving 34 nurses was conducted.", {"entities": []}], ["The primary outcome was an aggregated score of a positive score on lifestyle counselling delivered and an appropriate action on depressive symptoms.", {"entities": []}], ["Secondary outcomes included the various elements of the primary outcome, vascular risk factors (extracted from patient records), and patient-reported lifestyle behaviors.", {"entities": []}], ["Data were collected from medical records and a written survey among included patients.", {"entities": []}], ["A sample of 1782 patients with recorded cardiovascular disease or high cardiovascular risk was available at follow-up at 6\u00a0months.", {"entities": []}], ["No impact on the primary outcome was found; lifestyle counselling was recorded in a minority of patients (11.4\u00a0% in the intervention group and 10.3\u00a0% in the control group).", {"entities": []}], ["An effect was found on a secondary outcome: patients\u2019 physical activity level increased ( B 0.18; 95\u00a0% CI 0.02\u20130.35) on a seven-point scale.", {"entities": []}], ["The tailored improvement program showed no effect on the primary outcome.", {"entities": []}], ["This challenges the methodology of tailoring.", {"entities": []}], ["More involvement of the targeted health care professionals might offer ways to develop more effective implementation programs.", {"entities": []}], ["Physical activity might be the lifestyle issue that can be more easily changed than smoking or dietary habits.", {"entities": []}], ["Nederlands Trial register NTR4069", {"entities": []}], ["The Eosinophil Cationic Protein (ECP) is a potent multifunctional protein.", {"entities": []}], ["Three common polymorphisms are present in the ECP gene, which determine the function and production of the protein.", {"entities": []}], ["The aim was to study the relationship of these ECP gene polymorphisms to signs and symptoms of allergy and asthma in a community based cohort (The European Community Respiratory Health Survey (ECRHS)).", {"entities": [[107, 113, "DISEASE"]]}], ["Swedish and Estonian subjects (n = 757) were selected from the larger cohort of the ECRHS II study cohort.", {"entities": []}], ["The prevalence of the gene polymorphisms ECP434(G>C) (rs2073342), ECP562(G>C) (rs2233860) and ECP c.-38(A>C) (rs2233859) were analysed by DNA sequencing and/or real-time PCR and related to questionnaire-based information of allergy, asthma, smoking habits and to lung functions.", {"entities": [[233, 239, "DISEASE"]]}], ["Genotype prevalence showed both ethnic and gender differences.", {"entities": []}], ["Close associations were found between the ECP434(G>C) and ECP562(G>C) genotypes and smoking habits, lung function and expression of allergic symptoms.", {"entities": []}], ["Non-allergic asthma was associated with an increased prevalence of the ECP434GG genotype.", {"entities": [[4, 19, "DISEASE"], [13, 19, "DISEASE"]]}], ["The ECP c.-38(A>C) genotypes were independently associated to the subject being atopic.", {"entities": []}], ["Our results show associations of symptoms of allergy and asthma to ECP-genotypes, but also to smoking habits.", {"entities": [[57, 63, "DISEASE"]]}], ["ECP may be involved in impairment of lung functions in disease.", {"entities": []}], ["Gender, ethnicity and smoking habits are major confounders in the evaluations of genetic associations to allergy and asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["Previous epidemiologic studies have reported famine exposure during early life association with overweight or obesity in adulthood, but a consistent perspective has not been established to date.", {"entities": [[110, 117, "DISEASE"]]}], ["To determine, by conducting a systematic review and meta-analysis, whether exposure to famine could increase body mass index (BMI) in adult or not, and assess the association between famine exposure and the risk of overweight or obesity.", {"entities": [[229, 236, "DISEASE"]]}], ["Published articles were systematically searched (until August, 2017) from PubMed, ScienceDirect, Cochrane, and China National Knowledge Infrastructure.", {"entities": []}], ["Initially, comparing differences in BMI between exposed and non-exposed groups that weight mean difference (WMD) were used.", {"entities": []}], ["Subsequently, the effect of famine exposure on overweight or obesity risk, which pooled relative risks (RRs), odds ratios (ORs) or hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using a random-effects model.", {"entities": [[61, 68, "DISEASE"]]}], ["Twenty studies were included in this systematic review and meta-analysis.", {"entities": []}], ["Compared with non-exposed group, famine exposure group significantly increased the risk of overweight (OR = 1.10, 95% CI: 1.04\u20131.16) and obesity (OR = 1.15, 95% CI: 1.05\u20131.24).", {"entities": [[137, 144, "DISEASE"]]}], ["Sensitivity analyses revealed no significant change in the famine exposure and BMI, the risk of overweight and obesity study when any one study was excluded.", {"entities": [[111, 118, "DISEASE"]]}], ["Subgroup analyses showed that age, gender, exposure type, study type, continent, famine cause and paper publication date were associated with BMI, the risk of overweight and obesity.", {"entities": [[174, 181, "DISEASE"]]}], ["Meta-regression analyses suggested that continent, famine cause could partially explain heterogeneity for famine exposure and BMI studies.", {"entities": []}], ["The systematic review and meta-analysis indicates that famine exposure during early life may increase BMI, the risk of overweight and obesity, especially for female, fetal famine exposure or subject age less than 50.", {"entities": [[134, 141, "DISEASE"]]}], ["Furthermore, famine exposure group the risk of overweight and obesity in cross-sectional studies, Asian studies, famine cause by natural disaster or paper published from 2015 to the present studies are higher than that of non-exposed group.", {"entities": [[62, 69, "DISEASE"]]}], ["Cumulative risk (CR) models provide some of the most robust findings in the developmental literature, predicting numerous and varied outcomes.", {"entities": []}], ["Typically, however, these outcomes are predicted one at a time, across different samples, using concurrent designs, longitudinal designs of short duration, or retrospective designs.", {"entities": []}], ["We predicted that a single CR index, applied within a single sample, would prospectively predict diverse outcomes, i.e., depression, intelligence, school dropout, arrest, smoking, and physical disease from childhood to adulthood.", {"entities": []}], ["Further, we predicted that number of risk factors would predict number of adverse outcomes (cumulative outcome; CO).", {"entities": []}], ["We also predicted that early CR (assessed at age 5/6) explains variance in CO above and beyond that explained by subsequent risk (assessed at ages 12/13 and 19/20).", {"entities": []}], ["The sample consisted of 284 individuals, 48% of whom were diagnosed with a speech/language disorder.", {"entities": [[82, 99, "DISEASE"]]}], ["Cumulative risk, assessed at 5/6-, 12/13-, and 19/20-years-old, predicted aforementioned outcomes at age 25/26 in every instance.", {"entities": []}], ["Furthermore, number of risk factors was positively associated with number of negative outcomes.", {"entities": []}], ["Finally, early risk accounted for variance beyond that explained by later risk in the prediction of CO. We discuss these findings in terms of five criteria posed by these data, positing a \u201cmediated net of adversity\u201d model, suggesting that CR may increase some central integrative factor, simultaneously augmenting risk across cognitive, quality of life, psychiatric and physical health outcomes.", {"entities": []}], ["Among a panel of 21 cytokines (IL-1\u03b1, -1\u03b2, -2\u201313, and -15\u201318; interferon-\u03b3; granulocyte-macrophage colony-stimulating factor; and tumor necrosis factor \u03b1), we have recently observed that IL-17A is the most potent inducer for human \u03b2-defensin 2 ( hBD-2 ) in conducting airway epithelial cells (Kao, C. Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., and Wu, R. (2004) J. Immunol.", {"entities": []}], ["173, 3482\u20133491).", {"entities": []}], ["The molecular basis of this regulation is not known.", {"entities": []}], ["In this study, we demonstrated a coordinated degradation of inhibitory \u03baB(I\u03baB)-\u03b1 followed by a nuclear translocation of p50 and p65 NF-\u03baB subunits and their binding to NF-\u03baB sites of hBD-2 promoter region.", {"entities": []}], ["With site-directed mutagenesis, we demonstrated the requirement of two proximal NF-\u03baB binding sites (p\u03baB1, -205 to -186; p\u03baB2, -596 to -572) but not the distal site (d\u03baB, -2193 to -2182) in supporting IL-17A-induced hBD-2 promoter activity.", {"entities": []}], ["These results are consistent with the data of the chromatin immunoprecipitation assay, which showed enhanced p50 binding to these p\u03baB sites but not the d\u03baB site in cells after IL-17A treatment.", {"entities": []}], ["We also found that the NF-\u03baB binding cofactor, I \u03ba B -\u03b6, was up-regulated by IL-17A, and the knockdown of I \u03ba B -\u03b6 significantly diminished the IL-17A-induced hBD-2 expression.", {"entities": []}], ["This is the first demonstration of the involvement of two proximal NF-\u03baB sites and I\u03baB-\u03b6 in the regulation of hBD-2 by IL-17A, two important genes responsible for host defense.", {"entities": []}], ["There is a concern that allergic disease in childhood is higher than expected in Cuba.", {"entities": []}], ["The aim of this study was to determine the risk factors for eczema of infants aged 12\u201315\u00a0months living in Havana.", {"entities": []}], ["We used a cross-sectional epidemiological study design.", {"entities": []}], ["Data on eczema symptoms and a wide range of lifestyle factors were collected by researcher administered questionnaires.", {"entities": []}], ["Data were collected on 1956 children (96% response rate), of whom 672 (34%) were reported as having had eczema.", {"entities": []}], ["Independent risk factors for eczema included young maternal age (adjusted odds ratio (OR) 0.98 per additional year of age; 95% confidence interval (CI) 0.97-0.99), child\u2019s weight (OR 1.13 per additional kg; 95% CI: 1.03-1.25), insect sting allergy (OR 2.11; 95% CI: 1.33-3.35), rodents in the home (OR 1.39; 95% CI: 1.10-1.76), attendance at childcare facilities (OR 1.34: 95% CI: 1.05-1.70) and self-reported mould in the home (OR 1.23; 95% CI: 1.07-1.41).", {"entities": []}], ["Infant exposure to paracetamol was associated with an increased risk of eczema even after adjustment for wheeze (OR 1.22; 95% CI: 1.03-1.46).", {"entities": []}], ["Despite a very different culture and environment, the consistency of these findings with those from more economically developed countries suggests potential causal associations.", {"entities": []}], ["The association with paracetamol, even after adjustment for wheeze, suggests that intervention studies are required in young infants, to ascertain if this commonly used anti-pyretic medication increases allergic disease.", {"entities": []}], ["Sleep disorders encompass a wide spectrum of diseases with significant individual health consequences and high economic costs to society.", {"entities": []}], ["To facilitate the diagnosis and treatment of sleep disorders, this review provides a framework using the International Classification of Sleep Disorders, Primary and secondary insomnia are differentiated, and pharmacological and nonpharmacological treatments are discussed.", {"entities": []}], ["Common circadian rhythm disorders are described in conjunction with interventions, including chronotherapy and light therapy.", {"entities": []}], ["The diagnosis and treatment of restless legs syndrome/periodic limb movement disorder is addressed.", {"entities": [[54, 85, "DISEASE"], [45, 53, "DISEASE"]]}], ["Attention is focused on obstructive sleep apnea and upper airway resistance syndrome, and their treatment.", {"entities": [[76, 84, "DISEASE"]]}], ["The constellation of symptoms and findings in narcolepsy are reviewed together with diagnostic testing and therapy, Parasomnias, including sleep terrors, somnambulism, and rapid eye movement (REM) behavior sleep disorders are described, together with associated laboratory testing results and treatment.", {"entities": [[46, 56, "DISEASE"]]}], ["Association mapping is usually performed by testing the correlation between a single marker and phenotypes.", {"entities": []}], ["However, because patterns of variation within genomes are inherited as blocks, clustering markers into haplotypes for genome-wide scans could be a worthwhile approach to improve statistical power to detect associations.", {"entities": []}], ["The availability of high-density molecular data allows the possibility to assess the potential of both approaches to identify marker-trait associations in durum wheat.", {"entities": []}], ["In the present study, we used single marker- and haplotype-based approaches to identify loci associated with semolina and pasta colour in durum wheat, the main objective being to evaluate the potential benefits of haplotype-based analysis for identifying quantitative trait loci.", {"entities": []}], ["One hundred sixty-nine durum lines were genotyped using the Illumina 90K Infinium iSelect assay, and 12,234 polymorphic single nucleotide polymorphism (SNP) markers were generated and used to assess the population structure and the linkage disequilibrium (LD) patterns.", {"entities": []}], ["A total of 8,581 SNPs previously localized to a high-density consensus map were clustered into 406 haplotype blocks based on the average LD distance of 5.3 cM.", {"entities": []}], ["Combining multiple SNPs into haplotype blocks increased the average polymorphism information content (PIC) from 0.27 per SNP to 0.50 per haplotype.", {"entities": []}], ["The haplotype-based analysis identified 12 loci associated with grain pigment colour traits, including the five loci identified by the single marker-based analysis.", {"entities": []}], ["Furthermore, the haplotype-based analysis resulted in an increase of the phenotypic variance explained (50.4% on average) and the allelic effect (33.7% on average) when compared to single marker analysis.", {"entities": []}], ["The presence of multiple allelic combinations within each haplotype locus offers potential for screening the most favorable haplotype series and may facilitate marker-assisted selection of grain pigment colour in durum wheat.", {"entities": []}], ["These results suggest a benefit of haplotype-based analysis over single marker analysis to detect loci associated with colour traits in durum wheat.", {"entities": []}], ["To assess overall and cause-specific mortality and the quality of somatic care among psychiatric patients.", {"entities": []}], ["A register-based cohort study.", {"entities": []}], ["All individuals aged 20\u201379 years in Sweden in 2005.", {"entities": []}], ["In total 6\u2008294\u2008339 individuals.", {"entities": []}], ["The individuals were followed for mortality in 2006 and 2007, generating 72\u2008187 deaths.", {"entities": []}], ["Psychiatric patients were grouped according to their diagnosis in the National Patient Register.", {"entities": []}], ["Mortality risk of psychiatric patients was compared with that of non-psychiatric patients.", {"entities": []}], ["Estimates of RR of mortality were calculated as incidence rate ratios (IRRs) with 95% CIs using Poisson regression analysis.", {"entities": []}], ["Psychiatric patients were compared with non-psychiatric patients for three healthcare quality indicators: the proportion of avoidable hospitalisations, case death rate after myocardial infarction and statin use among diabetic patients.", {"entities": [[174, 195, "DISEASE"]]}], ["Compared with individuals with no episodes of treatment for mental disorder, psychiatric patients had a substantially increased risk of all studied causes of death as well as death from conditions considered amenable to intervention by the health service, that is, avoidable mortality.", {"entities": []}], ["The highest mortality was found among those with another mental disorder, predominantly substance abuse (for women, an IRR of 4.7 (95% CI 4.3 to 5.0) and for men, an IRR of 4.8 (95% CI 4.6 to 5.0)).", {"entities": [[88, 103, "DISEASE"]]}], ["The analysis of quality of somatic care revealed lower levels of healthcare quality for psychiatric patients, signalling failures in public health and medical care.", {"entities": []}], ["This study shows a marked increase in excess mortality, suggesting a lower quality of somatic healthcare in psychiatric patients.", {"entities": []}], ["To investigate whether psychiatric patients have higher overall and cause-specific mortality.", {"entities": []}], ["To study whether the quality of somatic care for psychiatric patients is different from the care provided to patients with no concurrent mental disorder.", {"entities": []}], ["This study shows a marked increase in excess mortality in mentally ill men and women.", {"entities": []}], ["The findings suggest a lower quality of healthcare in the treatment of somatic disorders in psychiatric patients regarding the indicators studied.", {"entities": []}], ["Careful medical examination of psychiatric patients together with efforts to promote a healthier life style may be of great importance in order to prevent, detect and treat somatic disease.", {"entities": []}], ["The strengths of the study include the population-based design, using national registers with high completeness.", {"entities": []}], ["We were unable to study the effects of health-related behaviours such as excessive alcohol consumption or tobacco smoking, which is a limitation.", {"entities": []}], ["Although angiogenesis is a hallmark feature of asthmatic inflammatory responses, therapeutic anti-angiogenesis interventions have received little attention.", {"entities": []}], ["Objective: Assess the effectiveness of anti-angiogenic Sn2 lipase-labile prodrugs delivered via \u03b1 v \u03b2 3 -micellar nanotherapy to suppress microvascular expansion, bronchial remodeling, and airway hyper-responsiveness in Brown Norway rats exposed to serial house dust mite (HDM) inhalation challenges.", {"entities": []}], ["Results: Anti-neovascular effectiveness of \u03b1 v \u03b2 3 -mixed micelles incorporating docetaxel-prodrug (Dxtl-PD) or fumagillin-prodrug (Fum-PD) were shown to robustly suppress neovascular expansion (p<0.01) in the upper airways/bronchi of HDM rats using simultaneous v \u03b2 3 -No-Drug) served as a carrier-only control.", {"entities": []}], ["Morphometric measurements of HDM rat airway size (perimeter) and vessel number at 21d revealed classic vascular expansion in control rats but less vascularity (p<0.001) after the anti-angiogenic nanotherapies.", {"entities": []}], ["CD31 RNA expression independently corroborated the decrease in airway microvasculature.", {"entities": []}], ["Methacholine (MCh) induced respiratory system resistance (Rrs) was high in the HDM rats receiving \u03b1 v \u03b2 3 -No-Drug micelles while \u03b1 v \u03b2 3 -Dxtl-PD or \u03b1 v \u03b2 3 -Fum-PD micelles markedly and equivalently attenuated airway hyper-responsiveness and improved airway compliance.", {"entities": []}], ["Total inflammatory BAL cells among HDM challenged rats did not differ with treatment, but \u03b1 v \u03b2 3 v \u03b2 3 -Dxtl-PD micelles.", {"entities": []}], ["Additionally, \u03b1 v \u03b2 3 -Dxtl-PD decreased BAL eosinophil and \u03b1 v \u03b2 3 v \u03b2 3 -No-Drug micelles, whereas \u03b1 v \u03b2 3 -Fum-PD micelles did not.", {"entities": []}], ["Conclusion: These results demonstrate the potential of targeted anti-angiogenesis nanotherapy to ameliorate the inflammatory hallmarks of asthma in a clinically relevant rodent model.", {"entities": [[138, 144, "DISEASE"]]}], ["Oxidative stress and inflammation play a pathogenetic role in idiopathic environmental intolerances (IEI), namely, multiple chemical sensitivity (MCS), fibromyalgia (FM), and chronic fatigue syndrome (CFS).", {"entities": [[175, 199, "DISEASE"], [191, 199, "DISEASE"], [115, 144, "DISEASE"], [152, 164, "DISEASE"]]}], ["Given the reported association of nitric oxide synthase (NOS) gene polymorphisms with inflammatory disorders, we aimed to investigate the distribution of NOS2A \u22122.5\u2009kb (CCTTT) n as well as Ser608Leu and NOS3 \u2212786T>C variants and their correlation with nitrite/nitrate levels, in a study cohort including 170 MCS, 108 suspected MCS (SMCS), 89 FM/CFS, and 196 healthy subjects.", {"entities": [[203, 207, "GENE"]]}], ["Patients and controls had similar distributions of NOS2A Ser608Leu and NOS3 \u2212786T>C polymorphisms.", {"entities": [[71, 75, "GENE"]]}], ["Interestingly, the NOS3 \u2212786TT genotype was associated with increased nitrite/nitrate levels only in IEI patients.", {"entities": [[19, 23, "GENE"]]}], ["We also found that the NOS2A \u22122.5\u2009kb (CCTTT) 11 allele represents a genetic determinant for FM/CFS, and the (CCTTT) 16 allele discriminates MCS from SMCS patients.", {"entities": []}], ["Instead, the (CCTTT) 8 allele reduces by three-, six-, and tenfold, respectively, the risk for MCS, SMCS, and FM/CFS.", {"entities": []}], ["Moreover, a short number of (CCTTT) repeats is associated with higher concentrations of nitrites/nitrates.", {"entities": []}], ["Here, we first demonstrate that NOS3 \u2212786T>C variant affects nitrite/nitrate levels in IEI patients and that screening for NOS2A \u22122.5\u2009kb (CCTTT) n polymorphism may be useful for differential diagnosis of various IEI.", {"entities": [[32, 36, "GENE"]]}], ["To investigate the role of TGF-\u03b2 and IL-6 in myofibroblasts (MFs) \u2014 lung cancer cell interactions, lung cancer cells (Lewis and CTM-167 cell lines) were stimulated by IL-6, MF-conditioned medium (MF-CM) or MFs, with or without TGF-\u03b2 signaling inhibitor \u2014 SB431542 and/or JAK2/STAT3 inhibitor \u2014 JSI-124.", {"entities": [[68, 79, "DISEASE"], [99, 110, "DISEASE"], [73, 79, "DISEASE"], [104, 110, "DISEASE"]]}], ["MFs were stimulated by TGF-\u03b2, cancer cell-CM or cancer cells, with or without SB431542 and JSI-124.", {"entities": [[30, 36, "DISEASE"], [48, 54, "DISEASE"]]}], ["Cell proliferation, the levels of cytokines, expression of mRNA and protein were determined.", {"entities": []}], ["Mice bearing xenograft tumors were intraperitoneally treated with SB431542 or JSI-124 and monitored for up to 45 days.", {"entities": []}], ["In co-culture systems, MFs secreted high levels of IL-6, while cancer cells produced high levels of TGF-\u03b2.", {"entities": [[63, 69, "DISEASE"]]}], ["Recombinant IL-6 and MF-CM activated STAT3 and upregulated TGF-\u03b2 in cancer cells.", {"entities": [[68, 74, "DISEASE"], [37, 42, "GENE"]]}], ["In contrast, cancer cell-CM or TGF-\u03b2 stimulated MFs to produce IL-6.", {"entities": [[13, 19, "DISEASE"]]}], ["Blockade of JAK2/STAT3 and TGF-\u03b2 signaling by specific inhibitors significantly inhibited cell proliferation in vitro and tumor growth in vivo of lung cancer cells.", {"entities": [[146, 157, "DISEASE"], [151, 157, "DISEASE"]]}], ["Our study demontrated that the TGF-\u03b2 and IL-6/JAK2/STAT3 signaling pathways form a positive feedback signaling loop that mediated the interactions between MFs and lung cancer cells.", {"entities": [[163, 174, "DISEASE"], [168, 174, "DISEASE"]]}], ["Targeted inhibiton of this signaling loop could be a new approach for lung cancer prevention and therapy.", {"entities": [[70, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality worldwide, and emphysema is a common component of COPD.", {"entities": []}], ["Currently, it is very difficult to detect early stage emphysema using conventional radiographic imaging without contrast agents, because the change in X-ray attenuation is not detectable with absorption-based radiography.", {"entities": []}], ["Compared with the absorption-based CT, phase contrast imaging has more advantages in soft tissue imaging, because of its high spatial resolution and contrast.", {"entities": []}], ["In this article, we used diffraction enhanced imaging (DEI) method to get the images of early stage emphysematous and healthy samples, then extract X-ray absorption, refraction, and ultra-small-angle X-ray scattering (USAXS) information from DEI images using multiple image radiography (MIR).", {"entities": []}], ["We combined the absorption image with the USAXS image by a scatter plot.", {"entities": []}], ["The critical threshold in the scatter plot was calibrated using the linear discriminant function in the pattern recognition.", {"entities": []}], ["USAXS image was sensitive to the change of tissue micro-structure, it could show the lesions which were invisible in the absorption image.", {"entities": []}], ["Combined with the absorption-based image, the USAXS information enabled better discrimination between healthy and emphysematous lung tissue in a mouse model.", {"entities": []}], ["The false-color images demonstrated that our method was capable of classifying healthy and emphysematous tissues.", {"entities": []}], ["Here we present USAXS images of early stage emphysematous and healthy samples, where the dependence of the USAXS signal on micro-structures of biomedical samples leads to improved diagnosis of emphysema in lung radiographs.", {"entities": []}], ["Since the identification of the p38 mitogen-activated protein kinase (MAPK) as a key signal-transducing molecule in the expression of the proinflammatory cytokine tumor necrosis factor (TNF) more than 10 years ago, huge efforts have been made to develop inhibitors of p38 MAPK with the intent to modulate unwanted TNF activity in diseases such as autoimmune diseases or sepsis.", {"entities": [[186, 189, "GENE"], [314, 317, "GENE"], [186, 189, "GENE"], [314, 317, "GENE"]]}], ["However, despite some anti-inflammatory effects in animal models, no p38 MAPK inhibitor has yet demonstrated clinical efficacy in human autoimmune disorders.", {"entities": []}], ["One possible reason for this paradox might relate to the fact that the p38 MAPK signaling cascade is involved in the functional regulation of several different cell types that all contribute to the complex pathogenesis of human autoimmune diseases.", {"entities": []}], ["In particular, p38 MAPK has a multifaceted role in CD4 T cells that have been implicated in initiating and driving sustained inflammation in autoimmune diseases, such as rheumatoid arthritis or systemic vasculitis.", {"entities": [[170, 190, "DISEASE"], [203, 213, "DISEASE"], [181, 190, "DISEASE"], [51, 54, "GENE"]]}], ["Here we review recent advances in the understanding of the role of the p38 MAPK signaling cascade in CD4 T cells and the consequences that its inhibition provokes in T cell functions in vitro and in vivo .", {"entities": [[101, 104, "GENE"]]}], ["These new data suggest that p38 MAPK inhibitors may elicit several unwanted effects in human autoimmune diseases but may be useful for the treatment of allergic disorders.", {"entities": []}], ["The Internet is a widely used source of information for patients searching for medical/health care information.", {"entities": []}], ["While many studies have assessed existing medical/health care information on the Internet, relatively few have examined methods for design and delivery of such websites, particularly those aimed at the general public.", {"entities": []}], ["This study describes a method of evaluating material for new medical/health care websites, or for assessing those already in existence, which is correlated with higher rankings on Google's Search Engine Results Pages (SERPs).", {"entities": []}], ["A website quality assessment (WQA) tool was developed using criteria related to the quality of the information to be contained in the website in addition to an assessment of the readability of the text.", {"entities": []}], ["This was retrospectively applied to assess existing websites that provide information about generic medicines.", {"entities": []}], ["The reproducibility of the WQA tool and its predictive validity were assessed in this study.", {"entities": []}], ["The WQA tool demonstrated very high reproducibility (intraclass correlation coefficient=0.95) between 2 independent users.", {"entities": []}], ["A moderate to strong correlation was found between WQA scores and rankings on Google SERPs.", {"entities": []}], ["Analogous correlations were seen between rankings and readability of websites as determined by Flesch Reading Ease and Flesch-Kincaid Grade Level scores.", {"entities": []}], ["The use of the WQA tool developed in this study is recommended as part of the design phase of a medical or health care information provision website, along with assessment of readability of the material to be used.", {"entities": []}], ["This may ensure that the website performs better on Google searches.", {"entities": []}], ["The tool can also be used retrospectively to make improvements to existing websites, thus, potentially enabling better Google search result positions without incurring the costs associated with Search Engine Optimization (SEO) professionals or paid promotion.", {"entities": []}], ["Respiratory syncytial virus (RSV) infection can result in severe disease partially due to its ability to interfere with the initiation of Th1 responses targeting the production of type I interferons (IFN) and promoting a Th2 immune environment.", {"entities": []}], ["Epigenetic modulation of gene transcription has been shown to be important in regulating inflammatory pathways.", {"entities": []}], ["RSV-infected bone marrow-derived DCs (BMDCs) upregulated expression of Kdm5b/Jarid1b H3K4 demethylase.", {"entities": []}], ["Kdm5b -specific siRNA inhibition in BMDC led to a 10-fold increase in IFN-\u03b2 as well as increases in IL-6 and TNF-\u03b1 compared to control-transfected cells.", {"entities": [[0, 5, "GENE"]]}], ["The generation of Kdm5b in vitro DC activation showing innate cytokine modulation.", {"entities": [[18, 23, "GENE"]]}], ["In vivo , infection of Kdm5b Kdm5b was blocked in DCs with siRNA or DCs from Kdm5b Respiratory syncytial virus (RSV) is a significant public health concern.", {"entities": [[23, 28, "GENE"], [29, 34, "GENE"], [77, 82, "GENE"], [23, 28, "GENE"], [29, 34, "GENE"], [77, 82, "GENE"], [23, 28, "GENE"], [29, 34, "GENE"], [77, 82, "GENE"]]}], ["Nearly all children are infected by two years of age, and severe infection often results in hospitalization.", {"entities": []}], ["There is no vaccine for RSV, and previous attempts have resulted in increased disease severity in immunized children once they were exposed to the virus.", {"entities": []}], ["Therefore, a better understanding of how RSV directs the immune response is needed.", {"entities": []}], ["In this study, we found that the protein KDM5B regulates an epigenetic mechanism that directs the immune response to RSV.", {"entities": [[41, 46, "GENE"]]}], ["KDM5B suppressed the activation of key antiviral signals in dendritic cells, and inhibition of KDM5B led to gene activation and increased antiviral function.", {"entities": [[0, 5, "GENE"], [95, 100, "GENE"], [0, 5, "GENE"], [95, 100, "GENE"]]}], ["This correlated with decreased pathology in the lungs.", {"entities": []}], ["Therefore, our data suggest that new attempts at designing a vaccine should consider the effects of vaccination on dendritic cells, and should consider strategies that will increase antiviral signals from dendritic cells.", {"entities": []}], ["It is generally assumed that urban slum residents have worse health status when compared with other urban populations, but better health status than their rural counterparts.", {"entities": []}], ["This belief/assumption is often because of their physical proximity and assumed better access to health care services in urban areas.", {"entities": []}], ["However, a few recent studies have cast doubt on this belief.", {"entities": []}], ["Whether slum dwellers are better off, similar to, or worse off as compared with rural and other urban populations remain poorly understood as indicators for slum dwellers are generally hidden in urban averages.", {"entities": []}], ["The aim of this study was to compare health and health-related indicators among slum, rural, and other urban populations in four countries where specific efforts have been made to generate health indicators specific to slum populations.", {"entities": []}], ["We conducted a comparative analysis of health indicators among slums, non-slums, and all urban and rural populations as well as national averages in Bangladesh, Kenya, Egypt, and India.", {"entities": []}], ["We triangulated data from demographic and health surveys, urban health surveys, and special cross-sectional slum surveys in these countries to assess differences in health indicators across the residential domains.", {"entities": []}], ["We focused the comparisons on child health, maternal health, reproductive health, access to health services, and HIV/AIDS indicators.", {"entities": []}], ["Within each country, we compared indicators for slums with non-slum, city/urban averages, rural, and national indicators.", {"entities": []}], ["Between-country differences were also highlighted.", {"entities": []}], ["In all the countries, except India, slum children had much poorer health outcomes than children in all other residential domains, including those in rural areas.", {"entities": []}], ["Childhood illnesses and malnutrition were higher among children living in slum communities compared to those living elsewhere.", {"entities": []}], ["Although treatment seeking was better among slum children as compared with those in rural areas, this did not translate to better mortality outcomes.", {"entities": []}], ["They bear a disproportionately much higher mortality burden than those living elsewhere.", {"entities": []}], ["Slum communities had higher coverage of maternal health services than rural communities but it was not possible to compare maternal mortality rates across these residential domains.", {"entities": []}], ["Compared to rural areas, slum communities had lower fertility and higher contraceptive use rates but these differences were reversed when slums were compared to other urban populations.", {"entities": []}], ["Slum\u2013rural differences in infant mortality were found to be larger in Bangladesh compared to Kenya.", {"entities": []}], ["Mortality and morbidity indicators were worse in slums than elsewhere.", {"entities": []}], ["However, indicators of access to care and health service coverage were found to be better in slums than in rural communities.", {"entities": []}], ["Goblet cell metaplasia, a common feature of chronic obstructive pulmonary disease (COPD), is associated with mucus hypersecretion which contributes to the morbidity and mortality among patients.", {"entities": [[44, 81, "DISEASE"]]}], ["Transcription factors SAM-pointed domain-containing Ets-like factor (SPDEF) and forkhead box protein A2 (FOXA2) regulate goblet cell differentiation.", {"entities": [[69, 74, "GENE"], [105, 110, "GENE"]]}], ["This study aimed to (1) investigate DNA methylation and expression of SPDEF and FOXA2 during goblet cell differentiation and (2) compare this in airway epithelial cells from patients with COPD and controls during mucociliary differentiation.", {"entities": [[70, 75, "GENE"], [80, 85, "GENE"]]}], ["To assess DNA methylation and expression of SPDEF and FOXA2 during goblet cell differentiation, primary airway epithelial cells, isolated from trachea (non-COPD controls) and bronchial tissue (patients with COPD), were differentiated by culture at the air-liquid interface (ALI) in the presence of cytokine interleukin (IL)-13 to promote goblet cell differentiation.", {"entities": [[44, 49, "GENE"], [54, 59, "GENE"]]}], ["We found that SPDEF expression was induced during goblet cell differentiation, while FOXA2 expression was decreased.", {"entities": [[14, 19, "GENE"], [85, 90, "GENE"]]}], ["Importantly, CpG number 8 in the SPDEF promoter was hypermethylated upon differentiation, whereas DNA methylation of FOXA2 promoter was not changed.", {"entities": [[33, 38, "GENE"], [117, 122, "GENE"]]}], ["In the absence of IL-13, COPD-derived ALI-cultured cells displayed higher SPDEF expression than control-derived ALI cultures, whereas no difference was found for FOXA2 expression.", {"entities": [[74, 79, "GENE"], [162, 167, "GENE"]]}], ["This was accompanied with hypomethylation of CpG number 6 in the SPDEF promoter and also hypomethylation of CpG numbers 10 and 11 in the FOXA2 promoter.", {"entities": [[65, 70, "GENE"], [137, 142, "GENE"]]}], ["These findings suggest that aberrant DNA methylation of SPDEF and FOXA2 is one of the factors underlying mucus hypersecretion in COPD, opening new avenues for epigenetic-based inhibition of mucus hypersecretion.", {"entities": [[56, 61, "GENE"], [66, 71, "GENE"]]}], ["The online version of this article (doi:10.1186/s13148-017-0341-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Atypical meningiomas are common central nervous system neoplasms with high recurrence rate and poorer prognosis compared to their grade I counterparts.", {"entities": []}], ["Surgical excision and radiotherapy remains the mainstay therapy but medical treatments are limited.", {"entities": []}], ["We explore new drug candidates using computational drug repurposing based on the gene expression signature of atypical meningioma tissue with subsequent analysis of drug-generated expression profiles.", {"entities": [[119, 129, "DISEASE"]]}], ["We further explore possible mechanisms of action for the identified drug candidates using ingenuity pathway analysis (IPA).", {"entities": []}], ["We extracted gene expression profiles for atypical meningiomas (12 samples) and normal meningeal tissue (4 samples) from the Gene Expression Omnibus, which were then used to generate a gene signature comprising of 281 differentially expressed genes.", {"entities": []}], ["Drug candidates were explored using both the Board Institute Connectivity Map (cmap) and Library of Integrated Network-Based Cellular Signatures (LINCS).", {"entities": []}], ["Functional analysis of significant differential gene expression for drug candidates was performed with IPA.", {"entities": []}], ["Using our integrated approach, we identified multiple, already licensed, drug candidates such as emetine, verteporfin, phenoxybenzamine and trazodone.", {"entities": []}], ["Analysis with IPA revealed that these drugs target signal cascades potentially relevant in pathogenesis of meningiomas, particular examples are the effect on ERK by trazodone, MAP kinases by emetine, and YAP-1 protein by verteporfin.", {"entities": []}], ["Gene expression profiling and use of drug expression profiles have yielded several plausible drug candidates for treating atypical meningioma, some of which have already been suggested by preceding studies.", {"entities": [[131, 141, "DISEASE"]]}], ["Although our analyses suggested multiple anti-tumour mechanisms for these drugs, further in vivo studies are required for validation.", {"entities": []}], ["To our knowledge this is the first study which combines relatively new, yet established computational techniques to identify additional treatments for a difficult to manage cerebral neoplasm.", {"entities": []}], ["Beyond proposing already approved drug candidates in the management of atypical meningioma the study highlights the promise held by computational techniques in improving our management strategies.", {"entities": [[80, 90, "DISEASE"]]}], ["The prevalence of smoking in nursing personnel remains high.", {"entities": []}], ["The aim of this study was to identify work factors that predict smoking cessation among nurses' aides.", {"entities": []}], ["Of 2720 randomly selected, Norwegian nurses' aides, who were smoking at least one cigarette per day when they completed a questionnaire in 1999, 2275 (83.6 %) completed a second questionnaire 15 months later.", {"entities": []}], ["A wide spectrum of work factors were assessed at baseline.", {"entities": []}], ["Respondents who reported smoking 0 cigarettes per day at follow-up were considered having stopped smoking.", {"entities": []}], ["The odds ratios and 95 % confidence intervals of stopping smoking were derived from logistic regression models.", {"entities": []}], ["Compared with working 1\u20139 hours per week, working 19\u201336 hours per week (odds ratio (OR) = 0.35; 95 % confidence interval (CI) = 0.13 \u2013 0.91), and working more than 36 hours per week (i.e.", {"entities": []}], ["more than full-time job) (OR = 0.27; CI = 0.09 \u2013 0.78) were associated with reduced odds of smoking cessation, after adjustments for daily consumption of cigarettes at baseline, age, gender, marital status, and having preschool children.", {"entities": []}], ["Adjusting also for chronic health problems gave similar results.", {"entities": []}], ["There seems to be a negative association between hours of work per week and the odds of smoking cessation in nurses' aides.", {"entities": []}], ["It is important that health institutions offer workplace-based services with documented effects on nicotine dependence, such as smoking cessation courses, so that healthcare workers who want to stop smoking, especially those with long working hours, do not have to travel to the programme or to dedicate their leisure time to it.", {"entities": [[99, 118, "DISEASE"]]}], ["The aim of this study is to formulate the best clinical practice in the diagnosis and management of chronic pruritus (CP).", {"entities": [[118, 120, "GENE"]]}], ["We searched PubMed, EMBASE, Scopus, Web of Science, and the WHO's regional databases, for studies on \u201cDiagnosis and management of chronic pruritus\u201d from January 1, 2014, to July 31, 2015.", {"entities": []}], ["We included programmatic reports and hand-searched references of published reviews and articles.", {"entities": []}], ["Two independent reviewers screened articles and extracted data.", {"entities": []}], ["We screened 87 of 95 studies that contained qualitative data.", {"entities": []}], ["Avoid: Dry climate, heat, alcohol compress, ice packs, frequent bathing and washing, intake of very hot and spicy food, intake of alcohol, contact with irritant substances, excitement, strain and stress, and allergens.", {"entities": []}], ["Using: Mild nonalkaline soaps, moisturizers, bathing oils, lukewarm water while bathing, soft cotton clothing and night creams/lotions, relaxation therapy, autogenic training, psychosocial education, educating patients to cope with itching and scratching, and educational programs.", {"entities": []}], ["Especially use of moisturizers is considered important.", {"entities": []}], ["In addition, symptomatic treatment options include systemic H1 antihistamines and topical corticosteroids.", {"entities": []}], ["Symptomatic therapy directed toward the cause (hepatic, renal, atopic, polycythemia, etc.).", {"entities": [[71, 83, "DISEASE"]]}], ["If refractory or cause is unknown, consider capsaicin, calcineurin inhibitors for localized pruritus and naltrexone, pregabalin, ultraviolet therapy, Cyclosporine for generalized itching.", {"entities": []}], ["CP is quite frequent finding associated with skin and systemic diseases in the overall population.", {"entities": [[0, 2, "GENE"]]}], ["It is known to significantly affect quality life score of an individual and also adds burden on the health-care cost.", {"entities": []}], ["A specific recommendation for treatment of CP is difficult as a result of varied and diverse possibility of underlying diseases associated with CP.", {"entities": [[43, 45, "GENE"], [144, 146, "GENE"], [43, 45, "GENE"], [144, 146, "GENE"]]}], ["Asymptomatic left ventricular (LV) dysfunction is highly prevalent in type 2 diabetes patients.", {"entities": []}], ["Unlike the other hypoglycemic drugs, SGLT2 inhibitors have shown potential benefits for reducing cardiovascular death and risk factors, aside from lowering plasma glucose levels.", {"entities": []}], ["With this study we aim at determining whether the treatment with empagliflozin is associated with an improvement in LV functions in diabetic patients with asymptomatic LV dysfunction against Sitagliptin, which is presumably neutral on myocardial function.", {"entities": []}], ["To determine changes in LV systolic and diastolic functions we will use s peckle - tracking echocardiography , a novel sensitive, non-invasive, bedside method allowing the calculation of LV global longitudinal strain (GLS), an index of myocardial deformability, as well as 3D echocardiography, which allows a better evaluation of LV volumes and mass.", {"entities": [[218, 221, "GENE"]]}], ["The EMPA-HEART trial will be a phase III, open label, active-controlled, parallel groups, single centre, exploratory study conducted in Pisa, Italy.", {"entities": []}], ["A cohort of 75 diabetic patients with normal LV systolic (2D-Echo EF\u00a0>\u00a050%) and renal (eGFR sec MDRD\u00a0>\u00a060\u00a0ml/min/1.73\u00a0mq) functions and no evidence of valvular and/or ischemic heart disease will be randomized to either Empagliflozin 10\u00a0mg/die or Sitagliptin 100\u00a0mg/die.", {"entities": [[167, 189, "DISEASE"], [176, 189, "DISEASE"], [87, 91, "GENE"]]}], ["The primary outcome is to detect a change in GLS from baseline to 1 and 6\u00a0months after treatment initiation.", {"entities": [[45, 48, "GENE"]]}], ["The secondary outcomes include changes from baseline to 6\u00a0months in 3-D Echocardiography EF, left atrial volume and E/E\u2032, VO 2 max as measured at cardiopulmonary test, cardiac autonomic function tests (R\u2013R interval during Valsalva manoeuvre, deep-breathing, lying-to-standing), and the determination of a set of plasma biomarkers aimed at studying volume, inflammation, oxidative stress, matrix remodelling, myocyte strain and injury.", {"entities": [[127, 130, "GENE"]]}], ["SGLT2 inhibitors might affect myocardial functions through mechanisms acting both directly and indirectly on the myocardium.", {"entities": []}], ["The set of instrumental and biohumoral tests of our study might actually detect the presence and entity of empagliflozin beneficial effects on the myocardium and shed light on the mechanisms involved.", {"entities": []}], ["Further, this study might eventually provide information to design a clinical strategy, based on echocardiography and/or biomarkers, to select the patients who might benefit more from this intervention.", {"entities": []}], ["Trial registration EUDRACT Code 2016-0022250-10", {"entities": []}], ["Social network structure is a fundamental determinant of human health, from infectious to chronic diseases.", {"entities": []}], ["However, quantitative and unbiased approaches to measuring social network structure are lacking.", {"entities": []}], ["We hypothesized that genetic relatedness of oral commensal bacteria could be used to infer social contact between humans, just as genetic relatedness of pathogens can be used to determine transmission chains of pathogens.", {"entities": []}], ["We used a traditional, questionnaire survey-based method to characterize the contact network of the School of Public Health at a large research university.", {"entities": []}], ["We then collected saliva from a subset of individuals to analyze their oral microflora using a modified deep sequencing multilocus sequence typing (MLST) procedure.", {"entities": []}], ["We examined micro-evolutionary changes in the S .", {"entities": []}], ["viridans group to uncover transmission patterns reflecting social network structure.", {"entities": []}], ["We amplified seven housekeeping gene loci from the Streptococcus viridans group, a group of ubiquitous commensal bacteria, and sequenced the PCR products using next-generation sequencing.", {"entities": []}], ["By comparing the generated S .", {"entities": []}], ["viridans reads between pairs of individuals, we reconstructed the social network of the sampled individuals and compared it to the network derived from the questionnaire survey-based method.", {"entities": []}], ["The genetic relatedness significantly (p-value < 0.001) correlated with social distance in the questionnaire-based network, and the reconstructed network closely matched the network derived from the questionnaire survey-based method.", {"entities": []}], ["Oral commensal bacterial are thus likely transmitted through routine physical contact or shared environment.", {"entities": []}], ["Their genetic relatedness can be used to represent a combination of social contact and shared physical space, therefore reconstructing networks of contact.", {"entities": []}], ["This study provides the first step in developing a method to measure direct social contact based on commensal organism genotyping, potentially capable of unmasking hidden social networks that contribute to pathogen transmission.", {"entities": []}], ["Indoor air quality (IAQ) in preschools is an important public health challenge.", {"entities": []}], ["Particular attention should be paid to younger children, because they are more vulnerable to air pollution than higher grade children and because they spend more time indoors.", {"entities": []}], ["Among air pollutants, particulate matter (PM) is of the greatest interest mainly due to its acute and chronic effects on children\u2019s health.", {"entities": []}], ["In addition, carbon dioxide (CO 2 ) levels indicate ventilation conditions.", {"entities": []}], ["In this paper, we present the concentrations of PM (PM 1 , PM 2.5 , PM 10 and total\u2014TSP) and CO 2 monitored in four naturally ventilated nursery schools located in the area of Gliwice, Poland.", {"entities": []}], ["The nursery schools were selected to characterize areas with different degrees of urbanization and traffic densities during the winter season.", {"entities": []}], ["The results indicate the problem of elevated concentrations of PM inside the examined classrooms, as well as that of high levels of CO 2 exceeding 1000 ppm in relation to outdoor air.", {"entities": []}], ["The characteristics of IAQ were significantly different, both in terms of classroom occupation (younger or older children) and of localization (urban or rural).", {"entities": []}], ["To evaluate the children\u2019s exposure to poor IAQ, indicators based on air quality guidelines were proposed to rank classrooms according to their hazard on the health of children.", {"entities": []}], ["The human leukocyte antigen-G (HLA-G) is considered an immune checkpoint molecule involved in tumor immune evasion.", {"entities": [[31, 36, "GENE"]]}], ["Hypoxia and the metabolic sensor hypoxia-inducible factor 1 (HIF-1) are hallmarks of metastasization, angiogenesis, and intense tumor metabolic activity.", {"entities": []}], ["The purpose of this review was to examine original in vitro studies carried out in human cancer cell lines, which reported data about HLA-G expression and HIF-1 mediated-HLA-G expression in response to hypoxia.", {"entities": [[89, 95, "DISEASE"], [134, 139, "GENE"], [170, 175, "GENE"]]}], ["The impact of HLA-G genomic variability on the hypoxia responsive elements (HREs) specific for HIF-1 binding was also discussed.", {"entities": [[14, 19, "GENE"]]}], ["Under hypoxia, HLA-G-negative cell lines might transcribe HLA-G without translation of the protein while in contrast, HLA-G-positive cell lines, showed a reduced HLA-G transcriptional activity and protein level.", {"entities": [[15, 20, "GENE"], [58, 63, "GENE"], [118, 123, "GENE"], [162, 167, "GENE"], [15, 20, "GENE"], [58, 63, "GENE"], [118, 123, "GENE"], [162, 167, "GENE"]]}], ["HIF-1 modulation of HLA-G expression induced by hypoxia was demonstrated in different cell lines.", {"entities": [[20, 25, "GENE"]]}], ["HLA-G SNPs rs1632947 and rs41551813 located in distinct HREs demonstrated a prominent role of HIF-1 binding by DNA looping.", {"entities": [[0, 5, "GENE"]]}], ["Our research revealed a fine regulation of HLA-G in hypoxic conditions through HIF-1, depending on the cellular type and HLA-G genomic variability.", {"entities": [[43, 48, "GENE"], [121, 126, "GENE"], [43, 48, "GENE"], [121, 126, "GENE"]]}], ["Specifically, SNPs found in HREs should be considered in future investigations as markers with potential clinical value especially in metastatic malignancies.", {"entities": []}], ["There is variation in antibiotic prescribing for lower respiratory tract infections (LRTI) in primary care that does not benefit patients.", {"entities": []}], ["This study aims to investigate clinicians' accounts of clinical influences on antibiotic prescribing decisions for LRTI to better understand variation and identify opportunities for improvement.", {"entities": []}], ["Multi country qualitative interview study.", {"entities": []}], ["Semi-structured interviews using open-ended questions and a patient scenario.", {"entities": []}], ["Data were subjected to five-stage analytic framework approach (familiarisation, developing a thematic framework from the interview questions and emerging themes, indexing, charting and mapping to search for interpretations), with interviewers commenting on preliminary reports.", {"entities": []}], ["Primary care.", {"entities": []}], ["80 primary care clinicians randomly selected from primary care research networks based in nine European cities.", {"entities": []}], ["Clinicians reported four main individual clinical factors that guided their antibiotic prescribing decision: auscultation, fever, discoloured sputum and breathlessness.", {"entities": []}], ["These were considered alongside a general impression of the patient derived from building a picture of the illness course, using intuition and familiarity with the patient.", {"entities": []}], ["Comorbidity and older age were considered main risk factors for poor outcomes.", {"entities": []}], ["Clinical factors were similar across networks, apart from C reactive protein near patient testing in Troms\u00f8.", {"entities": []}], ["Clinicians developed ways to handle diagnostic and management uncertainty through their own clinical routines.", {"entities": []}], ["Clinicians emphasised the importance of auscultation, fever, discoloured sputum and breathlessness, general impression of the illness course, familiarity with the patient, comorbidity, and age in informing their antibiotic prescribing decisions for LRTI.", {"entities": []}], ["As some of these factors may be overemphasised given the evolving evidence base, greater standardisation of assessment and integration of findings may help reduce unhelpful variation in management.", {"entities": []}], ["Non-clinical influences will also need to be addressed.", {"entities": []}], ["Clinicians' accounts of clinical influences on antibiotic prescribing decisions for LRTI.", {"entities": []}], ["Understand variation and identify opportunities for improvement.", {"entities": []}], ["Clinicians reported four main clinical factors that guided their antibiotic prescribing decision: auscultation findings, fever, discoloured sputum and breathlessness.", {"entities": []}], ["Clinical factors were similar across networks, apart from C reactive protein near patient testing used in Troms\u00f8.", {"entities": []}], ["These clinical factors were considered alongside a general impression of the patient derived from consideration of illness course, intuition and familiarity with the patient.", {"entities": []}], ["Clinicians developed ways to handle diagnostic and management uncertainty through their own clinical routines.", {"entities": []}], ["This is the first study to use semi-structured qualitative interviews to capture clinicians' views about LRTI management across a broad range of contrasting European countries.", {"entities": []}], ["The clinicians who participated were affiliated to a research network so may not have been representative of all general practitioners in their country.", {"entities": []}], ["Qualitative interviews gather reports of behaviour and attitude rather than actual behaviour, but by allowing clinicians to introduce and elaborate on themes spontaneously, we were able to gain an impression of the themes that held most prominence to the clinicians themselves.", {"entities": []}], ["The evaluation of patient-reported health-related quality of life (HRQOL) in pulmonary tuberculosis (TB) contributes to a comprehensive understanding of the burden associated with this disease.", {"entities": [[87, 99, "DISEASE"], [77, 99, "DISEASE"]]}], ["The aim of this study was to assess the overall impact of TB on the health status and on single health domains identified in the WHO definition of health, including physical, mental and social health aspects.", {"entities": []}], ["Four instruments for HRQOL evaluation were applied in a longitudinal multicentre study during six-month standard TB treatment in South Africa.", {"entities": []}], ["These included the generic SF-12 and EQ-5D-5L, the disease-specific St. George\u00b4s Respiratory Questionnaire (SGRQ) and the condition-specific Hospital Anxiety and Depression Scale (HADS).", {"entities": []}], ["Statistical analysis included significance testing, univariable and multivariable analysis, and repeated measures ANOVA.", {"entities": []}], ["Change over time in the physical component score (PCS) of SF-12 was defined as primary endpoint.", {"entities": []}], ["A target sample size of 96 patients was estimated.", {"entities": []}], ["HRQOL of the study participants was impaired in all physical, mental and psycho-social health domains at treatment start.", {"entities": []}], ["HRQOL improved significantly and in a clinically meaningful manner during the course of standard TB treatment, over the period of the study.", {"entities": []}], ["The greatest improvement (95%) was observed in mental health.", {"entities": []}], ["Younger patients with higher education and who were employed had a better HRQOL.", {"entities": []}], ["This study demonstrates the need for an integrative understanding of TB with HRQOL as core element to inform gaps in current TB management.", {"entities": []}], ["Improvements in the management of TB following an integrative patient-centred approach will contribute towards meeting the United Nations Sustainable Development Goal 3 (SDG3) target and will support the End TB strategy of the WHO.", {"entities": []}], ["The present study evaluated the antioxidant potential of Vernonia condensata Baker (Asteraceae).", {"entities": []}], ["Dried and powdered leaves were exhaustively extracted with ethanol by static maceration followed by partition to obtain the hexane, dichloromethane, ethyl acetate, and butanol fractions.", {"entities": []}], ["Total phenols and flavonoids contents were determined through spectrophotometry and flavonoids were identified by HPLC-DAD system.", {"entities": []}], ["The antioxidant activity was assessed by DPPH radical scavenging activity, TLC-bioautography, reducing power of Fe 50 of DPPH assay varied from 4.28 to 75.10\u2009 \u00b5 g/mL and TLC-bioautography detected the antioxidant compounds.", {"entities": []}], ["The reducing power of Fe \u03bc g/mL, while the reaction with phosphomolybdenum ranged from 13.54% to 32.63% and 56.02% to 135.00% considering ascorbic acid and rutin as reference, respectively.", {"entities": []}], ["At 30\u2009mg/mL, the ethanolic extract and fractions revealed significant effect against lipid peroxidation.", {"entities": []}], ["All these data sustain that V. condensata is an important and promising source of bioactive substances with antioxidant activity.", {"entities": []}], ["To be successful, cost control efforts must target Medicaid Managed Care (MMC) beneficiaries likely to incur high costs.", {"entities": []}], ["The critical question is how to identify potential high cost beneficiaries with simple, reproducible, transparent, auditable criteria.", {"entities": []}], ["Our objective in this analysis was to evaluate whether the total burden of comorbidity, assessed by the Charlson comorbidity index, could identify MMC beneficiaries who incurred high health care costs.", {"entities": []}], ["The MetroPlus MMC claims database was use to analyze six months of claims data from 07/07-12/07; the analysis focused on the total amount paid.", {"entities": []}], ["Age, gender, Charlson comorbidity score, serious mental illness and pregnancy were analyzed as predictors of total costs.", {"entities": []}], ["We evaluated the cost profile of 4,614 beneficiaries enrolled at MetroPlus, an MMC plan.", {"entities": []}], ["As hypothesized, the comorbidity index was a key correlate of total costs (p\u2009<\u2009.01).", {"entities": []}], ["Yearly costs were more related to the total burden of comorbidity than any specific comorbid disease.", {"entities": []}], ["For adults, in addition to comorbidity (p\u2009<\u2009.01) both serious mental illness (p\u2009<\u2009.01) and pregnancy (p\u2009<\u2009.01) were also related to total costs, while age, drug addiction and gender were not.", {"entities": []}], ["The model with age, gender, comorbidity, serious mental illness, pregnancy and addiction explained 20% of the variance in total costs.", {"entities": []}], ["In children, comorbidity (p\u2009<\u2009.01), serious mental illness (p\u2009<\u2009.01), addiction (p\u2009<\u2009.03) and pregnancy (p\u2009<\u2009.01) were associated with log cost; the model with those variables explained 6% of the variance in costs.", {"entities": []}], ["Comorbidity can be used to identify MMC beneficiaries most likely to have high costs.", {"entities": []}], ["Worldwide, obesity trends are causing serious public health concern and in many countries threatening the viability of basic health care delivery.", {"entities": [[11, 18, "DISEASE"]]}], ["It is an independent risk factor for cardiovascular diseases and significantly increases the risk of morbidity and mortality.", {"entities": []}], ["The last two decades have witnessed an increase in health care costs due to obesity and related issues among children and adolescents.", {"entities": [[76, 83, "DISEASE"]]}], ["Childhood obesity is a global phenomenon affecting all socio-economic groups, irrespective of age, sex or ethnicity.", {"entities": [[10, 17, "DISEASE"]]}], ["Aetiopathogenesis of childhood obesity is multi-factorial and includes genetic, neuroendocrine, metabolic, psychological, environmental and socio-cultural factors.", {"entities": [[31, 38, "DISEASE"]]}], ["Many co-morbid conditions like metabolic, cardiovascular, psychological, orthopaedic, neurological, hepatic, pulmonary and renal disorders are seen in association with childhood obesity.", {"entities": [[178, 185, "DISEASE"]]}], ["The treatment of overweight and obesity in children and adolescents requires a multidisciplinary, multi-phase approach, which includes dietary management, physical activity enhancement, restriction of sedentary behaviour, pharmacotherapy and bariatric surgery.", {"entities": [[32, 39, "DISEASE"]]}], ["A holistic approach to tackle the childhood obesity epidemic needs a collection of activities including influencing policy makers and legislation, mobilizing communities, restructuring organizational practices, establishing coalitions and networks, empowering providers, imparting community education as well as enriching and reinforcing individual awareness and skills.", {"entities": [[44, 51, "DISEASE"]]}], ["The implications of this global phenomenon on future generations will be serious unless appropriate action is taken.", {"entities": []}], ["To describe clinical aspects of pandemic (H1N1) 2009 virus\u2013associated pneumonia in children, we studied 80 such children, including 17 (21%) with complications, who were admitted to 5 hospitals in Japan during August\u2013November 2009 after a mean of 2.9 symptomatic days.", {"entities": [[70, 79, "DISEASE"]]}], ["All enrolled patients recovered (median hospitalization 6 days).", {"entities": []}], ["Timely access to hospitals may have contributed to favorable outcomes.", {"entities": []}], ["Our companion-animals, dogs, suffer increasingly from non-communicable diseases, analogous to those common in humans, such as allergic manifestations.", {"entities": []}], ["In humans, living in rural environments is associated with lower risk of allergic diseases.", {"entities": []}], ["Our aim was to explore whether a similar pattern can be found in dogs, using a nation-wide survey in Finland ( n \u2009=\u20095722).", {"entities": []}], ["We characterised the land-use around dog\u2019s home at the time of birth as well as around its current home, and described several lifestyle factors.", {"entities": []}], ["The severity of owner-reported allergic symptoms in dogs was estimated with a comprehensive set of questions, developed by experts of canine dermatology.", {"entities": []}], ["Also, the prevalence of diagnosed allergies in dog owners was recorded.", {"entities": []}], ["The results indicate that allergic symptoms are more prevalent in urban environments both in dog owners and in dogs (accounting the effect of dog breed).", {"entities": []}], ["Several factors related to rural living, such as bigger family size and regular contact with farm animals and other pets, were also protective against allergic symptoms in dogs.", {"entities": []}], ["Interestingly, allergic dogs were more likely to have allergic owners than healthy dogs were.", {"entities": []}], ["Therefore, we suggest that the mutual presence of allergic symptoms in both species indicates common underlying causal factors of allergic diseases.", {"entities": []}], ["The assessment of symptoms of chronic obstructive pulmonary disease (COPD) is important for monitoring and managing the disease and for evaluating outcomes of interventions.", {"entities": [[30, 67, "DISEASE"]]}], ["COPD patients experience symptoms during the day and night, and symptoms experienced at night often disturb sleep.", {"entities": []}], ["The aim of this paper is to describe methods used to develop a patient-reported outcome (PRO) instrument for evaluating nighttime symptoms of COPD, and to document evidence for the content validity of the instrument.", {"entities": []}], ["Literature review and clinician interviews were conducted to inform discussion guides to explore patients\u2019 nighttime COPD symptom experience.", {"entities": []}], ["Data from focus groups with COPD patients was used to develop a conceptual framework and the content of a new PRO instrument.", {"entities": []}], ["Patient understanding of the new instrument was assessed via cognitive interviews with COPD patients.", {"entities": []}], ["The literature review confirmed that there is no instrument with evidence of content validity currently available to assess nighttime symptoms of COPD.", {"entities": []}], ["Additionally, the literature review and clinician interviews suggested the need to understand patients\u2019 experience of specific symptoms in order to evaluate nighttime symptoms of COPD.", {"entities": []}], ["Analyses of patient focus group data (N = 27) supported saturation of concepts and aided in development of a conceptual framework.", {"entities": []}], ["Items were generated using patients\u2019 terminology to collect data on concepts in the framework including the occurrence and severity of COPD symptoms, use of rescue medication at night, and nocturnal awakening.", {"entities": []}], ["Response options were chosen to reflect concepts that were salient to patients.", {"entities": []}], ["Subsequent cognitive interviewing with ten COPD patients demonstrated that the items, response options, recall period, and instructions were understandable, relevant, and interpreted as intended.", {"entities": []}], ["A new PRO instrument, the Nighttime Symptoms of COPD Instrument (NiSCI), was developed with documented evidence of content validity.", {"entities": []}], ["The NiSCI is ready for empirical testing, including item reduction and evaluation of psychometric properties.", {"entities": []}], ["Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of the joints and bones.", {"entities": [[11, 20, "DISEASE"]]}], ["Omega-3 (\u03c93) fatty acid supplementation has been associated with a decreased production of inflammatory cytokines and eicosanoids involved in RA pathogenesis.", {"entities": []}], ["The aim of this study was to determine the therapeutic potential of \u03c93 monoglyceride (MAG-\u03c93) compounds in an in vivo rat model of RA induced by Complete Freund\u2019s Adjuvant (CFA).", {"entities": []}], ["CFA rats were untreated or treated per os with three specific compounds, namely, MAG-docosahexaenoic acid (MAG-DHA), MAG-eicosapentaenoic acid (MAG-EPA) and MAG-docosapentaenoic acid (MAG-DPA).", {"entities": []}], ["Morphological and histological analyses, as well as pro-inflammatory marker levels were determined following MAG-\u03c93 treatments.", {"entities": []}], ["Morphological and histological analyses revealed that MAG-EPA and MAG-DPA exhibited strong activity in reducing the progression and severity of arthritic disease in CFA rats.", {"entities": []}], ["Following MAG-EPA and MAG-DPA treatments, plasma levels of the pro-inflammatory cytokines; interleukin 17A (IL-17A), IL-1\u03b2, IL-6 and tumor necrosis factor \u03b1 (TNF\u03b1) were markedly lower when compared to CFA-untreated rats.", {"entities": []}], ["Results also revealed a decreased activation of p38 mitogen-activated protein kinases (p38 MAPK) and nuclear factor-kappa B (NF\u03baB) pathways correlated with a reduced expression of TNF\u03b1, cyclooxygenase-2 (COX-2), matrix metalloproteinase-2 (MMP-2) and MMP-9 in paw homogenates derived from MAG-EPA and MAG-DPA-treated rats.", {"entities": []}], ["Of interest, the combined treatment of MAG-EPA and vitamin E displayed an antagonistic effect on anti-inflammatory properties of MAG-EPA in CFA rats.", {"entities": []}], ["Altogether, the present data suggest that MAG-EPA, without vitamin E, represents a new potential therapeutic strategy for resolving inflammation in arthritis.", {"entities": [[148, 157, "DISEASE"]]}], ["Fractional exhaled nitric oxide (FENO) measurement is a useful diagnostic test of airway inflammation.", {"entities": []}], ["However, there have been few studies of FENO in workers exposed to nanomaterials.", {"entities": []}], ["The purpose of this study was to examine the effect of nanoparticle (NP) exposure on FENO and to assess whether the FENO is increased in workers exposed to nanomaterials (NM).", {"entities": []}], ["In this study, both exposed workers and non-exposed controls were recruited from NM handling plants in Taiwan.", {"entities": []}], ["A total of 437 subjects (exposed group = 241, non-exposed group = 196) completed the FENO and spirometric measurements from 2009\u20132011.", {"entities": []}], ["The authors used a control-banding (CB) matrix to categorize the risk level of each participant.", {"entities": []}], ["In a multivariate linear regression analysis, this study found a significant association between risk level 2 of NP exposure and FENO.", {"entities": []}], ["Furthermore, asthma, allergic rhinitis, peak expiratory flow rate (PEFR), and NF-\u03baB were also significantly associated with FENO.", {"entities": [[21, 38, "DISEASE"], [30, 38, "DISEASE"], [13, 19, "DISEASE"]]}], ["When the multivariate logistic regression model was adjusted for confounders, nano-TiO 2 in all of the NM exposed categories had a significantly increased risk in FENO > 35 ppb.", {"entities": []}], ["This study found associations between the risk level of NP exposure and FENO (particularly noteworthy for Nano-TiO 2 ).", {"entities": []}], ["Monitoring FENO in the lung could open up a window into the role nitric oxide (NO) may play in pathogenesis.", {"entities": []}], ["The Normalization Process Model is a conceptual tool intended to assist in understanding the factors that affect implementation processes in clinical trials and other evaluations of complex interventions.", {"entities": []}], ["It focuses on the ways that the implementation of complex interventions is shaped by problems of workability and integration.", {"entities": []}], ["In this paper the model is applied to two different complex trials: (i) the delivery of problem solving therapies for psychosocial distress, and (ii) the delivery of nurse-led clinics for heart failure treatment in primary care.", {"entities": []}], ["Application of the model shows how process evaluations need to focus on more than the immediate contexts in which trial outcomes are generated.", {"entities": []}], ["Problems relating to intervention workability and integration also need to be understood.", {"entities": []}], ["The model may be used effectively to explain the implementation process in trials of complex interventions.", {"entities": []}], ["The model invites evaluators to attend equally to considering how a complex intervention interacts with existing patterns of service organization, professional practice, and professional-patient interaction.", {"entities": []}], ["The justification for this may be found in the abundance of reports of clinical effectiveness for interventions that have little hope of being implemented in real healthcare settings.", {"entities": []}], ["Objective \u00a0To determine the effect of low dose aspirin on ulcer healing in patients with venous leg ulcers.", {"entities": []}], ["Design \u00a0Pragmatic, community based, parallel group, double blind, randomised controlled trial.", {"entities": []}], ["Setting \u00a0Five community nursing centres in New Zealand.", {"entities": []}], ["Participants \u00a0251 adults with venous leg ulcers who could safely be treated with aspirin or placebo: 125 were randomised to aspirin and 126 to placebo.", {"entities": []}], ["Interventions \u00a0150 mg oral aspirin daily or matching placebo for up to 24 weeks treatment, with compression therapy as standard background treatment.", {"entities": []}], ["Main outcome measures \u00a0The primary outcome was time to complete healing of the reference ulcer (largest ulcer if more than one ulcer was present).", {"entities": []}], ["Secondary outcomes included proportion of participants healed, change in ulcer area, change in health related quality of life, and adverse events.", {"entities": []}], ["Analysis was by intention to treat.", {"entities": []}], ["Results \u00a0The median number of days to healing of the reference ulcer was 77 in the aspirin group and 69 in the placebo group (hazard ratio 0.85, 95% confidence interval 0.64 to 1.13, P=0.25).", {"entities": []}], ["The number of participants healed at the endpoint was 88 (70%) in the aspirin group and 101 (80%) in the placebo group (risk difference \u22129.8%, 95% confidence interval \u221220.4% to 0.9%, P=0.07).", {"entities": []}], ["Estimated change in ulcer area was 4.1 cm Conclusion \u00a0Our findings do not support the use of low dose aspirin as adjuvant treatment for venous leg ulcers.", {"entities": []}], ["Trial registration \u00a0ClinicalTrials.gov NCT02158806.", {"entities": []}], ["The number of HIV-1 positive individuals developing some form of HIV-associated neurocognitive disorder (HAND) is increasing.", {"entities": []}], ["In these individuals, the integrity of the blood-brain barrier (BBB) is compromised due to an increase in exposure to pro-inflammatory mediators, viral proteins, and virus released from infected cells.", {"entities": []}], ["It has been shown that soluble CD40L (sCD40L) is released upon platelet activation and is an important mediator of the pathogenesis of HAND but the underlying mechanisms are unclear, emphasizing the need of an effective animal model.", {"entities": []}], ["Here, we have utilized a novel animal model in which wild-type (WT) mice were infected with EcoHIV; a derivative of HIV-1 that contains a substitution of envelope protein gp120 with that of gp80 derived from murine leukemia virus-1 (MuLV-1).", {"entities": [[215, 223, "DISEASE"]]}], ["As early as two-weeks post-infection, EcoHIV led to increased permeability of the BBB associated with decreased expression of tight junction protein claudin-5, in CD40L and platelet activation-dependent manner.", {"entities": []}], ["Treatment with an antiplatelet drug, eptifibatide, in EcoHIV-infected mice normalized BBB function, sCD40L release and platelet activity, thus implicating platelet activation and platelet-derived CD40L in virally induced BBB dysfunction.", {"entities": []}], ["Our results also validate and underscore the importance of EcoHIV infection mouse model as a tool to explore therapeutic targets for HAND.", {"entities": []}], ["eHealth is developing rapidly and brings with it a promise to reduce social health inequalities (SHIs).", {"entities": []}], ["Yet, it appears that it also has the potential to increase them.", {"entities": []}], ["The general objective of this review was to set out how to ensure that eHealth contributes to reducing SHIs rather than exacerbating them.", {"entities": []}], ["This review has three objectives: (1) identifying characteristics of people at risk of experiencing social inequality in health; (2) determining the possibilities of developing eHealth tools that avoid increasing SHI; and (3) modeling the process of using an eHealth tool by people vulnerable to SHI.", {"entities": []}], ["Following the EPPI approach (Evidence for Policy and Practice of Information of the Institute of Education at the University of London), two databases were searched for the terms SHIs and eHealth and their derivatives in titles and abstracts.", {"entities": []}], ["Qualitative, quantitative, and mixed articles were included and evaluated.", {"entities": []}], ["The software NVivo (QSR International) was employed to extract the data and allow for a metasynthesis of the data.", {"entities": []}], ["Of the 73 articles retained, 10 were theoretical, 7 were from reviews, and 56 were based on empirical studies.", {"entities": []}], ["Of the latter, 40 used a quantitative approach, 8 used a qualitative approach, 4 used mixed methods approach, and only 4 were based on participatory research-action approach.", {"entities": []}], ["The digital divide in eHealth is a serious barrier and contributes greatly to SHI.", {"entities": []}], ["Ethnicity and low income are the most commonly used characteristics to identify people at risk of SHI.", {"entities": []}], ["The most promising actions for reducing SHI via eHealth are to aim for universal access to the tool of eHealth, become aware of users\u2019 literacy level, create eHealth tools that respect the cultural attributes of future users, and encourage the participation of people at risk of SHI.", {"entities": []}], ["eHealth has the potential to widen the gulf between those at risk of SHI and the rest of the population.", {"entities": []}], ["The widespread expansion of eHealth technologies calls for rigorous consideration of interventions, which are not likely to exacerbate SHI.", {"entities": []}], ["Few studies have examined the relation between alexithymia (i.e.", {"entities": [[47, 58, "DISEASE"]]}], ["the inability to recognize and verbalize emotions) and professional burnout.", {"entities": []}], ["Considering the absence of relevant studies in the Greek scientific literature, the aim of this work was to examine the associations of alexithymia with the three facets of professional burnout, the perception of family support and depression in nursing personnel.", {"entities": [[136, 147, "DISEASE"]]}], ["The study was performed in one of the largest hospitals in Greece and included 95 nurses.", {"entities": []}], ["Assessments of alexithymia, burnout, depression and family support were made by means of the Toronto Alexithymia Scale, the Maslach Burnout Inventory, the Beck Depression Inventory and the Julkunen Family Support Scale, respectively.", {"entities": [[15, 26, "DISEASE"], [101, 112, "DISEASE"]]}], ["Student's t-test, Pearson's correlation and stepwise linear regression were used for the evaluation of data.", {"entities": []}], ["Alexithymia was correlated positively with depression, emotional exhaustion and depersonalization, and negatively with sense of family support and personal achievement.", {"entities": [[0, 11, "DISEASE"]]}], ["Additionally, family support was correlated positively with personal achievement and negatively with depression.", {"entities": []}], ["In the scientific literature there is a debate as to whether alexithymia is a stable personality characteristic or if it is dependent on symptoms of mental disorders.", {"entities": [[61, 72, "DISEASE"]]}], ["We tried to interpret the associations of alexithymia with professional burnout, depressive symptoms and family support.", {"entities": [[42, 53, "DISEASE"]]}], ["From this study it appears very likely that alexithymia is directly associated with depression and personal achievement, but also - indirectly - with the sense of family support.", {"entities": [[44, 55, "DISEASE"]]}], ["Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal disorder characterized by fever, pancytopenia, hepatosplenomegaly, and increased serum ferritin.", {"entities": [[103, 115, "DISEASE"]]}], ["HLH is being increasingly reported as a complication of dengue, a common tropical acute febrile illness.", {"entities": []}], ["After a cluster of pediatric dengue-associated HLH patients was identified during the 2012\u20132013 dengue epidemic in Puerto Rico, active surveillance and a case-control investigation was conducted at four referral hospitals to determine the incidence of HLH in children and identify risk factors for HLH following dengue.", {"entities": []}], ["Patients with dengue-associated HLH (cases) were matched by month of illness onset and admission hospital to dengue patients that did not develop HLH (controls).", {"entities": []}], ["During 2008\u20132013, a total of 33 HLH patients were identified, of which 22 (67%) were associated with dengue and 1 died (dengue-associated HLH case-fatality rate: 4.5%).", {"entities": []}], ["Two patients with dengue-associated HLH had illness onset in 2009, none had illness onset during the 2010 dengue epidemic, and 20 had illness onset during the 2012\u20132013 epidemic.", {"entities": []}], ["Frequency of infection with either dengue virus (DENV)-1 or DENV-4 did not differ between cases and controls.", {"entities": []}], ["Cases were younger than controls (median age: 1 vs. 13 years, p < 0.01), were hospitalized longer (18 vs. 5 days, p < 0.01), and were admitted more frequently to pediatric intensive care units (100% vs. 16%, p < 0.01).", {"entities": []}], ["Cases had co-infection (18.2% vs. 4.5%, p = 0.04), recent influenza-like illness (54.5% vs. 25.0%, p = 0.01), and longer duration of fever (7 vs. 5 days; p < 0.01).", {"entities": [[58, 67, "DISEASE"]]}], ["Cases were more likely to have lymphadenopathy, hepatomegaly, splenomegaly, anemia, and elevated liver transaminases (p \u2264 0.02).", {"entities": [[76, 82, "DISEASE"]]}], ["During this cluster of dengue-associated HLH cases that was temporally associated with the 2012\u20132013 epidemic, most patients with dengue-associated HLH were infants and had higher morbidity than dengue inpatients.", {"entities": []}], ["Physicians throughout the tropics should be aware of HLH as a potential complication of dengue, particularly in patients with anemia and severe liver injury.", {"entities": [[126, 132, "DISEASE"]]}], ["Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal medical condition that can occur after a patient has an infection.", {"entities": []}], ["While HLH is most commonly associated with Epstein-Barr virus infections, it has been reported as a complication of dengue, a common mosquito-borne, acute febrile illness.", {"entities": []}], ["After a cluster of pediatric dengue-associated HLH patients was identified in Puerto Rico, active surveillance and a case-control investigation was conducted to determine the rate of HLH in children and identify risk factors for HLH following dengue.", {"entities": []}], ["During 2008\u20132013, a total of 33 HLH patients were identified, of which 22 (67%) were associated with dengue and 1 died (dengue-associated HLH case-fatality rate: 4.5%).", {"entities": []}], ["Most (91%) dengue-associated HLH patients had illness onset during the 2012\u20132013 epidemic, however, HLH was not found to be associated with a particular type of dengue virus.", {"entities": []}], ["Dengue-associated HLH cases were younger than dengue inpatient controls, were hospitalized longer, and were admitted more frequently to the pediatric intensive care unit.", {"entities": []}], ["Cases had longer duration of fever, and were more likely to have anemia, hepatomegaly and elevated liver transaminases than controls.", {"entities": [[65, 71, "DISEASE"]]}], ["Physicians in the tropics should be aware that HLH may complicate dengue, and they should evaluate dengue patients who develop anemia and severe liver injury.", {"entities": [[127, 133, "DISEASE"]]}], ["Disease and diagnosis have been the subject of much ontological inquiry.", {"entities": []}], ["However, the insights gained therein have not yet been well enough applied to the study, management, and improvement of data quality in electronic health records (EHR) and administrative systems.", {"entities": []}], ["Data in these systems suffer from workarounds clinicians are forced to apply due to limitations in the current state-of-the art in system design which ignore the various types of entities that diagnoses as information content entities can be and are about.", {"entities": []}], ["This leads to difficulties in distinguishing amongst diagnostic assertions misdiagnosis from correct diagnosis, and the former from coincidentally correct statements about disease.", {"entities": []}], ["We applied recent advances in the ontological understanding of the aboutness relation to the problem of diagnosis and disease as defined by the Ontology for General Medical Science.", {"entities": []}], ["We created six scenarios that we analyzed using the method of Referent Tracking to identify all the entities and their relationships which must be present for each scenario to hold true.", {"entities": []}], ["We discovered deficiencies in existing ontological definitions and proposed revisions of them to account for the improved understanding that resulted from our analysis.", {"entities": []}], ["Our key result is that a diagnosis is an information content entity (ICE) whose concretization(s) are typically about a configuration in which there exists a disease that inheres in an organism and instantiates a certain type (e.g., hypertension).", {"entities": [[233, 245, "DISEASE"]]}], ["Misdiagnoses are ICEs whose concretizations succeed in aboutness on the level of reference for individual entities and types (the organism and the disease), but fail in aboutness on the level of compound expression (i.e., there is no configuration that corresponds in total with what is asserted).", {"entities": []}], ["Provenance of diagnoses as concretizations is critical to distinguishing them from lucky guesses, hearsay, and justified layperson belief.", {"entities": []}], ["Recent improvements in our understanding of aboutness significantly improved our understanding of the ontology of diagnosis and related information content entities, which in turn opens new perspectives for the implementation of data capture methods in EHR and other systems to allow diagnostic assertions to be captured with less ambiguity.", {"entities": []}], ["The online version of this article (doi:10.1186/s13326-016-0098-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Oligonucleotide delivery in vivo is commonly seen as the principal hurdle to the successful development of oligonucleotide drugs.", {"entities": []}], ["In an analysis of 26 oligonucleotide drugs recently evaluated in late-stage clinical trials we found that to date at least half have demonstrated suppression of the target mRNA and/or protein levels in the relevant cell types in man, including those present in liver, muscle, bone marrow, lung, blood and solid tumors.", {"entities": []}], ["Overall, this strongly implies that the drugs are being delivered to the appropriate disease tissues.", {"entities": []}], ["Strikingly we also found that the majority of the drug targets of the oligonucleotides lie outside of the drugable genome and represent new mechanisms of action not previously investigated in a clinical setting.", {"entities": []}], ["Despite the high risk of failure of novel mechanisms of action in the clinic, a subset of the targets has been validated by the drugs.", {"entities": []}], ["While not wishing to downplay the technical challenges of oligonucleotide delivery in vivo , here we demonstrate that target selection and validation are of equal importance for the success of this field.", {"entities": []}], ["Children with severe asthma have poor symptom control and elevated markers of airway oxidative and nitrosative stress.", {"entities": [[21, 27, "DISEASE"]]}], ["Paradoxically, they have decreased airway levels of S -nitrosothiols (SNOs), a class of endogenous airway smooth muscle relaxants.", {"entities": []}], ["This deficiency results from increased activity of an enzyme that both reduces SNOs to ammonia and oxidizes formaldehyde to formic acid, a volatile carboxylic acid that is more easily detected in exhaled breath condensate (EBC) than SNOs.", {"entities": []}], ["We therefore hypothesize that depletion of airway SNOs is related to asthma pathology, and breath formate concentration may be a proxy measure of SNO catabolism.", {"entities": [[69, 75, "DISEASE"]]}], ["We collected EBC samples from children and adolescents, including 38 with severe asthma, 46 with mild-to-moderate asthma and 16 healthy adolescent controls, and the concentration of ionic constituents was quantified using ion chromatography.", {"entities": [[81, 87, "DISEASE"], [114, 120, "DISEASE"]]}], ["The concentrations of EBC components with volatile conjugates were log-normally distributed.", {"entities": []}], ["Formate was the principal ion that displayed a significant difference between asthma status classifications.", {"entities": [[78, 84, "DISEASE"]]}], ["The mean EBC formate concentration was 40% higher in samples collected from all asthmatics than from healthy controls (mean\u200a=\u200a5.7 \u00b5M, mean\u00b1standard deviation\u200a=\u200a3.1\u221210.3 \u00b5M vs. 4.0, 2.8\u22125.8 \u00b5M, p\u200a=\u200a0.05).", {"entities": []}], ["EBC formate was higher in severe asthmatics than in mild-to-moderate asthmatics (6.8, 3.7\u221212.3 \u00b5M vs. 4.9, 2.8\u22128.7 \u00b5M, p\u200a=\u200a0.012).", {"entities": []}], ["In addition, formate concentration was negatively correlated with methacholine PC 20 (r\u200a=\u200a\u22120.39, p\u200a=\u200a0.002, asthmatics only), and positively correlated with the NO-derived ion nitrite (r\u200a=\u200a0.46, p<0.0001) as well as with total serum IgE (r\u200a=\u200a0.28, p\u200a=\u200a0.016, asthmatics only).", {"entities": [[79, 81, "GENE"]]}], ["Furthermore, formate was not significantly correlated with other volatile organic acids nor with inhaled corticosteroid dose.", {"entities": []}], ["We conclude that EBC formate concentration is significantly higher in the breath of children with asthma than in those without asthma.", {"entities": [[98, 104, "DISEASE"], [127, 133, "DISEASE"]]}], ["In addition, amongst asthmatics, formate is elevated in the breath of those with severe asthma compared to those with mild-to-moderate asthma.", {"entities": [[88, 94, "DISEASE"], [135, 141, "DISEASE"]]}], ["We suggest that this difference is related to asthma pathology and may be a product of increased catabolism of endogenous S -nitrosothiols.", {"entities": [[46, 52, "DISEASE"]]}], ["The study highlights the complex cultural religious factors affecting epilepsy and a need for integrated home-based care services.", {"entities": []}], ["Two focus group discussions exploring home-based carers\u2019 (HBCs) perspectives on epilepsy were conducted using a semi-structured focus group interview guide, which was based on Kleinman's explanatory model framework.", {"entities": []}], ["The audio-recorded data were transcribed verbatim, and a thematic analysis was done.", {"entities": []}], ["The three main themes were epilepsy names and metaphors, religious beliefs about the cause and treatment of epilepsy, and HBCs\u2019 perceived roles and strategies for engaging in epilepsy care.", {"entities": []}], ["Findings provide some insights for research, policy, and practice.", {"entities": []}], ["The Alpha-1 Foundation convened a workshop to consider the appropriateness of newborn screening for \u03b1-1-antitrypsin (AAT) deficiency.", {"entities": []}], ["A review of natural history and technical data was conducted.", {"entities": []}], ["Homozygous ZZ AAT deficiency is a common genetic disease occurring in 1 in 2000 to 3500 births; however, it is underrecognized and most patients are undiagnosed.", {"entities": [[41, 56, "DISEASE"]]}], ["AAT deficiency can cause chronic liver disease, cirrhosis, and liver failure in children and adults, and lung disease in adults.", {"entities": [[33, 46, "DISEASE"], [105, 117, "DISEASE"]]}], ["The clinical course is highly variable.", {"entities": []}], ["Some neonates present with cholestatic hepatitis and some children require liver transplantation, but many patients remain well into adulthood.", {"entities": [[39, 48, "DISEASE"]]}], ["Some adults develop emphysema.", {"entities": []}], ["There is no treatment for AAT liver disease, other than supportive care and liver transplant.", {"entities": [[30, 43, "DISEASE"]]}], ["There are no data on the effect of early diagnosis on liver disease.", {"entities": [[54, 67, "DISEASE"]]}], ["Avoidance of smoking is of proven benefit to reduce future lung disease, as is protein replacement therapy.", {"entities": [[59, 71, "DISEASE"]]}], ["Justifying newborn screening with the aim of reducing smoking and reducing adult lung disease-years in the future would be a significant paradigm shift for the screening field.", {"entities": [[81, 93, "DISEASE"]]}], ["Recent passage of the Genetic Information Nondiscrimination Act (GINA) and the Affordable Care Act may have a major effect on reducing the psychosocial and financial risks of newborn screening because many asymptomatic children would be identified.", {"entities": []}], ["Data on the risk\u2013benefit ratio of screening in the new legal climate are lacking.", {"entities": []}], ["Workshop participants recommended a series of pilot studies focused on generating new data on the risks and benefits of newborn screening.", {"entities": []}], ["Early-life antibiotic use is associated with increased risk for metabolic and immunological diseases, and mouse studies indicate a causal role of the disrupted microbiome.", {"entities": []}], ["However, little is known about the impacts of antibiotics on the developing microbiome of children.", {"entities": []}], ["Here we use phylogenetics, metagenomics and individual antibiotic purchase records to show that macrolide use in 2\u20137 year-old Finnish children ( N =142; sampled at two time points) is associated with a long-lasting shift in microbiota composition and metabolism.", {"entities": []}], ["The shift includes depletion of Actinobacteria, increase in Bacteroidetes and Proteobacteria, decrease in bile-salt hydrolase and increase in macrolide resistance.", {"entities": []}], ["Furthermore, macrolide use in early life is associated with increased risk of asthma and predisposes to antibiotic-associated weight gain.", {"entities": [[78, 84, "DISEASE"]]}], ["Overweight and asthmatic children have distinct microbiota compositions.", {"entities": []}], ["Penicillins leave a weaker mark on the microbiota than macrolides.", {"entities": []}], ["Our results support the idea that, without compromising clinical practice, the impact on the intestinal microbiota should be considered when prescribing antibiotics.", {"entities": []}], ["The impact of antibiotics on the microbiome and health of children is poorly understood.", {"entities": []}], ["Here, Korpela et al .", {"entities": []}], ["study the gut microbiome of 142 children and show that the use of macrolides, but not penicillins, is associated with long-lasting shifts in microbiota composition and increased risk of asthma and overweight.", {"entities": [[186, 192, "DISEASE"]]}], ["High-dose radiation-induced blood-brain barrier breakdown contributes to acute radiation toxicity syndrome and delayed brain injury, but there are few data on the effects of low dose cranial irradiation.", {"entities": [[98, 106, "DISEASE"]]}], ["Our goal was to measure blood-brain barrier changes after low (0.1 Gy), moderate (2 Gy) and high (10 Gy) dose irradiation under in vivo and in vitro conditions.", {"entities": []}], ["Cranial irradiation was performed on 10-day-old and 10-week-old mice.", {"entities": []}], ["Blood-brain barrier permeability for Evans blue, body weight and number of peripheral mononuclear and circulating endothelial progenitor cells were evaluated 1, 4 and 26 weeks postirradiation.", {"entities": []}], ["Barrier properties of primary mouse brain endothelial cells co-cultured with glial cells were determined by measurement of resistance and permeability for marker molecules and staining for interendothelial junctions.", {"entities": []}], ["Endothelial senescence was determined by senescence associated \u03b2-galactosidase staining.", {"entities": []}], ["Extravasation of Evans blue increased in cerebrum and cerebellum in adult mice 1 week and in infant mice 4 weeks postirradiation at all treatment doses.", {"entities": []}], ["Head irradiation with 10 Gy decreased body weight.", {"entities": []}], ["The number of circulating endothelial progenitor cells in blood was decreased 1 day after irradiation with 0.1 and 2 Gy.", {"entities": []}], ["Increase in the permeability of cultured brain endothelial monolayers for fluorescein and albumin was time- and radiation dose dependent and accompanied by changes in junctional immunostaining for claudin-5, ZO-1 and \u03b2-catenin.", {"entities": []}], ["The number of cultured brain endothelial and glial cells decreased from third day of postirradiation and senescence in endothelial cells increased at 2 and 10 Gy.", {"entities": []}], ["Not only high but low and moderate doses of cranial irradiation increase permeability of cerebral vessels in mice, but this effect is reversible by 6 months.", {"entities": []}], ["In-vitro experiments suggest that irradiation changes junctional morphology, decreases cell number and causes senescence in brain endothelial cells.", {"entities": []}], ["Please cite this paper as: Lee and Liu et\u00a0al.", {"entities": []}], ["(2012) 2009 pandemic Influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement.", {"entities": [[21, 30, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(601), e152\u2013e161.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 To better understand clinical and laboratory characteristics in children, adults, and patients with lung involvement suffering 2009 pandemic influenza A (H1N1).", {"entities": [[153, 162, "DISEASE"]]}], ["Methods\u2002 A total of 442 patients with 2009 pandemic influenza A (H1N1) were retrospectively analyzed.", {"entities": [[52, 61, "DISEASE"]]}], ["Results\u2002 Comparing to their adult counterpart ( n \u2003=\u200355), pediatric patients ( n \u2003=\u2003387) had significantly higher frequencies of fever, rhinorrhea, cough, sore throat, nausea/vomiting, and longer length of fever; lower frequencies of chest pain and dyspnea; higher incidence of lymphopenia; and lower incidence of elevated serum C\u2010reactive protein.", {"entities": [[278, 289, "DISEASE"]]}], ["Among the 227 patients with radiographs available, lung involvement was found in 19 (8\u00b74%) (52\u00b76% consolidation and 47\u00b74% interstitial infiltrations), including 18 children and one adult.", {"entities": []}], ["One child with lung consolidation died of multiorgan failure.", {"entities": []}], ["Significant findings in patients with lung involvement included predominant young age (\u226410\u2003years), prolonged fever, and delayed oseltamivir therapy (\u226548\u2003hours after onset of illness); higher frequencies of dyspnea, nausea/vomiting, and altered consciousness; and higher incidences of leukopenia, elevated serum creative kinase, and lactic dehydrogenase.", {"entities": [[284, 294, "DISEASE"]]}], ["Conclusions\u2002 Among patients with 2009 pandemic influenza A (H1N1), we found significant difference in clinical manifestations between children and adults, and significant differences in clinical and laboratory manifestations between patients with lung involvement and those without.", {"entities": [[47, 56, "DISEASE"]]}], ["On the basis of data from this study and the existing literature, early treatment with oseltamivir is recommended for patients with 2009 pandemic influenza A (H1N1), regardless of age.", {"entities": [[146, 155, "DISEASE"]]}], ["Adoption of a healthy diet has been identified as the cornerstone in the prevention and management of chronic diseases.", {"entities": []}], ["However, non-adherence to lifestyle changes raises an important issue since adherence level to dietary advice is a key determinant of the effectiveness of dietary treatment.", {"entities": []}], ["Therefore, based on the results of a Cochrane systematic review on interventions for enhancing adherence to dietary advice for preventing and managing chronic diseases in adults, the aim of this study is to assess the importance and applicability of interventions enhancing adherence to dietary advice in the Canadian context.", {"entities": []}], ["In phase 1, dietitians' opinion will be assessed through a Delphi study regarding the importance and the applicability in the Canadian context of the interventions found the most effective to enhance adherence to dietary advice through a Cochrane systematic review.", {"entities": []}], ["In phase 2, findings of the Cochrane systematic review assessing the effects of interventions for enhancing adherence to dietary advice will be reported in a practical format on an online knowledge translation tool for dietitians and other health professionals.", {"entities": []}], ["In recent years, there has been an increasing recognition of the failure to translate research findings into clinical practice.", {"entities": []}], ["Therefore, knowledge translation efforts need to prioritize effective interventions that will be the most relevant for practice and end-users by adapting them to the local context.", {"entities": []}], ["Our study will provide decision makers in the field of dietetic practice with essential knowledge on adherence for elaborating educational activities for academic or professional settings that will respond to dietitians' priorities in terms of importance and applicability to day-to-day practice.", {"entities": []}], ["Flexible bronchoscopy is more and more used for diagnosis and management of various pulmonary diseases in pediatrics.", {"entities": []}], ["As poor coordination of children, the procedure is usually performed under general anesthesia with spontaneous or controlled ventilation to increase children and bronchoscopists\u2019 safety and comfort.", {"entities": []}], ["Previous studies have reported that dexmedetomidine (DEX) could be safely and effectively used for flexible bronchoscopy in both adulate and children.", {"entities": []}], ["However, there is no trial to evaluate the dose-finding of safety and efficacy of dexmedetomidine-remifentanil (DEX-RF) in children undergoing flexible bronchoscopy.", {"entities": []}], ["The objective of this study is to evaluate the dose-finding of safety and efficacy of DEX-RF in children undergoing flexible bronchoscopy.", {"entities": []}], ["One hundred thirty-five children undergoing flexible bronchoscopy with DEX-RF were divided into 3 groups: Group DR1 (n\u200a=\u200a47, DEX infusion at 0.5\u200a\u03bcg\u00b7kg 2 ), respiratory rate), total cumulative dose of dexmedetomidine and remifentanil, the amount of midazolam and lidocaine, time to first dose of rescue midazolam and lidocaine, postoperative recovery time, adverse events, bronchoscopist satisfaction score were recorded.", {"entities": [[112, 115, "GENE"]]}], ["Anesthesia onset time was significantly shorter in DR3 group (14.23\u200a\u00b1\u200a5.45 vs 14.45\u200a\u00b1\u200a5.12 vs 11.13\u200a\u00b1\u200a4.51\u200aminutes, respectively, of DR1, DR2, DR3, P \u200a=\u200a0.003).", {"entities": [[133, 136, "GENE"]]}], ["Additionally, the perioperative hemodynamic profile was more stable in group DR3 than that in the other 2 groups.", {"entities": []}], ["Total number of children movements during flexible bronchoscopy was higher in DR1 group than the other 2 groups (46.81% 22/47 vs 34.88% 15/43 vs 17.78% 8/45, respectively, of DR1, DR2, DR3, P \u200a=\u200a0.012).", {"entities": [[78, 81, "GENE"], [175, 178, "GENE"], [78, 81, "GENE"], [175, 178, "GENE"]]}], ["Total doses of rescue midazolam and lidocaine were significantly higher in DR1 and DR2 groups than that of DR3 group ( P \u200a=\u200a0.000).", {"entities": [[75, 78, "GENE"]]}], ["The time to first dose of rescue midazolam and lidocaine was significantly longer in DR3 group than DR1 and DR2 groups ( P \u200a=\u200a0.000).", {"entities": [[100, 103, "GENE"]]}], ["Total cumulative dose of dexmedetomidine was more in DR2 and DR3 groups ( P \u200a=\u200a0.000), while the amount of remifentanil was more in DR1 and DR2 groups ( P \u200a=\u200a0.000).", {"entities": [[132, 135, "GENE"]]}], ["The time to recovery for discharge from the PACU was significantly shorter in DR1 group compared with the other 2 groups ( P \u200a=\u200a0.000).", {"entities": [[78, 81, "GENE"]]}], ["Results from bronchoscopist satisfaction score showed significantly higher in DR2 and DR3 groups than that of DR1 group ( P \u200a = \u200a0.025).", {"entities": [[110, 113, "GENE"]]}], ["There were significant differences among the 3 groups in terms of the overall incidence of hypertension, tachycardia, hypoxemia, and cough ( P \u200a<\u200a0.05).", {"entities": [[91, 103, "DISEASE"]]}], ["Though it required longer recovery time, high dose of DEX-RF, which provided better stable hemodynamic profiles and bronchoscopist satisfaction score, less amount of rescue scheme, and children movements, could be safely and efficacy used in children undergoing flexible bronchoscopy.", {"entities": []}], ["More than 90% of common variants associated with complex traits do not affect proteins directly, but instead the circuits that control gene expression.", {"entities": []}], ["This has increased the urgency of understanding the regulatory genome as a key component for translating genetic results into mechanistic insights and ultimately therapeutics.", {"entities": []}], ["To address this challenge, we developed HaploReg ( http://compbio.mit.edu/HaploReg ) to aid the functional dissection of genome-wide association study (GWAS) results, the prediction of putative causal variants in haplotype blocks, the prediction of likely cell types of action, and the prediction of candidate target genes by systematic mining of comparative, epigenomic and regulatory annotations.", {"entities": []}], ["Since first launching the website in 2011, we have greatly expanded HaploReg, increasing the number of chromatin state maps to 127 reference epigenomes from ENCODE 2012 and Roadmap Epigenomics, incorporating regulator binding data, expanding regulatory motif disruption annotations, and integrating expression quantitative trait locus (eQTL) variants and their tissue-specific target genes from GTEx, Geuvadis, and other recent studies.", {"entities": []}], ["We present these updates as HaploReg v4, and illustrate a use case of HaploReg for attention deficit hyperactivity disorder (ADHD)-associated SNPs with putative brain regulatory mechanisms.", {"entities": [[83, 123, "DISEASE"]]}], ["Many factors affect the microbiomes of humans, mice, and other mammals, but substantial challenges remain in determining which of these factors are of practical importance.", {"entities": []}], ["Considering the relative effect sizes of both biological and technical covariates can help improve study design and the quality of biological conclusions.", {"entities": []}], ["Care must be taken to avoid technical bias that can lead to incorrect biological conclusions.", {"entities": []}], ["The presentation of quantitative effect sizes in addition to P values will improve our ability to perform meta-analysis and to evaluate potentially relevant biological effects.", {"entities": []}], ["A better consideration of effect size and statistical power will lead to more robust biological conclusions in microbiome studies.", {"entities": []}], ["This study assessed the adherence profiles to inhaled therapies and the agreement between two patient self-report adherence methods in stable COPD lpatients from seven Latin American countries.", {"entities": []}], ["This observational, cross-sectional, multinational, multicenter study involved 795 COPD patients (post-bronchodilator forced expiratory volume in 1 second/forced vital capacity [FEV 1 /FVC] <0.70).", {"entities": [[178, 181, "GENE"]]}], ["Adherence to inhaled therapy was assessed using the specific Test of Adherence to Inhalers (10-item TAI) and the generic 8-item Morisky Medication Adherence Scale (MMAS-8) questionnaires.", {"entities": []}], ["The percentage agreement and the kappa index were used to compare findings.", {"entities": []}], ["59.6% of patients were male (69.5\u00b18.7 years); post-bronchodilator FEV 1 percent predicted was 50.0\u00b118.6%.", {"entities": [[66, 69, "GENE"]]}], ["Mean values for 10-item TAI and MMAS-8 questionnaires were 47.4\u00b14.9 and 6.8\u00b11.6, respectively.", {"entities": []}], ["Based on the TAI questionnaire, 54.1% of patients had good, 26.5% intermediate, and 19.4% poor adherence.", {"entities": []}], ["Using the MMAS-8 questionnaire, 51% had high, 29.1% medium, and 19.9% low adherence.", {"entities": []}], ["According to both questionnaires, patients with poor adherence had lower smoking history, schooling but higher COPD Assessment Test score, exacerbations in the past-year and post-bronchodilator FEV 1 .", {"entities": [[194, 197, "GENE"]]}], ["The agreement between 10-item TAI and MMAS-8 questionnaires was moderate (Kappa index: 0.42; agreement: 64.7%).", {"entities": []}], ["Suboptimal adherence to medication was frequent in COPD patients from Latin America.", {"entities": []}], ["Low adherence was associated with worse health status impairment and more exacerbations.", {"entities": []}], ["There was inadequate agreement between the two questionnaires.", {"entities": []}], ["Greater effort should be made to improve COPD patients\u2019 adherence to treatment, and assessment of adherence with more specific instruments, such as the TAI questionnaire, would be more convenient in these patients.", {"entities": []}], ["NCT02789540", {"entities": []}], ["Secondhand smoke (SHS) exposure is a modifiable risk factor associated with childhood asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["Associations with adolescent asthma and the relevance of the timing and patterns of exposure are unclear.", {"entities": [[29, 35, "DISEASE"]]}], ["Knowledge of critical windows of exposure is important for targeted interventions.", {"entities": []}], ["We used data until age 17 from 1454 children of the Dutch population-based PIAMA birth cohort.", {"entities": []}], ["Residential SHS exposure was assessed through parental questionnaires completed at ages 3\u00a0months, 1\u20138 (yearly), 11, 14, and 17\u00a0years.", {"entities": []}], ["Lifetime exposure was determined as; a) time window-specific exposure (prenatal, infancy, preschool, primary school, and secondary school); b) lifetime cumulative exposure; c) longitudinal exposure patterns using latent class growth modeling (LCGM).", {"entities": []}], ["Generalized estimation equations and logistic regression were used to analyze associations between exposure and asthma at ages 4 to 17\u00a0years, adjusting for potential confounders.", {"entities": [[112, 118, "DISEASE"]]}], ["With all three methods, we consistently found no association between SHS exposure and asthma at ages 4 to 17\u00a0years e.g.", {"entities": [[86, 92, "DISEASE"]]}], ["adjusted overall odds ratio (95% confidence interval) 0.67 (0.41\u20131.12), 1.00 (0.66\u20131.51) and 0.67 (0.41\u20131.11) for prenatal maternal active smoking, infancy, and preschool school time window exposures, respectively.", {"entities": []}], ["We assessed lifetime SHS exposure using different methods.", {"entities": []}], ["Different timing and patterns of SHS exposure were not associated with an increased risk of asthma in childhood and adolescence in our study.", {"entities": [[92, 98, "DISEASE"]]}], ["More longitudinal studies could investigate effects of lifetime SHS exposure on asthma in adolescence and later life.", {"entities": [[80, 86, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12940-017-0223-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Motor vehicle-related air pollution can potentially impair lung function.", {"entities": []}], ["The effect of pollution in people with compromised pulmonary function such as in COPD has not been previously investigated.", {"entities": []}], ["To examine the association of lung function with motor vehicle density in people with spirometrically determined COPD in a cross-sectional study.", {"entities": []}], ["In 2004\u201306, The North West Adelaide Health Study (NWAHS), a biomedical cohort of adults assessed pre and post-bronchodilator spirometry ( n \u2009=\u20093,103).", {"entities": []}], ["Traffic density, obtained from the motor vehicle inventory maintained by the South Australian Environment Protection Authority, was expressed as the daily numbers of vehicles travelling within a 200\u00a0m diameter zone around participants\u2019 geocoded residences.", {"entities": []}], ["In subjects with COPD (FEV 1 /FVC <0.7, n \u2009=\u2009221, 7.1\u00a0%), increasing daily vehicle density was associated with statistically significant decreases in lung function parameters after adjustment for smoking and socio-economic variables.", {"entities": [[23, 26, "GENE"]]}], ["Mean (95\u00a0% CI) post-bronchodilator % predicted FEV 1 was 81\u00a0% (76\u201387) in the low (\u22647179/day) compared with 71\u00a0% (67\u201375) in the high (\u226515,270/day) vehicle exposure group ( p \u2009<\u20090.05).", {"entities": [[47, 50, "GENE"]]}], ["Linear regression analysis in all subjects with COPD showed significant decrements in post-bronchodilator FEV 1 /FVC ratio and % predicted FEV 1 of 0.03 and 0.05\u00a0% respectively per daily increase in 1000 vehicles.", {"entities": [[106, 109, "GENE"], [139, 142, "GENE"], [106, 109, "GENE"], [139, 142, "GENE"]]}], ["In men with COPD ( n \u2009=\u2009150), the corresponding reductions were 0.03 and 0.06\u00a0%.", {"entities": []}], ["Smaller, non-significant decrements were seen in females.", {"entities": []}], ["No difference was seen in those without COPD.", {"entities": []}], ["Vehicle traffic density was associated with significant reductions in lung function in people with COPD.", {"entities": []}], ["Urban planning should consider the health impacts for those with pre-existing respiratory conditions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0451-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Air pollution is known to exacerbate chronic inflammatory conditions of the lungs including pulmonary hypertension, cardiovascular diseases and autoimmune diseases.", {"entities": [[102, 114, "DISEASE"], [92, 114, "DISEASE"]]}], ["Directly pathogenic antibodies bind pro-inflammatory cell receptors and cause or exacerbate inflammation.", {"entities": []}], ["In contrast, anti-inflammatory antibody isotypes (e.g.", {"entities": []}], ["mouse immunoglobulin G1, IgG1) bind inhibitory cell receptors and can inhibit inflammation.", {"entities": []}], ["Our previous studies showed that co-exposure to antigen and urban ambient particulate matter (PM 2.5 ) induced severe pulmonary arterial thickening and increased right ventricular systolic pressures in mice via T-cell produced cytokines, Interleukin (IL)-13 and IL-17A.", {"entities": []}], ["The aim of the current study was to understand how B cell and antibody responses integrate into this T cell cytokine network for the pulmonary hypertension phenotype.", {"entities": [[143, 155, "DISEASE"], [133, 155, "DISEASE"]]}], ["Special focus was on antigen-specific IgG1 that is the predominant antibody in the experimental response to antigen and urban ambient PM 2.5 .", {"entities": []}], ["Wild type and B cell-deficient mice were primed with antigen and then challenged with antigen and urban particulate matter and injected with antibodies as appropriate.", {"entities": []}], ["Our data surprisingly showed that B cells were necessary for the development of increased right ventricular pressures and molecular changes in the right heart in response to sensitization and intranasal challenge with antigen and PM 2.5 .", {"entities": []}], ["Further, our studies showed that both, the increase in right ventricular systolic pressure and right ventricular molecular changes were restored by reconstituting the B cell KO mice with antigen specific IgG1.", {"entities": []}], ["In addition, our studies identified a critical, non-redundant role of B cells for the IL-17A-directed inflammation in response to exposure with antigen and PM 2.5 , which was not corrected with antigen-specific IgG1.", {"entities": []}], ["In contrast, IL-13-directed inflammatory markers, as well as severe pulmonary arterial remodeling induced by challenge with antigen and PM 2.5 were similar in B cell-deficient and wild type mice.", {"entities": []}], ["Our studies have identified B cells and antigen specific IgG1 as potential therapeutic targets for pulmonary hypertension associated with immune dysfunction and environmental exposures.", {"entities": [[109, 121, "DISEASE"], [99, 121, "DISEASE"]]}], ["Chronic pelvic pain is a debilitating condition.", {"entities": []}], ["It is unknown if there is a clinical phenotype for adhesive disorders.", {"entities": []}], ["This study aimed to determine if the presence or absence, nature, severity and extent of adhesions correlated with demographic and patient reported clinical characteristics of women presenting with CPP.", {"entities": []}], ["Women undergoing a laparoscopy for the investigation of chronic pelvic pain were recruited prospectively; their pain and phenotypic characteristics were entered into a hierarchical cluster analysis.", {"entities": []}], ["The groups with differing baseline clinical and operative characteristics in terms of adhesions involvement were analyzed.", {"entities": []}], ["Sixty two women were recruited where 37 had adhesions.", {"entities": []}], ["A low correlation was found between women\u2019s reported current pain scores and that of most severe ( r \u2009=\u20090.34) or average pain experienced ( r \u2009=\u20090.44) in the last 6\u00a0months.", {"entities": []}], ["Three main groups of women with CPP were identified: Cluster 1 ( n \u2009=\u200935) had moderate severity of pain, with poor average and present pain intensity; Cluster 2 ( n \u2009=\u200914) had a long duration of symptoms/diagnosis, the worst current pain and worst physical, emotional and social functions; Cluster 3 ( n \u2009=\u200911) had the shortest duration of pain and showed the best evidence of coping with low (good) physical, social and emotional scores.", {"entities": []}], ["This cluster also had the highest proportion of women with adhesions (82%) compared to 51% in Cluster 1 and 71% in Cluster 2.", {"entities": []}], ["In this study, we found that there is little or no correlation between patient-reported pain, physical, emotional and functional characteristics scores with the presence or absence of intra-abdominal/pelvic adhesions found during investigative laparoscopy.", {"entities": []}], ["Most women who had adhesions had the lowest reported current pain scores.", {"entities": []}], ["This study seeks to explore methods for conducting economic evaluations alongside multinational trials by conducting a systematic review of the methods used in practice and the challenges that are typically faced by the researchers who conducted the economic evaluations.", {"entities": []}], ["A review was conducted for the period 2002 to 2012, with potentially relevant articles identified by searching the Medline, Embase and NHS EED databases.", {"entities": [[135, 138, "GENE"], [139, 142, "GENE"]]}], ["Studies were included if they were full economic evaluations conducted alongside a multinational trial.", {"entities": []}], ["A total of 44 studies out of a possible 2667 met the inclusion criteria.", {"entities": []}], ["Methods used for the analyses varied between studies, indicating a lack of consensus on how economic evaluation alongside multinational studies should be carried out.", {"entities": []}], ["The most common challenge appeared to be related to addressing differences between countries, which potentially hinders the generalisability and transferability of results.", {"entities": []}], ["Other challenges reported included inadequate sample sizes and choosing cost-effectiveness thresholds.", {"entities": []}], ["It is recommended that additional guidelines be developed to aid researchers in this area and that these be based on an understanding of the challenges associated with multinational trials and the strengths and limitations of alternative approaches.", {"entities": []}], ["Guidelines should focus on ensuring that results will aid decision makers in their individual countries.", {"entities": []}], ["The database of genotypes and phenotypes (dbGaP) developed by the National Center for Biotechnology Information (NCBI) is a resource that contains information on various genome-wide association studies (GWAS) and is currently available via NCBI's dbGaP Entrez interface.", {"entities": []}], ["The database is an important resource, providing GWAS data that can be used for new exploratory research or cross-study validation by authorized users.", {"entities": []}], ["However, finding studies relevant to a particular phenotype of interest is challenging, as phenotype information is presented in a non-standardized way.", {"entities": []}], ["To address this issue, we developed PhenDisco (phenotype discoverer), a new information retrieval system for dbGaP.", {"entities": []}], ["PhenDisco consists of two main components: (1) text processing tools that standardize phenotype variables and study metadata, and (2) information retrieval tools that support queries from users and return ranked results.", {"entities": []}], ["In a preliminary comparison involving 18 search scenarios, PhenDisco showed promising performance for both unranked and ranked search comparisons with dbGaP's search engine Entrez.", {"entities": []}], ["The system can be accessed at http://pfindr.net .", {"entities": []}], ["Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune disease.", {"entities": [[9, 28, "DISEASE"]]}], ["Adiponectin is an adipocyte-derived cytokine with anti-inflammatory, antidiabetic, and antiatherogenic properties.", {"entities": []}], ["No study has reported on the association between adiponectin (ADIPOQ) gene and SLE.", {"entities": [[62, 68, "GENE"]]}], ["Our aim is to investigate the association between single-nucleotide polymorphisms in ADIPOQ gene and SLE.", {"entities": [[85, 91, "GENE"]]}], ["We examined 179 SLE patients and 237 age- and gender-matched controls from Sichuan province in China.", {"entities": []}], ["Genotypes were determined using polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing.", {"entities": []}], ["Results show that there was no significant difference in the allele frequencies of rs1501299 ( P = .311, OR = 1.17, 95% CI: 0.86\u20131.59) and rs2241766 ( P = .929, OR = 0.99, 95% CI: 0.74\u20131.33) in ADIPOQ gene between SLE patients and controls.", {"entities": [[194, 200, "GENE"]]}], ["The same results were seen in their genotypes ( P < .05).", {"entities": []}], ["The allele frequencies of rs1501299 and rs2241766 polymorphisms of ADIPOQ may not be associated with SLE risk.", {"entities": [[67, 73, "GENE"]]}], ["The success of Fc-fusion bio-therapeutics has spurred the development of other Fc-fusion products for treating and/or vaccinating against a range of diseases.", {"entities": []}], ["We describe a method to modulate their function by converting them into well-defined stable polymers.", {"entities": []}], ["This strategy resulted in cylindrical hexameric structures revealed by tapping mode atomic force microscopy (AFM).", {"entities": [[109, 112, "GENE"]]}], ["Polymeric Fc-fusions were significantly less immunogenic than their dimeric or monomeric counterparts, a result partly owing to their reduced ability to interact with critical Fc-receptors.", {"entities": []}], ["However, in the absence of the fusion partner, polymeric IgG1-Fc molecules were capable of binding selectively to Fc\u03b3Rs, with significantly increased affinity owing to their increased valency, suggesting that these reagents may prove of immediate utility in the development of well-defined replacements for intravenous immunoglobulin (IVIG) therapy.", {"entities": []}], ["Overall, these findings establish an effective IgG Fc-fusion based polymeric platform with which the therapeutic and vaccination applications of Fc-fusion immune-complexes can now be explored.", {"entities": []}], ["cFLIP (cellular FLICE-like inhibitory protein) is structurally related to caspase-8 but lacks proteolytic activity due to multiple amino acid substitutions of catalytically important residues.", {"entities": []}], ["cFLIP protein is evolutionarily conserved and expressed as three functionally different isoforms in humans (cFLIP L , cFLIP S , and cFLIP R ).", {"entities": []}], ["cFLIP controls not only the classical death receptor-mediated extrinsic apoptosis pathway, but also the non-conventional pattern recognition receptor-dependent apoptotic pathway.", {"entities": []}], ["In addition, cFLIP regulates the formation of the death receptor-independent apoptotic platform named the ripoptosome.", {"entities": []}], ["Moreover, recent studies have revealed that cFLIP is also involved in a non-apoptotic cell death pathway known as programmed necrosis or necroptosis.", {"entities": []}], ["These functions of cFLIP are strictly controlled in an isoform-, concentration- and tissue-specific manner, and the ubiquitin-proteasome system plays an important role in regulating the stability of cFLIP.", {"entities": []}], ["In this review, we summarize the current scientific findings from biochemical analyses, cell biological studies, mathematical modeling, and gene-manipulated mice models to illustrate the critical role of cFLIP as a switch to determine the destiny of cells among survival, apoptosis, and necroptosis.", {"entities": []}], ["Integrated health care delivery systems devote considerable resources to developing quality improvement (QI) interventions.", {"entities": []}], ["Clinics serving vulnerable populations rarely have the resources for such development but might benefit greatly from implementing approaches shown to be effective in other settings.", {"entities": []}], ["Little trial-based research has assessed the feasibility and impact of such cross-setting translation and implementation in community health centers (CHCs).", {"entities": []}], ["We hypothesized that it would be feasible to implement successful QI interventions from integrated care settings in CHCs and would positively impact the CHCs.", {"entities": []}], ["We adapted Kaiser Permanente\u2019s successful intervention, which targets guideline-based cardioprotective prescribing for patients with diabetes mellitus (DM), through an iterative, stakeholder-driven process.", {"entities": [[133, 150, "DISEASE"]]}], ["We then conducted a cluster-randomized pragmatic trial in 11 CHCs in a staggered process with six \u201cearly\u201d CHCs implementing the intervention one year before five \u201c\u2018late\u201d CHCs.", {"entities": []}], ["We measured monthly rates of patients with DM currently prescribed angiotensin converting enzyme (ACE)-inhibitors/statins, if clinically indicated.", {"entities": []}], ["Through segmented regression analysis, we evaluated the intervention\u2019s effects in June 2011\u2013May 2013.", {"entities": []}], ["Participants included ~6500 adult CHC patients with DM who were indicated for statins/ACE-inhibitors per national guidelines.", {"entities": []}], ["Implementation of the intervention in the CHCs was feasible, with setting-specific adaptations.", {"entities": []}], ["One year post-implementation, in the early clinics, there were estimated relative increases in guideline-concordant prescribing of 37.6\u00a0% (95\u00a0% confidence interval (CI); 29.0\u201346.2\u00a0%) among patients indicated for both ACE-inhibitors and statins and 38.7\u00a0% (95\u00a0% CI; 23.2\u201354.2\u00a0%) among patients indicated for statins.", {"entities": []}], ["No such increases were seen in the late (control) clinics in that period.", {"entities": []}], ["To our knowledge, this was the first clinical trial testing the translation and implementation of a successful QI initiative from a private, integrated care setting into CHCs.", {"entities": []}], ["This proved feasible and had significant impact but required considerable adaptation and implementation support.", {"entities": []}], ["These results suggest the feasibility of adapting diverse strategies developed in integrated care settings for implementation in under-resourced clinics, with important implications for efficiently improving care quality in such settings.", {"entities": []}], ["NCT02299791 .", {"entities": []}], ["Excess mucus in the airways leads to obstruction in diseases such as chronic bronchitis, asthma, and cystic fibrosis.", {"entities": [[101, 116, "DISEASE"], [89, 95, "DISEASE"], [77, 87, "DISEASE"]]}], ["Mucins, the highly glycosolated protein components of mucus, are stored in membrane-bound granules housed in the cytoplasm of airway epithelial \"goblet\" cells until they are secreted into the airway lumen via an exocytotic process.", {"entities": []}], ["Precise mechanism(s) of mucin secretion, including the specific proteins involved in the process, have yet to be elucidated.", {"entities": []}], ["Previously, we have shown that the Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) protein regulates mucin secretion by orchestrating translocation of mucin granules from the cytosol to the plasma membrane, where the granules dock, fuse and release their contents into the airway lumen.", {"entities": [[82, 88, "GENE"]]}], ["Associated with MARCKS in this process are chaperone (Heat Shock Protein 70 [HSP70], Cysteine string protein [CSP]) and cytoskeletal (actin, myosin) proteins.", {"entities": [[16, 22, "GENE"]]}], ["However, additional granule-associated proteins that may be involved in secretion have not yet been elucidated.", {"entities": []}], ["Here, we isolated mucin granules and granule membranes from primary cultures of well differentiated human bronchial epithelial cells utilizing a novel technique of immuno-isolation, based on the presence of the calcium activated chloride channel hCLCA1 (the human ortholog of murine Gob-5) on the granule membranes, and verified via Western blotting and co-immunoprecipitation that MARCKS, HSP70, CSP and hCLCA1 were present on the granule membranes and associated with each other.", {"entities": [[382, 388, "GENE"]]}], ["We then subjected the isolated granules/membranes to liquid chromatography mass spectrometry (LC-MS/MS) to identify other granule associated proteins.", {"entities": []}], ["A number of additional cytoskeletal (e.g.", {"entities": []}], ["Myosin Vc) and regulatory proteins (e.g.", {"entities": []}], ["Protein phosphatase 4) associated with the granules and could play a role in secretion were discovered.", {"entities": []}], ["This is the first description of the airway goblet cell \"granulome.\"", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease.", {"entities": [[63, 88, "DISEASE"], [11, 29, "DISEASE"], [76, 88, "DISEASE"]]}], ["IPF is characterized by epithelial cell injury and reprogramming, increases in (myo)fibroblasts, and altered deposition of extracellular matrix.", {"entities": []}], ["The Wnt1-inducible signaling protein 1 (WISP1) is involved in impaired epithelial-mesenchymal crosstalk in pulmonary fibrosis.", {"entities": [[107, 125, "DISEASE"], [40, 45, "GENE"]]}], ["Here, we aimed to further investigate WISP1 regulation and function in primary human lung fibroblasts (phLFs).", {"entities": [[38, 43, "GENE"]]}], ["We demonstrate that WISP1 is directly upregulated by Transforming growth factor \u03b21 (TGF\u03b21) and Tumor necrosis factor \u03b1 (TNF\u03b1) in phLFs, using a luciferase-based reporter system.", {"entities": [[20, 25, "GENE"]]}], ["WISP1 mRNA and protein secretion increased in a time- and concentration-dependent manner by TGF\u03b21 and TNF\u03b1 in phLFs, as analysed by qPCR and ELISA, respectively.", {"entities": [[0, 5, "GENE"]]}], ["Notably, WISP1 is required for TGF\u03b21- and TNF\u03b1-dependent induction of interleukin 6 (IL-6), a mechanism that is conserved in IPF phLFs.", {"entities": [[9, 14, "GENE"]]}], ["The siRNA-mediated WISP1 knockdown led to a significant IL-6 reduction after TGF\u03b21 or TNF\u03b1 stimulation.", {"entities": [[19, 24, "GENE"]]}], ["Furthermore, siRNA-mediated downregulation or antibody-mediated neutralization of WISP1 reduced phLFs proliferation, a process that was in part rescued by IL-6.", {"entities": [[82, 87, "GENE"]]}], ["Taken together, these results strongly indicate that WISP1-induced IL-6 expression contributes to the pro-proliferative effect on fibroblasts, which is likely orchestrated by a variety of profibrotic mediators, including Wnts, TGF\u03b21 and TNF\u03b1.", {"entities": []}], ["Variation in development methods of Pressure Ulcer Risk Assessment Instruments has led to inconsistent inclusion of risk factors and concerns about content validity.", {"entities": []}], ["A new evidenced-based Risk Assessment Instrument, the Pressure Ulcer Risk Primary Or Secondary Evaluation Tool - PURPOSE-T was developed as part of a National Institute for Health Research (NIHR) funded Pressure Ulcer Research Programme (PURPOSE: RP-PG-0407-10056).", {"entities": []}], ["This paper reports the pre-test phase to assess and improve PURPOSE-T acceptability, usability and confirm content validity.", {"entities": []}], ["A descriptive study incorporating cognitive pre-testing methods and integration of service user views was undertaken over 3\u00a0cycles comprising PURPOSE-T training, a focus group and one-to-one think-aloud interviews.", {"entities": []}], ["Clinical nurses from 2 acute and 2 community NHS Trusts, were grouped according to job role.", {"entities": [[45, 48, "GENE"]]}], ["Focus group participants used 3 vignettes to complete PURPOSE-T assessments and then participated in the focus group.", {"entities": []}], ["Think-aloud participants were interviewed during their completion of PURPOSE-T. After each pre-test cycle analysis was undertaken and adjustment/improvements made to PURPOSE-T in an iterative process.", {"entities": []}], ["This incorporated the use of descriptive statistics for data completeness and decision rule compliance and directed content analysis for interview and focus group data.", {"entities": []}], ["Data were collected April 2012-June 2012.", {"entities": []}], ["Thirty-four nurses participated in 3 pre-test cycles.", {"entities": []}], ["Data from 3 focus groups, 12 think-aloud interviews incorporating 101 PURPOSE-T assessments led to changes to improve instrument content and design, flow and format, decision support and item-specific wording.", {"entities": []}], ["Acceptability and usability were demonstrated by improved data completion and appropriate risk pathway allocation.", {"entities": []}], ["The pre-test also confirmed content validity with clinical nurses.", {"entities": []}], ["The pre-test was an important step in the development of the preliminary PURPOSE-T and the methods used may have wider instrument development application.", {"entities": []}], ["PURPOSE-T proposes a new approach to pressure ulcer risk assessment, incorporating a screening stage, the inclusion of skin status to distinguish between those who require primary prevention and those who require secondary prevention/treatment and the use of colour to support pathway allocation and decision making.", {"entities": []}], ["Further clinical evaluation is planned to assess the reliability and validity of PURPOSE-T and it\u2019s impact on care processes and patient outcomes.", {"entities": []}], ["IL-17A induces the release of pro-inflammatory cytokines and of reactive oxygen species which could lead to neutrophilic inflammation.", {"entities": []}], ["We determined the role of IL-17 receptor (IL-17R) signalling in oxidant-induced lung emphysema and airway hyperresponsiveness.", {"entities": []}], ["IL-17R m ) and isometric contractile responses of intrapulmonary airways to acetylcholine were determined.", {"entities": []}], ["In wild-type mice but not in IL-17R m after chronic ozone exposure of wild-type mice was also observed in IL-17R", {"entities": []}], ["Early diagnosis of chronic obstructive pulmonary disease (COPD) in primary care settings is difficult to achieve chiefly due to lack of availability of spirometry.", {"entities": [[19, 56, "DISEASE"]]}], ["This study estimated the prevalence of airflow limitation among chronic smokers using a handheld spirometer in this setting.", {"entities": []}], ["This is a cross-sectional study performed on consecutive patients who were \u226540 years old with \u226510 pack-years smoking history.", {"entities": []}], ["Face-to-face interviews were carried out to obtain demographic data and relevant information.", {"entities": []}], ["Handheld spirometry was performed according to a standard protocol using the COPd-6 device (Model 4000, Vitalograph, Ennis, Ireland) in addition to standard spirometry.", {"entities": []}], ["Airflow limitation was defined as ratio of forced expiratory volume in 1 s (FEV 1 )/forced expiratory volume in 6 s <0.75 (COPd-6) or FEV 1 /forced vital capacity <0.7.", {"entities": [[76, 79, "GENE"], [134, 137, "GENE"], [76, 79, "GENE"], [134, 137, "GENE"]]}], ["Multiple logistic regression analyses were used to determine predictors of airflow limitation.", {"entities": []}], ["A total of 416 patients were recruited with mean age of 53 years old.", {"entities": []}], ["The prevalence of airflow limitation was 10.6% ( n = 44) with COPd-6 versus 6% as gauged using standard spirometry.", {"entities": []}], ["Risk factors for airflow limitation were age >65 years (odds ratio (OR) 3.732 95% confidence interval (CI): 1.100\u20131.280), a history of \u2018bad health\u2019 (OR 2.524, 95% CI: 1.037\u20136.142) and low to normal body mass index (OR 2.914, 95% CI: 1.191\u20137.190).", {"entities": []}], ["In a primary care setting, handheld spirometry (COPd-6) found a prevalence of airflow limitation of \u223c10% in smokers.", {"entities": []}], ["Patients were older, not overweight and had an ill-defined history of health problems.", {"entities": []}], ["Prevalence of COPD is unknown in Malaysia.", {"entities": []}], ["The prevalence of COPD using a handheld spirometer (COPd-6TM) was 10.6% versus 6% as gauged using standard spirometry.", {"entities": []}], ["Predictors of COPD were older age, lower BMI and a history of \u2018bad health\u2019.", {"entities": []}], ["Case-finding for COPD should be targeted in this special population.", {"entities": []}], ["Analyzing drug-drug interactions may unravel previously unknown drug action patterns, leading to the development of new drug discovery tools.", {"entities": []}], ["We present a new approach to analyzing drug-drug interaction networks, based on clustering and topological community detection techniques that are specific to complex network science.", {"entities": []}], ["Our methodology uncovers functional drug categories along with the intricate relationships between them.", {"entities": []}], ["Using modularity-based and energy-model layout community detection algorithms, we link the network clusters to 9 relevant pharmacological properties.", {"entities": []}], ["Out of the 1141 drugs from the DrugBank 4.1 database, our extensive literature survey and cross-checking with other databases such as Drugs.com, RxList, and DrugBank 4.3 confirm the predicted properties for 85% of the drugs.", {"entities": []}], ["As such, we argue that network analysis offers a high-level grasp on a wide area of pharmacological aspects, indicating possible unaccounted interactions and missing pharmacological properties that can lead to drug repositioning for the 15% drugs which seem to be inconsistent with the predicted property.", {"entities": []}], ["Also, by using network centralities, we can rank drugs according to their interaction potential for both simple and complex multi-pathology therapies.", {"entities": []}], ["Moreover, our clustering approach can be extended for applications such as analyzing drug-target interactions or phenotyping patients in personalized medicine applications.", {"entities": []}], ["We report that the hypodense eosinophil population in three patients with corticosteroid-unresponsive IHES was uniquely long lived ex vivo in the absence of exogenous cytokines.", {"entities": []}], ["Serum or plasma from these patients conferred prolonged viability ex vivo to normodense eosinophils from reference donors and converted them to a functionally activated hypodense phenotype.", {"entities": []}], ["In that antibody against IL-5 neutralized this activity in IHES serum, excessive quantities of this cytokine may account for the characteristic eosinophilia and long- lived, functionally augmented eosinophil phenotype in this disorder.", {"entities": [[144, 156, "DISEASE"]]}], ["Asthma exacerbation could be induced by respiratory syncytial virus (RSV), and the underlying pathogenic mechanism is related to complement activation.", {"entities": []}], ["Although complement might regulate CD4", {"entities": [[35, 38, "GENE"]]}], ["Risk factors for invasive pneumococcal disease (IPD) include young and old age, comorbidities (such as splenic dysfunction, immunodeficiencies, chronic renal disease, chronic heart or lung disease or cerebral spinal fluid leak), crowded environments or poor socioeconomic conditions.", {"entities": [[184, 196, "DISEASE"]]}], ["Universal use of the 7-valent pneumococcal conjugate (7vPncCRM) vaccine for infants and young children has led to significant decreases in IPD in the vaccinated population (direct protection), and there has also been a decrease in the incidence of IPD among the nonvaccinated population (indirect immunity; herd protection).", {"entities": []}], ["While 7vPncCRM vaccine is administered universally to children in USA, many countries of the European Union have chosen to target children with comorbidities.", {"entities": []}], ["This review aims to highlight individual risk factors for IPD, describe studies that evaluated pneumococcal conjugate vaccines in at-risk groups and estimate the proportion of at-risk children who may have been vaccinated in the European Union since the 7vPncCRM vaccine was introduced, using UK as an example.", {"entities": []}], ["Although immunisation targeting only children with comorbidities may achieve satisfactory results for a few, many otherwise healthy children at risk simply because of their age will be neglected, and herd protection might not be established.", {"entities": []}], ["RANTES and its CCR5 receptor trigger inflammation and its progression to insulin resistance in obese.", {"entities": [[15, 19, "GENE"]]}], ["In the present study, we investigated for the first time the effect of physical exercise on the expression of RANTES and CCR5 in obese humans.", {"entities": [[121, 125, "GENE"]]}], ["Fifty-seven adult nondiabetic subjects (17 lean and 40 obese) were enrolled in a 3-month supervised physical exercise.", {"entities": []}], ["RANTES and CCR5 expressions were measured in PBMCs and subcutaneous adipose tissue before and after exercise.", {"entities": [[11, 15, "GENE"]]}], ["Circulating plasma levels of RANTES were also investigated.", {"entities": []}], ["There was a significant increase in RANTES and CCR5 expression in the subcutaneous adipose tissue of obese compared to lean.", {"entities": [[47, 51, "GENE"]]}], ["In PBMCs, however, while the levels of RANTES mRNA and protein were comparable between both groups, CCR5 mRNA was downregulated in obese subjects ( P < 0.05).", {"entities": [[100, 104, "GENE"]]}], ["Physical exercise significantly reduced the expression of both RANTES and CCR5 ( P < 0.05) in the adipose tissue of obese individuals with a concomitant decrease in the levels of the inflammatory markers TNF- \u03b1 , IL-6, and P-JNK.", {"entities": [[74, 78, "GENE"]]}], ["Circulating RANTES correlated negatively with anti-inflammatory IL-1ra ( P = 0.001) and positively with proinflammatory IP-10 and TBARS levels ( P < 0.05).", {"entities": []}], ["Therefore, physical exercise may provide an effective approach for combating the deleterious effects associated with obesity through RANTES signaling in the adipose tissue.", {"entities": [[117, 124, "DISEASE"]]}], ["The molecular mechanisms of Idiopathic Pulmonary Fibrosis (IPF) remain elusive.", {"entities": []}], ["Transforming Growth Factor beta 1(TGF-\u03b21) is a key effector cytokine in the development of lung fibrosis.", {"entities": []}], ["We used microarray and computational biology strategies to identify genes whose expression is significantly altered in alveolar epithelial cells (A549) in response to TGF-\u03b21, IL-4 and IL-13 and Epstein Barr virus.", {"entities": []}], ["A549 cells were exposed to 10 ng/ml TGF-\u03b21, IL-4 and IL-13 at serial time points.", {"entities": []}], ["Total RNA was used for hybridisation to Affymetrix Human Genome U133A microarrays.", {"entities": []}], ["Each in vitro time-point was studied in duplicate and an average RMA value computed.", {"entities": []}], ["Expression data for each time point was compared to control and a signal log ratio of 0.6 or greater taken to identify significant differential regulation.", {"entities": []}], ["Using normalised RMA values and unsupervised Average Linkage Hierarchical Cluster Analysis, a list of 312 extracellular matrix (ECM) proteins or modulators of matrix turnover was curated via Onto-Compare and Gene-Ontology (GO) databases for baited cluster analysis of ECM associated genes.", {"entities": []}], ["Interrogation of the dataset using ontological classification focused cluster analysis revealed coordinate differential expression of a large cohort of extracellular matrix associated genes.", {"entities": []}], ["Of this grouping members of the ADAM (A disintegrin and Metalloproteinase domain containing) family of genes were differentially expressed.", {"entities": []}], ["ADAM gene expression was also identified in EBV infected A549 cells as well as IL-13 and IL-4 stimulated cells.", {"entities": []}], ["We probed pathologenomic activities (activation and functional activity) of ADAM19 and ADAMTS9 using siRNA and collagen assays.", {"entities": [[76, 82, "GENE"], [87, 94, "GENE"]]}], ["Knockdown of these genes resulted in diminished production of collagen in A549 cells exposed to TGF-\u03b21, suggesting a potential role for these molecules in ECM accumulation in IPF.", {"entities": []}], ["Histamine and prostaglandin E 2 (PGE 2 ), directly and via their effects on other cells, regulate the behaviour of vascular smooth muscle (VSM), but their effects on human VSM are incompletely resolved.", {"entities": []}], ["The effects of PGE 2 on histamine-evoked changes in intracellular free Ca i ) and adenylyl cyclase activity were measured in populations of cultured human aortic smooth muscle cells (ASMCs).", {"entities": []}], ["Selective ligands of histamine and EP receptors were used to identify the receptors that mediate the responses.", {"entities": []}], ["Histamine, via H 1 receptors, stimulates an increase in [Ca i that is entirely mediated by activation of inositol 1,4,5-trisphosphate receptors.", {"entities": []}], ["Selective stimulation of EP 2 or EP 4 receptors attenuates histamine-evoked Ca 2 on both Ca 2 receptors.", {"entities": []}], ["Two important inflammatory mediators, histamine via H 1 receptors and PGE 2 acting largely via EP 2 receptors, exert opposing effects on [Ca i in human ASMCs.", {"entities": []}], ["Studies all over the world reported that smoking relapses occur during the first two weeks after a quit date.", {"entities": []}], ["The current study aimed to assess the impact of the additional phone calls counselling during the first month on the abstinence rate at 3 and 6\u00a0months after quit date among smokers in Penang, Malaysia.", {"entities": []}], ["The study was conducted at Quit Smoking Clinic of two major hospitals in Penang, Malaysia.", {"entities": []}], ["All the eligible smokers who attended the clinics between February 1 Participants in our cohort smoked about 14 cigarettes per day on average (mean\u2009=\u200913.78\u2009\u00b1\u20097.0).", {"entities": []}], ["At 3\u00a0months, control group was less likely to quit smoking compared to intervention group (36.9% vs. 46.7%, verified smoking status) but this did not reach statistical significance (OR\u2009=\u20090.669; 95% CI\u2009=\u20090.395-1.133, P\u2009=\u20090.86).", {"entities": []}], ["However, at 6\u00a0months, 71.7% of the intervention group were successfully quit smoking (bio-chemically verified) compared to 48.6% of the control group ( P \u2009<\u20090.001).", {"entities": []}], ["The control group were significantly less likely to quit smoking (OR\u2009=\u20090.375; 95% CI\u2009=\u20090.217-0.645, P \u2009<\u20090.001).", {"entities": []}], ["Smoking cessation intervention consisting of phone calls counselling delivered during the first month of quit attempt revealed significantly higher abstinence rates compared with a standard care approach.", {"entities": []}], ["Therefore, the additional counselling in the first few weeks after stop smoking is a promising treatment strategy that should be evaluated further.", {"entities": []}], ["TCTR20140504001", {"entities": []}], ["Asthma is the most common chronic illness of childhood and its prevalence is increasing, causing much concern for identification of risk factors such as air pollution.", {"entities": [[0, 6, "DISEASE"]]}], ["We previously conducted a study showing a relationship between asthma visits in all persons < 65 years of age to emergency departments (EDs) and air pollution in Seattle, Washington.", {"entities": [[63, 69, "DISEASE"]]}], ["In that study the most frequent zip codes of the visits were in the inner city.", {"entities": []}], ["The Seattle-King County Department of Public Health (Seattle, WA) subsequently published a report which showed that the hospitalization rate for children in the inner city was over 600/100,000, whereas it was < 100/100,000 for children living in the suburbs.", {"entities": []}], ["Therefore, we conducted the present study to evaluate whether asthma visits to hospital emergency departments in the inner city of Seattle were associated with outdoor air pollution levels.", {"entities": [[62, 68, "DISEASE"]]}], ["ED visits to six hospitals for asthma and daily air pollution data were obtained for 15 months during 1995 and 1996.", {"entities": [[31, 37, "DISEASE"]]}], ["The association between air pollution and childhood ED visits for asthma from the inner city area with high asthma hospitalization rates were compared with those from lower hospital utilization areas.", {"entities": [[66, 72, "DISEASE"], [108, 114, "DISEASE"]]}], ["Daily ED counts were regressed against fine particulate matter (PM), carbon monoxide (CO), sulfur dioxide, and nitrogen dioxide using a semiparametric Poisson regression model.", {"entities": []}], ["Significant associations were found between ED visits for asthma in children and fine PM and CO. A change of 11 microg/m3 in fine PM was associated with a relative rate of 1.15 [95% confidence interval (CI), 1.08-1.23].", {"entities": [[58, 64, "DISEASE"]]}], ["There was no stronger association between ED visits for asthma and air pollution in the higher hospital utilization area than in the lower utilization area.", {"entities": [[56, 62, "DISEASE"]]}], ["These findings were seen when estimated PM2.5 concentrations were below the newly adopted annual National Ambient Air Quality Standard of 15 microg/m3.", {"entities": []}], ["In a cross-sectional survey using standardized questionnaires such as the Spiritual Needs Questionnaire (SpNQ), we analyze unmet spiritual needs of 275 patients with chronic diseases from Catholic Poland.", {"entities": []}], ["The factorial structure of SpNQ\u2019s Polish version is similar to the primary version and has good internal consistency (Cronbach\u2019s \u03b1 \u00a0=\u00a00.89).", {"entities": []}], ["Here, not only Inner Peace needs and Giving/Generativity needs were of relevance, but also Religious Needs and Existential Needs .", {"entities": []}], ["These needs were not significantly associated with life satisfaction, but with interpretations of illness.", {"entities": []}], ["To address such unmet needs, multi-professional teams should care for patients\u2019 multifaceted needs.", {"entities": []}], ["Median overall survival (OS) of patients with melanoma brain metastases (MBM) is usually 6\u00a0months or less.", {"entities": [[46, 54, "DISEASE"]]}], ["There are rare reports of patients with treated MBM who survived for years.", {"entities": []}], ["These outlier cases represent valuable opportunities to study the somatic and germline factors that may have influenced patient outcome and led to extended survival.", {"entities": []}], ["Here we report the clinical scenario of a 67\u00a0year old man with a recurrent brain metastasis from melanoma who has survived over 12\u00a0years post-resection.", {"entities": [[97, 105, "DISEASE"]]}], ["We review the literature relating to clinical and molecular variables associated with long term survival post-brain metastasis.", {"entities": []}], ["We present the somatic characteristics of this individual patient\u2019s tumor as well as an analysis of inherited genetic variants related to immune function.", {"entities": []}], ["The patient\u2019s resected brain tumor is BRAF V600E mutated, NRAS wild type (WT), and TERT C250T mutated.", {"entities": [[38, 42, "GENE"], [58, 62, "GENE"], [83, 87, "GENE"]]}], ["The patient is a carrier of germline variants in immunomodulatory loci associated with prolonged survival.", {"entities": []}], ["Our data suggest that genetic variants in immunomodulatory loci may partially contribute to this patient\u2019s unusually favorable outcome and should not be overlooked.", {"entities": []}], ["With further and future investigation, knowledge of inherited single nucleotide polymorphisms (SNPs) may provide clinicians with more individualized prognostic information for melanoma patients, with potential implications for surveillance strategies and therapeutic interventions.", {"entities": [[176, 184, "DISEASE"]]}], ["Bipolar disorder and schizophrenia are hypothesized to share some genetic background.", {"entities": [[21, 34, "DISEASE"], [0, 16, "DISEASE"]]}], ["In a two-phase study, we evaluated the effect of five promising candidate genes for psychotic disorders, DAOA , COMT , DTNBP1 , NRG1 , and AKT1 , on bipolar spectrum disorder, psychotic disorder, and related cognitive endophenotypes in a Finnish family-based sample ascertained for bipolar disorder.", {"entities": [[282, 298, "DISEASE"], [176, 194, "DISEASE"], [105, 109, "GENE"], [112, 116, "GENE"], [119, 125, "GENE"], [128, 132, "GENE"], [139, 143, "GENE"]]}], ["In initial screening of 362 individuals from 63 families, we found only marginal evidence for association with the diagnosis-based dichotomous classification.", {"entities": []}], ["Those associations did not strengthen when we genotyped the complete sample of 723 individuals from 180 families.", {"entities": []}], ["We observed a significant association of DAOA variants rs3916966 and rs2391191 with visuospatial ability (Quantitative Transmission Disequilibrium Test [QTDT]; p = 4 \u00d7 10 n = 159) with the two variants in almost complete linkage disequilibrium.", {"entities": [[41, 45, "GENE"]]}], ["The COMT variant rs165599 also associated with visuospatial ability, and in our dataset, we saw an additive effect of DAOA and COMT variants on this neuropsychological trait.", {"entities": [[4, 8, "GENE"], [127, 131, "GENE"], [118, 122, "GENE"], [4, 8, "GENE"], [127, 131, "GENE"]]}], ["The ancestral allele (Arg) of the nonsynonymous common DAOA variant rs2391191 (Arg30Lys) was found to predispose to impaired performance.", {"entities": [[55, 59, "GENE"]]}], ["The DAOA gene may play a role in predisposing individuals to a mixed phenotype of psychosis and mania and to impairments in related neuropsychological traits.", {"entities": [[4, 8, "GENE"]]}], ["Pharmacists are uniquely trained to provide guidance to patients in the selection of appropriate non-prescription therapy.", {"entities": []}], ["Physicians in Qatar may not always recognize how pharmacists function in assuring safe medication use.", {"entities": []}], ["Both these health professional groups come from heterogeneous training and experiences before migrating to the country and these backgrounds could influence collaborative patient care.", {"entities": []}], ["Qatar Petroleum (QP), the largest private employer in the country, has developed a pharmacist-guided medication consulting service at their primary care clinics, but physician comfort with pharmacists recommending drug therapy is currently unknown.", {"entities": []}], ["The objective of this study is to characterize physician perceptions of pharmacists and their roles in a primary care patient setting in Qatar.", {"entities": []}], ["This cross-sectional survey was developed following a comprehensive literature review and administered in English and Arabic.", {"entities": []}], ["Consenting QP physicians were asked questions to assess experiences, comfort and expectations of pharmacist roles and abilities to provide medication-related advice and recommend and monitor therapies.", {"entities": []}], ["The median age of the 62 (77.5%) physicians who responded was between 40 and 50\u2009years old and almost two-third were men (64.5%).", {"entities": []}], ["Fourteen different nationalities were represented.", {"entities": []}], ["Physicians were more comfortable with pharmacist activities closely linked to drug products than responsibilities associated with monitoring and optimization of patient outcomes.", {"entities": []}], ["Medication education (96.6%) and drug knowledge (90%) were practically unanimously recognized as abilities expected of pharmacists, but consultative roles, such as assisting in drug regimen design were less acknowledged.", {"entities": []}], ["They proposed pharmacist spend more time with physicians attending joint meetings or education events to help advance acceptance of pharmacists in patient-centered care at this site.", {"entities": []}], ["Physicians had low comfort and expectations of patient-oriented pharmacist roles but were not threatened to learn more about these capabilities or explore enhanced collaboration in patient care.", {"entities": []}], ["Endobronchial tuberculosis (EBTB) is a special form of pulmonary tuberculosis.", {"entities": [[14, 26, "DISEASE"], [65, 77, "DISEASE"], [55, 77, "DISEASE"]]}], ["In spite of much progress in the diagnosis of this disease in past years, delayed or mistaken diagnosis is still commonly seen.", {"entities": []}], ["The aim of this study is to try to find out some useful clues for the diagnosis of EBTB, especially the early diagnosis.", {"entities": []}], ["The medical records of patients with EBTB were analyzed retrospectively.", {"entities": []}], ["Results: The male-to-female ratio was 1:2.2 out of 22 patients.", {"entities": []}], ["Patients aged below 60-years-old constituted 72.7% of the cases.", {"entities": []}], ["22.7% of these patients were smokers.", {"entities": []}], ["The male-to-female ratio of smokers was 4:1.", {"entities": []}], ["68.2% of these patients tested all showed negative result for the HIV test.", {"entities": []}], ["The frequent complaints were cough, sputum, shortness of breath and fever, and antibiotic treatments were usually inefficacious.", {"entities": []}], ["Multiple lobes lesion, exudative shadow and atelectasis were the frequent radiological findings.", {"entities": []}], ["Acid-fast bacilli staining for sputum smear was positive in only 13.6% of these patients.", {"entities": []}], ["Tuberculin skin test was positive in 59.1% of these patients.", {"entities": []}], ["Granular lesion was the most common bronchoscopic appearance in these patients.", {"entities": []}], ["Histological changes showed distinctive tuberculose lesion in 72.2% of 18 patients undergoing bronchoscopic biopsy.", {"entities": []}], ["The diagnosis of EBTB is easily delayed or mistaken because of nonspecific clinical manifestations and the low incidence of positive acid-fast bacilli staining.", {"entities": []}], ["A high index of awareness of this disease is required for diagnosis.", {"entities": []}], ["Bronchoscopy should be performed as soon as possible in suspected patients, especially when patients present positive tuberculin skin test or no response to antibiotic treatments.", {"entities": []}], ["Exposure to ionising radiation is a well-established risk factor for multiple types of tumours, including malignant brain tumours.", {"entities": []}], ["In the 1950s, radiotherapy was used to treat Tinea Capitis (TC) in thousands of children, mostly of North-African and Middle Eastern origin, during the mass migration to Israel.", {"entities": []}], ["The over-representation of radiation-associated meningioma (RAM) and other cancers in specific families provide support for inherited genetic susceptibility to radiation-induced cancer.", {"entities": [[178, 184, "DISEASE"], [48, 58, "DISEASE"]]}], ["To test this hypothesis, we genotyped 15 families segregating RAM using high-density single-nucleotide polymorphism (SNP) arrays.", {"entities": []}], ["Using the family-based association test (FBAT) programme, we tested each polymorphism and haplotype for an association with RAM.", {"entities": []}], ["The strongest haplotype associations were attained at 18q21.1 ( P =7.5 \u00d7 10 P =2.8 \u00d7 10 P =1.6 \u00d7 10 PIAS2, KATNAL2, TCEB3C, TCEB3CL and CTNNA3 genes as risk factors for RAM.", {"entities": [[100, 105, "GENE"], [107, 114, "GENE"], [116, 122, "GENE"], [124, 131, "GENE"], [136, 142, "GENE"]]}], ["These findings suggest that any underlying genetic susceptibility to RAM is likely to be mediated through the co-inheritance of multiple risk alleles rather than a single major gene locus determining radiosensitivity.", {"entities": []}], ["An increase in the frequency of azole-resistant Aspergillus fumigatus has emerged.", {"entities": []}], ["Azoles are the mainstay of oral therapy for aspergillosis.", {"entities": [[44, 57, "DISEASE"]]}], ["Azole resistance in Aspergillus has been reported infrequently.", {"entities": []}], ["The first resistant isolate was detected in 1999 in Manchester, UK.", {"entities": []}], ["In a clinical collection of 519 A. fumigatus isolates, the frequency of itraconazole resistance was 5%, a significant increase since 2004 (p<0.001).", {"entities": []}], ["Of the 34 itraconazole-resistant isolates we studied, 65% (22) were cross-resistant to voriconazole and 74% (25) were cross-resistant to posaconazole.", {"entities": []}], ["Thirteen of 14 evaluable patients in our study had prior azole exposure; 8 infections failed therapy (progressed), and 5 failed to improve (remained stable).", {"entities": []}], ["Eighteen amino acid alterations were found in the target enzyme, Cyp51A, 4 of which were novel.", {"entities": []}], ["A population genetic analysis of microsatellites showed the existence of resistant mutants that evolved from originally susceptible strains, different cyp51A mutations in the same strain, and microalterations in microsatellite repeat number.", {"entities": []}], ["Azole resistance in A. fumigatus is an emerging problem and may develop during azole therapy.", {"entities": []}], ["There is a need for a readily available, non-invasive source of biomarkers that predict poor asthma control.", {"entities": [[93, 99, "DISEASE"]]}], ["We sought to determine if there is an association between the salivary inflammatory profile and disease control in children and adults with asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["In this cross-sectional study, we collected demographic and clinical information from two independent populations at different sites, resulting in convenience samples of 58 pediatric and 122 adult urban asthmatics.", {"entities": []}], ["Control was assessed by symptom questionnaire (children) and by Asthma Control Questionnaire and current exacerbation (adults).", {"entities": [[64, 70, "DISEASE"]]}], ["Saliva was collected in all subjects.", {"entities": []}], ["We applied principal component analysis to a 10-plex panel of relevant inflammatory markers to characterize marker profiles and determined if profiles were associated with asthma control.", {"entities": [[172, 178, "DISEASE"]]}], ["There were similar, strong correlations amongst biologically related markers in both populations: eosinophil-related: eotaxin-1/CCL11, RANTES/CCL5, and IL-5 (p<.001); myeloid/innate: IL-1\u03b2, IL-6, MCP-1/CCL2, and IL-8/CXCL8 (p<.001).", {"entities": []}], ["The first three principal components captured \u226574% of variability across all ten analytes in both populations.", {"entities": []}], ["In adults, the Principal Component 1 score, broadly reflective of all markers, but with greater weight given to myeloid/innate markers, was associated with Asthma Control Questionnaire score and exacerbation.", {"entities": [[156, 162, "DISEASE"]]}], ["The Principal Component 3 score, reflective of IP-10/CXCL10, was associated with current exacerbation.", {"entities": []}], ["In children, the Principal Component 1, 2, and 3 scores were associated with recent asthma symptoms.", {"entities": [[84, 90, "DISEASE"]]}], ["The Principal Component 2 score, reflective of higher eosinophil markers, was inversely correlated with symptoms.", {"entities": []}], ["The Principal Component 3 score was positively associated with all symptom outcomes.", {"entities": []}], ["The salivary inflammatory profile is associated with disease control in children and adults with asthma.", {"entities": [[97, 103, "DISEASE"]]}], ["Diet is known to play a key role in atherogenesis and in the development of cardiovascular events.", {"entities": []}], ["Dietary factors may mediate these processes acting as potential modulators of inflammation.", {"entities": []}], ["Potential Links between inflammatory properties of diet and the occurrence of cardiovascular events have not been tested previously.", {"entities": []}], ["We aimed to assess the association between the dietary inflammatory index (DII), a method to assess the inflammatory potential of the diet, and incident cardiovascular disease.", {"entities": []}], ["In the prospective, dynamic SUN cohort, 18,794 middle-aged, Spanish university graduates were followed up for 8.9 years (median).", {"entities": []}], ["A validated 136-item food-frequency questionnaire was used to calculate the DII.", {"entities": []}], ["The DII is based on scientific evidence about the relationship between diet and inflammatory biomarkers (C-reactive protein, IL-1\u03b2, IL-4, IL-6, IL-10 and TNF-\u03b1).", {"entities": []}], ["Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between the DII and incident cardiovascular disease (myocardial infarction, stroke or cardiovascular death).", {"entities": [[179, 200, "DISEASE"], [68, 70, "GENE"]]}], ["The risk for cardiovascular events progressively increased with each increasing quartile of DII (p trend = 0.017).", {"entities": []}], ["The multivariable-adjusted HR for participants in the highest (most pro-inflammatory) vs. the lowest quartile of the DII was 2.03 (95% CI 1.06\u20133.88).", {"entities": [[27, 29, "GENE"]]}], ["A pro-inflammatory diet was associated with a significantly higher risk for developing cardiovascular events.", {"entities": []}], ["Background: Soy protein may reduce coronary heart disease (CHD) risk by lowering LDL cholesterol, but few studies have assessed whether whole soy flour displays a similar effect.", {"entities": [[44, 57, "DISEASE"], [35, 57, "DISEASE"]]}], ["Objective: The aim of this study was to assess the dose effect of whole soy flour incorporated into muffins on plasma LDL cholesterol in hypercholesterolemic adults.", {"entities": []}], ["Methods: Adults aged 30\u201370 y ( n = 243) with elevated LDL cholesterol (\u22653.0 and \u22645.0 mmol/L) were stratified by LDL cholesterol and randomly assigned to consume 2 soy muffins containing 25 g soy protein [high-dose soy (HDS)], 1 soy and 1 wheat muffin containing 12.5 g soy protein and 12.5 g whey protein [low-dose soy (LDS)], or 2 wheat muffins containing 25 g whey protein (control) daily for 6 wk while consuming a self-selected diet.", {"entities": []}], ["Fasting blood samples were collected at weeks 0, 3, and 6 for analysis of plasma lipids [total, LDL, and HDL cholesterol and triglycerides (TGs)], glucose, insulin, C-reactive protein (CRP), and isoflavones.", {"entities": [[185, 188, "GENE"]]}], ["Blood pressures also were measured.", {"entities": []}], ["Dietary intake was assessed at weeks 0 and 4 with the use of 3 d food records.", {"entities": []}], ["Treatment effects were assessed with the use of intention-to-treat analysis with multiple imputation and LDL cholesterol as the primary outcome.", {"entities": []}], ["Results: In total, 213 (87.6%) participants completed the trial.", {"entities": []}], ["Participants were primarily Caucasian (83%) and mostly female (63%), with a mean \u00b1 SD body mass index (in kg/m P < 0.001), neither HDS nor LDS had a significant effect on LDL cholesterol compared with control (mean \u00b1 SEM changes: control, \u22120.04 \u00b1 0.05 mmol/L; HDS, 0.01 \u00b1 0.05 mmol/L; and LDS, \u22120.04 \u00b1 0.06 mmol/L).", {"entities": []}], ["There were no significant treatment effects on total or HDL cholesterol, TGs, CRP, homeostatic model assessment of insulin resistance, blood pressure, or the Framingham 10-y CHD risk score.", {"entities": [[78, 81, "GENE"]]}], ["Conclusion: Consuming 12.5 or 25 g protein from defatted soy flour incorporated into muffins does not reduce LDL cholesterol or other CHD risk factors in hypercholesterolemic adults.", {"entities": []}], ["This trial was registered at clinicaltrials.gov as NCT01547585.", {"entities": []}], ["Abnormality in mitochondria has been suggested to be associated with development of allergic airway disorders.", {"entities": []}], ["In this study, to evaluate the relationship between mitochondrial reactive oxygen species (ROS) and NLRP3 inflammasome activation in allergic asthma, we used a newly developed mitochondrial ROS inhibitor, NecroX-5.", {"entities": [[133, 148, "DISEASE"], [142, 148, "DISEASE"], [100, 105, "GENE"]]}], ["NecroX-5 reduced the increase of mitochondrial ROS generation in airway inflammatory cells, as well as bronchial epithelial cells, NLRP3 inflammasome activation, the nuclear translocation of nuclear factor- \u03ba B, increased expression of various inflammatory mediators and pathophysiological features of allergic asthma in mice.", {"entities": [[302, 317, "DISEASE"], [311, 317, "DISEASE"], [131, 136, "GENE"]]}], ["Finally, blockade of IL-1 \u03b2 substantially reduced airway inflammation and hyperresponsiveness in the asthmatic mice.", {"entities": []}], ["These findings suggest that mitochondrial ROS have a critical role in the pathogenesis of allergic airway inflammation through the modulation of NLRP3 inflammasome activation, providing a novel role of airway epithelial cells expressing NLRP3 inflammasome as an immune responder.", {"entities": [[145, 150, "GENE"], [237, 242, "GENE"], [145, 150, "GENE"], [237, 242, "GENE"]]}], ["Carcinogenesis is a complex process tightly regulated at multiple levels by post-translational modifications.", {"entities": []}], ["Epigenetics plays a major role in cancer development, all stable changes to the gene expression process that are not a result of a direct change in the DNA code are described as epigenetics.", {"entities": [[34, 40, "DISEASE"]]}], ["Epigenetic processes are regulated by post-translational modifications including ubiquitination which can directly affect either histones or transcription factors or may target their co-factors and interacting partners exerting an indirect effect.", {"entities": []}], ["Deubiquitination of these target proteins is equally important and alterations in this pathway can also lead to cancer development, progression and metastasis.", {"entities": [[112, 118, "DISEASE"]]}], ["Only the correct, unaltered balance between ubiquitination and deubiquitination ensures healthy cellular homeostasis.", {"entities": []}], ["In this review we focus on the role of deubiquitinating (DUB) enzymes in various aspects of epigenetics including the regulation of transcription factors, histone modifications, DNA damage repair pathways and cell cycle regulation.", {"entities": []}], ["We discuss the impact of those processes on tumourigenesis and potential therapeutic applications of DUBs for cancer treatment.", {"entities": [[110, 116, "DISEASE"]]}], ["Proliferation of bronchioalveolar stem cells (BASCs) is essential for epithelial repair.", {"entities": []}], ["XB130 is a novel adaptor protein involved in the regulation of epithelial cell survival, proliferation and migration through the PI3K/Akt pathway.", {"entities": []}], ["To determine the role of XB130 in airway epithelial injury repair and regeneration, a naphthalene-induced airway epithelial injury model was used with XB130 knockout (KO) mice and their wild type (WT) littermates.", {"entities": []}], ["In XB130 KO mice, at days 7 and 14, small airway epithelium repair was significantly delayed with fewer number of Club cells (previously called Clara cells).", {"entities": []}], ["CCSP (Club cell secreted protein) mRNA expression was also significantly lower in KO mice at day 7.", {"entities": []}], ["At day 5, there were significantly fewer proliferative epithelial cells in the KO group, and the number of BASCs significantly increased in WT mice but not in KO mice.", {"entities": []}], ["At day 7, phosphorylation of Akt, GSK-3\u03b2, and the p85\u03b1 subunit of PI3K was observed in airway epithelial cells in WT mice, but to a much lesser extent in KO mice.", {"entities": []}], ["Microarray data also suggest that PI3K/Akt-related signals were regulated differently in KO and WT mice.", {"entities": []}], ["An inhibitory mechanism for cell proliferation and cell cycle progression was suggested in KO mice.", {"entities": []}], ["XB130 is involved in bronchioalveolar stem cell and Club cell proliferation, likely through the PI3K/Akt/GSK-3\u03b2 pathway.", {"entities": []}], ["To investigate risk factors for first long-bone fractures in children up to 5 years old in order to provide evidence about which families could benefit from injury prevention interventions.", {"entities": []}], ["Population-based matched nested case\u2013control study using The Health Improvement Network, a UK primary care research database, 1988\u20132004.", {"entities": []}], ["Maternal, household and child risk factors for injury were assessed among 2456 children with long-bone fractures (cases).", {"entities": []}], ["23\u2005661controls were matched to cases on general practice.", {"entities": []}], ["Adjusted ORs and 95% CIs were estimated using conditional logistic regression.", {"entities": []}], ["Fractures of long-bones were independently associated with younger maternal age and higher birth order, with children who were the fourth-born in the family, or later, having a threefold greater odds of fracture compared to first-born children (adjusted OR 3.12, 95% CI 2.08 to 4.68).", {"entities": []}], ["Children over the age of 1\u2005year had a fourfold (13\u201324\u2005months, adjusted OR 4.09 95% CI 3.51 to 4.76) to fivefold (37+ months, adjusted OR 4.88 95% CI 4.21 to 5.66) increase in the odds of a long-bone fracture compared to children aged 0\u201312\u2005months.", {"entities": []}], ["Children in families with a history of maternal alcohol misuse had a raised odds of long-bone fracture (adjusted OR 2.33, 95% CI 1.13 to 4.82) compared to those with no documented history.", {"entities": []}], ["Risk factors for long-bone fractures in children less than 5 years old included age above 1\u2005year, increasing birth order, younger maternal age and maternal alcohol misuse.", {"entities": []}], ["These risk factors should be used to prioritise families and communities for injury prevention interventions.", {"entities": []}], ["A frailty paradigm would be useful in primary care to identify older people at risk, but appropriate metrics at that level are lacking.", {"entities": []}], ["We created and validated a simple instrument for frailty screening in Europeans aged \u226550.", {"entities": []}], ["Our study is based on the first wave of the Survey of Health, Ageing and Retirement in Europe (SHARE, http://www.share-project.org ), a large population-based survey conducted in 2004-2005 in twelve European countries.", {"entities": []}], ["Subjects : SHARE Wave 1 respondents (17,304 females and 13,811 males).", {"entities": []}], ["Measures : five SHARE variables approximating Fried's frailty definition.", {"entities": []}], ["Analyses (for each gender): 1) estimation of a discreet factor (DFactor) model based on the frailty variables using LatentGOLD Females : the DFactor model included 15,578 cases (standard R p < 0.001) between the three classes: non-frail ( N = 10,420; 66.9%), pre-frail ( N = 4,025; 25.8%), and frail ( N = 1,133; 7.3%).", {"entities": []}], ["Relative to the non-frail class, the age-adjusted Odds Ratio (with 95% Confidence Interval) for mortality at Wave 2 was 2.1 (1.4 - 3.0) in the pre-frail and 4.8 (3.1 - 7.4) in the frail.", {"entities": []}], ["Males : 12,783 cases (standard R p < 0.001): non-frail ( N = 10,517; 82.3%), pre-frail ( N = 1,871; 14.6%), and frail ( N = 395; 3.1%); age-adjusted OR (95% CI) for mortality: 3.0 (2.3 - 4.0) in the pre-frail, 6.9 (4.7 - 10.2) in the frail.", {"entities": []}], ["The SHARE Frailty Instrument has sufficient construct and predictive validity, and is readily and freely accessible via web calculators.", {"entities": []}], ["To our knowledge, SHARE-FI represents the first European research effort towards a common frailty language at the community level.", {"entities": []}], ["An estimated 863 million people\u2013a third of the world\u2019s urban population\u2013live in slums, yet there is little information on the disease burden in these settings, particularly regarding chronic preventable diseases.", {"entities": []}], ["From March to May 2012, we conducted a cluster randomized survey to estimate the prevalence of noncommunicable diseases (NCDs) and associated risk factors in a peri-urban shantytown north of Lima, Peru.", {"entities": []}], ["Field workers administered a questionnaire that included items from the WHO World Health Survey and the WHO STEPS survey of chronic disease risk factors.", {"entities": []}], ["We used logistic regression to assess the associations of NCDs and related risk factors with age and gender.", {"entities": []}], ["We accounted for sampling weights and the clustered sampling design using statistical survey methods.", {"entities": []}], ["A total of 142 adults were surveyed and had a weighted mean age of 36 years (range 18\u201381).", {"entities": []}], ["The most prevalent diseases were depression (12%) and chronic respiratory disease (8%), while lifetime prevalence of cancer, arthritis, myocardial infarction, and diabetes were all less than 5%.", {"entities": [[136, 157, "DISEASE"], [125, 134, "DISEASE"], [117, 123, "DISEASE"]]}], ["Fifteen percent of respondents were hypertensive and the majority (67%) was unaware of their condition.", {"entities": []}], ["Being overweight or obese was common for both genders (53%), but abdominal obesity was more prevalent in women (54% vs. 10% in men, p < 0.001).", {"entities": [[75, 82, "DISEASE"]]}], ["Thirty-five percent of men binge drank and 34% reported current smoking; these behaviors were less common among women (4% binge drank, p < 0.001; 8% smoked, p = 0.002).", {"entities": []}], ["Increasing age was associated with an increased risk of abdominal obesity (Odds Ratio (OR) = 1.04, 95% CI = 1.01, 1.07, p = 0.02), hypertension (OR = 1.06, 95% CI = 1.02, 1.10, p = 0.006), arthritis (OR = 1.07, 95% CI = 1.03, 1.11, p < 0.001) and cancer (OR = 1.13, 95% CI = 1.07, 1.20, p < 0.001) in adjusted models.", {"entities": [[131, 143, "DISEASE"], [66, 73, "DISEASE"], [189, 198, "DISEASE"], [247, 253, "DISEASE"]]}], ["The prevalences of other NCDs and related risk factors were similar when stratified by age or gender.", {"entities": []}], ["This study underlines the important burden of noncommunicable disease in informal settlements in Peru and suggests that prevention and treatment interventions could be optimized according to age and gender.", {"entities": []}], ["To investigate potential transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) to health care workers in a hospital, we serologically tested hospital contacts of the index case-patient in Saudi Arabia, 4 months after his death.", {"entities": [[65, 73, "DISEASE"]]}], ["None of the 48 contacts showed evidence of MERS-CoV infection.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF), a pleiotropic proinflammatory cytokine, has been showed to be associated with the immunopathogenesis of many diseases.", {"entities": [[40, 43, "GENE"]]}], ["Recent study demonstrated that MIF promoted tumorigenesis and tumor progression and played a critical role in various kinds of human cancer including head and neck squamous cell carcinoma(HNSCC).", {"entities": [[178, 187, "DISEASE"], [164, 187, "DISEASE"], [133, 139, "DISEASE"], [31, 34, "GENE"]]}], ["Hence, in this paper we retrospected the relationship between MIF and angiogenesis, epithelial-mesenchymal transition (EMT), inflammation, immune response, hypoxia microenvironment, and discussed whether it is a promising biomarker for diagnosis and supervisor of HNSCC.", {"entities": [[62, 65, "GENE"]]}], ["The purpose of our study was to determine the prevalence of traditional, complementary and alternative medicine (TCAM) use in patients with chronic diseases in lower Mekong countries.", {"entities": []}], ["A cross-sectional study was conducted in a health care setting using a random sample of 4799 adult patients (Mean age: 52.3\u00a0years, SD\u2009=\u200922.7) with chronic diseases in Cambodia, Vietnam and Thailand.", {"entities": []}], ["The measure included the International Questionnaire to measure usage of complementary and alternative medicine (I-CAM).", {"entities": []}], ["The 1\u00a0year prevalence of consulting TCAM providers was 26.0 %; 27.0\u00a0% in Cambodia, 26.3\u00a0% in Thailand, 23.9\u00a0% in Vietnam.", {"entities": []}], ["The most commonly consulted TCAM providers were the herbalist (17.3\u00a0%), massage therapist (6.0\u00a0%), and acupuncturist (5.5\u00a0%).", {"entities": []}], ["For all different types of TCAM providers more than 80\u00a0% of participants perceived the consultation as very or somewhat helpful.", {"entities": []}], ["The own use of herbal medicine was 41.0\u00a0%, own use of vitamins 26.5\u00a0% and the own use of other supplements 9.7\u00a0% in the past 12\u00a0months.", {"entities": []}], ["The most common self-help practices in the past 12\u00a0months included praying for your own health (30.1\u00a0%), meditation (13.9\u00a0%) and relaxation techniques (9.9\u00a0%).", {"entities": []}], ["In multivariate logistic regression analyses, older age, rural residence and having two or more chronic conditions was associated with the use a TCAM provider; being female, urban residence, residing in Vietnam and having two or more chronic conditions was associated with the use of TCAM products; and being female, older age, rural residence, higher formal education, and residing in Cambodia was associated with the use of TCAM self-help practices.", {"entities": []}], ["TCAM use is common among chronic disease patients in lower Mekong countries and is associated with several sociodemographic and disease specific factors.", {"entities": []}], ["Tobacco use is a major threat to public health in the United States, and the number one cause of preventable death.", {"entities": []}], ["Although most smokers try to quit unaided, robust data indicate that pairing behavioral support to US Food Drug Administration-approved cessation medications significantly increase cessation rates.", {"entities": []}], ["Those who do receive assistance in quitting usually receive very low intensity treatment, regardless of the severity of their dependence or their medical and environmental circumstances.", {"entities": []}], ["This is in stark contrast to how other substance use disorders are treated, where there are varying levels of care depending on addiction severity and biopsychosocial circumstances.", {"entities": []}], ["The American Society of Addiction Medicine (ASAM) developed a formal algorithm for assessing substance use disorders and determining the optimal level of care.", {"entities": []}], ["The ASAM Patient Placement Criteria are regularly used to determine the appropriate level of care for all substance use disorders except tobacco.", {"entities": []}], ["This paper will review key aspects of the ASAM dimensions of care and placement levels, with emphasis on how they apply to tobacco use and present case examples of typical smokers who would benefit from a higher intensity of tobacco dependence treatment.", {"entities": []}], ["We also present current barriers to reimbursing healthcare providers for these services.", {"entities": []}], ["We conclude with a commentary and discussion regarding recommendations for improvements in tobacco dependence treatment care.", {"entities": []}], ["Food allergy is a major public health problem for which there is no effective treatment.", {"entities": []}], ["We examined the immunological changes that occurred in a group of children with significant cow\u2019s milk allergy undergoing a novel and rapid high dose oral desensitization protocol enabled by treatment with omalizumab (anti-IgE mAb).", {"entities": []}], ["Within a week of treatment, the CD4", {"entities": [[32, 35, "GENE"]]}], ["The genotype information carried by Genome-wide association studies (GWAS) seems to have the potential to explain more of the \u2018missing heritability\u2019 of complex human phenotypes, given improved statistical approaches.", {"entities": []}], ["Several lines of evidence support the involvement of microRNA (miRNA) and other non-coding RNA in complex human traits and diseases.", {"entities": []}], ["We employed a novel, genetic annotation-informed enrichment method for GWAS that captures more polygenic effects than standard GWAS analysis, to investigate if miRNA-tagging Single Nucleotide Polymorphisms (SNPs) are enriched of associations with 15 complex human phenotypes.", {"entities": []}], ["We then leveraged the enrichment using a conditional False Discovery Rate (condFDR) approach to assess any improvement in the detection of individual miRNA SNPs associated with the disorders.", {"entities": []}], ["We found SNPs tagging miRNA transcription regions to be significantly enriched of associations with 10 of 15 phenotypes.", {"entities": []}], ["The enrichment remained significant after controlling for affiliation to other genomic categories, and was confirmed by replication.", {"entities": []}], ["Albeit only nominally significant, enrichment was found also in miRNA binding sites for 10 phenotypes out of 15.", {"entities": []}], ["Leveraging the enrichment in the condFDR framework, we observed a 2-4-fold increase in discovery of SNPs tagging miRNA regions.", {"entities": []}], ["Our results suggest that miRNAs play an important role in the polygenic architecture of complex human disorders and traits, and therefore that miRNAs are a genomic category that can and should be used to improve gene discovery.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1513-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Under the assumption that postoperative nausea and vomiting (PONV) may occur after total hip arthroplasty (THA) regardless of the anesthetic technique used, it is not clear whether general (GA) or spinal (SA) anesthesia has higher causal effect on this occurrence.", {"entities": []}], ["Conflicting results have been reported.", {"entities": []}], ["In this observational study, we selected all elective THA interventions performed in adults between 1999 and 2008 in a Swiss orthopedic clinic under general or spinal anesthesia.", {"entities": []}], ["To assess the effect of anesthesia type on the occurrence of PONV, we used the propensity score and matching methods, which allowed us to emulate the design and results of an RCT.", {"entities": []}], ["Among 3922 procedures, 1984 (51\u00a0%) patients underwent GA, of which 4.1\u00a0% experienced PONV, and 1938 underwent SA, of which 3.5\u00a0% experienced PONV.", {"entities": []}], ["We found that the average treatment effect on the treated, i.e.", {"entities": []}], ["the effect of anesthesia type for a sample of individuals that actually received spinal anesthesia compared to individuals who received GA, was ATET\u2009=\u20092.00\u00a0% [95\u00a0% CI, 0.78\u20133.19\u00a0%], which translated into an OR\u2009=\u20091.97 [95\u00a0% CI 1.35; 2.87].", {"entities": []}], ["This suggests that the type of anesthesia is not neutral regarding PONV, general anesthesia being more strongly associated with PONV than spinal anesthesia in orthopedic surgery.", {"entities": []}], ["An alcohol use disorder (AUD) is associated with an increased susceptibility to respiratory infection and injury and, upon hospitalization, higher mortality rates.", {"entities": []}], ["Studies in model systems show effects of alcohol on mitochondrial function, lipid metabolism and antioxidant systems.", {"entities": []}], ["The present study applied high-resolution metabolomics to test for these changes in bronchoalveolar lavage fluid (BALF) of subjects with an AUD.", {"entities": []}], ["Smokers were excluded to avoid confounding effects and compliance was verified by cotinine measurements.", {"entities": []}], ["Statistically significant metabolic features, differentially expressed by control and AUD subjects, were identified by statistical and bioinformatic methods.", {"entities": []}], ["The results show that fatty acid and acylcarnitine concentrations were increased in AUD subjects, consistent with perturbed mitochondrial and lipid metabolism.", {"entities": []}], ["Decreased concentrations of methyl-donor compounds suggest altered one-carbon metabolism and oxidative stress.", {"entities": []}], ["An accumulation of peptides suggests proteolytic activity, which could reflect altered epithelial barrier function.", {"entities": []}], ["Two metabolites of possible microbial origin suggest subclinical bacterial infection.", {"entities": []}], ["Furthermore, increased diacetylspermine suggests additional metabolic perturbations, which could contribute to dysregulated alveolar macrophage function and vulnerability to infection.", {"entities": []}], ["Together, the results show an extended metabolic consequence of AUD in the bronchoalveolar space.", {"entities": []}], ["Loss-of-function variants in the gene encoding filaggrin ( FLG ) are major determinants of eczema.", {"entities": [[59, 62, "GENE"]]}], ["We hypothesized that weakening of the physical barrier in FLG- deficient individuals may potentiate the effect of environmental exposures.", {"entities": []}], ["Therefore, we investigated whether there is an interaction between FLG loss-of-function mutations with environmental exposures (pets and dust mites) in relation to the development of eczema.", {"entities": [[67, 70, "GENE"]]}], ["We used data obtained in early life in a high-risk birth cohort in Denmark and replicated the findings in an unselected birth cohort in the United Kingdom.", {"entities": []}], ["Primary outcome was age of onset of eczema; environmental exposures included pet ownership and mite and pet allergen levels.", {"entities": []}], ["In Copenhagen ( n = 379), FLG mutation increased the risk of eczema during the first year of life (hazard ratio [HR] 2.26, 95% confidence interval [CI] 1.27\u20134.00, p = 0.005), with a further increase in risk related to cat exposure at birth amongst children with FLG mutation (HR 11.11, 95% CI 3.79\u201332.60, p < 0.0001); dog exposure was moderately protective (HR 0.49, 95% CI 0.24\u20131.01, p = 0.05), but not related to FLG genotype.", {"entities": [[26, 29, "GENE"], [262, 265, "GENE"], [415, 418, "GENE"], [113, 115, "GENE"], [276, 278, "GENE"], [358, 360, "GENE"], [26, 29, "GENE"], [262, 265, "GENE"], [415, 418, "GENE"], [113, 115, "GENE"], [276, 278, "GENE"], [358, 360, "GENE"], [113, 115, "GENE"], [276, 278, "GENE"], [358, 360, "GENE"], [26, 29, "GENE"], [262, 265, "GENE"], [415, 418, "GENE"]]}], ["In Manchester ( n = 503) an independent and significant association of the development of eczema by age 12 mo with FLG genotype was confirmed (HR 1.95, 95% CI 1.13\u20133.36, p = 0.02).", {"entities": [[115, 118, "GENE"], [143, 145, "GENE"]]}], ["In addition, the risk increased because of the interaction of cat ownership at birth and FLG genotype (HR 3.82, 95% CI 1.35\u201310.81, p = 0.01), with no significant effect of the interaction with dog ownership (HR 0.59, 95% CI 0.16\u20132.20, p = 0.43).", {"entities": [[89, 92, "GENE"], [103, 105, "GENE"], [208, 210, "GENE"], [103, 105, "GENE"], [208, 210, "GENE"]]}], ["Mite-allergen had no effects in either cohort.", {"entities": []}], ["The observed effects were independent of sensitisation.", {"entities": []}], ["We have demonstrated a significant interaction between FLG loss-of-function main mutations (501x and 2282del4) and cat ownership at birth on the development of early-life eczema in two independent birth cohorts.", {"entities": [[55, 58, "GENE"]]}], ["Our data suggest that cat but not dog ownership substantially increases the risk of eczema within the first year of life in children with FLG loss-of-function variants, but not amongst those without.", {"entities": [[138, 141, "GENE"]]}], ["FLG- deficient individuals may need to avoid cats but not dogs in early life.", {"entities": []}], ["In two independent cohorts of children, Hans Bisgaard and colleagues show an association between mutations in the filaggrin gene ( FLG ) and ownership of cats, but not dogs, with development of eczema.", {"entities": [[131, 134, "GENE"]]}], ["Eczema is a skin condition characterized by dry, red, and itchy patches on the skin.", {"entities": []}], ["Eczema is associated with asthma and allergy, though allergy rarely plays a role in development or severity of eczema.", {"entities": [[26, 32, "DISEASE"]]}], ["Eczema usually begins during infancy, typically on the face, scalp, neck, extensor sides of the forearms, and legs.", {"entities": []}], ["Up to one in five infants develops eczema, but in more than half of them, the condition improves or disappears completely before they are 15 years old.", {"entities": []}], ["If eczema persists into adulthood, it usually affects the face and the skin inside the knees and elbows.", {"entities": []}], ["There is no cure for eczema but it can be controlled by avoiding anything that makes its symptoms worse.", {"entities": []}], ["These triggers include irritants such as wool, strong soaps, perfumes, and dry environments.", {"entities": []}], ["A good skin-care routine and frequent moisturizing can also help to keep eczema under control, but in many cases, corticosteroid creams and ointments may be necessary to reduce inflammation.", {"entities": []}], ["Eczema tends to run in families.", {"entities": []}], ["This suggests that eczema is caused by genetic factors as well as by environmental factors.", {"entities": []}], ["Recently, researchers discovered that two common \u201closs-of-function\u201d variants in the gene encoding filaggrin ( FLG ) predispose people to eczema.", {"entities": [[110, 113, "GENE"]]}], ["People who inherit one or two defective genes make no filaggrin, a protein that normally forms a physical barrier in the skin that protects the body from potentially harmful substances in the environment.", {"entities": []}], ["Might the weakening of this barrier in filaggrin-deficient individuals affect their responses to environmental substances to which the skin is exposed?", {"entities": []}], ["In this study, the researchers test this potential explanation for how genetic and environmental factors (in particular, exposure to pets) might interact to determine an individual's chances of developing eczema.", {"entities": []}], ["To test their hypothesis, the researchers studied two independent groups of infants during their first year of life\u2014a high-risk group consisting of infants born in Copenhagen, Denmark to mothers with asthma and a group of infants born to women from the general population in Manchester, United Kingdom.", {"entities": [[200, 206, "DISEASE"]]}], ["The researchers determined which FLG variants each child had inherited and classified those with either one or two defective copies of FLG as having an FLG mutation.", {"entities": [[33, 36, "GENE"], [135, 138, "GENE"], [152, 155, "GENE"], [33, 36, "GENE"], [135, 138, "GENE"], [152, 155, "GENE"], [33, 36, "GENE"], [135, 138, "GENE"], [152, 155, "GENE"]]}], ["They determined pet exposure in early life by asking whether a dog or a cat was living in the parental home when the child was born (\u201cpet ownership\u201d) and then analyzed how these genetic and environmental factors affected the age of onset of eczema.", {"entities": []}], ["In both groups, children with FLG mutations were twice as likely to develop eczema during the first year of life as children without FLG mutations.", {"entities": [[30, 33, "GENE"], [133, 136, "GENE"], [30, 33, "GENE"], [133, 136, "GENE"]]}], ["For children without FLG mutations, cat ownership at birth had no effect on eczema risk but for children with FLG mutations, cat ownership at birth (but not dog ownership) further increased the risk of developing eczema.", {"entities": [[21, 24, "GENE"], [110, 113, "GENE"], [21, 24, "GENE"], [110, 113, "GENE"]]}], ["These findings show that FLG mutations and cat ownership at birth interact to determine the chances of a child developing eczema during the first year of life.", {"entities": [[25, 28, "GENE"]]}], ["They provide support, therefore, for the researchers' suggestion that the weakening of the skin's protective barrier that is caused by filaggrin deficiency increases the child's susceptibility to factors associated with cat exposure.", {"entities": []}], ["Only a small number of children in this study carried FLG mutations and were exposed to cats from birth, so these findings need confirming in independent studies.", {"entities": [[54, 57, "GENE"]]}], ["In addition, it is still not clear how exposure to cats drives the development of eczema.", {"entities": []}], ["Allergy was not the mechanism as the FLG -deficient children exposed to cat and who developed eczema did not develop cat-specific immunoglobin E antibodies.", {"entities": [[37, 40, "GENE"]]}], ["Nevertheless, these findings suggest that, to reduce their risk of developing eczema, filaggrin-deficient individuals should avoid cats (but not dogs) during the first few months of life.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0050131 .", {"entities": []}], ["The MedlinePlus Encyclopedia has a page on eczema (in English and Spanish); links to further information are provided by MedlinePlus EczemaNet is a comprehensive online information resource about eczema provided by the American Academy of Dermatologists The US National Institute of Arthritis and Musculoskeletal and Skin Diseases provides information on eczema The UK National Health Service Direct health encyclopedia provides information for patients on eczema (in several languages) The Copenhagen Studies on Asthma in Childhood (COPSAC) and Manchester Asthma and Allergy Study (MAAS) Web sites provide more information about the children involved in this research", {"entities": [[513, 519, "DISEASE"], [557, 563, "DISEASE"]]}], ["Innate lymphoid cells (ILCs), including NK cells, contribute to barrier immunity and tissue homeostasis.", {"entities": []}], ["In addition to the role of uterine NK cells in placentation and fetal growth, other uterine ILCs (uILCs) are likely to play roles in uterine physiology and pathology.", {"entities": []}], ["In this article, we report on the composition of uILCs in the endometrium during the luteal phase and in the decidua during early pregnancy.", {"entities": []}], ["Whereas nonkiller uILC1s and uILC2s are barely detectable in mouse and not detected in humans, a sizeable population of uILC3s is found in human endometrium and decidua, which are mostly NCR", {"entities": []}], ["Glabridin is a major flavonoid in Glycyrrhiza glabra (licorice) root, a traditional Asian medicine.", {"entities": []}], ["Glabridin is reported to have anti-atherogenic, anti-inflammatory and anti-nephritic properties; however its effects on vascular tone remain unexplored.", {"entities": []}], ["We examined the effect of glabridin on rat main mesenteric artery using isometric myography and also ELISA to measure cGMP levels.", {"entities": []}], ["Glabridin (30\u00a0\u03bcM) relaxed arteries pre-constricted with the thromboxane A 2 analog U46619 (0.2\u00a0\u03bcM) by ~\u00a060% in an endothelium-independent manner.", {"entities": []}], ["Relaxation to 30\u00a0\u03bcM glabridin was abolished by the guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (1\u00a0\u03bcM) and by the BK Ca channel blocker tetraethyammonium (1\u00a0mM) but was unaffected by the estrogen receptor antagonist ICI182780.", {"entities": []}], ["The concentration-response curve to glabridin (0.1 to 30\u00a0\u03bcM) was downshifted by the K ATP channel blocker glibenclamide (10\u00a0\u03bcM), the K V channel blocker 4-aminopyridine (300\u00a0\u03bcM), and the K IR blocker BaCl 2 (30\u00a0\u03bcM).", {"entities": []}], ["In U46619-contracted arteries partially relaxed by 0.1\u00a0\u03bcM sodium nitroprusside, application of 10 and 30\u00a0nM glabridin caused additional vasorelaxation.", {"entities": []}], ["Glabridin (30\u00a0\u03bcM) approximately doubled tissue [cyclic GMP].", {"entities": []}], ["Application of the phosphodiesterase inhibitor isobutylmethylxanthine caused a much larger rise in [cyclic GMP], and glabridin failed to cause vasorelaxation or a further rise in [cGMP] when co-applied with IBMX.", {"entities": []}], ["Vasorelaxation to glabridin is dependent on the opening of K Ca , probably caused by a rise in cellular [cyclic GMP] owing to phosphodiesterase inhibition.", {"entities": []}], ["In the presence of sodium nitroprusside an effect of glabridin is observed at nM concentrations, similar those measured in plasma following human ingestion of licorice flavonoid oil.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the leading cause of respiratory infections in children, elderly, and immunocompromised individuals.", {"entities": []}], ["Severe infection is associated with short- and long-term morbidity including pneumonia, recurrent wheezing, and abnormal pulmonary function, and several lines of evidence indicate that impaired adaptive immune responses during infection are critical in the pathophysiology of RSV-mediated disease.", {"entities": [[77, 86, "DISEASE"]]}], ["Myeloid Dendritic cells (mDCs) play a pivotal role in shaping antiviral immune responses in the respiratory tract; however, few studies have examined the interactions between RSV and individual mDC subsets.", {"entities": []}], ["In this study, we examined the effect of RSV on the functional response of primary mDC subsets (BDCA-1 BDCA-1 Both BDCA-1 RSV infection induces a distinct pattern of costimulatory molecule expression and cytokine production by BDCA-1 The differential expression of CD86 and pro-inflammatory cytokines by highly purified mDC subsets in response to RSV provides further evidence that BDCA-1", {"entities": [[265, 269, "GENE"]]}], ["In individuals with asthma, obesity induces the production of leptin and is associated with disease severity.", {"entities": [[28, 35, "DISEASE"], [20, 26, "DISEASE"]]}], ["Our objective was to evaluate the levels of serum leptin and their effect on Th1/Th2 balance in obese and non-obese children with asthma, as well as to investigate the association between serum leptin levels and clinical outcomes.", {"entities": [[130, 136, "DISEASE"]]}], ["We evaluated 50 atopic children with physician-diagnosed moderate-to-severe persistent asthma and 20 controls.", {"entities": [[87, 93, "DISEASE"]]}], ["The children with asthma were divided into two groups, by body mass index percentile: obese (n = 25) and non-obese (n = 25).", {"entities": [[18, 24, "DISEASE"]]}], ["From all subjects, we collected peripheral blood samples in order to determine the levels of leptin, IFN-\u03b3, and IL-4.", {"entities": []}], ["Asthma severity was assessed by an asthma symptom score, and the results were correlated with the parameters studied.", {"entities": [[0, 6, "DISEASE"], [35, 41, "DISEASE"]]}], ["Serum leptin levels were significantly higher in the obese asthma group than in the non-obese asthma group, as well as being significantly higher in the children with asthma than in the controls, whereas IFN-\u03b3 levels were significantly higher and IL-4 levels were significantly lower in the obese asthma group than in the non-obese asthma group.", {"entities": [[59, 65, "DISEASE"], [94, 100, "DISEASE"], [167, 173, "DISEASE"], [297, 303, "DISEASE"], [332, 338, "DISEASE"]]}], ["In addition, the obese asthma group showed higher asthma symptom scores and significantly lower FEV 1 (% of predicted) than did the non-obese asthma group.", {"entities": [[23, 29, "DISEASE"], [50, 56, "DISEASE"], [142, 148, "DISEASE"], [96, 99, "GENE"]]}], ["There was a significant positive correlation between leptin and IFN-\u03b3 levels only in the obese asthma group.", {"entities": [[95, 101, "DISEASE"]]}], ["Although leptin is involved in the pathogenesis of asthma in obese and non-obese children, its effect is more pronounced in the former.", {"entities": [[51, 57, "DISEASE"]]}], ["In the presence of high leptin levels, only obese children with asthma exhibited Th1 polarization, with higher IFN-\u03b3 levels and greater asthma severity.", {"entities": [[64, 70, "DISEASE"], [136, 142, "DISEASE"]]}], ["A obesidade induz a produ\u00e7\u00e3o de leptina em asm\u00e1ticos e est\u00e1 associada \u00e0 gravidade da doen\u00e7a.", {"entities": []}], ["Nosso objetivo foi avaliar os n\u00edveis de leptina s\u00e9rica e seu efeito no equil\u00edbrio Th1/Th2 em crian\u00e7as asm\u00e1ticas obesas e n\u00e3o obesas e investigar a associa\u00e7\u00e3o desses n\u00edveis com desfechos cl\u00ednicos.", {"entities": []}], ["O estudo envolveu 50 crian\u00e7as at\u00f3picas com diagn\u00f3stico m\u00e9dico de asma persistente moderada a grave e 20 controles.", {"entities": []}], ["Os asm\u00e1ticos foram agrupados como obesos (n = 25) e n\u00e3o obesos (n = 25) de acordo com o percentil do \u00edndice de massa corp\u00f3rea.", {"entities": []}], ["Amostras de sangue perif\u00e9rico foram coletadas de todos os sujeitos, e os n\u00edveis de leptina, IFN-\u03b3 e IL-4 foram determinados.", {"entities": []}], ["A gravidade da asma foi avaliada por um escore de sintomas de asma, e os resultados foram correlacionados com os par\u00e2metros estudados.", {"entities": [[33, 36, "GENE"]]}], ["Os n\u00edveis s\u00e9ricos de leptina foram significativamente maiores nos asm\u00e1ticos obesos do que nos asm\u00e1ticos n\u00e3o obesos, assim como nos asm\u00e1ticos comparados aos controles, enquanto os n\u00edveis de IFN-\u03b3 foram significativamente maiores e os de IL-4 foram significativamente menores nos asm\u00e1ticos obesos do que nos asm\u00e1ticos n\u00e3o obesos.", {"entities": []}], ["Os asm\u00e1ticos obesos tiveram maiores escores de sintomas de asma e VEF 1 (% do previsto) significativamente menor que os asm\u00e1ticos n\u00e3o obesos.", {"entities": []}], ["Houve uma correla\u00e7\u00e3o positiva significativa entre os n\u00edveis de leptina e IFN-\u03b3 somente entre os asm\u00e1ticos obesos.", {"entities": []}], ["Embora a leptina esteja envolvida na patog\u00eanese da asma em crian\u00e7as asm\u00e1ticas obesas ou n\u00e3o, seu efeito \u00e9 maior naquelas obesas.", {"entities": []}], ["Na presen\u00e7a de altos n\u00edveis de leptina, somente as crian\u00e7as asm\u00e1ticas obesas apresentaram polariza\u00e7\u00e3o Th1 com maiores n\u00edveis de IFN-\u03b3 e asma mais grave.", {"entities": []}], ["We evaluated the role of IL-10- in IL-33-mediated cholesterol reduction in macrophage-derived foam cells (MFCs) and the mechanism by which IL-33 upregulates IL-10.", {"entities": []}], ["Serum IL-33 and IL-10 levels in coronary artery disease patients were measured.", {"entities": []}], ["The effects of IL-33 on intra-MFC cholesterol level, IL-10, ABCA1 and CD36 expression, ERK 1/2, Sp1, STAT3 and STAT4 activation, and IL-10 promoter activity were determined.", {"entities": [[60, 65, "GENE"], [70, 74, "GENE"], [96, 99, "GENE"], [101, 106, "GENE"], [111, 116, "GENE"]]}], ["Core sequences were identified using bioinformatic analysis and site-specific mutagenesis.", {"entities": []}], ["The serum IL-33 levels positively correlated with those of IL-10.", {"entities": []}], ["IL-33 decreased cellular cholesterol level and upregulated IL-10 and ABCA1 but had no effect on CD36 expression.", {"entities": [[69, 74, "GENE"], [96, 100, "GENE"]]}], ["siRNA-IL-10 partially abolished cellular cholesterol reduction and ABCA1 elevation by IL-33 but did not reverse the decreased CD36 levels.", {"entities": [[67, 72, "GENE"], [126, 130, "GENE"]]}], ["IL-33 increased IL-10 mRNA production but had little effect on its stability.", {"entities": []}], ["IL-33 induced ERK 1/2 phosphorylation and increased the luciferase expression driven by the IL-10 promoter, with the highest extent within the \u22122000 to \u22121752\u2009bp segment of the 5\u2032-flank of the transcription start site; these effects were counteracted by U0126.", {"entities": []}], ["IL-33 activated Sp1, STAT3 and STAT4, but only the STAT3 binding site was predicted in the above segment.", {"entities": [[16, 19, "GENE"], [21, 26, "GENE"], [51, 56, "GENE"], [31, 36, "GENE"], [21, 26, "GENE"], [51, 56, "GENE"]]}], ["Site-directed mutagenesis of the predicted STAT3-binding sites (CTGC TTCC TGGCAGCAGAA\u2192CTGC C TGGCAGCAGAA) reduced luciferase activity, and a STAT3 inhibitor blocked the regulatory effects of IL-33 on IL-10 expression.", {"entities": [[43, 48, "GENE"], [141, 146, "GENE"]]}], ["Chromatin immunoprecipitation (CHIP) confirmed the STAT3-binding sequences within the \u22121997 to \u22121700 and \u22121091 to \u2212811\u2009bp locus regions.", {"entities": []}], ["IL-33 increased IL-10 expression in MFCs via activating ERK 1/2 and STAT3, which subsequently promoted IL-10 transcription and thus contributed to the beneficial effects of IL-33 on MFCs.", {"entities": [[68, 73, "GENE"]]}], ["Tear film hyperosmolarity and anterior ocular inflammation are two clinical signs that may be indicative of dry eye disease (DED).", {"entities": [[112, 123, "DISEASE"]]}], ["This condition can cause pathological and functional changes to the anterior ocular surface tissues.", {"entities": []}], ["A contributing factor may be dysfunctional aquaporin 5 (AQP5) water channels as they are the AQP subtype that expressed in the corneal epithelium and contribute to fluid efflux needed for corneal function.", {"entities": [[56, 60, "GENE"]]}], ["We determined if described hyperosmolarity-induced increases in proinflammatory cytokine expression and cell death are mediated through AQP5 upregulation and JNK1/2 MAPK signaling activation in both primary human corneal epithelial cells (HCECs), and in a HCEC line.", {"entities": [[136, 140, "GENE"]]}], ["Real time RT-PCR identified rises in IL-1\u03b2, IL-6, IL-8, TNF-\u03b1, caspase-1, and AQP5 mRNA levels upon step increases in osmolarity up to 550\u2009mOsm.", {"entities": [[78, 82, "GENE"]]}], ["Western blot analysis and the TUNEL assay identified corresponding rises in AQP5 and p-JNK1/2 protein expression and cell death respectively.", {"entities": [[76, 80, "GENE"]]}], ["JNK1/2 inhibition with SP600125, or siRNA AQP5 gene silencing reduced hypertonic-induced rises in proinflammatory cytokine expression and cell death.", {"entities": [[42, 46, "GENE"]]}], ["Taken together, hypertonicity-induced AQP5 upregulation leads to increases in proinflammatory cytokine expression and cell death through JNK1/2 MAPK activation.", {"entities": [[38, 42, "GENE"]]}], ["These results suggest that drug targeting AQP5 upregulation may be a therapeutic option in DED management.", {"entities": [[42, 46, "GENE"]]}], ["It is not known whether parasympathetic outflow simultaneously acts on bronchial tone and cardiovascular system waxing and waning both systems in parallel, or, alternatively, whether the regulation is more dependent on local factors and therefore independent on each system.", {"entities": []}], ["The aim of this study was to evaluate the simultaneous effect of different kinds of stimulations, all associated with parasympathetic activation, on bronchomotor tone and cardiovascular autonomic regulation.", {"entities": []}], ["Respiratory system resistance (Rrs, forced oscillation technique) and cardio-vascular activity (heart rate, oxygen saturation, tissue oxygenation index, blood pressure) were assessed in 13 volunteers at baseline and during a series of parasympathetic stimuli: O 2 inhalation, stimulation of the carotid sinus baroreceptors by neck suction, slow breathing, and inhalation of methacholine.", {"entities": []}], ["Pure cholinergic stimuli, like O 2 inhalation and baroreceptors stimulation, caused an increase in Rrs and a reduction in heart rate and blood pressure.", {"entities": []}], ["Slow breathing led to bradycardia and hypotension, without significant changes in Rrs.", {"entities": []}], ["However slow breathing was associated with deep inhalations, and Rrs evaluated at the baseline lung volumes was significantly increased, suggesting that the large tidal volumes reversed the airways narrowing effect of parasympathetic activation.", {"entities": []}], ["Finally inhaled methacholine caused marked airway narrowing, while the cardiovascular variables were unaffected, presumably because of the sympathetic activity triggered in response to hypoxemia.", {"entities": []}], ["All parasympathetic stimuli affected bronchial tone and moderately affected also the cardiovascular system.", {"entities": []}], ["However the response differed depending on the nature of the stimulus.", {"entities": []}], ["Slow breathing was associated with large tidal volumes that reversed the airways narrowing effect of parasympathetic activation.", {"entities": []}], ["This placebo-controlled study assessed the effects of the once-daily inhaled corticosteroid (ICS) fluticasone furoate (FF) and long-acting beta 2 -agonist (LABA) vilanterol (VI) on early and late asthmatic responses (EAR/LAR) and airway hyper-responsiveness (AHR).", {"entities": [[259, 262, "GENE"]]}], ["Patients ( n = 27) were randomized to FF (100 \u03bcg), VI (25 \u03bcg), FF/VI (100/25 \u03bcg), and placebo for 21 days (four periods).", {"entities": []}], ["Allergen challenge was performed 1 h post-dose on day 21.", {"entities": []}], ["AHR was assessed on day 22 using methacholine.", {"entities": [[0, 3, "GENE"]]}], ["Allergen challenge caused an early change (0\u20132 h) in minimum forced expiratory volume in 1 s (FEV 1 ) of \u22121.091 l (95% CI: \u22121.344; \u22120.837) following placebo therapy; changes were \u22120.955 l (\u22121.209; \u22120.702), \u22120.826 l (\u22121.070; \u22120.581), and \u22120.614 l (\u22120.858; \u22120.370) following VI, FF, or FF/VI therapy, respectively.", {"entities": [[94, 97, "GENE"]]}], ["Treatment differences were significant for all comparisons between therapies.", {"entities": []}], ["Mean changes in 0\u20132 h %FEV 1 were as follows: \u221228.05 (placebo), \u221223.10 (VI), \u221222.33 (FF), and \u221216.10 (FF/VI).", {"entities": [[23, 26, "GENE"]]}], ["Following placebo, the late change (4\u201310 h) in weighted mean FEV 1 was \u22120.466 l (\u22120.589; \u22120.343) and \u22120.298 l (\u22120.415; \u22120.181) after VI, and was +0.018 l with both FF/VI (\u22120.089; 0.124) and FF (\u22120.089; 0.125).", {"entities": [[61, 64, "GENE"]]}], ["Treatment differences were significant for all comparisons between therapies except FF/VI vs FF.", {"entities": []}], ["Mean changes in 4\u201310 h %FEV 1 were as follows: \u221221.08 (placebo), \u221214.30 (VI), \u22125.02 (FF), and \u22125.83 (FF/VI).", {"entities": [[24, 27, "GENE"]]}], ["AHR 24 h after allergen challenge was significantly reduced with FF/VI and FF vs placebo, and FF/VI was superior to either component.", {"entities": [[0, 3, "GENE"]]}], ["Combined treatment with FF/VI provides additive protection from the EAR relative to its components, significant protection over VI alone from the LAR, and confers sustained protection from hyper-responsiveness 24 h post-dose.", {"entities": []}], ["Community health interventions are increasingly employing partnerships combined with multilevel intervention models to achieve their objectives.", {"entities": []}], ["Resources and methods for project evaluation are often limited to changes in population health status or health behaviors, while broader contextual questions that may illuminate mechanisms for change across ecological levels and project sustainability may not be addressed.", {"entities": []}], ["This paper describes a project to prevent and control diabetes in a Latino community and presents practical methods for addressing some challenges to evaluation, using data sources that often may be overlooked.", {"entities": []}], ["A case study method was used to examine approaches to capture data that can help explain changes across ecological levels.", {"entities": []}], ["An ecological framework was used to organize sources of data.", {"entities": []}], ["Data sources and findings are related to project timelines and goals.", {"entities": []}], ["Although not a direct focus of the original research, substantial changes in community capacity were observed and measured over the course of the five-year project.", {"entities": []}], ["Documentation on community change was found in routine project reports, logs, the news media, meeting minutes, and community documents.", {"entities": []}], ["A logical progression of community change across ecological levels became evident.", {"entities": []}], ["A modest post hoc evaluation was feasible, using data routinely available from project and target community sources.", {"entities": []}], ["Specific questions for future research on how community change occurs and how such changes may relate to population health and sustainability are suggested.", {"entities": []}], ["Bombesin receptor subtype 3 (BRS-3), the orphan bombesin receptor, may play a role in the regulation of stress responses in lung and airway epithelia.", {"entities": []}], ["Bombesin receptor activated protein (BRAP )is a novel protein we found in our previous study which interacts with BRS-3.", {"entities": [[37, 41, "GENE"]]}], ["This study was designed to observe the subcellular location and wound repair function of BRAP in human bronchial epithelial cells (HBECs).", {"entities": [[89, 93, "GENE"]]}], ["BRAP ORF was amplified by RT-PCR and ligated to pEGFP-C1 vector, and then the recombinant plasmid pEGFP-C1-BRAP was transfected into Hela cells.", {"entities": [[0, 4, "GENE"], [107, 111, "GENE"]]}], ["The location of BRAP protein was observed by laser confocal microscope, and the expression of it was analyzed by Western-blot.", {"entities": [[16, 20, "GENE"]]}], ["At the same time,we built the recombinant plasmid pcDNA3.1(+)-BRAP, transfected it into HBECs and observed its impact on cell cycle and wound repair of HBECs.", {"entities": []}], ["The results showed that BRAP locates in membrane and cytoplasm and increases significantly in transfected cells.", {"entities": [[24, 28, "GENE"]]}], ["Flow cytometry results demonstrated that the recombinant plasmid increases S phase plus G2 phase of cell cycle by 25%.", {"entities": []}], ["Microscopic video analysis system showed that the repair index of wounded HBECs increases by 20% through stable expression of BRAP.", {"entities": [[126, 130, "GENE"]]}], ["The present study demonstrated that BRAP locates in the membrane and cytoplasm, suggesting that this protein is a cytoplasm protein, which promotes cell cycle and wound repair of HBECs.", {"entities": [[36, 40, "GENE"]]}], ["In addition to their respiratory symptoms, patients with COPD experience multiple, co-occurring symptoms.", {"entities": []}], ["The aims of this study were to identify subgroups of COPD patients based on their distinct experiences with 14 symptoms and to determine how these subgroups differed in demographic and clinical characteristics and disease-specific quality of life.", {"entities": []}], ["Patients with moderate, severe, and very severe COPD (n=267) completed a number of self-report questionnaires.", {"entities": []}], ["Latent class analysis was used to identify subgroups of patients with distinct symptom experiences based on the occurrence of self-reported symptoms using the Memorial Symptom Assessment Scale.", {"entities": []}], ["Based on the probability of occurrence of a number of physical and psychological symptoms, three subgroups of patients (ie, latent classes) were identified and named \u201chigh\u201d, \u201cintermediate\u201d, and \u201clow\u201d.", {"entities": []}], ["Across the three latent classes, the pairwise comparisons for the classification of airflow limitation in COPD were not significantly different, which suggests that measurements of respiratory function are not associated with COPD patients\u2019 symptom burden and their specific needs for symptom management.", {"entities": []}], ["While patients in both the \u201chigh\u201d and \u201cintermediate\u201d classes had high occurrence rates for respiratory symptoms, patients in the \u201chigh\u201d class had the highest occurrence rates for psychological symptoms.", {"entities": []}], ["Compared with the \u201cintermediate\u201d class, patients in the \u201chigh\u201d class were younger, more likely to be women, had significantly more acute exacerbations in the past year, and reported significantly worse disease-specific quality of life scores.", {"entities": []}], ["These findings suggest that subgroups of COPD patients with distinct symptom experiences can be identified.", {"entities": []}], ["Patients with a higher symptom burden warrant more detailed assessments and may have therapeutic needs that would not be identified using current classifications based only on respiratory function.", {"entities": []}], ["Morus alba , a medicinal plant in Asia, has been used traditionally to treat diabetes mellitus and hypoglycemia.", {"entities": [[99, 111, "DISEASE"], [77, 94, "DISEASE"]]}], ["However, the effects of M. alba extract (MAE) on atopic dermatitis have not been verified scientifically.", {"entities": [[49, 66, "DISEASE"], [56, 66, "DISEASE"]]}], ["We investigated the effects of MAE on atopic dermatitis through in vitro and in vivo experiments.", {"entities": [[38, 55, "DISEASE"], [45, 55, "DISEASE"]]}], ["We evaluated the effects of MAE on the production of nitric oxide (NO) and prostaglandin E 2 (PGE 2 ) in RAW 264.7, as well as thymus and activation-regulated chemokine (TARC/CCL17) in HaCaT cells.", {"entities": []}], ["In an in vivo experiment, atopic dermatitis was induced by topical application of house dust mites for four weeks, and the protective effects of MAE were investigated by measuring the severity of the skin reaction on the back and ears, the plasma levels of immunoglobulin E (IgE) and histamine, and histopathological changes in the skin on the back and ears.", {"entities": [[26, 43, "DISEASE"], [33, 43, "DISEASE"]]}], ["MAE suppressed the production of NO and PGE 2 in RAW 264.7 cells, as well as TARC in HaCaT cells, in a dose-dependent manner.", {"entities": []}], ["MAE treatment of NC/Nga mice reduced the severity of dermatitis and the plasma levels of IgE and histamine.", {"entities": [[53, 63, "DISEASE"]]}], ["MAE also reduced the histological manifestations of atopic dermatitis-like skin lesions such as erosion, hyperplasia of the epidermis and dermis, and inflammatory cell infiltration in the skin on the back and ears.", {"entities": [[52, 69, "DISEASE"], [59, 69, "DISEASE"]]}], ["Our results suggest that MAE has potent inhibitory effects on atopic dermatitis-like lesion and may be a beneficial natural resource for the treatment of atopic dermatitis.", {"entities": [[62, 79, "DISEASE"], [154, 171, "DISEASE"], [69, 79, "DISEASE"], [161, 171, "DISEASE"]]}], ["On the range of diagnoses, course of treatment, and long-term outcome in patients who chose to receive homeopathic medical treatment very little is known.", {"entities": []}], ["We investigated homeopathic practice in an industrialized country under everyday conditions.", {"entities": []}], ["In a prospective, multicentre cohort study with 103 primary care practices with additional specialisation in homeopathy in Germany and Switzerland, data from all patients (age >1 year) consulting the physician for the first time were observed.", {"entities": []}], ["The main outcome measures were: Patient and physician assessments (numeric rating scales from 0 to 10) and quality of life at baseline, and after 3, 12, and 24 months.", {"entities": []}], ["A total of 3,981 patients were studied including 2,851 adults (29% men, mean age 42.5 \u00b1 13.1 years; 71% women, 39.9 \u00b1 12.4 years) and 1,130 children (52% boys, 6.5 \u00b1 3.9 years; 48% girls, 7.0 \u00b1 4.3 years).", {"entities": []}], ["Ninety-seven percent of all diagnoses were chronic with an average duration of 8.8 \u00b1 8 years.", {"entities": []}], ["The most frequent diagnoses were allergic rhinitis in men, headache in women, and atopic dermatitis in children.", {"entities": [[33, 50, "DISEASE"], [82, 99, "DISEASE"], [42, 50, "DISEASE"], [89, 99, "DISEASE"]]}], ["Disease severity decreased significantly (p < 0.001) between baseline and 24 months (adults from 6.2 \u00b1 1.7 to 3.0 \u00b1 2.2; children from 6.1 \u00b1 1.8 to 2.2 \u00b1 1.9).", {"entities": []}], ["Physicians' assessments yielded similar results.", {"entities": []}], ["For adults and young children, major improvements were observed for quality of life, whereas no changes were seen in adolescents.", {"entities": []}], ["Younger age and more severe disease at baseline were factors predictive of better therapeutic success.", {"entities": []}], ["Disease severity and quality of life demonstrated marked and sustained improvements following homeopathic treatment period.", {"entities": []}], ["Our findings indicate that homeopathic medical therapy may play a beneficial role in the long-term care of patients with chronic diseases.", {"entities": []}], ["Autoimmune diseases mediated by a type of white blood cell\u2014T lymphocytes\u2014are currently treated using mainly broad-spectrum immunosuppressants that can lead to adverse side effects.", {"entities": []}], ["Antioxidants represent an alternative approach for therapy of autoimmune disorders; however, dietary antioxidants are insufficient to play this role.", {"entities": []}], ["Antioxidant carbon nanoparticles scavenge reactive oxygen species (ROS) with higher efficacy than dietary and endogenous antioxidants.", {"entities": []}], ["Furthermore, the affinity of carbon nanoparticles for specific cell types represents an emerging tactic for cell-targeted therapy.", {"entities": []}], ["Here, we report that nontoxic poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs), known scavengers of the ROS superoxide (O 2 in vivo effectiveness of PEG-HCCs in reducing T lymphocyte-mediated inflammation in delayed-type hypersensitivity and in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", {"entities": [[334, 352, "DISEASE"], [296, 313, "DISEASE"]]}], ["Our results suggest the preferential targeting of PEG-HCCs to T lymphocytes as a novel approach for T lymphocyte immunomodulation in autoimmune diseases without affecting other immune cells.", {"entities": []}], ["Non-celiac wheat sensitivity (NCWS) is defined as a reaction to ingested wheat after exclusion of celiac disease and wheat allergy.", {"entities": [[98, 112, "DISEASE"]]}], ["As its pathogenesis is incompletely understood, we evaluated the inflammatory response in the rectal mucosa of patients with well-defined NCWS.", {"entities": []}], ["The prospective study included 22 patients with irritable bowel syndrome (IBS)-like clinical presentation, diagnosed with NCWS by double-blind placebo-controlled challenge.", {"entities": [[48, 72, "DISEASE"], [64, 72, "DISEASE"]]}], ["Eight IBS patients not improving on wheat-free diet were used as controls.", {"entities": []}], ["Two weeks after oral challenge was performed with 80\u2009grams of wheat daily, cells were isolated from rectal biopsies and thoroughly characterized by fluorescence-activated cell sorting analysis for intracellular cytokines and surface markers.", {"entities": []}], ["Rectal biopsies from wheat-challenged NCWS patients showed that a significant mucosal CD45 These data indicate that, in patients with active NCWS, IFN-\u03b3-producing ILC1 cells infiltrate rectal mucosa and support a role for this innate lymphoid cell population in the pathogenesis of NCWS.", {"entities": []}], ["Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS).", {"entities": [[50, 71, "DISEASE"]]}], ["It affects more than two million people worldwide, mainly young adults, and may lead to progressive neurological disability.", {"entities": []}], ["Chemokines and their receptors have been shown to play critical roles in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a murine disease model induced by active immunization with myelin proteins or transfer of encephalitogenic CD4", {"entities": [[117, 134, "DISEASE"], [249, 252, "GENE"]]}], ["The protection of breastfeeding against respiratory tract infections in the first year of life has often been suggested.", {"entities": []}], ["Few studies examined the effect of breastfeeding on respiratory tract infections after infancy.", {"entities": []}], ["To examine the association between breastfeeding with lower respiratory tract infections (LRTI) and upper respiratory tract infections (URTI) after infancy up to 4 years of age (n = 5322).", {"entities": []}], ["This study was embedded in The Generation R study, a Dutch population-based prospective cohort study from fetal life until young adulthood.", {"entities": []}], ["Information on breastfeeding duration (never; <3 months; 3\u20136 months; \u22656 months) and dose (never; partially until 4 months; predominantly until 4 months) were collected by questionnaire at 2, 6, and 12 months of age.", {"entities": []}], ["Information on doctor attendance for LRTI and URTI were obtained by questionnaire at 2, 3, and 4 years of age.", {"entities": []}], ["Breastfeeding for 6 months or longer was significantly associated with a reduced risk of LRTI up to 4 years of age (aOR: 0.71; 95% CI: 0.51\u20130.98).", {"entities": []}], ["Similar ORs for LRTI were found with breastfeeding for less than 3 months and 3\u20136 months.", {"entities": []}], ["Although in the same direction, weaker ORs were found for URTI and breastfeeding duration.", {"entities": []}], ["The same trend was found for partial and predominant breastfeeding until 4 months and LRTI and URTI.", {"entities": []}], ["Breastfeeding duration for 6 months or longer is associated with a reduced risk of LRTI in pre-school children.", {"entities": []}], ["These findings are compatible with the hypothesis that the protective effect of breastfeeding for respiratory tract infections persist after infancy therefore supporting current recommendations for breastfeeding for at least 6 months.", {"entities": []}], ["Critical care echocardiography is developing rapidly with an increasing number of specialists now performing comprehensive studies using Doppler and other advanced techniques.", {"entities": []}], ["However, this imaging can be challenging, interpretation is far from simple in the complex critically ill patient and mistakes can be easy to make.", {"entities": []}], ["We aim to address clinically relevant areas where potential errors may occur and suggest methods to hopefully improve accuracy of imaging and interpretation.", {"entities": []}], ["Human primary monocytes comprise a heterogeneous population that can be classified into three subsets based on CD14 and CD16 expression: classical (CD14 in vitro , yet they express a remarkably high basal level of miR-146a, a microRNA known to negatively regulate the TLR pathway.", {"entities": [[111, 115, "GENE"], [148, 152, "GENE"], [111, 115, "GENE"], [148, 152, "GENE"], [214, 222, "GENE"]]}], ["This concurrence of a pro-inflammatory status and a high miR-146a level has been associated with cellular senescence in other cell types.", {"entities": [[57, 65, "GENE"]]}], ["Hence, we assessed the three monocyte subsets for evidence of senescence, including proliferative status, telomere length, cellular ROS levels, and mitochondrial membrane potential.", {"entities": []}], ["Indeed, the non-classical subset exhibited the clearest hallmarks of senescence, followed by the intermediate and then the classical subset.", {"entities": []}], ["In addition, the non-classical subset secreted pro-inflammatory cytokines basally in vitro .", {"entities": []}], ["The highly pro-inflammatory nature of the non-classical monocytes could be a manifestation of the senescence-associated secretory phenotype (SASP), likely induced by a high basal NF-\u03baB activity and IL-1\u03b1 production.", {"entities": []}], ["Finally, we observed an accumulation of the non-classical monocytes, in conjunction with higher levels of plasma TNF-\u03b1 and IL-8, in the elderly.", {"entities": []}], ["These factors may contribute to inflamm-aging and age-related inflammatory conditions, such as atherosclerosis and osteoarthritis.", {"entities": [[95, 110, "DISEASE"], [115, 129, "DISEASE"]]}], ["With our new understanding that the non-classical monocyte subset is a senescent population, we can now re-examine the role of this subset in disease conditions where this subset expands.", {"entities": []}], ["To assess odor identification (OI) as an indicator of presymptomatic Alzheimer disease (AD) pathogenesis in cognitively normal aging individuals at increased risk of AD dementia.", {"entities": [[169, 177, "DISEASE"]]}], ["In 274 members of the PREVENT-AD cohort of healthy aging persons with a parental or multiple-sibling history of AD dementia, we assessed the cross-sectional association of OI with potential indicators of presymptomatic AD.", {"entities": [[115, 123, "DISEASE"]]}], ["Some 101 participants donated CSF, thus enabling assessment of AD pathology with the biomarkers total tau (t-tau), phospho-tau (P 181 -tau), and their ratios with \u03b2-amyloid (A\u03b2 1-42 ).", {"entities": []}], ["Adjusted analyses considered age, cognition, APOE \u03b54 status, education, and sex as covariates.", {"entities": [[45, 49, "GENE"]]}], ["We measured OI using the University of Pennsylvania Smell Identification Test and cognitive performance using the Repeatable Battery for Assessment of Neuropsychological Status.", {"entities": []}], ["Standard kits provided assays of the AD biomarkers.", {"entities": []}], ["Analyses used robust-fit linear regression models.", {"entities": []}], ["Reduced OI was associated with lower cognitive score and older age, as well as increased ratios of CSF t-tau and P 181 -tau to A\u03b2 1-42 (all p < 0.02).", {"entities": []}], ["However, the observed associations of OI with age and cognition were unapparent in adjusted models that restricted observations to CSF donors and included AD biomarkers.", {"entities": []}], ["OI showed little association with CSF A\u03b2 1-42 alone except in APOE \u03b54 carriers having lowest-quartile A\u03b2 1-42 levels.", {"entities": [[62, 66, "GENE"]]}], ["These findings from healthy high-risk older individuals suggest that OI reflects degree of preclinical AD pathology, while its relationships with age and cognition result from the association of these latter variables with such pathology.", {"entities": []}], ["Diminished OI may be a practical and affordable biomarker of AD pathology.", {"entities": []}], ["Exposure to indoor allergens is crucial for IgE sensitization and development of allergic symptoms.", {"entities": []}], ["Residential settings influence the allergen amount in house dust and hence allergic sensitization.", {"entities": []}], ["Within this study, we investigated allergen exposure and molecule-based IgE levels in a geographically confined region and evaluated the impact of housing, pets and cleaning.", {"entities": []}], ["501 adolescents from Salzburg, Austria participated in this cross-sectional study.", {"entities": []}], ["House dust samples were examined regarding major mite, cat, dog, and mold allergens using a multiplex assay.", {"entities": []}], ["Serum samples of participants were analyzed for specific IgE to Der p 1, Der p 2, Fel d 1, Can f 1 and Alt a 1 using the multiplex array ImmunoCAP ISAC.", {"entities": []}], ["Information on allergies, living areas, dwelling form (house, flat, farm), pets, and household cleanliness were obtained by a questionnaire.", {"entities": []}], ["In investigated house dust samples, the concentration of cat allergen was highest while the prevalence of mold allergens was very low.", {"entities": []}], ["Participants showed IgE sensitization to Der p 1 (13.2%), Der p 2 (18.2%), Fel d 1 (14.4%), Can f 1 (2.4%) and Alt a 1 (2.0%).", {"entities": []}], ["In alpine regions, lower mite allergen concentrations were detected which correlated with reduced IgE levels.", {"entities": []}], ["A trend for increased sensitization prevalence from rural to alpine to urban regions was noted.", {"entities": []}], ["Living on farms resulted in lower sensitization prevalence to mite and cat allergens, even though exposure to mites was significantly elevated.", {"entities": []}], ["The presence of cats was associated with a lower sensitization rate and IgE levels to cat and mite allergens, and less frequent allergic diseases.", {"entities": []}], ["Cleaning did not impact allergen concentrations, while IgE reactivity to mites and allergic diseases were more pronounced when living in cleaner homes.", {"entities": []}], ["Allergen exposure to indoor allergens was influenced by setting of homes.", {"entities": []}], ["Living in a farm environment and having a cat at home showed a protective effect for IgE sensitization and allergies.", {"entities": []}], ["This cross-sectional study in combination with hereditary and lifestyle factors enables development of risk schemes for a more efficient management and potential prevention of allergic diseases.", {"entities": []}], ["The resumption of menses is an important indicator of recovery in anorexia nervosa (AN).", {"entities": []}], ["Patients with early-onset AN are at particularly great risk of suffering from the long-term physical and psychological consequences of persistent gonadal dysfunction.", {"entities": []}], ["However, the clinical variables that predict the recovery of menstrual function during weight gain in AN remain poorly understood.", {"entities": []}], ["The aim of this study was to investigate the impact of several clinical parameters on the resumption of menses in first-onset adolescent AN in a large, well-characterized, homogenous sample that was followed-up for 12\u00a0months.", {"entities": []}], ["A total of 172 female adolescent patients with first-onset AN according to DSM-IV criteria were recruited for inclusion in a randomized, multi-center, German clinical trial.", {"entities": []}], ["Menstrual status and clinical variables (i.e., premorbid body mass index (BMI), age at onset, duration of illness, duration of hospital treatment, achievement of target weight at discharge, and BMI) were assessed at the time of admission to or discharge from hospital treatment and at a 12-month follow-up.", {"entities": []}], ["Based on German reference data, we calculated the percentage of expected body weight (%EBW), BMI percentile, and BMI standard deviation score (BMI-SDS) for all time points to investigate the relationship between different weight measurements and resumption of menses.", {"entities": []}], ["Forty-seven percent of the patients spontaneously began menstruating during the follow-up period.", {"entities": []}], ["%EBW at the 12-month follow-up was strongly correlated with the resumption of menses.", {"entities": []}], ["The absence of menarche before admission, a higher premorbid BMI, discharge below target weight, and a longer duration of hospital treatment were the most relevant prognostic factors for continued amenorrhea.", {"entities": [[197, 207, "DISEASE"]]}], ["The recovery of menstrual function in adolescent patients with AN should be a major treatment goal to prevent severe long-term physical and psychological sequelae.", {"entities": []}], ["Patients with premenarchal onset of AN are at particular risk for protracted amenorrhea despite weight rehabilitation.", {"entities": [[77, 87, "DISEASE"]]}], ["Reaching and maintaining a target weight between the 15", {"entities": []}], ["Cystic fibrosis (CF) lungs are filled with thick mucus that obstructs airways and facilitates chronic infections.", {"entities": []}], ["Pseudomonas aeruginosa is a significant pathogen of this disease that produces a variety of toxic small molecules.", {"entities": []}], ["We used molecular networking-based metabolomics to investigate the chemistry of CF sputa and assess how the microbial molecules detected reflect the microbiome and clinical culture history of the patients.", {"entities": []}], ["Metabolites detected included xenobiotics, P. aeruginosa specialized metabolites and host sphingolipids.", {"entities": []}], ["The clinical culture and microbiome profiles did not correspond to the detection of P. aeruginosa metabolites in the same samples.", {"entities": []}], ["The P. aeruginosa molecules that were detected in sputum did not match those from laboratory cultures.", {"entities": []}], ["The pseudomonas quinolone signal (PQS) was readily detectable from cultured strains, but absent from sputum, even when its precursor molecules were present.", {"entities": []}], ["The lack of PQS production in vivo is potentially due to the chemical nature of the CF lung environment, indicating that culture-based studies of this pathogen may not explain its behavior in the lung.", {"entities": []}], ["The most differentially abundant molecules between CF and non-CF sputum were sphingolipids, including sphingomyelins, ceramides and lactosylceramide.", {"entities": []}], ["As these highly abundant molecules contain the inflammatory mediator ceramide, they may have a significant role in CF hyperinflammation.", {"entities": []}], ["This study demonstrates that the chemical makeup of CF sputum is a complex milieu of microbial, host and xenobiotic molecules.", {"entities": []}], ["Detection of a bacterium by clinical culturing and 16S rRNA gene profiling do not necessarily reflect the active production of metabolites from that bacterium in a sputum sample.", {"entities": []}], ["It has previously been demonstrated that an extensive upper limb neurological examination of individual muscle function, sensation in homonymous innervated territories, and nerve trunk allodynia is reliable and that the outcome reflects symptoms.", {"entities": []}], ["Since this approach may appear complicated and time consuming, this study deals with the value of an examination limited to manual testing of only six muscles.", {"entities": []}], ["Two examiners blinded to symptom status performed manual muscle testing of six muscles in 82 upper limbs with or without pain, weakness, and/or numbness/tingling.", {"entities": []}], ["The six muscles represent three antagonist pairs (pectoralis major/posterior deltoid, biceps/triceps, and radial flexor of wrist/short radial extensor of wrist).", {"entities": []}], ["The inter-rater reliability of detecting muscular weaknesses and the relation of weakness to the mentioned symptoms were analysed by kappa-statistics.", {"entities": []}], ["The two examiners recognized weaknesses in 48 and 55 limbs, respectively, with moderate agreement (median kappa\u2009=\u20090.58).", {"entities": []}], ["Out of these, 35 and 32 limbs, respectively, were symptomatic.", {"entities": []}], ["There was good correlation between findings and symptoms for one examiner (kappa\u2009=\u20090.61) and fair correlation for the other one (kappa\u2009=\u20090.33).", {"entities": []}], ["Both reached high sensitivity (0.92, 0.84) but less satisfactory specificity (0.70, 0.50).", {"entities": []}], ["Weaknesses agreed upon by the two examiners correlated moderately with symptoms (kappa\u2009=\u20090.57).", {"entities": []}], ["Weakness in one or more muscles was present in almost all symptomatic limbs but in many non-symptomatic limbs as well.", {"entities": []}], ["Manual testing of six muscles may represent a useful screening approach to upper limb neuropathic conditions, but a confirmative diagnosis requires further assessment.", {"entities": []}], ["Electron microscopy and crystallography studies of \u03b14\u03b27 integrin reveal the mechanism by which this atypical integrin enables rolling adhesion prior to integrin activation.", {"entities": []}], ["The lymphocyte homing receptor integrin \u03b1 4 \u03b2 7 is unusual for its ability to mediate both rolling and firm adhesion.", {"entities": []}], ["\u03b1 4 \u03b2 1 and \u03b1 4 \u03b2 7 are targeted by therapeutics approved for multiple sclerosis and Crohn\u2019s disease.", {"entities": [[62, 80, "DISEASE"]]}], ["Here, we show by electron microscopy and crystallography how two therapeutic Fabs, a small molecule (RO0505376), and mucosal adhesion molecule-1 (MAdCAM-1) bind \u03b1 4 \u03b2 7 .", {"entities": []}], ["A long binding groove at the \u03b1 4 \u2013\u03b2 7 interface for immunoglobulin superfamily domains differs in shape from integrin pockets that bind Arg-Gly-Asp motifs.", {"entities": []}], ["RO0505376 mimics an Ile/Leu-Asp motif in \u03b1 4 ligands, and orients differently from Arg-Gly-Asp mimics.", {"entities": []}], ["A novel auxiliary residue at the metal ion\u2013dependent adhesion site in \u03b1 4 \u03b2 7 is essential for binding to MAdCAM-1 in Mg 4 \u03b2 7 headpiece binds MAdCAM-1 and supports rolling adhesion.", {"entities": []}], ["Lack of induction of the open headpiece conformation by ligand binding enables rolling adhesion to persist until integrin activation is signaled.", {"entities": []}], ["Background : Electronic cigarette (EC) use has grown exponentially over the past few years.", {"entities": []}], ["The purpose of this survey was to assess the characteristics and experiences of a large sample of EC users and examine the differences between those who partially and completely substituted smoking with EC use.", {"entities": []}], ["Methods : A questionnaire was prepared, translated into 10 different languages and uploaded in an online survey tool.", {"entities": []}], ["EC users were asked to participate irrespective of their current smoking status.", {"entities": []}], ["Participants were divided according to their smoking status at the time of participation in two subgroups: former smokers and current smokers.", {"entities": []}], ["Results : In total, 19,414 participants were included in the analysis, with 88 of them (0.5%) reported not being smokers at the time of EC use initiation.", {"entities": []}], ["Complete substitution of smoking was reported by 81.0% of participants (former smokers) while current smokers had reduced smoking consumption from 20 to 4 cigarettes per day.", {"entities": []}], ["They were using ECs for a median of 10 months.", {"entities": []}], ["They initiated EC use with a median of 18 mg/mL nicotine-concentration liquids; 21.5% used higher than 20 mg/mL.", {"entities": []}], ["Only 3.5% of participants were using 0-nicotine liquids at the time of the survey.", {"entities": []}], ["Former smokers were highly dependent (Fagerstr\u00f6m Test for Cigarette Dependence = 7) and were heavier smokers (21 cigarettes per day when smoking) compared to current smokers.", {"entities": []}], ["The most important reasons for initiating EC use for both subgroups was to reduce the harm associated with smoking and to reduce exposure of family members to second-hand smoking.", {"entities": []}], ["Most considered ECs as less harmful than tobacco cigarettes, while 11.0% considered them absolutely harmless.", {"entities": []}], ["Side effects were reported by more than half of the participants (59.8%), with the most common being sore/dry mouth and throat; side effects were mild and in most cases were subsequently resolved (partially or completely).", {"entities": []}], ["Participants experienced significant benefits in physical status and improvements in pre-existing disease conditions (including respiratory disease such as asthma and chronic obstructive lung disease).", {"entities": [[175, 199, "DISEASE"], [156, 162, "DISEASE"], [187, 199, "DISEASE"]]}], ["Being former smoker was independently associated with positive effects in health and improvements in disease conditions.", {"entities": []}], ["Conclusions : The results of this worldwide survey of dedicated users indicate that ECs are mostly used to avoid the harm associated with smoking.", {"entities": []}], ["They can be effective even in highly-dependent smokers and are used as long-term substitutes for smoking.", {"entities": []}], ["High levels of nicotine are used at initiation; subsequently, users try to reduce nicotine consumption, with only a small minority using non-nicotine liquids.", {"entities": []}], ["Side effects are minor and health benefits are substantial, especially for those who completely substitute smoking with EC use.", {"entities": []}], ["Further population and interventional studies are warranted.", {"entities": []}], ["Familial steroid-sensitive idiopathic nephrotic syndrome is rare, and only approximately 3% of patients have affected siblings.", {"entities": [[38, 56, "DISEASE"], [48, 56, "DISEASE"]]}], ["Herein, we report seven cases of patients with steroid-sensitive idiopathic nephrotic syndrome from three Chinese families.", {"entities": [[76, 94, "DISEASE"], [86, 94, "DISEASE"]]}], ["Mutational screening of the Nphs2 gene was performed in all the patients.", {"entities": [[28, 33, "GENE"]]}], ["All seven of the familial steroid-sensitive idiopathic nephrotic syndrome cases in our sample exhibited minimal change disease, and one case also presented with mesangial proliferative glomerulonephritis, according to the renal pathology.", {"entities": [[185, 203, "DISEASE"], [55, 73, "DISEASE"], [161, 203, "DISEASE"], [65, 73, "DISEASE"], [171, 203, "DISEASE"]]}], ["No significant was associations were found between Nphs2 gene mutations and the onset of proteinuria and nephrotic syndrome in these familial cases.", {"entities": [[105, 123, "DISEASE"], [89, 100, "DISEASE"], [115, 123, "DISEASE"], [51, 56, "GENE"]]}], ["The presence of minimal change disease is important, but it is not an unusual finding in patients with familial steroid-sensitive idiopathic nephrotic syndrome, which appears to be clinically benign and genetically distinct from other types of nephrosis.", {"entities": [[141, 159, "DISEASE"], [151, 159, "DISEASE"], [244, 253, "DISEASE"]]}], ["Direct class switching to IgE generates IgE The mechanisms involved in the maintenance of memory IgE responses are poorly understood, and the role played by germinal center (GC) IgE", {"entities": [[174, 176, "GENE"]]}], ["Systematic reviews and meta-analyses of home telemonitoring interventions for patients with chronic diseases have increased over the past decade and become increasingly important to a wide range of clinicians, policy makers, and other health care stakeholders.", {"entities": []}], ["While a few criticisms about their methodological rigor and synthesis approaches have recently appeared, no formal appraisal of their quality has been conducted yet.", {"entities": []}], ["The primary aim of this critical review was to evaluate the methodology, quality, and reporting characteristics of prior reviews that have investigated the effects of home telemonitoring interventions in the context of chronic diseases.", {"entities": []}], ["Ovid MEDLINE, the Database of Abstract of Reviews of Effects (DARE), and Health Technology Assessment Database (HTA) of the Cochrane Library were electronically searched to find relevant systematic reviews, published between January 1966 and December 2012.", {"entities": [[112, 115, "GENE"]]}], ["Potential reviews were screened and assessed for inclusion independently by three reviewers.", {"entities": []}], ["Data pertaining to the methods used were extracted from each included review and examined for accuracy by two reviewers.", {"entities": []}], ["A validated quality assessment instrument, R-AMSTAR, was used as a framework to guide the assessment process.", {"entities": []}], ["Twenty-four reviews, nine of which were meta-analyses, were identified from more than 200 citations.", {"entities": []}], ["The bibliographic search revealed that the number of published reviews has increased substantially over the years in this area and although most reviews focus on studying the effects of home telemonitoring on patients with congestive heart failure, researcher interest has extended to other chronic diseases as well, such as diabetes, hypertension, chronic obstructive pulmonary disease, and asthma.", {"entities": [[223, 247, "DISEASE"], [335, 347, "DISEASE"], [349, 386, "DISEASE"], [392, 398, "DISEASE"]]}], ["Nevertheless, an important number of these reviews appear to lack optimal scientific rigor due to intrinsic methodological issues.", {"entities": []}], ["Also, the overall quality of reviews does not appear to have improved over time.", {"entities": []}], ["While several criteria were met satisfactorily by either all or nearly all reviews, such as the establishment of an a priori design with inclusion and exclusion criteria, use of electronic searches on multiple databases, and reporting of studies characteristics, there were other important areas that needed improvement.", {"entities": []}], ["Duplicate data extraction, manual searches of highly relevant journals, inclusion of gray and non-English literature, assessment of the methodological quality of included studies and quality of evidence were key methodological procedures that were performed infrequently.", {"entities": []}], ["Furthermore, certain methodological limitations identified in the synthesis of study results have affected the results and conclusions of some reviews.", {"entities": []}], ["Despite the availability of methodological guidelines that can be utilized to guide the proper conduct of systematic reviews and meta-analyses and eliminate potential risks of bias, this knowledge has not yet been fully integrated in the area of home telemonitoring.", {"entities": []}], ["Further efforts should be made to improve the design, conduct, reporting, and publication of systematic reviews and meta-analyses in this area.", {"entities": []}], ["To derive and validate a set of clinical risk prediction algorithm to estimate the 10-year risk of 11 common cancers.", {"entities": []}], ["Prospective open cohort study using routinely collected data from 753 QResearch general practices in England.", {"entities": []}], ["We used 565 practices to develop the scores and 188 for validation.", {"entities": []}], ["4.96 million patients aged 25\u201384\u2005years in the derivation cohort; 1.64 million in the validation cohort.", {"entities": []}], ["Patients were free of the relevant cancer at baseline.", {"entities": [[35, 41, "DISEASE"]]}], ["Cox proportional hazards models in the derivation cohort to derive 10-year risk algorithms.", {"entities": []}], ["Risk factors considered included age, ethnicity, deprivation, body mass index, smoking, alcohol, previous cancer diagnoses, family history of cancer, relevant comorbidities and medication.", {"entities": [[106, 112, "DISEASE"], [142, 148, "DISEASE"]]}], ["Measures of calibration and discrimination in the validation cohort.", {"entities": []}], ["Incident cases of blood, breast, bowel, gastro-oesophageal, lung, oral, ovarian, pancreas, prostate, renal tract and uterine cancers.", {"entities": []}], ["Cancers were recorded on any one of four linked data sources (general practitioner (GP), mortality, hospital or cancer records).", {"entities": [[112, 118, "DISEASE"]]}], ["We identified 228\u2005241 incident cases during follow-up of the 11 types of cancer.", {"entities": [[73, 79, "DISEASE"]]}], ["Of these 25\u2005444 were blood; 41\u2005315 breast; 32\u2005626 bowel, 12\u2005808 gastro-oesophageal; 32\u2005187 lung; 4811 oral; 6635 ovarian; 7119 pancreatic; 35\u2005256 prostate; 23\u2005091 renal tract; 6949 uterine cancers.", {"entities": []}], ["The lung cancer algorithm had the best performance with an R We have developed and validated a prediction models to quantify absolute risk of 11 common cancers.", {"entities": [[4, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["They can be used to identify patients at high risk of cancers for prevention or further assessment.", {"entities": []}], ["The algorithms could be integrated into clinical computer systems and used to identify high-risk patients.", {"entities": []}], ["There is a simple web calculator to implement the Qcancer 10 year risk algorithm together with the open source software for download (available at http://qcancer.org/10yr/ ).", {"entities": []}], ["Vaccines including conserved antigens from Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) have the potential to reduce the burden of acute otitis media.", {"entities": [[163, 175, "DISEASE"]]}], ["Little is known about the antibody response to such antigens in young children with recurrent acute otitis media, however, it has been suggested antibody production may be impaired in these children.", {"entities": [[100, 112, "DISEASE"]]}], ["We measured serum IgG levels against 4 pneumococcal (PspA1, PspA 2, CbpA and Ply) and 3 NTHi (P4, P6 and PD) proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent acute otitis media (median 7 episodes, requiring ventilation tube insertion) and 63 healthy age-matched controls, using a newly developed multiplex bead assay.", {"entities": [[216, 228, "DISEASE"]]}], ["Children with a history of recurrent acute otitis media had significantly higher geometric mean serum IgG levels against NTHi proteins P4, P6 and PD compared with healthy controls, whereas there was no difference in antibody levels against pneumococcal protein antigens.", {"entities": [[43, 55, "DISEASE"]]}], ["In both children with and without a history of acute otitis media, antibody levels increased with age and were significantly higher in children colonised with S. pneumoniae or NTHi compared with children that were not colonised.", {"entities": [[53, 65, "DISEASE"]]}], ["Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media.", {"entities": [[90, 102, "DISEASE"]]}], ["The mechanisms in which proteins induce immunity and potential protection requires further investigation but the dogma of impaired antibody responses in children with recurrent acute otitis media should be reconsidered.", {"entities": [[183, 195, "DISEASE"]]}], ["Catastrophic chemical or radiological events can cause thousands of casualties.", {"entities": []}], ["Such disasters require triage procedures to identify the development of health consequences requiring medical intervention.", {"entities": []}], ["Our objective is to analyze recent advancements in biotechnology for triage in mass emergency situations.", {"entities": []}], ["In addition to identifying persons \u201cat risk\u201d of developing health problems, these technologies can aid in securing the unaffected or \u201cworried well\u201d.", {"entities": []}], ["We also highlight the need for public/private partnerships to engage in some of the underpinning sciences, such as patho-physiological mechanisms of chemical and radiological hazards, and for the necessary investment in the development of rapid assessment tools through identification of biochemical, molecular, and genetic biomarkers to predict health effects.", {"entities": []}], ["For chemical agents, biomarkers of neurotoxicity, lung damage, and clinical and epidemiological databases are needed to assess acute and chronic effects of exposures.", {"entities": []}], ["For radiological exposures, development of rapid, sensitive biomarkers using advanced biotechnologies are needed to sort exposed persons at risk of life-threatening effects from persons with long-term risk or no risk.", {"entities": []}], ["The final implementation of rapid and portable diagnostics tools suitable for emergency care providers to guide triage and medical countermeasures use will need public support, since commercial incentives are lacking.", {"entities": []}], ["Exposure of the lungs to airborne toxicants from different sources in the environment may lead to acute and chronic pulmonary or even systemic inflammation.", {"entities": []}], ["Cigarette smoke is the leading cause of chronic obstructive pulmonary disease, although wood smoke in urban areas of underdeveloped countries is now recognized as a leading cause of respiratory disease.", {"entities": [[40, 77, "DISEASE"]]}], ["Mycotoxins from fungal spores pose an occupational risk for respiratory illness and also present a health hazard to those living in damp buildings.", {"entities": []}], ["Microscopic airborne particulates of asbestos and silica (from building materials) and those of heavy metals (from paint) are additional sources of indoor air pollution that contributes to respiratory illness and is known to cause respiratory illness in experimental animals.", {"entities": []}], ["Ricin in aerosolized form is a potential bioweapon that is extremely toxic yet relatively easy to produce.", {"entities": []}], ["Although the aforementioned agents belong to different classes of toxic chemicals, their pathogenicity is similar.", {"entities": []}], ["They induce the recruitment and activation of macrophages, activation of mitogen-activated protein kinases, inhibition of protein synthesis, and production of interleukin-1 beta.", {"entities": []}], ["Targeting either macrophages (using nanoparticles) or the production of interleukin-1 beta (using inhibitors against protein kinases, NOD-like receptor protein-3, or P2X7) may potentially be employed to treat these types of lung inflammation without affecting the natural immune response to bacterial infections.", {"entities": []}], ["Eosinophils reside in the colonic mucosa and increase significantly during disease.", {"entities": []}], ["Although a number of studies have suggested that eosinophils contribute to the pathogenesis of GI inflammation, the expanding scope of eosinophil-mediated activities indicate that they also regulate local immune responses and modulate tissue inflammation.", {"entities": []}], ["We sought to define the impact of eosinophils that respond to acute phases of colitis in mice.", {"entities": []}], ["Acute colitis was induced in mice by administration of dextran sulfate sodium, 2,4,6-trinitrobenzenesulfonic acid or oxazolone to C57BL/6J (control) or eosinophil deficient ( PHIL ) mice.", {"entities": []}], ["Eosinophils were also depleted from mice using antibodies against interleukin (IL)-5 or by grafting bone marrow from PHIL mice into control mice.", {"entities": []}], ["Colon tissues were collected and analysed by immunohistochemistry, flow cytometry and reverse transcription PCR; lipids were analysed by mass spectroscopy.", {"entities": []}], ["Eosinophil-deficient mice developed significantly more severe colitis, and their colon tissues contained a greater number of neutrophils, than controls.", {"entities": []}], ["This compensatory increase in neutrophils was accompanied by increased levels of the chemokines CXCL1 and CXCL2, which attract neutrophils.", {"entities": [[96, 101, "GENE"], [106, 111, "GENE"]]}], ["Lipidomic analyses of colonic tissue from eosinophil-deficient mice identified a deficiency in the docosahexaenoic acid-derived anti-inflammatory mediator 10, 17- dihydroxydocosahexaenoic acid (diHDoHE), namely protectin D1 (PD1).", {"entities": []}], ["Administration of an exogenous PD1-isomer (10S, 17S-DiHDoHE) reduced the severity of colitis in eosinophil-deficient mice.", {"entities": []}], ["The PD1-isomer also attenuated neutrophil infiltration and reduced levels of tumour necrosis factor-\u03b1, IL-1\u03b2, IL-6 and inducible NO-synthase in colons of mice.", {"entities": []}], ["Finally, in vitro assays identified a direct inhibitory effect of PD1-isomer on neutrophil transepithelial migration.", {"entities": []}], ["Eosinophils exert a protective effect in acute mouse colitis, via production of anti-inflammatory lipid mediators.", {"entities": []}], ["Recent findings suggest that the mental health costs of unemployment are related to both short- and long-term mental health scars.", {"entities": []}], ["The main policy tools for dealing with young people at risk of labor market exclusion are Active Labor Market Policy programs for youths (youth programs).", {"entities": []}], ["There has been little research on the potential effects of participation in youth programs on mental health and even less on whether participation in such programs alleviates the long-term mental health scarring caused by unemployment.", {"entities": []}], ["This study compares exposure to open youth unemployment and exposure to youth program participation between ages 18 and 21 in relation to adult internalized mental health immediately after the end of the exposure period at age 21 and two decades later at age 43.", {"entities": []}], ["The study uses a five wave Swedish 27-year prospective cohort study consisting of all graduates from compulsory school in an industrial town in Sweden initiated in 1981.", {"entities": []}], ["Of the original 1083 participants 94.3\u00a0% of those alive were still participating at the 27-year follow up.", {"entities": []}], ["Exposure to open unemployment and youth programs were measured between ages 18\u201321.", {"entities": []}], ["Mental health, indicated through an ordinal level three item composite index of internalized mental health symptoms (IMHS), was measured pre-exposure at age 16 and post exposure at ages 21 and 42.", {"entities": []}], ["Ordinal regressions of internalized mental health at ages 21 and 43 were performed using the Polytomous Universal Model (PLUM).", {"entities": []}], ["Models were controlled for pre-exposure internalized mental health as well as other available confounders.", {"entities": []}], ["Results show strong and significant relationships between exposure to open youth unemployment and IMHS at age 21 (OR\u2009=\u20092.48, CI\u2009=\u20091.57\u20133.60) as well as at age 43 (OR\u2009=\u20091.71, CI\u2009=\u20091.20\u20132.43).", {"entities": []}], ["No such significant relationship is observed for exposure to youth programs at age 21 (OR\u2009=\u20090.95, CI\u2009=\u20090.72\u20131.26) or at age 43 (OR\u2009=\u20091.23, CI\u2009=\u20090.93\u20131.63).", {"entities": []}], ["A considered and consistent active labor market policy directed at youths could potentially reduce the short- and long-term mental health costs of youth unemployment.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2496-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Aim : Children exposed to parental smoking are at increased long-term risk of subclinical atherosclerosis in adulthood.", {"entities": [[90, 105, "DISEASE"]]}], ["However, it has not been quantified if exposure to parental smoking in childhood is associated with adult systemic inflammation.", {"entities": []}], ["This study aimed to determine if childhood exposure to parental smoking was associated with high-sensitivity C-reactive protein (hsCRP) in adulthood.", {"entities": []}], ["Methods : This longitudinal analysis of 2,511 participants used data from the Cardiovascular Risk in Young Finns Study, a prospective cohort of Finnish children.", {"entities": []}], ["In 1980 or 1983, parents self-reported their smoking status and serum hsCRP was collected up to 31 years later in adulthood.", {"entities": []}], ["Results : Compared with children with non-smoking parents, the relative risk of developing high hsCRP (> 3 mg/L) in adulthood increased among those with 1 or both parents who smoked [relative risk (RR), 1.3; 95%confidence interval (CI), 1.0\u20131.8] after adjustment for socioeconomic status, cardiovascular risk factors, and smoking status in childhood and adulthood.", {"entities": []}], ["Moreover, children exposed to mother smoking [RR, 2.4; 95% CI, 1.3\u20134.2] had highest risk of developing high hsCRP in adulthood compared with those exposed to father smoking [RR, 1.6; 95% CI, 1.2\u20132.3] and both parents smoking [RR, 1.4; 95% CI, 0.9\u20132.0].", {"entities": []}], ["Conclusion : Our findings suggest that children exposed to parental smoking are at increased risk of having high hsCRP in adulthood.", {"entities": []}], ["Limiting children's exposure to passive smoking may have long-term benefits on general low-grade inflammation.", {"entities": []}], ["Cold injuries are rare but important causes of hospitalization.", {"entities": []}], ["We aimed to identify the magnitude of cold injury hospitalization, and assess causes, associated factors and treatment routines in a subarctic region.", {"entities": []}], ["In this retrospective analysis of hospital records from the 4 northernmost counties in Sweden, cases from 2000-2007 were identified from the hospital registry by diagnosis codes for accidental hypothermia, frostbite, and cold-water drowning.", {"entities": []}], ["Results were analyzed for pre-hospital site events, clinical events in-hospital, and complications observed with mild (temperature 34.9 - 32\u00b0C), moderate (31.9 - 28\u00b0C) and severe (<28\u00b0C), hypothermia as well as for frostbite and cold-water drowning.", {"entities": []}], ["From the 362 cases, average annual incidences for hypothermia, frostbite, and cold-water drowning were estimated to be 3.4/100 000, 1.5/100 000, and 0.8/100 000 inhabitants, respectively.", {"entities": []}], ["Annual frequencies for hypothermia hospitalizations increased by approximately 3 cases/year during the study period.", {"entities": []}], ["Twenty percent of the hypothermia cases were mild, 40% moderate, and 24% severe.", {"entities": []}], ["For 12%, the lowest documented core temperature was 35\u00b0C or higher, for 4% there was no temperature documented.", {"entities": []}], ["Body core temperature was seldom measured in pre-hospital locations.", {"entities": []}], ["Of 362 cold injury admissions, 17 (5%) died in hospital related to their injuries.", {"entities": []}], ["Associated co-factors and co-morbidities included ethanol consumption, dementia, and psychiatric diagnosis.", {"entities": [[71, 79, "DISEASE"]]}], ["The incidence of accidental hypothermia seems to be increasing in this studied sub-arctic region.", {"entities": []}], ["Likely associated factors are recognized (ethanol intake, dementia, and psychiatric diagnosis).", {"entities": [[58, 66, "DISEASE"]]}], ["Australia, like most countries, faces high and rapidly-rising drug costs.", {"entities": []}], ["There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by \u201cevergreening\u201d blockbuster drugs, through misuse of the patent system.", {"entities": []}], ["There is, however, very little empirical information about this behaviour.", {"entities": []}], ["We fill the gap by analysing all of the patents associated with 15 of the costliest drugs in Australia over the last 20 years.", {"entities": []}], ["Specifically, we search the patent register to identify all the granted patents that cover the active pharmaceutical ingredient of the high-cost drugs.", {"entities": []}], ["Then, we classify the patents by type, and identify their owners.", {"entities": []}], ["We find a mean of 49 patents associated with each drug.", {"entities": []}], ["Three-quarters of these patents are owned by companies other than the drug's originator.", {"entities": []}], ["Surprisingly, the majority of all patents are owned by companies that do not have a record of developing top-selling drugs.", {"entities": []}], ["Our findings show that a multitude of players seek monopoly control over innovations to blockbuster drugs.", {"entities": []}], ["Consequently, attempts to control drug costs by mitigating misuse of the patent system are likely to miss the mark if they focus only on the patenting activities of originators.", {"entities": []}], ["Measures from the Social Context Module of the Centers for Disease Control and Prevention\u2019s Behavioral Risk Factor Surveillance System were used on 2 population-based health surveys in Hawaii to explicate the role of the nonmedical and social determinants of health; these measures were also compared with conventional socioeconomic status (SES) variables.", {"entities": []}], ["Results showed that the self-reported SES vulnerabilities of food and housing insecurity are both linked to demographic factors and physical and mental health status and significant when controlling for the conventional measures of SES.", {"entities": []}], ["The social context module indicators should be increasingly used so results can inform appropriate interventions for vulnerable populations.", {"entities": []}], ["Association testing is a powerful tool for identifying disease susceptibility genes underlying complex diseases.", {"entities": []}], ["Technological advances have yielded a dramatic increase in the density of available genetic markers, necessitating an increase in the number of association tests required for the analysis of disease susceptibility genes.", {"entities": []}], ["As such, multiple-tests corrections have become a critical issue.", {"entities": []}], ["However the conventional statistical corrections on locus-specific multiple tests usually result in lower power as the number of markers increases.", {"entities": []}], ["Alternatively, we propose here the application of the longest significant run ( LSR ) method to estimate a region-specific p-value to provide an index for the most likely candidate region.", {"entities": [[80, 83, "GENE"]]}], ["An advantage of the LSR method relative to procedures based on genotypic data is that only p-value data are needed and hence can be applied extensively to different study designs.", {"entities": [[20, 23, "GENE"]]}], ["In this study the proposed LSR method was compared with commonly used methods such as Bonferroni's method and FDR controlling method.", {"entities": [[27, 30, "GENE"]]}], ["We found that while all methods provide good control over false positive rate, LSR has much better power and false discovery rate.", {"entities": [[79, 82, "GENE"]]}], ["In the authentic analysis on psoriasis and asthma disease data, the LSR method successfully identified important candidate regions and replicated the results of previous association studies.", {"entities": [[29, 38, "DISEASE"], [43, 49, "DISEASE"], [68, 71, "GENE"]]}], ["The proposed LSR method provides an efficient exploratory tool for the analysis of sequences of dense genetic markers.", {"entities": [[13, 16, "GENE"]]}], ["Our results show that the LSR method has better power and lower false discovery rate comparing with the locus-specific multiple tests.", {"entities": [[26, 29, "GENE"]]}], ["Robotic assisted surgery (RAS) represents a great challenge for anesthesiology due to the increased intraabdomial pressures required for surgical optimal approach.", {"entities": []}], ["The changes in lung physiology are difficult to predict and require fast decision making in order to prevent altered gas exchange.", {"entities": []}], ["The aim of this study was to document the combined effect of patient physical status, medical history and intraoperative position during RAS on lung physiology and to determine perioperative risk factors for hypercapnia.", {"entities": []}], ["We prospectively analyzed 62 patients who underwent elective RAS.", {"entities": []}], ["Age, co-morbidities and body mass index (BMI) were recorded before surgery.", {"entities": []}], ["Ventilatory parameters and arterial blood gas analysis were determined before induction of anesthesia, after tracheal intubation and on an hourly basis until the end of surgery.", {"entities": []}], ["In RAS, the induction of pneumoperitoneum was associated with a significant decrease in lung compliance from a mean of 42.5\u201326.7\u00a0ml\u00a0cm H 2 O p \u00a0=\u00a00.001) and an increase in plateau pressure from a mean of 16.1\u00a0mmHg to a mean of 23.6\u00a0mmHg ( p \u00a0=\u00a00.001).", {"entities": []}], ["Obesity, demonstrated by a BMI over 30, significantly correlates with a decrease in lung compliance after induction of anesthesia ( p \u00a0=\u00a00.001).", {"entities": [[0, 7, "DISEASE"]]}], ["A significant higher increase in arterial CO 2 tension was registered in patients undergoing RAS in steep Trendelenburg position ( p \u00a0=\u00a00.05), but no significant changes in end-tidal CO 2 were recorded.", {"entities": []}], ["A higher arterial to end-tidal CO 2 tension gradient was observed in patients with a BMI\u00a0>\u00a030 ( p \u00a0<\u00a00.001).", {"entities": []}], ["In conclusion, patients\u2019 physical status, especially obesity, represents the main risk factor for decreased lung compliance during RAS and patient positioning in either Trendelenburg or steep Trendelenburg during surgery has limited effects on respiratory physiology.", {"entities": [[53, 60, "DISEASE"]]}], ["Interleukin (IL)\u201017F plays a critical role in the pathophysiology of asthma.", {"entities": [[69, 75, "DISEASE"]]}], ["However, the precise role of IL\u201017F in airway smooth muscle cells (ASMCs) and its regulatory mechanisms remain to be defined.", {"entities": []}], ["Therefore, we sought to investigate the expression of IL\u20106 by IL\u201017F and the involvement of transforming growth factor \u03b2\u2010activated kinase 1 (TAK1) and nuclear factor (NF)\u2010\u03baB by in ASMCs.", {"entities": []}], ["ASMCs were cultured in the presence or absence of IL\u201017F.", {"entities": []}], ["The expression of IL\u20106 gene and protein was analyzed using real\u2010time PCR and ELISA, and the activation of TAK1 and NF\u2010\u03baB was detected by Western blotting.", {"entities": []}], ["The effect of TAK1 inhibitor 5Z\u20107\u2010oxozeaenol and NF\u2010\u03baB inhibitor BAY 11\u20107082 on the expression of IL\u20106 was investigated.", {"entities": []}], ["Finally, the short interfering RNAs (siRNAs) targeting TAK1 and a subunit of NF\u2010\u03baB, p65 were transfected into ASMCs.", {"entities": []}], ["The expression of IL\u20106 gene and protein was significantly induced by IL\u201017F.", {"entities": []}], ["IL\u201017F activated TAK1 and NF\u2010\u03baB in ASMCs.", {"entities": []}], ["Transfection of siRNAs targeting TAK1 abolished IL\u201017F\u2010induced phosphorylation of p65.", {"entities": []}], ["Both 5Z\u20107\u2010oxozeaenol and BAY 11\u20107082 significantly inhibited IL\u201017F\u2010induced IL\u20106 production in a dose\u2010dependent manner.", {"entities": []}], ["Similarly, transfection of the cells with siRNAs targeting TAK1 and p65 inhibited the expression of IL\u20106.", {"entities": []}], ["Collectively, these results provided evidence supporting the potential importance of the Th17\u2010ASMCs crosstalk via the IL\u201017F\u2010IL\u20106 axis in airway inflammation and as a candidate pharmacological target for airway inflammatory diseases such as asthma.", {"entities": [[241, 247, "DISEASE"]]}], ["To assess the health service utilisation of internal migrant children in Guangdong, China, and to explore the association between children\u2019s health service utilisation and their parents\u2019 acculturation.", {"entities": []}], ["Cross-sectional survey between April and May 2016.", {"entities": []}], ["Six society-run schools of Tianhe and Baiyun districts in Guangzhou City of China.", {"entities": []}], ["We recruited all students at grade 7 or 8 and one of their parents who resided in Guangzhou over 6\u2009months without permanent registered residence ( hukou ) in Guangzhou (1161 pairs completed this survey).", {"entities": []}], ["258 children were ill within the past 2\u2009weeks or during the last year.", {"entities": []}], ["The main outcome was self-reported health service utilisation.", {"entities": []}], ["Logistic regression analysis was conducted to explore the association between children\u2019s unmet needs for outpatient or inpatient service and their parents\u2019 acculturation (categorised into high, middle and low groups).", {"entities": []}], ["In total, 216 children, or 18.6% of the total subjects, were ill within the past 2\u2009weeks and were in need of outpatient service; 94 children, or 8.1% of the total subjects, were in need of inpatient service.", {"entities": []}], ["Among them, 17.6% and 46.8% of the migrant children had unmet needs for outpatient and inpatient services, respectively.", {"entities": []}], ["After controlling for enabling resources and predisposing characteristics, migrant children with parents in the middle-acculturation group (adjusted OR=3.17, 95% CIs 1.2 to 8.3, P<0.05) were more likely to have an unmet outpatient need than high-acculturation or low-acculturation groups, although only statistically significant when comparing with the high-acculturation group.", {"entities": []}], ["Stratified analysis suggested that this association could be moderated by their family economic status.", {"entities": []}], ["Our study suggested that the association between migrant children\u2019s health service utilisation and their parents\u2019 acculturation was complex and could be moderated by family economic status.", {"entities": []}], ["Increasing the service utilisation among migrant children requires improving the acculturation and economic status of the parents of internal migrants.", {"entities": []}], ["Unlike other vitamins, the vitamin D concentration in blood varies cyclically over the course of the year in relation to genetic (gender, ethnicity, polymorphisms) and environmental factors (sunlight exposure, diet, food-related or direct vitamin D supplementation, skin pigmentation).", {"entities": []}], ["Although the major diagnostics manufacturers have recently developed improved automated 25-hydroxy vitamin D immunoassays, the intra- and inter-laboratory variability is still high (especially at low vitamin D concentrations) which might lead to incorrect vitamin D deficiency/insufficiency diagnosis.", {"entities": []}], ["Moreover, despite recent efforts to standardize the assay and minimize its variability, the current bias for measured vitamin D concentrations is often still above the desirable \u00b1 10% criterion.", {"entities": []}], ["Because the implications of low vitamin D concentrations in non-skeletal diseases are still partially unknown, international guideline recommendations for establishing meaningful ranges, at any time over the course of the year, irrespective not only of environmental and personal factors but also of instrumental variability, are needed.", {"entities": []}], ["In this review, we discuss the main factors that influence the variability of vitamin D concentrations and whether a centile curve, individually calculated by a theoretical equation considering such factors, might be better suited than a fixed limit to assess abnormal vitamin D concentrations in otherwise healthy subjects.", {"entities": []}], ["Vitamin D reference ranges during pregnancy, childhood, or diagnosed illnesses, which merit separate discussion, are beyond the scope of this review.", {"entities": []}], ["The present study examined the clinico-pathological profile of sinonasal masses in patients attending an Ear Nose Throat clinic of a rural tertiary care hospital of western Maharashtra in India, between May 2007 to June 2009.", {"entities": []}], ["During the study period, 112 patients presented with sinonasal masses (male 68, female 44; age group 8-70 years).", {"entities": []}], ["Nasal polyploid masses were non-neoplastic in 80 (71.4%) subjects, and neoplastic in 32 (28.6%) cases.", {"entities": []}], ["Nasal obstruction was the most common (97.3%) presenting complaint, followed by rhinorrhoea (49.1%), hyposmia (31.25%), intermittent epistaxis (17.9%), headache (16.9%), facial swelling (11.6%) and eye-related symptoms (10.7%).", {"entities": []}], ["The most common site of origin of polyploid masses was the middle meatus (54.4%) followed by the lateral wall of the nasal cavity (16.1%) and superior meatus (10.7%).", {"entities": []}], ["Unilateral nasal masses was present in 47.7% patients, while the remaining patients had bilateral nasal masses.", {"entities": []}], ["Allergic (62.5%) and inflammatory (25%) polyps were the most common non-neoplastic mass.", {"entities": []}], ["Haemangioma (47.3%) and inverted papilloma (36.8%) were most common benign neoplastic mass; 92.3% of all malignant masses were squamous cell carcinoma.", {"entities": [[141, 150, "DISEASE"], [24, 42, "DISEASE"], [127, 150, "DISEASE"], [33, 42, "DISEASE"]]}], ["Surgery was the major mode of treatment.", {"entities": []}], ["It included Caldwell-Luc operation (7.1%), polypectomy (17.8%), excision of mass (25.0%) and functional endoscopic sinus surgery (44.6%).", {"entities": []}], ["Malignancies were treated with radiotherapy.", {"entities": []}], ["Endotoxin tolerance improves outcomes from gram negative sepsis but the underlying mechanism is not known.", {"entities": []}], ["We determined if endotoxin tolerance before or after pneumococcal sepsis improved survival and the role of lymphocytes in this protection.", {"entities": []}], ["Mice received lipopolysaccharide (LPS) or vehicle before or after a lethal dose of Streptococcus pneumonia e. Survival, quantitative bacteriology, liver function, and cytokine concentrations were measured.", {"entities": [[97, 106, "DISEASE"]]}], ["We confirmed the necessity of Toll-like receptor 4 (TLR4) for endotoxin tolerance using C3H/HeN (TLR4 replete) and C3H/HeJ (TLR4 deficient) mice.", {"entities": [[52, 56, "GENE"], [97, 101, "GENE"], [124, 128, "GENE"], [52, 56, "GENE"], [97, 101, "GENE"], [124, 128, "GENE"], [52, 56, "GENE"], [97, 101, "GENE"], [124, 128, "GENE"]]}], ["The role of complement was investigated through A/J mice deficient in C5 complement.", {"entities": [[70, 72, "GENE"]]}], ["CBA/CaHN-Btk Endotoxin tolerance improved survival from pneumococcal sepsis in mice with TLR4 that received LPS pretreatment or posttreatment.", {"entities": [[89, 93, "GENE"]]}], ["Survival was associated with reduced bacterial burden and serum cytokine concentrations.", {"entities": []}], ["Death was associated with abnormal liver function and blood glucose concentrations.", {"entities": []}], ["Endotoxin tolerance improved survival in A/J and CBA/CaHN-Btk TLR4 stimulation before or after S. pneumoniae infection improved survival and was dependent on T-cells but did not require an intact complement cascade or functional B cells.", {"entities": [[62, 66, "GENE"]]}], ["The present study was designed to investigate the antibacterial activities of the methanol extracts of four Cameroonian edible plants, locally used to treat microbial infections, and their synergistic effects with antibiotics against a panel of twenty nine Gram-negative bacteria including Multi-drug resistant (MDR) phenotypes expressing active efflux pumps.", {"entities": []}], ["The broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of the extracts [alone and in the presence of the efflux pumps inhibitor (EPI) Phenylalanine-Arginine \u03b2- Naphtylamide (PA\u03b2N)], and those of antibiotics in association with the two of the most active ones, Piper nigrum and Telfairia occidentalis .", {"entities": []}], ["The preliminary phytochemical screening of the extracts was conducted according to the standard phytochemical methods.", {"entities": []}], ["Phytochemical analysis showed the presence of alkaloids and flavonoids in all studied extracts.", {"entities": []}], ["Other chemical classes of secondary metabolites were selectively present in the extracts.", {"entities": []}], ["The results of the MIC determination indicated that the crude extracts from P. nigrum and V. amygdalina were able to inhibit the growth of all the twenty nine studied bacteria within a concentration range of 32 to 1024 \u03bcg/mL.", {"entities": []}], ["At a similar concentration range (32 to 1024 \u03bcg/mL) the extract from T. occidentalis inhibited the growth of 93.1% of the tested microorganisms.", {"entities": []}], ["At MIC/2 and MIC/5, synergistic effects were noted between the extracts from P. nigrum and T. occidentalis and seven of the tested antibiotics on more than 70% of the tested bacteria.", {"entities": []}], ["The overall results of the present study provide information for the possible use of the studied edible plants extracts in the control of bacterial infections including MDR phenotypes.", {"entities": []}], ["A 23 year old white male with a history of social and behavioural problems attempted to blind himself chemically, with alcohol, and mechanically, with a razor blade.", {"entities": []}], ["Observational case report of a patient who self-inflicted bilateral scleral lacerations with a razor blade, after losing his job.", {"entities": []}], ["The patient sustained bilateral inferior scleral perforations, with hypotony and a right traumatic cataract.", {"entities": [[99, 107, "DISEASE"]]}], ["He received urgent surgical repair, and prophylactic antibiotics.", {"entities": []}], ["There were no retinal breaks or detachments.", {"entities": []}], ["He later underwent successful cataract surgery to the right eye.", {"entities": [[30, 38, "DISEASE"]]}], ["Self-inflicted ocular injury may be possible in non-psychotic patients, as a situational response to a life event.", {"entities": []}], ["Urgent repair can completely restore vision in some cases.", {"entities": []}], ["Referral for psychiatric counseling is mandatory.", {"entities": []}], ["Osteoarthritis (OA) is one of the most common joint diseases in elderly people, however, the underlying mechanism of OA pathogenesis is not completely clear.", {"entities": []}], ["Periostin, the extracellular protein, has been shown by cDNA array analysis to be highly expressed in OA, but its function is not fully understood.", {"entities": []}], ["The purpose of this study was to examine the expression and function of periostin in human OA.", {"entities": []}], ["Human cartilage and synovia samples were used for the analysis of periostin expression and function.", {"entities": []}], ["The human cartilage samples were obtained from the knees of patients undergoing total knee arthroplasty as OA samples and from the femoral bone head of patients with femoral neck fracture as control samples.", {"entities": []}], ["Quantitative RT-PCR, ELISA, and immunohistochemistry were used for analysis of periostin expression in cartilage and synovia.", {"entities": []}], ["Human primary chondrocytes isolated from control cartilage were stimulated by periostin, and the alteration of OA related gene expression was examined using quantitative RT-PCR.", {"entities": []}], ["Immunocytochemistry of p65 was performed for the analysis of nuclear factor kappa B (NF\u03baB) activation.", {"entities": []}], ["The periostin mRNA was significantly higher in OA cartilage than in control cartilage.", {"entities": []}], ["Immunohistochemical analysis of periostin showed that the main positive signal was localized in chondrocytes and their periphery matrix near the erosive area, with less immunoreactivity in deeper zones.", {"entities": []}], ["There was positive correlation between Mankin score and periostin immunoreactivity.", {"entities": []}], ["The periostin expression was also detected in the fibrotic cartilage and tissue of subchondral bone.", {"entities": []}], ["In cultured human chondrocytes, periostin induced the expression of interleukin (IL)-6, IL-8, matrix metalloproteinase (MMP)-1, MMP-3, MMP-13, and nitric oxide synthase-2 (NOS2) in a dose- and time-dependent manner.", {"entities": [[172, 176, "GENE"]]}], ["The activation of NF\u03baB signaling was recognized by the nuclear translocation of p65.", {"entities": []}], ["Periostin-induced upregulation of these genes was suppressed by NF\u03baB inactivation in chondrocytes.", {"entities": []}], ["Periostin was upregulated in OA cartilage, and it may amplify inflammatory events and accelerate OA pathology.", {"entities": []}], ["The online version of this article (doi:10.1186/s12891-015-0682-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Potassium channels play a fundamental role in resetting the resting membrane potential of excitable cells.", {"entities": []}], ["Determining the intracellular trafficking and localization mechanisms of potassium channels provides a platform to fully characterize their maturation and functionality.", {"entities": []}], ["Previous investigations have discovered residues or motifs that exist in their primary structure, which directly promote anterograde trafficking of nascent potassium channels.", {"entities": []}], ["Recently, a non-conical di-acidic motif (E483/484) has been discovered in the C-terminus of the mammalian homologue of the Shaker voltage-gated potassium channel subfamily member 3 (Kv1.3), and was shown to disrupt the anterograde trafficking of Kv1.3.", {"entities": []}], ["We have further investigated the intracellular trafficking requirements of Kv1.3 both in vivo and in vitro .", {"entities": []}], ["First, three alternative C-terminal acidic residues, E443, E445, E447 were probed for their involvement within the early secretory pathway of Kv1.3.", {"entities": []}], ["Single point (E443A, E445A, and E447A) and double point (E443A-E445A, E445A-E447A) mutations exhibited no significant changes in their endoplasmic reticulum (ER) retention.", {"entities": []}], ["The triple point mutant E443A-E445A-E447A displayed a modest ER retention while deletion of the C-terminus showed dramatic ER retention.", {"entities": []}], ["Second, we demonstrate in vivo the requirement for the Sec24a isoform to confer anterograde trafficking using a siRNA knockdown assay.", {"entities": [[55, 61, "GENE"]]}], ["Third, we show in vitro the association of recombinantly expressed Kv1.3 and Sec24a proteins.", {"entities": [[77, 83, "GENE"]]}], ["These results expand upon previous studies aimed at deciphering the Kv1.3 secretory trafficking mechanisms and further show in vitro evidence of the association between Kv1.3 and the COPII cargo adaptor subunit isoform Sec24a.", {"entities": [[219, 225, "GENE"]]}], ["The online version of this article (doi:10.1186/s12858-015-0045-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Occupational asthma is a common type of asthma caused by a specific agent in the workplace.", {"entities": [[13, 19, "DISEASE"], [40, 46, "DISEASE"]]}], ["The basic alteration of occupational asthma is airways inflammation.", {"entities": [[37, 43, "DISEASE"]]}], ["Although most patients with occupational asthma are mature adults, there is evidence that airways inflammation starts soon after inception of exposure, including during apprenticeship.", {"entities": [[41, 47, "DISEASE"]]}], ["Airways hyper responsiveness to methacholine is a valid surrogate marker of airways inflammation, which has proved useful in occupational epidemiology.", {"entities": []}], ["But it is time-consuming, requires active subject's cooperation and is not readily feasible.", {"entities": []}], ["Other non-invasive and potentially more useful tests include the forced oscillation technique, measurement of fraction exhaled nitric oxide, and eosinophils count in nasal lavage fluid.", {"entities": []}], ["This study aims to investigate early development of airways inflammation and asthma-like symptoms in apprentice bakers, pastry-makers and hairdressers, three populations at risk of occupational asthma whose work-related exposures involve agents of different nature.", {"entities": [[77, 83, "DISEASE"], [194, 200, "DISEASE"]]}], ["The objectives are to (i) examine the performance of the non-invasive tests cited above in detecting early airways inflammation that might eventually develop into occupational asthma; and (ii) evaluate whether, and how, constitutional (e.g.", {"entities": [[176, 182, "DISEASE"]]}], ["atopy) and behavioural (e.g.", {"entities": []}], ["smoking) risk factors for occupational asthma modulate the effects of allergenic and/or irritative substances involved in these occupations.", {"entities": [[39, 45, "DISEASE"]]}], ["This paper presents the study rationale and detailed protocol.", {"entities": []}], ["Among 441 volunteers included at the first visit, 354 attended the fourth one.", {"entities": []}], ["Drop outs were investigated and showed unrelated to the study outcome.", {"entities": []}], ["Sample size and follow-up participation rates suggest that the data collected in this study will allow it to meet its objectives.", {"entities": []}], ["Lipoxin A 4 has been described as a major signal for the resolution of inflammation and is abnormally produced in the lungs of patients with cystic fibrosis (CF).", {"entities": [[141, 156, "DISEASE"]]}], ["In CF, the loss of chloride transport caused by the mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) Cl 4 to restore airway surface hydration, to stimulate airway epithelial repair, and to antagonise the proinflammatory program of the CF airway, circumventing some of the most difficult aspects of CF pathophysiology.", {"entities": [[68, 83, "DISEASE"], [121, 125, "GENE"]]}], ["The report points out novel aspects of the cellular mechanism involved in the physiological response to LXA 4 , including release of ATP from airway epithelial cell via pannexin channel and subsequent activation of and P2Y11 purinoreceptor.", {"entities": []}], ["Therefore, inadequate endogenous LXA 4 biosynthesis reported in CF exacerbates the ion transport abnormality and defective mucociliary clearance, in addition to impairing the resolution of inflammation, thus amplifying the vicious circle of airway dehydration, chronic infection, and inflammation.", {"entities": []}], ["Rtp801 , a stress \u2013 related protein triggered by adverse environmental conditions, inhibits mTOR and enhances oxidative stress \u2013 dependent cell death.", {"entities": [[92, 96, "GENE"]]}], ["We postulated that Rtp801 acts as potential amplifying switch in the development of cigarette smoke \u2013 induced lung injury, leading to emphysema.", {"entities": []}], ["Rtp801 was overexpressed in human emphysematous lungs and in lungs of mice exposed to cigarette smoke.", {"entities": []}], ["The upregulation of Rtp801 expression by cigarette smoke in the lung relied on oxidative stress \u2013 dependent activation of the CCAAT response element.", {"entities": []}], ["Rtp801 was necessary and sufficient for NF \u2013 \u03ba B activation in cultured cells and, when forcefully expressed in mouse lungs, it promoted NF \u2013 kB activation, alveolar inflammation, oxidative stress, and apoptosis of alveolar septal cells.", {"entities": []}], ["On the other hand, Rtp801 mice were markedly protected against acute cigarette smoke \u2013 induced lung injury, partly via increased mTOR signaling, and, when exposed chronically, against emphysema.", {"entities": [[129, 133, "GENE"]]}], ["Our data support the notion that Rtp801 may represent an important molecular sensor and mediator of lung injury to cigarette smoke.", {"entities": []}], ["Interstitial lung disease is a serious drug\u2010related condition that can cause life threatening organ failure.", {"entities": [[0, 25, "DISEASE"], [13, 25, "DISEASE"]]}], ["The incidence and risk factors of drug\u2010induced interstitial lung disease ( DILD ) are unknown in oncology phase\u00a0I trials.", {"entities": [[47, 72, "DISEASE"], [60, 72, "DISEASE"]]}], ["This study analyzed clinical information from 8906 patients with malignancies who were enrolled in 470 phase\u00a0I trials sponsored by the Cancer Therapy Evaluation Program, National Cancer Institute, from 1988 to 2014.", {"entities": []}], ["Logistic and Cox statistical analyses were utilized to determine clinical differences between patients who developed DILD and patients who did not.", {"entities": []}], ["In this study, the overall incidence rate of patients with pulmonary toxicity was 2.7%.", {"entities": []}], ["The overall incidence rate for DILD was 0.77%, whereas for grade\u00a03 or 4 DILD it was 0.31%.", {"entities": []}], ["Median time to occurrence of DILD was 1.4\u00a0months.", {"entities": []}], ["The Cox hazard analysis indicated smaller body surface area and a combination of thoracic radiation with investigational drug regimens were significant risk factors for time to occurrence of interstitial lung disease.", {"entities": [[191, 216, "DISEASE"], [204, 216, "DISEASE"]]}], ["Investigators should carefully monitor for DILD in oncology patients enrolled in phase\u00a0I trials with identified risk factors.", {"entities": []}], ["A 6\u2010month observation period would be sufficient to detect the onset of most DILD in such patients.", {"entities": []}], ["The objective of this study was to describe the prevalence of pairwise combinations of 17 long-term conditions.", {"entities": []}], ["Data were obtained from a national, representative population-based study including 162,283 Danish citizens aged 16 years or older.", {"entities": []}], ["We calculated the prevalence of each long-term condition given the presence of another long-term condition.", {"entities": []}], ["Compared with the general population, people with angina pectoris had more than twice the odds of having 12 of the 16 other long-term conditions, and inversely, people with cancer, tinnitus, or cataracts did not have notably higher odds for any of the other long-term conditions.", {"entities": [[173, 179, "DISEASE"]]}], ["The National Institute for Health and Care Excellence (NICE) recommends that GPs use routinely available data to identify patients most at risk of death and ill health from living in cold homes.", {"entities": []}], ["To investigate whether sociodemographic characteristics, clinical factors, and house energy efficiency characteristics could predict cold-related mortality.", {"entities": []}], ["A case-crossover analysis was conducted on 34 777 patients aged \u226565 years from the Clinical Practice Research Datalink who died between April 2012 and March 2014.", {"entities": []}], ["The average temperature of date of death and 3 days previously were calculated from Met Office data.", {"entities": []}], ["The average 3-day temperature for the 28th day before/after date of death were calculated, and comparisons were made between these temperatures and those experienced around the date of death.", {"entities": []}], ["Conditional logistic regression was applied to estimate the odds ratio (OR) of death associated with temperature and interactions between temperature and sociodemographic characteristics, clinical factors, and house energy efficiency characteristics, expressed as relative odds ratios (RORs).", {"entities": []}], ["Lower 3-day temperature was associated with higher risk of death (OR 1.011 per 1\u00b0C fall; 95% CI = 1.007 to 1.015; P <0.001).", {"entities": []}], ["No modifying effects were observed for sociodemographic characteristics, clinical factors, and house energy efficiency characteristics.", {"entities": []}], ["Analysis of winter deaths for causes typically associated with excess winter mortality ( N = 7710) showed some evidence of a weaker effect of lower 3-day temperature for females (ROR 0.980 per 1\u00b0C, 95% CI = 0.959 to 1.002, P = 0.082), and a stronger effect for patients living in northern England (ROR 1.040 per 1\u00b0C, 95% CI = 1.013 to 1.066, P = 0.002).", {"entities": []}], ["It is unlikely that GPs can identify older patients at highest risk of cold-related death using routinely available data, and NICE may need to refine its guidance.", {"entities": []}], ["Given the costly and time consuming process and high attrition rates in drug discovery and development, drug repositioning or drug repurposing is considered as a viable strategy both to replenish the drying out drug pipelines and to surmount the innovation gap.", {"entities": []}], ["Although there is a growing recognition that mechanistic relationships from molecular to systems level should be integrated into drug discovery paradigms, relatively few studies have integrated information about heterogeneous networks into computational drug-repositioning candidate discovery platforms.", {"entities": []}], ["Using known disease-gene and drug-target relationships from the KEGG database, we built a weighted disease and drug heterogeneous network.", {"entities": []}], ["The nodes represent drugs or diseases while the edges represent shared gene, biological process, pathway, phenotype or a combination of these features.", {"entities": []}], ["We clustered this weighted network to identify modules and then assembled all possible drug-disease pairs (putative drug repositioning candidates) from these modules.", {"entities": []}], ["We validated our predictions by testing their robustness and evaluated them by their overlap with drug indications that were either reported in published literature or investigated in clinical trials.", {"entities": []}], ["Previous computational approaches for drug repositioning focused either on drug-drug and disease-disease similarity approaches whereas we have taken a more holistic approach by considering drug-disease relationships also.", {"entities": []}], ["Further, we considered not only gene but also other features to build the disease drug networks.", {"entities": []}], ["Despite the relative simplicity of our approach, based on the robustness analyses and the overlap of some of our predictions with drug indications that are under investigation, we believe our approach could complement the current computational approaches for drug repositioning candidate discovery.", {"entities": []}], ["Patients with peripheral artery disease (PAD) experience significant morbidity and mortality.", {"entities": []}], ["The OMEGA-PAD I Trial, a randomized, double-blinded, placebo-controlled trial, addressed the hypothesis that short-duration, high-dose n-3 polyunsaturated fatty acids (n-3 PUFA) oral supplementation improves endothelial function and inflammation in PAD.", {"entities": []}], ["Eighty patients with stable claudication received 4.4\u00a0g of fish oil or placebo for 1\u00a0month.", {"entities": []}], ["The primary end point was endothelial function as measured by brachial artery flow-mediated vasodilation.", {"entities": []}], ["Secondary end points included biomarkers of inflammation, n-3 polyunsaturated fatty acids metabolome changes, lipid profile, and walking impairment questionnaires.", {"entities": []}], ["Although there was a significant increase in FMD in the fish oil group following treatment (0.7\u00b11.8% increase from baseline, P =0.04), this response was not different then the placebo group (0.6\u00b12.5% increase from baseline, P =0.18; between-group P =0.86) leading to a negative finding for the primary endpoint.", {"entities": []}], ["There was, however, a significant reduction in triglycerides (fish oil: \u221234\u00b146\u00a0mg/dL, P <0.001; placebo \u221210\u00b143\u00a0mg/dL, P =0.20; between-group differential P -value: 0.02), and an increase in the omega-3 index of 4\u00b11% ( P <0.001) in the fish oil group (placebo 0.1\u00b10.9%, P =0.49; between-group P <0.0001).", {"entities": []}], ["We observed a significant increase in the production of pathway markers of specialized pro-resolving mediators generated from n-3 polyunsaturated fatty acids in the fish oil group.", {"entities": []}], ["High-dose, short-duration fish oil supplementation did not lead to a different response in the primary end point of endothelial function between the treatment and placebo group, but improved serum triglycerides and increased the production of downstream n-3 polyunsaturated fatty acids\u2013derived products and mediators in patients with PAD.", {"entities": []}], ["URL: https://www.clinicaltrials.gov/.", {"entities": []}], ["Unique identifier: NCT01310270.", {"entities": []}], ["Human metapneumovirus (HMPV) is a newly discovered pathogen thought to be associated with respiratory disease.", {"entities": []}], ["We report the results of a study of 587 children hospitalized with respiratory infection over a 13-month period.", {"entities": []}], ["HMPV was detected in the nasopharyngeal aspirates from 32 (5.5%) children by reverse transcription-polymerase chain reaction.", {"entities": []}], ["HMPV infection was associated with clinical diagnoses of pneumonia (36%), asthma exacerbation (23%), or acute bronchiolitis (10%).", {"entities": [[57, 66, "DISEASE"], [74, 80, "DISEASE"], [110, 123, "DISEASE"]]}], ["When compared to those with respiratory syncytial virus infection, children with HMPV infection were older, and wheezing was more likely to represent asthma exacerbation rather than acute bronchiolitis.", {"entities": [[150, 156, "DISEASE"], [188, 201, "DISEASE"]]}], ["HMPV viral activity peaked during the spring-summer period in Hong Kong.", {"entities": []}], ["Phylogenetically, all HMPV virus strains from Hong Kong belonged to one of the two genetic lineages previously described.", {"entities": []}], ["HMPV contributed to 441.6 hospital admissions per 100,000 population < 6 years of age.", {"entities": []}], ["Many people with epilepsy (PWE) in resource\u2010poor countries do not receive appropriate treatment, a phenomenon referred to as the epilepsy treatment gap (ETG).", {"entities": []}], ["We conducted a qualitative study to explore the reasons for this gap and to identify possible interventions in Kilifi, Kenya.", {"entities": []}], ["Focus group discussions (FGDs) were carried out of PWE and their caregivers.", {"entities": []}], ["Individual interviews were conducted of PWE, their caregivers, traditional healers, community health workers and leaders, nurses and doctors.", {"entities": []}], ["In addition, a series of workshops was conducted, and four factors contributing to the ETG were identified: 1) lack of knowledge about the causes, treatment and prognosis of epilepsy; 2) inaccessibility to antiepileptic drugs; 3) misconceptions about epilepsy derived from superstitions about its origin; 4) and dissatisfaction with the communication skills of health providers.", {"entities": []}], ["These data indicated possible interventions: 1) education and support for PWE and their caregivers; 2) communication skills training for health providers; 3) and improved drug provision.", {"entities": []}], ["\u25ba Many with epilepsy do not receive appropriate treatment; epilepsy treatment gap (ETG).", {"entities": []}], ["\u25ba Qualitative study exploring reasons for ETG and identifying viable interventions in Kenya.", {"entities": []}], ["\u25ba ETG can be addressed through development of multifaceted interventions.", {"entities": []}], ["To explore access to primary healthcare and drug therapy by refugee children in the East Midlands region of England.", {"entities": []}], ["Interviews with refugees with children and a control group of British parents with children.", {"entities": []}], ["East Midlands region of England.", {"entities": []}], ["50 refugees with children and a control group of 50 parents with children.", {"entities": []}], ["Number of medicines used by children in the last month and the past 6\u2005months.", {"entities": []}], ["Health of parents and children.", {"entities": []}], ["Registration with a general practitioner (GP).", {"entities": []}], ["All families in both groups were registered with a GP.", {"entities": []}], ["There was no difference in the number of children in the two groups experiencing illnesses .In the last month, 30 refugee children received 60 medicines and 31 control children 63 medicines.", {"entities": []}], ["In the past 6\u2005months, 48 refugee children received 108 medicines and 43 control children 96 medicines.", {"entities": []}], ["There was no difference between the two groups of children in relation to the likelihood of receiving any medicines in either the last month (P=0.839) or the past 6\u2005months (p=0.81).", {"entities": []}], ["Children in the refugee group were more likely to receive prescribed medicines for the last month (p=0.008) and the past 6\u2005months (p<0.001).", {"entities": []}], ["They were also less likely to receive over the counter (OTC) medicines in the past 6\u2005months (p=0.009).", {"entities": [[56, 59, "GENE"]]}], ["The refugee children in this study in the East Midlands had access to primary healthcare, medicines and a family doctor.", {"entities": []}], ["They were more likely to receive prescribed medicines and less likely to receive OTC medicines, especially paracetamol.", {"entities": [[81, 84, "GENE"]]}], ["International guidelines establish evidence-based standards for asthma care; however, recommendations are often not implemented and many patients do not meet control targets.", {"entities": [[64, 70, "DISEASE"]]}], ["Regional pilot data demonstrated a knowledge-to-practice gap.", {"entities": []}], ["We engineered health system change in a multi-step approach described by the Canadian Institutes of Health Research knowledge translation framework.", {"entities": []}], ["Knowledge translation occurred at multiple levels: patient, practice and local health system.", {"entities": []}], ["A regional administrative infrastructure and inter-disciplinary care teams were developed.", {"entities": []}], ["The key project deliverable was a guideline-based interdisciplinary asthma management program.", {"entities": [[68, 74, "DISEASE"]]}], ["Six community organizations, 33 primary care physicians and 519 patients participated.", {"entities": []}], ["The program operating cost was $290/patient.", {"entities": []}], ["Six guideline-based care elements were implemented, including spirometry measurement, asthma controller therapy, a written self-management action plan and general asthma education, including the inhaler device technique, role of medications and environmental control strategies in 93, 95, 86, 100, 97 and 87% of patients, respectively.", {"entities": [[86, 92, "DISEASE"], [163, 169, "DISEASE"]]}], ["Of the total patients 66% were adults, 61% were female, the mean age was 35.7 (SD = \u00b124.2) years.", {"entities": []}], ["At baseline 42% had two or more symptoms beyond acceptable limits vs. 17% ( P < 0.001) post-intervention; 71% reported urgent/emergent healthcare visits at baseline (2.94 visits/year) vs. 45% (1.45 visits/year) ( P < 0.001); 39% reported absenteeism (5.0 days/year) vs. 19% (3.0 days/year) ( P < 0.001).", {"entities": []}], ["The mean follow-up interval was 22 (SD = \u00b17) months.", {"entities": []}], ["A knowledge-translation framework can guide multi-level organizational change, facilitate asthma guideline implementation, and improve health outcomes in community primary care practices.", {"entities": [[90, 96, "DISEASE"]]}], ["Program costs are similar to those of diabetes programs.", {"entities": []}], ["Program savings offset costs in a ratio of 2.1:1", {"entities": []}], ["Anti-neutrophil cytoplasmic antibody (ANCA) - associated vasculitis (AAV) is a life-threatening autoimmune disease characterized by an antibody-mediated glomerulonephritis and necrotizing vasculitis.", {"entities": [[153, 171, "DISEASE"], [57, 67, "DISEASE"], [188, 198, "DISEASE"]]}], ["Apart from antibodies, T cells are also involved in disease pathogenesis.", {"entities": []}], ["This review stresses the hallmarks of T cell-mediated pathology in AAV and highlights the characteristics of lesional and circulating T cells in the immune response in AAV.", {"entities": []}], ["Circulating effector T-cell populations are expanded and are in a persistent state of activation.", {"entities": []}], ["Circulating regulatory T-cell subsets are less well characterized but seem to be impaired in function.", {"entities": []}], ["Lesional effector T cells are present in granulomas, vasculitic lesions, and nephritis.", {"entities": [[77, 86, "DISEASE"]]}], ["Lesional T cells usually show pro-inflammatory properties and promote granuloma formation.", {"entities": []}], ["Apart from T cells, dendritic cells are abundantly present at the sites of inflammation and locally orchestrate the immune response.", {"entities": []}], ["Targeting the above-mentioned T cell-mediated disease mechanisms will potentially provide powerful therapeutic tools for AAV.", {"entities": []}], ["Inflammation of central nervous system (CNS) is usually associated with trauma and infection.", {"entities": []}], ["Neuroinflammation occurs in close relation to trauma, infection, and neurodegenerative diseases.", {"entities": []}], ["Low-level neuroinflammation is considered to have beneficial effects whereas chronic neuroinflammation can be harmful.", {"entities": []}], ["Innate immune system consisting of pattern-recognition receptors, macrophages, and complement system plays a key role in CNS homeostasis following injury and infection.", {"entities": []}], ["Here, we discuss how innate immune components can also contribute to neuroinflammation and neurodegeneration.", {"entities": []}], ["The Canadian Acute Respiratory Illness and Flu Scale (CARIFS) is a parent-proxy questionnaire that assesses severity of acute respiratory infections in children.", {"entities": []}], ["The aim was to (a) perform a cross-cultural adaptation and (b) prove that the Malay CARIFS is a reliable tool.", {"entities": []}], ["The CARIFS underwent forward and backward translations as recommended by international guidelines.", {"entities": []}], ["A pilot study was performed on the harmonised version and the final version of the Malay version of CARIFS was produced.", {"entities": []}], ["A test-retest, 1\u00a0h apart, was then performed on parents with children less than 13\u00a0years old, admitted with a respiratory tract infection.", {"entities": []}], ["Parents of children with asthma and who were not eloquent in Malay, were excluded.", {"entities": [[25, 31, "DISEASE"]]}], ["The data was analysed for consistency (Cronbach\u2019s alpha) and reliability (test-retest co-efficient).", {"entities": []}], ["Thirty-three parents were recruited.", {"entities": []}], ["Children were aged median (IQR) 6 (2.8, 13.3) months with a male: female ratio of 22:11 and 88\u00a0% were Malays.", {"entities": []}], ["Parents were interviewed at median (IQR) 6 (3, 11.5) days of admission.", {"entities": []}], ["The Cronbach\u2019s \u03b1 coefficient was 0.70 for all items.", {"entities": []}], ["The test\u2013retest reliability analysis had a minimum and maximum intraclass correlation coefficient of 0.63 and 0.97 respectively.", {"entities": []}], ["Clinically, the longer patients were admitted, the lower the severity score ( r \u2009=\u2009\u22120.35, p \u2009<\u20090.05), indicating that they were getting better.", {"entities": []}], ["The Malay version of CARIFS is a valid and reliable tool to determine severity\u00a0of respiratory illness in children.", {"entities": []}], ["Parent-centred questionnaires are useful and should be an adjunct to other methods, in monitoring response to treatment.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-015-0336-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a complex disease characterized by hyperresponsiveness, obstruction and inflammation of the airways.", {"entities": [[0, 6, "DISEASE"]]}], ["To date, several studies using different approaches as candidate genes approach, genome wide association studies, linkage analysis and genomic expression leaded to the identification of over 300 genes involved in asthma pathophysiology.", {"entities": [[213, 219, "DISEASE"]]}], ["Combining results from two studies of genomic expression, this study aims to perform an association analysis between genes differently expressed in bronchial biopsies of asthmatics compared to controls and asthma-related phenotypes using the same French-Canadian Caucasian population.", {"entities": [[206, 212, "DISEASE"]]}], ["Before correction, 31 of the 85 genes selected were associated with at least one asthma-related phenotype.", {"entities": [[81, 87, "DISEASE"]]}], ["We found four genes that survived the correction for multiple testing.", {"entities": []}], ["The rs11630178 in aggrecan gene ( AGC1) is associated with atopy (p=0.0003) and atopic asthma (p=0.0001), the rs1247653 in the interferon alpha-inducible protein 6 (IFI6) , the rs1119529 in adrenergic, alpha-2A-, receptor ( ADRA2A) and the rs13103321 in the alcohol dehydrogenase 1B (class I), beta polypeptide ( ADH1B), are associated with asthma (p=0.019; 0.01 and 0.002 respectively).", {"entities": [[87, 93, "DISEASE"], [341, 347, "DISEASE"], [165, 169, "GENE"], [224, 230, "GENE"], [313, 318, "GENE"]]}], ["To our knowledge, this is the first time those genes are associated with asthma and related traits.", {"entities": [[73, 79, "DISEASE"]]}], ["Consequently, our study confirms that genetic and expression studies are complementary to identify new candidate genes and to investigate their role to improve the comprehension of the complexity of asthma pathophysiology.", {"entities": [[199, 205, "DISEASE"]]}], ["Many countries are developing or reviewing national adaptation policy for climate change but the extent to which these meet the health needs of vulnerable groups has not been assessed.", {"entities": []}], ["This study examines the adequacy of such policies for nine known climate-vulnerable groups: people with mental health conditions, Aboriginal people, culturally and linguistically diverse groups, aged people, people with disabilities, rural communities, children, women, and socioeconomically disadvantaged people.", {"entities": []}], ["The study analyses an exhaustive sample of national adaptation policy documents from Annex 1 (\u2018developed\u2019) countries of the United Nations Framework Convention on Climate Change: 20 documents from 12 countries.", {"entities": []}], ["A \u2018critical computational linguistics\u2019 method was used involving novel software-driven quantitative mapping and traditional critical discourse analysis.", {"entities": []}], ["The study finds that references to vulnerable groups are relatively little present or non-existent, as well as poorly connected to language about practical strategies and socio-economic contexts, both also little present.", {"entities": []}], ["The conclusions offer strategies for developing policy that is better informed by a \u2018social determinants of health\u2019 definition of climate vulnerability, consistent with best practice in the literature and global policy prescriptions.", {"entities": []}], ["Childhood obesity has been a serious public health problem.", {"entities": [[10, 17, "DISEASE"]]}], ["An effective school-based physical activity (PA) intervention is still lacking in China.", {"entities": []}], ["This study aimed to assess the effectiveness of a school-based physical activity intervention during 12\u00a0weeks on obesity and related health outcomes in school children.", {"entities": [[113, 120, "DISEASE"]]}], ["It was a non-randomized controlled trial.", {"entities": []}], ["Altogether 921 children aged 7 to 15\u00a0years were recruited at baseline survey.", {"entities": []}], ["Children in the intervention group (n\u2009=\u2009388) participated in a multi-component physical activity intervention during 12\u00a0weeks that included improvement of physical education, extracurricular physical activities for overweight/obese students, physical activities at home, and health education lectures for students and parents.", {"entities": []}], ["Children (n\u2009=\u2009533) in the control group participated in usual practice.", {"entities": []}], ["Participants had mean age of 10.4\u00a0years, mean body mass index (BMI) of 19.59\u00a0kg/m P \u2009<\u20090.001).", {"entities": []}], ["The effects on triceps, subscapular, abdominal skinfold thickness and fasting glucose were also significant in intervention group compared with control group (all P \u2009<\u20090.05).", {"entities": []}], ["The change in duration of moderate to vigorous physical activity (MVPA) in intervention group (8.9\u2009\u00b1\u20094.3\u00a0min/day) was significantly different from that in control group (\u221213.8\u2009\u00b1\u20093.3\u00a0min/day).", {"entities": []}], ["The adjusted mean difference was 22.7\u00a0min/day (95% CI: 12.2 to 33.2\u00a0min/day, P \u2009<\u20090.001).", {"entities": []}], ["The school-based, multi-component physical activity intervention was effective to decreasing levels of BMI, skinfold thickness, fasting glucose and increasing duration of MVPA.", {"entities": []}], ["These findings provided evidence for the development of effective and feasible school-based obesity interventions.", {"entities": [[92, 99, "DISEASE"]]}], ["Clinicaltrials.gov Identifier: NCT02074332 (2014-02-26)", {"entities": []}], ["Epigenetic modifications play a central role in the differentiation and function of immune cells in adult animals.", {"entities": []}], ["Developmentally regulated epigenetic patterns also appear to contribute to the ontogeny of the immune system.", {"entities": []}], ["We show here that the epigenetic profile of the T-helper (Th) 2 locus undergoes changes in T lineage cells beginning in mid-gestation and extending throughout the first week of life.", {"entities": []}], ["In particular, regulatory regions of the Th2 locus are largely methylated at CpG residues among fetal liver common lymphoid progenitor cells.", {"entities": []}], ["The locus subsequently becomes highly hypomethylated among the downstream progeny of these cells within the fetal thymus.", {"entities": []}], ["This hypomethylated state is preserved until birth when the locus becomes rapidly re-methylated, achieving adult-like status by 3\u20136 days post birth.", {"entities": []}], ["Notably, the capacity for rapid, high level Th2 cytokine production is lost in parallel with this re-methylation.", {"entities": []}], ["In vitro organ culture and in vivo transplantation experiments indicate that signals from the adult environment are required to achieve the postnatal methylated state.", {"entities": []}], ["Together, these findings indicate that the Th2 bias of neonates may be conferred, in part, by an epigenetic profile inherited from fetal life.", {"entities": []}], ["However, the fetal program is rapidly terminated post birth by the development of signals leading to the acquisition of adult-like epigenetic patterns.", {"entities": []}], ["The literature from developed countries suggests a relationship between alcohol use and quality of life and social engagement, where harmful drinkers have lower quality of life and less social engagement.", {"entities": []}], ["Despite the high rates of harmful alcohol use in South Africa, little is known about the association between drinking pattern and quality of life and social engagement in this context.", {"entities": []}], ["We aimed to determine if quality of life and social engagement varied across different drinking patterns among older South African adults, contributed to drinking pattern when controlling for socio-demographic factors, and varied differentially between genders.", {"entities": []}], ["This is a secondary analysis of data from the Survey on Global Ageing and Adult Health (SAGE).", {"entities": []}], ["Alcohol use was measured as self-reports of use over the previous seven days, and we constructed gender-specific alcohol variables.", {"entities": []}], ["The WHO Quality of Life-scale was used to measure quality of life, and social engagement was measured by frequency of participation in social activities.", {"entities": []}], ["We used ANOVA to observe differences in quality of life and social engagement scores across drinking patterns, and regression models were used to identify factors independently associated with drinking pattern.", {"entities": []}], ["There were 2572 (84.4%) lifetime abstainers, and 475 (15.6%) persons who had a drink in the last 7\u00a0days.", {"entities": []}], ["In bivariate analysis, quality of life was lowest among at risk drinking men compared to abstainers (OR\u2009=\u20090.21, p\u2009=\u20090.02), although this association was not significant in adjusted analysis.", {"entities": []}], ["Social engagement did not vary statistically significantly across the drinking patterns in the total sample or within gender.", {"entities": []}], ["Quality of life and social engagement were not independently associated with drinking pattern among older adults in South Africa in this sample.", {"entities": []}], ["In order to better understand their alcohol use, further exploratory research is warranted to identify other potentially relevant subjective factors of alcohol use among older adults in South Africa.", {"entities": []}], ["Agents targeting programmed death receptor 1 (PD-1) or its ligand (PD-L1) have shown antitumor activity in the treatment of metastatic breast cancer (MBC).", {"entities": [[135, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["The aim of this study was to assess the activity of avelumab, a PD-L1 inhibitor, in patients with MBC.", {"entities": []}], ["In a phase 1 trial (JAVELIN Solid Tumor; NCT01772004), patients with MBC refractory to or progressing after standard-of-care therapy received avelumab intravenously 10\u00a0mg/kg every 2\u00a0weeks.", {"entities": []}], ["Tumors were assessed every 6\u00a0weeks by RECIST v1.1.", {"entities": []}], ["Adverse events (AEs) were graded by NCI-CTCAE v4.0.", {"entities": []}], ["Membrane PD-L1 expression was assessed by immunohistochemistry (Dako PD-L1 IHC 73-10 pharmDx).", {"entities": []}], ["A total of 168 patients with MBC, including 58 patients with triple-negative breast cancer (TNBC), were treated with avelumab for 2\u201350\u00a0weeks and followed for 6\u201315\u00a0months.", {"entities": [[77, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["Patients were heavily pretreated with a median of three prior therapies for metastatic or locally advanced disease.", {"entities": []}], ["Grade\u00a0\u2265\u00a03 treatment-related AEs occurred in 13.7% of patients, including two treatment-related deaths.", {"entities": []}], ["The confirmed objective response rate (ORR) was 3.0% overall (one complete response and four partial responses) and 5.2% in patients with TNBC.", {"entities": []}], ["A trend toward a higher ORR was seen in patients with PD-L1+ versus PD-L1\u2212\u00a0tumor-associated immune cells in the overall population (16.7% vs. 1.6%) and in the TNBC subgroup (22.2% vs. 2.6%).", {"entities": []}], ["Avelumab showed an acceptable safety profile and clinical activity in a subset of patients with MBC.", {"entities": []}], ["PD-L1 expression in tumor-associated immune cells may be associated with a higher probability of clinical response to avelumab in MBC.", {"entities": []}], ["Tuberculosis is a major public health concern resulting in high rates of morbidity and mortality worldwide, particularly in low- and middle-income countries.", {"entities": [[0, 12, "DISEASE"]]}], ["Tuberculosis requires a long and intensive course of treatment.", {"entities": [[0, 12, "DISEASE"]]}], ["Thus, various approaches, including patient empowerment, education and counselling sessions, and involvement of family members and community workers, have been suggested for improving treatment adherence and outcome.", {"entities": []}], ["The current randomized controlled trial aims to evaluate the effectiveness over usual care of an innovative multicomponent people-centered tuberculosis-care strategy in Armenia.", {"entities": [[139, 151, "DISEASE"]]}], ["Innovative Approach to Tuberculosis care in Armenia is an open-label, stratified cluster randomized controlled trial with two parallel arms.", {"entities": [[23, 35, "DISEASE"]]}], ["Tuberculosis outpatient centers are the clusters assigned to intervention and control arms.", {"entities": [[0, 12, "DISEASE"]]}], ["Drug-sensitive tuberculosis patients in the continuation phase of treatment in the intervention arm and their family members participate in a short educational and counselling session to raise their knowledge, decrease tuberculosis-related stigma, and enhance treatment adherence.", {"entities": [[15, 27, "DISEASE"], [219, 231, "DISEASE"]]}], ["Patients receive the required medications for one week during the weekly visits to the tuberculosis outpatient centers.", {"entities": [[87, 99, "DISEASE"]]}], ["Additionally, patients receive daily Short Message Service (SMS) reminders to take their medications and daily phone calls to assure adherence and monitoring of treatment potential side effects.", {"entities": [[60, 63, "GENE"]]}], ["Control-arm patients follow the World Health Organization - recommended directly observed treatment strategy, including daily visits to tuberculosis outpatient centers for drug-intake.", {"entities": [[136, 148, "DISEASE"]]}], ["The primary outcome is physician-reported treatment outcome.", {"entities": []}], ["Patients\u2019 knowledge, depression, quality of life, within-family tuberculosis-related stigma, family social support, and self-reported adherence to tuberculosis treatment are secondary outcomes.", {"entities": [[64, 76, "DISEASE"], [147, 159, "DISEASE"]]}], ["Improved adherence and tuberculosis treatment outcomes can strengthen tuberculosis control and thereby forestall tuberculosis and multidrug resistant tuberculosis epidemics.", {"entities": [[23, 35, "DISEASE"], [70, 82, "DISEASE"], [113, 125, "DISEASE"], [150, 162, "DISEASE"]]}], ["Positive findings on effectiveness of this innovative tuberculosis treatment people-centered approach will support its adoption in countries with similar healthcare and economic profiles.", {"entities": [[54, 66, "DISEASE"]]}], ["ClinicalTrials.gov registration number: NCT02082340 .", {"entities": []}], ["Date of registration: 4 March 2014.", {"entities": []}], ["Respiratory disease is the predominant cause of illness in children globally.", {"entities": []}], ["We describe a unique multidisciplinary South African birth cohort, the Drakenstein Child Health Study (DCHS), to investigate the incidence, risk factors, aetiology and long-term impact of early lower respiratory tract infection (LRTI) on child health.", {"entities": []}], ["Pregnant women from a poor, peri-urban community with high exposure to infectious diseases and environmental risk factors are enrolled with 1000 mother\u2013child pairs followed for at least 5\u2005years.", {"entities": []}], ["Biomedical, environmental, psychosocial and demographic risk factors are longitudinally measured.", {"entities": []}], ["Environmental exposures are measured using monitors placed at home visits.", {"entities": []}], ["Lung function is measured in children at 6\u2005weeks, annually and during LRTI episodes.", {"entities": []}], ["Microbiological investigations including microbiome and multiplex PCR measures are done longitudinally and at LRTI episodes.", {"entities": []}], ["The DCHS is a unique African birth cohort study that uses sophisticated measures to comprehensively investigate the early-life determinants of child health in an impoverished area of the world.", {"entities": []}], ["Traditional surface disinfectants that have long been applied in medicine, animal husbandry, manufacturing and institutions are inconvenient at best and dangerous at worst.", {"entities": []}], ["Moreover, some of these substances have adverse environmental impacts: for example, quaternary ammonium compounds (\u201cquats\u201d) are reproductive toxicants in both fish and mammals.", {"entities": []}], ["Halogens are corrosive both to metals and living tissues, are highly reactive, can be readily neutralized by metals, and react with organic matter to form toxic, persistent by-products such as dioxins and furans.", {"entities": []}], ["Aldehydes may be carcinogenic to both human and animals upon repeated exposures, are corrosive, cross-link living tissues and many synthetic materials, and may lose efficacy when pathogens enzymatically adapt to them.", {"entities": []}], ["Alcohols are flammable and volatile and can be enzymatically degraded by certain bacterial pathogens.", {"entities": []}], ["Quats are highly irritating to mucous membranes and over time can induce pathogen resistance, especially if they are not alternated with functionally different disinfectants.", {"entities": []}], ["In contrast, peracetic acid (PAA), a potent oxidizer, liberates hydrogen peroxide (itself a disinfectant), biodegrades to carbon dioxide, water and oxygen, and is at least as efficacious as contact biocides e.g., halogens and aldehydes.", {"entities": []}], ["Nevertheless, the standard form of liquid PAA is highly corrosive, is neutralized by metals and organic matter, gives off noxious odours and must be stored in vented containers.", {"entities": []}], ["For the reasons stated above, Bioxy formulations were developed, a series of powder forms of PAA, which are odourless, stable in storage and safe to transport and handle.", {"entities": []}], ["They generate up to 10% PAA in situ when dissolved in water.", {"entities": []}], ["A 0.2% aqueous solution of Bioxy (equivalent to 200 ppm PAA) effected a 6.76 log reduction in Methicillin-resistant Staphylococcus aureus (MRSA) within 2 minutes after application.", {"entities": []}], ["A 5% aqueous solution of Bioxy achieved a 3.93 log reduction in the bovine tuberculosis bacillus Mycobacterium bovis , within 10 minutes after contact.", {"entities": [[75, 87, "DISEASE"]]}], ["A 1% solution of Bioxy reduced vancomycin-resistant enterococci (VRE) and Pseudomonas aeruginosa by 6.31 and 7.18 logs, respectively, within 3 minutes after application.", {"entities": []}], ["A 0.5% solution of Bioxy inactivated porcine epidemic diarrhea virus (PEDV) within 15 minutes of contact, and a 5% solution of Bioxy realized a 5.36 log reduction in the spores of Clostridium difficile within 10 minutes of application.", {"entities": [[54, 62, "DISEASE"]]}], ["In summary, Bioxy is safe and easy to transport and store, poses negligible human, animal and environmental health risks, shows high levels of pathogen control efficacy and does not induce microbial resistance.", {"entities": []}], ["Further investigations are recommended to explore its use as an industrial biocide.", {"entities": []}], ["Background: Respimat Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing.", {"entities": []}], ["Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: \u201c1\u201d (dose released by child); \u201c2\u201d (dose released by parent/caregiver), and \u201c3\u201d (Respimat SMI with VHC, facemask, and parent/caregiver help).", {"entities": []}], ["Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success.", {"entities": []}], ["Inhalation profile in the successful handling configuration was verified with a pneumotachograph.", {"entities": []}], ["Patient satisfaction and preferences were investigated in a questionnaire.", {"entities": []}], ["Results: Of the children aged 4 to <5 years ( n =27) and 3 to <4 years ( n =30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC.", {"entities": []}], ["All children aged 2 to <3 years ( n =20) achieved success with the Respimat SMI and VHC.", {"entities": []}], ["Of those aged <2 years ( n =22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help.", {"entities": []}], ["Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators.", {"entities": []}], ["Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC.", {"entities": []}], ["Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use.", {"entities": []}], ["The increasing global popularity of herbal remedies requires further investigation to determine the probable factors driving this burgeoning phenomenon.", {"entities": []}], ["We propose that the users' perception of efficacy is an important factor and assessed the perceived efficacy of herbal remedies by users accessing primary health facilities throughout Trinidad.", {"entities": []}], ["Additionally, we determined how these users rated herbal remedies compared to conventional allopathic medicines as being less, equally or more efficacious.", {"entities": []}], ["A descriptive cross-sectional study was undertaken at 16 randomly selected primary healthcare facilities throughout Trinidad during June-August 2005.", {"entities": []}], ["A de novo , pilot-tested questionnaire was interviewer-administered to confirmed herbal users (previous or current).", {"entities": []}], ["Stepwise multiple regression analysis was done to determine the influence of predictor variables on perceived efficacy and comparative efficacy with conventional medicines.", {"entities": []}], ["265 herbal users entered the study and cited over 100 herbs for the promotion of health/wellness and the management of specific health concerns.", {"entities": []}], ["Garlic was the most popular herb (in 48.3% of the sample) and was used for the common cold, cough, fever, as 'blood cleansers' and carminatives.", {"entities": [[79, 90, "DISEASE"]]}], ["It was also used in 20% of hypertension patients.", {"entities": [[27, 39, "DISEASE"]]}], ["230 users (86.8%) indicated that herbs were efficacious and perceived that they had equal or greater efficacy than conventional allopathic medicines.", {"entities": []}], ["Gender, ethnicity, income and years of formal education did not influence patients' perception of herb efficacy; however, age did (p = 0.036).", {"entities": []}], ["Concomitant use of herbs and allopathic medicines was relatively high at 30%; and most users did not inform their attending physician.", {"entities": []}], ["Most users perceived that herbs were efficacious, and in some instances, more efficacious than conventional medicines.", {"entities": []}], ["We suggest that this perception may be a major contributing factor influencing the sustained and increasing popularity of herbs.", {"entities": []}], ["Evidence-based research in the form of randomized controlled clinical trials should direct the proper use of herbs to validate (or otherwise) efficacy and determine safety.", {"entities": []}], ["In the Caribbean, most indigenous herbs are not well investigated and this points to the urgent need for biomedical investigations to assess the safety profile and efficacy of our popular medicinal herbs.", {"entities": []}], ["Occupational asthma remains relatively under-recognized in India with little or no information regarding preventable causes.", {"entities": [[13, 19, "DISEASE"]]}], ["We studied occupations with an increased prevalence of self-reported asthma among adult men and women in India.", {"entities": [[69, 75, "DISEASE"]]}], ["Analysis is based on 64 725 men aged 15\u201354 years and 52 994 women aged 15\u201349 years who participated in India\u2019s third National Family Health Survey, 2005\u20132006, and reported their current occupation.", {"entities": []}], ["Prevalence odds ratios (ORs) for specific occupations and asthma were estimated using multivariate logistic regression, separately for men and women, adjusting for age, education, household wealth index, current tobacco smoking, cooking fuel use, rural/urban residence and access to healthcare.", {"entities": [[58, 64, "DISEASE"]]}], ["The prevalence of asthma among the working population was 1.9%.", {"entities": [[18, 24, "DISEASE"]]}], ["The highest odds ratios for asthma were found among men in the plant and machine operators and assemblers major occupation category (OR: 1.67; 95% CI: 1.14\u20132.45; p = 0.009).", {"entities": [[28, 34, "DISEASE"]]}], ["Men working in occupation subcategories of machine operators and assemblers (OR: 1.85; 95% CI: 1.24\u20132.76; p = 0.002) and mining, construction, manufacturing and transport (OR: 1.33; 95% CI: 1.00\u20131.77; p = 0.051) were at the highest risk of asthma.", {"entities": [[240, 246, "DISEASE"]]}], ["Reduced odds of asthma prevalence in men was observed among extraction and building trades workers (OR: 0.72; 95% CI: 0.53\u20130.97; p = 0.029).", {"entities": [[16, 22, "DISEASE"]]}], ["Among women none of the occupation categories or subcategories was found significant for asthma risk.", {"entities": [[89, 95, "DISEASE"]]}], ["Men and women employed in high-risk occupations were not at a higher risk of asthma when compared with those in low-risk occupations.", {"entities": [[77, 83, "DISEASE"]]}], ["This large population-based, nationally representative cross-sectional study has confirmed findings from high income countries showing high prevalence of asthma in men in a number of occupational categories and subcategories; however, with no evidence of increased risks for women in the same occupations.", {"entities": [[154, 160, "DISEASE"]]}], ["Many drugs used for non-cardiovascular and cardiovascular purposes, such as sotalol, have the side effect of prolonging cardiac repolarization, which can trigger life-threatening cardiac arrhythmias by inhibiting the potassium-channel IKr (KCNH2) .", {"entities": [[240, 245, "GENE"]]}], ["On the electrocardiogram (ECG), IKr inhibition induces an increase in QTc and Tpeak-Tend (TpTe) interval and a decrease of T wave maximal amplitude (TAmp).", {"entities": [[90, 94, "GENE"]]}], ["These changes vary markedly between subjects, suggesting the existence of predisposing genetic factors.", {"entities": []}], ["990 healthy individuals, prospectively challenged with an oral 80mg sotalol dose, were monitored for changes in ventricular repolarization on ECG between baseline and 3 hours post dosing.", {"entities": []}], ["QTc and TpTe increased by 5.5\u00b13.5% and 15\u00b119.6%, respectively, and TAmp decreased by 13.2\u00b115.5%.", {"entities": [[8, 12, "GENE"]]}], ["A principal-component analysis derived from the latter ECG changes was performed.", {"entities": []}], ["A random subsample of 489 individuals were subjected to a genome-wide-association analysis where 8,306,856 imputed single nucleotide polymorphisms (SNPs) were tested for association with QTc, TpTe and TAmp modulations, as well their derived principal-components, to search for common genetic variants associated with sotalol-induced IKr inhibition.", {"entities": [[192, 196, "GENE"]]}], ["None of the studied SNPs reached the statistical threshold for genome-wide significance.", {"entities": []}], ["This study supports the lack of common variants with larger effect sizes than one would expect based on previous ECG genome-wide-association studies.", {"entities": []}], ["Clinical trial registration : ClinicalTrials.gov NCT00773201", {"entities": []}], ["Respiratory tract infections (RTIs) are the most common reason for primary care (PC) consultations and for antibiotic prescribing and use.", {"entities": [[81, 83, "GENE"]]}], ["The majority of RTIs have a viral aetiology however, and antibiotic consumption is ineffective and unnecessary.", {"entities": []}], ["Inappropriate antibiotic use contributes greatly to antibiotic resistance (ABR) leading to complications, increased adverse events, reconsultations and costs.", {"entities": [[75, 78, "GENE"]]}], ["Improving antibiotic consumption is thus crucial to containing ABR, which has become an urgent priority worldwide.", {"entities": [[63, 66, "GENE"]]}], ["We will systematically review the evidence about interventions aimed at improving the quality of antibiotic prescribing and use for acute RTI.", {"entities": []}], ["We will include primary peer-reviewed and grey literature of studies conducted on in-hours and out-of-hours PC patients (adults and children): (1) randomised controlled trials (RCTs), quasi-RCTs and/or cluster-RCTs evaluating the effectiveness, feasibility and acceptability of patient-targeted and clinician-targeted interventions and (2) RCTs and other study designs evaluating the effectiveness of public campaigns and regulatory interventions.", {"entities": [[108, 110, "GENE"]]}], ["We will search MEDLINE (EBSCOHost), EMBASE (Elsevier), the Cochrane Library (Wiley), CINHAL (EBSCOHost), PsychINFO (EBSCOHost), Web of Science, LILACS (Latin American and Caribbean Literature on Health Sciences), TRIP (Turning Research Into Practice) and opensgrey.eu without language restriction.", {"entities": []}], ["We will also search the reference lists of included studies and relevant reviews.", {"entities": []}], ["Primary outcomes include the rates of (guideline-recommended) antibiotics prescribed and/or used.", {"entities": []}], ["Secondary outcomes include immediate or delayed use of antibiotics, and feasibility and acceptability outcomes.", {"entities": []}], ["We will assess study eligibility and risk of bias, and will extract data.", {"entities": []}], ["Data permitting, we will perform meta-analyses.", {"entities": []}], ["This is a systematic review protocol and so formal ethical approval is not required.", {"entities": []}], ["We will not collect confidential, personal or primary data.", {"entities": []}], ["The findings of this review will be disseminated at national and international scientific meetings.", {"entities": []}], ["PROSPERO trial (CRD42017035305).", {"entities": []}], ["The traditional classification of COPD, which relies solely on spirometry, fails to account for the complexity and heterogeneity of the disease.", {"entities": []}], ["Phenotyping is a method that attempts to derive a single or combination of disease attributes that are associated with clinically meaningful outcomes.", {"entities": []}], ["Deriving phenotypes entails the use of cluster analyses, and helps individualize patient management by identifying groups of individuals with similar characteristics.", {"entities": []}], ["We aimed to systematically review the literature for studies that had derived such phenotypes using unsupervised methods.", {"entities": []}], ["Two independent reviewers systematically searched multiple databases for studies that performed validated statistical analyses, free of definitive pre-determined hypotheses, to derive phenotypes among patients with COPD.", {"entities": []}], ["Data were extracted independently.", {"entities": []}], ["9156 citations were retrieved, of which, 8 studies were included.", {"entities": []}], ["The number of subjects ranged from 213 to 1543.", {"entities": []}], ["Most studies appeared to be biased: patients were more likely males, with severe disease, and recruited in tertiary care settings.", {"entities": []}], ["Statistical methods used to derive phenotypes varied by study.", {"entities": []}], ["The number of phenotypes identified ranged from 2 to 5.", {"entities": []}], ["Two phenotypes, with poor longitudinal health outcomes, were common across multiple studies: young patients with severe respiratory disease, few cardiovascular co-morbidities, poor nutritional status and poor health status, and a phenotype of older patients with moderate respiratory disease, obesity, cardiovascular and metabolic co-morbidities.", {"entities": [[293, 300, "DISEASE"]]}], ["The recognition that two phenotypes of COPD were often reported may have clinical implications for altering the course of the disease.", {"entities": []}], ["This review also provided important information on limitations of phenotype studies in COPD and the need for improvement in future studies.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0208-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The 2003 revision of the UK GMS contract rewards general practices for performance against clinical quality indicators.", {"entities": []}], ["Practices can exempt patients from treatment, and can receive maximum payment for less than full coverage of eligible patients.", {"entities": []}], ["This paper aims to estimate the gap between the percentage of maximum incentive gained and the percentage of patients receiving indicated care (the pay-performance gap), and to estimate how much of the gap is attributable respectively to thresholds and to exception reporting.", {"entities": []}], ["Analysis of Quality Outcomes Framework data in the National Primary Care Database and exception reporting data from the Information Centre from 8407 practices in England in 2005 \u2013 6.", {"entities": []}], ["The main outcome measures were the gap between the percentage of maximum incentive gained and the percentage of patients receiving indicated care at the practice level, both for individual indicators and a combined composite score.", {"entities": []}], ["An additional outcome was the percentage of that gap attributable respectively to exception reporting and maximum threshold targets set at less than 100%.", {"entities": []}], ["The mean pay-performance gap for the 65 aggregated clinical indicators was 13.3% (range 2.9% to 48%).", {"entities": []}], ["52% of this gap (6.9% of eligible patients) is attributable to thresholds being set at less than 100%, and 48% to patients being exception reported.", {"entities": []}], ["The gap was greater than 25% in 9 indicators: beta blockers and cholesterol control in heart disease; cholesterol control in stroke; influenza immunization in asthma; blood pressure, sugar and cholesterol control in diabetes; seizures in epilepsy and treatment of hypertension.", {"entities": [[264, 276, "DISEASE"], [133, 142, "DISEASE"], [87, 100, "DISEASE"], [159, 165, "DISEASE"]]}], ["Threshold targets and exception reporting introduce an incentive ceiling, which substantially reduces the percentage of eligible patients that UK practices need to treat in order to receive maximum incentive payments for delivering that care.", {"entities": []}], ["There are good clinical reasons for exception reporting, but after unsuitable patients have been exempted from treatment, there is no reason why all maximum thresholds should not be 100%, whilst retaining the current lower thresholds to provide incentives for lower performing practices.", {"entities": []}], ["Supplemental Digital Content is available in the text Under the assumption of gene\u2013environment independence, unknown/unmeasured environmental factors, irrespective of what they may be, cannot confound the genetic effects.", {"entities": []}], ["This may lead many people to believe that genetic heterogeneity across different levels of the studied environmental exposure should only mean gene\u2013environment interaction\u2014even though other environmental factors are not adjusted for.", {"entities": []}], ["However, this is not true if the odds ratio is the effect measure used for quantifying genetic effects.", {"entities": []}], ["This is because the odds ratio is a \u201cnoncollapsible\u201d measure\u2014a marginal odds ratio is not a weighted average of the conditional odds ratios, but instead has a tendency toward the null.", {"entities": []}], ["In this study, the authors derive formulae for gene\u2013environment interaction bias due to noncollapsibility.", {"entities": []}], ["They use computer simulation and real data example to show that the bias can be substantial for common diseases.", {"entities": []}], ["For genetic association study of nonrare diseases, researchers are advised to use collapsible measures, such as risk ratio or peril ratio.", {"entities": []}], ["Gastric cancer can progress from a chronic inflammation of the gastric mucosa resulting from Helicobacter pylori infection that activates the inflammatory response of the host.", {"entities": [[8, 14, "DISEASE"]]}], ["Therefore, polymorphisms in genes involved in the inflammatory response, such as inducible nitric oxide synthase ( NOS2 ), have been implicated in gastric carcinogenesis.", {"entities": [[115, 119, "GENE"]]}], ["The aim of this study was to evaluate the association of NOS2 polymorphisms Ser H. pylori infection.", {"entities": [[57, 61, "GENE"]]}], ["We conducted a population-based case-control study in 474 Southeast Brazilian individuals (150 with gastric cancer, 160 with chronic gastritis, and 164 healthy individuals), in which we performed NOS2 genotyping by PCR-RFLP.", {"entities": [[133, 142, "DISEASE"], [108, 114, "DISEASE"], [196, 200, "GENE"]]}], ["SNP Ser NOS2 SNP -954G/C was associated with higher risk of gastric cancer (OR = 1.87; 95% CI = 1.12-3.13).", {"entities": [[68, 74, "DISEASE"], [8, 12, "GENE"]]}], ["We also observed an association with risk factors such as smoking and alcohol intake in both the gastric cancer (OR = 2.68; 95% CI = 1.58-4.53; OR = 3.60; 95% CI = 2.05-6.32, respectively) and the chronic gastritis (OR = 1.93; 95% CI = 1.19-3.13; OR = 2.79; 95% CI = 1.55-5.02, respectively) groups.", {"entities": [[205, 214, "DISEASE"], [105, 111, "DISEASE"]]}], ["This is the first report of increased risk of gastric cancer in association with the -954G/C polymorphism.", {"entities": [[54, 60, "DISEASE"]]}], ["These findings show that several polymorphisms in the promoter region of the NOS2 gene may contribute to the susceptibility to gastric cancer.", {"entities": [[135, 141, "DISEASE"], [77, 81, "GENE"]]}], ["Polymorphism NOS2 -954 G/C, along with alcohol intake and tobacco smoking, is associated with gastric cancer.", {"entities": [[102, 108, "DISEASE"], [13, 17, "GENE"]]}], ["However, the NOS2 Ser NOS2 -1173C/T polymorphism was absent in the studied population.", {"entities": [[13, 17, "GENE"], [22, 26, "GENE"], [13, 17, "GENE"], [22, 26, "GENE"]]}], ["The KIDSCREEN questionnaires were developed by a collaborative effort of European pediatric researchers for use in epidemiologic public health surveys, clinical intervention studies, and research projects.", {"entities": []}], ["The article gives an overview of the development of the tool, summarizes its extensive applications in Europe, and describes the development of a new computerized adaptive test (KIDS-CAT) based on KIDSCREEN experiences.", {"entities": []}], ["The KIDSCREEN versions (self-report and proxy versions with 52, 27, and 10 items) were simultaneously developed in 13 different European countries to warrant cross-cultural applicability, using methods based on classical test theory (CTT: descriptive statistics, CFA and MAP, internal consistency, retest reliability measures) and item response theory (IRT: Rasch modeling, DIF analyses, etc.).", {"entities": [[374, 377, "GENE"]]}], ["The KIDS-CAT was developed (in cooperation with the US pediatric PROMIS project) based on archival data of European KIDSCREEN health surveys using IRT more extensively (IRC).", {"entities": []}], ["Research has shown that the KIDSCREEN is a reliable, valid, sensitive, and conceptually/linguistically appropriate QoL measure in 38 countries/languages by now.", {"entities": []}], ["European and national norm data are available.", {"entities": []}], ["New insights from KIDSCREEN studies stimulate pediatric health care.", {"entities": []}], ["Based on KIDSCREEN, the Kids-CAT promises to facilitate a very efficient, precise, as well as reliable and valid assessment of QoL.", {"entities": []}], ["The KIDSCREEN has standardized QoL measurement in Europe in children as a valid and cross-cultural comparable tool.", {"entities": []}], ["The Kids-CAT has the potential to further advance pediatric health measurement and care via Internet application.", {"entities": []}], ["Current studies on the aetiology of developmental defects of enamel (DDE) are subject to recall bias because of the retrospective collection of information.", {"entities": []}], ["Our objective was to investigate potential risk factors associated with the occurrence of DDE through a prospective cohort study.", {"entities": []}], ["Using a random community sample of Hong Kong children born in 1997, we performed a cohort study in which the subjects\u2019 background information, medical and dental records were prospectively collected.", {"entities": []}], ["A clinical examination to identify DDE was conducted in 2010 when the subjects were 12 years old.", {"entities": []}], ["The central incisor, lateral incisor and first molar in each quadrant were chosen as the index teeth and were examined \u2018wet\u2019 by two trained and calibrated examiners using the modified FDI (DDE) Index.", {"entities": []}], ["With a response rate of 74.9%, the 514 examined subjects had matched data for background information.", {"entities": []}], ["Diffuse opacites were the most common type of DDE.", {"entities": []}], ["Of the various possible aetiological factors considered, only experience of severe diseases during the period 0\u20133 years was associated with the occurrence of \u2018any defect\u2019 (p\u200a=\u200a0.017) and diffuse opacities (p\u200a=\u200a0.044).", {"entities": []}], ["The children with experience of severe diseases before 3 years of age were 7.89 times more likely to be affected by \u2018any defect\u2019 compared with those who did not have the experience (OR 7.89; 95% CI 1.07, 58.14; p\u200a=\u200a0.043).", {"entities": []}], ["However, after adjusting for confounding factors, the association no longer existed.", {"entities": []}], ["No variables could be identified as risk factors of DDE in this Hong Kong birth cohort.", {"entities": []}], ["Phenolic compounds constitute a group of secondary metabolites which have important functions in plants.", {"entities": []}], ["Besides the beneficial effects on the plant host, phenolic metabolites (polyphenols) exhibit a series of biological properties that influence the human in a health-promoting manner.", {"entities": []}], ["Evidence suggests that people can benefit from plant phenolics obtained either by the diet or through skin application, because they can alleviate symptoms and inhibit the development of various skin disorders.", {"entities": []}], ["Due to their natural origin and low toxicity, phenolic compounds are a promising tool in eliminating the causes and effects of skin aging, skin diseases, and skin damage, including wounds and burns.", {"entities": []}], ["Polyphenols also act protectively and help prevent or attenuate the progression of certain skin disorders, both embarrassing minor problems (e.g., wrinkles, acne) or serious, potentially life-threatening diseases such as cancer.", {"entities": [[157, 161, "DISEASE"], [221, 227, "DISEASE"]]}], ["This paper reviews the latest reports on the potential therapy of skin disorders through treatment with phenolic compounds, considering mostly a single specific compound or a combination of compounds in a plant extract.", {"entities": []}], ["The aim of this study was to evaluate the effects of Nigella sativa ( N. sativa ) oil (NSO) on ovarian oxidative damage following ischemia-reperfusion injury, using a rat model of ovarian torsion.", {"entities": [[130, 138, "DISEASE"]]}], ["Forty-eight female albino Wistar rats were divided into six groups: (Group 1) laparotomy only; (Group 2) intraperitoneal NSO (2 ml/kg), 1 hour following laparotomy; (Group 3) 3 hours of ovarian ischemia; (Group 4) 3 hours of ovarian ischemia followed by 3 hours of reperfusion; (Group 5) 3 hours of ovarian ischemia and 2 ml/kg of NSO 1 hour before laparotomy; (Group 6) 3 hours of reperfusion after 3 hours of ovarian ischemia and 2 ml/mg of NSO 1 hour before laparotomy.", {"entities": [[194, 202, "DISEASE"], [233, 241, "DISEASE"], [307, 315, "DISEASE"], [419, 427, "DISEASE"]]}], ["The antioxidant status, ceruloplasmin level, native thiol, total thiol, and disulfide levels of the control group (Group 1) were significantly increased compared with the ovarian ischemia-reperfusion group treated with NSO (Group 6) (p=0.003, p=0.002, p=0.006, p=0.001 and p=0.003, respectively); these levels in the ovarian ischemia group (Group 3) and ischemia-reperfusion group (Group 4) were statistically similar to those of the ovarian ischemia + NSO group (Group 5) and ovarian ischemia-reperfusion + NSO group (Group 6).", {"entities": [[179, 187, "DISEASE"], [325, 333, "DISEASE"], [354, 362, "DISEASE"], [442, 450, "DISEASE"], [485, 493, "DISEASE"]]}], ["In this preliminary rat study, administration of NSO shortly after the onset of ovarian ischemia-reperfusion injury, did not significantly reduce levels of markers of oxidative injury.", {"entities": [[88, 96, "DISEASE"]]}], ["Further studies are required to evaluate the ovarian changes at the tissue level, and to determine the optimum dose of NSO.", {"entities": []}], ["To determine whether particular environmental, medical, or behavioral risk factors existed among Cryptcoccus gattii \u2013infected persons compared with the general population, we conducted a sex-matched case\u2212control study on a subset of case-patients in British Columbia (1999\u20132001).", {"entities": []}], ["Exposures and underlying medical conditions among all case-patients (1999\u20132007) were also compared with results of provincial population\u2013based surveys and studies.", {"entities": []}], ["In case\u2212control analyses, oral steroids (matched odds ratio [MOR] 8.11, 95% confidence interval [CI] 1.74\u201337.80), pneumonia (MOR 2.71, 95% CI 1.05\u20136.98), and other lung conditions (MOR 3.21, 95% CI 1.08\u20139.52) were associated with infection.", {"entities": [[114, 123, "DISEASE"]]}], ["In population comparisons, case-patients were more likely to be > 50 years of age (p<0.001), current smokers (p<0.001), infected with HIV (p<0.001), or have a history of invasive cancer (p<0.001).", {"entities": [[179, 185, "DISEASE"]]}], ["Although C. gattii is commonly believed to infect persons with apparently healthy immune systems, several immunosuppressive and pulmonary conditions seem to be risk factors.", {"entities": []}], ["Nurses in Ghana play a vital role in the delivery of primary health care at both the household and community level.", {"entities": []}], ["However, there is lack of information on task shifting the management and control of hypertension to community health nurses in low- and middle-income countries including Ghana.", {"entities": [[85, 97, "DISEASE"]]}], ["The purpose of this study was to assess nurses\u2019 knowledge and practice of hypertension management and control pre- and post-training utilizing task-shifting strategies for hypertension control in Ghana (TASSH).", {"entities": [[74, 86, "DISEASE"], [172, 184, "DISEASE"]]}], ["A pre- and post- test survey was administered to 64 community health nurses (CHNs) and enrolled nurses (ENs) employed in community health centers and district hospitals before and after the TASSH training, followed by semi-structured qualitative interviews that assessed nurses\u2019 satisfaction with the training, resultant changes in practice and barriers and facilitators to optimal hypertension management.", {"entities": [[382, 394, "DISEASE"]]}], ["A total of 64 CHNs and ENs participated in the TASSH training.", {"entities": []}], ["The findings of the pre- and post-training assessments showed a marked improvement in nurses\u2019 knowledge and practice related to hypertension detection and treatment.", {"entities": [[128, 140, "DISEASE"]]}], ["At pre-assessment 26.9% of the nurses scored 80% or more on the hypertension knowledge test, whereas this improved significantly to 95.7% post-training.", {"entities": [[64, 76, "DISEASE"]]}], ["Improvement of interpersonal skills and patient education were also mentioned by the nurses as positive outcomes of participation in the intervention.", {"entities": []}], ["Findings suggest that if all nurses receive even brief training in the management and control of hypertension, major public health benefits are likely to be achieved in low-income countries like Ghana.", {"entities": [[97, 109, "DISEASE"]]}], ["However, more research is needed to ascertain implementation fidelity and sustainability of interventions such as TASSH that highlight the potential role of nurses in mitigating barriers to optimal hypertension control in Ghana.", {"entities": [[198, 210, "DISEASE"]]}], ["Trial registration for parent TASSH study: NCT01802372 .", {"entities": []}], ["Registered February 27, 2013.", {"entities": []}], ["Atopic dermatitis (AD) is associated with the effects of Th2 and Th22 cytokines.", {"entities": [[7, 17, "DISEASE"]]}], ["Recent studies, however, have also implicated Th17 in acute AD.", {"entities": []}], ["Functional studies of Th2 and Th22 cytokines revealed their roles in generating AD\u2019s molecular changes; IL-17A\u2019s role has yet to be defined.", {"entities": []}], ["In this issue,", {"entities": []}], ["Most guidelines recommend pulmonary rehabilitation (PR) for patients with chronic obstructive pulmonary disease (COPD) and modified Medical Research Council dyspnea scale (mMRC) levels \u22652, but the effectiveness of PR in patients with less advanced disease is not well established.", {"entities": [[74, 111, "DISEASE"]]}], ["Our aim was to investigate the effects of PR in patients with COPD and mMRC \u22641.", {"entities": []}], ["The methodology was developed as a part of evidence-based guideline development and is in accordance with the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group.", {"entities": []}], ["We identified randomized controlled trials (RCTs) through a systematic, multidatabase literature search and selected RCTs comparing the effects of PR with usual care in patients with COPD and mMRC \u22641.", {"entities": []}], ["Predefined critical outcomes were health-related quality of life (HRQoL), adverse effects and mortality, while walking distance, maximal exercise capacity, muscle strength, and dropouts were important outcomes.", {"entities": []}], ["Two authors independently extracted data, assessed trial eligibility and risk of bias, and graded the evidence.", {"entities": []}], ["Meta-analyses were performed when deemed feasible.", {"entities": []}], ["Four RCTs (489 participants) were included.", {"entities": []}], ["On the basis of moderate-quality evidence, we found a clinically and statistically significant improvement in short-term HRQoL of 4.2 units (95% confidence interval [CI]: [\u22124.51 to \u22123.89]) on St George\u2019s Respiratory Questionnaire, but not at the longest follow-up.", {"entities": []}], ["We also found a statistically significant improvement of 25.71 m (95% CI: [15.76\u201335.65]) in the 6-minute walk test with PR; however, this improvement was not considered clinically relevant.", {"entities": []}], ["No difference was found for mortality, and insufficient data prohibited meta-analysis for muscle strength and maximal exercise capacity.", {"entities": []}], ["No adverse effects were reported.", {"entities": []}], ["We found a moderate quality of evidence suggesting a small, significant improvement in short-term HRQoL and a clinically nonsignificant improvement in walking distance following PR in patients with COPD and mild symptoms.", {"entities": []}], ["This resulted in a weak recommendation of routine PR in these patients using the GRADE approach.", {"entities": []}], ["M. pneumoniae infections showed a strong epidemic peak, but Chlamydia spp.", {"entities": []}], ["were consistently detected throughout the year.", {"entities": []}], ["Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are difficult to propagate, and can cause clinically indistinguishable disease patterns.", {"entities": [[87, 96, "DISEASE"]]}], ["During 2011\u20132012, we used molecular methods to test adult patients in Germany with confirmed CAP for infection with these 2 pathogens.", {"entities": []}], ["Overall, 12.3% (96/783) of samples were positive for M. pneumoniae and 3.9% (31/794) were positive for Chlamydia spp.", {"entities": []}], ["; C. psittaci (2.1%) was detected more frequently than C. pneumoniae (1.4%).", {"entities": []}], ["M. pneumoniae P1 type 1 predominated, and levels of macrolide resistance were low (3.1%).", {"entities": []}], ["Quarterly rates of M. pneumoniae \u2013positive samples ranged from 1.5% to 27.3%, showing a strong epidemic peak for these infections, but of Chlamydia spp.", {"entities": []}], ["detection was consistent throughout the year.", {"entities": []}], ["M. pneumoniae \u2013positive patients were younger and more frequently female, had fewer co-occurring conditions, and experienced milder disease than did patients who tested negative.", {"entities": []}], ["Clinicians should be aware of the epidemiology of these pathogens in CAP.", {"entities": []}], ["Synchronous bilateral malignancy in the parotid glands is extremely rare.", {"entities": []}], ["The English literature reveals nine case reports.", {"entities": []}], ["The most common synchronous bilateral malignancies are acinic cell carcinoma.", {"entities": [[67, 76, "DISEASE"]]}], ["Epithelial\u2013myoepithelial carcinoma is an uncommon neoplasm comprising 1% of all salivary gland tumours.", {"entities": [[11, 34, "DISEASE"], [25, 34, "DISEASE"]]}], ["In this case report, we describe, to our best of knowledge, the first case of a patient with a synchronous bilateral epithelial\u2013myoepithelial carcinoma of the parotid gland.", {"entities": [[128, 151, "DISEASE"], [142, 151, "DISEASE"]]}], ["The clinical histopathological and immunohistochemical peculiarities are elucidated.", {"entities": []}], ["Imaging studies like ultrasonography are mandatory for both parotid glands and upper necks in the clinical presence of a unilateral parotid gland tumour.", {"entities": []}], ["Women with metastatic breast cancer (MBC) have average life expectancies of about 2\u00a0years, and report high levels of disease-related symptoms including pain, fatigue, sleep disturbance, psychological distress, and functional impairment.", {"entities": [[22, 35, "DISEASE"], [29, 35, "DISEASE"]]}], ["There is growing recognition of the limitations of medical approaches to managing such symptoms.", {"entities": []}], ["Yoga is a mind-body discipline that has demonstrated a positive impact on psychological and functional health in early stage breast cancer patients and survivors, but has not been rigorously studied in advanced cancer samples.", {"entities": [[125, 138, "DISEASE"], [132, 138, "DISEASE"], [211, 217, "DISEASE"]]}], ["This randomized controlled trial examines the feasibility and initial efficacy of a Mindful Yoga program, compared with a social support condition that controls for attention, on measures of disease-related symptoms such as pain and fatigue.", {"entities": []}], ["The study will be completed by December 2017.", {"entities": []}], ["Sixty-five women with MBC age\u2009\u2265\u200918 are being identified and randomized with a 2:1 allocation to Mindful Yoga or a support group control intervention.", {"entities": []}], ["The 120-min intervention sessions take place weekly for 8\u00a0weeks.", {"entities": []}], ["The study is conducted at an urban tertiary care academic medical center located in Durham, North Carolina.", {"entities": []}], ["The primary feasibility outcome is attendance at intervention sessions.", {"entities": []}], ["Efficacy outcomes include pain, fatigue, sleep quality, psychological distress, mindfulness and functional capacity at post-intervention, 3-month follow-up, and 6-month follow-up.", {"entities": []}], ["In this article, we present the challenges of designing a randomized controlled trial with long-term follow-up among women with MBC.", {"entities": []}], ["These challenges include ensuring adequate recruitment including of minorities, limiting and controlling for selection bias, tailoring of the yoga intervention to address special needs, and maximizing adherence and retention.", {"entities": []}], ["This project will provide important information regarding yoga as an intervention for women with advanced cancer, including preliminary data on the psychological and functional effects of yoga for MBC patients.", {"entities": [[106, 112, "DISEASE"]]}], ["This investigation will also establish rigorous methods for future research into yoga as an intervention for this population.", {"entities": []}], ["ClinicalTrials.gov identifer: NCT01927081 , registered August 16, 2013", {"entities": []}], ["Postoperative pulmonary complications (PPC) in patients with pulmonary diseases remain to be resolved clinical issue.", {"entities": []}], ["However, most evidence regarding PPC has been established more than 10\u00a0years ago.", {"entities": []}], ["Therefore, it is necessary to evaluate perioperative management using new inhalant drugs in patients with obstructive pulmonary diseases.", {"entities": []}], ["April 2014 through March 2015, 346 adult patients with pulmonary diseases (257 asthma, 89 chronic obstructive pulmonary disease (COPD)) underwent non-pulmonary surgery except cataract surgery in our university hospital.", {"entities": [[175, 183, "DISEASE"], [90, 127, "DISEASE"], [79, 85, "DISEASE"]]}], ["To analyze the risk factors for PPC, we retrospectively evaluated physiological backgrounds, surgical factors and perioperative specific treatment for asthma and COPD.", {"entities": [[151, 157, "DISEASE"]]}], ["Finally, 29 patients with pulmonary diseases (22 asthma, 7 COPD) had PPC.", {"entities": [[49, 55, "DISEASE"]]}], ["In patients with asthma, smoking index (\u2265 20 pack-years), peripheral blood eosinophil count (\u2265 200/mm History of smoking or severe asthma is a risk factor of PPC in patients with asthma, and age, upper abdominal surgery, or long operation time is a risk factor of PPC in patients with COPD.", {"entities": [[17, 23, "DISEASE"], [131, 137, "DISEASE"], [179, 185, "DISEASE"]]}], ["Adequate inhaled corticosteroids treatment in patients with eosinophilic asthma and introducing treatment for COPD in patients with COPD could reduce PPCs.", {"entities": [[73, 79, "DISEASE"], [150, 154, "GENE"]]}], ["For the purposes of this paper \"weaning is defined as the introduction of the first solid foods to infants\".", {"entities": []}], ["Global recommendations by the World Health Organisation (WHO) recommend that all infants be exclusively breast-fed for the first six months of life.", {"entities": []}], ["No global recommendations have been made for formula fed infants.", {"entities": []}], ["In Europe it is recommended that weaning foods should be introduced between 18 weeks and 26 weeks regardless of whether infants are breast or formula fed.", {"entities": []}], ["In the United Kingdom it is recommended that solids be introduced at around six-months for both breast and formula fed infants.", {"entities": []}], ["In Ireland official guidelines recommend that breast fed infants should be introduced solids at 6 months of age while for formula fed infants the recommendation is for 4 months.", {"entities": []}], ["The disparity between these global, European, UK and local recommendations may be a source of confusion for parents and health care professional based in Ireland.", {"entities": []}], ["Emerging evidence suggests that babies in Ireland are given solid foods before the recommended age but there has been little investigation of the weaning advice provided by health professionals.", {"entities": []}], ["Since community health professionals have routine parent interactions in the pre-weaning and early-weaning period and hence are in a unique position to positively influence parental weaning decisions, this study aimed to explore their knowledge, attitudes and advice practices about weaning.", {"entities": []}], ["A mixed-methods approach was used for the research, commencing with a multi-disciplinary focus group to guide and develop a questionnaire.", {"entities": []}], ["Questionnaires were then distributed in a postal survey to General Practitioners (GPs) ( n 179), Practice Nurses (PNs) ( n 121), Public Health Nurses (PHNs) ( n 107) and Community Dieticians (CDs) ( n 8).", {"entities": []}], ["The results indicate varying levels of knowledge of official weaning recommendations and a variety of advice practices.", {"entities": []}], ["CDs and PHNs acknowledged a clear role in providing weaning advice while demonstrating high confidence levels in providing this advice.", {"entities": []}], ["However, 19% of PNs and 7% of GP respondents did not acknowledge that they have a role in providing weaning advice to parents; even though Health Service Executive (HSE) written literature given to parents states that they should seek information from PNs and GPs.", {"entities": []}], ["Small pockets of misinformation about the introduction of solid foods persist amongst health professionals which may lead to inconsistent advice for parents.", {"entities": []}], ["Further research is needed.", {"entities": []}], ["Influenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics.", {"entities": [[0, 9, "DISEASE"]]}], ["The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomic segments, promote antigenic diversity and new subtypes, allowing the virus to evade vaccines and become resistant to antiviral drugs.", {"entities": [[48, 57, "DISEASE"]]}], ["There is thus a continuing need for new anti-influenza therapy using novel targets and creative strategies.", {"entities": [[45, 54, "DISEASE"]]}], ["In this review, we summarize prospective future therapeutic regimens based on recent molecular and genomic discoveries.", {"entities": []}], ["While the fractional concentration of exhaled nitric oxide (FeNO) has proven useful in asthma research, its exact role in clinical care remains unclear, in part due to unexplained inter-subject heterogeneity.", {"entities": [[87, 93, "DISEASE"]]}], ["In this study, we assessed the hypothesis that the effects of determinants of the fractional concentration of exhaled nitric oxide (FeNO) vary with differing levels of FeNO.", {"entities": []}], ["In a population-based cohort of 1542 school children aged 12\u201315 from the Southern California Children's Health Study, we used quantile regression to investigate if the relationships of asthma, socio-demographic and clinical covariates with FeNO vary across its distribution.", {"entities": [[185, 191, "DISEASE"]]}], ["Differences in FeNO between children with and without asthma increased steeply as FeNO increased (Estimated asthma effects (in ppb ) at selected 20 ppb ) at selected 20", {"entities": [[54, 60, "DISEASE"], [108, 114, "DISEASE"]]}], ["Relative to research on effects of environmental exposures on exacerbation of existing asthma, little research on incident asthma and environmental exposures has been conducted.", {"entities": [[87, 93, "DISEASE"], [123, 129, "DISEASE"]]}], ["However, this research is needed to better devise strategies for the prevention of asthma.", {"entities": [[83, 89, "DISEASE"]]}], ["The U.S. Environmental Protection Agency (EPA) and National Institute of Environmental Health Sciences held a conference in October 2004 to collaboratively discuss a future research agenda in this area.", {"entities": []}], ["The first three articles in this mini-monograph summarize the discussion on potential putative environmental exposure; they include an overview of asthma and conclusions of the workshop participants with respect to public health actions that could currently be applied to the problem and research needs to better understand and control the induction and incidence of asthma, the potential role of indoor/outdoor air pollutants in the induction of asthma), and biologics in the induction of asthma.", {"entities": [[147, 153, "DISEASE"], [367, 373, "DISEASE"], [447, 453, "DISEASE"], [490, 496, "DISEASE"]]}], ["Susceptibility is a key concept in the U.S. EPA \u201cAsthma Research Strategy\u201d document and is associated with the U.S. EPA framework of protecting vulnerable populations from potentially harmful environmental exposures.", {"entities": [[49, 55, "DISEASE"]]}], ["Genetics, age, and lifestyle (obesity, diet) are major susceptibility factors in the induction of asthma and can interact with environmental exposures either synergistically or antagonistically.", {"entities": [[30, 37, "DISEASE"], [98, 104, "DISEASE"]]}], ["Therefore, in this fourth and last article we consider a number of \u201csusceptibility factors\u201d that potentially influence the asthmatic response to environmental exposures and propose a framework for developing research hypotheses regarding the effects of environmental exposures on asthma incidence and induction.", {"entities": [[280, 286, "DISEASE"]]}], ["Farmer\u2019s lung (FL) is a common type of hypersensitivity pneumonitis.", {"entities": []}], ["It is often considered that fibrosis is the most frequent finding in chronic FL.", {"entities": []}], ["Nevertheless, three cohort studies have suggested that some patients with chronic FL may develop emphysema.", {"entities": []}], ["We aimed to evaluate the current prevalence of emphysema in active FL, to describe the radiological and functional features of emphysema in active FL, and to identify risk factors associated with emphysema in this population.", {"entities": []}], ["Patients aged over 18 years with active FL were prospectively recruited through the SOPHIA study (CPP Est; P-2009-521), between 2007 and 2015.", {"entities": []}], ["Each patient had complete medical history screening, clinical examination, high resolution computed tomodensitometry, bronchoalveolar lavage, pulmonary function tests and serum precipitins.", {"entities": []}], ["Among 33 patients with active FL, the prevalence of emphysema in this series of incident active FL cases was higher (48.5%) than that of fibrosis (12%) and was not dependent on smoking habits.", {"entities": []}], ["Most patients with emphysema did not have lung hyperinflation.", {"entities": []}], ["The possible risk factors for emphysema in active FL were a longer duration of exposure to organic dusts, and at a higher level.", {"entities": []}], ["Emphysema is found in half of patients with active FL and may be influenced by exposure patterns.", {"entities": []}], ["This study aimed to estimate the prevalence of methicillin-susceptible and -resistant Staphylococcus aureus (MSSA and MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) nasopharyngeal carriage among Doctors of Podiatric Medicine (Podiatrists) and to determine the potential risk factors.", {"entities": []}], ["A cross-sectional study was carried out in 2016\u20132017 among 239 podiatrists in Spain.", {"entities": []}], ["The presence of MSSA, MRSA, and MRSE was determined by microbiological analysis of nasal exudate and antimicrobial susceptibility was determined.", {"entities": []}], ["Each podiatrist completed a questionnaire.", {"entities": []}], ["The questionnaire comprised various parameters such as sex, age, podiatry experience duration, underlying diseases, prior antibiotic treatment, hospitalization during the last year, and use of a protective mask, an aspiration system, or gloves.", {"entities": []}], ["The prevalence of MSSA, MRSA, and MRSE was 23.0%, 1.3%, and 23.8%, respectively.", {"entities": []}], ["The MSSA prevalence was higher among podiatrists who did not use an aspiration system (32.3%) compared to those who did (19.3%; p \u00a0=\u20090.0305), and among podiatrists with respiratory diseases (36.8%) compared to those without (20.8%; p \u00a0=\u20090.0272).", {"entities": []}], ["The MRSE prevalence was higher among men (33.7%) compared to women (8.6%; p \u00a0=\u20090.0089), podiatrists aged \u226550 (38.5%) compared to \u226435 (17.8%; p \u00a0=\u20090.0101), and podiatrists with \u226515 (39.3%) compared to \u22645\u00a0years of podiatry experience (12.5%; p \u00a0=\u20090.0015).", {"entities": []}], ["Among the S. aureus strains, 84.5% were resistant to penicillin, 22.4% to erythromycin, 20.7% to clindamycin, and 12.7% to mupirocin.", {"entities": []}], ["The MRSE strains were resistant to penicillin (93.0%), erythromycin (78.9%), and mupirocin (73.7%).", {"entities": []}], ["The prevalence of S. aureus and S. epidermidis nasal carriage is low among Spanish podiatrists compared to other health professionals.", {"entities": []}], ["The online version of this article (10.1186/s13756-018-0318-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["For the analysis of gene-environment (GxE) interactions commonly single nucleotide polymorphisms (SNPs) are used to characterize genetic susceptibility, an approach that mostly lacks power and has poor reproducibility.", {"entities": []}], ["One promising approach to overcome this problem might be the use of weighted genetic risk scores (GRS), which are defined as weighted sums of risk alleles of gene variants.", {"entities": []}], ["The gold-standard is to use external weights from published meta-analyses.", {"entities": []}], ["In this study, we used internal weights from the marginal genetic effects of the SNPs estimated by a multivariate elastic net regression and thereby provided a method that can be used if there are no external weights available.", {"entities": []}], ["We conducted a simulation study for the detection of GxE interactions and compared power and type I error of single SNPs analyses with Bonferroni correction and corresponding analysis with unweighted and our weighted GRS approach in scenarios with six risk SNPs and an increasing number of highly correlated (up to 210) and noise SNPs (up to 840).", {"entities": []}], ["Applying weighted GRS increased the power enormously in comparison to the common single SNPs approach (e.g.", {"entities": []}], ["94.2% vs. 35.4%, respectively, to detect a weak interaction with an OR\u00a0\u2248\u00a01.04 for six uncorrelated risk SNPs and n \u00a0=\u00a0700 with a well-controlled type I error).", {"entities": []}], ["Furthermore, weighted GRS outperformed the unweighted GRS, in particular in the presence of SNPs without any effect on the phenotype (e.g.", {"entities": []}], ["90.1% vs. 43.9%, respectively, when 20 noise SNPs were added to the six risk SNPs).", {"entities": []}], ["This outperforming of the weighted GRS was confirmed in a real data application on lung inflammation in the SALIA cohort ( n \u00a0=\u00a0402).", {"entities": []}], ["However, in scenarios with a high number of noise SNPs (>200 vs. 6 risk SNPs), larger sample sizes are needed to avoid an increased type I error, whereas a high number of correlated SNPs can be handled even in small samples (e.g.", {"entities": []}], ["In conclusion, weighted GRS with weights from the marginal genetic effects of the SNPs estimated by a multivariate elastic net regression were shown to be a powerful tool to detect gene-environment interactions in scenarios of high Linkage disequilibrium and noise.", {"entities": []}], ["The online version of this article (doi:10.1186/s12863-017-0519-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives: The aim of the present study is to compare cardiovascular safety profiles of two dental anesthetics: articaine versus two standard mepivacaine solutions used during etiological periodontal treatment in cardiovascular patients.", {"entities": []}], ["Study Design: Using a cross-over study design, ten cardiovascular patients were randomly assigned to dental treatment with 1.8mL of a local anesthetic injected on each quadrant of the mouth: Articaine (40mg with Epinephrine 0.5mg % and 40mg with Epinephrine 1mg %) or Mepivacaine (30mg and 20mg with Epinephrine 1mg %).", {"entities": []}], ["A computer programme enabled continuous longitudinal data collection: O2 saturation, blood pressure (BP) and heart rate (HR).", {"entities": [[121, 123, "GENE"]]}], ["Results: No severe clinical side effects were observed.", {"entities": []}], ["During the treatment period, we observed statistically significant differences as regards HR between injections with and without adrenalin (p< 0.039) and as regards systolic (p< 0.046) and diastolic (p < 0.046) blood pressure during the stabilization period.", {"entities": [[90, 92, "GENE"]]}], ["In both cases, the parameters under study increase.", {"entities": []}], ["Age, gender, jaw treated, treatment duration and the rest of cardiovascular variables did not affect the results.", {"entities": []}], ["None of the patients underwent ischemic alterations or any other complication derived from the treatment or the anesthesia.", {"entities": []}], ["Conclusions: According to the results of our study, dental anesthetics with standard concentrations of Epinephrine seem to alter HR and BP.", {"entities": [[129, 131, "GENE"]]}], ["Although no cardiac ischemic alterations or any other cardiovascular complications have been observed, we must be cautious with the administration of anesthetics containing vasoconstrictors in patients with cardiovascular diseases.", {"entities": []}], ["Key words: Dental anesthesia, cardiovascular diseases, chronic periodontitis, drug toxicity.", {"entities": [[63, 76, "DISEASE"]]}], ["LncRNA-ATB (lncRNA was activated by transforming growth factor-\u03b2) has been reported to be involved in specific physiological and pathological processes in human diseases, and could serve as biomarkers for cancers.", {"entities": []}], ["However, the role of lncRNA-ATB in coal workers\u2019 pneumoconiosis (CWP) is still unknown.", {"entities": [[49, 63, "DISEASE"]]}], ["This study aimed to investigate the association between lncRNA-ATB and CWP.", {"entities": []}], ["Quantitative real-time polymerase chain reaction was performed to detect plasma lncRNA-ATB expression in 137 CWP patients, 72 healthy coal miners and 168 healthy controls.", {"entities": []}], ["LncRNA-ATB was significantly upregulated in CWP ( p < 0.05).", {"entities": []}], ["Compared with the healthy controls and healthy coal miners, the odds ratios (ORs) (95% confidence interval (CI)) for CWP were 2.57 (1.52\u20134.33) and 2.17 (1.04\u20134.53), respectively.", {"entities": []}], ["LncRNA-ATB was positively associated with transforming growth factor-\u03b21 (TGF-\u03b21) ( r = 0.30, p = 0.003) and negative correlated with vital capacity (VC) ( r = \u22120.18, p = 0.033) and forced vital capacity (FVC) ( r = \u22120.18, p = 0.046) in CWP patients.", {"entities": []}], ["Compared with healthy controls, the area under the curve (AUC) was 0.84, resulting in a 71.17% sensitivity and 88.14% specificity.", {"entities": []}], ["When compared with healthy coal miners, the AUC was 0.83, the sensitivity and specificity were 70.07% and 86.36%, respectively.", {"entities": []}], ["LncRNA-ATB expression is commonly increased in CWP and significantly correlates with the TGF-\u03b21 in CWP patients.", {"entities": []}], ["Furthermore, elevated lncRNA-ATB was associated with CWP risk and may serve as a potential biomarker for CWP.", {"entities": []}], ["Periostin (PN, gene name POSTN) is an extracellular matrix protein that is up-regulated in bronchial epithelial cells and lung fibroblasts by TH-2 cytokines.", {"entities": [[25, 30, "GENE"]]}], ["Its paralog, TGF-\u03b2-induced protein (\u03b2ig-h3, gene name TGFBI), is also expressed in the lung and up-regulated in bronchial myofibroblasts by TGF-\u03b2.", {"entities": [[54, 59, "GENE"]]}], ["PN and \u03b2ig-h3 contain fasciclin 1 modules that harbor putative recognition sequences for \u03b3-glutamyl carboxylase and are annotated in UniProt as undergoing vitamin K-dependent \u03b3-carboxylation of multiple glutamic acid residues.", {"entities": []}], ["\u03b3-carboxylation profoundly alters activities of other proteins subject to the modification, e.g., blood coagulation factors, and would be expected to alter the structure and function of PN and \u03b2ig-h3.", {"entities": []}], ["To analyze for the presence of \u03b3-carboxylation, proteins extracted from fibrotic lung were reacted with monoclonal antibodies specific for PN, \u03b2ig-h3, or modification with \u03b3-carboxyglutamic acid (Gla).", {"entities": [[196, 199, "GENE"]]}], ["In Western blots of 1-dimensional gels, bands stained with anti-PN or -\u03b2ig-h3 did not match those stained with anti-Gla.", {"entities": []}], ["In 2-dimensional gels, anti-PN-positive spots had pIs of 7.0 to >8, as expected for the unmodified protein, and there was no overlap between anti-PN-positive and anti-Gla-positive spots.", {"entities": []}], ["Recombinant PN and blood coagulation factor VII were produced in HEK293 cells that had been transfected with vitamin K 2, 3-epoxide reductase C1 to optimize \u03b3-carboxylation.", {"entities": []}], ["Recombinant PN secreted from these cells did not react with anti-Gla antibody and had pIs similar to that found in extracts of fibrotic lung whereas secreted factor VII reacted strongly with anti-Gla antibody.", {"entities": []}], ["Over 67% coverage of recombinant PN was achieved by mass spectrometry, including peptides with 19 of the 24 glutamates considered targets of \u03b3-carboxylation, but analysis revealed no modification.", {"entities": []}], ["Over 86% sequence coverage and three modified glutamic acid residues were identified in recombinant fVII.", {"entities": []}], ["These data indicate that PN and \u03b2ig-h3 are not subject to vitamin K-dependent \u03b3-carboxylation.", {"entities": []}], ["Wheezing is a common symptom in early childhood.", {"entities": []}], ["However, refractory wheezing is difficult to treat, and it may thus account for extensive use of medical resources.", {"entities": []}], ["It is therefore important to improve our understanding of the pathophysiology of refractory childhood wheezing.", {"entities": []}], ["In this descriptive study, we studied 156 children with refractory wheezing using fiberoptic bronchoscopy and bronchoalveolar lavage (BAL), and compared the results with a control group of 46 children with various pulmonary diseases but no wheezing.", {"entities": []}], ["Etiology and cell classification were analyzed for each BAL sample.", {"entities": []}], ["Overall, 21.8\u00a0% of children with refractory wheezing had airway malformations including tracheomalacia, airway stenosis, and tracheal bronchus.", {"entities": []}], ["The incidence of airway malformations increased to 31\u00a0% in infants under 12\u00a0months of age.", {"entities": []}], ["A significant increase in neutrophil ratio and decrease in macrophage ratio were observed in BAL from children with refractory wheezing compared with controls.", {"entities": []}], ["Pathogen infection led to a higher ratio of neutrophils in the wheezing group compared with controls.", {"entities": []}], ["However, there were no significant differences in neutrophil ratios among children with various pathogen infections.", {"entities": []}], ["Furthermore, children with refractory wheezing had a high rate of Mycoplasma pneumoniae infection.", {"entities": []}], ["Airway malformations might play an important role in children under 3\u00a0years of age with refractory wheezing, especially in infants under 12\u00a0months of age.", {"entities": []}], ["Neutrophil-mediated airway inflammation was characteristic of refractory wheezing in children under 3\u00a0years of age.", {"entities": []}], ["In addition, infections such as M. pneumoniae may aggravate airway inflammation and affect refractory wheezing.", {"entities": []}], ["Seasonal influenza causes considerable morbidity and mortality across all age groups, and influenza vaccination was recommended in 2010 for all persons aged 6 months and above.", {"entities": [[9, 18, "DISEASE"], [90, 99, "DISEASE"]]}], ["We estimated the averted costs due to influenza vaccination, taking into account the seasonal economic burden of the disease.", {"entities": [[38, 47, "DISEASE"]]}], ["We used recently published values for averted outcomes due to influenza vaccination for influenza seasons 2005-06, 2006-07, 2007-08, and 2008-09, and age cohorts 6 months-4 years, 5-19 years, 20-64 years, and 65 years and above.", {"entities": [[62, 71, "DISEASE"], [88, 97, "DISEASE"]]}], ["Costs were calculated according to a payer and societal perspective (in 2009 US$), and took into account medical costs and productivity losses.", {"entities": []}], ["When taking into account direct medical costs (payer perspective), influenza vaccination was cost saving only for the older age group (65\u2265) in seasons 2005-06 and 2007-08.", {"entities": [[67, 76, "DISEASE"]]}], ["Using the same perspective, influenza vaccination resulted in total costs of $US 1.7 billion (95%CI: $US 0.3\u20134.0 billion) in 2006-07 and $US 1.8 billion (95%CI: $US 0.1\u20134.1 billion) in 2008-09.", {"entities": [[28, 37, "DISEASE"]]}], ["When taking into account a societal perspective (and including the averted lost earnings due to premature death) averted deaths in the older age group influenced the results, resulting in cost savings for all ages combined in season 07-08.", {"entities": []}], ["Influenza vaccination was cost saving in the older age group (65\u2265) when taking into account productivity losses and, in some seasons, when taking into account medical costs only.", {"entities": [[0, 9, "DISEASE"]]}], ["Averted costs vary significantly per season; however, in seasons where the averted burden of deaths is high in the older age group, averted productivity losses due to premature death tilt overall seasonal results towards savings.", {"entities": []}], ["Indirect vaccination effects and the possibility of diminished case severity due to influenza vaccination were not considered, thus the averted burden due to influenza vaccine may be even greater than reported.", {"entities": [[84, 93, "DISEASE"], [158, 167, "DISEASE"]]}], ["Microglial-mediated neuroinflammation has been established as playing a vital role in pathogenesis of neurodegenerative disorders.", {"entities": []}], ["Thus, rational regulation of microglia functions to inhibit inflammation injury may be a logical and promising approach to neurodegenerative disease therapy.", {"entities": [[123, 148, "DISEASE"]]}], ["The purposes of the present study were to explore the neuroprotective effects and potential molecular mechanism of Schizandrin A (Sch A), a lignin compound isolated from Schisandra chinesnesis .", {"entities": []}], ["Our observations showed that Sch A could significantly down-regulate the increased production of nitric oxide (NO), tumor necrosis factor (TNF)-\u03b1 and interleukin (IL)-6 induced by lipopolysaccharide (LPS) both in BV-2 cells and primary microglia cells.", {"entities": [[139, 142, "GENE"]]}], ["Moreover, Sch A exerted obvious neuroprotective effects against inflammatory injury in neurons when exposed to microglia-conditioned medium.", {"entities": []}], ["Investigations of the mechanism showed the anti-inflammatory effect of Sch A involved the inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expression levels and inhibition of the LPS-induced TRAF6-IKK\u03b2-NF-\u03baB pathway.", {"entities": []}], ["Furthermore, inhibition of Jak2-Stat3 pathway activation and Stat3 nuclear translocation also was observed.", {"entities": [[32, 37, "GENE"], [61, 66, "GENE"]]}], ["In conclusion, SchA can exert anti-inflammatory and neuroprotective effects by alleviating microglia-mediated neuroinflammation injury through inhibiting the TRAF6-IKK\u03b2-NF-\u03baB and Jak2-Stat3 signaling pathways.", {"entities": []}], ["We evaluated the characteristics of and treatment outcomes in patients with benign tracheobronchial tumors.", {"entities": []}], ["We reviewed the records of patients with benign tracheobronchial tumors who underwent bronchoscopic intervention with mechanical removal and Nd: YAG laser cauterization, and evaluated the characteristics and treatment outcomes of 55 patients with hamartomas, leiomyomas, papillomas, typical carcinoids, or schwannomas seen between April 1999 and July 2012.", {"entities": []}], ["The most common tumors were hamartoma (n=24), leiomyoma (n=16), papilloma (n=7), typical carcinoid (n=5), and schwannoma (n=3).", {"entities": [[46, 55, "DISEASE"], [64, 73, "DISEASE"]]}], ["Forty-one patients (75%) had symptoms.", {"entities": []}], ["On chest computed tomography, 35 patients (64%) had round or ovoid lesions, accompanied by atelectasis (n=26, 47%) or obstructive pneumonia (n=17, 31%).", {"entities": [[130, 139, "DISEASE"]]}], ["Fatty components (n=9, 16%) and calcifications (n=7, 13%) were observed only in hamartomas, leiomyomas, and typical carcinoids.", {"entities": []}], ["At bronchoscopy, the typical findings were categorized according to tumor shape, surface, color, and visible vessels.", {"entities": []}], ["Fifty (91%) patients underwent complete resection.", {"entities": []}], ["Forty patients (73%) achieved successful bronchoscopic removal defined as complete resection without complications or recurrence.", {"entities": []}], ["Recurrences occurred in four papillomas, one leiomyoma, and one typical carcinoid.", {"entities": [[45, 54, "DISEASE"]]}], ["The proportions of tumor types ( p =0.029) differed between the successful and unsuccessful removal groups, and a pedunculated base ( p <0.001) and no spontaneous bleeding ( p =0.037) were more frequent in the successful removal group.", {"entities": []}], ["We described clinical, radiological, and typical bronchoscopic findings in patients with benign tracheobronchial tumors; these findings might help to differentiate such tumors.", {"entities": []}], ["Bronchoscopic intervention was a useful treatment modality, and tumor type, pedunculated base, and vascularity may influence successful tumor removal.", {"entities": []}], ["Medications with methyl-prednisolone sodium succinate containing lactose, which potentially contains traces of cow\u2019s milk proteins (CMP), could cause allergic reactions or compromise treatment of acute allergic reactions in sensitized patients.", {"entities": []}], ["We describe the unusual case of a one-year-old child affected by short bowel syndrome and history of severe cow\u2019s milk allergy (CMA) and anaphylactic reaction due to intravenous administration of methyl-prednisolone sodium succinate (Solu-Medrol 40\u00a0mg, Pfizer).", {"entities": [[65, 85, "DISEASE"], [77, 85, "DISEASE"]]}], ["He was admitted to our hospital for severe respiratory failure and was initially treated with methyl-prednisolone (Urbason 40\u00a0mg, Sanofi Aventis), then with methyl-prednisolone sodium succinate (Solu-Medrol 40\u00a0mg, Pfizer).", {"entities": [[43, 62, "DISEASE"]]}], ["After the intravenous administration of second steroid, immediate anaphylaxis was recorded and treatment was stopped.", {"entities": []}], ["Antihistamine and epinephrine were required and symptom resolution occurred.", {"entities": []}], ["Children who are highly sensitive to milk may have severe allergic reactions also after exposure to CMP through a different administration route than the oral one.", {"entities": []}], ["Patients who have food allergies need to pay particular attention to the prescription of drugs and their formulation.", {"entities": []}], ["Pain and itch are closely related sensations, yet qualitatively quite distinct.", {"entities": []}], ["Despite recent advances in brain imaging techniques, identifying the differences between pain and itch signals in the brain cortex is difficult due to continuous temporal and spatial changes in the signals.", {"entities": []}], ["The high spatial resolution of positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) has substantially advanced research of pain and itch, but these are uncomfortable because of expensiveness, importability and the limited operation in the shielded room.", {"entities": []}], ["Here, we used near infrared spectroscopy (NIRS), which has more conventional usability.", {"entities": []}], ["NIRS can be used to visualize dynamic changes in oxygenated hemoglobin and deoxyhemoglobin concentrations in the capillary networks near activated neural circuits in real-time as well as fMRI.", {"entities": []}], ["We observed distinct activation patterns in the frontal cortex for acute pain and histamine-induced itch.", {"entities": []}], ["The prefrontal cortex exhibited a pain-related and itch-related activation pattern of blood flow in each subject.", {"entities": []}], ["Although it looked as though that activation pattern for pain and itching was different in each subject, further cross correlation analysis of NIRS signals between each channels showed an overall agreement with regard to prefrontal area involvement.", {"entities": []}], ["As a result, pain-related and itch-related blood flow responses (delayed responses in prefrontal area) were found to be clearly different between pain ( \u03c4 \u200a=\u200a+18.7 sec) and itch ( \u03c4 \u200a=\u200a+0.63 sec) stimulation.", {"entities": []}], ["This is the first pilot study to demonstrate the temporal and spatial separation of a pain-induced blood flow and an itch-induced blood flow in human cortex during information processing.", {"entities": []}], ["Although medical treatment of COPD has advanced, nonadherence to medication regimens poses a significant barrier to optimal management.", {"entities": []}], ["Underuse, overuse, and improper use continue to be the most common causes of poor adherence to therapy.", {"entities": []}], ["An average of 40%\u201360% of patients with COPD adheres to the prescribed regimen and only 1 out of 10 patients with a metered dose inhaler performs all essential steps correctly.", {"entities": []}], ["Adherence to therapy is multifactorial and involves both the patient and the primary care provider.", {"entities": []}], ["The effect of patient instruction on inhaler adherence and rescue medication utilization in patients with COPD does not seem to parallel the good results reported in patients with asthma.", {"entities": [[180, 186, "DISEASE"]]}], ["While use of a combined inhaler may facilitate adherence to medications and improve efficacy, pharmacoeconomic factors may influence patient\u2019s selection of both the device and the regimen.", {"entities": []}], ["Patient\u2019s health beliefs, experiences, and behaviors play a significant role in adherence to pharmacological therapy.", {"entities": []}], ["This manuscript reviews important aspects associated with medication adherence in patients with COPD and identifies some predictors of poor adherence.", {"entities": []}], ["Objectives: To analyze the impact of caesarean section (CS) on mode of delivery, pregnancy-induced and pregnancy-associated disorders, as well as complications in the subsequent pregnancy within German gynecological practices.", {"entities": [[56, 58, "GENE"]]}], ["Methods: 1,801 women with CS and 1,801 matched women with vaginal delivery (VD) from the IMS Disease Analyzer database were included.", {"entities": [[26, 28, "GENE"]]}], ["The impact of previous CS on the mode of delivery and pregnancy-associated disorders as well as complications prior to or during birth in the subsequent pregnancy were analyzed.", {"entities": [[23, 25, "GENE"]]}], ["Cox regressions were used to determine the influence of CS with regard to these outcomes.", {"entities": [[56, 58, "GENE"]]}], ["Results: Medical abortion and single spontaneous delivery were significantly less frequent in women with a history of CS compared to VD (OR equal to 0.52 and 0.04 respectively), whereas CS after CS was the significantly more common mode of delivery (79.0% versus 9.3%, OR=36.47).", {"entities": [[118, 120, "GENE"], [186, 188, "GENE"], [195, 197, "GENE"], [118, 120, "GENE"], [186, 188, "GENE"], [195, 197, "GENE"], [118, 120, "GENE"], [186, 188, "GENE"], [195, 197, "GENE"]]}], ["Gestational hypertension without significant proteinuria, gestational hypertension with significant proteinuria, and polyhydramnios were more frequent in women with CS than in women with VD (OR equal to 6.80, 1.71, and 2.29).", {"entities": [[12, 24, "DISEASE"], [70, 82, "DISEASE"], [45, 56, "DISEASE"], [100, 111, "DISEASE"], [117, 131, "DISEASE"], [165, 167, "GENE"]]}], ["Hemorrhage and maternal care for known or suspected disproportion were more common in the CS group than in the VD group (OR equal to 1.34 and 3.75).", {"entities": [[90, 92, "GENE"]]}], ["Prolonged pregnancy, preterm labor, abnormalities arising from forces of labor, and perineal laceration during delivery were significantly less frequent in women with CS than in women with VD (OR between 0.32 and 0.75), whereas long labor was more common (OR=2.09).", {"entities": [[167, 169, "GENE"]]}], ["Conclusion: Women with CS were more likely to undergo further CS and to develop major pregnancy-associated diseases in the following pregnancy compared to women with VD.", {"entities": [[23, 25, "GENE"], [62, 64, "GENE"], [23, 25, "GENE"], [62, 64, "GENE"]]}], ["In the general population, physical activity is associated with improved health outcomes.", {"entities": []}], ["However, long-term sports participation may be associated with adverse outcomes, particularly at the elite level.", {"entities": []}], ["The aims of this study were to assess morbidity and health-related quality of life (HrQoL) amongst former rugby players, compared to an age-standardised general population sample.", {"entities": []}], ["A cross-sectional study of former elite, male, rugby players (n\u2009=\u2009259) was undertaken, and standardised morbidity ratios (SMR) calculated, assessing morbidity prevalence relative to English Longitudinal Study of Aging participants (ELSA, n\u2009=\u20095186).", {"entities": []}], ["HrQoL, measured using the EQ-5D, was compared to a Health Survey for England (HSE, n\u2009=\u20092981) sample.", {"entities": []}], ["In SMR analyses of participants aged 50+, diabetes was significantly lower amongst former players, (0.28, 95% CI 0.11\u20130.66), whereas osteoarthritis (4.00, 95% CI 3.32\u20134.81), joint replacement (6.02, 95% CI 4.66\u20137.77), osteoporosis (2.69, 95% CI 1.35\u20135.38), and anxiety (2.00, 95% CI 1.11\u20133.61) were significantly higher.", {"entities": [[218, 230, "DISEASE"], [133, 147, "DISEASE"]]}], ["More problems in HrQoL were reported amongst former players within the domains of mobility (p\u2009<\u20090.001), self-care (p\u2009=\u20090.041), usual activities (p\u2009<\u20090.001) and pain/discomfort (p\u2009<\u20090.001).", {"entities": []}], ["Morbidity and HrQoL differ between players and the general population, with higher musculoskeletal morbidity and lower diabetes amongst former players.", {"entities": []}], ["The magnitude of musculoskeletal morbidity may warrant proactive osteoarthritis management within this population.", {"entities": [[65, 79, "DISEASE"]]}], ["Bryophyllum pinnata ( B. pinnata ) is a common medicinal plant used in traditional medicine of India and of other countries for curing various infections, bowel diseases, healing wounds and other ailments.", {"entities": []}], ["However, its anticancer properties are poorly defined.", {"entities": []}], ["In view of broad spectrum therapeutic potential of B. pinnata we designed a study to examine anti-cancer and anti-Human Papillomavirus (HPV) activities in its leaf extracts and tried to isolate its active principle.", {"entities": [[98, 104, "DISEASE"]]}], ["A chloroform extract derived from a bulk of botanically well-characterized pulverized B .", {"entities": []}], ["pinnata leaves was separated using column chromatography with step- gradient of petroleum ether and ethyl acetate.", {"entities": []}], ["Fractions were characterized for phyto-chemical compounds by TLC, HPTLC and NMR and Biological activity of the fractions were examined by MTT-based cell viability assay, Electrophoretic Mobility Shift Assay, Northern blotting and assay of apoptosis related proteins by immunoblotting in human cervical cancer cells.", {"entities": [[302, 308, "DISEASE"], [293, 308, "DISEASE"]]}], ["Results showed presence of growth inhibitory activity in the crude leaf extracts with IC 50 at 552 \u03bcg/ml which resolved to fraction F4 (Petroleum Ether: Ethyl Acetate:: 50:50) and showed IC 50 at 91 \u03bcg/ml.", {"entities": []}], ["Investigations of anti-viral activity of the extract and its fraction revealed a specific anti-HPV activity on cervical cancer cells as evidenced by downregulation of constitutively active AP1 specific DNA binding activity and suppression of oncogenic c-Fos and c-Jun expression which was accompanied by inhibition of HPV18 transcription.", {"entities": [[120, 126, "DISEASE"], [111, 126, "DISEASE"]]}], ["In addition to inhibiting growth, fraction F4 strongly induced apoptosis as evidenced by an increased expression of the pro-apoptotic protein Bax, suppression of the anti-apoptotic molecules Bcl-2, and activation of caspase-3 and cleavage of PARP-1.", {"entities": [[142, 145, "GENE"]]}], ["Phytochemical analysis of fraction F4 by HPTLC and NMR indicated presence of activity that resembled Bryophyllin A.", {"entities": []}], ["Our study therefore demonstrates presence of anticancer and anti-HPV an activity in B .", {"entities": []}], ["pinnata leaves that can be further exploited as a potential anticancer, anti-HPV therapeutic for treatment of HPV infection and cervical cancer.", {"entities": [[137, 143, "DISEASE"], [128, 143, "DISEASE"]]}], ["Evidence is mounting that environmental exposures contribute to causation of disease in children.", {"entities": []}], ["Yet few pediatricians are trained to diagnose, treat, or prevent disease of environmental origin.", {"entities": []}], ["To develop a cadre of future leaders in pediatric environmental health (PEH), the Ambulatory Pediatric Association (APA) launched a new 3-year fellowship in 2001\u2014the world\u2019s first formal training program in PEH.", {"entities": []}], ["Sites were established at Boston Children\u2019s Hospital, Mount Sinai School of Medicine, George Washington University, University of Cincinnati, and University of Washington.", {"entities": []}], ["Fellows are trained in epidemiology, biostatistics, toxicology, risk assessment, and preventive medicine.", {"entities": []}], ["They gain clinical experience in environmental pediatrics and mentored training in clinical research, policy development, and evidence-based advocacy.", {"entities": []}], ["Thirteen fellows have graduated.", {"entities": []}], ["Two sites have secured follow-on federal funding to enable them to continue PEH training.", {"entities": []}], ["To assess objectively the program\u2019s success in preparing fellows for leadership careers in PEH, we conducted a mailed survey in 2006 with follow-up in 2007.", {"entities": []}], ["Fifteen (88%) of 17 fellows and graduates participated; program directors provided information on the remaining two.", {"entities": []}], ["Nine graduates are pursuing full-time academic careers, and two have leadership positions in governmental and environmental organizations.", {"entities": []}], ["Ten have published one or more first-authored papers.", {"entities": []}], ["Seven graduates are principal investigators on federal or foundation grants.", {"entities": []}], ["The strongest predictors of academic success are remaining affiliated with the fellowship training site and devoting < 20% of fellowship time to clinical practice.", {"entities": []}], ["The APA fellowship program is proving successful in preparing pediatricians for leadership careers in PEH.", {"entities": []}], ["In most countries chronic diseases lead to high health care costs and reduced productivity of people in society.", {"entities": []}], ["The best way to reduce costs of health sector and increase the empowerment of people is prevention of chronic diseases and appropriate health activities management through monitoring of patients.", {"entities": []}], ["To enjoy the full benefits of E-health, making use of methods and modern technologies is very important.", {"entities": []}], ["this literature review articles were searched with keywords like Patient monitoring, Mobile Health, and Chronic Disease in Science Direct, Google Scholar and Pub Med databases without regard to the year of publications.", {"entities": []}], ["Applying remote medical diagnosis and monitoring system based on mobile health systems can help significantly to reduce health care costs, correct performance management particularly in chronic disease management.", {"entities": []}], ["Also some challenges are in patient monitoring in general and specific aspects like threats to confidentiality and privacy, technology acceptance in general and lack of system interoperability with electronic health records and other IT tools, decrease in face to face communication between doctor and patient, sudden interruptions of telecommunication networks, and device and sensor type in specific aspect.", {"entities": []}], ["It is obvious identifying the opportunities and challenges of mobile technology and reducing barriers, strengthening the positive points will have a significant role in the appropriate planning and promoting the achievements of the health care systems based on mobile and helps to design a roadmap for improvement of mobile health.", {"entities": []}], ["We performed a review of studies of fluticasone propionate (FP)/salmeterol (SAL) (combination inhaled corticosteroid (ICS)/long-acting \u03b22-agonist (LABA)) in patients with COPD, which measured baseline (pretreatment) blood eosinophil levels, to test whether blood eosinophil levels \u22652% were associated with a greater reduction in exacerbation rates with ICS therapy.", {"entities": []}], ["Three studies of \u22651-year duration met the inclusion criteria.", {"entities": []}], ["Moderate and severe exacerbation rates were analysed according to baseline blood eosinophil levels (<2% vs \u22652%).", {"entities": []}], ["At baseline, 57\u201375% of patients had \u22652% blood eosinophils.", {"entities": []}], ["Changes in FEV 1 and St George's Respiratory Questionnaire (SGRQ) scores were compared by eosinophil level.", {"entities": [[11, 14, "GENE"]]}], ["For patients with \u22652% eosinophils, FP/SAL was associated with significant reductions in exacerbation rates versus tiotropium (INSPIRE: n=719, rate ratio (RR)=0.75, 95% CI 0.60 to 0.92, p=0.006) and versus placebo (TRISTAN: n=1049, RR=0.63, 95% CI 0.50 to 0.79, p<0.001).", {"entities": []}], ["No significant difference was seen in the <2% eosinophil subgroup in either study (INSPIRE: n=550, RR=1.18, 95% CI 0.92 to 1.51, p=0.186; TRISTAN: n=354, RR=0.99, 95% CI 0.67 to 1.47, p=0.957, respectively).", {"entities": []}], ["In SCO30002 (n=373), no significant effects were observed (FP or FP/SAL vs placebo).", {"entities": []}], ["No relationship was observed in any study between eosinophil subgroup and treatment effect on FEV 1 and SGRQ.", {"entities": [[94, 97, "GENE"]]}], ["Baseline blood eosinophil levels may represent an informative marker for exacerbation reduction with ICS/LABA in patients with COPD and a history of moderate/severe exacerbations.", {"entities": []}], ["The few previous studies examining the influence of the neighborhood context on health and health behavior among young gay, bisexual, and other men who have sex with men (YMSM) have predominantly focused on residential neighborhoods.", {"entities": []}], ["No studies have examined multiple neighborhood contexts among YMSM or the relationships between sociodemographic characteristics, psychosocial factors, social support network characteristics, health behaviors, and neighborhood concordance.", {"entities": []}], ["In this study, we assessed spatial polygamy by determining the amount of concordance between residential, social, and sex neighborhoods (defined as boroughs) in addition to examining individual-level characteristics that may be associated with neighborhood concordance.", {"entities": []}], ["These data come from the baseline assessment of Project 18, a cohort of racially and ethnically diverse YMSM residing in the New York City metropolitan area.", {"entities": []}], ["Participants (N = 598) provided information on their residential, social, and sex boroughs as well as information on their sociodemographic characteristics, psychosocial factors, social support network characteristics, and health behaviors (e.g., substance use and condomless sex).", {"entities": []}], ["Descriptive analyses were conducted to examine the distribution of boroughs reported across all three contexts, i.e.", {"entities": []}], [", residential, social, and sex boroughs.", {"entities": []}], ["Next, concordance between: (1) residential and social boroughs; (2) residential and sex boroughs; (3) social and sex boroughs; and (4) residential, social, and sex boroughs was assessed.", {"entities": []}], ["Finally, bivariable analyses were conducted to examine the relationships between sociodemographic characteristics, psychosocial factors, social support network characteristics, and health behaviors in relation to borough concordance.", {"entities": []}], ["Approximately two-thirds of participants reported concordance between residential/socializing, residential/sex, and sex/socializing boroughs, whereas 25% reported concordance between all three residential/socializing/sex boroughs.", {"entities": []}], ["Borough concordance varied by some individual-level characteristics.", {"entities": []}], ["For example, White YMSM and YMSM reporting lower perceived socioeconomic status were significantly more likely to report residential/socializing/sex borough concordance ( p < 0.001).", {"entities": []}], ["With regard to psychosocial factors, YMSM who reported experiencing gay-related stigma in public forums were more likely to report discordant socializing/sex and residential/socializing/sex boroughs ( p < 0.001).", {"entities": []}], ["Greater frequency of communication with network members (\u2265weekly) was associated with less residential/social borough concordance ( p < 0.05).", {"entities": []}], ["YMSM who reported residential/socializing/sex borough concordance were more likely to report recent (last 30 days) alcohol use, recent marijuana use, and recently engaging in condomless oral sex (all p < 0.05).", {"entities": []}], ["These findings suggest that spatial polygamy, or an individual moving across and experiencing multiple neighborhood contexts, is prevalent among urban YMSM and that spatial polygamy varies by multiple individual-level characteristics.", {"entities": []}], ["Future research among YMSM populations should consider multiple neighborhood contexts in order to provide a more nuanced understanding of how and which neighborhood contexts influence the health and well-being of YMSM.", {"entities": []}], ["This further examination of spatial polygamy (and individual-level characteristics associated with it) may increase understanding of the most appropriate locations for targeted disease prevention and health promotion interventions (e.g., HIV prevention interventions).", {"entities": []}], ["Most studies conducted at general practices investigate complex interventions and increasingly use cluster-randomised controlled trail (c-RCT) designs to do so.", {"entities": []}], ["Our primary objective is to evaluate how frequently complex interventions are shown to be more, equally or less effective than routine care in c-RCTs with a superior design.", {"entities": []}], ["The secondary aim is to discover whether the quality of a c-RCT determines the likelihood of the complex intervention being effective.", {"entities": []}], ["All c-RCTs of any design that have a patient-relevant primary outcome and with a duration of at least 1\u2005year will be included.", {"entities": []}], ["The search will be performed in three electronic databases (MEDLINE, EMBASE and the Cochrane Database of Systematic Reviews (CDSR)).", {"entities": []}], ["The screening process, data collection, quality assessment and statistical data analyses (if suitably similar and of adequate quality) will be performed in accordance with requirements of the Cochrane Handbook for Systematic Reviews of Interventions.", {"entities": []}], ["A feasibility project was carried out that was restricted to a search in MEDLINE and the CCTR for c-RCTs published in 1 of the 8 journals that are most relevant to general practice.", {"entities": []}], ["The process from trial selection to data collection, assessment and results presentation was piloted.", {"entities": []}], ["Of the 512 abstracts identified during the feasibility search, 21 studies examined complex interventions in a general practice setting.", {"entities": []}], ["Extrapolating the preliminary search to include all relevant c-RCTs in three databases, about 5000 abstracts and 150 primary studies are expected to be identified in the main study.", {"entities": []}], ["14 studies included in the feasibility project (67%) did not show a positive effect on a primary patient-relevant end point.", {"entities": []}], ["Ethical approval is not being sought for this review.", {"entities": []}], ["Findings will be disseminated via peer-reviewed journals that frequently publish articles on the results of c-RCTs and through presentations at international conferences.", {"entities": []}], ["PROSPERO CRD201400923.", {"entities": []}], ["A progressive global increase in the burden of allergic diseases has affected the industrialized world over the last half century and has been reported in the literature.", {"entities": []}], ["The clinical evidence reveals a general increase in both incidence and prevalence of respiratory diseases, such as allergic rhinitis (common hay fever) and asthma.", {"entities": [[115, 132, "DISEASE"], [124, 132, "DISEASE"], [156, 162, "DISEASE"]]}], ["Such phenomena may be related not only to air pollution and changes in lifestyle, but also to an actual increase in airborne quantities of allergenic pollen.", {"entities": []}], ["Experimental enhancements of carbon dioxide (CO ) have demonstrated changes in pollen amount and allergenicity, but this has rarely been shown in the wider environment.", {"entities": []}], ["The present analysis of a continental-scale pollen data set reveals an increasing trend in the yearly amount of airborne pollen for many taxa in Europe, which is more pronounced in urban than semi-rural/rural areas.", {"entities": []}], ["Climate change may contribute to these changes, however increased temperatures do not appear to be a major influencing factor.", {"entities": []}], ["Instead, we suggest the anthropogenic rise of atmospheric CO levels may be influential.", {"entities": []}], ["The question of the protective effect of breastfeeding on development of asthma has raised substantial interest, but the scientific evidence of the optimal duration of breastfeeding is controversial.", {"entities": [[73, 79, "DISEASE"]]}], ["The authors elaborated the optimal duration of breastfeeding with respect to the risk of asthma primarily, and secondarily to the risk of persistent wheezing, cough and phlegm in school age in a population-based cohort study with the baseline in 1991 and follow-up in 1997.", {"entities": [[89, 95, "DISEASE"]]}], ["The study population comprised 1984 children aged 7 to 14 years at the end of the follow-up (follow-up rate 77).", {"entities": []}], ["Information on breastfeeding was based on the baseline survey and information on the health outcomes at the follow-up.", {"entities": []}], ["There was a U-shaped relation between breastfeeding and the outcomes with the lowest risk with breastfeeding from four to nine months for asthma and seven to nine months for persistent wheezing, cough and phlegm.", {"entities": [[138, 144, "DISEASE"]]}], ["Our results suggest a U shape relation between duration of breastfeeding and risk of asthma with an optimal duration of 4 to 6 months.", {"entities": [[85, 91, "DISEASE"]]}], ["A true concave relation would explain the inconsistent results from the previous studies.", {"entities": []}], ["Interstitial lung disease (ILD) is a challenging clinical entity associated with multiple connective tissue diseases, and is a significant cause of morbidity and mortality.", {"entities": [[0, 25, "DISEASE"], [13, 25, "DISEASE"]]}], ["Effective therapies for connective tissue disease-associated interstitial lung disease (CTD-ILD) are still lacking.", {"entities": [[61, 86, "DISEASE"], [24, 49, "DISEASE"], [74, 86, "DISEASE"]]}], ["Multidisciplinary clinics dedicated to the early diagnosis and improved management of patients with CTD-ILD are now being established.", {"entities": []}], ["There is rapid progress in understanding and identifying the effector cells, the proinflammatory and profibrotic mediators, and the pathways involved in the pathogenesis of CTD-ILD.", {"entities": []}], ["Serum biomarkers may provide new insights as risk factors for pulmonary fibrosis and as measures of disease progression.", {"entities": [[62, 80, "DISEASE"]]}], ["Despite these recent advances, the management of patients with CTD-ILD remains suboptimal.", {"entities": []}], ["Further studies are therefore urgently needed to better understand these conditions, and to develop effective therapeutic interventions.", {"entities": []}], ["Clinical practice in chronic obstructive pulmonary disease (COPD) can be influenced by weather variability throughout the year.", {"entities": [[21, 58, "DISEASE"]]}], ["To explore the hypothesis of seasonal variability in clinical practice, the present study analyzes the results of the 2013\u20132014 Andalusian COPD audit with regard to changes in clinical practice according to the different seasons.", {"entities": []}], ["The Andalusian COPD audit was a pilot clinical project conducted from October 2013 to September 2014 in outpatient respiratory clinics of hospitals in Andalusia, Spain (8 provinces with more than 8 million inhabitants) with retrospective data gathering.", {"entities": []}], ["For the present analysis, astronomical seasons in the Northern Hemisphere were used as reference.", {"entities": []}], ["Bivariate associations between the different COPD guidelines and the clinical practice changes over the seasons were explored by using binomial multivariate logistic regression analysis with age, sex, Charlson comorbidity index, type of hospital, and COPD severity by forced expiratory volume in 1 second as covariates, and were expressed as odds ratio (OR) with 95% confidence intervals (CIs).", {"entities": []}], ["The Andalusian COPD audit included 621 clinical records from 9 hospitals.", {"entities": []}], ["After adjusting for covariates, only inhaler device satisfaction evaluation was found to significantly differ according to the seasons with an increase in winter (OR, 3.460; 95% CI, 1.469\u20138.151), spring (OR, 4.215; 95% CI, 1.814\u20139.793), and summer (OR, 3.371; 95% CI, 1.391\u20138.169) compared to that in autumn.", {"entities": []}], ["The rest of the observed differences were not significant after adjusting for covariates.", {"entities": []}], ["However, compliance with evaluating inhaler satisfaction was low.", {"entities": []}], ["The various aspects of clinical practice for COPD care were found to be quite homogeneous throughout the year for the variables evaluated.", {"entities": []}], ["Inhaler satisfaction evaluation, however, presented some significant variation during the year.", {"entities": []}], ["Inhaler device satisfaction should be evaluated during all clinical visits throughout the year for improved COPD management.", {"entities": []}], ["The convergent distribution of the Human Immunodeficiency Virus (HIV) and helminth infections has led to the suggestion that infection with helminths exacerbates the HIV epidemic in developing countries.", {"entities": []}], ["In South Africa, it is estimated that 57% of the population lives in poverty and carries the highest burden of both HIV and helmith infections, however, the disease interactions are under-researched.", {"entities": []}], ["We employed both coproscopy and Ascaris lumbricoides -specific serum IgE to increase diagnostic sensitivity and to distinguish between different helminth infection phenotypes and their effects on immune responses in HIV co-infected individuals.", {"entities": []}], ["Coproscopy was done by formol ether and Kato Katz methods.", {"entities": []}], ["HIV positive and negative adults were stratified according to the presence or absence of A. lumbricoides and/or Trichuris trichuria eggs with or without elevated Ascaris IgE.", {"entities": []}], ["Lymphocyte subsets were phenotyped by flow cytometry.", {"entities": []}], ["Viral loads, serum total IgE and eosinophils were also analysed.", {"entities": []}], ["Lymphocyte activation markers (CCR5, HLA-DR, CD25, CD38 and CD71) were determined.", {"entities": [[31, 35, "GENE"], [51, 55, "GENE"]]}], ["Non parametric statistics were used to describe differences in the variables between the subgroups.", {"entities": []}], ["Helminth prevalence ranged between 40%-60%.", {"entities": []}], ["Four distinct subgroups of were identified, and this included egg positive/high Ascaris -specific IgE (egg Ascaris IgE subgroups (egg 2 immune profile with a relatively competent response to HIV.", {"entities": []}], ["People with both helminth egg excretion and high Ascaris -IgE levels had dysregulated immune cells, high viral loads with more immune activation.", {"entities": []}], ["A modified Th 2 helminth response in individuals with egg positive stools and low Ascaris IgE showed a better HIV related immune profile.", {"entities": []}], ["Future research on helminth-HIV co-infection should include parasite-specific IgE measurements in addition to coproscopy to delineate the different response phenotypes.", {"entities": []}], ["Helminth infection affects the immune response to HIV in some individuals with high IgE and egg excretion in stool.", {"entities": []}], ["Melioidosis is an endemic disease caused by the bacterium Burkholderia pseudomallei .", {"entities": [[0, 11, "DISEASE"]]}], ["Concerns exist regarding B. pseudomallei use as a potential bio-threat agent causing persistent infections and typically manifesting as severe pneumonia capable of causing fatal bacteremia.", {"entities": [[143, 152, "DISEASE"]]}], ["Development of suitable therapeutics against melioidosis is complicated due to high degree of genetic and phenotypic variability among B. pseudomallei isolates and lack of data establishing commonly accepted strains for comparative studies.", {"entities": [[45, 56, "DISEASE"]]}], ["Further, the impact of strain variation on virulence, disease presentation, and mortality is not well understood.", {"entities": []}], ["Therefore, this study evaluate and compare the virulence and disease progression of B. pseudomallei strains K96243 and HBPUB10303a, following aerosol challenge in a standardized BALB/c mouse model of infection.", {"entities": []}], ["The natural history analysis of disease progression monitored conditions such as weight, body temperature, appearance, activity, bacteremia, organ and tissue colonization (pathological and histological analysis) and immunological responses.", {"entities": []}], ["This study provides a detailed, direct comparison of infection with different B. pseudomallei strains and set up the basis for a standardized model useful to test different medical countermeasures against Burkholderia species.", {"entities": []}], ["Further, this protocol serves as a guideline to standardize other bacterial aerosol models of infection or to define biomarkers of infectious processes caused by other intracellular pathogens.", {"entities": []}], ["Telephone survey (TS) has been a popular tool for conducting health surveys, particularly in developed countries.", {"entities": []}], ["However, the feasibility, and reliability of TS are not adequately explored in Sri Lanka.", {"entities": []}], ["The main aim of this study is to assess the effectiveness of telephone-based survey in estimating the prevalence of common non-communicable diseases (NCDs) in Sri Lanka.", {"entities": []}], ["We carried out an observational cross-sectional study using telephone interview method in Galle district, Sri Lanka.", {"entities": []}], ["The study participants were selected randomly from the residents living in the households with fixed land telephone lines.", {"entities": []}], ["The prevalence of the main NCDs was estimated using descriptive statistics.", {"entities": []}], ["Overall, 975 telephone numbers belonging to six main areas of Galle district were called, and 48% agreed to participate in the study.", {"entities": []}], ["Of the non-respondents, 22% actively declined to participate.", {"entities": []}], ["Data on NCDs were gathered from 1470 individuals.", {"entities": []}], ["The most common self-reported NCD was hypertension (17.%), followed by diabetes (16.3%) and dyslipidaemia (15.6%).", {"entities": [[38, 50, "DISEASE"]]}], ["Smoking was exclusively seen in males (7.4%), and regular alcohol use was significantly more common in males (19.2%) than females (0.4%, P \u2009<\u2009.001).", {"entities": []}], ["Our study revealed average response rate for telephone based interview in Sri Lankan setting.", {"entities": []}], ["Overall prevalence of main NCDs in this study showed a comparable prevalence to studies used face to face interview method.", {"entities": []}], ["This study supports the potential use of telephone-based survey to assess heath related information in Sri Lanka.", {"entities": []}], ["Atopic eczema (AE) is a common chronic inflammatory skin disorder.", {"entities": []}], ["In order to dissect the genetic background several linkage and genetic association studies have been performed.", {"entities": []}], ["Yet very little is known about specific genes involved in this complex skin disease, and the underlying molecular mechanisms are not fully understood.", {"entities": [[71, 83, "DISEASE"]]}], ["We used human DNA microarrays to identify a molecular picture of the programmed responses of the human genome to AE.", {"entities": []}], ["The transcriptional program was analyzed in skin biopsy samples from lesional and patch-tested skin from AE patients sensitized to Malassezia sympodialis ( M. sympodialis ), and corresponding biopsies from healthy individuals.", {"entities": []}], ["The most notable feature of the global gene-expression pattern observed in AE skin was a reciprocal expression of induced inflammatory genes and repressed lipid metabolism genes.", {"entities": []}], ["The overall transcriptional response in M. sympodialis patch-tested AE skin was similar to the gene-expression signature identified in lesional AE skin.", {"entities": []}], ["In the constellation of genes differentially expressed in AE skin compared to healthy control skin, we have identified several potential susceptibility genes that may play a critical role in the pathological condition of AE.", {"entities": []}], ["Many of these genes, including genes with a role in immune responses, lipid homeostasis, and epidermal differentiation, are localized on chromosomal regions previously linked to AE.", {"entities": []}], ["Through genome-wide expression profiling, we were able to discover a distinct reciprocal expression pattern of induced inflammatory genes and repressed lipid metabolism genes in skin from AE patients.", {"entities": []}], ["We found a significant enrichment of differentially expressed genes in AE with cytobands associated to the disease, and furthermore new chromosomal regions were found that could potentially guide future region-specific linkage mapping in AE.", {"entities": []}], ["The full data set is available at http://microarray-pubs.stanford.edu/eczema .", {"entities": []}], ["Please cite this paper as: Larcombe et\u00a0al.", {"entities": []}], ["(2011) Sexual dimorphism in lung function responses to acute influenza A infection.", {"entities": [[61, 70, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(5), 334\u2013342.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Males are generally more susceptible to respiratory infections; however, there are few data on the physiological responses to such infections in males and females.", {"entities": []}], ["Objectives\u2002 To determine whether sexual dimorphism exists in the physiological/inflammatory responses of weanling and adult BALB/c mice to influenza.", {"entities": [[139, 148, "DISEASE"]]}], ["Methods\u2002 Weanling and adult mice of both sexes were inoculated with influenza A or appropriate control solution.", {"entities": [[68, 77, "DISEASE"]]}], ["Respiratory mechanics, responsiveness to methacholine (MCh), viral titre and bronchoalveolar lavage (BAL) cellular inflammation/cytokines were measured 4 (acute) and 21 (resolution) days post\u2010inoculation.", {"entities": []}], ["Results\u2002 Acute infection impaired lung function and induced hyperresponsiveness and cellular inflammation in both sexes at both ages.", {"entities": []}], ["Males and females responded differently with female mice developing greater abnormalities in tissue damping and elastance and greater MCh responsiveness at both ages.", {"entities": []}], ["BAL inflammation, cytokines and lung viral titres were similar between the sexes.", {"entities": []}], ["At resolution, all parameters had returned to baseline levels in adults and weanling males; however, female weanlings had persisting hyperresponsiveness.", {"entities": []}], ["Conclusions\u2002 We identified significant differences in the physiological responses of male and female mice to infection with influenza A, which occurred in the absence of variation in viral titre and cellular inflammation.", {"entities": [[124, 133, "DISEASE"]]}], ["High-dose benzodiazepine (BZD) dependence is associated with a wide variety of negative health consequences.", {"entities": []}], ["Affected individuals are reported to suffer from severe mental disorders and are often unable to achieve long-term abstinence via recommended discontinuation strategies.", {"entities": []}], ["Although it is increasingly understood that treatment interventions should take subjective experiences and beliefs into account, the perceptions of this group of individuals remain under-investigated.", {"entities": []}], ["We conducted an exploratory qualitative study with 41 adult subjects meeting criteria for (high-dose) BZD-dependence, as defined by ICD-10.", {"entities": []}], ["One-on-one in-depth interviews allowed for an exploration of this group\u2019s views on the reasons behind their initial and then continued use of BZDs, as well as their procurement strategies.", {"entities": []}], ["Mayring\u2019s qualitative content analysis was used to evaluate our data.", {"entities": []}], ["In this sample, all participants had developed explanatory models for why they began using BZDs.", {"entities": []}], ["We identified a multitude of reasons that we grouped into four broad categories, as explaining continued BZD use: (1) to cope with symptoms of psychological distress or mental disorder other than substance use, (2) to manage symptoms of physical or psychological discomfort associated with somatic disorder, (3) to alleviate symptoms of substance-related disorders, and (4) for recreational purposes, that is, sensation-seeking and other social reasons.", {"entities": []}], ["Subjects often considered BZDs less dangerous than other substances and associated their use more often with harm reduction than as recreational.", {"entities": []}], ["Specific obtainment strategies varied widely: the majority of participants oscillated between legal and illegal methods, often relying on the black market when faced with treatment termination.", {"entities": []}], ["Irrespective of comorbidity, participants expressed a clear preference for medically related explanatory models for their BZD use.", {"entities": []}], ["We therefore suggest that clinicians consider patients\u2019 motives for long-term, high-dose BZD use when formulating treatment plans for this patient group, especially since it is known that individuals are more compliant with approaches they perceive to be manageable, tolerable, and effective.", {"entities": []}], ["The high affinity immunoglobulin E (IgE) receptor-Fc\u03b5R1 is mainly expressed on the surface of effector cells.", {"entities": []}], ["Cross-linking of IgE Abs bound to Fc\u03b5R1 by multi-valent antigens can induce the activation of these cells and the secretion of inflammatory mediators.", {"entities": []}], ["Since Fc\u03b5R1 plays a central role in the induction and maintenance of allergic responses, this study aimed to investigate the association of Fc\u03b5R1 with the allergic phenotype of C\u03b5 expression and cytokine and histamine release from peripheral leukocytes.", {"entities": []}], ["Peripheral leukocytes from 67 allergic and 50 non-allergic subjects were used for genotyping analysis.", {"entities": []}], ["Peripheral mononuclear cells (PBMCs) were used for C\u03b5 expression and ELISpot analysis, while polymorphonuclear cells (PMNs) were used for histamine release.", {"entities": []}], ["The association between genotype polymorphism of the Fc\u03b5R1\u03b1 promoter region (rs2427827 and rs2251746) and allergic features of C\u03b5 expression and histamine were analyzed, and their effects on leukocytes function were compared with wild type.", {"entities": []}], ["The genotype polymorphisms of Fc\u03b5R1\u03b1 promoter region with CT and TT in rs2427827 and TC in rs2251746 were significantly higher in allergic patients than in non-allergic controls.", {"entities": []}], ["Patients with single nucleotide polymorphism (SNP) of Fc\u03b5R1\u03b1 promoter region had high levels of total IgE, mite-specific Der p 2 (Group 2 allergen of Dermatophagoides pteronyssinus )-specific IgE and IgE secretion B cells.", {"entities": []}], ["The mRNA expression of Fc\u03b5R1\u03b1 was significantly increased after Der p2 stimulation in PBMCs with SNPs of the Fc\u03b5R1\u03b1 promoter region.", {"entities": []}], ["Despite the increased C\u03b5 mRNA expression in PBMCs and histamine release from PMNs and the up-regulated mRNA expression of interleukin (IL)-6 and IL-8 secretions after Der p2 stimulation, there was no statistically significant difference between SNPs of the Fc\u03b5R1\u03b1 promoter region and the wild type.", {"entities": []}], ["SNPs of Fc\u03b5R1\u03b1 promoter region were associated with IgE expression, IgE producing B cells, and increased Der p2-induced Fc\u03b5R1\u03b1 mRNA expression.", {"entities": []}], ["These SNPs may be used as a disease marker for IgE-mediated allergic inflammation caused by Dermatophagoides pteronyssinus .", {"entities": []}], ["Atypical pathogens such as Mycoplasma pneumoniae , Chlamydophila pneumoniae , and Legionella pneumophila are increasingly recognized as important causes of community acquired pneumonia (CAP) worldwide.", {"entities": [[175, 184, "DISEASE"]]}], ["Such etiological data for Vietnam is scarce and clinical doctors lack accurate information on which to base their diagnosis and treatment of pneumonia.", {"entities": [[141, 150, "DISEASE"]]}], ["This study identifies the prevalence and risk factors of severe community acquired pneumonia due to these atypical pathogens (severe- Ap CAP) in children aged 1\u201315 years with CAP in a pediatric hospital in Hanoi, Vietnam.", {"entities": [[83, 92, "DISEASE"]]}], ["722 hospitalized children with CAP were recruited for detecting those atypical pathogens, using multiplex PCR and ELISA.", {"entities": []}], ["Clinical and epidemiological data were collected.", {"entities": []}], ["Multivariate logistic-regression analyses were performed to evaluate the associations of potential risk factors with severe- Ap CAP.", {"entities": []}], ["Among 215 atypical pathogen-positive CAP cases, 45.12% (97/215) were severe- Ap CAP.", {"entities": []}], ["Among the severe- Ap CAP group, 55.67% (54/97) cases were caused by pure atypical pathogens and 44.33% (43/97) resulted from a co-infection with typical respiratory pathogens.", {"entities": []}], ["M. pneumoniae was the most common, with 86.6% cases (84/97) in the severe- Ap CAP group, whereas C. pneumoniae and L. pneumophila were less frequent (6.19% and 7.22%, respectively).", {"entities": []}], ["The highest rate of severe- Ap CAP was in children younger than two years (65.98%).", {"entities": []}], ["The differences related to age are statistically significant ( P \u2009=\u20090.008).", {"entities": []}], ["The factors significantly associated with severe- Ap CAP were age (OR\u2009=\u20090.84, 95% CI\u2009=\u20090.75-0.93, P \u2009=\u20090.001), co-infection with typical bacteria (OR\u2009=\u20094.86, 95% CI\u2009=\u20092.17-10.9, P \u2009<\u20090.0001), co-infection with respiratory viruses (OR\u2009=\u20094.36, 95% CI\u2009=\u20091.46-13.0, P \u2009=\u20090.008), respiratory/cardiac system malformation (OR\u2009=\u200914.8, 95% CI\u2009=\u20091.12 -196, P \u2009=\u20090.041) and neonatal pneumonia (OR\u2009=\u200911.1, 95% CI\u2009=\u20091.06 -116, P \u2009=\u20090.044).", {"entities": [[372, 381, "DISEASE"]]}], ["Severe- Ap CAP presented at a significant rate in Vietnamese children.", {"entities": []}], ["More than 50% of severe- Ap CAP cases were associated with pure atypical pathogen infection.", {"entities": []}], ["M. pneumoniae appeared most frequently.", {"entities": []}], ["The highest rate of severe- Ap CAP was in children younger than two years.", {"entities": []}], ["Younger age and co-infection with typical bacteria or viruses were the most significant risk factors, while respiratory/cardiac system malformation and neonatal pneumonia were additional potential risk factors, associated with severe- Ap CAP in Vietnamese children.", {"entities": [[161, 170, "DISEASE"]]}], ["The online version of this article (doi:10.1186/1471-2458-14-1304) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chemotherapy and radiation therapy may increase risk for interstitial pneumonitis (IP) in breast cancer patients, but there are little current population-based data on IP incidence in these patients.", {"entities": [[90, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["We assessed population-based incidence rates (IRs) of IP among Danish breast cancer patients and compared these with IRs for the Danish general population.", {"entities": [[70, 83, "DISEASE"], [77, 83, "DISEASE"]]}], ["Through the Danish Cancer Registry, we identified all Danish breast cancer patients ( n =35\u2009823) diagnosed between 1994 and 2004.", {"entities": [[61, 74, "DISEASE"], [19, 25, "DISEASE"], [68, 74, "DISEASE"]]}], ["Treatment data were obtained from the Danish Breast Cancer Cooperation Group database, and data on IP, from the Danish National Registry of Patients.", {"entities": [[45, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["We computed IRs of IP among breast cancer patients and age-standardised incidence rate ratios (SIRs) comparing breast cancer patients with the general population.", {"entities": [[28, 41, "DISEASE"], [111, 124, "DISEASE"], [35, 41, "DISEASE"], [118, 124, "DISEASE"]]}], ["During follow-up, 28 breast cancer patients were registered with an IP diagnosis (IR=17.3 per 100\u2009000 person-years (p-y) (95% confidence intervals (95% CI): 11.7\u201324.6)).", {"entities": [[21, 34, "DISEASE"], [28, 34, "DISEASE"]]}], ["When follow-up was restricted to 1 year after the first breast cancer diagnosis, eight patients with IP were identified (IR=23.4 per 100\u2009000 p-y (95% CI: 11.0\u201344.1)).", {"entities": [[56, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["The SIR comparing breast cancer patients with the general population was 8.4 (95% CI: 5.7\u201311.9).", {"entities": [[18, 31, "DISEASE"], [25, 31, "DISEASE"]]}], ["Thus, although IP is a rare adverse event among breast cancer patients, its risk is substantially higher than that in the general population.", {"entities": [[48, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["Four patients allergic to many mammalian sera were found to have circulating, skin-sensitizing antibodies for these sera.", {"entities": []}], ["A study of these antibodies by in vitro neutralization and subsequent local passive transfer showed that, in the case of each patient, one particular mammalian serum neutralized antibodies for all sera whereas other mammalian sera neutralized antibodies for themselves alone or for themselves plus one or several additional sera but not for all sera.", {"entities": []}], ["The possibility of multiple common allergenic determinants in mammalian sera is discussed.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is the result of persistent and progressive pathologic abnormalities in the small airways, most often associated with alveolar loss.", {"entities": []}], ["Smoking cessation is the most effective intervention to slow down the progression of COPD.", {"entities": []}], ["Long-acting inhaled bronchodilators are prescribed for the symptomatic relief at any stage of disease severity.", {"entities": []}], ["For patients whose COPD cannot be not sufficiently controlled with long-acting bronchodilator monotherapy, international guidelines suggest the possibility of associating a long-acting beta 2 agonist (LABA) with a long-acting muscarinic antagonist (LAMA), ie, dual bronchodilation.", {"entities": []}], ["This is not a new concept as the combination of short-acting agents has been popular in the past.", {"entities": []}], ["In recent years, several fixed-dose combinations containing a LAMA and a LABA in a single inhaler have been approved by regulatory authorities in several countries.", {"entities": []}], ["Among the new LAMA/LABA combinations, the fixed-dose combination of indacaterol 110 \u00b5g/glycopyrronium 50 \u00b5g (QVA149) has been shown in a series of clinical trials to be as safe as the single components and placebo, and more effective than placebo and the single components with regard to lung function, symptoms, and patient-oriented outcomes.", {"entities": []}], ["Furthermore, QVA149 achieved better bronchodilation than salmeterol 50 \u00b5g/fluticasone 500 \u00b5g twice daily.", {"entities": []}], ["Compared with tiotropium, a well-recognized treatment for COPD, the percentage of patients that exceed the minimal clinical important difference for dyspnea and health-related quality of life measurements was superior with QVA149.", {"entities": []}], ["Other patient-oriented outcomes, such as daily symptoms, night-time awakening, and use of rescue medication consistently favored QVA149.", {"entities": []}], ["Finally, QVA149 was significantly superior to LAMAs for reducing all types of exacerbation.", {"entities": []}], ["In conclusion, several years after introduction of dual bronchodilation, the fixed-dose combination of indacaterol 110 \u00b5g/glycopyrronium 50 \u00b5g in a single inhaler for once-daily administration via the Breezhaler", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is defined as a disease characterized by persistent, progressive airflow limitation.", {"entities": []}], ["Recent studies have underlined that COPD is correlated to many systemic manifestations, probably due to an underlying pattern of systemic inflammation.", {"entities": []}], ["In COPD fractional exhaled Nitric Oxide (FeNO) levels are related to smoking habits and disease severity, showing a positive relationship with respiratory functional parameters.", {"entities": []}], ["Moreover FeNO is increased in patients with COPD exacerbation, compared with stable ones.", {"entities": []}], ["In alpha-1 antitrypsin deficiency, a possible cause of COPD, FeNO levels may be monitored to early detect a disease progression.", {"entities": []}], ["FeNO measurements may be useful in clinical setting to identify the level of airway inflammation, per se and in relation to comorbidities, such as pulmonary arterial hypertension and cardiovascular diseases, either in basal conditions or during treatment.", {"entities": [[166, 178, "DISEASE"]]}], ["Finally, some systemic inflammatory diseases, such as psoriasis, have been associated with higher FeNO levels and potentially with an increased risk of developing COPD.", {"entities": [[54, 63, "DISEASE"]]}], ["In these systemic inflammatory diseases, FeNO monitoring may be a useful biomarker for early diagnosis of COPD development.", {"entities": []}], ["Maternal environment and lifestyle factors may modify placental function to match the mother\u2019s capacity to support the demands of fetal growth.", {"entities": []}], ["Much remains to be understood about maternal influences on placental metabolic and amino acid transporter gene expression.", {"entities": []}], ["We investigated the influences of maternal lifestyle and body composition (e.g.", {"entities": []}], ["fat and muscle content) on a selection of metabolic and amino acid transporter genes and their associations with fetal growth.", {"entities": []}], ["RNA was extracted from 102 term Southampton Women\u2019s Survey placental samples.", {"entities": []}], ["Expression of nine metabolic, seven exchange, eight accumulative and three facilitated transporter genes was analyzed using quantitative real-time PCR.", {"entities": []}], ["Increased placental LAT2 (p = 0.01), y LAT2 (p = 0.03), aspartate aminotransferase 2 (p = 0.02) and decreased aspartate aminotransferase 1 (p = 0.04) mRNA expression associated with pre-pregnancy maternal smoking.", {"entities": [[20, 24, "GENE"], [39, 43, "GENE"], [20, 24, "GENE"], [39, 43, "GENE"]]}], ["Placental mRNA expression of TAT1 (p = 0.01), ASCT1 (p = 0.03), mitochondrial branched chain aminotransferase (p = 0.02) and glutamine synthetase (p = 0.05) was positively associated with maternal strenuous exercise.", {"entities": []}], ["Increased glutamine synthetase mRNA expression (r = 0.20, p = 0.05) associated with higher maternal diet quality (prudent dietary pattern) pre-pregnancy.", {"entities": []}], ["Lower LAT4 (r = -0.25, p = 0.05) and aspartate aminotransferase 2 mRNA expression (r = -0.28, p = 0.01) associated with higher early pregnancy diet quality.", {"entities": []}], ["Lower placental ASCT1 mRNA expression associated with measures of increased maternal fat mass, including pre-pregnancy BMI (r = -0.26, p = 0.01).", {"entities": []}], ["Lower placental mRNA expression of alanine aminotransferase 2 associated with greater neonatal adiposity, for example neonatal subscapular skinfold thickness (r = -0.33, p = 0.001).", {"entities": []}], ["A number of maternal influences have been linked with outcomes in childhood, independently of neonatal size; our finding of associations between placental expression of transporter and metabolic genes and maternal smoking, physical activity and diet raises the possibility that their effects are mediated in part through alterations in placental function.", {"entities": []}], ["The observed changes in placental gene expression in relation to modifiable maternal factors are important as they could form part of interventions aimed at maintaining a healthy lifestyle for the mother and for optimal fetal development.", {"entities": []}], ["Among the strategies used to reform primary care, the participation of nurses in primary care practices appears to offer a promising avenue to better meet the needs of vulnerable patients.", {"entities": []}], ["The present study explores the perceptions and expectations of patients with multimorbidity regarding nurses' presence in primary care practices.", {"entities": []}], ["18 primary (health) care patients with multimorbidity participated in semi-directed interviews, in order to explore their perceptions and expectations in regard to the involvement of nurses in primary care practices.", {"entities": []}], ["Interviews were audio-recorded and transcribed.", {"entities": []}], ["After reviewing the transcripts, the principal investigator and research assistants performed thematic analysis independently and reached consensus on the retained themes.", {"entities": []}], ["Patients with multimorbidity were open to the participation of nurses in primary care practices.", {"entities": []}], ["They expected greater accessibility, for both themselves and for new patients.", {"entities": []}], ["However, the issue of shared roles between nurses and doctors was a source of concern.", {"entities": []}], ["Many patients held the traditional view of the nurse's role as an assistant to the doctor in his or her various duties.", {"entities": []}], ["In general, participants said they were confident about nurses' competency but expressed concern about nurses performing certain acts that their doctor used to, notwithstanding a close collaboration between the two professionals.", {"entities": []}], ["Patients with multimorbidity are open to the involvement of nurses in primary care practices.", {"entities": []}], ["However, they expect this participation to be established using clear definitions of professional roles and fields of practice.", {"entities": []}], ["Lower lung function is associated with an elevated systemic white cell count in men.", {"entities": []}], ["However, these observations have not been demonstrated in a representative population that includes females and may be susceptible to confounding by recent airway infections or recent cigarette smoking.", {"entities": []}], ["We tested the hypothesis that lung function is inversely associated with systemic white cell count in a population-based study.", {"entities": []}], ["The study population consisted adults aged 17\u221290+ years who participated in the Third National Health and Nutrition Examination Survey who did not report a recent cough, cold or acute illness in a non-smoking and smoking population.", {"entities": []}], ["In non-smoking adults with the highest quintile of the total white cell count had a FEV 1 125.3 ml lower than those in the lowest quintile (95% confidence interval CI: \u2212163.1 to \u201387.5).", {"entities": [[84, 87, "GENE"]]}], ["Adults with the highest quintile of the total white cell count had a FVC 151.1 ml lower than those in the lowest quintile (95% confidence interval CI: \u2212195.0 to \u2212107.2).", {"entities": []}], ["Similar associations were observed for granulocytes, mononuclear cells and lymphocytes.", {"entities": []}], ["In current smokers, similar smaller associations observed for total white cell count, granulocytes and mononuclear cells.", {"entities": []}], ["Systemic cellular inflammation levels are inversely associated with lung function in a population of both non-smokers and smokers without acute illnesses.", {"entities": []}], ["This may contribute to the increased mortality observed in individuals with a higher baseline white cell count.", {"entities": []}], ["Bronchiectasis is prevalent in patients with COPD.", {"entities": [[0, 14, "DISEASE"]]}], ["The objective of this study was to assess the clinical characteristics and prognostic value of bronchiectasis in patients with COPD in China.", {"entities": [[95, 109, "DISEASE"]]}], ["Data from patients diagnosed with COPD at the Shanghai Pulmonary Hospital between January 2009 and December 2013 were retrospectively collected and analyzed.", {"entities": []}], ["SPSS statistical software was used to analyze the data.", {"entities": []}], ["Data from 896 patients with COPD were analyzed.", {"entities": []}], ["Bronchiectasis was present in 311 patients.", {"entities": [[0, 14, "DISEASE"]]}], ["The isolation of pseudomonas aeruginosa (PA) from sputum was the variable most significantly associated with the presence of bronchiectasis in patients with COPD (hazard ratio (HR), 2.93; 95% confidence interval (CI), 1.35\u20136.37; P\u2009=\u20090.007).", {"entities": [[125, 139, "DISEASE"], [177, 179, "GENE"]]}], ["During follow-up (median of 21 months; interquartile range: 10-39 months), there were 75 deaths, of which 39 were in the bronchiectasis group.", {"entities": [[121, 135, "DISEASE"]]}], ["The presence of bronchiectasis (HR, 1.77; 95% CI, 1.02\u20133.08; P\u2009=\u20090.043) was associated with an increase in all-cause mortality in patients with COPD.", {"entities": [[16, 30, "DISEASE"], [32, 34, "GENE"]]}], ["These results suggest that bronchiectasis in patients with COPD was associated with the isolation of PA from the sputum.", {"entities": [[27, 41, "DISEASE"]]}], ["Bronchiectasis was an independent risk factor for all-cause mortality in patients with COPD.", {"entities": [[0, 14, "DISEASE"]]}], ["CD8 T cells assist in the clearance of respiratory syncytial virus (RSV) infection from the lungs.", {"entities": []}], ["However, disease after RSV infection is in part caused by excessive T cell activity, and a balance is therefore needed between beneficial and harmful cellular immune responses.", {"entities": []}], ["The chemokine CCL3 (MIP1\u03b1) is produced following RSV infection and is broadly chemotactic for both T cells and natural killer (NK) cells.", {"entities": [[14, 18, "GENE"]]}], ["We therefore investigated its role in RSV disease.", {"entities": []}], ["CCL3 was produced biphasically, in both the early (day 1) and late (day 6\u20137) stages of infection.", {"entities": [[0, 4, "GENE"]]}], ["CCL3 depletion did not alter the recruitment of natural killer (NK) cells to the lungs during the early stage, but depletion did affect the later adaptive phase.", {"entities": [[0, 4, "GENE"]]}], ["While fewer T cells were recruited to the lungs of either CCL3 knockout or anti-CCL3 treated RSV infected mice, more RSV-specific pro-inflammatory T cells were recruited to the lung when CCL3 responses were impaired.", {"entities": [[58, 62, "GENE"], [80, 84, "GENE"], [187, 191, "GENE"], [58, 62, "GENE"], [80, 84, "GENE"], [187, 191, "GENE"]]}], ["This increase in RSV-specific pro-inflammatory T cells was accompanied by increased weight loss and illness after RSV infection.", {"entities": []}], ["CCL3 regulates the balance of T cell populations in the lung and can alter the outcome of RSV infection.", {"entities": [[0, 4, "GENE"]]}], ["Understanding the role of inflammatory mediators in the recruitment of pathogenic T cells to the lungs may lead to novel methods to control RSV disease.", {"entities": []}], ["Please cite this paper as: Koul PA., et\u00a0al.", {"entities": []}], ["(2011) Pandemic and seasonal influenza viruses among patients with acute respiratory illness in Kashmir (India).", {"entities": [[29, 38, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(6), e521\u2013e527.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 With the emergence of pandemic influenza A (2009A/H1N1) virus in India, we sought to determine the prevalence and clinical presentations of seasonal and pandemic influenza viruses among acute respiratory illness (ARI) patients from Srinagar, a temperate climate area in northern India, during the peak winter season.", {"entities": [[43, 52, "DISEASE"], [174, 183, "DISEASE"]]}], ["Methods\u2002 Combined throat and nasal swabs, obtained from 194 (108 male) presenting with ARI from January to March 2010 (Week 53\u2010week 10), were tested by RT\u2010PCR for influenza A and B, including 2009A/H1N1 viruses.", {"entities": [[163, 172, "DISEASE"]]}], ["HA1 gene of selected 2009A/H1N1\u2010positive samples was sequenced, and phylogenetic analysis was carried out.", {"entities": []}], ["Results\u2002 Twenty\u2010one (10\u00b78%, age 15\u201380\u2003years, median age 40\u2003years) patients tested positive for influenza viruses: 13 (62%) for 2009A/H1N1 virus, 6 (28\u00b75%) for seasonal influenza A (H3N2), and 2 (9\u00b75%) for influenza B. Twelve of the 13 patients with 2009A/H1N1 presented with febrile ARI, and eight had associated comorbidities.", {"entities": [[95, 104, "DISEASE"], [168, 177, "DISEASE"], [205, 214, "DISEASE"]]}], ["All of the patients recovered.", {"entities": []}], ["Phylogenetic analysis of HA gene ( n \u2003=\u20038) revealed that all strains from Srinagar clustered in 2009A/H1N1 clade seven along with the other 2009A/H1N1 strains from India.", {"entities": []}], ["Amino acid substitutions in the HA protein defining clade seven (P83S, S203T, and I321V) were found in almost all isolates from Srinagar.", {"entities": []}], ["Conclusions\u2002 Both seasonal and 2009A/H1N1 viruses appear to be associated with ARI in Srinagar.", {"entities": []}], ["The 2009A/H1N1 in Srinagar is genetically similar to globally circulating clade 7 strains, with unique signature sequences in the HA gene.", {"entities": []}], ["Further investigations into ascertain the role of these mutations in possible alteration of the virulence and transmissibility of the virus are needed.", {"entities": []}], ["A parameter in a statistical model is identified if its value can be uniquely determined from the distribution of the observable data.", {"entities": []}], ["We consider the context of an instrumental variable analysis with a binary outcome for estimating a causal risk ratio.", {"entities": []}], ["The semiparametric generalized method of moments and structural mean model frameworks use estimating equations for parameter estimation.", {"entities": []}], ["In this paper, we demonstrate that lack of identification can occur in either of these frameworks, especially if the instrument is weak.", {"entities": []}], ["In particular, the estimating equations may have no solution or multiple solutions.", {"entities": []}], ["We investigate the relationship between the strength of the instrument and the proportion of simulated data sets for which there is a unique solution of the estimating equations.", {"entities": []}], ["We see that this proportion does not appear to depend greatly on the sample size, particularly for weak instruments (\u03c1", {"entities": []}], ["The diverse and evolving role of a psychologist within a respiratory multidisciplinary team (MDT) is described, providing a working model for service provision.", {"entities": []}], ["The rationale for appointing a psychologist within a respiratory MDT is presented first, citing relevant policy and research and outlining the wider psychosocial impact of respiratory disease.", {"entities": []}], ["This is followed by an insight into the psychologist\u2019s role by highlighting important areas, including key therapy themes and the challenge of patient engagement.", {"entities": []}], ["The way in which the psychologist supports the collective aims and aspirations of respiratory colleagues to provide a more holistic package of care is illustrated throughout.", {"entities": []}], ["A biosensor comprising tyrosinase immobilized on a single-walled carbon nanotube-modified glassy carbon electrode has been developed.", {"entities": []}], ["The sensitive element, ie, tyrosinase, was immobilized using a drop-and-dry method followed by cross-linking.", {"entities": []}], ["Tyrosinase maintained high bioactivity on this nanomaterial, catalyzing the oxidation of epinephrine to epinephrine-quinone, which was electrochemically reduced (\u22120.07 V versus Ag/AgCl) on the biosensor surface.", {"entities": []}], ["Under optimum conditions, the biosensor showed a linear response in the range of 10\u2013110 \u03bcM.", {"entities": []}], ["The limit of detection was calculated to be 2.54 \u03bcM with a correlation coefficient of 0.977.", {"entities": []}], ["The repeatability, expressed as the relative standard deviation for five consecutive determinations of 10", {"entities": []}], ["Asthma causes significant morbidity worldwide in adults and children alike, and incurs large healthcare costs.", {"entities": [[0, 6, "DISEASE"]]}], ["The statin drugs, which treat hyperlipidemia and cardiovascular diseases, have pleiotropic effects beyond lowering cholesterol, including immunomodulatory, anti-inflammatory, and anti-fibrotic properties which may benefit lung health.", {"entities": []}], ["Using an allergic mouse model of asthma, we previously demonstrated a benefit of statins in reducing peribronchiolar eosinophilic inflammation, airway hyperreactivity, goblet cell hyperplasia, and lung IL-4 and IL-13 production.", {"entities": [[33, 39, "DISEASE"]]}], ["In this study, we evaluated whether simvastatin inhibits IL-13-induced pro-inflammatory gene expression of asthma-related cytokines in well-differentiated primary mouse tracheal epithelial (MTE) cell cultures.", {"entities": [[107, 113, "DISEASE"]]}], ["We hypothesized that simvastatin reduces the expression of IL-13-inducible genes in MTE cells.", {"entities": []}], ["We harvested tracheal epithelial cells from na\u00efve BALB/c mice, grew them under air-liquid interface (ALI) cell culture conditions, then assessed IL-13-induced gene expression in MTE cells using a quantitative real-time PCR mouse gene array kit.", {"entities": []}], ["We found that simvastatin had differential effects on IL-13-mediated gene expression (inhibited eotaxin-1; MCP-1,-2,-3; and osteopontin (SPP1), while it induced caspase-1 and CCL20 (MIP-3\u03b1)) in MTE cells.", {"entities": [[137, 141, "GENE"], [175, 180, "GENE"]]}], ["For other asthma-relevant genes such as TNF, IL-4, IL-10, CCL12 (MCP-5), CCL5 (RANTES), and CCR3, there were no significant IL-13-inducible or statin effects on gene expression.", {"entities": [[10, 16, "DISEASE"], [40, 43, "GENE"], [73, 77, "GENE"], [92, 96, "GENE"]]}], ["Simvastatin modulates the gene expression of selected IL-13-inducible pro-inflammatory cytokines and chemokines in primary mouse tracheal epithelial cells.", {"entities": []}], ["The airway epithelium may be a viable target tissue for the statin drugs.", {"entities": []}], ["Further research is needed to assess the mechanisms of how statins modulate epithelial gene expression.", {"entities": []}], ["The objective of this study was to investigate the relationship between prenatal and postnatal risk factors and the prevalence of allergic rhinitis (AR) in Chinese children of specific ages.", {"entities": [[130, 147, "DISEASE"], [139, 147, "DISEASE"]]}], ["This study was a cross-sectional survey.", {"entities": []}], ["Students from 8 metropolitan cities in China were studied in November and December, 2005.", {"entities": []}], ["There were 20,803 elementary-school Chinese children (49.6% boys, mean age, 9.19 years) enrolled.", {"entities": []}], ["Questions from the standard questionnaire of the International Study of Asthma and Allergies in Children were completed to enable us to examine the pattern of current AR.", {"entities": []}], ["The potential confounders and pre-and postnatal risk factors were analyzed using logistic regression.", {"entities": []}], ["The overall prevalence of AR was found in this study to be 9.8%.", {"entities": []}], ["After adjusting for several likely confounders, there was a higher likelihood of AR in school-aged children who were not exclusively breastfed in the first 4 months of their lives (odds ratio [OR]: 1.28; 95% confidence interval [CI]: 1.16\u20131.41), children who were born post-term (OR: 1.34; 95% CI: 1.12\u20131.60), children delivered by cesarean section (OR: 1.07; 95% CI: 1.00\u20131.19), or children born to mothers who experienced depressive symptoms during the pre- and postnatal periods (OR: 1.28; 95% CI: 1.15\u20131.42).", {"entities": []}], ["AR in school-aged children was found to be associated with pre- and postnatal events.", {"entities": []}], ["These findings indicate that strategies to reduce exposure to risk factors during pre- and postnatal periods for childhood allergies might be warranted.", {"entities": []}], ["Here we used a systems biology approach and artificial intelligence to identify a neuroprotective agent for the treatment of peripheral nerve root avulsion.", {"entities": []}], ["Based on accumulated knowledge of the neurodegenerative and neuroprotective processes that occur in motoneurons after root avulsion, we built up protein networks and converted them into mathematical models.", {"entities": []}], ["Unbiased proteomic data from our preclinical models were used for machine learning algorithms and for restrictions to be imposed on mathematical solutions.", {"entities": []}], ["Solutions allowed us to identify combinations of repurposed drugs as potential neuroprotective agents and we validated them in our preclinical models.", {"entities": []}], ["The best one, NeuroHeal, neuroprotected motoneurons, exerted anti-inflammatory properties and promoted functional locomotor recovery.", {"entities": []}], ["NeuroHeal endorsed the activation of Sirtuin 1, which was essential for its neuroprotective effect.", {"entities": []}], ["These results support the value of network-centric approaches for drug discovery and demonstrate the efficacy of NeuroHeal as adjuvant treatment with surgical repair for nervous system trauma.", {"entities": []}], ["PDE9 inhibitors show potential for treatment of diseases such as diabetes.", {"entities": []}], ["To help with discovery of PDE9 inhibitors, we performed mutagenesis, kinetic, crystallographic, and molecular dynamics analyses on the active site residues of Gln453 and its stabilizing partner Glu406.", {"entities": []}], ["The crystal structures of the PDE9 Q453E mutant (PDE9Q453E) in complex with inhibitors IBMX and (S)-BAY73-6691 showed asymmetric binding of the inhibitors in two subunits of the PDE9Q453E dimer and also the significant positional change of the M-loop at the active site.", {"entities": []}], ["The kinetic analysis of the Q453E and E406A mutants suggested that the invariant glutamine is critical for binding of substrates and inhibitors, but is unlikely to play a key role in the differentiation between substrates of cGMP and cAMP.", {"entities": []}], ["The molecular dynamics simulations suggest that residue Glu406 may be protonated and may thus explain the hydrogen bond distance between two side chain oxygens of Glu453 and Glu406 in the crystal structure of the PDE9Q453E mutant.", {"entities": []}], ["The information from these studies may be useful for design of PDE9 inhibitors.", {"entities": []}], ["Influenza vaccination is administered annually as a preventive measure against influenza infection and influenza-related complications in high-risk individuals, such as those with asthma.", {"entities": [[0, 9, "DISEASE"], [79, 88, "DISEASE"], [103, 112, "DISEASE"], [180, 186, "DISEASE"]]}], ["However, the effectiveness of influenza vaccination in people with asthma against influenza-related complications is still not well established.", {"entities": [[30, 39, "DISEASE"], [82, 91, "DISEASE"], [67, 73, "DISEASE"]]}], ["We will search the following databases: MEDLINE (Ovid), EMBASE (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, Cochrane Database of Systematic Reviews (CDSR), Web of Science Core Collection, Science direct, WHO Library Information System (WHOLIS), Global Health Library and Chinese databases (CNKI, Wanfang and ChongQing VIP) from Jan 1970 to Jan 2016 for observational and experimental studies on effectiveness of influenza vaccine in people with asthma.", {"entities": [[508, 517, "DISEASE"], [541, 547, "DISEASE"], [414, 417, "GENE"]]}], ["The identification of studies will be complemented with the searching of the reference lists and citations, and contacting influenza vaccine manufacturers to identify unpublished or ongoing studies.", {"entities": [[123, 132, "DISEASE"]]}], ["Two reviewers will extract data and appraise the quality of each study independently.", {"entities": []}], ["Separate meta-analyses will be undertaken for observational and experimental evidence using fixed-effect or random-effects models, as appropriate.", {"entities": []}], ["Formal ethical approval is not required, as primary data will not be collected.", {"entities": []}], ["The review will be disseminated in peer-reviewed publications and conference presentations.", {"entities": []}], ["A large number of trials show that the anti-immunoglobulin (Ig) E antibody omalizumab is very effective in patients with severe allergic asthma.", {"entities": [[128, 143, "DISEASE"], [137, 143, "DISEASE"]]}], ["This is acknowledged in consensus documents.", {"entities": []}], ["The drug also has a good safety profile and a pharmacoeconomic advantage due to a reduction in the number of hospitalizations for asthma attacks.", {"entities": [[130, 136, "DISEASE"]]}], ["In recent years, some studies have shown that omalizumab is effective also in nonallergic asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["Effects on the complex signaling mechanisms leading to activation of effector cells and to mediator release may account for this outcome.", {"entities": []}], ["Indeed, omalizumab has been reported to be effective in a number of IgE-mediated and non-IgE-mediated disorders.", {"entities": []}], ["Concerning the former, clinical efficacy has been observed in rhinitis, allergic bronchopulmonary aspergillosis, latex allergy, atopic dermatitis, allergic urticaria, and anaphylaxis.", {"entities": [[98, 111, "DISEASE"], [156, 165, "DISEASE"], [128, 145, "DISEASE"], [62, 70, "DISEASE"], [147, 165, "DISEASE"], [72, 111, "DISEASE"], [135, 145, "DISEASE"]]}], ["In addition, omalizumab has been demonstrated to be able to prevent systemic reactions to allergen immunotherapy, thus enabling completion of treatment in patients who otherwise would have to stop it.", {"entities": []}], ["Concerning non-IgE-mediated disorders, omalizumab has been reported to be effective in nasal polyposis, autoimmune urticaria, chronic idiopathic urticaria, physical urticaria, idiopathic angioedema, and mastocytosis.", {"entities": [[115, 124, "DISEASE"], [145, 154, "DISEASE"], [165, 174, "DISEASE"], [203, 215, "DISEASE"], [187, 197, "DISEASE"]]}], ["Current indications for treatment with omalizumab are confined to severe allergic asthma.", {"entities": [[73, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["Consequently, any other prescription can only be off-label.", {"entities": []}], ["However, it is reasonable to expect that the use of omalizumab will be approved for particularly important indications, such as anaphylaxis, in the near future.", {"entities": []}], ["To perform a meta-analysis to investigate the association between cyclooxygenase-2 (COX-2) -1195G>A gene polymorphism and gastrointestinal cancers.", {"entities": []}], ["Publications related to the COX-2 -1195G>A gene polymorphism and gastrointestinal cancers published before July 2016 were retrieved from PubMed, EMBASE, Web of Science, China Biological Medicine Database, China National Knowledge Infrastructure, and CQVIP Database.", {"entities": []}], ["Meta-analysis was performed using Stata11.0 software.", {"entities": []}], ["The strength of the association was evaluated by calculating the combined odds ratios (ORs) and the corresponding 95%CIs.", {"entities": []}], ["The retrieved publications were excluded or included one by one for sensitivity analysis.", {"entities": []}], ["In addition, the funnel plot, Begg\u2019s rank correlation test, and Egger\u2019s linear regression method were applied to analyse whether the included publications had publication bias.", {"entities": []}], ["A total of 24 publications related to the COX-2 -1195G>A gene polymorphism were included, including 28 studies involving 11043 cases and 18008 controls.", {"entities": []}], ["The meta-analysis results showed that the COX-2 -1195G>A gene polymorphism significantly correlated with an increased risk of gastrointestinal cancers, particularly gastric cancer (A vs G: OR = 1.35; AA/AG vs GG: OR = 1.54; AA vs GG/AG: OR = 1.43; AA vs GG: OR = 1.80; AG vs GG: OR = 1.35).", {"entities": [[173, 179, "DISEASE"]]}], ["Compared to the Caucasian population in America and Europe, the COX-2 -1195G>A gene polymorphism in the Asian population (A vs G: OR = 1.30; AA/AG vs GG: OR = 1.50; AA vs GG/AG: OR = 1.35; AA vs GG: OR = 1.71; AG vs GG: OR = 1.37) significantly increased gastrointestinal cancer risk.", {"entities": [[272, 278, "DISEASE"]]}], ["The sensitivity analysis ( P < 0.05) and the false positive report probability ( P < 0.2) confirmed the reliability of the results.", {"entities": []}], ["The results showed that the COX-2 -1195G>A gene polymorphism might be a potential risk factor for gastrointestinal cancers.", {"entities": []}], ["Further validation by a large homogeneous study is warranted.", {"entities": []}], ["Some patients with chronic obstructive pulmonary disease (COPD) show increased airway inflammation and bacterial colonization during stable phase.", {"entities": [[19, 56, "DISEASE"]]}], ["The aim of this study was to follow COPD patients and investigate chronic colonization with pathogenic bacteria during stable disease phase, and relate these findings to clinical parameters, inflammatory pattern, lung function, and exacerbations.", {"entities": []}], ["Forty-three patients with COPD were included while in a stable state and followed up monthly until exacerbation or for a maximum of 6 months.", {"entities": []}], ["The patients completed the Clinical COPD Questionnaire and Medical Research Council dyspnea scale questionnaires, and exhaled breath condensate was collected, followed by spirometry, impulse oscillometry, and sputum induction.", {"entities": []}], ["Ten patients were chronically colonized (ie, colonized at all visits) with Haemophilus influenzae during stable phase.", {"entities": []}], ["These patients had higher sputum levels of leukotriene B 4 ( P <0.001), 8-isoprostane ( P =0.002), myeloperoxidase activity ( P =0.028), and interleukin-8 ( P =0.02) during stable phase when compared with other patients.", {"entities": []}], ["In addition, they had lower forced vital capacity ( P =0.035) and reactance at 5 Hz ( P =0.034), but there was no difference in forced expiratory volume in 1 second (FEV 1 ), FEV 1 % predicted, forced vital capacity % predicted, exhaled breath condensate biomarkers, C-reactive protein, or Clinical COPD Questionnaire and Medical Research Council dyspnea scale results.", {"entities": [[166, 169, "GENE"], [175, 178, "GENE"], [166, 169, "GENE"], [175, 178, "GENE"]]}], ["Three patients had intermittent colonization (colonized at only some visits) of H. influenzae during stable phase, and had lower levels of inflammatory biomarkers in sputum when compared with the chronically colonized patients.", {"entities": []}], ["The difference in airway inflammation seen during stable phase in patients chronically colonized with H. influenzae was not observed during exacerbations.", {"entities": []}], ["Some COPD patients who were chronically colonized with H. influenzae during stable phase showed increased airway inflammation and reduced lung volumes when compared with non-chronically colonized patients.", {"entities": []}], ["To evaluate the role of human bocavirus (hBoV) as a causative agent of respiratory disease, the importance of the viral load in respiratory disease type and severity and the pathogenicity of the different hBoV species, we studied all hBoV-positive nasopharyngeal samples collected from children who attended an emergency room for a respiratory tract infection during three winters (2009\u20132010, 2011\u20132012, and 2013\u20132014).", {"entities": []}], ["Human bocavirus was detected using the respiratory virus panel fast assay and real-time PCR.", {"entities": []}], ["Of the 1,823 nasopharyngeal samples, 104 (5.7%) were positive for hBoV; a similar prevalence was observed in all three periods studied.", {"entities": []}], ["Among hBoV-infected children, 53.8% were between 1\u20132 years old, and hBoV was detected alone in 57/104 (54.8%) cases.", {"entities": []}], ["All of the detected hBoV strains belonged to genotype 1.", {"entities": []}], ["The median hBoV load was significantly higher in samples containing strains with both the N546H and T590S mutations compared to other samples (p<0.05).", {"entities": []}], ["Children with a single hBoV-1 infection more frequently had upper respiratory tract infections (URTIs) than those who were co-infected (37.0% vs 17.8%, respectively, p = 0.04).", {"entities": []}], ["The duration of hospitalization was longer among children with high viral loads than that observed among children with low viral loads (8.0 \u00b12.2 days vs 5.0 \u00b11.5 days, respectively, p = 0.03), and the use of aerosol therapy was more frequent among children with high viral loads than among those with low viral loads (77.1% vs 55.7%, respectively, p = 0.04).", {"entities": []}], ["This study shows that hBoV is a relatively uncommon but stable infectious agent in children and that hBoV1 seems to be the only strain detected in Italy in respiratory samples.", {"entities": []}], ["From a clinical point of view, hBoV1 seems to have in the majority of healthy children relatively low clinical relevance.", {"entities": []}], ["Moreover, the viral load influences only the duration of hospitalization and the use of aerosol therapy without any association with the site of the respiratory disease.", {"entities": []}], ["Atopic dermatitis (AD) is characterized by epidermal barrier defects and recurrent microbial skin infections.", {"entities": [[7, 17, "DISEASE"]]}], ["AD patients with a history of eczema herpeticum (ADEH+) have more severe skin disease and more highly T H 2 polarized immune responses as compared to uncomplicated AD (ADEH\u2212).", {"entities": [[30, 47, "DISEASE"], [73, 85, "DISEASE"]]}], ["However, the mechanisms linking epidermal barrier defects and viral skin infection are not well understood.", {"entities": []}], ["Recently, it has been reported that interleukin (IL)-25 may play a role in augmenting T H 2 responses.", {"entities": []}], ["We examined protein expression of IL-25 in the skin biopsies from normal subjects (n=10), ADEH\u2212 (n=18), ADEH+ (n=7) and psoriasis (n=9).", {"entities": [[120, 129, "DISEASE"]]}], ["IL-25 expression was increased in the skin from ADEH\u2212, ADEH+ and psoriasis compared to normal skin, and was significantly greater in lesional ADEH+ skin than in lesional ADEH- skin.", {"entities": [[65, 74, "DISEASE"]]}], ["Importantly, we demonstrated that IL-25 enhances herpes simplex virus (HSV)-1 and vaccinia virus replication by inhibiting filaggrin expression, and IL-25 acts synergistically with IL-4 and IL-13 to enhance HSV-1 replication in vitro .", {"entities": [[49, 63, "DISEASE"], [82, 90, "DISEASE"]]}], ["In contrast, interferon-\u03b3 inhibited HSV-1 replication in vitro .", {"entities": []}], ["Additionally, we demonstrate that filaggrin is a critical protein to inhibit HSV-1 replication because filaggrin small interfering RNA knockdown enhances HSV-1 replication in vitro .", {"entities": []}], ["Filaggrin breakdown products, however, inhibited HSV-1 replication in vitro .", {"entities": []}], ["To report a case of keratitis and a case of conjunctivitis caused by synthetic fibers from toy teddy bears.", {"entities": [[20, 29, "DISEASE"], [44, 58, "DISEASE"]]}], ["Case stories with histopathological analysis.", {"entities": []}], ["1) A two-year-old girl developed a severe case of keratitis and corneal ulceration.", {"entities": [[50, 59, "DISEASE"]]}], ["The initial treatment with various antibiotics gave no improvement and eventually the patient developed spontaneous perforation of the cornea.", {"entities": []}], ["The corneal swabs contained no bacteria or fungi.", {"entities": []}], ["Corneal grafting was performed and the corneal button was sent for histopathological examination.", {"entities": []}], ["2) A five-year-old girl presented with ocular irritation in her left eye.", {"entities": []}], ["Examination revealed a conjunctival granuloma in the inferior fornix.", {"entities": []}], ["The lesion was excised and histopathologically examined.", {"entities": []}], ["Microscopy revealed synthetic fibers embedded in the cornea and in the conjunctival granuloma.", {"entities": []}], ["The diagnosis was confirmed by demonstration of marked birefringence of the synthetic fibers.", {"entities": []}], ["Microscopical examination of synthetic fibers from two different types of fur (whiskers and face hairs) from the two-year-old girl's teddy bear was performed.", {"entities": []}], ["Hairs from the face of the teddy bear were morphologically and microscopically identical with the fibers causing the severe corneal ulceration in the two-year-old girl.", {"entities": []}], ["Doctors should especially in small children be aware of the risk of ocular consequences of close exposure of synthetic fibers from stuffed toy animals.", {"entities": []}], ["Corneal ulceration, clinically presenting as corneal infection with negative culturing and staining, should lead to a different clinical strategy and treatment.", {"entities": []}], ["The treatment of conjunctival synthetic fiber granuloma is excision and antibiotic eye drops.", {"entities": []}], ["Among long-term care (LTC) residents, we explored the association between anemia status and hemoglobin (Hb) level with Activities of Daily Living (ADL) functioning and health-related quality of life (HRQOL).", {"entities": [[74, 80, "DISEASE"]]}], ["Data were derived from the AnalytiCare database, containing laboratory and Minimum Data Set (MDS) reports for 27 LTC facilities in Colorado.", {"entities": []}], ["Study timeframe was 1/1/07-9/15/08.", {"entities": []}], ["Patients were selected based on: residence in LTC >90 days, Hb and serum creatinine value within 90 days of the earliest non-admission (index) MDS.", {"entities": []}], ["From the index MDS, the method of 1) Carpenter et al.", {"entities": []}], ["[BMC Geriatrics 6:7(2006)] was used to derive a summary measure of ADL performance (the MDS-ADL score) and 2) Wodchis et al.", {"entities": []}], ["[IJTAHC 19:3(2003)] was used to assign HRQOL scores (MDS items were mapped to the Health Utilities Index Mark 2 (HUI2) scoring function to create the MDS-HSI score).", {"entities": []}], ["Anemia was defined as Hb <12 g/dL females and <13 g/dL males.", {"entities": [[0, 6, "DISEASE"]]}], ["Adjusted linear regression was used to evaluate the independent association of anemia and hemoglobin level on MDS-ADL and MDS-HSI scores.", {"entities": [[79, 85, "DISEASE"]]}], ["838 residents met all inclusion criteria; 46% of residents were anemic.", {"entities": []}], ["Mean (SD) MDS-ADL score was 14.9 (7.5) [0\u201328 scale, where higher score indicates worse functioning].", {"entities": []}], ["In the adjusted model, anemia was associated with a significantly worse MDS-ADL score (+1.62 points, P =.001).", {"entities": [[23, 29, "DISEASE"]]}], ["Residents with Hb levels 10 to <11 g/dL had significantly worse ADL score (+2.06 points, P =.005) than the >13 g/dL reference.", {"entities": []}], ["The mean MDS-HSI score was 0.431 (0.169) [range, where 0=dead to 1=perfect health].", {"entities": []}], ["Compared with non-anemic residents, in this adjusted model, residents with anemia had significantly worse MDS-HSI scores (\u22120.034 points, P =.005).", {"entities": [[75, 81, "DISEASE"]]}], ["Residents with hemoglobin levels <10 g/dL had significantly worse MDS-HSI scores (\u22120.058 points, P =.016) than the >13 g/dL reference.", {"entities": []}], ["After adjusting for several covariates, LTC residents with anemia, and many of those with moderate to severe declines in Hb level, had significantly poorer outcomes in both ADL functioning and HRQOL.", {"entities": [[59, 65, "DISEASE"]]}], ["The association between Hb level and the HRQOL measure of MDS-HSI appears to be largely explained by the mobility domain of the HRQOL measure.", {"entities": []}], ["Indoor air may be contaminated by diverse gaseous and particulate pollutants that may adversely affect health.", {"entities": []}], ["As a basis for controlling adverse health effects of indoor air pollution, the presence of a hazard needs to be confirmed, and the quantitative relationship between exposure and response needs to be described.", {"entities": []}], ["Toxicological, clinical, and epidemiological studies represent complementary approaches for obtaining the requisite evidence.", {"entities": []}], ["The assessment of the effects of complex mixtures poses a difficult challenge for epidemiologists.", {"entities": []}], ["Understanding the effects of exposure may require accurate assessment of concentrations and personal exposures to multiple agents and analytical approaches that can identify independent effects of single agents and the synergistic or antagonistic effects that may occur in mixtures.", {"entities": []}], ["The array of epidemiological study designs for this task includes descriptive studies, cohort studies, and case-control studies, each having potential advantages and disadvantages for studying complex mixtures.", {"entities": []}], ["This presentation considers issues related to exposure assessment and study design for addressing the effects of complex mixtures in indoor air.", {"entities": []}], ["Some herbal medications induce acute kidney injury.", {"entities": []}], ["The acute kidney injuries caused by herbal medications are mild and commonly treated by palliative care.", {"entities": []}], ["A 51-years-old man who drank the juice squeezed from the raw tubers of Dioscorea quinqueloba ( D. quinqueloba ) was admitted with nausea, vomiting and chilling.", {"entities": []}], ["He developed a seizure with decreased level of consciousness.", {"entities": []}], ["He was diagnosed with acute kidney injury, which was cured by continuous venovenous hemodialfiltration.", {"entities": []}], ["Non-detoxified D. quinqueloba can cause severe acute kidney injury with toxic encephalopathy.", {"entities": [[72, 92, "DISEASE"]]}], ["It is critical to inform possible adverse effects of the medicinal herbs and to implement more strict regulation of these products.", {"entities": []}], ["Obesity is a global epidemic associated with aging-like cellular processes; in both aging and obesity, resistance to hormones such as insulin and leptin can be observed.", {"entities": [[0, 7, "DISEASE"], [94, 101, "DISEASE"]]}], ["Leptin is a circulating hormone/cytokine with central and peripheral effects that is released mainly by subcutaneous white adipose tissue.", {"entities": []}], ["Centrally, leptin controls food intake, energy expenditure, and fat distribution, whereas it controls (among several others) insulin sensitivity, free fatty acids (FFAs) oxidation, and lipolysis in the periphery.", {"entities": []}], ["Aging is associated with important changes in both the distribution and the composition of adipose tissue.", {"entities": []}], ["Fat is redistributed from the subcutaneous to the visceral depot and increased inflammation participates in adipocyte dysfunction.", {"entities": []}], ["This redistribution of adipose tissue in favor of visceral fat influences negatively both longevity and healthy aging as shown in numerous animal models.", {"entities": []}], ["These modifications observed during aging are also associated with leptin resistance.", {"entities": []}], ["This resistance blunts normal central and peripheral functions of leptin, which leads to a decrease in neuroendocrine function and insulin sensitivity, an imbalance in energy regulation, and disturbances in lipid metabolism.", {"entities": []}], ["Here, we review how age-related leptin resistance triggers metabolic disturbances and affects the longevity of obese patients.", {"entities": []}], ["Furthermore, we discuss the potential impacts of leptin resistance on the decline of brown adipose tissue thermogenesis observed in elderly individuals.", {"entities": []}], ["Information on the costs and benefits of eHealth interventions is needed, not only to document value for money and to support decision making in the field, but also to form the basis for developing business models and to facilitate payment systems to support large-scale services.", {"entities": []}], ["In the absence of solid evidence of its effects, key decision makers may doubt the effectiveness, which, in turn, limits investment in, and the long-term integration of, eHealth services.", {"entities": []}], ["However, it is not realistic to conduct economic evaluations of all eHealth applications and services in all situations, so we need to be able to generalize from those we do conduct.", {"entities": []}], ["This implies that we have to select the most appropriate methodology and data collection strategy in order to increase the transferability across evaluations.", {"entities": []}], ["This paper aims to contribute to the understanding of how to apply economic evaluation methodology in the eHealth field.", {"entities": []}], ["It provides a brief overview of basic health economics principles and frameworks and discusses some methodological issues and challenges in conducting cost-effectiveness analysis of eHealth interventions.", {"entities": []}], ["Issues regarding the identification, measurement, and valuation of costs and benefits are outlined.", {"entities": []}], ["Furthermore, this work describes the established techniques of combining costs and benefits, presents the decision rules for identifying the preferred option, and outlines approaches to data collection strategies.", {"entities": []}], ["Issues related to transferability and complexity are also discussed.", {"entities": []}], ["Despite the legal authority to confirm, override or modify healthcare insurance decisions made by physicians and government officials, health tribunal decisions have not been empirically analyzed.", {"entities": []}], ["Using a novel quantitative methodology, all 387 Health Services Appeal and Review Board written and publicly available electronic decisions released over a five-year time period were statistically analyzed with respect to Ontario public health insurance requests for global cross-border healthcare.", {"entities": []}], ["The statistical results found that patients knew their diagnosis prior to requesting cross-border healthcare, and 84% of patients requested specific northern US facilities for specific treatment.", {"entities": []}], ["Two specific healthcare facilities in the US were requested for either surgery or assessments.", {"entities": []}], ["A significant number of patients were seeking cross-border healthcare for pain treatment.", {"entities": []}], ["This research challenges the assumption that cross-border treatment requests result only from domestic delay when instead patients are seeking specific treatments at specific facilities.", {"entities": []}], ["This novel quantitative research methodology and data source of written and publicly available electronic Health Services Appeal and Review Board decisions should be used to inform policy decision regarding the utilization and evaluation of Canada's healthcare system and publicly funded healthcare insurance.", {"entities": []}], ["Several studies have reported negative relations between allergic diseases and school performance but have not simultaneously considered various allergic diseases, including allergic rhinitis, asthma, and atopic dermatitis, and only examined a limited number of participants.", {"entities": [[174, 191, "DISEASE"], [205, 222, "DISEASE"], [183, 191, "DISEASE"], [193, 199, "DISEASE"], [212, 222, "DISEASE"]]}], ["The present study investigated the associations of allergic rhinitis, asthma, and atopic dermatitis with school performance in a large, representative Korean adolescent population.", {"entities": [[51, 68, "DISEASE"], [82, 99, "DISEASE"], [60, 68, "DISEASE"], [70, 76, "DISEASE"], [89, 99, "DISEASE"]]}], ["A total of 299,695 7th through 12th grade students participated in the Korea Youth Risk Behaviour Web-based Survey (KYRBWS) from 2009 to 2013.", {"entities": []}], ["The subjects\u2019 history of allergic rhinitis, asthma, and atopic dermatitis and number of school absences due to these diseases in the previous 12 months were examined and compared.", {"entities": [[25, 42, "DISEASE"], [56, 73, "DISEASE"], [34, 42, "DISEASE"], [44, 50, "DISEASE"], [63, 73, "DISEASE"]]}], ["School performance was classified into 5 levels.", {"entities": []}], ["The relations between allergic disorders and school performance were analyzed using multiple logistic regressions with complex sampling and adjusted for the subjects\u2019 durations of sleep, days of physical activity, body mass indexes (BMIs), regions of residence, economic levels, parents\u2019 education levels, stress levels, smoking status, and alcohol use.", {"entities": []}], ["A subgroup analysis of the economic groups was performed.", {"entities": []}], ["Allergic rhinitis was positively correlated with better school performance in a dose-dependent manner (adjusted odds ratios, AOR, [95% confidence interval, CI] = 1.50 [1.43\u20131.56 > 1.33 [1.28\u20131.38] > 1.17 [1.13\u20131.22] > 1.09 [1.05\u20131.14] for grades A > B > C > D; P < 0.001).", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["Asthma was negatively correlated with better school performance (AOR [95% CI] = 0.74 [0.66\u20130.83], 0.87 [0.79\u20130.96], 0.83 [0.75\u20130.91], 0.93 [0.85\u20131.02] for performance A, B, C, and D, respectively; P < 0.001).", {"entities": [[0, 6, "DISEASE"]]}], ["Atopic dermatitis was not significantly correlated with school performance.", {"entities": [[0, 17, "DISEASE"], [7, 17, "DISEASE"]]}], ["The subgroup analysis of the students\u2019 economic levels revealed associations between allergic diseases and school performance.", {"entities": []}], ["Compared to other allergic disorders, the asthma group had more school absences due to their symptoms (P < 0.001).", {"entities": [[42, 48, "DISEASE"]]}], ["School performance was positively correlated with allergic rhinitis and negatively correlated with asthma in Korean adolescents, even after adjusting for other variables.", {"entities": [[50, 67, "DISEASE"], [59, 67, "DISEASE"], [99, 105, "DISEASE"]]}], ["The asthma group had an increased number of school absence days, which presumably contributes to these students\u2019 poor school performance.", {"entities": [[4, 10, "DISEASE"]]}], ["New non-sputum biomarker tests for active tuberculosis (TB) diagnostics are of the highest priority for global TB control.", {"entities": [[42, 54, "DISEASE"]]}], ["We performed in-depth proteomic analysis using the 4,000-plex SOMAscan assay on 1,470 serum samples from seven countries where TB is endemic.", {"entities": []}], ["All samples were from patients with symptoms and signs suggestive of active pulmonary TB that were systematically confirmed or ruled out for TB by culture and clinical follow-up.", {"entities": []}], ["HIV coinfection was present in 34% of samples, and 25% were sputum smear negative.", {"entities": []}], ["Serum protein biomarkers were identified by stability selection using L1-regularized logistic regression and by Kolmogorov-Smirnov (KS) statistics.", {"entities": []}], ["A naive Bayes classifier using six host response markers (HR6 model), including SYWC, kallistatin, complement C9, gelsolin, testican-2, and aldolase C, performed well in a training set (area under the sensitivity-specificity curve [AUC] of 0.94) and in a blinded verification set (AUC of 0.92) to distinguish TB and non-TB samples.", {"entities": [[110, 112, "GENE"]]}], ["Differential expression was also highly significant ( P < 10", {"entities": []}], ["Citizens, patients and their representatives are increasingly insisting on working with health professionals to organize and discuss research protocols.", {"entities": []}], ["The International Committee of Medical Journal Editors recommended setting up a public clinical trial registry where anyone can find key information about a trial.", {"entities": []}], ["Around the world, governments have, in fact, now begun to legislate mandatory disclosure of all clinical trials.", {"entities": []}], ["The aims of the present survey were to assess the availability of clinical trial registries for Italian citizens and to examine the transparency of the data items reported.", {"entities": []}], ["The availability of open-access clinical trial registries was surveyed on a sample of 182 websites, including research institutes and centers of excellence (IRCCS-teaching hospitals), hospitals and associations.", {"entities": []}], ["For each registry we downloaded a sample of two trials to assess the correspondence of the data items reported.", {"entities": []}], ["Results from the Italian and international registries were compared.", {"entities": []}], ["Fifteen percent of the sample had an open-access registry of clinical trials.", {"entities": []}], ["Comparison of the data items available, in terms of completeness and transparency, from institutional and international registries indicated wide variability.", {"entities": []}], ["Italian citizens, patients and their associations have scant access to local registries of clinical trials, and international registries are generally more informative.", {"entities": []}], ["On the European level, advocacy and lobby actions are needed among citizens and patients to boost the diffusion of open-access clinical trial registries without language barriers, thereby facilitating participation, access to information, and the coordination of clinical research.", {"entities": []}], ["The aim of this study was to compare the anti-oxidative and anti-inflammatory activities of gamma-irradiated persimmon leaf extract (GPLE) with those of non-irradiated persimmon leaf extract (PLE).", {"entities": []}], ["Ethanolic extract of persimmon leaf was exposed to gamma irradiation at a dose of 10 kGy.", {"entities": []}], ["After gamma irradiation, the color of the extract changed from dark brown to light brown.", {"entities": []}], ["The anti-oxidative and anti-inflammatory activities of GPLE and PLE were assessed from: total polyphenol and total flavonoid contents; 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay; 2,2\u2032-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay, and levels of pro-inflammatory mediators such as nitric oxide (NO), prostaglandin E 2 (PGE 2 ), tumor necrosis factor alpha (TNF-\u03b1) and interleukin-6 (IL-6).", {"entities": []}], ["The total polyphenol contents of GPLE and PLE were determined to be 224.44\u00a0\u00b1\u00a01.54 and 197.33\u00a0\u00b1\u00a05.81 mg gallic acid equivalents (GAE)/g, respectively, and the total flavonoid contents of GPLE and PLE were 206.27\u00a0\u00b1\u00a01.15 and 167.60\u00a0\u00b1\u00a02.00 mg quercetin equivalents (QUE)/g, respectively.", {"entities": []}], ["The anti-oxidant activities of GPLE and PLE as measured by DPPH assays were 338.33\u00a0\u00b1\u00a030.19 \u03bcg/ml (IC50) and 388.68\u00a0\u00b1\u00a08.45 \u03bcg/ml (IC50), respectively, and those measured by ABTS assays were 510.49\u00a0\u00b1\u00a015.12 \u03bcg/ml (IC50) and 731.30\u00a0\u00b1\u00a010.63 \u03bcg/ml (IC50), respectively.", {"entities": []}], ["IC50 is the inhibitor concentration that reduces the response by 50%.", {"entities": []}], ["GPLE strongly inhibited the production of NO, PGE 2 and IL-6 compared with PLE in lipopolysaccharide-stimulated RAW264.7 macrophages.", {"entities": []}], ["Furthermore, GPLE significantly inhibited the production of TNF-\u03b1 and IL-6 cytokines compared with PLE in phorbol 12-myristate 13-acetate (PMA) plus A23187-stimulated HMC-1 human mast cells.", {"entities": []}], ["These results indicate that gamma irradiation of PLE can enhance its anti-oxidative and anti-inflammatory activities through elevation of the phenolic contents.", {"entities": []}], ["Therefore, gamma-irradiated PLE has potential for use in the food and cosmetic industries.", {"entities": []}], ["Extreme temperature is associated with adverse birth outcomes but it is unclear whether it increases early delivery risk.", {"entities": []}], ["We aimed to determine the association between ambient temperature and early delivery.", {"entities": []}], ["Medical records from 223,375 singleton deliveries from 12 U.S. sites were linked to local ambient temperature.", {"entities": []}], ["Exposure to hot (> 90th percentile) or cold (< 10th percentile) using site-specific and window-specific temperature distributions were defined for 3-months preconception, 7-week periods during the first two trimesters, 1 week preceding delivery, and whole pregnancy.", {"entities": []}], ["Poisson regression with generalized estimating equations calculated the relative risk (RR) and 95% confidence interval for early deliveries associated with hot/cold exposures, adjusting for conception month, humidity, site, sex, maternal demographics, parity, insurance, prepregnancy body mass index, pregnancy complications, and smoking or drinking during pregnancy.", {"entities": []}], ["Acute temperature associations were estimated separately for warm (May\u2013September) and cold season (October\u2013April) in a case-crossover analysis using conditional logistic regression.", {"entities": []}], ["Compared with mild temperature (10\u201390th percentile), exposure to hot or cold during weeks 1\u20137 increased risk for early preterm (< 34 weeks) [RR hot : 1.11 (95% CI: 1.01, 1.21); RR cold : 1.20 (95% CI: 1.11, 1.30)], late preterm (34\u201336 weeks) [RR cold : 1.09 (95% CI: 1.04, 1.15)], and early term (37\u201338 weeks) [RR hot : 1.04 (95% CI: 1.02, 1.07); RR cold : 1.03 (95% CI: 1.00, 1.05)] delivery.", {"entities": []}], ["Findings were similar for hot exposures during weeks 15\u201321.", {"entities": []}], ["Examining deliveries at each week from 23 through 38, whole-pregnancy hot exposures increased delivery risk by 6\u201321% at weeks 34 and 36\u201338.", {"entities": []}], ["In the case-crossover analysis, a 5\u00b0F increase during the week preceding delivery was associated with 12\u201316% higher and 4\u20135% lower early delivery risk during warm and cold season, respectively.", {"entities": []}], ["Both acute and chronic ambient temperature extremes may affect early delivery risk.", {"entities": []}], ["Ha S, Liu D, Zhu Y, Kim SS, Sherman S, Mendola P. 2017.", {"entities": []}], ["Ambient temperature and early delivery of singleton pregnancies.", {"entities": []}], ["Environ Health Perspect 125:453\u2013459;\u2002http://dx.doi.org/10.1289/EHP97Citation: Ha S, Liu D, Zhu Y, Kim SS, Sherman S, Mendola P. 2017.", {"entities": []}], ["Ambient temperature and early delivery of singleton pregnancies.", {"entities": []}], ["Environ Health Perspect 125:453\u2013459;\u2002 http://dx.doi.org/10.1289/EHP97", {"entities": []}], ["The obesity-asthma phenotype is characterized by increased asthma severity and decreased glucocorticoid responsiveness.", {"entities": [[4, 11, "DISEASE"], [12, 18, "DISEASE"], [59, 65, "DISEASE"]]}], ["To date, the mechanism underlying the association between obesity and asthma remain to be fully elucidated.", {"entities": [[58, 65, "DISEASE"], [70, 76, "DISEASE"]]}], ["The present study investigated the correlation between oxidative stress and the nuclear factor (NF)-\u03baB pathway in obese asthmatic mice.", {"entities": []}], ["The animals were divided into the following groups: Control (n=8), comprising C57BL/6J mice without exposure to a high-fat diet; non-obese asthma group (n=8), comprising mice of a normal weight subjected to the induction of asthma; obese control group (n=8), comprising C57BL/6J mice subjected to a high-fat diet; and obese asthmatic group (n=8), comprising obese mice subject to the induction of asthma.", {"entities": [[139, 145, "DISEASE"], [224, 230, "DISEASE"], [397, 403, "DISEASE"]]}], ["The levels of the malondialdehyde (MDA) oxidant and glutathione (GSH) antioxidant in the lungs and bronchoalveolar lavage fluid (BALF) were measured using ELISA.", {"entities": []}], ["The expression levels of inhibitory \u03baB kinase-\u03b2 (IKK-\u03b2) and the inhibitor of \u03baB\u03b1 (I\u03baB-\u03b1) in the pulmonary tissues was determined using western blot analysis.", {"entities": []}], ["An electrophoretic mobility shift assay was performed to determine the transcription activity of NF-\u03baB.", {"entities": []}], ["The levels of MDA in the BALF and lung tissues increased significantly in the two asthmatic groups, compared with the control groups (P<0.01).", {"entities": []}], ["The asthmatic mice showed significantly lower concentrations of GSH in the BALF and lung tissues, compared with the control groups (P<0.01).", {"entities": []}], ["In the asthmatic animals, the expression of I\u03baB kinase (IKK)-\u03b2 and activation of NF-\u03baB were upregulated in the pulmonary tissues, compared with those in the control groups (P<0.01).", {"entities": []}], ["The expression of IKK-\u03b2 and transcriptional activity of NF-\u03baB were significantly higher the in obese asthmatic mice, compared with the non-obese asthmatic mice (P<0.01).", {"entities": []}], ["On examining the expression levels of I\u03baB-\u03b1 in the pulmonary tissues, a significant reduction was found in the asthmatic animals, compared with the controls (P<0.01).", {"entities": []}], ["In addition, the level of I\u03baB-\u03b1 was significantly lower in the obese asthmatics, compared with the non-obese asthmatics (P<0.01).", {"entities": []}], ["MDA was positively correlated with NF-\u03baB in the obese asthmatic group (R=0.83; P<0.05) and non-obese asthmatic group (R=0.82; P<0.05).", {"entities": []}], ["Oxidative stress was upregulated in the pulmonary tissues of the asthmatic mice.", {"entities": []}], ["This upregulation was more marked in the obese asthmatic mice, and was positively correlated with activation of the NF-\u03baB signaling pathway in the pulmonary tissues.", {"entities": []}], ["The results in the present study indicated that higher oxidative stress and activation of the NF-\u03baB signaling pathway were observed in the lung tissues of the obese asthmatics.", {"entities": []}], ["Furthermore, a positive correlation was identified between oxidative stress and NF-\u03baB.", {"entities": []}], ["The treatment of hypertension in children and adolescents has been markedly changed in recent years by several factors, including the publication of new consensus recommendations, the obesity epidemic, and the increased availability of information on efficacy and safety of antihypertensive medications in the young.", {"entities": [[17, 29, "DISEASE"], [184, 191, "DISEASE"]]}], ["In this review we present an updated approach to the outpatient management of hypertension in the child or adolescent, utilizing representative cases to illustrate important principles as well as possible controversies.", {"entities": [[78, 90, "DISEASE"]]}], ["Genome-wide association studies (GWAS) have identified numerous loci influencing cross-sectional lung function, but less is known about genes influencing longitudinal change in lung function.", {"entities": []}], ["We performed GWAS of the rate of change in forced expiratory volume in the first second (FEV 1 ) in 14 longitudinal, population-based cohort studies comprising 27,249 adults of European ancestry using linear mixed effects model and combined cohort-specific results using fixed effect meta-analysis to identify novel genetic loci associated with longitudinal change in lung function.", {"entities": [[89, 92, "GENE"]]}], ["Gene expression analyses were subsequently performed for identified genetic loci.", {"entities": []}], ["As a secondary aim, we estimated the mean rate of decline in FEV 1 by smoking pattern, irrespective of genotypes, across these 14 studies using meta-analysis.", {"entities": [[61, 64, "GENE"]]}], ["The overall meta-analysis produced suggestive evidence for association at the novel IL16/STARD5/TMC3 locus on chromosome 15 ( P \u200a=\u200a 5.71 \u00d7 10 1 measurements per participant identified the novel ME3 locus on chromosome 11 ( P \u200a=\u200a 2.18 \u00d7 10 1 decline in two additional cohort studies.", {"entities": [[194, 197, "GENE"]]}], ["We confirmed gene expression of IL16 , STARD5 , and ME3 in multiple lung tissues.", {"entities": [[32, 36, "GENE"], [39, 45, "GENE"], [52, 55, "GENE"]]}], ["Publicly available microarray data confirmed differential expression of all three genes in lung samples from COPD patients compared with controls.", {"entities": []}], ["Irrespective of genotypes, the combined estimate for FEV 1 decline was 26.9, 29.2 and 35.7 mL/year in never, former, and persistent smokers, respectively.", {"entities": [[53, 56, "GENE"]]}], ["In this large-scale GWAS, we identified two novel genetic loci in association with the rate of change in FEV 1 that harbor candidate genes with biologically plausible functional links to lung function.", {"entities": [[105, 108, "GENE"]]}], ["Fresh-cut fruit consumption is increasing due to the rising public demand for convenience and awareness of fresh-cut fruit's health benefits.", {"entities": []}], ["The entire tissue of fruits and vegetables is rich in bioactive compounds, such as phenolic compounds, carotenoids, and vitamins.", {"entities": []}], ["The fresh-cut fruit industry deals with the perishable character of its products and the large percentage of byproducts, such as peels, seeds, and unused flesh that are generated by different steps of the industrial process.", {"entities": []}], ["In most cases, the wasted byproducts can present similar or even higher contents of antioxidant and antimicrobial compounds than the final produce can.", {"entities": []}], ["In this context, this hypothesis article finds that the antioxidant enrichment and antimicrobial protection of fresh-cut fruits, provided by the fruit's own byproducts, could be possible.", {"entities": []}], ["The tumor necrosis factor (TNF) antagonists are parenterally administered biologic response modifiers indicated for the management of rheumatoid arthritis.", {"entities": [[134, 154, "DISEASE"], [145, 154, "DISEASE"], [27, 30, "GENE"]]}], ["Although infliximab, etanercept, and adalimumab are all members of this class, they differ in route of administration and dosing regimen.", {"entities": []}], ["In the USA and in Europe, infliximab, in combination with oral methotrexate, is administered intravenously, initially at a dose of 3 mg/kg at weeks 0, 2, and 6, then every 8 weeks thereafter.", {"entities": []}], ["The US Food and Drug Administration (FDA) has further approved that the dosage can be increased to 10 mg/kg and the doses can be given as often as every 4 weeks to optimize patient outcome (information based on the US package insert dated June 2002).", {"entities": []}], ["Etanercept and adalimumab are given subcutaneously and can be self-injected.", {"entities": []}], ["The FDA-approved dose of etanercept is 25 mg twice weekly, and of adalimumab is 40 mg every 2 weeks with methotrexate, or 40 mg alone.", {"entities": []}], ["Medication adherence, possibly the most important factor in maintaining the benefits of anti-TNF therapy, is influenced by the interaction between the patient and his or her healthcare team, the patient's attitude toward the disease and medication regimen, and the choice of therapy.", {"entities": []}], ["Studies comparing the access to health care of rural and urban populations have been contradictory and inconclusive.", {"entities": []}], ["These studies are complicated by the influence of other factor which have been shown to be related to access and utilization.", {"entities": []}], ["This study assesses the equity of access to health care services across the rural-urban continuum in Canada before and after taking other determinants of access into account.", {"entities": []}], ["This is a cross-sectional study of the population of the 10 provinces of Canada using data from the Canadian Community Health Survey (CCHS 2.1).", {"entities": []}], ["Five different measures of access and utilization are compared across the continuum of rural-urban.", {"entities": []}], ["Known determinants of utilization are taken into account according to Andersen's Health Behaviour Model (HBM); location of residence at the levels of province, health region, and community is also controlled for.", {"entities": []}], ["This study found that residents of small cities not adjacent to major centres, had the highest reported utilisation rates of influenza vaccines and family physician services, were most likely to have a regular medical doctor, and were most likely to report unmet need.", {"entities": [[125, 134, "DISEASE"]]}], ["Among the rural categories there was a gradient with the most rural being least likely to have had a flu shot, use specialist physicians services, or have a regular medical doctor.", {"entities": []}], ["Residents of the most urban centres were more likely to report using specialist physician services.", {"entities": []}], ["Many of these differences are diminished or eliminated once other factors are accounted for.", {"entities": []}], ["After adjusting for other factors those living in the most urban areas were more likely to have seen a specialist physician.", {"entities": []}], ["Those in rural communities had a lower odds of receiving a flu shot and having a regular medical doctor.", {"entities": []}], ["People residing in the most urban and most rural communities were less likely to have a regular medical doctor.", {"entities": []}], ["Those in any of the rural categories were less likely to report unmet need.", {"entities": []}], ["Inequities in access to care along the rural-urban continuum exist and can be masked when evaluation is done at a very large scale with gross indicators of rural-urban.", {"entities": []}], ["Understanding the relationship between rural-urban and other determinants will help policy makers to target interventions appropriately: to specific demographic, provincial, community, or rural categories.", {"entities": []}], ["Interleukin-6 (IL-6) plays a contributory role in the progression and severity of many forms of cancer; it however remains unclear whether the relevance between circulating IL-6 and cancer is causal.", {"entities": [[96, 102, "DISEASE"], [182, 188, "DISEASE"]]}], ["We therefore meta-analyzed published articles in this regard using IL-6 gene -174G/C variant as an instrument.", {"entities": []}], ["Seventy-eight and six articles were eligible for the association of -174G/C variant with cancer and circulating IL-6, respectively.", {"entities": [[89, 95, "DISEASE"]]}], ["Overall analyses failed to identify any significance between -174G/C and cancer risk.", {"entities": [[73, 79, "DISEASE"]]}], ["In Asians, carriers of the -174CC genotype had an 1.95-fold increased cancer risk compared with the -174GG genotype carriers (P\u2009=\u20090.009).", {"entities": [[70, 76, "DISEASE"]]}], ["By cancer type, significance was only attained for liver cancer with the -174C allele conferring a reduced risk under allelic (odds ratio or OR\u2009=\u20090.74; P\u2009=\u20090.001), homozygous genotypic (OR\u2009=\u20090.59; P\u2009=\u20090.029) and dominant (OR\u2009=\u20090.67; P\u2009=\u20090.004) models.", {"entities": [[51, 63, "DISEASE"], [3, 9, "DISEASE"], [57, 63, "DISEASE"]]}], ["Carriers of the -174CC genotype (weighted mean difference or WMD\u2009=\u2009\u22124.23\u2009pg/mL; P\u2009<\u20090.001) and -174C allele (WMD\u2009=\u2009\u22123.43\u2009pg/mL; P\u2009<\u20090.001) had circulating IL-6 reduced significantly compared with the non-carriers.", {"entities": []}], ["In further Mendelian randomization analysis, a reduction of 1\u2009pg/mL in circulating IL-6 was significantly associated with an 12% reduced risk of liver cancer.", {"entities": [[145, 157, "DISEASE"], [151, 157, "DISEASE"]]}], ["Long-term genetically-reduced circulating IL-6 might be causally associated with a lower risk of liver cancer.", {"entities": [[97, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Cancer is the leading cause of death in Canada.", {"entities": [[0, 6, "DISEASE"]]}], ["Early cancer diagnosis could improve patients\u2019 prognosis and quality of life.", {"entities": [[6, 12, "DISEASE"]]}], ["This study aimed to analyze the factors influencing elapsed time between the first help-seeking trigger and cancer diagnosis with respect to the three most common and deadliest cancer types: lung, breast, and colorectal.", {"entities": [[108, 114, "DISEASE"], [177, 183, "DISEASE"]]}], ["This paper presents the qualitative component of a larger project based on a sequential explanatory design.", {"entities": []}], ["Twenty-two patients diagnosed were interviewed, between 2011 to 2013, in oncology clinics of four hospitals in the two most populous regions in Quebec (Canada).", {"entities": []}], ["Transcripts were analyzed using the Model of Pathways to Treatment.", {"entities": []}], ["Pre-diagnosis elapsed time and phases are difficult to appraise precisely and vary according to cancer sites and symptoms specificity.", {"entities": [[96, 102, "DISEASE"]]}], ["This observation makes the Model of Pathways to Treatment challenging to use to analyze patients\u2019 experiences.", {"entities": []}], ["Analyses identified factors contributing to elapsed time that are linked to type of cancer, to patients, and to health system organization.", {"entities": [[84, 90, "DISEASE"]]}], ["This research allowed us to identify avenues for reducing the intervals between first symptoms and cancer diagnosis.", {"entities": [[99, 105, "DISEASE"]]}], ["The existence of inequities in access to diagnostic services, even in a universal healthcare system, was highlighted.", {"entities": []}], ["To evaluate how changes in lung volume affect volumetric measurements of lung nodules using a multi-detector row CT.", {"entities": []}], ["Ten subjects with asthma or chronic bronchitis who had one or more lung nodules were included.", {"entities": [[18, 24, "DISEASE"], [36, 46, "DISEASE"]]}], ["For each subject, two sets of CT images were obtained at inspiration and at expiration.", {"entities": []}], ["A total of 33 nodules (23 nodules \u2265 3 mm) were identified and their volume measured using a semiautomatic volume measurement program.", {"entities": []}], ["Differences between nodule volume on inspiration and expiration were compared using the paired t-test.", {"entities": []}], ["Percent differences, between on inspiration and expiration, in nodule attenuation, total lung volume, whole lung attenuation, and regional lung attenuation, were computed and compared with percent difference in nodule volume determined by linear correlation analysis.", {"entities": []}], ["The difference in nodule volume observed between inspiration and expiration was significant ( p < 0.01); the mean percent difference in lung nodule volume was 23.1% for all nodules and for nodules \u2265 3 mm.", {"entities": []}], ["The volume of nodules was measured to be larger on expiration CT than on inspiration CT (28 out of 33 nodules; 19 out of 23 nodules \u2265 3 mm).", {"entities": []}], ["A statistically significant correlation was found between the percent difference of lung nodule volume and lung volume or regional lung attenuation ( p < 0.05) for nodules \u2265 3 mm.", {"entities": []}], ["Volumetric measurements of pulmonary nodules were significantly affected by changes in lung volume.", {"entities": []}], ["The variability in this respiration-related measurement should be considered to determine whether growth has occurred in a lung nodule.", {"entities": []}], ["The objective of our study was to assess the psychometric properties of the Medical Outcomes Study's 12-Item Short Form Survey Instrument (SF-12) for use in a low-income African American community.", {"entities": []}], ["The SF-12, a commonly used functional health status assessment, was developed based on responses of an ethnically homogeneous sample of whites.", {"entities": []}], ["Our assessment addressed the appropriateness of the instrument for establishing baseline indicators for mental and physical health status as part of Nashville, Tennessee's, Racial and Ethnic Approaches to Community Health (REACH) 2010 initiative, a community-based participatory research study.", {"entities": []}], ["A cross-sectional random residential sample of 1721 African Americans responded to a telephone survey that included the SF-12 survey items and other indicators of mental and physical health status.", {"entities": []}], ["The SF-12 was assessed by examining item-level characteristics, estimates of scale reliability (internal consistency), and construct validity.", {"entities": []}], ["Construct validity assessed by the method of extreme groups determined that SF-12 summary scores varied for individuals who differed in self-reported medical conditions.", {"entities": []}], ["Convergent and discriminate validity assessed by multitrait analysis yielded satisfactory coefficients.", {"entities": []}], ["Concurrent validity was also shown to be satisfactory, assessed by correlating SF-12 summary scores with independent measures of physical and mental health status.", {"entities": []}], ["The SF-12 appears to be a valid measure for assessing health status of low-income African Americans.", {"entities": []}], ["Small insertions and deletions occur in humans at a lower rate compared to nucleotide changes, but evolve under more constraint than nucleotide changes.", {"entities": []}], ["While the evolution of insertions and deletions have been investigated using ape outgroups, the now available genome of a Neandertal can shed light on the evolution of indels in more recent times.", {"entities": []}], ["We used the Neandertal genome together with several primate outgroup genomes to differentiate between human insertion/deletion changes that likely occurred before the split from Neandertals and those that likely arose later.", {"entities": []}], ["Changes that pre-date the split from Neandertals show a smaller proportion of deletions than those that occurred later.", {"entities": []}], ["The presence of a Neandertal-shared allele in Europeans or Asians but the absence in Africans was used to detect putatively introgressed indels in Europeans and Asians.", {"entities": []}], ["A larger proportion of these variants reside in intergenic regions compared to other modern human variants, and some variants are linked to SNPs that have been associated with traits in modern humans.", {"entities": []}], ["Our results are in agreement with earlier results that suggested that deletions evolve under more constraint than insertions.", {"entities": []}], ["When considering Neandertal introgressed variants, we find some evidence that negative selection affected these variants more than other variants segregating in modern humans.", {"entities": []}], ["Among introgressed variants we also identify indels that may influence the phenotype of their carriers.", {"entities": []}], ["In particular an introgressed deletion associated with a decrease in the time to menarche may constitute an example of a former Neandertal-specific trait contributing to modern human phenotypic diversity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12862-017-1018-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Aluminum use and primary aluminum production results in the generation of various particles, fumes, gases, and airborne materials with the potential for inducing a wide range of lung pathology.", {"entities": []}], ["Nevertheless, the presence of diffuse parenchymal or interstitial lung disease related to these processes remains controversial.", {"entities": [[53, 78, "DISEASE"], [66, 78, "DISEASE"]]}], ["The relatively uncommon occurrence of interstitial lung diseases in aluminum-exposed workers\u2014despite the extensive industrial use of aluminum\u2014the potential for concurrent exposure to other fibrogenic fibers, and the previous use of inhaled aluminum powder for the prevention of silicosis without apparent adverse respiratory effects are some of the reasons for this continuing controversy.", {"entities": [[278, 287, "DISEASE"]]}], ["Specific aluminum-induced parenchymal diseases described in the literature, including existing evidence of interstitial lung diseases, associated with primary aluminum production are reviewed.", {"entities": []}], ["Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied during the \u2018preclinical\u2019 stage (pathology present with cognition intact) before severe neuronal damage occurs, or upon recognizing very mild cognitive impairment.", {"entities": []}], ["Developing and judiciously administering such therapies will require biomarker panels to identify early AD pathology, classify disease stage, monitor pathological progression, and predict cognitive decline.", {"entities": []}], ["To discover such biomarkers, we measured AD-associated changes in the cerebrospinal fluid (CSF) proteome.", {"entities": []}], ["CSF samples from individuals with mild AD (Clinical Dementia Rating [CDR] 1) (n\u200a=\u200a24) and cognitively normal controls (CDR 0) (n\u200a=\u200a24) were subjected to two-dimensional difference-in-gel electrophoresis.", {"entities": [[52, 60, "DISEASE"]]}], ["Within 119 differentially-abundant gel features, mass spectrometry (LC-MS/MS) identified 47 proteins.", {"entities": []}], ["For validation, eleven proteins were re-evaluated by enzyme-linked immunosorbent assays (ELISA).", {"entities": []}], ["Six of these assays (NrCAM, YKL-40, chromogranin A, carnosinase I, transthyretin, cystatin C) distinguished CDR 1 and CDR 0 groups and were subsequently applied (with tau, p-tau181 and A\u03b242 ELISAs) to a larger independent cohort (n\u200a=\u200a292) that included individuals with very mild dementia (CDR 0.5).", {"entities": [[280, 288, "DISEASE"], [21, 26, "GENE"]]}], ["Receiver-operating characteristic curve analyses using stepwise logistic regression yielded optimal biomarker combinations to distinguish CDR 0 from CDR>0 (tau, YKL-40, NrCAM) and CDR 1 from CDR<1 (tau, chromogranin A, carnosinase I) with areas under the curve of 0.90 (0.85\u20130.94 95% confidence interval [CI]) and 0.88 (0.81\u20130.94 CI), respectively.", {"entities": [[169, 174, "GENE"]]}], ["Four novel CSF biomarkers for AD (NrCAM, YKL-40, chromogranin A, carnosinase I) can improve the diagnostic accuracy of A\u03b242 and tau.", {"entities": [[34, 39, "GENE"]]}], ["Together, these six markers describe six clinicopathological stages from cognitive normalcy to mild dementia, including stages defined by increased risk of cognitive decline.", {"entities": [[100, 108, "DISEASE"]]}], ["Such a panel might improve clinical trial efficiency by guiding subject enrollment and monitoring disease progression.", {"entities": []}], ["Further studies will be required to validate this panel and evaluate its potential for distinguishing AD from other dementing conditions.", {"entities": []}], ["Numerous reports have described the epidemiological and clinical characteristics of influenza A (H1N1) 2009 infected patients.", {"entities": [[84, 93, "DISEASE"]]}], ["However, data on the effects of bacterial coinfection on these patients are very scarce.", {"entities": []}], ["Therefore, this study explores the impact of bacterial coinfection on the clinical and laboratory parameters amongst H1N1 hospitalized patients.", {"entities": []}], ["This retrospective study involved hospitalized patients with laboratory-confirmed H1N1 infections (September 2009 to May 2010).", {"entities": []}], ["Relevant clinical data and the detection of bacterial coinfection from respiratory or sterile site samples were obtained.", {"entities": []}], ["Multiplex PCR was used to determine the co-existence of other respiratory viruses.", {"entities": []}], ["Comparison was made between patients with and without bacterial coinfection.", {"entities": []}], ["The occurrence of coinfection was 34%; 14 (28%) bacterial and only 3 (6%) viral.", {"entities": []}], ["Mycoplasma pneumoniae (n = 5) was the commonest bacteria followed by Staphylococcus aureus (n = 3).", {"entities": []}], ["In univariate analysis, clinical factors associated with bacterial coinfection were age > 50 years (p = 0.02), presence of comorbidity (p = 0.04), liver impairment (p = 0.02), development of complications (p = 0.004) and supplemental oxygen requirement (p = 0.02).", {"entities": []}], ["Leukocytosis (p = 0.02) and neutrophilia (p = 0.004) were higher in bacterial coinfected patients.", {"entities": []}], ["Multivariate logistic regression analysis revealed that age > 50 years and combined complications were predictive of bacterial coinfection.", {"entities": []}], ["Bacterial coinfection is not uncommon in H1N1 infected patients and is more frequently noted in the older aged patients and is associated with higher rates of complications.", {"entities": []}], ["Also, as adjunct to clinical findings, clinicians need to have a higher index of suspicion if neutrophilia was identified at admission as it may denote bacterial coinfection.", {"entities": []}], ["Guided by the practice of classical epidemiology, research into the genetic basis of complex disease has usually taken for granted the dictum that causative mutations are invariably over-represented among clinically affected as compared to unaffected individuals.", {"entities": []}], ["However, we show that this supposition is not true and that a mutation contributing to the etiology of a complex disease can, under certain circumstances, be depleted among patients.", {"entities": []}], ["Populations with defined disease prevalence were repeatedly simulated under a Wright-Fisher model, assuming various types of population history and genotype-phenotype relationship.", {"entities": []}], ["For each simulation, the resulting mutation-specific population frequencies and odds ratios (ORs) were evaluated.", {"entities": []}], ["In addition, the relationship between mutation frequency and OR was studied using real data from the NIH GWAS catalogue of reported phenotype associations of single-nucleotide polymorphisms (SNPs).", {"entities": []}], ["While rare diseases (prevalence <1%) were found to be consistently caused by rare mutations with ORs>1, up to 20% of mutations causing a pandemic disease (prevalence 10\u201320%) had ORs<1, and their population frequency ranged from 0% to 100%.", {"entities": []}], ["Moreover, simulation-based ORs exhibited a wide distribution, irrespective of mutation frequency.", {"entities": []}], ["In conclusion, a substantial proportion of mutations causing common complex diseases may appear \u2018protective\u2019 in genetic epidemiological studies and hence would normally tend to be excluded, albeit erroneously, from further study.", {"entities": []}], ["This apparently paradoxical result is explicable in terms of mutual confounding of the respective genotype-phenotype relationships due to a negative correlation between causal mutations induced by their common gene genealogy.", {"entities": []}], ["As would be predicted by our findings, a significant negative correlation became apparent in published genome-wide association studies between the OR of genetic variants associated with a particular disease and the prevalence of that disease.", {"entities": []}], ["To report the outcome of children with life-threatening asthma (LTA) admitted to a university Pediatric Intensive Care Unit (PICU).", {"entities": [[56, 62, "DISEASE"], [64, 67, "GENE"]]}], ["Retrospective study between October 2002 and May 2010 was carried out.", {"entities": []}], ["Every child with LTA and bronchospasm was included.", {"entities": [[17, 20, "GENE"]]}], ["30 admissions of 28 patients (13 M, 17 F) were identified which accounted for 3% of total PICU admissions (n = 1033) over the study period.", {"entities": []}], ["The majority of patients were toddlers (median age 3.1 years).", {"entities": []}], ["Few had past history of prematurity, lung diseases, or neuro-developmental conditions.", {"entities": []}], ["Approximately half had previous admissions for asthma and one-forth with history of non-compliance to recommended treatment for asthma.", {"entities": [[47, 53, "DISEASE"], [128, 134, "DISEASE"]]}], ["One patient had parainfluenza virus and one had rhinovirus isolated.", {"entities": []}], ["None of these factors were associated with need for mechanical ventilation (n = 6 admissions).", {"entities": []}], ["Comparing with patients who did not receive mechanical ventilation, ventilated children had significantly higher PIM2 score (1.65 versus 0.4, p < 0.001), higher PCO 2 levels (9.3 kPa versus 5.1 kPa, p = 0.01) and longer PICU stay (median 2.5 days versus 2 days, p = 0.03) The majority of patients received systemic corticosteroids, intravenous or inhaled bronchodilators.", {"entities": [[113, 117, "GENE"]]}], ["There was one pneumothorax but no death in this series.", {"entities": [[14, 26, "DISEASE"]]}], ["LTA accounted for a small percentage of PICU admissions.", {"entities": [[0, 3, "GENE"]]}], ["Previous hospital admissions for asthma and history of non-compliance were common.", {"entities": [[33, 39, "DISEASE"]]}], ["Approximately one quarters required ventilatory supports.", {"entities": []}], ["Regardless of the need for mechanical ventilation, all patients survived with prompt treatment.", {"entities": []}], ["Airway stem/progenitor epithelial cells (AECs) are notable for their differentiation capacities in response to lung injury.", {"entities": []}], ["Our previous finding highlighted the regenerative capacity of AECs following transplantation in repairing tracheal injury and reducing the severity of alveolar damage associated acute lung injury in a rabbit model.", {"entities": []}], ["The goal of this study is to further investigate the potential of AECs to re-populate the tracheal epithelium and to study their stimulatory effect on inhibiting pro-inflammatory cytokines, epithelial cell migration and proliferation, and epithelial-to-mesenchymal transition (EMT) process following tracheal injury.", {"entities": []}], ["Two in vitro culture assays were applied in this study; the direct co-culture assay that involved a culture of decellularised tracheal epithelium explants and AECs in a rotating tube, and indirect co-culture assay that utilized microporous membrane-well chamber system to separate the partially decellularised tracheal epithelium explants and AEC culture.", {"entities": []}], ["The co-culture assays provided evidence of the stimulatory behaviour of AECs to enhance tracheal epithelial cell proliferation and migration during early wound repair.", {"entities": []}], ["Factors that were secreted by AECs also markedly suppressed the production of IL-1\u03b2 and IL-6 and initiated the EMT process during tracheal remodelling.", {"entities": []}], ["We estimated the disability weights in the South Korean population by using a paired comparison-only model wherein \u2018full health\u2019 and \u2018being dead\u2019 were included as anchor points, without resorting to a cardinal method, such as person trade-off.", {"entities": []}], ["The study was conducted via 2 types of survey: a household survey involving computer-assisted face-to-face interviews and a web-based survey (similar to that of the GBD 2010 disability weight study).", {"entities": []}], ["With regard to the valuation methods, paired comparison, visual analogue scale (VAS), and standard gamble (SG) were used in the household survey, whereas paired comparison and population health equivalence (PHE) were used in the web-based survey.", {"entities": []}], ["Accordingly, we described a total of 258 health states, with \u2018full health\u2019 and \u2018being dead\u2019 designated as anchor points.", {"entities": []}], ["In the analysis, 4 models were considered: a paired comparison-only model; hybrid model between paired comparison and PHE; VAS model; and SG model.", {"entities": []}], ["A total of 2,728 and 3,188 individuals participated in the household and web-based survey, respectively.", {"entities": []}], ["The Pearson correlation coefficients of the disability weights of health states between the GBD 2010 study and the current models were 0.802 for Model 2, 0.796 for Model 1, 0.681 for Model 3, and 0.574 for Model 4 (all P- values<0.001).", {"entities": []}], ["The discrimination of values according to health state severity was most suitable in Model 1.", {"entities": []}], ["Based on these results, the paired comparison-only model was selected as the best model for estimating disability weights in South Korea, and for maintaining simplicity in the analysis.", {"entities": []}], ["Thus, disability weights can be more easily estimated by using paired comparison alone, with \u2018full health\u2019 and \u2018being dead\u2019 as one of the health states.", {"entities": []}], ["As noted in our study, we believe that additional evidence regarding the universality of disability weight can be observed by using a simplified methodology of estimating disability weights.", {"entities": []}], ["The prevalence of chronic obstructive pulmonary disease (COPD) in females appears to be increasing.", {"entities": [[18, 55, "DISEASE"]]}], ["Recent studies have revealed that the percentage of women with COPD in Greece is approximately 12.5%.", {"entities": []}], ["To evaluate the burden of COPD among males and females in Greece through a nationwide cross-sectional survey and to explore sex differences regarding functional characteristics and exacerbation frequency.", {"entities": []}], ["Data collection was completed in a 6-month period.", {"entities": []}], ["The present study followed a nationwide sampling approach of respiratory medicine physicians.", {"entities": []}], ["The sampling approach included three steps: 1) estimation of expected incidence and prevalence of COPD cases in each prefecture of Greece and in total; 2) estimation of expected incidence of COPD cases per physician in each prefecture; and 3) creation of a frame of three different sampling zones.", {"entities": []}], ["Following this sampling, data were provided by 199 respiratory physicians.", {"entities": []}], ["The participating physicians provided data from 6,125 COPD patients.", {"entities": []}], ["Female patients represented 28.7% of the study participants.", {"entities": []}], ["Female COPD patients were, on average, 5 years younger than male COPD patients.", {"entities": []}], ["Never smokers accounted for 9.4% within female patients, compared to 2.7% of males ( P <0.001).", {"entities": []}], ["Female patients were characterized by milder forms of the disease.", {"entities": []}], ["Comorbidities were more prevalent in men, with the exception of gastroesophageal reflux (14.6% versus 17.1% for men and women, respectively, P =0.013).", {"entities": []}], ["Female COPD patients had a higher expected number of outpatient visits per year (by 8.9%) than males ( P <0.001), although hospital admissions did not differ significantly between sexes ( P =0.116).", {"entities": []}], ["Females had fewer absences from work due to COPD per year, by 19.0% ( P <0.001), compared to males.", {"entities": []}], ["The differences observed between male and female COPD patients provide valuable information which could aid the prevention and management of COPD in Greece.", {"entities": []}], ["Statins are pharmacological inhibitors of the activity of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR), an enzyme responsible for the synthesis of cholesterol.", {"entities": [[101, 106, "GENE"]]}], ["Some recent experimental studies have shown that besides their effects on the primary and secondary prevention of cardiovascular diseases, statins may also have beneficial anti-inflammatory effects through diverse mechanisms.", {"entities": []}], ["On the other hand, the induction and activity of regulatory T cells (Treg) are key processes in the prevention of pathology during chronic inflammatory and autoimmune diseases.", {"entities": []}], ["Hence, strategies oriented towards the therapeutic expansion of Tregs are gaining special attention among biomedical researchers.", {"entities": []}], ["The potential effects of statins on the biology of Treg are of particular importance because of their eventual application as in vivo inducers of Treg in the treatment of multiple conditions.", {"entities": []}], ["In this paper we review the experimental evidence pointing out to a potential effect of statins on the role of regulatory T cells in different conditions and discuss its potential clinical significance.", {"entities": []}], ["Hepatitis C virus (HCV) infection is associated with increased systemic oxidative stress, which leads to cardiovascular events, diabetes, and chronic kidney disease.", {"entities": [[150, 164, "DISEASE"]]}], ["Similarly, cataract is also associated with increased oxidative stress.", {"entities": [[11, 19, "DISEASE"]]}], ["The association between HCV infection and increased risk of cataract remains unclear.", {"entities": [[60, 68, "DISEASE"]]}], ["A total of 11,652 HCV-infected patients and 46,608 age- and sex-matched non-HCV infected patients were identified during 2003\u20132011.", {"entities": []}], ["All patient data were tracked until a diagnosis of cataract, death, or the end of 2011.", {"entities": [[51, 59, "DISEASE"]]}], ["Cumulative incidences and hazard ratios (HRs) were calculated.", {"entities": []}], ["The mean follow-up durations were 5.29 and 5.86 years for the HCV and non-HCV cohorts, respectively.", {"entities": []}], ["The overall incidence density rate for cataract was 1.36 times higher in the HCV cohort than in the non-HCV cohort (1.86 and 1.37 per 100 person-y, respectively).", {"entities": [[39, 47, "DISEASE"]]}], ["After adjusting for age, sex, comorbidities of diabetes, hypertension, hyperlipidemia, asthma, chronic obstructive pulmonary disease, coronary artery disease, and anxiety, patients with HCV infection had an increased risk of cataract compared with those without HCV infection [adjusted HR = 1.23, 95% confidence interval (CI) = 1.14\u20131.32].", {"entities": [[57, 69, "DISEASE"], [225, 233, "DISEASE"], [95, 132, "DISEASE"], [87, 93, "DISEASE"], [286, 288, "GENE"]]}], ["HCV-infected patients receiving interferon\u2013ribavirin therapy had a 1.83 times higher (95% CI = 1.40\u20132.38) risk of cataract than non-HCV infected patients did.", {"entities": [[114, 122, "DISEASE"]]}], ["HCV infection, even without the complication of cirrhosis, is associated with an increased risk of cataract, and this risk is higher in HCV-infected patients undergoing interferon\u2013ribavirin therapy.", {"entities": [[99, 107, "DISEASE"]]}], ["The deleted in liver cancer 1 (DLC1) and plasminogen activator inhibitor 1 (PAI-1) are known to be closely associated with tumor growth and metastasis in several kinds of human tumors.", {"entities": [[15, 27, "DISEASE"], [21, 27, "DISEASE"], [31, 35, "GENE"]]}], ["The aim of this study was to investigate the expression of DLC1 and PAI-1 in ovarian carcinoma, and evaluate their relations with the prognosis of ovarian carcinoma.", {"entities": [[85, 94, "DISEASE"], [155, 164, "DISEASE"], [77, 94, "DISEASE"], [147, 164, "DISEASE"], [59, 63, "GENE"]]}], ["Immunohistochemical staining and Western blot were used to examine the expressions of DLC1 and PAI-1 protein in 25 specimens normal ovarian tissues, 52 specimens of serous cystadenocarcinoma tissues and 23 specimens of mucinous cystadenocarcinoma tissues.", {"entities": [[172, 190, "DISEASE"], [228, 246, "DISEASE"], [219, 246, "DISEASE"], [165, 190, "DISEASE"], [86, 90, "GENE"]]}], ["Chi-square test, Logistic regression and Partial Correlate analysis were performed to evaluate the association between DLC1 and PAI-1 with clinicopathological characteristics.", {"entities": [[119, 123, "GENE"]]}], ["Overall survival was estimated by Kaplan-Meier curves and multivariate Cox analysis.", {"entities": []}], ["The relationships between DLC1 and PAI-1 protein expression were analyzed by Pearson\u2019s correlation coefficient.", {"entities": [[26, 30, "GENE"]]}], ["The expression of DLC1 protein in ovarian carcinoma tissues was significantly lower than that in normal ovarian tissues, but it was converse for PAI-1.", {"entities": [[42, 51, "DISEASE"], [34, 51, "DISEASE"], [18, 22, "GENE"]]}], ["In ovarian carcinoma, the expression of DLC1 was significantly associated with advanced FIGO stage, ascites and positive lymph node metastasis, whereas PAI-1 protein was closely related with advanced FIGO stage, poor histological differentiation and lymph node metastasis.", {"entities": [[11, 20, "DISEASE"], [3, 20, "DISEASE"], [40, 44, "GENE"]]}], ["The expression of DLC1 was negatively correlated with PAI-1 in ovarian carcinoma.", {"entities": [[71, 80, "DISEASE"], [63, 80, "DISEASE"], [18, 22, "GENE"]]}], ["Ovarian cancer patients with negative expression of DLC1 and positive expression of PAI-1 had the worst overall survival time compared to other patients.", {"entities": [[8, 14, "DISEASE"], [52, 56, "GENE"]]}], ["The expression of DLC1 and PAI-1 were closely related with the metastasis and invasion of ovarian carcinoma, only the combination of DLC1 and PAI-1 could serve as an independent prognostic factor of ovarian carcinoma.", {"entities": [[98, 107, "DISEASE"], [207, 216, "DISEASE"], [90, 107, "DISEASE"], [199, 216, "DISEASE"], [18, 22, "GENE"], [133, 137, "GENE"], [18, 22, "GENE"], [133, 137, "GENE"]]}], ["Selective serotonin reuptake inhibitors (SSRIs) are one of the most commonly prescribed classes of antidepressants.", {"entities": []}], ["Glaucoma is the second leading cause of blindness globally and iatrogenic glaucoma has been implicated across disparate medication classes.", {"entities": [[40, 49, "DISEASE"], [0, 8, "DISEASE"], [74, 82, "DISEASE"]]}], ["Available studies that have sought to determine the association between SSRI exposure and glaucoma have provided mixed results.", {"entities": [[90, 98, "DISEASE"]]}], ["The aim of the study herein was to investigate whether an association exists between SSRI exposure and glaucoma incidence.", {"entities": [[103, 111, "DISEASE"]]}], ["Glaucoma cases were identified from Taiwan\u2019s National Health Insurance Research Database with a new primary diagnosis of glaucoma between 1997 and 2009.", {"entities": [[0, 8, "DISEASE"], [121, 129, "DISEASE"]]}], ["The date wherein the cases were diagnosed with glaucoma was operationalized as the index date.", {"entities": [[47, 55, "DISEASE"]]}], ["The control group was comprised of individuals within the database who were not diagnosed with glaucoma.", {"entities": [[95, 103, "DISEASE"]]}], ["15,865 glaucoma cases were compared to 77,014 sex-, age-, residence- and insurance premium-matched controls on measures of prescribed duration and dosage of SSRIs up to 365 days before index date to proxy SSRIs exposure.", {"entities": [[7, 15, "DISEASE"]]}], ["Individuals receiving SSRIs were at greater risk of glaucoma incidence (OR = 1.39; 95% CI = 1.29\u20131.50); the foregoing increased likelihood was reduced after adjusting for confounding variables (aOR = 1.09; 95% CI = 1.00,1.18).", {"entities": [[52, 60, "DISEASE"]]}], ["SSRI treatment of longer duration (i.e.", {"entities": []}], [">365 days) and higher doses (\u22651 defined daily dose) were associated with greater risk of glaucoma incidence (aOR = 1.36; 95% CI = 1.08\u20131.71).", {"entities": [[89, 97, "DISEASE"]]}], ["Subgroup analysis showed that the effect of SSRIs on glaucoma was limited to individuals younger than 65 years of age (aOR = 1.37; 95% CI = 1.25\u20131.50), without diabetes (aOR = 1.39; 95% CI = 1.27\u20131.52), without hypertension (aOR = 1.46; 95% CI = 1.31\u20131.63) or hypercholesterolemia (aOR = 1.35; 95% CI = 1.23\u20131.48).", {"entities": [[211, 223, "DISEASE"], [53, 61, "DISEASE"]]}], ["Treatment with SSRIs was associated with greater risk of having a diagnosis of glaucoma, particularly in individuals with longer duration and/or higher average dose of SSRI.", {"entities": [[79, 87, "DISEASE"]]}], ["Our findings suggest that individuals receiving SSRIs treatment for extended periods of time and/or at relatively higher therapeutic doses should be monitored for symptoms associated with glaucoma.", {"entities": [[188, 196, "DISEASE"]]}], ["The aim of this review was to establish the frequency with which trials take into account missingness, and to discover what methods trialists use for adjustment in randomised controlled trials with longitudinal measurements.", {"entities": []}], ["Failing to address the problems that can arise from missing outcome data can result in misleading conclusions.", {"entities": []}], ["Missing data should be addressed as a means of a sensitivity analysis of the complete case analysis results.", {"entities": []}], ["One hundred publications of randomised controlled trials with longitudinal measurements were selected randomly from trial publications from the years 2005 to 2012.", {"entities": []}], ["Information was extracted from these trials, including whether reasons for dropout were reported, what methods were used for handing the missing data, whether there was any explanation of the methods for missing data handling, and whether a statistician was involved in the analysis.", {"entities": []}], ["The main focus of the review was on missing data post dropout rather than missing interim data.", {"entities": []}], ["Of all the papers in the study, 9 (9%) had no missing data.", {"entities": []}], ["More than half of the papers included in the study failed to make any attempt to explain the reasons for their choice of missing data handling method.", {"entities": []}], ["Of the papers with clear missing data handling methods, 44 papers (50%) used adequate methods of missing data handling, whereas 30 (34%) of the papers used missing data methods which may not have been appropriate.", {"entities": []}], ["In the remaining 17 papers (19%), it was difficult to assess the validity of the methods used.", {"entities": []}], ["An imputation method was used in 18 papers (20%).", {"entities": []}], ["Multiple imputation methods were introduced in 1987 and are an efficient way of accounting for missing data in general, and yet only 4 papers used these methods.", {"entities": []}], ["Out of the 18 papers which used imputation, only 7 displayed the results as a sensitivity analysis of the complete case analysis results.", {"entities": []}], ["61% of the papers that used an imputation explained the reasons for their chosen method.", {"entities": []}], ["Just under a third of the papers made no reference to reasons for missing outcome data.", {"entities": []}], ["There was little consistency in reporting of missing data within longitudinal trials.", {"entities": []}], ["Prostaglandin D 2 (PGD 2 ) and cysteinyl leukotrienes (cysLTs) are lipid mediators derived from mast cells, which activate T H 2 cells.", {"entities": [[19, 22, "GENE"]]}], ["The combination of PGD 2 and cysLTs (notably cysteinyl leukotriene E 4 [LTE 4 ]) enhances T H 2 cytokine production.", {"entities": [[19, 22, "GENE"]]}], ["However, the synergistic interaction of cysLTs with PGD 2 in promoting T H 2 cell activation is still poorly understood.", {"entities": [[52, 55, "GENE"]]}], ["The receptors for these mediators are drug targets in the treatment of allergic diseases, and hence understanding their interaction is likely to have clinical implications.", {"entities": []}], ["We aimed to comprehensively define the roles of PGD 2 , LTE 4 , and their combination in activating human T H 2 cells and how such activation might allow the T H 2 cells to engage downstream effectors, such as neutrophils, which contribute to the pathology of allergic responses.", {"entities": [[48, 51, "GENE"]]}], ["The effects of PGD 2 , LTE 4 , and their combination on human T H 2 cell gene expression were defined by using a microarray, and changes in specific inflammatory pathways were confirmed by means of PCR array, quantitative RT-PCR, ELISA, Luminex, flow cytometry, and functional assays, including analysis of downstream neutrophil activation.", {"entities": [[15, 18, "GENE"]]}], ["Blockade of PGD 2 and LTE 4 was tested by using TM30089, an antagonist of chemoattractant receptor-homologous molecule expressed on T H 2 cells, and montelukast, an antagonist of cysteinyl leukotriene receptor 1.", {"entities": [[12, 15, "GENE"]]}], ["PGD 2 and LTE 4 altered the transcription of a wide range of genes and induced diverse functional responses in T H 2 cells, including cell adhesion, migration, and survival and cytokine production.", {"entities": [[0, 3, "GENE"]]}], ["The combination of these lipids synergistically or additively enhanced T H 2 responses and, strikingly, induced marked production of diverse nonclassical T H 2 inflammatory mediators, including IL-22, IL-8, and GM-CSF, at concentrations sufficient to affect neutrophil activation.", {"entities": []}], ["PGD 2 and LTE 4 activate T H 2 cells through different pathways but act synergistically to promote multiple downstream effector functions, including neutrophil migration and survival.", {"entities": [[0, 3, "GENE"]]}], ["Combined inhibition of both PGD 2 and LTE 4 pathways might provide an effective therapeutic strategy for allergic responses, particularly those involving interaction between T H 2 cells and neutrophils, such as in patients with severe asthma.", {"entities": [[235, 241, "DISEASE"], [28, 31, "GENE"]]}], ["This study evaluated risks of the emergency room visits (ERV) for cerebrovascular diseases, heart diseases, ischemic heart disease, hypertensive diseases, chronic renal failure (CRF), diabetes mellitus (DM), asthma, chronic airway obstruction not elsewhere classified (CAO), and accidents associated with the ambient temperature from 2000 to 2009 in metropolitan Taipei.", {"entities": [[108, 130, "DISEASE"], [117, 130, "DISEASE"], [208, 214, "DISEASE"], [184, 201, "DISEASE"]]}], ["The distributed lag non-linear model was used to estimate the cumulative relative risk (RR) and confidence interval (CI) of cause-specific ERV associated with daily temperature from lag 0 to lag 3 after controlling for potential confounders.", {"entities": []}], ["This study identified that temperatures related to the lowest risk of ERV was 26 \u00b0C for cerebrovascular diseases, 18 \u00b0C for CRF, DM, and accidents, and 30 \u00b0C for hypertensive diseases, asthma, and CAO.", {"entities": [[185, 191, "DISEASE"]]}], ["These temperatures were used as the reference temperatures to measure RR for the corresponding diseases.", {"entities": []}], ["A low temperature (14\u00b0C) increased the ERV risk for cerebrovascular diseases, hypertensive diseases, and asthma, with respective cumulative 4-day RRs of 1.56 (95% CI: 1.23, 1.97), 1.78 (95% CI: 1.37, 2.34), and 2.93 (95% CI: 1.26, 6.79).", {"entities": [[105, 111, "DISEASE"]]}], ["The effects were greater on, or after, lag one.", {"entities": []}], ["At 32\u00b0C, the cumulative 4-day RR for ERV was significant for CRF (RR\u200a=\u200a2.36; 95% CI: 1.33, 4.19) and accidents (RR\u200a=\u200a1.23; 95% CI: 1.14, 1.33) and the highest RR was seen on lag 0 for CRF (RR\u200a=\u200a1.69; 95% CI: 1.01, 3.58), DM (RR\u200a=\u200a1.69; 95% CI: 1.09, 2.61), and accidents (RR\u200a=\u200a1.19; 95% CI: 1.11, 1.27).", {"entities": []}], ["Higher temperatures are associated with the increased ERV risks for CRF, DM, and accidents and lower temperatures with the increased ERV risks for cerebrovascular diseases, hypertensive diseases, and asthma in the subtropical metropolitan.", {"entities": [[200, 206, "DISEASE"]]}], ["An important component of the policy to deal with the H1N1 pandemic in 2009 was to develop and implement vaccination.", {"entities": []}], ["Since pregnant women were found to be at particular risk of severe morbidity and mortality, the World Health Organization and the European Centers for Disease Control advised vaccinating pregnant women, regardless of trimester of pregnancy.", {"entities": []}], ["This study reports a survey of vaccination policies for pregnant women in European countries.", {"entities": []}], ["Questionnaires were sent to European competent authorities of 27 countries via the European Medicines Agency and to leaders of registries of European Surveillance of Congenital Anomalies in 21 countries.", {"entities": []}], ["Replies were received for 24 out of 32 European countries of which 20 had an official pandemic vaccination policy.", {"entities": []}], ["These 20 countries all had a policy targeting pregnant women.", {"entities": []}], ["For two of the four countries without official pandemic vaccination policies, some vaccination of pregnant women took place.", {"entities": []}], ["In 12 out of 20 countries the policy was to vaccinate only second and third trimester pregnant women and in 8 out of 20 countries the policy was to vaccinate pregnant women regardless of trimester of pregnancy.", {"entities": []}], ["Seven different vaccines were used for pregnant women, of which four contained adjuvants.", {"entities": []}], ["Few countries had mechanisms to monitor the number of vaccinations given specifically to pregnant women over time.", {"entities": []}], ["Vaccination uptake varied.", {"entities": []}], ["Differences in pandemic vaccination policy and practice might relate to variation in perception of vaccine efficacy and safety, operational issues related to vaccine manufacturing and procurement, and vaccination campaign systems.", {"entities": []}], ["Increased monitoring of pandemic influenza vaccine coverage of pregnant women is recommended to enable evaluation of the vaccine safety in pregnancy and pandemic vaccination campaign effectiveness.", {"entities": [[33, 42, "DISEASE"]]}], ["The aim of this study was to investigate whether genetic variations at positions -1082, -819, and -592 in the interleukin (IL)-10 promoter affect IL-10 production in children with irritable bowel syndrome (IBS).", {"entities": [[180, 204, "DISEASE"], [196, 204, "DISEASE"]]}], ["Ninety-four children with IBS and 102 children as healthy controls (HCs) were enrolled.", {"entities": []}], ["Genomic DNA was extracted, and IL-10 -1082, -819, and -592 polymorphisms were detected by direct sequencing from all participants.", {"entities": []}], ["Peripheral blood mononuclear cells (PBMCs) from 46 IBS children and 38 HCs were isolated and cultured with and without 5 ng/mL Escherichia coli lipopolysaccharide (LPS).", {"entities": []}], ["IL-10 levels in the culture supernatants were measured by enzyme-linked immunosorbent assay.", {"entities": []}], ["There were no significant differences in the distribution of IL-10 -1082, -819, and -592 polymorphisms or in the allele and haplotype frequencies between IBS children and HCs.", {"entities": []}], ["PBMCs from children with IBS had significantly lower IL-10 levels after LPS stimulation than PBMCs from HCs (p=0.011); however, LPS-induced IL-10 levels in PBMCs with different genotypes of -819 and -592 polymorphisms were not significantly different between IBS patients and HCs.", {"entities": []}], ["Although significantly lower LPS-induced IL-10 production by PBMCs was noted, it is unlikely that IL-10 production was fully genetically determined in our IBS children.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT01131442.", {"entities": []}], ["The extracellular matrix is a dynamic and complex network of macromolecules responsible for maintaining and influencing cellular functions of the airway.", {"entities": []}], ["The role of fibronectin, an extracellular matrix protein, is well documented in asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["However, the expression and function of fibulin-1, a secreted glycoprotein which interacts with fibronectin, has not been reported.", {"entities": []}], ["Fibulin-1 is widely expressed in basement membranes in many organs including the lung.", {"entities": []}], ["There are four isoforms in humans (A\u2013D) of which fibulin-1C and 1D predominate.", {"entities": []}], ["The objective of this study was to study the expression of fibulin-1 in volunteers with and without asthma, and to examine its function in vitro .", {"entities": [[100, 106, "DISEASE"]]}], ["We used immunohistochemistry and dot-blots to examine fibulin-1 levels in bronchial biopsies, bronchoalveolar lavage fluid and serum.", {"entities": []}], ["Real-time PCR for fibulin-1C and 1D, and ELISA and western blotting for fibulin-1 were used to study the levels in airway smooth muscle cells.", {"entities": []}], ["The function of fibulin-1C was determined by assessing its role, using an antisense oligonucleotide, in cell proliferation, migration and wound healing.", {"entities": []}], ["A murine model of airway hyperresponsiveness (AHR) was used to explore the biological significance of fibulin-1.", {"entities": [[46, 49, "GENE"]]}], ["Levels of fibulin-1 were significantly increased in the serum and bronchoalveolar lavage fluid of 21 asthmatics compared with 11 healthy volunteers.", {"entities": []}], ["In addition fibulin-1 was increased in asthma derived airway smooth muscle cells and fibulin-1C contributed to the enhanced proliferation and wound repair in these cells.", {"entities": [[39, 45, "DISEASE"]]}], ["These features were reversed when fibulin-1C was suppressed using an antisense oligomer.", {"entities": []}], ["In a mouse model of AHR, treatment with an AO inhibited the development of AHR to methacholine.", {"entities": [[20, 23, "GENE"], [75, 78, "GENE"], [20, 23, "GENE"], [75, 78, "GENE"]]}], ["Our data collectively suggest fibulin-1C may be worthy of further investigation as a target for airway remodeling in asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["In rice, several allergens have been identified such as the non-specific lipid transfer protein-1, the \u03b1-amylase/trypsin-inhibitors, the \u03b1-globulin, the 33\u00a0kDa glyoxalase I (Gly I), the 52\u201363\u00a0kDa globulin, and the granule-bound starch synthetase.", {"entities": []}], ["The goal of the present study was to define optimal rice extraction and detection methods that would allow a sensitive and reproducible measure of several classes of known rice allergens.", {"entities": []}], ["In a three-laboratory ring-trial experiment, several protein extraction methods were first compared and analyzed by 1D multiplexed SDS-PAGE.", {"entities": []}], ["In a second phase, an inter-laboratory validation of 2D-DIGE analysis was conducted in five independent laboratories, focusing on three rice allergens (52\u00a0kDa globulin, 33\u00a0kDa glyoxalase I, and 14\u201316\u00a0kDa \u03b1-amylase/trypsin inhibitor family members).", {"entities": []}], ["The results of the present study indicate that a combination of 1D multiplexed SDS-PAGE and 2D-DIGE methods would be recommended to quantify the various rice allergens.", {"entities": []}], ["Representative multiplexed detection and 2D-DIGE profile of rice endogenous allergens.", {"entities": []}], ["IL-4 subverts protective immunity to multiple intracellular pathogens including the fungus Histoplasma capsulatum .", {"entities": []}], ["Previously, we reported that H. capsulatum -challenged CCR2 H. capsulatum synergistically elicited an IL-33 response in macrophages via STAT6/IRF-4 and Dectin-1 pathways respectively.", {"entities": [[55, 59, "GENE"]]}], ["Neutralizing IL-33 in CCR2", {"entities": [[22, 26, "GENE"]]}], ["Adiponectin is reported to be related to the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[60, 97, "DISEASE"]]}], ["Genetic variants in the gene encoding adiponectin ( ADIPOQ ) have been reported to be associated with adiponectin level in several genome\u2013wide linkage and association studies.", {"entities": [[52, 58, "GENE"]]}], ["However, relatively little is known about the effects of ADIPOQ gene variants on COPD susceptibility.", {"entities": [[57, 63, "GENE"]]}], ["We determined the frequencies of single-nucleotide polymorphisms (SNPs) in ADIPOQ in a Chinese Han population and their possible association with COPD susceptibility.", {"entities": [[75, 81, "GENE"]]}], ["We conducted a case\u2013control study of 279 COPD patients and 367 age- and gender-distribution-matched control subjects.", {"entities": []}], ["Seven tagging SNPs in ADIPOQ , including rs710445, rs16861205, rs822396, rs7627128, rs1501299, rs3821799 and rs1063537 were genotyped by SNaPshot.", {"entities": [[22, 28, "GENE"]]}], ["Association analysis of genotypes/alleles and haplotypes constructed from these loci with COPD was conducted under different genetic models.", {"entities": []}], ["The alleles or genotypes of rs1501299 distributed significantly differently in COPD patients and controls (allele: P \u200a=\u200a0.002, OR\u200a=\u200a1.43 and 95%CI\u200a=\u200a1.14\u20131.79; genotype: P \u200a=\u200a0.008).", {"entities": []}], ["The allele A at rs1501299 was potentially associated with an increased risk of COPD in all dominant model analysis ( P \u200a=\u200a0.009; OR: 1.54; 95%CI: 1.11\u20132.13), recessive model analyses ( P \u200a=\u200a0.015; OR: 1.75; 95% CI: 1.11\u20132.75) and additive model analyses ( P \u200a=\u200a0.003; OR: 2.11; 95% CI: 1.29\u20133.47).", {"entities": []}], ["In haplotype analysis, we observed haplotypes AAAAACT and GGACCTC had protective effects, while haplotypes AGAACTC, AGGCCTC, GGAACTC, GGACACT and GGGCCTC were significantly associated with the increased risk of COPD.", {"entities": []}], ["We conducted the first investigation of the association between the SNPs in ADIPOQ and COPD risk.", {"entities": [[76, 82, "GENE"]]}], ["Our current findings suggest that ADIPOQ may be a potential risk gene for COPD.", {"entities": [[34, 40, "GENE"]]}], ["Further studies in larger groups are warranted to confirm our results.", {"entities": []}], ["Viruses of the Enterovirus genus of picornaviruses, including poliovirus, coxsackievirus B3 (CVB3), and human rhinovirus, commandeer the functions of host cell proteins to aid in the replication of their small viral genomic RNAs during infection.", {"entities": []}], ["One of these host proteins is a cellular DNA repair enzyme known as 5\u2032 tyrosyl-DNA phosphodiesterase 2 (TDP2).", {"entities": [[104, 108, "GENE"]]}], ["TDP2 was previously demonstrated to mediate the cleavage of a unique covalent linkage between a viral protein (VPg) and the 5\u2032 end of picornavirus RNAs.", {"entities": [[0, 4, "GENE"]]}], ["Although VPg is absent from actively translating poliovirus mRNAs, the removal of VPg is not required for the in vitro translation and replication of the RNA.", {"entities": []}], ["However, TDP2 appears to be excluded from replication and encapsidation sites during peak times of poliovirus infection of HeLa cells, suggesting a role for TDP2 during the viral replication cycle.", {"entities": [[9, 13, "GENE"], [157, 161, "GENE"], [9, 13, "GENE"], [157, 161, "GENE"]]}], ["Using a mouse embryonic fibroblast cell line lacking TDP2, we found that TDP2 is differentially required among enteroviruses.", {"entities": [[53, 57, "GENE"], [73, 77, "GENE"], [53, 57, "GENE"], [73, 77, "GENE"]]}], ["Our single-cycle viral growth analysis shows that CVB3 replication has a greater dependency on TDP2 than does poliovirus or human rhinovirus replication.", {"entities": [[95, 99, "GENE"]]}], ["During infection, CVB3 protein accumulation is undetectable (by Western blot analysis) in the absence of TDP2, whereas poliovirus protein accumulation is reduced but still detectable.", {"entities": [[105, 109, "GENE"]]}], ["Using an infectious CVB3 RNA with a reporter, CVB3 RNA could still be replicated in the absence of TDP2 following transfection, albeit at reduced levels.", {"entities": [[99, 103, "GENE"]]}], ["Overall, these results indicate that TDP2 potentiates viral replication during enterovirus infections of cultured cells, making TDP2 a potential target for antiviral development for picornavirus infections.", {"entities": [[37, 41, "GENE"], [128, 132, "GENE"], [37, 41, "GENE"], [128, 132, "GENE"]]}], ["Picornaviruses are one of the most prevalent groups of viruses that infect humans and livestock worldwide.", {"entities": []}], ["These viruses include the human pathogens belonging to the Enterovirus genus, such as poliovirus, coxsackievirus B3 (CVB3), and human rhinovirus.", {"entities": []}], ["Diseases caused by enteroviruses pose a major problem for public health and have significant economic impact.", {"entities": []}], ["Poliovirus can cause paralytic poliomyelitis.", {"entities": [[31, 44, "DISEASE"], [21, 44, "DISEASE"]]}], ["CVB3 can cause hand, foot, and mouth disease and myocarditis.", {"entities": [[31, 44, "DISEASE"], [49, 60, "DISEASE"]]}], ["Human rhinovirus is the causative agent of the common cold, which has a severe economic impact due to lost productivity and severe health consequences in individuals with respiratory dysfunction, such as asthma.", {"entities": [[47, 58, "DISEASE"], [204, 210, "DISEASE"]]}], ["By gaining a better understanding of the enterovirus replication cycle, antiviral drugs against enteroviruses may be developed.", {"entities": []}], ["Here, we report that the absence of the cellular enzyme TDP2 can significantly decrease viral yields of poliovirus, CVB3, and human rhinovirus, making TDP2 a potential target for an antiviral against enterovirus infections.", {"entities": [[56, 60, "GENE"], [151, 155, "GENE"], [56, 60, "GENE"], [151, 155, "GENE"]]}], ["Previous studies have revealed significant differences in microbiome compositions between infants delivered via cesarean section (C-section) and natural vaginal birth.", {"entities": []}], ["However, the importance of the delivery mode in the first days of life remains unclear.", {"entities": []}], ["Importantly, this stage is minimally affected by infant feeding.", {"entities": []}], ["Here, we used a metagenomic sequencing technique to characterize the meconium microbiome from the feces of a Chinese cohort of vaginally and C-section-delivered infants, including in vitro fertilization (IVF) newborns, during the first 24\u2009h after birth.", {"entities": []}], ["Meconium microbiome diversity was higher in vaginally delivered infants than that in C-section-delivered infants.", {"entities": []}], ["Propionibacterium species were most abundant in the vaginally delivered infants, whereas the C-section group had high levels of Bacillus licheniformis .", {"entities": []}], ["The two IVF newborns delivered by C-section harbored microbial communities similar to the vaginal microbiome in terms of taxonomic composition.", {"entities": []}], ["Metabolic functions of the C-section group suffered more from the influence of the dominant group ( B. licheniformis ), whereas the vaginal group was more homogeneous, with a metabolism dominated by multi-microbes.", {"entities": []}], ["Moreover, different modes of delivery affected the antibiotic resistance gene (ARG) prevalence.", {"entities": []}], ["These findings provide novel information for the development of strategies to guide a healthy mode of delivery and promote the formation of healthy microbiota.", {"entities": []}], ["Background .", {"entities": []}], ["Respiratory complaints are commonly encountered in medicine and respiratory diseases place a high burden on healthcare infrastructure.", {"entities": []}], ["Healthcare planning should be based on adequate information: this study will help us to analyze the pattern of respiratory disease admissions in the medical wards in a developing country.", {"entities": []}], ["The medical records of patients admitted into the medical wards over a 5-year period were retrieved and reviewed.", {"entities": []}], ["Information obtained included demography, diagnosis, comorbid conditions, and risk factors for respiratory disease.", {"entities": []}], ["Three thousand four hundred and ninety patients were admitted into the medical wards with 325 (9.3%) of them diagnosed with a respiratory condition.", {"entities": []}], ["There were 121 females and 204 males.", {"entities": []}], ["The average age of the patients was 40.7 \u00b1 14.7 years.", {"entities": []}], ["Only 7% of the patients smoked cigarette.", {"entities": []}], ["The commonest respiratory conditions were tuberculosis (66.8%) and pneumonia (24.9%).", {"entities": [[67, 76, "DISEASE"], [42, 54, "DISEASE"]]}], ["The commonest comorbidity was HIV infection (39.7%).", {"entities": []}], ["Tuberculosis/HIV coinfection rate was 50.7%.", {"entities": [[0, 12, "DISEASE"]]}], ["HIV infection was the single most important predictor of an adverse outcome (OR 5.1, 95% CI 2.05\u201312.7, P < 0.001).", {"entities": []}], ["Conclusion .", {"entities": []}], ["Infective conditions make up a large percentage of respiratory diseases in low income countries with HIV infection constituting a significant risk factor for a poor disease outcome.", {"entities": []}], ["Socioeconomic status is known to influence the prevalence, severity and mortality of obstructive lung diseases, but it is uncertain whether it affects the use of diagnostic spirometry in patients initiating treatment for these conditions.", {"entities": []}], ["The objective of this paper was to examine a possible association between education, income, labour market affiliation, cohabitation status and having spirometry performed when initiating medication targeting obstructive pulmonary disease.", {"entities": []}], ["We conducted a population-based cohort study.", {"entities": []}], ["Danish national registers were linked, retrieving data on prescriptions, spirometry testing, socioeconomic and demographic variables in all first time users of medication targeting obstructive lung disease in 2008.", {"entities": [[181, 205, "DISEASE"], [193, 205, "DISEASE"]]}], ["A total of 37,734 persons were included and approximately half of the cohort had spirometry performed.", {"entities": []}], ["Among medication users under 65\u00a0years of age, being unemployed was significantly associated with reduced odds of having spirometry performed, the strongest association was seen in men (OR\u2009=\u20090.82, CI\u2009=\u20090.73-0.91).", {"entities": []}], ["Medium income was associated with increased odds of having spirometry performed in men (OR\u2009=\u20091.18, CI\u2009=\u20091.06-1.30) and high educational level (>12\u00a0years) was associated with reduced odds of having spirometry performed in women (OR\u2009=\u20090.86, CI\u2009=\u20090.78-0.94).", {"entities": []}], ["Cohabitation status was not associated with having spirometry performed.", {"entities": []}], ["Among medication users over 65\u00a0years of age, living alone was associated with reduced odds of having spirometry performed among men (OR\u2009=\u20090.78, CI\u2009=\u20090.69-0.88).", {"entities": []}], ["Social inequity in spirometry testing among patients initiating medication targeting obstructive lung disease was confirmed in this study.", {"entities": [[85, 109, "DISEASE"], [97, 109, "DISEASE"]]}], ["Increased focus on spirometry testing among elderly men living alone, among the unemployed and among women with higher education is required when initiating medication.", {"entities": []}], ["Objective To investigate whether placebo controls should be used in the evaluation of surgical interventions.", {"entities": []}], ["Design Systematic review.", {"entities": []}], ["Data sources We searched Medline, Embase, and the Cochrane Controlled Trials Register from their inception to November 2013.", {"entities": []}], ["Study selection Randomised clinical trials comparing any surgical intervention with placebo.", {"entities": []}], ["Surgery was defined as any procedure that both changes the anatomy and requires a skin incision or use of endoscopic techniques.", {"entities": []}], ["Data extraction Three reviewers (KW, BJFD, IR) independently identified the relevant trials and extracted data on study details, outcomes, and harms from included studies.", {"entities": []}], ["Results In 39 out of 53 (74%) trials there was improvement in the placebo arm and in 27 (51%) trials the effect of placebo did not differ from that of surgery.", {"entities": []}], ["In 26 (49%) trials, surgery was superior to placebo but the magnitude of the effect of the surgical intervention over that of the placebo was generally small.", {"entities": []}], ["Serious adverse events were reported in the placebo arm in 18 trials (34%) and in the surgical arm in 22 trials (41.5%); in four trials authors did not specify in which arm the events occurred.", {"entities": []}], ["However, in many studies adverse events were unrelated to the intervention or associated with the severity of the condition.", {"entities": []}], ["The existing placebo controlled trials investigated only less invasive procedures that did not involve laparotomy, thoracotomy, craniotomy, or extensive tissue dissection.", {"entities": []}], ["Conclusions Placebo controlled trial is a powerful, feasible way of showing the efficacy of surgical procedures.", {"entities": []}], ["The risks of adverse effects associated with the placebo are small.", {"entities": []}], ["In half of the studies, the results provide evidence against continued use of the investigated surgical procedures.", {"entities": []}], ["Without well designed placebo controlled trials of surgery, ineffective treatment may continue unchallenged.", {"entities": []}], ["To be added.", {"entities": []}], ["Immunoglobulin heavy chain (IgH) class-switch recombination (CSR) replaces initially expressed C\u03bc (IgM) constant regions (C H ) exons with downstream C H exons.", {"entities": []}], ["Stimulation of B cells with anti-CD40 plus interleukin-4 induces CSR from C\u03bc to C\u03b31 (IgG1) and C\u03b5 (IgE), the latter of which contributes to the pathogenesis of atopic diseases.", {"entities": []}], ["Although C\u03b5 CSR can occur directly from C\u03bc, most mature peripheral B cells undergo CSR to C\u03b5 indirectly, namely from C\u03bc to C\u03b31, and subsequently to C\u03b5.", {"entities": []}], ["Physiological mechanisms that influence CSR to C\u03b31 versus C\u03b5 are incompletely understood.", {"entities": []}], ["In this study, we report a role for B cell developmental maturity in IgE CSR.", {"entities": []}], ["Based in part on a novel flow cytometric IgE CSR assay, we show that immature B cells preferentially switch to IgE versus IgG1 through a mechanism involving increased direct CSR from C\u03bc to C\u03b5.", {"entities": []}], ["Our findings suggest that IgE dysregulation in certain immunodeficiencies may be related to impaired B cell maturation.", {"entities": []}], ["To investigate parental smoking patterns and their association with wheezing in children.", {"entities": []}], ["We performed a case-control study that included 105 children between 6 and 23 months of age who were divided into two groups: cases (children with 3 previous episodes of wheezing) and controls (healthy children without wheezing).", {"entities": []}], ["The children's exposure to cigarette smoking was estimated using a questionnaire completed by the mothers and by the children's urinary cotinine levels.", {"entities": []}], ["Based on both the questionnaire results and cotinine levels, exposure to cigarette smoking was higher in the households of cases in which the incidence of maternal smoking was significantly higher than that of paternal smoking.", {"entities": []}], ["Children in this group were more affected by maternal smoking and by the total number of cigarettes smoked inside the house.", {"entities": []}], ["Additionally, the questionnaire results indicated that the risk of wheezing was dose dependent.", {"entities": []}], ["The presence of allergic components, such as atopic dermatitis and siblings with allergic rhinitis and asthma, greatly increased the odds ratio when wheezing was associated with cotinine levels.", {"entities": [[81, 98, "DISEASE"], [45, 62, "DISEASE"], [90, 98, "DISEASE"], [103, 109, "DISEASE"], [52, 62, "DISEASE"]]}], ["Children exposed to tobacco smoke have an increased risk of developing wheezing syndrome.", {"entities": [[80, 88, "DISEASE"]]}], ["This risk increases in association with the number of cigarettes smoked inside the house and the presence of other allergic components in the family.", {"entities": []}], ["Efficient diagnosis of tuberculosis (TB) is met with multiple challenges, calling for a shift of focus from pathogen-centric diagnostics towards identification of host-based multi-marker signatures.", {"entities": [[23, 35, "DISEASE"]]}], ["Transcriptomics offer a list of differentially expressed genes, but cannot by itself identify the most influential contributors to the disease phenotype.", {"entities": []}], ["Here, we describe a computational pipeline that adopts an unbiased approach to identify a biomarker signature.", {"entities": []}], ["Data from RNA sequencing from whole blood samples of TB patients were integrated with a curated genome-wide molecular interaction network, from which we obtain a comprehensive perspective of variations that occur in the host due to TB.", {"entities": []}], ["We then implement a sensitive network mining method to shortlist gene candidates that are most central to the disease alterations.", {"entities": []}], ["We then apply a series of filters that include applicability to multiple publicly available datasets as well as additional validation on independent patient samples, and identify a signature comprising 10 genes \u2014 FCGR1A , HK3 , RAB13 , RBBP8 , IFI44L , TIMM10 , BCL6 , SMARCD3 , CYP4F3 and SLPI , that can discriminate between TB and healthy controls as well as distinguish TB from latent tuberculosis and HIV in most cases.", {"entities": [[389, 401, "DISEASE"], [213, 219, "GENE"], [222, 225, "GENE"], [228, 233, "GENE"], [236, 241, "GENE"], [244, 250, "GENE"], [253, 259, "GENE"], [262, 266, "GENE"], [269, 276, "GENE"], [279, 285, "GENE"], [290, 294, "GENE"]]}], ["The signature has the potential to serve as a diagnostic marker of TB.", {"entities": []}], ["\u2022 An integrated systems biology approach has been adopted to study the host response to tuberculosis.", {"entities": [[88, 100, "DISEASE"]]}], ["\u2022 A multi-gene host biomarker signature is identified for detecting pulmonary tuberculosis from patient blood samples \u2022 The signature discriminates TB from HIV and latent-TB and can serve as an adjuvant tool in confirming TB diagnosis An integrated systems biology approach has been adopted to study the host response to tuberculosis.", {"entities": [[78, 90, "DISEASE"], [321, 333, "DISEASE"], [68, 90, "DISEASE"]]}], ["A multi-gene host biomarker signature is identified for detecting pulmonary tuberculosis from patient blood samples The signature discriminates TB from HIV and latent-TB and can serve as an adjuvant tool in confirming TB diagnosis Host factors that are altered significantly due to tuberculosis are investigated, with an aim to identify a biomarker panel.", {"entities": [[76, 88, "DISEASE"], [282, 294, "DISEASE"], [66, 88, "DISEASE"]]}], ["A network approach provides a genome-wide view of the molecular interactions, analogous to a road network of a city.", {"entities": []}], ["By comparing networks between healthy and TB samples, we identify the set of variations in a systematic fashion, analogous to identifying all major variations in the traffic flow in a city between two time points.", {"entities": []}], ["We then apply a series of filters to identify the most discriminating genes among them.", {"entities": []}], ["The 10-gene signature is seen to be characteristic of TB.", {"entities": []}], ["Surgical treatment of GERD by Nissen fundoplication is effective and safe, providing good results in the control of the disease.", {"entities": []}], ["However, some authors have questioned the efficacy of this procedure and few studies on the long-term outcomes are available in the literature, especially in Brazil.", {"entities": []}], ["To evaluate patients operated for gastro-esophageal reflux disease, for at least 10 years, by Nissen fundoplication.", {"entities": []}], ["Thirty-two patients were interviewed and underwent upper digestive endoscopy, esophageal manometry, 24 h pH monitoring and barium esophagogram, before and after Nissen fundoplication.", {"entities": []}], ["Most patients were asymptomatic, satisfied with the result of surgery (87.5%) 10 years after operation, due to better symptom control compared with preoperative and, would do it again (84.38%).", {"entities": []}], ["However, 62.5% were in use of some type of anti-reflux drugs.", {"entities": []}], ["The manometry revealed lower esophageal sphincter with a mean pressure of 11.7 cm H 2 O and an average length of 2.85 cm.", {"entities": []}], ["The average DeMeester index in pH monitoring was 11.47.", {"entities": []}], ["The endoscopy revealed that most patients had a normal result (58.06%) or mild esophagitis (35.48%).", {"entities": [[79, 90, "DISEASE"]]}], ["Barium swallow revealed mild esophageal dilatation in 25,80% and hiatal hernia in 12.9% of cases.", {"entities": []}], ["After at least a decade, most patients were satisfied with the operation, asymptomatic or had milder symptoms of GERD, being better and with easier control, compared to the preoperative period.", {"entities": []}], ["Nevertheless, a considerable percentage still employed anti-reflux medications.", {"entities": []}], ["Cancer and infections are leading causes of mortality in systemic lupus erythematosus (SLE) after diseases of the circulatory system, and therefore preventing these complications is important.", {"entities": [[66, 85, "DISEASE"], [57, 85, "DISEASE"], [0, 6, "DISEASE"]]}], ["In this study, we examined two categories of preventive services in SLE: cancer surveillance (cervical, breast, and colon) and immunizations (influenza and pneumococcal).", {"entities": [[142, 151, "DISEASE"], [73, 79, "DISEASE"]]}], ["We compared the receipt of these services in SLE to the general population, and identified subgroups of patients who were less likely to receive these services.", {"entities": []}], ["We compared preventive services reported by insured women with SLE enrolled in the University of California, San Francisco Lupus Outcomes Study (n = 685) to two representative samples derived from a statewide health interview survey, a general population sample (n = 18,013) and a sample with non-rheumatic chronic conditions (n = 4,515).", {"entities": []}], ["In addition, using data from the cohort in both men and women (n = 742), we applied multivariate regression analyses to determine whether characteristics of individuals (for example, sociodemographic and disease factors), health systems (for example, number of visits, involvement of generalists or rheumatologists in care, type of health insurance) or neighborhoods (neighborhood poverty) influenced the receipt of services.", {"entities": []}], ["The receipt of preventive care in SLE was similar to both comparison samples.", {"entities": []}], ["For cancer surveillance, 70% of eligible respondents reported receipt of cervical cancer screening and mammography, and 62% reported colon cancer screening.", {"entities": [[133, 145, "DISEASE"], [4, 10, "DISEASE"], [82, 88, "DISEASE"], [139, 145, "DISEASE"], [73, 88, "DISEASE"]]}], ["For immunizations, 59% of eligible respondents reported influenza immunization, and 60% reported pneumococcal immunization.", {"entities": [[56, 65, "DISEASE"]]}], ["In multivariate regression analyses, several factors were associated with a lower likelihood of receiving preventive services, including younger age and lower educational attainment.", {"entities": []}], ["We did not observe any effects by neighborhood poverty.", {"entities": []}], ["A higher number of physician visits and involvement of generalist providers in care was associated with a higher likelihood of receiving most services.", {"entities": []}], ["Although receipt of cancer screening procedures and immunizations in our cohort was comparable to the general population, we observed significant variability by sociodemographic factors such as age and educational attainment.", {"entities": [[20, 26, "DISEASE"]]}], ["Further research is needed to identify the physician, patient or health system factors contributing to this observed variation in order to develop effective quality improvement interventions.", {"entities": []}], ["The present study was performed to investigate the molecular mechanism of ankylosing spondylitis (AS).", {"entities": [[85, 96, "DISEASE"], [74, 96, "DISEASE"]]}], ["The interaction between micro (mi)RNA-130a and its target tumor necrosis factor (TNF)-1\u03b1 and histone deactylase (HDAC)3 was assessed in peripheral blood mononuclear cells (PBMCs) from AS patients.", {"entities": [[81, 84, "GENE"]]}], ["Increased HDAC3 and decreased miRNA-130a levels were observed in PBMCs from AS patients.", {"entities": [[10, 15, "GENE"]]}], ["HDAC3 knockdown or HDAC3 inhibition promoted the expression of miRNA-130a, and HDAC3 was recruited to the promoter region of the gene encoding miRNA-130a in PBMCs.", {"entities": [[0, 5, "GENE"], [19, 24, "GENE"], [79, 84, "GENE"], [0, 5, "GENE"], [19, 24, "GENE"], [79, 84, "GENE"], [0, 5, "GENE"], [19, 24, "GENE"], [79, 84, "GENE"]]}], ["In addition, miR-130a overexpression led to a decrease, whereas miR-130a inhibition led to an increase of TNF-1\u03b1 expression in PBMCs.", {"entities": [[13, 21, "GENE"], [64, 72, "GENE"], [13, 21, "GENE"], [64, 72, "GENE"]]}], ["Furthermore, HDAC3 knockdown or HDAC3 inhibition was associated with simultaneous upregulation of the expression of miR-130a and downregulation of the expression of TNF-1\u03b1 in PBMCs.", {"entities": [[13, 18, "GENE"], [32, 37, "GENE"], [13, 18, "GENE"], [32, 37, "GENE"], [116, 124, "GENE"]]}], ["These results indicated that HDAC3 was involved in the regulation of the underlying molecular mechanism of AS by forming a negative feedback loop with miR-130a and enhancement of TNF-1\u03b1 expression.", {"entities": [[29, 34, "GENE"], [151, 159, "GENE"]]}], ["Bangladesh has achieved remarkable gains in health indicators during the last four decades despite low levels of economic development.", {"entities": []}], ["However, the persistence of inequities remains disturbing.", {"entities": []}], ["This success was also accompanied by health and demographic transitions, which in turn brings new challenges for a nation that has yet to come to terms with pre-transition health challenges.", {"entities": []}], ["It is therefore important to understand the causes of death and their relationship with socioeconomic status (SES).", {"entities": []}], ["The paper aims to assess the causes of death by SES based on surveillance data from a rural area of Bangladesh, in order to understand the situation and inform policy makers and programme leaders.", {"entities": []}], ["We analysed population-based mortality data collected from the Chakaria Health and Demographic Surveillance System in Bangladesh.", {"entities": []}], ["The causes of death were determined by using a Bayesian-based programme for interpreting verbal autopsy findings (InterVA-4).", {"entities": []}], ["The data included 1,391 deaths in 217,167 person-years of observation between 2010 and 2012.", {"entities": []}], ["The wealth index constructed using household assets was used to assess the SES, and disease burdens were compared among the wealth quintiles.", {"entities": []}], ["Analysing cause of death (CoD) revealed that non-communicable diseases (NCDs) were the leading causes of deaths (37%), followed by communicable diseases (CDs) (22%), perinatal and neonatal conditions (11%), and injury and accidents (6%); the cause of remaining 24% of deaths could not be determined.", {"entities": []}], ["Age-specific mortality showed premature birth, respiratory infections, and drowning were the dominant causes of death for childhood mortality (0\u201314 years), which was inversely associated with SES ( p <0.04).", {"entities": []}], ["For adult and the elderly (15 years and older), NCDs were the leading cause of death (51%), followed by CDs (23%).", {"entities": []}], ["For adult and the elderly, NCDs concentrated among the population from higher SES groups ( p <0.005), and CDs among the lower SES groups ( p <0.001).", {"entities": []}], ["Epidemiologic transition is taking place with a shift from the dominance of CDs to NCDs.", {"entities": []}], ["SES inequity in mortality still persists \u2013 the poor suffer from CDs in all age groups, whereas those better off suffer more from NCDs than CDs.", {"entities": []}], ["Policy makers thus need to consider the social distribution of diseases before developing any public health action targeted towards reducing mortality and the extent of disease burden in an equitable manner.", {"entities": []}], ["We conducted a population-based study of 313 case\u2013control pairs in Kuwait to examine the aetiology of thyroid cancer, the second most common neoplasm among women in this and several other countries in the Gulf region.", {"entities": [[102, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["Among the demographic variables, individuals with 12+ years of education had a significantly reduced risk of thyroid cancer (OR=0.6; 95% CI: 0.3\u20130.9).", {"entities": [[109, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["The average age at diagnosis (\u00b1s.d.)", {"entities": []}], ["of thyroid cancer was 34.7\u00b111 years in women and 39\u00b113.4 years in men.", {"entities": [[3, 17, "DISEASE"], [11, 17, "DISEASE"]]}], ["History of thyroid nodule was reported only by cases ( n =34; 10.9%; lower 95% CI: 12.0); and goitre by 21 cases and four controls (OR=5.3; 95% CI: 1.8\u201315.3).", {"entities": []}], ["There was no significant increase in risk with history of hypothyroidism (OR=1.8) or hyperthyroidism (OR=1.7).", {"entities": [[85, 100, "DISEASE"], [58, 72, "DISEASE"]]}], ["For any benign thyroid disease, the OR was 6.4 (95% CI: 3.4\u201312.0); and the population attributable risk was about 26% (95% CI: 21.1\u201330.9).", {"entities": []}], ["Stepwise regression analysis showed that high consumption of processed fish products (OR=2.2; 95% CI: 1.6\u20133.0) fresh fish (OR=0.5; 95% CI: 0.4\u20130.7) and chicken (OR=1.7; 95% CI: 1.2\u20132.3) were independently associated with thyroid cancer with significant dose-response relationships.", {"entities": [[221, 235, "DISEASE"], [229, 235, "DISEASE"]]}], ["Among the thyroid cancer patients who reported high consumption of fish products, a large majority also reported high consumption of fresh fish (98%) and shellfish (68%).", {"entities": [[10, 24, "DISEASE"], [18, 24, "DISEASE"]]}], ["No clear association emerged with consumption of cruciferous vegetables.", {"entities": []}], ["These data support the hypothesis that hyperplastic thyroid disease is strongly related to thyroid cancer; and that habitual high consumption of various seafoods may be relevant to the aetiology of thyroid cancer.", {"entities": [[91, 105, "DISEASE"], [198, 212, "DISEASE"], [99, 105, "DISEASE"], [206, 212, "DISEASE"]]}], ["The association with chicken consumption requires further study.", {"entities": []}], ["British Journal of Cancer (2002) 86 , 1745\u20131750.", {"entities": [[19, 25, "DISEASE"]]}], ["doi: 10.1038/sj.bjc.6600303 www.bjcancer.com \u00a9 2002 Cancer Research UK", {"entities": [[52, 58, "DISEASE"]]}], ["Important proteomic and functional differences between peripheral blood myeloid dendritic cells, monocyte-derived dendritic cells (moDC) and KG-1 cells have been identified.", {"entities": []}], ["Dendritic cells (DCs) are specialized antigen presenting cells that play a pivotal role in bridging innate and adaptive immune responses.", {"entities": []}], ["Given the scarcity of peripheral blood myeloid dendritic cells (mDCs) investigators have used different model systems for studying DC biology.", {"entities": []}], ["Monocyte-derived dendritic cells (moDCs) and KG-1 cells are routinely used as mDC models, but a thorough comparison of these cells has not yet been carried out, particularly in relation to their proteomes.", {"entities": []}], ["We therefore sought to run a comparative study of the proteomes and functional properties of these cells.", {"entities": []}], ["Despite general similarities between mDCs and the model systems, moDCs and KG-1 cells, our findings identified some significant differences in the proteomes of these cells, and the findings were confirmed by ELISA detection of a selection of proteins.", {"entities": []}], ["This was particularly noticeable with proteins involved in cell growth and maintenance (for example, fibrinogen \u03b3 chain (FGG) and ubiquinol cytochrome c) and cell-cell interaction and integrity (for example, fascin and actin).", {"entities": [[121, 124, "GENE"]]}], ["We then examined the surface phenotype, cytokine profile, endocytic and T-cell-activation ability of these cells in support of the proteomic data, and obtained confirmatory evidence for differences in the maturation status and functional attributes between mDCs and the two DC models.", {"entities": []}], ["We have identified important proteomic and functional differences between mDCs and two DC model systems.", {"entities": []}], ["These differences could have major functional implications, particularly in relation to DC-T cell interactions, the so-called immunological synapse, and, therefore, need to be considered when interpreting data obtained from model DC systems.", {"entities": []}], ["In the recent years, bioinformatics methods have been reported with a high degree of success for candidate gene identification.", {"entities": []}], ["In this milieu, we have used an integrated bioinformatics approach assimilating information from gene ontologies (GO), protein\u2013protein interaction (PPI) and network analysis to predict candidate genes related to oral squamous cell carcinoma (OSCC).", {"entities": [[231, 240, "DISEASE"], [217, 240, "DISEASE"]]}], ["A total of 40973 PPIs were considered for 4704 cancer-related genes to construct human cancer gene network (HCGN).", {"entities": [[47, 53, "DISEASE"], [87, 93, "DISEASE"]]}], ["The importance of each node was measured in HCGN by ten different centrality measures.", {"entities": []}], ["We have shown that the top ranking genes are related to a significantly higher number of diseases as compared to other genes in HCGN.", {"entities": []}], ["A total of 39 candidate oral cancer target genes were predicted by combining top ranked genes and the genes corresponding to significantly enriched oral cancer related GO terms.", {"entities": [[29, 35, "DISEASE"], [153, 159, "DISEASE"]]}], ["Initial verification using literature and available experimental data indicated that 29 genes were related with OSCC.", {"entities": []}], ["A detailed pathway analysis led us to propose a role for the selected candidate genes in the invasion and metastasis in OSCC.", {"entities": []}], ["We further validated our predictions using immunohistochemistry (IHC) and found that the gene FLNA was upregulated while the genes ARRB1 and HTT were downregulated in the OSCC tissue samples.", {"entities": [[94, 98, "GENE"], [131, 136, "GENE"], [141, 144, "GENE"]]}], ["The aim of this study was to estimate the serum levels of surfactant protein D (SP-D), soluble intercellular adhesion molecule-1 (sICAM-1), and high-sensitivity C-reactive protein (hs-CRP) in patients with chronic obstructive pulmonary disease (COPD) and to assess the correlation of these indices with COPD severity.", {"entities": [[206, 243, "DISEASE"]]}], ["This analytic cross-sectional study was carried out on 64 COPD male patients, and 26 apparently healthy age-matched males as a control.", {"entities": []}], ["Chest X-ray, spirometry and arterial blood gases were done for only COPD patients.", {"entities": []}], ["Serum levels of SP-D, sICAM-1 and hs-CRP were determined by enzyme-linked immunosorbent assay in both patient and control groups.", {"entities": []}], ["The serum levels of SP-D, sICAM-1 and hs-CRP were significantly higher in COPD patients than controls (p < 0.001 for each).", {"entities": []}], ["Also, these biomarkers were significantly higher in stages III and IV compared to either stage I or II (p < 0.01 for each).", {"entities": []}], ["SP-D was significantly positively correlated with sICAM-1 and hs-CRP (r = 515, p < 0.001; r = 501, p < 0.001, respectively) and negatively correlated with PaO 2 (r = \u22120.651, p < 0.001) and all parameters of spirometry.", {"entities": []}], ["SP-D, sICAM and hs-CRP were significantly higher in COPD patients in comparison with controls.", {"entities": []}], ["Moreover, SP-D, sICAM-1, and hs-CRP were significantly negatively correlated with FEV 1 %.", {"entities": [[82, 85, "GENE"]]}], ["Accordingly, estimation of these biochemical indices may be used as biomarkers for assessment of COPD severity.", {"entities": []}], ["Knowledge on the long-term development of adiposity throughout childhood/adolescence and its prenatal determinants and health sequelae is lacking.", {"entities": []}], ["We sought to (1) identify trajectories of Body Mass Index (BMI) from 1 to 18\u2005years of age, (2) examine associations of maternal gestational smoking and early pregnancy overweight with offspring BMI trajectories and (3) determine whether BMI trajectories predict health outcomes: asthma, lung function parameters (forced expiratory volume in one second (FEV 1 )/forced vital capacity (FVC) ratio), and blood pressure, at 18\u2005years.", {"entities": [[279, 285, "DISEASE"], [353, 356, "GENE"]]}], ["The Isle of Wight birth cohort, a population-based sample of 1456 infants born between January 1989 and February 1990, was prospectively assessed at ages 1, 2, 4, 10 and 18\u2005years.", {"entities": []}], ["Group-based trajectory modelling was applied to test for the presence of latent BMI trajectories.", {"entities": []}], ["Associations were assessed using log-binomial and linear regression models.", {"entities": []}], ["Four trajectories of BMI were identified: \u2018normal\u2019, \u2018early persistent obesity\u2019, \u2018delayed overweight\u2019, and \u2018early transient overweight\u2019.", {"entities": [[70, 77, "DISEASE"]]}], ["Risk factors for being in the early persistent obesity trajectory included maternal smoking during pregnancy (RR 2.16, 95% CI 1.02 to 4.68) and early pregnancy overweight (3.16, 1.52 to 6.58).", {"entities": [[47, 54, "DISEASE"]]}], ["When comparing the early persistent obesity to the normal trajectory, a 2.15-fold (1.33 to 3.49) increased risk of asthma, 3.2% (0.4% to 6.0%) deficit in FEV 1 /FVC ratio, and elevated systolic 11.3\u2005mm\u2005Hg (7.1 to 15.4) and diastolic 12.0\u2005mm\u2005Hg (8.9 to 15.1) blood pressure were observed at age 18\u2005years.", {"entities": [[36, 43, "DISEASE"], [115, 121, "DISEASE"], [154, 157, "GENE"]]}], ["Maternal prenatal exposures show prolonged effects on offspring's propensity towards overweight-obesity.", {"entities": [[96, 103, "DISEASE"]]}], ["Distinct morbid BMI trajectories are evident during the first 18\u2005years of life that are associated with higher risk of asthma, reduced FEV 1 /FVC ratio, and elevated blood pressure.", {"entities": [[119, 125, "DISEASE"], [135, 138, "GENE"]]}], ["Histamine inhibits formation and release of phagocyte-derived reactive oxygen species, and thereby protects natural killer and T cells against oxidative damage.", {"entities": []}], ["Thus, the addition of histamine may potentially improve the efficacy of interleukin-2 (IL-2).", {"entities": []}], ["Two randomised phase II trials of IL-2 with or without histamine dihydrochloride (HDC) in patients with metastatic renal cell carcinoma (mRCC) were run in parallel.", {"entities": [[126, 135, "DISEASE"], [115, 135, "DISEASE"], [82, 85, "GENE"]]}], ["A total of 41 patients were included in Manchester, UK and 63 in Aarhus, Denmark.", {"entities": []}], ["The self-administered, outpatient regimen included IL-2 as a fixed dose, 18 MIU s.c. once daily, 5 days per week for 3 weeks followed by 2 weeks rest.", {"entities": []}], ["Histamine dihydrochloride was added twice daily, 1.0\u2009mg s.c., concomitantly with IL-2.", {"entities": []}], ["A maximum of four cycles were given.", {"entities": []}], ["The Danish study showed a statistically significant 1-year survival benefit (76 vs 47%, P =0.03), a trend towards benefit in both median survival (18.3 vs 11.4 months, P =0.07), time to PD (4.5 vs 2.2 months, P =0.13) and clinical benefit (CR+PR+SD) (58 vs 37%, P =0.10) in favour of IL-2/HDC, whereas the UK study was negative for all end points.", {"entities": []}], ["Only three patients had grade 4 toxicity; however, two were fatal.", {"entities": []}], ["A randomised phase III trial is warranted to clarify the potential role of adding histamine to IL-2 in mRCC.", {"entities": []}], ["Acetaminophen is often used with a non-steriodal anti-inflammatory drug for acute pain.", {"entities": []}], ["Hitherto, these drugs have had to be given separately, typically at different time intervals.", {"entities": []}], ["Maxigesic Adults (more than 16 yr) having one or more wisdom teeth removed under general or local anaesthesia were instructed to take two tablets before operation, then two tablets every 6 h for up to 48 h of: (i) a combination of acetaminophen 500 mg and ibuprofen 150 mg per tablet (Maxigesic The mean ( sem ) time-corrected AUC on rest and activity, respectively, were: combination group 22.3 (3.2) and 28.4 (3.4); acetaminophen group 33.0 (3.1) and 40.4 (3.3); and ibuprofen group 34.8 (3.2) and 40.2 (3.4); P <0.01 for each of the four comparisons of combination vs constituent drug.", {"entities": []}], ["There was no pharmacokinetic interaction between acetaminophen and ibuprofen administered together.", {"entities": []}], ["Nitration of the major birch pollen allergen Bet v 1 alters the immune responses toward this protein, but the underlying chemical mechanisms are not yet understood.", {"entities": []}], ["Here we address the efficiency and site-selectivity of the nitration reaction of recombinant protein samples of Bet v 1.0101 with different nitrating agents relevant for laboratory investigations (tetranitromethane, TNM), for physiological processes (peroxynitrite, ONOO 3 /NO 2 ).", {"entities": []}], ["We determined the total tyrosine nitration degrees (ND) and the NDs of individual tyrosine residues (ND Y ).", {"entities": []}], ["High-performance liquid chromatography coupled to diode array detection and HPLC coupled to high-resolution mass spectrometry analysis of intact proteins, HPLC coupled to tandem mass spectrometry analysis of tryptic peptides, and amino acid analysis of hydrolyzed samples were performed.", {"entities": []}], ["The preferred reaction sites were tyrosine residues at the following positions in the polypeptide chain: Y83 and Y81 for TNM, Y150 for ONOO 3 /NO 2 .", {"entities": []}], ["The tyrosine residues Y83 and Y81 are located in a hydrophobic cavity, while Y150 and Y158 are located in solvent-accessible and flexible structures of the C-terminal region.", {"entities": []}], ["The heterogeneous reaction with O 3 /NO 2 was found to be strongly dependent on the phase state of the protein.", {"entities": []}], ["Nitration rates were about one order of magnitude higher for aqueous protein solutions (\u223c20% per day) than for protein filter samples (\u223c2% per day).", {"entities": []}], ["Overall, our findings show that the kinetics and site-selectivity of nitration strongly depend on the nitrating agent and reaction conditions, which may also affect the biological function and adverse health effects of the nitrated protein.", {"entities": []}], ["To summarize literature describing approaches aimed at automatically identifying patients with a common phenotype.", {"entities": []}], ["We performed a review of studies describing systems or reporting techniques developed for identifying cohorts of patients with specific phenotypes.", {"entities": []}], ["Every full text article published in (1) Journal of American Medical Informatics Association , (2) Journal of Biomedical Informatics , (3) Proceedings of the Annual American Medical Informatics Association Symposium , and (4) Proceedings of Clinical Research Informatics Conference within the past 3\u2005years was assessed for inclusion in the review.", {"entities": []}], ["Only articles using automated techniques were included.", {"entities": []}], ["Ninety-seven articles met our inclusion criteria.", {"entities": []}], ["Forty-six used natural language processing (NLP)-based techniques, 24 described rule-based systems, 41 used statistical analyses, data mining, or machine learning techniques, while 22 described hybrid systems.", {"entities": []}], ["Nine articles described the architecture of large-scale systems developed for determining cohort eligibility of patients.", {"entities": []}], ["We observe that there is a rise in the number of studies associated with cohort identification using electronic medical records.", {"entities": []}], ["Statistical analyses or machine learning, followed by NLP techniques, are gaining popularity over the years in comparison with rule-based systems.", {"entities": []}], ["There are a variety of approaches for classifying patients into a particular phenotype.", {"entities": []}], ["Different techniques and data sources are used, and good performance is reported on datasets at respective institutions.", {"entities": []}], ["However, no system makes comprehensive use of electronic medical records addressing all of their known weaknesses.", {"entities": []}], ["The apparent rapid increase in IgE-mediated food allergy and its implications are now widely recognized, but little is known about the relationship between family history (an indirect measure of genetic risk) and the risk of food allergy.", {"entities": [[44, 56, "DISEASE"], [225, 237, "DISEASE"]]}], ["In a population-based study of 5,276 one year old infants (HealthNuts), the prevalence of oral food challenge-confirmed food allergy was measured.", {"entities": [[120, 132, "DISEASE"]]}], ["Associations between family history of allergic disease and food allergy in infants were examined using multiple logistic regression.", {"entities": [[60, 72, "DISEASE"]]}], ["Food allergy was diagnosed in 534 infants.", {"entities": [[0, 12, "DISEASE"]]}], ["Compared to those with no family history of allergic disease, children meeting the current definition of \u201chigh risk\u201d for allergic disease (one immediate family member with a history of any allergic disease) showed only a modest increase (OR 1.4, 95% CI 1.1\u20131.7) in food allergy, while having two or more allergic family members was more strongly predictive of food allergy in the child (OR 1.8, 95% CI 1.5\u20132.3).", {"entities": [[265, 277, "DISEASE"], [360, 372, "DISEASE"]]}], ["There were also differences in the associations between family history and egg and peanut allergy in the child.", {"entities": []}], ["Re-defining \u201chigh risk\u201d as two or more allergic family members may be more useful for identification of groups with a significantly increased risk of food allergy both clinically and within research studies.", {"entities": [[150, 162, "DISEASE"]]}], ["To determine whether an elevated fetal umbilical artery Doppler (UAD) pulsatility index (PI) at 28\u2005weeks\u2019 gestation, in the absence of fetal growth restriction (FGR) and prematurity, is associated with adverse neurocognitive outcome in children aged 12 years.", {"entities": [[161, 164, "GENE"]]}], ["Prospective cohort study, comparing children with a normal fetal UAD PI (<90th centile) (n=110) and those with an elevated PI (\u226590th centile) (n=40).", {"entities": []}], ["UAD was performed at 28, 32 and 34\u2005weeks gestation.", {"entities": []}], ["At 12\u2005years of age, all children were assessed under standardised conditions at Queen's University, Belfast, UK to determine cognitive and behavioural outcomes using the British Ability Score-II and Achenbach Child Behavioural Checklist Parent Rated Version under standardised conditions.", {"entities": []}], ["Regression analysis was performed, controlling for confounders such as gender, socioeconomic status and age at assessment.", {"entities": []}], ["The mean age of follow-up was 12.4\u2005years (\u00b10.5 SD) with 44% of children male (n=63).", {"entities": []}], ["When UAD was assessed at 28\u2005weeks, the elevated fetal UAD group had lower scores in cognitive assessments of information processing and memory.", {"entities": []}], ["Parameters included (1) recall of objects immediate verbal (p=0.002), (2) delayed verbal (p=0.008) and (3) recall of objects immediate spatial (p=0.0016).", {"entities": []}], ["There were no significant differences between the Doppler groups at 32 or 34\u2005weeks' gestation.", {"entities": []}], ["An elevated UAD PI at 28\u2005weeks' gestation in the absence of FGR or prematurity is associated with lower scores of declarative memory in children aged 12\u2005years.", {"entities": [[60, 63, "GENE"]]}], ["A potential explanation for this is an element of placental insufficiency in the presence of the appropriately grown fetus, which affects the development of the fetal hippocampus and information processing and memory long-term.", {"entities": [[50, 73, "DISEASE"]]}], ["These findings, however, had no impact on overall academic ability, mental processing and reasoning or overall behavioural function.", {"entities": []}], ["Mesenchymal stem cells (MSCs) are partially defined by their ability to differentiate into tissues including bone, cartilage and adipose in vitro , but it is their trophic, paracrine and immunomodulatory functions that may have the greatest therapeutic impact in vivo .", {"entities": []}], ["Unlike pharmaceutical treatments that deliver a single agent at a specific dose, MSCs are site regulated and secrete bioactive factors and signals at variable concentrations in response to local microenvironmental cues.", {"entities": []}], ["Significant progress has been made in understanding the biochemical and metabolic mechanisms and feedback associated with MSC response.", {"entities": [[122, 125, "GENE"]]}], ["The anti-inflammatory and immunomodulatory capacity of MSC may be paramount in the restoration of localized or systemic conditions for normal healing and tissue regeneration.", {"entities": [[55, 58, "GENE"]]}], ["Allogeneic MSC treatments, categorized as a drug by regulatory agencies, have been widely pursued, but new studies demonstrate the efficacy of autologous MSC therapies, even for individuals affected by a disease state.", {"entities": [[11, 14, "GENE"], [154, 157, "GENE"], [11, 14, "GENE"], [154, 157, "GENE"]]}], ["Safety and regulatory concerns surrounding allogeneic cell preparations make autologous and minimally manipulated cell therapies an attractive option for many regenerative, anti-inflammatory and autoimmune applications.", {"entities": []}], ["We investigated the net changes in prevalence of symptoms of asthma and rhinitis over 10\u00a0years in a cohort of young by baseline sensitization status.", {"entities": [[72, 80, "DISEASE"], [61, 67, "DISEASE"]]}], ["One thousand one hundred ninety three Chilean adults subjects aged 22\u201328 living in a semi-rural area of central Chile answered a lifestyle and the European Community Respiratory Health Survey (ECRHS) questionnaires.", {"entities": []}], ["Bronchial hyper-responsiveness (BHR) and skin prick test (SPT) to eight allergens were measured at baseline in 2001.", {"entities": []}], ["Ten years later, 772 participants completed the questionnaires again.", {"entities": []}], ["Estimates of adjusted net changes in prevalence of symptoms by sensitization status at baseline and association between sensitization status at baseline and respiratory symptoms ten years later were assessed.", {"entities": []}], ["A quarter of the participants were sensitized to at least one allergen in 2001.", {"entities": []}], ["Prevalence of wheeze had a net change per year of \u22120.37\u00a0% (95\u00a0% Confidence Interval \u22120.71 to 0.02\u00a0%; p \u2009=\u20090.067).", {"entities": []}], ["Self-reported nasal allergies in the last 12\u00a0months increased by 0.83\u00a0% per year (95\u00a0% CI 0.49 to 1.17\u00a0%; p \u2009<\u20090.001).", {"entities": []}], ["Those sensitized to either cat fur (OR 1.76; CI 1.01 to 3.05), cockroach, (OR 2.09; 1.13 to 3.86) blend of grass and pollens (1.78; 95\u00a0% CI 1.08 to 2.92), or weeds (OR 1.77; 95\u00a0% CI 1.01 to 3.12) in 2001 were more likely to have wheeze in the last 12\u00a0months 10\u00a0years later.", {"entities": []}], ["Symptoms of asthma remained stable or slightly changed over 10\u00a0years in adults, whilst rhinitis and nasal allergies greatly increased.", {"entities": [[87, 95, "DISEASE"], [12, 18, "DISEASE"]]}], ["Being sensitized to at least one allergen is a risk factor for persistent symptoms of asthma and rhinitis, but not for determining net changes of symptoms over time.", {"entities": [[97, 105, "DISEASE"], [86, 92, "DISEASE"]]}], ["The underlying causes for the contrasting trends between asthma and nasal allergy are unknown.", {"entities": [[57, 63, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0273-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Emerging evidence suggests that the T H 17 subset of \u03b1\u03b2 T cells contributes to the development of allergic asthma.", {"entities": [[98, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["In this study we found that mice lacking \u03b1v\u03b28 on dendritic cells failed to generate T H 17 cells in the lung and were protected from AHR in response to house dust mite and ovalbumin sensitization and challenge.", {"entities": [[133, 136, "GENE"]]}], ["Because loss of T H 17 cells inhibited airway narrowing without obvious effects on airway inflammation or epithelial morphology, we examined the direct effects of T H 17 cytokines on mouse and human airway smooth muscle function.", {"entities": []}], ["IL-17A enhanced contractile force generation through a NF-\u03baB/RhoA/ROCK2 signaling cascade.", {"entities": []}], ["Mice lacking integrin \u03b1v\u03b28 on dendritic cells showed impaired activation of this pathway after OVA sensitization and challenge, and the diminished contraction of tracheal rings from these mice was reversed by IL-17A.", {"entities": []}], ["These data indicate that IL-17A produced by T H 17 cells contributes to allergen-induced AHR through direct effects on airway smooth muscle.", {"entities": [[89, 92, "GENE"]]}], ["There is growing awareness of sudden unexplained death in alcohol misuse (SUDAM) in which there is no obvious cause of death, no evidence of acute alcohol toxicity or alcoholic ketoacidosis, and the heart is morphologically normal.", {"entities": []}], ["This study describes the characteristics of a cohort with SUDAM from a tertiary cardiovascular referral center and compares the findings with those of individuals who died from sudden arrhythmic death syndrome (SADS).", {"entities": [[201, 209, "DISEASE"]]}], ["Cases in this retrospective cross-sectional study were identified from a database of referrals to our center spanning approximately 40 years.", {"entities": []}], ["Cases with recorded heavy use of alcohol and non-alcohol users were selected, then limited to those with SUDAM or SADS aged 16 to 64 years.", {"entities": []}], ["62 cases of SUDAM and 41 cases of SADS were identified.", {"entities": []}], ["The SUDAM group were older than the SADS group; mean age 35.8 years and 27.7 years respectively (P=0.0002).", {"entities": []}], ["There was also a higher incidence of significant psychiatric illness in SUDAM (19.7%) than SADS (2.4%) cases.", {"entities": []}], ["Post mortem liver examination was more likely to reveal heavy livers in SUDAM than SADS (2196.1g and 1572.4g respectively; P=0.0033) and more fatty liver change (24.2% and 2.4%).", {"entities": []}], ["SUDAM tends to occur in individuals who are older and have heavier livers than those with SADS.", {"entities": []}], ["Psychiatric illness is also more common.", {"entities": []}], ["SADS, unlike SUDAM, is often associated with heritable channelopathies that may affect surviving family members.", {"entities": []}], ["Therefore, differentiating between SUDAM and SADS identifies families likely to benefit from screening for these mutations, thus preventing further sudden arrhythmic deaths.", {"entities": []}], ["Objective To examine the association between chronic use of proton pump inhibitors (PPIs) and risk of hip fracture.", {"entities": []}], ["Design Prospective cohort study.", {"entities": []}], ["Setting Nurses\u2019 Health Study, which originally recruited from the 11 most populous states in the US.", {"entities": []}], ["Participants 79\u2009899 postmenopausal women enrolled in the Nurses\u2019 Health Study who provided data on the use of PPIs and other risk factors biennially since 2000 and were followed up to 1 June 2008.", {"entities": []}], ["Main outcome measure Incident hip fracture Results During 565\u2009786 person years of follow-up, we documented 893 incident hip fractures.", {"entities": []}], ["The absolute risk of hip fracture among regular users of PPIs was 2.02 events per 1000 person years, compared with 1.51 events per 1000 person years among non-users.", {"entities": []}], ["Compared with non-users, the risk of hip fracture among women who regularly used PPIs for at least two years was 35% higher (age adjusted hazard ratio 1.35 (95% confidence interval 1.13 to 1.62)), with longer use associated with increasing risk (P trend <0.01).", {"entities": []}], ["Adjustment for risk factors, including body mass index, physical activity, and intake of calcium did not materially alter this association (hazard ratio 1.36 (1.13 to 1.63)).", {"entities": []}], ["These associations were also not changed after accounting for reasons for PPI use.", {"entities": []}], ["The relation between PPI use and fracture differed by smoking history (P interaction =0.03).", {"entities": []}], ["Among current and former smokers, PPI use was associated with greater than 50% increase in risk of fracture, with a multivariate hazard ratio for fracture of 1.51 (1.20 to 1.91).", {"entities": []}], ["In contrast, among women who never smoked there was no association (multivariate hazard ratio 1.06 (0.77 to 1.46)).", {"entities": []}], ["In a meta-analysis of these results with 10 prior studies, the pooled odds ratio of hip fracture associated with PPI use was 1.30 (1.25 to 1.36).", {"entities": []}], ["Conclusion Chronic use of PPIs is associated with increased risk of hip fracture, particularly among women with a history of smoking.", {"entities": []}], ["In Ghana, the older adult population is projected to increase from 5.3% of the total population in 2015 to 8.9% by 2050.", {"entities": []}], ["National and local governments will need information about non-communicable diseases (NCDs) in this population in order to allocate health system resources and respond to the health needs of older adults.", {"entities": []}], ["The 2007/08 Study on global AGEing and adult health (SAGE) Wave 1 in Ghana used face-to-face interviews in a nationally representative sample of persons aged 50-plus years.", {"entities": []}], ["Individual respondents were asked about their overall health, diagnosis of 10 chronic non-communicable conditions, and common health risk factors.", {"entities": []}], ["A number of anthropometric and health measurements were also taken in all respondents, including height, weight, waist and hip circumferences, and blood pressure (BP).", {"entities": []}], ["This paper includes 4,724 adults aged 50-plus years.", {"entities": []}], ["The highest prevalence of self-reported chronic conditions was for hypertension [14.2% (95% CI 12.8\u201315.6)] and osteoarthritis [13.8%, (95% CI 11.7\u201315.9)].", {"entities": [[67, 79, "DISEASE"], [111, 125, "DISEASE"]]}], ["The figure for hypertension reached 51.1% (95% CI 48.9\u201353.4) when based on BP measurement.", {"entities": [[15, 27, "DISEASE"]]}], ["The prevalence of current smokers was 8.1% (95% CI 7.0\u20139.2), while 2.0 (95% CI 1.5\u20132.5) were infrequent/frequent heavy drinkers, 67.9% (95% CI 65.2\u201370.5) consume insufficient fruits and vegetables, and 25.7% (95% CI 23.1\u201328.3) had a low level of physical activity.", {"entities": []}], ["Almost 10% (95% CI 8.3\u201311.1) of adults were obese and 77.6% (95% CI 76.0\u201379.2) had a high-risk waist-to-hip ratio (WHR).", {"entities": []}], ["Risks from tobacco and alcohol consumption continued into older age, while insufficient fruit and vegetable intake, low physical activity and obesity increased with increasing age.", {"entities": [[142, 149, "DISEASE"]]}], ["The patterns of risk factors varied by income quintile, with higher prevalence of obesity and low physical activity in wealthier respondents, and higher prevalence of insufficient fruit and vegetable intake and smoking in lower-income respondents.", {"entities": [[82, 89, "DISEASE"]]}], ["The multivariate analysis showed that only urban/rural residence and body mass index (BMI) were common determinates of both self-reported and measured hypertension, while all other determinants have differing patterns.", {"entities": [[151, 163, "DISEASE"]]}], ["The findings show a high burden of chronic diseases in the older Ghanaian population, as well as high rates of modifiable health risk factors.", {"entities": []}], ["The government could consider targeting these health behaviors in conjunction with work to improve enrolment rates in the National Health Insurance Scheme.", {"entities": []}], ["One injection of corifollitropin alfa replaces the first seven daily FSH injections in controlled ovarian stimulation (COS) cycles.", {"entities": []}], ["Repeated treatment with therapeutic proteins may cause immune responses or hypersensitivity reactions.", {"entities": []}], ["We assessed the immunogenicity and safety of corifollitropin alfa treatment in up to three COS cycles.", {"entities": []}], ["In this multicentre, phase III uncontrolled trial, patients (>60 kg) started treatment with one injection of 150 \u00b5g corifollitropin alfa on cycle Day 2 or 3 of menses and 0.25 mg ganielix on stimulation Day 5 or 6.", {"entities": []}], ["Primary outcome measures were antibody formation against corifollitropin alfa (using highly sensitive radioimmunoprecipitation assay), hypersensitivity reactions, local tolerance and adverse events (AEs).", {"entities": []}], ["First, second and third COS cycles were started by 682, 375 and 198 patients, respectively.", {"entities": []}], ["No clinically relevant immunogenicity or drug-related hypersensitivity was observed.", {"entities": []}], ["For 192 patients undergoing their third cycle a post-treatment blood sample was negative in the anti-corifollitropin antibody assay, resulting in an upper limit of the one-sided 95% confidence interval (CI) of 1.5%.", {"entities": []}], ["Most frequent AEs were procedural pain (17.7%, 95% CI: 14.9\u201320.8%), headache (9.1%, 95% CI: 7.0\u201311.5%) and pelvic pain (7.6%, 95% CI: 5.7\u20139.9%).", {"entities": []}], ["Cumulative ongoing pregnancy rate after three cycles, including frozen-thawed embryo transfer cycles and spontaneous pregnancies, was 61% (95% CI: 56\u201365%) after censoring for patients who discontinued.", {"entities": []}], ["Treatment with corifollitropin alfa can safely and effectively initiate and sustain ovarian stimulation during the first 7 days of COS in normal responder patients undergoing up to three treatment cycles, without concerns of immunogenicity.", {"entities": []}], ["The trial was registered under ClinicalTrials.gov identifier NCT00696878.", {"entities": []}], ["Neisseria meningitidis and Bordetella pertussis are Gram-negative bacterial pathogens that can cause serious diseases in humans.", {"entities": [[38, 47, "DISEASE"]]}], ["N. meningitidis outer membrane vesicle (OMV) vaccines and whole cell pertussis vaccines have been successfully used in humans to control infections with these pathogens.", {"entities": [[69, 78, "DISEASE"]]}], ["The mechanisms behind their effectiveness are poorly defined.", {"entities": []}], ["Here we investigated the role of Toll-like receptor (TLR) 2 and TLR4 in the induction of immune responses in mice after immunization with these vaccines.", {"entities": [[64, 68, "GENE"]]}], ["Innate and adaptive immune responses were compared between wild type mice and mice deficient in TLR2, TLR4, or TRIF.", {"entities": [[96, 100, "GENE"], [102, 106, "GENE"]]}], ["TRIF-deficient and TLR4-deficient mice showed impaired immunity after immunization.", {"entities": []}], ["In contrast, immune responses were not lower in TLR2\u2212/\u2212 mice but tended even to be higher after immunization.", {"entities": []}], ["Together our data demonstrate that TLR4 activation contributes to the immunogenicity of the N. meningitidis OMV vaccine and the whole cell pertussis vaccine, but that TLR2 activation is not required.", {"entities": [[139, 148, "DISEASE"], [35, 39, "GENE"], [167, 171, "GENE"]]}], ["Many patients with aspirin-induced asthma have severe methacholine airway hyperresponsiveness (AHR), suggesting a relationship between aspirin and methacholine in airway response.", {"entities": [[35, 41, "DISEASE"], [95, 98, "GENE"]]}], ["This study was performed to determine whether methacholine AHR affects the response of asthmatics to inhaled aspirin.", {"entities": [[59, 62, "GENE"]]}], ["The clinical records of 207 asthmatic patients who underwent inhalation challenges with both aspirin and methacholine were reviewed retrospectively.", {"entities": []}], ["An oral aspirin challenge was performed in patients with a negative inhalation response.", {"entities": []}], ["The bronchial reactivity index (BRindex) was calculated from the percent decrease in lung function divided by the last dose of the stimulus.", {"entities": []}], ["Forty-one (20.9%) and 14 (7.1%) patients showed a positive response to aspirin following an inhalation and oral challenge, respectively.", {"entities": []}], ["Only 24.3 and 14.3% of the responders had a history of aspirin intolerance, respectively.", {"entities": []}], ["The methacholine BRindex was significantly higher in the inhalation responders (1.46 \u00b1 0.02) than in the oral responders (1.36 \u00b1 0.03, p < 0.01) and in non-responders (n = 141, 1.37 \u00b1 0.01, p < 0.001).", {"entities": []}], ["The aspirin BRindex was significantly correlated with the methacholine BRindex (r = 0.270, p < 0.001).", {"entities": []}], ["Three of four patients who received the oral challenge, despite a positive inhalation test, showed negative responses to the oral challenge.", {"entities": []}], ["Two of these patients had severe AHR.", {"entities": [[33, 36, "GENE"]]}], ["A considerable number of asthmatic patients with no history of aspirin intolerance responded to the inhalation aspirin challenge.", {"entities": []}], ["The airway response to aspirin was significantly correlated with methacholine-AHR, and a false-positive response to aspirin inhalation test seemed to occur primarily in patients with severe AHR.", {"entities": [[78, 81, "GENE"], [190, 193, "GENE"]]}], ["Rosana Norman and colleagues conduct a systematic review and meta-analysis to assess the relationship between child physical abuse, emotional abuse, and neglect, and subsequent mental and physical health outcomes.", {"entities": []}], ["Child sexual abuse is considered a modifiable risk factor for mental disorders across the life course.", {"entities": []}], ["However the long-term consequences of other forms of child maltreatment have not yet been systematically examined.", {"entities": []}], ["The aim of this study was to summarise the evidence relating to the possible relationship between child physical abuse, emotional abuse, and neglect, and subsequent mental and physical health outcomes.", {"entities": []}], ["A systematic review was conducted using the Medline, EMBASE, and PsycINFO electronic databases up to 26 June 2012.", {"entities": []}], ["Published cohort, cross-sectional, and case-control studies that examined non-sexual child maltreatment as a risk factor for loss of health were included.", {"entities": []}], ["All meta-analyses were based on quality-effects models.", {"entities": []}], ["Out of 285 articles assessed for eligibility, 124 studies satisfied the pre-determined inclusion criteria for meta-analysis.", {"entities": []}], ["Statistically significant associations were observed between physical abuse, emotional abuse, and neglect and depressive disorders (physical abuse [odds ratio (OR)\u200a=\u200a1.54; 95% CI 1.16\u20132.04], emotional abuse [OR\u200a=\u200a3.06; 95% CI 2.43\u20133.85], and neglect [OR\u200a=\u200a2.11; 95% CI 1.61\u20132.77]); drug use (physical abuse [OR\u200a=\u200a1.92; 95% CI 1.67\u20132.20], emotional abuse [OR\u200a=\u200a1.41; 95% CI 1.11\u20131.79], and neglect [OR\u200a=\u200a1.36; 95% CI 1.21\u20131.54]); suicide attempts (physical abuse [OR\u200a=\u200a3.40; 95% CI 2.17\u20135.32], emotional abuse [OR\u200a=\u200a3.37; 95% CI 2.44\u20134.67], and neglect [OR\u200a=\u200a1.95; 95% CI 1.13\u20133.37]); and sexually transmitted infections and risky sexual behaviour (physical abuse [OR\u200a=\u200a1.78; 95% CI 1.50\u20132.10], emotional abuse [OR\u200a=\u200a1.75; 95% CI 1.49\u20132.04], and neglect [OR\u200a=\u200a1.57; 95% CI 1.39\u20131.78]).", {"entities": []}], ["Evidence for causality was assessed using Bradford Hill criteria.", {"entities": []}], ["While suggestive evidence exists for a relationship between maltreatment and chronic diseases and lifestyle risk factors, more research is required to confirm these relationships.", {"entities": []}], ["This overview of the evidence suggests a causal relationship between non-sexual child maltreatment and a range of mental disorders, drug use, suicide attempts, sexually transmitted infections, and risky sexual behaviour.", {"entities": []}], ["All forms of child maltreatment should be considered important risks to health with a sizeable impact on major contributors to the burden of disease in all parts of the world.", {"entities": []}], ["The awareness of the serious long-term consequences of child maltreatment should encourage better identification of those at risk and the development of effective interventions to protect children from violence.", {"entities": []}], ["Please see later in the article for the Editors' Summary Child maltreatment\u2014the abuse and neglect of children\u2014is a global problem.", {"entities": []}], ["There are four types of child maltreatment\u2014sexual abuse (the involvement of a child in sexual activity that he or she does not understand, is unable to give consent to, or is not developmentally prepared for), physical abuse (the use of physical force that harms the child's health, survival, development, or dignity), emotional abuse (the failure to provide a supportive environment by, for example, verbally threatening the child), and neglect (the failure to provide for all aspects of the child's well-being).", {"entities": []}], ["Most child maltreatment is perpetrated by parents or parental guardians, many of whom were maltreated themselves as children.", {"entities": []}], ["Other risk factors for parents abusing their children include poverty, mental health problems, and alcohol and drug misuse.", {"entities": []}], ["Although there is considerable uncertainty about the frequency and severity of child maltreatment, according to the World Health Organization (WHO) about 20% of women and 5%\u201310% of men report being sexually abused as children, and the prevalence of physical abuse in childhood may be 25%\u201350%.", {"entities": []}], ["Child maltreatment has a large public health impact.", {"entities": []}], ["Sometimes this impact is immediate and direct (injuries and deaths), but, more often, it is long-term, affecting emotional development and overall health.", {"entities": []}], ["For child sexual abuse, the relationship between abuse and mental disorders in adult life is well-established.", {"entities": []}], ["Exposure to other forms of child maltreatment has also been associated with a wide range of psychological and behavioral problems, but the health consequences of physical abuse, emotional abuse, and neglect have not been systematically examined.", {"entities": []}], ["A better understanding of the long-term health effects of child maltreatment is needed to inform maltreatment prevention strategies and to improve treatment for children who have been abused or neglected.", {"entities": []}], ["In this systematic review and meta-analysis, the researchers quantify the association between exposure to physical abuse, emotional abuse, and neglect in childhood and mental health and physical health outcomes in later life.", {"entities": []}], ["A systematic review uses predefined criteria to identify all the research on a given topic; a meta-analysis is a statistical approach that combines the results of several studies.", {"entities": []}], ["The researchers identified 124 studies that investigated the relationship between child physical abuse, emotional abuse, or neglect and various health outcomes.", {"entities": []}], ["Their meta-analysis of data from these studies provides suggestive evidence that child physical abuse, emotional abuse, and neglect are causally linked to mental and physical health outcomes.", {"entities": []}], ["For example, emotionally abused individuals had a three-fold higher risk of developing a depressive disorder than non-abused individuals (an odds ratio [OR] of 3.06).", {"entities": []}], ["Physically abused and neglected individuals also had a higher risk of developing a depressive disorder than non-abused individuals (ORs of 1.54 and 2.11, respectively).", {"entities": []}], ["Other mental health disorders associated with child physical abuse, emotional abuse, or neglect included anxiety disorders, drug abuse, and suicidal behavior.", {"entities": []}], ["Individuals who had been non-sexually maltreated as children also had a higher risk of sexually transmitted diseases and/or risky sexual behavior than non-maltreated individuals.", {"entities": []}], ["Finally, there was weak and inconsistent evidence that child maltreatment increased the risk of chronic diseases and lifestyle risk factors such as smoking.", {"entities": []}], ["By providing suggestive evidence of a causal link between non-sexual child maltreatment and mental health disorders, drug use, suicide attempts, and sexually transmitted diseases and risky sexual behavior, these findings contribute to our understanding of the non-injury health impacts of child maltreatment.", {"entities": []}], ["Although most of the studies included in the meta-analysis were undertaken in high-income countries, the findings suggest that this link occurs in both high- and low-to-middle-income countries.", {"entities": []}], ["They also suggest that neglect may be as harmful as physical and emotional abuse.", {"entities": []}], ["However, they need to be interpreted carefully because of the limitations of this meta-analysis, which include the possibility that children who have been abused may share other, unrecognized factors that are actually the cause of their later mental health problems.", {"entities": []}], ["Importantly, this confirmation that physical abuse, emotional abuse, and neglect in childhood are important risk factors for a range of health problems draws attention to the need to develop evidence-based strategies for preventing child maltreatment both to reduce childhood suffering and to alleviate an important risk factor for later health problems.", {"entities": []}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001349 .", {"entities": []}], ["The World Health Organization provides information on child maltreatment and its prevention (in several languages); Preventing Child Maltreatment: A Guide to Taking Action and Generating Evidence is a 2006 report produced by WHO and the International Society for Prevention of Child Abuse and Neglect The US Centers for Disease Control and Prevention provides information on child maltreatment and links to additional resources The National Society for the Prevention of Cruelty to Children (NSPCC) is a not-for-profit organization that aims to end all cruelty to children in the UK; Childline is a resource provided by the NSPCC that provides help, information, and support to children who are being abused The Hideout is a UK-based website that helps children and young people understand domestic abuse Childhelp is a US not-for-profit organization dedicated to helping victims of child abuse and neglect; its website includes a selection of personal stories about child maltreatment", {"entities": []}], ["Human herpesvirus type 6B (HHV-6B) is a strong inducer of IFN-alpha and has the capacity to promote Th1 responses and block Th2 responses in vitro .", {"entities": []}], ["In this study we addressed whether inactivated HHV-6B can also induce IFN lambda responses and to what extent interferons alpha and lambda affect Th1/Th2 polarization.", {"entities": []}], ["We show that inactivated HHV-6B induced IFN-lambda1 (IL-29) but not IFN-lambda2 (IL-28A) responses in plasmacytoid DC and that this induction was mediated through TLR9.", {"entities": [[163, 167, "GENE"]]}], ["We have previously shown that HHV-6B promotes Th1 responses and blocks Th2 responses in both humans and mice.", {"entities": []}], ["We now show that neutralization of IFN-alpha but not IFN-lambda1 blocked the HHV-6B-induced enhancement of Th1 responses in MLR, but did not affect the HHV-6-induced dampening of Th2 responses.", {"entities": []}], ["Similarly, blockage of TLR9 counteracted HHV-6Bs effects on the Th1/Th2 balance.", {"entities": [[23, 27, "GENE"]]}], ["In addition, IFN-alpha but not IFN-lambda1 promoted IFN-gamma production and blocked IL-5 and IL-13 production in purified CD4+ T-cells.", {"entities": []}], ["The lack of effect of IFN-lambda1 correlated with the absence of the IFN-lambda receptor IL-28Ralfa chain on the cell surface of both resting and activated CD4+ T-cells.", {"entities": []}], ["We conclude that inactivated HHV-6B is a strong inducer of IFN-lambda1 in plasmacytoid DC and that this induction is TLR9-dependent.", {"entities": []}], ["However, human CD4+ T-cells do not express the IFN-lambda receptor and are refractory to IFN-lambda1 treatment.", {"entities": []}], ["The HHV-6B-induced alterations in the Th1/Th2 balance are instead mediated mainly through TLR9 and IFN-alpha.", {"entities": [[90, 94, "GENE"]]}], ["Evidence has been submitted of the existence of a common antigenic substance in horse dander and horse serum.", {"entities": []}], ["This evidence has been derived from three lines of study: ( a ) Cross-precipitation tests involving (1) the titration of antisera against horse serum with saline extract of horse dander and (2) titration of antisera against horse dander with normal horse serum.", {"entities": []}], ["( b ) Cross-anaphylactic tests by the uterine strip method of Dale.", {"entities": []}], ["( c ) Cross-anaphylactic tests in living guinea pigs by the usual shock method.", {"entities": []}], ["It seems likely from the work here described that the common antigen is present in small proportion in horse dander.", {"entities": []}], ["Its concentration in horse serum is not indicated by the results obtained.", {"entities": []}], ["Acute encephalitis syndrome (AES) is a common cause of coma in Nepali children.", {"entities": [[19, 27, "DISEASE"], [6, 18, "DISEASE"]]}], ["The Glasgow coma scale (GCS) is used to assess the level of coma in these patients and predict outcome.", {"entities": []}], ["Alternative coma scales may have better inter-rater reliability and prognostic value in encephalitis in Nepali children, but this has not been studied.", {"entities": [[88, 100, "DISEASE"]]}], ["The Adelaide coma scale (ACS), Blantyre coma scale (BCS) and the Alert, Verbal, Pain, Unresponsive scale (AVPU) are alternatives to the GCS which can be used.", {"entities": []}], ["Children aged 1\u201314\u00a0years who presented to Kanti Children\u2019s Hospital, Kathmandu with AES between September 2010 and November 2011 were recruited.", {"entities": []}], ["All four coma scales (GCS, ACS, BCS and AVPU) were applied on admission, 48\u00a0h later and on discharge.", {"entities": []}], ["Inter-rater reliability (unweighted kappa) was measured for each.", {"entities": []}], ["Correlation and agreement between total coma score and outcome (Liverpool outcome score) was measured by Spearman\u2019s rank and Bland\u2013Altman plot.", {"entities": []}], ["The prognostic value of coma scales alone and in combination with physiological variables was investigated in a subgroup ( n \u00a0=\u00a022).", {"entities": []}], ["A multivariable logistic regression model was fitted by backward stepwise.", {"entities": []}], ["Fifty children were recruited.", {"entities": []}], ["Inter-rater reliability using the variables scales was fair to moderate.", {"entities": []}], ["However, the scales poorly predicted clinical outcome.", {"entities": []}], ["Combining the scales with physiological parameters such as systolic blood pressure improved outcome prediction.", {"entities": []}], ["This is the first study to compare four coma scales in Nepali children with AES.", {"entities": []}], ["The scales exhibited fair to moderate inter-rater reliability.", {"entities": []}], ["However, the study is inadequately powered to answer the question on the relationship between coma scales and outcome.", {"entities": []}], ["Further larger studies are required.", {"entities": []}], ["Microbial ecology and chemical composition of Brazilian kefir beverage was performed.", {"entities": []}], ["The microorganisms associated with Brazilian kefir were investigated using a combination of phenotypic and genotypic methods.", {"entities": []}], ["A total of 359 microbial isolates were identified.", {"entities": []}], ["Lactic acid bacteria (60.5%) were the major isolated group identified, followed by yeasts (30.6%) and acetic acid bacteria (8.9%).", {"entities": []}], ["Lactobacillus paracasei (89 isolates), Lactobacillus parabuchneri (41 isolates), Lactobacillus casei (32 isolates), Lactobacillus kefiri (31 isolates), Lactococcus lactis (24 isolates), Acetobacter lovaniensis (32 isolates), Kluyveromyces lactis (31 isolates), Kazachstania aerobia (23 isolates), Saccharomyces cerevisiae (41 isolates) and Lachancea meyersii (15 isolates) were the microbial species isolated.", {"entities": []}], ["Scanning electron microscopy showed that the microbiota was dominated by bacilli (short and curved long) cells growing in close association with lemon-shaped yeasts cells.", {"entities": []}], ["During the 24 h of fermentation, the protein content increased, while lactose and fat content decreased.", {"entities": []}], ["The concentration of lactic acid ranged from 1.4 to 17.4 mg/ml, and that of acetic acid increased from 2.1 to 2.73 mg/ml.", {"entities": []}], ["The production of ethanol was limited, reaching a final mean value of 0.5 mg/ml.", {"entities": []}], ["Over the last four decades, molecular cloning has evolved tremendously.", {"entities": []}], ["Efficient products allowing assembly of multiple DNA fragments have become available.", {"entities": []}], ["However, cost-effective tools for engineering antibodies of different specificities, isotypes and species are still needed for many research and clinical applications in academia.", {"entities": []}], ["Here, we report a method for one-step assembly of antibody heavy- and light-chain DNAs into a single mammalian expression vector, starting from DNAs encoding the desired variable and constant regions, which allows antibodies of different isotypes and specificity to be rapidly generated.", {"entities": []}], ["As a proof of principle we have cloned, expressed and characterized functional recombinant tumor-associated antigen-specific chimeric IgE/\u03ba and IgG 1 /\u03ba, as well as recombinant grass pollen allergen Phl p 7 specific fully human IgE/\u03bb and IgG 4 /\u03bb antibodies.", {"entities": []}], ["This method utilizing the antibody expression vectors, available at Addgene, has many applications, including the potential to support simultaneous processing of antibody panels, to facilitate mechanistic studies of antigen-antibody interactions and to conduct early evaluations of antibody functions.", {"entities": []}], ["To investigate the influence of phthalate exposure on lung function in the Canadian population.", {"entities": []}], ["We tested the association between 1-second forced expiratory volume (FEV l ), forced vital capacity (FVC), and urinary phthalate metabolite levels in a nationally representative sample of 3147, from 6 to 49 years old.", {"entities": [[69, 72, "GENE"]]}], ["An interquartile increase in mono-n-butyl phthalate was associated with decreases in percent predicted FEV 1 of 0.8% (95% confidence interval = 0.3 to 1.4) and in FVC of 0.9% (95% confidence interval = 0.3 to 1.5).", {"entities": [[103, 106, "GENE"]]}], ["Results were similar for mono-3-carboxypropyl phthalate, mono-benzyl phthalate, and di(2-ethylhexyl) phthalate metabolites, but significant effects of the latter were only seen in males and those at least 17 years old.", {"entities": []}], ["These results provide evidence that phthalate exposure may adversely affect lung function in the Canadian population.", {"entities": []}], ["Given that these chemicals are ubiquitous, the population health burden may be significant if the associations were causal.", {"entities": []}], ["Salivary cortisol is widely used in research but little is known about the typical, or expected, functioning of the HPA-axis in adolescents in naturalistic settings, nor whether the extensive array of confounders documented in the literature is applicable in this situation.", {"entities": []}], ["In a school-based study, 2995 15-year-old pupils provided two saliva samples, 30\u00a0min apart, in morning sessions timed to capture peak cortisol decline.", {"entities": []}], ["The collection protocol was a balance between the large sample size obtainable in a school situation and a limited number of samples, constrained by the school timetable.", {"entities": []}], ["In addition, pupils completed a questionnaire containing items previously shown to be associated with cortisol levels (e.g.", {"entities": []}], ["time since awakening and life events), and their height and weight were measured.", {"entities": []}], ["Outcome measures were cortisol levels at Times 1 and 2, and change (per minute) in cortisol between the two time points.", {"entities": []}], ["Median (IQR) cortisol levels for males and females were 10.5 (8.1) and 11.6 (9.3)\u00a0nmol/L at Time 1, and 8.2 (6.0) and 8.1 (6.5)\u00a0nmol/L at Time 2.", {"entities": []}], ["73% had a decline in cortisol level of more than 10% across the two time points, compatible with the expected diurnal pattern.", {"entities": []}], ["In bivariate analyses, cortisol sampled on Monday, times of measurement and since awakening, prior smoking and several life events were associated with cortisol levels at Times 1 and 2 in both sexes.", {"entities": []}], ["However, in multivariate analysis, few of these variables remained after controlling for times of measurement and since awakening and, in addition, the final models differed between the sexes.", {"entities": []}], ["Two events (friend dying and splitting with a boy/girlfriend) predicted cortisol levels in both sexes while age, maturity, recent eating and smoking were predictors only in males.", {"entities": []}], ["Several factors associated with cortisol change differed from those observed for absolute levels.", {"entities": []}], ["Further adjustment for school clustering affected some associations, particularly time of measurement.", {"entities": []}], ["This study managed many of the problems found in naturalistic research on cortisol and provides norms for morning cortisol levels in 15-year-old adolescents.", {"entities": []}], ["Previous studies showed that heparin's anti-allergic activity is molecular weight dependent and resides in oligosaccharide fractions of <2500 daltons.", {"entities": []}], ["To investigate the structural sequence of heparin's anti-allergic domain, we used nitrous acid depolymerization of porcine heparin to prepare an oligosaccharide, and then fractionated it into disaccharide, tetrasaccharide, hexasaccharide, and octasaccharide fractions.", {"entities": []}], ["The anti-allergic activity of each oligosaccharide fraction was tested in allergic sheep.", {"entities": []}], ["Allergic sheep without (acute responder) and with late airway responses (LAR; dual responder) were challenged with Ascaris suum antigen with and without inhaled oligosaccharide pretreatment and the effects on specific lung resistance and airway hyperresponsiveness (AHR) to carbachol determined.", {"entities": [[266, 269, "GENE"]]}], ["Additional inflammatory cell recruitment studies were performed in immunized ovalbumin-challenged BALB/C mice with and without treatment.", {"entities": []}], ["The inhaled tetrasaccharide fraction was the minimal effective chain length to show anti-allergic activity.", {"entities": []}], ["This fraction showed activity in both groups of sheep; it was also effective in inhibiting LAR and AHR, when administered after the antigen challenge.", {"entities": [[99, 102, "GENE"]]}], ["Tetrasaccharide failed to modify the bronchoconstrictor responses to airway smooth muscle agonists (histamine, carbachol and LTD 4 ), and had no effect on antigen-induced histamine release in bronchoalveolar lavage fluid in sheep.", {"entities": []}], ["In mice, inhaled tetrasaccharide also attenuated the ovalbumin-induced peribronchial inflammatory response and eosinophil influx in the bronchoalveolar lavage fluid.", {"entities": []}], ["Chemical analysis identified the active structure to be a pentasulfated tetrasaccharide ([IdoU2S (1\u21924)GlcNS6S (1\u21924) IdoU2S (1\u21924) AMan-6S]) which lacked anti-coagulant activity.", {"entities": []}], ["These results demonstrate that heparin tetrasaccharide possesses potent anti-allergic and anti-inflammatory properties, and that the domains responsible for anti-allergic and anti-coagulant activity are distinctly different.", {"entities": []}], ["Multiple sclerosis (MS) is a disorder of the central nervous system (CNS) characterised by inflammation and neuronal degeneration.", {"entities": []}], ["It is believed to result from the complex interaction of a number of genes, each with modest effect.", {"entities": []}], ["Chemokines are vital to the migration of cells to sites of inflammation, including the CNS, and many are implicated in MS pathogenesis.", {"entities": []}], ["Most of the CC chemokine genes are encoded in a cluster on chromosome 17q11.2-12, which has been identified in a number of genome wide screens as being potentially associated with MS. We conducted a two-stage analysis to investigate the chemokine gene cluster for association with MS. After sequencing the chemokine genes in several DNA pools to identify common polymorphisms, 12 candidate single-nucleotide polymorphisms (SNPs) were genotyped in a cohort of Australian MS trio families.", {"entities": []}], ["Marginally significant (uncorrected) transmission distortion was identified for four of the SNPs after stratification for several factors.", {"entities": []}], ["We also identified marginally significant (uncorrected) transmission distortion for haplotypes encompassing the CCL2 and CCL11 genes, using two independent cohorts, which was consistent with recent reports from another group.", {"entities": [[112, 116, "GENE"], [121, 126, "GENE"]]}], ["Our results implicate several chemokines as possibly being associated with MS susceptibility, and given that chemokines and their receptors are suitable targets for therapeutic agents, further investigation is warranted in this region.", {"entities": []}], ["Injury outcome studies have tended to collect limited pre-injury characteristics, focus on a narrow range of injury types, predictors and outcomes, and be restricted to high threat to life injuries.", {"entities": []}], ["We sought to identify the role of pre-injury socio-demographic and health characteristics, injury and injury-related healthcare in determining short-term functional outcomes for a wide range of injuries.", {"entities": []}], ["Study participants (aged 18-64 years inclusive) were those in the Prospective Outcomes of Injury Study, a cohort of 2856 persons who were injured and registered with New Zealand's national no-fault injury insurance agency.", {"entities": []}], ["All information used in this paper was obtained directly from the participants, primarily by telephone interviews, approximately three months after their injury.", {"entities": []}], ["The functional outcomes of interest were the five dimensions of the EQ-5D plus a cognitive dimension.", {"entities": []}], ["We initially examined bivariate relationships between our independent measures and the dependent measures.", {"entities": []}], ["Our multivariate analyses included adjustment for pre-injury EQ-5D status and time between injury and when information was obtained from participants.", {"entities": []}], ["Substantial portions of participants continued to have adverse outcomes approximately three months after their injury.", {"entities": []}], ["Key pervasive factors predicting adverse outcomes were: being female, prior chronic illness, injuries to multiple body regions, being hospitalized for injury, self-perceived threat to life, and difficulty accessing health services.", {"entities": []}], ["Future injury outcome studies should include participants whose injuries are considered 'minor', as judged by acute health service utilization, and also consider a wider range of potential predictors of adverse outcomes.", {"entities": []}], ["Short chain fatty acids (SCFAs) produced by intestinal microbes mediate anti-inflammatory effects, but whether they impact on antimicrobial host defenses remains largely unknown.", {"entities": []}], ["This is of particular concern in light of the attractiveness of developing SCFA-mediated therapies and considering that SCFAs work as inhibitors of histone deacetylases which are known to interfere with host defenses.", {"entities": []}], ["Here we show that propionate, one of the main SCFAs, dampens the response of innate immune cells to microbial stimulation, inhibiting cytokine and NO production by mouse or human monocytes/macrophages, splenocytes, whole blood and, less efficiently, dendritic cells.", {"entities": []}], ["In proof of concept studies, propionate neither improved nor worsened morbidity and mortality parameters in models of endotoxemia and infections induced by gram-negative bacteria ( Escherichia coli, Klebsiella pneumoniae ), gram-positive bacteria ( Staphylococcus aureus, Streptococcus pneumoniae ) and Candida albicans .", {"entities": []}], ["Moreover, propionate did not impair the efficacy of passive immunization and natural immunization.", {"entities": []}], ["Therefore, propionate has no significant impact on host susceptibility to infections and the establishment of protective anti-bacterial responses.", {"entities": []}], ["These data support the safety of propionate-based therapies, either via direct supplementation or via the diet/microbiota, to treat non-infectious inflammation-related disorders, without increasing the risk of infection.", {"entities": []}], ["Patient organisations may be exposed to conflicts of interest and undue influence through pharmaceutical industry (Pharma) donations.", {"entities": []}], ["We examined advertising and disclosure of financial support by pharmaceutical companies on the websites of major patient organisations.", {"entities": []}], ["Sixty-nine national and international patient organisations covering 10 disease states were identified using a defined Google search strategy.", {"entities": []}], ["These were assessed for indicators of transparency, advertising, and disclosure of Pharma funding using an abstraction tool and inspection of annual reports.", {"entities": []}], ["Data were analysed by simple tally, with medians calculated for financial data.", {"entities": []}], ["Patient organisations websites were clear about their identity, target audience and intention but only a third were clear on how they derived their funds.", {"entities": []}], ["Only 4/69 websites stated advertising and conflict of interest policies.", {"entities": []}], ["Advertising was generally absent.", {"entities": []}], ["54% of sites included an annual report, but financial reporting and disclosure of donors varied substantially.", {"entities": []}], ["Corporate donations were itemised in only 7/37 reports and none gave enough information to show the proportion of funding from Pharma.", {"entities": []}], ["45% of organisations declared Pharma funding on their website but the annual reports named more Pharma donors than did the websites (median 6 vs. 1).", {"entities": []}], ["One third of websites showed one or more company logos and/or had links to Pharma websites.", {"entities": []}], ["Pharma companies' introductions were present on 10% of websites, some of them mentioning specific products.", {"entities": []}], ["Two patient organisations had obvious close ties to Pharma.", {"entities": []}], ["Patient organisation websites do not provide enough information for visitors to assess whether a conflict of interest with Pharma exists.", {"entities": []}], ["While advertising of products is generally absent, display of logos and corporate advertisements is relatively common.", {"entities": []}], ["Display of clear editorial and advertising policies and disclosure of the nature and degree of corporate donations is needed on patient organisations' websites.", {"entities": []}], ["An ethical code to guide patient organisations and their staff members on how to collaborate with Pharma is also necessary, if patient organisations are to remain independent and truly represent the interests and views of patients.", {"entities": []}], ["As many organizations rely on Pharma donations, self-regulation may not suffice and independent oversight bodies should take the lead in requiring this.", {"entities": []}], ["Despite the significant interest in \u03b2 2 -Adrenergic receptor (ADRB2) polymorphisms related to asthma, whether ADRB2 genetic variants are similarly associated with acute respiratory tract infections have not been studied.", {"entities": [[94, 100, "DISEASE"], [62, 67, "GENE"], [110, 115, "GENE"], [62, 67, "GENE"], [110, 115, "GENE"]]}], ["We hypothesized that genetic variants in ADRB2 associated with a response to asthma therapy during an asthma exacerbation were also associated with severity of acute respiratory tract infections.", {"entities": [[77, 83, "DISEASE"], [102, 108, "DISEASE"], [41, 46, "GENE"]]}], ["To test this hypothesis, we genotyped 5 common polymorphisms in the promoter region and coding block of the ADRB2 gene (loci -2387, -2274, -1343, +46, and +79) from 374 Caucasian and African American term infants who were enrolled at the time of acute respiratory illness over four respiratory viral seasons.", {"entities": [[108, 113, "GENE"]]}], ["Severity of respiratory tract infections was measured using a bronchiolitis severity score (BSS; range\u2009=\u20090-12, clinically significant difference\u2009=\u20090.5) with a higher score indicating more severe disease.", {"entities": [[62, 75, "DISEASE"]]}], ["We assigned the promoter, coding and combined promoter and coding haplotypes to the unphased genotype data.", {"entities": []}], ["The associations between each of these five single-nucleotide polymorphisms (SNPs) as well as the haplotypes and infant BSS were analyzed using nonparametric univariate analysis and multivariable proportional odds model separately in Caucasians and African Americans.", {"entities": []}], ["There was no significant association between infant BSS and each of the SNPs in both Caucasians and African Americans.", {"entities": []}], ["However, promoter haplotype CCA was associated with a decreased BSS in African Americans in a dose dependent manner.", {"entities": []}], ["The median (interquartile range) BSS of infants with no copies of the CCA haplotype, one copy, and two copies of the CCA haplotype were 5.5 (2.0, 8.0), 4.0 (1.0, 7.5), and 3.0 (1.0, 4.0), respectively.", {"entities": []}], ["This dose dependent relationship persisted after adjusting for infant age, gender, daycare exposure, secondhand smoke exposure, prior history of breastfeeding, siblings at home, and enrollment season (adjusted odds ratio: 0.59, 95\u00a0% confidence interval: 0.36, 0.98).", {"entities": []}], ["There was no similar protective relationship of haplotype CCA on severity of respiratory tract infections identified in Caucasians.", {"entities": []}], ["ADRB2 genotype may be predictive of severity of acute respiratory tract infections in African Americans, and potentially identify a subset of infants who may respond to beta-agonist therapy.", {"entities": [[0, 5, "GENE"]]}], ["The online version of this article (doi:10.1186/s12881-015-0229-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Estimation of functional connectivity in gene sets derived from genome-wide or other biological experiments is one of the essential tasks of bioinformatics.", {"entities": []}], ["A promising approach for solving this problem is to compare gene networks built using experimental gene sets with random networks.", {"entities": []}], ["One of the resources that make such an analysis possible is CrossTalkZ, which uses the FunCoup database.", {"entities": []}], ["However, existing methods, including CrossTalkZ, do not take into account individual types of interactions, such as protein/protein interactions, expression regulation, transport regulation, catalytic reactions, etc., but rather work with generalized types characterizing the existence of any connection between network members.", {"entities": []}], ["We developed the online tool FunGeneNet, which utilizes the ANDSystem and STRING to reconstruct gene networks using experimental gene sets and to estimate their difference from random networks.", {"entities": []}], ["To compare the reconstructed networks with random ones, the node permutation algorithm implemented in CrossTalkZ was taken as a basis.", {"entities": []}], ["To study the FunGeneNet applicability, the functional connectivity analysis of networks constructed for gene sets involved in the Gene Ontology biological processes was conducted.", {"entities": []}], ["We showed that the method sensitivity exceeds 0.8 at a specificity of 0.95.", {"entities": []}], ["We found that the significance level of the difference between gene networks of biological processes and random networks is determined by the type of connections considered between objects.", {"entities": []}], ["At the same time, the highest reliability is achieved for the generalized form of connections that takes into account all the individual types of connections.", {"entities": []}], ["By taking examples of the thyroid cancer networks and the apoptosis network, it is demonstrated that key participants in these processes are involved in the interactions of those types by which these networks differ from random ones.", {"entities": [[26, 40, "DISEASE"], [34, 40, "DISEASE"]]}], ["FunGeneNet is a web tool aimed at proving the functionality of networks in a wide range of sizes of experimental gene sets, both for different global networks and for different types of interactions.", {"entities": []}], ["Using examples of thyroid cancer and apoptosis networks, we have shown that the links over-represented in the analyzed network in comparison with the random ones make possible a biological interpretation of the original gene/protein sets.", {"entities": [[18, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["The FunGeneNet web tool for assessment of the functional enrichment of networks is available at http://www-bionet.sscc.ru/fungenenet/ .", {"entities": []}], ["The online version of this article (10.1186/s12864-018-4474-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Parkinson\u2019s disease (PD) is the most common cause of neurodegenerative movement disorder and the second most common cause of dementia.", {"entities": [[125, 133, "DISEASE"]]}], ["Genes are thought to have a stronger effect on age-at-onset of PD than on risk, yet there has been a phenomenal success in identifying risk loci but not age-at-onset modifiers.", {"entities": []}], ["We conducted a genome-wide study for age-at-onset.", {"entities": []}], ["We analysed familial and non-familial PD separately, per prior evidence for strong genetic effect on age-at-onset in familial PD.", {"entities": []}], ["GWAS was conducted in 431 unrelated PD individuals with at least one affected relative (familial PD) and 1544 non-familial PD from the NeuroGenetics Research Consortium (NGRC); an additional 737 familial PD and 2363 non-familial PD were used for replication.", {"entities": []}], ["In familial PD, two signals were detected and replicated robustly: one mapped to LHFPL2 on 5q14.1 (P NGRC\u2009 = \u2009 3E-8, P Replication\u2009 = \u2009 2E-5, P NGRC\u2009+\u2009Replication\u2009 = \u2009 1E-11), the second mapped to TPM1 on 15q22.2 (P NGRC\u2009 = \u2009 8E-9, P Replication\u2009 = \u2009 2E-4, P NGRC\u2009+\u2009Replication\u2009 = \u2009 9E-11).", {"entities": [[81, 87, "GENE"], [197, 201, "GENE"]]}], ["The variants that were associated with accelerated onset had low frequencies (<0.02).", {"entities": []}], ["The LHFPL2 variant was associated with earlier onset by 12.33 [95% CI: 6.2; 18.45] years in NGRC, 8.03 [2.95; 13.11] years in replication, and 9.79 [5.88; 13.70] years in the combined data.", {"entities": [[4, 10, "GENE"]]}], ["The TPM1 variant was associated with earlier onset by 15.30 [8.10; 22.49] years in NGRC, 9.29 [1.79; 16.79] years in replication, and 12.42 [7.23; 17.61] years in the combined data.", {"entities": [[4, 8, "GENE"]]}], ["Neither LHFPL2 nor TPM1 was associated with age-at-onset in non-familial PD.", {"entities": [[8, 14, "GENE"], [19, 23, "GENE"]]}], ["LHFPL2 (function unknown) is overexpressed in brain tumours.", {"entities": [[0, 6, "GENE"]]}], ["TPM1 encodes a highly conserved protein that regulates muscle contraction, and is a tumour-suppressor gene.", {"entities": [[0, 4, "GENE"]]}], ["The discovery of a bacterium, Helicobacter pylori , that is resident in the human stomach and causes chronic disease (peptic ulcer and gastric cancer) was radical on many levels.", {"entities": [[118, 130, "DISEASE"], [143, 149, "DISEASE"]]}], ["Whereas the mouth and the colon were both known to host a large number of microorganisms, collectively referred to as the microbiome, the stomach was thought to be a virtual Sahara desert for microbes because of its high acidity.", {"entities": []}], ["We now know that H. pylori is one of many species of bacteria that live in the stomach, although H. pylori seems to dominate this community.", {"entities": []}], ["H. pylori does not behave as a classical bacterial pathogen: disease is not solely mediated by production of toxins, although certain H. pylori genes, including those that encode exotoxins, increase the risk of disease development.", {"entities": []}], ["Instead, disease seems to result from a complex interaction between the bacterium, the host, and the environment.", {"entities": []}], ["Furthermore, H. pylori was the first bacterium observed to behave as a carcinogen.", {"entities": []}], ["The innate and adaptive immune defenses of the host, combined with factors in the environment of the stomach, apparently drive a continuously high rate of genomic variation in H. pylori .", {"entities": []}], ["Studies of this genetic diversity in strains isolated from various locations across the globe show that H. pylori has coevolved with humans throughout our history.", {"entities": []}], ["This long association has given rise not only to disease, but also to possible protective effects, particularly with respect to diseases of the esophagus.", {"entities": []}], ["Given this complex relationship with human health, eradication of H. pylori in nonsymptomatic individuals may not be the best course of action.", {"entities": []}], ["The story of H. pylori teaches us to look more deeply at our resident microbiome and the complexity of its interactions, both in this complex population and within our own tissues, to gain a better understanding of health and disease.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterised by irreversible airflow obstruction, neutrophilic airway inflammation and chronic bacterial colonisation, however the role of the innate immune response in the pathogenesis of COPD remains unclear.", {"entities": []}], ["Induced sputum was obtained from adults with COPD (n\u200a=\u200a22), and healthy controls (n\u200a=\u200a29) and was processed for differential cell counts.", {"entities": []}], ["The sputum supernatant was assayed for innate immune mediators using ELISA, whilst sputum gene expression was measured using real-time PCR.", {"entities": []}], ["Peripheral blood neutrophils were isolated and their response to lipopolysaccaride (LPS) stimulation was assessed in a subgroup of participants with COPD (n\u200a=\u200a13) and healthy controls (n\u200a=\u200a21).", {"entities": []}], ["Participants with COPD had significantly higher protein levels of interleukin (IL)-8, and neutrophil elastase (NE) and detection of oncostatin M (OSM) compared to healthy controls.", {"entities": [[146, 149, "GENE"]]}], ["Gene expression for toll-like receptor (TLR) 2, IL-8 and OSM were also significantly higher in COPD participants.", {"entities": [[57, 60, "GENE"]]}], ["The level of IL-1\u03b2, surfactant protein (SP)-A, matrix metalloproteinase (MMP)-9 and TLR4 mRNA was not significantly different between groups.", {"entities": [[84, 88, "GENE"]]}], ["The level of innate immune response markers were highly associated with the presence of sputum neutrophils, each other and the degree of airflow limitation (FEV 1 /FVC).", {"entities": [[157, 160, "GENE"]]}], ["Peripheral blood neutrophils from participants with COPD had an increased response to stimulation by LPS; with a greater fold increase in the production of IL-8 and MMP-9 protein, and gene expression of IL-8, TLR2 and TLR4.", {"entities": [[209, 213, "GENE"], [218, 222, "GENE"]]}], ["The innate immune response is increased in the airways and circulating neutrophils in COPD, and may be an important mechanism involved in disease pathogenesis.", {"entities": []}], ["The main purpose of the present work was studying the biodistribution of amikacin solid lipid nanoparticles (SLNs) after pulmonary delivery to increase its concentration in the lungs for treatment of cystic fibrosis lung infections and also providing a new method for clinical application of amikacin.", {"entities": [[200, 215, "DISEASE"]]}], ["To achieve this aim, in vitro optimization, the desired SLNs and free drug were administered through pulmonary and i.v.", {"entities": []}], ["routes to male rats and qualitative and biodistribution studies were done.", {"entities": []}], ["Results showed that pulmonary delivery of SLNs of amikacin by microsprayer caused higher drug concentration in lungs than kidneys while i.v.", {"entities": []}], ["administration of free drug caused reverse conditions.", {"entities": []}], ["It seems that pulmonary delivery of SLNs may improve patients' compliance due to reduction of drug side effects in kidneys and elongation of drug dosing intervals due to the sustained drug release from SLNs.", {"entities": []}], ["Although adult asthma is attributable to occupational factors, few reports are available on asthma prevalence among health care workers in Japan.", {"entities": [[15, 21, "DISEASE"], [92, 98, "DISEASE"]]}], ["The objective of this study was to estimate the prevalence of asthma and wheeze among Japanese nursing professionals.", {"entities": [[62, 68, "DISEASE"]]}], ["A cross-sectional study was conducted by postal survey using a translated version of the European Community Respiratory Health Survey questionnaire from April to June 2013.", {"entities": []}], ["The analysis included 4634 nursing professionals (257 men and 4377 women) and the overall response rate was 84.8%.", {"entities": []}], ["The prevalence of current asthma and wheeze were 10.7% (95% confidence interval (CI), 9.9%\u201311.7%) and 15.6% (95% CI, 14.5%\u201316.6%), respectively.", {"entities": [[26, 32, "DISEASE"]]}], ["More than one year of work experience as a nursing professional and more than one year of experience with bed-making tasks were associated with odds ratios (ORs) of 1.95 (95% CI, 1.12\u20133.39) and 1.64 (95% CI, 1.15\u20132.23) for wheeze, respectively.", {"entities": []}], ["Current smoking was significantly associated with the presence of wheeze, with ORs of 2.27 for men (95% CI, 1.11\u20134.64) and 2.01 for women (95% CI, 1.54\u20132.64).", {"entities": []}], ["Among female nurses, latex allergy was associated with wheeze (OR, 1.87; 95% CI, 1.56\u20132.23), as was body mass index \u226530 (OR, 2.76; 95% CI, 1.65\u20134.62).", {"entities": []}], ["This study has provided the prevalence of asthma and wheeze among Japanese nursing professionals.", {"entities": [[42, 48, "DISEASE"]]}], ["Employment period, bed-making tasks, latex allergy, obesity, and smoking may be risk factors for prevalent wheeze among nursing professionals.", {"entities": [[52, 59, "DISEASE"]]}], ["Pre-eclampsia or Eclampsia (PE or E) accounts for 25% of cases of maternal mortality worldwide.", {"entities": [[4, 13, "DISEASE"], [17, 26, "DISEASE"]]}], ["There is some evidence of a link to dietary factors, but few studies have explored this association in developing countries, where the majority of the burden falls.", {"entities": []}], ["We examined the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E in Indian women.", {"entities": []}], ["Cross-sectional data from India\u2019s third National Family Health Survey (NFHS-3, 2005-06) was used for this study.", {"entities": []}], ["Self-reported symptoms suggestive of PE or E during pregnancy were obtained from 39,657 women aged 15-49 years who had had a live birth in the five years preceding the survey.", {"entities": []}], ["Multivariable logistic regression analysis was used to estimate the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E after adjusting for maternal, health and lifestyle factors, and socio-demographic characteristics of the mother.", {"entities": []}], ["In their most recent pregnancy, 1.2% (n=456) of the study sample experienced symptoms suggestive of PE or E. Mothers who consumed an adequately diversified diet were 34% less likely (OR: 0.66; 95% CI: 0.51-0.87) to report PE or E symptoms than mothers with inadequately diversified dietary intake.", {"entities": []}], ["The likelihood of reporting PE or E symptoms was also 36% lower (OR: 0.64; 95% CI: 0.47-0.88) among those mothers who consumed iron and folic acid supplementation for at least 90 days during their last pregnancy.", {"entities": []}], ["As a sensitivity analysis, we stratified our models sequentially by education, wealth, antenatal care visits, birth interval, and parity.", {"entities": []}], ["Our results remained largely unchanged: both adequately diversified dietary intake and iron and folic acid supplementation during pregnancy were associated with a reduced occurrence of PE or E symptoms.", {"entities": []}], ["Having a adequately diversified dietary intake and iron and folic acid supplementation in pregnancy was associated with a reduced occurrence of symptoms suggestive of PE or E in Indian women.", {"entities": []}], ["Vaccinating school-aged children against influenza can reduce age-specific and population-level illness attack rates.", {"entities": [[41, 50, "DISEASE"]]}], ["Using a stochastic simulation model of influenza transmission, the authors assessed strategies for vaccinating children in the United States, varying the vaccine type, coverage level, and reproductive number R (average number of secondary cases produced by a typical primary case).", {"entities": [[39, 48, "DISEASE"]]}], ["Results indicated that vaccinating children can substantially reduce population-level illness attack rates over a wide range of scenarios.", {"entities": []}], ["The greatest absolute reduction in influenza illness cases per season occurred at R values ranging from 1.2 to 1.6 for a given vaccine coverage level.", {"entities": [[35, 44, "DISEASE"]]}], ["The indirect, total, and overall effects of vaccinating children were strong when transmission intensity was low to intermediate.", {"entities": []}], ["The indirect effects declined rapidly as transmission intensity increased.", {"entities": []}], ["In a mild influenza season ( R = 1.1), approximately 19 million influenza cases could be prevented by vaccinating 70% of children.", {"entities": [[10, 19, "DISEASE"], [64, 73, "DISEASE"]]}], ["At most, nearly 100 million cases of influenza illness could be prevented, depending on the proportion of children vaccinated and the transmission intensity.", {"entities": [[37, 46, "DISEASE"]]}], ["Given the current worldwide threat of novel influenza A (H1N1), with an estimated R of 1.4\u20131.6, health officials should consider strategies for vaccinating children against novel influenza A (H1N1) as well as seasonal influenza.", {"entities": [[44, 53, "DISEASE"], [179, 188, "DISEASE"], [218, 227, "DISEASE"]]}], ["Toxocariasis is a zoonotic disease that poses a threat to public health worldwide.", {"entities": []}], ["This disease primarily affects children and is caused by the presence in the digestive tract of a common roundworm of dogs, Toxocara canis , or cats, Toxocara cati.", {"entities": []}], ["Toxocara is responsible for the presentation of various syndromes in humans depending on the affected organs.", {"entities": []}], ["In this study, the prevalence of anti- T. canis antibodies was investigated in children aged 3\u201316 years from semirural populations in the municipalities of Amecameca and Chalco in M\u00e9xico.", {"entities": []}], ["An ELISA was used to determine the presence of anti- T. canis antibodies in blood samples.", {"entities": []}], ["Of the 183 sera obtained for this study, 22 were positive for anti- T. canis antibodies (12.02\u00a0%).", {"entities": []}], ["Of these, 6.50\u00a0% were from males and 5.4\u00a0% were from females.", {"entities": []}], ["Risk factors were investigated and it was found that living near a cattle operation had a statistically significant association with (Chi p \u2009=\u20090.01) and was a risk factor for (OR\u2009=\u20094.25, p \u2009=\u20090.02) seropositivity to T. canis .", {"entities": []}], ["Keeping dogs with short hair (Chi p \u2009=\u20090.07) showed a tendency toward seropositivity for T. canis , as did the habit of sleeping with pets (Chi p \u2009=\u20090.06).", {"entities": []}], ["Seropositivity to T. canis was confirmed in children in the Amecameca and Chalco regions of M\u00e9xico and the risk factors were identified.", {"entities": []}], ["These findings provide important insight into the prevalence and spread of this zoonotic parasite.", {"entities": []}], ["Chitinase hydrolyzes chitin, which is an N -acetyl-D-glucosamine polymer that is present in a wide range of organisms, including insects, parasites and fungi.", {"entities": []}], ["Although mammals do not contain any endogenous chitin, humans and mice express two active chitinases, chitotriosidase (Chit1) and acidic mammalian chitinase (AMCase).", {"entities": [[119, 124, "GENE"]]}], ["Because the level of expression of these chitinases is increased in many inflammatory conditions, including Gaucher disease and mouse models of asthma, both chitinases may play important roles in the pathophysiologies of these and other diseases.", {"entities": [[144, 150, "DISEASE"]]}], ["We recently established a quantitative PCR system using a single standard DNA and showed that AMCase mRNA is synthesized at extraordinarily high levels in mouse stomach tissues.", {"entities": []}], ["In this study, we applied this methodology to the quantification of chitinase mRNAs in human tissues and found that both chitinase mRNAs were widely expressed in normal human tissues.", {"entities": []}], ["Chit1 mRNA was highly expressed in the human lung, whereas AMCase mRNA was not overexpressed in normal human stomach tissues.", {"entities": [[0, 5, "GENE"]]}], ["The levels of these mRNAs in human tissues were significantly lower than the levels of housekeeping genes.", {"entities": []}], ["Because the AMCase expression levels were quite different between the human and mouse stomach tissues, we developed a quantitative PCR system to compare the mRNA levels between human and mouse tissues using a human-mouse hybrid standard DNA.", {"entities": []}], ["Our analysis showed that Chit1 mRNA is expressed at similar levels in normal human and mouse lung.", {"entities": [[25, 30, "GENE"]]}], ["In contrast, the AMCase expression level in human stomach was significantly lower than that expression level observed in mouse stomach.", {"entities": []}], ["These mRNA differences between human and mouse stomach tissues were reflecting differences in the chitinolytic activities and levels of protein expression.", {"entities": []}], ["Thus, the expression level of the AMCase in the stomach is species-specific.", {"entities": []}], ["Self-management interventions (SMIs) are recommended for individuals with COPD to help monitor symptoms and optimize health-related quality of life (HRQOL).", {"entities": []}], ["However, SMIs vary widely in content, delivery, and intensity, making it unclear which methods and techniques are associated with improved outcomes.", {"entities": []}], ["This systematic review aimed to summarize the current evidence base surrounding the effectiveness of SMIs for improving HRQOL in people with COPD.", {"entities": []}], ["Systematic reviews that focused upon SMIs were eligible for inclusion.", {"entities": []}], ["Intervention descriptions were coded for behavior change techniques (BCTs) that targeted self-management behaviors to address 1) symptoms, 2) physical activity, and 3) mental health.", {"entities": []}], ["Meta-analyses and meta-regression were used to explore the association between health behaviors targeted by SMIs, the BCTs used, patient illness severity, and modes of delivery, with the impact on HRQOL and emergency department (ED) visits.", {"entities": []}], ["Data related to SMI content were extracted from 26 randomized controlled trials identified from 11 systematic reviews.", {"entities": []}], ["Patients receiving SMIs reported improved HRQOL (standardized mean difference =\u22120.16; 95% confidence interval [CI] =\u22120.25, \u22120.07; P =0.001) and made fewer ED visits (standardized mean difference =\u22120.13; 95% CI =\u22120.23, \u22120.03; P =0.02) compared to patients who received usual care.", {"entities": []}], ["Patients receiving SMIs targeting mental health alongside symptom management had greater improvement of HRQOL (Q=4.37; P =0.04) and fewer ED visits (Q=5.95; P =0.02) than patients receiving SMIs focused on symptom management alone.", {"entities": []}], ["Within-group analyses showed that HRQOL was significantly improved in 1) studies with COPD patients with severe symptoms, 2) single-practitioner based SMIs but not SMIs delivered by a multidisciplinary team, 3) SMIs with multiple sessions but not single session SMIs, and 4) both individual- and group-based SMIs.", {"entities": []}], ["SMIs can be effective at improving HRQOL and reducing ED visits, with those targeting mental health being significantly more effective than those targeting symptom management alone.", {"entities": []}], ["There is limited capacity to assess the comparative risks of medications after they enter the market.", {"entities": []}], ["For rare adverse events, the pooling of data from multiple sources is necessary to have the power and sufficient population heterogeneity to detect differences in safety and effectiveness in genetic, ethnic and clinically defined subpopulations.", {"entities": []}], ["However, combining datasets from different data custodians or jurisdictions to perform an analysis on the pooled data creates significant privacy concerns that would need to be addressed.", {"entities": []}], ["Existing protocols for addressing these concerns can result in reduced analysis accuracy and can allow sensitive information to leak.", {"entities": []}], ["To develop a secure distributed multi-party computation protocol for logistic regression that provides strong privacy guarantees.", {"entities": []}], ["We developed a secure distributed logistic regression protocol using a single analysis center with multiple sites providing data.", {"entities": []}], ["A theoretical security analysis demonstrates that the protocol is robust to plausible collusion attacks and does not allow the parties to gain new information from the data that are exchanged among them.", {"entities": []}], ["The computational performance and accuracy of the protocol were evaluated on simulated datasets.", {"entities": []}], ["The computational performance scales linearly as the dataset sizes increase.", {"entities": []}], ["The addition of sites results in an exponential growth in computation time.", {"entities": []}], ["However, for up to five sites, the time is still short and would not affect practical applications.", {"entities": []}], ["The model parameters are the same as the results on pooled raw data analyzed in SAS, demonstrating high model accuracy.", {"entities": []}], ["The proposed protocol and prototype system would allow the development of logistic regression models in a secure manner without requiring the sharing of personal health information.", {"entities": []}], ["This can alleviate one of the key barriers to the establishment of large-scale post-marketing surveillance programs.", {"entities": []}], ["We extended the secure protocol to account for correlations among patients within sites through generalized estimating equations, and to accommodate other link functions by extending it to generalized linear models.", {"entities": []}], ["The initial immune response to Schistosoma mansoni eggs presumably results in IL-4 production, as schistosome eggs are strong Th2-inducing antigens and the differentiation of antigen-specific Th2 cells is largely dependent on the presence of IL-4 during priming of naive Th cells.", {"entities": []}], ["Consistent with this concept, intraperitoneal injection of mice with schistosome eggs results in an upregulation of IL-4 production by peritoneal exudate cells (PECs) within 12 h. Egg-induced IL-4 is rapidly bound by its receptor, suggesting that this cytokine is utilized by a cell type present at the site of antigen deposition or is complexed to soluble receptor.", {"entities": []}], ["The peak of early IL-4 production is accompanied by a local eosinophilia and the apparent disappearance of mast cells.", {"entities": [[60, 72, "DISEASE"]]}], ["Studies utilizing either IL-4, IL-5, or mast cell-deficient mice indicate that the eosinophilia is dependent on mast cells and IL-5 and independent of IL-4.", {"entities": [[83, 95, "DISEASE"]]}], ["Strikingly, egg-induced IL-4 production is absent in animals lacking the early peritoneal eosinophilia.", {"entities": [[90, 102, "DISEASE"]]}], ["Immunocytochemical analysis of PEC following egg injection indicates that the eosinophils themselves make IL-4.", {"entities": []}], ["These data strongly suggest that egg-induced IL-5 plays an essential role in recruiting eosinophils to the site of antigen deposition and that it is these eosinophils that then directly produce early IL-4.", {"entities": []}], ["The difference in efficacy of long-acting muscarinic antagonists (LAMAs) and long-acting \u03b2 2 -agonists (LABAs) for dynamic lung hyperinflation (DLH) in COPD is unclear.", {"entities": []}], ["The purpose of this study was to elucidate the difference in efficacy of LAMA and LABA alone and the combination thereof for DLH.", {"entities": []}], ["Thirty stable patients were enrolled and randomly divided into two groups following baseline measurements.", {"entities": []}], ["One group was treated with 5 \u03bcg tiotropium (Respimat inhaler) for 4 weeks following a 4-week treatment with 150 \u03bcg indacaterol, while the other group was treated with indacaterol for 4 weeks following a 4-week treatment with tiotropium.", {"entities": []}], ["For both groups, these treatments were followed by a combination of the two drugs for 4 weeks.", {"entities": []}], ["Pulmonary function tests, including DLH evaluated by metronome-paced incremental hyperventilation and exercise tolerance evaluated by the shuttle-walk test, were performed at the end of each treatment period.", {"entities": []}], ["In total, 23 patients completed this study.", {"entities": []}], ["Both tiotropium and indacaterol alone significantly increased forced expiratory volume in 1 second, exercise tolerance, and improved health status.", {"entities": []}], ["Tiotropium significantly improved DLH, but indacaterol did not.", {"entities": []}], ["The combination therapy resulted in further improvements in lung function and exercise tolerance, but not in DLH.", {"entities": []}], ["The efficacy of tiotropium in inhibiting DLH following metronome-paced incremental hyperventilation may be superior to that of 150 \u03bcg indacaterol, although the effects on airflow obstruction were the same, and the combination therapy showed further improvement in airflow obstruction, but not in DLH.", {"entities": []}], ["We conducted a placebo-controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.", {"entities": [[92, 100, "DISEASE"], [67, 91, "DISEASE"], [67, 80, "DISEASE"]]}], ["We compared azithromycin (250\u2005mg alternate days, 12\u2005weeks) with placebo.", {"entities": []}], ["Primary outcome was FEV 1 change at 12\u2005weeks.", {"entities": [[20, 23, "GENE"]]}], ["48 patients were randomised; (25 azithromycin, 23 placebo).", {"entities": []}], ["It was established, post randomisation that two did not have BOS.", {"entities": []}], ["46 patients were analysed as intention to treat (ITT) with 33 \u2018Completers\u2019.", {"entities": []}], ["ITT analysis included placebo patients treated with open-label azithromycin after study withdrawal.", {"entities": []}], ["The ITT analysis (n=46, 177 observations) estimated mean difference in FEV 1 between treatments (azithromycin minus placebo) was 0.035\u2005L, with a 95% CI of \u22120.112\u2005L to 0.182\u2005L (p=0.6).", {"entities": [[71, 74, "GENE"]]}], ["Five withdrawals, who were identified at the end of the study as having been randomised to placebo (four with rapid loss in FEV 1 , one withdrawn consent) had received rescue open-label azithromycin, with improvement in subsequent FEV 1 at 12\u2005weeks.", {"entities": [[124, 127, "GENE"], [231, 234, "GENE"], [124, 127, "GENE"], [231, 234, "GENE"]]}], ["Study Completers showed an estimated mean difference in FEV 1 between treatment groups (azithromycin minus placebo) of 0.278\u2005L, with 95% CI for the mean difference: 0.170\u2005L to 0.386\u2005L (p=<0.001).", {"entities": [[56, 59, "GENE"]]}], ["Nine of 23 ITT patients in the azithromycin group had \u226510% gain in FEV 1 from baseline.", {"entities": [[67, 70, "GENE"]]}], ["No patients in the placebo group had \u226510% gain in FEV 1 from baseline while on placebo (p=0.002).", {"entities": [[50, 53, "GENE"]]}], ["Seven serious adverse events, three azithromycin, four in the placebo group, were deemed unrelated to study medication.", {"entities": []}], ["Azithromycin therapy improves FEV 1 in patients with BOS and appears superior to placebo.", {"entities": [[30, 33, "GENE"]]}], ["This study strengthens evidence for clinical practice of initiating azithromycin therapy in BOS.", {"entities": []}], ["EU-CTR, 2006-000485-36/GB.", {"entities": []}], ["Polymorphisms of CHI3L1 are associated with inter-individual YKL-40 levels and YKL-40 is associated with an increased mortality and is elevated in patients with cardiovascular disease.", {"entities": [[17, 23, "GENE"]]}], ["We investigated the association between single nucleotide polymorphisms (SNPs) of CHI3L1 , serum YKL-40 levels and all-cause and cardiovascular mortality and first-time incidence of myocardial infarction, ischemic heart disease (IHD) and stroke.", {"entities": [[205, 227, "DISEASE"], [214, 227, "DISEASE"], [182, 203, "DISEASE"], [82, 88, "GENE"]]}], ["12 SNPs of CHI3L1 were genotyped and serum YKL-40 was measured in 2656 Danes representative of the general population.", {"entities": [[11, 17, "GENE"]]}], ["Median follow-up period was 15 (0\u201316) years.", {"entities": []}], ["Admission data and deaths were ascertained from registers from the Danish National Board of Health.", {"entities": []}], ["Fourth quartile YKL-40 levels were associated with an increased mortality risk of ischemic stroke (HR 2.44 (1.01\u20135.88), p\u200a=\u200a0.041) and so were homozygotes of the minor allele of rs872129 (HR 9.35 (1.25\u201369.87, p\u200a=\u200a0.022)).", {"entities": [[99, 101, "GENE"], [188, 190, "GENE"], [99, 101, "GENE"], [188, 190, "GENE"]]}], ["Both continuous YKL-40 levels and 4 High YKL-40 levels (>85 ng/ml) and rs872129 were associated with an increased mortality risk of ischemic stroke, but high YKL-40 levels were also inverse related with the risk of incidence of IHD.", {"entities": []}], ["This could be a chance finding but could also elucidate that YKL-40 plays different roles in development of thromboembolisms versus the formation of local thrombosis.", {"entities": []}], ["Inflammatory response is considered the most important period that regulates the entire healing process.", {"entities": []}], ["Conjugated linoleic acid (CLA), a class of linoleic acid positional and geometric isomers, is well known for its antioxidant and anti-inflammatory properties.", {"entities": []}], ["We hypothesized that dietary CLA supplementation accelerates cutaneous wound healing by regulating antioxidant and anti-inflammatory functions.", {"entities": []}], ["To investigate wound closure rates and inflammatory responses, we used a full-thickness excisional wound model after 2-week treatments with control, 0.5%, or 1% CLA-supplemented diet.", {"entities": []}], ["Mice fed dietary CLA supplementation had reduced levels of oxidative stress and inflammatory markers.", {"entities": []}], ["Moreover, the wound closure rate was improved significantly in mice fed a 1% CLA-supplemented diet during early stage of wound healing (inflammatory stage).", {"entities": []}], ["We conclude that dietary CLA supplementation enhances the early stage of cutaneous wound healing as a result of modulating oxidative stress and inflammatory responses.", {"entities": []}], ["The efficacy of topical ophthalmic corticosteroids depends upon small modifications in preparations, such as drug concentration.", {"entities": []}], ["The aim of this study was to confirm that hydrocortisone acetate (HC-ac) ophthalmic ointments of 2.5% and 1% are more effective than a 0.5% eye ointment.", {"entities": []}], ["In this randomized, double-blind, placebo-controlled, parallel-group clinical study, the change of signs and symptoms of acute inflammation of the ocular surface and adnexa was evaluated in 411 subjects.", {"entities": []}], ["Median time to clinically relevant response as estimated by 50% reduction in clinical signs and symptoms (CSS) total score over the entire trial was similar for subjects treated with HC-ac 2.5% (73.5\u00a0h) and for subjects treated with HC-ac 1.0% (67.7\u00a0h) and was considerably and significantly longer for subjects treated with HC-ac 0.5% (111.8\u00a0h) [p\u2009<\u20090.001 for both dosages].", {"entities": []}], ["All trial medications were safe and well tolerated.", {"entities": []}], ["Hydrocortisone acetate 2.5% and Hydrocortisone acetate 1% eye ointments are efficacious and safe treatments for acute inflammations of the ocular surface or adnexa, and showed significantly better efficacy than a control group treated with Hydrocortisone acetate 0.5% therapy.", {"entities": []}], ["Current Controlled Trials ISRCTN15464650 .", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["We investigated the incidence of ischemic heart disease (IHD) in relation to accumulated exposure to particulate matter (PM) in a cohort of aluminum workers.", {"entities": [[33, 55, "DISEASE"], [42, 55, "DISEASE"]]}], ["We adjusted for time varying confounding characteristic of the healthy worker survivor effect, using a recently introduced method for the estimation of causal target parameters.", {"entities": []}], ["Applying longitudinal targeted minimum loss-based estimation, we estimated the difference in marginal cumulative risk of IHD in the cohort comparing counterfactual outcomes if always exposed above to always exposed below a PM 2.5 exposure cut-off.", {"entities": []}], ["Analyses were stratified by sub-cohort employed in either smelters or fabrication facilities.", {"entities": []}], ["We selected two exposure cut-offs a priori, at the median and 10th percentile in each sub-cohort.", {"entities": []}], ["In smelters, the estimated IHD risk difference after 15 years of accumulating PM 2.5 exposure during follow-up was 2.9% (0.6%, 5.1%) using the 10th percentile cut-off of 0.10 mg/m The accumulation of exposure to PM 2.5 appears to result in higher risks of IHD in both aluminum smelter and fabrication workers.", {"entities": []}], ["This represents the first longitudinal application of targeted minimum loss-based estimation, a method for generating doubly robust semi-parametric efficient substitution estimators of causal parameters, in the fields of occupational and environmental epidemiology.", {"entities": []}], ["To date, more than 125 species of nontuberculous mycobacteria (NTM) have been identified.", {"entities": [[63, 66, "GENE"]]}], ["In this study, we investigated the frequency and clinical implication of the rarely isolated NTM from respiratory specimens.", {"entities": [[93, 96, "GENE"]]}], ["Patients with NTM isolated from their respiratory specimens between July 1, 2010 and June 31, 2012 were screened for inclusion.", {"entities": [[14, 17, "GENE"]]}], ["Rare NTM were defined as those NTM not falling within the group of eight NTM species commonly identified at our institution: Mycobacterium avium , M. intracellulare , M. abscessus , M. massiliense , M. fortuitum , M. kansasii , M. gordonae , and M. peregrinum .", {"entities": [[5, 8, "GENE"], [31, 34, "GENE"], [73, 76, "GENE"], [5, 8, "GENE"], [31, 34, "GENE"], [73, 76, "GENE"], [5, 8, "GENE"], [31, 34, "GENE"], [73, 76, "GENE"]]}], ["Clinical, radiographic and microbiological data from patients with rare NTM were reviewed and analyzed.", {"entities": [[72, 75, "GENE"]]}], ["During the study period, 73 rare NTM were isolated from the respiratory specimens of 68 patients.", {"entities": [[33, 36, "GENE"]]}], ["Among these, M. conceptionense was the most common (nine patients, 12.3%).", {"entities": []}], ["The median age of the 68 patients with rare NTM was 68\u00a0years, while 39 of the patients were male.", {"entities": [[44, 47, "GENE"]]}], ["Rare NTM were isolated only once in majority of patient (64 patients, 94.1%).", {"entities": [[5, 8, "GENE"]]}], ["Among the four patients from whom rare NTM were isolated two or more times, only two showed radiographic aggravation caused by rare NTM during the follow-up period.", {"entities": [[39, 42, "GENE"], [132, 135, "GENE"], [39, 42, "GENE"], [132, 135, "GENE"]]}], ["Most of the rarely identified NTM species were isolated from respiratory specimens only once per patient, without concomitant clinical aggravation.", {"entities": [[30, 33, "GENE"]]}], ["Clinicians could therefore observe such patients closely without invasive work-ups or treatment, provided the patients do not have decreased host immunity towards mycobacteria.", {"entities": []}], ["In order to satisfy different needs, medical terminology systems must have richer structures.", {"entities": []}], ["This study examines whether a Swedish primary health care version of the mono-hierarchical ICD-10 (KSH97-P) may obtain a richer structure using category and chapter mappings from KSH97-P to SNOMED CT and SNOMED CT's structure.", {"entities": []}], ["Manually-built mappings from KSH97-P's categories and chapters to SNOMED CT's concepts are used as a starting point.", {"entities": []}], ["The mappings are manually evaluated using computer-produced information and a small number of mappings are updated.", {"entities": []}], ["A new and poly-hierarchical chapter division of KSH97-P's categories has been created using the category and chapter mappings and SNOMED CT's generic structure.", {"entities": []}], ["In the new chapter division, most categories are included in their original chapters.", {"entities": []}], ["A considerable number of concepts are included in other chapters than their original chapters.", {"entities": []}], ["Most of these inclusions can be explained by ICD-10's design.", {"entities": []}], ["KSH97-P's categories are also extended with attributes using the category mappings and SNOMED CT's defining attribute relationships.", {"entities": []}], ["About three-fourths of all concepts receive an attribute of type Finding site and about half of all concepts receive an attribute of type Associated morphology .", {"entities": []}], ["Other types of attributes are less common.", {"entities": []}], ["It is possible to use mappings from KSH97-P to SNOMED CT and SNOMED CT's structure to enrich KSH97-P's mono-hierarchical structure with a poly-hierarchical chapter division and attributes of type Finding site and Associated morphology .", {"entities": []}], ["The final mappings are available as additional files for this paper.", {"entities": []}], ["Diuretics are recommended as initial treatment for hypertension.", {"entities": [[51, 63, "DISEASE"]]}], ["Several studies have suggested suboptimal persistence and adherence to thiazide diuretic monotherapy; this study compared patient persistence and adherence with hydrochlorothiazide (HCTZ) monotherapy to fixed-dose combinations containing HCTZ.", {"entities": []}], ["Patients with at least one prescription claim during 2001 to 2003 for either HCTZ or one of the following fixed-dose combinations: angiotensin-receptor blockers/HCTZ (ARB/HCTZ), angiotensin-converting enzyme inhibitor/HCTZ (ACEI/HCTZ), or beta blockers/HCTZ (BB/HCTZ) were identified.", {"entities": []}], ["Patients were required to be continuously benefit-eligible six months pre- and one year post-index date, and to have no prescription claims for any antihypertensive therapy six months prior to the index date.", {"entities": []}], ["Patients were followed for one year to assess persistence, medication possession ratio (MPR), adherence (MPR >80%), and proportion of days covered (PDC) with initial antihypertensive therapy.", {"entities": [[148, 151, "GENE"]]}], ["Logistic regression was used to calculate adjusted odds ratios for persistence, adherence and PDC, adjusted for age, gender, business segment, RxRisk disease categories, average co-pay and concurrent cardiovascular-related medication utilization.", {"entities": [[94, 97, "GENE"]]}], ["The study cohort consisted of 48,212 patients; 72.5% used HCTZ, 13.2% ACEI/HCTZ, 9.3% ARB/HCTZ, and 5.0% BB/HCTZ.", {"entities": []}], ["Mean age was 53.7 years and 66.5% were female.", {"entities": []}], ["A significantly lower proportion of patients using HCTZ (29.9%) remained persistent with therapy at 12 months compared with ARB/HCTZ (52.6%; OR = 0.37, CI = 0.36, 0.38), ACEI/HCTZ (51.4%; OR = 0.38, CI = 0.37, 0.39), and BB/HCTZ (51.9%; OR = 0.38, 0.37, 0.40).", {"entities": []}], ["Similarly, PDC was lower for HCTZ patients (32.5%) as compared to ARB/HCTZ (53.7%; OR = 0.39, CI = 0.37, 0.40), ACEI/HCTZ (50.9%; OR = 0.42, CI = 0.40, 0.43), and BB/HCTZ (51.3%; OR = 0.44, CI 0.42, 0.45).", {"entities": [[11, 14, "GENE"]]}], ["MPR was also significantly lower for HCTZ patients as compared to those using fixed-dose combination therapies.", {"entities": []}], ["Initiating HCTZ fixed-dose combination therapy with an ACEI, ARB, or BB was associated with greater persistence and adherence as compared to HCTZ monotherapy.", {"entities": []}], ["Further research is needed to determine the relationship between improved persistence and adherence with blood pressure control.", {"entities": []}], ["Asthma represents one of the most common chronic conditions encountered in primary care and diagnosis should be confirmed objectively with the demonstration of variable airflow obstruction.", {"entities": [[0, 6, "DISEASE"]]}], ["As many asthmatics have normal lung function at the time of clinical presentation, objective confirmation of airflow limitation may be challenging.", {"entities": []}], ["Fluctuations in airflow obstruction can be documented with simple office spirometry after bronchodilator challenge, home monitoring of peak expiratory flow and bronchoconstriction induced by spasmogens such as methacholine.", {"entities": []}], ["We present a case highlighting the challenge of objective confirmation of asthma diagnosis in primary care and provide a critical review of the diagnostic approaches highlighted above.", {"entities": [[74, 80, "DISEASE"]]}], ["Our aim is to provide a pragmatic interpretation of the available literature with a view to assisting clinicians in selecting the diagnostic test best suited for individualised patient encounters.", {"entities": []}], ["The etiology of disease pathogenesis can be largely explained by genetic variations and several types of environmental factors.", {"entities": []}], ["In genetically disease-susceptible individuals, subsequent environmental triggers may induce disease development.", {"entities": []}], ["The human body is colonized by complex commensal microbes that have co-evolved with the host immune system.", {"entities": []}], ["With the adaptation to modern lifestyles, its composition has changed depending on host genetics, changes in diet, overuse of antibiotics against infection and elimination of natural enemies through the strengthening of sanitation.", {"entities": []}], ["In particular, commensal microbiota is necessary in the development, induction and function of T cells to maintain host immune homeostasis.", {"entities": []}], ["Alterations in the compositional diversity and abundance levels of microbiota, known as dysbiosis, can trigger several types of autoimmune and inflammatory diseases through the imbalance of T-cell subpopulations, such as Th1, Th2, Th17 and Treg cells.", {"entities": []}], ["Recently, emerging evidence has identified that dysbiosis is involved in the progression of rheumatoid arthritis, type 1 and 2 diabetic mellitus, and asthma, together with dysregulated T-cell subpopulations.", {"entities": [[92, 112, "DISEASE"], [103, 112, "DISEASE"], [150, 156, "DISEASE"]]}], ["In this review, we will focus on understanding the complicated microbiota-T-cell axis between homeostatic and pathogenic conditions and elucidate important insights for the development of novel targets for disease therapy.", {"entities": []}], ["Exhaled breath volatile organic compound (VOC) analysis for airway disease monitoring is promising.", {"entities": []}], ["However, contrary to nitric oxide the method for exhaled breath collection has not yet been standardized and the effects of expiratory flow and breath-hold have not been sufficiently studied.", {"entities": []}], ["These manoeuvres may also reveal the origin of exhaled compounds.", {"entities": []}], ["15 healthy volunteers (34\u2009\u00b1\u20097\u00a0years) participated in the study.", {"entities": []}], ["Subjects inhaled through their nose and exhaled immediately at two different flows (5\u00a0L/min and 10\u00a0L/min) into methylated polyethylene bags.", {"entities": []}], ["In addition, the effect of a 20\u00a0s breath-hold following inhalation to total lung capacity was studied.", {"entities": []}], ["The samples were analyzed for ethanol and acetone levels immediately using proton-transfer-reaction mass-spectrometer (PTR-MS, Logan Research, UK).", {"entities": []}], ["Ethanol levels were negatively affected by expiratory flow rate (232.70\u2009\u00b1\u200933.50\u00a0ppb vs. 202.30\u2009\u00b1\u200927.28\u00a0ppb at 5\u00a0L/min and 10\u00a0L/min, respectively, p\u2009<\u20090.05), but remained unchanged following the breath hold (242.50\u2009\u00b1\u200934.53 vs. 237.90\u2009\u00b1\u200935.86\u00a0ppb, without and with breath hold, respectively, p\u2009=\u20090.11).", {"entities": []}], ["On the contrary, acetone levels were increased following breath hold (1.50\u2009\u00b1\u20090.18\u00a0ppm) compared to the baseline levels (1.38\u2009\u00b1\u20090.15\u00a0ppm), but were not affected by expiratory flow (1.40\u2009\u00b1\u20090.14\u00a0ppm vs. 1.49\u2009\u00b1\u20090.14\u00a0ppm, 5\u00a0L/min vs. 10\u00a0L/min, respectively, p\u2009=\u20090.14).", {"entities": []}], ["The diet had no significant effects on the gasses levels which showed good inter and intra session reproducibility.", {"entities": []}], ["Exhalation parameters such as expiratory flow and breath-hold may affect VOC levels significantly; therefore standardisation of exhaled VOC measurements is mandatory.", {"entities": []}], ["Our preliminary results suggest a different origin in the respiratory tract for these two gasses.", {"entities": []}], ["Heart failure (HF) is frequently the consequence of sustained, abnormal neurohormonal, and mechanical stress and remains a leading cause of death worldwide.", {"entities": []}], ["The key pathophysiological process leading to HF is cardiac remodeling, a term referring to maladaptation to cardiac stress at the molecular, cellular, tissue, and organ levels.", {"entities": []}], ["HF and many of the conditions that predispose one to HF are associated with oxidative stress.", {"entities": []}], ["Increased generation of reactive oxygen species (ROS) in the heart can directly lead to increased necrosis and apoptosis of cardiomyocytes which subsequently induce cardiac remodeling and dysfunction.", {"entities": []}], ["Nuclear factor-erythroid-2- (NF-E2-) related factor 2 (Nrf2) is a transcription factor that controls the basal and inducible expression of a battery of antioxidant genes and other cytoprotective phase II detoxifying enzymes that are ubiquitously expressed in the cardiovascular system.", {"entities": []}], ["Emerging evidence has revealed that Nrf2 and its target genes are critical regulators of cardiovascular homeostasis via the suppression of oxidative stress, which is the key player in the development and progression of HF.", {"entities": []}], ["The purpose of this review is to summarize evidence that activation of Nrf2 enhances endogenous antioxidant defenses and counteracts oxidative stress-associated cardiac remodeling and HF.", {"entities": []}], ["Adequate performance assessment benefits from the use of disaggregated data to allow a proper evaluation of health systems.", {"entities": []}], ["Since routinely collected data are usually not disaggregated enough to allow stratified analyses of healthcare needs, utilisation, cost and quality across different sectors, international research projects could fill this gap by exploring means to data collection or even providing individual-level data.", {"entities": []}], ["The aim of this paper is therefore to (1) study the availability and accessibility of relevant European-funded health projects, and (2) to analyse their contents and methodologies.", {"entities": []}], ["The European Commission Public Health Projects Database and CORDIS were searched for eligible projects, which were then analysed by information openly available online.", {"entities": []}], ["Overall, only a few of the 39 identified projects produced data useful for proper performance assessment, due to, for example, lacking available or accessible data, or poor linkage of health status to costs and patient experiences.", {"entities": []}], ["Other problems were insufficient databases to identify projects and poor communication of project contents and results.", {"entities": []}], ["A new approach is necessary to improve accessibility to and coverage of data on outcomes, quality and costs of health systems enabling decision-makers and health professionals to properly assess performance.", {"entities": []}], ["The online version of this article (doi:10.1186/s12961-016-0165-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["An era of increased awareness of sports concussions may decrease a provider\u2019s ability to diagnose the athlete\u2019s actual condition and may ultimately prolong the restriction of the injured athlete from sports.", {"entities": []}], ["Trauma-triggered migraine is a source of headaches, especially in athletes with a family history of migraines.", {"entities": [[17, 25, "DISEASE"]]}], ["Research articles were primarily obtained through the electronic database PubMed from 1993 to August 2012.", {"entities": []}], ["Primary research parameters included trauma-induced headaches, trauma-induced migraines, and posttraumatic migraine.", {"entities": [[107, 115, "DISEASE"]]}], ["The secondary search parameters included concussions, migraine treatments, and traumatic migraine treatments.", {"entities": [[54, 62, "DISEASE"], [89, 97, "DISEASE"]]}], ["Clinical review with case report.", {"entities": []}], ["There are no symptoms that distinguish trauma-triggered migraines from concussions, as headache is the most common complaint for both conditions.", {"entities": []}], ["There is a paucity of studies that offer treatment guidelines for athletes with recurring headaches after trauma sustained during sporting events.", {"entities": []}], ["Preventive treatment of migraines has been validated and proven effective.", {"entities": []}], ["Trauma-triggered migraine should be considered in the differential for recurrent trauma-induced headaches.", {"entities": [[17, 25, "DISEASE"]]}], ["There is a lack of research evaluating efficacy and side effects of treatment of trauma-triggered migraine, and no information was found directing when an athlete can safely return to play.", {"entities": [[98, 106, "DISEASE"]]}], ["Regular physical activity has important health benefits for children with type 1 diabetes mellitus (T1DM), yet children and their parents face barriers to participation such as lack of self-efficacy or concerns around hypoglycaemia.", {"entities": [[74, 98, "DISEASE"], [81, 98, "DISEASE"]]}], ["Multimedia interventions are useful for educating children about their health and demonstrate potential to improve children\u2019s health-related self-efficacy, but few paediatric clinics offer web-based resources as part of routine care.", {"entities": []}], ["The Steps to Active Kids with Diabetes (STAK-D) programme is an online intervention grounded in psychological theory (social cognitive theory) and informed by extensive preliminary research.", {"entities": []}], ["The aim of the programme is to encourage and support safe engagement with physical activity for children with T1DM.", {"entities": []}], ["The aim of this research is to explore the feasibility of delivering the STAK-D programme to children aged 9\u201312 years with T1DM, and to assess the feasibility of further research to demonstrate its clinical and cost-effectiveness.", {"entities": []}], ["Up to 50 children aged 9\u201312 years with T1DM and their parents will be recruited from two paediatric diabetes clinics in the UK.", {"entities": []}], ["Child-parent dyads randomised to the intervention group will have access to the intervention website (STAK-D) and a wrist-worn activity monitor for 6\u00a0months.", {"entities": []}], ["The feasibility of intervention and further research will be assessed by rate of recruitment, adherence, retention, data completion and adverse events.", {"entities": []}], ["Qualitative interviews will be undertaken with a subsample of children and parents (up to 25 dyads) and health care professionals (up to 10).", {"entities": []}], ["Health outcomes and the feasibility of outcome measurement tools will be assessed.", {"entities": []}], ["These include self-efficacy (CSAPPA), objective physical activity, self-reported physical activity (PAQ), fear of hypoglycaemia (CHFS; PHFS), glycaemic control (HbA1c), insulin dose, Body Mass Index (BMI), health-related quality of life (CHU9D; CHQ-PF28), health service use and patient-clinician communication.", {"entities": []}], ["Assessments will be taken at baseline (T0), 8\u00a0weeks (T1) and at 6-month follow-up (T2).", {"entities": []}], ["The goal of this feasibility trial is to assess the delivery of STAK-D to promote physical activity among children with T1DM, and to assess the potential for further, definitive research to demonstrate its effectiveness.", {"entities": []}], ["Results will provide the information necessary to design a larger randomised controlled trial and maximise the recruitment rate, intervention delivery and trial retention.", {"entities": []}], ["ISRCTN, ISRCTN48994721 .", {"entities": []}], ["Registered on 28 October 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1719-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The molecular mechanisms that contribute to an eosinophil-rich airway inflammation in asthma are unclear.", {"entities": [[86, 92, "DISEASE"]]}], ["A predominantly T helper 2 (Th2)-type cell response has been documented in allergic asthma.", {"entities": [[75, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["Here we show that mice deficient in the p50 subunit of nuclear factor (NF)- \u03baB are incapable of mounting eosinophilic airway inflammation compared with wild-type mice.", {"entities": []}], ["This deficiency was not due to a block in T cell priming or proliferation in the p50", {"entities": []}], ["Tobacco use started several centuries ago and increased markedly after the invention of the cigarette making machine.", {"entities": []}], ["Once people start smoking they find it difficult to quit the habit.", {"entities": []}], ["This is due to the addictive effect of nicotine in tobacco smoke.", {"entities": []}], ["Various epidemiologic and laboratory studies clearly showed that smoking is associated with various diseases such as heart diseases, asthma and emphysema and the associated increase in morbidity and mortality of smokers.", {"entities": [[133, 139, "DISEASE"]]}], ["Several studies implicate nicotine as the causative factor in tobacco smoke.", {"entities": []}], ["Apart from nicotine, various carcinogens also occur in tobacco smoke resulting in an increase in the incidence of cancer in smokers.", {"entities": [[114, 120, "DISEASE"]]}], ["While the smoking habit is decreasing in developed countries, tobacco use increases in the developing countries.", {"entities": []}], ["Smoking prevalence is also highest in poor communities and amongst those with low education levels.", {"entities": []}], ["It is important to note that, although ther is a decline in the number of smokers in the developed countries, there is a three to four decades lag between the peak in smoking prevalence and the subsequent peak in smoking related mortality.", {"entities": []}], ["It has been shown that maternal smoking induces respiratory diseases in the offspring.", {"entities": []}], ["There is also evidence that parental smoking may program the offspring to develop certain diseases later in life.", {"entities": []}], ["Various studies showed that maternal nicotine exposure during pregnancy and lactation via tobacco smoke of nicotine replacement therapy (NRT), program the offspring to develop compromised lung structure later in life with the consequent compromised lung function.", {"entities": []}], ["This implies that NRT is not an option to assist pregnant or lactating smokers to quit the habit.", {"entities": []}], ["Even paternal smoking may have an adverse effect on the health of the offspring since it has been shown that 2", {"entities": []}], ["Patients with obstructive lung disease often require ventilatory support via invasive or noninvasive mechanical ventilation, depending on the severity of the exacerbation.", {"entities": [[14, 38, "DISEASE"], [26, 38, "DISEASE"]]}], ["The use of inhaled bronchodilators can significantly reduce airway resistance, contributing to the improvement of respiratory mechanics and patient-ventilator synchrony.", {"entities": []}], ["Although various studies have been published on this topic, little is known about the effectiveness of the bronchodilators routinely prescribed for patients on mechanical ventilation or about the deposition of those drugs throughout the lungs.", {"entities": []}], ["The inhaled bronchodilators most commonly used in ICUs are beta adrenergic agonists and anticholinergics.", {"entities": []}], ["Various factors might influence the effect of bronchodilators, including ventilation mode, position of the spacer in the circuit, tube size, formulation, drug dose, severity of the disease, and patient-ventilator synchrony.", {"entities": []}], ["Knowledge of the pharmacological properties of bronchodilators and the appropriate techniques for their administration is fundamental to optimizing the treatment of these patients.", {"entities": []}], ["Pacientes com doen\u00e7as pulmonares obstrutivas frequentemente necessitam de suporte ventilat\u00f3rio atrav\u00e9s de ventila\u00e7\u00e3o mec\u00e2nica invasiva ou n\u00e3o invasiva, dependendo da gravidade da exacerba\u00e7\u00e3o.", {"entities": []}], ["O uso de broncodilatadores inalat\u00f3rios pode reduzir significativamente a resist\u00eancia das vias a\u00e9reas, contribuindo para a melhora da mec\u00e2nica respirat\u00f3ria e da sincronia do paciente com o respirador.", {"entities": []}], ["Apesar dos diversos estudos publicados, pouco se conhece sobre a efic\u00e1cia dos broncodilatadores rotineiramente prescritos para pacientes em ventila\u00e7\u00e3o mec\u00e2nica ou sobre sua distribui\u00e7\u00e3o pulmonar.", {"entities": []}], ["Os agonistas beta-adren\u00e9rgicos e as drogas anticolin\u00e9rgicas s\u00e3o os broncodilatadores inalat\u00f3rios mais usados em UTIs.", {"entities": []}], ["Muitos fatores podem influenciar no efeito das drogas broncodilatadoras, entre eles o modo ventilat\u00f3rio, a posi\u00e7\u00e3o do espa\u00e7ador no circuito, o tamanho do tubo, a formula\u00e7\u00e3o/dose da droga, a gravidade da doen\u00e7a e a sincronia do paciente.", {"entities": []}], ["O conhecimento das propriedades farmacol\u00f3gicas das drogas broncodilatadoras e das t\u00e9cnicas adequadas para sua administra\u00e7\u00e3o s\u00e3o fundamentais para otimizar o tratamento desses pacientes.", {"entities": []}], ["Human genetic background strongly influences susceptibility to malaria infection and progression to severe disease and death.", {"entities": [[63, 70, "DISEASE"]]}], ["Classical genetic studies identified haemoglobinopathies and erythrocyte-associated polymorphisms, as protective against severe disease.", {"entities": []}], ["High throughput genotyping by mass spectrometry allows multiple single nucleotide polymorphisms (SNPs) to be examined simultaneously.", {"entities": []}], ["We compared the prevalence of 65 human SNP's, previously associated with altered risk of malaria, between Tanzanian children with and without severe malaria.", {"entities": [[89, 96, "DISEASE"], [149, 156, "DISEASE"]]}], ["Five hundred children, aged 1\u201310 years, with severe malaria were recruited from those admitted to hospital in Muheza, Tanzania and compared with matched controls.", {"entities": [[52, 59, "DISEASE"]]}], ["Genotyping was performed by Sequenom MassArray, and conventional PCR was used to detect deletions in the alpha-thalassaemia gene.", {"entities": []}], ["SNPs in two X-linked genes were associated with altered risk of severe malaria in females but not in males: heterozygosity for one or other of two SNPs in the G6PD gene was associated with protection from all forms of severe disease whilst two SNPs in the gene encoding CD40L were associated with respiratory distress.", {"entities": [[71, 78, "DISEASE"], [159, 163, "GENE"]]}], ["A SNP in the adenyl cyclase 9 (ADCY9) gene was associated with protection from acidosis whilst a polymorphism in the IL-1\u03b1 gene (IL1A) was associated with an increased risk of acidosis.", {"entities": [[31, 36, "GENE"], [129, 133, "GENE"]]}], ["SNPs in the genes encoding IL-13 and reticulon-3 (RTN3) were associated with increased risk of cerebral malaria.", {"entities": [[95, 111, "DISEASE"], [104, 111, "DISEASE"], [50, 54, "GENE"]]}], ["This study confirms previously known genetic associations with protection from severe malaria (HbS, G6PD).", {"entities": [[86, 93, "DISEASE"], [100, 104, "GENE"]]}], ["It identifies two X-linked genes associated with altered risk of severe malaria in females, identifies mutations in ADCY9, IL1A and CD40L as being associated with altered risk of severe respiratory distress and acidosis, both of which are characterised by high serum lactate levels, and also identifies novel genetic associations with severe malaria (TRIM5) and cerebral malaria(IL-13 and RTN3).", {"entities": [[362, 378, "DISEASE"], [72, 79, "DISEASE"], [342, 349, "DISEASE"], [371, 378, "DISEASE"], [116, 121, "GENE"], [123, 127, "GENE"], [351, 356, "GENE"], [389, 393, "GENE"]]}], ["Further studies are required to test the generality of these associations and to understand their functional consequences.", {"entities": []}], ["Eukaryotic microorganisms are important but understudied components of the human microbiome.", {"entities": []}], ["Here we present a pipeline for analysis of deep sequencing data on single cell eukaryotes.", {"entities": []}], ["We designed a new 18S rRNA gene-specific PCR primer set and compared a published rRNA gene internal transcribed spacer (ITS) gene primer set.", {"entities": []}], ["Amplicons were tested against 24 specimens from defined eukaryotes and eight well-characterized human stool samples.", {"entities": []}], ["A software pipeline https://sourceforge.net/projects/brocc/ was developed for taxonomic attribution, validated against simulated data, and tested on pyrosequence data.", {"entities": []}], ["This study provides a well-characterized tool kit for sequence-based enumeration of eukaryotic organisms in human microbiome samples.", {"entities": []}], ["The cerebellum is a crucial structure for cognitive function as well as motor control.", {"entities": []}], ["Benign brain tumors such as schwannomas, meningiomas, and epidermoids tend to occur in the cerebellopontine angle cisterns and may cause compression of the posterior lateral cerebellum near the superior posterior fissure, where the eloquent area for cognitive function was recently identified.", {"entities": []}], ["The present study examined cognitive impairment in patients with benign cerebellar tumors before and after surgical intervention in order to clarify the functional implications of this region in humans.", {"entities": []}], ["Patients with cerebellar tumors showed deficits in psychomotor speed and working memory compared with healthy controls.", {"entities": []}], ["Moreover, these impairments were more pronounced in patients with right cerebellar tumors.", {"entities": []}], ["Functional magnetic resonance imaging during performance of a lure task also demonstrated that cerebellar tumors affected pattern separation or the ability to distinguish similar experiences of episodic memory or events with discrete, non-overlapping representations, which is one of the important cognitive functions related to the hippocampus.", {"entities": []}], ["The present findings indicate that compression of the human posterior lateral cerebellum affects hippocampal memory function.", {"entities": []}], ["This report describes the apparent \u2018resurrection\u2019 of a patient in an emergency department setting.", {"entities": []}], ["Befittingly named the \u2018Lazarus phenomenon\u2019, the recovery of spontaneous circulation after cessation of cardiopulmonary resuscitation is an extremely rare occurrence that was first described in 1982 and has been mentioned only 38 times in the medical literature.", {"entities": []}], ["Our patient\u2019s case is remarkable in that it helps illustrate many of the mechanisms of this rare phenomenon.", {"entities": []}], ["It also serves as a reminder of our limitations in determining when to terminate cardiopulmonary resuscitation and suggests that cessation of cardiopulmonary resuscitation should be approached with more care.", {"entities": []}], ["An 89-year-old Caucasian woman with a medical history of hypertension, atrial fibrillation, hypothyroidism, aortic insufficiency, lymphedema and hypoxia secondary to partial lung resection presented to our hospital after a witnessed fall unassociated with head trauma or loss of consciousness.", {"entities": [[57, 69, "DISEASE"], [92, 106, "DISEASE"], [130, 140, "DISEASE"]]}], ["On examination, our patient was saturating at 85 percent and exhibited a decreased range of motion of the upper extremities and left hip.", {"entities": []}], ["Radiographic images revealed a left femoral neck and left distal radius fracture.", {"entities": []}], ["Our patient was stabilized on 100 percent fraction of inspired oxygen and was awaiting transfer to an in-patient unit when, at 3:30\u00a0a.m., she went into cardiac arrest.", {"entities": []}], ["An advanced cardiac life support protocol was initiated, at which time our patient was intubated and administered epinephrine, vasopressin and sodium bicarbonate.", {"entities": []}], ["Our patient remained unresponsive and asystolic so cardiopulmonary resuscitation was abandoned at 3:48\u00a0a.m. After five minutes a ventricular contraction was noted at 3:51\u00a0a.m.", {"entities": []}], ["This progressed to sinus rhythm with a pulse at 3:53\u00a0a.m. Our patient was stabilized on norepinephrine and moved to our Intensive Care Unit.", {"entities": []}], ["At 10:55\u00a0a.m., however, our patient again arrested and, despite resuscitative efforts, was pronounced dead at 11:03\u00a0a.m. Our patient\u2019s case clearly illustrates many of the proposed mechanisms for delayed return of spontaneous circulation including pulmonary hyper-inflation, hyperkalemia, delayed drug onset, and embolism dislodgement.", {"entities": []}], ["Our patient represents a humbling and disturbing reminder that our medical acumen does not necessarily dictate the fate of our patients and that the decision to discontinue cardiopulmonary resuscitation should be approached with care by incorporating techniques such as end-tidal carbon dioxide, ventilator disconnect and passive monitoring.", {"entities": []}], ["Maternal exposure to air pollution has been related to fetal growth in a number of recent scientific studies.", {"entities": []}], ["The objective of this study was to assess the association between exposure to air pollution during pregnancy and anthropometric measures at birth in a cohort in Valencia, Spain.", {"entities": []}], ["Seven hundred and eighty-five pregnant women and their singleton newborns participated in the study.", {"entities": []}], ["Exposure to ambient nitrogen dioxide (NO 2 ) was estimated by means of land use regression.", {"entities": []}], ["NO 2 spatial estimations were adjusted to correspond to relevant pregnancy periods (whole pregnancy and trimesters) for each woman.", {"entities": []}], ["Outcome variables were birth weight, length, and head circumference (HC), along with being small for gestational age (SGA).", {"entities": []}], ["The association between exposure to residential outdoor NO 2 and outcomes was assessed controlling for potential confounders and examining the shape of the relationship using generalized additive models (GAM).", {"entities": []}], ["For continuous anthropometric measures, GAM indicated a change in slope at NO 2 concentrations of around 40 \u03bcg/m 2 exposure >40 \u03bcg/m 2 during the second trimester was associated with being SGA-weight, odds ratio (OR): 1.37 (1.01-1.85).", {"entities": []}], ["For SGA-length the estimate for the same comparison was OR: 1.42 (0.89-2.25).", {"entities": []}], ["Prenatal exposure to traffic-related air pollution may reduce fetal growth.", {"entities": []}], ["Findings from this study provide further evidence of the need for developing strategies to reduce air pollution in order to prevent risks to fetal health and development.", {"entities": []}], ["Hematopoietic prostaglandin D 2 synthase (H-PGDS, GST Sigma) is a member of the glutathione S-transferase super family of enzymes that catalyses the conjugation of electrophilic substances with reduced glutathione.", {"entities": []}], ["The enzyme catalyses the conversion of PGH 2 to PGD 2 which mediates inflammatory responses.", {"entities": [[48, 51, "GENE"]]}], ["The inhibition of H-PGDS is of importance in alleviating damage to tissues due to unwarranted synthesis of PGD 2 .", {"entities": [[107, 110, "GENE"]]}], ["Combretum molle has been used in African ethno medicinal practices and has been shown to reduce fever and pain.", {"entities": []}], ["The effect of C. molle alkaloid extract on H-PGDS was thus, investigated.", {"entities": []}], ["H-PGDS was expressed in Escherichia coli XL1-Blue cells and purified using nickel immobilized metal affinity chromatography.", {"entities": []}], ["The effect of C. molle alkaloid extract on H-PGDS activity was determined with 1-chloro-2, 4-dinitrobenzene (CDNB) as substrate.", {"entities": []}], ["The effect of C. molle alkaloid extract with time on H-PGDS was determined.", {"entities": []}], ["The mechanism of inhibition was then investigated using CDNB and glutathione (GSH) as substrates.", {"entities": []}], ["A specific activity of 24\u00a0\u03bcmol/mg/min was obtained after H-PGDS had been purified.", {"entities": []}], ["The alkaloid extract exhibited a 70% inhibition on H-PGDS with an IC 50 of 13.7\u00a0\u03bcg/ml.", {"entities": []}], ["C. molle alkaloid extract showed an uncompetitive inhibition of H-PGDS with K i \u2009=\u200941\u00a0\u03bcg/ml towards GSH, and non-competitive inhibition towards CDNB with K i \u2009=\u20097.7\u00a0\u03bcg/ml and K i The data shows that C. molle alkaloid extract is a potent inhibitor of H-PGDS.", {"entities": []}], ["This study thus supports the traditional use of the plant for inflammation.", {"entities": []}], ["Amyloid beta (A\u03b2) accumulation in the walls of leptomeningeal arteries as cerebral amyloid angiopathy ( CAA ) is a major feature of Alzheimer's disease.", {"entities": [[74, 101, "DISEASE"]]}], ["In this study, we used global quantitative proteomic analysis to examine the hypothesis that the leptomeningeal arteries derived from patients with CAA have a distinct endophenotypic profile compared to those from young and elderly controls.", {"entities": []}], ["Freshly dissected leptomeningeal arteries from the Newcastle Brain Tissue Resource and Edinburgh Sudden Death Brain Bank from seven elderly (82.9 \u00b1 7.5 years) females with severe capillary and arterial CAA , as well as seven elderly (88.3 \u00b1 8.6 years) and five young (45.4 \u00b1 3.9 years) females without CAA were used in this study.", {"entities": []}], ["Arteries from four patients with CAA , two young and two elderly controls were individually analysed using quantitative proteomics.", {"entities": []}], ["Key proteomic findings were then validated using immunohistochemistry.", {"entities": []}], ["Bioinformatics interpretation of the results showed a significant enrichment of the immune response/classical complement and extracellular matrix remodelling pathways ( P < 0.05) in arteries affected by CAA vs .", {"entities": []}], ["those from young and elderly controls.", {"entities": []}], ["Clusterin (apolipoprotein J) and tissue inhibitor of metalloproteinases\u20103 ( TIMP 3), validated using immunohistochemistry, were shown to co\u2010localize with A\u03b2 and to be up\u2010regulated in leptomeningeal arteries from CAA patients compared to young and elderly controls.", {"entities": []}], ["Global proteomic profiling of brain leptomeningeal arteries revealed that clusterin and TIMP 3 increase in leptomeningeal arteries affected by CAA .", {"entities": []}], ["We propose that clusterin and TIMP 3 could facilitate perivascular clearance and may serve as novel candidate therapeutic targets for CAA.", {"entities": []}], ["Lignosus rhinocerotis (Cooke) Ryvarden (Polyporales, Basidiomycota), also known as the tiger milk mushroom, has received much interest in recent years owing to its wide-range ethnobotanical uses and the recent success in its domestication.", {"entities": []}], ["The sclerotium is the part with medicinal value.", {"entities": []}], ["Using two-dimensional gel electrophoresis coupled with mass spectrometry analysis, a total of 16 non-redundant, major proteins were identified with high confidence level in L. rhinocerotis sclerotium based on its genome as custom mapping database.", {"entities": []}], ["Some of these proteins, such as the putative lectins, immunomodulatory proteins, superoxide dismutase, and aegerolysin may have pharmaceutical potential; while others are involved in nutrient mobilization and the protective antioxidant mechanism in the sclerotium.", {"entities": []}], ["The findings from this study provide a molecular basis for future research on potential pharmacologically active proteins of L. rhinocerotis.", {"entities": []}], ["The aim of this study was to investigate the associations between attention deficit hyperactivity disorder (ADHD), the most common neuropsychiatric disorder in school children, and childhood allergic disease by evaluating their respective prevalence.", {"entities": [[66, 106, "DISEASE"]]}], ["Subjects were comprised of first and second grade students in twenty two elementary schools in a city in the Republic of Korea.", {"entities": []}], ["The mode of measurement for ADHD was based on DSM-IV from clinical interviews conducted by child psychiatrists.", {"entities": []}], ["Along with the diagnostic interviews, we also used the epidemiological questionnaires, Computerized Attention Deficit-Hyperactivity Disorder Diagnostic System, the abbreviated Conner\u2019s Parent Rating Scale (CPRS), and DuPaul\u2019s ADHD Rating Scales.", {"entities": []}], ["Allergic conditions, such as asthma, have been separately evaluated based on the questionnaire items whose validity and reliability were proved by the International Study of Asthma and Allergies in Children (ISAAC).", {"entities": [[29, 35, "DISEASE"], [174, 180, "DISEASE"]]}], ["All questionnaires were completed by the subjects\u2019 parents.", {"entities": []}], ["The lifetime prevalence rate of asthma in ADHD patients was 36.6%, compared to a prevalence of 24.3% in control subjects.", {"entities": [[32, 38, "DISEASE"]]}], ["The lifetime prevalence rate of allergic rhinitis in ADHD patients was 59.0%, compared to a prevalence of 47.0% in control subjects.", {"entities": [[32, 49, "DISEASE"], [41, 49, "DISEASE"]]}], ["Statistically significant difference has been found between the two groups.", {"entities": []}], ["In the logistic regression model of the ADHD and the control group, the relative risk of asthma was 1.60 times higher (confidence interval 1.301-1.964), the relative risk of allergic rhinitis was 1.38 times higher (confidence interval 1.124-1.681), which showed statistical significance.", {"entities": [[174, 191, "DISEASE"], [183, 191, "DISEASE"], [89, 95, "DISEASE"]]}], ["The findings of this study suggest significant association between ADHD and childhood asthma and allergic rhinitis.", {"entities": [[97, 114, "DISEASE"], [106, 114, "DISEASE"], [86, 92, "DISEASE"]]}], ["Therefore, appropriate evaluation and treatment are needed for asthmatic children with attention-deficit symptoms, or allergic rhinitis with ADHD.", {"entities": [[118, 135, "DISEASE"], [127, 135, "DISEASE"]]}], ["Besides, further research is needed to determine the etiological approach towards ADHD, asthma, and allergic rhinitis.", {"entities": [[100, 117, "DISEASE"], [109, 117, "DISEASE"], [88, 94, "DISEASE"]]}], ["Macrophage activation is associated with profound transcriptional reprogramming.", {"entities": []}], ["Although much progress has been made in the understanding of macrophage activation, polarization, and function, the transcriptional programs regulating these processes\u00a0remain poorly characterized.", {"entities": []}], ["We stimulated human macrophages with diverse activation signals, acquiring a data set of 299 macrophage transcriptomes.", {"entities": []}], ["Analysis of this data set revealed a spectrum of macrophage activation states extending the current M1 versus M2-polarization model.", {"entities": []}], ["Network analyses identified central transcriptional regulators associated with all macrophage activation complemented by regulators related to stimulus-specific programs.", {"entities": []}], ["Applying these transcriptional programs to human alveolar macrophages from smokers and patients with chronic obstructive pulmonary disease (COPD) revealed an unexpected loss of inflammatory signatures in COPD patients.", {"entities": [[101, 138, "DISEASE"]]}], ["Finally, by integrating murine data from the ImmGen project we propose a refined, activation-independent core signature for human and murine macrophages.", {"entities": []}], ["This resource serves as a framework for future research into regulation of macrophage activation in health and disease.", {"entities": []}], ["\u2022 Macrophages react with specific transcriptional programming upon distinct signals \u2022 Activation by TNF, PGE 2 , and P3C activates a STAT4-associated transcriptional program \u2022 NFKB1, JUNB, and CREB1 are central transcription factors of macrophage activation \u2022 Inflammatory signatures are lost in alveolar macrophages from COPD patients Macrophages react with specific transcriptional programming upon distinct signals Activation by TNF, PGE 2 , and P3C activates a STAT4-associated transcriptional program NFKB1, JUNB, and CREB1 are central transcription factors of macrophage activation Inflammatory signatures are lost in alveolar macrophages from COPD patients", {"entities": [[100, 103, "GENE"], [432, 435, "GENE"], [176, 181, "GENE"], [506, 511, "GENE"], [183, 187, "GENE"], [513, 517, "GENE"], [193, 198, "GENE"], [523, 528, "GENE"], [100, 103, "GENE"], [432, 435, "GENE"], [176, 181, "GENE"], [506, 511, "GENE"], [183, 187, "GENE"], [513, 517, "GENE"], [193, 198, "GENE"], [523, 528, "GENE"]]}], ["Healthcare systems are complex networks where relationships affect outcomes.", {"entities": []}], ["The importance of primary care increases while health care acknowledges multimorbidity, the impact of combinations of different diseases in one person.", {"entities": []}], ["Active listing and consultations in primary care could be used as proxies of the relationships between patients and primary care.", {"entities": []}], ["Our objective was to study hospitalisation as an outcome of primary care, exploring the associations with active listing, number of consultations in primary care and two groups of practices, while taking socioeconomic status and morbidity burden into account.", {"entities": []}], ["A cross-sectional study using zero-inflated negative binomial regression to estimate odds of any hospital admission and mean number of days hospitalised for the population over 15\u00a0years ( N \u00a0=\u2009123,168) in the Swedish county of Blekinge during 2007.", {"entities": []}], ["Explanatory factors were listed as active or passive in primary care, number of consultations in primary care and primary care practices grouped according to ownership.", {"entities": []}], ["The models were adjusted for sex, age, disposable income, education level and multimorbidity level.", {"entities": []}], ["Mean days hospitalised was 0.94 (95%CI 0.90\u20130.99) for actively listed and 1.32 (95%CI 1.24\u20131.40) for passively listed.", {"entities": []}], ["For patients with 0\u20131 consultation in primary care mean days hospitalised was 1.21 (95%CI 1.13\u20131.29) compared to 0.77 (95%CI 0.66\u20130.87) days for patients with 6\u20137 consultations.", {"entities": []}], ["Mean days hospitalised was 1.22 (95%CI 1.16\u20131.28) for listed in private primary care and 0.98 (95%CI 0.94\u20131.01) for listed in public primary care, with odds for hospital admission 0.51 (95%CI 0.39\u20130.63) for public primary care compared to private primary care.", {"entities": []}], ["Active listing and more consultations in primary care are both associated with reduced mean days hospitalised, when adjusting for socioeconomic status and multimorbidity level.", {"entities": []}], ["Different odds of any hospitalisation give a difference in mean days hospitalised associated with type of primary care practice.", {"entities": []}], ["To promote well performing primary care to maintain good relationships with patients could reduce mean days hospitalised.", {"entities": []}], ["Atrial fibrillation (AF) is the most common cardiac arrhythmia and increases the risk of ischemic stroke 4 to 5-fold.", {"entities": []}], ["The first choice of anticoagulant therapy (AT) is the vitamin K antagonist (VKA).", {"entities": []}], ["Contraindication to VKA or poor control of the International Normalized Ratio leads to the administration of direct-acting oral anticoagulants.", {"entities": []}], ["There is a trend toward inadequate AT in nonvalvular AF (NVAF) patients.", {"entities": []}], ["Aim: To evaluate the impact of the implementation of a decision support tool linked to the digital clinical history on the adequacy of AT, the incidence of complications, and the mortality in patients with NVAF in primary care centers (PCCs) of the Catalan Institute of Health (ICS).", {"entities": []}], ["Randomized clinical trial in 287 PCCs, formed by 2 groups (intervention and control).", {"entities": []}], ["Population: patients controlled in PCCs, diagnosed with NVAF 1 year before the implementation of the decision support tool and with VKA treatment over a minimum of 1 year.", {"entities": []}], ["A simple randomization method will be performed at a sector level.", {"entities": []}], ["The decision support tool will be available for 1 year.", {"entities": []}], ["The time in therapeutic range (TTR) will be available in the digital clinical history only to professionals of the intervention group.", {"entities": [[31, 34, "GENE"]]}], ["The information system for primary care research development database will be used for the data extraction.", {"entities": []}], ["Statistical analysis will be done at 3 time points: before the implementation of the tool, at 1 year, and at 2 years after the beginning of the intervention.", {"entities": []}], ["Multilevel (patient and professional levels) logistic regression models will be used to estimate the effect of the intervention.", {"entities": []}], ["This study protocol was approved by the Ethical Committee of Clinical Investigation of the Institut Universitari d\u2019Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria Jordi Gol (code P17/091).", {"entities": []}], ["Articles will be published in scientific journals.", {"entities": []}], ["Clinical-Trials.gov: NCT03367325.", {"entities": []}], ["General practitioners (GPs) play a central role in disseminating information and most health policies are tending to develop this pivotal role of GPs in dissemination of health-related information to the public.", {"entities": []}], ["The objective of this study was to evaluate use of the waiting room by GPs as a vector for health promotion.", {"entities": []}], ["A cross-sectional study was conducted on a representative sample of GPs using semi-structured, face-to-face interviews.", {"entities": []}], ["A structured grid was used to describe the documents.", {"entities": []}], ["Quantitative and qualitative analysis was performed.", {"entities": []}], ["Sixty GPs participated in the study.", {"entities": []}], ["They stated that a waiting room had to be pleasant, but agreed that it was a useful vector for providing health information.", {"entities": []}], ["The GPs stated that they distributed documents designed to improve patient care by encouraging screening, providing health education information and addressing delicate subjects more easily.", {"entities": []}], ["However, some physicians believed that this information can sometimes make patients more anxious.", {"entities": []}], ["A large number of documents were often available, covering a variety of topics.", {"entities": []}], ["General practitioners intentionally use their waiting rooms to disseminate a broad range of health-related information, but without developing a clearly defined strategy.", {"entities": []}], ["It would be interesting to correlate the topics addressed by waiting room documents with prevention practices introduced during the visit.", {"entities": []}], ["Acute respiratory infections (ARIs) are leading causes of hospitalisation in Australian children and, if recurrent, are associated with increased risk of chronic pulmonary disorders later in life.", {"entities": []}], ["Chronic (>4\u2005weeks) cough in children following ARI is associated with decreased quality-of-life scores and increased health and societal economic costs.", {"entities": []}], ["We will determine whether a validated evidence-based cough algorithm, initiated when chronic cough is first diagnosed after presentation with ARI, improves clinical outcomes in children compared with usual care.", {"entities": []}], ["A multicentre, parallel group, open-label, randomised controlled trial, nested within a prospective cohort study in Southeast Queensland, Australia, is underway.", {"entities": []}], ["750 children aged <15\u2005years will be enrolled and followed weekly for 8\u2005weeks after presenting with an ARI with cough.", {"entities": []}], ["214 children from this cohort with persistent cough at day 28 will be randomised to either early initiation of a cough management algorithm or usual care (107 per group).", {"entities": []}], ["Randomisation is stratified by reason for presentation, site and total cough duration at day 28 (<6 and \u22656\u2005weeks).", {"entities": []}], ["Demographic details, risk factors, clinical histories, examination findings, cost-of-illness data, an anterior nasal swab and parent and child exhaled carbon monoxide levels (when age appropriate) are collected at enrolment.", {"entities": []}], ["Weekly contacts will collect cough status and cost-of-illness data.", {"entities": []}], ["Additional nasal swabs are collected at days 28 and 56.", {"entities": []}], ["The primary outcome is time-to-cough resolution.", {"entities": []}], ["Secondary outcomes include direct and indirect costs of illness and the predictors of chronic cough postpresentation.", {"entities": []}], ["The Children's Health Queensland (HREC/15/QRCH/15) and the Queensland University of Technology University (1500000132) Research Ethics Committees have approved the study.", {"entities": []}], ["The study will inform best-practice management of cough in children.", {"entities": []}], ["ACTRN12615000132549.", {"entities": []}], ["Computerized decision support systems (CDSSs) are increasingly used to improve quality of care.", {"entities": []}], ["There is evidence for moderate to large effects from randomized controlled trials (RCTs), but evidence on their effectiveness when implemented at a national level is lacking.", {"entities": []}], ["In the Netherlands, the Dutch College of General Practitioners (NHG) initiated their successful guideline program already 30\u00a0years ago.", {"entities": []}], ["NHGDoc, a CDSS based on these NHG guidelines, covering multiple disease areas for general practice, was developed in 2006 with the aim to improve quality of primary care.", {"entities": []}], ["In this paper, a protocol is presented to evaluate the uptake and effects of NHGDoc.", {"entities": []}], ["A cluster RCT will be conducted among 120 general practices in the Netherlands.", {"entities": []}], ["Eligible general practices will be randomized to receive either the regular NHGDoc decision support modules (control arm) or the regular modules plus an additional module on heart failure (intervention arm).", {"entities": []}], ["The heart failure module consists of patient-specific alerts concerning the treatment of patients with heart failure.", {"entities": []}], ["The effect evaluation will focus on performance indicators (e.g., prescription behavior) as well as on patient outcomes (e.g., hospital admissions) relevant in the domain of heart failure.", {"entities": []}], ["Additionally, a process evaluation will be conducted to gain insight into the barriers and facilitators that affect the uptake and impact of NHGDoc.", {"entities": []}], ["Results of this study will provide insight in the uptake and impact of a multiple-domain covering CDSS for primary care implemented by a national guideline organization to improve the quality of primary care.", {"entities": []}], ["Whereas the trial focuses on a specific domain of care\u2014heart failure\u2014conclusions of this study will shed light on the functioning of CDSSs covering multiple disease areas for primary care, particularly as this study also explores the factors contributing to the system\u2019s uptake and effectiveness.", {"entities": []}], ["Clinical trials NCT01773057 The online version of this article (doi:10.1186/s13012-014-0145-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The study objective was to determine the level and correlates of self-reported medication low adherence in the US general population.", {"entities": []}], ["A 30 min cross-sectional online survey was conducted with a national sample of adults.", {"entities": []}], ["9202 adults (aged 18+) who had filled at least three or more prescriptions at a community pharmacy in the past 12 months.", {"entities": []}], ["Self-reported medication adherence was measured with the 8-item Morisky Medication Adherence Scale.", {"entities": []}], ["Low adherence was reported by 42.0%, 29.4% had medium adherence and 28.6% had high adherence.", {"entities": []}], ["Low adherence was significantly associated with: lower age, being of Hispanic origin or African-American, having difficulty with healthcare, medication or transportation costs, needing the support of others to access primary care, health limiting activity, using multiple providers, infrequent visits to primary care providers and visiting an emergency department >3 times in last 12 months.", {"entities": []}], ["A very high level of low medication adherence is seen in the general population, particularly for ethnic minorities, those who use multiple healthcare providers and those who experience barriers to access for regular primary care.", {"entities": []}], ["As clinical, patient education and counselling, and healthcare policy initiatives are directed to tracking the problem of low medication adherence, these should be priority populations for research and interventions.", {"entities": []}], ["Free radicals and oxidative stress have been recognized as important factors in the biology of aging and in many age-associated degenerative diseases.", {"entities": []}], ["Antioxidant systems deteriorate during aging.", {"entities": []}], ["It is, thus, considered that one way to reduce the rate of aging and the risk of chronic disease is to avoid the formation of free radicals and reduce oxidative stress by strengthening antioxidant defences.", {"entities": []}], ["Phytochemicals present in fruits, vegetables, grains, and other foodstuffs have been linked to reducing the risk of major oxidative stress-induced diseases.", {"entities": []}], ["Some dietary components of foods possess biological activities which influence circadian rhythms in humans.", {"entities": []}], ["Chrononutrition studies have shown that not only the content of food, but also the time of ingestion contributes to the natural functioning of the circadian system.", {"entities": []}], ["Dietary interventions with antioxidant-enriched foods taking into account the principles of chrononutrition are of particular interest for the elderly since they may help amplify the already powerful benefits of phytochemicals as natural instruments with which to prevent or delay the onset of common age-related diseases.", {"entities": []}], ["In order to address the role that the ambient air pollution mix, comprised of gaseous pollutants and various physical and chemical measures of particulate matter, plays in exacerbating cardiorespiratory disease, daily measures of fine and coarse particulate mass, aerosol chemistry (sulfates and acidity), and gaseous pollution (ozone, nitrogen dioxide, sulfur dioxide, and carbon monoxide) were collected in Toronto, Ontario, Canada, in the summers of 1992, 1993, and 1994.", {"entities": []}], ["These time series were then compared with concurrent data on the number of daily admissions to hospitals for either cardiac diseases (ischemic heart disease, heart failure, and dysthymias) or respiratory diseases (tracheobronchitis, chronic obstructive long disease, asthma, and pneumonia).", {"entities": [[134, 156, "DISEASE"], [143, 156, "DISEASE"], [279, 288, "DISEASE"], [267, 273, "DISEASE"]]}], ["After adjusting the admission time series for long-term temporal trends, seasonal variations, the effects of short-term epidemics, day of the week effects, and ambient temperature and dew point temperature, positive associations were observed for all ambient air pollutants for both respiratory and cardiac diseases.", {"entities": []}], ["Ozone was least sensitive to adjustment for the gaseous and particulate pollution measures.", {"entities": []}], ["However, the association between the health outcomes and carbon monoxide, fine and coarse mass, sulfate levels and aerosol acidity could be explained by adjustment for exposure to gaseous pollutants.", {"entities": []}], ["Increases in ozone, nitrogen dioxide, and sulfur dioxide equivalent to their interquartile ranges corresponded to an 11% and 13% increase in daily hospitalizations for respiratory and cardiac diseases, respectively.", {"entities": []}], ["The inclusion of any one of the particulate air pollutants in multiple regression models did not increase these percentages.", {"entities": []}], ["Particle mass and chemistry could not be identified as an independent risk factor for the exacerbation of cardiorespiratory diseases in this study beyond that attributable to climate and gaseous air pollution.", {"entities": []}], ["We recommend that effects of particulate matter on health be assessed in conjunction with temporally covarying gaseous air pollutants.", {"entities": []}], ["Despite a number of important differences in the pathogenesis, course and prognosis of asthma and chronic obstructive pulmonary disease (COPD), these two entities also have common features with airway inflammation being one of them.", {"entities": [[98, 135, "DISEASE"], [87, 93, "DISEASE"]]}], ["Airway remodeling is a characteristic feature of asthma, but data on the bronchial wall thickening in COPD patients are still scarce.", {"entities": [[49, 55, "DISEASE"]]}], ["To assess the relation between the inflammatory cell count in the bronchoalveolar lavage fluid (BALF) and thickness of bronchial walls assessed by high resolution computed tomography (HRCT) in asthma and COPD patients.", {"entities": [[193, 199, "DISEASE"]]}], ["The study was conducted in 9 patients with mild-to-moderate asthma (M/F 4/5, mean age 35 \u00b1 10 years) and 11 patients with mild-to-moderate COPD (M/F 7/4, mean age 57 \u00b1 9 years).", {"entities": [[60, 66, "DISEASE"]]}], ["In all subjects lung function tests and HRCT scanning of the chest were performed.", {"entities": []}], ["External (D) and internal (L) diameters of the airways were assessed at five selected lung levels.", {"entities": []}], ["The lumen area (A L ), wall area (WA), wall thickness (WT) and bronchial wall thickness (WT/D ratio) were calculated.", {"entities": []}], ["Eight patients with asthma and 8 patients with COPD underwent fiberoptic bronchoscopy and bronchoalveolar lavage (BAL).", {"entities": [[20, 26, "DISEASE"]]}], ["Total and differential cell counts were assessed in the BAL fluid.", {"entities": []}], ["Mean FEV 1 % pred was 80 \u00b1 19%, and 73 \u00b1 20% in asthma and COPD patients, respectively (NS).", {"entities": [[48, 54, "DISEASE"], [5, 8, "GENE"]]}], ["No significant differences in the total and differential cell counts in BALF were found in patients with asthma and COPD.", {"entities": [[105, 111, "DISEASE"]]}], ["There were no significant differences in the airway diameter or airway wall thickness.", {"entities": []}], ["The mean inner airway diameter was 1.4 \u00b1 0.3 and 1.2 \u00b1 0.3 mm and the mean lumen area was 1.8 \u00b1 0.7 and 1.6 \u00b1 0.7 mm In mild-to-moderate asthma and COPD the airway diameter and thickness are similar.", {"entities": [[137, 143, "DISEASE"]]}], ["In asthmatics, the airway diameter might be associated with eosinophil count in BAL fluid.", {"entities": []}], ["Although congestive heart failure (CHF) patients typically present with abnormal auscultatory findings on lung examination, respiratory sounds are not normally subjected to additional analysis.", {"entities": [[9, 33, "DISEASE"]]}], ["The aim of this pilot study was to examine respiratory sound patterns of CHF patients using acoustic-based imaging technology.", {"entities": []}], ["Lung vibration energy was examined during acute exacerbation and after clinical improvement.", {"entities": []}], ["Respiratory sounds throughout the respiratory cycle were captured using an acoustic-based imaging technique.", {"entities": []}], ["Twenty-three consecutive CHF patients were imaged at the time of presentation to the emergency department and after clinical improvement.", {"entities": []}], ["Digital images were created (a larger image represents more homogeneously distributed vibration energy of respiratory sound).", {"entities": []}], ["Geographical area of the images and respiratory sound patterns were quantitatively analyzed.", {"entities": []}], ["Data from the CHF patients were also compared to healthy volunteers.", {"entities": []}], ["The median (interquartile range) geographical areas of the vibration energy image of acute CHF patients without and with radiographically evident pulmonary edema were 66.9 (9.0) and 64.1(9.0) kilo-pixels, respectively ( p < 0.05).", {"entities": [[146, 161, "DISEASE"]]}], ["After clinical improvement, the geographical area of the vibration energy image of CHF patients without and with radiographically evident pulmonary edema were increased by 18 \u00b1 15% ( p < 0.05) and 25 \u00b1 16% ( p < 0.05), respectively.", {"entities": [[138, 153, "DISEASE"]]}], ["With clinical improvement of acute CHF exacerbations, there was more homogenous distribution of lung vibration energy, as demonstrated by the increased geographical area of the vibration energy image.", {"entities": []}], ["Dried blood spot (DBS) sample collection has gained increased interest across the pharmaceutical industry as a potential alternative to plasma for pharmacokinetic (PK) evaluations.", {"entities": []}], ["However, regulatory guidelines and examples of late-stage clinical trial applications in the literature are lacking.", {"entities": []}], ["This paper communicates Merck\u2019s strategy for the implementation of DBS exemplified by experience on a late-stage program (MK-8931).", {"entities": []}], ["In this program, DBS was proposed as the sole matrix for phase 3 studies to decrease logistical burden in an aging target patient population (Alzheimer\u2019s disease).", {"entities": []}], ["In vitro and bioanalytical tests demonstrated initial method feasibility and suitability for further evaluations in the clinic.", {"entities": []}], ["An in vivo dataset was developed initially in healthy subjects (phase 1 study) and then in patients (phase 2/3 study) to establish a quantitative relationship between the blood and plasma concentrations (bridging dataset) using descriptive and population PK analyses.", {"entities": []}], ["This allowed for PK conclusions to be seamlessly drawn across the clinical program without impact from the choice of matrix.", {"entities": []}], ["This integrated information package ( in vitro , bioanalytical and clinical) was presented to major regulatory agencies (FDA and EMA) for regulatory input.", {"entities": []}], ["Based on this package, regulatory concurrence was gained on accepting DBS as the sole matrix in late-stage clinical trials.", {"entities": []}], ["Inflammation is a hallmark of acute lung injury and chronic airway diseases.", {"entities": []}], ["In chronic airway diseases, it is associated with profound tissue remodeling.", {"entities": []}], ["Peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) is a ligand-activated transcription factor, that belongs to the nuclear receptor family.", {"entities": []}], ["Agonists for PPAR\u03b1 have been recently shown to reduce lipopolysaccharide (LPS)- and cytokine-induced secretion of matrix metalloproteinase-9 (MMP-9) in human monocytes and rat mesangial cells, suggesting that PPAR\u03b1 may play a beneficial role in inflammation and tissue remodeling.", {"entities": []}], ["We have investigated the role of PPAR\u03b1 in a mouse model of LPS-induced airway inflammation characterized by neutrophil and macrophage infiltration, by production of the chemoattractants, tumor necrosis factor-\u03b1 (TNF-\u03b1), keratinocyte derived-chemokine (KC), macrophage inflammatory protein-2 (MIP-2) and monocyte chemoattractant protein-1 (MCP-1), and by increased MMP-2 and MMP-9 activity in bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["The role of PPAR\u03b1 in this model was studied using both PPAR\u03b1-deficient mice and mice treated with the PPAR\u03b1 activator, fenofibrate.", {"entities": []}], ["Upon intranasal exposure to LPS, PPAR\u03b1 Using both genetic and pharmacological approaches, our data clearly show that PPAR\u03b1 downregulates cell infiltration, chemoattractant production and enhanced MMP activity triggered by LPS in mouse lung.", {"entities": []}], ["This suggests that PPAR\u03b1 activation may have a beneficial effect in acute or chronic inflammatory airway disorders involving neutrophils and macrophages.", {"entities": []}], ["Irritable bowel syndrome (IBS) is a functional bowel disorder with a large negative impact on HRQOL.", {"entities": [[16, 24, "DISEASE"]]}], ["The present study examines whether severity of bowel symptoms is directly related to HRQOL, and/or indirectly, mediated by the patients\u2019 illness perceptions.", {"entities": []}], ["Patients were recruited from an IBS support group ( N \u00a0=\u00a0123), and data were collected online.", {"entities": []}], ["HRQOL was measured with the Quality of Life Measure for Persons with IBS and illness perceptions with the brief Illness Perception Questionnaire.", {"entities": []}], ["Mediation models were tested using the bootstrapping procedure developed by Hayes.", {"entities": []}], ["Irritable bowel syndrome symptom severity is directly related to total HRQOL and its subscales; after entering the mediator variables (i.e.", {"entities": [[16, 24, "DISEASE"]]}], ["the patients\u2019 illness perceptions) into the model, this direct association remained only significant for total HRQOL.", {"entities": []}], ["The relationship between bowel symptom severity and total HRQOL was partially mediated by illness perceptions, and its relationship with each of the HRQOL subscales was fully mediated by the patients\u2019 illness perceptions.", {"entities": []}], ["Perceived consequences were a mediator of the relationship between bowel symptom severity, total HRQOL as well as its subscales, with the exception of Sexuality.", {"entities": []}], ["Bowel symptom severity not only has a direct relationship with HRQOL, but also an indirect relationship via the patients\u2019 cognitive and emotional representations of their illness.", {"entities": []}], ["In order to better understand this relationship, future research should not only include illness perceptions but also assess cognitive and behavioural coping responses.", {"entities": []}], ["Clinicians wanting to improve patients\u2019 HRQOL should not only focus on the patients\u2019 symptoms, but also on their illness beliefs and coping responses.", {"entities": []}], ["Ambulatory practices that actively partner with patients and families in quality improvement (QI) report benefits such as better patient/family interactions with physicians and staff, and patient empowerment.", {"entities": []}], ["However, creating effective patient/family partnerships for ambulatory care improvement is not yet routine.", {"entities": []}], ["The objective of this paper is to provide practices with concrete evidence about meaningfully involving patients and families in QI activities.", {"entities": []}], ["Review of literature published from 2000\u20132015 and a focus group conducted in 2014 with practice advisors.", {"entities": []}], ["Thirty articles discussed 26 studies or examples of patient/family partnerships in ambulatory care QI.", {"entities": []}], ["Patient and family partnership mechanisms included QI committees and advisory councils.", {"entities": []}], ["Facilitators included process transparency, mechanisms for acting on patient/family input, and compensation.", {"entities": []}], ["Challenges for practices included uncertainty about how best to involve patients and families in QI.", {"entities": []}], ["Several studies found that patient/family partnership was a catalyst for improvement and reported that partnerships resulted in process improvements.", {"entities": []}], ["Focus group results were concordant.", {"entities": []}], ["This paper describes emergent mechanisms and processes that ambulatory care practices use to partner with patients and families in QI including outcomes, facilitators, and challenges.", {"entities": []}], ["Gordon and Betty Moore Foundation.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-016-0364-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although IL-4 and IL-13 share the IL-13 receptor, IL-13 exhibits unique functions.", {"entities": []}], ["To elicit the cellular basis of these differences, signal transduction processes have been compared.", {"entities": []}], ["Additionally, the role of the IL-4 receptor alpha (IL-4R\u03b1) variant Q551R was investigated.", {"entities": []}], ["Peripheral blood mononuclear cells from donors were stimulated with IL-4 and IL-13.", {"entities": []}], ["The phosphorylation status of effector substrates was detected by immunostaining.", {"entities": []}], ["Binding of SHP-2 to IL-4R\u03b1 was investigated by using synthetic peptides.", {"entities": []}], ["SHP-2 bound IL-4R\u03b1 synthetic peptide; this binding was reduced in the presence of the R551 variant.", {"entities": []}], ["Stimulation with IL-4 increased SHP-1 phosphorylation, however, stimulation with IL-13 increased SHP-2 phosphorylation.", {"entities": []}], ["PI3-kinase phosphorylation was elevated following stimulation with IL-13 in all individuals and with IL-4 only in R551 individuals.", {"entities": []}], ["Jak1, Tyk2 and IRS-2 signals were reduced after IL-13 stimulation in Q551 individuals.", {"entities": [[0, 4, "GENE"], [6, 10, "GENE"]]}], ["STAT3 phosphorylation was markedly increased in R551 individuals, following stimulation with both IL-4 and IL-13.", {"entities": [[0, 5, "GENE"]]}], ["However, STAT3 was only detected immediately in nuclear extracts from variant individuals after stimulation with IL-13; in wildtype individuals STAT3 was only detected after IL-4 treatment.", {"entities": [[9, 14, "GENE"], [144, 149, "GENE"], [9, 14, "GENE"], [144, 149, "GENE"]]}], ["IL-4 and IL-13 appear to promote distinct signal transduction cascades.", {"entities": []}], ["SHP-1 seems to be predominately activated by IL-4 and to influence the PI3-kinase, in contrast, SHP-2 seems to be predominately activated by IL-13 and to influence Jak1, Tyk2 and IRS-2.", {"entities": [[164, 168, "GENE"], [170, 174, "GENE"]]}], ["Both phosphatases control STAT3.", {"entities": [[26, 31, "GENE"]]}], ["In the presence of the variant R551, SHP-1/2 activation is reduced and signal transduction is altered.", {"entities": []}], ["STAT3 signaling appears be further regulated on the level of nuclear translocation.", {"entities": [[0, 5, "GENE"]]}], ["Whipple's disease (WD) is an infectious disease caused by Tropheryma whipplei , which replicates in macrophages and induces the release of interleukin (IL)-16, a substrate of caspase 3, and macrophage apoptosis.", {"entities": []}], ["The disease is characterized by intestinal, cardiac or neurological manifestations; its diagnosis is based on invasive analysis requiring tissue biopsies or cerebrospinal fluid puncture.", {"entities": []}], ["The disease progression is slow and often complicated by relapses despite empirical antibiotic treatment.", {"entities": []}], ["We monitored circulating levels of IL-16 and nucleosomes in 36 French patients with WD; among them, some patients were enrolled in a longitudinal follow-up.", {"entities": []}], ["As compared to control subjects, the circulating levels of both IL-16 and nucleosomes were increased in untreated patients with WD presenting as intestinal, cardiac or neurological manifestations.", {"entities": []}], ["This finding was specific to WD since the circulating levels of IL-16 and nucleosomes were not increased in patients with unrelated inflammatory diseases such as inflammatory bowel disease or Q fever endocarditis.", {"entities": [[162, 188, "DISEASE"], [200, 212, "DISEASE"]]}], ["We also found that increased levels of IL-16 and nucleosomes were related to the activity of the disease.", {"entities": []}], ["Indeed, successful antibiotic treatment decreased those levels down to those of control subjects.", {"entities": []}], ["In contrast, patients who suffered from relapses exhibited circulating levels of IL-16 and nucleosomes as high as those of untreated patients.", {"entities": []}], ["Circulating levels of both IL-16 and nucleosomes were increased in WD.", {"entities": []}], ["This finding provides simple and non-invasive tools for the diagnosis and the prognosis of WD.", {"entities": []}], ["The degree to which symptoms such as dyspnea affect patients with COPD is individualized.", {"entities": []}], ["To address the gap between clinical symptom measures and self-perceived disease burden, we investigated the symptom status of adult patients with COPD and followed with an administrative claims analysis of health care resource utilization and costs.", {"entities": []}], ["This was a hybrid US observational study consisting of a cross-sectional patient survey followed by a retrospective analysis of administrative claims data.", {"entities": []}], ["The primary COPD symptom measures were the modified Medical Research Council (mMRC) Dyspnea scale and the COPD Assessment Test (CAT).", {"entities": []}], ["A total of 673 patients completed the survey.", {"entities": []}], ["Of these, 65% reported mMRC grades 0\u20131 (low symptomatology) and 35% reported mMRC grades 2\u20134 (high symptomatology); 25% reported CAT score <10 (low symptomatology) and 75% reported CAT score \u226510 (high symptomatology).", {"entities": []}], ["More patients with high symptomatology (by either measure) had at least one COPD-related inpatient hospitalization, emergency room visit, physician office visit, or other outpatient services, and filled at least one COPD-related prescription medication vs patients with low symptomatology.", {"entities": []}], ["COPD-related costs were higher for patients with high symptomatology than patients with low symptomatology.", {"entities": []}], ["In a multivariate analysis, COPD-related costs were also higher in patients reporting severe symptoms.", {"entities": []}], ["Patients with high COPD symptomatology utilized more health care resources and had higher COPD-related health care costs during the 6-month post-survey period than patients with low symptomatology.", {"entities": []}], ["The incidence and severity of chronic lung diseases is growing and affects between 100 and 150 million people worldwide and is associated with a significant rate of mortality.", {"entities": []}], ["Unfortunately, the initial cause that triggers most chronic lung diseases remains unknown and current available therapies only ameliorate, but do not cure the disease.", {"entities": []}], ["Thus, there is a need for identification of new targets and development of novel therapies especially for those most severely affected.", {"entities": []}], ["IL-6, like other inflammatory cytokines, has been shown to be elevated in different lung diseases, but it was considered a byproduct of ongoing inflammation in the lung.", {"entities": []}], ["However, recent studies support a dissociation of IL-6 from inflammation in the lung and suggest that this cytokine plays an active role in pathogenesis of asthma and, in all likelihood, COPD.", {"entities": [[156, 162, "DISEASE"]]}], ["IL-6 may therefore be a germane target for treatment of these and other chronic lung disease.", {"entities": [[80, 92, "DISEASE"]]}], ["Here, we provide an overview of the studies in mouse models and human patients that provide support for the involvement of IL-6 in lung diseases.", {"entities": []}], ["Thalidomide is known to have anti-inflammatory and immunomodulatory actions.", {"entities": []}], ["However, the effect and the anti-asthmatic mechanism of thalidomide in the pathogenesis of asthmatic airways are not fully understood.", {"entities": []}], ["This study is designed to determine the effect and the potential mechanism of thalidomide in the pathogenesis of asthmatic airways using animal model of allergic asthma.", {"entities": [[153, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["Six-week-old female BALB/C mice were sensitized with alum plus ovalbumin (OVA) and were exposed to OVA via intranasal route for 3 days for challenge.", {"entities": []}], ["Thalidomide 200 mg/kg was given via gavage twice a day from a day before the challenge and airway hyperresponsivenss (AHR), airway inflammatory cells, and cytokines in bronchoalveolar lavage fluids (BALF) were evaluated.", {"entities": [[118, 121, "GENE"]]}], ["The expression levels of pro-inflammatory cytokines and other mediators were evaluated using ELISA, real time (RT)-qPCR, and flow cytometry.", {"entities": []}], ["CRL-2456, alveolar macrophage cell line, was used to test the direct effect of thalidomide on the activation of macrophages in vitro .", {"entities": []}], ["The mice with thalidomide treatment showed significantly reduced levels of allergen-induced BALF and lung inflammation, AHR, and the expression of a number of pro-inflammatory cytokines and mediators including Th2 related, IL-17 cytokines, and altered levels of allergen-specific IgG1/IgG2a.", {"entities": [[120, 123, "GENE"]]}], ["Of interesting note, thalidomide treatment significantly reduced expression levels of allergen- or Th2 cytokine-stimulated alternative activation of macrophages in vivo and in vitro .", {"entities": []}], ["These studies highlight a potential use of thalidomide in the treatment of allergic diseases including asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["This study further identified a novel inhibitory effect of thalidomide on alternative activation of macrophages as a potential mechanism of anti-asthmatic effect of thalidomide.", {"entities": []}], ["Severe asthma is found in approximately 10% of patients with asthma.", {"entities": [[7, 13, "DISEASE"], [61, 67, "DISEASE"]]}], ["Some factors associated with worse asthma control include rhinitis, gastroesophageal reflux disease, vocal cord dysfunction (VCD), nasal polyposis and bronchiectasis.", {"entities": [[58, 66, "DISEASE"], [151, 165, "DISEASE"], [35, 41, "DISEASE"], [68, 99, "DISEASE"]]}], ["Therefore, we evaluated the prevalence of these illnesses in patients with severe asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["We conducted a retrospective analysis of data obtained from electronic medical records of patients with severe asthma between January 2006 and June 2008.", {"entities": [[111, 117, "DISEASE"]]}], ["Symptoms of rhinitis and gastroesophageal reflux disease were evaluated as well as intolerance to nonsteroidal anti-inflammatory drugs.", {"entities": [[12, 20, "DISEASE"], [25, 56, "DISEASE"]]}], ["We evaluated the results of esophagogastroduodenoscopy, videolaryngoscopy and CT scans of the chest in order to confirm gastroesophageal reflux disease, nasal polyposis, vocal cord dysfunction and bronchiectasis.", {"entities": [[197, 211, "DISEASE"], [120, 151, "DISEASE"]]}], ["We evaluated 245 patients.", {"entities": []}], ["Rhinitis symptoms were present in 224 patients (91.4%); 18 (7.3%) had intolerance to nonsteroidal anti-inflammatory drugs, and 8 (3.3%) had nasal polyposis.", {"entities": [[0, 8, "DISEASE"]]}], ["Symptoms of gastroesophageal reflux disease were reported for 173 (70.6%) patients, although the diagnosis of gastroesophageal reflux disease was confirmed based on esophagogastroduodenoscopy or laryngoscopy findings in just 58 (33.6%) patients.", {"entities": [[12, 43, "DISEASE"], [110, 141, "DISEASE"]]}], ["Vocal cord dysfunction was suspected in 16 (6.5%) and confirmed through laryngoscopy in 4 (1.6%).", {"entities": []}], ["The patient records provided CT scans of the chest for 105 patients, and 26 (24.8%) showed bronchiectasis.", {"entities": [[91, 105, "DISEASE"]]}], ["Rhinitis and gastroesophageal reflux disease were the most common comorbidities observed, in addition to bronchiectasis.", {"entities": [[0, 8, "DISEASE"], [105, 119, "DISEASE"], [13, 44, "DISEASE"]]}], ["Therefore, in patients with severe asthma, associated diseases should be investigated as the cause of respiratory symptoms and uncontrolled asthma.", {"entities": [[35, 41, "DISEASE"], [140, 146, "DISEASE"]]}], ["There is paucity of data on the smoking habits of rural populations in developing countries.", {"entities": []}], ["This study aimed to explore cigarette smoking practices of a rural community in Ethiopia.", {"entities": []}], ["A community based cross-sectional study was conducted among 548 individuals from a random sample of households in a rural town and its surrounding rural districts.", {"entities": []}], ["Descriptive statistics and logistic regression were performed.", {"entities": []}], ["Twenty-eight percent (95% CI: 24.3% - 31.6%) of the respondents were current smokers.", {"entities": []}], ["A total of 105 (68%) smokers expressed an interest to quit while 37 (34%) had tried to quit previously but without success.", {"entities": []}], ["There was high exposure to second-hand smoke: 285 (52%) homes allowed indoor smoking, and in 181 (33%) indoor smoking took place daily.", {"entities": []}], ["Current smoking was strongly associated with male sex (OR\u2009=\u200983.0; 95% CI: 11.5 \u2013 599.0), and being a student was found to be protective of smoking (OR\u2009=\u20090.04; 95% CI: 0.005 \u2013 0.05).", {"entities": []}], ["Cigarette smoking is prevalent among the male rural town population in Ethiopia.", {"entities": []}], ["In addition, a high level of exposure to indoor second-hand smoke exists.", {"entities": []}], ["There is a need for investment in rural tobacco control, including educational campaigns and cost-effective smoking cessation services.", {"entities": []}], ["Helicobacter pylori ( H. pylori ) infects more than half of the world\u2019s population, causing chronic gastritis, peptic ulcers and gastric cancer.", {"entities": [[100, 109, "DISEASE"], [137, 143, "DISEASE"]]}], ["Urease B subunit (UreB), a conserved protein of H. pylori , is capable of inducing specific CD4 317\u2013329 and UreB 409\u2013421 , which are recognized by a major population of CD4 H. pylori ; cells secreting IL-17A did not.", {"entities": [[92, 95, "GENE"], [169, 172, "GENE"], [92, 95, "GENE"], [169, 172, "GENE"]]}], ["Taken together, our results suggest that two novel immunodominant epitopes can induce Th1 and Th17 immune responses, but only the induced Th1 lymphocytes mediate protection against H. pylori .", {"entities": []}], ["The aim of the present study was to investigate the chemical composition of the essential oil of Artemisia vestita and to determine the antibacterial activity of the essential oil and its two major components, grandisol and 1,8-cineole, against certain respiratory infection-causing bacterial strains, in vitro and in vivo .", {"entities": []}], ["The chemical composition of the essential oil was analyzed using gas chromatography-mass spectrometry.", {"entities": []}], ["A micro-well dilution method was used to determine the minimum inhibition concentration (MIC) values of the essential oil and its major constituents.", {"entities": []}], ["A model of Streptococcus pyogenes infection in mice was used to determine its in vivo activities.", {"entities": []}], ["Lung and blood samples were obtained to assess bacterial cell counts.", {"entities": []}], ["Toxicity evaluation of the essential oil and its components was completed by performing biochemical analysis of the serum, particularly monitoring aspartate transaminase, alanine transaminase, urea and creatinine.", {"entities": []}], ["The essential oil exhibited potent antibacterial activity, whereas the two major constituents were less potent.", {"entities": []}], ["The essential oil exhibited MIC values between 20 and 80 \u03bc g/ml, while the values of the two constituents were between 130 and 200 \u03bc g/ml.", {"entities": []}], ["Scanning electron microscopy results demonstrated that the essential oil inhibited biofilm formation and altered its architecture.", {"entities": []}], ["Survival curves indicated that the essential oil led to a reduction in the viability of different bacteria.", {"entities": []}], ["The essential oil also induced significant leakage of potassium ions from S. pyogenes .", {"entities": []}], ["The essential oil (100 \u03bc g/mouse) and grandisol (135 \u03bc g/mouse) significantly reduced the number of viable bacterial cells in the lungs (P<0.01).", {"entities": []}], ["However, intake of 100 \u03bc g/mouse of essential oil or grandisol 135 \u03bc g/mouse once or twice each day for 9 days did not produce any toxic effects in the mice.", {"entities": []}], ["In conclusion, the in vitro and in vivo results suggested that the essential oil of A. vestita and one of its major constituents, grandisol, can significantly inhibit the growth of different bacterial strains.", {"entities": []}], ["T-lymphocytes and B-lymphocytes are key players in allergic asthma, with B-lymphocytes producing antigen-specific immunoglobulins E (IgE).", {"entities": [[51, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["We used a mouse model of chemical-induced asthma and transferred B-lymphocytes from sensitized animals into na\u00efve wild type mice, B-lymphocyte knock-out (B-KO) mice or severe combined immunodeficiency (SCID) mice.", {"entities": [[168, 200, "DISEASE"], [42, 48, "DISEASE"]]}], ["On days 1 and 8, BALB/c mice were dermally sensitized with 0.3% toluene diisocyanate (TDI) (20\u00b5l/ear).", {"entities": []}], ["On day 15, mice were euthanized and the auricular lymph nodes isolated.", {"entities": []}], ["B-lymphocytes (CD19", {"entities": [[15, 19, "GENE"]]}], ["The impact of chronic obstructive pulmonary disease (COPD) severity on survival after curative resection of early\u2010stage lung cancer (NSCLC) has not been sufficiently elucidated.", {"entities": [[120, 131, "DISEASE"], [14, 51, "DISEASE"], [125, 131, "DISEASE"]]}], ["We retrospectively reviewed 250 consecutive patients who underwent lobectomy with lymph nodal dissection for pathological stage I\u2013II NSCLC.", {"entities": []}], ["Among the COPD patients, 28 were classified as Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1, 21 as GOLD 2, and one as GOLD 3.", {"entities": []}], ["The cumulative overall survival (OS) of the non\u2010COPD, GOLD 1, and GOLD 2\u20133 groups at five\u2009years was 90.7%, 85.7%, and 55.3%, respectively, ( P \u2009<\u20090.0001), while recurrence\u2010free survival (RFS) between the groups at five\u2009years was 84.7%, 80.7%, and 72.9%, respectively.", {"entities": []}], ["Although RFS in the GOLD 2\u20133 group tended to indicate a poor prognosis, there was no statistical difference between the groups ( P \u2009=\u20090.385).", {"entities": []}], ["In multivariate analysis, age \u226575\u2009years, pN1, and GOLD 2\u20133 COPD were independent factors for a poor prognosis ( P \u2009=\u20090.034, P \u2009=\u20090.010, and P \u2009=\u20090.030, respectively).", {"entities": []}], ["Our results indicate that early stage NSCLC patients with COPD had a significantly increased risk of poorer OS and potentially an increased risk of poor RFS.", {"entities": []}], ["Easy access to next generation sequencing has enabled the rapid analysis of complex microbial populations.", {"entities": []}], ["To take full advantage of these technologies, animal models enabling the manipulation of human microbiomes and the study of the impact of such perturbations on the host are needed.", {"entities": []}], ["To this aim we are developing experimentally tractable and clinically relevant pig models of the human adult and infant gastro-intestinal tract.", {"entities": []}], ["The intestine of germ-free piglets was populated with human adult or infant fecal microbial populations, and the piglets were maintained on solid or milk diet, respectively.", {"entities": []}], ["Amplicons of 16S rRNA V6 region were deep-sequenced to monitor to what extent the transplanted human microbiomes changed in the pig.", {"entities": []}], ["Within 24 h of transfer of human fecal microbiome to pigs, bacterial microbiomes rich in Proteobacteria emerged.", {"entities": []}], ["These populations evolved toward a more diverse composition rich in Bacteroidetes and Firmicutes .", {"entities": []}], ["In the experiment where infant microbiome was used, the phylogenetic composition of the transplanted bacterial population converged toward that of the human inoculum.", {"entities": []}], ["A majority of sequences belonged to a relatively small number of operational taxonomic units, whereas at the other end of the abundance spectrum, a large number of rare and transient OTUs were detected.", {"entities": []}], ["Analysis of fecal and colonic microbiomes originating from the same animal indicate that feces closely replicate the colonic microbiome.", {"entities": []}], ["We conclude that the pig intestine can be colonized with human fecal microbiomes to generate a realistic model of the human GI tract.", {"entities": []}], ["White adipose tissue is recognized as a highly active organ, which is closely related to a large number of physiological and metabolic processes besides storing triglycerides.", {"entities": []}], ["However, little is known regarding the response of adipose tissue to acute inflammation.", {"entities": []}], ["Therefore, in this study we employed growing pigs to investigate the changes of lipid metabolism and proteome in white adipose tissue after lipopolysaccharide (LPS) stimulation as a model for bacterial infection.", {"entities": []}], ["The expression of lipid metabolism and inflammation related genes was determined by quantitative real-time polymerase chain reaction.", {"entities": []}], ["Label-free proteomics analysis was used to investigate changes of the protein profile in white adipose tissue and western blot was used to verify changes of selected adipokines.", {"entities": []}], ["The results indicated that LPS significantly increased the expression of toll-like receptor (TLR) 2/4 pathway-related genes and pro-inflammatory factors.", {"entities": []}], ["Lipid metabolism related genes, including acetyl-CoA carboxylase 1 (ACACA), fatty acid synthase (FASN), stearoyl-CoA desaturase (SCD), uncoupling protein 2 (UCP2), and 11 \u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1), were down-regulated and the lipolytic enzyme activity was decreased after LPS injection.", {"entities": [[68, 73, "GENE"], [97, 101, "GENE"], [129, 132, "GENE"], [157, 161, "GENE"]]}], ["Proteome analysis revealed 47 distinct proteins with\u2009>\u20092-fold changes.", {"entities": []}], ["The down-regulation of two proteins (cAMP-dependent protein kinase type II-alpha regulatory subunit and \u03b2-tubulin) has been verified by western blot analysis.", {"entities": []}], ["In addition, the abundance of two adipokines (adiponectin and zinc-\u03b12-glycoprotein) was significantly increased after LPS injection.", {"entities": []}], ["In conclusion, LPS challenge can cause acute inflammation in white adipose tissue.", {"entities": []}], ["Concurrently, lipid metabolism was significantly suppressed and the abundance of several proteins changed in white adipose tissue.", {"entities": []}], ["The results provide new clues to understand the adipose dysfunction during inflammation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12944-015-0067-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many epidemiological studies conducted in the last several years have reported associations between exposure to airborne particulate matter, measured as PM10 (<10 microm in diameter), and daily morbidity and mortality.", {"entities": []}], ["However, much of the evidence involves effects on the elderly population; there is less evidence about the effects of particulates on children, especially those under 2 years of age.", {"entities": []}], ["To examine these issues, we conducted time-series analyses of 2 years of daily visits to primary health care clinics in Santiago, Chile, where counts were computed for either upper or lower respiratory symptoms and for cohorts of children 3-15 years of age and below age 2.", {"entities": []}], ["Daily PM10 and ozone measurements and meteorological variables were available from instruments located in downtown Santiago.", {"entities": []}], ["The multiple regression analysis indicates a statistically significant association between PM10 and medical visits for lower respiratory symptoms in children ages 3-15 and in children under age 2.", {"entities": []}], ["PM10 is also associated with medical visits related to upper respiratory symptoms in the older cohort, while ozone is associated with visits related to both lower and upper respiratory symptoms in the older cohort.", {"entities": []}], ["For children under age 2, a 50- microg/m3 change in PM10 (the approximate interquartile range) is associated with a 4-12% increase in lower respiratory symptoms.", {"entities": []}], ["For children 3-15 years of age, the increase in lower respiratory symptoms ranges from 3 to 9% for a 50- microg/m3 change in PM10 and 5% per 50 ppb change in ozone.", {"entities": []}], ["These magnitudes are similar to results from studies of children undertaken in Western industrial nations.", {"entities": []}], ["To identify predictive factors and mortality of patients with influenza admitted to intensive care units (ICU) we carried out a prospective cohort study of patients hospitalized with laboratory-confirmed influenza in adult ICUs in a network of Canadian hospitals between 2006 and 2012.", {"entities": [[62, 71, "DISEASE"], [204, 213, "DISEASE"]]}], ["There were 626 influenza-positive patients admitted to ICUs over the six influenza seasons, representing 17\u00b79% of hospitalized influenza patients, 3\u00b71/10 000 hospital admissions.", {"entities": [[15, 24, "DISEASE"], [73, 82, "DISEASE"], [127, 136, "DISEASE"]]}], ["Variability occurred in admission rate and proportion of hospital influenza patients who were admitted to ICUs (proportion range by year: 11\u00b77\u201329\u00b74%; 21\u00b73% in the 2009\u20132010 pandemic).", {"entities": [[66, 75, "DISEASE"]]}], ["In logistic regression models ICU patients were younger during the pandemic and post-pandemic period, and more likely to be obese than hospital non-ICU patients.", {"entities": []}], ["Influenza B accounted for 14\u00b72% of all ICU cases and had a similar ICU admission rate as influenza A. Influenza-related mortality was 17\u00b78% in ICU patients compared to 2\u00b70% in non-ICU patients.", {"entities": [[0, 9, "DISEASE"], [89, 98, "DISEASE"], [102, 111, "DISEASE"]]}], ["As a highly conserved metabolic pathway, the Wnt signaling pathway is involved in cell differentiation, proliferation and several other processes.", {"entities": []}], ["In normal cells, this pathway is suppressed, and abnormal activation is often associated with tumor occurrence and development.", {"entities": []}], ["In certain types of tumor, Wnt inhibitory factor 1 (WIF-1), an inhibitor of the Wnt pathway, inhibits tumor growth.", {"entities": []}], ["However, the effect of the expression of WIF-1 on gallbladder cancer remains to be fully elucidated.", {"entities": [[50, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["In the current study, reverse transcription-quantitative polymerase chain reaction and western blotting were conducted.", {"entities": []}], ["The present study demonstrated that, in gallbladder cancer, WIF-1 generally exhibited low levels of expression as a result of gene promoter methylation.", {"entities": [[40, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["Treatment with the drug, 5-aza-2-deoxycytidine, increased the expression of WIF-1 in the GBC-SD gallbladder cell line.", {"entities": []}], ["In addition, a WIF-1-expression plasmid was transfected into GBC-SD cells, and it was found that cell proliferation, invasion and metastasis declined significantly, whereas the apoptotic rate increased.", {"entities": []}], ["A nude mouse tumor transplantation experiment showed that the oncogenicity of the GBC-SD cells expressing WIF-1 was substantially lower, compared with that of the untransfected GBC-SD cells and of GBD-SD cells expressing the control plasmid.", {"entities": []}], ["A fluorescent protein chip experiment showed that the restored expression of WIF-1 affected the expression of several cellular proteins.", {"entities": []}], ["These alterations may explain the different biological behavior of the tumor cells expressing WIF-1.", {"entities": []}], ["As an effective inhibitory factor of the Wnt signaling pathway, WIF-1 modulated the expression of proteins controlling the proliferation, apoptosis and metastasis of gallbladder tumor cells, thus suppressing the tumor.", {"entities": []}], ["Therefore, WIF-1 may be an effective treatment target for gallbladder cancer.", {"entities": [[58, 76, "DISEASE"], [70, 76, "DISEASE"]]}], ["Rapid response teams (RRTs) have been shown to reduce cardiopulmonary arrests outside the intensive care unit (ICU).", {"entities": []}], ["Yet the utility of RRTs remains in question, as most large studies have failed to demonstrate a significant reduction in hospital-wide mortality after RRT implementation.", {"entities": []}], ["A cohort design with historical controls was used to determine the effect on hospital-wide mortality of an RRT in which clinical judgment, in addition to vital-signs criteria, was widely promoted as a key trigger for activation.", {"entities": []}], ["All nonprisoner patients admitted to a tertiary referral public teaching hospital from 2003 through 2008 were included.", {"entities": []}], ["In total, 77, 021 admissions before RRT implementation (2003 through 2005) and 79, 013 admissions after RRT implementation (2006 through 2008) were evaluated.", {"entities": []}], ["The a priori primary outcome was unadjusted hospital-wide mortality.", {"entities": []}], ["A Poisson regression model was then used to adjust for hospital-wide mortality trends over time.", {"entities": []}], ["Secondary outcomes defined a priori were unadjusted out-of-ICU mortality and out-of-ICU cardiopulmonary-arrest codes.", {"entities": []}], ["In total, 855 inpatient RRTs (10.8 per 1, 000 hospital-wide discharges) were activated during the 3-year postintervention period.", {"entities": []}], ["Forty-seven percent of RRTs were activated for reasons of clinical judgment.", {"entities": []}], ["Hospital-wide mortality decreased from 15.50 to 13.74 deaths per 1, 000 discharges after RRT implementation (relative risk, 0.887; 95% confidence interval (CI), 0.817 to 0.963; P = 0.004).", {"entities": []}], ["After adjusting for inpatient mortality trends over time, the reduction in hospital-wide mortality remained statistically significant (relative risk, 0.825; 95% CI, 0.694 to 0.981; P = 0.029).", {"entities": []}], ["Out-of-ICU mortality decreased from 7.08 to 4.61 deaths per 1, 000 discharges (relative risk, 0.651; 95% CI, 0.570 to 0.743; P < 0.001).", {"entities": []}], ["Out-of-ICU cardiopulmonary-arrest codes decreased from 3.28 to 1.62 codes per 1, 000 discharges (relative risk, 0.493; 95% CI, 0.399 to 0.610; P < 0.001).", {"entities": []}], ["Implementation of an RRT in which clinical judgment, in addition to vital-signs criteria, was widely cited as a rationale for activation, was associated with a significant reduction in hospital-wide mortality, out-of-ICU mortality, and out-of-ICU cardiopulmonary-arrest codes.", {"entities": []}], ["The frequent use of clinical judgment as a criterion for RRT activation was associated with high RRT utilization.", {"entities": []}], ["Theophylline is a nonspecific inhibitor of phosphodiesterases that, despite exerting bronchodilator and anti-inflammatory effects, is a third-line therapy rarely used to treat chronic airflow limitation.", {"entities": []}], ["We wished to evaluate the efficacy of oral theophylline as measured by improvements in trough (pre-dose) or peak (post-dose) FEV 1 and FVC in patients with clinically stable COPD.", {"entities": [[125, 128, "GENE"]]}], ["Meta-analysis of randomized, placebo-controlled trials reported as of June 2005 in which theophylline was orally administered to stable COPD patients and the functional evaluations included pre- and post-theophylline values for FEV 1 and FVC.", {"entities": [[228, 231, "GENE"]]}], ["A total of 18 trials were included in the meta-analysis.", {"entities": []}], ["The weighted mean differences (WMD) with 95% confidence intervals (95% CI) for improvement over placebo in trough FEV 1 and FVC were 0.108L (0.053\u20130.163) and 0.186L (0.036\u20130.336), respectively, while peak FEV 1 and FVC improved by 0.096L (0.044\u20130.147) and 0.242L (0.11\u20130.374), respectively.", {"entities": [[114, 117, "GENE"], [205, 208, "GENE"], [114, 117, "GENE"], [205, 208, "GENE"]]}], ["Treatment with oral theophylline improves both trough and peak FEV 1 and FVC in clinically stable COPD patients.", {"entities": [[63, 66, "GENE"]]}], ["These results support previously reported benefits of theophylline in COPD.", {"entities": []}], ["Adrenalin solution given subcutaneously is usually rapidly absorbed, probably by lymphatic channels.", {"entities": []}], ["The speed of this process may be influenced by the circulation rate.", {"entities": []}], ["The relative amounts of adrenalin at any moment unabsorbed at the site of inoculation, carried in the circulating fluids, and taken up by the reacting tissues can be calculated from figures extracted from the curve of the blood pressure changes.", {"entities": []}], ["The relative rates of transference of adrenalin into the blood and from the circulation into the tissues can also be estimated.", {"entities": []}], ["When absorption takes place rapidly a large quantity of the drug comes into action at once and the maximum occurs early, the curve of blood pressure reaches a considerable height, and subsides quickly.", {"entities": []}], ["When absorption is slow the apex appears later and does not reach so high a level.", {"entities": []}], ["The response to adrenalin bears a logarithmic relationship to the dose employed and a method of allowing for this is indicated.", {"entities": []}], ["To assess whether the secular trends in type 2 diabetes prevalence differ between abdominally obese and non\u2010obese individuals.", {"entities": []}], ["Data from the National Health and Nutrition Examination Surveys (NHANES) were used to estimate the prevalence of type 2 diabetes and abdominal obesity among individuals aged \u226520 years in the USA from 1999/2000 to 2013/2014, after standardization to the age, sex and ethnicity population distribution estimates on January 1, 2014, as published by the US Census Bureau.", {"entities": [[143, 150, "DISEASE"]]}], ["The prevalence of abdominal obesity in the US population increased from 47.4% (95% confidence interval [CI] 42.6\u201052.2) in 1999/2000 to 57.2% (95% CI 55.9\u201058.5) in 2013/2014.", {"entities": [[28, 35, "DISEASE"]]}], ["A significant increase was observed in all age groups: 20 to 44, 45 to 64, and \u226565 years.", {"entities": []}], ["The prevalence of type 2 diabetes has also increased from 8.8% (95% CI 7.2\u201010.4) in 1999/2000 to 11.7% (95% CI 10.9\u201012.6) in 2013/2014, with no substantial change in trend over the recent years.", {"entities": []}], ["However, the increase in the prevalence of type 2 diabetes was limited to individuals with abdominal obesity, and more specifically to individuals aged \u226545 years with abdominal obesity, with no significant change in prevalence in the non\u2010obese group and in individuals aged <45 years.", {"entities": [[101, 108, "DISEASE"], [177, 184, "DISEASE"]]}], ["These findings highlight the critical importance of abdominal obesity\u2014both as a likely key contributor to the continuing epidemic of type 2 diabetes in the USA and as a priority target for public health interventions.", {"entities": [[62, 69, "DISEASE"]]}], ["Helminths immunomodulate their hosts and induce a regulatory, anti-inflammatory milieu that prevents allergies and autoimmune diseases.", {"entities": []}], ["Helminth immunomodulation may benefit sepsis outcome by preventing exacerbated inflammation and severe pathology, but the influence on bacterial clearance remains unclear.", {"entities": []}], ["To address this, mice were chronically infected with the filarial nematode Litomosoides sigmodontis (L.s.)", {"entities": []}], ["and the outcome of acute systemic inflammation caused by i.p.", {"entities": []}], ["Escherichia coli injection was determined.", {"entities": []}], ["infection significantly improved E. coli -induced hypothermia, bacterial clearance and sepsis survival and correlated with reduced concentrations of associated pro-inflammatory cytokines/chemokines and a less pronounced pro-inflammatory macrophage gene expression profile.", {"entities": []}], ["Improved sepsis outcome in L.s.", {"entities": []}], ["-infected animals was mediated by macrophages, but independent of the alternatively activated macrophage subset.", {"entities": []}], ["Endosymbiotic Wolbachia bacteria that are present in most human pathogenic filariae, as well as L.s.", {"entities": []}], [", signal via TLR2 and modulate macrophage function.", {"entities": [[13, 17, "GENE"]]}], ["Here, gene expression profiles of peritoneal macrophages from L.s.", {"entities": []}], ["-infected mice revealed a downregulation of genes involved in TLR signaling, and pulsing of macrophages in vitro with L.s.", {"entities": []}], ["extract reduced LPS-triggered activation.", {"entities": []}], ["Subsequent transfer improved sepsis outcome in na\u00efve mice in a Wolbachia - and TLR2-dependent manner.", {"entities": []}], ["In vivo, phagocytosis was increased in macrophages from L.s.", {"entities": []}], ["-infected wild type, but not TLR2-deficient animals.", {"entities": []}], ["In association, L.s.", {"entities": []}], ["infection neither improved bacterial clearance in TLR2-deficient animals nor ameliorated E. coli -induced hypothermia and sepsis survival.", {"entities": []}], ["These results indicate that chronic L.s.", {"entities": []}], ["infection has a dual beneficial effect on bacterial sepsis, reducing pro-inflammatory immune responses and improving bacterial control.", {"entities": []}], ["Thus, helminths and their antigens may not only improve the outcome of autoimmune and allergic diseases, but may also present new therapeutic approaches for acute inflammatory diseases that do not impair bacterial control.", {"entities": []}], ["As the human immune system evolved in the presence of helminth infections, it is postulated that improved hygiene and subsequent loss of helminth infections and their immunomodulatory functions contributed to the sharp increase of autoimmune diseases and allergies over the last decades.", {"entities": []}], ["Accordingly, helminth-induced anti-inflammatory, regulatory immune responses ameliorate allergy and autoimmune diseases and are likely to impact other immunological disorders including sepsis.", {"entities": []}], ["Sepsis is an exacerbated, systemic inflammatory disease that occurs when pathogens cannot be locally confined and spread via the blood stream.", {"entities": []}], ["Thus, efficient sepsis therapies should reduce excessive inflammation without impairing protective immune responses.", {"entities": []}], ["In the present study we demonstrate that chronic filarial infection modulates macrophages to a less pro-inflammatory phenotype with improved phagocytic capacity.", {"entities": []}], ["This immunomodulation reduces sepsis-induced inflammation and hypothermia and clears bacteria more efficiently thus improving sepsis survival.", {"entities": []}], ["Moreover, we found that Wolbachia , the endosymbiotic bacteria of filariae, play a crucial role in triggering the correct macrophage response via TLR2.", {"entities": [[146, 150, "GENE"]]}], ["Thus, our observations suggest that helminths and helminth-derived antigens may not only present new treatment options for allergies and autoimmune diseases, but may also allow treatment of sepsis caused inflammation without impairing bacterial control.", {"entities": []}], ["The workshop entitled \u2018Interventions to Slow Aging in Humans: Are We Ready?\u2019 was held in Erice, Italy, on October 8\u201313, 2013, to bring together leading experts in the biology and genetics of aging and obtain a consensus related to the discovery and development of safe interventions to slow aging and increase healthy lifespan in humans.", {"entities": []}], ["There was consensus that there is sufficient evidence that aging interventions will delay and prevent disease onset for many chronic conditions of adult and old age.", {"entities": []}], ["Essential pathways have been identified, and behavioral, dietary, and pharmacologic approaches have emerged.", {"entities": []}], ["Although many gene targets and drugs were discussed and there was not complete consensus about all interventions, the participants selected a subset of the most promising strategies that could be tested in humans for their effects on healthspan.", {"entities": []}], ["These were: (i) dietary interventions mimicking chronic dietary restriction (periodic fasting mimicking diets, protein restriction, etc.", {"entities": []}], ["); (ii) drugs that inhibit the growth hormone/IGF-I axis; (iii) drugs that inhibit the mTOR\u2013S6K pathway; or (iv) drugs that activate AMPK or specific sirtuins.", {"entities": []}], ["These choices were based in part on consistent evidence for the pro-longevity effects and ability of these interventions to prevent or delay multiple age-related diseases and improve healthspan in simple model organisms and rodents and their potential to be safe and effective in extending human healthspan.", {"entities": []}], ["The authors of this manuscript were speakers and discussants invited to the workshop.", {"entities": []}], ["The following summary highlights the major points addressed and the conclusions of the meeting.", {"entities": []}], ["Traffic crashes and related injuries are important causes of morbidity and mortality and impose insofar an important burden on public health.", {"entities": []}], ["However, research in this area is often under-funded.", {"entities": []}], ["The aim of this study was to analyse quantity, evolution and geographic distribution of traffic medicine-related research.", {"entities": []}], ["This multi-sectorial field covers both transport and health care sectors.", {"entities": []}], ["A scientometric approach in combination with visualizing density equalizing mapping was used to analyse published data related to the field of traffic medicine between 1900 and 2008 within the \u201cWeb of Science\u201d (WoS) database.", {"entities": []}], ["In total, 5,193 traffic medicine-associated items were produced between 1900 and 2008.", {"entities": []}], ["The United States was found to have the highest research activity with a production of n\u2009=\u20092,330 published items, followed by Germany (n\u2009=\u2009298) and Canada (n\u2009=\u2009219).", {"entities": []}], ["Cooperation analyses resulted in a peak of published multilateral cooperations in the year of 2003.", {"entities": []}], ["The country with the highest multilateral activity was the USA.", {"entities": []}], ["The average number of cited references per publication varied heavily over the last 20 years with a maximum of 27.67 in 1995 and a minimum of 15.08 in 1998.", {"entities": []}], ["Also, a further in-depth analysis was performed with a focus solely on public health aspects which revealed similar trends.", {"entities": []}], ["Summarizing the present data it can be stated traffic medicine-related research productivity grows annually.", {"entities": []}], ["Also, an active networking between countries is present.", {"entities": []}], ["The data of the present study may be used by scientific organisations in order to gain detailed information about research activities in this field which is extremely important for public health.", {"entities": []}], ["Extending the classical concept considering an imbalance exclusively of T helper(h) 1 and Th2 cells on the bottom of many inflammatory diseases, Th17 cells were recently described.", {"entities": []}], ["Today, there is sufficient experimental evidence to classify psoriasis and allergic contact dermatitis (ACD) amongst other inflammatory skin disorders as IL-17 associated diseases.", {"entities": [[84, 102, "DISEASE"], [61, 70, "DISEASE"], [75, 102, "DISEASE"], [92, 102, "DISEASE"], [104, 107, "GENE"]]}], ["In several human studies, T-cell-clones could be isolated from eczema biopsies, and high IL-17 levels were observed after challenge with allergen.", {"entities": []}], ["In the last years, the phenotype of these IL-17 releasing T cells was in the focus of discussion.", {"entities": []}], ["It has been suggested that Th17 could be identified by expression of retinoic acid receptor-related orphan receptor (ROR)C (humans) or ROR \u03b3 t (mice) and IL-17, accompanied by the absence of IFN- \u03b3 and IL-22.", {"entities": []}], ["In cells from skin biopsies, contact allergens elevate IL-17A, IL-23, and RORC within the subset of Th cells.", {"entities": [[74, 78, "GENE"]]}], ["The indications for a participation of Th17 in the development of ACD are supported by data from IL-17 deficient mice with reduced contact hypersensitivity (CHS) reactions that could be restored after transplantation of wild type CD4", {"entities": [[66, 69, "GENE"], [230, 233, "GENE"]]}], ["Medication adherence is critical for patient treatment.", {"entities": []}], ["This study involved evaluating how implementing Short Message Service (SMS) reminders affected patient medication adherence and related factors.", {"entities": [[71, 74, "GENE"]]}], ["We used a structured questionnaire to survey outpatients at three medical centers.", {"entities": []}], ["Patients aged 20\u00a0years and older who were prescribed more than 7\u00a0days of a prescription medication were randomized into SMS intervention or control groups.", {"entities": [[120, 123, "GENE"]]}], ["The intervention group received daily messages reminding them of aspects regarding taking their medication; the control group received no messages.", {"entities": []}], ["A phone follow-up was performed to assess outcomes after 8\u00a0days.", {"entities": []}], ["Data were collected from 763 participants in the intervention group and 435 participants in the control group.", {"entities": []}], ["After participants in the intervention group received SMS reminders to take medication or those in the control group received no messages, incidences of delayed doses were decreased by 46.4 and 78.8% for those in the control and intervention groups, respectively.", {"entities": [[54, 57, "GENE"]]}], ["The rate of missed doses was decreased by 90.1% for participants in the intervention group and 61.1% for those in the control group.", {"entities": []}], ["We applied logistic regression analysis and determined that participants in the intervention group had a 3.2-fold higher probability of having a decrease in delayed doses compared with participants in the control group.", {"entities": []}], ["Participants in the intervention group also showed a 2.2-fold higher probability of having a decrease in missed doses compared with participants in the control group.", {"entities": []}], ["Use of SMS significantly affected the rates of taking medicine on schedule.", {"entities": [[7, 10, "GENE"]]}], ["Therefore, daily SMS could be useful for reminding patients to take their medicine on schedule.", {"entities": [[17, 20, "GENE"]]}], ["Climate change and associated increases in climate variability will likely further exacerbate global health disparities.", {"entities": []}], ["More research is needed, particularly in developing countries, to accurately predict the anticipated impacts and inform effective interventions.", {"entities": []}], ["Building on the information presented at the 2009 Joint Indo\u2013U.S.", {"entities": []}], ["Workshop on Climate Change and Health in Goa, India, we reviewed relevant literature and data, addressed gaps in knowledge, and identified priorities and strategies for future research in India.", {"entities": []}], ["The scope of the problem in India is enormous, based on the potential for climate change and variability to exacerbate endemic malaria, dengue, yellow fever, cholera, and chikungunya, as well as chronic diseases, particularly among the millions of people who already experience poor sanitation, pollution, malnutrition, and a shortage of drinking water.", {"entities": [[171, 182, "DISEASE"], [144, 156, "DISEASE"], [158, 165, "DISEASE"], [127, 134, "DISEASE"]]}], ["Ongoing efforts to study these risks were discussed but remain scant.", {"entities": []}], ["A universal theme of the recommendations developed was the importance of improving the surveillance, monitoring, and integration of meteorological, environmental, geospatial, and health data while working in parallel to implement adaptation strategies.", {"entities": []}], ["It will be critical for India to invest in improvements in information infrastructure that are innovative and that promote interdisciplinary collaborations while embarking on adaptation strategies.", {"entities": []}], ["This will require unprecedented levels of collaboration across diverse institutions in India and abroad.", {"entities": []}], ["The data can be used in research on the likely impacts of climate change on health that reflect India\u2019s diverse climates and populations.", {"entities": []}], ["Local human and technical capacities for risk communication and promoting adaptive behavior must also be enhanced.", {"entities": []}], ["Interleukin (IL)-18 is an important regulator of innate and acquired immune responses and has multiple roles in chronic inflammation and autoimmune disorders.", {"entities": []}], ["Obesity is characterized by low- grade chronic inflammation.", {"entities": [[0, 7, "DISEASE"]]}], ["IL-18 has been suggested as an adipogenic cytokine that is associated with excess adiposity.", {"entities": []}], ["The purpose of this study is to evaluate the relationship between IL-18 gene polymorphisms (\u2212137\u2009G/C and \u2212607\u2009C/A) and obesity.", {"entities": [[119, 126, "DISEASE"]]}], ["All 680 subjects were genotyped for the polymorphisms of IL-18 gene promoters (at positions \u2212137\u2009G/C and \u2212607\u2009C/A) using a polymerase chain reaction (271 cases with BMI \u226525\u2009kg/m Analyses of the genotype distributions revealed that IL-18 \u2013607\u2009C/A polymorphism was associated with an increase in body mass index in obese women in the Korean population (chi(2)\u2009=\u200912.301, df \u2009=\u20092, p \u2009=\u20090.015).", {"entities": []}], ["Carriage of the A allele at position \u2212607 in the promoter of the IL-18 gene may have a role in the development of obesity.", {"entities": [[114, 121, "DISEASE"]]}], ["Patient reported outcome measures (PROMs) are widely used in mental healthcare research for quality of life assessment but most fail to capture the breadth of health and non-health domains that can be impacted.", {"entities": []}], ["We report the psychometric validation of a novel, multi-dimensional instrument based on Amartya Sen\u2019s capability approach intended for use as an outcome measure in mental health research.", {"entities": []}], ["The Oxford Capabilities Questionnaire for Mental Health (OxCAP-MH) is a 16-item self-complete capability measure that covers multiple domains of functioning and welfare.", {"entities": []}], ["Data for validation of the instrument were collected through a national randomised controlled trial of community treatment orders for patients with psychosis.", {"entities": []}], ["Complete OxCAP-MH data were available for 172 participants.", {"entities": []}], ["Internal consistency was established with Cronbach\u2019s alpha; an interclass correlation coefficient was used to assess test-retest reliability in a\u00a0sub-sample ( N \u2009=\u200950) tested one week apart.", {"entities": []}], ["Construct validity was established by comparing OxCAP-MH total scores with established instruments of illness severity and functioning: EuroQol (EQ-5D), Brief Psychiatric Rating Scale (BPRS), Global Assessment of Functioning (GAF) and Objective Social Outcomes Index (SIX).", {"entities": []}], ["Sensitivity was established by calculating standard error of measurement using distributional methods.", {"entities": []}], ["The OxCAP-MH showed good internal consistency (Cronbach\u2019s alpha 0.79) and test-retest reliability (ICC\u2009=\u20090.86).", {"entities": []}], ["Convergent validity was evidenced by strong correlations with the EQ-5D (VAS 0.52, p \u2009<\u2009.001) (Utility 0.45, p \u2009<\u2009.001), and divergent validity through more modest associations with the BPRS (\u22120.41, p \u2009<\u2009.001), GAF (0.24, p \u2009<\u2009.001) and SIX (0.12, p \u2009=\u2009ns).", {"entities": []}], ["A change of 9.2 points on a 0\u2013100 scale was found to be meaningful on statistical grounds.", {"entities": []}], ["The OxCAP-MH has demonstrable reliability and construct validity and represents a promising multi-dimensional alternative to existing patient-reported outcome measures for quality of life used in mental health research.", {"entities": []}], ["The online version of this article (10.1186/s12955-017-0825-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Smoking is the principle risk factor for development of chronic obstructive pulmonary disease (COPD).", {"entities": [[56, 93, "DISEASE"]]}], ["Multidrug resistance-associated protein 1 (MRP1) is known to protect against toxic compounds and oxidative stress, and might play a role in protection against smoke-induced disease progression.", {"entities": []}], ["We questioned whether MRP1-mediated transport is influenced by pulmonary drugs that are commonly prescribed in COPD.", {"entities": []}], ["The immortalized human bronchial epithelial cell line 16HBE14o Formoterol had a minor effect, whereas budesonide concentration-dependently decreased CF transport by MRP1.", {"entities": []}], ["Remarkably, addition of formoterol to the highest concentration of budesonide increased CF transport.", {"entities": []}], ["Ipratropium bromide inhibited CF transport at low concentrations and tended to increase CF transport at higher levels.", {"entities": []}], ["NAC increased CF transport by MRP1 in a concentration-dependent manner.", {"entities": []}], ["Our data suggest that, besides their positive effects on respiratory symptoms, budesonide, formoterol, ipratropium bromide, and NAC modulate MRP1 activity in bronchial epithelial cells.", {"entities": []}], ["Further studies are required to assess whether stimulation of MRP1 activity is beneficial for long-term treatment of COPD.", {"entities": []}], ["Gastroesophageal reflux disease (GERD) occurs when stomach acid frequently backs up (or refluxes) into the gullet (or esophagus), and it has serious consequences for the quality of life.", {"entities": []}], ["Usually this is felt as heartburn.", {"entities": []}], ["Because severely mentally retarded people usually do not utter complaints of heartburn, it requires a high index of suspicion to discover possible GERD.", {"entities": []}], ["Therefore it is relevant for care professionals such as nurses to have knowledge of those with a higher risk of GERD and of the possible manifestations of GERD.", {"entities": []}], ["Using a predefined search method, electronic databases were searched for studies relating the presence of symptoms to the presence of GERD.", {"entities": []}], ["Relevant data were extracted and the methodological quality of the studies assessed.", {"entities": []}], ["The results of the included studies were synthesized and conclusions about the level of evidence were drawn.", {"entities": []}], ["Nineteen studies were found relating symptoms to the presence of GERD.", {"entities": []}], ["Only four were of good methodological quality.", {"entities": []}], ["The studies were very diverse concerning the studied population, the study method, and the kind of symptoms examined.", {"entities": []}], ["This makes it difficult to synthesize the results of the studies.", {"entities": []}], ["There is evidence that patients with cerebral palsy, patients using anticonvulsive drugs, and those with an IQ lower than 35 more frequently have GERD.", {"entities": [[37, 51, "DISEASE"]]}], ["There is also evidence that vomiting, rumination and hematemesis are associated with a higher risk of the presence of GERD, whereas there is no clear scientific evidence that particular behavior symptoms are indicative for GERD.", {"entities": []}], ["The possible manifestations of GERD are many and varied.", {"entities": []}], ["A guideline will be made for care professionals to aid systematic observation of possible manifestations of GERD.", {"entities": []}], ["Earaches and outer ear infections are commonly associated with swimming.", {"entities": []}], ["In this study, we estimated the excess risk and health burden of earaches due to swimming in natural fresh and marine waters using results from a survey of over 50,000 beachgoers at nine beaches across the United States.", {"entities": []}], ["Prospective cohort studies were conducted at four freshwater and five marine sites in the United States and Puerto Rico.", {"entities": []}], ["Beach visitors were enrolled on summer weekends and holidays.", {"entities": []}], ["Ten to twelve days after the beach visit, respondents answered questions about health symptoms, including earaches or ear infections experienced since the beach visit.", {"entities": []}], ["Economic and physical burdens were also obtained.", {"entities": []}], ["Fixed slope, random intercept (beach site) multivariate logistic regression models were used to estimate the relationship between head immersion swimming exposure and earaches.", {"entities": []}], ["Model results were used to calculate excess risk for earaches attributable to swimming.", {"entities": []}], ["The overall incidence of self-reported earache was 1.6% in the 10\u201312 days after the beach visit.", {"entities": []}], ["Earaches were more frequent in head immersion swimmers compared to non-swimmers for all beach sites and age groups.", {"entities": []}], ["Earaches were unassociated with water sample measures of fecal contamination and turbidity.", {"entities": []}], ["After adjustment for covariates, we calculated 7.12 excess earaches among head immersion swimmers per 1,000 swimming events.", {"entities": []}], ["Twenty-four percent of those with earache reported missing their regular activities; 28% visited a doctor; 4% visited the emergency room; and 31% and 40% used prescription and non-prescription medications, respectively.", {"entities": []}], ["There are at least 128 million swimming events in natural waters annually.", {"entities": []}], ["Such frequent exposures could result in 900,000 excess earaches, 260,000 visits to the doctor, 39,900 visits to the emergency room, nearly $4 million dollars in out-of-pocket expenditures on prescription and over-the-counter medications, and close to 75,000 hours of clinician time.", {"entities": []}], ["More accurate estimates of swimming exposure are needed to improve population burden and associated cost estimates.", {"entities": []}], ["Prevalence of pulmonary tuberculosis (PTB) is known to be high in the indigenous tribal community Saharia in Madhya Pradesh, India.", {"entities": [[24, 36, "DISEASE"], [14, 36, "DISEASE"]]}], ["The risk factors for PTB are not well known among them.", {"entities": []}], ["This study was done to determine various risk factors associated with PTB in the indigenous community Saharia .", {"entities": []}], ["A prevalence survey was conducted among Saharias of Gwalior district of Madhya Pradesh.", {"entities": []}], ["The population surveyed was 12,123 which was the source of cases and controls for the present study.", {"entities": []}], ["All the bacillary-positive cases and controls in the ratio of 1:5 were included in the survey.", {"entities": []}], ["Data were collected by the trained health workers from the patients and controls using a semi-structured pre-coded and pre-tested questionnaire which included data on risk factors including demographic factors, host-related factors and household factors.", {"entities": []}], ["The individuals were also screened for diabetes mellitus and HIV.", {"entities": [[39, 56, "DISEASE"]]}], ["Malnutrition and history of asthma were associated with an increased risk of PTB.", {"entities": [[28, 34, "DISEASE"]]}], ["More than 56 per cent cases were attributed to malnutrition and 12 per cent attributed to asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["Low family income, alcohol consumption and smoking were the other contributors.", {"entities": []}], ["The risk was higher in males as compared to females.", {"entities": []}], ["The study emphasized that the main contributors were social factors.", {"entities": []}], ["Nutrition supplementation, especially in tuberculosis (TB) patients and integrated approach to improve their living conditions are needed to control TB in this community.", {"entities": [[41, 53, "DISEASE"]]}], ["The human leukocyte antigen (HLA) DRB1*1501 has been consistently associated with multiple sclerosis (MS) in nearly all populations tested.", {"entities": [[82, 100, "DISEASE"], [29, 32, "GENE"]]}], ["This points to a specific antigen presentation as the pathogenic mechanism though this does not fully explain the disease association.", {"entities": []}], ["The identification of expression quantitative trait loci (eQTL) for genes in the HLA locus poses the question of the role of gene expression in MS susceptibility.", {"entities": [[81, 84, "GENE"]]}], ["We analyzed the eQTLs in the HLA region with respect to MS-associated HLA-variants obtained from genome-wide association studies (GWAS).", {"entities": [[29, 32, "GENE"], [70, 73, "GENE"]]}], ["We found that the Tag of DRB1*1501 , rs3135388 A allele, correlated with high expression of DRB1 , DRB5 and DQB1 genes in a Caucasian population.", {"entities": [[25, 29, "GENE"], [92, 96, "GENE"], [108, 112, "GENE"]]}], ["In quantitative terms, the MS-risk AA genotype carriers of rs3135388 were associated with 15.7-, 5.2- and 8.3-fold higher expression of DQB1 , DRB5 and DRB1 , respectively, than the non-risk GG carriers.", {"entities": [[136, 140, "GENE"], [152, 156, "GENE"]]}], ["The haplotype analysis of expression-associated variants in a Spanish MS cohort revealed that high expression of DRB1 and DQB1 alone did not contribute to the disease.", {"entities": [[113, 117, "GENE"], [122, 126, "GENE"]]}], ["However, in Caucasian, Asian and African American populations, the DRB1*1501 allele was always highly expressed.", {"entities": []}], ["In other immune related diseases such as type 1 diabetes, inflammatory bowel disease, ulcerative colitis, asthma and IgA deficiency, the best GWAS-associated HLA SNPs were also eQTLs for different HLA Class II genes.", {"entities": [[58, 84, "DISEASE"], [106, 112, "DISEASE"], [86, 104, "DISEASE"], [158, 161, "GENE"], [197, 200, "GENE"], [158, 161, "GENE"], [197, 200, "GENE"]]}], ["Our data suggest that the DR/DQ expression levels, together with specific structural properties of alleles, seem to be the causal effect in MS and in other immunopathologies rather than specific antigen presentation alone.", {"entities": []}], ["We investigated whether circulating osteopontin (OPN) could be used as a biomarker for cervical cancer.", {"entities": [[96, 102, "DISEASE"], [87, 102, "DISEASE"]]}], ["We employed a monoclonal antibody (mAb 659) specific for the unique and intact thrombin-sensitive site in OPN using an inhibition ELISA.", {"entities": []}], ["We found significantly higher levels of OPN in 33 cervical cancer patients in both the plasma (mean +/- SD, 612 +/- 106 ng/mL) and serum (424 +/- 121 ng/mL) compared to healthy subjects [409 +/- 56 ng/mL, from 31 plasma samples ( P < 0.0001), and 314 +/- 98 ng/mL, from 32 serum samples ( P = 0.0002), respectively].", {"entities": [[59, 65, "DISEASE"], [50, 65, "DISEASE"]]}], ["Similar results were obtained when the plasma from a bigger group (147 individuals) of cervical cancer patients (560 +/- 211 ng/mL) were compared with the same plasma samples of the healthy individuals ( P = 0.0014).", {"entities": [[96, 102, "DISEASE"], [87, 102, "DISEASE"]]}], ["More significantly, the OPN level was highest in stage III-IV disease (614 +/- 210 ng/mL, from 52 individuals; P = 0.0001) and least and non-discriminatory in stage I (473 +/- 110 ng/mL, from 40 individuals; P = 0.5318).", {"entities": []}], ["No such discrimination was found when a mAb of a different specificity (mAb 446) was used in a similar inhibition ELISA to compare the two groups in the first study; a commercial capture ELISA also failed.", {"entities": []}], ["The possibility that the target epitope recognized by the antibody probe in these assays was absent from the circulating OPN due to protein truncation was supported by gel fractionation of the OPN found in patients\u2019 plasma: 60\u201364 kDa fragments were found instead of the presumably full-length OPN (68 kDa) seen in healthy people.", {"entities": []}], ["How these fragments are generated and what possible role they play in cancer biology remain interesting questions.", {"entities": [[70, 76, "DISEASE"]]}], ["In a recent issue of the European Respiratory Journal , S in et\u00a0al .", {"entities": []}], ["[1] presented recommendations on the definition of asthma\u2013chronic obstructive pulmonary disease overlap syndrome (ACOS).", {"entities": [[58, 95, "DISEASE"], [104, 112, "DISEASE"], [51, 57, "DISEASE"]]}], ["The presented conclusions, based on a round table discussion, are very important and notable, especially considering the current lack of specific clinical criteria for ACOS.", {"entities": []}], ["One of the key recommendations is that asthma or atopy should be diagnosed before age of 40\u2005years (or patients should have very large airway reversibility) in order to fulfil the criteria of ACOS.", {"entities": [[39, 45, "DISEASE"]]}], ["However, the scientific basis of using the 40-year cut-off remains debatable.", {"entities": []}], ["In addition, the proposal raises a major concern of underdiagnosing adult-onset asthma and ACOS if the suggested age limit is used.", {"entities": [[80, 86, "DISEASE"]]}], ["The suggested asthma-onset age limit of 40 as a criterion for ACOS may lead to severe underdiagnosis of ACOS http://ow.ly/rVSk30ckrOq", {"entities": [[14, 20, "DISEASE"]]}], ["Motivation: Gene set enrichment (GSE) analysis allows researchers to efficiently extract biological insight from long lists of differentially expressed genes by interrogating them at a systems level.", {"entities": []}], ["In recent years, there has been a proliferation of GSE analysis methods and hence it has become increasingly difficult for researchers to select an optimal GSE tool based on their particular dataset.", {"entities": []}], ["Moreover, the majority of GSE analysis methods do not allow researchers to simultaneously compare gene set level results between multiple experimental conditions.", {"entities": []}], ["Results: The ensemble of genes set enrichment analyses (EGSEA) is a method developed for RNA-sequencing data that combines results from twelve algorithms and calculates collective gene set scores to improve the biological relevance of the highest ranked gene sets.", {"entities": []}], ["EGSEA\u2019s gene set database contains around 25 000 gene sets from sixteen collections.", {"entities": []}], ["It has multiple visualization capabilities that allow researchers to view gene sets at various levels of granularity.", {"entities": []}], ["EGSEA has been tested on simulated data and on a number of human and mouse datasets and, based on biologists\u2019 feedback, consistently outperforms the individual tools that have been combined.", {"entities": []}], ["Our evaluation demonstrates the superiority of the ensemble approach for GSE analysis, and its utility to effectively and efficiently extrapolate biological functions and potential involvement in disease processes from lists of differentially regulated genes.", {"entities": []}], ["Availability and Implementation: EGSEA is available as an R package at http://www.bioconductor.org/packages/EGSEA/ .", {"entities": []}], ["The gene sets collections are available in the R package EGSEAdata from http://www.bioconductor.org/packages/EGSEAdata/ .", {"entities": []}], ["Contacts: monther.alhamdoosh@csl.com.au or mritchie@wehi.edu.au Supplementary information: Bioinformatics online.", {"entities": []}], ["Protease inhibitors have important function during homeostasis, inflammation and tissue injury.", {"entities": []}], ["In this study, we described the role of Schistosoma mansoni Sm KI-1 serine protease inhibitor in parasite development and as a molecule capable of regulating different models of inflammatory diseases.", {"entities": []}], ["First, we determine that recombinant (r) Sm KI-1 and its Kunitz domain but not the C-terminal region possess inhibitory activity against trypsin and neutrophil elastase (NE).", {"entities": []}], ["To better understand the molecular basis of NE inhibition by S m KI-1, molecular docking studies were also conducted.", {"entities": []}], ["Docking results suggest a complete blockage of NE active site by Sm KI-1 Kunitz domain.", {"entities": []}], ["Additionally, r Sm KI-1 markedly inhibited the capacity of NE to kill schistosomes.", {"entities": []}], ["In order to further investigate the role of Sm KI-1 in the parasite, we designed specific siRNA to knockdown Sm KI-1 in S .", {"entities": []}], ["SmKI-1 gene suppression in larval stage of S .", {"entities": []}], ["mansoni robustly impact in parasite development in vitro and in vivo .", {"entities": []}], ["To determine the ability of Sm KI-1 to interfere with neutrophil migration and function, we tested Sm KI-1 anti-inflammatory potential in different murine models of inflammatory diseases.", {"entities": []}], ["Treatment with Sm KI-1 rescued acetaminophen (APAP)-mediated liver damage, with a significant reduction in both neutrophil recruitment and elastase activity.", {"entities": []}], ["In the model of gout arthritis, this protein reduced neutrophil accumulation, IL-1\u03b2 secretion, hypernociception, and overall pathological score.", {"entities": [[21, 30, "DISEASE"], [16, 20, "DISEASE"]]}], ["Finally, we demonstrated the ability of Sm KI-1 to inhibit early events that trigger neutrophil recruitment in pleural cavities of mice in response to carrageenan.", {"entities": []}], ["In conclusion, Sm KI-1 is a key protein in S .", {"entities": []}], ["mansoni survival and it has the ability to inhibit neutrophil function as a promising therapeutic molecule against inflammatory diseases.", {"entities": []}], ["Schistosoma mansoni is one of the main agents of schistosomiasis, which is the most important human helminthic infection in terms of global morbidity and mortality.", {"entities": [[49, 64, "DISEASE"]]}], ["Although schistosomiasis represents a major public health problem in endemic countries, evidences show that S .", {"entities": [[9, 24, "DISEASE"]]}], ["mansoni downregulates inflammatory responses in many diseases.", {"entities": []}], ["Fortunately, the control of inflammatory responses is extended to pathogen-derived antigens, leading us to study one S .", {"entities": []}], ["mansoni Kunitz type protease inhibitor ( Sm KI-1), found in larval and adult phases of the parasite.", {"entities": []}], ["We demonstrate that Sm KI-1 inhibits trypsin and neutrophil elastase (NE).", {"entities": []}], ["Additionally, live parasites that SmKI-1 gene has been suppressed using siRNA displayed an impaired schistosome development both in vitro and in vivo .", {"entities": []}], ["Further, we demonstrate that Sm KI-1 possesses an anti-inflammatory potential in three different murine models of inflammatory diseases: acetaminophen (APAP)-mediated liver damage, gout arthritis, and pleural inflammation in response to carrageenan.", {"entities": [[186, 195, "DISEASE"], [181, 185, "DISEASE"]]}], ["In these inflammatory disease models, we evaluated Sm KI-1 effect on neutrophil and our results demonstrate this molecule is able to inhibit neutrophil migration and function, regulating inflammation.", {"entities": []}], ["Thus, our data suggest that Sm KI-1 is a promising therapeutic molecule against inflammatory diseases.", {"entities": []}], ["Mannose-binding Allium sativum leaf agglutinin (ASAL) is highly antinutritional and toxic to various phloem-feeding hemipteran insects.", {"entities": []}], ["ASAL has been expressed in a number of agriculturally important crops to develop resistance against those insects.", {"entities": []}], ["Awareness of the safety aspect of ASAL is absolutely essential for developing ASAL transgenic plants.", {"entities": []}], ["Following the guidelines framed by the Food and Agriculture Organization/World Health Organization, the source of the gene, its sequence homology with potent allergens, clinical tests on mammalian systems, and the pepsin resistance and thermostability of the protein were considered to address the issue.", {"entities": []}], ["No significant homology to the ASAL sequence was detected when compared to known allergenic proteins.", {"entities": []}], ["The ELISA of blood sera collected from known allergy patients also failed to show significant evidence of cross-reactivity.", {"entities": []}], ["In vitro and in vivo assays both indicated the digestibility of ASAL in the presence of pepsin in a minimum time period.", {"entities": []}], ["With these experiments, we concluded that ASAL does not possess any apparent features of an allergen.", {"entities": []}], ["This is the first report regarding the monitoring of the allergenicity of any mannose-binding monocot lectin having insecticidal efficacy against hemipteran insects.", {"entities": []}], ["In the canonical model of smooth muscle (SM) contraction, the contractile force is generated by phosphorylation of the myosin regulatory light chain (RLC 20 ) by the myosin light chain kinase (MLCK).", {"entities": []}], ["Moreover, phosphorylation of the myosin targeting subunit (MYPT1) of the RLC 20 phosphatase (MLCP) by the RhoA-dependent ROCK kinase, inhibits the phosphatase activity and consequently inhibits dephosphorylation of RLC 20 with concomitant increase in contractile force, at constant intracellular [Ca 20 and MYPT1 were both significantly decreased.", {"entities": []}], ["Experiments involving the irreversible MLCP inhibitor microcystin-LR, in the absence of Ca 20 upon RSK inhibition are not due solely to the increase in the phosphatase activity, but reflect direct or indirect phosphorylation of RLC 20 by RSK.", {"entities": []}], ["Finally, we show that agonist (U46619) stimulation of SM leads to activation of extracellular signal-regulated kinases ERK1/2 and PDK1, consistent with a canonical activation cascade for RSK.", {"entities": []}], ["Thus, we demonstrate a novel and important physiological function of the p90 ribosomal S6 kinase, which to date has been typically associated with the regulation of gene expression.", {"entities": []}], ["The lung clearance index (LCI), measured by multiple breath washout (MBW), reflects global ventilation inhomogeneity and is a sensitive marker of early cystic fibrosis (CF) lung disease.", {"entities": [[152, 167, "DISEASE"], [173, 185, "DISEASE"]]}], ["Current evidence is based on a customized mass spectrometry system that uses sulfur hexafluoride (SF 6 ) as a tracer gas, which is not widely available.", {"entities": []}], ["Nitrogen (N 2 ) washout may be better suited for clinical use and multi-center trials.", {"entities": []}], ["To compare the results obtained from a N 2 washout system to those generated by the SF 6 based system in healthy children and children with CF.", {"entities": []}], ["Children with CF were recruited from outpatient clinics; healthy children were recruited from the Research4Kids online portal.", {"entities": []}], ["Participants performed MBW SF6 (Amis 2000, Innovision, Denmark) and MBW N2 (ExhalyzerD, EcoMedics, Switzerland) in triplicate, in random order on the same day.", {"entities": []}], ["Agreement between systems was assessed by Bland-Altman plot.", {"entities": []}], ["Sixty-two healthy and 61 children with CF completed measurements on both systems.", {"entities": []}], ["In health there was good agreement between systems (limits of agreement \u22120.7 to 1.9); on average N 2 produced higher values of LCI (mean difference 0.58 (95% CI 0.42 to 0.74)).", {"entities": []}], ["In CF the difference between systems was double that in health with a clear bias towards disproportionately higher LCI N2 compared to LCI SF6 at higher mean values of LCI.", {"entities": []}], ["LCI N2 and LCI SF6 have similar discriminative power and intra-session repeatability but are not interchangeable.", {"entities": []}], ["MBW N2 offers a valid new tool to investigate early obstructive lung disease in CF, but requires independent normative values.", {"entities": [[52, 76, "DISEASE"], [64, 76, "DISEASE"]]}], ["Mental disorders such as depression are common and rank as major contributors to the global burden of disease.", {"entities": []}], ["Condition recognition and subsequent management of depression is variable and influenced by the attitudes and beliefs of clinicians as well as those of patients.", {"entities": []}], ["Most studies examining health professionals\u2019 attitudes have been conducted in Western nations; this study explores beliefs and attitudes about depression among doctors working in Lahore, Pakistan.", {"entities": []}], ["A cross-sectional survey conducted in 2015 used a questionnaire concerning demographics, education in psychiatry, beliefs about depression causes, and attitudes about depression using the Revised Depression Attitude Questionnaire (R-DAQ).", {"entities": []}], ["A convenience sample of 700 non-psychiatrist medical practitioners based in six hospitals in Lahore was approached to participate in the survey.", {"entities": []}], ["Six hundred and one (86\u00a0%) of the doctors approached consented to participate; almost all respondents (99\u00a0%) endorsed one of various biopsychosocial causes of depression (38 to 79\u00a0% for particular causes), and 37\u00a0% (between 13 and 19\u00a0% for particular causes) noted that supernatural forces could be responsible.", {"entities": []}], ["Supernatural causes were more commonly held by female doctors, those working in rural settings, and those with greater psychiatry specialist education.", {"entities": []}], ["Attitudes to depression were mostly less confident or optimistic and less inclined to a generalist perspective than those of clinicians in the UK or European nations, and deterministic perspectives that depression is a natural part of aging or due to personal failings were particularly common.", {"entities": []}], ["However, there was substantial confidence in the efficacy of antidepressants and psychological therapy.", {"entities": []}], ["More confident and therapeutically optimistic views and a more generalist perspective about depression management were associated with a rejection of supernatural explanations of the origin of depression.", {"entities": []}], ["Non-psychiatrist medical practitioners in Pakistan hold a range of views about the causes of depression, with supernatural explanations held by more than a third.", {"entities": []}], ["Depression attitudes appear less positive than among UK and European clinicians, with the notions that depression is due to a lack of stamina and will-power and a natural part of growing old being especially commonly held; more positive attitudes appear to be associated with a rejection of supernatural explanatory models of depression.", {"entities": []}], ["The fraction of exhaled nitric oxide (FeNO) and blood eosinophils, markers of local and systemic eosinophilic inflammation, respectively, are increased in asthmatic patients.", {"entities": []}], ["Little is known concerning the relationship between the FeNO levels and blood eosinophils in asthmatics.", {"entities": []}], ["Twenty severe asthmatics with persistent FeNO elevation (\u226540\u2009ppb) and blood eosinophilia (\u22653%) despite maintenance therapy including high\u2010daily\u2010dose inhaled corticosteroids were analyzed.", {"entities": [[76, 88, "DISEASE"]]}], ["We investigated the response of FeNO and blood eosinophils to systemic corticosteroids treatment and the change in Asthma Control Questionnaire (ACQ) according to differences in the response of FeNO and blood eosinophils to steroid.", {"entities": [[115, 121, "DISEASE"]]}], ["The changes in blood eosinophils were not correlated with the changes in FeNO levels by systemic steroid treatment ( r \u2009=\u20090.37, P \u2009=\u20090.11).", {"entities": []}], ["50% of the subjects showed both \u226520% reductions in FeNO levels and blood eosinophils.", {"entities": []}], ["There were significant differences in the ACQ score between the steroid response group and poor response group ( P \u2009<\u20090.005).", {"entities": []}], ["The group in which both FeNO and blood eosinophils were suppressed fulfilled the change in score of \u22650.5 on the ACQ.", {"entities": []}], ["In the patients with severe asthma, responses to systemic corticosteroids were variable in terms of FeNO and blood eosinophils.", {"entities": [[28, 34, "DISEASE"]]}], ["It was necessary to suppress both persistent eosinophilia and high FeNO for the improvement of asthma control.", {"entities": [[45, 57, "DISEASE"], [95, 101, "DISEASE"]]}], ["The relationship between pet exposure and the respiratory disease in childhood has been a controversial topic, much is still unknown about the nature of the associations between pet exposure and children\u2019s respiratory health stratified by gender and allergic predisposition.", {"entities": []}], ["The objective of the present study was to assess the relationship between pet exposure and respiratory symptoms in Chinese children, and to investigate the modified effects of gender and allergic predisposition on such relationship.", {"entities": []}], ["31,049 children were selected from 25 districts of 7 cities in Northeast China in 2009.", {"entities": []}], ["Information on respiratory health and exposure to home environmental factors was obtained via a standard questionnaire designed by the American Thoracic Society.", {"entities": []}], ["Children with an allergic predisposition were found to have more frequent exposure to pets than those without an allergic predisposition (18.5% vs. 15.4%).", {"entities": []}], ["In children without an allergic predisposition, pet exposure was associated with increased susceptibility to respiratory symptoms/diseases, with girls being more susceptible than boys.", {"entities": []}], ["No association was found between pet exposure and respiratory symptoms/diseases in boys with an allergic predisposition.", {"entities": []}], ["In girls with an allergic predisposition, association was found between doctor-diagnosed asthma and pet exposure of their mother during pregnancy (adjusted odds ratio (ORs)\u2009=\u20092.03; 95% confidence interval (CI): 1.01-4.33), and their current pet exposure (ORs\u2009=\u20091.37; 95%CI: 1.00-1.88).", {"entities": [[89, 95, "DISEASE"]]}], ["Pet exposure in children without an allergic predisposition was associated with increased susceptibility to respiratory disease, with girls being more susceptible than boys.", {"entities": []}], ["Dematiaceous fungi (black fungi) are a heterogeneous group of fungi present in diverse environments worldwide.", {"entities": []}], ["Many species in this group are known to cause allergic reactions and potentially fatal diseases in humans and animals, especially in tropical and subtropical climates.", {"entities": []}], ["This study represents the first survey of dematiaceous fungi in Malaysia and provides observations on their diversity as well as in vitro response to antifungal drugs.", {"entities": []}], ["Seventy-five strains isolated from various clinical specimens were identified by morphology as well as an internal transcribed spacer (ITS)-based phylogenetic analysis.", {"entities": []}], ["The combined molecular and conventional approach enabled the identification of three classes of the Ascomycota phylum and 16 genera, the most common being Cladosporium, Cochliobolus and Neoscytalidium .", {"entities": []}], ["Several of the species identified have not been associated before with human infections.", {"entities": []}], ["Among 8 antifungal agents tested, the azoles posaconazole (96%), voriconazole (90.7%), ketoconazole (86.7%) and itraconazole (85.3%) showed in vitro activity (MIC \u22641 \u00b5g/mL) to the largest number of strains, followed by anidulafungin (89.3%), caspofungin (74.7%) and amphotericin B (70.7%).", {"entities": []}], ["Fluconazole appeared to be the least effective with only 10.7% of isolates showing in vitro susceptibility.", {"entities": []}], ["Overall, almost half (45.3%) of the isolates showed reduced susceptibility (MIC >1 \u00b5g/mL) to at least one antifungal agent, and three strains (one Pyrenochaeta unguis-hominis and two Nigrospora oryzae ) showed potential multidrug resistance.", {"entities": []}], ["The pivotal role of neutrophils and macrophages in smoking-related lung inflammation and COPD development is well-established.", {"entities": []}], ["We aimed to assess whether sputum concentrations of Human Neutrophil Peptides (HNP), Neutrophil Elastase (NE), Interleukin-8 (IL-8), and Metalloproteinase-9 (MMP-9), major products of neutrophils and macrophages, could be used to trace airway inflammation and progression towards pulmonary functional impairment characteristic of COPD.", {"entities": []}], ["Forty-two symptomatic smokers and 42 COPD patients underwent pulmonary function tests; sputum samples were collected at enrolment, and 6 months after smoking cessation.", {"entities": []}], ["HNP, NE, IL-8, MMP-9 levels were increased in individuals with COPD ( p < 0.0001).", {"entities": []}], ["HNP and NE concentrations were higher in patients with severe airways obstruction, as compared to patients with mild-to-moderate COPD ( p = 0.002).", {"entities": []}], ["A negative correlation was observed between FEV 1 and HNP, NE and IL-8 levels ( p < 0.01), between FVC 1 /FVC and HNP, NE and IL-8 levels ( p < 0.01), and between NE enrolment levels and FEV 1 decline after 2 years ( p = 0.04).", {"entities": [[44, 47, "GENE"], [187, 190, "GENE"], [44, 47, "GENE"], [187, 190, "GENE"]]}], ["ROC analysis, to discriminate symptomatic smokers and COPD patients, showed the following AUCs: for HNP 0.92; for NE 0.81; for IL-8 0.89; for MMP-9 0.81; for HNP, IL-8 and MMP-9 considered together 0.981.", {"entities": []}], ["The data suggest that the measurement of sputum markers may have an important role in clinical practice for monitoring COPD.", {"entities": []}], ["A 21-year-old female presented with progressive bilateral visual loss for the past 8 years.", {"entities": []}], ["The patient had no history of systemic disease, surgery or medications.", {"entities": []}], ["Complete ophthalmologic examination and topography were performed.", {"entities": []}], ["On ophthalmic examination, uncorrected visual acuity was counting fingers at 2.5 m (20/50 with pinhole) in the right and left eyes.", {"entities": []}], ["Both corneas appeared hazy on gross examination.", {"entities": []}], ["On slit-lamp biomicroscopy, focal grayish-white opacities with indistinct borders were noted in the superficial and deep corneal stroma of both eyes.", {"entities": []}], ["Both corneas were thin and bulging.", {"entities": []}], ["Corneal topography showed a pattern consistent with keratoconus.", {"entities": [[52, 63, "DISEASE"]]}], ["The patient underwent penetrating keratoplasty (PKP).", {"entities": []}], ["Histopathologic studies after PKP confirmed the diagnosis of macular corneal dystrophy and keratoconus in the same eye.", {"entities": [[91, 102, "DISEASE"], [61, 86, "DISEASE"], [69, 86, "DISEASE"]]}], ["The patient was clinically diagnosed as a case of concurrent macular dystrophy and keratoconus, which is a very rare presentation.", {"entities": [[83, 94, "DISEASE"]]}], ["Permanent neonatal diabetes mellitus (PNDM) is a rare condition presenting before six months of age.", {"entities": [[10, 36, "DISEASE"], [19, 36, "DISEASE"]]}], ["Mutations in the genes encoding the ATP-sensitive potassium (KATP) channel are the most common causes.", {"entities": []}], ["Sulfonylurea (SU) therapy leads to dramatic improvement in diabetes control and quality of life in most patients who carry these mutations.", {"entities": []}], ["Here, we report the long-term follow-up results of two siblings with PNDM who were treated with insulin until ABCC8 gene mutation was identified, and were successfully transferred to oral SU therapy.", {"entities": [[110, 115, "GENE"]]}], ["After 3.5 years of follow-up on SU, one patient had a very good response, while the other one had a poor response.", {"entities": []}], ["Bad compliance to diet was thought to be the most probable reason for poor glycemic control in this patient.", {"entities": []}], ["In conclusion, molecular genetic diagnosis in all patients with PNDM is recommended.", {"entities": []}], ["Compliance to treatment should be an important aspect of the follow-up of these patients.", {"entities": []}], ["Conflict of interest: None declared.", {"entities": []}], ["The early identification of dengue infection is essential for timely and effective quarantine and vector control measures for preventing outbreaks of the disease.", {"entities": []}], ["Kaohsiung City is responsible for most of the dengue cases in Taiwan.", {"entities": []}], ["Thus, this study aims to identify major factors involved in the prevalence of dengue fever by analyzing the epidemiological and clinical characteristics, and to establish associations between weather parameters and dengue occurrence in this City.", {"entities": []}], ["A retrospective study was conducted with 3,322 confirmed dengue cases.", {"entities": []}], ["Appropriate statistical methods were used to compare differences and correlations between dengue occurrence and demographic, clinical and weather parameters.", {"entities": []}], ["The outbreak of dengue fever was found to be initiated by imported cases of dengue viruses from other endemic countries.", {"entities": []}], ["Most of the confirmed cases were not reported to the health authority during the first visit to a doctor, and it took a median of 5 days after the appearance of the first syndromes for medical personnel to report suspected dengue cases.", {"entities": []}], ["Accordingly, Aedes mosquitoes would have enough time to be infected and transmit the dengue virus.", {"entities": []}], ["The diagnosis and notification criteria should not only include common symptoms of fever, myalgia, headache, skin rash and arthralgia, but should also be adjusted to include the most frequent symptoms of loss of appetite and feeling thirsty to shorten the notification time.", {"entities": []}], ["Significantly positive correlations were found between the number of confirmed cases and weather parameters ( i .", {"entities": []}], ["e ., temperature, rainfall and relative humidity) at a time lag of 1 month and 2 months.", {"entities": []}], ["The predictive models for dengue occurrence using these three parameters at a 2-month lag time were established.", {"entities": []}], ["The surveillance of imported cases, adjustment of notification criteria and application of climatic predictive models would be helpful in strengthening the dengue early warning surveillance system.", {"entities": []}], ["The aim of this study was to explore the serum peptide profiles from honeybee stung and non-stung individuals.", {"entities": []}], ["Two groups of serum samples obtained from 27 beekeepers were included in our study.", {"entities": []}], ["The first group of samples was collected within 3 h after a bee sting (stung beekeepers), and the samples were collected from the same person a second time after at least six weeks after the last bee sting (non-stung beekeepers).", {"entities": []}], ["Peptide profile spectra were determined using MALDI-TOF mass spectrometry combined with Omix, ZipTips and magnetic beads based on weak-cation exchange (MB-WCX) enrichment strategies in the mass range of 1\u201310 kDa.", {"entities": []}], ["The samples were classified, and discriminative models were established by using the quick classifier, genetic algorithm and supervised neural network algorithms.", {"entities": []}], ["All of the statistical algorithms used in this study allow distinguishing analyzed groups with high statistical significance, which confirms the influence of honeybee sting on the serum peptidome profile.", {"entities": []}], ["The results of this study may broaden the understanding of the human organism\u2019s response to honeybee venom.", {"entities": []}], ["Due to the fact that our pilot study was carried out on relatively small datasets, it is necessary to conduct further proteomic research of the response to honeybee sting on a larger group of samples.", {"entities": []}], ["The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) showed that treatment of pregnant women with mild gestational diabetes mellitus is beneficial for both women and their infants.", {"entities": [[123, 143, "DISEASE"], [135, 152, "DISEASE"]]}], ["It is still uncertain whether there are benefits of similar treatment for women with borderline gestational diabetes.", {"entities": [[96, 116, "DISEASE"]]}], ["This trial aims to assess whether dietary and lifestyle advice and treatment given to pregnant women who screen for borderline gestational diabetes reduces neonatal complications and maternal morbidities.", {"entities": [[127, 147, "DISEASE"]]}], ["Design : Multicentre, randomised controlled trial.", {"entities": []}], ["Inclusion criteria : Women between 24 Trial entry and randomisation : Women with an abnormal oral glucose tolerance test (fasting venous plasma glucose \u22655.5 mmol/L or 2 hour glucose \u22657.8 mmol/L) will not be eligible and will be offered treatment for gestational diabetes, consistent with recommendations based on results of the ACHOIS trial.", {"entities": [[250, 270, "DISEASE"]]}], ["Eligible women will be randomised into either the \u2018Routine Care Group\u2019 or the \u2018Intervention Group\u2019.", {"entities": []}], ["Study groups : Women in the \u2018Routine Care Group\u2019 will receive routine obstetric care reflecting current clinical practice in Australian hospitals.", {"entities": []}], ["Women in the \u2018Intervention Group\u2019 will receive obstetric care, which will include dietary and lifestyle advice, monitoring of blood glucose and further medical treatment for hyperglycaemia as appropriate.", {"entities": []}], ["Primary study outcome : Incidence of large for gestational age infants.", {"entities": []}], ["Sample size : A sample size of 682 women will be sufficient to show a 50% reduction in the risk of large for gestational age infants (alpha 0.05 two-tailed, 80% power, 4% loss to follow up) from 14% to 7% with dietary and lifestyle advice and treatment.", {"entities": []}], ["A conclusive trial outcome will provide reliable evidence of relevance for the care of women with borderline glucose intolerance in pregnancy and their infants.", {"entities": [[109, 128, "DISEASE"]]}], ["Australian New Zealand Clinical Trials Registry - ACTRN12607000174482", {"entities": []}], ["Helminths have profound effects on the immune response, allowing long-term survival of parasites with minimal damage to the host.", {"entities": []}], ["Some of these effects \"spill-over\", altering responses to non-helminth antigens or allergens.", {"entities": []}], ["It is suggested that this may lead to impaired responses to immunizations and infections, while conferring benefits against inflammatory responses in allergic and autoimmune disease.", {"entities": []}], ["These effects might develop in utero, through exposure to maternal helminth infections, or through direct exposure in later life.", {"entities": []}], ["To determine the effects of helminths and their treatment in pregnancy and in young children on immunological and disease outcomes in childhood.", {"entities": []}], ["The trial has three randomized, double-blind, placebo-controlled interventions at two times, in two people: a pregnant woman and her child.", {"entities": []}], ["Pregnant women are randomized to albendazole or placebo and praziquantel or placebo.", {"entities": []}], ["At age 15 months their children are randomized to three-monthly albendazole or placebo, to continue to age five years.", {"entities": []}], ["The proposed designation for this sequence of interventions is a 2 X 2(x2) factorial design.", {"entities": []}], ["Children are immunized with BCG and against polio, Diphtheria, tetanus, Pertussis, Haemophilus, hepatitis B and measles.", {"entities": [[112, 119, "DISEASE"], [63, 70, "DISEASE"], [96, 105, "DISEASE"]]}], ["Primary immunological outcomes are responses to BCG antigens and tetanus toxoid in whole blood cytokine assays and antibody assays at one, three and five years of age.", {"entities": [[65, 72, "DISEASE"]]}], ["Primary disease outcomes are incidence of malaria, pneumonia, diarrhoea, tuberculosis, measles, vertical HIV transmission, and atopic disease episodes, measured at clinic visits and twice-monthly home visits.", {"entities": [[87, 94, "DISEASE"], [51, 60, "DISEASE"], [73, 85, "DISEASE"], [42, 49, "DISEASE"]]}], ["Effects on anaemia, growth and intellectual development are also assessed.", {"entities": []}], ["This trial, with a novel design comprising related interventions in pregnant women and their offspring, is the first to examine effects of helminths and their treatment in pregnancy and early childhood on immunological, infectious disease and allergic disease outcomes.", {"entities": []}], ["The results will enhance understanding of both detrimental and beneficial effects of helminth infection and inform policy.", {"entities": []}], ["Clinical Trials 2007; 4: 42\u201357.", {"entities": []}], ["http://ctj.sagepub.com", {"entities": []}], ["This retrospective case-control study explored the factors associated with anaphylactic shock during surgery for cystic echinococcosis (CE) at the First Affiliated Hospital of Xinjiang Medical University between October 2008 and September 2013.", {"entities": [[120, 134, "DISEASE"], [113, 134, "DISEASE"]]}], ["Patients who suffered from anaphylactic shock (n=16) were age-matched 3:1 to patients who did not (n=43).", {"entities": []}], ["Multivariate analysis suggested that IL-4 levels (odds ratio=1.096; 95% confidence interval=1.015\u20131.185; P =0.02) and cyst size (odds ratio=3.028, 95% confidence interval=1.259\u20137.283, P =0.013) were independently associated with CE-induced perioperative anaphylactic shock.", {"entities": []}], ["Using the receiver operating characteristic (ROC) curves and a cut-off value of 415.7 ng/ml, IL-4 showed an area under the ROC (AUC) of 0.926, sensitivity of 75.0%, and specificity of 97.7%.", {"entities": []}], ["Using a cut-off value of 7.8 cm, cyst size showed an AUC of 0.828, sensitivity of 81.3%, and specificity of 76.7%.", {"entities": []}], ["In conclusion, results suggest that levels of IL-4 and cyst size were independently associated with echinococcosis-induced perioperative anaphylactic shock.", {"entities": [[100, 114, "DISEASE"]]}], ["These results could help identifying patients with echinococcosis at risk of anaphylactic shock in whom appropriate prophylaxis could be undertaken.", {"entities": [[51, 65, "DISEASE"]]}], ["Our current state of knowledge on noninvasive positive pressure\t\t\t ventilation (NPPV) and technical aspects are discussed in the present review.", {"entities": []}], ["In patients with chronic obstructive pulmonary disease, NPPV can be considered\t\t\t a valid therapeutic option to prevent endotracheal intubation.", {"entities": [[17, 54, "DISEASE"]]}], ["Evidence\t\t\t suggests that, before eventual endotracheal intubation, NPPV should be\t\t\t considered as first-line intervention in the early phases of acute exacerbation\t\t\t of chronic obstructive pulmonary disease.", {"entities": [[172, 209, "DISEASE"]]}], ["Small randomized and non-randomized\t\t\t studies on the application of NPPV in patients with acute hypoxaemic\t\t\t respiratory failure showed promising results, with reduction in complications\t\t\t such as sinusitis and ventilator-associated pneumonia, and in the duration of\t\t\t intensive care unit stay.", {"entities": [[111, 130, "DISEASE"], [236, 245, "DISEASE"], [200, 209, "DISEASE"]]}], ["The conventional use of NPPV in hypoxaemic acute\t\t\t respiratory failure still remains controversial, however.", {"entities": [[52, 71, "DISEASE"]]}], ["Large randomized\t\t\t studies are still needed before extensive clinical application in this\t\t\t condition.", {"entities": []}], ["Capsaicin-sensitive sensory C-fibers derived from vagal ganglia innervate the visceral organs, and respond to inflammatory mediators and noxious stimuli.", {"entities": []}], ["These neurons play an important role in maintenance of visceral homeostasis, and contribute to the symptoms of visceral inflammatory diseases.", {"entities": []}], ["Vagal sensory neurons are located in two ganglia, the jugular ganglia (derived from the neural crest), and the nodose ganglia (from the epibranchial placodes).", {"entities": []}], ["The functional difference, especially in response to immune mediators, between jugular and nodose neurons is not fully understood.", {"entities": []}], ["In this study, we microscopically isolated murine nodose and jugular capsaicin-sensitive / Trpv1 -expressing C-fiber neurons and performed transcriptome profiling using ultra-low input RNA sequencing.", {"entities": [[91, 96, "GENE"]]}], ["RNAseq detected genes with significantly differential expression in jugular and nodose neurons, which were mostly involved in neural functions.", {"entities": []}], ["Transcriptional regulators, including Cited1 , Hoxb5 and Prdm12 showed distinct expression patterns in the two C-fiber neuronal populations.", {"entities": [[38, 44, "GENE"], [47, 52, "GENE"], [57, 63, "GENE"]]}], ["Common and specific expression of immune receptor proteins was characterized in each neuronal type.", {"entities": []}], ["The expression of immune receptors that have received little or no attention from vagal sensory biologists is highlighted including receptors for certain chemokines (CXCLs), interleukins (IL-4) and interferons (IFN\u03b1, IFN\u03b3).", {"entities": []}], ["Stimulation of immune receptors with their cognate ligands led to activation of the C-fibers in isolated functional assays.", {"entities": []}], ["Advancing the science and practice of health promotion and disease management on the Internet requires a systematic program of research examining the population impact of such programs.", {"entities": []}], ["With impact described as the combination of effectiveness and participation, such research needs to include the examination of the quality and effectiveness of programs that are available to the general public, as well as descriptive and predictive knowledge about population readiness to participate in such programs.", {"entities": []}], ["There have been few studies examining the quality of interactive health behavior change (HBC) programs on the Internet, and even fewer investigations of the effectiveness of such programs.", {"entities": []}], ["Based on the review of over 300 HBC programs on the Internet using the \u201c5 A's\u201d of Health Behavior Change on the Internet (HBC-I Screener), which represent standard minimum guidelines for evaluation, it appears HBC on the Internet is in the early stages of development.", {"entities": []}], ["As health behavior change on the Internet matures from the provision of health information to meeting the requirements necessary to produce health behavior change, and as program developers take advantage of the interactive nature of the Internet, the basic screening and expanded evaluation criteria developed in this project will provide templates for both consumers and developers of programs.", {"entities": []}], ["The second component necessary for evaluating the impact of HBC on the Internet is the extent to which the population is ready to participate in such programs.", {"entities": []}], ["We need to move beyond a narrow focus on early adopters and produce a population perspective that includes those not ready, those getting ready, and those ready to use such programs, as well as those already participating.", {"entities": []}], ["By understanding participation levels of such programs, and what drives this participation, the development and dissemination of practical tailored and targeted interventions can help maximize population participation in Internet programs for health behavior change.", {"entities": []}], ["Though traditional Korean medicine plays an important role in the Korean parallel health care system, there is limited information about the preference and usage of traditional Korean medicine compared to Western medicine because they have different disease classification systems.", {"entities": []}], ["The aim of this study is to determine the relative preference for traditional Korean medicine using data acquired nationwide.", {"entities": []}], ["Data from the 2008 Korea Health Panel were analyzed to determine the preference of medical services by disease.", {"entities": []}], ["The use of traditional Korean medicine use is defined by the type of medical institution they used.", {"entities": []}], ["Disease types, number of visits and out of pocket expenditures were analyzed.", {"entities": []}], ["Traditional Korean medicine was used in only a small number of cases that were emergencies or hospitalization.", {"entities": []}], ["However, in terms of outpatient services, traditional Korean medicine was used in 7.8% of all cases and represented 9.9% of total medical costs.", {"entities": []}], ["Among disease groups, traditional Korean medicine use was higher in patients with nervous system and musculoskeletal system diseases.", {"entities": []}], ["And patients with musculoskeletal and nervous system diseases such as arthrosis were the most likely to use traditional Korean medicine particularly in an outpatient setting.", {"entities": []}], ["Korean characteristics of service use resemble the complementary and alternative medicine use in other countries in terms of disease group, and the complementary and alternative medicine should be considered to estimate the burden of disease in countries with parallel health care systems, such as Korea.", {"entities": []}], ["This is the first study determined the actual preference of traditional Korean medicine for specific chronic diseases.", {"entities": []}], ["Chronic fatigue syndrome (CFS) is a debilitating condition of unknown etiology and no definitive pharmacotherapy.", {"entities": [[0, 24, "DISEASE"], [16, 24, "DISEASE"]]}], ["Patients are usually prescribed symptomatic treatment or self-medicate.", {"entities": []}], ["We evaluated prescription and non-prescription drug use among persons with CFS in Georgia and compared it to that in non-fatigued Well controls and also to chronically Unwell individuals not fully meeting criteria for CFS.", {"entities": []}], ["A population-based, case-control study.", {"entities": []}], ["To identify persons with possible CFS-like illness and controls, we conducted a random-digit dialing telephone screening of 19,807 Georgia residents, followed by a detailed telephone interview of 5,630 to identify subjects with CFS-like illness, other chronically Unwell , and Well subjects.", {"entities": []}], ["All those with CFS-like illness (n = 469), a random sample of chronically Unwell subjects (n = 505), and Well individuals (n = 641) who were age-, sex-, race-, and geographically matched to those with CFS-like illness were invited for a clinical evaluation and 783 participated (48% overall response rate).", {"entities": []}], ["Clinical evaluation identified 113 persons with CFS, 264 Unwell subjects with insufficient symptoms for CFS (named ISF), and 124 Well controls; the remaining 280 subjects had exclusionary medical or psychiatric conditions, and 2 subjects could not be classified.", {"entities": []}], ["Subjects were asked to bring all medications taken in the past 2 weeks to the clinic where a research nurse viewed and recorded the name and the dose of each medication.", {"entities": []}], ["More than 90% of persons with CFS used at least one drug or supplement within the preceding two weeks.", {"entities": []}], ["Among users, people with CFS used an average of 5.8 drugs or supplements, compared to 4.1 by ISF and 3.7 by Well controls.", {"entities": []}], ["Persons with CFS were significantly more likely to use antidepressants, sedatives, muscle relaxants, and anti-acids than either Well controls or the ISF group.", {"entities": []}], ["In addition, persons with CFS were significantly more likely to use pain-relievers, anti-histamines and cold/sinus medications than were Well controls.", {"entities": []}], ["Medical care providers of patients with chronic fatigue syndrome should be aware of polypharmacy as a problem in such patients, and the related potential iatrogenic effects and drug interactions.", {"entities": [[40, 64, "DISEASE"], [56, 64, "DISEASE"]]}], ["Commensal bacteria that colonize mammalian barrier surfaces are reported to influence T helper type 2 (T H 2) cytokine\u2013dependent inflammation and susceptibility to allergic disease, although the mechanisms that underlie these observations are poorly understood.", {"entities": []}], ["In this report, we identify that deliberate alteration of commensal bacterial populations via oral antibiotic treatment resulted in elevated serum immunoglobulin E (IgE) levels, increased steady\u2013state circulating basophil populations, and exaggerated basophil\u2013mediated T H 2 cell responses and allergic inflammation.", {"entities": []}], ["Elevated serum IgE levels correlated with increased circulating basophil populations in mice and subjects with hyperimmunoglobulinemia E syndrome.", {"entities": [[137, 145, "DISEASE"]]}], ["Furthermore, B cell\u2013intrinsic expression of MyD88 was required to limit serum IgE levels and circulating basophil populations in mice.", {"entities": [[44, 49, "GENE"]]}], ["Commensal\u2013derived signals were found to influence basophil development by limiting proliferation of bone marrow\u2013resident precursor populations.", {"entities": []}], ["Collectively, these results identify a previously unrecognized pathway through which commensal\u2013derived signals influence basophil hematopoiesis and susceptibility to T H 2 cytokine\u2013dependent inflammation and allergic disease.", {"entities": []}], ["The aim of this article was to address questions on how parents use the internet to find information and support regarding children, health and family life.", {"entities": []}], ["Another aim was to find out how professionals use the internet to provide support and information to parents.", {"entities": []}], ["This was done by a literature review.", {"entities": []}], ["Articles were searched for in five databases with a search strategy called \"building block\" approach.", {"entities": []}], ["The review showed that the majority of today's parents search for both information and social support on the internet.", {"entities": []}], ["However, there are considerable differences due to gender, age and socio-economic differences.", {"entities": []}], ["First time middle class mothers aged 30\u201335 are most active in looking up health and parent information on the internet.", {"entities": []}], ["In the same time, several studies report diminishing class differences on parent web sites.", {"entities": []}], ["An important reason to the increasing number of parents who turn to the internet for information and interaction has shown to be the weakened support many of today's parents experience from their own parents, relatives and friends.", {"entities": []}], ["Professionals have recognized the parents' great interest for going online and offer both information and support on the net.", {"entities": []}], ["Many benefits are reported, for example the possibility to reach out to a wider audience and to increase access to organisations without an increase in costs.", {"entities": []}], ["Other benefits include the possibility for parents to remain anonymous in their contacts with professionals and that parents' perceived need for information can be effectively met around the clock.", {"entities": []}], ["Interventions for wider groups of parents, such as parent training on the net, are still very rare and more research is needed to evaluate different types of interventions on the net.", {"entities": []}], ["However, most studies were empirical and lacked theoretical frameworks which leave questions on how we can more fully understand this phenomenon unanswered.", {"entities": []}], ["Cathepsin K is a key enzyme involved in the degradation of organic bone matrix by osteoclasts.", {"entities": []}], ["Inhibition of bone resorption observed in human and animal models deficient for cathepsin K has identified this enzyme as a suitable target for intervention by small molecules with the potential to be used as therapeutic agents in the treatment of osteoporosis.", {"entities": [[248, 260, "DISEASE"]]}], ["Odanacatib (ODN) is a nonbasic selective cathepsin K inhibitor with good pharmacokinetic parameters such as minimal in vitro metabolism, long half-life, and oral bioavailability.", {"entities": []}], ["In preclinical studies, ovariectomized monkeys and rabbits treated with ODN showed substantial inhibition of bone resorption markers along with increases in bone mineral density (BMD).", {"entities": []}], ["Significant differences were observed in the effects of ODN treatment compared with those of other antiresorptive agents such as bisphosphonates and denosumab.", {"entities": []}], ["ODN displayed compartment-specific effects on trabecular versus cortical bone formation, with treatment resulting in marked increases in periosteal bone formation and cortical thickness in ovariectomized monkeys whereas trabecular bone formation was reduced.", {"entities": []}], ["Furthermore, osteoclasts remained viable.", {"entities": []}], ["Phase I and II studies conducted in postmenopausal women showed ODN to be safe and well tolerated.", {"entities": []}], ["After 5 years, women who received ODN 50 mg weekly continuously from year 1 (n = 13), showed BMD increases from baseline of 11.9% at the lumbar spine, 9.8% at the femoral neck, 10.9% at the hip trochanter, and 8.5% at the total hip.", {"entities": []}], ["Additionally, these subjects maintained a low level of the urine bone resorption marker N-terminal telopeptide/creatinine (\u221267.4% from baseline) through 5 years of treatment, while levels of serum bone-specific alkaline phosphatase remained only slightly reduced relative to baseline (\u221215.3%).", {"entities": []}], ["In women who were switched from ODN to placebo after 2 years, bone turnover markers were transiently increased and BMD gains reversed after 12 months off medication.", {"entities": []}], ["Adverse experiences in the ODN-treated group were not significantly different from the placebo group.", {"entities": []}], ["In conclusion, available data suggests that cathepsin K inhibition could be a promising intervention with which to treat osteoporosis.", {"entities": [[121, 133, "DISEASE"]]}], ["Ongoing studies are expected to provide information on the long-term efficacy in fracture reduction and safety of prolonged treatment with ODN.", {"entities": []}], ["An efficient, all-solid-phase synthesis of argifin, a cyclic peptide chitinase inhibitor with chemotherapeutic potential, is described.", {"entities": []}], ["A new, highly efficient, all-solid-phase synthesis of argifin, a natural product cyclic pentapeptide chitinase inhibitor, is reported.", {"entities": []}], ["The synthesis features attachment of an orthogonally protected Asp residue to the solid support and assembly of the linear peptide chain by Fmoc SPPS prior to cyclisation and side-chain manipulation on-resin.", {"entities": []}], ["Introduction of the key N -methyl carbamoyl-substituted Arg side chain is achieved via derivatisation of a selectively protected Orn residue, prior to cleavage from the resin and side-chain deprotection.", {"entities": []}], ["A severe aspartimide side-reaction observed upon final deprotection is circumvented by the use of a novel aqueous acidolysis procedure.", {"entities": []}], ["The flexibility of the synthesis is demonstrated by the preparation of a series of argifin analogues designed from the X-ray structure of the natural product in complex with a representative family 18 chitinase.", {"entities": []}], ["A broad variety of natural environmental stimuli, genotypic influences and timing all contribute to expression of protective versus maladaptive immune responses and the resulting clinical outcomes in humans.", {"entities": []}], ["The role of commonly co-segregating Toll-like receptor 4 ( TLR4 ) non-synonymous single nucleotide polymorphisms Asp299Gly and Thr399Ile in this process remains highly controversial.", {"entities": [[59, 63, "GENE"]]}], ["Moreover, what differential impact these polymorphisms might have in at risk populations with respiratory dysfunction, such as current asthma or a history of infantile bronchiolitis, has never been examined.", {"entities": [[135, 141, "DISEASE"], [168, 181, "DISEASE"]]}], ["Here we determine the importance of these polymorphisms in modulating LPS and respiratory syncytial virus (RSV) - driven cytokine responses.", {"entities": []}], ["We focus on both healthy children and those with clinically relevant respiratory dysfunction.", {"entities": []}], ["To elucidate the impact of TLR4 Asp299Gly and Thr399Ile on cytokine production, we assessed multiple immune parameters in over 200 pediatric subjects aged 7\u20139.", {"entities": [[27, 31, "GENE"]]}], ["Genotyping was followed by quantification of pro- and anti-inflammatory cytokine responses by fresh peripheral blood mononuclear cells upon acute exposure to LPS or RSV.", {"entities": []}], ["In contrast to early reports, neither SNP influenced immune responses evoked by LPS exposure or RSV infection, as measured by the intermediate phenotype of pro- and anti-inflammatory cytokine responses to these ubiquitous agents.", {"entities": []}], ["There is no evidence of altered sensitivity in populations with \u201cat risk\u201d clinical phenotypes.", {"entities": []}], ["Genomic medicine seeks to inform clinical practice.", {"entities": []}], ["Determination of the TLR4 Asp299Gly/Thr399Ile haplotype is of no clinical benefit in predicting the nature or intensity of cytokine production in children whether currently healthy or among specific at-risk groups characterized by prior infantile broncholitis or current asthma.", {"entities": [[271, 277, "DISEASE"], [21, 25, "GENE"]]}], ["This study aimed to explore the related metabolic biomarkers and to observe the effects of Yangxin Decoction (YXD) on plasma metabolism of patients with unstable angina (UA).", {"entities": []}], ["In total, 10 patients with UA (intervention group) and 10 healthy participants (control group) were recruited for this study from January 2009 to December 2010.", {"entities": []}], ["Plasma samples from both groups were analyzed using liquid chromatography mass spectrometry (LC-MS).", {"entities": []}], ["Principle component analysis (PCA) and partial least squares (PLS) were used to explore the correlations between metabolic markers in patients with UA.", {"entities": []}], ["The LC-MS results indicated that the serum levels of 5 potential metabolic markers, namely, ceramide, glycocholic acid, allocholic acid, lithocholic acid, and leukotriene (LT) B4, were significantly higher in the intervention group than those in the control group.", {"entities": [[172, 174, "GENE"]]}], ["The results of this study demonstrated potential metabolic markers that can be used to distinguish and diagnose patients with UA.", {"entities": []}], ["A central function of the endoplasmic reticulum (ER) is to coordinate protein biosynthetic and secretory activities in the cell.", {"entities": []}], ["Alterations in ER homeostasis cause accumulation of misfolded/unfolded proteins in the ER.", {"entities": []}], ["To maintain ER homeostasis, eukaryotic cells have evolved the unfolded protein response (UPR), an essential adaptive intracellular signaling pathway that responds to metabolic, oxidative stress, and inflammatory response pathways.", {"entities": []}], ["The UPR has been implicated in a variety of diseases including metabolic disease, neurodegenerative disease, inflammatory disease, and cancer.", {"entities": [[82, 107, "DISEASE"], [135, 141, "DISEASE"]]}], ["Signaling components of the UPR are emerging as potential targets for intervention and treatment of human disease.", {"entities": []}], ["A fast-acting inhibitor of serine elastase has been detected at high levels in human neutrophils, fresh monocytes, matured monocytes, and macrophages.", {"entities": []}], ["The elastase inhibitor was isolated from large scale cultures of the monocyte-like cell line U937 by DNase chromatography, disulfide exchange, Phenyl-Sepharose, Red A-agarose, and DEAE HPLC chromatography with an average yield of 480 micrograms from 1.8 x 10(10) cells.", {"entities": []}], ["The isolated polypeptide was verified as elastase inhibitor by its ability to (a) form a covalent complex with elastase; and (b) inhibit the elastinolytic activity of elastase.", {"entities": []}], ["The purified elastase inhibitor molecule is unique, i.e., physiochemical and/or functional properties distinguish it from all other serine proteinase inhibitors.", {"entities": []}], ["Treatment with iodoacetamide abrogates the ability of the molecule to form a complex with elastase, thereby providing evidence for the presence of an essential cysteine residue.", {"entities": []}], ["Based on functional criteria, this elastase inhibitor has been grouped with the proteinase inhibitors of the serpin superfamily.", {"entities": []}], ["The purified elastase inhibitor is a single polypeptide of Mr approximately 42,000.", {"entities": []}], ["The NH2 terminus appears to be blocked.", {"entities": []}], ["Compositional analyses indicates five cysteine residues per molecule of approximately 360 amino acid residues.", {"entities": []}], ["Negligible levels of carbohydrate were detected on gas-liquid chromatography.", {"entities": []}], ["This finding and the insensitivity of the molecule to peptide N-glycosidase F treatment strongly indicate that the elastase inhibitor is a nonglycosylated protein.", {"entities": []}], ["Inappropriate use of antimicrobials is one of the major modifiable contributors to antimicrobial resistance.", {"entities": []}], ["There is currently no validated survey tool available to assess knowledge and confidence of medical students in infectious diseases (ID) compared to other diseases states, and little is known about this topic.", {"entities": []}], ["A cross-sectional survey of final year medical students attending universities around Australia was conducted between August and September, 2015.", {"entities": []}], ["A survey unique from other published studies was developed to survey satisfaction in education, confidence and knowledge in ID, and how this compared to these factors in cardiovascular diseases.", {"entities": []}], ["Reliability and validity was demonstrated in the survey tool used.", {"entities": []}], ["Students were more likely to rate university education as sufficient for cardiovascular diseases (91.3%) compared to ID (72.5%), and were more confident in their knowledge of cardiovascular diseases compared to ID (74.38% vs. 53.76%).", {"entities": []}], ["Students tended to answer more cardiovascular disease related clinical questions correctly (mean score 78%), compared to questions on antimicrobial use (mean score 45%).", {"entities": []}], ["Poor knowledge and confidence amongst final year medical students in Australia were observed in ID.", {"entities": []}], ["Antimicrobial stewardship agenda should include the provision of additional training in antimicrobial prescribing to the future medical workforce.", {"entities": []}], ["Cell division relies on coordinated regulation of the cell cycle.", {"entities": []}], ["A process including a well-defined series of strictly regulated molecular mechanisms involving cyclin-dependent kinases, retinoblastoma protein, and polo-like kinases.", {"entities": [[121, 135, "DISEASE"]]}], ["Dysfunctions in cell cycle regulation are associated with disease such as cancer, diabetes, and neurodegeneration.", {"entities": [[74, 80, "DISEASE"]]}], ["Compartmentalization of cellular signaling is a common strategy used to ensure the accuracy and efficiency of cellular responses.", {"entities": []}], ["Compartmentalization of intracellular signaling is maintained by scaffolding proteins, such as A-kinase anchoring proteins (AKAPs).", {"entities": []}], ["AKAPs are characterized by their ability to anchor the regulatory subunits of protein kinase A (PKA), and thereby achieve guidance to different cellular locations via various targeting domains.", {"entities": []}], ["Next to PKA, AKAPs also associate with several other signaling elements including receptors, ion channels, protein kinases, phosphatases, small GTPases, and phosphodiesterases.", {"entities": []}], ["Taking the amount of possible AKAP signaling complexes and their diverse localization into account, it is rational to believe that such AKAP-based complexes regulate several critical cellular events of the cell cycle.", {"entities": []}], ["In fact, several AKAPs are assigned as tumor suppressors due to their vital roles in cell cycle regulation.", {"entities": []}], ["Here, we first briefly discuss the most important players of cell cycle progression.", {"entities": []}], ["After that, we will review our recent knowledge of AKAPs linked to the regulation and progression of the cell cycle, with special focus on AKAP12, AKAP8, and Ezrin.", {"entities": [[139, 145, "GENE"], [147, 152, "GENE"]]}], ["At last, we will discuss this specific AKAP subset in relation to diseases with focus on a diverse subset of cancer.", {"entities": [[109, 115, "DISEASE"]]}], ["Previous observations propose that risk-taking behaviors such as cigarette smoking are prevailing among young people with chronic conditions including diabetes.", {"entities": []}], ["The purpose of this study was to examine whether cigarette smoking is more prevalent among diabetics than non-diabetics and whether it differs by age at the time of diagnosis with diabetes from young adulthood (YAH) to adulthood (AH).", {"entities": []}], ["We used US panel data from the National Longitudinal Study of Adolescent Health (Add Health Study) during the years 2001 to 2002 (Wave III, YAH) and 2007 to 2008 (Wave IV, AH).", {"entities": []}], ["Multivariate logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of cigarette use behaviors according to age at the time of diagnosis with diabetes, after adjusting for demographic and selected behavioral factors.", {"entities": []}], ["Of 12 175 study participants, 2.6% reported having been diagnosed with diabetes up to AH.", {"entities": []}], ["Early-onset diabetics (age at diagnosis <13 years) were more likely than non-diabetics to report frequent cigarette smoking (smoking on \u226520 days during the previous 30 days) in YAH (OR, 3.34; 95% CI, 1.27 to 8.79).", {"entities": []}], ["On the other hand, late-onset diabetics (age at diagnosis \u226513 years) were more likely than non-diabetics to report heavy cigarette smoking (smoking \u226510 cigarettes per day during the previous 30 days) in AH (OR, 1.54; 95% CI, 1.03 to 2.30).", {"entities": []}], ["The current study indicated that diabetics are more likely than non-diabetics to smoke cigarettes frequently and heavily in YAH and AH.", {"entities": []}], ["Effective smoking prevention and cessation programs uniquely focused on diabetics need to be designed and implemented.", {"entities": []}], ["Tuberculosis of the spine is a still a common disease entity, not only in developing countries but is also returning in developed countries especially in the immune-compromised patients.", {"entities": [[0, 12, "DISEASE"]]}], ["Conservative treatment with chemotherapy is still the main stay of treatment.", {"entities": []}], ["This article focuses on the clinical and radiological outcomes, and problems with conservative treatment.", {"entities": []}], ["The available literature of anti-tuberculosis chemotherapy in managing spinal tuberculosis was reviewed.", {"entities": [[33, 45, "DISEASE"], [78, 90, "DISEASE"]]}], ["Data sources included relevant literature of the English language identified through Medline search from 1946 to 2011.", {"entities": []}], ["Personal experience and unpublished reviews from the authors\u2019 institution were also included.", {"entities": []}], ["Although majority of patients respond well to anti-tuberculosis chemotherapy, about 15\u00a0% of them develop paradoxical response.", {"entities": [[51, 63, "DISEASE"]]}], ["The Medical Research Council (MRC) studies have shown that for patients without significant neurological deficits, operative and conservative treatment could produce the same clinical outcome at 15\u00a0years follow-up.", {"entities": []}], ["Patients treated operatively with debridement and spinal fusion with strut graft had faster bony fusion and less kyphotic deformity.", {"entities": []}], ["In contrast, those treated with drugs alone or with simple debridement without fusion may result in disease reactivation, severe kyphosis or late instability, which in turn may lead to late-onset Pott\u2019s paraplegia, back pain, sagittal imbalance and compromised pulmonary function that are difficult or risky to treat.", {"entities": [[203, 213, "DISEASE"]]}], ["Recognition of the clinical and radiologic features of these late sequels is important for the management.", {"entities": []}], ["Prevention of deformity in the early disease has been added to the modern standard of treatment of TB spine.", {"entities": []}], ["Rashida Ferrand and colleagues show that HIV infection is the commonest cause of hospitalization among adolescents in a high HIV prevalence setting.", {"entities": []}], ["Survival to older childhood with untreated, vertically acquired HIV infection, which was previously considered extremely unusual, is increasingly well described.", {"entities": []}], ["However, the overall impact on adolescent health in settings with high HIV seroprevalence has not previously been investigated.", {"entities": []}], ["Adolescents (aged 10\u201318 y) systematically recruited from acute admissions to the two public hospitals in Harare, Zimbabwe, answered a questionnaire and underwent standard investigations including HIV testing, with consent.", {"entities": []}], ["Pre-set case-definitions defined cause of admission and underlying chronic conditions.", {"entities": []}], ["Participation was 94%.", {"entities": []}], ["139 (46%) of 301 participants were HIV-positive (median age of diagnosis 12 y: interquartile range [IQR] 11\u201314 y), median CD4 count\u200a=\u200a151; IQR 57\u2013328 cells/\u00b5l), but only four (1.3%) were herpes simplex virus-2 (HSV-2) positive.", {"entities": [[187, 201, "DISEASE"], [122, 125, "GENE"]]}], ["Age (median 13 y: IQR 11\u201316 y) and sex (57% male) did not differ by HIV status, but HIV-infected participants were significantly more likely to be stunted ( z -score<\u22122: 52% versus 23%, p <0.001), have pubertal delay (15% versus 2%, p <0.001), and be maternal orphans or have an HIV-infected mother (73% versus 17%, p <0.001).", {"entities": []}], ["69% of HIV-positive and 19% of HIV-negative admissions were for infections, most commonly tuberculosis and pneumonia.", {"entities": [[107, 116, "DISEASE"], [90, 102, "DISEASE"]]}], ["84 (28%) participants had underlying heart, lung, or other chronic diseases.", {"entities": []}], ["Case fatality rates were significantly higher for HIV-related admissions (22% versus 7%, p <0.001), and significantly associated with advanced HIV, pubertal immaturity, and chronic conditions.", {"entities": []}], ["HIV is the commonest cause of adolescent hospitalisation in Harare, mainly due to adult-spectrum opportunistic infections plus a high burden of chronic complications of paediatric HIV/AIDS.", {"entities": []}], ["Low HSV-2 prevalence and high maternal orphanhood rates provide further evidence of long-term survival following mother-to-child transmission.", {"entities": []}], ["Better recognition of this growing phenomenon is needed to promote earlier HIV diagnosis and care.", {"entities": []}], ["Please see later in the article for the Editors' Summary Acquired immunodeficiency syndrome (AIDS) has killed more than 25 million people since 1981, and more than 30 million people are now infected with the human immunodeficiency virus (HIV) that causes AIDS.", {"entities": [[83, 91, "DISEASE"]]}], ["HIV destroys the cells in the immune system that normally provide protection against disease-causing organisms.", {"entities": []}], ["Consequently, people infected with HIV are susceptible to so-called opportunistic infections, including tuberculosis and pneumonia.", {"entities": [[121, 130, "DISEASE"], [104, 116, "DISEASE"]]}], ["HIV is most commonly spread through unprotected sex with an infected partner but another major route of transmission is mother-to-child (vertical transmission) during pregnancy or delivery or during breast feeding.", {"entities": []}], ["Mother-to-child transmission can be prevented by giving antiviral drugs to HIV-positive mothers during their pregnancy and to their newborn children.", {"entities": []}], ["But, although most mothers in developed countries have access to this intervention, fewer than half of HIV-positive mothers in low- and middle-income countries receive this treatment and, every year, nearly half a million children become infected with HIV.", {"entities": []}], ["It is generally thought that HIV infections in infants progress rapidly and that half of the children who acquire HIV from their mothers will die before their second birthday if not treated with antiretroviral drugs.", {"entities": []}], ["However, as the AIDS epidemic matures, more children are surviving to adolescence with untreated, vertically acquired HIV infection in sub-Saharan Africa, the region where most children with HIV/AIDS live.", {"entities": []}], ["Little is known about the burden of HIV infection and its contribution to illness and death in adolescents in sub-Saharan Africa but this information is needed to help health care providers prepare for this new aspect of the AIDS epidemic.", {"entities": []}], ["In this study, the researchers examine the causes of acute hospital admissions (admissions for conditions with a sudden onset and usually a short course) among adolescents in Zimbabwe, a country where the HIV epidemic started early and where one in seven adults is HIV-positive and more than 17,000 children are infected with HIV every year, mainly through vertical transmission.", {"entities": []}], ["The researchers recruited 301 10\u201318-year olds who were admitted to each of the two public hospitals in Harare (Zimbabwe) for acute illnesses between September 2007 and April 2008.", {"entities": []}], ["Each patient completed a questionnaire about themselves and their health and underwent standard investigations, including HIV testing.", {"entities": []}], ["Nearly half the participants were HIV positive; about a quarter of these HIV-positive individuals only found out about their status during the study.", {"entities": []}], ["HIV-positive participants were more likely to be stunted, to have pubertal delay, and to be maternal orphans or have an HIV-infected mother than HIV-negative participants.", {"entities": []}], ["69% of HIV-positive participants were admitted to hospital because of infections, often tuberculosis or pneumonia whereas only 19% of the HIV-negative participants were admitted for infections.", {"entities": [[104, 113, "DISEASE"], [88, 100, "DISEASE"]]}], ["More than a quarter of all the participants had underlying heart, lung, or other chronic conditions.", {"entities": []}], ["Finally, 22% of the HIV-positive participants died while in hospital compared to only 7% of the HIV-negative participants.", {"entities": []}], ["Factors that increased the risk of death among all the participants were advanced HIV infection, pubertal immaturity, and chronic conditions.", {"entities": []}], ["These findings indicate that HIV infection is the commonest cause of acute adolescent admission to hospital in Harare (and probably elsewhere in Zimbabwe).", {"entities": []}], ["Most of these admissions are due to opportunistic infections similar to those seen in HIV-positive adults and to long-term complications of having HIV/AIDS as an infant such as delayed puberty.", {"entities": []}], ["Other findings indicate that most of the HIV-positive adolescents who participated in this study were infected via vertical transmission, which supports the idea that long-term survival after vertical infection is possible.", {"entities": []}], ["Because the AIDS epidemic started early in Zimbabwe, there is likely to be a lag before adolescent survivors of vertical HIV transmission become common elsewhere.", {"entities": []}], ["Nevertheless, all African countries and other places where HIV infection in adults is common need to recognize that the burden of HIV in their acutely unwell adolescents is likely to increase over the next few years.", {"entities": []}], ["To deal with this emerging aspect of the AIDS epidemic, measures must be introduced to ensure early diagnosis of HIV in this previously neglected age group so that treatment can be started before HIV-positive adolescents become critically ill.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000178 .", {"entities": []}], ["This study is further discussed in a PLoS Medicine Perspective by Glenda Gray Information is available from the US National Institute of Allergy and Infectious Diseases on HIV infection and AIDS HIV InSite has comprehensive information on all aspects of HIV/AIDS, including a list of articles and other sources of information about the primary care of adolescents with HIV Information is available from Avert , an international AIDS charity on many aspects of HIV/AIDS, including information on the HIV and AIDS in Zimbabwe , and on children, HIV, and AIDS (in English and Spanish) UNICEF also has information about children and HIV and AIDS (in several languages)", {"entities": []}], ["Since iron can contribute to detrimental radical generating processes through the Fenton and Haber-Weiss reactions, it seems to be a reasonable approach to modulate iron-related pathways in inflammation.", {"entities": []}], ["In the human organism a counterregulatory reduction in iron availability is observed during inflammatory diseases.", {"entities": []}], ["Under pathological conditions with reduced or increased baseline iron levels different consequences regarding protection or susceptibility to inflammation have to be considered.", {"entities": []}], ["Given the role of iron in development of inflammatory diseases, pharmaceutical agents targeting this pathway promise to improve the clinical outcome.", {"entities": []}], ["The objective of this review is to highlight the mechanisms of iron regulation and iron chelation, and to demonstrate the potential impact of this strategy in the management of several acute and chronic inflammatory diseases, including cancer.", {"entities": [[236, 242, "DISEASE"]]}], ["Cervical cancer strikes hard in low-resource regions yet primary prevention is still rare.", {"entities": [[9, 15, "DISEASE"], [0, 15, "DISEASE"]]}], ["Pilot projects have however showed that Human Papillomavirus (HPV) vaccination programs can attain high uptake.", {"entities": []}], ["Nevertheless, a study accompanying a vaccination demonstration project in Eldoret, Kenya, revealed less encouraging outcomes: uptake during an initial phase targeting ten schools (i.e., 4000 eligible girls), was low and more schools had to be included to reach the proposed number of 3000 vaccinated girls.", {"entities": []}], ["The previously conducted study also revealed that many mothers had not received promotional information which had to reach them through schools: teachers were sensitized by health staff and asked to invite students and parents for HPV vaccination in the referral hospital.", {"entities": []}], ["In this qualitative study, we investigate factors that hampered promotion and vaccine uptake.", {"entities": []}], ["Focus group discussions\u00a0(FGD) with teachers (4) and fathers (3) were organized to assess awareness and attitudes towards the vaccination program, cervical cancer and the HPV vaccine, as well as a FGD with the vaccinators (1) to discuss the course of the program and potential improvements.", {"entities": [[155, 161, "DISEASE"], [146, 161, "DISEASE"]]}], ["Discussions were recorded, transcribed, translated, and analyzed using thematic analysis In addition, a meeting with the program coordinator was set up to reflect upon the program and the results of the FGD, and to formulate recommendations for future programs.", {"entities": []}], ["Cervical cancer was poorly understood by fathers and teachers and mainly linked with nonconforming sexual behavior and modern lifestyle.", {"entities": [[9, 15, "DISEASE"], [0, 15, "DISEASE"]]}], ["Few had heard about the vaccination opportunity: feeling uncomfortable to discuss cervical cancer and not considering it as important had hampered information flow.", {"entities": [[91, 97, "DISEASE"], [82, 97, "DISEASE"]]}], ["Teachers requested more support from health staff to address unexpected questions from parents.", {"entities": []}], ["Non-uptake was also the result of distrust towards new vaccines.", {"entities": []}], ["Schools entering the program in the second phase reacted faster: they were better organized, e.g., in terms of transport, while the community was already more familiarized with the vaccine.", {"entities": []}], ["Close collaboration between teachers and health staff is crucial to obtain high HPV vaccine uptake among schoolgirls.", {"entities": []}], ["Promotional messages should, besides providing correct information, tackle misbeliefs, address stigma and stress the priority to vaccinate all, regardless of lifestyle.", {"entities": []}], ["Monitoring activities and continuous communication could allow for detection of rumors and unequal uptake in the community.", {"entities": []}], ["Naive CD4 \u2022 ILC2-deficient mice have impaired Th2 cell responses to allergen \u2022 Allergen-induced Th2 cell differentiation is dependent on ILC2-derived IL-13 \u2022 ILC2 activation by allergen requires IL-33 from epithelial cells \u2022 ILC2-derived IL-13 promotes DC migration to lymph node ILC2-deficient mice have impaired Th2 cell responses to allergen Allergen-induced Th2 cell differentiation is dependent on ILC2-derived IL-13 ILC2 activation by allergen requires IL-33 from epithelial cells ILC2-derived IL-13 promotes DC migration to lymph node", {"entities": [[6, 9, "GENE"]]}], ["A relevant proportion of allergic rhinoconjunctivitis (ARC) patients experience recurrent symptoms after successfully completing allergen immunotherapy ( AIT ).", {"entities": []}], ["This prospective, controlled, noninterventional study used internationally standardized instruments to determine the clinical effects of a preseasonal, ultra\u2010short\u2010course booster AIT on clinical outcome parameters.", {"entities": []}], ["This two\u2010arm study included patients aged \u226512 years with recurrent grass pollen\u2010induced seasonal AR who had completed a successful course of any grass pollen AIT at least 5 years before enrolment.", {"entities": []}], ["Overall, 56 patients received one preseasonal short\u2010course booster AIT using tyrosine\u2010absorbed grass pollen allergoids containing the adjuvant monophosphoryl lipid A ( MPL CSMS ) was recorded in the (peak) grass pollen season.", {"entities": [[168, 171, "GENE"]]}], ["Furthermore, concomitant (antiallergic) medication use, the patients\u2019 state of health, Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) results and safety/tolerability of the treatment were assessed.", {"entities": []}], ["The CSMS in the peak grass pollen season was significantly lower in the booster AIT group (\u0394=38.4%, P <.01).", {"entities": []}], ["Moreover, significantly more patients in this group used no concomitant antiallergic medication throughout the peak grass pollen season.", {"entities": []}], ["Twice as many patients in the booster AIT group as in the control group reported having a better state of health than in the preceding season.", {"entities": []}], ["MiniRQLQ results showed significant differences favouring the booster AIT .", {"entities": []}], ["The booster AIT was generally well tolerated, with only two patients reporting mild, grade 1 systemic adverse events.", {"entities": []}], ["Booster AIT using tyrosine\u2010absorbed allergoids containing the adjuvant MPL", {"entities": [[71, 74, "GENE"]]}], ["RNA interference mediated through antisense transcripts is a fundamentally important mechanism regulating gene expression that remains incompletely understood.", {"entities": []}], ["Here, we have used next-generation sequencing to determine from mouse CD4+ T cells the functional implications of antisense transcripts binding to argonaute (AGO) proteins that mediate RNA interference and post-transcriptional gene silencing.", {"entities": []}], ["This effort identified 90 new microRNAs (miRNAs) and six endogenous hairpin RNA-derived small interfering RNAs (siRNAs) mapping to distinct introns.", {"entities": []}], ["Unexpectedly, 69 miRNAs were expressed as non-canonical isomiRs as the dominant AGO-binding transcript, with extensive 3\u2032 terminal nucleotide modifications.", {"entities": []}], ["Furthermore, differential expression analysis between AGO1- and AGO2-bound miRNAs suggested preferential binding of isomiRs ending with 3\u2032 adenine residues to AGO1 and 3\u2032 uridine residues to AGO2.", {"entities": []}], ["Analysis of the putative targets of all miRNAs suggested a striking preference for regulating transcription and transcription factors with additional evidence of a functional division of labor between AGO proteins in this regard.", {"entities": []}], ["We further provide evidence that multiple mitochondrial genomic loci serve as the source of endogenous cis -natural antisense transcripts.", {"entities": []}], ["These findings imply diversity in AGO protein function based on differential miRNA binding and indicate that RNA interference-based gene regulation is more complex than previously recognized.", {"entities": []}], ["Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life.", {"entities": [[6, 15, "DISEASE"]]}], ["This condition is initially triggered by the deposition of monosodium urate crystals into the joint space.", {"entities": []}], ["This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint.", {"entities": []}], ["While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use.", {"entities": []}], ["Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.", {"entities": [[79, 88, "DISEASE"]]}], ["The aim of the current study was to evaluate the relative contributions of mental and physical conditions to days out of role among adults aged 18 years and above in Singapore.", {"entities": []}], ["The Singapore Mental Health Study was a cross-sectional epidemiological survey of a nationally representative sample of residents aged 18 years or older.", {"entities": []}], ["Diagnosis of mental disorders was established using the Composite International Diagnostic Interview; while chronic physical conditions were established using a checklist.", {"entities": []}], ["Days out of role were assessed using a WHO Disability Assessment Schedule item.", {"entities": []}], ["Multivariate regression analyses were used to estimate individual-level and societal-level effects of disorders.", {"entities": []}], ["Overall, 8.7% of respondents reported at least one day out of role, with a mean of 5.8 days.", {"entities": []}], ["The most disabling conditions at the individual level were cancer (118.9 additional days), cardiovascular diseases (93.5), and bipolar disorder (71.0).", {"entities": [[127, 143, "DISEASE"], [59, 65, "DISEASE"]]}], ["At the societal level, cardiovascular diseases contributed the highest population attributable risk proportion (45%), followed by cancer (39.3%), and hypertension (13.5%).", {"entities": [[150, 162, "DISEASE"], [130, 136, "DISEASE"]]}], ["Mental and physical conditions are linked to significant losses in productivity for society as well as role disability for individuals, underscoring the need to enhance prevention and intervention efforts to increase overall productivity and improve individual functioning.", {"entities": []}], ["The granulomatosis with polyangiitis, initially known as Wegener's granulomatosis, is a small and medium vessels vasculitis.", {"entities": [[113, 123, "DISEASE"]]}], ["It's classic form presents a triad: necrotizing granuloma of respiratory tract, necrotizing cutaneous vasculitis and glomerulonephritis.", {"entities": [[117, 135, "DISEASE"], [102, 112, "DISEASE"]]}], ["This vasculitis has cytoplasmic antineutrophil antibodies as signal.", {"entities": [[5, 15, "DISEASE"]]}], ["This work illustrates a case, of multisystemic rare disease, in which the segment and treatment were considered satisfactory for symptoms remission.", {"entities": []}], ["For much of the history of toxicology, the sensitivity of the developing organism to chemical perturbation attracted limited attention.", {"entities": []}], ["Several tragic episodes and new insights finally taught us that the course of early brain development incurs unique risks.", {"entities": []}], ["Although the process is exquisitely controlled, its lability renders it highly susceptible to damage from environmental chemicals.", {"entities": []}], ["Such disturbances, as recognized by current testing protocols and legislation such as the Food Quality Protection Act, can result in outcomes ranging from death to malformations to functional impairment.", {"entities": []}], ["The latter are the most difficult to determine.", {"entities": []}], ["First, they require a variety of measures to assay their extent.", {"entities": []}], ["Second, adult responses may prove an inadequate guide to the response of the developing brain, which is part of the reason for proposing additional safety factors for children.", {"entities": []}], ["Third, neuropsychological tests are deployed in complex circumstances in which many factors, including economic status, combine to produce a particular effect such as lowered intelligence quotient score.", {"entities": []}], ["Fourth, the magnitude of the effect, for most environmental exposure levels, may be relatively small but extremely significant for public health.", {"entities": []}], ["Fifth, changes in brain function occur throughout life, and some consequences of early damage may not even emerge until advanced age.", {"entities": []}], ["Such factors need to be addressed in estimating the influence of a particular agent or group of agents on brain development and its functional expression.", {"entities": []}], ["It is especially important to consider ways of dealing with multiple risks and their combinations in addition to the prevailing practice of estimating risks in isolation.", {"entities": []}], ["Research on the impact of depression treatment on expenditures is nascent and shows results that vary from negative associations with healthcare expenditures to increased expenditures.", {"entities": []}], ["However many of these studies did not include psychotherapy as part of the depression treatment.", {"entities": []}], ["None of these studies included \u201cno treatment\u201d as a comparison group.", {"entities": []}], ["In addition, no study has included a broad group of chronic physical conditions in studying depression treatment expenditures.", {"entities": []}], ["We determined the association between depression treatment and short-term healthcare expenditures using a nationally representative sample of Medicare beneficiaries with chronic physical conditions and depression.", {"entities": []}], ["In this retrospective cohort study, we examined the association between depression treatment in the baseline year and healthcare expenditures in the following year using data from 2000 through 2005 of the Medicare Current Beneficiary Survey (MCBS), a nationally representative survey of Medicare beneficiaries.", {"entities": []}], ["Using the rotating panel design of MCBS, we derived five two-year cohorts: 2000\u20132001, 2001\u20132002, 2002\u20132003, 2003\u20132004, and 2004\u20132005.", {"entities": []}], ["The study sample included 1,055 elderly Medicare beneficiaries aged 65 or over.", {"entities": []}], ["We compared healthcare expenditures of no depression treatment group with depression treatment groups using t-tests.", {"entities": []}], ["Linear regressions of log-transformed dollars were used to assess the relationship between depression treatment and healthcare expenditures after controlling for demographic, socio-economic, health status, lifestyle risk factors, year of observation and baseline expenditures.", {"entities": []}], ["Compared to no depression treatment ($16,795), the average total expenditures were higher for those who used antidepressants only ($17,425) and those who used psychotherapy with or without antidepressants ($19,733).", {"entities": []}], ["After controlling for the independent variables, antidepressant use and psychotherapy with or without antidepressants were associated with 20.2% (95% CI: 14.1-26.7%) and 29.4% (95% CI: 18.8-41.0%) increase in total expenditures, respectively.", {"entities": []}], ["We observed that depression treatment was positively associated with inpatient, medical provider and prescription drug expenditures.", {"entities": []}], ["Among the elderly Medicare beneficiaries with chronic physical conditions, depression treatment was associated with greater short-term healthcare expenditures.", {"entities": []}], ["Future research needs to replicate these findings and also examine whether depression treatment reduces expenditures over a longer period of time.", {"entities": []}], ["High mobility group protein B1 (HMGB1) has been reported to serve important roles in various pathological conditions.", {"entities": [[32, 37, "GENE"]]}], ["Toll-like receptor 4 (TLR4), as one of the HMGB1 receptors, has been reported to be involved in the development of certain inflammatory diseases by activating nuclear factor NF-\u03ba-B (NF-\u03baB).", {"entities": [[22, 26, "GENE"], [43, 48, "GENE"]]}], ["However, there are few studies investigating the effects of HMGB1, TLR4 and NF-\u03baB on human inflammatory dermatoses.", {"entities": [[60, 65, "GENE"], [67, 71, "GENE"]]}], ["In the present study, the distribution and characteristics of HMGB1, TLR4 and NF-\u03baB p65 expression in psoriasis and atopic eczema (AE) were investigated.", {"entities": [[102, 111, "DISEASE"], [62, 67, "GENE"], [69, 73, "GENE"]]}], ["In addition, immunohistochemical analysis was performed to evaluate their expression and distribution in normal skin, and in patients with AE or psoriasis.", {"entities": [[145, 154, "DISEASE"]]}], ["Spearman's correlation analysis was used to predicate their relevancy.", {"entities": []}], ["The present study identified that the p65 level in epithelial nuclei in AE skin was increased compared with normal and psoriasis skin (P<0.01).", {"entities": [[119, 128, "DISEASE"]]}], ["The level of extracellular HMGB1 in AE skin was also increased compared with normal and psoriasis skin (P<0.01).", {"entities": [[88, 97, "DISEASE"], [27, 32, "GENE"]]}], ["Meanwhile, TLR4 expression on the epithelial membranes of AE skin was increased compared with psoriasis skin (P<0.01).", {"entities": [[94, 103, "DISEASE"], [11, 15, "GENE"]]}], ["Furthermore, the level of extracellular HMGB1 was positively correlated with epithelial membrane TLR4 (r=0.3856; P<0.05) and epithelial nuclear p65 (r=0.5894; P<0.01) in AE skin.", {"entities": [[40, 45, "GENE"], [97, 101, "GENE"]]}], ["These results indicated that the HMGB1-TLR4-NF-\u03baB signaling pathway is activated in AE and may account for its pathogenesis, but not in psoriasis.", {"entities": [[136, 145, "DISEASE"]]}], ["Therefore, HMGB1, TLR4 and NF-\u03baB p65 have the potential to be targets for the treatment of human inflammatory dermatoses, including AE.", {"entities": [[11, 16, "GENE"], [18, 22, "GENE"]]}], ["Research has consistently shown that while women generally live longer than men, they report more illness and use of health care services (including medication).", {"entities": []}], ["In the literature, the reasons for women's elevated medication use are not clear.", {"entities": []}], ["This paper investigates the associations between over-the-counter (OTC) and prescription (Rx) medication use and selected social and demographic variables in men and women.", {"entities": [[67, 70, "GENE"]]}], ["While a larger proportion of women than men used medication throughout the study, the proportion of people using medication did not increase.", {"entities": []}], ["The use of OTC and Rx medication increased by number of physician visits for women and men.", {"entities": [[11, 14, "GENE"]]}], ["Medication use increased with age, chronic disease and number of physician visits, and decreased with the perception of good to excellent health.", {"entities": []}], ["The relationship with other factors varied for women and men depending on their education level, income and social roles.", {"entities": []}], ["For women, the social roles of being married or previously married, being employed or being a parent did not increase their likelihood of medication use.", {"entities": []}], ["Reported income adequacy is not associated with the chances of mediation use among highly educated women, but for women with low levels, medication use increases as income adequacy decreases.", {"entities": []}], ["More complete data are needed about social roles and their relation to mediation use.", {"entities": []}], ["Data that would allow an assessment of the appropriateness of OTC and Rx drug use or the reasons for such use need to be collected.", {"entities": [[62, 65, "GENE"]]}], ["More research is needed to better understand the distribution and determinants of specific medication use.", {"entities": []}], ["Human biomonitoring has evolved beyond margins to ascertain exposure-response relationship in environmental associated human diseases.", {"entities": []}], ["As occupational ailments continue to dominate global concerns, biomonitoring strategies have evolved better in terms of evaluating health risks associated with systemic uptake from chronic (long-term) environment exposures.", {"entities": []}], ["Even though contributions of acute toxic exposures (short-term) towards initiation of disease processes have been gradually recognized, a comprehensive approach delineating mechanistic insights of such an implication remains elusive.", {"entities": []}], ["Molecular biomonitoring in a strictly selected defined surviving cohort of the infamous Bhopal gas tragedy \u201cas a model\u201d, could provide an unparallel opportunity to discern the long standing implications of acute exposures.", {"entities": []}], ["Besides comprehending clinical significance of isocyanate toxicity, the results might provide a framework for understanding the molecular repercussions pertaining to a host of other such acute environmental exposures.", {"entities": []}], ["The investigative strategy might also be helpful in identification of biomarkers with potential for translational research.", {"entities": []}], ["Verbascum thapsus is used in tribal medicine as an antispasmodic, anti-tubercular agent and wormicide.", {"entities": []}], ["In this study, we investigated the antispasmodic and anthelmintic activities of crude aqueous methanolic extract of the plant.", {"entities": []}], ["V. thapsus extracts were tested against roundworms ( Ascaridia galli ) and tapeworms ( Raillietina spiralis ).", {"entities": []}], ["Each species of worm was placed into a negative control group, an albendazole treatment group, or a V. thapsus treatment group, and the time taken for paralysis and death was determined.", {"entities": []}], ["In addition, relaxation activity tests were performed on sections of rabbit's jejunum.", {"entities": []}], ["Plant extracts were tested on KCl-induced contractions and the relaxation activities were quantified against atropine.", {"entities": []}], ["V. thapsus calcium chloride curves were constructed to investigate the mode of action of the plant extracts.", {"entities": []}], ["We detected flavonoids, saponins, tannins, terpenoids, glycosides, carbohydrates, proteins, fats and fixed oils in V. thapsus .", {"entities": []}], ["For both species of worm, paralysis occurred fastest at the highest concentration of extract.", {"entities": []}], ["The relative index values for paralysis in A. galli were 4.58, 3.41 and 2.08, at concentrations of 10, 20 and 40 mg/ml of plant extract, respectively.", {"entities": []}], ["The relative index for death in A. galli suggested that V. thapsus extract is wormicidal at high concentration.", {"entities": []}], ["Similarly, the relative indexes for paralysis and death in R. spiralis suggested that the extract is a more potent wormicidal agent than albendazole.", {"entities": []}], ["The mean EC 50 relaxation activity values for spontaneous and KCl induced contractions were 7.5 \u00b1 1.4 mg/ml (6.57-8.01, n = 6) and 7.9 \u00b1 0.41 mg/ml (7.44-8.46, n = 6), respectively.", {"entities": []}], ["The relaxation activity of the extract was 11.42 \u00b1 2, 17.0 \u00b1 3, 28.5 \u00b1 4, and 128.0 \u00b1 7% of the maximum observed for atropine at corresponding concentrations.", {"entities": []}], ["The calcium chloride curves showed that V. thapsus extracts (3 mg/ml), had a mean EC 50 (log molar [calcium]) value of -1.9 \u00b1 0.06 (-1.87 - -1.98, n = 6) vs .", {"entities": []}], ["control EC 50 = -2.5 \u00b1 0.12 (-2.37 - -2.56, n = 6), whereas the verapamil (0.1 \u03bcM) EC 50 was -1.7 \u00b1 0.1 (-1.6 - -1.8, n = 6) vs .", {"entities": []}], ["control EC 50 = -2.4 \u00b1 0.09 (-2.3 - -2.47, n = 5).", {"entities": []}], ["Our results suggest that V. thapsus , which is currently used by some tribes in the Malakand region of Pakistan, has anthelmintic and antispasmodic value.", {"entities": []}], ["In order to increase inhaled corticosteroid (ICS) use and to reduce hospitalization, emergency department visits and ultimately the economic burden of asthma, \"Korean Asthma Management Guideline for Adults 2007\" was developed.", {"entities": [[151, 157, "DISEASE"], [167, 173, "DISEASE"]]}], ["To assess the guideline effects on physician's ICS prescription for asthma, we conducted segmented regression and multilevel logistic regression using National Health Insurance claims database of outpatient visits from 2003 to 2010.", {"entities": [[68, 74, "DISEASE"]]}], ["We set each quarter of a year as a time unit and compared ICS prescription between before and after guideline dissemination.", {"entities": []}], ["A total of 624,309 quarterly visits for asthma was observed.", {"entities": [[40, 46, "DISEASE"]]}], ["The ICS prescription rate before and after guideline dissemination was 13.3% and 16.4% respectively ( P < 0.001).", {"entities": []}], ["In the segmented regression, there was no significant guideline effect on overall ICS prescription rate.", {"entities": []}], ["In multilevel logistic regression analyses, the effect of guideline on overall ICS prescription was not significant (odds ratio, 1.03; 95% CI, 1.00-1.06).", {"entities": []}], ["In subgroup analysis, ICS prescription increased in secondary care hospitals (odds ratio, 1.15; 95% CI, 1.02-1.30) and in general hospitals (odds ratio, 1.10; 95% CI, 1.04-1.16).", {"entities": []}], ["However, in primary clinics, which covered 81.7% of asthma cases, there was no significant change (odds ratio, 0.98; 95% CI, 0.94-1.02).", {"entities": [[52, 58, "DISEASE"]]}], ["From the in-depth interview, we could identify that the reimbursement criteria of the Health Insurance Review and Assessment Service and patient's preference for oral drug were barriers for the ICS prescription.", {"entities": []}], ["The domestic asthma clinical guideline have no significant effect on ICS prescription, especially in primary clinics.", {"entities": [[13, 19, "DISEASE"]]}], ["Hospitals play a critical role in the health promotion of the society.", {"entities": []}], ["This study aimed to determine the impact of establishing standards of health promoting hospitals on hospital indicators in Shahroud.", {"entities": []}], ["This applied study was a quasi-experimental one which was conducted in 2013.", {"entities": []}], ["Standards of health promoting hospitals were established as an intervention procedure in the Fatemiyeh hospital.", {"entities": []}], ["Parameters of health promoting hospitals were compared in intervention and control hospitals before and after of intervention (6 months).", {"entities": []}], ["The data were analyzed using chi-square and t-test.", {"entities": []}], ["With the establishment of standards for health promotion hospitals, standard scores in intervention and control hospitals were found to be 72.26 \u00b1 4.1 and 16.26 \u00b1 7.5, respectively.", {"entities": []}], ["T-test showed a significant difference between the mean scores of the hospitals under study (P = 0.001).The chi-square test also showed a significant relationship between patient satisfaction before and after the intervention so that patients\u2019 satisfaction was higher after the intervention (P = 0.001).", {"entities": []}], ["Commenting on the short-term or long-term positive impacts of establishing standards of health promoting hospitals on all hospital indicators is a bit difficult but preliminary results show the positive impact of the implementation of standards in case hospitals which has led to the improvement of many indicators in the hospital.", {"entities": []}], ["In this study, poly(lactic- co -glycolic acid) (PLGA) was used as a carrier to construct disulfiram-loaded porous microparticle through the emulsion solvent evaporation method, using ammonium bicarbonate as a porogen.", {"entities": []}], ["The microparticle possessed highly porous surface, suitable aerodynamic diameter for inhalation (8.31\u00b11.33 \u00b5m), favorable drug loading (4.09%\u00b10.11%), and sustained release profile.", {"entities": []}], ["The antiproliferation effect of release supernatant was detected through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using non-small-cell lung cancer A549 as a model, with only 13.3% of cell viability observed for the release supernatant at 7 days.", {"entities": [[161, 172, "DISEASE"], [166, 172, "DISEASE"]]}], ["The antiproliferation mechanism was elucidated to be associated with the enhanced induction of cell apoptosis and cell cycle arrest at S phase through flow cytometry and Western blotting analysis.", {"entities": []}], ["Finally, wound healing and transwell migration assay showed that they could efficiently inhibit the cell migration.", {"entities": []}], ["These results demonstrated that disulfiram-loaded porous PLGA microparticle could achieve favorable antitumor efficiency, implying the potential of treating non-small-cell lung cancer in a pulmonary administration.", {"entities": [[172, 183, "DISEASE"], [177, 183, "DISEASE"]]}], ["Fullerenes are nanoparticles composed of carbon atoms arranged in a spherical hollow cage-like structure.", {"entities": []}], ["Numerous studies have evaluated the therapeutic potential of fullerene derivates against oxidative stress-associated conditions, including the prevention or treatment of arthritis.", {"entities": [[170, 179, "DISEASE"]]}], ["On the other hand, fullerenes are not only able to quench, but also to generate harmful reactive oxygen species.", {"entities": []}], ["The reactivity of fullerenes may change in time due to the oxidation and polymerization of fullerenes in an air atmosphere.", {"entities": []}], ["In this study, we therefore tested the dependence between the age of fullerene films (from one week to one year) and the proliferation, viability and metabolic activity of human osteosarcoma cells (lines MG-63 and U-2 OS).", {"entities": [[178, 190, "DISEASE"]]}], ["We also monitored potential membrane and DNA damage and morphological changes of the cells.", {"entities": []}], ["After seven days of cultivation, we did not observe any cytotoxic morphological changes, such as enlarged cells or cytosolic vacuole formation.", {"entities": []}], ["Furthermore, there was no increased level of DNA damage.", {"entities": []}], ["The increasing age of the fullerene films did not cause enhancement of cytotoxicity.", {"entities": []}], ["On the contrary, it resulted in an improvement in the properties of these materials, which are more suitable for cell cultivation.", {"entities": []}], ["Therefore, fullerene films could be considered as a promising material with potential use as a bioactive coating of cell carriers for bone tissue engineering.", {"entities": []}], ["Lipid nanocapsules (LNCs) are potential drug carriers for pulmonary delivery since they can be nebulized without any structural or functional changes, and the aerosols produced are highly compatible with pulmonary drug delivery in human beings.", {"entities": []}], ["The alveolar surface tension, in vitro cytotoxicity, biodistribution and pulmonary toxicity in rats of a single endotracheal spray of LNCs or paclitaxel-loaded LNCs were studied.", {"entities": []}], ["In vitro cytotoxicity of LNCs after a spray remained unchanged.", {"entities": []}], ["Biodistribution study showed a homogeneous repartition in the lungs in rats with an improvement in lung retention of the radiolabeled tracer loaded in LNCs compared to the absence of LNCs with a lung half-time of 8.8\u00b10.7 hours.", {"entities": []}], ["Bronchoalveolar fluid analysis revealed transient 7-day alveolar inflammation, reaching a maximum between days 2 and 4, characterized by a peak of granulocytes at day 1 followed by a peak of lymphocytes at day 3.", {"entities": []}], ["Alveolar protein levels were increased at days 3 and 7.", {"entities": []}], ["Acute inflammation was increased with paclitaxel-loaded LNCs in comparison with blank LNCs but dropped out at day 7.", {"entities": []}], ["No histological pulmonary lesion was observed at day 60.", {"entities": []}], ["LNCs lowered surface tension to a greater degree than Curosurf", {"entities": []}], ["Chronic diseases, primarily cardiovascular disease, respiratory disease, diabetes and cancer, are the leading cause of death and disability worldwide.", {"entities": [[86, 92, "DISEASE"]]}], ["In sub-Saharan Africa (SSA), where communicable disease prevalence still outweighs that of non-communicable disease (NCDs), rates of NCDs are rapidly rising and evidence for primary healthcare approaches for these emerging NCDs is needed.", {"entities": []}], ["A systematic review and evidence synthesis of primary care approaches for chronic disease in SSA.", {"entities": []}], ["Quantitative and qualitative primary research studies were included that focused on priority NCDs interventions.", {"entities": []}], ["The method used was best-fit framework synthesis.", {"entities": []}], ["Three conceptual models of care for NCDs in low- and middle-income countries were identified and used to develop an a priori framework for the synthesis.", {"entities": []}], ["The literature search for relevant primary research studies generated 3759 unique citations of which 12 satisfied the inclusion criteria.", {"entities": []}], ["Eleven studies were quantitative and one used mixed methods.", {"entities": []}], ["Three higher-level themes of screening, prevention and management of disease were derived.", {"entities": []}], ["This synthesis permitted the development of a new evidence-based conceptual model of care for priority NCDs in SSA.", {"entities": []}], ["For this review there was a near-consensus that passive rather than active case-finding approaches are suitable in resource-poor settings.", {"entities": []}], ["Modifying risk factors among existing patients through advice on diet and lifestyle was a common element of healthcare approaches.", {"entities": []}], ["The priorities for disease management in primary care were identified as: availability of essential diagnostic tools and medications at local primary healthcare clinics and the use of standardized protocols for diagnosis, treatment, monitoring and referral to specialist care.", {"entities": []}], ["The online version of this article (doi:10.1186/s12875-017-0613-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["S -nitrosylation is an important mediator of multiple nitric oxide-dependent biological processes, including eukaryotic cellular events such as macrophage apoptosis and proinflammatory signaling.", {"entities": []}], ["Many pathogenic bacteria possess NO detoxification mechanisms, such as the nitric oxide reductase (NorB) of Neisseria meningitidis and the flavohemoglobins (Hmp) of Salmonella enterica and Escherichia coli , which serve to protect the microorganism from nitrosative stress within the intracellular environment.", {"entities": []}], ["In this study, we demonstrate that expression of meningococcal NorB increases the rate at which low-molecular-weight S -nitrosothiol (SNO) decomposes in vitro .", {"entities": []}], ["To determine whether this effect occurs in cells during infection by bacteria, we induced SNO formation in murine macrophages by activation with lipopolysaccharide and \u03b3-interferon and observed a reduced abundance of SNO during coincubation with N. meningitidis, S. enterica , or E. coli .", {"entities": []}], ["In each case, this effect was shown to be dependent on bacterial NO detoxification genes, which act to prevent SNO formation through the removal of NO.", {"entities": []}], ["This may represent a novel mechanism of host cell injury by bacteria.\u2014Laver, J. R., Stevanin, T. M., Messenger, S. L., Dehn Lunn, A., Lee, M. E., Moir, J. W. B., Poole, R. K., Read, R. C. Bacterial nitric oxide detoxification prevents host cell S -nitrosothiol formation: a novel mechanism of bacterial pathogenesis.", {"entities": []}], ["This paper describes the effects of immune genes genetic variants and mRNA expression on depression's risk, severity, and response to antidepressant treatment, through a systematic review on all papers published between 2000 and 2016.", {"entities": []}], ["Our results, based largely on case\u2013control studies, suggest that common genetic variants and gene-expression pathways are involved in both immune activation and depression.", {"entities": []}], ["The most replicated and relevant genetic variants include polymorphisms in the genes for interleukin (IL)-1\u03b2, IL-6, IL-10, monocyte chemoattractant protein-1, tumor necrosis factor-alpha, C-reactive protein, and phospholipase A2.", {"entities": []}], ["Moreover, increased blood cytokines mRNA expression (especially of IL-1\u03b2) identifies patients that are less likely to respond to conventional antidepressants.", {"entities": []}], ["However, even for the most replicated findings there are inconsistent results, not only between studies, but also between the immune effects of the genetic variants and the resulting effects on depression.", {"entities": []}], ["We find evidence that these discrepant findings may be explained, at least in part, by the heterogeneity of the depression immunophenotype, by environmental influences and gene \u00d7 environment interactions, and by the complex interfacing of genetic variants with gene expression.", {"entities": []}], ["Indeed, some of the most robust findings have been obtained in patients developing depression in the context of treatment with interferon-alpha, a widely used model to mimic depression in the context of inflammation.", {"entities": []}], ["Further \u2018omics' approaches, through GWAS and transcriptomics, will finally shed light on the interaction between immune genes, their expression, and the influence of the environment, in the pathogenesis of depression.", {"entities": []}], ["Chlorpyrifos (CPF) is a commonly used organophosphate insecticide (OP).", {"entities": []}], ["In adults, exposure to OPs has been inconsistently associated with reduced lung function.", {"entities": []}], ["OP exposure and lung function has not been assessed in adolescents.", {"entities": []}], ["The objective of this study was to assess CPF exposure and lung function among Egyptian adolescents.", {"entities": []}], ["We conducted a 10-month study of male adolescent pesticide applicators (n = 38) and non-applicators of similar age (n = 24).", {"entities": []}], ["Urinary 3,5,6-trichloro-2-pyridinol (TPCy), a CPF-specific metabolite, was analyzed in specimens collected throughout the study.", {"entities": []}], ["Spirometry was performed twice after pesticide application: day 146, when TCPy levels were elevated and day 269, when TCPy levels were near baseline.", {"entities": []}], ["Applicators had higher levels of TCPy (mean cumulative TCPy day 146 = 33,217.6; standard deviation (SD) = 49,179.3) than non-applicators (mean cumulative TCPy day 146 = 3290.8; SD = 3994.9).", {"entities": []}], ["Compared with non-applicators, applicators had higher odds of reporting wheeze, odds ratio = 3.41 (95% CI: 0.70; 17.41).", {"entities": []}], ["Cumulative urinary TCPy was inversely associated with spirometric measurements at day 146, but not at day 269.", {"entities": []}], ["Although generally non-significant, results were consistent with an inverse association between exposure to CPF and lung function.", {"entities": []}], ["The prevalence of cardiovascular diseases (CVD) within low-income and middle-income countries has reached epidemic proportions.", {"entities": []}], ["However, the association between out-of-pocket (OOP) payment and socioeconomic status (SES) of patients with CVD is not well studied.", {"entities": []}], ["We aimed to understand the financial burden among Chinese middle-aged and older patients with CVD, and whether there was an association with SES.", {"entities": []}], ["A nationally representative survey\u2014 The China Health and Retirement Longitudinal Survey (CHARLS)\u2014was conducted in 28 provinces of mainland China in 2011 and 2013.", {"entities": []}], ["Of the over 18 000 CHARLS respondents, eligible participants were those aged 45 years and over who had been previously diagnosed with CVD.", {"entities": []}], ["Financial burden was measured by individual OOP payment and household catastrophic health expenditure (CHE) occurrence (ie, the annual household health expenditure was 40% or more of the total non-food household expenditure).", {"entities": []}], ["Multilevel regression models were used to explore the association between financial burden and SES.", {"entities": []}], ["Among CHARLS respondents, CVD prevalence increased from 14.7% in 2011 to 16.6% in 2013.", {"entities": []}], ["Average annual CVD OOP payment increased from 5000 RMB (770 USD) to 6120 RMB (970 USD).", {"entities": []}], ["Furthermore, CHE occurrence increased from 44.2% to 48.1%.", {"entities": []}], ["Patients spent almost twice on outpatient as on inpatient services.", {"entities": []}], ["Two of the three SES indicators (total household expenditure, occupation type) were found to be associated with CVD OOP payment amount, and the likelihood of CHE.", {"entities": []}], ["Unemployed patients had a higher likelihood of CHE compared with agricultural workers.", {"entities": []}], ["Rural-urban difference was associated with the likelihood of CHE in 2011 alone.", {"entities": []}], ["The Chinese health system should use this health expenditure pattern among patients with CVD to create more equitable health insurance schemes that financially balance between outpatient and inpatient care, and provide better financial risk protection to patients with low SES.", {"entities": []}], ["Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an important downregulatory molecule expressed on both T and B lymphocytes.", {"entities": []}], ["Numerous population genetics studies have documented significant associations between autoimmune diseases and single nucleotide polymorphisms (SNPs) within and around the CTLA-4 region of chromosome 2 in man.", {"entities": []}], ["Furthermore, circulating levels of a soluble form of CTLA-4 (sCTLA-4) have been reported in a variety of autoimmune mediated diseases.", {"entities": []}], ["Despite these findings, the relationship between levels of sCTLA-4 protein, mRNA transcript levels, and SNPs within the CTLA-4 region have not been clearly defined.", {"entities": []}], ["In order to further clarify this relationship, we have tested four different SNPs within the CTLA-4 region among subjects whom are negative (n = 53) versus positive (n = 28) for sCTLA-4.", {"entities": []}], ["Our data do not support a clear association between sCTLA-4 levels and any of the four SNPs tested.", {"entities": []}], ["The variation in the SNPs tested does not appear to effect sCTLA-4 protein levels, despite reports that they affect sCTLA-4 mRNA.", {"entities": []}], ["Alpinia pahangensis , a wild ginger distributed in the lowlands of Pahang, Malaysia, is used by the locals to treat flatulence.", {"entities": []}], ["In this study, the antioxidant and cytotoxic activities of the crude aqueous methanol and fractionated extracts of Alpinia pahangensis against five different cancer and one normal cell lines were investigated.", {"entities": [[158, 164, "DISEASE"]]}], ["The total phenolic content of each extract and its fractions were also quantified.", {"entities": []}], ["This is the first report on the antioxidant and cytotoxic activities of Alpinia pahangensis extract.", {"entities": []}], ["In the current study, the crude methanol and fractionated extract of the rhizomes of Alpinia pahangensis were investigated for their antioxidant activity using four different assays namely, the DPPH scavenging activity, superoxide anion scavenging, \u03b2-carotene bleaching and reducing power assays whilst their phenolic contents were measured by the Folin-Ciocalteu\u2019s method.", {"entities": []}], ["In vitro neutral red cytotoxicity assay was employed to evaluate the cytotoxic activity against five different cancer cell lines, colon cancer (HCT 116 and HT-29), cervical cancer (Ca Ski), breast cancer (MCF7) and lung cancer (A549) cell lines, and one normal cell line (MRC-5).", {"entities": [[215, 226, "DISEASE"], [190, 203, "DISEASE"], [130, 142, "DISEASE"], [111, 117, "DISEASE"], [136, 142, "DISEASE"], [173, 179, "DISEASE"], [197, 203, "DISEASE"], [220, 226, "DISEASE"], [164, 179, "DISEASE"]]}], ["The extract that showed high cytotoxic activity was further investigated for its chemical constituents by GC-MS (gas chromatography\u2013mass spectrometry) analysis.", {"entities": []}], ["The ethyl acetate fraction showed the strongest DPPH radical scavenging (0.35\u2009\u00b1\u20090.094\u00a0mg/ml) and SOD activities (51.77\u2009\u00b1\u20094.9%) whilst the methanol extract showed the highest reducing power and also the strongest antioxidant activity in the \u03b2-carotene bleaching assays in comparison to other fractions.", {"entities": []}], ["The highest phenolic content was found in the ethyl acetate fraction, followed by the crude methanol extract, hexane and water fractions.", {"entities": []}], ["The results showed a positive correlation between total phenolic content with DPPH radical scavenging capacities and SOD activities.", {"entities": []}], ["The hexane fraction showed potent cytotoxic effect against KB, Ca Ski and HCT 116 cell lines with IC 50 of 5.8\u2009\u00b1\u20090.1 and 9.1\u2009\u00b1\u20092.0 ug/ml, respectively.", {"entities": []}], ["The major components of hexane fraction analysed by GC-MS analysis were mostly methyl esters.", {"entities": []}], ["The current study suggests that the methanol extract and ethyl acetate fraction of A. pahangensis is a potential source of natural antioxidant for protective as well as prevention of life-threatening diseases.", {"entities": []}], ["The hexane fraction of A. pahangensis may have the potential to be developed into therapeutic option for treating cancer.", {"entities": [[114, 120, "DISEASE"]]}], ["This experiment was designed to establish the localization and neurochemical phenotyping of sympathetic neurons supplying prepyloric area of the porcine stomach in a physiological state and during acetylsalicylic acid (ASA) induced gastritis.", {"entities": [[232, 241, "DISEASE"]]}], ["In order to localize the sympathetic perikarya the stomachs of both control and acetylsalicylic acid treated (ASA group) animals were injected with neuronal retrograde tracer Fast Blue (FB).", {"entities": []}], ["Seven days post FB injection, animals were divided into a control and ASA supplementation group.", {"entities": []}], ["The ASA group was given 100 mg/kg of b.w.", {"entities": []}], ["ASA orally for 21 days.", {"entities": []}], ["The Pure Parsimony Haplotyping (PPH) problem is a NP-hard combinatorial optimization problem that consists of finding the minimum number of haplotypes necessary to explain a given set of genotypes.", {"entities": []}], ["PPH has attracted more and more attention in recent years due to its importance in analysis of many fine-scale genetic data.", {"entities": []}], ["Its application fields range from mapping complex disease genes to inferring population histories, passing through designing drugs, functional genomics and pharmacogenetics.", {"entities": []}], ["In this article we investigate, for the first time, a recent version of PPH called the Pure Parsimony Haplotype problem under Uncertain Data (PPH-UD).", {"entities": []}], ["This version mainly arises when the input genotypes are not accurate, i.e., when some single nucleotide polymorphisms are missing or affected by errors.", {"entities": []}], ["We propose an exact approach to solution of PPH-UD based on an extended version of Catanzaro et al.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["Cardiovascular disease is a common comorbidity and cause of mortality in chronic obstructive pulmonary disease.", {"entities": [[73, 110, "DISEASE"]]}], ["A better understanding of mechanisms of cardiovascular risk in chronic obstructive pulmonary disease patients is needed to improve clinical outcomes.", {"entities": [[63, 100, "DISEASE"]]}], ["We hypothesized that such patients have increased arterial stiffness, wave reflections, and subclinical atherosclerosis compared with controls and that these findings would be independent of smoking status and other confounding factors.", {"entities": [[104, 119, "DISEASE"]]}], ["A total of 458 patients with a diagnosis of chronic obstructive pulmonary disease and 1657 controls (43% were current or ex-smokers) with no airflow limitation were matched for age, sex, and body mass index.", {"entities": [[44, 81, "DISEASE"]]}], ["All individuals underwent assessments of carotid\u2013femoral (aortic) pulse wave velocity, augmentation index, and carotid intima\u2013media thickness.", {"entities": []}], ["The mean age of the cohort was 67\u00b18 years and 58% were men.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease had increased aortic pulse wave velocity (9.95\u00b12.54 versus 9.27\u00b12.41 m/s; P <0.001), augmentation index (28\u00b110% versus 25\u00b110%; P <0.001), and carotid intima\u2013media thickness (0.83\u00b10.19 versus 0.74\u00b10.14 mm; P <0.001) compared with controls.", {"entities": [[14, 51, "DISEASE"]]}], ["Chronic obstructive pulmonary disease was associated with increased levels of each vascular biomarker independently of physiological confounders, smoking, and other cardiovascular risk factors.", {"entities": [[0, 37, "DISEASE"]]}], ["In this large case-controlled study, chronic obstructive pulmonary disease was associated with increased arterial stiffness, wave reflections, and subclinical atherosclerosis, independently of traditional cardiovascular risk factors.", {"entities": [[159, 174, "DISEASE"], [37, 74, "DISEASE"]]}], ["These findings suggest that the cardiovascular burden observed in this condition may be mediated through these mechanisms and supports the concept that chronic obstructive pulmonary disease is an independent risk factor for cardiovascular disease.", {"entities": [[152, 189, "DISEASE"]]}], ["High risk prescribing can compromise independent wellbeing and quality of life in older adults.", {"entities": []}], ["The aims of this project are to determine the prevalence, risk factors, clinical consequences, and costs of high risk prescribing, and to assess the impact of interventions on high risk prescribing in older people.", {"entities": []}], ["The proposed project will utilise data from the 45 and Up Study, a large scale cohort of 267,153 men and women aged 45 and over recruited during 2006\u20132009 from the state of New South Wales, Australia linked to a range of administrative health datasets.", {"entities": []}], ["High risk prescribing will be assessed using three indicators: polypharmacy (use of five or more medicines); Beers Criteria (an explicit measure of potentially inappropriate medication use); and Drug Burden Index (a pharmacologic dose-dependent measure of cumulative exposure to anticholinergic and sedative medicines).", {"entities": []}], ["Individual risk factors from the 45 and Up Study questionnaire, and health system characteristics from health datasets that are associated with the likelihood of high risk prescribing will be identified.", {"entities": []}], ["The main outcome measures will include hospitalisation (first admission to hospital, total days in hospital, cause-specific hospitalisation); admission to institutionalised care; all-cause mortality, and, where possible, cause-specific mortality.", {"entities": []}], ["Economic costs to the health care system and implications of high risk prescribing will be also investigated.", {"entities": []}], ["In addition, changes in high risk prescribing will be evaluated in relation to certain routine medicines-related interventions.", {"entities": []}], ["The statistical analysis will be conducted using standard pharmaco-epidemiological methods including descriptive analysis, univariate and multivariate regression analysis, controlling for relevant confounding factors, using a number of different approaches.", {"entities": []}], ["The availability of large-scale data is useful to identify opportunities for improving prescribing, and health in older adults.", {"entities": []}], ["The size of the 45 and Up Study, along with linkage to health databases provides an important opportunity to investigate the relationship between high risk prescribing and adverse outcomes in a real-world population of older adults.", {"entities": []}], ["The objective of this study was to evaluate the epidemiology of infection in Polish long-term care facilities (LTCFs) and to analyse the capabilities and legitimacy of implementing continuous targeted surveillance.", {"entities": []}], ["The study investigated the relationship between the presence of infection and health status, tested using a point prevalence study (PPS) and incidence study.", {"entities": []}], ["A 1-day PPS was carried out in October 2009, with prospective continuous surveillance between December 2009 and November 2010.", {"entities": []}], ["Infections were defined according to McGeer\u2019s criteria.", {"entities": []}], ["The surveillance encompassed 193 people.", {"entities": []}], ["The prevalence was 14.0\u00a0% in residential homes (RHs) and 18.7\u00a0% in the nursing home (NH).", {"entities": []}], ["Various types of infections (in the PPS) were observed significantly more frequently in patients with asthma, wounds, atherosclerosis of lower extremities, tracheotomy tubes and conditions in patients hospitalised in intensive care units (ICUs) up to 1 year before the PPS day.", {"entities": [[118, 133, "DISEASE"], [102, 108, "DISEASE"]]}], ["The incidence rate was 2.7/1,000\u00a0patient days (pds).", {"entities": []}], ["The factors determined to be important for the risk of infection (in the continuous study) include the general status of patients, expressed using Barthel, abbreviated mental and Katz scales, as well as limited physical activity, stool incontinence and urinary catheterisation.", {"entities": []}], ["In the PPS study, only a slight relationship was shown between the general status of residents and the risk of infection.", {"entities": []}], ["None of the general status scales used clinically were shown to be helpful in estimating that risk, similarly to the five-point physical activity scale.", {"entities": []}], ["Prospective continuous surveillance shows a possibility of limiting the range of infection control in\u00a0the\u00a0LTCFs within targeted surveillance in a population of patients that requires intensive nursing procedures.", {"entities": []}], ["As a marker, one could point to the low score in the Barthel or Katz scales or low physical activity/bedridden persons.", {"entities": []}], ["Asthma is a common childhood atopic disease associated with chronicity and impaired quality of life.", {"entities": [[0, 6, "DISEASE"]]}], ["As there is no cure for this disease, treatment relies on avoidance of triggers such as food and aeroallergens, the use of inhaled bronchodilators/corticosteroids and antiallergic or immunomodulating therapies.", {"entities": []}], ["Inhaled corticosteroids (ICSs) and bronchodilators have been the mainstay.", {"entities": []}], ["However, in Asia, myths and fallacies regarding Western medicine and corticosteroids are prevalent and lead to nonadherence to treatment.", {"entities": []}], ["Also, use of traditional and proprietary herbal medicines is popular.", {"entities": []}], ["In the past decades, a novel class of nonsteroidal immunomodulating montelukasts has become available.", {"entities": []}], ["This article reviews the evidence for the effectiveness and clinical efficacy of these medications.", {"entities": []}], ["A number of randomized and controlled trials have been performed over the years.", {"entities": []}], ["The majority of studies confirm the usefulness of montelukast as monotherapy and add-on therapy to ICS in mild to moderate childhood asthma across all age groups.", {"entities": [[133, 139, "DISEASE"]]}], ["ICSs are generally superior to montelukasts for asthma management.", {"entities": [[48, 54, "DISEASE"]]}], ["However, montelukast has a place in the treatment of young children with viral-triggered wheezing diseases, exercise-induced asthma, and in children whose parents are steroid-phobic and find ICS unacceptable.", {"entities": [[125, 131, "DISEASE"]]}], ["To investigate the effects of Panax notoginseng (PN) on microvascular injury in colitis, its mechanisms, initial administration time and dosage.", {"entities": []}], ["Dextran sodium sulfate (DSS)- or iodoacetamide (IA)-induced rat colitis models were used to evaluate and investigate the effects of ethanol extract of PN on microvascular injuries and their related mechanisms.", {"entities": []}], ["PN administration was initiated at 3 and 7 d after the model was established at doses of 0.5, 1.0 and 2.0 g/kg for 7 d. The severity of colitis was evaluated by disease activity index (DAI).", {"entities": []}], ["The pathological lesions were observed under a microscope.", {"entities": []}], ["Microvessel density (MVD) was evaluated by immunohistochemistry.", {"entities": [[21, 24, "GENE"]]}], ["Vascular permeability was evaluated using the Evans blue method.", {"entities": []}], ["The serum concentrations of cytokines, including vascular endothelial growth factor (VEGF)A121, VEGFA165, interleukin (IL)-4, IL-6, IL-10 and tumor necrosis factor (TNF)-\u03b1, were detected by enzyme-linked immunosorbent assay.", {"entities": [[165, 168, "GENE"]]}], ["Myeloperoxidase (MPO) and superoxide dismutase (SOD) were measured to evaluate the level of oxidative stress.", {"entities": [[17, 20, "GENE"]]}], ["Expression of hypoxia-inducible factor (HIF)-1\u03b1 protein was detected by western blotting.", {"entities": []}], ["Obvious colonic inflammation and injuries of mucosa and microvessels were observed in DSS- and IA-induced colitis groups.", {"entities": []}], ["DAI scores, serum concentrations of VEGFA121, VEGFA165, VEGFA165/VEGFA121, IL-6 and TNF-\u03b1, and concentrations of MPO and HIF-1\u03b1 in the colon were significantly higher while serum concentrations of IL-4 and IL-10 and MVD in colon were significantly lower in the colitis model groups than in the normal control group.", {"entities": [[113, 116, "GENE"], [216, 219, "GENE"]]}], ["PN promoted repair of injuries of colonic mucosa and microvessels, attenuated inflammation, and decreased DAI scores in rats with colitis.", {"entities": []}], ["PN also decreased the serum concentrations of VEGFA121, VEGFA165, VEGFA165/VEGFA121, IL-6 and TNF-\u03b1, and concentrations of MPO and HIF-1\u03b1 in the colon, and increased the serum concentrations of IL-4 and IL-10 as well as the concentration of SOD in the colon.", {"entities": [[123, 126, "GENE"]]}], ["The efficacy of PN was dosage dependent.", {"entities": []}], ["In addition, DAI scores in the group administered PN on day 3 were significantly lower than in the group administered PN on day 7.", {"entities": []}], ["PN repairs vascular injury in experimental colitis via attenuating inflammation and oxidative stress in the colonic mucosa.", {"entities": []}], ["Efficacy is related to initial administration time and dose.", {"entities": []}], ["Nonsense mutations are at the origin of many cancers and inherited genetic diseases.", {"entities": []}], ["The consequence of nonsense mutations is often the absence of mutant gene expression due to the activation of an mRNA surveillance mechanism called nonsense-mediated mRNA decay (NMD).", {"entities": []}], ["Strategies to rescue the expression of nonsense-containing mRNAs have been developed such as NMD inhibition or nonsense mutation readthrough.", {"entities": []}], ["Using a dedicated screening system, we sought molecules capable to block NMD.", {"entities": []}], ["Additionally, 3 cell lines derived from patient cells and harboring a nonsense mutation were used to study the effect of the selected molecule on the level of nonsense-containing mRNAs and the synthesis of proteins from these mutant mRNAs.", {"entities": []}], ["We demonstrate here that amlexanox, a drug used for decades, not only induces an increase in nonsense-containing mRNAs amount in treated cells, but also leads to the synthesis of the full-length protein in an efficient manner.", {"entities": []}], ["We also demonstrated that these full length proteins are functional.", {"entities": []}], ["As a result of this dual activity, amlexanox may be useful as a therapeutic approach for diseases caused by nonsense mutations.", {"entities": []}], ["Sensitization in early childhood may precede respiratory allergy in adolescence.", {"entities": []}], ["IgE reactivity against 132 allergen molecules was evaluated using the MeDALL microarray in sera obtained from a random sample of 786 children at the age of 4, 8 and 16\u00a0years in a population based birth cohort (BAMSE).", {"entities": []}], ["Symptoms were analyzed by questionnaire at ages 4, 8 and 16\u00a0years.", {"entities": []}], ["Clinically and independent relevant allergen molecules accounting for \u2265\u00a090% of IgE reactivities in sensitized individuals and at all time-points were identified as risk molecules and used to predict respiratory allergy.", {"entities": []}], ["The data was replicated in the Manchester Asthma and Allergy Study (MAAS) birth cohort by studying IgE reactivity with the use of a commercial IgE microarray.", {"entities": [[42, 48, "DISEASE"]]}], ["Sera were obtained from children at the ages of 3, 5, 8 and 11\u00a0years (N\u00a0=\u00a0248) and the outcome was studied at 11\u00a0years.", {"entities": []}], ["In the BAMSE cohort 4 risk molecules could be identified, i.e.", {"entities": []}], [": Ara h 1 (peanut), Bet v 1 (birch), Fel d 1 (cat), Phl p 1 (grass).", {"entities": []}], ["For MAAS the corresponding number of molecules was 5: Der p 1 (dust mite), Der f 2 (dust mite), Phl p 1 (grass), Phl p 5 (grass), Fel d 1 (cat).", {"entities": []}], ["In BAMSE, early IgE reactivity to \u2265\u00a03 of 4 allergen molecules at four years predicted incident and persistent asthma and/or rhinitis at 16\u00a0years (87% and 95%, respectively).", {"entities": [[124, 132, "DISEASE"], [110, 116, "DISEASE"]]}], ["The corresponding proportions in the MAAS cohort at 16\u00a0years were 100% and 100%, respectively, for IgE reactivity to \u2265\u00a03 of 5 risk molecules.", {"entities": []}], ["IgE reactivity to a few allergen molecules early in life identifies children with a high risk of asthma and/or rhinitis at 16\u00a0years.", {"entities": [[111, 119, "DISEASE"], [97, 103, "DISEASE"]]}], ["These findings will be of importance for developing preventive strategies for asthma and rhinitis in children.", {"entities": [[89, 97, "DISEASE"], [78, 84, "DISEASE"]]}], ["\u2022 IgE reactivity to only few allergen molecules in early childhood predicts respiratory allergy in adolescence \u2022 It may be possible to develop individualized risk prediction charts for allergic respiratory diseases.", {"entities": []}], ["\u2022 These findings could be targets for novel intervention therapies.", {"entities": []}], ["IgE reactivity to only few allergen molecules in early childhood predicts respiratory allergy in adolescence It may be possible to develop individualized risk prediction charts for allergic respiratory diseases.", {"entities": []}], ["These findings could be targets for novel intervention therapies.", {"entities": []}], ["Birth cohorts are essential for understanding the life course of allergy.", {"entities": []}], ["With a novel approach using a large panel of micro-arrayed allergen molecules from more than forty allergen sources, we identified a strong IgE signature against a handful of allergen molecules at ages 3\u20135\u00a0years that predicted respiratory allergy with >\u00a090% probability up until adolescence in two geographically separate populations.", {"entities": []}], ["The results suggest generalizability across populations.", {"entities": []}], ["The findings are of clinical importance for pediatricians or physicians seeing children at a young age, who could perform early allergy diagnosis with the key allergen molecules to initiate preventive measures", {"entities": []}], ["Diacylglycerol kinases (DGKs) are a diverse family of enzymes that catalyze the conversion of diacylglycerol (DAG), a crucial second messenger of receptor-mediated signaling, to phosphatidic acid (PA).", {"entities": []}], ["Both DAG and PA are bioactive molecules that regulate a wide set of intracellular signaling proteins involved in innate and adaptive immunity.", {"entities": []}], ["Clear evidence points to a critical role for DGKs in modulating T cell activation, function, and development.", {"entities": []}], ["More recently, studies have elucidated factors that control DGK function, suggesting an added complexity to how DGKs act during signaling.", {"entities": []}], ["This review summarizes the available knowledge of the function and regulation of DGK isoforms in signal transduction with a particular focus on T lymphocytes.", {"entities": []}], ["Spleen tyrosine kinase (Syk) is involved in the development of the adaptive immune system and has been recognized as being important in the function of additional cell types, including platelets, phagocytes, fibroblasts, and osteoclasts, and in the generation of the inflammasome.", {"entities": [[24, 27, "GENE"]]}], ["Preclinical studies presented compelling evidence that Syk inhibition may have therapeutic value in the treatment of rheumatoid arthritis and other forms of arthritis, systemic lupus erythematosus, autoimmune cytopenias, and allergic and autoinflammatory diseases.", {"entities": [[117, 137, "DISEASE"], [177, 196, "DISEASE"], [128, 137, "DISEASE"], [157, 166, "DISEASE"], [168, 196, "DISEASE"], [55, 58, "GENE"]]}], ["In addition, Syk inhibition may have a place in limiting tissue injury associated with organ transplant and revascularization procedures.", {"entities": [[13, 16, "GENE"]]}], ["Clinical trials have documented exciting success in the treatment of patients with rheumatoid arthritis, autoimmune cytopenias, and allergic rhinitis.", {"entities": [[132, 149, "DISEASE"], [83, 103, "DISEASE"], [141, 149, "DISEASE"], [94, 103, "DISEASE"]]}], ["While the extent and severity of side effects appear to be limited so far, larger studies will unravel the risk involved with the clinical benefit.", {"entities": []}], ["Overuse of asthma relievers, particularly without anti-inflammatory preventers, increases asthma risks.", {"entities": [[11, 17, "DISEASE"], [90, 96, "DISEASE"]]}], ["This study aimed to identify how many reliever-only users have urgent healthcare, explore their attitudes and beliefs about asthma and its treatment, and investigate whether purchasing over-the-counter relievers was associated with worse asthma outcomes than by prescription.", {"entities": [[124, 130, "DISEASE"], [238, 244, "DISEASE"]]}], ["Cross-sectional population-based Internet survey in Australia.", {"entities": []}], ["Of 2686 participants \u226516 years with current asthma randomly drawn from a web-based panel, 1038 (50.7% male) used only reliever medication.", {"entities": [[44, 50, "DISEASE"]]}], ["Urgent asthma-related healthcare; Asthma Control Test (ACT); patient attitudes about asthma and medications; reliever purchase (with/without prescription).", {"entities": [[7, 13, "DISEASE"], [34, 40, "DISEASE"], [85, 91, "DISEASE"]]}], ["Of 1038 reliever-only participants, 23.3% had required urgent healthcare for asthma in the previous year, and only 36.0% had a non-urgent asthma review.", {"entities": [[77, 83, "DISEASE"], [138, 144, "DISEASE"]]}], ["Those needing urgent healthcare were more likely than those without such events to be male (56.5% vs 49.0%, p=0.003) and current smokers (29.4% vs 23.3%, p=0.009).", {"entities": []}], ["Only 30.6% had well-controlled asthma (ACT \u226520) compared with 71.0% of those with no urgent healthcare (p<0.0001), and 20.8% used relievers regularly to prevent asthma symptoms (vs 5.5% of those without urgent healthcare).", {"entities": [[31, 37, "DISEASE"], [161, 167, "DISEASE"]]}], ["Those with urgent healthcare were more frustrated by their asthma and less happy with how they managed it, and they were less confident about their ability to manage worsening asthma, but just as likely as those without urgent healthcare to manage worsening asthma themselves rather than visit a doctor.", {"entities": [[59, 65, "DISEASE"], [176, 182, "DISEASE"], [258, 264, "DISEASE"]]}], ["Reliever-only users purchasing over-the-counter relievers were no more likely than those purchasing relievers by prescription to have uncontrolled asthma (35.9% vs 40.6%, p=0.23) but were less likely to have had a non-urgent asthma review.", {"entities": [[147, 153, "DISEASE"], [225, 231, "DISEASE"]]}], ["One-quarter of the reliever-only population had needed urgent asthma healthcare in the previous year, demonstrating the importance of identifying such patients.", {"entities": [[62, 68, "DISEASE"]]}], ["Their attitudes and beliefs suggest opportunities for targeting this population in the community.", {"entities": []}], ["Although osteoporosis and its related fractures are common in patients with COPD, patients at high risk of fracture are poorly identified, and consequently, undertreated.", {"entities": [[9, 21, "DISEASE"]]}], ["Since there are no fracture prevention guidelines available that focus on COPD patients, we developed a clinical approach to improve the identification and treatment of COPD patients at high risk of fracture.", {"entities": []}], ["We organised a round-table discussion with 8 clinical experts in the field of COPD and fracture prevention in the Netherlands in December 2013.", {"entities": []}], ["The clinical experts presented a review of the literature on COPD, osteoporosis and fracture prevention.", {"entities": [[67, 79, "DISEASE"]]}], ["Based on the Dutch fracture prevention guideline, they developed a 5-step clinical approach for fracture prevention in COPD.", {"entities": []}], ["Thereby, they took into account both classical risk factors for fracture (low body mass index, older age, personal and family history of fracture, immobility, smoking, alcohol intake, use of glucocorticoids and increased fall risk) and COPD-specific risk factors for fracture (severe airflow obstruction, pulmonary exacerbations and oxygen therapy).", {"entities": []}], ["Severe COPD (defined as postbronchodilator FEV 1 \u2009<\u200950% predicted) was added as COPD-specific risk factor to the list of classical risk factors for fracture.", {"entities": [[43, 46, "GENE"]]}], ["The 5-step clinical approach starts with case finding using clinical risk factors, followed by risk evaluation (dual energy X-ray absorptiometry and imaging of the spine), differential diagnosis, treatment and follow-up.", {"entities": []}], ["This systematic clinical approach, which is evidence-based and easy-to-use in daily practice by pulmonologists, should contribute to optimise fracture prevention in COPD patients at high risk of fracture.", {"entities": []}], ["Children with chronic kidney disease (CKD), requiring dialysis or kidney transplantation, have a mortality rate of up to 30-fold higher than the general aged-matched population, and severely impaired quality of life.", {"entities": [[22, 36, "DISEASE"]]}], ["Symptoms such as fatigue and pain are prevalent and debilitating.", {"entities": []}], ["Children with CKD are at risk of cognitive impairment, and poorer educational, vocational, and psychosocial outcomes compared with their well peers, which have consequences through to adulthood.", {"entities": []}], ["Treatment regimens for children with CKD are long-term, complex, and highly intrusive.", {"entities": []}], ["While many trials have been conducted to improve outcomes in children with CKD, the outcomes measured and reported are often not relevant to patients and clinicians, and are highly variable.", {"entities": []}], ["These problems can diminish the value of trials as a means to improve the lives of children with CKD.", {"entities": []}], ["The Standardised Outcomes in Nephrology\u2014Children and Adolescents (SONG-Kids) study aims to develop a core outcome set for trials in children and adolescents with any stage of CKD that is based on the shared priorities of all stakeholders.", {"entities": []}], ["SONG-Kids involves five phases: a systematic review to identify outcomes (both domains and measures) that have been reported in randomised controlled trials involving children aged up to 21 years with CKD; focus groups (using nominal group technique) with adolescent patients and caregivers of paediatric patients (all ages) to identify outcomes that are relevant and important to patients and their family and the reasons for their choices; semistructured key informant interviews with health professionals involved in the care of children with CKD to ascertain their views on establishing core outcomes in paediatric nephrology; an international three-round online Delphi survey with patients, caregivers, clinicians, researchers, policy-makers, and members from industry to develop consensus on important outcome domains; and a stakeholder workshop to review and finalise the set of core outcome domains for trials in children with CKD (including nondialysis-dependent, dialysis, and kidney transplantation).", {"entities": []}], ["Establishing a core outcome set to be reported in all trials conducted in children with any stage of CKD will enhance the relevance, transparency, and impact of research to improve the lives of children and adolescents with CKD.", {"entities": []}], ["Pruritus is one of the most bothersome symptoms in patients on maintenance hemodialysis (HD), however little progress is seen in our understanding of its pathogenesis.", {"entities": []}], ["The aim of this study was to evaluate the frequency of pruritus in HD patients in Tehran, Iran, and to correlate its presence and intensity with relevant clinical and laboratory parameters.", {"entities": []}], ["One hundred sixty-seven patients on maintenance HD at three out-patient HD units were enrolled in the study.", {"entities": []}], ["Itch intensity was scored as mild, moderate and severe.", {"entities": []}], ["Some relevant clinical and laboratory parameters (age, sex, xerosis, presence of neuropathy, duration of dialysis, history of atopy and laboratory findings including hematocrit, creatinine, urea, calcium, phosphorus, parathyroid hormone [PTH] and alkaline phosphatase) were evaluated.", {"entities": [[81, 91, "DISEASE"], [238, 241, "GENE"]]}], ["Pruritus was found in 41.9% of patients.", {"entities": []}], ["The intensity of itching was mild, moderate and severe, in 51.4%, 11.4% and 37.7% of patients, respectively.", {"entities": []}], ["In 22 patients (31.4%) pruritus intensified during and after dialysis.", {"entities": []}], ["There was no significant difference in the serum levels of creatinine, blood urea nitrogen, calcium, phosphorus, alkaline phosphatase, PTH and hematocrit between patients with and without pruritus.", {"entities": [[135, 138, "GENE"]]}], ["Age, sex, xerosis, underlying renal disease, history of atopy and duration of haemodialysis were not significantly different between the two groups.", {"entities": []}], ["However, neuropathy was significantly more common in the pruritic group (63.8% versus 42.1%) (pv = 0.006).", {"entities": [[9, 19, "DISEASE"]]}], ["Clinical neuropathy was the only significant finding in the pruritic group in our study.", {"entities": [[9, 19, "DISEASE"]]}], ["This finding justifies further research on nerve function and neurotransmitters in hemodialysis patients and the introduction of new drugs targeting neuropathy.", {"entities": [[149, 159, "DISEASE"]]}], ["YKL-40, also known as human cartilage glycoprotein-39 or chitinase-3-like-1, is a pro-inflammatory protein that is highly expressed in rheumatoid arthritis (RA) patients.", {"entities": [[135, 155, "DISEASE"], [146, 155, "DISEASE"]]}], ["Angiogenesis is a critical step in the pathogenesis of RA, promoting the infiltration of inflammatory cells into joints and providing oxygen and nutrients to RA pannus.", {"entities": []}], ["In this study, we examined the effects of YKL-40 in the production of the pro-inflammatory cytokine interleukin-18 (IL-18), and the stimulation of angiogenesis and accumulation of osteoblasts.", {"entities": []}], ["We observed that YKL-40 induces IL-18 production in osteoblasts and thereby stimulates angiogenesis of endothelial progenitor cells (EPCs).", {"entities": []}], ["We found that this process occurs through the suppression of miR-590-3p via the focal adhesion kinase (FAK)/PI3K/Akt signaling pathway.", {"entities": [[61, 71, "GENE"]]}], ["YKL-40 inhibition reduced angiogenesis in in vivo models of angiogenesis: the chick embryo chorioallantoic membrane (CAM) and Matrigel plug models.", {"entities": []}], ["We report that YKL-40 stimulates IL-18 expression in osteoblasts and facilitates EPC angiogenesis.", {"entities": []}], ["To produce a fetal weight chart representative of a Tanzanian population, and compare it to weight charts from Sub-Saharan Africa and the developed world.", {"entities": []}], ["A longitudinal observational study in Northeastern Tanzania.", {"entities": []}], ["Pregnant women were followed throughout pregnancy with serial trans-abdominal ultrasound.", {"entities": []}], ["All pregnancies with pathology were excluded and a chart representing the optimal growth potential was developed using fetal weights and birth weights.", {"entities": []}], ["The weight chart was compared to a chart from Congo, a chart representing a white population, and a chart representing a white population but adapted to the study population.", {"entities": []}], ["The prevalence of SGA was assessed using all four charts.", {"entities": []}], ["A total of 2193 weight measurements from 583 fetuses/newborns were included in the fetal weight chart.", {"entities": []}], ["Our chart had lower percentiles than all the other charts.", {"entities": []}], ["Most importantly, in the end of pregnancy, the 10 We developed a weight chart representative for a Tanzanian population and provide evidence for the necessity of developing regional specific weight charts for correct identification of SGA.", {"entities": []}], ["Our weight chart is an important tool that can be used for clinical risk assessments of newborns and for evaluating the effect of intrauterine exposures on fetal and newborn weight.", {"entities": []}], ["Acute effects of air pollution on respiratory health have traditionally been investigated with data on inpatient admissions, emergency room visits, and mortality.", {"entities": []}], ["In this study, we aim to describe the total acute effects of air pollution on health care use for respiratory symptoms (ICD10-J00-J99).", {"entities": []}], ["This will be done by investigating primary health care (PHC) visits, inpatient admissions, and emergency room visits together in five municipalities in southern Sweden, using a case-crossover design.", {"entities": []}], ["Between 2005 and 2010, there were 81,019 visits to primary health care, 38,217 emergency room visits, and 25,271 inpatient admissions for respiratory symptoms in the study area.", {"entities": []}], ["There was a 1.85% increase (95% CI: 0.52 to 3.20) in the number of primary health care visits associated with a 10 \u00b5g/m 2 ) levels in Malm\u00f6, but not in the other municipalities.", {"entities": []}], ["Air pollution levels were generally not associated with emergency room visits or inpatient admissions, with one exception (in Helsingborg there was a 2.52% increase in emergency room visits for respiratory symptoms associated with a 10 \u00b5g/m 10 ).", {"entities": []}], ["In conclusion, the results give weak support for short-term effects of air pollution on health care use associated with respiratory health symptoms in the study area.", {"entities": []}], ["Food insecurity and hunger during childhood are associated with an array of developmental problems in multiple domains, including impulse control problems and violence.", {"entities": []}], ["Unfortunately, extant research is based primarily on small convenience samples and an epidemiological assessment of the hunger-violence link is lacking.", {"entities": []}], ["The current study employed data from Wave 1 (2001\u20132002) and Wave 2 (2004\u20132005) of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).", {"entities": []}], ["The NESARC is a nationally representative sample of non-institutionalized U.S. residents aged 18 years and older.", {"entities": []}], ["Participants who experienced frequent hunger during childhood had significantly greater impulsivity, worse self-control, and greater involvement in several forms of interpersonal violence.", {"entities": []}], ["These effects were stronger among whites, Hispanics, and males.", {"entities": []}], ["The findings support general theoretical models implicating impulse control problems as a key correlate of crime and violence and add another facet to the importance of ameliorating food neglect in the United States.", {"entities": []}], ["We have characterized the immune system involvement in the disease processes of idiopathic pulmonary fibrosis in novel ways.", {"entities": [[91, 109, "DISEASE"], [80, 109, "DISEASE"]]}], ["To do so, we analyzed lung tissue from 21 cases of idiopathic pulmonary fibrosis and 21 (non-fibrotic, non-cancerous) controls for immune cell and inflammation-related markers.", {"entities": [[62, 80, "DISEASE"], [51, 80, "DISEASE"]]}], ["The immunohistochemical analysis of the tissue was grouped by patterns of severity in disease pathology.", {"entities": []}], ["There were significantly greater numbers of CD68", {"entities": [[44, 48, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is increasingly being recognized as a highly heterogeneous disorder, composed of varying pathobiology.", {"entities": []}], ["Accurate detection of COPD subtypes by image biomarkers are urgently needed to enable individualized treatment thus improving patient outcome.", {"entities": []}], ["We adapted the Parametric Response Map (PRM), a voxel-wise image analysis technique, for assessing COPD phenotype.", {"entities": []}], ["We analyzed whole lung CT scans of 194 COPD individuals acquired at inspiration and expiration from the COPDGene Study.", {"entities": []}], ["PRM identified the extent of functional small airways disease (fSAD) and emphysema as well as provided CT-based evidence that supports the concept that fSAD precedes emphysema with increasing COPD severity.", {"entities": []}], ["PRM is a versatile imaging biomarker capable of diagnosing disease extent and phenotype, while providing detailed spatial information of disease distribution and location.", {"entities": []}], ["PRMs ability to differentiate between specific COPD phenotypes will allow for more accurate diagnosis of individual patients complementing standard clinical techniques.", {"entities": []}], ["The peptide welding technology (PWT) is a novel chemical strategy that allows the synthesis of multibranched peptides with high yield, purity, and reproducibility.", {"entities": []}], ["With this approach, a tetrabranched derivative of neuropeptide S (NPS) has been synthesized and pharmacologically characterized.", {"entities": [[66, 69, "GENE"]]}], ["The in vitro activity of PWT1-NPS has been studied in a calcium mobilization assay.", {"entities": []}], ["In vivo, PWT1-NPS has been investigated in the locomotor activity (LA) and recovery of the righting reflex (RR) tests.", {"entities": []}], ["In calcium mobilization studies, PWT1-NPS behaved as full agonist at the mouse NPS receptor (NPSR) being threefold more potent than NPS.", {"entities": [[38, 41, "GENE"], [79, 82, "GENE"], [132, 135, "GENE"], [38, 41, "GENE"], [79, 82, "GENE"], [132, 135, "GENE"]]}], ["The selective NPSR antagonists [", {"entities": []}], ["Inflammatory myofibroblastic tumor (IMT) is an uncommon neoplastic entity with a tendency of local recurrence and a low risk of distant metastasis.", {"entities": []}], ["Involvement of trachea is extremely rare.", {"entities": []}], ["A 34-week pregnant woman previously diagnosed with asthma for 2 months was admitted with persistent wheezing and hemoptysis.", {"entities": [[51, 57, "DISEASE"]]}], ["A computed tomography scan and bronchoscopy revealed a gigantic polyp in the trachea.", {"entities": []}], ["Tracheal inflammatory myofibroblastic tumor.", {"entities": []}], ["The mass was removed with an electrocautery snare and identified histologically as an IMT.", {"entities": []}], ["Further immunochemical staining showed strong positive staining for smooth muscle actin and platelet-derived growth factor receptor \u03b1 (PDGFRA), weak positive staining for caldesmon, and negative staining for anaplastic lymphoma kinase (ALK)1, desmin, S-100, and CD34.", {"entities": [[219, 227, "DISEASE"], [135, 141, "GENE"], [262, 266, "GENE"]]}], ["The tracheal IMT strongly expressed estrogen receptor-\u03b1 (ER-\u03b1), which indicated that the development of this rare IMT might have been associated with hormone fluctuations that occurred during the pregnancy.", {"entities": []}], ["Follow-up and histological analyses revealed no evidence of recurrence and metastasis.", {"entities": []}], ["This report describes an extremely rare case of a tracheal IMT that presented a diagnostic dilemma for the clinician and the pathologist.", {"entities": []}], ["Tracheal IMT is a challenge for the clinician in diagnosis due to the nonspecific clinical presentation.", {"entities": []}], ["Histology and immunohistochemistry are required to reach an accurate diagnosis of IMT.", {"entities": []}], ["The purpose of this study was to evaluate the relationship between glycated hemoglobin (HbA1c) and chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes.", {"entities": [[99, 136, "DISEASE"]]}], ["We conducted a retrospective cohort study involving 45,753 patients with type 2 diabetes, who participated in the National Diabetes Case Management Program in Taiwan.", {"entities": []}], ["HbA1c at baseline and COPD events over the subsequent years were analyzed.", {"entities": []}], ["After multivariate adjustment, the COPD risk increased among patients with HbA1c levels <6.0%, compared with that in patients with HbA1c levels ranging from 6.0% to 7.0% (hazard ratio: 1.19, 95% confidence interval (CI): 1.06\u20131.34).", {"entities": []}], ["Similarly, high HbA1c levels (\u226510%) were independently associated with COPD (1.19, 95% CI: 1.06\u20131.32).", {"entities": []}], ["A U-shaped relationship was observed between HbA1c levels and COPD incidence.", {"entities": []}], ["HbA1c levels lower than 6.0% and higher than 10% are associated with an increased risk of COPD in patients with type 2 diabetes.", {"entities": []}], ["These findings suggest that meeting the recommended HbA1c targets might reduce the risk of COPD, but care should be taken not to pose risks to this population.", {"entities": []}], ["The use of thiazolidinediones (TZDs) has been associated with an increased fracture risk.", {"entities": []}], ["In addition, type 2 diabetes mellitus (T2DM) has been linked with fracture.", {"entities": [[20, 37, "DISEASE"], [13, 37, "DISEASE"]]}], ["We evaluated to what extent the association between TZD use and fracture risk is related to the drug or to the underlying disease.", {"entities": []}], ["We conducted a population-based cohort study using the Danish National Health Registers (1996\u20132007), which link pharmacy data to the national hospital registry.", {"entities": []}], ["Oral antidiabetic users ( n \u00a0=\u00a0180,049) were matched 1:3 by year of birth and sex to nonusers.", {"entities": []}], ["Cox proportional hazards models were used to estimate hazard ratios (HRs) of fracture.", {"entities": []}], ["Time-dependent adjustments were made for age, comorbidity, and drug use.", {"entities": []}], ["We created a proxy indicator for the severity of disease.", {"entities": []}], ["The first stage was defined as current use of either a biguanide or a sulfonyluerum, the second stage as current use of a biguanide and a sulfonyluerum at the same time, the third stage as patients using TZDs, and the fourth stage as patients using insulin.", {"entities": []}], ["The risk of osteoporotic fracture was increased 1.3-fold for stages 3 and 4 compared with controls.", {"entities": []}], ["Risk with current TZD use (stage 3 HR\u00a0=\u00a01.27, 95\u00a0% CI 1.06\u20131.52) and risk with current use of insulin (stage 4 HR\u00a0=\u00a01.25, 95\u00a0% CI 1.20\u20131.31) were similar.", {"entities": [[35, 37, "GENE"], [111, 113, "GENE"], [35, 37, "GENE"], [111, 113, "GENE"]]}], ["In the first (HR\u00a0=\u00a01.15, 95\u00a0% CI 1.13\u20131.18) and second (HR\u00a0=\u00a01.00, 95\u00a0% CI 0.96\u20131.04) stages risks were lower.", {"entities": [[14, 16, "GENE"], [56, 58, "GENE"], [14, 16, "GENE"], [56, 58, "GENE"]]}], ["Risk of osteoporotic fracture was similar for TZD users and insulin users.", {"entities": []}], ["When studying fracture risk with TZDs, the underlying T2DM should be taken into account.", {"entities": []}], ["Regulation of IgE concentration in the blood is a complex trait, with high concentrations associated with parasitic infections as well as allergic diseases.", {"entities": []}], ["A/J strain mice have significantly higher plasma concentrations of IgE, both at baseline and after ovalbumin antigen exposure, when compared to C57BL/6J strain mice.", {"entities": []}], ["Our objective was to determine the genomic regions associated with this difference in phenotype.", {"entities": []}], ["To achieve this, we used a panel of recombinant congenic strains (RCS) derived from A/J and C57BL/6J strains.", {"entities": []}], ["We measured IgE in the RCS panel at baseline and following allergen exposure.", {"entities": []}], ["Using marker by marker analysis of the RCS genotype and phenotype data, we identified multiple regions associated with the IgE phenotype.", {"entities": []}], ["A single region was identified to be associated with baseline IgE level, while multiple regions wereassociated with the phenotype after allergen exposure.", {"entities": []}], ["The most significant region was found on Chromosome 4, from 81.46 to 86.17\u00a0Mbp.", {"entities": [[75, 78, "GENE"]]}], ["Chromosome 4 substitution strain mice had significantly higher concentration of IgE than their background parental strain mice, C57BL/6J.", {"entities": []}], ["Our data presents multiple candidate regions associated with plasma IgE concentration at baseline and following allergen exposure, with the most significant one located on Chromosome 4.", {"entities": []}], ["Heightened inflammation, including expression of COX-2, is associated with COPD pathogenesis.", {"entities": []}], ["RelB is an NF-\u03baB family member that attenuates COX-2 in response to cigarette smoke by a mechanism that may involve the miRNA miR-146a.", {"entities": [[0, 4, "GENE"], [126, 134, "GENE"]]}], ["There is no information on the expression of RelB in COPD or if RelB prevents COX-2 expression through miR-146a.", {"entities": [[45, 49, "GENE"], [64, 68, "GENE"], [45, 49, "GENE"], [64, 68, "GENE"], [103, 111, "GENE"]]}], ["RelB, Cox-2 and miR-146a levels were evaluated in lung fibroblasts and blood samples derived from non-smokers (Normal) and smokers (At Risk) with and without COPD by qRT-PCR.", {"entities": [[0, 4, "GENE"], [16, 24, "GENE"]]}], ["RelB and COX-2 protein levels were evaluated by western blot.", {"entities": [[0, 4, "GENE"]]}], ["Human lung fibroblasts from Normal subjects and smokers with and without COPD, along with RelB knock-down (siRNA) in Normal cells, were exposed to cigarette smoke extract (CSE) in vitro and COX-2 mRNA/protein and miR-146a levels assessed.", {"entities": [[90, 94, "GENE"], [213, 221, "GENE"]]}], ["Basal expression of RelB mRNA and protein were significantly lower in lung cells derived from smokers with and without COPD, the latter of which expressed more Cox-2 mRNA and protein in response to CSE.", {"entities": [[20, 24, "GENE"]]}], ["Knock-down of RelB in Normal fibroblasts increased Cox-2 mRNA and protein induction by CSE.", {"entities": [[14, 18, "GENE"]]}], ["Basal miR-146a levels were not different between the three groups, and only Normal fibroblasts increased miR-146a expression in response to smoke.", {"entities": [[6, 14, "GENE"], [105, 113, "GENE"], [6, 14, "GENE"], [105, 113, "GENE"]]}], ["There was a positive correlation between systemic RelB and Cox-2 mRNA levels and circulating miR-146a levels were higher only in GOLD stage I subjects.", {"entities": [[50, 54, "GENE"], [93, 101, "GENE"]]}], ["Our data indicate that RelB attenuates COX-2 expression in lung structural cells, such that loss of pulmonary RelB may be an important determinant in the aberrant, heightened inflammation associated with COPD pathogenesis.", {"entities": [[23, 27, "GENE"], [110, 114, "GENE"], [23, 27, "GENE"], [110, 114, "GENE"]]}], ["Inflammation is increasingly recognized as a contributor to the pathophysiology of neuropsychiatric disorders, including depression, anxiety disorders and autism, though the factors leading to contextually inappropriate or sustained inflammation in pathological conditions are yet to be elucidated.", {"entities": []}], ["Microglia, as the key mediators of inflammation in the CNS, serve as likely candidates in initiating pathological inflammation and as an ideal point of therapeutic intervention.", {"entities": []}], ["Glucose deprivation, as a component of the pathophysiology of ischemia or occurring transiently in diabetes, may serve to modify microglial function contributing to inflammatory injury.", {"entities": [[62, 70, "DISEASE"]]}], ["To this end, primary microglia were cultured from postnatal rat brain and subject to glucose deprivation in vitro .", {"entities": []}], ["Microglia were characterized for their proliferation, phagocytic function and secretion of inflammatory factors, and tested for their capacity to respond to a potent inflammatory stimulus.", {"entities": []}], ["In the absence of glucose, microglia remained capable of proliferation, phagocytosis and inflammatory activation and showed increased release of inflammatory factors after presentation of an inflammatory stimulus.", {"entities": []}], ["Glucose-deprived microglia demonstrated increased phagocytic activity and decreased accumulation of lipids in lipid droplets over a 48-h timecourse, suggesting they may use scavenged lipids as a key alternate energy source during metabolic stress.", {"entities": []}], ["In the present manuscript, we present novel findings that glucose deprivation may sensitize microglial release of inflammatory mediators and prime microglial functions for both survival and inflammatory roles, which may contribute to psychiatric comorbidities of ischemia, diabetes and/or metabolic disorder.", {"entities": [[263, 271, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s12035-017-0422-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hedgehog (Hh) signaling modulates T cell development and function but its exact role remains a matter of debate.", {"entities": []}], ["To further address this issue we made use of conditional knock-out mice in which the Hh receptor Patched1 (Ptch) is inactivated in the T cell lineage.", {"entities": []}], ["Thymocyte development was moderately compromised by the deletion of Ptch as characterized by reduced numbers of CD4 and CD8 single-positive cells.", {"entities": [[112, 115, "GENE"]]}], ["In contrast, peripheral T cells were not affected.", {"entities": []}], ["Proliferation and IFN\u03b3 secretion by Ptch -deficient T cells were indistinguishable from controls irrespectively of whether we used strong or suboptimal conditions for stimulation.", {"entities": []}], ["Analysis of CTL and T reg cell functions did not reveal any differences between both genotypes, and T cell apoptosis induced by glucocorticoids or \u03b3-irradiation was also similar.", {"entities": []}], ["Surprisingly, absence of Ptch did not lead to an activation of canonic Hh signaling in peripheral T cells as indicated by unaltered expression levels of Gli1 and Gli2 .", {"entities": [[153, 157, "GENE"], [162, 166, "GENE"]]}], ["To test whether we could uncover any role of Ptch in T cells in vivo we subjected the mutant mice to three different disease models, namely allogeneic bone marrow transplantation mimicking graft-versus-host disease, allergic airway inflammation as a model of asthma and growth of adoptively transferred melanoma cells as a means to test tumor surveillance by the immune system.", {"entities": [[303, 311, "DISEASE"], [259, 265, "DISEASE"]]}], ["Nonetheless, we were neither able to demonstrate any difference in the disease courses nor in any pathogenic parameter in these three models of adaptive immunity.", {"entities": []}], ["We therefore conclude that the Hh receptor Ptch is dispensable for T cell function in vitro as well as in vivo .", {"entities": []}], ["Transforming growth factor \u03b21 (TGF-\u03b21)-mediated epithelial mesenchymal transition (EMT) of alveolar epithelial cells (AEC) may contribute to lung fibrosis.", {"entities": []}], ["Since PPAR\u03b3 ligands have been shown to inhibit fibroblast activation by TGF-\u03b21, we assessed the ability of the thiazolidinediones rosiglitazone (RGZ) and ciglitazone (CGZ) to regulate TGF-\u03b21-mediated EMT of A549 cells, assessing changes in cell morphology, and expression of cell adhesion molecules E-cadherin (epithelial cell marker) and N-cadherin (mesenchymal cell marker), and collagen 1\u03b11 (COL1A1), CTGF and MMP-2 mRNA.", {"entities": [[395, 401, "GENE"], [404, 408, "GENE"]]}], ["Serum-deprived A549 cells (human AEC cell line) were pre-incubated with RGZ and CGZ (1 - 30 \u03bcM) in the absence or presence of the PPAR\u03b3 antagonist GW9662 (10 \u03bcM) before TGF\u03b2-1 (0.075-7.5 ng/ml) treatment for up to 72 hrs.", {"entities": []}], ["Changes in E-cadherin, N-cadherin and phosphorylated Smad2 and Smad3 levels were analysed by Western blot, and changes in mRNA levels including COL1A1 assessed by RT-PCR.", {"entities": [[53, 58, "GENE"], [63, 68, "GENE"], [144, 150, "GENE"]]}], ["TGF\u03b2-1 (2.5 ng/ml)-induced reductions in E-cadherin expression were associated with a loss of epithelial morphology and cell-cell contact.", {"entities": []}], ["Concomitant increases in N-cadherin, MMP-2, CTGF and COL1A1 were evident in predominantly elongated fibroblast-like cells.", {"entities": [[44, 48, "GENE"], [53, 59, "GENE"]]}], ["Neither RGZ nor CGZ prevented TGF\u03b21-induced changes in cell morphology, and PPAR\u03b3-dependent inhibitory effects of both ligands on changes in E-cadherin were only evident at submaximal TGF-\u03b21 (0.25 ng/ml).", {"entities": []}], ["However, both RGZ and CGZ inhibited the marked elevation of N-cadherin and COL1A1 induced by TGF-\u03b21 (2.5 ng/ml), with effects on COL1A1 prevented by GW9662.", {"entities": [[75, 81, "GENE"], [129, 135, "GENE"], [75, 81, "GENE"], [129, 135, "GENE"]]}], ["Phosphorylation of Smad2 and Smad3 by TGF-\u03b21 was not inhibited by RGZ or CGZ.", {"entities": [[19, 24, "GENE"], [29, 34, "GENE"]]}], ["RGZ and CGZ inhibited profibrotic changes in TGF-\u03b21-stimulated A549 cells independently of inhibition of Smad phosphorylation.", {"entities": []}], ["Their inhibitory effects on changes in collagen I and E-cadherin, but not N-cadherin or CTGF, appeared to be PPAR\u03b3-dependent.", {"entities": [[88, 92, "GENE"]]}], ["Further studies are required to unravel additional mechanisms of inhibition of TGF-\u03b21 signalling by thiazolidinediones and their implications for the contribution of EMT to lung fibrosis.", {"entities": []}], ["Metabolic syndrome is associated with visceral obesity, insulin resistance and an increased risk of cardiovascular diseases.", {"entities": [[47, 54, "DISEASE"], [10, 18, "DISEASE"]]}], ["Visceral fat tissue primarily consists of adipocytes that secrete cytokines leading to a state of systemic inflammation in obese conditions.", {"entities": []}], ["One of the IGF-independent functions of IGFBP-3 is its role as an anti-inflammatory molecule.", {"entities": []}], ["Our study in obese adolescents show a decrease in total IGFBP-3 levels and increase in proteolyzed IGFBP-3 in circulation when compared to their normal counterparts and establishes a positive correlation between IGFBP-3 proteolysis and adiposity parameters as well as insulin resistance.", {"entities": []}], ["In human adipocytes, we show that IGFBP-3 inhibits TNF-\u03b1-induced NF-\u03baB activity in an IGF-independent manner, thereby restoring the deregulated insulin signaling and negating TNF-\u03b1-induced inhibition of glucose uptake.", {"entities": []}], ["IGFBP-3 further inhibits TNF-\u03b1, CRP and high glucose-induced NF-\u03baB activity in human aortic endothelial cells (HAECs) and subsequently suppresses monocyte adhesion to HAEC through the IGFBP-3 receptor.", {"entities": [[32, 35, "GENE"]]}], ["In conclusion, these findings suggest that reduced levels of IGFBP-3 in circulation and reduced expression of IGFBP-3 in macrophages in obesity may result in suppression of its anti-inflammatory functions and therefore IGFBP-3 may present itself as a therapeutic for obesity-induced insulin resistance and for events occurring in the early stages of atherosclerosis.", {"entities": [[350, 365, "DISEASE"], [136, 143, "DISEASE"], [267, 274, "DISEASE"]]}], ["Attention deficit hyperactivity disorder (ADHD) is increasingly recognized as a common disorder not only in children, but also in the adult population.", {"entities": []}], ["Similarly, asthma also has a substantial prevalence among adults.", {"entities": [[11, 17, "DISEASE"]]}], ["Previous studies concerning a potential relationship between ADHD and asthma have not presented consistent results.", {"entities": [[70, 76, "DISEASE"]]}], ["A cross-sectional study of 594 adult patients diagnosed with ADHD, compared with 719 persons from the general population.", {"entities": []}], ["Information was collected between 1997 and 2005 using auto-questionnaires rating past and present symptoms of ADHD, co-morbid conditions, including asthma, and work status.", {"entities": [[148, 154, "DISEASE"]]}], ["The prevalence of asthma was significantly higher in the ADHD patient group compared to the controls, 24.4% vs. 11.3% respectively (OR = 2.54, 95% CI 1.89-3.44), and controls with asthma scored higher on ratings of both past and present symptoms of ADHD.", {"entities": [[18, 24, "DISEASE"], [180, 186, "DISEASE"]]}], ["Female ADHD patients had a significantly higher prevalence of asthma compared to male ADHD patients (30.9% vs. 18.2%, OR = 2.01, CI 1.36-2.95), but in controls a slight female preponderance was not statistically significant.", {"entities": [[62, 68, "DISEASE"]]}], ["In both ADHD patients and controls, having asthma was associated with an increased prevalence of symptoms of mood- and anxiety disorders.", {"entities": [[43, 49, "DISEASE"]]}], ["The present findings point to a co-morbidity of ADHD and asthma, and these patients may represent a clinical and biological subgroup of adult patients with ADHD.", {"entities": [[57, 63, "DISEASE"]]}], ["Smoking remains a leading health risk factor among Europeans.", {"entities": []}], ["Tobacco, together with other factors, will lead to an expansive epidemic of chronic diseases, including COPD, among the working population in Russia.", {"entities": []}], ["The general aim of the RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology (RESPECT) study is to gain a better understanding of the prevalence, pathogenesis and symptoms of COPD.", {"entities": []}], ["The RESPECT study is a prospective, population-based cohort study of subjects aged 35\u201370 years in two north-west regions of the Russian Federation (Saint Petersburg and Arkhangelsk).", {"entities": []}], ["The study includes three components: a cross-sectional study (prevalence), a case-control study and a cohort study (diagnostic).", {"entities": []}], ["An investigator who interviewed the patient completed three questionnaires.", {"entities": []}], ["Spirometry, including a reversibility test, was offered to all participants.", {"entities": []}], ["Individuals displaying forced expiratory volume in 1\u00a0s (FEV 1 )/forced vital capacity (FVC)\u2009<\u20090.7 and/or FEV 1 /FVC\u2009<\u2009the lower limit of normal before and/or after bronchodilation were included in a follow-up study and were examined by a pulmonologist using a standardized comprehensive examination protocol.", {"entities": [[56, 59, "GENE"], [105, 108, "GENE"], [56, 59, "GENE"], [105, 108, "GENE"]]}], ["A future case-control study of two matched groups of patients (heavy smokers with COPD versus heavy smokers without COPD) will provide information on which factors (biomarkers, including pneumoproteins, in serum and induced sputum) are related to tobacco-induced COPD.", {"entities": []}], ["In total, 3133 individuals (2122 from St. Petersburg and 1012 from Arkhangelsk) aged 35\u201370 years agreed to participate in this study and met the inclusion criteria.", {"entities": []}], ["In total, 2974 participants met the quality criteria for spirometry, and 2388 reversibility tests were performed.", {"entities": []}], ["A cohort of newly defined obstructive pulmonary disease patients (247 persons) was established for follow-up investigation.", {"entities": []}], ["The RESPECT study will provide information regarding the prevalence of COPD in the north-west region of the Russian Federation.", {"entities": []}], ["Moreover, the comprehensive RESPECT database will enable us to explore new research questions, provide novel insight into the risk factors and different phenotypes of COPD, and contribute to an improved understanding of the reasons why some heavy smokers develop the disease whereas others do not.", {"entities": []}], ["NCT02307799 (the release date: 12/01/2014)", {"entities": []}], ["Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system.", {"entities": []}], ["TLRs are present and functional in CD4 CM ), constitute the main reservoir of latent HIV-1.", {"entities": [[35, 38, "GENE"]]}], ["However, how TLR ligands affect the quiescence of latent HIV within central memory CD4 We evaluated the ability of a broad panel of TLR agonists to reactivate latent HIV-1.", {"entities": [[83, 86, "GENE"]]}], ["The TLR-1/2 agonist Pam3CSK4 leads to viral reactivation of quiescent HIV in a model of latency based on cultured T CM and in resting CD4 Our findings suggest that the signaling through TLR-1/2 pathway via Pam3CSK4 or other reagents should be explored as an anti-latency strategy either alone or in combination with other anti-latency drugs.", {"entities": [[134, 137, "GENE"]]}], ["Manual chest wall compression (CWC) during expiration is a technique for removing airway secretions in patients with respiratory disorders.", {"entities": []}], ["However, there have been no reports about the physiological effects of CWC in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[92, 129, "DISEASE"]]}], ["To compare the effects of CWC on expiratory flow rates in patients with COPD and asymptomatic controls.", {"entities": []}], ["Fourteen subjects were recruited from among patients with COPD who were receiving pulmonary rehabilitation at the University Hospital (COPD group).", {"entities": []}], ["Fourteen age-matched healthy subjects were also consecutively recruited from the local community (Healthy control group).", {"entities": []}], ["Airflow and lung volume changes were measured continuously with the subjects lying in supine position during 1 minute of quiet breathing (QB) and during 1 minute of CWC by a physical therapist.", {"entities": []}], ["During CWC, both the COPD group and the healthy control group showed significantly higher peak expiratory flow rates (PEFRs) than during QB (mean difference for COPD group 0.14 L/sec, 95% confidence interval (CI) 0.04 to 0.24, p<0.01, mean difference for healthy control group 0.39 L/sec, 95% CI 0.25 to 0.57, p<0.01).", {"entities": []}], ["In the between-group comparisons, PEFR was significantly higher in the healthy control group than in the COPD group (-0.25 L/sec, 95% CI -0.43 to -0.07, p<0.01).", {"entities": []}], ["However, the expiratory flow rates at the lung volume at the PEFR during QB and at 50% and 25% of tidal volume during QB increased in the healthy control group (mean difference for healthy control group 0.31 L/sec, 95% CI 0.15 to 0.47, p<0.01: 0.31 L/sec, 95% CI 0.15 to 0.47, p<0.01: 0.27 L/sec, 95% CI 0.13 to 0.41, p<0.01, respectively) but not in the COPD group (0.05 L/sec, 95% CI -0.01 to 0.12: -0.01 L/sec, 95% CI -0.11 to 0.08: 0.02 L/sec, 95% CI -0.05 to 0.90) with the application of CWC.", {"entities": []}], ["The effects of chest wall compression on expiratory flow rates was different between COPD patients and asymptomatic controls.", {"entities": []}], ["Dysbiosis is a hallmark of inflammatory bowel disease (IBD), but it is unclear which specific intestinal bacteria predispose to and which protect from IBD and how they are regulated.", {"entities": [[27, 53, "DISEASE"]]}], ["Peptidoglycan recognition proteins ( Pglyrps ) are antibacterial, participate in maintaining intestinal microflora, and modulate inflammatory responses.", {"entities": []}], ["Mice deficient in any one of the four Pglyrp genes are more sensitive to dextran sulfate sodium (DSS)-induced colitis, and stools from Pglyrp -deficient mice transferred to wild type (WT) germ-free mice predispose them to much more severe colitis than stools from WT mice.", {"entities": []}], ["However, the identities of these Pglyrp -regulated bacteria that predispose Pglyrp -deficient mice to colitis or protect WT mice from colitis are not known.", {"entities": []}], ["Here we identified significant changes in \u03b2-diversity of stool bacteria in Pglyrp -deficient mice compared with WT mice.", {"entities": []}], ["The most consistent changes in microbiome in all Pglyrp -deficient mice were in Bacteroidales , from which we selected four species, two with increased abundance ( Prevotella falsenii and Parabacteroides distasonis ) and two with decreased abundance ( Bacteroides eggerthii and Alistipes finegoldii ).", {"entities": []}], ["We then gavaged WT mice with stock type strains of these species to test the hypothesis that they predispose to or protect from DSS-induced colitis.", {"entities": []}], ["falsenii , P .", {"entities": []}], ["distasonis , and B .", {"entities": []}], ["eggerthii all enhanced DSS-induced colitis in both WT mice with otherwise undisturbed intestinal microflora and in WT mice with antibiotic-depleted intestinal microflora.", {"entities": []}], ["By contrast, A .", {"entities": []}], ["finegoldii (which is the most abundant species in WT mice) attenuated DSS-induced colitis both in WT mice with otherwise undisturbed intestinal microflora and in WT mice with antibiotic-depleted intestinal microflora, similar to the colitis protective effect of the entire normal microflora.", {"entities": []}], ["These results identify P .", {"entities": []}], ["falsenii , P .", {"entities": []}], ["distasonis , and B .", {"entities": []}], ["eggerthii as colitis-promoting species and A .", {"entities": []}], ["finegoldii as colitis-protective species.", {"entities": []}], ["Certain perfluoroalkyl and polyfluoroalkyl substances (PFAS) are widespread, persistent environmental contaminants.", {"entities": [[55, 59, "GENE"]]}], ["Prenatal PFAS exposure has been associated with lower birth weight; however, impacts on body composition and factors responsible for this association are unknown.", {"entities": [[9, 13, "GENE"]]}], ["We aimed to estimate associations between maternal PFAS concentrations and offspring weight and adiposity at birth, and secondarily to estimate associations between PFAS concentrations and maternal glucose and lipids, and to evaluate the potential for these nutrients to mediate associations between PFAS and neonatal outcomes.", {"entities": [[51, 55, "GENE"], [165, 169, "GENE"], [300, 304, "GENE"], [51, 55, "GENE"], [165, 169, "GENE"], [300, 304, "GENE"], [51, 55, "GENE"], [165, 169, "GENE"], [300, 304, "GENE"]]}], ["Within the Healthy Start prospective cohort, concentrations of 11 PFAS, fasting glucose, and lipids were measured in maternal mid-pregnancy serum ( n = 628 ).", {"entities": [[66, 70, "GENE"]]}], ["Infant body composition was measured using air displacement plethysmography.", {"entities": []}], ["Associations between PFAS and birth weight and adiposity, and between PFAS and maternal glucose and lipids, were estimated via linear regression.", {"entities": [[21, 25, "GENE"], [70, 74, "GENE"], [21, 25, "GENE"], [70, 74, "GENE"]]}], ["Associations were decomposed into direct and indirect effects.", {"entities": []}], ["Five PFAS were detectable in > 50 % of participants.", {"entities": [[5, 9, "GENE"]]}], ["Maternal perfluorooctanoate (PFOA) and perfluorononanoate (PFNA) concentrations were inversely associated with birth weight.", {"entities": []}], ["Adiposity at birth was approximately 10% lower in the highest categories of PFOA, PFNA, and perfluorohexane sulfonate (PFHxS) compared to the lowest categories.", {"entities": []}], ["PFOA, PFNA, perfluorodecanoate (PFDeA), and PFHxS were inversely associated with maternal glucose.", {"entities": []}], ["Up to 11.6% of the effect of PFAS on neonatal adiposity was mediated by maternal glucose concentrations.", {"entities": [[29, 33, "GENE"]]}], ["Perfluorooctane sulfonate (PFOS) was not significantly associated with any outcomes studied.", {"entities": []}], ["Follow-up of offspring will determine the potential long-term consequences of lower weight and adiposity at birth associated with prenatal PFAS exposure.", {"entities": [[139, 143, "GENE"]]}], ["https://doi.org/10.1289/EHP641", {"entities": []}], ["Objective .", {"entities": []}], ["We evaluated whether the methylenetetrahydrofolate reductase ( MTHFR ) 677C>T marker influences the risk and severity of Alzheimer's disease (AD) and whether AD is associated with homocysteine, vitamin B12, and cholesterol levels in Egypt.", {"entities": [[63, 68, "GENE"]]}], ["Forty-three Alzheimer's cases and 32 non-AD controls were genotyped for the 677C>T polymorphism.", {"entities": []}], ["Clinical characteristics and levels of homocysteine, vitamin B12, and cholesterol were assessed.", {"entities": []}], ["No significant differences in the frequencies of the MTHFR alleles or genotypes between AD cases and controls ( P = 0.14) were identified.", {"entities": [[53, 58, "GENE"]]}], ["The 677T mutant allele was significantly overrepresented in AD cases compared to controls (OR = 2.22; P = 0.03).", {"entities": []}], ["The 677T/T frequency was three times higher in AD patients than in controls, which could increase plasma homocysteine levels.", {"entities": []}], ["Severe cases of AD were the most frequent in patients with the T/T genotype (11.6%).", {"entities": []}], ["The effect of the MTHFR polymorphism on the risk of AD may be independent of homocysteine, vitamin B12, or even cholesterol levels.", {"entities": [[18, 23, "GENE"]]}], ["Conclusions .", {"entities": []}], ["The MTHFR 677C>T polymorphism\u2014especially the presence of one copy of the T allele\u2014appears to confer a potential risk for the development of AD.", {"entities": [[4, 9, "GENE"]]}], ["The T/T genotype may contribute to hypercysteinemia as a sensitive marker.", {"entities": []}], ["Chronic urticaria is a challenging problem since the exact cause and mechanism involved in the disease development have still remained unknown.", {"entities": [[8, 17, "DISEASE"]]}], ["This disease is associated with mast cells activation and immunoinflammatory processes.", {"entities": []}], ["Interestingly, dysfunctions of the neuroendocrine\u2013immune system due to stress and other factors seem to appear as a very interesting theory for urticaria pathogenesis.", {"entities": [[144, 153, "DISEASE"]]}], ["Dehydroepiandrosterone and its sulfate derivative (DHEA-S) appear to have regulatory effects in immune homeostasis and are regulated by the nervous system, and it is suggested that they may be an integral element of neuroimmunomodulation.", {"entities": []}], ["Our studies showed substantially decreased serum concentration of DHEA-S in patients with chronic urticaria.", {"entities": [[98, 107, "DISEASE"]]}], ["However, current knowledge prevents answering whether lower circulating DHEA-S concentration is a primary phenomenon or just an accompanying one which appears as a response of different systems to the course of the illness and may not be of any importance for the pathogenesis of urticaria whatsoever.", {"entities": [[280, 289, "DISEASE"]]}], ["This review is a summary of clinical research on the role of DHEA in chronic urticaria.", {"entities": [[77, 86, "DISEASE"]]}], ["to characterize the care services performed through risk rating by the Manchester Triage System, identifying demographics (age, gender), main flowcharts, discriminators and outcomes in pediatric emergency cross-sectional quantitative study.", {"entities": []}], ["Data on risk classification were obtained through a search of computerized registration data from medical records of patients treated in the pediatric emergency within one year.", {"entities": []}], ["Descriptive statistics with absolute and relative frequencies was used for the analysis.", {"entities": []}], ["10,921 visits were conducted in the pediatric emergency, mostly male (54.4%), aged between 29 days and two years (44.5%).", {"entities": []}], ["There was a prevalence of the urgent risk category (43.6%).", {"entities": []}], ["The main flowchart used in the care was worried parents (22.4%) and the most prevalent discriminator was recent event (15.3%).", {"entities": []}], ["The hospitalization outcome occurred in 10.4% of care performed in the pediatric emergency, however 61.8% of care needed to stay under observation and / or being under the health team care in the pediatric emergency.", {"entities": []}], ["worried parents was the main flowchart used and recent events the most prevalent discriminator, comprising the hospitalization outcomes and permanency in observation in the pediatric emergency before discharge from the hospital.", {"entities": []}], ["To assess the efficacy and safety of panzyga\u00ae (intravenous immunoglobulin 10%) in preventing serious bacterial infections (SBIs) in patients with primary immunodeficiency diseases (PIDs), a prospective, open-label, multicenter, phase 3 study and an open-label extension study were undertaken.", {"entities": []}], ["Initially, the study drug (infusion rate \u22640.08\u00a0mL/kg/min) was administered at intervals of 3 or 4\u00a0weeks for 12\u00a0months, followed by 3\u00a0months of panzyga\u00ae at infusion rates increasing from 0.08 to 0.14\u00a0mL/kg/min.", {"entities": []}], ["The primary endpoint in the main study was the rate of SBIs per patient-year on treatment.", {"entities": []}], ["Secondary outcomes included non-serious infections, work/school absence, episodes of fever, quality of life, and adverse events (AEs).", {"entities": []}], ["The main study enrolled 51 patients (35% female, mean age 26.8\u00a0years), with 21 participating in the extension study.", {"entities": []}], ["The rate of SBIs per patient-year was 0.08 in the total population; there were four SBIs in the 4-weekly treatment group (2/30 patients) and none in the 3-weekly group ( n \u00a0=\u00a021).", {"entities": []}], ["Compared with 4-weekly treatment, 3-weekly treatment was associated with a higher rate of upper respiratory tract infections (RTIs), ear infections, and work/school absences, but a lower rate of lower RTIs and fever.", {"entities": []}], ["Treatment was generally well tolerated; no AE led to treatment withdrawal or death.", {"entities": []}], ["Overall, the use of panzyga\u00ae in patients with antibody-deficient PID was associated with a low rate of AEs and was effective in preventing SBIs, exceeding US FDA and European Medicines Agency recommendations for efficacy.", {"entities": []}], ["Previous reports indicate the presence of histological abnormalities in the brains of individuals with autism spectrum disorders (ASD) suggestive of a dysplastic process.", {"entities": []}], ["In this study we identified areas of abnormal cortical thinning within the cerebral cortex of ASD individuals and examined the same for neuronal morphometric abnormalities by using computerized image analysis.", {"entities": []}], ["The study analyzed celloidin-embedded and Nissl-stained serial full coronal brain sections of 7 autistic (ADI-R diagnosed) and 7 age/sex-matched neurotypicals.", {"entities": []}], ["Sections were scanned and manually segmented before implementing an algorithm using Laplace\u2019s equation to measure cortical width.", {"entities": []}], ["Identified areas were then subjected to analysis for neuronal morphometry.", {"entities": []}], ["Results of our study indicate the presence within our ASD population of circumscribed foci of diminished cortical width that varied among affected individuals both in terms of location and overall size with the frontal lobes being particularly involved.", {"entities": []}], ["Spatial statistic indicated a reduction in size of neurons within affected areas.", {"entities": []}], ["Granulometry confirmed the presence of smaller pyramidal cells and suggested a concomitant reduction in the total number of interneurons.", {"entities": []}], ["The neuropathology is consistent with a diagnosis of focal cortical dysplasia (FCD).", {"entities": []}], ["Results from the medical literature (e.g., heterotopias) and our own study suggest that the genesis of this cortical malformation seemingly resides in the heterochronic divisions of periventricular germinal cells.", {"entities": []}], ["The end result is that during corticogenesis radially migrating neuroblasts (future pyramidal cells) are desynchronized in their development from those that follow a tangential route (interneurons).", {"entities": []}], ["The possible presence of a pathological mechanism in common among different conditions expressing an autism-like phenotype argue in favor of considering ASD a \u201csequence\u201d rather than a syndrome.", {"entities": [[184, 192, "DISEASE"]]}], ["Focal cortical dysplasias in ASD may serve to explain the high prevalence of seizures and sensory abnormalities in this patient population.", {"entities": []}], ["Background: Increasing evidence suggests a proatherogenic role for lipoprotein-associated phospholipase A 2 (Lp-PLA2).", {"entities": []}], ["A meta-analysis of published cohorts has shown that Lp-PLA2 is an independent predictor of coronary heart disease events and stroke.", {"entities": [[100, 113, "DISEASE"], [91, 113, "DISEASE"]]}], ["Objective: In this study, we investigated whether the association between air pollution and cardiovascular disease might be partly explained by increased Lp-PLA2 mass in response to exposure.", {"entities": []}], ["Methods: A prospective longitudinal study of 200 patients who had had a myocardial infarction was performed in Augsburg, Germany.", {"entities": [[72, 93, "DISEASE"]]}], ["Up to six repeated clinical examinations were scheduled every 4\u20136 weeks between May 2003 and March 2004.", {"entities": []}], ["Supplementary to the multicenter AIRGENE protocol, we assessed repeated plasma Lp-PLA2 concentrations.", {"entities": []}], ["Air pollution data from a fixed monitoring site representing urban background concentrations were collected.", {"entities": []}], ["We measured hourly means of particle mass [particulate matter (PM) < 10 \u00b5m (PM 10 ) and PM < 2.5 \u00b5m (PM 2.5 ) in aerodynamic diameter] and particle number concentrations (PNCs), as well as the gaseous air pollutants carbon monoxide (CO), sulfur dioxide (SO 2 ), ozone (O 3 ), nitric oxide (NO), and nitrogen dioxide (NO 2 ).", {"entities": []}], ["Data were analyzed using mixed models with random patient effects.", {"entities": []}], ["Results: Lp-PLA2 showed a positive association with PM 10 , PM 2.5 , and PNCs, as well as with CO, NO 2 , NO, and SO 2 4\u20135 days before blood withdrawal (lag 4\u20135).", {"entities": []}], ["A positive association with O 3 was much more immediate (lag 0).", {"entities": []}], ["However, inverse associations with some pollutants were evident at shorter time lags.", {"entities": []}], ["Conclusion: These preliminary findings should be replicated in other study populations because they suggest that the accumulation of acute and subacute effects or the chronic exposure to ambient particulate and gaseous air pollution may result in the promotion of atherosclerosis, mediated, at least in part, by increased levels of Lp-PLA2.", {"entities": [[264, 279, "DISEASE"]]}], ["The study aimed to evaluate the anti- Sporothrix sp.", {"entities": []}], ["activity of the essential oil of Origanum majorana Linn.", {"entities": []}], ["(marjoram), its chemical analysis, and its cytotoxic activity.", {"entities": []}], ["A total of 18 fungal isolates of Sporothrix brasiliensis ( n : 17) from humans, dogs and cats, and a standard strain of Sporothrix schenckii ( n : 1) were tested using the broth microdilution technique (Clinical and Laboratory Standard Institute \u2013 CLSI M27-A3) and the results were expressed in minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC).", {"entities": []}], ["The MIC 50 and MIC 90 of itraconazole against S. brasiliensis were 2\u00a0\u03bcg/mL and 8\u00a0\u03bcg/mL, respectively, and the MFC 50 and MFC 90 were 2\u00a0\u03bcg/mL and >16\u00a0\u03bcg/mL, respectively, with three S. brasiliensis isolates resistant to antifungal.", {"entities": []}], ["S. schenckii was sensitive at MIC of 1\u00a0\u03bcg/mL and MFC of 8\u00a0\u03bcg/mL.", {"entities": []}], ["For the oil of O. majorana L., all isolates were susceptible to MIC of \u22642.25\u20139\u00a0mg/mL and MFC of \u22642.25\u201318\u00a0mg/mL.", {"entities": []}], ["The MIC 50 and MIC 90 were \u22642.25\u00a0mg/mL and 4.5\u00a0mg/mL, respectively, and the MFC 50/90 values were twice more than the MIC.", {"entities": []}], ["Twenty-two compounds were identified by gas chromatography with a flame ionization detector (CG-FID) and 1,8-cineole and 4-terpineol were the majority.", {"entities": []}], ["Through the colorimetric (MTT) assay, the toxicity was observed in 70\u201380% of VERO cells between 0.078 and 5\u00a0mg/mL.", {"entities": []}], ["For the first time, the study demonstrated the satisfactory in vitro anti- Sporothrix sp.", {"entities": []}], ["activity of marjoram oil and further studies are needed to ensure its safe and effective use.", {"entities": []}], ["We studied in vivo the potential involvement of nuclear factor- \u03ba B (NF- \u03ba B) pathway in the molecular mechanism of the anti-inflammatory and immunomodulatory activity of azithromycin in the lung.", {"entities": []}], ["Mice transiently transfected with the luciferase gene under the control of a NF- \u03ba B responsive element were used to assess in vivo NF- \u03ba B activation by bioluminescence imaging.", {"entities": []}], ["Bioluminescence as well as inflammatory cells and concentrations of proinflammatory cytokines in bronchoalveolar lavage fluids, were monitored in an acute model of pulmonary inflammation resulting from intratracheal instillation of lipopolysaccharide.", {"entities": []}], ["Lipopolysaccharide (LPS) instillation induced a marked increase in lung bioluminescence in mice transiently transfected with the luciferase gene under the control of an NF- \u03ba B responsive element, with significant luciferase expression in resident cells such as endothelial and epithelial cells, as assessed by duoplex immunofluorescence staining.", {"entities": []}], ["Activation of NF- \u03ba B and inflammatory cell lung infiltration linearly correlated when different doses of bortezomib were used to inhibit NF- \u03ba B activation.", {"entities": []}], ["Pretreatment with azithromycin significantly decreased lung bioluminescence and airways cell infiltration induced by LPS, also reducing proinflammatory cytokines concentrations in bronchoalveolar lavages and inhibiting NF- \u03ba B nuclear translocation.", {"entities": []}], ["The results obtained using a novel approach to monitor NF- \u03ba B activation, provided, for the first time, in vivo evidence that azithromycin treatment results in pulmonary anti-inflammatory activity associated with the inhibition of NF- \u03ba B activation in the lung.", {"entities": []}], ["The application of metabolomics to biological samples has been a key focus in systems biology research, which is aimed at the development of rapid diagnostic methods and the creation of personalized medicine.", {"entities": []}], ["More recently, there has been a strong focus towards this approach applied to non-invasively acquired samples, such as saliva and exhaled breath.", {"entities": []}], ["The analysis of these biological samples, in conjunction with other sample types and traditional diagnostic tests, has resulted in faster and more reliable characterization of a range of health disorders and diseases.", {"entities": []}], ["As the sampling process involved in collecting exhaled breath and saliva is non-intrusive as well as comparatively low-cost and uses a series of widely accepted methods, it provides researchers with easy access to the metabolites secreted by the human body.", {"entities": []}], ["Owing to its accuracy and rapid nature, metabolomic analysis of saliva and breath (known as salivaomics and breathomics, respectively) is a rapidly growing field and has shown potential to be effective in detecting and diagnosing the early stages of numerous diseases and infections in preclinical studies.", {"entities": []}], ["This review discusses the various collection and analyses methods currently applied in two of the least used non-invasive sample types in metabolomics, specifically their application in salivaomics and breathomics research.", {"entities": []}], ["Some of the salient research completed in this field to date is also assessed and discussed in order to provide a basis to advocate their use and possible future scientific directions.", {"entities": []}], ["ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) is a universally confirmed susceptibility gene for asthma and has recently emerged as a crucial modulator in lipid metabolism, inflammation and endoplasmic reticulum (ER) stress-the mechanisms also closely involved in atherosclerosis (AS).", {"entities": [[271, 286, "DISEASE"], [104, 110, "DISEASE"], [45, 51, "GENE"]]}], ["Here we first presented the evidence of two single nucleotide polymorphisms regulating ORMDL3 expression (rs7216389 and rs9303277) significantly associated with AS risk and the evidence of increased ORMDL3 expression in AS cases compared to controls, in Chinese Han population.", {"entities": [[87, 93, "GENE"], [199, 205, "GENE"], [87, 93, "GENE"], [199, 205, "GENE"]]}], ["Following the detection of its statistical correlation with AS, we further explored the functional relevance of ORMDL3 and hypothesized a potential role mediating autophagy as autophagy is activated upon modified lipid, inflammation and ER stress.", {"entities": [[112, 118, "GENE"]]}], ["Our results demonstrated that in endothelial cells oxidized low-density lipoprotein (ox-LDL) up-regulated ORMDL3 expression and knockdown of ORMDL3 alleviated not only ox-LDL-induced but also basal autophagy.", {"entities": [[106, 112, "GENE"], [141, 147, "GENE"], [106, 112, "GENE"], [141, 147, "GENE"]]}], ["BECN1 is essential for autophagy initiation and silencing of ORMDL3 suppressed ox-LDL-induced as well as basal BECN1 expression.", {"entities": [[0, 5, "GENE"], [111, 116, "GENE"], [61, 67, "GENE"], [0, 5, "GENE"], [111, 116, "GENE"]]}], ["In addition, deletion of ORMDL3 resulted in greater sensitivity to ox-LDL-induced cell death.", {"entities": [[25, 31, "GENE"]]}], ["Taken together, ORMDL3 might represent a causal gene mediating autophagy in endothelial cells in the pathogenesis of AS.", {"entities": [[16, 22, "GENE"]]}], ["To evaluate the feasibility of continuous telemetric trans-abdominal fetal electrocardiogram (a-fECG) in women undergoing labour induction at home.", {"entities": []}], ["Low risk women with singleton term pregnancy undergoing labour induction with retrievable, slow-release dinoprostone pessaries (n\u200a=\u200a70) were allowed home for up to 24 hours, while a-fECG and uterine activity were monitored in hospital via wireless technology.", {"entities": []}], ["Semi-structured diaries were analysed using a combined descriptive and interpretive approach.", {"entities": []}], ["62/70 women (89%) had successful home monitoring; 8 women (11%) were recalled because of signal loss.", {"entities": []}], ["Home monitoring lasted between 2\u201322 hours (median 10 hours).", {"entities": []}], ["Good quality signal was achieved most of the time (86%, SD 10%).", {"entities": []}], ["3 women were recalled back to hospital for suspicious a-fECG.", {"entities": []}], ["In 2 cases suspicious a-fECG persisted, requiring Caesarean section after recall to hospital.", {"entities": []}], ["48/51 women who returned the diary coped well (94%); 46/51 were satisfied with home monitoring (90%).", {"entities": []}], ["Continuous telemetric trans-abdominal fetal ECG monitoring of ambulatory women undergoing labour induction is feasible and acceptable to women.", {"entities": []}], ["To examine the use of medication of top-level male players during the 2014 FIFA World Cup Brazil.", {"entities": []}], ["Retrospective survey.", {"entities": []}], ["736 top level players.", {"entities": []}], ["The teams\u2019 physicians disclosed a list of the medications used by each player within 72\u2005h before each match of the 2014 FIFA World Cup Brazil.", {"entities": []}], ["Average number of medications used per player per match or during the tournament; average number and percentage of players using at least one medication per match or during the tournament.", {"entities": []}], ["67.0% of all players took various types of medication during the tournament.", {"entities": []}], ["The most used medications during the tournament were non-steroidal anti-inflammatory drugs (NSAIDs), by 54.2% of all players, followed by analgaesics (12.6%); \u03b2-2 agonists were only used by 0.5%.", {"entities": []}], ["On average, 0.8 medications per player were used before each match.", {"entities": []}], ["More players were reported taking medications during the knockout round than during the qualification round (0.36\u00b10.48 vs 0.49\u00b10.50, p<0.001).", {"entities": []}], ["Players from the South American and Asian Confederations took twice as many medications per match as players from the African Confederation (1.17\u00b11.55 and 1.01\u00b11.26 vs 0.48\u00b10.69, both p<0.001).", {"entities": []}], ["There was high use of NSAIDs during the 2014 FIFA World Cup.", {"entities": []}], ["Although the intake of NSAIDs per match (0.35\u00b10.46 vs 0.31\u00b10.48, p<0.01) in the 2014 FIFA World Cup decreased compared to the 2010 FIFA World Cup, the average use was still higher than in the 2006 FIFA World Cup, and the average number of all used medications per player remained the same level as 4\u2005years prior, with all its implications for the player's health.", {"entities": []}], ["More efforts need to be undertaken worldwide in order to reduce the administration of medications in sports, through continuous education for players, starting from a young age, as well as for doctors and paramedics.", {"entities": []}], ["Extremely preterm infants often receive mechanical ventilation (MV), which can contribute to bronchopulmonary dysplasia (BPD).", {"entities": []}], ["However, the effects of MV alone on the extremely preterm lung and the lung\u2019s capacity for repair are poorly understood.", {"entities": []}], ["To characterise lung injury induced by MV alone, and mechanisms of injury and repair, in extremely preterm lungs and to compare them with very preterm lungs.", {"entities": []}], ["Extremely preterm lambs (0.75 of term) were transiently exposed by hysterotomy and underwent 2 h of injurious MV.", {"entities": []}], ["Lungs were collected 24 h and at 15 d after MV.", {"entities": []}], ["Immunohistochemistry and morphometry were used to characterise injury and repair processes.", {"entities": []}], ["qRT-PCR was performed on extremely and very preterm (0.85 of term) lungs 24 h after MV to assess molecular injury and repair responses.", {"entities": []}], ["24 h after MV at 0.75 of term, lung parenchyma and bronchioles were severely injured; tissue space and myofibroblast density were increased, collagen and elastin fibres were deformed and secondary crest density was reduced.", {"entities": []}], ["Bronchioles contained debris and their epithelium was injured and thickened.", {"entities": []}], ["24 h after MV at 0.75 and 0.85 of term, mRNA expression of potential mediators of lung repair were significantly increased.", {"entities": []}], ["By 15 days after MV, most lung injury had resolved without treatment.", {"entities": []}], ["Extremely immature lungs, particularly bronchioles, are severely injured by 2 h of MV.", {"entities": []}], ["In the absence of continued ventilation these injured lungs are capable of repair.", {"entities": []}], ["At 24 h after MV, genes associated with injurious MV are unaltered, while potential repair genes are activated in both extremely and very preterm lungs.", {"entities": []}], ["COPD patients have an increased prevalence of osteoporosis (OP) compared with healthy people.", {"entities": [[46, 58, "DISEASE"]]}], ["Physical inactivity in COPD patients is a crucial risk factor for OP; the COPD assessment test (CAT) is the newest assessment tool for the health status and daily activities of COPD patients.", {"entities": []}], ["This study investigated the relationship among daily physical activity (DPA), CAT scores, and bone mineral density (BMD) in COPD patients with or without OP.", {"entities": []}], ["This study included 30 participants.", {"entities": []}], ["Ambulatory DPA was measured using actigraphy and oxygen saturation by using a pulse oximeter.", {"entities": []}], ["BMD was measured using dual-energy X-ray absorptiometry.", {"entities": []}], ["OP was defined as a T-score (standard deviations from a young, sex-specific reference mean BMD) less than or equal to \u22122.5 SD for the lumbar spine, total hip, and femoral neck.", {"entities": []}], ["We quantified oxygen desaturation during DPA by using a desaturation index and recorded all DPA, except during sleep.", {"entities": []}], ["COPD patients with OP had lower DPA and higher CAT scores than those of patients without OP.", {"entities": []}], ["DPA was significantly positively correlated with (lumbar spine, total hip, and femoral neck) BMD ( r =0.399, 0.602, 0.438, respectively, all P <0.05) and T-score ( r =0.471, 0.531, 0.459, respectively, all P <0.05), whereas CAT scores were significantly negatively correlated with (total hip and femoral neck) BMD ( r =\u22120.412, \u22120.552, respectively, P <0.05) and (lumbar spine, total hip, and femoral neck) T-score ( r =\u22120.389, \u22120.429, \u22120.543, respectively, P <0.05).", {"entities": []}], ["Low femoral neck BMD in COPD patients was related to high CAT scores.", {"entities": []}], ["Our results show no significant difference in desaturation index, low SpO 2 , and inflammatory markers (IL-6, TNF-\u03b1, IL-8/CXCL8, CRP, and 8-isoprostane) between the two groups.", {"entities": [[129, 132, "GENE"]]}], ["Chest physicians should be aware that COPD patients with OP have low DPA and high CAT scores.", {"entities": []}], ["The need for widely accepted and validated animal models to test the potential allergenicity and potency of novel (biotechnology-derived) proteins has become an important issue for their safety evaluation.", {"entities": []}], ["In this article, we summarize the results of the development of an oral sensitization protocol for food proteins in the rat.", {"entities": []}], ["Young Brown Norway rats were exposed to either various purified allergenic proteins (e.g., ovalbumin, partly purified), a whole food (cow's milk), or total protein extracts (hen's egg white, peanut) by daily gavage dosing during 42 days without the use of an adjuvant.", {"entities": []}], ["The results showed that Brown Norway rats can be sensitized orally to the various allergenic food proteins tested, resulting in antigen-specific immunoglobulin (Ig) G and IgE responses, without the use of adjuvants.", {"entities": []}], ["Animals orally exposed to cow's milk or total protein extracts of egg white also developed specific IgE and IgG antibodies that recognized the same proteins compared with antibodies from patients allergic to egg white or cow's milk.", {"entities": []}], ["We also studied local and systemic immune-mediated effects.", {"entities": []}], ["In ovalbumin-sensitized rats, some clinical symptoms of food allergy were studied upon an oral challenge with ovalbumin.", {"entities": [[56, 68, "DISEASE"]]}], ["The results demonstrated that gut permeability was increased and that in some animals breathing frequency and systolic blood pressure were temporarily decreased.", {"entities": []}], ["The results obtained show that the Brown Norway rat provides a suitable animal model for food allergy research and for the study of relative allergenicity of existing and novel food proteins.", {"entities": [[89, 101, "DISEASE"]]}], ["Atopic dermatitis (AD) is a chronic and inflammatory skin disease that can place a significant burden on quality of life for patients.", {"entities": [[53, 65, "DISEASE"], [7, 17, "DISEASE"]]}], ["AD most frequently appears under the age of six and although its prevalence is increasing worldwide, therapeutic treatment options are limited.", {"entities": []}], ["Chlorella vulgaris (CV) is a species of the freshwater green algae genus chlorella, and has been reported to modulate allergy-inducible factors when ingested.", {"entities": []}], ["Here, we examined the effect of CV supplementation on AD-like symptoms in NC/Nga mice.", {"entities": []}], ["CV was orally administrated for six weeks while AD-like symptoms were induced via topical application of Dermatophagoides farinae extract (DFE).", {"entities": []}], ["CV treatment reduced dermatitis scores, epidermal thickness, and skin hydration.", {"entities": [[21, 31, "DISEASE"]]}], ["Histological analysis also revealed that CV treatment reduced DFE-induced eosinophil and mast cell infiltration into the skin, while analysis of serum chemokine levels indicated that CV treatment downregulated thymus- and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) levels.", {"entities": []}], ["In addition, CV treatment downregulated mRNA expression levels of IL-4 and IFN-\u03b3.", {"entities": []}], ["Taken together, these results suggest that CV extract may have potential as a nutraceutical ingredient for the prevention of AD.", {"entities": []}], ["Wheezing is a common problem in children under five with acute respiratory infections (ARIs).", {"entities": []}], ["Viruses are known to be responsible for a considerable proportion of ARIs in children.", {"entities": []}], ["This study was undertaken to know the viral aetiology of wheezing among the children less than five years of age, admitted to a tertiary care hospital in eastern India.", {"entities": []}], ["Seventy five children, under the age of five years admitted with wheezing, were included in the study.", {"entities": []}], ["Throat and nasal swabs were collected, and real-time multiplex polymerase chain reaction (PCR) assay was used to screen for influenza 1 and 2, respiratory syncytial virus (RSV), parainfluenza virus (PIV) 1, 2, 3 and 4, rhinovirus, human meta-pneumovirus, bocavirus (HBoV), Coronavirus , adenovirus, Enterovirus and Parechovirus .", {"entities": [[124, 133, "DISEASE"]]}], ["The total viral detection rate was 28.57 per cent.", {"entities": []}], ["Viral RNA markers were detected from children diagnosed to be having pneumonia (3 cases), bronchiolitis (9 cases), episodic wheeze (2 cases) and multitrigger wheeze (6 cases).", {"entities": [[69, 78, "DISEASE"], [90, 103, "DISEASE"]]}], ["RSV was the most common virus (35%) followed by PIV1, 2 and 3 (20%), HBoV (10%) and rhinovirus (5%).", {"entities": []}], ["However, mixed infection was observed in 30 per cent of cases.", {"entities": []}], ["The study reported the presence of respiratory viral agents in 28.57 per cent of children with wheezing; RSV and PIV were most common, accounting to 55 per cent of the total cases.", {"entities": []}], ["Mixed infection was reported in 30 per cent of cases.", {"entities": []}], ["Seasonal variation in the occurrence of these viruses was also noted.", {"entities": []}], ["Further studies need to be done with a large sample and longer follow up period to verify these findings.", {"entities": []}], ["As an immune modulator, vitamin D is involved in various pathophysiological mechanisms in a plethora of diseases.", {"entities": []}], ["This study aims to correlate the vitamin D deficiency status and clinical progression of liver diseases associated with hepatitis B virus (HBV) infection in patients in Vietnam and to compare it to healthy controls.", {"entities": [[120, 129, "DISEASE"]]}], ["We quantified the levels of total vitamin D [25-(OH) D2 and D3] in serum samples from 400 HBV patients (chronic hepatitis B infection [CHB], n \u2009=\u2009165; HBV-associated liver cirrhosis [LC], n \u2009=\u2009127; HBV-associated hepatocellular carcinoma [HCC], n \u2009=\u2009108) and 122 unrelated healthy controls (HC).", {"entities": [[213, 237, "DISEASE"], [228, 237, "DISEASE"], [166, 181, "DISEASE"], [112, 121, "DISEASE"]]}], ["Univariate and multivariate analyses were performed in order to determine the association between vitamin D levels and distinct clinical parameters.", {"entities": []}], ["The prevalence of vitamin D inadequacy (<30\u00a0ng/mL) was high among healthy individuals (81.7\u00a0%) as well as in HBV patients (84.3\u00a0%).", {"entities": []}], ["Vitamin D deficiency (<20\u00a0ng/ml) or severe deficiency (<10\u00a0ng/ml) was observed more frequently among HBV patients (52\u00a0%) and subgroups (CHB, 47.8\u00a0%; LC, 54.4\u00a0%; HCC, 55.3\u00a0%) compared to the control group (32.5\u00a0%) ( P \u2009<\u20090.001).", {"entities": []}], ["Vitamin D levels and HBV-DNA load were strongly and inversely correlated (rho\u2009=\u2009\u22120.57, P \u2009<\u20090.0001).", {"entities": []}], ["Multivariate regression analysis also revealed an independent association of HBV-DNA loads with low vitamin D levels ( P \u2009=\u20090.0004).", {"entities": []}], ["In addition, reduced vitamin D levels were associated with significant clinical progression of LC (Child-Pugh C versus Child-Pugh A, P \u2009=\u20090.0018; Child-Pugh C versus Child-Pugh B, P \u2009=\u20090.016).", {"entities": []}], ["Vitamin D deficiency was observed in the majority of HBV-infected patients and associated with adverse clinical outcomes.", {"entities": []}], ["Our findings suggest that substitution of vitamin D may be a supportive option in the treatment of chronic liver diseases, in particular of HBV-associated disorders.", {"entities": []}], ["The use of dry gases during mechanical ventilation has been associated with the risk of serious airway complications.", {"entities": []}], ["The goal of the present study was to quantify the plasma levels of TNF-alpha and IL-6 and to determine the radiological, hemodynamic, gasometric, and microscopic changes in lung mechanics in dogs subjected to short-term mechanical ventilation with and without humidification of the inhaled gas.", {"entities": []}], ["The experiment was conducted for 24 hours in 10 dogs divided into two groups: Group I (n\u200a=\u200a5), mechanical ventilation with dry oxygen dispensation, and Group II (n\u200a=\u200a5), mechanical ventilation with oxygen dispensation using a moisture chamber.", {"entities": []}], ["Variance analysis was used.", {"entities": []}], ["No changes in physiological, hemodynamic, or gasometric, and radiographic constants were observed.", {"entities": []}], ["Plasma TNF-alpha levels increased in group I, reaching a maximum 24 hours after mechanical ventilation was initiated (ANOVA p\u200a=\u200a0.77).", {"entities": []}], ["This increase was correlated to changes in mechanical ventilation.", {"entities": []}], ["Plasma IL-6 levels decreased at 12 hours and increased again towards the end of the study (ANOVA p>0.05).", {"entities": []}], ["Both groups exhibited a decrease in lung compliance and functional residual capacity values, but this was more pronounced in group I. Pplat increased in group I (ANOVA p\u200a=\u200a0.02).", {"entities": []}], ["Inhalation of dry gas caused histological lesions in the entire respiratory tract, including pulmonary parenchyma, to a greater extent than humidified gas.", {"entities": []}], ["Humidification of inspired gases can attenuate damage associated with mechanical ventilation.", {"entities": []}], ["Although the role of complete gene inactivation by two loss-of-function mutations inherited in trans is well-established in recessive Mendelian diseases, we have not yet explored how such gene knockouts (KOs) could influence complex human phenotypes.", {"entities": []}], ["Here, we developed a statistical framework to test the association between gene KOs and quantitative human traits.", {"entities": []}], ["Our method is flexible, publicly available, and compatible with common genotype format files (e.g.", {"entities": []}], ["PLINK and vcf).", {"entities": []}], ["We characterized gene KOs in 4498 participants from the NHLBI Exome Sequence Project (ESP) sequenced at high coverage (>100\u00d7), 1976 French Canadians from the Montreal Heart Institute Biobank sequenced at low coverage (5.7\u00d7), and >100 000 participants from the Genetic Investigation of ANthropometric Traits (GIANT) Consortium genotyped on an exome array.", {"entities": []}], ["We tested associations between gene KOs and three anthropometric traits: body mass index (BMI), height and BMI-adjusted waist-to-hip ratio (WHR).", {"entities": []}], ["Despite our large sample size and multiple datasets available, we could not detect robust associations between specific gene KOs and quantitative anthropometric traits.", {"entities": []}], ["Our results highlight several limitations and challenges for future gene KO studies in humans, in particular when there is no prior knowledge on the phenotypes that might be affected by the tested gene KOs.", {"entities": []}], ["They also suggest that gene KOs identified with current DNA sequencing methodologies probably do not strongly influence normal variation in BMI, height, and WHR in the general human population.", {"entities": []}], ["We argue that the recommendations made by the Institute of Medicine\u2019s Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity , are methodologically and ethically confused.", {"entities": []}], ["We argue that a proper understanding of evolution and complexity theory in terms of the science and ethics of using chimpanzees in biomedical research would have had led the committee to recommend not merely limiting but eliminating the use of chimpanzees in biomedical research.", {"entities": []}], ["Specifically, we argue that a proper understanding of the difference between the gross level of examination of species and examinations on finer levels can shed light on important methodological and ethical inconsistencies leading to ignorance of potentially unethical practices and policies regarding the use of animals in scientific research.", {"entities": []}], ["To compare whether depressive symptoms are more strongly related to subsequent or prior glycemic control in type 2 diabetes and to test whether patient characteristics modify these longitudinal associations.", {"entities": []}], ["On two occasions separated by 6 months, depressive symptoms and glycemic control were assessed in 253 adults with type 2 diabetes.", {"entities": []}], ["Regression analyses examined depressive symptoms as both a predictor and outcome of glycemic control and tested whether medication regimen (e.g., insulin versus oral drugs) was an effect modifier before and after adjusting for baseline levels of the outcome being predicted.", {"entities": []}], ["Depressive symptom severity predicted poor glycemic control 6 months later ( P = 0.018) but not after baseline glycemic control was taken into account ( P = 0.361).", {"entities": []}], ["Although baseline glycemic control did not generally predict depressive symptoms 6 months later ( P = 0.558), it significantly interacted with regimen ( P = 0.008).", {"entities": []}], ["Specifically, glycemic control predicted depressive symptoms among patients prescribed insulin (\u03b2 = 0.31, P = 0.002) but not among those prescribed oral medication alone (\u03b2 = \u22120.10, P = 0.210).", {"entities": []}], ["Classifying depression dichotomously produced similar but weaker findings.", {"entities": []}], ["Depressive symptoms do not necessarily lead to worsened glycemic control.", {"entities": []}], ["In contrast, insulin-treated patients in poor glycemic control are at moderate risk for worsening of depressive symptoms.", {"entities": []}], ["These patients should be carefully monitored to determine whether depression treatment should be initiated or intensified.", {"entities": []}], ["There are little data about adverse effects and immunogenicity of flu vaccine in Asian pregnant women.", {"entities": []}], ["This prospective trial (NCT01514708) enrolled 46 pregnant women who received a single intramuscular dose of trivalent flu vaccine (AdimFlu-S\u00ae) containing 15 mcg of hemagglutinin for each strain/0.5 mL from influenza A (H1N1), influenza A (H3N2), and influenza B after the first trimester.", {"entities": [[206, 215, "DISEASE"], [226, 235, "DISEASE"], [250, 259, "DISEASE"]]}], ["Blood samples were collected at day 0 and 28 after vaccination, and at delivery.", {"entities": []}], ["Cord blood was also collected.", {"entities": []}], ["Hemagglutination inhibition (HAI) assays were performed to determine seroprotection and seroconversion rates and fold increase in the HAI geometric mean titer (GMT).", {"entities": []}], ["Twenty-eight days after vaccination the seroprotection rate against H1N1, H3N2, and influenza B was 91.3%, 84.8% and 56.5%, respectively.", {"entities": [[84, 93, "DISEASE"]]}], ["The GMT fold increase was 12.8, 8.4, and 4.6 for H1N1, H3N2, and influenza B, respectively.", {"entities": [[65, 74, "DISEASE"]]}], ["At delivery, both the seroprotection rate (86.4%, 68.2%, and 47.7%) and GMT fold increase (9.4, 5.7 and 3.8) were slightly lower than day 28.", {"entities": []}], ["The seroprotection rate and GMT fold increase in maternal and cord blood samples were comparable.", {"entities": []}], ["No significant adverse effects were detected.", {"entities": []}], ["Trivalent flu vaccine induces a strong immune response in pregnant women and their infants without adverse effects.", {"entities": []}], ["Clinical Trials.", {"entities": []}], ["gov NCT01514708", {"entities": []}], ["We report a case of bronchiolitis obliterans associated with Stevens-Johnson syndrome.", {"entities": [[77, 85, "DISEASE"], [20, 44, "DISEASE"], [20, 33, "DISEASE"]]}], ["A 59-year-old man presented with respiratory distress that gradually worsened over 3 months.", {"entities": []}], ["He had been diagnosed with Stevens-Johnson syndrome 3 months before admission.", {"entities": [[43, 51, "DISEASE"]]}], ["He had no history of previous airway disease.", {"entities": []}], ["On physical examination, expiratory breathing sounds were not audible, and a chest X-ray revealed a hyperinflated lung.", {"entities": []}], ["A pulmonary function test indicated a severe obstructive pattern.", {"entities": []}], ["Computed tomography scans of inspiratory and expiratory phases of respiration showed oligemia and air trapping, and both were more prominent on expiration view than on inspiration view.", {"entities": []}], ["The pathogenesis of bronchiolitis obliterans associated with Stevens-Johnson syndrome is largely unknown.", {"entities": [[77, 85, "DISEASE"], [20, 44, "DISEASE"], [20, 33, "DISEASE"]]}], ["CD4 Plasmodium falciparum .", {"entities": [[0, 3, "GENE"]]}], ["Using a co-culture system of malaria-infected red blood cells (iRBCs) and peripheral blood mononuclear cells from healthy individuals, we found that two populations of Foxp3 in vivo as a consequence of immune activation during malaria infection, and potentially a range of other infectious diseases.", {"entities": [[29, 36, "DISEASE"], [227, 234, "DISEASE"], [168, 173, "GENE"]]}], ["Infection with the malaria parasite Plasmodium falciparum affects 300\u2013600 million people each year.", {"entities": [[19, 26, "DISEASE"]]}], ["Regulatory T cells (Tregs) expressing the transcription factor Foxp3, which drives genes involved in immunosuppression, are specialized immune cells that can inhibit both protective and harmful inflammatory responses during malaria.", {"entities": [[224, 231, "DISEASE"], [63, 68, "GENE"]]}], ["While Treg numbers are increased during malaria infection, little is known about how they are induced by the parasite.", {"entities": [[40, 47, "DISEASE"]]}], ["We addressed this question using an in vitro culture system to model the interaction of the malaria parasite with human immune cells.", {"entities": [[92, 99, "DISEASE"]]}], ["We found that the parasite induced soluble immune mediators, including the T cell growth-factor IL-2 and the regulatory proteins IL-10 and TGF\u03b2, which drive the induction and expansion of Tregs.", {"entities": []}], ["These Tregs expressed high levels of Foxp3 and suppressed the production of inflammation and protective immunity-driving mediators by concurrently induced effector T cells.", {"entities": [[37, 42, "GENE"]]}], ["Importantly, we demonstrate that induction of Tregs by the malaria parasite did not necessarily require direct contact with antigen-presenting cells.", {"entities": [[59, 66, "DISEASE"]]}], ["Our findings suggest that the parasite induces Tregs in an antigen non-specific manner, which may explain why malarial immunosuppression is not confined to malaria-specific immune responses, and provide new insights into the mechanisms governing Treg induction during malaria infection, and potentially other infectious diseases.", {"entities": [[156, 163, "DISEASE"], [268, 275, "DISEASE"]]}], ["Swallowing difficulties are common, and dysphagia occurs frequently in intensive care unit (ICU) patients after extubation.", {"entities": []}], ["Yet, no guidelines on postextubation swallowing assessment exist.", {"entities": []}], ["We aimed to investigate the safety and effectiveness of nurse-performed screening (NPS) for postextubation dysphagia in the medical ICU.", {"entities": [[83, 86, "GENE"]]}], ["We conducted a retrospective cohort study of mechanically ventilated patients who were extubated in a 20-bed medical ICU.", {"entities": []}], ["Phase I (no NPS, October 2012 to January 2014) and phase II (NPS, February 2014 to July 2015) were compared.", {"entities": [[12, 15, "GENE"], [61, 64, "GENE"], [12, 15, "GENE"], [61, 64, "GENE"]]}], ["In phase II, extubated patients received NPS up to three times on consecutive days; patients who failed were referred to speech-language pathologists.", {"entities": [[41, 44, "GENE"]]}], ["Outcomes analyzed included oral feeding at ICU discharge, reintubation, ICU readmission, postextubation pneumonia, ICU and/or hospital mortality, and ICU and/or hospital length of stay (LOS).", {"entities": [[104, 113, "DISEASE"]]}], ["Subgroup analysis was done for patients extubated after >72\u00a0h of mechanical ventilation, as the latter may predispose patients to postextubation dysphagia.", {"entities": []}], ["Multivariable adjustments for Acute Physiology and Chronic Health Evaluation (APACHE) II score and comorbidities were done because of baseline differences between the phases.", {"entities": []}], ["A total of 468 patients were studied (281 in phase I, 187 in phase II).", {"entities": []}], ["Patients in phase II had higher APACHE II scores than those in phase I (27.2\u2009\u00b1\u20098.2 vs. 25.4\u2009\u00b1\u20098.2; P \u2009=\u20090.018).", {"entities": []}], ["Despite this, patients in phase II showed a 111\u00a0% increase in (the odds of) oral feeding at ICU discharge and a 59\u00a0% decrease in postextubation pneumonia (multivariate P values 0.001 and 0.006, respectively).", {"entities": [[144, 153, "DISEASE"]]}], ["In the subgroup analysis, NPS was associated with a 127\u00a0% increase in oral feeding at ICU discharge, an 80\u00a0% decrease in postextubation pneumonia, and a 25\u00a0% decrease in hospital LOS (multivariate P values 0.021, 0.004, and 0.009, respectively).", {"entities": [[136, 145, "DISEASE"], [26, 29, "GENE"]]}], ["No other outcome differences were found.", {"entities": []}], ["NPS for dysphagia is safe and may be superior to no screening with respect to several patient-centered outcomes.", {"entities": [[0, 3, "GENE"]]}], ["The online version of this article (doi:10.1186/s13054-016-1507-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["\u03b2-Catenin is a plasma membrane-associated protein that plays a dual role in cellular signalling by stabilizing cadherin mediated cell\u2013cell contact and by regulating TCF-/LEF-mediated gene transcription.", {"entities": []}], ["Traditionally, the role of \u03b2-catenin in health and disease has mainly been studied in the context of development and uncontrolled cell growth in diseases such as cancer.", {"entities": [[162, 168, "DISEASE"]]}], ["Recent findings indicate, however, that \u03b2-catenin also plays a significant role in fibro-proliferative diseases of several organ systems and that \u03b2-catenin regulates mitogenic responses of smooth muscle cells.", {"entities": []}], ["As several diseases of the internal organs are characterized by structural and phenotypic abnormalities of smooth muscle, including increased fibro-proliferative responses, these findings implicate that \u03b2-catenin could play a broad pathophysiological role.", {"entities": []}], ["This article will review this potential novel role for \u03b2-catenin and associated intracellular signalling in smooth muscle and discuss the hypothesis that it plays a central role in smooth muscle remodelling.", {"entities": []}], ["The elicitation of anti-drug antibodies (ADA) against biotherapeutics can have detrimental effects on drug safety, efficacy, and pharmacokinetics.", {"entities": [[41, 44, "GENE"]]}], ["The immunogenicity of biotherapeutics is, therefore, an important issue.", {"entities": []}], ["There is evidence that protein aggregation can result in enhanced immunogenicity; however, the precise immunological and biochemical mechanisms responsible are poorly defined.", {"entities": []}], ["In the context of biotherapeutic drug development and safety assessment, understanding the mechanisms underlying aggregate immunogenicity is of considerable interest.", {"entities": []}], ["This review provides an overview of the phenomenon of protein aggregation, the production of unwanted aggregates during bioprocessing, and how the immune response to aggregated protein differs from that provoked by non-aggregated protein.", {"entities": []}], ["Of particular interest is the nature of the interaction of aggregates with the immune system and how subsequent ADA responses are induced.", {"entities": [[112, 115, "GENE"]]}], ["Pathways considered here include \u2018classical\u2019 activation of the immune system involving antigen presenting cells and, alternatively, the breakdown of B-cell tolerance.", {"entities": []}], ["Additionally, methods available to screen for aggregation and immunogenicity will be described.", {"entities": []}], ["With an increased understanding of aggregation-enhanced immune responses, it may be possible to develop improved manufacturing and screening processes to avoid, or at least reduce, the problems associated with ADA.", {"entities": [[210, 213, "GENE"]]}], ["South Asian and other minority communities suffer poorer asthma outcomes, have a higher rate of unscheduled care and benefit less from most existing self-management interventions when compared to the majority population.", {"entities": [[57, 63, "DISEASE"]]}], ["Possible reasons for these differences include failure to implement asthma self-management strategies, or that strategies implemented were inappropriate for their needs; alternatively, they may relate to the minority and/or lower socioeconomic status of these populations.", {"entities": [[68, 74, "DISEASE"]]}], ["We aimed to synthesise evidence from randomised controlled trials for asthma self-management in South Asian and Black populations from different sociocultural contexts, and identify barriers and facilitators to implementing self-management.", {"entities": [[70, 76, "DISEASE"]]}], ["We systematically searched eight electronic databases, and research registers, and manually searched relevant journals and reference lists of reviews.", {"entities": []}], ["Seventeen trials met the inclusion criteria and were analysed narratively.", {"entities": []}], ["We found two culturally targeted interventions compared to fifteen culturally modified interventions.", {"entities": []}], ["Interventions used diverse self-management strategies; education formed a central component.", {"entities": []}], ["Interventions in South Asian and African-American minority communities were less effective than interventions delivered in indigenous populations in South Asia, though the latter trials were at higher risk of bias.", {"entities": []}], ["Education, with continuous professional support, was common to most interventions.", {"entities": []}], ["Facilitators to asthma self-management included: ensuring culturally/linguistically appropriate education, adapting to learning styles, addressing daily stressors/social support and generic self-management strategies.", {"entities": [[16, 22, "DISEASE"]]}], ["In conclusion, when developing and evaluating self-management interventions aimed at different cultures, the influence of sociocultural contexts (including whether patients are from a minority or indigenous population) can be important for the conceptualisation of culture and customisation of self-management strategies.", {"entities": []}], ["Simultaneous combined superficial peroneal nerve and peroneous brevis muscle biopsy, via the same cutaneous incision, allows examination of several tissue specimens and significantly improves the diagnosis of systemic diseases with peripheral nerve involvement.", {"entities": []}], ["Vasculitides are certainly the most frequently diagnosed on neuro-muscular biopsies, but this procedure is also well advised to asses a diagnosis of sarcoidosis or amyloidosis.", {"entities": [[164, 175, "DISEASE"], [149, 160, "DISEASE"]]}], ["More occasionally, combined nerve and muscle biopsy may reveal an unpredicted diagnosis of cholesterol embolism, intra-vascular lymphoma, or enables complementary diagnosis investigations on mitochondrial cytopathy or storage disease.", {"entities": [[91, 111, "DISEASE"], [128, 136, "DISEASE"]]}], ["This study is the first to evaluate an assessment aid for attention-deficit/hyperactivity disorder (ADHD) according to both Class-I evidence standards of American Academy of Neurology and De Novo requirements of US Food and Drug Administration.", {"entities": []}], ["The assessment aid involves a method to integrate an electroencephalographic (EEG) biomarker, theta/beta ratio (TBR), with a clinician's ADHD evaluation.", {"entities": []}], ["The integration method is intended as a step to help improve certainty with criterion E (i.e., whether symptoms are better explained by another condition).", {"entities": []}], ["To evaluate the assessment aid, investigators conducted a prospective, triple-blinded, 13-site, clinical cohort study.", {"entities": []}], ["Comprehensive clinical evaluation data were obtained from 275 children and adolescents presenting with attentional and behavioral concerns.", {"entities": []}], ["A qualified clinician at each site performed differential diagnosis.", {"entities": []}], ["EEG was collected by separate teams.", {"entities": []}], ["The reference standard was consensus diagnosis by an independent, multidisciplinary team (psychiatrist, psychologist, and neurodevelopmental pediatrician), which is well-suited to evaluate criterion E in a complex clinical population.", {"entities": []}], ["Of 209 patients meeting ADHD criteria per a site clinician's judgment, 93 were separately found by the multidisciplinary team to be less likely to meet criterion E, implying possible overdiagnosis by clinicians in 34% of the total clinical sample ( 93/275 ).", {"entities": []}], ["Of those 93, 91% were also identified by EEG, showing a relatively lower TBR ( 85/93 ).", {"entities": []}], ["Further, the integration method was in 97% agreement with the multidisciplinary team in the resolution of a clinician's uncertain cases ( 35/36 ).", {"entities": []}], ["TBR showed statistical power specific to supporting certainty of criterion E per the multidisciplinary team ( Cohen's d, 1.53 ).", {"entities": []}], ["Patients with relatively lower TBR were more likely to have other conditions that could affect criterion E certainty ( 10 significant results; P\u00a0\u2264\u00a00.05 ).", {"entities": []}], ["Integration of this information with a clinician's ADHD evaluation could help improve diagnostic accuracy from 61% to 88%.", {"entities": []}], ["The EEG-based assessment aid may help improve accuracy of ADHD diagnosis by supporting greater criterion E certainty.", {"entities": []}], ["There is conflicting evidence regarding the benefit of adjunctive corticosteroid therapy in patients with Mycoplasma pneumoniae pneumonia.", {"entities": [[128, 137, "DISEASE"]]}], ["We hypothesised that corticosteroid therapy could reduce mortality and length of stay (LOS) in such patients.", {"entities": []}], ["Adult patients with M. pneumoniae pneumonia from January 2010 to December 2013 were identified from the Japanese Diagnosis Procedure Combination inpatient database.", {"entities": [[34, 43, "DISEASE"]]}], ["The effects of low-dose and high-dose corticosteroid therapies on mortality, LOS, drug costs and hyperglycaemia requiring insulin treatment were evaluated using propensity score analyses.", {"entities": []}], ["Eligible patients ( n \u2009=\u20092228) from 630 hospitals were divided into no-corticosteroid ( n \u2009=\u20091829), low-dose corticosteroid ( n \u2009=\u2009267) and high-dose corticosteroid ( n \u2009=\u2009132) groups.", {"entities": []}], ["The propensity score-matched pairs were generated from no-corticoid and low-dose corticoid groups (251 pairs), or no-corticoid and high-dose corticosteroid groups (120 pairs).", {"entities": []}], ["Adjunctive corticosteroid therapy did not decrease 30-day mortality.", {"entities": []}], ["In addition, both low-dose and high-dose corticosteroid therapies were associated with increases in LOS.", {"entities": []}], ["Furthermore, hyperglycaemia requiring insulin treatment and drug cost increased with corticosteroid use.", {"entities": []}], ["Adjunctive treatment with low-dose or high-dose corticosteroids may not be beneficial in M. pneumoniae pneumonia.", {"entities": [[103, 112, "DISEASE"]]}], ["A growing number of randomized controlled trials (RCTs) have investigated the therapeutic value of yoga interventions.", {"entities": []}], ["This bibliometric analysis aimed to provide a comprehensive review of the characteristics of the totality of available randomized yoga trials.", {"entities": []}], ["All RCTs of yoga were eligible.", {"entities": []}], ["Medline/PubMed, Scopus, the Cochrane Library, IndMED, and the tables of content of yoga specialty journals not listed in medical databases were screened through February 2014.", {"entities": []}], ["Bibliometric data, data on participants, and intervention were extracted and analyzed descriptively.", {"entities": []}], ["Published between 1975 and 2014, a total of 366 papers were included, reporting 312 RCTs from 23 different countries with 22,548 participants.", {"entities": []}], ["The median study sample size was 59 (range 8\u2013410, interquartile range\u2009=\u200931, 93).", {"entities": []}], ["Two hundred sixty-four RCTs (84.6%) were conducted with adults, 105 (33.7%) with older adults and 31 (9.9%) with children.", {"entities": []}], ["Eighty-four RCTs (26.9%) were conducted with healthy participants.", {"entities": []}], ["Other trials enrolled patients with one of 63 varied medical conditions; the most common being breast cancer (17 RCTs, 5.4%), depression (14 RCTs, 4.5%), asthma (14 RCTs, 4.5%) and type 2 diabetes mellitus (13 RCTs, 4.2%).", {"entities": [[95, 108, "DISEASE"], [154, 160, "DISEASE"], [102, 108, "DISEASE"], [188, 205, "DISEASE"], [181, 205, "DISEASE"]]}], ["Whilst 119 RCTs (38.1%) did not define the style of yoga used, 35 RCTs (11.2%) used Hatha yoga and 30 RCTs (9.6%) yoga breathing.", {"entities": []}], ["The remaining 128 RCTs (41.0%) used 46 varied yoga styles, with a median intervention length of 9\u00a0weeks (range 1\u00a0day to 1\u00a0year; interquartile range\u2009=\u20095, 12).", {"entities": []}], ["Two hundred and forty-four RCTs (78.2%) used yoga postures, 232 RCTs (74.4%) used breath control, 153 RCTs (49.0%) used meditation and 32 RCTs (10.3%) used philosophy lectures.", {"entities": []}], ["One hundred and seventy-four RCTs (55.6%) compared yoga with no specific treatment; 21 varied control interventions were used in the remaining RCTs.", {"entities": []}], ["This bibliometric analysis presents the most complete up-to-date overview on published randomized yoga trials.", {"entities": []}], ["While the available research evidence is sparse for most conditions, there was a marked increase in published RCTs in recent years.", {"entities": []}], ["The online version of this article (doi:10.1186/1472-6882-14-328) contains supplementary material, which is available to authorized users.", {"entities": []}], ["IL-33, a member of the IL-1 cytokine family and a ligand to receptor ST2, has great potential to induce a T helper 2-type inflammatory response.", {"entities": []}], ["IL-33 is proven to be released by epithelial cells during their injury by different environmental stimuli such as airborne allergens, viruses, and air pollutants.", {"entities": []}], ["IL-33 acting as an endogenous danger signal is termed an alarmin.", {"entities": []}], ["As such, this cytokine is considered to play a crucial role in an allergic inflammatory disease such as rhinitis.", {"entities": [[104, 112, "DISEASE"]]}], ["Recent investigations regarding the IL-33/ST2 axis involvement in Th2 inflammatory response and pathogenesis of rhinitis have been reviewed.", {"entities": [[112, 120, "DISEASE"]]}], ["The role of IL-33 as a novel promising therapeutic target has also been discussed.", {"entities": []}], ["This paper presents findings from the Tobacco Control in Arizona Healthcare Systems Survey, conducted in 2000.", {"entities": []}], ["The purpose of the survey was to assess the status of Arizona healthcare systems' awareness and implementation of tobacco cessation and prevention measures.", {"entities": []}], ["The 20-item survey was developed by The University of Arizona HealthCare Partnership in collaboration with the Arizona Department of Health Services Bureau of Tobacco Education and Prevention.", {"entities": []}], ["It was mailed to representatives of Arizona's 40 healthcare systems, including commercial and Medicare managed care organizations, \"managed Medicaid\" organizations, Veterans Affairs Health Care Systems, and Indian Health Service Medical Centers.", {"entities": []}], ["Thirty-three healthcare systems (83%) completed the survey.", {"entities": []}], ["The majority of healthcare systems reported awareness of at least one tobacco cessation and prevention clinical practice guideline, but only one third reported full guideline implementation.", {"entities": []}], ["While a majority covered some form of behavioral therapy, less than half reported covering tobacco treatment medications.", {"entities": []}], ["\"Managed Medicaid\" organizations administered through the Arizona Health Care Cost Containment System were significantly less likely to offer coverage for behavioral therapy and less likely to cover pharmacotherapy than were their non-Medicaid counterparts in managed care, Veterans Affairs Health Care Systems and Indian Health Service Medical Centers.", {"entities": []}], ["Arizona healthcare system coverage for tobacco cessation in the year 2000 was comparable to national survey findings of the same year.", {"entities": []}], ["The findings that only 10% of \"Managed Medicaid\" organizations covered tobacco treatment medication and were significantly less likely to cover behavioral therapy were important given the nearly double smoking prevalence among Medicaid patients.", {"entities": []}], ["Throughout the years of the program, the strategic plan of the Arizona Department of Health Services Bureau of Tobacco Education and Prevention has included the goal of identifying and eliminating tobacco related disparities for special populations, including low-income groups.", {"entities": []}], ["Of importance, in 2008 the Arizona Health Care Cost Containment System was authorized to provide tobacco cessation pharmacotherapy as a covered benefit for its members.", {"entities": []}], ["Breathlessness in advanced disease causes significant distress to patients and carers and presents management challenges to health care professionals.", {"entities": []}], ["The Breathlessness Intervention Service (BIS) seeks to improve the care of breathless patients with advanced disease (regardless of cause) through the use of evidence-based practice and working with other healthcare providers.", {"entities": []}], ["BIS delivers a complex intervention (of non-pharmacological and pharmacological treatments) via a multi-professional team.", {"entities": []}], ["BIS is being continuously developed and its impact evaluated using the MRC's framework for complex interventions (PreClinical, Phase I and Phase II completed).", {"entities": []}], ["This paper presents the protocol for Phase III.", {"entities": []}], ["Phase III comprises a pragmatic, fast-track, single-blind randomised controlled trial of BIS versus standard care.", {"entities": []}], ["Due to differing disease trajectories, the service uses two broad service models: one for patients with malignant disease (intervention delivered over two weeks) and one for patients with non-malignant disease (intervention delivered over four weeks).", {"entities": []}], ["The Phase III trial therefore consists of two sub-protocols: one for patients with malignant conditions (four week protocol) and one for patients with non-malignant conditions (eight week protocol).", {"entities": []}], ["Mixed method interviews are conducted with patients and their lay carers at three to five measurement points depending on randomisation and sub-protocol.", {"entities": []}], ["Qualitative interviews are conducted with referring and non-referring health care professionals (malignant disease protocol only).", {"entities": []}], ["The primary outcome measure is 'patient distress due to breathlessness' measured on a numerical rating scale (0-10).", {"entities": []}], ["The trial includes economic evaluation.", {"entities": []}], ["Analysis will be on an intention to treat basis.", {"entities": []}], ["This is the first evaluation of a breathlessness intervention for advanced disease to have followed the MRC framework and one of the first palliative care trials to use fast track methodology and single-blinding.", {"entities": []}], ["The results will provide evidence of the clinical and cost-effectiveness of the service, informing its longer term development and implementation of the model in other centres nationally and internationally.", {"entities": []}], ["It adds to methodological developments in palliative care research where complex interventions are common but evidence sparse.", {"entities": []}], ["ClinicalTrials.gov: NCT00678405 ISRCTN: ISRCTN04119516", {"entities": []}], ["The specific eradication of pathogenic T cells for the treatment of allograft rejections and autoimmune disorders without impairment of overall immune function is a fundamental goal.", {"entities": []}], ["Here, cell-sized poly(lactic-co-glycolic acid) microparticles (PLGA MPs) were prepared as a scaffold to co-display the peptide/major histocompatibility complex (pMHC, target antigen) and anti-Fas monoclonal antibody (apoptosis-inducing molecule) for the generation of biodegradable killer MPs.", {"entities": []}], ["Ovalbumin (OVA) antigen-targeted killer MPs significantly depleted OVA-specific CD8 in vitro and in OT-1 mice.", {"entities": []}], ["After intravenous administration, the killer MPs predominantly accumulated in the liver, lungs, and gut of OT-1 mice with a retention time of up to 48 hours.", {"entities": []}], ["The killing effects exerted by killer MPs persisted for 4 days after two injections.", {"entities": []}], ["Moreover, the H-2K", {"entities": []}], ["Parishin is a phenolic glucoside isolated from Gastrodia elata , which is an important traditional Chinese medicine; this glucoside significantly extended the replicative lifespan of K6001 yeast at 3, 10, and 30\u2009 \u03bc M. To clarify its mechanism of action, assessment of oxidative stress resistance, superoxide dismutase (SOD) activity, malondialdehyde (MDA), and reactive oxygen species (ROS) assays, replicative lifespans of sod1 , sod2 , uth1 , and skn7 yeast mutants, and real-time quantitative PCR (RT-PCR) analysis were conducted.", {"entities": [[424, 428, "GENE"], [431, 435, "GENE"]]}], ["The significant increase of cell survival rate in oxidative stress condition was observed in parishin-treated groups.", {"entities": []}], ["Silent information regulator 2 ( Sir2 ) gene expression and SOD activity were significantly increased after treating parishin in normal condition.", {"entities": []}], ["Meanwhile, the levels of ROS and MDA in yeast were significantly decreased.", {"entities": []}], ["The replicative lifespans of sod1 , sod2 , uth1, and skn7 mutants of K6001 yeast were not affected by parishin.", {"entities": [[29, 33, "GENE"], [36, 40, "GENE"]]}], ["We also found that parishin could decrease the gene expression of TORC1 , ribosomal protein S26A ( RPS26A ), and ribosomal protein L9A ( RPL9A ) in the target of rapamycin (TOR) signaling pathway.", {"entities": []}], ["Gene expression levels of RPS26A and RPL9A in uth1 , as well as in uth1 , sir2 double mutants, were significantly lower than those of the control group.", {"entities": []}], ["Besides, TORC1 gene expression in uth1 mutant of K6001 yeast was inhibited significantly.", {"entities": []}], ["These results suggested that parishin exhibited antiaging effects via regulation of Sir2/Uth1/TOR signaling pathway.", {"entities": []}], ["Primary-care based randomized controlled trials (RCTs) build an important evidence base for general practice but little evidence exists about barriers to recruitment which often hamper such trials.", {"entities": []}], ["We investigated the issues that impeded and facilitated recruitment to a clinical trial in general practice.", {"entities": []}], ["GPs participating in a cluster RCT that tested interventions for improving medication adherence and asthma control completed a survey comprising quantitative and free text questions about their recruitment experiences.", {"entities": [[100, 106, "DISEASE"]]}], ["We used backward regression to analyze quantitative data and coded free text responses into themes.", {"entities": []}], ["40/55 of enrolled GPs recruited patients, but only one-third reached the planned recruitment target (5 patients/GP).", {"entities": []}], ["In univariate analyses, poor patient recruitment by GPs was significantly associated with longer time to first patient enrolment, GP-perceived poor access to eligible patients and GP working in a practice training medical students.", {"entities": []}], ["In regression analysis, only the first was significant (p\u2009=\u20090.001); the explained variance of the model was 48%.", {"entities": []}], ["Themes from free text responses described recruitment barriers at the level of GP (e.g.", {"entities": []}], ["GPs excluding patients for whom research appeared too challenging), practice (e.g.", {"entities": []}], ["practice cultures disempowered GPs), patient (e.g.", {"entities": []}], ["reluctance to change treatment for research) and study (e.g.", {"entities": []}], ["protocol requirements complicating recruitment).", {"entities": []}], ["Facilitators included GPs perceiving good support from the research team.", {"entities": []}], ["Targeted recruitment support early in the recruitment phase may enhance recruitment rates.", {"entities": []}], ["Over time, interventions to enhance a general practice research culture are also likely to enhance skills to recruit patients, even for complex interventions.", {"entities": []}], ["We recommend systematic evaluation of recruitment approaches and outcomes in future RCTs to optimize feasibility and success of these important trials.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry ACTRN12610000854033 (date registered 14/10/2010).", {"entities": []}], ["The International Hapmap project serves as a valuable resource for human genome variation data, however its applicability to other populations has yet to be exhaustively investigated.", {"entities": []}], ["In this paper, we use high density genotyping chips and resequencing strategies to compare the Singapore Chinese population with the Hapmap populations.", {"entities": []}], ["First we compared 1028 and 114 unrelated Singapore Chinese samples genotyped using the Illumina Human Hapmap 550 k chip and Affymetrix 500 k array respectively against the 270 samples from Hapmap.", {"entities": []}], ["Secondly, data from 20 candidate genes on 5q31-33 resequenced for an asthma candidate gene based study was also used for the analysis.", {"entities": [[69, 75, "DISEASE"]]}], ["A total of 237 SNPs were identified through resequencing of which only 95 SNPs (40%) were in Hapmap; however an additional 56 SNPs (24%) were not genotyped directly but had a proxy SNP in the Hapmap.", {"entities": []}], ["At the genome-wide level, Singapore Chinese were highly correlated with Hapmap Han Chinese with correlation of 0.954 and 0.947 for the Illumina and Affymetrix platforms respectively with deviant SNPs randomly distributed within and across all chromosomes.", {"entities": []}], ["The high correlation between our population and Hapmap Han Chinese reaffirms the applicability of Hapmap based genome-wide chips for GWA studies.", {"entities": []}], ["There is a clear population signature for the Singapore Chinese samples and they predominantly resemble the southern Han Chinese population; however when new migrants particularly those with northern Han Chinese background were included, population stratification issues may arise.", {"entities": []}], ["Future studies needs to address population stratification within the sample collection while designing and interpreting GWAS in the Chinese population.", {"entities": []}], ["Knowledge of adverse events associated with regadenoson perfusion cardiac magnetic resonance (CMR) and patient tolerability has implications for patient safety and staff training.", {"entities": []}], ["We sought to assess the safety and tolerability of regadenoson stress CMR.", {"entities": []}], ["A group of 728 consecutive patients (median age 58, 44% female) and 25 normal volunteers (median age 21, 24% female) were recruited from August 2009 to March 2012 using a prospective, cross-sectional study design.", {"entities": []}], ["Subjects were stressed using fixed-dose regadenoson and imaged using a 1.5T MRI scanner.", {"entities": []}], ["Symptoms and adverse events including death, myocardial infarction (MI), ventricular tachycardia (VT)/ventricular fibrillation (VF), hospitalization, arrhythmias, and haemodynamic stability were assessed.", {"entities": [[45, 66, "DISEASE"]]}], ["There were no occurrences of death, MI, VT/VF, high-grade atrioventricular block, or stress-induced atrial fibrillation.", {"entities": []}], ["Notable adverse events included one case of bronchospasm and one case of heart failure exacerbation resulting in hospitalization.", {"entities": []}], ["The most common symptoms in patients were dyspnoea (30%, n = 217), chest discomfort (27%, n = 200), and headache (15%, n = 111).", {"entities": []}], ["There was minimal change between baseline and peak systolic and diastolic blood pressure in both patients and volunteers ( P > 0.05).", {"entities": []}], ["A blunted heart rate response to regadenoson was noted in patients with body mass index (BMI) \u226530 kg/m P < 0.001), and diabetes ( P = 0.001).", {"entities": []}], ["Regadenoson CMR is well tolerated and can be performed safely with few adverse events.", {"entities": []}], ["Few data are available to evaluate the impact of Syrian war on civilian population; to describe this impact on child health, this article uses data from M\u00e9decins Sans Fronti\u00e8res-Operational Centre Amsterdam\u2019s activities in Tal-Abyad and Kobane cities, northern Syria (2013\u20132016).", {"entities": []}], ["Data were obtained from routine medical datasets and narrative reports, for out-patient clinics, immunisation, nutritional monitoring and assessments, and in-patient care, and were analysed quantitatively and qualitatively.", {"entities": []}], ["Infections were the largest contributor to morbidity.", {"entities": []}], ["The proportion of <\u20095 year out-patient consultations of infectious diseases that are listed for outbreak monitoring in emergencies was 15% in 2013, 51% in 2014, 75% in 2015 and 70% in 2016.", {"entities": []}], ["Thalassemia was recorded in 0.5% of 2014 <\u20095 year out-patient consultations and 3.4% of 2013\u20132014 <\u200918-year in-patient admissions.", {"entities": []}], ["Measles immunisation activities and routine Extended Programme for Immunisation were re-activated across northern Syria; however, immunisation coverage could not be calculated.", {"entities": []}], ["Results from our routine data must be compared cautiously, due to differences in settings and disease categories.", {"entities": []}], ["Conclusion : With such scattered interventions, routine data are limited in providing a quantified evidence of emergency\u2019s health impact; however, they help in drawing a picture of children\u2019s health status and highlighting difficulties in providing curative and preventive services, in order to reflect part of population\u2019s plight.", {"entities": []}], ["Complementary medicines (CMs) are popular amongst Australians and community pharmacy is a major supplier of these products.", {"entities": []}], ["This study explores pharmacy customer use, attitudes and perceptions of complementary medicines, and their expectations of pharmacists as they relate to these products.", {"entities": []}], ["Pharmacy customers randomly selected from sixty large and small, metropolitan and rural pharmacies in three Australian states completed an anonymous, self administered questionnaire that had been pre-tested and validated.", {"entities": []}], ["1,121 customers participated (response rate 62%).", {"entities": []}], ["72% had used CMs within the previous 12 months, 61% used prescription medicines daily and 43% had used both concomitantly.", {"entities": []}], ["Multivitamins, fish oils, vitamin C, glucosamine and probiotics were the five most popular CMs.", {"entities": []}], ["72% of people using CMs rated their products as 'very effective' or 'effective enough'.", {"entities": []}], ["CMs were as frequently used by customers aged 60 years or older as younger customers (69% vs. 72%) although the pattern of use shifted with older age.", {"entities": []}], ["Most customers (92%) thought pharmacists should provide safety information about CMs, 90% thought they should routinely check for interactions, 87% thought they should recommend effective CMs, 78% thought CMs should be recorded in customer's medication profile and 58% thought pharmacies stocking CMs should also employ a complementary medicine practitioner.", {"entities": []}], ["Of those using CMs, 93% thought it important for pharmacists to be knowledgeable about CMs and 48% felt their pharmacist provides useful information about CMs.", {"entities": []}], ["CMs are widely used by pharmacy customers of all ages who want pharmacists to be more involved in providing advice about these products.", {"entities": []}], ["There have been few studies of pulmonary actinomycosis, which is an uncommon anaerobic infection.", {"entities": [[41, 54, "DISEASE"]]}], ["Consequently, the optimal therapeutic regimen, appropriate duration of treatment, long-term prognosis, and factors predicting prognosis are not well established.", {"entities": []}], ["We retrospectively reviewed the medical records of histopathologically confirmed cases of pulmonary actinomycosis seen between November 2003 and December 2012.", {"entities": [[100, 113, "DISEASE"]]}], ["The study included 68 patients with a mean age of 58.4\u2009\u00b1\u200911.6 years.", {"entities": []}], ["Of the 68, initial surgery was performed in 15 patients (22.1%), while the remaining 53 (77.9%) received antibiotic therapy initially.", {"entities": []}], ["In the initial antibiotic group, 45/53 (84.9%) were cured without relapse (median antibiotic duration 5.3 months).", {"entities": []}], ["5/53 (9.4%) patients were refractory medically (median antibiotic duration 9.7 months), and 3/53 (5.7%) experienced a recurrence (median time to relapse 35.3 months).", {"entities": []}], ["In the initial surgery group, 14/15 (93.3%) were cured and treatment failure occurred in one (6.7%).", {"entities": []}], ["In the multivariate analysis, the absence of an antibiotic response at 1 month was the only independent factor associated with a poor treatment outcome, with an adjusted odds ratio of 49.2 (95% CI, 3.34\u2013724.30).", {"entities": []}], ["There was no significant difference in treatment outcome based on the size of the parenchymal lesion, comorbidities, whether intravenous antibiotics were used, antibiotic therapy duration, or whether the initial treatment was surgical.", {"entities": []}], ["Antibiotic treatment with or without surgery was effective for treatment of pulmonary actinomycosis.", {"entities": [[86, 99, "DISEASE"]]}], ["Nevertheless, treatment failure or recurrence occurred in a considerable proportion of patients, especially those resistant to the initial antibiotic treatment.", {"entities": []}], ["Vaspin is a novel adipocytokine that has potential insulin-sensitizing effects.", {"entities": []}], ["The aim of this study is to explore the role of vaspin in the progression of type 2 diabetes mellitus (T2DM) in humans through a longitudinal process.", {"entities": [[84, 101, "DISEASE"], [77, 101, "DISEASE"]]}], ["This was a 2-year follow-up study that included 132 patients with T2DM and 170 non-diabetic subjects.", {"entities": []}], ["The serum vaspin and adiponectin levels were determined with ELISA.", {"entities": []}], ["Anthropometric measurements, circulating glucose, hemoglobin A1c, insulin level, liver function, kidney function, and lipid profile were measured for each participant.", {"entities": []}], ["The new onset of T2DM was counted in non-diabetic subjects and the glycemic control was analyzed in T2DM patients at follow-up.", {"entities": []}], ["At enrollment, the serum vaspin and adiponectin levels were lower in T2DM patients compared with non-diabetic subjects.", {"entities": []}], ["Significant positive correlation between serum vaspin and HDL-C levels (r\u200a=\u200a0.23, P \u200a=\u200a0.006) was observed in non-diabetic controls.", {"entities": []}], ["The serum vaspin concentration was also significantly correlated with body mass index (BMI) (r\u200a=\u200a0.19, P \u200a=\u200a0.028), waist-hip ratio (WHR) (r\u200a=\u200a0.17, P \u200a=\u200a0.035) and homeostasis model assessment of insulin resistance (HOMA-IR) (r\u200a=\u200a0.14, P \u200a=\u200a0.029) in T2DM patients.", {"entities": []}], ["In cohort analyses, it was found that lower serum vaspin [odds ratio (OR)\u200a=\u200a0.52, 95% confidence interval (CI): 0.10\u20130.87, P \u200a=\u200a0.015] and adiponectin (OR\u200a=\u200a0.35, 95% CI: 0.20\u20130.72, P \u200a=\u200a0.015) levels at baseline were risk factors for new onset of T2DM at follow-up.", {"entities": []}], ["The percentage of insulin treatment in T2DM patients was higher in the sub-group with lower serum vaspin level than that in the sub-group with higher vaspin level at follow-up (55.3% vs. 44.7%, P \u200a=\u200a0.020).", {"entities": []}], ["Our study indicates that low serum concentration of vaspin is a risk factor for the progression of T2DM.", {"entities": []}], ["Self-rated health (SRH) is a single-item measure that is one of the most widely used measures of general health in population health research.", {"entities": []}], ["Relatively little is known about changes and the trajectories of SRH in people with chronic medical conditions.", {"entities": []}], ["The aims of the present study were to identify and describe longitudinal trajectories of self-rated health (SRH) status in people with diabetes.", {"entities": []}], ["A prospective community study was carried out between 2008 and 2011.", {"entities": []}], ["SRH was assessed at baseline and yearly at follow-ups (n=1288).", {"entities": []}], ["Analysis was carried out through trajectory modeling.", {"entities": []}], ["The trajectory groups were subsequently compared at 4 years follow-up with respect to functioning.", {"entities": []}], ["Four distinct trajectories of SRH were identified: 1) 72.2% of the participants were assigned to a persistently good SRH trajectory; 2) 10.1% were assigned to a persistently poor SRH trajectory; 3) mean SRH scores changed from good to poor for one group (7.3%); while 4) mean SRH scores changed from poor to medium/good for another group (10.4%).", {"entities": []}], ["Those with a persistently poor perception of health status were at higher risk for poor functioning at 4 years follow-up than those whose SRH scores decreased from good to poor.", {"entities": []}], ["SRH is an important predictor for poor functioning in diabetes, but the trajectory of SRH seems to be even more important.", {"entities": []}], ["Health professionals should pay attention to not only SRH per se, but also changes in SRH over time.", {"entities": []}], ["Critically ill patients are characterized as individuals hospitalized in the Intensive Care Unit (ICU) and can evolve to sepsis, septic shock or even death.", {"entities": []}], ["Among others, genetic factors can influence the outcome of critically ill patients.", {"entities": []}], ["HLA-G is a non-classical class Ib molecule that has limited protein variability, presenting seven isoforms generated by alternative splicing, and presents immunomodulatory properties.", {"entities": [[0, 5, "GENE"]]}], ["Polymorphisms at the 3'UTR are thought to influence HLA-G gene expression.", {"entities": [[52, 57, "GENE"]]}], ["It was previously observed that increased sHLA-G5 levels were predictive of survival among septic shock patients.", {"entities": []}], ["We assessed the frequencies of 7 polymorphisms in exon 8 at the 3' UTR of HLA-G and associated these variants with different clinical outcomes in critically ill patients.", {"entities": [[74, 79, "GENE"]]}], ["Exon 8 at the 3' UTR of the HLA-G gene from 638 critically ill subjects was amplified by PCR and sequenced.", {"entities": [[28, 33, "GENE"]]}], ["Genotypes were identified using FinchTV software v.1.4.0 and the most probable haplotype constitution of each sample was determined by PHASE software v.2.1.", {"entities": []}], ["Haplotype frequencies, linkage disequilibrium, heterozygosity test and Hardy-Weinberg Equilibrium were estimated using ARLEQUIN software v.3.5.", {"entities": []}], ["Among all critically ill patients, an association between carriers of the +2960IN_+3142 G_+3187A haplotype and septic shock (P = 0.047) was observed.", {"entities": []}], ["Septic patients who carried the +2960IN_+3142G_+3187A haplotype presented an increased risk for septic shock (P = 0.031).", {"entities": []}], ["The present study showed, for the first time, an association between polymorphisms in exon 8 at the 3 'UTR of HLA-G gene and outcomes of critically ill patients.", {"entities": [[110, 115, "GENE"]]}], ["These results may be important for understanding the mechanisms involved in evolution to septic shock in critically ill patients.", {"entities": []}], ["Endothelin-1 (ET-1) and Nitric Oxide (NO) are crucial mediators for establishing pulmonary artery hypertension (PAH).", {"entities": [[98, 110, "DISEASE"]]}], ["We tested the hypothesis that their imbalance might also occur in COPD patients with PAH.", {"entities": []}], ["The aims of the study were to measure exhaled breath condensate (EBC) and circulating levels of ET-1, as well as exhaled NO (FENO) levels by, respectively, a specific enzyme immunoassay kit, and by chemiluminescence analysis in 3 groups of subjects: COPD with PAH (12), COPD only (36), and healthy individuals (15).", {"entities": []}], ["In order to evaluate pulmonary-artery systolic pressure (PaPs), all COPD patients underwent Echo-Doppler assessment.", {"entities": []}], ["Significantly increased exhaled and circulating levels of ET-1 were found in COPD with PAH compared to both COPD (p < 0.0001) only, and healthy controls (p < 0.0001).", {"entities": []}], ["In COPD with PAH, linear regression analysis showed good correlation between ET-1 in EBC and PaPs (r = 0.621; p = 0.031), and between arterial levels of ET-1 and PaPs (r = 0.648; p = 0.022), while arterial levels of ET-1 inversely correlated with FEV 1 %, (r = -0.59, p = 0.043), and PaPs negatively correlated to PaO 2 (r = -0.618; p = 0.032).", {"entities": [[247, 250, "GENE"]]}], ["Significantly reduced levels of FENO were found in COPD associated with PAH, compared to COPD only (22.92 \u00b1 11.38 vs.35.07 \u00b1 17.53 ppb; p = 0.03).", {"entities": []}], ["Thus, we observed an imbalanced output in the breath between ET-1 and NO, as expression of pulmonary endothelium and epithelium impairment, in COPD with PAH compared to COPD only.", {"entities": []}], ["Whether this imbalance is an early cause or result of PAH due to COPD is still unknown and deserves further investigations.", {"entities": []}], ["In this systematic review of studies investigating decision-making in the context of breast cancer preventive therapy, we observed low uptake of all agents and poor long-term persistence.", {"entities": [[85, 98, "DISEASE"], [92, 98, "DISEASE"]]}], ["Our meta-analysis including over 21 000 women demonstrated that only 1 in 6 eligible women decided to take preventive therapy.", {"entities": []}], ["Persistence for 5 years was low, limiting the preventive effect in these women.", {"entities": []}], ["Preventive therapy is a risk reduction option for women who have an increased risk of breast cancer.", {"entities": [[86, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["The effectiveness of preventive therapy to reduce breast cancer incidence depends on adequate levels of uptake and adherence to therapy.", {"entities": [[50, 63, "DISEASE"], [57, 63, "DISEASE"]]}], ["We aimed to systematically review articles reporting uptake and adherence to therapeutic agents to prevent breast cancer among women at increased risk, and identify the psychological, clinical and demographic factors affecting these outcomes.", {"entities": [[107, 120, "DISEASE"], [114, 120, "DISEASE"]]}], ["Searches were carried out in PubMed, CINAHL, EMBASE and PsychInfo, yielding 3851 unique articles.", {"entities": []}], ["Title, abstract and full text screening left 53 articles, and a further 4 studies were identified from reference lists, giving a total of 57.", {"entities": []}], ["This review was prospectively registered with PROSPERO (CRD42014014957).", {"entities": []}], ["Twenty-four articles reporting 26 studies of uptake in 21 423 women were included in a meta-analysis.", {"entities": []}], ["The pooled uptake estimate was 16.3% [95% confidence interval (CI) 13.6\u201319.0], with high heterogeneity ( I P < 0.001).", {"entities": []}], ["Uptake was unaffected by study location or agent, but was significantly higher in trials [25.2% (95% CI 18.3\u201332.2)] than in non-trial settings [8.7% (95% CI 6.8\u201310.9)] ( P < 0.001).", {"entities": []}], ["Factors associated with higher uptake included having an abnormal biopsy, a physician recommendation, higher objective risk, fewer side-effect or trial concerns, and older age.", {"entities": []}], ["Adherence (day-to-day use or persistence) over the first year was adequate.", {"entities": []}], ["However, only one study reported a persistence of \u226580% by 5 years.", {"entities": []}], ["Factors associated with lower adherence included allocation to tamoxifen (versus placebo or raloxifene), depression, smoking and older age.", {"entities": []}], ["Risk of breast cancer was discussed in all qualitative studies.", {"entities": [[8, 21, "DISEASE"], [15, 21, "DISEASE"]]}], ["Uptake of therapeutic agents for the prevention of breast cancer is low, and long-term persistence is often insufficient for women to experience the full preventive effect.", {"entities": [[51, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["Uptake is higher in trials, suggesting further work should focus on implementing preventive therapy within routine care.", {"entities": []}], ["The lungs are generated by branching morphogenesis as a result of reciprocal signalling interactions between the epithelium and mesenchyme during development.", {"entities": []}], ["Mutations that disrupt formation of either the correct number or shape of epithelial branches affect lung function.", {"entities": []}], ["This, in turn, can lead to congenital abnormalities such as cystadenomatoid malformations, pulmonary hypertension or lung hypoplasia.", {"entities": [[101, 113, "DISEASE"], [91, 113, "DISEASE"]]}], ["Defects in lung architecture are also associated with adult lung disease, particularly in cases of idiopathic lung fibrosis.", {"entities": [[60, 72, "DISEASE"]]}], ["Identifying the signalling pathways which drive epithelial tube formation will likely shed light on both congenital and adult lung disease.", {"entities": [[126, 138, "DISEASE"]]}], ["Here we show that mutations in the planar cell polarity (PCP) genes Celsr1 and Vangl2 lead to disrupted lung development and defects in lung architecture.", {"entities": [[68, 74, "GENE"], [79, 85, "GENE"]]}], ["Lungs from Celsr1 Vangl2 mouse mutants are small and misshapen with fewer branches, and by late gestation exhibit thickened interstitial mesenchyme and defective saccular formation.", {"entities": [[11, 17, "GENE"], [18, 24, "GENE"]]}], ["We observe a recapitulation of these branching defects following inhibition of Rho kinase, an important downstream effector of the PCP signalling pathway.", {"entities": []}], ["Moreover, epithelial integrity is disrupted, cytoskeletal remodelling perturbed and mutant endoderm does not branch normally in response to the chemoattractant FGF10.", {"entities": [[160, 165, "GENE"]]}], ["We further show that Celsr1 and Vangl2 proteins are present in restricted spatial domains within lung epithelium.", {"entities": [[21, 27, "GENE"], [32, 38, "GENE"]]}], ["Our data show that the PCP genes Celsr1 and Vangl2 are required for foetal lung development thereby revealing a novel signalling pathway critical for this process that will enhance our understanding of congenital and adult lung diseases and may in future lead to novel therapeutic strategies.", {"entities": [[33, 39, "GENE"], [44, 50, "GENE"]]}], ["Isodon rugosus is used in folk Pakistan traditional practices to cure ailments related to gastrointestinal, respiratory and cardiovascular problems.", {"entities": []}], ["Present study was undertaken to validate these folkloric uses.", {"entities": []}], ["A crude methanol extract of the aerial parts of Isodon rugosus (Ir.Cr.)", {"entities": []}], ["was used for both in vitro and in vivo experiments.", {"entities": []}], ["The plant extract was tested on isolated rabbit jejunum preparations for possible presence of spasmolytic activity.", {"entities": []}], ["Moreover, isolated rabbit tracheal and aorta preparations were used to ascertain the relaxant effects of the extract.", {"entities": []}], ["Acetylcholinesterase and butyrylcholinesterase inhibitory activities of Ir.Cr were also determined as well as its antioxidant activity.", {"entities": []}], ["The in vivo antiemetic activity of the extract was evaluated by using the chick emesis model, while the analgesic and antipyretic activities were conducted on albino mice.", {"entities": []}], ["The application of the crude extract of I. rugosus to isolated rabbit jejunum preparations exhibited relaxant effect (0.01-0.3\u00a0mg/ml).", {"entities": []}], ["The Ir.Cr also relaxed K M)- as well as K M)- and K The observed relaxant effect on isolated rabbit jejunum, trachea and aorta preparations caused by Ir.Cr is possibly to be mediated through Ca", {"entities": []}], ["L\u00fcneburg, Nicole, Patricia Siques, Julio Brito, Juan Jos\u00e9 De La Cruz, Fabiola Le\u00f3n-Velarde, Juliane Hannemann, Cristian Ibanez, and Rainer B\u00f6ger.", {"entities": []}], ["Long-term intermittent exposure to high altitude elevates asymmetric dimethylarginine in first exposed young adults.", {"entities": []}], ["High Alt Med Biol .", {"entities": []}], ["18:226\u2013233, 2017.\u2014Hypoxia-induced dysregulation of pulmonary and cerebral circulation may be related to an impaired nitric oxide (NO) pathway.", {"entities": []}], ["We investigated the effect of chronic intermittent hypobaric hypoxia (CIH) on metabolites of the NO pathway.", {"entities": []}], ["We measured asymmetric and symmetric dimethylarginine (ADMA and SDMA) and monomethyl-L-arginine (L-NMMA) and assessed their associations with acclimatization in male draftees ( n \u2009=\u200972) undergoing CIH shifts at altitude (3550\u2009m) during 3 months.", {"entities": []}], ["Sixteen Andean natives living at altitude (3675\u2009m) (chronic hypobaric hypoxia [CH]) were included for comparison.", {"entities": []}], ["In CIH, ADMA and L-NMMA plasma concentrations increased from 1.14\u2009\u00b1\u20090.04 to 1.95\u2009\u00b1\u20090.09\u2009\u03bcmol/L (mean\u2009\u00b1\u2009SE) and from 0.22\u2009\u00b1\u20090.07 to 0.39\u2009\u00b1\u20090.03\u2009\u03bcmol/L, respectively, ( p \u2009<\u20090.001 for both) after 3 months, whereas SDMA did not change.", {"entities": []}], ["The concentrations of ADMA and L-NMMA were higher in CH (3.48\u2009\u00b1\u20090.07, 0.53\u2009\u00b1\u20090.08\u2009\u03bcmol/L; p \u2009<\u20090.001) as compared with CIH.", {"entities": []}], ["In both CIH and CH, ADMA correlated with hematocrit ( r p \u2009<\u20090.05; r p \u2009<\u20090.01).", {"entities": []}], ["In CIH, an association of ADMA levels with poor acclimatization status was observed.", {"entities": []}], ["We conclude that the endogenous NO synthase inhibitors, ADMA and L-NMMA, are elevated in hypoxia.", {"entities": []}], ["This may contribute to impaired NO production at altitude and may also be predictive of altitude-associated health impairment.", {"entities": []}], ["This review summarizes the current literature for the prevalence and medical costs of noncommunicable chronic diseases among adult Medicaid beneficiaries to inform future program design.", {"entities": []}], ["The databases MEDLINE and CINAHL were searched in August 2016 using keywords, including Medicaid , health status , and healthcare cost , to identify original studies that were published during 2000\u20132016, examined Medicaid as an independent population group, examined prevalence or medical costs of chronic conditions, and included adults within the age group 18\u201364 years.", {"entities": []}], ["The review and data extraction was conducted in Fall 2016\u2013Spring 2017.", {"entities": []}], ["Disease-related costs (costs specifically to treat the disease) and total costs (all-cause medical costs for a patient with the disease) are presented separately.", {"entities": []}], ["Among the 29 studies selected, prevalence estimates for enrollees aged 18\u201364 years were 8.8%\u201311.8% for heart disease, 17.2%\u201327.4% for hypertension, 16.8%\u201323.2% for hyperlipidemia, 7.5%\u201312.7% for diabetes, 9.5% for cancer, 7.8%\u201319.3% for asthma, 5.0%\u201322.3% for depression, and 55.7%\u201362.1% for one or more chronic conditions.", {"entities": [[134, 146, "DISEASE"], [103, 116, "DISEASE"], [237, 243, "DISEASE"], [214, 220, "DISEASE"]]}], ["Estimated annual per patient disease-related costs (2015 U.S. dollars) were $3,219\u2013$4,674 for diabetes, $3,968\u2013$6,491 for chronic obstructive pulmonary disease, and $989\u2013$3,069 for asthma.", {"entities": [[122, 159, "DISEASE"], [181, 187, "DISEASE"]]}], ["Estimated hypertension-related costs were $687, but total costs per hypertensive beneficiary ranged much higher.", {"entities": [[10, 22, "DISEASE"]]}], ["Estimated total annual healthcare costs were $29,271\u2013$51,937 per beneficiary with heart failure and $11,446\u2013$20,585 per beneficiary with schizophrenia.", {"entities": [[137, 150, "DISEASE"]]}], ["Costs among beneficiaries with cancer were $29,384\u2013$46,194 for the 6 months following diagnosis.", {"entities": [[31, 37, "DISEASE"]]}], ["These findings could help inform the evaluation of interventions to prevent and manage noncommunicable chronic diseases and their potential to control costs among the vulnerable Medicaid population.", {"entities": []}], ["We conducted a systematic literature review to identify and critically evaluate studies of serious adverse health effects (SAHEs) in humans using nicotine replacement therapy (NRT) products.", {"entities": []}], ["Serious adverse health effects refer to adverse events, leading to substantial disruption of the ability to conduct normal life functions.", {"entities": []}], ["Strength of evidence evaluations and conclusions were also determined for the identified SAHEs.", {"entities": []}], ["We evaluated 34 epidemiological studies and clinical trials, relating NRT use to cancer, reproduction/development, CVD, stroke and/or other SAHEs in patients, and four meta-analyses on effects in healthy populations.", {"entities": [[81, 87, "DISEASE"]]}], ["The overall evidence suffers from many limitations, the most significant being the short-term exposure (\u226412\u00a0weeks) and follow-up to NRT product use in most of the studies, the common failure to account for changes in smoking behaviour following NRT use, and the sparse information on SAHEs by type of NRT product used.", {"entities": []}], ["The only SAHE from NRT exposure we identified was an increase in respiratory congenital abnormalities reported in one study.", {"entities": []}], ["Limited evidence indicated a lack of effect between NRT exposure and SAHEs for CVD and various reproduction/developmental endpoints.", {"entities": []}], ["For cancer, stroke and other SAHEs, the evidence was inadequate to demonstrate any association with NRT use.", {"entities": [[4, 10, "DISEASE"]]}], ["Our conclusions agree with recent statements from authoritative bodies.", {"entities": []}], ["The online version of this article (doi:10.1007/s00204-016-1856-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Ultraviolet radiation (UVR) has been associated with various health outcomes, including skin cancers, vitamin D insufficiency, and multiple sclerosis.", {"entities": [[131, 149, "DISEASE"]]}], ["Measurement of UVR has been difficult, traditionally relying on subject recall.", {"entities": []}], ["We investigated trends in satellite-derived UVB from 1978 to 2014 within the continental United States (US) to inform UVR exposure assessment and determine the potential magnitude of misclassification bias created by ignoring these trends.", {"entities": []}], ["Monthly UVB data remotely sensed from various NASA satellites were used to investigate changes over time in the United States using linear regression with a harmonic function.", {"entities": []}], ["Linear regression models for local geographic areas were used to make inferences across the entire study area using a global field significance test.", {"entities": []}], ["Temporal trends were investigated across all years and separately for each satellite type due to documented differences in UVB estimation.", {"entities": []}], ["UVB increased from 1978 to 2014 in 48% of local tests.", {"entities": []}], ["The largest UVB increase was found in Western Nevada (0.145 kJ/m", {"entities": []}], ["The number of people on antiretroviral therapy (ART) for the long-term management of HIV in low- and middle-income countries (LMICs) is continuing to increase, along with the prevalence of Non-Communicable Diseases (NCDs).", {"entities": []}], ["The need to provide large volumes of HIV patients with ART has led to significant adaptations in how medication is delivered, but access to NCD care remains limited in many contexts.", {"entities": []}], ["Medication Adherence Clubs (MACs) were established in Kibera, Kenya to address the large numbers of patients requiring chronic HIV and/or NCD care.", {"entities": []}], ["Stable NCD and HIV patients can now collect their chronic medication every three months through a club, rather than through individual clinic appointments.", {"entities": []}], ["We conducted a qualitative research study to assess patient and health-care worker perceptions and experiences of MACs in the urban informal settlement of Kibera, Kenya.", {"entities": []}], ["A total of 106 patients (with HIV and/or other NCDs) and health-care workers were purposively sampled and included in the study.", {"entities": []}], ["Ten focus groups and 19 in-depth interviews were conducted and 15 sessions of participant observation were carried out at the clinic where the MACs took place.", {"entities": []}], ["Thematic data analysis was conducted using NVivo software, and coding focussed on people\u2019s experiences of MACs, the challenges they faced and their perceptions about models of care for chronic conditions.", {"entities": []}], ["MACs were considered acceptable to patients and health-care workers because they saved time, prevented unnecessary queues in the clinic and provided people with health education and group support whilst they collected their medication.", {"entities": []}], ["Some patients and health-care workers felt that MACs reduced stigma for HIV positive patients by treating HIV as any other chronic condition.", {"entities": []}], ["Staff and patients reported challenges recruiting patients into MACs, including patients not fully understanding the eligibility criteria for the clubs.", {"entities": []}], ["There were also some practical challenges during the implementation of the clubs, but MACs have shown that it is possible to learn from ART provision and enable stable HIV and NCD patients to collect chronic medication together in a group.", {"entities": []}], ["Extending models of care previously only offered to HIV-positive cohorts to NCD patients can help to de-stigmatise HIV, allow for the efficient clinical management of co-morbidities and enable patients to benefit from peer support.", {"entities": []}], ["Through MACs, we have demonstrated that an integrated approach to providing medication for chronic diseases including HIV can be implemented in resource-poor settings and could thus be rolled out in other similar contexts.", {"entities": []}], ["Anoctamin1 (ANO1)/transmembrane protein 16A (TMEM16A), a calcium-activated chloride channel (CaCC), is involved in many physiological functions such as fluid secretion, smooth muscle contraction, nociception and cancer progression.", {"entities": [[212, 218, "DISEASE"], [12, 16, "GENE"]]}], ["To date, only a few ANO1 inhibitors have been described, and these have low potency and selectivity for ANO1.", {"entities": [[20, 24, "GENE"], [104, 108, "GENE"], [20, 24, "GENE"], [104, 108, "GENE"]]}], ["Here, we performed a high-throughput screening to identify highly potent and selective small molecule inhibitors of ANO1.", {"entities": [[116, 120, "GENE"]]}], ["Three novel ANO1 inhibitors were discovered from screening of 54,400 synthetic small molecules, and they were found to fully block ANO1 channel activity with an IC 50 < 3 \u03bcM.", {"entities": [[12, 16, "GENE"], [131, 135, "GENE"], [12, 16, "GENE"], [131, 135, "GENE"]]}], ["Electrophysiological analysis revealed that the most potent inhibitor, 2-(4-chloro-2-methylphenoxy)-N-[(2-methoxyphenyl)methylideneamino]-acetamide (Ani9), completely inhibited ANO1 chloride current with submicromolar potency.", {"entities": [[177, 181, "GENE"]]}], ["Notably, unlike previous small-molecule ANO1 inhibitors identified to date, Ani9 displayed high selectivity for ANO1 as compared to ANO2, which shares a high amino acid homology to ANO1.", {"entities": [[40, 44, "GENE"], [112, 116, "GENE"], [181, 185, "GENE"], [40, 44, "GENE"], [112, 116, "GENE"], [181, 185, "GENE"], [132, 136, "GENE"], [40, 44, "GENE"], [112, 116, "GENE"], [181, 185, "GENE"]]}], ["In addition, Ani9 did not affect the intracellular calcium signaling and CFTR chloride channel activity.", {"entities": [[73, 77, "GENE"]]}], ["Our results suggest that Ani9 may be a useful pharmacological tool for studying ANO1 and a potential development candidate for drug therapy of cancer, hypertension, pain, diarrhea and asthma.", {"entities": [[151, 163, "DISEASE"], [171, 179, "DISEASE"], [184, 190, "DISEASE"], [143, 149, "DISEASE"], [80, 84, "GENE"]]}], ["Case studies and anecdotal reports have documented a range of acute illnesses associated with exposure to cyanobacteria and their toxins in recreational waters.", {"entities": []}], ["The epidemiological data to date are limited; we sought to improve on the design of some previously conducted studies in order to facilitate revision and refinement of guidelines for exposure to cyanobacteria in recreational waters.", {"entities": []}], ["A prospective cohort study was conducted to investigate the incidence of acute symptoms in individuals exposed, through recreational activities, to low (cell surface area <2.4 mm Of individuals approached, 3,595 met the eligibility criteria, 3,193 (89%) agreed to participate and 1,331 (37%) completed both the questionnaire and follow-up interview.", {"entities": []}], ["Respiratory symptoms were 2.1 (95%CI: 1.1\u20134.0) times more likely to be reported by subjects exposed to high levels of cyanobacteria than by those exposed to low levels.", {"entities": []}], ["Similarly, when grouping all reported symptoms, individuals exposed to high levels of cyanobacteria were 1.7 (95%CI: 1.0\u20132.8) times more likely to report symptoms than their low-level cyanobacteria-exposed counterparts.", {"entities": []}], ["A significant increase in reporting of minor self-limiting symptoms, particularly respiratory symptoms, was associated with exposure to higher levels of cyanobacteria of mixed genera.", {"entities": []}], ["We suggest that exposure to cyanobacteria based on total cell surface area above 12 mm", {"entities": []}], ["We explored the burden of respiratory tract infections (RTIs) in young children with regard to day-care initiation.", {"entities": []}], ["Longitudinal prospective birth cohort study.", {"entities": []}], ["We recruited 1827 children for follow-up until the age of 24 months collecting diary data on RTIs and daycare.", {"entities": []}], ["Children with continuous daycare type and complete data were divided into groups of centre-based daycare (n=299), family day care (FDC) (n=245) and home care (n=350).", {"entities": []}], ["Using repeated measures variance analyses, we analysed days per month with symptoms of respiratory tract infection, antibiotic treatments and parental absence from work for a period of 6 months prior to and 9 months after the start of daycare.", {"entities": []}], ["We documented a significant effect of time and type of daycare, as well as a significant interaction between them for all outcome measures.", {"entities": []}], ["There was a rise in mean days with symptoms from 3.79 (95% CI 3.04 to 4.53) during the month preceding centre-based daycare to 10.57 (95% CI 9.35 to 11.79) at 2 months after the start of centre-based daycare, with a subsequent decrease within the following 9 months.", {"entities": []}], ["Similar patterns with a rise and decline were observed in the use of antibiotics and parental absences.", {"entities": []}], ["The start of FDC had weaker effects.", {"entities": []}], ["Our findings were not changed when taking into account confounding factors.", {"entities": []}], ["Our study shows the rapid increase in respiratory infections after start of daycare and a relatively fast decline in the course of time with continued daycare.", {"entities": []}], ["It is important to support families around the beginning of daycare.", {"entities": []}], ["Visual impairment is common in older people and the presence of additional health conditions can compromise health and rehabilitation outcomes.", {"entities": []}], ["A small number of studies have suggested that comorbities are common in visual impairment; however, those studies have relied on self-report and have assessed a relatively limited number of comorbid conditions.", {"entities": []}], ["We conducted a cross-sectional analysis of a dataset of 291,169 registered patients (65-years-old and over) within 314 primary care practices in Scotland, UK.", {"entities": []}], ["Visual impairment was identified using Read Code ever recorded for blindness and/or low vision (within electronic medical records).", {"entities": [[67, 76, "DISEASE"]]}], ["Prevalence, odds ratios (from prevalence rates standardised by stratifying individuals by age groups (65 to 69\u00a0years; 70 to 74; 75 to 79; 80 to 84; and 85 and over), gender and deprivation quintiles) and 95% confidence intervals (95% CI) of 37 individual chronic physical/mental health conditions and total number of conditions were calculated and compared for those with visual impairment to those without.", {"entities": []}], ["Twenty seven of the 29 physical health conditions and all eight mental health conditions were significantly more likely to be recorded for individuals with visual impairment compared to individuals without visual impairment, after standardising for age, gender and social deprivation.", {"entities": []}], ["Individuals with visual impairment were also significantly more likely to have more comorbidities (for example, five or more conditions (odds ratio (OR) 2.05 95% CI 1.94 to 2.18)).", {"entities": []}], ["Patients aged 65\u00a0years and older with visual impairment have a broad range of physical and mental health comorbidities compared to those of the same age without visual impairment, and are more likely to have multiple comorbidities.", {"entities": []}], ["This has important implications for clinical practice and for the future design of integrated services to meet the complex needs of patients with visual impairment, for example, embedding depression and hearing screening within eye care services.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-014-0181-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Edible Bird\u2019s Nest (EBN) as a popular traditional Chinese medicine is believed to have health enhancing and antiviral activities against influenza A virus (IAV); however, the molecular mechanism behind therapeutic effects of EBN is not well characterized.", {"entities": [[137, 146, "DISEASE"]]}], ["In this study, EBNs that underwent different enzymatic preparation were tested against IAV infected cells.", {"entities": []}], ["50% cytotoxic concentration (CC 50 ) and 50% inhibitory concentration (IC 50 ) of the EBNs against IAV strain A/Puerto Rico/8/1934(H1N1) were determined by HA and MTT assays.", {"entities": []}], ["Subsequently, the sialic acid content of the used EBNs were analyzed by fluorometric HPLC.", {"entities": []}], ["Western Blotting and immunofluorescent staining were used to investigate the effects of EBNs on early endosomal trafficking and autophagy process of influenza virus.", {"entities": [[149, 158, "DISEASE"]]}], ["This study showed that post inoculations of EBNs after enzymatic preparations have the highest efficacy to inhibit IAV.", {"entities": []}], ["While CC50 of the tested EBNs ranged from 27.5\u201332\u00a0mg/ml, the IC50 of these compounds ranged between 2.5\u20134.9\u00a0mg/ml.", {"entities": []}], ["EBNs could inhibit IAV as efficient as commercial antiviral agents, such as amantadine and oseltamivir with different mechanisms of action against IAV.", {"entities": []}], ["The antiviral activity of these EBNs correlated with the content of N -acetyl neuraminic acid.", {"entities": []}], ["EBNs could affect early endosomal trafficking of the virus by reducing Rab5 and RhoA GTPase proteins and also reoriented actin cytoskeleton of IAV infected cells.", {"entities": [[80, 84, "GENE"]]}], ["In addition, for the first time this study showed that EBNs can inhibit intracellular autophagy process of IAV life cycle as evidenced by reduction of LC3-II and increasing of lysosomal degradation.", {"entities": []}], ["The results procured in this study support the potential of EBNs as supplementary medication or alternative to antiviral agents to inhibit influenza infections.", {"entities": [[139, 148, "DISEASE"]]}], ["Evidently, EBNs can be a promising antiviral agent; however, these natural compounds should be screened for their metabolites prior to usage as therapeutic approach.", {"entities": []}], ["Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis which has multiple effects in lung development and physiology.", {"entities": []}], ["VEGF is expressed in several parts of the lung and the pleura while it has been shown that changes in its expression play a significant role in the pathophysiology of some of the most common respiratory disorders, such as acute lung injury, asthma, chronic obstructive pulmonary disease, obstructive sleep apnea, idiopathic pulmonary fibrosis, pulmonary hypertension, pleural disease, and lung cancer.", {"entities": [[354, 366, "DISEASE"], [389, 400, "DISEASE"], [249, 286, "DISEASE"], [368, 383, "DISEASE"], [344, 366, "DISEASE"], [324, 342, "DISEASE"], [241, 247, "DISEASE"], [313, 342, "DISEASE"], [394, 400, "DISEASE"]]}], ["However, the exact role of VEGF in the lung is not clear yet, as there is contradictory evidence that suggests either a protective or a harmful role.", {"entities": []}], ["VEGF seems to interfere in a different manner, depending on its amount, the location, and the underlying pathologic process in lung tissue.", {"entities": []}], ["The lack of VEGF in some disease entities may provide implications for its substitution, whereas its overexpression in other lung disorders has led to interventions for the attenuation of its action.", {"entities": []}], ["Many efforts have been made in order to regulate the expression of VEGF and anti-VEGF antibodies are already in use for the management of lung cancer.", {"entities": [[138, 149, "DISEASE"], [143, 149, "DISEASE"]]}], ["Further research is still needed for the complete understanding of the exact role of VEGF in health and disease, in order to take advantage of its benefits and avoid its adverse effects.", {"entities": []}], ["The scope of the present review is to summarize from a clinical point of view the changes in VEGF expression in several disorders of the respiratory system and focus on its diagnostic and therapeutic implications.", {"entities": []}], ["This paper provides an overview of the Korean Burden of Disease (KBoD) study, which was the first such study to assess the national burden of disease using disability-adjusted life years (DALYs) in an advanced Asian country.", {"entities": []}], ["The KBoD study generally followed the approach utilized in the original Global Burden of Disease study (GBD), with the exception of the disease classification and epidemiological data estimation methods used, and the relative weightings of disabilities.", {"entities": []}], ["The results of the present study reveal that the burden of disease per 100,000 of the Korean population originates primarily from; cancer (1,525 Person Years, PYs), cardiovascular disease (1,492 PYs), digestive disease (1,140 PYs), diabetes mellitus (990 PYs), and certain neuro-psychiatric conditions (883 PYs).", {"entities": [[131, 137, "DISEASE"], [232, 249, "DISEASE"]]}], ["These results are largely consistent with those of developed countries, but also represent uniquely Korean characteristics.", {"entities": []}], ["The UK government recommends that at least 75% of people aged under 64 with certain conditions receive an annual influenza vaccination.", {"entities": [[113, 122, "DISEASE"]]}], ["Primary care practices often fall short of this target and strategies to increase vaccine uptake are required.", {"entities": []}], ["Text messaging reminders are already used in 30% of practices to remind patients about vaccination, but there has been no trial addressing their effectiveness in increasing influenza vaccine uptake in the UK.", {"entities": [[173, 182, "DISEASE"]]}], ["The aims of the study are (1) to develop the methodology for conducting cluster randomised trials of text messaging interventions utilising routine electronic health records and (2) to assess the effectiveness of using a text messaging influenza vaccine reminder in achieving an increase in influenza vaccine uptake in patients aged 18\u201364 with chronic conditions, compared with standard care.", {"entities": [[236, 245, "DISEASE"], [291, 300, "DISEASE"]]}], ["This cluster randomised trial will recruit general practices across three settings in English primary care (Clinical Practice Research Datalink, ResearchOne and London iPLATO text messaging software users) and randomise them to either standard care or a text messaging campaign to eligible patients.", {"entities": []}], ["Flu vaccine uptake will be ascertained using routinely collected, anonymised electronic patient records.", {"entities": []}], ["This protocol outlines the proposed study design and analysis methods.", {"entities": []}], ["This study will determine the effectiveness of text messaging vaccine reminders in primary care in increasing influenza vaccine uptake, and will strengthen the methodology for using electronic health records in cluster randomised trials of text messaging interventions.", {"entities": [[110, 119, "DISEASE"]]}], ["This trial was approved by the Surrey Borders Ethics Committee (13/LO/0872).", {"entities": []}], ["The trial results will be disseminated at national conferences and published in a peer-reviewed medical journal.", {"entities": []}], ["The results will also be distributed to the Primary Care Research Network and to all participating general practices.", {"entities": []}], ["This study is registered at controlled-trials.com ISRCTN48840025, July 2013.", {"entities": []}], ["Patients with RA (Rheumatoid Arthritis) are more sedentary than the general population.", {"entities": []}], ["Reduction of Sedentary Behaviour (SB) has been suggested as a mean for improvement of health in patients with chronic diseases and mobility problems.", {"entities": []}], ["Short-term intervention studies have demonstrated that SB can be reduced by behavioural interventions in healthy populations.", {"entities": []}], ["However, it remains unexplored whether it is valid for patients with RA also.", {"entities": []}], ["Therefore, the aim of this trial is to investigate the efficacy of an individually tailored, theory-based motivational counseling intervention on reducing daily sitting time in sedentary patients with RA.", {"entities": []}], ["Additionally, to explore whether a reduction in daily sitting time is associated with reduced pain and fatigue, self-reported physical function, self-efficacy, improved health-related quality of life (HR-QoL) and cardiovascular biomarker levels, and finally to assess the cost-effectiveness of the intervention.", {"entities": []}], ["For this parallel group randomized trial, 150 patients with RA and at least 5 hours of sitting time per day, will be recruited from a rheumatology outpatient clinic, and block-randomized to the intervention group or the control group receiving usual care.", {"entities": []}], ["The intervention includes: 1) individual motivational counseling (in total 3 sessions) on reduction of daily sitting time in combination with 2) individual Short Text Message Service (SMS) reminders over a 16-week intervention period.", {"entities": [[184, 187, "GENE"]]}], ["Primary outcome is change in daily sitting time (minutes) from baseline to 16 weeks measured objectively using an ActivPAL\u00ae Activity Monitor.", {"entities": []}], ["Secondary outcomes include fatigue, pain, physical function, HR-QoL, self-efficacy, costs and cost-effectiveness.", {"entities": []}], ["Furthermore, anthropometric measures will be included as well as measurement of blood pressure and serum lipids.", {"entities": []}], ["All outcomes are assessed at baseline and repeated after 16 weeks.", {"entities": []}], ["Follow-up assessments are made at 6 and 18 months post-intervention.", {"entities": []}], ["The intervention is simple, non-invasive and may be implemented at low costs.", {"entities": []}], ["If the study confirms the positive results expected, the intervention might be implemented in clinical practice and potentially transferred to other clinical populations.", {"entities": []}], ["ClinicalTrial.gov registration number: NCT01969604 .", {"entities": []}], ["Date of registration: 17 October 2013.", {"entities": []}], ["The \u2018never event\u2019 concept has been implemented in many acute hospital settings to help prevent serious patient safety incidents.", {"entities": []}], ["Benefits include increasing awareness of highly important patient safety risks among the healthcare workforce, promoting proactive implementation of preventive measures, and facilitating incident reporting.", {"entities": []}], ["To develop a preliminary list of never events for general practice.", {"entities": []}], ["Application of a range of consensus-building methods in Scottish and UK general practices.", {"entities": []}], ["A total of 345 general practice team members suggested potential never events.", {"entities": []}], ["Next, \u2018informed\u2019 staff ( n =15) developed criteria for defining never events and applied the criteria to create a list of candidate never events.", {"entities": []}], ["Finally, UK primary care patient safety \u2018experts\u2019 ( n = 17) reviewed, refined, and validated a preliminary list via a modified Delphi group and by completing a content validity index exercise.", {"entities": []}], ["There were 721 written suggestions received as potential never events.", {"entities": []}], ["Thematic categorisation reduced this to 38.", {"entities": []}], ["Five criteria specific to general practice were developed and applied to produce 11 candidate never events.", {"entities": []}], ["The expert group endorsed a preliminary list of 10 items with a content validity index (CVI) score of >80%.", {"entities": []}], ["A preliminary list of never events was developed for general practice through practitioner experience and consensus-building methods.", {"entities": []}], ["This is an important first step to determine the potential value of the never event concept in this setting.", {"entities": []}], ["It is now intended to undertake further testing of this preliminary list to assess its acceptability, feasibility, and potential usefulness as a safety improvement intervention.", {"entities": []}], ["Recent reviews on placebo effects in clinical trials suggest that objective changes following placebo treatments may not exist or, at least, have been considerably overestimated.", {"entities": []}], ["However, the possibility that yet unidentified subsets of parameters are responsive to placebo treatments has not been taken into account.", {"entities": []}], ["Therefore, the aim of the present study is to examine the effects of placebo treatments on objectively measured outcome parameters by specifically focusing on peripheral disease processes.", {"entities": []}], ["An initial dataset was collected from a MEDLINE search for placebo-controlled, randomized clinical trials.", {"entities": []}], ["Trials with stable disease conditions were identified, and the effects of placebo treatments on peripheral outcome parameters were estimated by the changes from baseline in the placebo groups.", {"entities": []}], ["An explorative data analysis was conducted in order to identify parameter classes with differential responsiveness to placebo treatments.", {"entities": []}], ["A subgroup meta-analysis of a second dataset was performed to test whether the preliminary classification would also apply to placebo effects derived from the comparison of placebo groups with untreated control groups.", {"entities": []}], ["The explorative analysis of outcome parameters and strength of placebo effects yielded a classification into responsive \"physical\" versus non-responsive \"biochemical\" parameters.", {"entities": []}], ["In total, 50% of trials measuring physical parameters showed significant placebo effects, compared with 6% of trials measuring biochemical parameters.", {"entities": []}], ["A subgroup meta-analysis substantiated the differential response (physical parameters: n = 14, Hedges' pooled effect size g = 0.34, 95% CI 0.22 to 0.46; biochemical parameters: n = 15, g = 0.03, 95% CI -0.04 to 0.10).", {"entities": []}], ["The subanalysis of the second dataset supported the classification and revealed a significant improvement for physical parameters ( n = 20, g = 0.22, 95% CI 0.07 to 0.36) and a deterioration for biochemical parameters ( n = 6, g = -0.17, 95% CI -0.31 to -0.02).", {"entities": []}], ["The results suggest that placebo interventions can improve physical disease processes of peripheral organs more easily and effectively than biochemical processes.", {"entities": []}], ["This differential response offers a good starting point for theoretical considerations on possible mediating mechanisms, and for future investigations in this field.", {"entities": []}], ["A previous Phase IIIb study (NCT01462929) in patients with moderate to severe COPD demonstrated that 6 weeks of treatment with aclidinium led to improvements in 24-hour bronchodilation comparable to those with tiotropium, and improvement of symptoms versus placebo.", {"entities": []}], ["This post hoc analysis was performed to assess the effect of treatment in the symptomatic patient group participating in the study.", {"entities": []}], ["Symptomatic patients (defined as those with Evaluating Respiratory Symptoms [E-RS\u2122] in COPD baseline score \u226510 units) received aclidinium bromide 400 \u03bcg twice daily (BID), tiotropium 18 \u03bcg once daily (QD), or placebo, for 6 weeks.", {"entities": []}], ["Lung function, COPD respiratory symptoms, and incidence of adverse events (AEs) were assessed.", {"entities": []}], ["In all, 277 symptomatic patients were included in this post hoc analysis.", {"entities": []}], ["Aclidinium and tiotropium treatment improved forced expiratory volume in 1 second (FEV 1 ) from baseline to week 6 at all time points over 24 hours versus placebo.", {"entities": [[83, 86, "GENE"]]}], ["In addition, improvements in FEV 1 from baseline during the nighttime period were observed for aclidinium versus tiotropium on day 1 (aclidinium 157 mL, tiotropium 67 mL; P <0.001) and week 6 (aclidinium 153 mL, tiotropium 90 mL; P <0.05).", {"entities": [[29, 32, "GENE"]]}], ["Aclidinium improved trough FEV 1 from baseline versus placebo and tiotropium at day 1 (aclidinium 136 mL, tiotropium 68 mL; P <0.05) and week 6 (aclidinium 137 mL, tiotropium 71 mL; P <0.05).", {"entities": [[27, 30, "GENE"]]}], ["Aclidinium also improved early-morning and nighttime symptom severity, limitation of early-morning activities, and E-RS Total and domain scores versus tiotropium (except E-RS Chest Symptoms) and placebo over 6 weeks.", {"entities": []}], ["Tolerability showed similar incidence of AEs in each arm.", {"entities": []}], ["In this post hoc analysis of symptomatic patients with moderate to severe COPD, aclidinium 400 \u03bcg BID provided additional improvements compared with tiotropium 18 \u03bcg QD in: 1) bronchodilation, particularly during the nighttime, 2) daily COPD symptoms (E-RS), 3) early-morning and nighttime symptoms, and 4) early-morning limitation of activity.", {"entities": []}], ["Organophosphorous (OP) Nerve agents (NAs) are known as the deadliest chemical warfare agents.", {"entities": []}], ["They are divided into two classes of G and V agents.", {"entities": []}], ["Most of them are liquid at room temperature.", {"entities": []}], ["NAs chemical structures and mechanisms of actions are similar to OP pesticides, but their toxicities are higher than these compounds.", {"entities": []}], ["The main mechanism of action is irreversible inhibition of Acetyl Choline Esterase (AChE) resulting in accumulation of toxic levels of acetylcholine (ACh) at the synaptic junctions and thus induces muscarinic and nicotinic receptors stimulation.", {"entities": []}], ["However, other mechanisms have recently been described.", {"entities": []}], ["Central nervous system (CNS) depression particularly on respiratory and vasomotor centers may induce respiratory failure and cardiac arrest.", {"entities": [[101, 120, "DISEASE"]]}], ["Intermediate syndrome after NAs exposure is less common than OP pesticides poisoning.", {"entities": [[13, 21, "DISEASE"]]}], ["There are four approaches to detect exposure to NAs in biological samples: (I) AChE activity measurement, (II) Determination of hydrolysis products in plasma and urine, (III) Fluoride reactivation of phosphylated binding sites and (IV) Mass spectrometric determination of cholinesterase adducts.", {"entities": []}], ["The clinical manifestations are similar to OP pesticides poisoning, but with more severity and fatalities.", {"entities": []}], ["The management should be started as soon as possible.", {"entities": []}], ["The victims should immediately be removed from the field and treatment is commenced with auto-injector antidotes (atropine and oximes) such as MARK I kit.", {"entities": []}], ["A 0.5% hypochlorite solution as well as novel products like M291 Resin kit, G117H and Phosphotriesterase isolated from soil bacterias, are now available for decontamination of NAs.", {"entities": []}], ["Atropine and oximes are the well known antidotes that should be infused as clinically indicated.", {"entities": []}], ["However, some new adjuvant and additional treatment such as magnesium sulfate, sodium bicarbonate, gacyclidine, benactyzine, tezampanel, hemoperfusion, antioxidants and bioscavengers have recently been used for OP NAs poisoning.", {"entities": []}], ["Cytokines such as interleukin 1 (IL-1) promote adhesiveness in human umbilical vein endothelial cells for leukocytes including basophils, eosinophils, and neutrophils, and induce expression of adherence molecules including ICAM-1 (intercellular adhesion molecule-1), ELAM-1 (endothelial-leukocyte adhesion molecule-1), and VCAM-1 (vascular cell adhesion molecule-1).", {"entities": []}], ["In the present study, blocking monoclonal antibodies (mAb) recognizing ICAM-1, ELAM-1, and VCAM-1 have been used to compare their roles in IL-1-induced adhesion of human basophils, eosinophils, and neutrophils.", {"entities": []}], ["IL-1 treatment of endothelial cell monolayers for 4 hours induced a four- to eight-fold increase in adhesion for each cell type.", {"entities": []}], ["Treatment of endothelial cells with either anti-ICAM-1 or anti-ELAM-1 mAb inhibited IL-1-induced adherence of each cell type.", {"entities": []}], ["In contrast, treatment with anti-VCAM-1 mAb inhibited basophil and eosinophil (but not neutrophil) adhesion, and was especially effective in blocking eosinophil adhesion.", {"entities": []}], ["The effects of these mAb were at least additive.", {"entities": []}], ["Indirect immunofluorescence and flow cytometry demonstrated expression of VLA-4 alpha (very late activation antigen-4 alpha, a counter-receptor for VCAM-1) on eosinophils and basophils but not on neutrophils.", {"entities": []}], ["These data document distinct roles for ICAM-1, ELAM-1, and VCAM-1 during basophil, eosinophil, and neutrophil adhesion in vitro, and suggest a novel mechanism for the recruitment of eosinophils and basophils to sites of inflammation in vivo.", {"entities": []}], ["To determine the prevalence of potentially inappropriate prescribing (PIP) in a cohort of community-dwelling middle-aged people and assess the relationship between PIP and emergency department (ED) visits, general practitioner (GP) visits and quality of life (QoL).", {"entities": []}], ["Prospective cohort study.", {"entities": []}], ["The Irish Longitudinal Study on Ageing (TILDA), a nationally representative cohort study of ageing.", {"entities": []}], ["Individuals aged 45\u201364 years recruited to TILDA who were eligible for the means-tested General Medical Services scheme and followed up after 2\u2009years.", {"entities": []}], ["PIP was determined in the 12 months preceding baseline and follow-up TILDA data collection by applying the PRescribing Optimally in Middle-aged People\u2019s Treatments (PROMPT) criteria to participants\u2019 medication dispensing data.", {"entities": []}], ["At follow-up, the reported rates of ED and GP visits over 12 months (primary outcome) and the CASP-R12 (Control Autonomy Self-realisation Pleasure) measure of QoL (secondary outcome).", {"entities": []}], ["Multivariate negative binomial (rates) and linear regression (CASP-R12) models controlling for potential confounders.", {"entities": []}], ["At 2-year follow-up (n=808), PIP was detected in 42.9% by the PROMPT criteria.", {"entities": []}], ["An ED visit was reported by 18.7% and 94.4% visited a GP (median 4 visits, IQR 2\u20136).", {"entities": []}], ["Exposure to \u22652\u2009PROMPT criteria was associated with higher rates of healthcare utilisation and lower QoL in unadjusted regression.", {"entities": []}], ["However, in multivariate analysis, the associations between PIP and rates of ED visits (adjusted incidence rate ratio (IRR) 0.92, 95% CI 0.53 to 1.58), and GP visits (IRR 1.06, 95%\u2009CI 0.87 to 1.28), and CASP-R12 score (adjusted \u03b2 coefficient 0.35, 95%\u2009CI \u22120.93 to 1.64) were not statistically significant.", {"entities": []}], ["Numbers of medicines and comorbidities were associated with higher healthcare utilisation.", {"entities": []}], ["Although PIP was prevalent in this study population, there was no evidence of a relationship with ED and GP visits and QoL.", {"entities": []}], ["Further research should evaluate whether the PROMPT criteria are related to these and other adverse outcomes in the general middle-aged population.", {"entities": []}], ["Coxsackievirus A16 (CVA16) and enterovirus 71 (EV71) are two of the major causes of hand, foot and mouth disease (HFMD) world-wide.", {"entities": [[84, 112, "DISEASE"], [99, 112, "DISEASE"]]}], ["Although many studies have focused on infection and pathogenic mechanisms, the transcriptome profile of the host cell upon CVA16 infection is still largely unknown.", {"entities": []}], ["In this study, we compared the mRNA and miRNA expression profiles of human embryonic kidney 293T cells infected and non-infected with CVA16.", {"entities": []}], ["We highlighted that the transcription of SCARB2 , a cellular receptor for both CVA16 and EV71, was up-regulated by nearly 10-fold in infected cells compared to non-infected cells.", {"entities": [[41, 47, "GENE"]]}], ["The up-regulation of SCARB2 transcription induced by CVA16 may increase the possibility of subsequent infection of CVA16/EV71, resulting in the co-infection with two viruses in a single cell.", {"entities": [[21, 27, "GENE"]]}], ["This explanation would partly account for the co-circulation and genetic recombination of a great number of EV71 and CVA16 viruses.", {"entities": []}], ["Based on correlation analysis of miRNAs and genes, we speculated that the high expression of SCARB2 is modulated by down-regulation of miRNA has-miR-3605-5p.", {"entities": [[93, 99, "GENE"]]}], ["At the same time, we found that differentially expressed miRNA target genes were mainly reflected in the extracellular membrane (ECM)-receptor interaction and circadian rhythm pathways, which may be related to clinical symptoms of patients infected with CVA16, such as aphthous ulcers, cough, myocarditis, somnolence and potentially meningoencephalitis.", {"entities": [[333, 352, "DISEASE"], [293, 304, "DISEASE"]]}], ["The miRNAs hsa-miR-149-3p and hsa-miR-5001-5p may result in up-regulation of genes in these morbigenous pathways related to CVA16 and further cause clinical symptoms.", {"entities": []}], ["The present study elucidated the changes in 293T cells upon CVA16 infection at transcriptome level, containing highly up-regulated SCARB2 and genes in ECM-receptor interaction and circadian rhythm pathways, and key miRNAs in gene expression regulation.", {"entities": [[131, 137, "GENE"]]}], ["These results provided novel insight into the pathogenesis of HFMD induced by CVA16 infection.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-3253-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Profiling amino acids and acylcarnitines in whole blood spots is a powerful tool in the laboratory diagnosis of several inborn errors of metabolism.", {"entities": []}], ["Emerging data suggests that altered blood levels of amino acids and acylcarnitines are also associated with common metabolic diseases in adults.", {"entities": []}], ["Thus, the identification of common genetic determinants for blood metabolites might shed light on pathways contributing to human physiology and common diseases.", {"entities": []}], ["We applied a targeted mass-spectrometry-based method to analyze whole blood concentrations of 96 amino acids, acylcarnitines and pathway associated metabolite ratios in a Central European cohort of 2,107 adults and performed genome-wide association (GWA) to identify genetic modifiers of metabolite concentrations.", {"entities": []}], ["We discovered and replicated six novel loci associated with blood levels of total acylcarnitine, arginine (both on chromosome 6; rs12210538, rs17657775), propionylcarnitine (chromosome 10; rs12779637), 2-hydroxyisovalerylcarnitine (chromosome 21; rs1571700), stearoylcarnitine (chromosome 1; rs3811444), and aspartic acid traits (chromosome 8; rs750472).", {"entities": []}], ["Based on an integrative analysis of expression quantitative trait loci in blood mononuclear cells and correlations between gene expressions and metabolite levels, we provide evidence for putative causative genes: SLC22A16 for total acylcarnitines, ARG1 for arginine, HLCS for 2-hydroxyisovalerylcarnitine, JAM3 for stearoylcarnitine via a trans-effect at chromosome 1, and PPP1R16A for aspartic acid traits.", {"entities": [[213, 221, "GENE"], [248, 252, "GENE"], [267, 271, "GENE"], [306, 310, "GENE"], [373, 381, "GENE"]]}], ["Further, we report replication and provide additional functional evidence for ten loci that have previously been published for metabolites measured in plasma, serum or urine.", {"entities": []}], ["In conclusion, our integrative analysis of SNP, gene-expression and metabolite data points to novel genetic factors that may be involved in the regulation of human metabolism.", {"entities": []}], ["At several loci, we provide evidence for metabolite regulation via gene-expression and observed overlaps with GWAS loci for common diseases.", {"entities": []}], ["These results form a strong rationale for subsequent functional and disease-related studies.", {"entities": []}], ["Human metabolite levels differ between individuals due to environmental and genetic factors.", {"entities": []}], ["In the present work, we analyzed whole blood levels of amino acids and acylcarnitines, reflecting disease relevant metabolic pathways, in a cohort of 2,107 individuals.", {"entities": []}], ["We then performed a genome wide association analysis to discover genetic variants influencing metabolism.", {"entities": []}], ["Thereby, we discovered six novel regions in the genome and confirmed ten regions previously found to be associated with metabolites in plasma, serum or urine.", {"entities": []}], ["Subsequently, we analyzed whether these variants regulate gene-expression in peripheral mononuclear cells and at several loci we identified novel causal relations between SNPs, gene-expression and metabolite levels.", {"entities": []}], ["These findings help explaining the functional mechanisms by which associated genetic variants regulate metabolism.", {"entities": []}], ["Finally, several SNPs associated with blood metabolites in our study overlap with previously identified loci for human diseases (e.g.", {"entities": []}], ["kidney disease), suggesting a shared genetic basis or pathomechanisms involving metabolic alterations.", {"entities": [[0, 14, "DISEASE"]]}], ["The identified loci are strong candidates for future functional studies directed to understand human metabolism and pathogenesis of related diseases.", {"entities": []}], ["Mesenchymal stem cells (MSCs) derived from bone marrow are plural-potent stem cells with immune regulatory functions.", {"entities": []}], ["We aimed to evaluate role of Fc\u03b3RIIB in the regulation of bone marrow-derived MSC function.", {"entities": [[78, 81, "GENE"]]}], ["MSCs were prepared from mouse bone marrow derived from wild-type (WT) or Fc\u03b3RIIB-deficient (Fc\u03b3RIIB-/-) mice.", {"entities": []}], ["MSCs were co-cultured with bone marrow-derived dendritic cells (BMDCs), and BMDC maturation and function were evaluated by flow cytometric analysis and carboxyfluorescein succinimidyl ester-labeled OT-II T-cell addition.", {"entities": []}], ["An acute asthma model was established by aeresol ovalbumin challenge in mice.", {"entities": [[9, 15, "DISEASE"]]}], ["Mice received WT or Fc\u03b3RIIB-/- MSC therapy.", {"entities": [[31, 34, "GENE"]]}], ["Lung function was evaluated by histological examination and cytokine production measurement.", {"entities": []}], ["mRNA and protein expression levels of target genes were examined by real-time quantitative polymerase chain reactionor western blotting.", {"entities": []}], ["We found that MSCs derived from bone marrow exhibit a high level of Fc\u03b3RIIB expression.", {"entities": []}], ["Fc\u03b3RIIB deficiency impaired the suppressive function of MSCs, as Fc\u03b3RIIB deficiency efficiently reversed the inhibitory effect of MSCs on BMDC maturation and function.", {"entities": []}], ["Additionally, Fc\u03b3RIIB-/-MSCs were less potent at suppressing asthma in model mice, possibly through reduced expression of Smad2, Smad3, Cox-2, and prostaglandin E2 in Fc\u03b3RIIB-/-MSCs.", {"entities": [[61, 67, "DISEASE"], [122, 127, "GENE"], [129, 134, "GENE"]]}], ["Fc\u03b3RIIB might play an essential role in regulating the inhibitory effects of MSCs derived from bone marrow.", {"entities": []}], ["The specific targeting of interleukin-4 receptor \u03b1 (IL4R\u03b1) receptor offers a promising therapeutic approach for inhibition of tumor cell progression in breast cancer patients.", {"entities": [[152, 165, "DISEASE"], [159, 165, "DISEASE"]]}], ["In the current study, the in vitro efficacy of superparamagnetic iron oxide nanoparticles conjugated with anti-IL4R\u03b1 blocking antibodies (SPION-IL4R\u03b1) via polyethylene glycol polymers was evaluated in 4T1 breast cancer cells.", {"entities": [[205, 218, "DISEASE"], [212, 218, "DISEASE"]]}], ["Cell viability, reactive oxygen species generation, and apoptosis frequency were assessed in vitro in 4T1 cancer cell lines following exposure to SPION-IL4R\u03b1 alone or combined with doxorubicin.", {"entities": [[106, 112, "DISEASE"]]}], ["In addition, immunofluorescence assessments and fluorimetrywere performed to confirm the specific targeting and interaction of the developed nanocarriers with IL4R\u03b1 receptors in breast cancer cells.", {"entities": [[178, 191, "DISEASE"], [185, 191, "DISEASE"]]}], ["Blocking of IL4R\u03b1 receptors caused a significant decrease in cell viability and induced apoptosis in 4T1 cells.", {"entities": []}], ["In addition, combined treatment with SPION-IL4R\u03b1+doxorubicin caused significant increases in cell death, apoptosis, and oxidative stress compared to either SPION-IL4R\u03b1 or doxorubicin alone, indicating the enhanced therapeutic efficacy of this combination.", {"entities": []}], ["The decrease in fluorescence intensity upon immunofluorescence and fluorimetry assays combined with increased viability and decreased apoptosis following the blocking of IL4R\u03b1 receptors confirmed the successful binding of the synthesized nanocarriers to the target sites on murine 4T1 breast cancerous cells.", {"entities": []}], ["These results suggest that SPION-IL4R\u03b1 nanocarriers might be used for successfulreduction of tumor growth and inhibition of progression of metastasis in vivo .", {"entities": []}], ["This study was undertaken to evaluate the incidence and risk factors associated with relative adrenal insufficiency (RAI) in Korean critically-ill patients.", {"entities": []}], ["All patients who were admitted to the Medical Intensive Care Unit (MICU) of Samsung Medical Center between January 1, 2006 and April 30, 2007 were prospectively evaluated using a short corticotropin stimulation test on the day of admission.", {"entities": []}], ["RAI was defined as an increase in the serum cortisol level of <9 \u00b5g/dL from the baseline after administration of 250 \u00b5g of corticotropin.", {"entities": []}], ["In all, 123 patients were recruited and overall the incidence of RAI was 44% (54/123).", {"entities": []}], ["The presence of septic shock ( P =0.001), the Simplified Acute Physiology Score (SAPS) II ( P =0.003), the Sequential Organ Failure Assessment (SOFA) score ( P =0.001), the mean heart rate ( P =0.040), lactate levels ( P =0.001), arterial pH ( P =0.047), treatment with vasopressors at ICU admission ( P =0.004), and the 28-day mortality ( P =0.041) were significantly different between patients with and without RAI.", {"entities": []}], ["The multivariate analysis showed that the SOFA score was an independent predictor of RAI in critically-ill patients (odd ratio=1.235, P =0.032).", {"entities": []}], ["Our data suggest that RAI is frequently found in Korean critically-ill patients and that a high SOFA score is an independent predictor of RAI in these patients.", {"entities": []}], ["Residents of the dense urban core neighborhoods of New York City (NYC) have expressed increasing concern about the potential human health impacts of diesel vehicle emissions.", {"entities": []}], ["We measured concentrations of particulate matter [less than/equal to] 2.5 micro in aerodynamic diameter (PM(2.5)) and diesel exhaust particles (DEP) on sidewalks in Harlem, NYC, and tested whether spatial variations in concentrations were related to local diesel traffic density.", {"entities": []}], ["Eight-hour (1000-1800 hr) air samples for PM(2.5 )and elemental carbon (EC) were collected for 5 days in July 1996 on sidewalks adjacent to four geographically distinct Harlem intersections.", {"entities": [[22, 24, "GENE"]]}], ["Samples were taken using portable monitors worn by study staff.", {"entities": []}], ["Simultaneous traffic counts for diesel trucks, buses, cars, and pedestrians were carried out at each intersection on [Greater/equal to] 2 of the 5 sampling days.", {"entities": [[54, 58, "GENE"]]}], ["Eight-hour diesel vehicle counts ranged from 61 to 2,467 across the four sites.", {"entities": []}], ["Mean concentrations of PM(2.5) exhibited only modest site-to-site variation (37-47 microg/m(3)), reflecting the importance of broader regional sources of PM(2.5).", {"entities": []}], ["In contrast, EC concentrations varied 4-fold across sites (from 1.5 to 6 microg/m(3)), and were associated with bus and truck counts on adjacent streets and, at one site, with the presence of a bus depot.", {"entities": []}], ["A high correlation (r = 0.95) was observed between EC concentrations measured analytically and a blackness measurement based on PM(2.5) filter reflectance, suggesting the utility of the latter as a surrogate measure of DEP in future community-based studies.", {"entities": []}], ["These results show that local diesel sources in Harlem create spatial variations in sidewalk concentrations of DEP.", {"entities": []}], ["The study also demonstrates the feasibility of a new paradigm for community-based research involving full and active partnership between academic scientists and community-based organizations.", {"entities": []}], ["The aim of this study was to analyse whether patients with occupational asthma (OA) caused by low molecular weight (LMW) agents differed from patients with OA caused by high molecular weight (HMW) with regard to risk factors, asthma presentation and severity, and response to various diagnostic tests.", {"entities": [[72, 78, "DISEASE"], [226, 232, "DISEASE"]]}], ["Seventy-eight patients with OA diagnosed by positive specific inhalation challenge (SIC) were included.", {"entities": []}], ["Anthropometric characteristics, atopic status, occupation, latency periods, asthma severity according to the Global Initiative for Asthma (GINA) control classification, lung function tests and SIC results were analysed.", {"entities": [[76, 82, "DISEASE"], [131, 137, "DISEASE"]]}], ["OA was induced by an HMW agent in 23 patients (29%) and by an LMW agent in 55 (71%).", {"entities": []}], ["A logistic regression analysis confirmed that patients with OA caused by LMW agents had a significantly higher risk of severity according to the GINA classification after adjusting for potential confounders (OR = 3.579, 95% CI 1.136\u201311.280; p = 0.029).", {"entities": []}], ["During the SIC, most patients with OA caused by HMW agents presented an early reaction (82%), while in patients with OA caused by LMW agents the response was mainly late (73%) (p = 0.0001).", {"entities": []}], ["Similarly, patients with OA caused by LMW agents experienced a greater degree of bronchial hyperresponsiveness, measured as the difference in the methacholine dose-response ratio (DRR) before and after SIC (1.77, range 0\u201316), compared with patients with OA caused by HMW agents (0.87, range 0\u201372), (p = 0.024).", {"entities": []}], ["OA caused by LMW agents may be more severe than that caused by HMW agents.", {"entities": []}], ["The severity of the condition may be determined by the different mechanisms of action of these agents.", {"entities": []}], ["We carried out bibliographic searches in PubMed and Embase.com for the period from 1996 to 2008 with the aim of reviewing the scientific literature on the relationship between various sources of indoor air pollution and the respiratory health of children under the age of five.", {"entities": []}], ["Those studies that included adjusted correlation measurements for the most important confounding variables and which had an adequate population size were considered to be more relevant.", {"entities": []}], ["The results concerning the relationship between gas energy sources and children's respiratory health were heterogeneous.", {"entities": []}], ["Indoor air pollution from biomass combustion in the poorest countries was found to be an important risk factor for lower respiratory tract infections.", {"entities": []}], ["Solvents involved in redecorating, DYI work, painting, and so forth, were found to be related to an increased risk for general respiratory problems.", {"entities": []}], ["The distribution of papers depending on the pollution source showed a clear relationship with life-style and the level of development.", {"entities": []}], ["Aeroallergy results from maladaptive immune responses to ubiquitous, otherwise innocuous environmental proteins", {"entities": []}], ["Easy-to-collect epidemiological information is critical for the more accurate estimation of the prevalence and burden of different non-communicable diseases around the world.", {"entities": []}], ["Current measurement is restricted by limitations in existing measurement systems in the developing world and the lack of biometry tests for non-communicable diseases.", {"entities": []}], ["Diagnosis based on self-reported signs and symptoms (\u201cSymptomatic Diagnosis,\u201d or SD) analyzed with computer-based algorithms may be a promising method for collecting timely and reliable information on non-communicable disease prevalence.", {"entities": []}], ["The objective of this study was to develop and assess the performance of a symptom-based questionnaire to estimate prevalence of non-communicable diseases in low-resource areas.", {"entities": []}], ["As part of the Population Health Metrics Research Consortium study, we collected 1,379 questionnaires in Mexico from individuals who suffered from a non-communicable disease that had been diagnosed with gold standard diagnostic criteria or individuals who did not suffer from any of the 10 target conditions.", {"entities": []}], ["To make the diagnosis of non-communicable diseases, we selected the Tariff method, a technique developed for verbal autopsy cause of death calculation.", {"entities": []}], ["We assessed the performance of this instrument and analytical techniques at the individual and population levels.", {"entities": []}], ["The questionnaire revealed that the information on health care experience retrieved achieved 66.1% (95% uncertainty interval [UI], 65.6\u201366.5%) chance corrected concordance with true diagnosis of non-communicable diseases using health care experience and 0.826 (95% UI, 0.818\u20130.834) accuracy in its ability to calculate fractions of different causes.", {"entities": []}], ["SD is also capable of outperforming the current estimation techniques for conditions estimated by questionnaire-based methods.", {"entities": []}], ["SD is a viable method for producing estimates of the prevalence of non-communicable diseases in areas with low health information infrastructure.", {"entities": []}], ["This technology can provide higher-resolution prevalence data, more flexible data collection, and potentially individual diagnoses for certain conditions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-014-0245-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Metabolic syndrome (MetS) and diabetes confer a high risk for developing subsequent cardiovascular disease (CVD).", {"entities": [[10, 18, "DISEASE"]]}], ["Persons with MetS constitute 24\u201334\u00a0% of the employee population at Baptist Health South Florida (BHSF), a self-insured healthcare organization.", {"entities": []}], ["The Baptist Employee Healthy Heart Study (BEHHS) aims to assess the addition of a personalized, interactive, web-based, nutrition-management and lifestyle-management program to the existing health-expertise web platform available to BHSF employees in reducing and/or stabilizing CVD and lifestyle risk factors and markers of subclinical CVD.", {"entities": []}], ["Subjects with MetS or Type II Diabetes will be recruited from an employee population at BHSF and randomized to either an intervention or a control arm.", {"entities": []}], ["The intervention arm will be given access to a web-based personalized diet-modification and weight-modification program.", {"entities": []}], ["The control arm will be reminded to use the standard informational health website available and accessible to all BHSF employees.", {"entities": []}], ["Subjects will undergo coronary calcium testing, carotid intima-media thickness scans, peripheral arterial tonometry, and advanced lipid panel testing at visit 1, in addition to lifestyle and medical history questionnaires.", {"entities": []}], ["All tests will be repeated at visits 2 and 4 with the exception of the coronary calcium test, which will only be performed at baseline and visit 4.", {"entities": []}], ["Visit 3 will capture vitals, anthropometrics, and responses to the questionnaires only.", {"entities": []}], ["Results of this study will provide information on the effectiveness of personalized, web-based, lifestyle-management tools in reducing healthcare costs, promoting healthy choices, and reducing cardiovascular risk in an employee population.", {"entities": []}], ["It will also provide information about the natural history of carotid atherosclerosis and endothelial dysfunction in asymptomatic but high-risk populations.", {"entities": [[70, 85, "DISEASE"]]}], ["ClinicalTrials.gov registry, NCT01912209 .", {"entities": []}], ["Registered on 3 July 2013.", {"entities": []}], ["Gymnema sylvestre (Asclepiadaceae), popularly known as \u201cgurmar\u201d for its distinct property as sugar destroyer, is a reputed herb in the Ayurvedic system of medicine.", {"entities": []}], ["The phytoconstituents responsible for sweet suppression activity includes triterpene saponins known as gymnemic acids, gymnemasaponins, and a polypeptide, gurmarin.", {"entities": []}], ["The herb exhibits a broad range of therapeutic effects as an effective natural remedy for diabetes, besides being used for arthritis, diuretic, anemia, osteoporosis, hypercholesterolemia, cardiopathy, asthma, constipation, microbial infections, indigestion, and anti-inflammatory.", {"entities": [[209, 221, "DISEASE"], [152, 164, "DISEASE"], [123, 132, "DISEASE"], [201, 207, "DISEASE"], [144, 150, "DISEASE"]]}], ["G. sylvestre has good prospects in the treatment of diabetes as it shows positive effects on blood sugar homeostasis, controls sugar cravings, and promotes regeneration of pancreas.", {"entities": []}], ["The herbal extract is used in dietary supplements since it reduces body weight, blood cholesterol, and triglyceride levels and holds great prospects in dietary as well as pharmacological applications.", {"entities": []}], ["This review explores the transition of a traditional therapeutic to a modern contemporary medication with an overview of phytochemistry and pharmacological activities of the herb and its phytoconstituents.", {"entities": []}], ["Replication of influenza virus in the host cells results in production of immune mediators like cytokines.", {"entities": [[15, 24, "DISEASE"]]}], ["Excessive secretion of cytokines (hypercytokinemia) has been observed during highly pathogenic avian influenza virus ( HPAI \u2010H5N1) infections resulting in high fatality rates.", {"entities": [[101, 110, "DISEASE"], [95, 110, "DISEASE"]]}], ["The exact mechanism of hypercytokinemia during influenza virus infection is still not known completely.", {"entities": [[47, 56, "DISEASE"]]}], ["As promoter DNA methylation changes are linked with expression changes in genes, we intend to identify whether changes in promoter DNA methylation have any role in expression of cytokines during influenza A virus infection.", {"entities": [[195, 204, "DISEASE"]]}], ["A panel of 24 cytokine genes and genes known to be involved in inflammatory response were analyzed for their promoter DNA methylation changes during influenza A virus infections.", {"entities": [[149, 158, "DISEASE"]]}], ["Four different strains of influenza A viruses, viz.", {"entities": [[26, 35, "DISEASE"]]}], ["H5N1, H1N1, pandemic (2009) H1N1, and a vaccine strain of H5N1, were used for the study.", {"entities": []}], ["We found seven of the total 24 inflammatory genes studied, showing significant changes in their promoter methylation levels in response to virus infection.", {"entities": []}], ["These genes included proinflammatory cytokines CXCL 14, CCL 25, CXCL 6, and interleukines IL 13, IL 17C, IL 4R.", {"entities": []}], ["The changes in DNA methylation levels varied across different strains of influenza viruses depending upon their virulence.", {"entities": [[73, 82, "DISEASE"]]}], ["Significant promoter hypomethylation in IL 17C and IL 13 genes was observed in cells infected with HPAI \u2010H5N1 virus compared with other influenza viruses.", {"entities": [[136, 145, "DISEASE"]]}], ["This decrease in methylation was found to be positively correlating with the increased expression of these genes.", {"entities": []}], ["Analysis of IL 17C promoter region using bisulfite sequencing resulted in identification of a CpG site within Retinoid X receptor\u2010alpha ( RXR \u2010\u03b1) transcription factor binding site undergoing demethylation specifically in H5N1\u2010infected cells but not in other influenza\u2010infected cells.", {"entities": [[258, 267, "DISEASE"]]}], ["Thus, the study could demonstrate that changes in promoter methylation in certain specific cytokine genes actually have a possible role in their expression changes during influenza A virus infection.", {"entities": [[171, 180, "DISEASE"]]}], ["This study is an analysis of a pilot COPD clinical audit that evaluated adherence to guidelines for patients with COPD in a stable disease phase during a routine visit in specialized secondary care outpatient clinics in order to identify the variables associated with the decision to step-up or step-down pharmacological treatment.", {"entities": []}], ["This study was a pilot clinical audit performed at hospital outpatient respiratory clinics in the region of Andalusia, Spain (eight provinces with over eight million inhabitants), in which 20% of centers in the area (catchment population 3,143,086 inhabitants) were invited to participate.", {"entities": []}], ["Treatment changes were evaluated in terms of the number of prescribed medications and were classified as step-up, step-down, or no change.", {"entities": []}], ["Three backward stepwise binominal multivariate logistic regression analyses were conducted to evaluate variables associated with stepping up, stepping down, and inhaled corticosteroids discontinuation.", {"entities": []}], ["The present analysis evaluated 565 clinical records (91%) of the complete audit.", {"entities": []}], ["Of those records, 366 (64.8%) cases saw no change in pharmacological treatment, while 99 patients (17.5%) had an increase in the number of drugs, 55 (9.7%) had a decrease in the number of drugs, and 45 (8.0%) noted a change to other medication for a similar therapeutic scheme.", {"entities": []}], ["Exacerbations were the main factor in stepping up treatment, as were the symptoms themselves.", {"entities": []}], ["In contrast, rather than symptoms, doctors used forced expiratory volume in 1 second and previous treatment with long-term antibiotics or inhaled corticosteroids as the key determinants to stepping down treatment.", {"entities": []}], ["The majority of doctors did not change the prescription.", {"entities": []}], ["When changes were made, a number of related factors were noted.", {"entities": []}], ["Future trials must evaluate whether these therapeutic changes impact clinically relevant outcomes at follow-up.", {"entities": []}], ["The nonapeptide CHEC-9 (CHEASAAQC), a putative inhibitor of secreted phospholipase A2 (sPLA2), has been shown previously to inhibit neuron death and aspects of the inflammatory response following systemic treatment of rats with cerebral cortex lesions.", {"entities": []}], ["In this study, the properties of CHEC-9 inhibition of sPLA2 enzymes were investigated, using a venom-derived sPLA2 group I and the plasma of rats and humans as the sources of enzyme activity.", {"entities": []}], ["The results highlight the advantages of inhibitors with uncompetitive properties for inflammatory disorders including those resulting in degeneration of neurons.", {"entities": []}], ["Samples of enzyme and plasma were reacted with 1-Palmitoyl-2-Pyrenedecanoyl Phosphatidylcholine, a sPLA2 substrate that forms phospholipid vesicles in aqueous solutions.", {"entities": []}], ["Some of the plasma samples were collected from restrained peptide-treated rats in order to confirm the validity of the in vitro assays for extrapolation to in vivo effects of the peptide.", {"entities": []}], ["The enzyme reactions were analyzed in terms of well-studied relationships between the degree of inhibition and the concentrations of different reactants.", {"entities": []}], ["We also examined interactions between different components of the reaction mixture on native polyacrylamide gels.", {"entities": []}], ["In all cases, the peptide showed the properties of an uncompetitive (or anti-competitive) enzyme inhibitor with Ki values less than 100 nanomolar.", {"entities": []}], ["The electrophoresis experiments suggested CHEC-9 modifies the binding properties of the enzyme only in the presence of substrate, consistent with its classification as an uncompetitive inhibitor.", {"entities": []}], ["Both the in vitro observations and the analysis of plasma samples from restrained rats injected with peptide suggest the efficacy of the peptide increases under conditions of high enzyme activity.", {"entities": []}], ["Modeling studies by others have shown that uncompetitive inhibitors may be optimal for enzyme inhibition therapy because, unlike competitive inhibitors, they are not rendered ineffective by the accumulation of unmodified substrate.", {"entities": []}], ["Such conditions likely apply to several instances of neuroinflammation where there are cascading increases in sPLA2s and their substrates, both systemically and in the CNS.", {"entities": []}], ["Thus, the present results may explain the efficacy of CHEC-9 in vivo .", {"entities": []}], ["Inhibition of neprilysin, an enzyme degrading natriuretic and other vasoactive peptides, is beneficial in heart failure with reduced ejection fraction (HFrEF), as shown in PARADIGM\u2010HF which compared the angiotensin receptor\u2013neprilysin inhibitor ( ARNI ) sacubitril/valsartan with enalapril.", {"entities": []}], ["As neprilysin is also one of many enzymes clearing amyloid\u2010\u03b2 peptides from the brain, there is a theoretical concern about the long\u2010term effects of sacubitril/valsartan on cognition.", {"entities": []}], ["Therefore, we have examined dementia\u2010related adverse effects ( AEs ) in PARADIGM\u2010HF and placed these findings in the context of other recently conducted HFrEF trials.", {"entities": [[28, 36, "DISEASE"]]}], ["In PARADIGM\u2010HF , patients with symptomatic HFrEF were randomized to sacubitril/valsartan 97/103\u2009mg b.i.d.", {"entities": []}], ["or enalapril 10\u2009mg b.i.d.", {"entities": []}], ["in a 1:1 ratio.", {"entities": []}], ["We systematically searched AE reports, coded using the Medical Dictionary for Regulatory Activities ( MedDRA ), using Standardized MedDRA Queries ( SMQs ) with \u2018broad\u2019 and \u2018narrow\u2019 preferred terms related to dementia.", {"entities": [[208, 216, "DISEASE"]]}], ["In PARADIGM\u2010HF , 8399 patients aged 18\u201396 years were randomized and followed for a median of 2.25\u2009years (up to 4.3\u2009years).", {"entities": []}], ["The narrow SMQ search identified 27 dementia\u2010related AEs : 15 (0.36%) on enalapril and 12 (0.29%) on sacubitril/valsartan [hazard ratio ( HR ) 0.73, 95% confidence interval ( CI ) 0.33\u20131.59].", {"entities": [[36, 44, "DISEASE"], [138, 140, "GENE"]]}], ["The broad search identified 97 (2.30%) and 104 (2.48%) AEs ( HR 1.01, 95% CI 0.75\u20131.37), respectively.", {"entities": [[61, 63, "GENE"]]}], ["The rates of dementia\u2010related AEs in both treatment groups in PARADIGM\u2010HF were similar to those in three other recent trials in HFrEF.", {"entities": [[13, 21, "DISEASE"]]}], ["We found no evidence that sacubitril/valsartan, compared with enalapril, increased dementia\u2010related AEs , although longer follow\u2010up may be necessary to detect such a signal and more sensitive tools are needed to detect lesser degrees of cognitive impairment.", {"entities": [[83, 91, "DISEASE"]]}], ["Further studies to address this question are warranted.", {"entities": []}], ["Although health risks to pesticides containing Bacillus thuringiensis (Bt) have been minimal, the potential allergenicity of these organisms has not been evaluated.", {"entities": []}], ["Therefore, a health survey was conducted in farm workers before and after exposure to Bt pesticides.", {"entities": []}], ["Farm workers who picked vegetables that required Bt pesticide spraying were evaluated before the initial spraying operation (n = 48) and 1 and 4 months after (n = 32 and 20, respectively).", {"entities": []}], ["Two groups of low- (n = 44) and medium- (n = 34) exposure workers not directly exposed to Bt spraying were also assessed.", {"entities": []}], ["The investigation included questionnaires, nasal/mouth lavages, ventilatory function assessment, and skin tests to indigenous aeroallergens and to a variety of Bt spore and vegetative preparations.", {"entities": []}], ["To authenticate exposure to the organism present in the commercial preparation, isolates from lavage specimens were tested for Bt genes by DNA-DNA hybridization.", {"entities": []}], ["Humoral immunoglobulin G (IgG) and immunoglobulin E (IgE) antibody responses to spore and vegetative Bt extracts were assayed.", {"entities": []}], ["There was no evidence of occupationally related respiratory symptoms.", {"entities": []}], ["Positive skin-prick tests to several spore extracts were seen chiefly in exposed workers.", {"entities": []}], ["In particular, there was a significant (p < 0.05) increase in the number of positive skin tests to spore extracts 1 and 4 months after exposure to Bt spray.", {"entities": []}], ["The number of positive skin test responses was also significantly higher in high (p < 0.05) than in low- or medium-exposure workers.", {"entities": []}], ["The majority of nasal lavage cultures from exposed workers was positive for the commercial Bt organism, as demonstrated by specific molecular genetic probes.", {"entities": []}], ["Specific IgE antibodies were present in more high-exposure workers (p < 0.05) than in the low and medium groups.", {"entities": []}], ["Specific IgG antibodies occurred more in the high (p < 0.05) than in the low-exposure group.", {"entities": []}], ["Specific IgG and IgE antibodies to vegetative organisms were present in all groups of workers.", {"entities": []}], ["Exposure to Bt sprays may lead to allergic skin sensitization and induction of IgE and IgG antibodies, or both.", {"entities": []}], ["Emerging research suggests that much pediatric affliction has origins in the vulnerable phase of fetal development.", {"entities": []}], ["Prenatal factors including deficiency of various nutrients and exposure to assorted toxicants are major etiological determinants of myriad obstetrical complications, pediatric chronic diseases, and perhaps some genetic mutations.", {"entities": []}], ["With recent recognition that modifiable environmental determinants, rather than genetic predestination, are the etiological source of most chronic illness, modification of environmental factors prior to conception offers the possibility of precluding various mental and physical health conditions.", {"entities": []}], ["Environmental and lifestyle modification through informed patient choice is possible but evidence confirms that, with little to no training in clinical nutrition, toxicology, or environmental exposures, most clinicians are ill-equipped to counsel patients about this important area.", {"entities": []}], ["With the totality of available scientific evidence that now exists on the potential to modify disease-causing gestational determinants, failure to take necessary precautionary action may render members of the medical community collectively and individually culpable for preventable illness in children.", {"entities": []}], ["We advocate for environmental health education of maternity health professionals and the widespread adoption and implementation of preconception care.", {"entities": []}], ["This will necessitate the translation of emerging knowledge from recent research literature, to health professionals, to reproductive-aged women, and to society at large.", {"entities": []}], ["The tyrosine kinase A (TrkA) receptor is a validated therapeutic intervention point for a wide range of conditions.", {"entities": []}], ["TrkA activation by nerve growth factor (NGF) binding the second extracellular immunoglobulin (TrkAIg2) domain triggers intracellular signaling cascades.", {"entities": [[40, 43, "GENE"]]}], ["In the periphery, this promotes the pain phenotype and, in the brain, cell survival or differentiation.", {"entities": []}], ["Reproducible structural information and detailed validation of protein\u2013ligand interactions aid drug discovery.", {"entities": []}], ["However, the isolated TrkAIg2 domain crystallizes as a \u03b2-strand-swapped dimer in the absence of NGF, occluding the binding surface.", {"entities": [[96, 99, "GENE"]]}], ["Here we report the design and structural validation by nuclear magnetic resonance spectroscopy of the first stable, biologically active construct of the TrkAIg2 domain for binding site confirmation.", {"entities": []}], ["Our structure closely mimics the wild-type fold of TrkAIg2 in complex with NGF (1WWW.pdb), and the", {"entities": [[75, 78, "GENE"]]}], ["Potential associations between oral health and respiratory disease, including chronic obstructive pulmonary disease (COPD), have been suggested in several studies.", {"entities": [[78, 115, "DISEASE"]]}], ["Among the indicators reflecting oral health, the number of natural teeth is an integrated and simple index to assess in the clinic.", {"entities": []}], ["In this study, we examined the relationship between the number of natural teeth and airflow obstruction, which is a central feature of COPD.", {"entities": []}], ["A total of 3,089 participants over 40 years, who underwent reliable spirometry and oral health assessments were selected from the Korean National Health and Nutrition Examination Survey 2012, a cross-sectional and nationally representative survey.", {"entities": []}], ["Spirometry results were classified as normal, restrictive, or obstructive pattern.", {"entities": []}], ["Total number and pairs of natural teeth were counted after excluding third molars.", {"entities": []}], ["After adjusting for other variables, such as age, body mass index, socioeconomic factors, and oral health factors, the group with airflow obstruction showed significantly fewer natural teeth than the other groups in males ( P =0.014 and 0.008 for total number and total pairs of natural teeth, respectively).", {"entities": []}], ["Compared with participants with full dentition, the adjusted odds ratio for airflow obstruction in males with fewer than 20 natural teeth was 4.18 (95% confidence interval: 2.06\u20138.49) and with fewer than 10 pairs of natural teeth was 4.74 (95% confidence interval: 2.34\u20139.62).", {"entities": []}], ["However, there was no significant association between the total number or pairs of natural teeth and airflow obstruction after adjustment in females.", {"entities": []}], ["Loss of natural teeth was significantly associated with the presence of airflow obstruction in males.", {"entities": []}], ["Our finding suggests that the number of natural teeth could be one of the available indices for obstructive lung diseases, including COPD.", {"entities": []}], ["CD147 or EMMPRIN is a member of the immunoglobulin superfamily in humans.", {"entities": []}], ["It is widely expressed in human tumors and plays a central role in the progression of many cancers by stimulating the secretion of matrix metalloproteinases (MMPs) and cytokines.", {"entities": []}], ["CD147 regulates cell proliferation, apoptosis, and tumor cell migration, metastasis and differentiation, especially under hypoxic conditions.", {"entities": []}], ["CD147 is also important to many organ systems.", {"entities": []}], ["This review will provide a detailed overview of the discovery, characterization, molecular structure, diverse biological functions and regulatory mechanisms of CD147 in human physiological and pathological processes.", {"entities": []}], ["In particular, recent studies have demonstrated the potential application of CD147 not only as a phenotypic marker of activated regulatory T cells but also as a potential diagnostic marker for early-stage disease.", {"entities": []}], ["Moreover, CD147 is recognized as an effective therapeutic target for hepatocellular carcinoma (HCC) and other cancers, and exciting clinical progress has been made in HCC treatment using CD147-directed monoclonal antibodies.", {"entities": [[69, 93, "DISEASE"], [84, 93, "DISEASE"]]}], ["Methamphetamine (MA) abuse is a major public health and safety concern throughout the world and a growing burden on healthcare costs.", {"entities": []}], ["The purpose of the present study was to investigate the protective effect of fluoxetine against MA-induced chronic pulmonary inflammation and to evaluate the potential role of nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidative stress.", {"entities": []}], ["Wistar rats were divided into control, MA and two fluoxetine-treated groups.", {"entities": []}], ["Rats in the MA and the two fluoxetine-treated groups were treated daily with intraperitoneal injection of 10 mg/kg MA twice daily.", {"entities": []}], ["Rats in the two fluoxetine-treated groups were injected intragastrically with fluoxetine (2 and 10 mg/kg) once daily, respectively.", {"entities": []}], ["After 5 weeks, the rats were euthanized and hematoxylin and eosin staining, immunohistochemistry, western blot analysis and redox assay were performed.", {"entities": []}], ["It was demonstrated that chronic exposure to MA can induce pulmonary inflammation in rats, with the symptoms of inflammatory cell infiltration, crowded lung parenchyma, thickened septum and a reduced number of alveolar sacs.", {"entities": [[219, 223, "GENE"]]}], ["Fluoxetine attenuated pulmonary inflammation and the expression of interleukin-6 and tumor necrosis factor-\u03b1 in rat lungs.", {"entities": []}], ["Fluoxetine inhibited MA-induced increases in the expression levels of serotonin transporter (SERT) and p-p38 mitogen-activated protein kinase (MAPK), and reversed the MA-induced decrease in nuclear Nrf2 and human heme oxygenase-1 in lungs.", {"entities": []}], ["Fluoxetine at 10 mg/kg significantly reversed the reduced glutathione (GSH) level, the ratio of GSH/oxidized glutathione, and the reactive oxygen species level in rat lungs from the MA group.", {"entities": []}], ["These findings suggested that fluoxetine, a SERT inhibitor, has a protective effect against MA-induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats.", {"entities": []}], ["Solid self-emulsifying drug delivery system (SSEDDS), which incorporates liquid SEDDS into a solid dosage form, has been recently introduced to improve the oral bioavail-ability of poorly water-soluble drugs.", {"entities": []}], ["However, supersaturated drug generated by SSEDDS is thermodynamically unstable and tends to precipitate rapidly prior to absorption, resulting in compromised bioavailability.", {"entities": []}], ["The aim of this study was to construct a novel supersaturated SSEDDS (super-SSEDDS) by combining SSEDDS with appropriate precipitation inhibitor.", {"entities": []}], ["Fenofibrate (FNB), a sparingly soluble drug, was selected as a model drug in this study.", {"entities": []}], ["An optimized SSEDDS was prepared by solvent evaporation by using mesoporous silica Santa Barbara Amorphous-15 as the inert carrier.", {"entities": []}], ["Supersaturation assay was conducted to evaluate the precipitation inhibition capacity of different polymers, and the results showed that Soluplus", {"entities": []}], ["Currently, contamination of indoor environment by fungi and molds is considered as a public health problem.", {"entities": []}], ["The monitoring of indoor airborne fungal contamination is a common tool to help understanding the link between fungi in houses and respiratory problems.", {"entities": []}], ["Classical analytical monitoring methods, based on cultivation and microscopic identification, depend on the growth of the fungi.", {"entities": []}], ["Consequently, they are biased by difficulties to grow some species on certain culture media and under certain conditions or by noncultivable or dead fungi that can consequently not be identified.", {"entities": []}], ["However, they could have an impact on human health as they might be allergenic.", {"entities": []}], ["Since molecular methods do not require a culture step, they seem an excellent alternative for the monitoring of indoor fungal contaminations.", {"entities": []}], ["As a case study, we developed a SYBR\u00ae green real-time PCR-based assay for the specific detection and identification of Aspergillus versicolor , which is frequently observed in indoor environment and known to be allergenic.", {"entities": []}], ["The developed primers amplify a short region of the internal transcribed spacer 1 from the 18S ribosomal DNA complex.", {"entities": []}], ["Subsequently, the performance of this quantitative polymerase chain reaction (qPCR) method was assessed using specific criteria, including an evaluation of the selectivity, PCR efficiency, dynamic range, and repeatability.", {"entities": []}], ["The limit of detection was determined to be 1 or 2 copies of genomic DNA of A. versicolor .", {"entities": []}], ["In order to demonstrate that this SYBR\u00ae green qPCR assay is a valuable alternative for monitoring indoor fungal contamination with A. versicolor , environmental samples collected in contaminated houses were analyzed and the results were compared to the ones obtained with the traditional methods.", {"entities": []}], ["Exposure to fine and ultra-fine ambient particles is still a problem of concern in many industrialised parts of the world and the intensified use of nanotechnology may further increase exposure to small particles.", {"entities": []}], ["Complex in vitro coculture systems may be valuable tools to study particle-induced processes and to extrapolate effects of particles on the lung.", {"entities": []}], ["A system consisting of four different human cell lines which mimics the cell response of the alveolar surface in vitro was developed to study native aerosol exposure (Vitrocell\u2122 chamber).", {"entities": []}], ["The system is composed of an alveolar type-II cell line (A549), differentiated macrophage-like cells (THP-1), mast cells (HMC-1) and endothelial cells (EA.hy 926), seeded in a 3D-orientation on a microporous membrane.", {"entities": []}], ["The spatial distribution of the cells in the tetraculture was analysed by confocal laser scanning microscopy (CLSM), showing a confluent layer of endothelial and epithelial cells on both sides of the transwell.", {"entities": []}], ["Macrophage-like cells and mast cells can be found on top of the epithelial cells.", {"entities": []}], ["The cells formed colonies under submerged conditions, which disappeared at the ALI.", {"entities": []}], ["To evaluate the response to oxidative stress, the dichlorodihydrofluorescein diacetate (DCFH-DA) assay was used together with 2,2\u2019-azobis-2-methyl-propanimidamide-dihydrochloride (AAPH) as inducer of oxidative stress.", {"entities": []}], ["The tetraculture showed less induction of reactive oxygen species (ROS) production after being treated with a positive control compared to the monocultures of EA.hy 926, THP-1 and HMC-1.", {"entities": []}], ["Submerged cultures showed elevated ROS and IL-8 levels compared to ALI cultures.", {"entities": []}], ["The Vitrocell\u2122 aerosol exposure system was not significantly influencing the viability.", {"entities": []}], ["Using this system, cells were exposed to an aerosol of 50\u00a0nm SiO 2 -Rhodamine NPs in PBS.", {"entities": [[78, 81, "GENE"]]}], ["The distribution of the NPs in the tetraculture after exposure was evaluated by CLSM.", {"entities": [[24, 27, "GENE"]]}], ["Fluorescence from internalized particles was detected in CD11b-positive THP-1 cells only.", {"entities": []}], ["The system can be used in conjunction with a native aerosol exposure system and may finally lead to a more realistic judgement regarding the hazard of new compounds and/or new nano-scaled materials in the future.", {"entities": []}], ["The results for the ROS production and IL-8 secretion suggest that submerged exposure may lead to an overestimation of observed effects.", {"entities": []}], ["The 2009 pandemic influenza A (H1N1) (PIA) virus infected large parts of the pediatric population with a wide clinical spectrum and an initially unknown complication rate.", {"entities": [[18, 27, "DISEASE"]]}], ["The aims of our study were to define clinical characteristics and outcome of pandemic influenza A (H1N1) 2009-associated hospitalizations (PIAH) in children <18\u2009years of age.", {"entities": [[86, 95, "DISEASE"]]}], ["All hospitalized cases of children <18\u2009years of age with laboratory-confirmed pandemic influenza A (H1N1) 2009 in the region of Wuerzburg (Northern Bavaria, Germany) between July 2009 and March 2010 were identified.", {"entities": [[87, 96, "DISEASE"]]}], ["For these children a medical chart review was performed to determine their clinical characteristics and complications.", {"entities": []}], ["Between July 2009 and March 2010, 94 PIAH (62% males) occurred in children <18\u2009years of age, with a median age of 7\u2009years (IQR: 3\u201312\u2009years).", {"entities": []}], ["Underlying diseases and predisposing factors were documented in 40 (43%) children; obesity (n\u2009=\u200912, 30%), asthma (n\u2009=\u200910, 25%) and neurologic disorders (n\u2009=\u20098, 20%) were most frequently reported.", {"entities": [[83, 90, "DISEASE"], [106, 112, "DISEASE"]]}], ["Sixteen (17%) children received oxygen supplementation; three (3%) children required mechanical ventilation.", {"entities": []}], ["Six (6%) children were admitted to an intensive care unit, four of them with underlying chronic diseases.", {"entities": []}], ["Most PIAH demonstrated a benign course of disease.", {"entities": []}], ["However, six children (6%) needed treatment at an intensive care unit for severe complications.", {"entities": []}], ["Drug-related problems, including medication errors and adverse drug events, are common among old people.", {"entities": []}], ["Due to, for example, greater susceptibility to side effects, people with dementia are even more at risk of drug-related problems.", {"entities": [[73, 81, "DISEASE"]]}], ["The objectives of this study were to assess the occurrence and character of drug-related problems found among old people with dementia or cognitive impairment.", {"entities": [[126, 134, "DISEASE"]]}], ["Data from a randomized controlled clinical trial exploring the effects of a pharmacist intervention as part of a hospital ward team in patients 65\u00a0years and older with dementia or cognitive impairment were used.", {"entities": [[168, 176, "DISEASE"]]}], ["The study was conducted between 2012 and 2014 in the orthopedic and medicine wards in two hospitals located in Northern Sweden.", {"entities": []}], ["Drug-related problems identified in this patient group were classified and described, and associations with different factors were investigated.", {"entities": []}], ["Clinical pharmacists identified at least one DRP in 66% (140/212) of participants in the intervention group, for a total of 310 DRPs.", {"entities": []}], ["Ineffective drug/inappropriate drug and unnecessary drug therapy were the most common drug-related problems.", {"entities": []}], ["Discontinuation of drug therapy was the most common action carried out.", {"entities": []}], ["Drug-related problems were more common among people prescribed a larger number of drugs and among people with an earlier stroke.", {"entities": []}], ["Drug-related problems are common among people with dementia and cognitive impairment.", {"entities": [[51, 59, "DISEASE"]]}], ["Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.", {"entities": []}], ["The C-type lectin DC-SIGN (CD209) is known to be the major dengue receptor on human dendritic cells, and a single nucleotide polymorphism (SNP) in the promoter region of CD209 (\u2212336 A/G; rs4804803) is susceptible to many infectious diseases.", {"entities": [[27, 32, "GENE"], [170, 175, "GENE"], [27, 32, "GENE"], [170, 175, "GENE"]]}], ["We reason that variations in the DC-SIGN gene might have a broad influence on viral replication and host immune responses.", {"entities": []}], ["We studied whether the rs4804803 SNP was associated with a susceptibility to dengue fever (DF) and/or dengue hemorrhagic fever (DHF) through genotyping analysis in a Taiwanese cohort.", {"entities": [[102, 126, "DISEASE"]]}], ["We generated monocyte-derived dendritic cells (MDDCs) from individuals with AA or AG genotype of rs4804803 to study the viral replication and immune responses for functional validation.", {"entities": []}], ["A total of 574 DNA samples were genotyped, including 176 DF, 135 DHF, 143 other non-dengue febrile illnesses (OFI) and 120 population controls.", {"entities": []}], ["A strong association between GG/AG genotypes of rs4804803 and risk of DHF was found when compared among DF, OFI and controls ( p \u200a=\u200a0.004, 3\u00d710 p \u200a=\u200a0.002 and 0.020, respectively).", {"entities": []}], ["Moreover, MDDCs from individuals with AG genotype with a higher cell surface DC-SIGN expression had a significantly higher TNF\u03b1, IL-12p40, and IP-10 production than those with AA genotype in response to dengue infection.", {"entities": []}], ["However, the viral replication in MDDCs with AG genotype was significantly lower than those with AA genotype.", {"entities": []}], ["With both genotypes, MDDCs revealed an increase in viral replication following the addition of anti-IP-10 neutralizing antibody.", {"entities": []}], ["The rs4804803 SNP in the CD209 promoter contributed to susceptibility to dengue infection and complication of DHF.", {"entities": [[25, 30, "GENE"]]}], ["This SNP with AG genotype affects the cell surface DC-SIGN expression related to immune augmentation and less viral replication.", {"entities": []}], ["Dengue fever (DF) is an arthropod-borne disease that is prevalent in tropical and subtropical regions of the world.", {"entities": []}], ["DC-SIGN [dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing non-integrin] is a major receptor for dengue infection.", {"entities": []}], ["DC-SIGN, also called CD209, expresses on dendritic cells (DCs) that bind to ICAM-3, which is expressed on T cells to facilitate the initial interaction between DCs and T cells.", {"entities": [[21, 26, "GENE"]]}], ["Variations in the CD209 promoter (\u2212336 A/G; rs4804803) genotype are involved in the pathogenesis of human infectious diseases.", {"entities": [[18, 23, "GENE"]]}], ["Here we found that patients with dengue hemorrhagic fever (DHF) had a higher frequency of the AG or GG genotype of rs4804803 than DF or controls.", {"entities": [[33, 57, "DISEASE"]]}], ["Functional studies determined that monocyte-derived DCs (MDDCs) from individuals with AG genotype had significantly higher cell surface DC-SIGN expression, associated with higher TNF\u03b1, IL-12p40, and IP-10 production, but lower viral replication than those with AA genotype.", {"entities": []}], ["An increase in DEN-2 replication in MDDCs was observed following the addition of anti-IP-10 neutralizing antibody.", {"entities": []}], ["These findings highlight the fact that the rs4804803 SNP in the CD209 promoter is associated with DHF and correlated to DC-SIGN expression and immune augmentation.", {"entities": [[64, 69, "GENE"]]}], ["Smoking is a major risk factor for several diseases including chronic obstructive pulmonary disease (COPD).", {"entities": [[62, 99, "DISEASE"]]}], ["To better understand the systemic effects of cigarette smoke exposure and mild to moderate COPD\u2014and to support future biomarker development\u2014we profiled the serum lipidomes of healthy smokers, smokers with mild to moderate COPD (GOLD stages 1 and 2), former smokers, and never-smokers ( n = 40 per group) (ClinicalTrials.gov registration: NCT01780298).", {"entities": []}], ["Serum lipidome profiling was conducted with untargeted and targeted mass spectrometry-based lipidomics.", {"entities": []}], ["Guided by weighted lipid co-expression network analysis, we identified three main trends comparing smokers, especially those with COPD, with non-smokers: a general increase in glycero(phospho)lipids, including triglycerols; changes in fatty acid desaturation (decrease in \u03c9-3 polyunsaturated fatty acids, and an increase in monounsaturated fatty acids); and an imbalance in eicosanoids (increase in 11,12- and 14,15-DHETs (dihydroxyeicosatrienoic acids), and a decrease in 9- and 13-HODEs (hydroxyoctadecadienoic acids)).", {"entities": []}], ["The lipidome profiles supported classification of study subjects as smokers or non-smokers, but were not sufficient to distinguish between smokers with and without COPD.", {"entities": []}], ["Overall, our study yielded further insights into the complex interplay between smoke exposure, lung disease, and systemic alterations in serum lipid profiles.", {"entities": [[95, 107, "DISEASE"]]}], ["\u2018Fine-tuning\u2019 of protein abundance makes microRNAs (miRNAs) pervasively implicated in human biology.", {"entities": []}], ["Although targeting many mRNAs endows the power of single miRNA to regulate complex biological processes, its functional roles in a particular tissue will be inevitably restricted because only a subset of its target genes is expressed.", {"entities": []}], ["Here, we analyze the characteristics of miRNA regulation upon target genes according to tissue-specific gene expression by constructing tissue-specific protein interaction networks for ten main types of tissues in the human body.", {"entities": []}], ["Commonly expressed proteins are under more intensive but lower-cost miRNAs control than proteins with the tissue-specific expression.", {"entities": []}], ["MiRNAs that target more commonly expressed genes usually regulate more tissue-specific genes.", {"entities": []}], ["This is consistent with the previous finding that tissue-specific proteins tend to be functionally connected with commonly expressed proteins.", {"entities": []}], ["But to a particular miRNA such a balance is not invariable among different tissues implying diverse tissue regulation modes executed by miRNAs.", {"entities": []}], ["These results suggest miRNAs that interact with more commonly expressed genes can be expected to play important tissue-specific roles.", {"entities": []}], ["The ability to compare incremental changes in Quality Adjusted Life Years (QALYs) generated by different condition-specific preference-based measures (CSPBMs), or indeed between generic measures, is often criticised even where the valuation methods and source of values are the same.", {"entities": []}], ["A key concern is the impact of excluding key dimensions from a descriptive system.", {"entities": []}], ["This study examines the impact of adding a generic pain/discomfort dimension to a CSPBM, the AQL-5D (an asthma-specific CSPBM), by valuing samples of states from the AQL-5D with and without the new dimension using an interviewer administered time trade-off with a sample of the UK general public.", {"entities": [[104, 110, "DISEASE"]]}], ["180 respondents provided 720 valuations for states with and without pain/discomfort.", {"entities": []}], ["As expected the additional pain/discomfort dimension was found to have a significant and relatively large coefficient.", {"entities": []}], ["More importantly for comparing changes in QALYs across populations the addition of pain/discomfort significantly impacts on the coefficients of the other dimensions and the degree of impact differs by dimension and severity level.", {"entities": []}], ["The net effect on the utility value depends on the severity of their state: the addition of pain/discomfort at level 1 (no pain/discomfort) or 2 (moderate pain/discomfort) significantly increased the mean health state values in an asthma patient population; whereas level 3 pain/discomfort (extreme) reduced values.", {"entities": [[231, 237, "DISEASE"]]}], ["Comparability between measures requires that the impact of different dimensions on preferences is additive, whether or not they are included in the classification system.", {"entities": []}], ["Our results cast doubt on this assumption, implying that the chosen measure must contain all important and relevant dimensions in its classification system.", {"entities": []}], ["\u25ba As expected the additional pain or discomfort dimension was associated with significant coefficients for levels 2 and 3 in the model of the health state valuation data.", {"entities": []}], ["\u25ba The additional dimension had a significant impact on the coefficients of other dimensions, but this differed by dimension and level.", {"entities": []}], ["\u25ba The net impact on the health state value depended on the level of the pain or discomfort dimension, with level 1 or 2 being associated with higher values and level 3 with lower values.", {"entities": []}], ["\u25ba This has important implications for the strategy of adding dimensions to existing instruments and for the achievement cross instrument comparability.", {"entities": []}], ["Uteroglobin (UG) is an antiinflammatory protein secreted by the epithelial lining of all organs communicating with the external environment.", {"entities": []}], ["We reported previously that UG-knockout mice manifest exaggerated inflammatory response to allergen, characterized by increased eotaxin and Th2 cytokine gene expression, and eosinophil infiltration in the lungs.", {"entities": []}], ["In this study, we uncovered that the airway epithelia of these mice also express high levels of cyclooxygenase (COX)-2, a key enzyme for the production of proinflammatory lipid mediators, and the bronchoalveolar lavage fluid (BALF) contain elevated levels of prostaglandin D 2 .", {"entities": []}], ["These effects are abrogated by recombinant UG treatment.", {"entities": []}], ["Although it has been reported that prostaglandin D 2 mediates allergic inflammation via its receptor, DP, neither the molecular mechanism(s) of DP signaling nor the mechanism by which UG suppresses DP-mediated inflammatory response are clearly understood.", {"entities": []}], ["Here we report that DP signaling is mediated via p38 mitogen\u2013activated protein kinase, p44/42 mitogen\u2013activated protein kinase, and protein kinase C pathways in a cell type\u2013specific manner leading to nuclear factor\u2013\u03baB activation stimulating COX-2 gene expression.", {"entities": []}], ["Further, we found that recombinant UG blocks DP-mediated nuclear factor\u2013\u03baB activation and suppresses COX-2 gene expression.", {"entities": []}], ["We propose that UG is an essential component of a novel innate homeostatic mechanism in the mammalian airways to repress allergen-induced inflammatory responses.", {"entities": []}], ["Acute lower respiratory infections (ALRIs) are leading causes of hospitalisation in children.", {"entities": []}], ["Birth defects occur in 5% of live births in Western Australia (WA).", {"entities": []}], ["The association between birth defects and ALRI hospitalisation is unknown.", {"entities": []}], ["We conducted a retrospective cohort study of 245,249 singleton births in WA (1996-2005).", {"entities": []}], ["Population-based hospitalisation data were linked to the WA Register of Developmental Anomalies to investigate ALRI hospitalisations in children with and without birth defects.", {"entities": []}], ["We used negative binomial regression to estimate associations between birth defects and number of ALRI hospitalisations before age 2\u00a0years, adjusting for known risk factors.", {"entities": []}], ["Overall, 9% of non-Aboriginal children and 37% of Aboriginal children with birth defects had at least one ALRI admission before age 2\u00a0years.", {"entities": []}], ["Aboriginal children (IRR 2.3, 95% CI: 1.9-2.8) and non-Aboriginal children (IRR 2.0, 95% CI: 1.8-2.2) with birth defects had higher rates of hospitalisation for an ALRI than children with no birth defects.", {"entities": []}], ["Rates of ALRI hospitalisation varied by type of defect but were increased for all major birth defects categories, the highest rate being for children with Down syndrome (IRR 8.0, 95% CI: 5.6-11.5).", {"entities": [[160, 168, "DISEASE"]]}], ["The rate of ALRI hospitalisation was 3 times greater in children with multiple birth defects than in those with isolated defects.", {"entities": []}], ["Children with birth defects experience higher rates of hospitalisation for ALRIs before age 2\u00a0years than children with no birth defects.", {"entities": []}], ["Optimal vaccination coverage and immunoprophylaxis for specific categories of birth defects would assist in reducing hospitalisation rates for ALRI.", {"entities": []}], ["An unusually high number of severe pneumonia cases with considerable mortality is being observed with the pandemic H1N1 2009 virus infections globally.", {"entities": [[35, 44, "DISEASE"]]}], ["In India, all mild as well as critically ill cases were admitted and treated in the government hospitals during the initial phase of the pandemic.", {"entities": []}], ["The present study was undertaken during this early phase of the pandemic.", {"entities": []}], ["The role of viral load and host factors in the pathogenesis were assessed by examining 26 mild (MP), 15 critically ill patients (CIP) and 20 healthy controls from Pune, India.", {"entities": []}], ["Sequential blood and lung aspirate samples were collected from CIP.", {"entities": []}], ["Viral load and cytokines/chemokine levels were determined from the plasma and lung aspirates of the patients.", {"entities": []}], ["TLR levels were determined by staining and FACS analysis.", {"entities": []}], ["Gene profiling was done for both cells in the lung aspirates and PBMCs using TaqMan Low Density arrays.", {"entities": []}], ["Antibody titres and isotyping was done using HA protein based ELISAs.", {"entities": []}], ["13/15 critically ill patients expired.", {"entities": []}], ["All plasma samples were negative for the virus irrespective of the patient's category.", {"entities": []}], ["Sequential lung samples from CIP showed lower viral loads questioning association of viral replication with the severity.", {"entities": []}], ["Anti-rpH1N1-09-HA-IgG titres were significantly higher in critically ill patients and both categories circulated exclusively IgG1 isotype.", {"entities": []}], ["Critically ill patients exhibited increase in TLR-3, 4, 7 and decrease in TLR-2 expressions.", {"entities": []}], ["The disease severity correlated with increased plasma levels of IL1RA, IL2, IL6, CCL3, CCL4 and IL10.", {"entities": [[71, 74, "GENE"], [76, 79, "GENE"], [81, 85, "GENE"], [87, 91, "GENE"], [96, 100, "GENE"]]}], ["Majority of the immune-function genes were down-regulated in the PBMCs and up-regulated in the cells from lung aspirates of critically ill patients.", {"entities": []}], ["No distinct pattern differentiating fatal and surviving patients was observed when sequential samples were examined for various parameters.", {"entities": []}], ["Disease severity was associated with pronounced impairment of host immune response.", {"entities": []}], ["Understanding healthcare-seeking patterns for respiratory illness can help improve estimations of disease burden and inform public health interventions to control acute respiratory disease in Indonesia.", {"entities": []}], ["The objectives of this study were to describe healthcare-seeking behaviors for respiratory illnesses in one rural and one urban community in Western Java, and to explore the factors that affect care seeking.", {"entities": []}], ["From February 8, 2012 to March 1, 2012, a survey was conducted in 2520 households in the East Jakarta and Bogor districts to identify reported recent respiratory illnesses, as well as all hospitalizations from the previous 12-month period.", {"entities": []}], ["We found that 4% (10% of those less than 5 years) of people had respiratory disease resulting in a visit to a healthcare provider in the past 2 weeks; these episodes were most commonly treated at government (33%) or private (44%) clinics.", {"entities": []}], ["Forty-five people (0.4% of those surveyed) had respiratory hospitalizations in the past year, and just over half of these (24/45, 53%) occurred at a public hospital.", {"entities": []}], ["Public health programs targeting respiratory disease in this region should account for care at private hospitals and clinics, as well as illnesses that are treated at home, in order to capture the true burden of illness in these communities.", {"entities": []}], ["We studied the diagnostic accuracy of bedside lung ultrasound (the presence of a comet-tail sign), N-terminal pro-brain natriuretic peptide (NT-proBNP) and clinical assessment (according to the modified Boston criteria) in differentiating heart failure (HF)-related acute dyspnea from pulmonary (chronic obstructive pulmonary disease (COPD)/asthma)-related acute dyspnea in the prehospital setting.", {"entities": [[296, 333, "DISEASE"], [341, 347, "DISEASE"]]}], ["Our prospective study was performed at the Center for Emergency Medicine, Maribor, Slovenia, between July 2007 and April 2010.", {"entities": []}], ["Two groups of patients were compared: a HF-related acute dyspnea group ( n = 129) and a pulmonary (asthma/COPD)-related acute dyspnea group ( n = 89).", {"entities": [[99, 105, "DISEASE"]]}], ["All patients underwent lung ultrasound examinations, along with basic laboratory testing, rapid NT-proBNP testing and chest X-rays.", {"entities": []}], ["The ultrasound comet-tail sign has 100% sensitivity, 95% specificity, 100% negative predictive value (NPV) and 96% positive predictive value (PPV) for the diagnosis of HF.", {"entities": []}], ["NT-proBNP (cutoff point 1,000 pg/mL) has 92% sensitivity, 89% specificity, 86% NPV and 90% PPV.", {"entities": []}], ["The Boston modified criteria have 85% sensitivity, 86% specificity, 80% NPV and 90% PPV.", {"entities": []}], ["In comparing the three methods, we found significant differences between ultrasound sign and (1) NT-proBNP ( P < 0.05) and (2) Boston modified criteria ( P < 0.05).", {"entities": []}], ["The combination of ultrasound sign and NT-proBNP has 100% sensitivity, 100% specificity, 100% NPV and 100% PPV.", {"entities": []}], ["With the use of ultrasound, we can exclude HF in patients with pulmonary-related dyspnea who have positive NT-proBNP (> 1,000 pg/mL) and a history of HF.", {"entities": []}], ["An ultrasound comet-tail sign alone or in combination with NT-proBNP has high diagnostic accuracy in differentiating acute HF-related from COPD/asthma-related causes of acute dyspnea in the prehospital emergency setting.", {"entities": [[144, 150, "DISEASE"]]}], ["ClinicalTrials.gov NCT01235182 .", {"entities": []}], ["Skin testing is recommended for children at risk for this disease.", {"entities": []}], ["In 1996, the American Academy of Pediatrics (AAP) recommended targeted tuberculin skin testing (TST) of children while discouraging routine TST of children without risk factors for tuberculosis (TB).", {"entities": [[181, 193, "DISEASE"]]}], ["Recent studies have provided evidence in support of the targeted TST and recommendations that favor risk assessment over universal screening with TST.", {"entities": []}], ["While evidence for targeted TB testing exists and benefits of screening programs are clear, administrative logistics could be a greater issue.", {"entities": []}], ["The challenge for public health and school officials is to develop a screening program that avoids stigmatization of the at-risk group.", {"entities": []}], ["Until then, pediatric healthcare providers will continue to have a key role in identifying children at risk for latent TB infection by using the AAP-endorsed risk-assessment questionnaire and should screen children with TST only when >1 risk factor is present.", {"entities": []}], ["Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities.", {"entities": [[65, 78, "DISEASE"]]}], ["Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management.", {"entities": []}], ["The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies.", {"entities": []}], ["Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions.", {"entities": []}], ["Patients\u2019 reported medication use was compared with documentation in the hospital medical records and pharmacy database.", {"entities": []}], ["Medication adherence was assessed using the 8-question \u00a9Morisky Medication Adherence Scale (MMAS-8).", {"entities": []}], ["The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis.", {"entities": []}], ["All p-values were 2-sided (\u03b1\u2009=\u20090.05).", {"entities": []}], ["Twenty-seven patients (54.0\u00a0%) had \u22651 discrepancy between reported and documented medicines.", {"entities": []}], ["Patients with \u22651 discrepancy were older ( p \u2009=\u20090.04) and multivariate analysis identified taking \u22655 conventional medicines or having a \u2018low\u2019 or \u2018medium\u2019 adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8\u201367.4), 20.7 (95 % CI 1.3\u2013337.7) and 49.0 (95 % CI 3.3\u2013718.5) respectively).", {"entities": []}], ["Concordance was highest for liver disease medicines (71.9\u00a0%) and lowest for complementary and alternative medicines (14.5\u00a0%) and respiratory medicines (0\u00a0%).", {"entities": [[28, 41, "DISEASE"]]}], ["There is significant discrepancy between sources of patient medication information within the hepatology clinic.", {"entities": []}], ["Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study.", {"entities": []}], ["Screening and surveillance approaches for workers exposed to nanomaterials could aid in early detection of health effects, provide data for epidemiological studies and inform action to decrease exposure.", {"entities": []}], ["The aim of this review is to identify such screening and surveillance approaches, in order to extract available data regarding (i) the studies that have successfully been implemented in present day, (ii) identification of the most common and/or toxic nano-related health hazards for workers and (iii) possible exposure surveillance markers.", {"entities": []}], ["This review contributes to the current understanding of the risk associated with nanomaterials by determining the knowledge gap and making recommendations based on current findings.", {"entities": []}], ["A systematic review was conducted.", {"entities": []}], ["PubMed and Embase were searched to identify articles reporting on any surveillance-related study that described both exposure to nanomaterials and the health indicators that were measured.", {"entities": []}], ["Four reviewers worked in pairs to independently assess the eligibility of studies and risk of bias before extraction of data.", {"entities": []}], ["Studies were categorised according to the type of study and the medical surveillance performed, which included the type of nanomaterial, any exposure details provided, as well as health indicators and biomarkers tested.", {"entities": []}], ["Initially 92 studies were identified, from which 84 full texts were assessed for eligibility.", {"entities": []}], ["Seven studies met all the inclusion criteria, i.e.", {"entities": []}], ["those performed in Taiwan, Korea, Czech Republic and the US.", {"entities": []}], ["Of these, six compared health indicators between exposed and unexposed workers and one study described a surveillance program.", {"entities": []}], ["All studies were at a high risk of bias.", {"entities": []}], ["Workers were exposed to a mix of nanomaterials in three studies, carbon-based nanomaterials in two studies, nano-silver in one study and nano-titanium oxide in the other study.", {"entities": []}], ["Two studies did not find a difference in biomarkers between exposed and unexposed workers.", {"entities": []}], ["In addition, differences in early effects on pulmonary function or neurobehavioral tests were not observed.", {"entities": []}], ["One study found an increased prevalence of allergic dermatitis and \u201csneezing\u201d in the exposed group.", {"entities": [[52, 62, "DISEASE"]]}], ["This review of recently published data on surveillance studies proves that there is a gap in the current knowledge, where most of the surveillance-related studies reported do not follow a set format that provides the required information on ENM characterisation, the type of exposure and the measured indicators/biomarkers.", {"entities": []}], ["Hence, there is very low quality evidence that screening and surveillance might detect adverse health effects associated with workplace exposure.", {"entities": []}], ["This systematic review is relevant because it proves that, although surveillance programs have been initiated and preliminary results are being published, the current studies are actually not answering the important questions or solving the overall problem regarding what the potential health hazards are among workers either handling or potentially exposed to ENMs.", {"entities": []}], ["The recommendations, thus proposed, are based on an obvious need for (i) exposure registries, where longitudinal follow-up studies should inform surveillance, (ii) known exposure measurements or summary indices for ENMs as a reference (iii) validation of candidate biomarkers and (iv) studies that compare the effects of these surveillance approaches to usual care, e.g.", {"entities": []}], ["those commonly followed for bulk-size hazardous materials.", {"entities": []}], ["Chronic arsenic toxicity occurs primarily through inadvertent ingestion of contaminated water and food or occupational exposure, but it can also occur through medicinal ingestion.", {"entities": []}], ["This case features a 53-year-old lifetime nonsmoker with chronic asthma treated for 10 years in childhood with Chinese traditional medicine containing arsenic.", {"entities": [[65, 71, "DISEASE"]]}], ["The patient was diagnosed with Bowen\u2019s disease and developed extensive-stage small-cell carcinoma of the lung 10 years and 47 years, respectively, after the onset of arsenic exposure.", {"entities": [[88, 97, "DISEASE"]]}], ["Although it has a long history as a medicinal agent, arsenic is a carcinogen associated with many malignancies including those of skin and lung.", {"entities": []}], ["It is more commonly associated with non\u2013small-cell lung cancer, but the temporal association with Bowen\u2019s disease in the absence of other chemical or occupational exposure strongly points to a causal role for arsenic in this case of small-cell lung cancer.", {"entities": [[51, 62, "DISEASE"], [244, 255, "DISEASE"], [56, 62, "DISEASE"], [249, 255, "DISEASE"]]}], ["Individuals with documented arsenic-induced Bowen\u2019s disease should be considered for more aggressive screening for long-term complications, especially the development of subsequent malignancies.", {"entities": []}], ["Since the SOX2 amplification was identified in lung squamous cell carcinoma (lung SCC), SOX2 transcriptional downstream targets have been actively investigated; however, such targets are often cell line specific.", {"entities": [[66, 75, "DISEASE"], [52, 75, "DISEASE"], [47, 75, "DISEASE"], [10, 14, "GENE"], [88, 92, "GENE"], [10, 14, "GENE"], [88, 92, "GENE"]]}], ["Here, in order to identify highly consensus SOX2 downstream genes in lung SCC cells, we used RNA-seq data from 178 lung SCC specimens (containing tumor and tumor-associated cells) and analyzed the correlation between SOX2 and previously-reported SOX2 -controlled genes in lung SCC.", {"entities": [[44, 48, "GENE"], [217, 221, "GENE"], [246, 250, "GENE"], [44, 48, "GENE"], [217, 221, "GENE"], [246, 250, "GENE"], [44, 48, "GENE"], [217, 221, "GENE"], [246, 250, "GENE"]]}], ["In addition, we used another RNA-seq dataset from 105 non-small cell lung cancer cell lines (NSCLC; including 4 lung SCC cell lines) and again analyzed the correlation between SOX2 and the reported SOX2 -controlled genes in the NSCLC cell lines (no tumor-associated cells).", {"entities": [[69, 80, "DISEASE"], [74, 80, "DISEASE"], [176, 180, "GENE"], [198, 202, "GENE"], [176, 180, "GENE"], [198, 202, "GENE"]]}], ["We combined the two analyses and identified genes commonly correlated with SOX2 in both datasets.", {"entities": [[75, 79, "GENE"]]}], ["Among the 99 genes reported as SOX2 downstream and/or correlated genes, we found 4 negatively-correlated (e.g., CDKN1A ) and 11 positively-correlated genes with SOX2 .", {"entities": [[31, 35, "GENE"], [161, 165, "GENE"], [112, 118, "GENE"], [31, 35, "GENE"], [161, 165, "GENE"]]}], ["We used biological studies to demonstrate that CDKN1A was suppressed by SOX2 in lung SCC cells.", {"entities": [[47, 53, "GENE"], [72, 76, "GENE"]]}], ["G1 cell cycle arrest induced by SOX2 siRNA was rescued by CDKN1A siRNA.", {"entities": [[32, 36, "GENE"], [58, 64, "GENE"]]}], ["These results indicate that the tumorigenic effect of SOX2 in lung SCC cells is mediated in part by suppression of CDKN1A .", {"entities": [[54, 58, "GENE"], [115, 121, "GENE"]]}], ["Childhood absence epilepsy (CAE) is an idiopathic generalised epilepsy (IGE) characterised by typical absence seizures manifested by transitory loss of awareness with 2.5\u20134\u00a0Hz spike-wave complexes on ictal EEG.", {"entities": []}], ["A genetic component to the aetiology is well recognised but the mechanism of inheritance and the genes involved are yet to be fully established.", {"entities": []}], ["A genome wide single nucleotide polymorphism (SNP)-based high density linkage scan was carried out using 41 nuclear pedigrees with at least two affected members.", {"entities": []}], ["Multipoint parametric and non-parametric linkage analyses were performed using MERLIN 1.1.1 and a susceptibility locus was identified on chromosome 3p23-p14 ( Z mean \u00a0=\u00a03.9, p \u00a0<\u00a00.0001; HLOD\u00a0=\u00a03.3, \u03b1 \u00a0=\u00a00.7).", {"entities": []}], ["The linked region harbours the functional candidate genes TRAK1 and CACNA2D2 .", {"entities": [[58, 63, "GENE"], [68, 76, "GENE"]]}], ["Fine-mapping using a tagSNP approach demonstrated disease association with variants in TRAK1 .", {"entities": [[87, 92, "GENE"]]}], ["DNA methylation is an important epigenetic regulator of gene expression.", {"entities": []}], ["Recent studies have revealed widespread associations between genetic variation and methylation levels.", {"entities": []}], ["However, the mechanistic links between genetic variation and methylation remain unclear.", {"entities": []}], ["To begin addressing this gap, we collected methylation data at \u223c300,000 loci in lymphoblastoid cell lines (LCLs) from 64 HapMap Yoruba individuals, and genome-wide bisulfite sequence data in ten of these individuals.", {"entities": []}], ["We identified (at an FDR of 10%) 13,915 cis methylation QTLs (meQTLs)\u2014i.e., CpG sites in which changes in DNA methylation are associated with genetic variation at proximal loci.", {"entities": []}], ["We found that meQTLs are frequently associated with changes in methylation at multiple CpGs across regions of up to 3 kb.", {"entities": []}], ["Interestingly, meQTLs are also frequently associated with variation in other properties of gene regulation, including histone modifications, DNase I accessibility, chromatin accessibility, and expression levels of nearby genes.", {"entities": []}], ["These observations suggest that genetic variants may lead to coordinated molecular changes in all of these regulatory phenotypes.", {"entities": []}], ["One plausible driver of coordinated changes in different regulatory mechanisms is variation in transcription factor (TF) binding.", {"entities": [[117, 119, "GENE"]]}], ["Indeed, we found that SNPs that change predicted TF binding affinities are significantly enriched for associations with DNA methylation at nearby CpGs.", {"entities": [[49, 51, "GENE"]]}], ["DNA methylation is an important epigenetic mark that contributes to many biological processes including the regulation of gene expression.", {"entities": []}], ["Genetic variation has been associated with quantitative changes in DNA methylation (meQTLs).", {"entities": []}], ["We identified thousands of meQTLs using an assay that allowed us to measure methylation levels at around 300 thousand cytosines.", {"entities": []}], ["We found that meQTLs are enriched with loci that is also associated with quantitative changes in gene expression, DNase I hypersensitivity, PolII occupancy, and a number of histone marks.", {"entities": []}], ["This suggests that many molecular events are likely regulated in concert.", {"entities": []}], ["Finally, we found that changes in transcription factor binding as well as transcription factor abundance are associated with changes in DNA methylation near transcription factor binding sites.", {"entities": []}], ["This work contributes to our understanding of the regulation of DNA methylation in the larger context of gene regulatory landscape.", {"entities": []}], ["Smoking cessation following hospitalization for Acute Coronary Syndrome (ACS) significantly reduces subsequent mortality.", {"entities": []}], ["Depressed mood is a major barrier to cessation post-ACS.", {"entities": []}], ["Although existing counseling treatments address smoking and depression independently in ACS patients, no integrated treatment addresses both.", {"entities": []}], ["We developed an integrated treatment combining gold standard cessation counseling with behavioral activation-based mood management; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS).", {"entities": []}], ["The purpose of this pilot randomized controlled trial was to test feasibility, acceptability, and preliminary efficacy of BAT-CS vs. Standard of Care (SC).", {"entities": []}], ["Participants were recruited during hospitalization for ACS and were randomly assigned to BAT-CS or SC.", {"entities": []}], ["The nicotine patch was offered in both conditions.", {"entities": []}], ["Smoking, mood, and stress outcomes were collected at end-of-treatment and 24-week follow-up.", {"entities": []}], ["Fifty-nine participants (28 BAT-CS, 31 SC) were recruited over 42\u00a0weeks, and assessment completion was above 80% in both conditions.", {"entities": []}], ["Treatment acceptability and fidelity were high.", {"entities": []}], ["At 24\u00a0week follow-up adjusted odds ratios favoring BAT-CS were 1.27 (95% CI: 0.41\u20133.93) for 7-day point prevalence abstinence and 1.27 (95% CI: 0.42\u20133.82) for continuous abstinence.", {"entities": []}], ["Time to first smoking lapse was significantly longer in BAT-CS (62.4 vs. 31.8\u00a0days, p \u00a0=\u00a00.03).", {"entities": []}], ["At 24-weeks, effect sizes for mood and stress outcomes ranged from \u03b7 partial of.07\u2013.11, with significant between treatment effects for positive affect, negative affect, and stress.", {"entities": []}], ["The design of this study proved feasible and acceptable.", {"entities": []}], ["Results provide preliminary evidence that combining behavioral activation with standard smoking cessation counseling could be efficacious for this high risk population.", {"entities": []}], ["A larger trial with longer follow-up is warranted.", {"entities": []}], ["NCT01964898 .", {"entities": []}], ["First received by clinicaltrials.gov October 15, 2013.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4250-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A method for assessing the model validity of randomised controlled trials of homeopathy is needed.", {"entities": []}], ["To date, only conventional standards for assessing intrinsic bias (internal validity) of trials have been invoked, with little recognition of the special characteristics of homeopathy.", {"entities": []}], ["We aimed to identify relevant judgmental domains to use in assessing the model validity of homeopathic treatment (MVHT).", {"entities": []}], ["We define MVHT as the extent to which a homeopathic intervention and the main measure of its outcome, as implemented in a randomised controlled trial (RCT), reflect 'state-of-the-art' homeopathic practice.", {"entities": []}], ["Using an iterative process, an international group of experts developed a set of six judgmental domains, with associated descriptive criteria.", {"entities": []}], ["The domains address: (I) the rationale for the choice of the particular homeopathic intervention; (II) the homeopathic principles reflected in the intervention; (III) the extent of homeopathic practitioner input; (IV) the nature of the main outcome measure; (V) the capability of the main outcome measure to detect change; (VI) the length of follow-up to the endpoint of the study.", {"entities": []}], ["Six papers reporting RCTs of homeopathy of varying design were randomly selected from the literature.", {"entities": []}], ["A standard form was used to record each assessor's independent response per domain, using the optional verdicts 'Yes', 'Unclear', 'No'.", {"entities": []}], ["Concordance among the eight verdicts per domain, across all six papers, was evaluated using the kappa (\u03ba) statistic.", {"entities": []}], ["The six judgmental domains enabled MVHT to be assessed with 'fair' to 'almost perfect' concordance in each case.", {"entities": []}], ["For the six RCTs examined, the method allowed MVHT to be classified overall as 'acceptable' in three, 'unclear' in two, and 'inadequate' in one.", {"entities": []}], ["Future systematic reviews of RCTs in homeopathy should adopt the MVHT method as part of a complete appraisal of trial validity.", {"entities": []}], ["Prior investigations showed that increased levels of cyclic AMP down-regulate lung inflammatory changes, stimulating the interest in phosphodiesterase (PDE)4 as therapeutic target.", {"entities": []}], ["Here, we described the synthesis, pharmacological profile and docking properties of a novel sulfonamide series ( 5 and 6a-k ) designed as PDE4 inhibitors.", {"entities": []}], ["Compounds were screened for their selectivity against the four isoforms of human PDE4 using an IMAP fluorescence polarized protocol.", {"entities": []}], ["The effect on allergen- or LPS-induced lung inflammation and airway hyper-reactivity (AHR) was studied in A/J mice, while the xylazine/ketamine-induced anesthesia test was employed as a behavioral correlate of emesis in rodents.", {"entities": [[86, 89, "GENE"]]}], ["As compared to rolipram, the most promising screened compound, 6a (LASSBio-448) presented a better inhibitory index concerning PDE4D/PDE4A or PDE4D/PDE4B.", {"entities": []}], ["Accordingly, docking analyses of the putative interactions of LASSBio-448 revealed similar poses in the active site of PDE4A and PDE4C, but slight unlike orientations in PDE4B and PDE4D.", {"entities": [[119, 124, "GENE"], [129, 134, "GENE"], [170, 175, "GENE"], [180, 185, "GENE"]]}], ["LASSBio-448 (100 mg/kg, oral), 1 h before provocation, inhibited allergen-induced eosinophil accumulation in BAL fluid and lung tissue samples.", {"entities": []}], ["Under an interventional approach, LASSBio-448 reversed ongoing lung eosinophilic infiltration, mucus exacerbation, peribronchiolar fibrosis and AHR by allergen provocation, in a mechanism clearly associated with blockade of pro-inflammatory mediators such as IL-4, IL-5, IL-13 and eotaxin-2.", {"entities": [[144, 147, "GENE"]]}], ["LASSBio-448 (2.5 and 10 mg/kg) also prevented inflammation and AHR induced by LPS.", {"entities": [[63, 66, "GENE"]]}], ["Finally, the sulfonamide derivative was shown to be less pro-emetic than rolipram and cilomilast in the assay employed.", {"entities": []}], ["These findings suggest that LASSBio-448 is a new PDE4 inhibitor with marked potential to prevent and reverse pivotal pathological features of diseases characterized by lung inflammation, such as asthma.", {"entities": [[195, 201, "DISEASE"]]}], ["First, we present a general analytical approach to estimating the association between medium-term changes in air pollution and health across small areas.", {"entities": []}], ["As a specific illustration, we then applied the approach to data on London residents from a 4-year period to test whether reductions in traffic-related air pollution were associated with reductions in cardio-respiratory hospital admissions.", {"entities": []}], ["A binomial distribution was used to model change in admissions over time in each small area, which was measured as the proportion of admissions in 2003\u20132004 out of admissions over all study years (2001\u20132004).", {"entities": []}], ["Annual average concentrations of nitrogen oxides (NO x ) were modelled using an emissions-dispersion model.", {"entities": []}], ["The association between change in NO x and change in hospital admissions was estimated using logistic regression and an instrumental variable approach.", {"entities": []}], ["For some diagnostic groups, suggestive associations between reductions in NO x and reductions in admissions were observed, for example, OR=0.97 (95% CI 0.96 to 0.99) for an IQR decrease in NO x (3\u2005\u03bcg/m In this illustration, there was relatively limited power to detect an association between changes in air pollution and hospital admissions over time.", {"entities": []}], ["However, the analytical approach could deliver more robust estimates of the health effects of changes in air pollution in settings with greater spatial contrast in changes in air pollution over time.", {"entities": []}], ["Mast cells are known to have a detrimental impact on a variety of pathological conditions.", {"entities": []}], ["There is therefore an urgent need of developing strategies that limit their harmful effects.", {"entities": []}], ["The aim of this study was to accomplish this by developing a means of inducing mast cell apoptosis.", {"entities": []}], ["The strategy was to identify novel compounds that induce mast cell apoptosis by permeabilization of their secretory lysosomes (granules).", {"entities": []}], ["As a candidate, we assessed mefloquine, an anti-malarial drug that has been proposed to have lysosome-permeabilizing activity.", {"entities": []}], ["Mefloquine was added to mast cells and administered in vivo, followed by assessment of the extent and mechanisms of mast cell death.", {"entities": []}], ["Mefloquine was cytotoxic to murine and human mast cells.", {"entities": []}], ["Mefloquine induced apoptotic cell death of wild-type mast cells whereas cells lacking the granule compounds serglycin proteoglycan or tryptase were shown to undergo necrotic cell death, the latter finding indicating a role of the mast cell granules in mefloquine-induced cell death.", {"entities": []}], ["In support of this, mefloquine was shown to cause compromised granule integrity and to induce leakage of granule components into the cytosol.", {"entities": []}], ["Mefloquine-induced cell death was refractory to caspase inhibitors but was completely abrogated by reactive oxygen species inhibition.", {"entities": []}], ["These findings identify mefloquine as a novel anti-mast cell agent, which induces mast cell death through a granule-mediated pathway.", {"entities": []}], ["Mefloquine may thus become useful in therapy aiming at limiting harmful effects of mast cells.", {"entities": []}], ["Many patients with chronic heart failure (CHF) receive treatment in primary care, but data have shown that the quality of care for these patients needs to be improved.", {"entities": []}], ["We aimed to evaluate the impact and feasibility of a programme for improving primary care for patients with CHF.", {"entities": []}], ["An observational study was performed in 19 general practices in the south-eastern part of the Netherlands, evaluation involving 15 general practitioners and 77 CHF patients.", {"entities": []}], ["The programme for improvement comprised educational and organizational components and was delivered by a trained practice visitor to the practices.", {"entities": []}], ["The evaluation was based on case registration forms completed by health professionals and telephone interviews.", {"entities": []}], ["Management relating to diet and physical exercise seemed to have improved as eight patients were referred to dieticians and five to physiotherapists.", {"entities": []}], ["The seasonal influenza vaccination rate increased from 94% to 97% (75/77).", {"entities": [[13, 22, "DISEASE"]]}], ["No impact on smoking was observed.", {"entities": []}], ["Pharmaceutical treatment was adjusted according to guideline recommendations in 12% of the patients (9/77); 7 patients started recommended medication and 2 patients received dosage adjustments.", {"entities": []}], ["General practitioners perceived the programme to be feasible.", {"entities": []}], ["Clinical task delegation to nurses and assistants increased in some practices, but collaboration with other healthcare providers remained limited.", {"entities": []}], ["The improvement programme proved to have moderate impact on patient care.", {"entities": []}], ["Its effectiveness should be tested in a larger rigorous evaluation study using modifications based on the pilot experiences.", {"entities": []}], ["Adherence to preventive drug treatment is a clinical problem and we hypothesised that patients\u2019 beliefs about medicines and stroke are associated with adherence.", {"entities": []}], ["The objective was to examine associations between beliefs of patients with stroke about stroke and drug treatment and their adherence to drug treatment.", {"entities": []}], ["Cross-sectional questionnaire survey.", {"entities": []}], ["Patients with stroke from 25 Swedish hospitals were included.", {"entities": []}], ["Questionnaires were sent to 989 patients to assess their perceptions about stroke (Brief Illness Perception Questionnaire, Brief IPQ), beliefs about medicines (Beliefs about Medicines Questionnaires, BMQ) and adherence to treatment (Medication Adherence Report Scale, MARS) 3\u2005months after stroke onset.", {"entities": [[268, 272, "GENE"]]}], ["Only patients living at home were included in the analysis.", {"entities": []}], ["The primary outcome was self-reported adherence as measured on MARS.", {"entities": [[63, 67, "GENE"]]}], ["MARS scores were dichotomised into adherent/non-adherent.", {"entities": [[0, 4, "GENE"]]}], ["Background and clinical data from the Swedish Stroke register were included.", {"entities": []}], ["811 patients were still living at home and 595 answered the questionnaire.", {"entities": []}], ["Complete MARS data were available for 578 patients and 72 (12.5%) of these were classified as non-adherent.", {"entities": [[9, 13, "GENE"]]}], ["Non-adherent patients scored lower on positive beliefs as measured on BMQ-necessity (OR\u2009=\u20090.90, 95% CI 0.83 to 0.98) and BMQ-benefit (OR=0.77, 95% CI 0.68 to 0.87), and higher on negative beliefs as measured on BMQ-concern (OR=1.12, 95% CI 1.05 to 1.21), BMQ-overuse (OR=1.29, 95% CI 1.14 to 1.45), and BMQ-harm (OR=1.12, 95% CI 1.01 to 1.24).", {"entities": []}], ["The Brief IPQ showed that non-adherent patients believed their current treatment to be less useful (p=0.001).", {"entities": []}], ["This study showed associations between beliefs of Swedish patients with stroke about medicines and adherence.", {"entities": []}], ["Positive beliefs were less common and negative more common among non-adherent.", {"entities": []}], ["To improve adherence, patients\u2019 beliefs about medicines should be considered.", {"entities": []}], ["Antiepileptic drugs (AEDs) are widely used as long-term adjunctive therapy or as monotherapy in epilepsy and other indications and consist of a group of drugs that are highly susceptible to drug interactions.", {"entities": []}], ["The purpose of the present review is to focus upon clinically relevant interactions where AEDs are involved and especially on pharmacokinetic interactions.", {"entities": []}], ["The older AEDs are susceptible to cause induction (carbamazepine, phenobarbital, phenytoin, primidone) or inhibition (valproic acid), resulting in a decrease or increase, respectively, in the serum concentration of other AEDs, as well as other drug classes (anticoagulants, oral contraceptives, antidepressants, antipsychotics, antimicrobal drugs, antineoplastic drugs, and immunosupressants).", {"entities": []}], ["Conversely, the serum concentrations of AEDs may be increased by enzyme inhibitors among antidepressants and antipsychotics, antimicrobal drugs (as macrolides or isoniazid) and decreased by other mechanisms as induction, reduced absorption or excretion (as oral contraceptives, cimetidine, probenicid and antacides).", {"entities": []}], ["Pharmacokinetic interactions involving newer AEDs include the enzyme inhibitors felbamate, rufinamide, and stiripentol and the inducers oxcarbazepine and topiramate.", {"entities": []}], ["Lamotrigine is affected by these drugs, older AEDs and other drug classes as oral contraceptives.", {"entities": []}], ["Individual AED interactions may be divided into three levels depending on the clinical consequences of alterations in serum concentrations.", {"entities": []}], ["This approach may point to interactions of specific importance, although it should be implemented with caution, as it is not meant to oversimplify fact matters.", {"entities": []}], ["Level 1 involves serious clinical consequences, and the combination should be avoided.", {"entities": []}], ["Level 2 usually implies cautiousness and possible dosage adjustments, as the combination may not be possible to avoid.", {"entities": []}], ["Level 3 refers to interactions where dosage adjustments are usually not necessary.", {"entities": []}], ["Updated knowledge regarding drug interactions is important to predict the potential for harmful or lacking effects involving AEDs.", {"entities": []}], ["Community-acquired pneumonia (CAP) is a common cause of pediatric admission to hospital.", {"entities": [[19, 28, "DISEASE"]]}], ["The objectives of this study were twofold: 1) to describe the clinical characteristics of CAP in children admitted to a tertiary care pediatric hospital in the pneumococcal vaccination era and, 2) to examine the antimicrobial selection in hospital and on discharge.", {"entities": []}], ["A retrospective review of healthy immunocompetent children admitted to a tertiary pediatric hospital from January 2007 to December 2008 with clinical features consistent with pneumonia and a radiographically-confirmed consolidation was performed.", {"entities": [[175, 184, "DISEASE"]]}], ["Clinical, microbiological and antimicrobial data were collected.", {"entities": []}], ["One hundred and thirty-five hospitalized children with pneumonia were evaluated.", {"entities": [[55, 64, "DISEASE"]]}], ["Mean age at admission was 4.8 years (range 0\u201317 years).", {"entities": []}], ["Two thirds of patients had been seen by a physician in the 24 hours prior to presentation; 56 (41.5%) were on antimicrobials at admission.", {"entities": []}], ["52 (38.5%) of patients developed an effusion, and 22/52 (42.3%) had pleural fluid sampled.", {"entities": []}], ["Of 117 children who had specimens (blood/pleural fluid) cultured, 9 (7.7%) had pathogens identified (7 Streptococcus pneumoniae, 1 Group A Streptococcus, and 1 Rhodococcus).", {"entities": []}], ["55% of patients received 2 or more antimicrobials in hospital.", {"entities": []}], ["Cephalosporins were given to 130 patients (96.1%) in hospital.", {"entities": []}], ["Only 21/126 patients (16.7%) were discharged on amoxicillin.", {"entities": []}], ["The median length of stay was 3 days (IQR 2\u20134) for those without effusion and 9 (IQR 5\u201313) for those with effusion.", {"entities": []}], ["No deaths were related to pneumonia.", {"entities": [[26, 35, "DISEASE"]]}], ["This study provides comprehensive data on the clinical characteristics of hospitalized children with CAP in the pneumococcal 7-valent vaccine era.", {"entities": []}], ["Empiric antimicrobial choice at our institution is variable, highlighting a need for heightened antimicrobial stewardship.", {"entities": []}], ["Atopic dermatitis (AD, atopic eczema) is driven by a complex relationship between genetic predisposition and environmental exposures.", {"entities": [[7, 17, "DISEASE"]]}], ["We sought to determine the impact of specific climatic factors on the US prevalence of AD.", {"entities": []}], ["We used a merged analysis of the 2007 National Survey of Children's Health from a representative sample of 91,642 children age 0\u201317 years and the 2006\u20132007 National Climate Data Center and Weather Service measurements of relative humidity (%), indoor heating degree days (HDD), clear sky UV indices ozone levels, and outdoor air temperature.", {"entities": []}], ["As a proxy for AD, we used an affirmative response to the NSCH survey question asking whether the participant\u2019s child has been given a doctor diagnosis of \u201ceczema or any other kind of skin allergy\u201d in the previous 12 months.", {"entities": []}], ["In multivariate models controlling for sex, race/ethnicity, age and household income, eczema prevalence was significantly lower with highest-quartile mean annual relative humidity (logistic regression, adjusted odds ratio [95% confidence interval]=0.82 [0.71\u20130.96], P=0.01) and issued UV index (0.73 [0.64\u20130.84], P<0.0001), and with two other factors associated with increased UV exposure.", {"entities": []}], ["Eczema prevalence was decreased with highest-quartile air temperature (0.80 [0.70\u20130.92], P=0.002), but increased with 3", {"entities": []}], ["Suppression of gonadal testosterone synthesis represents the standard first line therapy for treatment of metastatic prostate cancer.", {"entities": [[126, 132, "DISEASE"], [117, 132, "DISEASE"]]}], ["However, in the majority of patients who develop castration-resistant prostate cancer (CRPC), it is possible to detect persistent activation of the androgen receptor (AR) through androgens produced in the adrenal gland or within the tumor itself.", {"entities": [[79, 85, "DISEASE"], [70, 85, "DISEASE"]]}], ["Abiraterone acetate was developed as an irreversible inhibitor of the dual functional cytochrome P450 enzyme CYP17 with activity as a 17\u03b1-hydroxylase and 17,20-lyase.", {"entities": []}], ["CYP17 is necessary for production of nongonadal androgens from cholesterol.", {"entities": []}], ["Regulatory approval of abiraterone in 2011, based on a phase III trial showing a significant improvement in overall survival (OS) with abiraterone and prednisone versus prednisone, represented proof of principle that targeting AR is essential for improving outcomes in men with CRPC.", {"entities": []}], ["Inhibition of 17\u03b1-hydroxylase by abiraterone results in accumulation of upstream mineralocorticoids due to loss of cortisol-mediated suppression of pituitary adrenocorticotropic hormone (ACTH), providing a rationale for development of CYP17 inhibitors with increased specificity for 17,20-lyase (orteronel, galeterone and VT-464) that can potentially be administered without exogenous corticosteroids.", {"entities": []}], ["In this article, we review the development of abiraterone and other CYP17 inhibitors; recent studies with abiraterone that inform our understanding of clinical parameters such as drug effects on quality-of-life, potential early predictors of response, and optimal sequencing of abiraterone with respect to other agents; and results of translational studies providing insights into resistance mechanisms to CYP17 inhibitors leading to clinical trials with drug combinations designed to prolong abiraterone benefit or restore abiraterone activity.", {"entities": []}], ["The biological activities of macrophage migration inhibitory factor (MIF) might be mediated through a classical receptor- mediated or non-classical endocytic pathway.", {"entities": [[69, 72, "GENE"]]}], ["JAB1 (C-Jun activation domain-binding protein-1) promotes the degradation of the tumor suppressor, p53, and the cyclin-dependent kinase inhibitor, p27.", {"entities": []}], ["When MIF and JAB1 are bound to each other in various intracellular sites, MIF inhibits the positive regulatory effects of JAB1 on the activity of AP-1.", {"entities": [[5, 8, "GENE"], [74, 77, "GENE"], [5, 8, "GENE"], [74, 77, "GENE"]]}], ["The intestinal parasite, Anisakis simplex , has an immunomodulatory effect.", {"entities": []}], ["The molecular mechanism of action of As-MIF and human JAB1 are poorly understood.", {"entities": []}], ["In this study, As-MIF and hJAB1 were expressed and purified with high solubility.", {"entities": []}], ["The structure of As-MIF and hJAB1 interaction was modeled by homology modeling based on the structure of Ace-MIF.", {"entities": []}], ["This study provides evidence indicating that the MIF domain of As-MIF interacts directly with the MPN domain of hJAB1, and four structure-based mutants of As-MIF and hJAB1 disrupt the As-MIF-hJAB1 interaction.", {"entities": [[49, 52, "GENE"], [66, 69, "GENE"], [158, 161, "GENE"], [187, 190, "GENE"]]}], ["The TRPA1 ion channel is expressed in nociceptive (pain-sensitive) somatosensory neurons and is activated by a wide variety of chemical irritants, such as acrolein in smoke or isothiocyanates in mustard.", {"entities": [[4, 9, "GENE"]]}], ["Here, we investigate the enhancement of TRPA1 function caused by inflammatory mediators, which is thought to be important in lung conditions such as asthma and COPD.", {"entities": [[149, 155, "DISEASE"], [40, 45, "GENE"]]}], ["Protein kinase A is an important kinase acting downstream of inflammatory mediators to cause sensitization of TRPA1.", {"entities": [[110, 115, "GENE"]]}], ["By using site-directed mutagenesis, patch-clamp electrophysiology and calcium imaging we identify four amino acid residues, S86, S317, S428, and S972, as the principal targets of PKA-mediated phosphorylation and sensitization of TRPA1.", {"entities": [[229, 234, "GENE"]]}], ["The aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1\u00a0year post-chemotherapy.", {"entities": [[87, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["A single-center longitudinal study was conducted with ESBC patients diagnosed between December 2011 and June 2014.", {"entities": []}], ["Data on the medication use of individual patients were retrieved from prescription databases, supplemented by records from the National Electronic Health Records.", {"entities": []}], ["The data covered the period from ESBC diagnosis to 1\u00a0year post-chemotherapy.", {"entities": []}], ["Medication types were classified according to the World Health Organization\u2019s Anatomical Therapeutic Chemical classification system, and medication for chronic diseases was created by adapting a list of 20 chronic diseases provided by the U.S. Department of Human and Health Services.", {"entities": []}], ["Of the 107 patients involved in the study (mean age 51.1\u2009\u00b1\u20098.4\u00a0years; 78.5\u00a0% Chinese), 46.7\u00a0% manifested non-cancer comorbidities, of which hypertension (24.3\u00a0%) was the most prevalent, followed by hyperlipidemia (13.1\u00a0%) and diabetes (5.6\u00a0%).", {"entities": [[140, 152, "DISEASE"], [109, 115, "DISEASE"]]}], ["Calcium channel blockers (12.1\u00a0%) and lipid-modifying agents (11.2\u00a0%) were the most common chronic medication types used before chemotherapy, and their use persisted during chemotherapy (10.3 and 11.2\u00a0%, respectively) and after chemotherapy (11.2 and 13.1\u00a0%, respectively).", {"entities": []}], ["Hormonal therapy was the predominant post-chemotherapy medication (77.6\u00a0%).", {"entities": []}], ["A statistically significant increase ( p \u2009<\u20090.0001) was observed in the mean number of chronic disease medication classes prescribed to patients between the pre-chemotherapy (0.53\u2009\u00b1\u20091.04) and chemotherapy (0.62\u2009\u00b1\u20091.08) periods and between the chemotherapy and post-chemotherapy (1.63\u2009\u00b1\u20091.35) periods.", {"entities": []}], ["There is an increase in trend of chronic medication usage in breast cancer survivors after cancer treatment.", {"entities": [[61, 74, "DISEASE"], [68, 74, "DISEASE"], [91, 97, "DISEASE"]]}], ["This study provides important insights into the design of medication management programs tailored to this population.", {"entities": []}], ["Future studies should incorporate a control population to improve the interpretation of study results.", {"entities": []}], ["Bee venom acupuncture (BVA) is an effective treatment for chronic low back pain (CLBP) through the pharmacological effects of bee venom and the simultaneous stimulation of acupoints.", {"entities": []}], ["However, evidence of its efficacy and safety in humans remains unclear.", {"entities": []}], ["Using a double-blind, randomized study, 54 patients with non-specific CLBP were assigned to the BVA and sham groups.", {"entities": []}], ["All participants underwent six sessions of real or sham BVA for 3 weeks, in addition to administration of 180 mg of loxonin per day.", {"entities": []}], ["The primary outcome, that is, \u201cbothersomeness\u201d derived from back pain, was assessed using the visual analog scale.", {"entities": []}], ["Secondary outcomes included pain intensity, dysfunction related to back pain (Oswestry Disability Index), quality of life (EuroQol 5-Dimension), and depressive mood (Beck\u2019s depression inventory).", {"entities": []}], ["Outcomes were evaluated every week during the treatment period and followed up at weeks 4, 8, and 12.", {"entities": []}], ["After 3 weeks of the treatment, significant improvements were observed in the bothersomeness, pain intensity, and functional status in the BVA group compared with the sham group.", {"entities": []}], ["Although minimal adverse events were observed in both groups, subsequent recovery was achieved without treatment.", {"entities": []}], ["Consequently, our results suggest that it can be used along with conventional pharmacological therapies for the treatment of CLBP.", {"entities": []}], ["Exposure to air pollution is a leading global health risk.", {"entities": []}], ["Secondary organic aerosol (SOA) constitute a large portion of ambient particulate matter (PM).", {"entities": []}], ["In this study, the water-soluble oxidative potential (OP) determined by dithiothreitol (DTT) consumption and intracellular reactive oxygen and nitrogen species (ROS/RNS) production was measured for SOA generated from the photooxidation of naphthalene in the presence of iron sulfate and ammonium sulfate seed particles.", {"entities": []}], ["The measured intrinsic OP varied for aerosol formed using different initial naphthalene concentrations, however, no trends were observed between OP and bulk aerosol composition or seed type.", {"entities": []}], ["For all experiments, aerosol generated in the presence of iron-containing seed induced higher ROS/RNS production compared to that formed in the presence of inorganic seed.", {"entities": []}], ["This effect was primarily attributed to differences in aerosol carbon oxidation state \\documentclass[12pt]{minimal} \t\t\t\t\\usepackage{amsmath} \t\t\t\t\\usepackage{wasysym} \t\t\t\t\\usepackage{amsfonts} \t\t\t\t\\usepackage{amssymb} \t\t\t\t\\usepackage{amsbsy} \t\t\t\t\\usepackage{mathrsfs} \t\t\t\t\\usepackage{upgreek} \t\t\t\t\\setlength{\\oddsidemargin}{-69pt} \t\t\t\t\\begin{document}$${\\boldsymbol{(}}{\\bar{{\\bf{O}}{\\bf{S}}}}_{{\\bf{c}}}{\\boldsymbol{)}}$$\\end{document} ( O S \u00af c ) .", {"entities": []}], ["In the presence of iron, radical concentrations are elevated via iron redox cycling, resulting in more oxidized species.", {"entities": []}], ["An exponential trend was also observed between ROS/RNS and \\documentclass[12pt]{minimal} \t\t\t\t\\usepackage{amsmath} \t\t\t\t\\usepackage{wasysym} \t\t\t\t\\usepackage{amsfonts} \t\t\t\t\\usepackage{amssymb} \t\t\t\t\\usepackage{amsbsy} \t\t\t\t\\usepackage{mathrsfs} \t\t\t\t\\usepackage{upgreek} \t\t\t\t\\setlength{\\oddsidemargin}{-69pt} \t\t\t\t\\begin{document}$${\\boldsymbol{(}}{\\bar{{\\bf{O}}{\\bf{S}}}}_{{\\bf{c}}}{\\boldsymbol{)}}$$\\end{document} ( O S \u00af c ) for all naphthalene SOA, regardless of seed type or aerosol formation condition.", {"entities": []}], ["This may have important implications as aerosol have an atmospheric lifetime of a week, over which \\documentclass[12pt]{minimal} \t\t\t\t\\usepackage{amsmath} \t\t\t\t\\usepackage{wasysym} \t\t\t\t\\usepackage{amsfonts} \t\t\t\t\\usepackage{amssymb} \t\t\t\t\\usepackage{amsbsy} \t\t\t\t\\usepackage{mathrsfs} \t\t\t\t\\usepackage{upgreek} \t\t\t\t\\setlength{\\oddsidemargin}{-69pt} \t\t\t\t\\begin{document}$${\\boldsymbol{(}}{\\bar{{\\bf{O}}{\\bf{S}}}}_{{\\bf{c}}}{\\boldsymbol{)}}$$\\end{document} ( O S \u00af c ) increases due to continued photochemical aging, potentially resulting in more toxic aerosol.", {"entities": []}], ["Human \u03b2-globin disorders are relatively common genetic diseases cause by mutations in the \u03b2-globin gene.", {"entities": []}], ["Increasing the expression of the \u03b3 -globin gene has great benefits in reducing complications associated with these diseases.", {"entities": []}], ["The Oct-1 transcription factor is involved in the transcriptional regulation of the \u03b3-globin gene.", {"entities": []}], ["The human \u03b3 -globin genes (both A \u03b3 and G \u03b3 -globin genes) carry three Oct-1 transcription factor consensus sequences within their promoter regions.", {"entities": []}], ["We have studied the possibility of inducing \u03b3 -globin gene expression using decoy oligonucleotides that target the Oct-1 transcription factor consensus sequence.", {"entities": []}], ["A double-stranded 22 bp decoy oligonucleotide containing the Oct-1 consensus sequence was synthesized.", {"entities": []}], ["The results obtained from our in vitro binding assay revealed a strong competitive binding of the decoy oligonucleotide for the Oct-1 transcription factor.", {"entities": []}], ["When K562 human erythroleukemia cells were treated with the Oct-1 decoy oligonucleotide, significant increases in the level of the \u03b3 -globin mRNA were observed.", {"entities": []}], ["The results of our western blots further demonstrated significant increases of the fetal hemoglobin (HbF, \u03b12\u03b32) in the Oct-1 decoy oligonucleotide-treated K562 cells.", {"entities": []}], ["The results of our immunoprecipitation (IP) studies revealed that the treatment of K562 cells with the Oct-1 decoy oligonucleotide significantly reduced the level of the endogenous \u03b3 -globin gene promoter region DNA co-precipitated with the Oct-1 transcription factor.", {"entities": []}], ["These results suggest that the decoy oligonucleotide designed for the Oct-1 transcription factor consensus sequence could induce expression of the endogenous \u03b3 -globin gene through competitive binding of the Oct-1 transcription factor, resulting in activation of the \u03b3 -globin genes.", {"entities": []}], ["Therefore, disrupting the bindings of the Oct-1 transcriptional factors with the decoy oligonucleotide provides a novel approach for inducing expression of the \u03b3 -globin genes.", {"entities": []}], ["It also provides an innovative strategy for the treatment of many disease conditions, including sickle cell anemia and \u03b2-thalassemia.", {"entities": [[96, 114, "DISEASE"], [121, 132, "DISEASE"], [108, 114, "DISEASE"]]}], ["The study of cross-reactivity in allergy is key to both understanding.", {"entities": []}], ["the allergic response of many patients and providing them with a rational treatment In the present study, protein microarrays and a co-sensitization graph approach were used in conjunction with an allergen microarray immunoassay.", {"entities": []}], ["This enabled us to include a wide number of proteins and a large number of patients, and to study sensitization profiles among members of the LTP family.", {"entities": []}], ["Fourteen LTPs from the most frequent plant food-induced allergies in the geographical area studied were printed into a microarray specifically designed for this research.", {"entities": []}], ["212 patients with fruit allergy and 117 food-tolerant pollen allergic subjects were recruited from seven regions of Spain with different pollen profiles, and their sera were tested with allergen microarray.", {"entities": []}], ["This approach has proven itself to be a good tool to study cross-reactivity between members of LTP family, and could become a useful strategy to analyze other families of allergens.", {"entities": []}], ["Recent advances demonstrate a relationship between chronic/recurrent inflammation and prostate cancer (PCA).", {"entities": [[95, 101, "DISEASE"], [86, 101, "DISEASE"]]}], ["Among inflammatory regulators, toll-like receptors (TLRs) play a critical role in innate immune responses.", {"entities": []}], ["However, it remains unclear whether variant TLR genes influence PCA risk among men of African descent.", {"entities": []}], ["Therefore, we evaluated the impact of 32 TLR -associated single nucleotide polymorphisms (SNPs) on PCA risk among African-Americans and Jamaicans.", {"entities": []}], ["SNP profiles of 814 subjects were evaluated using Illumina\u2019s Veracode genotyping platform.", {"entities": []}], ["Single and combined effects of SNPs in relation to PCA risk were assessed using age-adjusted logistic regression and entropy-based multifactor dimensionality reduction (MDR) models.", {"entities": []}], ["Seven sequence variants detected in TLR6 , TOLLIP , IRAK4 , IRF3 were marginally related to PCA.", {"entities": [[36, 40, "GENE"], [43, 49, "GENE"], [52, 57, "GENE"], [60, 64, "GENE"]]}], ["However, none of these effects remained significant after adjusting for multiple hypothesis testing.", {"entities": []}], ["Nevertheless, MDR modeling revealed a complex interaction between IRAK4 rs4251545 and TLR2 rs1898830 as a significant predictor of PCA risk among U.S. men (permutation testing p-value = 0.001).", {"entities": [[66, 71, "GENE"], [86, 90, "GENE"]]}], ["MDR identified an interaction between IRAK4 and TLR2 as the best two factor model for predicting PCA risk among men of African descent.", {"entities": [[38, 43, "GENE"], [48, 52, "GENE"]]}], ["However, these findings require further assessment and validation.", {"entities": []}], ["Myocardial infarction causes significant mortality and morbidity.", {"entities": [[0, 21, "DISEASE"]]}], ["Timely diagnosis allows clinicians to risk stratify their patients and select appropriate treatment.", {"entities": []}], ["Biomarkers have been used to assist with timely diagnosis, while an increasing number of novel markers have been identified to predict outcome following an acute myocardial infarction or acute coronary syndrome.", {"entities": [[202, 210, "DISEASE"], [162, 183, "DISEASE"], [156, 183, "DISEASE"]]}], ["This may facilitate tailoring of appropriate therapy to high-risk patients.", {"entities": []}], ["This review focuses on a variety of promising biomarkers which provide diagnostic and prognostic information.", {"entities": []}], ["Heart-type Fatty Acid Binding Protein and copeptin in combination with cardiac troponin help diagnose myocardial infarction or acute coronary syndrome in the early hours following symptoms.", {"entities": [[142, 150, "DISEASE"], [102, 123, "DISEASE"]]}], ["An elevated N-Terminal Pro-B-type Natriuretic Peptide has been well validated to predict death and heart failure following a myocardial infarction.", {"entities": [[125, 146, "DISEASE"]]}], ["Similarly other biomarkers such as Mid-regional pro-Atrial Natriuretic Peptide, ST2, C-Terminal pro-endothelin 1, Mid-regional pro-Adrenomedullin and copeptin all provide incremental information in predicting death and heart failure.", {"entities": []}], ["Growth differentiation factor-15 and high-sensitivity C-reactive protein predict death following an acute coronary syndrome.", {"entities": [[115, 123, "DISEASE"]]}], ["Pregnancy associated plasma protein A levels following chest pain predicts risk of myocardial infarction and revascularisation.", {"entities": [[83, 104, "DISEASE"]]}], ["Some biomarkers such as myeloperoxidase and high-sensitivity C-reactive protein in an apparently healthy population predicts risk of coronary disease and allows clinicians to initiate early preventative treatment.", {"entities": []}], ["In addition to biomarkers, various well-validated scoring systems based on clinical characteristics are available to help clinicians predict mortality risk, such as the Thrombolysis In Myocardial Infarction score and Global Registry of Acute Coronary Events score.", {"entities": [[185, 206, "DISEASE"]]}], ["A multimarker approach incorporating biomarkers and clinical scores will increase the prognostic accuracy.", {"entities": []}], ["However, it is important to note that only troponin has been used to direct therapeutic intervention and none of the new prognostic biomarkers have been tested and proven to alter outcome of therapeutic intervention.", {"entities": []}], ["Novel biomarkers have improved prediction of outcome in acute myocardial infarction, but none have been demonstrated to alter the outcome of a particular therapy or management strategy.", {"entities": [[62, 83, "DISEASE"], [56, 83, "DISEASE"]]}], ["Randomised trials are urgently needed to address this translational gap before the use of novel biomarkers becomes common practice to facilitate tailored treatment following an acute coronary event.", {"entities": []}], ["Tribulus terrestris ( T. terrestris ) has been used as a traditional medicine for the treatment of a variety of diseases, including inflammation, edema and hypertension.", {"entities": [[156, 168, "DISEASE"]]}], ["The aqueous and ethanol extracts of T. terrestris contain alkaloids, flavonoids, tannins, quinines and phenolic compounds.", {"entities": []}], ["Tribulusamide D is a compound that has been isolated from the ethanol extract of T. terrestris .", {"entities": []}], ["The present study investigated the anti-inflammatory effect of tribulusamide D on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.", {"entities": []}], ["Tribulusamide D inhibited the production of LPS-induced nitric oxide and prostaglandin E 2 , by reducing the expression of inducible nitric oxide synthase and cyclooxygenase-2 expression, respectively.", {"entities": []}], ["The expression of these genes associated with inflammation was determined using reverse transcription-polymerase chain reaction and western blot analysis.", {"entities": []}], ["Furthermore, tribulusamide D reduced the expression of LPS-induced inflammatory cytokines, including interleukin (IL)-6, IL-10 and tumor necrosis factor-\u03b1.", {"entities": []}], ["They were quantified using an enzyme-linked immunosorbent assay.", {"entities": []}], ["In addition, the present study confirmed that the inhibitory effects of tribulusamide D on the inflammatory response were mediated through inactivation of mitogen-activated protein kinase p38 and inhibition of nuclear localization of nuclear factor-B, which were also determined by western blot analysis.", {"entities": []}], ["To the best of our knowledge, the current study is the first to demonstrate that tribulusamide D exerts anti-inflammatory activity by altering the expression of inflammatory mediators and cytokines, indicating that tribulusamide D could be developed as a potential therapeutic agent for the treatment of inflammatory disorders.", {"entities": []}], ["In a community in northern Chile, explosive procedures are used by two local industrial mines (gold, copper).", {"entities": []}], ["We hypothesized that the prevalence of asthma and rhinoconjunctivitis in the community may be associated with air pollution emissions generated by the mines.", {"entities": [[39, 45, "DISEASE"]]}], ["A cross-sectional study of 288 children (aged 6\u201315 years) was conducted in a community in northern Chile using a validated questionnaire in 2009.", {"entities": []}], ["The proximity between each child\u2019s place of residence and the mines was assessed as indicator of exposure to mining related air pollutants.", {"entities": []}], ["Logistic regression, semiparametric models and spatial Bayesian models with a parametric form for distance were used to calculate odds ratios and 95\u00a0% confidence intervals.", {"entities": []}], ["The prevalence of asthma and rhinoconjunctivitis was 24 and 34\u00a0%, respectively.", {"entities": [[18, 24, "DISEASE"]]}], ["For rhinoconjunctivitis, the odds ratio for average distance between both mines and child\u2019s residence was 1.72 (95\u00a0% confidence interval 1.00, 3.04).", {"entities": []}], ["The spatial Bayesian models suggested a considerable increase in the risk for respiratory diseases closer to the mines, and only beyond a minimum distance of more than 1800\u00a0m the health impact was considered to be negligible.", {"entities": []}], ["The findings indicate that air pollution emissions related to industrial gold or copper mines mainly occurring in rural Chilean communities might increase the risk of respiratory diseases in children.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-016-0149-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic obstructive pulmonary disease and emphysema develops in 15% of ex-smokers despite sustained quitting, while 10% are free of emphysema or severe lung obstruction.", {"entities": [[0, 37, "DISEASE"]]}], ["The cause of the incapacity of the immune system to clear the inflammation in the first group remains unclear.", {"entities": []}], ["We searched genes that were protecting ex-smokers without emphysema, using microarrays on portions of human lungs surgically removed; we found that loss of lung function in patients with chronic obstructive pulmonary disease and emphysema was associated with a lower expression of CD46 and verified this finding by qRT-PCR and flow cytometry.", {"entities": [[187, 224, "DISEASE"], [281, 285, "GENE"]]}], ["Also, there was a significant association among decreased CD46 These data suggest that higher expression of CD46 in the lungs of ex-smoker protects them from emphysema and chronic obstructive pulmonary disease by clearing the inflammation impeding the proliferation of CD8", {"entities": [[172, 209, "DISEASE"], [58, 62, "GENE"], [108, 112, "GENE"], [58, 62, "GENE"], [108, 112, "GENE"]]}], ["Mucopolysaccharidosis type II, an X-linked recessive disorder is the most common lysosomal storage disease detected among Filipinos.", {"entities": [[81, 106, "DISEASE"]]}], ["This is a case series involving 23 male Filipino patients confirmed to have Hunter syndrome.", {"entities": [[83, 91, "DISEASE"]]}], ["The clinical and biochemical characteristics were obtained and mutation testing of the IDS gene was done on the probands and their female relatives.", {"entities": [[87, 90, "GENE"]]}], ["The mean age of the patients was 11.28 (SD 4.10) years with an average symptom onset at 1.2 (SD 1.4) years.", {"entities": []}], ["The mean age at biochemical diagnosis was 8 (SD 3.2) years.", {"entities": []}], ["The early clinical characteristics were developmental delay, joint stiffness, coarse facies, recurrent respiratory tract infections, abdominal distention and hernia.", {"entities": []}], ["Majority of the patients had joint contractures, severe intellectual disability, error of refraction, hearing loss and valvular regurgitation on subspecialists\u2019 evaluation.", {"entities": [[56, 79, "DISEASE"]]}], ["The mean GAG concentration was 506.5\u00a0mg (SD 191.3)/grams creatinine while the mean plasma iduronate-2-sulfatase activity was 0.86 (SD 0.79) nmol/mg plasma/4\u00a0h. Fourteen (14) mutations were found: 6 missense (42.9%), 4 nonsense (28.6%), 2 frameshift (14.3%), 1 exon skipping at the cDNA level (7.1%), and 1 gross insertion (7.1%).", {"entities": []}], ["Six (6) novel mutations were observed (43%): p.C422F, p.P86Rfs*44, p.Q121*, p.L209Wfs*4, p.T409R, and c.1461_1462insN[710].", {"entities": []}], ["The age at diagnosis in this series was much delayed and majority of the patients presented with severe neurologic impairment.", {"entities": []}], ["The results of the biochemical tests did not contribute to the phenotypic classification of patients.", {"entities": []}], ["The effects of the mutations were consistent with the severe phenotype seen in the majority of the patients.", {"entities": []}], ["Group 2 innate lymphoid cells (ILC2s) release interleukin-13 (IL-13) during protective immunity to helminth infection and detrimentally during allergy and asthma.", {"entities": [[155, 161, "DISEASE"]]}], ["Using two mouse models to deplete ILC2s in\u00a0vivo, we demonstrate that T helper 2 (Th2) cell responses are impaired in the absence of ILC2s.", {"entities": []}], ["We show that MHCII-expressing ILC2s interact with antigen-specific T\u00a0cells to instigate a dialog in which IL-2 production from T\u00a0cells promotes ILC2 proliferation and IL-13 production.", {"entities": []}], ["Deletion of MHCII renders IL-13-expressing ILC2s incapable of efficiently inducing Nippostrongylus brasiliensis expulsion.", {"entities": []}], ["Thus, during transition to adaptive T\u00a0cell-mediated immunity, the ILC2 and T\u00a0cell crosstalk contributes to their mutual maintenance, expansion and cytokine production.", {"entities": []}], ["This interaction appears to augment dendritic-cell-induced T\u00a0cell activation and identifies a previously unappreciated pathway in the regulation of type-2 immunity.", {"entities": []}], ["\u2022 Genetic ablation of ILC2s impairs type-2 immunity \u2022 MHCII-expressing ILC2s potentiate Th2 responses \u2022 IL-2 from T\u00a0cells promotes ILC2 proliferation and expression of type-2 cytokines \u2022 MHCII and IL-13 expression by ILC2s is important for N.\u00a0brasiliensis expulsion Genetic ablation of ILC2s impairs type-2 immunity MHCII-expressing ILC2s potentiate Th2 responses IL-2 from T\u00a0cells promotes ILC2 proliferation and expression of type-2 cytokines MHCII and IL-13 expression by ILC2s is important for N.\u00a0brasiliensis expulsion Type-2 innate lymphoid cells proliferate and release interleukin-13 during protective immunity to helminth infection and detrimentally during allergy and asthma.", {"entities": [[678, 684, "DISEASE"]]}], ["McKenzie and colleagues establish that these activities are potentiated through an MHC class II-mediated dialogue with T\u00a0cells.", {"entities": []}], ["Lower respiratory tract infections continue to exact unacceptable worldwide mortality, often because the infecting pathogen cannot be identified.", {"entities": []}], ["The respiratory epithelia provide protection from pneumonias through organism-specific generation of antimicrobial products, offering potential insight into the identity of infecting pathogens.", {"entities": []}], ["This study assesses the capacity of the host gene expression response to infection to predict the presence and identity of lower respiratory pathogens without reliance on culture data.", {"entities": []}], ["Mice were inhalationally challenged with S. pneumoniae , P. aeruginosa , A. fumigatus or saline prior to whole genome gene expression microarray analysis of their pulmonary parenchyma.", {"entities": []}], ["Characteristic gene expression patterns for each condition were identified, allowing the derivation of prediction rules for each pathogen.", {"entities": []}], ["After confirming the predictive capacity of gene expression data in blinded challenges, a computerized algorithm was devised to predict the infectious conditions of subsequent subjects.", {"entities": []}], ["We observed robust, pathogen-specific gene expression patterns as early as 2 h after infection.", {"entities": []}], ["Use of an algorithmic decision tree revealed 94.4% diagnostic accuracy when discerning the presence of bacterial infection.", {"entities": []}], ["The model subsequently differentiated between bacterial pathogens with 71.4% accuracy and between non-bacterial conditions with 70.0% accuracy, both far exceeding the expected diagnostic yield of standard culture-based bronchoscopy with bronchoalveolar lavage.", {"entities": []}], ["These data substantiate the specificity of the pulmonary innate immune response and support the feasibility of a gene expression-based clinical tool for pneumonia diagnosis.", {"entities": [[153, 162, "DISEASE"]]}], ["Transcription factor (TF) networks play a key role in controlling the transfer of genetic information from gene to mRNA.", {"entities": [[22, 24, "GENE"]]}], ["Much progress has been made on understanding and reverse-engineering TF network topologies using a range of experimental and theoretical methodologies.", {"entities": [[69, 71, "GENE"]]}], ["Less work has focused on using these models to examine how TF networks respond to changes in the cellular environment.", {"entities": [[59, 61, "GENE"]]}], ["In this paper, we have developed a simple, pragmatic methodology, TIGER i ( T ranscription-factor-activity I llustrator for G lobal E xplanation of R egulatory i nteraction), to model the response of an inferred TF network to changes in cellular environment.", {"entities": [[212, 214, "GENE"]]}], ["The methodology was tested using publicly available data comparing gene expression profiles of a mouse p38\u03b1 (Mapk14) knock-out line to the original wild-type.", {"entities": [[109, 115, "GENE"]]}], ["Using the model, we have examined changes in the TF network resulting from the presence or absence of p38\u03b1.", {"entities": [[49, 51, "GENE"]]}], ["A part of this network was confirmed by experimental work in the original paper.", {"entities": []}], ["Additional relationships were identified by our analysis, for example between p38\u03b1 and HNF3, and between p38\u03b1 and SOX9, and these are strongly supported by published evidence.", {"entities": [[114, 118, "GENE"]]}], ["FXR and MYC were also discovered in our analysis as two novel links of p38\u03b1.", {"entities": [[8, 11, "GENE"]]}], ["To provide a computational methodology to the biomedical communities that has more user-friendly interface, we also developed a standalone GUI (graphical user interface) software for TIGERi and it is freely available at https://github.com/namshik/tigeri/ .", {"entities": []}], ["We therefore believe that our computational approach can identify new members of networks and new interactions between members that are supported by published data but have not been integrated into the existing network models.", {"entities": []}], ["Moreover, ones who want to analyze their own data with TIGER i could use the software without any command line experience.", {"entities": []}], ["This work could therefore accelerate researches in transcriptional gene regulation in higher eukaryotes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-017-1636-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Continuity of care is widely considered a principle of primary care that decreases healthcare utilization and mortality.", {"entities": []}], ["However, the effect of continuity of care on health-related quality of life (HRQoL) for adult patients with hypertension remains unclear.", {"entities": [[108, 120, "DISEASE"]]}], ["To further evaluate the effect of continuity of care, we implemented a cohort study among hypertensive patients aged over 35\u00a0years ( n \u2009=\u20091200) in six townships in Qianjiang District, Chongqing, China, between 2012 and 2014.", {"entities": []}], ["The study ultimately included 1079 participants.", {"entities": []}], ["The continuity of care index was calculated using claim-based longitudinal data obtained from hypertension follow-up service records.", {"entities": [[94, 106, "DISEASE"]]}], ["The baseline and endline survey-based data, tested by the SF-36 scale, were used to assess HRQoL.", {"entities": []}], ["To control selection bias and examine the effect of continuity of care, a kernel-based propensity score matching difference-in-differences (DID) method was used.", {"entities": []}], ["Additionally, descriptive statistics, chi-squared test, and Mann\u2013Whitney nonparametric test were used to summarize characteristics, evaluate proportional differences, and analyze statistical differences, respectively.", {"entities": []}], ["Our results showed that patients in the high continuity of care group presented greater improvement in both Physical Component Summary (PCS, DID\u2009=\u20095.192\u2009\u00b1\u20091.970, p \u2009<\u20090.001) and Mental Component Summary (MCS, DID\u2009=\u20097.900\u2009\u00b1\u20091.815, p \u2009=\u20090.008) than those in the low continuity of care group.", {"entities": []}], ["Moreover, patients in the high continuity of care group showed significant improvement in physical functioning, role-physical, general health, role-emotional, and mental health.", {"entities": []}], ["Our findings indicate that a long-term physician-patient relationship may improve HRQoL in patients with hypertension.", {"entities": [[105, 117, "DISEASE"]]}], ["However, more unified measurement tools are needed to evaluate continuity of care.", {"entities": []}], ["Further studies should include more study settings.", {"entities": []}], ["Self-management of mobility and fall risk can be important in fall prevention; however, it remains unstudied.", {"entities": []}], ["Therefore, the current study assessed whether community-dwelling older persons were able to repeatedly self-assess maximum step length (MSL) and gait speed (GS) in their own home for a 6-month period, how these tests changed during this period and if these changes were related to falling.", {"entities": []}], ["This is a prospective study.", {"entities": []}], ["This study was conducted at home.", {"entities": []}], ["A total of 56 community-dwelling older adults (24 women (43%), mean age 76.2 (SD 3.9) years) entered the study; of which, 45 completed the study.", {"entities": []}], ["Participants performed MSL and GS once a week in their own home during a 6-month period.", {"entities": []}], ["Repeated MSL and GS measurements were the primary outcomes.", {"entities": []}], ["Falls, self-management and mobility were the secondary outcomes.", {"entities": []}], ["Self-assessment of MSL and GS by older persons is feasible.", {"entities": []}], ["Compliance of repeatedly self-measuring MSL and GS was good; the median number of weekly measurements was 23.0 (88%) and 21.0 (81%) for MSL and GS, respectively.", {"entities": []}], ["Drop-outs showed less self-management abilities compared to the participants who completed the study (p=0.049).", {"entities": []}], ["Linear mixed models showed a small significant improvement in MSL and GS over time (p<0.001), without an influence on falling.", {"entities": []}], ["Most community-dwelling older persons are able and willing to repeatedly assess their MSL and GS.", {"entities": []}], ["Self-managing mobility and fall risk did not increase fall occurrence.", {"entities": []}], ["The fact that older persons can be actively involved in their own healthcare is clinically relevant.", {"entities": []}], ["Further studies are needed to examine the (cost-)effectiveness of self-management in fall prevention interventions.", {"entities": []}], ["Results of a national survey of asthmatic children that evaluated management goals established in 2004 by the National Asthma Education and Prevention Program (NAEPP) indicated that asthma symptom control fell short on nearly every goal.", {"entities": [[119, 125, "DISEASE"], [182, 188, "DISEASE"]]}], ["An Internet-based survey was administered to adult caregivers of children aged 6-12 years with moderate to severe asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["Asthma was categorized as uncontrolled when the caregiver reported pre-specified criteria for daytime symptoms, nighttime awakening, activity limitation, or rescue medication based on the NAEPP guidelines.", {"entities": [[0, 6, "DISEASE"]]}], ["Children's health-related quality of life (HRQOL) and caregivers' quality of life (QOL) were assessed using the Child Health Questionnaire Parent Form 28 (CHQ-PF28) and caregiver's work productivity using a modified Work Productivity and Activity Impairment Questionnaire.", {"entities": []}], ["Children with uncontrolled vs. controlled asthma were compared.", {"entities": [[42, 48, "DISEASE"]]}], ["360 caregivers of children with uncontrolled asthma and 113 of children with controlled asthma completed the survey.", {"entities": [[45, 51, "DISEASE"], [88, 94, "DISEASE"]]}], ["Children with uncontrolled asthma had significantly lower CHQ-PF28 physical (mean 38.1 vs 49.8, uncontrolled vs controlled, respectively) and psychosocial (48.2 vs 53.8) summary measure scores.", {"entities": [[27, 33, "DISEASE"]]}], ["They were more likely to miss school (5.5 vs 2.2 days), arrive late or leave early (26.7 vs 7.1%), miss school-related activities (40.6 vs 6.2%), use a rescue inhaler at school (64.2 vs 31.0%), and visit the health office or school nurse (22.5 vs 8.8%).", {"entities": []}], ["Caregivers of children with uncontrolled asthma reported significantly greater work and activity impairment and lower QOL for emotional, time-related and family activities.", {"entities": [[41, 47, "DISEASE"]]}], ["Poorly controlled asthma symptoms impair HRQOL of children, QOL of their caregivers, and productivity of both.", {"entities": [[18, 24, "DISEASE"]]}], ["Proper treatment and management to improve symptom control may reduce humanistic and economic burdens on asthmatic children and their caregivers.", {"entities": []}], ["The propensity of naive CD4 T cells to become T helper (Th) type 2 cells correlates with susceptibility to infection by the protozoal parasite Leishmania major .", {"entities": [[24, 27, "GENE"]]}], ["Using genetic linkage analysis, we earlier identified Dice1 as a Th2 cell bias-controlling quantitative trait locus on chromosome 16.", {"entities": []}], ["Using interval-specific congenic mapping, we now resolve Dice1 into two independent genetic loci, Dice1.1 and Dice1.2 , which control Il4 expression from naive Th cells and thereby indirectly control Th2 cell bias.", {"entities": [[134, 137, "GENE"]]}], ["Interestingly, only one of the two congenic intervals containing Dice1.1 and Dice1.2 , respectively, also contained an L. major response locus, indicating that L. major responsiveness can be insensitive to determinants that influence Th2 cell bias by controlling naive T cell Il4 expression.", {"entities": [[276, 279, "GENE"]]}], ["These results lay the groundwork for identifying the Dice1.1 and Dice1.2 genes controlling naive T cell Il4 expression and L. major responses, and for testing whether these control other Th2 cell\u2013dependent processes such as worm expulsion, allergic asthma, and dermatitis.", {"entities": [[240, 255, "DISEASE"], [249, 255, "DISEASE"], [261, 271, "DISEASE"], [104, 107, "GENE"]]}], ["Internet-based health resources can support informal caregivers who are caring for children or adolescents with health care needs.", {"entities": []}], ["However, few studies discriminate informal caregivers\u2019 needs from those of their care recipients or those of people caring for adults.", {"entities": []}], ["This study reviews the literature of health-related Internet use among informal caregivers of children and adolescents.", {"entities": []}], ["A total of 17 studies were selected from literature searches conducted in 6 electronic databases: PubMed, Cochrane, CINAHL, PsycINFO, ERIC, and EMBASE.", {"entities": []}], ["All databases searches were limited to articles published in the years 2004 to 2014 in peer-reviewed publications.", {"entities": []}], ["Search terms consisted of \u201chealth-related Internet use,\u201d \u201ceHealth,\u201d \u201cInternet use for health-related purpose(s),\u201d \u201cWeb-based resource(s),\u201d and \u201conline resources,\u201d combined with informal caregiver (or \u201cparents\u201d) of \u201cchild,\u201d \u201cadolescent,\u201d \u201cstudent,\u201d \u201cyouth,\u201d and \u201cteen.\u201d The age range of the children receiving care was limited to younger than 22 years.", {"entities": []}], ["Their informal caregivers were defined as persons (parents) who provided unpaid care or assistance to a child or an adolescent with health problems.", {"entities": []}], ["Among 17 empirical studies, the majority of informal caregivers of children with medical issues were the parents.", {"entities": []}], ["Quantitative studies (14/17, 77%) reported prevalence and predictors of health-related Internet use, while mixed-methods and qualitative studies (3/17, 24%) investigated informal caregiver perceptions of helpful health-related Internet use and barriers of use.", {"entities": []}], ["The prevalence of health-related Internet use varied (11%-90%) dependent upon how health-related Internet use was operationalized and measured.", {"entities": []}], ["Disease-specific information was used for decision making about treatment, while social support via virtual communities and email were used for informal caregiver emotional needs.", {"entities": []}], ["A digital divide of Internet access was identified in lower educated minorities.", {"entities": []}], ["Most studies had methodological challenges resulting from convenience sampling, cross-sectional surveys, lack of theoretical frameworks, or no clear definitions of health-related Internet use.", {"entities": []}], ["This study provides an important understanding of how family members use Internet-based information and support systems during child caregiving.", {"entities": []}], ["Healthcare providers and policy makers should integrate family needs into their current practices and policies.", {"entities": []}], ["Further rigorous research is required to design efficient and effective nursing interventions.", {"entities": []}], ["Antieosinophil serum (AES), obtained by immunizing rabbits with a highly purified suspension of mouse eosinophils, contains high titers of specific agglutinating and cytotoxic antibodies to eosinophils.", {"entities": []}], ["Absorption with macrophages, lymphocytes, and neutrophils does not affect the antieosinophilic activity while it is markedly lowered by absorption with eosinophils.", {"entities": []}], ["One dose of AES (0.1 ml) injected into mice with schistosomiasis mansoni caused a mean decrease in circulating eosinophils of 90% within 1 h which was maintained for 5 days, followed by gradual recovery.", {"entities": [[49, 64, "DISEASE"]]}], ["No other changes in the total or differential white cell counts were noted.", {"entities": []}], ["In normal mice AES markedly depressed exudation of eosinophils in the peritoneal cavity after repeated saline stimulation.", {"entities": []}], ["Some of the immunological and clinical implications of a monospecific AES are discussed.", {"entities": []}], ["Recent work shows that depression is intimately associated with changes in cognitive functioning, including memory, attention, verbal fluency, and other aspects of higher-order cognitive processing.", {"entities": []}], ["Changes in cognitive functioning are more likely to occur when depressive episodes are recurrent and to abate to some degree during periods of remission.", {"entities": []}], ["However, with accumulating frequency and duration of depressive episodes, cognitive deficits can become enduring, being evident even when mood improves.", {"entities": []}], ["Such changes in cognitive functioning give depression links to mild cognitive impairment and thereby with neurodegenerative conditions, including Alzheimer\u2019s disease, Parkinson\u2019s disease, schizophrenia, and multiple sclerosis.", {"entities": [[188, 201, "DISEASE"], [207, 225, "DISEASE"]]}], ["Depression may then be conceptualized on a dimension of depression \u2013 mild cognitive impairment \u2013 dementia.", {"entities": [[97, 105, "DISEASE"]]}], ["The biological underpinnings of depression have substantial overlaps with those of neurodegenerative conditions, including reduced neurogenesis, increased apoptosis, reactive oxygen species, tryptophan catabolites, autoimmunity, and immune-inflammatory processes, as well as decreased antioxidant defenses.", {"entities": []}], ["These evolving changes over the course of depressive episodes drive the association of depression with neurodegenerative conditions.", {"entities": []}], ["As such, the changes in cognitive functioning in depression have important consequences for the treatment of depression and in reconceptualizing the role of depression in wider neuroprogressive conditions.", {"entities": []}], ["Here we review the data on changes in cognitive functioning in recurrent major depression and their association with other central conditions.", {"entities": []}], ["Polyvinyl chloride (PVC) materials have been linked to asthma in several epidemiologic studies, but the possible causal factors remain unknown.", {"entities": [[55, 61, "DISEASE"]]}], ["We challenged 10 subjects experimentally to degraded PVC products under controlled conditions.", {"entities": []}], ["All of the subjects had previously experienced respiratory symptoms suspected to be caused by this kind of exposure in their work place.", {"entities": []}], ["Five subjects had doctor-diagnosed asthma.", {"entities": [[35, 41, "DISEASE"]]}], ["The subjects were exposed to degraded PVC material in an exposure chamber; a challenge with ceramic tile was used as the control test.", {"entities": []}], ["We followed exhaled nitric oxide, nasal NO, lung functions, cytokines [tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-4 (IL-4), IL-6, and IL-12] and NO in nasal lavage fluid (NAL) during and after the exposures.", {"entities": []}], ["We also measured 2-ethylhexanol in exhaled breath samples and NAL.", {"entities": []}], ["On the morning after the PVC exposure, subjects reported respiratory tract symptoms significantly more often than they did after the control test (50% vs. 0%, respectively; p = 0.029; n = 10).", {"entities": []}], ["We did not detect any changes in lung functions or levels of exhaled NO, nasal NO, or NO in NAL after PVC challenge compared with the control test.", {"entities": []}], ["Cytokine levels increased after both exposures, with no statistically significant difference between situations.", {"entities": []}], ["All of the exhaled breath samples collected during the PVC exposure contained 2-ethylhexanol.", {"entities": []}], ["PVC flooring challenge can evoke respiratory tract symptoms in exposed subjects.", {"entities": []}], ["Our results do not support the hypothesis that PVC materials themselves evoke immediate asthmatic reactions.", {"entities": []}], ["The chamber test used is well suited to this type of exposure study.", {"entities": []}], ["Vitamin D is a promising, though under-explored, potential modifiable risk factor for acute respiratory infections (ARIs).", {"entities": []}], ["We sought to investigate the association of vitamin D status with ARI in a large, nationally-representative sample of non-institutionalized individuals from the United States.", {"entities": []}], ["We analyzed 14,108 individuals over 16 years of age in the National Health and Nutrition Survey (NHANES) 2001\u20132006 in this cross-sectional study.", {"entities": []}], ["We used locally weighted scatterplot smoothing (LOWESS) to depict the relationship between increasing 25-hydroxyvitamin D (25OHD) levels and ARI.", {"entities": []}], ["We then performed a multivariable regression analysis to investigate the association of 25OHD levels with ARI, while adjusting for known confounders.", {"entities": []}], ["The median serum 25OHD level was 21 (IQR 15\u201327) ng/mL.", {"entities": []}], ["Overall, 4.8% (95% CI: 4.5\u20135.2) of participants reported an ARI within 30 days before their participation in the national survey.", {"entities": []}], ["LOWESS analysis revealed a near-linear relationship between vitamin D status and the cumulative frequency of ARI up to 25OHD levels around 30 ng/mL.", {"entities": []}], ["After adjusting for season, demographic factors, and clinical data, 25OHD levels <30 ng/mL were associated with 58% higher odds of ARI (OR 1.58; 95% CI: 1.07\u20132.33) compared to levels \u226530 ng/mL.", {"entities": []}], ["Among the 14,108 participants in NHANES 2001\u20132006, 25OHD levels were inversely associated with ARI.", {"entities": []}], ["Carefully designed, randomized, controlled trials are warranted to determine the effect of optimizing vitamin D status on the risk of ARI.", {"entities": []}], ["To describe the experience of an outpatient clinic with the multidisciplinary evaluation of intensive care unit survivors and to analyze their social, psychological, and physical characteristics in a low-income population and a developing country.", {"entities": []}], ["Retrospective cohort study.", {"entities": []}], ["Adult survivors from a general intensive care unit were evaluated three months after discharge in a post-intensive care unit outpatient multidisciplinary clinic over a period of 6 years (2008-2014) in a University Hospital in southern Brazil.", {"entities": []}], ["A total of 688 out of 1945 intensive care unit survivors received care at the clinic.", {"entities": []}], ["Of these, 45.2% had psychological disorders (particularly depression), 49.0% had respiratory impairments (abnormal spirometry), and 24.6% had moderate to intense dyspnea during daily life activities.", {"entities": []}], ["Patients experienced weight loss during hospitalization (mean=11.7%) but good recovery after discharge (mean gain=9.1%), and 94.6% were receiving nutrition orally.", {"entities": []}], ["One-third of patients showed a reduction of peripheral muscular strength, and 5.7% had moderate to severe tetraparesis or tetraplegia.", {"entities": []}], ["There was a significant impairment in quality of life (SF-36), particularly in the physical and emotional aspects and in functional capacity.", {"entities": []}], ["The economic impacts on the affected families, which were mostly low-income families, were considerable.", {"entities": []}], ["Most patients did not have full access to rehabilitation services, even though half of the families were receiving financial support from the government.", {"entities": []}], ["A significant number of intensive care unit survivors evaluated 3 months after discharge had psychological, respiratory, motor, and socioeconomic problems; these findings highlight that strategies aimed to assist critically ill patients should be extended to the post-hospitalization period and that this problem is particularly important in low-income populations.", {"entities": []}], ["Several cytokines may play roles in the immunological pathogenesis of mycoplasmal pneumonia caused by Mycoplasma pneumoniae .", {"entities": [[82, 91, "DISEASE"]]}], ["In this study, we investigated serum cytokine profiles in children with mycoplasmal pneumonia.", {"entities": [[84, 93, "DISEASE"]]}], ["The serum levels of interleukin (IL)-8, IL-10, and IL-18 were examined using ELISA kits in 34 patients with M .", {"entities": []}], ["pneumoniae infection (Group 1, 11 with severe mycoplasmal pneumonia; Group 2, 13 with mild mycoplasmal pneumonia; Group 3, 10 with asthma) and 32 age-matched, non-infected controls.", {"entities": [[58, 67, "DISEASE"], [103, 112, "DISEASE"], [131, 137, "DISEASE"]]}], ["The serum levels of IL-8, IL-10, and IL-18 increased significantly in patients with mycoplasmal pneumonia compared with those in controls (P<0.01).", {"entities": [[96, 105, "DISEASE"]]}], ["The serum levels of IL-10 decreased significantly in Group 1 compared with those in Group 2 (P<0.01).", {"entities": []}], ["The serum levels of IL-18 increased significantly in Group 1 compared with those in Group 2 (P<0.01).", {"entities": []}], ["The serum levels of IL-10 and IL-18 decreased significantly in 10 M .", {"entities": []}], ["pneumoniae -infected patients with asthma compared with those in 24 M .", {"entities": [[35, 41, "DISEASE"]]}], ["pneumoniae -infected patients without asthma (P<0.01).", {"entities": [[38, 44, "DISEASE"]]}], ["We examined the level of interleukins (IL-8, IL-10 and IL-18) after the patients started therapy.", {"entities": []}], ["The data showed that IL-18 were lower after therapy (P<0.01).", {"entities": []}], ["Collectively, our data suggested that these cytokines may be involved in the pathogenesis of mycoplasmal pneumonia.", {"entities": [[105, 114, "DISEASE"]]}], ["In the combined use of bronchodilators of different classes, ie, long-acting \u03b2 2 -agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both directly, through LABA-mediated stimulation of \u03b2 2 -adrenergic receptors, and indirectly, through LAMA-mediated inhibition of acetylcholine action at muscarinic receptors.", {"entities": []}], ["The clinical trial data for LABAs/LAMAs in the treatment of chronic obstructive pulmonary disease (COPD) continue to be promising, and these combinations will provide the convenience of delivering the two major bronchodilator classes, recommended as first-line maintenance options in COPD treatment guidelines.", {"entities": [[60, 97, "DISEASE"]]}], ["COPD is a complex condition that has pulmonary and extrapulmonary manifestations.", {"entities": []}], ["These clinical manifestations are highly variable, and several are associated with different responses to currently available therapies.", {"entities": []}], ["The concept of a COPD phenotype is rapidly evolving from one focusing on the clinical characteristics to one linking the underlying biology to the phenotype of the disease.", {"entities": []}], ["Identification of the peculiarities of the different COPD phenotypes will permit us to implement a more personalized treatment in which the patient\u2019s characteristics, together with his or her genotype, will be key to choosing the best treatment option.", {"entities": []}], ["At present in Japan, fixed combinations of inhaled corticosteroids (ICSs) and LABAs are frequently prescribed in the earlier stages of COPD.", {"entities": []}], ["However, ICSs increase the risk of pneumonia.", {"entities": [[35, 44, "DISEASE"]]}], ["Notably, 10%\u201330% of patients with COPD with or without a history of asthma have persistent circulating and airway eosinophilia associated with an increased risk of exacerbations and sensitivity to steroids.", {"entities": [[114, 126, "DISEASE"], [68, 74, "DISEASE"]]}], ["Thus, sputum or blood eosinophil counts might identify a subpopulation in which ICSs could have potentially deleterious effects as well as a subpopulation that benefits from ICSs.", {"entities": []}], ["In this review, I propose one plausible approach to position ICSs and LABAs/LAMAs in clinical practice, based on both the extent of airflow obstruction and the presence of an asthma component or airway eosinophilic inflammation.", {"entities": [[175, 181, "DISEASE"]]}], ["This approach is a tentative move toward personalized treatment for COPD patients, and with progress in knowledge and developments in physiology, lung imaging, medical biology, and genetics, identification of COPD phenotypes that provide prognostic and therapeutic information that can affect clinically meaningful outcomes is an urgent medical need.", {"entities": []}], ["T-bet acts as a functional repressor in association with Bcl-6 to antagonize SOCS1, SOCS3, TCF-1, and late-stage IFN-\u03b3 to regulate Th1 development.", {"entities": [[77, 82, "GENE"], [84, 89, "GENE"]]}], ["The T-box transcription factor T-bet is important for the differentiation of naive CD4 Socs1 , Socs3 , and Tcf7 (TCF-1) as gene targets that are negatively regulated by T-bet.", {"entities": [[83, 86, "GENE"], [87, 92, "GENE"], [95, 100, "GENE"], [107, 111, "GENE"]]}], ["Significantly, T-bet\u2019s role in the repression of these genes is through a direct interaction with their promoters.", {"entities": []}], ["Consistent with this, we identified two T-bet DNA-binding elements in the Socs1 promoter that are functionally used to down-regulate transcription in primary Th1 cells.", {"entities": [[74, 79, "GENE"]]}], ["Importantly, T-bet\u2019s novel role in transcriptional repression is because of its ability to physically associate with, and functionally recruit, the transcriptional repressor Bcl-6 to a subset of promoters.", {"entities": []}], ["Furthermore, T-bet functionally recruits Bcl-6 to the Ifng locus in late stages of Th1 differentiation to repress its activity, possibly to prevent the overproduction of IFN-\u03b3, which could result in autoimmunity.", {"entities": [[54, 58, "GENE"]]}], ["Collectively, these data establish a novel mechanism for T-bet\u2013mediated gene repression in which two lineage-defining transcription factors, one a classical activator and one a repressor, collaborate to promote and properly regulate Th1 development.", {"entities": []}], ["General practitioners often care for patients with several concurrent chronic medical conditions (multimorbidity).", {"entities": []}], ["Recent data suggest that multimorbidity might be observed more often than isolated diseases in primary care.", {"entities": []}], ["We explored the age- and gender-related prevalence of multimorbidity and compared these estimates to the prevalence estimates of other common specific diseases found in Swiss primary care.", {"entities": []}], ["We analyzed data from the Swiss FIRE (Family Medicine ICPC Research using Electronic Medical Record) project database, representing a total of 509,656 primary care encounters in 98,152 adult patients between January 1, 2009 and July 31, 2011.", {"entities": []}], ["For each encounter, medical problems were encoded using the second version of the International Classification of primary Care (ICPC-2).", {"entities": []}], ["We defined chronic health conditions using 147 pre-specified ICPC-2 codes and defined multimorbidity as 1) two or more chronic health conditions from different ICPC-2 rubrics, 2) two or more chronic health conditions from different ICPC-2 chapters, and 3) two or more medical specialties involved in patient care.", {"entities": []}], ["We compared the prevalence estimates of multimorbidity defined by the three methodologies with the prevalence estimates of common diseases encountered in primary care.", {"entities": []}], ["Overall, the prevalence estimates of multimorbidity were similar for the three different definitions (15% [95%CI 11-18%], 13% [95%CI 10-16%], and 14% [95%CI 11-17%], respectively), and were higher than the prevalence estimates of any specific chronic health condition (hypertension, uncomplicated 9% [95%CI 7-11%], back syndrome with and without radiating pain 6% [95%CI 5-7%], non-insulin dependent diabetes mellitus 3% [95%CI 3-4%]), and degenerative joint disease 3% [95%CI 2%-4%]).", {"entities": [[269, 281, "DISEASE"], [320, 328, "DISEASE"], [400, 417, "DISEASE"]]}], ["The prevalence estimates of multimorbidity rose more than 20-fold with age, from 2% (95%CI 1-2%) in those aged 20\u201329 years, to 38% (95%CI 31-44%) in those aged 80 or more years.", {"entities": []}], ["The prevalence estimates of multimorbidity were similar for men and women (15% vs. 14%, p=0.288).", {"entities": []}], ["In primary care, prevalence estimates of multimorbidity are higher than those of isolated diseases.", {"entities": []}], ["Among the elderly, more than one out of three patients suffer from multimorbidity.", {"entities": []}], ["Management of multimorbidity is a principal concern in this vulnerable patient population.", {"entities": []}], ["Interactions between tumor cells and cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TMEN) significantly influence cancer growth and metastasis.", {"entities": [[37, 43, "DISEASE"], [135, 141, "DISEASE"]]}], ["Transforming growth factor-\u03b2 (TGF-\u03b2) is known to be a critical mediator of the CAF phenotype, and osteopontin (OPN) expression in tumors is associated with more aggressive phenotypes and poor patient outcomes.", {"entities": []}], ["The potential link between these two pathways has not been previously addressed.", {"entities": []}], ["Utilizing in vitro studies using human mesenchymal stem cells (MSCs) and MDA-MB231 (OPN+) and MCF7 (OPN\u2212) human breast cancer cell lines, we demonstrate that OPN induces integrin-dependent MSC expression of TGF-\u03b21 to mediate adoption of the CAF phenotype.", {"entities": [[112, 125, "DISEASE"], [119, 125, "DISEASE"], [189, 192, "GENE"]]}], ["This OPN-TGF-\u03b21 pathway requires the transcription factor, myeloid zinc finger 1 (MZF1).", {"entities": [[82, 86, "GENE"]]}], ["In vivo studies with xenotransplant models in NOD-scid mice showed that OPN expression increases cancer growth and metastasis by mediating MSC-to-CAF transformation in a process that is MZF1- and TGF-\u03b21-dependent.", {"entities": [[97, 103, "DISEASE"]]}], ["We conclude that tumor-derived OPN engenders MSC-to-CAF transformation in the microenvironment to promote tumor growth and metastasis via the OPN-MZF1-TGF-\u03b21 pathway.", {"entities": []}], ["Heart rate is an important contributor in the pathophysiology of both coronary artery disease (CAD) and heart failure (HF).", {"entities": []}], ["Ivabradine is an anti-anginal and anti-ischaemic agent, which selectively and specifically inhibits the I f current in the sino-atrial node and provides pure heart rate reduction without altering other cardiac parameters, including conduction, and without directly affecting other haemodynamic parameters.", {"entities": []}], ["It is approved for the treatment of CAD and HF.", {"entities": []}], ["This article summarises the pharmacological properties, pharmacokinetics, clinical efficacy and tolerability of ivabradine in the treatment of CAD and HF, and presents evidence demonstrating that the pharmacological and clinical properties and clinical efficacy of ivabradine make it an important therapeutic choice for patients with stable CAD or HF.", {"entities": []}], ["The positive effect of ivabradine on angina pectoris symptoms and its ability to reduce myocardial ischemia make it an important agent in the management of patients with stable CAD or chronic HF.", {"entities": [[99, 107, "DISEASE"]]}], ["Further studies are underway to add to the already robust evidence of ivabradine for the prevention of cardiovascular events in patients with CAD but without clinical HF.", {"entities": []}], ["The SIGNIFY (Study assessInG the morbidity\u2013mortality beNefits of the I f inhibitor ivabradine in patients with coronarY artery disease) trial includes patients with stable CAD and an LVEF above 40\u00a0%, with no clinical sign of HF, and is investigating the long-term effects (over a period of 48\u00a0months) of ivabradine in a large study population.", {"entities": []}], ["So far, this study has included more than 19,000 patients from 51 countries.", {"entities": []}], ["Studies on medication safety in pregnancy often rely on an oversimplification of medication use into exposed or non-exposed, without considering intensity and timing of use in pregnancy, or concomitant medication use.", {"entities": []}], ["This study uses paracetamol in pregnancy as the motivating example to introduce a method of clustering medication exposures longitudinally throughout pregnancy.", {"entities": []}], ["The aim of this study was to use hierarchical cluster analysis (HCA) to better identify clusters of medication exposure throughout pregnancy.", {"entities": []}], ["Data from the Norwegian Mother and Child Cohort Study was used to identify subclasses of women using paracetamol during pregnancy.", {"entities": []}], ["HCA with customized distance measure was used to identify clusters of medication exposures in pregnancy among children at 18 months.", {"entities": []}], ["The pregnancies in the study (N = 9 778) were grouped in 5 different clusters depending on their medication exposure profile throughout pregnancy.", {"entities": []}], ["Using HCA, we identified and described profiles of women exposed to different medications in combination with paracetamol during pregnancy.", {"entities": []}], ["Identifying these clusters allows researchers to define exposure in ways that better reflects real-world medication usage patterns.", {"entities": []}], ["This method could be extended to other medications and used as pre-analysis for identifying risks associated with different profiles of exposure.", {"entities": []}], ["To be meaningful, a core outcome set (COS) should be relevant to all stakeholders including patients and carers.", {"entities": []}], ["This review aimed to explore the methods by which patients and carers have been included as participants in COS development exercises and, in particular, the use and reporting of qualitative methods.", {"entities": []}], ["In August 2015, a search of the Core Outcomes Measures in Effectiveness Trials (COMET) database was undertaken to identify papers involving patients and carers in COS development.", {"entities": []}], ["Data were extracted to identify the data collection methods used in COS development, the number of health professionals, patients and carers participating in these, and the reported details of qualitative research undertaken.", {"entities": []}], ["Fifty-nine papers reporting patient and carer participation were included in the review, ten of which reported using qualitative methods.", {"entities": []}], ["Although patients and carers participated in outcome elicitation for inclusion in COS processes, health professionals tended to dominate the prioritisation exercises.", {"entities": []}], ["Of the ten qualitative papers, only three were reported as a clear pre-designed part of a COS process.", {"entities": []}], ["Qualitative data were collected using interviews, focus groups or a combination of these.", {"entities": []}], ["None of the qualitative papers reported an underpinning methodological framework and details regarding data saturation, reflexivity and resource use associated with data collection were often poorly reported.", {"entities": []}], ["Five papers reported difficulty in achieving a diverse sample of participants and two reported that a large and varied range of outcomes were often identified by participants making subsequent rating and ranking difficult.", {"entities": []}], ["Consideration of the best way to include patients and carers throughout the COS development process is needed.", {"entities": []}], ["Additionally, further work is required to assess the potential role of qualitative methods in COS, to explore the knowledge produced by different qualitative data collection methods, and to evaluate the time and resources required to incorporate qualitative methods into COS development.", {"entities": []}], ["Leukotriene E4 ( LTE 4) that plays a key role in airway inflammation is expressed on platelets and eosinophils.", {"entities": []}], ["We investigated whether blocking of the P2Y12 receptor can suppress eosinophilic inflammation in a mouse model of asthma because platelets and eosinophils share this receptor to be activated.", {"entities": [[114, 120, "DISEASE"]]}], ["BALB /c mice were sensitized by intraperitoneal injection of ovalbumin ( OVA ), followed by OVA nebulization.", {"entities": []}], ["On each challenge day, clopidogrel, a P2Y12 antagonist was administered 30 min.", {"entities": []}], ["before each challenge.", {"entities": []}], ["Forty\u2010eight hours after the last OVA challenge, mice were assessed for airway hyperresponsiveness ( AHR ), cell composition and cytokine levels, including chemokine ligand 5 ( CCL 5), in bronchoalveolar lavage ( BAL ) fluid.", {"entities": [[100, 103, "GENE"]]}], ["EOL cells were treated with LTE 4, with or without clopidogrel treatment, and intracellular and extracellular eosinophil cationic protein ( ECP ) expressions were measured to find the inhibiting function of P2Y12 antagonist on eosinophilic activation.", {"entities": []}], ["The levels of P2Y12 expression were increased markedly in the lung homogenates of OVA \u2010sensitized and \u2010challenged mice after platelet depletion.", {"entities": []}], ["Administration of clopidogrel decreased AHR and the number of airway inflammatory cells, including eosinophils, in BAL fluid following OVA challenge.", {"entities": [[40, 43, "GENE"]]}], ["These results were associated with decreased levels of Th2 cytokines and CCL 5.", {"entities": []}], ["Histological examination showed that inflammatory cells as well as mucus\u2010containing goblet cells were reduced in clopidogrel\u2010administered mice compared to vehicle\u2010treated mice.", {"entities": []}], ["Clopidogrel inhibited extracellular ECP secretion after LTE 4 stimulation in EOL \u20101 cells.", {"entities": []}], ["Clopidogrel could prevent development of AHR and airway inflammation in a mouse model of asthma.", {"entities": [[89, 95, "DISEASE"], [41, 44, "GENE"]]}], ["P2Y12 can be a novel therapeutic target to the suppression of eosinophils in asthma.", {"entities": [[77, 83, "DISEASE"]]}], ["We assessed the relationship between the heterogeneity of HCC on preoperative non-contrast-enhanced CT and patient prognosis.", {"entities": []}], ["The heterogeneity of CT images from 122 patients was assessed and texture feature parameters such as mean, standard deviation (SD), entropy, mean of the positive pixels (MPP), skewness, and kurtosis were obtained using filtration.", {"entities": []}], ["The relationship between CT texture features and 5-year overall survival (OS) or disease-free survival (DFS) was assessed.", {"entities": []}], ["Multivariate regression analysis was performed to evaluate the independence of texture feature from clinical or pathological parameters.", {"entities": []}], ["The Kaplan-Meier curves for OS or DFS was significantly different between patient groups dichotomized by cut-off values for all CT texture parameters with filtration at at least one filter level.", {"entities": []}], ["Multivariate regression analysis showed the independence of most CT texture parameters on clinical and pathological parameters for OS with filtration at at least one filter level and without filtration except kurtosis.", {"entities": []}], ["SD, entropy, and MPP with coarse filter, and skewness without filtration showed a significant correlation for DFS.", {"entities": []}], ["CT texture features of non-contrast-enhanced CT images showed a relationship with HCC prognosis.", {"entities": []}], ["Multivariate regression analysis showed the possibility of CT texture feature increase the prognostic prediction of HCC by clinical and pathological information.", {"entities": []}], ["Muscle wasting and chronic inflammation are predominant features of patients with COPD.", {"entities": []}], ["Systemic inflammation is associated with an accelerated decline in lung function.", {"entities": []}], ["In this study, the prevalence of sarcopenia and the relationships between sarcopenia and systemic inflammations in patients with stable COPD were investigated.", {"entities": []}], ["In a cross-sectional design, muscle strength and muscle mass were measured by handgrip strength (HGS) and bioelectrical impedance analysis in 80 patients with stable COPD.", {"entities": [[97, 100, "GENE"]]}], ["Patients (\u226540 years old) diagnosed with COPD were recruited from outpatient clinics, and then COPD stages were classified.", {"entities": []}], ["Sarcopenia was defined as the presence of both low muscle strength (by HGS) and low muscle mass (skeletal muscle mass index [SMMI]).", {"entities": [[71, 74, "GENE"]]}], ["Levels of circulating inflammatory biomarkers (IL-6 and high-sensitivity TNF\u03b1 [hsTNF\u03b1]) were measured.", {"entities": []}], ["Sarcopenia was prevalent in 20 (25%) patients.", {"entities": []}], ["Patients with sarcopenia were older, had lower body mass index, and a higher percentage of cardiovascular diseases.", {"entities": []}], ["In addition, they had significantly higher modified Medical Research Council scores and lower 6-minute walk distance than those without sarcopenia.", {"entities": []}], ["HGS was significantly correlated with age, modified Medical Research Council score, and COPD Assessment Test scores.", {"entities": [[0, 3, "GENE"]]}], ["Both HGS and SMMI had associations with IL-6 and hsTNF\u03b1 (HGS, r =\u22120.35, P =0.002; SMMI, r =\u22120.246, P =0.044) level.", {"entities": [[5, 8, "GENE"], [57, 60, "GENE"], [5, 8, "GENE"], [57, 60, "GENE"]]}], ["In multivariate analysis, old age, lower body mass index, presence of cardiovascular comorbidities, and higher hsTNF\u03b1 levels were significant determinants for sarcopenia in patients with stable COPD.", {"entities": []}], ["Sarcopenia is very common in patients with stable COPD, and is associated with more severe dyspnea-scale scores and lower exercise tolerance.", {"entities": []}], ["Systemic inflammation could be an important contributor to sarcopenia in the stable COPD population.", {"entities": []}], ["Hedera helix L. is an important traditional medicinal plant in Europe.", {"entities": []}], ["The main active components are triterpenoid saponins, but none of the potential enzymes involved in triterpenoid saponins biosynthesis have been discovered and annotated.", {"entities": []}], ["Here is reported the first study of global transcriptome analyses using the Illumina HiSeq H .", {"entities": []}], ["In total, over 24 million clean reads were produced and 96,333 unigenes were assembled, with an average length of 1385 nt; more than 79,085 unigenes had at least one significant match to an existing gene model.", {"entities": []}], ["Differentially Expressed Gene analysis identified 6,222 and 7,012 unigenes which were expressed either higher or lower in leaf samples when compared with roots.", {"entities": []}], ["After functional annotation and classification, two pathways and 410 unigenes related to triterpenoid saponins biosynthesis were discovered.", {"entities": []}], ["The accuracy of these de novo sequences was validated by RT-qPCR analysis and a RACE clone.", {"entities": []}], ["These data will enrich our knowledge of triterpenoid saponin biosynthesis and provide a theoretical foundation for molecular research on H .", {"entities": []}], ["Our study aimed to describe the association between food patterns and gender, parental education, physical activity, sleeping and obesity in 1976 children aged 5\u221210 years old.", {"entities": [[130, 137, "DISEASE"]]}], ["Dietary intake was measured by a semi quantitative food frequency questionnaire; body mass index was calculated and categorized according to the IOTF classification.", {"entities": []}], ["Factor analysis and generalized linear models were applied to identify food patterns and their associations.", {"entities": []}], ["TV viewing and male gender were significant positive predictors for fast-food, sugar sweetened beverages and pastry pattern, while a higher level of maternal education and longer sleeping duration were positively associated with a dietary patterns that included fruit and vegetables.", {"entities": []}], ["Environmental factors such as tobacco exposure, indoor climate and diet are known to be involved in the development of allergy related diseases.", {"entities": []}], ["The aim was to determine the impact of altered exposure to these factors during pregnancy and infancy on the incidence of allergy related diseases at 2 years of age.", {"entities": []}], ["Children from a non-selected population of mothers were recruited to a controlled, multicenter intervention study in primary health care.", {"entities": []}], ["The interventions were an increased maternal and infant intake of n-3 PUFAs and oily fish, reduced parental smoking, and reduced indoor dampness during pregnancy and the children\u2019s first 2 years of life.", {"entities": []}], ["Questionnaires on baseline data and exposures, and health were collected at 2 years of age.", {"entities": []}], ["The prevalence of smoking amongst the mothers and fathers was approximately halved at 2 years of age in the intervention cohort compared to the control cohort.", {"entities": []}], ["The intake of n-3 PUFA supplement and oily fish among the children in the intervention cohort was increased.", {"entities": []}], ["There was no significant change for indoor dampness.", {"entities": []}], ["The odds ratio for the incidence of asthma was 0.72 (95% CI, 0.55-0.93; NNT b 53), and 0.75 for the use of asthma medication (95% CI, 0.58-0.96).", {"entities": [[36, 42, "DISEASE"], [107, 113, "DISEASE"], [72, 75, "GENE"]]}], ["The odds ratio for asthma among girls was 0.41 (95% CI 0.24-0.70; NNT b 32), and for boys 0.93 (95% CI 0.68-1.26).", {"entities": [[19, 25, "DISEASE"], [66, 69, "GENE"]]}], ["There were no significant change for wheeze and atopic dermatitis.", {"entities": [[48, 65, "DISEASE"], [55, 65, "DISEASE"]]}], ["Reduced tobacco exposure and increased intake of oily fish during pregnancy and early childhood may be effective in reducing the incidence of asthma at 2 years of age.", {"entities": [[142, 148, "DISEASE"]]}], ["The differential impact in boys and girls indicates that the pathophysiology of asthma may depend on the sex of the children.", {"entities": [[80, 86, "DISEASE"]]}], ["Current Controlled Trials ISRCTN28090297.", {"entities": []}], ["Previous studies in western countries have observed that women are less likely than men to receive intensive care and mechanical ventilation (MV).", {"entities": []}], ["We aimed to investigate whether the gender difference also exists in Asian populations and in the provision of different types of MV including invasive (INV) and noninvasive ventilation (NIV).", {"entities": []}], ["We analyzed all adult hospital patients between 2005 and 2007 in the claims data from 1,000,000 randomly selected people in the Taiwan National Health Insurance Research Database.", {"entities": []}], ["NIV-only was defined as patients receiving NIV as the only ventilator treatment during hospitalization.", {"entities": []}], ["Gender difference was assessed using multivariable analyses with/without considering a hospital cluster effect by generalized estimating equations models.", {"entities": []}], ["Subgroup analyses for gender difference in NIV use were performed using propensity score matching method.", {"entities": []}], ["Of the 128,327 patients enrolled, 53.8% were men, 9.2% received intensive care and 5.2% used MV.", {"entities": []}], ["After adjusting for potential confounders, women were less likely than men to receive intensive care (adjusted odds ratio [aOR] 0.77, 95% confidence interval [CI] 0.73-0.82) and MV (aOR 0.84, 95% CI 0.78-0.91).", {"entities": []}], ["Among MV patients, 6.8% received NIV-only; the proportion of which was higher in women than in men (8.6% vs. 5.7%, P < 0.001).", {"entities": []}], ["After controlling for confounders and a cluster effect, women remained more likely to receive NIV-only (aOR 1.61, 95% CI 1.32-1.96).", {"entities": []}], ["Subgroup analyses showed that patients with underlying congestive heart failure (CHF) had the highest difference in the provision of NIV-only (female-to-male aOR 2.76, 95% CI 1.38-5.53).", {"entities": [[55, 79, "DISEASE"]]}], ["A hospital cluster effect on the gender difference in NIV use was found in patients with diseases other than chronic obstructive pulmonary disease and CHF.", {"entities": [[109, 146, "DISEASE"]]}], ["Gender differences existed not only in the provision but also in the types of MV.", {"entities": []}], ["Further studies are needed to understand why gender differences occur.", {"entities": []}], ["Carbon markets afford potentially useful opportunities for supporting socially and environmentally sustainable land management programs but, to date, have been little applied in globally significant fire-prone savanna settings.", {"entities": []}], ["While fire is intrinsic to regulating the composition, structure and dynamics of savanna systems, in north Australian savannas frequent and extensive late dry season wildfires incur significant environmental, production and social impacts.", {"entities": []}], ["Here we assess the potential of market-based savanna burning greenhouse gas emissions abatement and allied carbon biosequestration projects to deliver compatible environmental and broader socio-economic benefits in a highly biodiverse north Australian setting.", {"entities": []}], ["Drawing on extensive regional ecological knowledge of fire regime effects on fire-vulnerable taxa and communities, we compare three fire regime metrics (seasonal fire frequency, proportion of long-unburnt vegetation, fire patch-size distribution) over a 15-year period for three national parks with an indigenously (Aboriginal) owned and managed market-based emissions abatement enterprise.", {"entities": []}], ["Our assessment indicates improved fire management outcomes under the emissions abatement program, and mostly little change or declining outcomes on the parks.", {"entities": []}], ["We attribute improved outcomes and putative biodiversity benefits under the abatement program to enhanced strategic management made possible by the market-based mitigation arrangement.", {"entities": []}], ["For these same sites we estimate quanta of carbon credits that could be delivered under realistic enhanced fire management practice, using currently available and developing accredited Australian savanna burning accounting methods.", {"entities": []}], ["We conclude that, in appropriate situations, market-based savanna burning activities can provide transformative climate change mitigation, ecosystem health, and community benefits in northern Australia, and, despite significant challenges, potentially in other fire-prone savanna settings.", {"entities": []}], ["Furanodienone, a major bioactive constituents of sesquiterpene derived from Rhizoma Curcumae , has been proven to possess the potent anticancer efficacy on human breast cancer cells.", {"entities": [[162, 175, "DISEASE"], [169, 175, "DISEASE"]]}], ["Here, we investigated the cytotoxicity of furanodienone on human colorectal carcinoma cell lines in vitro and in vivo , as well as its underlying molecular mechanisms in the induction of apoptosis.", {"entities": [[76, 85, "DISEASE"]]}], ["In this study, we found that furanodienone significantly inhibited proliferation of RKO and HT-29 cells, induced mitochondrial dysfunction characterized by collapse of mitochondrial transmembrane potential and reduction of ATP level, and promoted the production of reactive oxygen species (ROS) that functions upstream of caspase-dependent apoptosis.", {"entities": []}], ["The antioxidant N -acetyl cysteine, a ROS scavenger, abolished this apoptosis induced by furanodienone.", {"entities": []}], ["In addition, furanodienone elevated the expression of p-p38, p-JNK, but decreased p-ERK, as a result of the produced ROS.", {"entities": []}], ["The specific inhibitors U0126, SP600125 and SB202190 attenuated the expression of MAPKs, and regulated the expression of cleaved caspase-8, -9 and -3.", {"entities": []}], ["Furthermore, the potential inhibitory effect of furanodienone on CRC cells was also corroborated in mouse xenograft model.", {"entities": []}], ["In conclusion, the results demonstrated that furanodienone-triggered ROS plays a pivotal role in apoptosis as an upstream molecule-modulating activity of caspases in mitochondrial pathway via stimulating MAPKs signaling pathway.", {"entities": []}], ["Our finding may provide a novel candidate for development of antitumor drugs targeting on colorectal cancer.", {"entities": [[90, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["Background: Adverse health effects associated with diesel exhaust (DE) are thought to be mediated in part by oxidative stress, but the detailed mechanisms are largely unknown.", {"entities": []}], ["MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and may respond to exposures such as DE.", {"entities": []}], ["Objectives: We profiled peripheral blood cellular miRNAs in participants with mild asthma who were exposed to controlled DE with and without antioxidant supplementation.", {"entities": [[83, 89, "DISEASE"]]}], ["Methods: Thirteen participants with asthma underwent controlled inhalation of filtered air and DE in a double-blinded, randomized crossover study of three conditions: a ) DE plus placebo (DEP), b ) filtered air plus placebo (FAP), or c ) DE with N -acetylcysteine supplementation (DEN).", {"entities": [[36, 42, "DISEASE"], [225, 228, "GENE"]]}], ["Total cellular RNA was extracted from blood drawn before exposure and 6 hr after exposure for miRNA profiling by the NanoString nCounter assay.", {"entities": [[72, 74, "GENE"]]}], ["MiRNAs significantly associated with DEP exposure and a predicted target [nuclear factor (erythroid-derived 2)-like 2 ( NRF2 )] as well as antioxidant enzyme genes were assessed by reverse transcription\u2013quantitative polymerase chain reaction (RT-qPCR) for validation, and we also assessed the ability of N -acetylcysteine supplementation to block the effect of DE on these specific miRNAs.", {"entities": []}], ["8-hydroxy-2\u00b4-deoxyguanosine (8-OHdG) was measured in plasma as a systemic oxidative stress marker.", {"entities": []}], ["Results: Expression of miR-21, miR-30e, miR-215, and miR-144 was significantly associated with DEP.", {"entities": [[23, 29, "GENE"], [31, 38, "GENE"], [40, 47, "GENE"], [53, 60, "GENE"]]}], ["The change in miR-144 was validated by RT-qPCR.", {"entities": [[14, 21, "GENE"]]}], ["NRF2 and its downstream antioxidant genes [glutamate cysteine ligase catalytic subunit ( GCLC ) and NAD(P)H:quinone oxidoreductase 1 ( NQO1 )] were negatively associated with miR-144 levels.", {"entities": [[89, 93, "GENE"], [135, 139, "GENE"], [175, 182, "GENE"]]}], ["Increases in miR-144 and miR-21 were associated with plasma 8-hydroxydeoxyguanosine 8-OHdG level and were blunted by antioxidant (i.e, DEN).", {"entities": [[13, 20, "GENE"], [25, 31, "GENE"]]}], ["Conclusions: Systemic miRNAs with plausible biological function are altered by acute moderate-dose DE exposure.", {"entities": []}], ["Oxidative stress appears to mediate DE-associated changes in miR-144.", {"entities": [[61, 68, "GENE"]]}], ["To examine gender and racial disparities in ischaemic heart disease (IHD) mortality related to metalworking fluid exposures and in the healthy worker survivor effect.", {"entities": [[54, 67, "DISEASE"]]}], ["A cohort of white and black men and women autoworkers in the USA was followed from 1941 to 1995 with quantitative exposure to respirable particulate matter from water-based metalworking fluids.", {"entities": []}], ["Separate analyses used proportional hazards models and g-estimation.", {"entities": []}], ["The HR for IHD among black men was 3.29 (95% CI 1.49 to 7.31) in the highest category of cumulative synthetic fluid exposure.", {"entities": [[4, 6, "GENE"]]}], ["The HR for IHD among white women exposed to soluble fluid reached 2.44 (95% CI 0.96 to 6.22).", {"entities": [[4, 6, "GENE"]]}], ["However, no increased risk was observed among white men until we corrected for the healthy worker survivor effect.", {"entities": []}], ["Results from g-estimation indicate that if white male cases exposed to soluble or synthetic fluid had been unexposed to that fluid type, then 1.59 and 1.20\u2005years of life would have been saved on average, respectively.", {"entities": []}], ["We leveraged the strengths of two different analytic approaches to examine the IHD risks of metalworking fluids.", {"entities": []}], ["All workers may have the same aetiological risk; however, black and female workers may experience more IHD from water-based metalworking fluid exposure because of a steeper exposure\u2013response or weaker healthy worker survivor effect.", {"entities": []}], ["Interplays between Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB) in human and host professional phagocytes, namely macrophages (M\u03c6s) and dendritic cells (DCs), are central to immune protection against TB and to TB pathogenesis.", {"entities": [[33, 45, "DISEASE"], [72, 84, "DISEASE"]]}], ["We and others have recently shown that the C-type lectin dendritic cell\u2013specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN; CD209) mediates important interactions between mycobacteria and human monocyte-derived DCs (MoDCs) in vitro.", {"entities": [[146, 151, "GENE"]]}], ["In order to explore the possible role of DC-SIGN in M. tuberculosis infection in vivo, we have analysed DC-SIGN expression in broncho-alveolar lavage (BAL) cells from patients with TB ( n = 40) or with other non-mycobacterial lung pathologies, namely asthma ( n = 14) and sarcoidosis ( n = 11), as well as from control individuals ( n = 9).", {"entities": [[55, 67, "DISEASE"], [272, 283, "DISEASE"], [251, 257, "DISEASE"]]}], ["We show that in patients with TB, up to 70% of alveolar M\u03c6s express DC-SIGN.", {"entities": []}], ["By contrast, the lectin is barely detected in alveolar M\u03c6s from all other individuals.", {"entities": []}], ["Flow cytometry, RT-PCR, and enzyme-linked immunosorbent assay analyses of BAL-derived fluids and cells indicated that M. tuberculosis infection induces DC-SIGN expression in alveolar M\u03c6s by a mechanism that is independent of Toll-like receptor-4, interleukin (IL)-4, and IL-13.", {"entities": [[121, 133, "DISEASE"]]}], ["This mechanism most likely relies on the secretion of soluble host and/or mycobacterial factors that have yet to be identified, as both infected and uninfected bystander M\u03c6s were found to express DC-SIGN in the presence of M. tuberculosis .", {"entities": [[226, 238, "DISEASE"]]}], ["Immunohistochemical examination of lung biopsy samples from patients with TB showed that the bacilli concentrate in pulmonary regions enriched in DC-SIGN-expressing alveolar M\u03c6s in vivo.", {"entities": []}], ["Ex vivo binding and inhibition of binding experiments further revealed that DC-SIGN\u2013expressing alveolar M\u03c6s constitute preferential target cells for M. tuberculosis, as compared to their DC-SIGN Altogether, our results provide further evidence for an important role of DC-SIGN during TB in humans.", {"entities": [[152, 164, "DISEASE"]]}], ["DC-SIGN induction in alveolar M\u03c6s may have important consequences on lung colonization by the tubercle bacillus, and on pulmonary inflammatory and immune responses in the infected host.", {"entities": []}], ["Alveolar macrophages from patients with TB express higher levels of DC-SIGN compared with controls.", {"entities": []}], ["Ex-vivo infection induced DC-SIGN in infected and bystander cells, which made the latter more susceptible.", {"entities": []}], ["The natural fungal compound ascofuranone (5-chloro-3-[(2E,6E)-7-[(2S)-5,5-dimethyl-4-oxo-tetrahydrofuran-2-yl]-3-methyl-octa-2,6-dienyl]-2,4-dihydroxy-6-methyl-benzaldehyde, MW 420.93) (AF) isolated from Ascochyta viciae has been known to promote cell cycle arrest and inhibit invasion of tumor cells.", {"entities": []}], ["We have previously studied a structurally similar compound ascochlorin (ASC; MW 404.93) with regard to its anti-inflammatory activity in LPS- stimulated RAW 264.7 macrophages.", {"entities": []}], ["In order to examine the relationship between the anti-inflammatory activities and the molecular differences between AF and ASC, the activity of AF is herein studied, because ASC has a unique trimethyl oxocyclohexyl structure, while AF has a unique dimethyl-oxo-tetrahydrofuran structure.", {"entities": []}], ["AF dose-dependently inhibited the production of NO and iNOS and the COX-2 mRNA and protein levels in RAW 264.7 cells.", {"entities": []}], ["In addition, AF suppressed mRNA expression levels of inflammatory cytokines such as TNF-\u03b1, IL-6, and IL-1\u03b2, as assessed by RT-PCR.", {"entities": []}], ["AF (30\u201350 \u03bcg/ml) treatment clearly inhibited the nuclear translocation of NF-\u03baB, AP-1 (p-c-Jun) from the cytosolic space.", {"entities": []}], ["Phosphorylation of I\u03baB, which functions to maintain the activity of NF-\u03baB, was decreased by AF treatment.", {"entities": []}], ["Moreover, AF suppressed the binding of NF-\u03baB (p65).", {"entities": []}], ["Inhibition of IkBa phosphorylation and degradation inhibits nuclear translocation of p65.", {"entities": []}], ["Immunofluorescence confocal microscopy analysis also revealed that translocation of NF-\u03baB and AP-1 (p-c-Jun) was decreased upon AF treatment.", {"entities": []}], ["AF specifically decreased the expression level of p-ERK, but not the expression level of p-p38 or p-JNK.", {"entities": []}], ["Given these results, we suggest that AF suppresses the inflammatory response by targeting p-ERK.", {"entities": []}], ["This indicates that AF is a negative regulator of LPS-stimulated nuclear translocation of NF-\u03baB and AP-1 (p-c-Jun) in RAW 264.7 macrophages, and specifically it targets p-ERK.", {"entities": []}], ["Therefore, AF and ASC exert their effects in different ways, most probably because their structural differences allow for specific recognition and inhibition of their target MAPKs.", {"entities": []}], ["Our results further suggest that AF could be a natural bioactive compound useful for treating inflammation-mediated pathological diseases.", {"entities": []}], ["In Europe, administration of an inhaled corticosteroid (ICS) combined with a long-acting \u03b22 agonist is approved in chronic obstructive pulmonary disease (COPD) patients with a pre-bronchodilator FEV 1 \u2009<\u200960% predicted normal, a history of repeated exacerbations, and who have significant symptoms despite regular bronchodilator therapy.", {"entities": [[115, 152, "DISEASE"], [195, 198, "GENE"]]}], ["Minimal data are available on the use of the fluticasone propionate/salmeterol xinafoate combination (FSC) in the real-life COPD setting and prescription compliance with the licensed specifications.", {"entities": []}], ["A French observational study was performed to describe the COPD population prescribed with FSC, prescription modalities, and the coherence of prescription practices with the market authorized population.", {"entities": []}], ["Data were collected for patients initiating FSC treatment (500\u00a0\u03bcg fluticasone propionate, 50\u00a0\u03bcg salmeterol, dry powder inhaler) prescribed by a general practitioner (GP) or a pulmonologist, using physician and patient questionnaires.", {"entities": []}], ["A total of 710 patients were included, 352 by GPs and 358 by pulmonologists.", {"entities": []}], ["Mean age was over 60\u00a0years, and 70% of patients were male.", {"entities": []}], ["More than half were retired, and overweight or obese.", {"entities": []}], ["Approximately half were current smokers and one-third had cardiovascular comorbidities.", {"entities": []}], ["According to both physician evaluation and GOLD 2006 classification, the majority of patients (>75%) had moderate to very severe COPD.", {"entities": []}], ["Strict compliance by prescribing physicians with the market-approved population for dry powder inhaler SFC in COPD was low, notably in ICS-na\u00efve patients; all three conditions were fulfilled in less than a quarter of patients with prior ICS and less than 7% of ICS-na\u00efve patients.", {"entities": []}], ["Prescription of dry powder inhaler SFC by GPs and pulmonologists has very low conformity with the three conditions defining the licensed COPD population.", {"entities": []}], ["Prescription practices need to be improved and systematic FEV 1 evaluation for COPD diagnosis and treatment management should be emphasized.", {"entities": [[58, 61, "GENE"]]}], ["The effects of S -ethyl cysteine (SEC) and S -methyl cysteine (SMC) on lipopolysaccharide (LPS)-induced acute lung injury in mice were examined.", {"entities": []}], ["Eight hours after LPS challenge, SEC or SMC was supplied in drinking water at 0.5% or 1% for 3 days.", {"entities": []}], ["LPS increased lung myeloperoxidase activity, neutrophil counts and edema.", {"entities": []}], ["SEC or SMC post-intake attenuated these events.", {"entities": []}], ["SEC or SMC suppressed LPS-induced lung expression of cyclooxygenase-2, nuclear factor-\u03baB and mitogen-activated protein kinase, and lowered the generation of tumor necrosis factor-alpha, monocyte chemoattractant protein-1 and prostaglandin E 2 .", {"entities": []}], ["LPS enhanced the expression of p47", {"entities": []}], ["Major advances have been made in the treatment of cancer with targeted therapy and immunotherapy; several FDA-approved agents with associated improvement of 1-year survival rates became available for stage IV melanoma patients.", {"entities": [[209, 217, "DISEASE"], [50, 56, "DISEASE"]]}], ["Before 2010, the 1-year survival were quite low, at 30%; in 2011, the rise to nearly 50% in the setting of treatment with Ipilimumab, and rise to 70% with BRAF inhibitor monotherapy in 2013 was observed.", {"entities": [[155, 159, "GENE"]]}], ["Even more impressive are 1-year survival rates considering combination strategies with both targeted therapy and immunotherapy, now exceeding 80%.", {"entities": []}], ["Can we improve response rates even further, and bring these therapies to more patients?", {"entities": []}], ["In fact, despite these advances, responses are heterogeneous and are not always durable.", {"entities": []}], ["There is a critical need to better understand who will benefit from therapy, as well as proper timing, sequence and combination of different therapeutic agents.", {"entities": []}], ["How can we better understand responses to therapy and optimize treatment regimens?", {"entities": []}], ["The key to better understanding therapy and to optimizing responses is with insights gained from responses to targeted therapy and immunotherapy through translational research in human samples.", {"entities": []}], ["Combination therapies including chemotherapy, radiotherapy, targeted therapy, electrochemotherapy with immunotherapy agents such as Immune Checkpoint Blockers are under investigation but there is much room for improvement.", {"entities": []}], ["Adoptive T cell therapy including tumor infiltrating lymphocytes and chimeric antigen receptor modified T cells therapy is also efficacious in metastatic melanoma and outcome enhancement seem likely by improved homing capacity of chemokine receptor transduced T cells.", {"entities": [[154, 162, "DISEASE"]]}], ["Tumor infiltrating lymphocytes therapy is also efficacious in metastatic melanoma and outcome enhancement seem likely by improved homing capacity of chemokine receptor transduced T cells.", {"entities": [[73, 81, "DISEASE"]]}], ["Understanding the mechanisms behind the development of acquired resistance and tests for biomarkers for treatment decisions are also under study and will offer new opportunities for more efficient combination therapies.", {"entities": []}], ["Knowledge of immunologic features of the tumor microenvironment associated with response and resistance will improve the identification of patients who will derive the most benefit from monotherapy and might reveal additional immunologic determinants that could be targeted in combination with checkpoint blockade.", {"entities": []}], ["The future of advanced melanoma needs to involve education and trials, biobanks with a focus on primary tumors, bioinformatics and empowerment of patients and clinicians.", {"entities": [[23, 31, "DISEASE"]]}], ["Regadenoson was approved for clinical use in Europe in 2011.", {"entities": []}], ["Since then, it has become the default form of stress at our institution.", {"entities": []}], ["We have assessed the side-effect profile and tolerability of regadenoson in patients undergoing clinically indicated myocardial perfusion scintigraphy between July 2011 and July 2012.", {"entities": []}], ["Clinical, stress and imaging data were recorded prospectively.", {"entities": []}], ["Symptoms during stress were recorded and defined as mild, moderate or severe.", {"entities": []}], ["An adverse event was defined as any symptom that persisted for more than 30\u00a0min or that required investigation or treatment.", {"entities": []}], ["Of 1,764 consecutive patients, 1,581 (90\u00a0%) received regadenoson combined with submaximal exercise unless contraindicated.", {"entities": []}], ["Symptoms were common (63\u00a0%) but transient and well-tolerated.", {"entities": []}], ["The severity of symptoms was recorded in most patients as mild (84\u00a0%).", {"entities": []}], ["Dyspnoea (36\u00a0%) and chest discomfort (12\u00a0%) were the commonest side effects.", {"entities": []}], ["Adverse events were reported in eight patients (0.5\u00a0%), thought to be vasovagal in seven of these.", {"entities": []}], ["All patients recovered fully without sequelae.", {"entities": []}], ["There were no deaths, myocardial infarction or hospital admissions.", {"entities": [[22, 43, "DISEASE"]]}], ["Regadenoson stress was performed in 206 patients (12\u00a0%) with asthma or chronic obstructive pulmonary disease (COPD) without bronchospasm or any other major side effect.", {"entities": [[71, 108, "DISEASE"], [61, 67, "DISEASE"]]}], ["We studied the symptom profile of regadenoson in the largest European cohort to date.", {"entities": []}], ["Regadenoson combined with submaximal exercise was well tolerated, notably also in patients with asthma or COPD.", {"entities": [[96, 102, "DISEASE"]]}], ["The majority of regadenoson-related adverse events were vasovagal episodes without sequelae.", {"entities": []}], ["Memory T cells respond rapidly to repeated antigen exposure and can maintain their population for extended periods through self-renewal.", {"entities": []}], ["These characteristics of memory T cells have mainly been studied during viral infections, whereas their existence and functions in allergic diseases have been studied incompletely.", {"entities": []}], ["Since allergic patients can suffer repeated relapses caused by intermittent allergen exposure, we hypothesized that allergen- specific memory Th2 cells are present and the factors necessary for the maintenance of these cells are provided by the lung and airways.", {"entities": []}], ["Using a murine model of airway inflammation, we found that allergen-specific CD4 T cells survived longer than 70 days in the lung and airways in an IL-7 dependent fashion.", {"entities": [[77, 80, "GENE"]]}], ["These T cells showing homeostatic proliferation were largely found in the mediastinal lymph node (mLN), rather than the airways; however, cells residing in the lung and airways developed recall responses successfully.", {"entities": [[98, 101, "GENE"]]}], ["We also found that CD4 T cells exhibited differential phenotypes in the mLN and in the lung.", {"entities": [[19, 22, "GENE"], [72, 75, "GENE"]]}], ["Altogether, we believe that allergen-specific memory T cells reside and function in the lung and airways, while their numbers are replenished through homeostatic turnover in the mLNs.", {"entities": []}], ["Furthermore, we determined that IL-7 signaling is important for the homeostasis of these cells.", {"entities": []}], ["Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures.", {"entities": [[146, 149, "GENE"], [231, 234, "GENE"], [146, 149, "GENE"], [231, 234, "GENE"]]}], ["In this paper, the major changes from the updated 2015 procedural guidelines are highlighted, focusing on the important changes related to new instrumentation with improved image information and the possibility to reduce radiation exposure, which is further discussed in relation to the recent developments of new International Commission on Radiological Protection (ICRP) models.", {"entities": []}], ["Introduction of the selective coronary vasodilator regadenoson and the use of coronary CT-contrast agents for hybrid imaging with SPECT/CT angiography are other important areas for nuclear cardiology that were not included in the previous guidelines.", {"entities": []}], ["A large number of minor changes have been described in more detail in the fully revised version available at the EANM home page: http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf .", {"entities": []}], ["Diabetic nephropathy and cardiovascular disease are strongly related in adults with type 1 diabetes, yet little is known about this relationship in adolescents prior to the onset of detectable clinical disease.", {"entities": []}], ["We hypothesized that cardiopulmonary fitness would be directly associated with albumin-to-creatinine ratio (ACR) and inversely related to estimated glomerular filtration rate (eGFR) in adolescents with type 1 diabetes.", {"entities": [[108, 111, "GENE"], [176, 180, "GENE"]]}], ["Sixty-nine adolescents with type 1 diabetes and 13 nondiabetic control subjects of similar pubertal stage and BMI had insulin sensitivity (glucose infusion rate [GIR]), measured by hyperinsulinemic-euglycemic clamp, and lean body mass, measured by DEXA.", {"entities": []}], ["Cardiopulmonary fitness was measured by cycle ergometry to obtain peak volume of oxygen (VO 2 peak), and renal function was measured by eGFR using the Bouvet equation (measuring creatinine and cystatin C levels) and ACR.", {"entities": [[136, 140, "GENE"], [216, 219, "GENE"]]}], ["Adolescents (15.5 \u00b1 2.2 years of age) with type 1 diabetes (6.3 \u00b1 3.8 years diabetes duration) had reduced VO 2 peak (31.5 \u00b1 6.3 vs. 36.2 \u00b1 7.9 mL/kg \u22c5 min, P = 0.046) and VO 2 peak/lean kg (43.7 \u00b1 7.0 vs. 51.0 \u00b1 8.6 mL/lean kg \u22c5 min, P = 0.007) compared with nondiabetic control subjects.", {"entities": []}], ["eGFR was inversely associated with VO 2 peak and VO 2 peak/lean kg after adjusting for sex, Tanner stage, GIR, HbA 1c level, systolic blood pressure, and LDL cholesterol level (\u03b2 \u00b1 SE, VO 2 peak: \u22120.19 \u00b1 0.07, P = 0.02; VO 2 peak/lean kg: \u22120.19 \u00b1 0.09, P = 0.048).", {"entities": [[0, 4, "GENE"]]}], ["Moreover, participants in the highest tertile for eGFR had significantly lower sex- and Tanner-adjusted VO 2 peak and VO 2 peak/lean kg compared with participants in the lowest tertile.", {"entities": [[50, 54, "GENE"]]}], ["Adolescents with type 1 diabetes had reduced exercise capacity, which was strongly associated with renal health, independent of insulin sensitivity.", {"entities": []}], ["Future studies should examine the underlying interrelated pathophysiology in order to identify probable targets for treatment to reduce cardiovascular and renal complications.", {"entities": []}], ["Grounded on the ethical principle of respect for persons, parental permission and child assent function together to protect the child and to foster the development of the child\u2019s self-determination.", {"entities": []}], ["Although both parental permission and child assent involve the same components of information sharing, comprehension, and voluntariness, how these three components are understood and operationalized should differ depending on the developmental level of the child.", {"entities": []}], ["For example, the amount of information that a child must comprehend to provide meaningful and developmentally appropriate child assent (or dissent) should be allowed to vary with the age and maturity of the child.", {"entities": []}], ["By understanding child assent together with the important protections of parental permission, child assent does not need to be burdened with the same informational and process requirements.", {"entities": []}], ["As a result, the age (as a proxy for developmental stage) at which a child is deemed capable of assent would be lower (i.e., 5 to 7 years old).", {"entities": []}], ["By assuming a lack of capacity, the potential arises to dishonor and disregard a child\u2019s wishes by failing to solicit meaningful assent or dissent.", {"entities": []}], ["Further research needs to be done on how best to obtain truly informed and voluntary parental permission and child assent for research participation.", {"entities": []}], ["Patient: Male, 4 Final Diagnosis: Cortical blindness after complicated general anesthesia Symptoms: Blindness \u2022 fine motor activity derangements Medication: \u2014 Clinical Procedure: General anesthesia for unilateral inguinal hydrocelectomy Specialty: Anesthesiology Rare disease We report a case of transient cortical blindness after urological surgery.", {"entities": [[34, 52, "DISEASE"], [306, 324, "DISEASE"], [43, 52, "DISEASE"], [100, 109, "DISEASE"], [315, 324, "DISEASE"]]}], ["We present the case of a 4-year-old boy with visual loss following complicated general anesthesia during urological surgery.", {"entities": []}], ["The results of ophthalmological examinations were normal.", {"entities": []}], ["The complication was diagnosed as cortical blindness after obtaining an extinguished flash visual-evoked potential (flash VEP).", {"entities": [[34, 52, "DISEASE"], [43, 52, "DISEASE"]]}], ["The visual acuity persisted to be hand motion after 4 months.", {"entities": []}], ["We report a very rare case of cortical blindness after urological surgery.", {"entities": [[30, 48, "DISEASE"], [39, 48, "DISEASE"]]}], ["Unrecognized causes of cortical blindness are common in the children.", {"entities": [[23, 41, "DISEASE"], [32, 41, "DISEASE"]]}], ["Because of the long survival and increasing surgical management in this age group, it is of great importance and perhaps it will be necessary to alert parents about it.", {"entities": []}], ["Anesthesiologists have a unique opportunity to facilitate positive outcomes for these patients through risk identification and appropriate management.", {"entities": []}], ["Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed to relieve pain and inflammation.", {"entities": []}], ["These NSAIDs have also analgesic effects and can be administered via oral, injectable, and topical routes.", {"entities": []}], ["During inflammation, a number of synovial mediators and cytokines are released which decrease the pH level of the synovial fluid.", {"entities": []}], ["Administration of acidic NSAIDs further decreases the pH levels and hence contributes to the destruction of the cartilage.", {"entities": []}], ["To our knowledge, no cellular-based study regarding the chondrotoxicity of phenyl alkanoic acid derivatives on NSAIDs was conducted before.", {"entities": []}], ["Thus, the aim of this pioneering study was to examine the effect of frequently prescribed NSAIDs, a phenyl alkanoic acid derivative, flurbiprofen, on the proliferation and differentiation of human primer chondrocyte cultures in vitro.", {"entities": []}], ["Primer chondrocyte cultures were prepared from osteochondral tissue obtained during surgery for gonarthrosis.", {"entities": []}], ["Samples not exposed to the pharmacological agent were used as the control group.", {"entities": []}], ["The samples were treated with 1, 10, 100, 250, 500, or 1000\u00a0\u03bcM of the agent for 24, 48, and 72\u00a0h. The cell viability, toxicity, and proliferation were assessed with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) analysis and prechondrocytic precursor stage-specific embryonic antigen-1 (SSEA-1) expression using a commercial ELISA kit spectrophotometrically.", {"entities": []}], ["The surface morphology of the samples in each group was compared using an inverted light microscope and an environmental scanning electron microscope (ESEM).", {"entities": []}], ["An analysis of variance was used to compare between-group differences.", {"entities": []}], ["Tukey\u2019s honest significant difference (HSD) method (95\u00a0% confidence interval) was used to evaluate the differences and significance in averages.", {"entities": []}], ["The alpha significance value was considered <0.01.", {"entities": []}], ["Statistically significant cytotoxicity was observed in the treatment groups.", {"entities": []}], ["NSAID had a significant negative effect on the proliferation and differentiation of chondrocytes as compared to the control group ( p \u2009<\u20090.01).", {"entities": []}], ["Before administering phenyl alkanoic acid derivatives in the clinical setting, their role in suppressing the proliferation and differentiation of chondrocytes should be taken into account.", {"entities": []}], ["Thus, caution should be given when prescribing these drugs.", {"entities": []}], ["This study examined gender-specific factors associated with the use of mental health services (MHS) for suicidal ideation (SI).", {"entities": []}], ["We included data on 6,768 males and 12,475 females who had experienced SI over the past year from the nationwide 2013 Korean Community Health Survey.", {"entities": []}], ["These individuals were grouped as MHS users for SI if they had received professional counseling at medical institutions, professional counseling agencies, or community health centers for SI-related problems.", {"entities": []}], ["Their information on sociodemographic factors, socio-familial relationships, health behaviors, and health status were included as exposures in a logistic regression analysis.", {"entities": []}], ["Of the 19,243 individuals, 7.0% of the males and 10.5% of the females used MHS for SI treatment.", {"entities": []}], ["For males with SI, living in an urban area, being a widower, and having unhealthy behaviors (frequent alcohol consumption and infrequent walking) were associated with underuse of MHS.", {"entities": []}], ["For females with SI, frequent contact with friends, low level of religious activity, and good self-rated health were associated with underuse of MHS.", {"entities": []}], ["For both males and females, those who were younger, completed higher education, and experienced depression/suicide attempts in the past year were more likely to use MHS for SI.", {"entities": []}], ["These findings suggest that gender-specific factors should be used to inform suicide prevention strategies.", {"entities": []}], ["The substantial economic impact of influenza on society results primarily from lost work time and reduced productivity of patients and caregivers and increased use of medical resources.", {"entities": [[35, 44, "DISEASE"]]}], ["Additionally, since the 1980s, aging of the US population has meant rising influenza-related morbidity and mortality.", {"entities": [[75, 84, "DISEASE"]]}], ["According to the most current published data on this topic, in 2003 the total economic burden of influenza epidemics in the USA across all age groups was US$87.1\u00a0billion.", {"entities": [[97, 106, "DISEASE"]]}], ["As of February 2013, overall vaccine effectiveness for the 2012/2013 season was estimated to be 56\u00a0%.", {"entities": []}], ["The Centers for Disease Control and Prevention\u2019s National Center for Immunization and Respiratory Diseases has concluded that more effective vaccines and vaccination strategies are needed.", {"entities": []}], ["Moderate efficacy of the influenza vaccine, continued questions regarding the value of treatment with antivirals, and a growing self-care movement have led to increased use of over-the-counter (OTC) medicines, which play a vital role in managing symptoms associated with mild to moderate influenza and provide an estimated US$102\u00a0billion in annual savings for the US healthcare system.", {"entities": [[25, 34, "DISEASE"], [288, 297, "DISEASE"], [194, 197, "GENE"]]}], ["A primary benefit to society of using OTC medicines to manage influenza is decreased use of the healthcare system, thereby mitigating the socioeconomic burden of influenza.", {"entities": [[62, 71, "DISEASE"], [162, 171, "DISEASE"], [38, 41, "GENE"]]}], ["Considering the stresses placed on the US healthcare system and the substantial productivity losses resulting from seasonal influenza as well as the growing self-care movement, OTC medicines will play an important role in the course of future influenza epidemics.", {"entities": [[124, 133, "DISEASE"], [243, 252, "DISEASE"], [177, 180, "GENE"]]}], ["The purpose of this research was to explore the role of masculinity and heterosexual gender relations in new and expectant fathers\u2019 explanations of their continued smoking.", {"entities": []}], ["We conducted a secondary analysis of in-depth interviews with 20 fathers.", {"entities": []}], ["Two themes were identified: (1) reconciling with partners to maintain a smoke-free family home; and (2) smoking to self-regulate emotions and maintain relationships.", {"entities": []}], ["Fathers\u2019 decisions to smoke and changes in smoking behavior were shaped by ideals of masculinity and by partner relationships and family and social contexts, including division of domestic duties and childcare.", {"entities": []}], ["Recognizing the influence of both masculinity and gender relations could provide new directions for supporting men\u2019s smoking cessation efforts during early parenthood.", {"entities": []}], ["\u00a9 2014 The Authors.", {"entities": []}], ["Research in Nursing & Health Published by Wiley Periodicals, Inc.", {"entities": []}], ["Recently, prebiotic supplementation of infant formula has become common practice; however the impact on the intestinal microbiota has not been completely elucidated.", {"entities": []}], ["In this study, neonatal piglets were randomized to: formula (FORM, n = 8), formula supplemented with 2 g/L each galactooligosaccharides (GOS) and polydextrose (PDX, F+GP, n = 9) or a sow-reared (SOW, n = 12) reference group for 19 days.", {"entities": []}], ["The ileal (IL) and ascending colon (AC) microbiota were characterized using culture-dependent and -independent methods.", {"entities": []}], ["16S amplicon sequencing identified no differences at the genera level in the IL.", {"entities": []}], ["Interestingly, six genera in the AC were significantly different between FORM and F+GP (P<0.05): Lactobacillus , Ruminococcus , Parabacteroides , Oscillospira , Hydrogenoanaerobacterium and Catabacter .", {"entities": []}], ["In particular, the relative abundance of AC Lactobacillus was higher (P = 0.04) in F+GP as compared to FORM.", {"entities": []}], ["Culture-dependent analysis of the IL and AC lactobacilli communities of FORM and F+GP revealed a Lactobacillus spp.", {"entities": []}], ["composition similar to 16S amplicon sequencing.", {"entities": []}], ["Additional analysis demonstrated individual Lactobacillus isolates were unable to ferment PDX.", {"entities": []}], ["Conversely, a majority of lactobacilli isolates could ferment GOS, regardless of piglet diet.", {"entities": []}], ["In addition, the ability of lactobacilli isolates to ferment the longer chain GOS fragments (DP 3 or greater), which are expected to be present in the distal intestine, was not different between FORM and F+GP.", {"entities": []}], ["In conclusion, prebiotic supplementation of formula impacted the AC microbiota; however, direct utilization of GOS or PDX does not lead to an increase in Lactobacillus spp.", {"entities": []}], ["Influenza and pneumonia combined are the leading causes of death due to infectious diseases in the United States.", {"entities": [[0, 9, "DISEASE"], [14, 23, "DISEASE"]]}], ["We describe factors associated with pneumonia among adults hospitalized with influenza.", {"entities": [[77, 86, "DISEASE"], [36, 45, "DISEASE"]]}], ["Through the Emerging Infections Program, we identified adults\u2009\u2265\u200918\u00a0years, who were hospitalized with laboratory-confirmed influenza during October 2005 through April 2008, and had a chest radiograph (CXR) performed.", {"entities": [[122, 131, "DISEASE"]]}], ["Pneumonia was defined as the presence of a CXR infiltrate and either an ICD-9-CM code or discharge summary diagnosis of pneumonia.", {"entities": [[0, 9, "DISEASE"], [120, 129, "DISEASE"]]}], ["Among 4,765 adults hospitalized with influenza, 1392 (29\u00a0%) had pneumonia.", {"entities": [[37, 46, "DISEASE"], [64, 73, "DISEASE"]]}], ["In multivariable analysis, factors associated with pneumonia included: age\u2009\u2265\u200975\u00a0years, adjusted odds ratio (AOR) 1.27 (95\u00a0% confidence interval 1.10\u20131.46), white race AOR 1.24 (1.03\u20131.49), nursing home residence AOR 1.37 (1.14\u20131.66), chronic lung disease AOR 1.37 (1.18\u20131.59), immunosuppression AOR 1.45 (1.19\u20131.78), and asthma AOR 0.76 (0.62\u20130.92).", {"entities": [[51, 60, "DISEASE"], [321, 327, "DISEASE"], [242, 254, "DISEASE"]]}], ["Patients with pneumonia were significantly more likely to require intensive care unit (ICU) admission (27\u00a0% vs. 10\u00a0%), mechanical ventilation (18\u00a0% vs. 5\u00a0%), and to die (9\u00a0% vs. 2\u00a0%).", {"entities": [[14, 23, "DISEASE"]]}], ["Pneumonia was present in nearly one-third of adults hospitalized with influenza and was associated with ICU admission and death.", {"entities": [[70, 79, "DISEASE"], [0, 9, "DISEASE"]]}], ["Among patients hospitalized with influenza, older patients and those with certain underlying conditions are more likely to have pneumonia.", {"entities": [[33, 42, "DISEASE"], [128, 137, "DISEASE"]]}], ["Pneumonia is common among adults hospitalized with influenza and should be evaluated and treated promptly.", {"entities": [[51, 60, "DISEASE"], [0, 9, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12879-015-1004-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The outcome of many infections depends on the initial interactions between agent and host.", {"entities": []}], ["Aiming at elucidating the effect of the M. tuberculosis Mce1 protein complex on host transcriptional and immunological responses to infection with M. tuberculosis , RNA from murine macrophages at 15, 30, 60 min, 4 and 10 hrs post-infection with M. tuberculosis H37Rv or \u0394- mce1 H37Rv was analyzed by whole-genome microarrays and RT-QPCR.", {"entities": [[43, 55, "DISEASE"], [150, 162, "DISEASE"], [248, 260, "DISEASE"]]}], ["Immunological responses were measured using a 23-plex cytokine assay.", {"entities": []}], ["Compared to uninfected controls, 524 versus 64 genes were up-regulated by 15 min post H37Rv- and \u0394- mce1 H37Rv-infection, respectively.", {"entities": []}], ["By 15 min post-H37Rv infection, a decline of 17 cytokines combined with up-regulation of Ccl24 (26.5-fold), Clec4a2 (23.2-fold) and Ppar\u03b3 (10.5-fold) indicated an anti-inflammatory response initiated by IL-13.", {"entities": [[89, 94, "GENE"]]}], ["Down-regulation of Il13ra1 combined with up-regulation of Il12b (30.2-fold), suggested switch to a pro-inflammatory response by 4 hrs post H37Rv-infection.", {"entities": [[19, 26, "GENE"], [58, 63, "GENE"]]}], ["Whereas no significant change in cytokine concentration or transcription was observed during the first hour post \u0394- mce1 H37Rv-infection, a significant decline of IL-1b, IL-9, IL-13, Eotaxin and GM-CSF combined with increased transcription of Il12b (25.1-fold) and Inb1 (17.9-fold) by 4 hrs, indicated a pro-inflammatory response.", {"entities": [[243, 248, "GENE"]]}], ["The balance between pro-and anti-inflammatory responses during the early stages of infection may have significant bearing on outcome.", {"entities": []}], ["Several studies have reported that the citrus red mites Panonychus citri were an important allergen of citrus-cultivating farmers in Jeju Island.", {"entities": []}], ["The aim of the present study was to purify and assess properties of a cysteine protease from the mites acting as a potentially pathogenic factor to citrus-cultivating farmers.", {"entities": []}], ["A cysteine protease was purified using column chromatography of Mono Q anion exchanger and Superdex 200 HR gel filtration.", {"entities": [[104, 106, "GENE"]]}], ["It was estimated to be 46 kDa by gel filtration column chromatography and consisted of 2 polypeptides, at least.", {"entities": []}], ["Cysteine protease inhibitors, such as trans poxy-succinyl-L-leucyl-amido (4-guanidino) butane (E-64) and iodoacetic acid (IAA) totally inhibited the enzyme activities, whereas serine or metalloprotease inhibitors did not affect the activities.", {"entities": []}], ["In addition, the purified enzyme degraded human IgG, collagen, and fibronectin, but not egg albumin.", {"entities": []}], ["From these results, the cysteine protease of the mites might be involved in the pathogenesis such as tissue destruction and penetration instead of nutrient digestion.", {"entities": []}], ["Lung involvement is a common extra-articular manifestation of rheumatoid arthritis (RA) that confers significant morbidity and mortality.", {"entities": [[62, 82, "DISEASE"], [73, 82, "DISEASE"]]}], ["The objective of the present study is to assess which respiratory symptoms and patient and disease characteristics are most highly associated with pulmonary function test (PFT) abnormalities in an RA patient cohort without clinical cardiovascular disease.", {"entities": []}], ["A total of 159 individuals with RA and without clinically evident cardiovascular disease were evaluated.", {"entities": []}], ["Respiratory symptoms were assessed with the Lung Tissue Research Consortium questionnaire and all patients underwent evaluation with PFTs.", {"entities": []}], ["Demographic, lifestyle, RA disease and treatment characteristics were collected.", {"entities": []}], ["Subclinical coronary artery disease was assessed by cardiac computed tomography.", {"entities": []}], ["Multivariable regression analysis was used to identify pulmonary symptoms and nonpulmonary parameters associated with PFT abnormalities.", {"entities": []}], ["Areas under the receiver operating characteristic curves (AUC) were calculated to evaluate the discrimination of these variables for identifying patients with PFT abnormalities.", {"entities": []}], ["Respiratory symptoms were reported by 42% of the patient population.", {"entities": []}], ["Although only 6% carried a prior diagnosis of lung disease, PFT abnormalities were identified in 28% of the subjects.", {"entities": [[46, 58, "DISEASE"]]}], ["Symptoms combined with other patient and RA characteristics (body mass index, current smoking, anti-cyclic citrullinated peptide antibodies, and current prednisone use) performed satisfactorily in predicting the PFT abnormalities of obstruction (AUC = 0.91, 95% confidence interval = 0.78 to 0.98), restriction (AUC = 0.79, 95% confidence interval = 0.75 to 0.93) and impaired diffusion (AUC = 0.85, 95% confidence interval = 0.59 to 0.92).", {"entities": []}], ["Co-morbid subclinical coronary artery disease did not modify these relationships.", {"entities": []}], ["Assessment of respiratory symptoms along with a limited number of clinical parameters may serve as a useful and inexpensive clinical tool for identifying RA patients in need of further pulmonary investigation.", {"entities": []}], ["Trefoil factor 3 (TFF3) serves an important role in intestinal mucosal damage and healing, and contributes to the pathogenesis and treatment of inflammatory bowel disease (IBD).", {"entities": [[144, 170, "DISEASE"], [18, 22, "GENE"]]}], ["The aim of the present study was to determine the association between TFF3 and microRNA-7-5p (miR-7-5p) in IBD.", {"entities": [[70, 74, "GENE"]]}], ["Tissue immunohistochemistry was applied to evaluate the relative expression of TFF3, and reverse transcription-quantitative polymerase chain reaction was performed to determine the expression of miR-7-5p in lesional tissue obtained from patients with IBD and healthy control tissues.", {"entities": [[79, 83, "GENE"]]}], ["A dual-luciferase reporter assay was used to investigate whether TFF3 was a target of miR-7-5p, and western blotting was performed to determine the expression of TFF3 when miR-7-5p was overexpressed or suppressed.", {"entities": [[65, 69, "GENE"], [162, 166, "GENE"], [65, 69, "GENE"], [162, 166, "GENE"]]}], ["The protein expression levels of TFF3 were decreased and miR-7-5p was overexpressed in the lesional tissue of patients with IBD compared with in healthy control tissues.", {"entities": [[33, 37, "GENE"]]}], ["TFF3 was identified as a target of miR-7-5p, and TFF3 protein expression was negatively regulated by miR-7-5p in human colonic epithelial LS174T cells.", {"entities": [[0, 4, "GENE"], [49, 53, "GENE"], [0, 4, "GENE"], [49, 53, "GENE"]]}], ["The present study demonstrated a negative association between the expression of miR-7-5p and TFF3 in IBD lesional tissues and normal tissues.", {"entities": [[93, 97, "GENE"]]}], ["In conclusion, TFF3 was identified as a novel target of miR-7-5p and miR-7-5p may serve as a promising therapeutic target for IBD.", {"entities": [[15, 19, "GENE"]]}], ["All organisms are connected in a complex web of relationships.", {"entities": []}], ["Although many of these are benign, not all are, and everything alive devotes significant resources to identifying and neutralizing threats from other species.", {"entities": []}], ["From bacteria through to primates, the presence of some kind of effective immune system has gone hand in hand with evolutionary success.", {"entities": []}], ["This article focuses on mammalian immunity, the challenges that it faces, the mechanisms by which these are addressed, and the consequences that arise when it malfunctions.", {"entities": []}], ["The main goal of treating hypertension is to reduce blood pressure to physiological levels and thereby prevent risk of cardiovascular disease and hypertension-associated target organ damage.", {"entities": [[26, 38, "DISEASE"], [146, 158, "DISEASE"]]}], ["Despite reductions in major risk factors and the availability of a plethora of effective antihypertensive drugs, the control of blood pressure to target values is still poor due to multiple factors including apparent drug resistance and lack of adherence.", {"entities": []}], ["An explanation for this problem is related to the current reductionist and \u2018trial-and-error\u2019 approach in the management of hypertension, as we may oversimplify the complex nature of the disease and not pay enough attention to the heterogeneity of the pathophysiology and clinical presentation of the disorder.", {"entities": [[123, 135, "DISEASE"]]}], ["Taking into account specific risk factors, genetic phenotype, pharmacokinetic characteristics, and other particular features unique to each patient, would allow a personalized approach to managing the disease.", {"entities": []}], ["Personalized medicine therefore represents the tailoring of medical approach and treatment to the individual characteristics of each patient and is expected to become the paradigm of future healthcare.", {"entities": []}], ["The advancement of systems biology research and the rapid development of high-throughput technologies, as well as the characterization of different \u2013omics, have contributed to a shift in modern biological and medical research from traditional hypothesis-driven designs toward data-driven studies and have facilitated the evolution of personalized or precision medicine for chronic diseases such as hypertension.", {"entities": [[398, 410, "DISEASE"]]}], ["Inhaled corticosteroids (ICSs) are used as first-line drugs for asthma, and various novel antiasthma drugs targeting type 2 immune mediators are now under development.", {"entities": [[64, 70, "DISEASE"]]}], ["However, molecularly targeted drugs are expensive, creating an economic burden on patients.", {"entities": []}], ["We and others previously found pendrin/SLC26A4 as a downstream molecule of IL-13, a signature type 2 cytokine critical for asthma, and showed its significance in the pathogenesis of asthma using model mice.", {"entities": [[123, 129, "DISEASE"], [182, 188, "DISEASE"]]}], ["However, the molecular mechanism of how pendrin causes airway inflammation remained elusive.", {"entities": []}], ["We have recently demonstrated that hypothiocyanite (OSCN 2 O 2 generated by DUOX into OSCN \u03ba B in airway epithelial cells, whereas OSCN", {"entities": []}], ["Sphingosine 1-phosphate (S1P) is a lysophospholipid mediator which activates G protein\u2013coupled sphingosine 1-phosphate receptors and thus evokes a variety of cell and tissue responses including lymphocyte trafficking, endothelial development, integrity, and maturation.", {"entities": []}], ["We performed five all-atom 700 ns molecular dynamics simulations of the sphingosine 1-phosphate receptor 1 (S1P 1 ) based on recently released crystal structure of that receptor with an antagonist.", {"entities": []}], ["We found that the initial movements of amino acid residues occurred in the area of highly conserved W269 The activation of G-protein-coupled receptors (GPCRs) depends on small differences in agonist and antagonist structures resulting in specific forces they impose on the helical bundle of the receptor.", {"entities": []}], ["Having the crystal structures of GPCRs in different stages of activation it is possible to investigate the successive conformational changes leading to full activation.", {"entities": []}], ["The long molecular dynamics simulations can fill the gap spanning between those structures and provide an overview of the activation processes.", {"entities": []}], ["The water molecules are recognized to be crucial in the activation process which link shifting of ligand in the binding site, the actions of molecular switches and finally the movements of fragments of TM helices.", {"entities": []}], ["Here, we present five 700 ns MD simulations of lipid S1P 1 receptor, either in Apo form, or bound to antagonist ML056 or natural agonist S1P.", {"entities": []}], ["The Apo and antagonist-bound receptor structures exhibited similar behavior, with their TM bundles nearly intact, while in the case of the agonist-bound receptor we observed movements of intracellular ends of some of TM helices.", {"entities": []}], ["Estimates of Human Papillomavirus (HPV) prevalence in a population prior to and after HPV vaccine introduction are essential to evaluate the short-term impact of vaccination.", {"entities": []}], ["Between 2010 and 2012 we conducted a population-based cross-sectional study in Germany to determine HPV prevalence, genotype distribution and risk factors for HPV-infection in women aged 20-25\u00a0years.", {"entities": []}], ["Women were recruited by a two-step cluster sampling approach.", {"entities": []}], ["A home-based self-collection of cervicovaginal lavages was used.", {"entities": []}], ["Specimens were analysed using a general primer GP5+/GP6+-based polymerase chain reaction and genotyped for 18 high-risk and 6 low-risk HPV- strains by Luminex-based multiplexed genotyping.", {"entities": []}], ["Among 787 included women, 512 were not vaccinated against HPV.", {"entities": []}], ["In the non-vaccinated population, HPV prevalence of any type was 38.1%, with HPV 16 (19.5%) being the most prevalent genotype.", {"entities": []}], ["Prevalence of any high-risk type was 34.4%, and in 17.4% of all women, more than one genotype was identified.", {"entities": []}], ["A higher number of lifetime sexual partners and low educational status were independently associated with HPV-infection.", {"entities": []}], ["In 223 vaccinated women, prevalence of HPV 16/18 was significantly lower compared to non-vaccinated women (13.9% vs. 22.5%, p\u2009=\u20090.007).", {"entities": []}], ["When stratifying by age groups, this difference was only significant in women aged 20-21\u00a0years, who at time of vaccination were on average younger and had less previous sexual contacts than women aged 22-25\u00a0years.", {"entities": []}], ["We demonstrate a high prevalence of high-risk HPV genotypes in non-vaccinated women living in Germany that can be potentially prevented by vaccination.", {"entities": []}], ["Probable first vaccination effects on the HPV prevalence were observed in women who were vaccinated at younger age.", {"entities": []}], ["This finding reinforces the recommendation to vaccinate girls in early adolescence.", {"entities": []}], ["Ranitidine hydrochloride is a widely used drug that is generally well-tolerated.", {"entities": []}], ["Anaphylaxis is rarely observed with ranitidine.", {"entities": []}], ["We report a case who developed severe anaphylaxis following single dose of intravenous ranitidine.", {"entities": []}], ["The article highlights the importance of recognition of this serious adverse event and re-emphasizes the need for cautious use of drugs, especially in those with known history of allergy.", {"entities": []}], ["Laparoscopy has quickly become the standard surgical approach to repair paraesophageal hernias.", {"entities": []}], ["Although many centers routinely perform this procedure, relatively high recurrence rates have led many surgeons to question this approach.", {"entities": []}], ["We sought to evaluate outcomes in our cohort of patients with an emphasis on recurrence rates and symptom improvement and their correlation with true radiologic recurrence seen on contrast imaging.", {"entities": []}], ["We retrospectively identified 126 consecutive patients who underwent laparoscopic repair of a large paraesophageal hernia between 2000 and 2010.", {"entities": []}], ["Clinical outcomes were reviewed, and data were collected regarding operative details, perioperative and postoperative complications, symptoms, and follow-up imaging.", {"entities": []}], ["Radiologic evidence of any size hiatal hernia was considered to indicate a recurrence.", {"entities": []}], ["There were 95 female and 31 male patients with a mean age (\u00b1 standard deviation) of 71 \u00b1 14 years.", {"entities": []}], ["Laparoscopic repair was completed successfully in 120 of 126 patients, with 6 operations converted to open procedures.", {"entities": []}], ["Crural reinforcement with mesh was performed in 79% of patients, and 11% underwent a Collis gastroplasty.", {"entities": []}], ["Fundoplications were performed in 90% of patients: Nissen (112), Dor (1), and Toupet (1).", {"entities": []}], ["Radiographic surveillance, obtained at a mean time interval of 23 months postoperatively, was available in 89 of 126 patients (71%).", {"entities": []}], ["Radiographic evidence of a recurrence was present in 19 patients (21%).", {"entities": []}], ["Reoperation was necessary in 6 patients (5%): 5 for symptomatic recurrence (4%) and 1 for dysphagia (1%).", {"entities": []}], ["The median length of stay was 4 days.", {"entities": []}], ["Laparoscopic paraesophageal hernia repair results in an excellent outcome with a short length of stay when performed at an experienced center.", {"entities": []}], ["Radiologic recurrence is observed relatively frequently with routine surveillance; however, many of these recurrences are small, and few patients require correction of the recurrence.", {"entities": []}], ["Furthermore, these small recurrent hernias are often asymptomatic and do not seem to be associated with the same risk of severe complications developing as the initial paraesophageal hernia.", {"entities": []}], ["The prevalence of chronic diseases, such as immune, neurobehavioral, and metabolic disorders has increased in recent decades.", {"entities": []}], ["According to the concept of Developmental Origin of Health and Disease (DOHaD), developmental factors associated with environmental exposures and maternal lifestyle choices may partly explain the observed increase.", {"entities": []}], ["Register-based epidemiology is a prime tool to investigate the effects of prenatal exposures over the whole life course.", {"entities": []}], ["Our aim is to establish a Finnish register-based birth cohort, which can be used to investigate various (prenatal) exposures and their effects during the whole life course with first analyses focusing on maternal smoking and air pollution.", {"entities": []}], ["In this paper we (i) review previous studies to identify knowledge gaps and overlaps available for cross-validation, (ii) lay out the MATEX study plan for register linkages, and (iii) analyse the study power of the baseline MATEX cohort for selected endpoints identified from the international literature.", {"entities": []}], ["The MATEX cohort is a fully register-based cohort identified from the Finnish Medical Birth Register (MBR) (1987\u20132015).", {"entities": []}], ["Information from the MBR will be linked with other Finnish health registers and the population register to link the cohort with air quality data.", {"entities": []}], ["Epidemiological analyses will be conducted for maternal smoking and air pollution and a range of health endpoints.", {"entities": []}], ["The MATEX cohort consists of 1.75 million mother-child pairs with a maximum follow up time of 29\u00a0years.", {"entities": []}], ["This makes the cohort big enough to reach sufficient statistical power to investigate rare outcomes, such as birth anomalies, childhood cancers, and sudden infant death syndrome (SIDS).", {"entities": [[169, 177, "DISEASE"], [149, 177, "DISEASE"]]}], ["The linkage between different registers allows for an extension of the scope of the cohort and a follow up from the prenatal period to decades later in life.", {"entities": []}], ["The online version of this article (10.1186/s12889-017-4881-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Supplemental Digital Content is available in the text Asthma is considered as a clinical and molecularly heterogeneous disorder.", {"entities": [[54, 60, "DISEASE"]]}], ["Systemic inflammation is suggested to play an important role in a group of asthma patients.", {"entities": [[75, 81, "DISEASE"]]}], ["We hypothesized that there is a subgroup of patients with asthma characterized by systemic inflammation.", {"entities": [[58, 64, "DISEASE"]]}], ["In this study, we aimed to discriminate asthma subtypes based on circulating biomarkers and to determine whether a systemic inflammatory endotype of asthma could be identified.", {"entities": [[40, 46, "DISEASE"], [149, 155, "DISEASE"]]}], ["In the present cross-sectional study, 50 patients with untreated asthma were prospectively recruited from a single academic outpatient clinic, and characterized with respect to clinical, functional, and inflammatory parameters.", {"entities": [[65, 71, "DISEASE"]]}], ["The expression profiles of 20 serum cytokines were assessed by anti-human cytokine antibody array.", {"entities": []}], ["Then, hierarchical clustering analysis was performed based on principal component analysis (PCA)-transformed data to classify the clinical groups.", {"entities": []}], ["PCA showed that 6 independent components accounted for 80.113% of the variance, and PCA-based hierarchical clustering identified 3 endotypes.", {"entities": []}], ["One of the endotypes was evidenced by elevated systemic inflammation markers such as leptin, vascular endothelial growth factor (VEGF), and reduced levels of soluble receptor for advanced glycation end products (sRAGE), an anti-inflammatory molecule.", {"entities": []}], ["More female patients were included, with higher circulating neutrophil counts and more severe symptoms.", {"entities": []}], ["In conclusion, we identified an endotype of asthma characterized by systemic inflammation and severe symptoms.", {"entities": [[44, 50, "DISEASE"]]}], ["Increased levels of VEGF, leptin and decreased level of sRAGE may contribute to the systemic inflammation of this asthma endotype.", {"entities": [[114, 120, "DISEASE"]]}], ["We examined temporal associations between objectively-measured physical activity (PA) during the day and in the evening, and sleep quantity and quality.", {"entities": []}], ["PA and sleep were measured by actigraphs for an average of one week in an epidemiological cohort study of 275 eight-year-old children.", {"entities": []}], ["For each one standard deviation (SD) unit of increased PA during the day, sleep duration was decreased by 0.30, sleep efficiency by 0.16, and sleep fragmentation increased by 0.08 SD units that night.", {"entities": []}], ["For each one SD unit increase in sleep duration and efficiency the preceding night, PA the following day decreased by 0.09 and 0.16 SD units, respectively.", {"entities": []}], ["When we contrasted days with a high amount of moderate to vigorous activity during the day or in the evening to days with a more sedentary profile, the results were essentially similar.", {"entities": []}], ["However, moderate to vigorous PA in the evening shortened sleep latency.", {"entities": []}], ["The relationship between a higher level of PA and poorer sleep is bidirectional.", {"entities": []}], ["These within-person findings challenge epidemiological findings showing that more active people report better sleep.", {"entities": []}], ["Since only a few studies using objective measurements of both PA and sleep have been conducted in children, further studies are needed to confirm/refute these results.", {"entities": []}], ["The purpose of this study was to determine the prevalence and clinical effects of untreated dental caries in Pakistani children residing in orphanages using the DMFT and PUFA index; association of decay and untreated dental caries with demographics including type of orphanage; behavioural and dental visiting pattern; and association of dental pain experience and type of orphanage with dental visiting.", {"entities": [[92, 105, "DISEASE"], [217, 230, "DISEASE"]]}], ["A cross-sectional survey was conducted on a total of 753 orphan children belonging to 4-17\u00a0years of age group residing in twin cities of Rawalpindi and Islamabad, Pakistan.", {"entities": []}], ["Clinical examination of children was performed using the DMFT and PUFA index for the assessment of dental caries and untreated decay, followed by questionnaire enquiring about eating and oral hygiene habits, dental visiting pattern and dental pain and swelling experience.", {"entities": [[99, 112, "DISEASE"]]}], ["Association between dental decay, child\u2019s dental visiting and pain as a consequence of untreated decay was carried out using chi square test and logistic regression analysis.", {"entities": []}], ["The overall caries prevalence was 34.8% and overall prevalence of PUFA/pufa was 15.9%.", {"entities": []}], ["The mean score of DMFT and dmft was 1.18 (SD 0.39) and 1.04 (SD 0.23), and mean PUFA was 1.18 (SD 0.57) and mean pufa score 1.14 (SD 0.35).", {"entities": []}], ["Untreated caries ratio was found to be 49.1% indicating half the decay had progressed to involve the pulp.", {"entities": []}], ["No significant association of gender was found with DMFT, dmft, PUFA and pufa ( p \u00a0>\u00a00.05), however, when analysed individually, the \u2018D\u2019 component of DMFT was significantly associated with male gender ( p \u00a0=\u00a00.05).", {"entities": []}], ["Furthermore, no significant association of DMFT/dmft or PUFA/pufa in either dentition was found with behavioural characteristics such as dietary and oral hygiene habits.", {"entities": []}], ["Also, 66.2% children who experienced pain had not been to the dentist in the past year ( p \u00a0=\u00a00.013) and 52.6% children who mentioned experiencing pain at night had not been to the dentist in the past year ( p \u00a0=\u00a00.009).", {"entities": []}], ["Children with decay were more likely to have visited the dentist (OR 3.3, 95% CI 1.42-7.6, p \u00a0=\u00a00.006).", {"entities": []}], ["However, children who reported to have experienced pain were less likely to have visited the dentist in the past year (OR 0.53, 95% CI 0.32-0.88, p \u00a0=\u00a00.014).", {"entities": []}], ["Moderate levels of decay were found in the sample with \u2018d\u2019 component majorly responsible for the cumulative DMFT index.", {"entities": []}], ["However, alarmingly almost half of the decay component (49.1%) had progressed to involve the pulp.", {"entities": []}], ["Experiencing pain in teeth prompted dental visits.", {"entities": []}], ["Initiation of preventive services for children residing in orphanages in Pakistan would help greatly towards reducing the burden of untreated decay.", {"entities": []}], ["The online version of this article (doi:10.1186/s12903-017-0399-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The human intestinal parasite Schistosoma mansoni causes a chronic disease, schistosomiasis or bilharzia.", {"entities": [[76, 91, "DISEASE"]]}], ["According to the current literature, the parasite induces vigorous immune responses that are controlled by Th2 helper cells at the expense of Th1 helper cells.", {"entities": []}], ["The latter cell type is, however, indispensable for anti-viral immune responses.", {"entities": []}], ["Remarkably, there is no reliable literature among 230 million patients worldwide describing defective anti-viral immune responses in the upper respiratory tract, for instance against influenza A virus or against respiratory syncitial virus (RSV).", {"entities": [[183, 192, "DISEASE"]]}], ["We therefore re-examined the immune response to a human isolate of S. mansoni and challenged mice in the chronic phase of schistosomiasis with influenza A virus, or with pneumonia virus of mice (PVM), a mouse virus to model RSV infections.", {"entities": [[143, 152, "DISEASE"], [170, 179, "DISEASE"], [122, 137, "DISEASE"]]}], ["We found that mice with chronic schistosomiasis had significant, systemic immune responses induced by Th1, Th2, and Th17 helper cells.", {"entities": [[32, 47, "DISEASE"]]}], ["High serum levels of TNF- \u03b1 , IFN- \u03b3 , IL-5, IL-13, IL-2, IL-17, and GM-CSF were found after mating and oviposition.", {"entities": []}], ["The lungs of diseased mice showed low-grade inflammation, with goblet cell hyperplasia and excessive mucus secretion, which was alleviated by treatment with an anti-TNF- \u03b1 agent (Etanercept).", {"entities": []}], ["Mice with chronic schistosomiasis were to a relative, but significant extent protected from a secondary viral respiratory challenge.", {"entities": [[18, 33, "DISEASE"]]}], ["The protection correlated with the onset of oviposition and TNF- \u03b1 -mediated goblet cell hyperplasia and mucus secretion, suggesting that these mechanisms are involved in enhanced immune protection to respiratory viruses during chronic murine schistosomiasis.", {"entities": [[243, 258, "DISEASE"]]}], ["Indeed, also in a model of allergic airway inflammation mice were protected from a viral respiratory challenge with PVM.", {"entities": []}], ["Cystic fibrosis (CF) is a lifelong, inflammatory multi-organ disease and the most common lethal, genetic condition in Caucasian populations, with a median survival rate of 41.5 years.", {"entities": []}], ["Pulmonary disease, characterized by infective exacerbations, bronchiectasis and increasing airway insufficiency is the most serious manifestation of this disease process, currently responsible for over 80% of CF deaths.", {"entities": [[61, 75, "DISEASE"]]}], ["Chronic dysregulation of the innate immune and host inflammatory response has been proposed as a mechanism central to this genetic condition, primarily driven by the nuclear factor \u03baB (NF-\u03baB) pathway.", {"entities": []}], ["Chronic activation of this transcription factor complex leads to the production of pro-inflammatory cytokines and mediators such as IL-6, IL-8 and TNF-\u03b1.", {"entities": []}], ["A20 has been described as a central and inducible negative regulator of NF-\u03baB.", {"entities": []}], ["This intracellular molecule negatively regulates NF-\u03baB-driven pro-inflammatory signalling upon toll-like receptor activation at the level of TRAF6 activation.", {"entities": [[141, 146, "GENE"]]}], ["Silencing of A20 increases cellular levels of p65 and induces a pro-inflammatory state.", {"entities": []}], ["We have previously shown that A20 expression positively correlates with lung function (FEV 1 %) in CF.", {"entities": [[87, 90, "GENE"]]}], ["Despite improvement in survival rates in recent years, advancements in available therapies have been incremental.", {"entities": []}], ["We demonstrate that the experimental use of naturally occurring plant diterpenes such as gibberellin on lipopolysaccharide-stimulated cell lines reduces IL-8 release in an A20-dependent manner.", {"entities": []}], ["We discuss how the use of a novel bio-informatics gene expression connectivity-mapping technique to identify small molecule compounds that similarly mimic the action of A20 may lead to the development of new therapeutic approaches capable of reducing chronic airway inflammation in CF.", {"entities": []}], ["We measured fractional exhaled nitric oxide (FE NO ), spirometry, blood pressure, oxygen saturation of the blood (SaO 2 ), and pulse rate in 16 older subjects with asthma or chronic obstructive pulmonary disease (COPD) in Seattle, Washington.", {"entities": [[174, 211, "DISEASE"], [164, 170, "DISEASE"]]}], ["Data were collected daily for 12 days.", {"entities": []}], ["We simultaneously collected PM 10 and PM 2.5 (particulate matter \u226410 \u03bcm or \u22642.5 \u03bcm, respectively) filter samples at a central outdoor site, as well as outside and inside the subjects\u2019 homes.", {"entities": []}], ["Personal PM 10 filter samples were also collected.", {"entities": []}], ["All filters were analyzed for mass and light absorbance.", {"entities": []}], ["We analyzed within-subject associations between health outcomes and air pollution metrics using a linear mixed-effects model with random intercept, controlling for age, ambient relative humidity, and ambient temperature.", {"entities": []}], ["For the 7 subjects with asthma, a 10 \u03bcg/m 10 and PM 2.5 was associated with a 5.9 [95% confidence interval (CI), 2.9\u20138.9] and 4.2 ppb (95% CI, 1.3\u20137.1) increase in FE NO , respectively.", {"entities": [[24, 30, "DISEASE"]]}], ["A 1 \u03bcg/m NO of 2.3 ppb (95% CI, 1.1\u20133.6), 4.0 ppb (95% CI, 2.0\u20135.9), and 1.2 ppb (95% CI, 0.2\u20132.2), respectively.", {"entities": []}], ["No significant association was found between PM or BC measures and changes in spirometry, blood pressure, pulse rate, or SaO 2 in these subjects.", {"entities": []}], ["Results from this study indicate that FE NO may be a more sensitive marker of PM exposure than traditional health outcomes and that particle-associated BC is useful for examining associations between primary combustion constituents of PM and health outcomes.", {"entities": []}], ["Despite reports advocating for integration of research into healthcare delivery, scant literature exists describing how this can be accomplished.", {"entities": []}], ["Examples highlighting application of qualitative research methods embedded into a healthcare system are particularly needed.", {"entities": []}], ["This article describes the process and value of embedding qualitative research as the second phase of an explanatory, sequential, mixed methods study to improve antibiotic stewardship for acute sinusitis.", {"entities": [[194, 203, "DISEASE"]]}], ["Purposive sampling of providers for in-depth interviews improved understanding of unwarranted antibiotic prescribing and elicited stakeholder recommendations for improvement.", {"entities": []}], ["Qualitative data collection, transcription and constant comparative analyses occurred iteratively.", {"entities": []}], ["Emerging themes and sub-themes identified primary drivers of unwarranted antibiotic prescribing patterns and recommendations for improving practice.", {"entities": []}], ["These findings informed the design of a health system intervention to improve antibiotic stewardship for acute sinusitis.", {"entities": [[111, 120, "DISEASE"]]}], ["Core components of the intervention are also described.", {"entities": []}], ["Qualitative research can be effectively applied in learning healthcare systems to elucidate quantitative results and inform improvement efforts.", {"entities": []}], ["The online version of this article (doi:10.1186/s12961-016-0122-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During October 2011 several residents and staff members at a long-term care facility (LTCF) for elderly fell ill with respiratory symptoms.", {"entities": []}], ["Several of the residents required hospitalization and one died.", {"entities": []}], ["Non-typeable Haemophilus influenzae (NTHi) was identified as the causative pathogen.", {"entities": []}], ["A descriptive analysis of the outbreak and countermeasures was performed.", {"entities": []}], ["For each identified bacterial isolate implied in the outbreak, standard laboratory resistance testing was performed, as well as molecular typing and phylogenetic analysis.", {"entities": []}], ["The identified H. influenzae was beta-lactamase negative but had strikingly high MIC-values of ampicillin, cefuroxime and cefotaxime.", {"entities": []}], ["All isolates displayed the same mutation in the fts I gene encoding penicillin-binding protein (PBP) 3, and all but one were identified as sequence type 14 by Multilocus Sequence Typing (MLST).", {"entities": []}], ["In total 15 individuals in connection to the LTCF; 8 residents, 6 staff members and one partner to a staff member were colonized with the strain.", {"entities": []}], ["This report illustrates the existence of non-typeable H. influenzae with high virulence, and furthermore emphasizes the importance of continuous surveillance of possible outbreaks in health care facilities and prompt measures when outbreaks occur.", {"entities": []}], ["Interleukin-33 (IL-33) is an IL-1 family member, which exhibits both pro- and anti-inflammatory properties solely based on the type of the disease itself.", {"entities": []}], ["Generally, IL-33 is expressed by both endothelial and epithelial cells and mediates its function based on the interaction with various receptors, mainly with ST2 variants.", {"entities": []}], ["IL-33 is a potent inducer for the Th2 immune response which includes defence mechanism in brain diseases.", {"entities": []}], ["Thus, in this paper, we review the biological features of IL-33 and the critical roles of IL-33/ST2 pathway in selected neurological disorders including Alzheimer's disease, multiple sclerosis, and malaria infection to discuss the involvement of IL-33/ST2 pathway during these brain diseases and its potential as future immunotherapeutic agents or for intervention purposes.", {"entities": [[174, 192, "DISEASE"], [198, 205, "DISEASE"]]}], ["Arginases are enzymes that are involved in many human diseases and have been targeted for new treatments.", {"entities": []}], ["Here a series of cinnamides was designed, synthesized and evaluated in vitro and in silico for their inhibitory activity against mammalian arginase.", {"entities": []}], ["Using a microassay on purified liver bovine arginase (b-ARG I), ( E )- N -(2-phenylethyl)-3,4-dihydroxycinnamide, also named caffeic acid phenylamide (CAPA), was shown to be slightly more active than our natural reference inhibitor, chlorogenic acid (IC 50 = 6.9 \u00b1 1.3 and 10.6 \u00b1 1.6 \u00b5M, respectively) but it remained less active that the synthetic reference inhibitor N l -arginine nor-NOHA (IC 50 = 1.7 \u00b1 0.2 \u00b5M).", {"entities": []}], ["Enzyme kinetic studies showed that CAPA was a competitive inhibitor of arginase with Ki = 5.5 \u00b1 1 \u00b5M.", {"entities": []}], ["Whereas the activity of nor-NOHA was retained (IC 50 = 5.7 \u00b1 0.6 \u00b5M) using a human recombinant arginase I (h-ARG I), CAPA showed poorer activity (IC 50 = 60.3 \u00b1 7.8 \u00b5M).", {"entities": []}], ["However, our study revealed that the cinnamoyl moiety and catechol function were important for inhibitory activity.", {"entities": []}], ["Docking results on h-ARG I demonstrated that the caffeoyl moiety could penetrate into the active-site pocket of the enzyme, and the catechol function might interact with the cofactor Mn", {"entities": []}], ["Excess weight contributes to the development and progression of Type 2 diabetes mellitus (T2DM).", {"entities": [[71, 88, "DISEASE"]]}], ["Distorted body image amongst urban Black women and the perception that thinness is linked with HIV, may however be compounding the problem, particularly in areas with a high HIV burden.", {"entities": []}], ["This study aimed to compare the perception of body image in urban Black women with and without T2DM.", {"entities": []}], ["A cross-sectional comparative study was conducted on 328 Black women systematically sampled into two groups (with and without T2DM).", {"entities": []}], ["Body mass index (BMI) (weight [kg]/height [m Seventy-two per cent had T2DM and in this group 89% were obese, with a mean BMI of 39.5 kg/m p < 0.05).", {"entities": []}], ["Both groups (99% of the study group) also perceived thinness as being associated with HIV.", {"entities": []}], ["This study identified an incongruence between PBI and actual BMI amongst urban Black women.", {"entities": []}], ["This, combined with their belief that thinness is associated with HIV, places those with T2DM at risk of secondary complications arising from diabetes mellitus, and those without diabetes mellitus at a higher risk of developing T2DM.", {"entities": [[142, 159, "DISEASE"], [179, 196, "DISEASE"]]}], ["A discrepancy between PBI and BMI may therefore serve as a risk marker to alert clinicians to use a more ethno-cultural specific approach in engaging with urban Black women regarding weight loss strategies in the future.", {"entities": []}], ["Active smoking increases asthma severity and is related to diminished treatment efficacy.", {"entities": [[25, 31, "DISEASE"]]}], ["Animal models in which inhalation of both allergen and mainstream cigarette smoke are combined can help us to understand the complex interaction between both agents.", {"entities": []}], ["We have recently shown that, in allergic mice, the airway inflammation can be cleared by repeated allergen challenge, resulting in the establishment of a state of inhalational tolerance.", {"entities": []}], ["In this study, we assessed in vivo the impact of cigarette smoke on the efficacy and time course of this form of tolerance induction.", {"entities": []}], ["We exposed sensitized mice to concurrent mainstream cigarette smoke and allergen (Ovalbumin- OVA) and measured the airway inflammation at different time points.", {"entities": []}], ["We first confirmed that aerosolized OVA administered for a prolonged time period (4\u20138 weeks) resulted in the establishment of tolerance.", {"entities": []}], ["Concurrent OVA and smoke exposure for 2 weeks showed that tobacco smoke enhanced the Th-2 driven airway inflammation in the acute phase.", {"entities": []}], ["In addition, the induction of the tolerance by repeated inhalational OVA challenge was delayed significantly by the tobacco smoke, since 4 weeks of concurrent exposure resulted in a more persistent eosinophilic airway inflammation, paralleled by a more mature dendritic cell phenotype.", {"entities": []}], ["However, smoke exposure could not prevent the establishment of tolerance after 8 weeks of antigen exposure as shown by both histopathology (disappearance of the Th-2 driven inflammation) and by in vivo functional experiments.", {"entities": []}], ["In these tolerized mice, some of the inflammatory responses to the smoke were even attenuated.", {"entities": []}], ["Cigarette smoke enhances acute allergic inflammation and delays, but does not abrogate the development of tolerance due to prolonged challenge with inhaled antigen in experimental asthma.", {"entities": [[180, 186, "DISEASE"]]}], ["To evaluate the association of asthma\u2013chronic obstructive pulmonary disease syndrome (ACOS) with neurodegenerative diseases (stroke, Parkinson's disease and dementia) and the role of the steroids in the neurodegenerative diseases among the ACOS cohort.", {"entities": [[157, 165, "DISEASE"], [38, 75, "DISEASE"], [76, 84, "DISEASE"], [31, 37, "DISEASE"]]}], ["Comparison of the ACOS cohort ( N = 10,260) with the non-ACOS cohort ( n = 20,513) based on the patients aged \u226740 years in the National Health Insurance Research Database from January 1, 2000 to December 31, 2010.", {"entities": []}], ["These patients follow up to diagnosis of neurodegenerative diseases or the December 31, 2011; using multivariable Cox proportional hazards models.", {"entities": []}], ["After adjustment for potential confounders, the [adjusted hazard ratio (aHR), 95% confidence interval (CI)] in the ACOS cohort were [1.39, 1.28\u20131.50] [1.56, 1.34\u20131.81] and [1.43, 1.29\u20131.59] for stroke, Parkinson's disease, dementia; respectively.", {"entities": [[223, 231, "DISEASE"], [72, 75, "GENE"]]}], ["The [aHR, 95% CI] for ACOS cohort with (inhaler corticosteroids \u22670.13 gram/ oral steroids \u22670.08gram) were with less risk (all aHR<1, p values <0.05) for these 3 neurodegenerative diseases except Parkinson's disease with inhaler corticosteroids >0.43 gram.", {"entities": [[5, 8, "GENE"], [126, 129, "GENE"], [5, 8, "GENE"], [126, 129, "GENE"]]}], ["The risk of stroke and dementia were the lower in patients with < 250 \u03bcg/d of a fluticasone equivalent inhaler corticosteroids (aHR = 0.53, 95% CI = 0.35\u20130.79; aHR = 0.53, 95% CI = 0.31\u20130.90, respectively).", {"entities": [[23, 31, "DISEASE"], [128, 131, "GENE"], [160, 163, "GENE"], [128, 131, "GENE"], [160, 163, "GENE"]]}], ["The ACOS cohort had a higher risk of the neurodegenerative diseases.", {"entities": []}], ["The lower dose of the inhaler corticosteroids with cumulative dose \u22670.13 gram have the less risk of stroke and dementia.", {"entities": [[111, 119, "DISEASE"]]}], ["A prevalence study was conducted among office workers in Malaysia (N= 695).", {"entities": []}], ["The aim of this study was to examine associations between asthma, airway symptoms, rhinitis and house dust mites (HDM) and cat allergy and HDM levels in office dust.", {"entities": [[83, 91, "DISEASE"], [58, 64, "DISEASE"]]}], ["Medical data was collected by a questionnaire.", {"entities": []}], ["Skin prick tests were performed for HDM allergens ( Dermatophagoides pteronyssinus , Dermatophagoides farinae) and cat allergen Felis domesticus .", {"entities": []}], ["Indoor temperature and relative air humidity (RH) were measured in the offices and vacuumed dust samples were analyzed for HDM allergens.", {"entities": []}], ["The prevalence of D .", {"entities": []}], ["pteronyssinus , D .", {"entities": []}], ["farinae and cat allergy were 50.3%, 49.0% and 25.5% respectively.", {"entities": []}], ["Totally 9.6% had doctor-diagnosed asthma, 15.5% had current wheeze and 53.0% had current rhinitis.", {"entities": [[89, 97, "DISEASE"], [34, 40, "DISEASE"]]}], ["The Der p 1 (from D .", {"entities": []}], ["pteronyssinus ) and Der f 1 (from D .", {"entities": []}], ["farinae ) allergens levels in dust were 556 ng/g and 658 ng/g respectively.", {"entities": []}], ["Statistical analysis was conducted by multilevel logistic regression, adjusting for age, gender, current smoking, HDM or cat allergy, home dampness and recent indoor painting at home.", {"entities": []}], ["Office workers with HDM allergy had more wheeze (p= 0.035), any airway symptoms (p= 0.032), doctor-diagnosed asthma (p= 0.005), current asthma (p= 0.007), current rhinitis (p= 0.021) and rhinoconjuctivitis (p< 0.001).", {"entities": [[163, 171, "DISEASE"], [109, 115, "DISEASE"], [136, 142, "DISEASE"]]}], ["Cat allergy was associated with wheeze (p= 0.021), wheeze when not having a cold (p= 0.033), any airway symptoms (p= 0.034), doctor-diagnosed asthma (p= 0.010), current asthma (p= 0.020) and nasal allergy medication (p= 0.042).", {"entities": [[142, 148, "DISEASE"], [169, 175, "DISEASE"]]}], ["Der f 1 level in dust was associated with daytime breathlessness (p= 0.033) especially among those with HDM allergy.", {"entities": []}], ["Der f 1 levels were correlated with indoor temperature (p< 0.001) and inversely correlated with RH (p< 0.001).", {"entities": []}], ["In conclusion, HDM and cat allergies were common and independently associated with asthma, airway symptoms and rhinitis.", {"entities": [[111, 119, "DISEASE"], [83, 89, "DISEASE"]]}], ["Der f 1 allergen can be a risk factor for daytime breathlessness.", {"entities": []}], ["Many uncertainties remain regarding optimal therapies and strategies for the treatment of inflammatory bowel disease.", {"entities": [[90, 116, "DISEASE"]]}], ["Setting research priorities addressing therapies requires a partnership between health care professionals, patients and organisations supporting patients.", {"entities": []}], ["We aimed to use the structure of the James Lind Alliance Priority Setting Partnership, which has been used in other disease areas, to identify and prioritise unanswered questions about treatments for inflammatory bowel disease.", {"entities": [[200, 226, "DISEASE"]]}], ["The James Lind Priority Setting Partnership uses methods agreed and adopted in other disease areas to work with patients and clinicians: to identify uncertainties about treatments; to agree by consensus a prioritised list of uncertainties for research; then to translate these uncertainties into research questions which are amenable to hypothesis testing; and finally to take results to research commissioning bodies to be considered for funding.", {"entities": []}], ["A total of 1636 uncertainties were collected in the initial survey from 531 respondents, which included 22% health care professionals and 78% patients and carers.", {"entities": []}], ["Using the rigorously applied processes of the priority setting partnership, this list was distilled down to the top 10 research priorities for inflammatory bowel disease.", {"entities": [[143, 169, "DISEASE"]]}], ["The top priorities were: identifying treatment strategies to optimise efficacy, safety and cost-effectiveness; and stratifying patients with regard to their disease course and treatment response.", {"entities": []}], ["Diet and symptom control [pain, incontinence and fatigue] were also topics which were prioritised.", {"entities": []}], ["A partnership involving multidisciplinary clinicians, patients and organisations supporting patients has identified the top 10 research priorities in the treatment of patients with inflammatory bowel disease.", {"entities": [[181, 207, "DISEASE"]]}], ["To evaluate the effect of a single course of high dose dexamethasone (HD-DXM) on CD28 and CTLA-4 expression in patients with newly-diagnosed primary immune thrombocytopenia (ITP).", {"entities": [[156, 172, "DISEASE"], [81, 85, "GENE"]]}], ["Twenty-8 ITP patients (18\u00a0females and 10\u00a0males, age range 18\u201365\u00a0years, median age 38.5\u00a0years) enrolled in this study and 26 healthy volunteers (19\u00a0women and 7\u00a0men, age range 16\u201366\u00a0years, median age 37\u00a0years) served as a control group.", {"entities": []}], ["The patients were treated with HD-DXM (40\u00a0mg/day) for 4 consecutive days.", {"entities": []}], ["CD28 and CTLA-4 expression was assessed by flow cytometry once-monthly for 6\u00a0months.", {"entities": [[0, 4, "GENE"]]}], ["Plasma levels of the cytokines IFN-\u03b3 and IL-10 were determined by enzyme-linked immunosorbent assay.", {"entities": []}], ["One month after treatment, a platelet response was observed in 23 (82%) of the patients.", {"entities": []}], ["The response rates over the next 5\u00a0months were 71%, 57%, 53%, 46%, and 39%, chronologically.", {"entities": []}], ["We observed a significant decrease in CD28 expression after the first month (34.7 \u00b1 4.8% vs. 44.5 \u00b1 4.4% before treatment), after which the CD28 levels gradually increased.", {"entities": [[38, 42, "GENE"], [140, 144, "GENE"], [38, 42, "GENE"], [140, 144, "GENE"]]}], ["In contrast, CTLA-4 expression increased after the first month (3.2 \u00b1 0.5% vs. 0.8 \u00b1 0.4 before treatment), after which the CTLA-4 levels gradually decreased.", {"entities": []}], ["Similar dynamic changes were seen in the levels of IFN-\u03b3 and IL-10.", {"entities": []}], ["The dynamic changes of CD28 and CTLA-4 were consistent with those of IFN-\u03b3 and IL-10 and with the effectiveness of HD-DXM in the treatment of ITP.", {"entities": [[23, 27, "GENE"]]}], ["Our results suggest that a disturbed CD28/CTLA-4 balance may contribute to the immunopathogenesis of ITP.", {"entities": []}], ["Lifestyle habits of physicians are of paramount importance both because they influence the physician\u2019s own health and because these habits have been shown to affect patients\u2019 care.", {"entities": []}], ["There is limited information on physician health and lifestyle habits in Bahrain.", {"entities": []}], ["In a cross-sectional study design, an anonymous self-administered questionnaire that assesses wellbeing and lifestyle habits was distributed to a random sample of 175 out of 320 primary health care physicians in Bahrain.", {"entities": []}], ["Descriptive analyses were performed, and the variables were cross-tabulated using SPSS version 20.0.", {"entities": []}], ["152 physicians agreed to participate in the study.", {"entities": []}], ["Respondents were 67.1\u00a0% female with a mean age of 45 (SD\u2009=\u200910).", {"entities": []}], ["The majority were of Bahraini nationality.", {"entities": []}], ["The most prevalent reported health conditions were hyperlipidaemia (25.5\u00a0%), hypertension (20.3\u00a0%), and diabetes (11.0\u00a0%).", {"entities": [[77, 89, "DISEASE"]]}], ["Only 29.6\u00a0% of physicians reported performing\u2009\u2265\u200930\u00a0min of exercise in a usual week.", {"entities": []}], ["Of physicians exercising\u2009\u2265\u200930\u00a0min weekly, only 13\u00a0% exercised\u2009\u2265\u20095\u00a0days weekly.", {"entities": []}], ["98.0\u00a0% report never drinking, 1.3\u00a0% report previously drinking, and 0.7\u00a0% report drinking less than once weekly.", {"entities": []}], ["The average body mass index (BMI) was 27.8 (SD\u2009=\u20095), with 39\u00a0% of physicians being overweight and 33\u00a0% obese.", {"entities": []}], ["BMI was directly associated with sleep time (P0.027, r There is a clear pattern of unfavourable lifestyle habits and obesity among primary health care physicians in Bahrain.", {"entities": [[117, 124, "DISEASE"]]}], ["We encourage institutions and public health sectors to be more proactive in assisting physicians to attain healthier lifestyles.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1969-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Free fatty acid receptors 2 and 3 (FFAR2/FFA2/GPR43 and FFAR3/FFA3/GPR41) are mammalian receptors for gut microbiota\u2013derived short-chain fatty acids (SCFAs).", {"entities": []}], ["These receptors are promising drug targets for obesity, colitis, colon cancer, asthma, and arthritis.", {"entities": [[47, 54, "DISEASE"], [65, 77, "DISEASE"], [91, 100, "DISEASE"], [79, 85, "DISEASE"], [71, 77, "DISEASE"]]}], ["Here, we demonstrate that FFAR2 and FFAR3 interact to form a heteromer in primary human monocytes and macrophages via proximity ligation assay, and during heterologous expression in HEK293 cells via bimolecular fluorescence complementation and fluorescence resonance energy transfer.", {"entities": [[26, 31, "GENE"], [36, 41, "GENE"]]}], ["The FFAR2-FFAR3 heteromer displayed enhanced cytosolic Ca \u03b1q inhibition (YM254890), or G \u03b1i inhibition (pertussis toxin).", {"entities": [[104, 113, "DISEASE"]]}], ["Unlike homomeric FFAR2/3, the heteromer lacked the ability to inhibit cAMP production but gained the ability to induce p38 phosphorylation in HEK293 and inflammatory monocytes via a CATPB- and YM254890-sensitive mechanism.", {"entities": []}], ["Our data, taken together, reveal that FFAR2 and FFAR3 may interact to form a receptor heteromer with signaling that is distinct from the parent homomers\u2014a novel pathway for drug targeting.\u2014Ang, Z., Xiong, D., Wu, M., Ding, J. L. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.", {"entities": [[38, 43, "GENE"], [229, 234, "GENE"], [48, 53, "GENE"], [235, 240, "GENE"]]}], ["Carotid body O 2 -chemosensitivity determines the hypoxic ventilatory response (HVR) as part of crucial regulatory reflex within oxygen homeostasis.", {"entities": []}], ["Nicotine has been suggested to attenuate HVR in neonates of smoking mothers.", {"entities": []}], ["However, whether smoking affects HVR in adulthood has remained unclear and probably blurred by acute ventilatory stimulation through cigarette smoke.", {"entities": []}], ["We hypothesized that HVR is substantially reduced in smokers when studied after an overnight abstinence from cigarettes i.e.", {"entities": []}], ["after nicotine elimination.", {"entities": []}], ["We therefore determined the isocapnic HVR of 23 healthy male smokers (age 33.9\u2009\u00b1\u20092.0\u00a0years, BMI 24.2\u2009\u00b1\u20090.5\u00a0kg\u00a0m Smokers and non-smokers were comparable with regard to factors known to affect isocapnic HVR such as plasma levels of glucose and thiols as well as intracellular levels of glutathione in blood mononuclear cells.", {"entities": []}], ["As a new finding, abstinent smokers had a significantly lower isocapnic HVR (0.024\u2009\u00b1\u20090.002 vs. 0.037\u2009\u00b1\u20090.003\u00a0l\u00a0min P \u2009=\u20090.002) compared to non-smokers.", {"entities": []}], ["However, upon re-exposure to cigarettes the smokers\u2019 HVR increased immediately to the non-smokers\u2019 level.", {"entities": []}], ["This is the first report of a substantial HVR reduction in abstinent adult smokers which appears to be masked by daily smoking routine and may therefore have been previously overlooked.", {"entities": []}], ["A low HVR may be suggested as a novel link between smoking and aggravated hypoxemia during sleep especially in relevant clinical conditions such as COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0323-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Use of the hospital emergency department (ED) for medical conditions not likely to require immediate treatment is a controversial topic.", {"entities": []}], ["It has been faulted for ED overcrowding, increased expenditures, and decreased quality of care.", {"entities": []}], ["On the other hand, such avoidable ED utilization may be a manifestation of barriers to primary care access.", {"entities": []}], ["A random 10% subsample of all ED visits with unmasked variables, or approximately 7.2% of all ED visits in California between 2006 and 2010 are used in the analysis.", {"entities": []}], ["Using panel data methods, we employ linear probability and fractional probit models with hospital fixed effects to analyze the associations between avoidable ED utilization in California and observable patient characteristics.", {"entities": []}], ["We also test whether shorter estimated road distances to the hospital ED are correlated with non-urgent ED utilization, as defined by the New York University ED Algorithm.", {"entities": []}], ["We then investigate whether proximity of a Federally Qualified Health Center (FQHC) is correlated with reductions in non-urgent ED utilization among Medicaid patients.", {"entities": []}], ["We find that relative to the reference group of adults aged 35\u201364, younger patients generally have higher scores for non-urgent conditions and lower scores for urgent conditions.", {"entities": []}], ["However, elderly patients (\u226565) use the ED for conditions more likely to be urgent.", {"entities": []}], ["Relative to male and white patients, respectively, female patients and all identified racial and ethnic minorities use the ED for conditions more likely to be non-urgent.", {"entities": []}], ["Patients with non-commercial insurance coverage also use the ED for conditions more likely to be non-urgent.", {"entities": []}], ["Medicare and Medicaid patients who live closer to the hospital ED have higher probability scores for non-emergent visits.", {"entities": []}], ["However, among Medicaid enrollees, those who live in zip codes with an FQHC within 0.5 mile of the zip code population centroid visit the ED for medical conditions less likely to be non-emergent.", {"entities": []}], ["These patterns of ED utilization point to potential barriers to care among historically vulnerable groups, observable even when using rough estimates of travel distances and avoidable ED utilization.", {"entities": []}], ["The online version of this article (doi:10.1186/s12939-015-0158-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives To quantify the effects of possible risk factors for herpes zoster at different ages.", {"entities": [[64, 77, "DISEASE"]]}], ["Design Case-control study.", {"entities": []}], ["Setting UK Clinical Practice Research Datalink primary care data.", {"entities": []}], ["Participants 144 959 adults diagnosed with zoster between 2000 and 2011; 549 336 age, sex, and practice matched controls.", {"entities": []}], ["Main outcome measures Conditional logistic regression was used to generate adjusted odds ratios to estimate the strength of association of each potential risk factor with zoster and assess effect modification by age.", {"entities": []}], ["Results The median age of the cases and controls was 62 years.", {"entities": []}], ["Factors associated with increased risk of zoster included rheumatoid arthritis (3111 (2.1%) v 8029 (1.5%); adjusted odds ratio 1.46, 99% confidence interval 1.38 to 1.55), inflammatory bowel disease (1851 (1.3%) v 5118 (0.9%); 1.36, 1.26 to 1.46), chronic obstructive pulmonary disease (6815 (4.7%) v 20 201 (3.7%); 1.32, 1.27 to 1.37), asthma (10 243 (7.1%) v 31 865 (5.8%); 1.21, 1.17 to 1.25), chronic kidney disease (8724 (6.0%) v 29 437 (5.4%); 1.14, 1.09 to 1.18), and depression (6830 (4.7%) v 22 052 (4.0%); 1.15, 1.10 to 1.20).", {"entities": [[172, 198, "DISEASE"], [405, 419, "DISEASE"], [58, 78, "DISEASE"], [248, 285, "DISEASE"], [69, 78, "DISEASE"], [337, 343, "DISEASE"]]}], ["Type 1, but not type 2, diabetes showed some association with zoster (adjusted odds ratio 1.27, 1.07 to 1.50).", {"entities": []}], ["The relative effects of many assessed risk factors were larger in younger patients.", {"entities": []}], ["Patients with severely immunosuppressive conditions were at greatest risk of zoster\u2014for example, patients with lymphoma (adjusted odds ratio 3.90, 3.21 to 4.74) and myeloma (2.16, 1.84 to 2.53), who are not eligible for zoster vaccination.", {"entities": [[165, 172, "DISEASE"], [111, 119, "DISEASE"]]}], ["Conclusions A range of conditions were associated with increased risk of zoster.", {"entities": []}], ["In general, the increased risk was proportionally greater in younger age groups.", {"entities": []}], ["Current vaccines are contraindicated in people at the greatest risk of zoster, highlighting the need for alternative risk reduction strategies in these groups.", {"entities": []}], ["Hiccup (Singultus) is a sudden and involuntary contraction of the diaphragm followed by a sharp closure of the epiglottis which results in the production of a specific \u201chic\u201d sound.", {"entities": []}], ["Normally, hiccups are treated without intervention.", {"entities": []}], ["Intractable hiccups occur rarely but are a disturbing symptom underlying other health related disorders.", {"entities": []}], ["We report the clinical case of a 67-year-old male patient with myocardial infarction accompanied by intractable hiccups during the course of 8\u00a0months, and who was non-responsive to chlorpromazine or metoclopramide, and baclofen; drugs routinely used to treat this condition.", {"entities": [[63, 84, "DISEASE"]]}], ["This sustained hiccup had severely restricted the patient's ability to intake food and sleep.", {"entities": []}], ["To explore alternative treatments, we investigated the adjuvant administration of lansoprazole, dimenhydrinate and clonazepam in this patient.", {"entities": []}], ["We discovered that this drug combination was capable of successfully terminating his intractable hiccups, with no further evidence of recurrence.", {"entities": []}], ["No similar treatment is previously reported for intractable hiccups.", {"entities": []}], ["We further suggest a hypothesis concerning a potential mechanism on the anti-hiccup effect of dimenhydrinate.", {"entities": []}], ["We identified that the adjuvant use of lansoprazole, clonazepam and dimenhydrinate was capable of attenuating the symptoms of our patient with intractable hiccups.", {"entities": []}], ["Over the last few years a decreasing trend in smoking has occurred not only in the general population but also during pregnancy.", {"entities": []}], ["Several countries have implemented laws requiring all enclosed workplace and public places to be free of second hand smoke (SHS).", {"entities": []}], ["In Spain, legislation to reduce SHS was implemented in 2005.", {"entities": []}], ["The present study examines the possible effect of this legislation on prenatal SHS exposure.", {"entities": []}], ["Mothers and newborns were recruited from 3 independent studies performed in Hospital del Mar (Barcelona) and approved by the local Ethics Committee: 415 participated in a study in 1996-1998, 283 in 2002-2004 and 207 in 2008.", {"entities": []}], ["A standard questionnaire, including neonatal and sociodemographic variables,tobacco use and exposure during pregnancy, was completed at delivery for all the participants in the three study groups.", {"entities": []}], ["Fetal exposure to tobacco was studied by measuring cotinine in cord blood by radioimmunoassay (RIA).", {"entities": []}], ["32.8% of the pregnant women reported to smoke during pregnancy in 1996-1998, 25.9% in 2002-2004 and 34.1% in 2008.", {"entities": []}], ["In the most recent group, the percentage of no prenatal SHS exposure (cord blood cotinine 0.2-1 ng/mL) showed an increase compared to the previous groups while the percentages of both: low (1.1-14 ng/mL) and very high (> 100 ng/mL) prenatal SHS exposure showed a decrease.", {"entities": []}], ["The results of the three study periods (1996-2008) demonstrated a significant increase in the percentage of newborns free from SHS exposure and a decrease in the percentage of newborns exposed to SHS during pregnancy, especially at the very high levels of exposure.", {"entities": []}], ["A significant maternal smoking habit was noted in this geographical area with particular emphasis on immigrant pregnant smoking women.", {"entities": []}], ["Our study indicates that there is a significant maternal smoking habit in this geographical area.", {"entities": []}], ["Our recommendation is that campaigns against smoking should be directed more specifically towards pregnant women with particular emphasis on non-native pregnant smokers due to the highest prevalence of tobacco consumption in the immigrant women.", {"entities": []}], ["Respiratory syncytial virus (RSV) most often causes severe respiratory disease in the very young and the elderly.", {"entities": []}], ["Acute disease can also cause exacerbations of asthma in any age group.", {"entities": [[46, 52, "DISEASE"]]}], ["Recent findings provide insight into how the innate and adaptive immune systems respond to RSV infection and provide preliminary evidence that these effects vary significantly by RSV strain and host.", {"entities": []}], ["Components of cell signaling pathways that induce inflammatory cytokine expression during the innate immune response and alter epithelial cell polarity through activating transcription factors, namely NF-\u03baB, are now more clearly understood.", {"entities": []}], ["New studies also reveal how RSV infection skews T helper (Th) cell differentiation away from the cell-mediated Th1 subset and towards the Th2 subset.", {"entities": []}], ["There are also new data supporting preferential Th17 differentiation during RSV infection.", {"entities": []}], ["In addition, effective immune system regulation of IL-10 expression and T regulatory cell (Treg) airway accumulation are essential for effective RSV clearance.", {"entities": []}], ["This systematic review aims first to summarize the previous areas of application of computational fluid dynamics (CFD) and then to demonstrate that CFD is also a suitable instrument for generating three-dimensional images that depict drug effects on nasal mucosa.", {"entities": [[114, 117, "GENE"], [148, 151, "GENE"], [114, 117, "GENE"], [148, 151, "GENE"]]}], ["Special emphasis is placed on the three-dimensional visualization of the antiobstructive effect of nasal steroids and antihistamines in the treatment of allergic rhinitis.", {"entities": [[153, 170, "DISEASE"], [162, 170, "DISEASE"]]}], ["In the beginning, CFD technology was only used to demonstrate physiological and pathophysiological airflow conditions in the nose and to aid in preoperative planning and postoperative monitoring of surgical outcome in the field of rhinosurgery.", {"entities": [[18, 21, "GENE"]]}], ["The first studies using CFD examined nasal respiratory physiology, important functions of the nose, such as conditioning and warming of inspired air, and the influence of pathophysiological changes on nasal breathing.", {"entities": [[24, 27, "GENE"]]}], ["Also, postoperative outcome of surgical procedures could be \"predicted\" using the nasal airflow model.", {"entities": []}], ["Later studies focused on the three-dimensional visualization of the effect of nasal sprays in healthy subjects and postoperative patients.", {"entities": []}], ["A completely new approach, however, was the use of CFD in the area of allergic rhinitis and the treatment of its cardinal symptom of nasal obstruction.", {"entities": [[70, 87, "DISEASE"], [79, 87, "DISEASE"], [51, 54, "GENE"]]}], ["In two clinical trials, a suitable patient with a positive history of allergic rhinitis was enrolled during a symptom-free period after the pollen season.", {"entities": [[70, 87, "DISEASE"], [79, 87, "DISEASE"]]}], ["The patient developed typical allergic rhinitis symptoms after provocation with birch pollen.", {"entities": [[30, 47, "DISEASE"], [39, 47, "DISEASE"]]}], ["The 3-D visualization showed that the antiallergic treatment successfully counteracted the effects of nasal allergen provocation on nasal airflow.", {"entities": []}], ["These observations were attributed to the antiobstructive effect of a nasal steroid (mometasone furoate) and a systemic antihistamine (levocetirizine), respectively.", {"entities": []}], ["CFD therefore constitutes a non-invasive, precise, reliable and objective examination procedure for generating three-dimensional images that depict the effects of drugs used in the treatment of allergic rhinitis.", {"entities": [[194, 211, "DISEASE"], [203, 211, "DISEASE"], [0, 3, "GENE"]]}], ["Sublingual immunotherapy ( SLIT ) is a potential efficacious and safe treatment option for patients with respiratory, IgE\u2010mediated allergic diseases.", {"entities": []}], ["A combined tolerability, dose\u2010finding study with a sublingual liquid birch pollen preparation ( SB ) was conducted.", {"entities": []}], ["Two hundred and sixty\u2010nine adults with birch\u2010pollen\u2010induced AR were randomized to placebo, SB: 3333, 10 000, 20 000 or 40 000 AUN/ml.", {"entities": []}], ["Differences in symptom scores following a titrated nasal provocation test ( TNPT ) at baseline and after 5 months of treatment were determined.", {"entities": []}], ["Safety, tolerability, birch\u2010pollen\u2010specific immunoglobulin levels and peak nasal inspiratory flow ( PNIF ) were also measured (all measures determined outside the birch pollen season).", {"entities": []}], ["In all treatment groups, an improvement in symptom scores after treatment compared to baseline was observed, with an additional stepwise improvement in the active groups compared to placebo, which was significant in high\u2010dose groups ( P = 0.008 and P < 0.001, respectively).", {"entities": []}], ["For this primary endpoint, a significant linear dose\u2013response curve was observed: the higher the dose, the better the improvement observed.", {"entities": []}], ["Likewise, active treatment resulted in an increase in PNIF and serum IgG levels compared to placebo.", {"entities": []}], ["The highest improvements were found in the 40 000 AUN/ml group.", {"entities": []}], ["All active dosages resulted in more adverse reactions than placebo, which were mainly mild and well\u2010controlled.", {"entities": []}], ["A multicentre trial evaluated the dose\u2013response and tolerability of SB .", {"entities": []}], ["All active treatment groups showed better responses than placebo for both primary and secondary parameters.", {"entities": []}], ["The results indicate that, within the studied dose range, SB 40 000 AUN /ml is the most optimal effective and safe dose (ClinicalTrials.gov: NCT 01639768).", {"entities": []}], ["Crystallographic and solution studies have shown that IgE molecules are acutely bent in their Fc region.", {"entities": []}], ["Crystal structures reveal the C\u03b52 domain pair folded back onto the C\u03b53-C\u03b54 domains, but is the molecule exclusively bent or can the C\u03b52 domains adopt extended conformations and even \u201cflip\u201d from one side of the molecule to the other?", {"entities": []}], ["We report the crystal structure of IgE-Fc captured in a fully extended, symmetrical conformation and show by molecular dynamics, calorimetry, stopped-flow kinetic, SPR and FRET analyses, that the antibody can indeed adopt such extended conformations in solution.", {"entities": [[164, 167, "GENE"]]}], ["This diversity of conformational states available to IgE-Fc offers a new perspective on IgE function in allergen recognition, as part of the B cell receptor and as a therapeutic target in allergic disease.", {"entities": []}], ["Four patients from three Norwegian families presented with a common skin phenotype of warts, molluscum contagiosum, and dermatitis since early childhood, and various other immunological features.", {"entities": [[93, 114, "DISEASE"], [120, 130, "DISEASE"]]}], ["Warts are a common manifestation of human papilloma virus ( HPV ), but when they are overwhelming, disseminated and/or persistent, and presenting together with other immunological features, a primary immunodeficiency disease ( PIDD ) may be suspected.", {"entities": [[42, 51, "DISEASE"], [192, 224, "DISEASE"]]}], ["The four patients were exome sequenced as part of a larger study for detecting genetic causes of primary immunodeficiencies.", {"entities": []}], ["No disease\u2010causing variants were identified in known primary immunodeficiency genes or in other disease\u2010related OMIM genes.", {"entities": []}], ["However, the same homozygous missense variant in CARMIL 2 (also known as RLTPR ) was identified in all four patients.", {"entities": [[73, 78, "GENE"]]}], ["In each family, the variant was located within a narrow region of homozygosity, representing a potential region of autozygosity.", {"entities": []}], ["CARMIL 2 is a protein of undetermined function.", {"entities": []}], ["A role in T\u2010cell activation has been suggested and the mouse protein homolog (Rltpr) is essential for costimulation of T\u2010cell activation via CD 28, and for the development of regulatory T cells.", {"entities": [[78, 83, "GENE"]]}], ["Immunophenotyping demonstrated reduced regulatory, CD 4+ memory, and CD 4+ follicular T cells in all four patients.", {"entities": []}], ["In addition, they all seem to have a deficiency in IFN \u03b3 \u2010synthesis in CD 4+ T cells and NK cells.", {"entities": []}], ["We report a novel primary immunodeficiency, and a differential molecular diagnosis to CXCR 4\u2010 , DOCK 8\u2010 , GATA 2\u2010 , MAGT 1\u2010 , MCM 4\u2010 , STK 4\u2010 , RHOH \u2010 , TMC 6\u2010, and TMC 8\u2010 related diseases.", {"entities": []}], ["The specific variant may represent a Norwegian founder variant segregating on a population\u2010specific haplotype.", {"entities": []}], ["Relapses of immune\u2010mediated hemolytic anemia ( IMHA ), thrombocytopenia ( ITP ), or polyarthropathy ( IMPA ) occur despite normal hematologic and cytologic parameters.", {"entities": [[55, 71, "DISEASE"], [28, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["Thymidine kinase 1 ( TK 1), canine C\u2010reactive protein (c\u2010 CRP ), haptoglobin ( HPT ), and 25\u2010Hydroxyvitamin\u2010 D (25( OH )D) might be adjunct to current monitoring strategies.", {"entities": [[58, 61, "GENE"]]}], ["Compare serum concentrations of TK 1, c\u2010 CRP , HPT , and 25( OH )D in dogs with well\u2010 and poorly controlled primary IMHA , ITP , or IMPA .", {"entities": [[41, 44, "GENE"]]}], ["Thirty\u2010eight client\u2010owned dogs.", {"entities": []}], ["Prospective descriptive study.", {"entities": []}], ["Dogs diagnosed with IMHA , ITP , or IMPA had serum biomarker concentrations measured commercially.", {"entities": []}], ["Disease control was assessed by hematocrit/ PCV and reticulocyte count, platelet count, and synovial fluid cytology for IMHA , ITP , and IMPA , respectively.", {"entities": []}], ["Statistical analysis performed by Mann\u2010Whitney rank\u2010sum tests and receiver operating characteristic curves.", {"entities": []}], ["TK 1 and c\u2010 CRP , but not HPT significantly decreased with well\u2010 versus poorly controlled IMHA ( P = 0.047, P = 0.028, P = 0.37).", {"entities": [[12, 15, "GENE"]]}], ["C\u2010 CRP , but not TK or HPT was significantly lower with well\u2010 versus poorly controlled IMPA ( P = 0.05, P = 0.28, P = 0.84).", {"entities": [[3, 6, "GENE"]]}], ["Sensitivity and specificity of TK and c\u2010 CRP (simultaneously) for detecting dogs with poorly controlled IMHA were 88 and 100%, respectively.", {"entities": [[41, 44, "GENE"]]}], ["Sensitivity and specificity of c\u2010 CRP for detecting poorly controlled dogs with IMPA were 13 and 100%, respectively.", {"entities": [[34, 37, "GENE"]]}], ["92% of dogs were vitamin D insufficient (<100 ng/mL) regardless of disease control.", {"entities": []}], ["Combining TK 1 and c\u2010 CRP might act markers of disease control in dogs with IMHA .", {"entities": [[22, 25, "GENE"]]}], ["Canine\u2010 CRP cannot be recommended as an independent marker of disease control in IMPA .", {"entities": [[8, 11, "GENE"]]}], ["25( OH )D insufficiency in immune\u2010mediated disorders might benefit from further study to determine if supplementation could improve therapeutic response or reduce disease risk.", {"entities": []}], ["The South African Department of Health (DOH) publishes annual guidelines identifying priority groups, including immunosuppressed individuals and healthcare workers (HCW), for influenza vaccination and treatment.", {"entities": [[175, 184, "DISEASE"]]}], ["How these guidelines have impacted HCW and their patients, particularly those infected with HIV, remains unknown.", {"entities": []}], ["We aimed to describe the knowledge, attitudes and practices regarding influenza and the vaccine among South African HCW.", {"entities": [[70, 79, "DISEASE"]]}], ["Surveys were distributed by two local non-governmental organizations in public health clinics and hospitals in 21 districts/municipalities (5 of 9 provinces).", {"entities": []}], ["There were 1164 respondents; median age 41 years; 978/1126 (87%) female; 801/1122 (71%) nurses.", {"entities": []}], ["One-third (34%) of HCW reported getting influenza vaccine 2013/2014 and most (94%) recommended influenza vaccine to patients infected with HIV.", {"entities": [[40, 49, "DISEASE"], [95, 104, "DISEASE"]]}], ["Ability to get vaccine free of charge (aOR 1.69; 95% CI 1.21\u20132.37) and having received influenza government training (aOR 1.50; 95% CI 1.04\u20132.15) were significantly associated with self-reported vaccination in 2013/2014.", {"entities": [[87, 96, "DISEASE"]]}], ["Self-reported 2013/2014 vaccination (aOR 3.76; 95% CI 1.28\u201311.03) and availability of influenza vaccine during the healthcare visit (aOR 2.56; 95% CI 1.18\u20135.57) were significantly associated with recommending influenza vaccine to patients infected with HIV/AIDS.", {"entities": [[86, 95, "DISEASE"], [209, 218, "DISEASE"]]}], ["Only one-third of participants were vaccinated in 2013\u20132014 but those who were vaccinated were more likely to recommend vaccination to their patients.", {"entities": []}], ["Free and close access to influenza vaccine were associated with a higher likelihood of getting vaccinated in 2013/2014.", {"entities": [[25, 34, "DISEASE"]]}], ["HCW who reported getting the influenza vaccine themselves, had vaccine to offer during the patient consult and were familiar with DOH guidelines/trainings were more likely to recommend vaccine to HIV-infected patients.", {"entities": [[29, 38, "DISEASE"]]}], ["Synthetic vitreous fibers (SVFs) are inorganic noncrystalline materials widely used in residential and industrial settings for insulation, filtration, and reinforcement purposes.", {"entities": []}], ["SVFs conventionally include three major categories: fibrous glass, rock/slag/stone (mineral) wool, and ceramic fibers.", {"entities": []}], ["Previous in vitro studies from our laboratory demonstrated length-dependent cytotoxic effects of glass fibers on rat alveolar macrophages which were possibly associated with incomplete phagocytosis of fibers \u2265 17 \u03bcm in length.", {"entities": []}], ["The purpose of this study was to examine the influence of fiber length on primary human alveolar macrophages, which are larger in diameter than rat macrophages, using length-classified Manville Code 100 glass fibers (8, 10, 16, and 20 \u03bcm).", {"entities": []}], ["It was hypothesized that complete engulfment of fibers by human alveolar macrophages could decrease fiber cytotoxicity; i.e.", {"entities": []}], ["shorter fibers that can be completely engulfed might not be as cytotoxic as longer fibers.", {"entities": []}], ["Human alveolar macrophages, obtained by segmental bronchoalveolar lavage of healthy, non-smoking volunteers, were treated with three different concentrations (determined by fiber number) of the sized fibers in vitro .", {"entities": []}], ["Cytotoxicity was assessed by monitoring cytosolic lactate dehydrogenase release and loss of function as indicated by a decrease in zymosan-stimulated chemiluminescence.", {"entities": []}], ["Microscopic analysis indicated that human alveolar macrophages completely engulfed glass fibers of the 20 \u03bcm length.", {"entities": []}], ["All fiber length fractions tested exhibited equal cytotoxicity on a per fiber basis, i.e.", {"entities": []}], ["increasing lactate dehydrogenase and decreasing chemiluminescence in the same concentration-dependent fashion.", {"entities": []}], ["The data suggest that due to the larger diameter of human alveolar macrophages, compared to rat alveolar macrophages, complete phagocytosis of longer fibers can occur with the human cells.", {"entities": []}], ["Neither incomplete phagocytosis nor length-dependent toxicity was observed in fiber-exposed human macrophage cultures.", {"entities": []}], ["In contrast, rat macrophages exhibited both incomplete phagocytosis of long fibers and length-dependent toxicity.", {"entities": []}], ["The results of the human and rat cell studies suggest that incomplete engulfment may enhance cytotoxicity of fiber glass.", {"entities": []}], ["However, the possibility should not be ruled out that differences between human versus rat macrophages other than cell diameter could account for differences in fiber effects.", {"entities": []}], ["The nominal group technique (NGT) allows stakeholders to directly generate items for needs assessment surveys.", {"entities": []}], ["The objective was to demonstrate the use of NGT discussions to develop survey items on (1) challenges experienced by informal caregivers of people living with systemic sclerosis (SSc) and (2) preferences for support services.", {"entities": []}], ["Three NGT groups were conducted.", {"entities": []}], ["In each group, participants generated lists of challenges and preferred formats for support services.", {"entities": []}], ["Participants shared items, and a master list was compiled, then reviewed by participants to remove or merge overlapping items.", {"entities": []}], ["Once a final list of items was generated, participants independently rated challenges on a scale from 1 (not at all important) to 10 (extremely important) and support services on a scale from 1 (not at all likely to use) to 10 (very likely to use).", {"entities": []}], ["Lists generated in the NGT discussions were subsequently reviewed and integrated into a single list by research team members.", {"entities": []}], ["SSc patient conferences held in the USA and Canada.", {"entities": []}], ["Informal caregivers who previously or currently were providing care for a family member or friend with SSc.", {"entities": []}], ["A total of six men and seven women participated in the NGT discussions.", {"entities": []}], ["Mean age was 59.8 years (SD=12.6).", {"entities": []}], ["Participants provided care for a partner (n=8), parent (n=1), child (n=2) or friend (n=2).", {"entities": []}], ["A list of 61 unique challenges was generated with challenges related to gaps in information, resources and support needs identified most frequently.", {"entities": []}], ["A list of 18 unique support services was generated; most involved online or in-person delivery of emotional support and educational material about SSc.", {"entities": []}], ["The NGT was an efficient method for obtaining survey items directly from SSc caregivers on important challenges and preferences for support services.", {"entities": []}], ["Background: Phthalates have antiandrogenic effects and may disrupt lipid and carbohydrate metabolism.", {"entities": []}], ["Racial/ethnic subpopulations have been documented to have varying urinary phthalate concentrations and prevalences of childhood obesity.", {"entities": [[128, 135, "DISEASE"]]}], ["Objective: We examined associations between urinary phthalate metabolites and body mass outcomes in a nationally representative sample of U.S. children and adolescents.", {"entities": []}], ["Methods: We performed stratified and whole-sample cross-sectional analyses of 2,884 children 6\u201319 years of age who participated in the 2003\u20132008 National Health and Nutrition Examination Survey.", {"entities": []}], ["Multivariable linear and logistic analyses of body mass index z -score, overweight, and obesity were performed against molar concentrations of low-molecular-weight (LMW), high-molecular-weight (HMW), and di-2-ethylhexylphthalate (DEHP) metabolites, controlling for sex, television watching, caregiver education, caloric intake, poverty\u2013income ratio, race/ethnicity, serum cotinine, and age group.", {"entities": [[88, 95, "DISEASE"]]}], ["We used sensitivity analysis to examine robustness of results to removing sample weighting, normalizing phthalate concentrations for molecular weight, and examining different dietary intake covariates.", {"entities": []}], ["Results: In stratified, multivariable models, each log unit (roughly 3-fold) increase in LMW metabolites was associated with 21% and 22% increases in odds (95% CI: 1.05\u20131.39 and 1.07\u20131.39, respectively) of overweight and obesity, and a 0.090-SD unit increase in BMI z -score (95% CI: 0.003\u20130.18), among non-Hispanic blacks.", {"entities": [[221, 228, "DISEASE"]]}], ["Significant associations were not identified in any other racial/ethnic subgroup or in the study sample as a whole after controlling for potential confounders, associations were not significant for HMW or DEHP metabolites, and results did not change substantially with sensitivity analysis.", {"entities": []}], ["Conclusions: We identified a race/ethnicity\u2013specific association of phthalates with childhood obesity in a nationally representative sample.", {"entities": [[94, 101, "DISEASE"]]}], ["Further study is needed to corroborate the association and evaluate genetic/epigenomic predisposition and/or increased phthalate exposure as possible explanations for differences among racial/ethnic subgroups.", {"entities": []}], ["Thus far, none of the preclinically successful and promising immunomodulatory agents for type 1 diabetes mellitus (T1DM) has conferred stable, long-term insulin independence to diabetic patients.", {"entities": [[89, 113, "DISEASE"], [96, 113, "DISEASE"]]}], ["The majority of these immunomodulators are humanised antibodies that target immune cells or cytokines.", {"entities": []}], ["These as well as fusion proteins and inhibitor proteins all share varying adverse event occurrence and severity.", {"entities": []}], ["Other approaches have included intact putative autoantigens or autoantigen peptides.", {"entities": []}], ["Considerable logistical outlays have been deployed to develop and to translate humanised antibodies targeting immune cells, cytokines, and cytokine receptors to the clinic.", {"entities": []}], ["Very recent phase III trials with the leading agent, a humanised anti-CD3 antibody, call into question whether further development of these biologics represents a step forward or more of the same.", {"entities": []}], ["Combination therapies of one or more of these humanised antibodies are also being considered, and they face identical, if not more serious, impediments and safety issues.", {"entities": []}], ["This paper will highlight the preclinical successes and the excitement generated by phase II trials while offering alternative possibilities and new translational avenues that can be explored given the very recent disappointment in leading agents in more advanced clinical trials.", {"entities": []}], ["Spirometry-based parameters of pulmonary function such as forced expiratory volume in 1\u00a0second (FEV 1 ) have prognostic value beyond respiratory morbidity and mortality.", {"entities": [[96, 99, "GENE"]]}], ["FEV 1 divided by height cubed (FEV 1 /Ht 1 %) and its use is independent of reference equations.", {"entities": [[0, 3, "GENE"], [31, 34, "GENE"], [0, 3, "GENE"], [31, 34, "GENE"]]}], ["Yet, limited data are available on the very old adults (80\u00a0years and older) and in association to other adverse health outcomes relevant for this age group.", {"entities": []}], ["This study aims to investigate the short-term prognostic value of FEV 1 /Ht In a population-based prospective cohort study of 501 very old adults in Belgium, comprehensive geriatric assessment and spirometry were performed at baseline and after 1.7\u2009\u00b1\u20090.21\u00a0years.", {"entities": [[66, 69, "GENE"]]}], ["Kaplan-Meier curves for 3-year all-cause mortality and hospitalization rates and multivariable analysis adjusted for age, sex, smoking status, co-morbidities, anemia, high C reactive protein and creatinine levels examined the association of FEV 1 /Ht Individuals in the lowest quartile of FEV 1 /Ht In a cohort of very old adults, low FEV 1 expressed as FEV 1 /Ht 1 /Ht", {"entities": [[159, 165, "DISEASE"], [241, 244, "GENE"], [289, 292, "GENE"], [335, 338, "GENE"], [354, 357, "GENE"], [241, 244, "GENE"], [289, 292, "GENE"], [335, 338, "GENE"], [354, 357, "GENE"], [241, 244, "GENE"], [289, 292, "GENE"], [335, 338, "GENE"], [354, 357, "GENE"], [241, 244, "GENE"], [289, 292, "GENE"], [335, 338, "GENE"], [354, 357, "GENE"]]}], ["In lung disease, physical activity (PA) yields beneficial health effects, but its association with the function of healthy lungs has rarely been studied.", {"entities": [[3, 15, "DISEASE"]]}], ["We investigated the association of accelerometer-based PA with spirometric indices, maximal inspiratory mouth pressure (PI max ) and lung diffusion capacity in lung-healthy adults.", {"entities": [[123, 126, "GENE"]]}], ["In total, 341 apparently lung-healthy participants from the population-based KORA (Cooperative Health Research in the Region of Augsburg) FF4 cohort study (45% male, aged 48-68\u00a0years, 47% never smokers) completed lung function testing and wore ActiGraph accelerometers over a one week period at the hip.", {"entities": []}], ["In adjusted regression analyses, moderate to vigorous PA (MVPA) was characterized as: sex-specific activity quartiles, achieving \u2265\u200910 consecutive minutes (yes vs. no), and meeting the WHO PA recommendations (yes vs. no).", {"entities": []}], ["Positive associations of MVPA-quartiles with forced expiratory volume in 1\u00a0s (FEV 1 ), forced vital capacity (FVC), and corresponding Global Lung Function Initiative z-scores were found.", {"entities": [[78, 81, "GENE"]]}], ["Subjects in the most active quartile (>\u200947 or >\u200950\u00a0min/day for females and males, respectively) had 142\u00a0ml [95% CI: 23, 260] higher FEV 1 and 155\u00a0ml [95% CI: 10, 301] higher FVC than those in the least active quartile (<\u200917 or <\u200921\u00a0min/day for females and males, respectively); however these associations were stronger among ex\u2212/current smokers.", {"entities": [[132, 135, "GENE"]]}], ["Achieving at least once 10 consecutive minutes of MVPA was only associated with higher PI max [\u03b2-estimate: 0.57\u00a0kPa; 95% CI: 0.04, 1.10], remaining significant among never smokers.", {"entities": [[90, 93, "GENE"]]}], ["No associations were found with diffusion capacity or for reaching the WHO-recommended 150\u00a0min of MVPA/week in 10-min bouts.", {"entities": []}], ["Although the effects were small, active subjects showed higher spirometric results.", {"entities": []}], ["The observed associations were more pronounced among ever smokers suggesting a higher benefit of PA for subjects being at a higher risk for chronic lung diseases.", {"entities": []}], ["The online version of this article (10.1186/s12890-017-0562-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It is currently postulated that steroid-sensitive idiopathic nephrotic syndrome (SSNS) and steroid-resistant idiopathic nephrotic syndrome (SRNS), which are not related to the mutation of a gene coding for podocyte structures or for glomerular basement membrane proteins, result from a circulating factor affecting podocyte shape and function.", {"entities": [[61, 79, "DISEASE"], [120, 138, "DISEASE"], [71, 79, "DISEASE"], [130, 138, "DISEASE"]]}], ["T lymphocytes have for a long time been suspected to be involved in the pathophysiology of these diseases.", {"entities": []}], ["The successful treatment of steroid-dependant nephrotic syndrome with rituximab suggests a potential role for B lymphocytes.", {"entities": [[46, 64, "DISEASE"], [56, 64, "DISEASE"]]}], ["Clinical and experimental data indicate roles for cytokines IL-13, TNF\u03b1, circulating cardiotrophin-like cytokine factor 1 (member of the IL-6 family), circulating hemopexin, radical oxygen species, and the soluble urokinase-type plasminogen activator receptor (suPAR) in the development of nephrotic syndrome.", {"entities": [[290, 308, "DISEASE"], [300, 308, "DISEASE"]]}], ["Podocyte metabolism modifications\u2014leading to the overexpression of the podocyte B7-1antigen (CD 80), hypoactivity of the podocyte enzyme sphingomyelin phosphodiesterase acid-like 3 b (SMPDL3b), and to the podocyte production of a hyposialylated form of the angiopoietin-like 4 (Angptl4)\u2014are mechanisms possibly involved in the changes in the podocyte cytoskeleton leading to SSNS and or SRNS.", {"entities": [[184, 191, "GENE"], [278, 285, "GENE"]]}], ["Different multifactorial pathophysiological mechanisms can be advocated for SSNS and SRNS.", {"entities": []}], ["The present paper reviews the experimental and clinical data upon which the different hypotheses are based and reports their possible clinical applications.", {"entities": []}], ["Single-incision laparoscopic surgery had been proven effective for appendectomy, cholecystectomy, and inguinal hernia repair.", {"entities": []}], ["However, single-incision thoracoscopic surgery (SITS) in primary spontaneous pneumothorax (PSP) has not been reported.", {"entities": [[77, 89, "DISEASE"]]}], ["We prospectively enrolled 30 PSP patients who received thoracoscopic surgery in the division of Thoracic Surgery of China Medical University Hospital.", {"entities": []}], ["Ten patients received SITS and 20 patients received traditional three-port thoracoscopic surgery.", {"entities": []}], ["The operative time, blood loss, wound size, visual analog scale (VAS) pain score, and patient satisfaction score were compared.", {"entities": []}], ["There was no significant difference in the operative time and blood loss between the two groups.", {"entities": []}], ["However, the VAS pain scores were significantly better in the SITS group in first 24 hours after surgery.", {"entities": []}], ["Patient satisfaction scores in the SITS group were also significantly better in the first 24 and 48 hours after operation.", {"entities": []}], ["Although three-port thoracoscopic surgery for PSP is well established, SITS results in better patient satisfaction and decreased postoperative pain in the treatment of PSP.", {"entities": []}], ["Early haemoperfusion (HP) therapy has been found to be very effective in acute paraquat (PQ) poisoning, but the effective rescue window is still uncertain.", {"entities": [[22, 24, "GENE"]]}], ["Demographic data and the type of therapies administered of 621 patients were included as confounding factors in this retrospective study.", {"entities": []}], ["After receiver operating characteristic curve analysis and intra-group/subgroup analysis, the initiation of glucocorticoid therapy within 3\u2009hrs of exposure with a second treatment given <21\u2009hrs after exposure, HP initiated within 4\u2009hrs of exposure with a second treatment given <20\u2009hrs after exposure, the appearance of pulmonary lesions \u22648 days after exposure and six other variables were used in a multiple analysis.", {"entities": [[210, 212, "GENE"]]}], ["The strength of positivity of the PQ urine test on admission, HP initiated within 4\u2009hrs of exposure with a second treatment given <20\u2009hrs after exposure, the appearance of pulmonary lesions \u22648 days after exposure, and stage III AKI on admission were independent factors of survival probability.", {"entities": [[62, 64, "GENE"]]}], ["HP therapy for acute PQ poisoning was the main therapeutic intervention investigated in this study.", {"entities": [[0, 2, "GENE"]]}], ["Outcomes were time dependent, and the crucial factor was the initiation of therapy within 4\u2009hrs of PQ poisoning followed by a second treatment within 20\u2009hrs.", {"entities": []}], ["Di(2-ethylhexyl)phthalate (DEHP), the plasticizer used in the biomedical production of blood storage bags, hemodialysis systems, cardiopulmonary bypass (CPB) circuitry, and intubation tubes, is extracted from the plastic material when it comes into contact with biological fluids and is converted to its principal metabolite, mono(2-ethylhexyl)phthalate (MEHP).", {"entities": []}], ["We have shown that MEHP causes cardiac and respiratory arrest, as well as hypotension, when infused into anesthetized rats.", {"entities": []}], ["Using a well-ventilated in vitro rat heart-lung preparation, we investigated the effect of MEHP on pulmonary artery pressure (PAP) and found that MEHP had a hypertensive effect on the pulmonary vasculature ending in constriction and edema.", {"entities": []}], ["There was a significant increase of 0.58 mm Hg/min in the PAP of isolated rat lungs when perfused with MEHP dissolved in Krebs-Henseleit (K-H) buffer (p = 0.0003).", {"entities": []}], ["The rat lungs that were perfused with K-H buffer only increased 0.094 mm Hg/min during the same perfusion time of 20 min.", {"entities": []}], ["The water gained during this time was 0.22 g/min with MEHP in the buffer compared to 0.04 g/min with buffer alone.", {"entities": []}], ["The pO2 in the effluent did not decrease during the perfusion time.", {"entities": []}], ["The concentration of MEHP in the rat lungs after perfusion varied from 20 to 40 micrograms/g.", {"entities": []}], ["Although the mechanism of action of MEHP on PAP is too complex to be fully elucidated by this model, the increase in PAP which we have demonstrated is significant and adds yet another toxic effect of this major metabolite of the ubiquitous plasticizer, DEHP.", {"entities": []}], ["Pulmonary fibroblasts have key roles in the formation and maintenance of lung structure and function, and are involved in tissue repair and remodeling.", {"entities": []}], ["Transforming growth factor-\u03b21 (TGF-\u03b21) induces differentiation of fibroblasts into myofibroblasts, the key effector cells in fibrotic states, which are characterized by the expression of \u03b1-smooth muscle actin (\u03b1-SMA) markers.", {"entities": []}], ["1\u03b1,25-Dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] has been implicated in regulating differentiation, and the vitamin D receptor (VDR) may be a regulator of TGF-\u03b2 signaling.", {"entities": [[124, 127, "GENE"]]}], ["In addition, there is presently only limited information regarding microRNA (miRNA) regulation of lung fibroblast differentiation.", {"entities": []}], ["To determine the role of 1,25(OH) 2 D 3 in regulating the differentiation of fibroblasts induced by TGF-\u03b21 and the functional importance of miR-27b , cell culture systems, cell transfection and the 3\u2032 untranslated region (3\u2032UTR) luciferase assay were employed.", {"entities": [[140, 147, "GENE"]]}], ["1,25(OH) 2 D 3 inhibited differentiation and downregulated miR-27b expression in human lung fibroblasts induced by TGF-\u03b21.", {"entities": [[59, 66, "GENE"]]}], ["In addition, human lung fibroblasts were transfected with miR-27b mimic or miR-27b inhibitor, and demonstrated that the overexpression of miR-27b decreased the VDR protein expression and increased the expression of \u03b1-SMA, while reducing levels of miR-27b had opposing effects.", {"entities": [[58, 65, "GENE"], [75, 82, "GENE"], [138, 145, "GENE"], [247, 254, "GENE"], [58, 65, "GENE"], [75, 82, "GENE"], [138, 145, "GENE"], [247, 254, "GENE"], [58, 65, "GENE"], [75, 82, "GENE"], [138, 145, "GENE"], [247, 254, "GENE"], [160, 163, "GENE"], [58, 65, "GENE"], [75, 82, "GENE"], [138, 145, "GENE"], [247, 254, "GENE"]]}], ["Finally, the luciferase reporter assays were performed to confirm that miR-27b directly targeted VDR 3\u2032UTR.", {"entities": [[71, 78, "GENE"], [97, 100, "GENE"]]}], ["Taken together, these results suggest that 1,25(OH) 2 D 3 inhibits lung fibroblast differentiation induced by TGF-\u03b21 via miR-27b targeting VDR 3\u2032UTR, which may be used as a novel treatment strategy in differentiation pathways.", {"entities": [[121, 128, "GENE"], [139, 142, "GENE"]]}], ["This report describes the design and conduct of two sequential historical prospective morbidity surveys of workers and residents from the Upper Ottawa Street Landfill Site in Hamilton, Ontario.", {"entities": []}], ["The workers study was carried out first and was a hypothesis-generating study.", {"entities": []}], ["Workers and controls were administered a health questionnaire, which was followed by an assessment of recall bias through medical chart abstraction.", {"entities": []}], ["Multiple criteria were used to identify health problems associated with landfill site exposure.", {"entities": []}], ["Those problems with highest credibility included clusters of respiratory, skin, narcotic, and mood disorders.", {"entities": []}], ["These formed the hypothesis base in the subsequent health study of residents living adjacent to the landfill site.", {"entities": []}], ["In that study, the association between mood, narcotic, skin, and respiratory conditions with landfill site exposure was confirmed using the following criteria: strength of association; consistency with the workers study; risk gradient by duration of residence and proximity to the landfill; absence of evidence that less healthy people moved to the area; specificity; and the absence of recall bias.", {"entities": []}], ["The validity of these associations were reduced by three principal problems: the high refusal rate among the control population; socioeconomic status differences between the study groups; and the fact that the conditions found in excess were imprecisely defined and potentially interchangeable with other conditions.", {"entities": []}], ["Offsetting these problems were the multiple criteria used to assess each hypothesis, which were applied according to present rules.", {"entities": []}], ["Evidence is presented that supports the hypothesis that vapors, fumes, or particulate matter emanating from the landfill site, as well as direct skin exposure, may have lead to the health problems found in excess.", {"entities": []}], ["Evidence is also presented supporting the hypothesis that perception of exposure and, therefore, of risk, may explain the results of the study.", {"entities": []}], ["However, based on the analyses performed, it is the conclusion of the authors that the adverse effects seen were more likely the result of chemical exposure than of perception of risk.", {"entities": []}], ["To compare self-reported health and well-being in a sample of cancer survivors with individuals who have not had cancer and with individuals who have a serious chronic condition other than cancer.", {"entities": [[62, 68, "DISEASE"], [113, 119, "DISEASE"], [189, 195, "DISEASE"]]}], ["A cross-sectional survey drawn from an online panel of 400\u2009000 UK citizens supplemented with other online recruitment and telephone recruitment.", {"entities": []}], ["The participants were 4892 individuals 30 years of age or above, including 780 individuals with a previous cancer diagnosis, 1372 individuals with one or more of 10 chronic conditions but not cancer and 2740 individuals without a previous cancer diagnosis or chronic condition.", {"entities": [[107, 113, "DISEASE"], [192, 198, "DISEASE"], [239, 245, "DISEASE"]]}], ["Thirteen measures of health and well-being were constructed from answers to 25 survey items covering physical, psychological and social dimensions of health and well-being.", {"entities": []}], ["Cancer survivors were significantly more likely to report poor health outcomes across all 13 measures than those with no history of cancer or a chronic condition.", {"entities": [[0, 6, "DISEASE"], [132, 138, "DISEASE"]]}], ["The adjusted odds ratios for cancer survivors with no chronic conditions compared with healthy participants ranged from 1.37 (95% confidence interval (CI): 1.31\u20131.96) for emotional well-being to 3.34 (95% CI: 2.74\u20134.08) for number of health professionals consulted in the last 12 months.", {"entities": [[29, 35, "DISEASE"]]}], ["The health profile of cancer survivors was similar to those with a history of a serious chronic health condition.", {"entities": [[22, 28, "DISEASE"]]}], ["A substantial number of individuals who have had a diagnosis of cancer experience ongoing poor health and well-being following cancer and cancer treatment.", {"entities": [[64, 70, "DISEASE"], [127, 133, "DISEASE"], [138, 144, "DISEASE"]]}], ["The results of this study provide an initial basis for the development of specific help and support for cancer survivors.", {"entities": [[104, 110, "DISEASE"]]}], ["Human leukotriene A4 hydrolase (hLTA4H), which is the final and rate-limiting enzyme of arachidonic acid pathway, converts the unstable epoxide LTA4 to a proinflammatory lipid mediator LTB4 through its hydrolase function.", {"entities": []}], ["The LTA4H is a bi-functional enzyme that also exhibits aminopeptidase activity with a preference over arginyl tripeptides.", {"entities": [[4, 9, "GENE"]]}], ["Various mutations including E271Q, R563A, and K565A have completely or partially abolished both the functions of this enzyme.", {"entities": []}], ["The crystal structures with these mutations have not shown any structural changes to address the loss of functions.", {"entities": []}], ["Molecular dynamics simulations of LTA4 and tripeptide complex structures with functional mutations were performed to investigate the structural and conformation changes that scripts the observed differences in catalytic functions.", {"entities": []}], ["The observed protein-ligand hydrogen bonds and distances between the important catalytic components have correlated well with the experimental results.", {"entities": []}], ["This study also confirms based on the structural observation that E271 is very important for both the functions as it holds the catalytic metal ion at its location for the catalysis and it also acts as N-terminal recognition residue during peptide binding.", {"entities": []}], ["The comparison of binding modes of substrates revealed the structural changes explaining the importance of R563 and K565 residues and the required alignment of substrate at the active site.", {"entities": []}], ["The results of this study provide valuable information to be utilized in designing potent hLTA4H inhibitors as anti-inflammatory agents.", {"entities": []}], ["Inflammatory bowel disease (IBD) consists of ulcerative colitis (UC) and Crohn\u2019s disease (CD), which are complex genetic disorders resulting from the interplay between several genetic and environmental risk factors.", {"entities": [[0, 26, "DISEASE"], [45, 63, "DISEASE"]]}], ["The arylamine N-acetyltransferase 2 (NAT2) enzyme detoxifies a wide spectrum of naturally occurring xenobiotics including carcinogens and drugs.", {"entities": [[37, 41, "GENE"]]}], ["Acetylation catalyzed by NAT2 is an important process in metabolic activation of arylamines to electrophilic intermediates that initiate carcinogenesis.", {"entities": [[25, 29, "GENE"]]}], ["The aim of our study was to determine whether there is any association between the susceptibility to inflammatory bowel disease among the variations of NAT2 genotypes.", {"entities": [[101, 127, "DISEASE"], [152, 156, "GENE"]]}], ["This study was carried out in 80 patients with IBD.", {"entities": []}], ["The control group consisted of 100 healthy volunteers.", {"entities": []}], ["The most common mutations found in the Caucasian population are at the positions 481T, 803G, 590A and 857A on the NAT2 gene.", {"entities": [[114, 118, "GENE"]]}], ["This was determined using the polymerase chain reaction\u2013restriction fragment length polymorphism method with DNA extracted from peripheral blood.", {"entities": []}], ["Risk of IBD development was 3.86 for the carriers of the NAT2*5/NAT2*7 genotype and 2.53 for the carriers with NAT2*6/NAT2*7 , but it was not statistically significant.", {"entities": []}], ["A statistically significant correlation between the NAT2*7 allele prevalence and the risk for developing IBD was found (OR\u00a0=\u00a05.8; P \u00a0=\u00a00.005).", {"entities": []}], ["Higher prevalence of the NAT2*7 allele in patients with IBD and the obtained OR values could suggest that this mutation has the effect of increasing IBD development .", {"entities": []}], ["Future studies are needed to confirm our assumptions on larger group of patients.", {"entities": []}], ["MicroRNAs (miRNAs) are thought to exert their functions by modulating the expression of hundreds of target genes and each to a small degree, but it remains unclear how small changes in hundreds of target genes are translated into the specific function of a miRNA.", {"entities": []}], ["Here, we conducted an integrated analysis of transcriptome and translatome of primary B cells from mutant mice expressing miR-17~92 at three different levels to address this issue.", {"entities": []}], ["We found that target genes exhibit differential sensitivity to miRNA suppression and that only a small fraction of target genes are actually suppressed by a given concentration of miRNA under physiological conditions.", {"entities": []}], ["Transgenic expression and deletion of the same miRNA gene regulate largely distinct sets of target genes.", {"entities": []}], ["miR-17~92 controls target gene expression mainly through translational repression and 5\u2019UTR plays an important role in regulating target gene sensitivity to miRNA suppression.", {"entities": []}], ["These findings provide molecular insights into a model in which miRNAs exert their specific functions through a small number of key target genes.", {"entities": []}], ["MicroRNAs (miRNAs) are small RNAs encoded by our genome.", {"entities": []}], ["Each miRNA binds hundreds of target mRNAs and performs specific functions.", {"entities": []}], ["It is thought that miRNAs exert their function by reducing the expression of all these target genes and each to a small degree.", {"entities": []}], ["However, these target genes often have very diverse functions.", {"entities": []}], ["It has been unclear how small changes in hundreds of target genes with diverse functions are translated into the specific function of a miRNA.", {"entities": []}], ["Here we take advantage of recent technical advances to globally examine the mRNA and protein levels of 868 target genes regulated by miR-17~92, the first oncogenic miRNA, in mutant mice with transgenic overexpression or deletion of this miRNA gene.", {"entities": []}], ["We show that miR-17~92 regulates target gene expression mainly at the protein level, with little effect on mRNA.", {"entities": []}], ["Surprisingly, only a small fraction of target genes respond to miR-17~92 expression changes.", {"entities": []}], ["Further studies show that the sensitivity of target genes to miR-17~92 is determined by a non-coding region of target mRNA.", {"entities": []}], ["Our findings demonstrate that not every target gene is equal, and suggest that the function of a miRNA is mediated by a small number of key target genes.", {"entities": []}], ["The Internet is increasingly used by citizens as source of health information.", {"entities": []}], ["Young, highly educated adults use the Internet frequently to search for health-related information.", {"entities": []}], ["Our study explores whether reported chronic conditions or self-reported health status differed among Finnish university students using the Finnish Student Health Services web-based health advice service compared with those not using the service.", {"entities": []}], ["Cross-sectional study performed by a national postal survey in 2004.", {"entities": []}], ["Material: A random sample (n = 5 030) of a population of 101 805 undergraduate Finnish university students aged 19\u201335.", {"entities": []}], ["The response rate: 63% (n = 3 153).", {"entities": []}], ["Main outcome measures: Proportion of university students reporting use a of web-based health advice service, diagnosed chronic conditions, and self-reported health status of users and non-users of a web-based health advice service.", {"entities": []}], ["Statistical methods: Data were presented with frequency distributions and cross-tabulations and the \u03c7 12% (n = 370) of Finnish undergraduate students had used the web-based health advice service and were identified as 'users'.", {"entities": []}], ["The proportion of male students reporting allergic rhinitis or conjunctivitis was greater among users than non-users (24%, n = 22 vs. 15%, n = 154, \u03c7 Among young, highly educated adults the use of a web-based health advice service is not associated with self-reported health status.", {"entities": [[42, 59, "DISEASE"], [51, 59, "DISEASE"], [63, 77, "DISEASE"]]}], ["However, a web-based health advice service could offer support for managing several specific chronic conditions.", {"entities": []}], ["More research data is needed to evaluate the role of web-based health advice services that supplement traditional forms of health services.", {"entities": []}], ["KIOM-CRC#BP3B (BP3B) is a novel herbal prescription that is composed of three plant extracts.", {"entities": []}], ["Our preliminary study identified that BP3B exhibited potent anti-proliferative activity against various types of cancer cell lines in vitro.", {"entities": [[113, 119, "DISEASE"]]}], ["Because the in vivo anti-tumor effect of BP3B is not evaluated before clinical trial, we want to test it using patient\u2019s samples.", {"entities": []}], ["To confirm the in vivo anti-cancer effect of BP3B, we used genetically characterized patient-derived colon tumor xenograft (PDTX) mouse model.", {"entities": [[28, 34, "DISEASE"]]}], ["Anti-cancer activity was evaluated with apoptosis, proliferation, angiogenesis and histological analysis.", {"entities": [[5, 11, "DISEASE"]]}], ["Oral administration of BP3B significantly inhibited the tumor growth in two PDTX models.", {"entities": []}], ["Furthermore, TUNEL assay showed that BP3B induced apoptosis of tumor tissues, which was associated with degradation of PARP and Caspase 8 and activation of Caspase 3.", {"entities": []}], ["We also observed that BP3B inhibited cancer cell proliferation by down-regulation of Cyclin D1 and induction of p27 proteins.", {"entities": [[37, 43, "DISEASE"]]}], ["Inhibition of angiogenesis in BP3B-treated group was observed with immunofluorescence staining using CD31 and Tie-2 antibodies.", {"entities": []}], ["These findings indicated that BP3B has a strong growth-inhibitory activity against colon cancer in in vivo model and will be a good therapeutic candidate for treatment of refractory colon cancer.", {"entities": [[83, 95, "DISEASE"], [182, 194, "DISEASE"], [89, 95, "DISEASE"], [188, 194, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12906-016-1447-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Nutrients such as docosahexaenoic acid (DHA), prebiotics and \u03b2-glucan have been associated with reduced incidence of respiratory illnesses and allergic manifestations (AM).", {"entities": []}], ["Our objective was to assess if consumption of a cow\u2019s milk-based beverage with these and other nutrients supports respiratory, gastrointestinal, and skin health in otherwise well-nourished, healthy children.", {"entities": []}], ["In this double-blind, randomized, controlled trial, healthy children (1\u20134\u00a0years of age) from two daycare centers in Brazil were fed three servings/day of a cow\u2019s milk-based beverage (CMBB; n \u2009=\u2009125) containing DHA, the prebiotics polydextrose (PDX) and galactooligosaccharides (GOS), \u03b2-glucan, and other key nutrients, or a control cow\u2019s milk-based beverage (control; n \u2009=\u2009131) for up to 28\u00a0weeks.", {"entities": []}], ["Occurrence of respiratory infections, diarrheal disease and AM was assessed by study pediatricians and the number of episodes were analyzed with the Cochran-Mantel-Haenszel test and the Andersen-Gill model.", {"entities": []}], ["The CMBB group had fewer episodes of AM, which included allergic rhinitis or conjunctivitis, wheezing, allergic cough, eczema and urticaria, compared to the control group ( p \u2009=\u20090.021).", {"entities": [[56, 73, "DISEASE"], [130, 139, "DISEASE"], [65, 73, "DISEASE"], [77, 91, "DISEASE"]]}], ["The hazard ratio for increased number of episodes of AM was lower in the CMBB group compared to control (HR, 0.64; 95\u00a0% CI 0.47\u20130.89; p \u2009=\u20090.007).", {"entities": [[105, 107, "GENE"]]}], ["There was no difference in the incidence of respiratory infections and diarrheal disease between groups.", {"entities": []}], ["A cow\u2019s milk-based beverage containing DHA, PDX/GOS, and yeast \u03b2-glucan, and supplemented with micronutrients, including zinc, vitamin A and iron, when consumed 3 times/day for 28\u00a0weeks by healthy 1- to 4-year-old children was associated with fewer episodes of allergic manifestations in the skin and the respiratory tract.", {"entities": []}], ["registration number: NCT01431469", {"entities": []}], ["It has been reported that motor vehicle emissions contribute nearly a quarter of world energy-related greenhouse gases and cause nonnegligible air pollution primarily in urban areas.", {"entities": []}], ["Reducing car use and increasing ecofriendly alternative transport, such as public and active transport, are efficient approaches to mitigate harmful environmental impacts caused by a large amount of vehicle use.", {"entities": []}], ["Besides the environmental benefits of promoting alternative transport, it can also induce other health and economic benefits.", {"entities": []}], ["At present, a number of studies have been conducted to evaluate cobenefits from greenhouse gas mitigation policies.", {"entities": []}], ["However, relatively few have focused specifically on the transport sector.", {"entities": []}], ["A comprehensive understanding of the multiple benefits of alternative transport could assist with policy making in the areas of transport, health, and environment.", {"entities": []}], ["However, there is no straightforward method which could estimate cobenefits effect at one time.", {"entities": []}], ["In this paper, the links between vehicle emissions and air quality, as well as the health and economic benefits from alternative transport use, are considered, and methodological issues relating to the modelling of these cobenefits are discussed.", {"entities": []}], ["Gene-gene interactions may be partly responsible for complex traits such as obesity.", {"entities": [[76, 83, "DISEASE"]]}], ["Increasing evidence suggests that the renin-angiotensin system (RAS) contributes to the etiology of obesity.", {"entities": [[100, 107, "DISEASE"]]}], ["How the epistasis of genes in the RAS contributes to obesity is still under research.", {"entities": [[53, 60, "DISEASE"]]}], ["We aim to evaluate the contribution of RAS-related gene interactions to a predisposition of obesity in a Chinese population.", {"entities": [[92, 99, "DISEASE"]]}], ["We selected six single nucleotide polymorphisms (SNPs) located in angiotensin ( AGT ), angiotensin converting enzyme ( ACE ), angiotensin type 1 receptor ( AGTR1 ), MAS1 , nitric oxide synthase 3 ( NOS3 ) and the bradykinin B2 receptor gene ( BDKRB2 ), and genotyped them in 324 unrelated individuals with obesity (BMI \u226528 kg/m rs220721 polymorphism in the MAS1 gene and the rs1799722 polymorphism in the gene BDKB2R .", {"entities": [[306, 313, "DISEASE"], [80, 83, "GENE"], [156, 161, "GENE"], [165, 169, "GENE"], [357, 361, "GENE"], [198, 202, "GENE"], [243, 249, "GENE"], [165, 169, "GENE"], [357, 361, "GENE"]]}], ["The best two-locus combination scored 9 for cross-validation consistency and 9 for sign test (p\u200a=\u200a0.0107).", {"entities": []}], ["This interaction showed the maximum consistency and minimum prediction error among all gene-gene interaction models evaluated.", {"entities": []}], ["Moreover, the combination of the MAS1 rs220721 and the BDKRB2 rs1799722 was associated with a significantly increased risk of obesity (OR 1.82, CI 95%: 1.15\u20132.88, p\u200a=\u200a0.0103).", {"entities": [[126, 133, "DISEASE"], [33, 37, "GENE"], [55, 61, "GENE"]]}], ["These results suggest that the SNPs from the RAS-related genes may contribute to the risk of obesity in an interactive manner in a Chinese population.", {"entities": [[93, 100, "DISEASE"]]}], ["The gene-gene interaction may serve as a novel area for obesity research.", {"entities": [[56, 63, "DISEASE"]]}], ["Sleep-disordered breathing (SDB) is a prevalent disorder with a major impact in women, especially postmenopausal women.", {"entities": []}], ["However, few studies have investigated the prevalence of a specific SDB, snoring, among women especially those with menopausal syndrome.", {"entities": [[127, 135, "DISEASE"]]}], ["Computer-assisted telephone interviews were conducted in Taiwan.", {"entities": []}], ["Adults over 20\u00a0years of age were interviewed.", {"entities": []}], ["The number of successful interviews was calculated based on the population prior to the study.", {"entities": []}], ["Demographic data and information about snoring, menopausal syndrome, and medical conditions were obtained.", {"entities": [[59, 67, "DISEASE"]]}], ["In total, 3624 adults, 1473 males and 2151 females, completed the interviews.", {"entities": []}], ["Both men and women shows an increase in snoring until age 50 to 59\u00a0years, followed by a decline in snoring that is less steep among women.", {"entities": []}], ["The prevalence of snoring increased significantly in females after age 50\u00a0years, which is the mean menopausal age in our country ( p \u00a0<\u00a00.05).", {"entities": []}], ["After adjusting for age, body mass index, and other major diseases, the percentage of women with snoring was significantly higher among those with menopausal syndrome than those without menopausal syndrome ( p \u00a0=\u00a00.021, odds ratio\u00a0=\u00a01.629).", {"entities": [[158, 166, "DISEASE"], [197, 205, "DISEASE"]]}], ["This population-based study revealed different snoring percentages among men and women and diminishing differences in the older population.", {"entities": []}], ["Additionally, the percentage of women with snoring was increased among those women who were older than 50\u00a0years and those with menopausal syndrome.", {"entities": [[138, 146, "DISEASE"]]}], ["Population-representative surveys that assess childhood maltreatment and health are a valuable resource to explore the implications of child maltreatment for population health.", {"entities": []}], ["Systematic identification and evaluation of such surveys is needed to facilitate optimal use of their data and to inform future research.", {"entities": []}], ["To inform researchers of the existence and nature of population-representative surveys relevant to understanding links between childhood maltreatment and health; to evaluate the assessment of childhood maltreatment in this body of work.", {"entities": []}], ["We included surveys that: 1) were representative of the non-institutionalized population of any size nation or of any geopolitical region \u2265 10 million people; 2) included a broad age range (\u2265 40 years); 3) measured health; 4) assessed childhood maltreatment retrospectively; and 5) were conducted since 1990.", {"entities": []}], ["We used Internet and database searching (including CINAHL, Embase, ERIC, Global Health, MEDLINE, PsycINFO, Scopus, Social Policy and Practice: January 1990 to March 2014), expert consultation, and other means to identify surveys and associated documentation.", {"entities": []}], ["Translations of non-English survey content were verified by fluent readers of survey languages.", {"entities": []}], ["We developed checklists to abstract and evaluate childhood maltreatment content.", {"entities": []}], ["Fifty-four surveys from 39 countries met inclusion criteria.", {"entities": []}], ["Sample sizes ranged from 1,287-51,945 and response rates from 15%-96%.", {"entities": []}], ["Thirteen surveys assessed neglect, 15 emotional abuse; 18 exposure to family violence; 26 physical abuse; 48 sexual abuse.", {"entities": []}], ["Fourteen surveys assessed more than three types; six of these were conducted since 2010.", {"entities": []}], ["In nine surveys childhood maltreatment assessments were detailed (+10 items for at least one type of maltreatment).", {"entities": []}], ["Seven surveys\u2019 assessments had known reliability and/or validity.", {"entities": []}], ["Data from 54 surveys can be used to explore the population health relevance of child maltreatment.", {"entities": []}], ["Assessment of childhood maltreatment is not comprehensive but there is evidence of recent improvement.", {"entities": []}], ["Besides reducing gastric acid secretion, proton pump inhibitors (PPIs) suppress Th2-cytokine-stimulated expression of an eosinophil chemoattractant (eotaxin-3) by esophageal epithelial cells through acid-independent, anti-inflammatory mechanisms.", {"entities": []}], ["To explore acid-inhibitory and acid-independent, anti-inflammatory PPI effects in reducing esophageal eosinophilia, we studied eotaxin-3 expression by the proximal and distal esophagus of children with esophageal eosinophilia before and after PPI therapy.", {"entities": [[102, 114, "DISEASE"], [213, 225, "DISEASE"]]}], ["In vitro , we studied acid and bile salt effects on IL-13-stimulated eotaxin-3 expression by esophageal epithelial cells.", {"entities": []}], ["Among 264 children with esophageal eosinophilia seen at a tertiary pediatric hospital from 2008 through 2012, we identified 10 with esophageal biopsies before and after PPI treatment alone.", {"entities": [[35, 47, "DISEASE"]]}], ["We correlated epithelial cell eotaxin-3 immunostaining with eosinophil numbers in those biopsies.", {"entities": []}], ["In vitro , we measured eotaxin-3 protein secretion by esophageal squamous cells stimulated with IL-13 and exposed to acid and/or bile salt media, with or without omeprazole.", {"entities": []}], ["There was strong correlation between peak eosinophil numbers and peak eotaxin-3-positive epithelial cell numbers in esophageal biopsies.", {"entities": []}], ["Eotaxin-3 expression decreased significantly with PPIs only in the proximal esophagus.", {"entities": []}], ["In esophageal cells, exposure to acid-bile salt medium significantly suppressed IL-13-induced eotaxin-3 secretion; omeprazole added to the acid-bile salt medium further suppressed that eotaxin-3 secretion, but not as profoundly as at pH-neutral conditions.", {"entities": []}], ["In children with esophageal eosinophilia, PPIs significantly decrease eotaxin-3 expression in the proximal but not the distal esophagus.", {"entities": [[28, 40, "DISEASE"]]}], ["In esophageal squamous cells, acid and bile salts decrease Th2 cytokine-stimulated eotaxin-3 secretion profoundly, possibly explaining the disparate PPI effects on the proximal and distal esophagus.", {"entities": []}], ["In the distal esophagus, where acid reflux is greatest, a PPI-induced reduction in acid reflux (an effect that could increase eotaxin-3 secretion induced by Th2 cytokines) might mask the acid-independent, anti-inflammatory PPI effect of decreasing cytokine-stimulated eotaxin-3 secretion.", {"entities": []}], ["Measuring the care experience at end-of-life (EOL) to inform quality improvement is a priority in many countries.", {"entities": []}], ["We validated the CaregiverVoice survey, a modified version of the VOICES questionnaire, completed by bereaved caregivers to capture perceptions of care received in the last three months of a patient\u2019s life.", {"entities": []}], ["We conducted a retrospective survey of bereaved caregivers representing palliative care patients who died in a residential hospice and/or received palliative homecare in Ontario, Canada.", {"entities": []}], ["Statistical analyses were completed to establish construct and concurrent validity, as well as reliability of the survey.", {"entities": []}], ["Responses were obtained from 906 caregivers: 330 surveyed from homecare agencies and 576 from hospices.", {"entities": []}], ["The CaregiverVoice survey demonstrated concurrent validity in scores correlating to FAMCARE2 items, and construct validity in performing according to expected patterns, e.g., correlation of scores to qualitative perceptions and significant variability based on care contexts such as place of death and setting of care ( p \u00a0<\u00a00.01).", {"entities": []}], ["Reliability was exhibited in good inter-item correlation of ratings for specific care settings and no significant differences in ratings regardless of whether up to a year had passed since death of patient.", {"entities": []}], ["The CaregiverVoice survey demonstrated validity and reliability in the populations assessed.", {"entities": []}], ["This survey represents one common measure that can be standardized across multiple care settings and is useful for assessing the care experience that can help inform local and national quality improvement activities.", {"entities": []}], ["The online version of this article (doi:10.1186/s12904-017-0227-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Snake gallbladder, a traditional Chinese medicine, has been believed in various Asian countries to improve visual acuity and alleviate rheumatism.", {"entities": []}], ["Bile acids, a major component of the gallbladder, are toxic to the liver and kidney in humans and animals due to its detergent effects, while also exhibiting therapeutic effects due to an increase in the gallbladder contractions of muscle strips in patients with cholesterol gallstones.", {"entities": []}], ["Secretion of bile acids in human and mammals depends on the bile salt export pump (BSEP), a liver-specific adenosine triphosphate (ATP)-binding cassette transporter encoded by ABCB11 .", {"entities": [[176, 182, "GENE"]]}], ["However, the presence of BSEP in snakes has not been thoroughly explored.", {"entities": []}], ["Here we confirm the existence of BSEP and its coding DNA sequence in snakes on both the proteomic and genetic level.", {"entities": []}], ["This work provides information on the snake ABCB11 sequence and helps further potential genetic manipulation to affect bile salt metabolism.", {"entities": [[44, 50, "GENE"]]}], ["Our study provides the foundation for research on bile acid production from snakes by using modern genetic and proteomic methodologies.", {"entities": []}], ["There has been considerable debate surrounding the ethics of sham-controlled trials of procedures and interventions.", {"entities": []}], ["Critics argue that these trials are unethical because participants assigned to the control group have no prospect of benefit from the trial, yet they are exposed to all the risks of the sham intervention.", {"entities": []}], ["However, the placebo effect associated with sham procedures can often be substantial and has been well documented in the scientific literature.", {"entities": []}], ["We argue that, in light of the scientific evidence supporting the benefits of sham interventions for pain and Parkinson's disease that stem from the placebo effect, these sham-controlled trials should be considered as offering potential direct benefit to participants.", {"entities": []}], ["If scientific evidence demonstrates the positive effect of placebo from sham interventions on other conditions, sham-controlled trials of interventions for the treatment of these conditions should be considered to have prospects of benefit as well.", {"entities": []}], ["This potential benefit should be taken into account by research ethics committees in risk-benefit analyses, and be included in informed consent documents.", {"entities": []}], ["Recruitment is a challenge in developing population-representative pregnancy and birth cohorts.", {"entities": []}], ["We developed a collaborative recruitment infrastructure (CRI) to recruit pregnant women for 4 pregnancy cohorts using: faxes from obstetrical offices, in-clinic recruiters, university and funder-driven free-media events, paid-media, and attendance at relevant tradeshows.", {"entities": []}], ["Recruitment rates and demographic differences were compared between recruitment methods.", {"entities": []}], ["We received 5008 referrals over 40\u00a0months.", {"entities": []}], ["Compared to fax, free-media referrals were 13 times more likely to be recruited (OR 13.0, 95% CI 4.2, 40.4: p\u2009<\u20090.001) and paid-media referrals were 4 times more likely to be recruited (OR 4.6, 95% CI 2.1, 10.3: p\u2009<\u20090.001).", {"entities": []}], ["Among paid-media advertisements, free-to-read print (e.g.", {"entities": []}], ["Metro) was the most effective (OR 3.3, 95% CI 2.3, 4.5: p\u2009<\u20090.05).", {"entities": []}], ["Several demographic differences were identified between recruitment methods and against a reference population.", {"entities": []}], ["Between recruitment methods, media recruits had a similar proportion families with incomes\u2009\u2265\u2009$40,000 (paid-media: 94.4%; free-media: 93.3%) compared to fax recruits (95.7%), while in-clinic recruits were less likely to have family incomes\u2009\u2265\u2009$40,000 (88.8%, p\u2009<\u20090.05).", {"entities": []}], ["Maternal recruits from fax and in-clinic were more likely to attend university (Fax: 92.6%, in-clinic 89.8%) versus the reference population (52.0%; p\u2009<\u20090.05 for both) and both were less likely to smoke (Fax: 6.8%, in-clinic 4.2%) versus reference (18.6%; p\u2009<\u20090.05 for both).", {"entities": []}], ["However, while fax referrals were more likely to be Caucasian (85.9% versus reference 77.5%; p\u2009<\u20090.05), in-clinic referrals were not significantly different (78.2%; P\u2009>\u20090.05).", {"entities": []}], ["Recruitment methods result in different recruitment rates and participant demographics.", {"entities": []}], ["A variety of methods are required to recruit a generalizable sample.", {"entities": []}], ["The geriatric population is increasing, and asthma severity increases with age.", {"entities": [[44, 50, "DISEASE"]]}], ["We determined the predictors of asthma control, exacerbation, and the factors that affect asthma-specific quality of life (A-QOL) in elderly asthmatic patients.", {"entities": [[32, 38, "DISEASE"], [90, 96, "DISEASE"]]}], ["This was a prospective, multicenter, real-life study for 6 months with stepwise pharmacologic treatment based on the Global Initiative for Asthma (GINA) guideline.", {"entities": [[139, 145, "DISEASE"]]}], ["A total of 296 asthmatic patients aged \u2265 60 yr were recruited from 5 university centers in Korea.", {"entities": []}], ["The improved-asthma control group was defined as the group of patients who maintained well-controlled or improved disease and the not-improved asthma control group was defined as the remaining patients.", {"entities": [[13, 19, "DISEASE"], [143, 149, "DISEASE"]]}], ["Fewer number of medications for comorbidities (2.8 \u00b1 3.3 in the improved vs. 4.5 \u00b1 4.4 in the control) and higher physical functioning (PF) scale (89.8 \u00b1 14.2 in the improved vs. 82.0 \u00b1 16.4 in the control) were significant predictors in the improved-asthma control group (OR = 0.863, P = 0.004 and OR = 1.028, P = 0.018, respectively).", {"entities": [[251, 257, "DISEASE"]]}], ["An asthma control test (ACT) score of \u2264 19 at baseline was a significant predictor of asthma exacerbation (OR = 3.938, P = 0.048).", {"entities": [[3, 9, "DISEASE"], [86, 92, "DISEASE"]]}], ["Asthma duration ( F = 5.656, P = 0.018), ACT score ( F = 12.237, P = 0.001) at baseline, and the presence of asthma exacerbation ( F = 5.565, P = 0.019) were significant determinants of changes in A-QOL.", {"entities": [[0, 6, "DISEASE"], [109, 115, "DISEASE"]]}], ["The number of medications for comorbidities and performance status determined by the PF scale may be important parameters for assessing asthma control in elderly asthmatic patients.", {"entities": [[136, 142, "DISEASE"]]}], ["Data on clinical presentation, morbidity and mortality of 2009 pandemic influenza virus (H1N1v) in paediatric population are still emerging; most of the data so far available came from selected cohorts of children admitted to tertiary care paediatric hospitals.", {"entities": [[72, 81, "DISEASE"]]}], ["An observational study involving all the 19 Divisions of Paediatrics of the Veneto Region was conducted with the aim of investigating into the demographic and clinical characteristics, the treatment, the outcome and the risk factors for disease severity of H1N1v infection occurring in children.", {"entities": []}], ["Two hundred children, median age of 4.15 years (range 0-15) were enrolled from the last week of October till the first week of January 2010 for an overall hospitalization rate of 23/100.000.", {"entities": []}], ["At least one underlying medical condition was found in 44% of patients.", {"entities": []}], ["Fever and cough were the most frequent symptoms (93% and 65% respectively).", {"entities": []}], ["11 patients (6%) were admitted to a PICU and 5 (2.5%) required mechanical ventilation.", {"entities": []}], ["Antiviral therapy was administered in 103 patients (51.5%) Death occurred in 2 patients (1%); both had severe prior medical conditions.", {"entities": []}], ["Pre-existing neurologic diseases (OR 7.82; 95%CI: 1.15-53.34), the presence of hypoxemia (OR 10.47; 95%CI: 2.12-51.70) and anemia (Haemoglobin < 10 g/dL) (OR 14.15; 95%CI: 2.36-84.64) were risk factor for Intensive Care Unit admission.", {"entities": [[123, 129, "DISEASE"]]}], ["This observational study in a given area of North-East Italy confirms the rather favourable prognosis of children with influenza A H1N1 (2009).", {"entities": [[119, 128, "DISEASE"]]}], ["Pre-existing conditions, and which is new, significant anemia, are risk factors for a complicated course.", {"entities": [[55, 61, "DISEASE"]]}], ["The purpose of this study is to report the prevalence, clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with acute heart failure (HF).", {"entities": []}], ["Retrospective analysis of prospectively collected data.", {"entities": []}], ["Data were derived from Gulf CARE (Gulf aCute heArt failuRe rEgistry), a prospective multicentre study of consecutive patients hospitalised with acute HF in 2012 in seven Middle Eastern countries and analysed according to the presence or absence of prior stroke; demographics, management and outcomes were compared.", {"entities": []}], ["A total of 5005 patients with HF.", {"entities": []}], ["In-hospital and 1-year outcome.", {"entities": []}], ["The prevalence of prior stroke in patients with HF was 8.1%.", {"entities": []}], ["Patients with stroke with HF were more likely to be admitted under the care of internists rather than cardiologists.", {"entities": []}], ["When compared with patients without stroke, patients with stroke were more likely to be older and to have diabetes mellitus, hypertension, atrial fibrillation, hyperlipidaemia, chronic kidney disease, ischaemic heart disease, peripheral arterial disease and left ventricular dysfunction (p=0.001 for all).", {"entities": [[125, 137, "DISEASE"], [185, 199, "DISEASE"], [211, 224, "DISEASE"], [106, 123, "DISEASE"]]}], ["Patients with stroke were less likely to be smokers (0.003).", {"entities": []}], ["There were no significant differences in terms of precipitating risk factors for HF hospitalisation between the two groups.", {"entities": []}], ["Patients with stroke with HF had a longer hospital stay (mean\u00b1SD days; 11\u00b114 vs 9\u00b113, p=0.03), higher risk of recurrent strokes and 1-year mortality rates (32.7% vs 23.2%, p=0.001).", {"entities": []}], ["Multivariate logistic regression analysis showed that stroke is an independent predictor of in-hospital and 1-year mortality.", {"entities": []}], ["This observational study reports high prevalence of prior stroke in patients hospitalised with HF.", {"entities": []}], ["Internists rather than cardiologists were the predominant caregivers in this high-risk group.", {"entities": []}], ["Patients with stroke had higher risk of in-hospital recurrent strokes and long-term mortality rates.", {"entities": []}], ["NCT01467973.", {"entities": []}], ["The best outcomes for treating childhood obesity have come from comprehensive family-based programmes.", {"entities": [[41, 48, "DISEASE"]]}], ["However there are questions over their generalisability.", {"entities": []}], ["To examine the acceptability and effectiveness of \u2018family-based behavioural treatment\u2019 (FBBT) for childhood obesity in an ethnically and socially diverse sample of families in a UK National Health Service (NHS) setting.", {"entities": [[108, 115, "DISEASE"], [206, 209, "GENE"]]}], ["In this parallel group, randomised controlled trial, 72 obese children were randomised to FBBT or waiting list control.", {"entities": []}], ["Primary outcomes were body mass index (BMI) and BMI standard deviation scores (SDS).", {"entities": [[79, 82, "GENE"]]}], ["Secondary outcomes were weight, weight SDS, height, height SDS, waist, waist SDS, fat mass index, fat free mass index, blood pressure, and psychosocial measures.", {"entities": [[39, 42, "GENE"], [59, 62, "GENE"], [77, 80, "GENE"], [39, 42, "GENE"], [59, 62, "GENE"], [77, 80, "GENE"], [39, 42, "GENE"], [59, 62, "GENE"], [77, 80, "GENE"]]}], ["Outcomes were assessed at baseline and post-treatment, with analyses on the 6 month data done on an intent-to-treat (ITT) basis.", {"entities": []}], ["Follow-up anthropometric data were collected at twelve months for the treatment group.", {"entities": []}], ["ITT analyses included all children with baseline data (n=60).", {"entities": []}], ["There were significant BMI SDS changes (p<0.01) for the treatment and control groups of \u22120.11 (0.16) and \u22120.10 (1.6).", {"entities": [[27, 30, "GENE"]]}], ["The treatment group showed a significant reduction in systolic blood pressure (\u22120.24 (0.7), p<0.05) and improvements in quality of life and eating attitudes (p<0.05), with no significant changes for the control group.", {"entities": []}], ["However the between-group treatment effects for BMI, body composition, blood pressure and psychosocial outcomes were not significant.", {"entities": []}], ["There was no overall change in BMI or BMI SDS from 0-12 months for the treatment group.", {"entities": [[42, 45, "GENE"]]}], ["No adverse effects were reported.", {"entities": []}], ["Both treatment and control groups experienced significant reductions in level of overweight, but with no significant difference between them.", {"entities": []}], ["There were no significant group differences for any of the secondary outcomes.", {"entities": []}], ["Autism spectrum disorders (ASDs) affect as many as 1 in 45 children and are characterized by deficits in sociability and communication, as well as stereotypic movements.", {"entities": []}], ["Many children also show severe anxiety.", {"entities": []}], ["The lack of distinct pathogenesis and reliable biomarkers hampers the development of effective treatments.", {"entities": []}], ["As a result, most children with ASD are prescribed psychopharmacologic agents that do not address the core symptoms of ASD.", {"entities": []}], ["Autoantibodies against brain epitopes in mothers of children with ASD and many such children strongly correlate with allergic symptoms and indicate an aberrant immune response, as well as disruption of the blood\u2013brain barrier (BBB).", {"entities": []}], ["Recent epidemiological studies have shown a strong statistical correlation between risk for ASD and either maternal or infantile atopic diseases, such as asthma, eczema, food allergies and food intolerance, all of which involve activation of mast cells (MCs).", {"entities": [[154, 160, "DISEASE"]]}], ["These unique tissue immune cells are located perivascularly in all tissues, including the thalamus and hypothalamus, which regulate emotions.", {"entities": []}], ["MC-derived inflammatory and vasoactive mediators increase BBB permeability.", {"entities": []}], ["Expression of the inflammatory molecules interleukin (IL-1\u03b2), IL-6, 1\u2009L-17 and tumor necrosis factor (TNF) is increased in the brain, cerebrospinal fluid and serum of some patients with ASD, while NF-kB is activated in brain samples and stimulated peripheral blood immune cells of other patients; however, these molecules are not specific.", {"entities": [[102, 105, "GENE"]]}], ["Instead the peptide neurotensin is uniquely elevated in the serum of children with ASD, as is corticotropin-releasing hormone, secreted from the hypothalamus under stress.", {"entities": []}], ["Both peptides trigger MC to release IL-6 and TNF, which in turn, stimulate microglia proliferation and activation, leading to disruption of neuronal connectivity.", {"entities": [[45, 48, "GENE"]]}], ["MC-derived IL-6 and TGF\u03b2 induce maturation of Th17 cells and MCs also secrete IL-17, which is increased in ASD.", {"entities": []}], ["Serum IL-6 and TNF may define an ASD subgroup that benefits most from treatment with the natural flavonoid luteolin.", {"entities": [[15, 18, "GENE"]]}], ["Atopic diseases may create a phenotype susceptible to ASD and formulations targeting focal inflammation of the brain could have great promise in the treatment of ASD.", {"entities": []}], ["Respiratory system diseases are common and major ailments that seriously endanger human health.", {"entities": []}], ["Resveratrol, a polyphenolic phytoalexin, is considered an anti-inflammatory, antioxidant, and anticancer agent.", {"entities": []}], ["Thanks to its wide range of biological activities, resveratrol has become a hotspot in many fields, including respiratory system diseases.", {"entities": []}], ["Indeed, research has demonstrated that resveratrol is helpful to relieve pulmonary function in the general population.", {"entities": []}], ["Meanwhile, growing evidence indicates that resveratrol plays a protective role in respiratory system diseases.", {"entities": []}], ["This review aimed to summarize the main protective effects of resveratrol in respiratory system diseases, including its anti-inflammatory, antiapoptotic, antioxidant, antifibrotic, antihypertensive, and anticancer activities.", {"entities": []}], ["We found that resveratrol plays a protective role in the respiratory system through a variety of mechanisms, and so it may become a new drug for the treatment of respiratory system diseases.", {"entities": []}], ["Excessive inflammatory and oxidative stress lead to circulatory failure, multiple organ dysfunction, and high mortality in patients with sepsis.", {"entities": []}], ["Microbial infection-induced DNA hypermethylation is associated with the augmentation of inflammation and oxidative stress.", {"entities": []}], ["In our previous study, the antiarrhythmic drug procainamide inhibits the expression of DNA methyltransferase 1 (DNMT1) and diminishes IL-6 levels in rats with rhabdomyolysis.", {"entities": [[112, 117, "GENE"]]}], ["Thus, we further evaluated the effects of procainamide on the development of circulatory failure and multiple organ dysfunction in rats with endotoxic shock.", {"entities": []}], ["Male Wistar rats were intravenously infused with saline or lipopolysaccharide (LPS) followed by procainamide administration.", {"entities": []}], ["The changes of hemodynamics, blood glucose, biochemical variables, and plasma nitric oxide (NO) levels were analyzed during the experimental period.", {"entities": []}], ["At the end of experiments, animal organs were also obtained for examining superoxide production, neutrophil infiltration, and DNA methylation status.", {"entities": []}], ["Our results showed that LPS induced circulatory failure, multiple organ dysfunction, and high mortality rate in endotoxemic rats.", {"entities": []}], ["Overt neutrophil infiltration and superoxide production, accompanied by the elevations of DNMT1 and 5-methylcytosine levels in the lung of endotoxemic rats were also observed.", {"entities": [[90, 95, "GENE"]]}], ["Treatment of endotoxemic animals with procainamide not only inhibited the increased levels of DNMT1 and 5-methylcytosine but also ameliorated neutrophil infiltration and superoxide production in the lung.", {"entities": [[94, 99, "GENE"]]}], ["In addition, the anti-inflammatory gene, IL27RA, was down-regulated in the LPS group and up-regulated in the LPS + Procainamide group.", {"entities": [[41, 47, "GENE"]]}], ["Procainamide also diminished IL27RA methylation in the lung of endotoxemic rat.", {"entities": [[29, 35, "GENE"]]}], ["Moreover, both DNMT inhibitors procainamide and hydralazine improved hypotension, hypoglycemia, and multiple organ dysfunction of LPS-treated rats.", {"entities": [[82, 94, "DISEASE"]]}], ["Thus, we suggest that the beneficial effects of procainamide could be attributed to the suppression of DNA methylation, neutrophil infiltration, superoxide production, and NO formation.", {"entities": []}], ["It seems that this old drug may have new potential uses in infectious diseases, in particular, associated with endotoxemia.", {"entities": []}], ["Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease.", {"entities": [[37, 50, "DISEASE"], [184, 197, "DISEASE"], [28, 50, "DISEASE"], [175, 197, "DISEASE"]]}], ["We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design.", {"entities": []}], ["We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48\u2008897 controls free of the disease) and a prospective cohort design including 30\u2008725 participants free of cardiovascular disease from Finland and Sweden.", {"entities": [[68, 81, "DISEASE"], [219, 232, "DISEASE"], [59, 81, "DISEASE"], [210, 232, "DISEASE"]]}], ["We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease.", {"entities": [[173, 186, "DISEASE"], [164, 186, "DISEASE"]]}], ["For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression.", {"entities": []}], ["In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10\u00b77 years' follow-up (IQR 6\u00b77\u201313\u00b76).", {"entities": [[71, 84, "DISEASE"], [62, 84, "DISEASE"]]}], ["Genetic risk score was associated with a first coronary heart disease event.", {"entities": [[56, 69, "DISEASE"], [47, 69, "DISEASE"]]}], ["When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1\u00b766-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1\u00b735\u20132\u00b704, p value for linear trend=7\u00b73\u00d710 Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event.", {"entities": [[141, 154, "DISEASE"], [325, 338, "DISEASE"], [458, 471, "DISEASE"], [132, 154, "DISEASE"], [316, 338, "DISEASE"], [449, 471, "DISEASE"]]}], ["The potential clinical use of this panel of SNPs remains to be defined.", {"entities": []}], ["The Wellcome Trust; Academy of Finland Center of Excellence for Complex Disease Genetics; US National Institutes of Health; the Donovan Family Foundation.", {"entities": []}], ["The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity.", {"entities": []}], ["Here we studied the effect of hyperglycemia on smooth muscle function.", {"entities": [[30, 43, "DISEASE"]]}], ["Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction.", {"entities": [[158, 171, "DISEASE"]]}], ["RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG.", {"entities": [[0, 4, "GENE"], [82, 90, "GENE"]]}], ["Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice.", {"entities": [[53, 57, "GENE"], [109, 113, "GENE"], [53, 57, "GENE"], [109, 113, "GENE"]]}], ["Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice.", {"entities": [[55, 59, "GENE"], [112, 116, "GENE"], [55, 59, "GENE"], [112, 116, "GENE"]]}], ["The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo , suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression.", {"entities": [[160, 164, "GENE"], [273, 277, "GENE"], [18, 26, "GENE"], [192, 200, "GENE"], [219, 227, "GENE"], [18, 26, "GENE"], [192, 200, "GENE"], [219, 227, "GENE"], [160, 164, "GENE"], [273, 277, "GENE"]]}], ["Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle.", {"entities": []}], ["Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction.", {"entities": [[168, 176, "GENE"], [181, 185, "GENE"]]}], ["NAC treatment also reversed the decrease in gastric emptying in ob/ob mice.", {"entities": []}], ["We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.", {"entities": [[67, 75, "GENE"]]}], ["This study was performed to estimate the direct medical costs and epidemiology of pneumonia in adults of Korea.", {"entities": [[82, 91, "DISEASE"]]}], ["We conducted a multi-center, retrospective, observational study and collected data targeting for community-acquired pneumonia patients ( \u2265 50 yr) from 11 hospitals.", {"entities": [[116, 125, "DISEASE"]]}], ["Costs attributable to the treatment of pneumonia were estimated by reviewing resource utilization and epidemiology data (distribution of pathogen, hospital length of stay, overall outcome) were also collected.", {"entities": [[39, 48, "DISEASE"]]}], ["A total 693 patients were included; average 70.1 ( \u00b1 10.5) aged, 57.3% male and average 1.16 CURB-65 (confusion, blood urea nitrogen, respiratory rate, blood pressure, age > 65 yr) scored.", {"entities": []}], ["The pathogen was identified in the 32.9% (228 patients); Streptococcus pneumoniae accounted for 22.4% (51 patients) of identified pathogens.", {"entities": []}], ["The hospital mortality was 3.2% (especially, for S. pneumoniae was 5.9%) and average length of stay was 9 days.", {"entities": []}], ["The mean total cost for the treatment of pneumonia was US dollar (USD) 1,782 (SD: USD 1,501).", {"entities": [[41, 50, "DISEASE"]]}], ["Compared to the cost of all caused pneumonia, that of pneumococcal pneumonia was higher, USD 2,049 ( \u00b1 USD 1,919), but not statistically significant.", {"entities": [[35, 44, "DISEASE"], [67, 76, "DISEASE"]]}], ["Charge of hospitalization accounted the greatest part of total medical costs.", {"entities": []}], ["The economic burden of pneumonia was high in Korea, and the prevention of pneumonia should be considered as effective strategy.", {"entities": [[23, 32, "DISEASE"], [74, 83, "DISEASE"]]}], ["Long chain polyunsaturated fatty acids (LCPUFA) are bioactive components of membrane phospholipids and serve as substrates for signaling molecules.", {"entities": []}], ["LCPUFA can be obtained directly from animal foods or synthesized endogenously from 18 carbon precursors via the FADS2 coded enzyme.", {"entities": [[112, 117, "GENE"]]}], ["Vegans rely almost exclusively on endogenous synthesis to generate LCPUFA and we hypothesized that an adaptive genetic polymorphism would confer advantage.", {"entities": []}], ["The rs66698963 polymorphism, a 22-bp insertion\u2013deletion within FADS2 , is associated with basal FADS1 expression, and coordinated induction of FADS1 and FADS2 in vitro.", {"entities": [[63, 68, "GENE"], [153, 158, "GENE"], [96, 101, "GENE"], [143, 148, "GENE"], [96, 101, "GENE"], [143, 148, "GENE"], [63, 68, "GENE"], [153, 158, "GENE"]]}], ["Here, we determined rs66698963 genotype frequencies from 234 individuals of a primarily vegetarian Indian population and 311 individuals from the US.", {"entities": []}], ["A much higher I/I genotype frequency was found in Indians (68%) than in the US (18%).", {"entities": []}], ["Analysis using 1000 Genomes Project data confirmed our observation, revealing a global I/I genotype of 70% in South Asians, 53% in Africans, 29% in East Asians, and 17% in Europeans.", {"entities": []}], ["Tests based on population divergence, site frequency spectrum, and long-range haplotype consistently point to positive selection encompassing rs66698963 in South Asian, African, and some East Asian populations.", {"entities": []}], ["Basal plasma phospholipid arachidonic acid (ARA) status was 8% greater in I/I compared with D/D individuals.", {"entities": []}], ["The biochemical pathway product\u2013precursor difference, ARA minus linoleic acid, was 31% and 13% greater for I/I and I/D compared with D/D, respectively.", {"entities": []}], ["This study is consistent with previous in vitro data suggesting that the insertion allele enhances n-6 LCPUFA synthesis and may confer an adaptive advantage in South Asians because of the traditional plant-based diet practice.", {"entities": []}], ["Late onset sepsis is a frequent complication of prematurity associated with increased mortality and morbidity.", {"entities": []}], ["The commensal bacteria of the gastrointestinal tract play a key role in the development of healthy immune responses.", {"entities": []}], ["Healthy term infants acquire these commensal organisms rapidly after birth.", {"entities": []}], ["However, colonisation in preterm infants is adversely affected by delivery mode, antibiotic treatment and the intensive care environment.", {"entities": []}], ["Altered microbiota composition may lead to increased colonisation with pathogenic bacteria, poor immune development and susceptibility to sepsis in the preterm infant.", {"entities": []}], ["Probiotics are live microorganisms, which when administered in adequate amounts confer health benefits on the host.", {"entities": []}], ["Amongst numerous bacteriocidal and nutritional roles, they may also favourably modulate host immune responses in local and remote tissues.", {"entities": []}], ["Meta-analyses of probiotic supplementation in preterm infants report a reduction in mortality and necrotising enterocolitis.", {"entities": []}], ["Studies with sepsis as an outcome have reported mixed results to date.", {"entities": []}], ["Allergic diseases are increasing in incidence in \"westernised\" countries.", {"entities": []}], ["There is evidence that probiotics may reduce the incidence of these diseases by altering the intestinal microbiota to influence immune function.", {"entities": []}], ["This is a multi-centre, randomised, double blinded, placebo controlled trial investigating supplementing preterm infants born at < 32 weeks' gestation weighing < 1500 g, with a probiotic combination ( Bifidobacterium infantis, Streptococcus thermophilus and Bifidobacterium lactis ).", {"entities": []}], ["A total of 1,100 subjects are being recruited in Australia and New Zealand.", {"entities": []}], ["Infants commence the allocated intervention from soon after the start of feeds until discharge home or term corrected age.", {"entities": []}], ["The primary outcome is the incidence of at least one episode of definite (blood culture positive) late onset sepsis before 40 weeks corrected age or discharge home.", {"entities": []}], ["Secondary outcomes include: Necrotising enterocolitis, mortality, antibiotic usage, time to establish full enteral feeds, duration of hospital stay, growth measurements at 6 and 12 months' corrected age and evidence of atopic conditions at 12 months' corrected age.", {"entities": []}], ["Results from previous studies on the use of probiotics to prevent diseases in preterm infants are promising.", {"entities": []}], ["However, a large clinical trial is required to address outstanding issues regarding safety and efficacy in this vulnerable population.", {"entities": []}], ["This study will address these important issues.", {"entities": []}], ["Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN012607000144415 The product \"ABC Dophilus Probiotic Powder for Infants", {"entities": []}], ["Schistosomiasis is considered second only to malaria as the most devastating parasitic disease in tropical countries.", {"entities": [[45, 52, "DISEASE"], [0, 15, "DISEASE"]]}], ["Schistosome cercariae invade the host by penetrating the skin and migrate though the lungs and portal circulation to their final destination in the hepatic portal system and eventually the mesenteric veins.", {"entities": []}], ["Previous studies have shown that the cytotoxic pathways that target schistosomulum in the lung-stage involve nitric oxide (NO) produced by macrophages.", {"entities": []}], ["By contrast, skin-stage schistosomulas can evade clearance, indicating that they might be freed from macrophage NO-mediated cytotoxicity to achieve immune evasion; however, the critical molecules and mechanisms involved remain unknown.", {"entities": []}], ["Recombinant SjCa8 (rSjCa8), an 8-kDa calcium-binding protein that is stage-specifically expressed in cercaria and early skin-stage schistosomulas of Schistosoma japonicum , was incubated with mouse RAW264.7 macrophages.", {"entities": []}], ["Effects on macrophage proliferation were determined using Cell Counting Kit-8.", {"entities": []}], ["Next, transwell assay was carried out to further investigate the role of rSjCa8 in macrophage migration.", {"entities": []}], ["The effects of rSjCa8 on macrophage apoptosis were evaluated using confocal microscopy and flow cytometry.", {"entities": []}], ["Additional impacts of rSjCa8 on NO release by lipopolysaccharide (LPS)-stimulated macrophages as well as the underlying mechanisms were explored using fluorescent probe, nitric oxide signaling pathway microarray, quantitative real-time PCR, mutagenesis, and neutralizing antibody approaches.", {"entities": []}], ["rSjCa8 exhibited a striking inhibitory effect on macrophage migration, but did not markedly increase cell proliferation or apoptosis.", {"entities": []}], ["Additionally, rSjCa8 potently inhibited NO release by LPS-stimulated macrophages in a dose- and time-dependent manner, and the inhibitory mechanism was closely associated with intracellular Ca Myc , Gadd45a , Txnip , Fas , Sod2 , Nos2 , and Hmgb1 .", {"entities": [[193, 196, "GENE"], [199, 206, "GENE"], [209, 214, "GENE"], [217, 220, "GENE"], [223, 227, "GENE"], [230, 234, "GENE"], [241, 246, "GENE"]]}], ["Vaccination with rSjCa8 increased NO concentration in the challenging skin area of infected mice and reduced the number of migrated schistosomula after skin penetration by cercariae.", {"entities": []}], ["Our findings indicate that SjCa8 might be a novel molecule that plays a critical role in immune evasion by S. japonicum cercaria during the process of skin penetration.", {"entities": []}], ["The inhibitory impacts of rSjCa8 on macrophage migration and [Ca i -dependent NO release suggest it might represent a novel vaccine candidate and chemotherapeutic target for the prevention and treatment of schistosomiasis.", {"entities": [[206, 221, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s13071-015-1119-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Etiologies of pediatric intensive care unit (PICU) mortality are diverse.", {"entities": []}], ["This study aimed to investigate the pattern of PICU mortality in a regional trauma center, and explore factors associated with prolonged non-survival.", {"entities": []}], ["Demographic data of all PICU deaths in a regional trauma center were analyzed.", {"entities": []}], ["Factors associated with prolonged nonsurvival (length of stay) were investigated with univariate log rank and multivariate Cox-Regression forward stepwise tests.", {"entities": []}], ["There were 88 deaths (males 61%; infants 23%) over 10\u00a0years (median PICU stay\u2009=\u20093.5\u00a0days, interquartile range: 1 and 11\u00a0days).", {"entities": []}], ["The mean annual mortality rate of PICU admissions was 5.8%.", {"entities": []}], ["Septicemia with gram positive, gram negative and fungal pathogens were present in 13 (16%), 13 (16%) and 4 (5%) of these patients, respectively.", {"entities": []}], ["Viruses were isolated in 25 patients (28%).", {"entities": []}], ["Ninety percent of these 88 patients were ventilated, 75% required inotropes, 92% received broad spectrum antibiotic coverage, 32% received systemic corticosteroids, 56% required blood transfusion and 39% received anticonvulsants.", {"entities": []}], ["Thirty nine patients (44%) had a DNAR (Do-Not-Attempt-Resuscitation) order with their deaths at the PICU.", {"entities": []}], ["Comparing with non-trauma category, trauma patients had higher mortality score, no premorbid disease, suffered asystole preceding PICU admission and subsequent brain death.", {"entities": []}], ["Oncologic conditions were the most prevalent diagnosis in the non-trauma category.", {"entities": []}], ["There was no gunshot or asthma death in this series.", {"entities": [[24, 30, "DISEASE"]]}], ["Prolonged non-survival was significantly associated with DNAR, fungal infections, and mechanical ventilation but negatively associated with bacteremia.", {"entities": []}], ["Death in the PICU is a heterogeneous event that involves infants and children.", {"entities": []}], ["Resuscitation was not attempted at the time of their deaths in nearly half of the patients in honor of parents\u2019 wishes.", {"entities": []}], ["Parents often make DNAR decision when medical futility becomes evident.", {"entities": []}], ["They could be reassured that DNAR did not mean \u201cabandoning\u201d care.", {"entities": []}], ["Instead, DNAR patients had prolonged PICU stay and received the same level of PICU supports as patients who did not respond to cardiopulmonary resuscitation.", {"entities": []}], ["Children and young adults of reproductive age have emerged as groups that are highly vulnerable to the current 2009 H1N1 pandemic.", {"entities": []}], ["The sex of an individual is a fundamental factor that can influence exposure, susceptibility and immune responses to influenza.", {"entities": [[117, 126, "DISEASE"]]}], ["Worldwide, the incidence, disease burden, morbidity and mortality rates following exposure to the 2009 H1N1 influenza virus differ between males and females and are often age-dependent.", {"entities": [[108, 117, "DISEASE"]]}], ["Pregnancy and differences in the presentation of various risk factors contribute to the worse outcome of infection in women.", {"entities": []}], ["Vaccination and antiviral treatment efficacy also vary in a sex-dependent manner.", {"entities": []}], ["Finally, sex-specific genetic and hormonal differences may contribute to the severity of influenza and the clearance of viral infection.", {"entities": [[89, 98, "DISEASE"]]}], ["The contribution of sex and gender to influenza can only be determined by a greater consideration of these factors in clinical and epidemiological studies and increased research into the biological basis underlying these differences.", {"entities": [[38, 47, "DISEASE"]]}], ["An abnormally high incidence of lung disease has been observed in the residents of Libby, Montana, which has been attributed to occupational and environmental exposure to fibrous amphiboles originating from a nearby contaminated vermiculite mine.", {"entities": [[32, 44, "DISEASE"]]}], ["The composition of Libby amphibole (LA) is complex and minimal toxicity data are available.", {"entities": []}], ["In this study, we conduct a comparative particle toxicity analysis of LA compared with standard reference asbestiform amphibole samples.", {"entities": []}], ["Primary human airway epithelial cells (HAEC) were exposed to two different LA samples as well as standard amphibole reference samples.", {"entities": []}], ["Analysis of the samples included a complete particle size distribution analysis, calculation of surface area by electron microscopy and by gas adsorption and quantification of surface-conjugated iron and hydroxyl radical production by the fibers.", {"entities": []}], ["Interleukin-8 mRNA levels were quantified by qRT-PCR to measure relative pro-inflammatory response induced in HAEC in response to amphibole fiber exposure.", {"entities": []}], ["The relative contribution of key physicochemical determinants on the observed pro-inflammatory response were also evaluated.", {"entities": []}], ["The RTI amosite reference sample contained the longest fibers and demonstrated the greatest potency at increasing IL-8 transcript levels when evaluated on an equal mass basis.", {"entities": []}], ["The two LA samples and the UICC amosite reference sample consisted of similar particle numbers per milligram as well as similar particle size distributions and induced comparable levels of IL-8 mRNA.", {"entities": []}], ["A strong correlation was observed between the elongated particle (aspect ratio \u22653:1) dose metrics of length and external surface area.", {"entities": []}], ["Expression of the IL-8 data with respect to either of these metrics eliminated the differential response between the RTI amosite sample and the other samples that was observed when HAEC were exposed on an equal mass basis.", {"entities": []}], ["On an equal mass basis, LA is as potent as the UICC amosite reference sample at inducing a pro-inflammatory response in HAEC but is less potent than the RTI amosite sample.", {"entities": []}], ["The results of this study show that the particle length and particle surface area are highly correlated metrics that contribute significantly to the toxicological potential of these amphibole samples with respect to the inflammogenic response induced in airway epithelial cells.", {"entities": []}], ["Cigarette smoke (CS) increases the risk of chronic obstructive pulmonary disease (COPD) by causing inflammation, emphysema, and reduced lung function.", {"entities": [[43, 80, "DISEASE"], [17, 19, "GENE"]]}], ["Additionally, CS can induce autophagy which contributes to COPD.", {"entities": [[14, 16, "GENE"]]}], ["Arachidonic acid-derived epoxyeicosatrienoic acids (EETs) have promising anti-inflammatory properties that may protect the heart and liver by regulating autophagy.", {"entities": []}], ["For this reason, the effect of decreased soluble epoxide hydrolase (sEH, Ephx2)-mediated EET hydrolysis on inflammation, emphysema, lung function, and autophagy was here studied in CS-induced COPD in vivo .", {"entities": [[73, 78, "GENE"]]}], ["Adult male wild-type (WT) C57BL/6J and Ephx2", {"entities": [[39, 44, "GENE"]]}], ["Incorporating the influence of genetic variation in the risk assessment process is often considered, but no generalized approach exists.", {"entities": []}], ["Many common human diseases such as asthma, cancer, and cardiovascular disease are complex in nature, as they are influenced variably by environmental, physiologic, and genetic factors.", {"entities": [[35, 41, "DISEASE"], [43, 49, "DISEASE"]]}], ["The genetic components most responsible for differences in individual disease risk are thought to be DNA variants (polymorphisms) that influence the expression or function of mediators involved in the pathological processes.", {"entities": []}], ["The purpose of this study was to estimate the combinatorial contribution of multiple genetic variants to disease risk.", {"entities": []}], ["We used a logistic regression model to help estimate the joint contribution that multiple genetic variants would have on disease risk.", {"entities": []}], ["This model was developed using data collected from molecular epidemiology studies of allergic asthma that examined variants in 16 susceptibility genes.", {"entities": [[85, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["Based on the product of single gene variant odds ratios, the risk of developing asthma was assigned to genotype profiles, and the frequency of each profile was estimated for the general population.", {"entities": [[80, 86, "DISEASE"]]}], ["Our model predicts that multiple disease variants broaden the risk distribution, facilitating the identification of susceptible populations.", {"entities": []}], ["This model also allows for incorporation of exposure information as an independent variable, which will be important for risk variants associated with specific exposures.", {"entities": []}], ["The present model provided an opportunity to estimate the relative change in risk associated with multiple genetic variants.", {"entities": []}], ["This will facilitate identification of susceptible populations and help provide a framework to model the genetic contribution in probabilistic risk assessment.", {"entities": []}], ["Diagnosis of asthma is often challenging in primary-care physicians due to lack of tools measuring airway obstruction and variability.", {"entities": [[13, 19, "DISEASE"]]}], ["Symptom-based diagnosis of asthma utilizing objective diagnostic parameters and appropriate software would be useful in clinical practice.", {"entities": [[27, 33, "DISEASE"]]}], ["A total of 302 adult patients with respiratory symptoms responded to a questionnaire regarding asthma symptoms and provoking factors.", {"entities": [[95, 101, "DISEASE"]]}], ["Questions were asked and recorded by physicians into a computer program.", {"entities": []}], ["A definite diagnosis of asthma was made based on a positive response to methacholine bronchial provocation or bronchodilator response (BDR) testing.", {"entities": [[24, 30, "DISEASE"]]}], ["Multivariate logistic regression analysis was used to evaluate the significance of questionnaire responses in terms of discriminating asthmatics.", {"entities": []}], ["Asthmatic patients showed higher total symptom scores than non-asthmatics (mean 5.93 vs. 4.93; p <0.01).", {"entities": []}], ["Multivariate logistic regression analysis identified that response to questions concerning the following significantly discriminated asthmatics; wheezing with dyspnea, which is aggravated at night, and by exercise, cold air, and upper respiratory infection.", {"entities": []}], ["Moreover, the presence of these symptoms was found to agree significantly with definite diagnosis of asthma (by kappa statistics).", {"entities": [[101, 107, "DISEASE"]]}], ["Receiver-operating characteristic curve analysis revealed that the diagnostic accuracy of symptom-based diagnosis was high with an area under the curve of 0.647\u00b10.033.", {"entities": []}], ["Using a computer-assisted symptom-based diagnosis program, it is possible to increase the accuracy of diagnosing asthma in general practice, when the facilities required to evaluate airway hyperresponsiveness or BDR are unavailable.", {"entities": [[113, 119, "DISEASE"]]}], ["Type 2 helper T (T H ) cells produce interleukin 13 (IL-13) when stimulated by papain or house dust mites (HDM) and induce eosinophilic inflammation.", {"entities": []}], ["This innate response is dependent on IL-33 but not T cell antigen receptors (TCRs).", {"entities": []}], ["While type 2 innate lymphoid cells (ILC2s) are the dominant innate producers of IL-13 in na\u00efve animals, we show here that in helminth-infected mice, T H 2 cell numbers increased and became major mediators of innate type II responses.", {"entities": []}], ["T H 2 cells made important contributions to HDM-induced antigen\u2013non-specific eosinophilic inflammation and protected mice recovering from Ascaris suum infection against subsequent infection with the phylogenetically distant nematode Nippostrongylus brasiliensis .", {"entities": []}], ["Our findings reveal a previously unappreciated role of effector T H 2 cells during TCR-independent innate-like immune responses.", {"entities": []}], ["Ovarian cancer G protein-coupled receptor 1 (OGR1) stimulation by extracellular protons causes the activation of G proteins and subsequent cellular functions.", {"entities": [[8, 14, "DISEASE"]]}], ["However, the physiological and pathophysiological roles of OGR1 in airway responses remain largely unknown.", {"entities": []}], ["In the present study, we show that OGR1-deficient mice are resistant to the cardinal features of asthma, including airway eosinophilia, airway hyperresponsiveness (AHR), and goblet cell metaplasia, in association with a remarkable inhibition of Th2 cytokine and IgE production, in an ovalbumin (OVA)-induced asthma model.", {"entities": [[122, 134, "DISEASE"], [97, 103, "DISEASE"], [308, 314, "DISEASE"], [164, 167, "GENE"]]}], ["Intratracheal transfer to wild-type mice of OVA-primed bone marrow-derived dendritic cells (DCs) from OGR1-deficient mice developed lower AHR and eosinophilia after OVA inhalation compared with the transfer of those from wild-type mice.", {"entities": [[146, 158, "DISEASE"], [138, 141, "GENE"]]}], ["Migration of OVA-pulsed DCs to peribronchial lymph nodes was also inhibited by OGR1 deficiency in the adoption experiments.", {"entities": []}], ["The presence of functional OGR1 in DCs was confirmed by the expression of OGR1 mRNA and the OGR1-sensitive Ca", {"entities": []}], ["This study evaluated the loss of Klotho in human lungs with COPD and the underlying mechanisms.", {"entities": []}], ["COPD (chronic obstructive pulmonary disease) is associated with sustained inflammation, excessive injury, and accelerated lung aging.", {"entities": [[6, 43, "DISEASE"]]}], ["Human Klotho (KL) is an anti-aging protein that protects cells against inflammation and damage.", {"entities": [[14, 16, "GENE"]]}], ["In the present study, we quantified KL expression in the lungs of COPD patients and in an ozone-induced mouse model of COPD, and investigated the mechanisms that control KL expression and function in the airways.", {"entities": [[36, 38, "GENE"], [170, 172, "GENE"], [36, 38, "GENE"], [170, 172, "GENE"]]}], ["KL distribution and levels in human and mouse airways were measured by immunohistochemistry and Western blotting.", {"entities": [[0, 2, "GENE"]]}], ["The effect of CSE (cigarette smoke extract) on KL expression was detected in human bronchial epithelial cells.", {"entities": [[47, 49, "GENE"]]}], ["Moreover, the effect of KL on CSE-mediated inflammation and hydrogen peroxide-induced cellular injury/apoptosis was determined using siRNAs.", {"entities": [[24, 26, "GENE"]]}], ["KL expression was decreased in the lungs of smokers and further reduced in patients with COPD.", {"entities": [[0, 2, "GENE"]]}], ["Similarly, 6\u00a0weeks of exposure to ozone decreased KL levels in airway epithelial cells.", {"entities": [[50, 52, "GENE"]]}], ["CSE and TNF\u03b1 (tumour necrosis factor \u03b1) decreased KL expression and release from airway epithelial cells, which was associated with enhanced pro-inflammatory cytokine expression.", {"entities": [[50, 52, "GENE"]]}], ["Moreover, KL depletion increased cell sensitivity to cigarette smoke-induced inflammation and oxidative stress-induced cell damage.", {"entities": [[10, 12, "GENE"]]}], ["These effects involved the NF-\u03baB (nuclear factor \u03baB), MAPK (mitogen-activated protein kinase) and Nrf2 (nuclear factor erythroid 2-related factor 2) pathways.", {"entities": []}], ["Reduced KL expression in COPD airway epithelial cells was associated with increased oxidative stress, inflammation and apoptosis.", {"entities": [[8, 10, "GENE"]]}], ["These data provide new insights into the mechanisms associated with the accelerated lung aging in COPD development.", {"entities": []}], ["Viruses are successful and omnipresent.", {"entities": []}], ["Influenza A is a particularly important virus of humans.", {"entities": [[0, 9, "DISEASE"]]}], ["The article reviews the 2009 emergence of the pandemic influenza A virus, focusing on the potential origin of the virus and the distinctive clinical and epidemiological impact of the 2009 pandemic.", {"entities": [[55, 64, "DISEASE"]]}], ["To gain insight into patient and doctor delay in testicular cancer (TC) and factors associated with delay.", {"entities": [[49, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["Sixty of the 66 eligible men; median age 26 (range 17\u201345) years, diagnosed with TC at the University Medical Center Groningen completed a questionnaire on patients\u2019 delay: interval from symptom onset to first consultation with a general practitioner (GP) and doctors\u2019 delay: interval between GP and specialist visit.", {"entities": []}], ["Median patient reported delay was 30 (range 1\u2013365) days.", {"entities": []}], ["Patient delay and TC tumor stage were associated (p = .01).", {"entities": []}], ["Lower educated men and men embarrassed about their scrotal change reported longer patient delay (r = -.25, r = .79 respectively).", {"entities": []}], ["Age, marital status, TC awareness, warning signals, nor perceived limitations were associated with patient delay.", {"entities": []}], ["Median patient reported time from GP to specialist (doctors\u2019 delay) was 7 (range 0\u2013240) days.", {"entities": []}], ["Referral time and disease stage were associated (p = .04).", {"entities": []}], ["Six patients never reported a scrotal change.", {"entities": []}], ["Of the 54 patients reporting a testicular change, 29 (54%) patients were initially \u2018misdiagnosed\u2019, leading to a median doctors\u2019 delay of 14 (1\u2013240) days, which was longer (p< .001) than in the 25 (46%) patients whose GP suspected TC (median doctors\u2019 delay 1(0\u20137 days).", {"entities": []}], ["High variation in patients\u2019 and doctors\u2019 delay was found.", {"entities": []}], ["Most important risk variables for longer patient delay were embarrassment and lower education.", {"entities": []}], ["Most important risk variable in GP\u2019s was \u2018misdiagnosis\u2019.", {"entities": []}], ["TC awareness programs for men and physicians are required to decrease delay in the diagnosis of TC and improve disease free survival.", {"entities": []}], ["Sepsis is one of the highest causes of mortality in hospitalized people and a common complication in both surgical and clinical patients admitted to hospital for non-infectious reasons.", {"entities": []}], ["Sepsis is especially common in older people and its incidence is likely to increase substantially as a population ages.", {"entities": []}], ["Despite its increased prevalence and mortality in older people, immune responses in the elderly during septic shock appear similar to that in younger patients.", {"entities": []}], ["The purpose of this study was to conduct a genome-wide gene expression analysis of circulating neutrophils from old and young septic patients to better understand how aged individuals respond to severe infectious insult.", {"entities": []}], ["We detected several genes whose expression could be used to differentiate immune responses of the elderly from those of young people, including genes related to oxidative phosphorylation, mitochondrial dysfunction and TGF-\u03b2 signaling, among others.", {"entities": []}], ["Our results identify major molecular pathways that are particularly affected in the elderly during sepsis, which might have a pivotal role in worsening clinical outcomes compared with young people with sepsis.", {"entities": []}], ["Until recently cancer medical therapy was limited to chemotherapy that could not differentiate cancer cells from normal cells.", {"entities": [[15, 21, "DISEASE"], [95, 101, "DISEASE"]]}], ["More recently with the remarkable mushroom of immunology, newer tools became available, resulting in the novel possibility to attack cancer with the specificity of the immune system.", {"entities": [[133, 139, "DISEASE"]]}], ["Herein we will review some of the recent achievement of immunotherapy in such aggressive cancers as melanoma, prostatic cancer, colorectal carcinoma, and hematologic malignancies.", {"entities": [[139, 148, "DISEASE"], [100, 108, "DISEASE"], [120, 126, "DISEASE"]]}], ["Immunotherapy of tumors has developed several techniques: immune cell transfer, vaccines, immunobiological molecules such as monoclonal antibodies that improve the immune responses to tumors.", {"entities": []}], ["This can be achieved by blocking pathways limiting the immune response, such as CTLA-4 or Tregs.", {"entities": []}], ["Immunotherapy may also use cytokines especially proinflammatory cytokines to enhance the activity of cytotoxic T cells (CTLs) derived from tumor infiltrating lymphocytes (TILs).", {"entities": []}], ["The role of newly discovered cytokines remains to be investigated.", {"entities": []}], ["Alternatively, an other mechanism consists in enhancing the expression of TAAs on tumor cells.", {"entities": []}], ["Finally, monoclonal antibodies may be used to target oncogenes.", {"entities": []}], ["Free fatty acid receptor 2 (FFA2; GPR43) is a G protein-coupled seven-transmembrane receptor for short-chain fatty acids (SCFAs) that is implicated in inflammatory and metabolic disorders.", {"entities": []}], ["The SCFA propionate has close to optimal ligand efficiency for FFA2 and can hence be considered as highly potent given its size.", {"entities": []}], ["Propionate, however, does not discriminate between FFA2 and the closely related receptor FFA3 (GPR41).", {"entities": []}], ["To identify FFA2-selective ligands and understand the molecular basis for FFA2 selectivity, a targeted library of small carboxylic acids was examined using holistic, label-free dynamic mass redistribution technology for primary screening and the receptor-proximal G protein [ O -thio)triphosphate activation, inositol phosphate, and cAMP accumulation assays for hit confirmation.", {"entities": []}], ["Structure-activity relationship analysis allowed formulation of a general rule to predict selectivity for small carboxylic acids at the orthosteric binding site where ligands with substituted sp sp sp -hybridized \u03b1-carbons prefer FFA2.", {"entities": []}], ["The orthosteric binding mode was verified by site-directed mutagenesis: replacement of orthosteric site arginine residues by alanine in FFA2 prevented ligand binding, and molecular modeling predicted the detailed mode of binding.", {"entities": []}], ["Based on this, selective mutation of three residues to their non-conserved counterparts in FFA3 was sufficient to transfer FFA3 selectivity to FFA2.", {"entities": []}], ["Thus, selective activation of FFA2 via the orthosteric site is achievable with rather small ligands, a finding with significant implications for the rational design of therapeutic compounds selectively targeting the SCFA receptors.", {"entities": []}], ["Hyperresponsiveness of the airways to nonspecific stimuli is a characteristic feature of asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Airway responsiveness is usually characterized in terms of the position and shape of the dose\u2013response curve to methacholine (MDR).", {"entities": []}], ["In the study we have investigated the influence of fluticasone propionate (FP), a topically active glucocorticoid, on arachidonic acid (AA) metabolites in broncho-alveolar lavage (BAL) fluid (i.e.", {"entities": []}], ["TxB 2 , PGE 2 , PGD 2 , 6kPGF 1\u03b1 and LTC 4 ) on the one hand and MDR curves on the other hand.", {"entities": [[16, 19, "GENE"]]}], ["The effect of FP was studied in a randomized, double-blind, placebo-controlled design in 33 stable nonsmoking asthmatics; 16 patients received FP (500 \u03bcg b.i.d.)", {"entities": []}], ["whereas 17 patients were treated with placebo.", {"entities": []}], ["We found that the forced expiratory volume in 1s (FEV 1 % predicted) increased, the log 2 PC 20 methacholine increased and the plateau value (% fall in FEV 1 ) decreased after a 12 week treatment period.", {"entities": [[50, 53, "GENE"], [152, 155, "GENE"], [90, 92, "GENE"], [50, 53, "GENE"], [152, 155, "GENE"]]}], ["No changes in AA-metabolites could be determined after treatment except for PGD 2 which decreased nearly significantly (p = 0.058) within the FP treated group, whereas the change of PGD 2 differed significantly ( p = 0.05) in the FP treated group from placebo.", {"entities": [[76, 79, "GENE"], [182, 185, "GENE"], [76, 79, "GENE"], [182, 185, "GENE"]]}], ["The levels of the other AA metabolites (i.e.", {"entities": []}], ["TxB 2 , PGE 2 , 6kPGF 1\u03b1 and LTC 4 ) remained unchanged after treatment and were not significantly different from the placebo group.", {"entities": []}], ["Our results support the hypothesis that although FP strongly influences the position, the shape and also the maximum response plateau of the MDR curve, this effect is not mainly achieved by influence on the level of AA metabolites.", {"entities": []}], ["Other pro-inflammatory factors may be of more importance for the shape of the MDR curve.", {"entities": []}], ["It is suggested that these pro-inflammatory factors are downregulated by FP.", {"entities": []}], ["Migraine occurs in about 15% of the general population.", {"entities": [[0, 8, "DISEASE"]]}], ["Migraine is usually managed by medication, but some patients do not tolerate migraine medication due to side effects or prefer to avoid medication for other reasons.", {"entities": [[0, 8, "DISEASE"], [77, 85, "DISEASE"]]}], ["Non-pharmacological management is an alternative treatment option.", {"entities": []}], ["We systematically reviewed randomized clinical trials (RCTs) on manual therapies for migraine.", {"entities": [[85, 93, "DISEASE"]]}], ["The RCTs suggest that massage therapy, physiotherapy, relaxation and chiropractic spinal manipulative therapy might be equally effective as propranolol and topiramate in the prophylactic management of migraine.", {"entities": [[201, 209, "DISEASE"]]}], ["However, the evaluated RCTs had many methodological shortcomings.", {"entities": []}], ["Therefore, any firm conclusion will require future, well-conducted RCTs on manual therapies for migraine.", {"entities": [[96, 104, "DISEASE"]]}], ["To investigate the effectiveness of oxycodone compared with fentanyl for attenuating the hemodynamic response during endotracheal intubation.", {"entities": []}], ["This study was conducted from June 2014 to February 2015 on healthy adults undergoing general anesthesia at the Yeungnam University Hospital, Daegu, Republic of Korea.", {"entities": []}], ["Ninety-five patients were randomly assigned to one of 3 groups to receive the following drugs; Group F: fentanyl 2 \u00b5g/kg; Group O/70: oxycodone 140 \u00b5g/kg; Group O/100: oxycodone 200 \u00b5g/kg.", {"entities": []}], ["Five minutes after injection of the study drug, general anesthesia was induced with propofol 1.5 mg/kg and rocuronium 0.8 mg/kg.", {"entities": []}], ["The mean blood pressure (MBP), heart rate (HR), peripheral oxygen saturation (SpO 2 ), and bispectral index (BIS) were compared before administration of the study drug (T1), just before endotracheal intubation (T2), one minute after endotracheal intubation (T3), and 7.5 minutes after endotracheal intubation (T4).", {"entities": [[25, 28, "GENE"], [43, 45, "GENE"]]}], ["Complications were assessed.", {"entities": []}], ["The 2 oxycodone groups showed no significant differences in MBP, HR, SpO 2 , and BIS compared to Group F at the time points assessed.", {"entities": [[60, 63, "GENE"], [65, 67, "GENE"]]}], ["The incidence of complications was comparable among the groups.", {"entities": []}], ["Oxycodone could successfully be used to attenuate the sympathetic response during anesthetic induction.", {"entities": []}], ["The hemodynamic profiles and incidence of complications were clinically similar among the groups, but Group O/70 tended to show a lower rate of complications of apnea.", {"entities": []}], ["Adverse drug reactions (ADR's) could be expected more frequently in pregnant women.", {"entities": []}], ["This study was performed in order to identify ADR's to tocolytic drugs in hospitalised pregnant women.", {"entities": []}], ["A prospective cohort study was performed in two General Hospitals of the Instituto Mexicano del Seguro Social (IMSS) in Mexico City.", {"entities": []}], ["Two hundred and seven women undergoing labor, premature labor, threatened abortion or suffering any obstetric related disease were included.", {"entities": []}], ["Drug prescription and signs and symptoms of any potential ADR were registered daily during the hospital stay.", {"entities": []}], ["Any potential ADR to tocolytic drugs was evaluated and classified by three of the authors using the Kramer's algorithm.", {"entities": []}], ["Of the 207 patients, an ADR was positively classified in 25 cases (12.1%, CI95% 8.1 to 17.5%).", {"entities": []}], ["All ADR's were classified as minor reactions.", {"entities": []}], ["Grouping patients with diagnosis of threatened abortion, premature labor or under labor (n= 114), 24 ADR's were related to terbutaline, accounting for a rate of 21.1 ADR's per 100 obstetric patients.", {"entities": []}], ["Obstetric patients suffering an ADR were older than obstetric patients without any ADR.", {"entities": []}], ["However, the former received less drugs/day \u00d7 patient Terbutaline, used as a tocolytic drug, was related to a high frequency of minor ADRs and to a high rate of effcicacy.", {"entities": []}], ["Some patients share characteristics of both COPD and asthma.", {"entities": [[53, 59, "DISEASE"]]}], ["As yet, there is no gold standard to identify patients with the so-called asthma\u2013COPD overlap syndrome (ACOS).", {"entities": [[94, 102, "DISEASE"], [74, 80, "DISEASE"]]}], ["To describe the differences between ACOS patients and the remaining COPD patients, and to compare the clinical characteristics of patients diagnosed with ACOS by two different criteria: previous diagnosis of asthma before the age of 40 years; and the diagnostic criteria of the Spanish guidelines of COPD.", {"entities": [[208, 214, "DISEASE"]]}], ["Multicenter, observational, cross-sectional study performed in 3,125 COPD patients recruited in primary care and specialized outpatient clinics.", {"entities": []}], ["Patients with COPD and a history of asthma before the age of 40 years were diagnosed with ACOS and compared to the remaining COPD patients.", {"entities": [[36, 42, "DISEASE"]]}], ["Subsequently, ACOS patients were subdivided based on whether they fulfilled the Spanish guidelines of the COPD diagnostic criteria or not, and they were compared.", {"entities": []}], ["ACOS was diagnosed in 15.9% of the patients.", {"entities": []}], ["These patients had different basal characteristics compared to the remaining COPD patients, including a higher frequency of women and more exacerbations despite lower tobacco exposure and better lung function.", {"entities": []}], ["They were more likely to have features of asthma, such as a positive bronchodilator test, higher peripheral eosinophilia, and higher total immunoglobulin E. Within the ACOS group, only one-third fulfilled the diagnostic criteria of the Spanish guidelines of COPD; these individuals were not significantly different from the remaining ACOS patients, except for having more exacerbations and poorer lung function.", {"entities": [[108, 120, "DISEASE"], [42, 48, "DISEASE"]]}], ["ACOS patients diagnosed on the basis of a previous diagnosis of asthma differed from the remaining COPD patients, but they were similar to ACOS patients diagnosed according to more restrictive criteria, suggesting that a history of asthma before the age of 40 years could be a useful criterion to suspect ACOS in a patient with COPD.", {"entities": [[64, 70, "DISEASE"], [232, 238, "DISEASE"]]}], ["To determine the effect of a model osteoarthritis (OA) consultation (MOAC) informed by National Institute for Health and Care Excellence (NICE) recommendations compared with usual care on recorded quality of care of clinical OA in general practice.", {"entities": [[35, 49, "DISEASE"]]}], ["Two-arm cluster randomised controlled trial.", {"entities": []}], ["Eight general practices in Cheshire, Shropshire, or Staffordshire UK.", {"entities": []}], ["General practitioners and nurses with patients consulting with clinical OA.", {"entities": []}], ["Following six-month baseline period practices were randomised to intervention ( n \u00a0=\u00a04) or usual care ( n \u00a0=\u00a04).", {"entities": []}], ["Intervention practices delivered MOAC (enhanced initial GP consultation, nurse-led clinic, OA guidebook) to patients aged \u226545 years consulting with clinical OA.", {"entities": []}], ["An electronic (e-)template for consultations was used in all practices to record OA quality care indicators.", {"entities": []}], ["Quality of OA care over six months recorded in the medical record.", {"entities": []}], ["1851 patients consulted in baseline period (1015 intervention; 836 control); 1960 consulted following randomisation (1118 intervention; 842 control).", {"entities": []}], ["At baseline wide variations in quality of care were noted.", {"entities": []}], ["Post-randomisation increases were found for written advice on OA (4\u201328%), exercise (4\u201322%) and weight loss (1\u201315%) in intervention practices but not controls (1\u20133%).", {"entities": []}], ["Intervention practices were more likely to refer to physiotherapy (10% vs 2%, odds ratio 5.30; 95% CI 2.11, 13.34), and prescribe paracetamol (22% vs 14%, 1.74; 95% CI 1.27, 2.38).", {"entities": []}], ["The intervention did not improve all aspects of care but increased core NICE recommendations of written advice on OA, exercise and weight management.", {"entities": []}], ["There remains a need to reduce variation and uniformly enhance improvement in recorded OA care.", {"entities": []}], ["ISRCTN06984617.", {"entities": []}], ["Fatal anaphylaxis in humans is rare and unpredictable.", {"entities": []}], ["We note a trend to provide allergic individuals with care plans that recommend immediate use of epinephrine autoinjectors if allergen ingestion is suspected, even in the absence of any allergic symptoms, without any supporting evidence base.", {"entities": []}], ["Instructions to use an autoinjector device, irrespective of reaction severity and especially when symptoms are actually absent, are likely to add to parental and patient anxiety.", {"entities": []}], ["Of greater concern is the possibility of epinephrine being administered \u201ctoo early\u201d to treat initial, mild symptoms that then progress to severe anaphylaxis.", {"entities": []}], ["It is not hard to visualize a scenario where one or both epinephrine autoinjectors have been deployed for mild symptoms, yet the reaction progresses to a severe reaction and no further epinephrine is available for administration.", {"entities": []}], ["Epinephrine needs to be available as a rescue treatment for anaphylaxis, potentially buying valuable minutes while emergency medical services are activated to attend.", {"entities": []}], ["Food-allergic individuals and their carers need to be provided with more constructive strategies and support than merely being told to \u201cuse your pen.\u201d", {"entities": []}], ["Over the past decade technological advances in the realm of ultrasound have allowed what was once a cumbersome and large machine to become essentially hand-held.", {"entities": []}], ["This coupled with a greater understanding of lung sonography has revolutionized our bedside assessment of patients.", {"entities": []}], ["Using ultrasound not as a diagnostic test, but instead as a component of the physical exam, may allow it to become the stethoscope of the 21", {"entities": []}], ["Animal-based remedies constitute an integral part of Traditional Medicine and this is true in Brazil as well both in rural and urban areas of the country.", {"entities": []}], ["Due to its long history, zootherapy has in fact become an integral part of folk medicine in the country.", {"entities": []}], ["The use of these natural resources for medical purposes, however, is not restricted to human diseases treatment, being also widely used for the treatment of animal illnesses.", {"entities": []}], ["Ethnoveterinary is a science that involves the popular practical knowledge used to treat and prevent animal diseases.", {"entities": []}], ["This study documents ethnoveterinary practices in one local semi-arid region in Northeast Brazil and discusses the findings in the surveyed area.", {"entities": []}], ["Information was obtained through the use of semi-structured questionnaires.", {"entities": []}], ["A total of 20 respondents (09 men and 11 women) provided information on animal species and body parts used as medicine, information concerning the illnesses to which the remedies were prescribed were also obtained.", {"entities": []}], ["Eleven animal species were used in the treatment of 11 diseases in the surveyed area.", {"entities": []}], ["The species inventoried comprise 3 taxonomic categories: mammals (05), reptiles (04) and birds (02).", {"entities": []}], ["The obtained results proves that the use of animals or their derived products as therapeutic resources to the treatment of animal diseases represent a common practice and is culturally important in the studied area.", {"entities": []}], ["It is evident that the popular knowledge about the ethnoveterinary practices is, frequently, passed through generations.", {"entities": []}], ["We also noticed that, besides the cultural aspects, the socio-economic context permeates the use of zootherapics, since these practices constitute an alternative to the medicines acquired in veterinarian pharmacies, which have a high cost.", {"entities": []}], ["Myocardial infarction due to nonatherosclerotic coronary thrombosis in young woman with ulcerative colitis is rare.", {"entities": [[48, 67, "DISEASE"], [88, 106, "DISEASE"]]}], ["A 23-year-old Chinese woman with a 3-year history of ulcerative colitis was admitted to the coronary care unit due to prolonged chest pain.", {"entities": [[53, 71, "DISEASE"]]}], ["Myocardial infarction due to nonatherosclerotic coronary thrombosis was diagnosed in this young woman.", {"entities": [[48, 67, "DISEASE"]]}], ["Coronary artery thrombosis in ulcerative colitis is a serious condition and can occur in the young population.", {"entities": [[30, 48, "DISEASE"]]}], ["The aim of this study was to explore the prevalence of type I allergic diseases in patients with breast cancer by carrying out a questionnaire survey and IgE detection in a healthy population and in patients with breast cancer.", {"entities": [[97, 110, "DISEASE"], [213, 226, "DISEASE"], [104, 110, "DISEASE"], [220, 226, "DISEASE"]]}], ["There were 309 patients enrolled and they were further divided into the type I allergic disease group, the newly diagnosed breast cancer with type I allergic disease group, the re-visit breast cancer with type I allergic disease group, and the re-visit breast cancer without type I allergic disease group, as well as a healthy control group.", {"entities": [[123, 136, "DISEASE"], [186, 199, "DISEASE"], [253, 266, "DISEASE"], [130, 136, "DISEASE"], [193, 199, "DISEASE"], [260, 266, "DISEASE"]]}], ["Serum total IgE level was detected by immunoassay.", {"entities": []}], ["The IgE value in the healthy population with type I allergic diseases (89.3\u00b151.4 IU/ml) was significantly higher than in those without type I allergic diseases (45.6\u00b165.1 IU/ml).", {"entities": []}], ["There was no significant difference between IgE values in the re-visit breast cancer patients with type I allergic disease (25.1\u00b165.1 IU/ml) and those without type I allergic disease (23.0\u00b145.9 IU/ml).", {"entities": [[71, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["The area under the ROC curve was 0.618\u00b10.04, sensitivity was 78%, specificity was 47.1%, Youden index was 0.251, and IgE threshold was 32.6 IU/ml.", {"entities": []}], ["The patients with newly diagnosed breast cancer were susceptible to type I allergic disease at about the same levels as in the healthy population.", {"entities": [[34, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["There was no correlation between breast cancer and type I allergic disease.", {"entities": [[33, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["The thrombin-induced polymerisation of fibrinogen to form fibrin is well established as a late stage of blood clotting.", {"entities": []}], ["It is known that Parkinson\u2019s Disease (PD) is accompanied by dysregulation in blood clotting, but it is less widely known as a coagulopathy.", {"entities": []}], ["In recent work, we showed that the presence of tiny amounts of bacterial lipopolysaccharide (LPS) in healthy individuals could cause clots to adopt an amyloid form, and this could be observed via scanning electron microscopy (SEM) or via the fluorescence of thioflavin-T.", {"entities": []}], ["This could be prevented by the prior addition of lipopolysaccharide-binding protein (LBP).", {"entities": [[85, 88, "GENE"]]}], ["We had also observed by SEM this unusual clotting in the blood of patients with Parkinson\u2019s Disease.", {"entities": []}], ["We hypothesised, and here show, that this too can be prevented by LBP in the context of PD.", {"entities": [[66, 69, "GENE"]]}], ["This adds further evidence implicating inflammatory microbial cell wall products as an accompaniment to the disease, and may be part of its aetiology.", {"entities": []}], ["This may lead to novel treatment strategies in PD designed to target microbes and their products.", {"entities": []}], ["The purpose of this study was to establish a prediction rule for severe illness in adult patients hospitalized with pandemic influenza A (H1N1) 2009.", {"entities": [[125, 134, "DISEASE"]]}], ["At the time of initial presentation, the baseline characteristics of those with severe illness (i.e., admission to intensive care unit, mechanical ventilation, or death) were compared to those of patients with non-severe illnesses.", {"entities": []}], ["A total of 709 adults hospitalized with pandemic influenza A (H1N1) 2009 were included: 75 severe and 634 non-severe cases.", {"entities": [[49, 58, "DISEASE"]]}], ["The multivariate analysis demonstrated that altered mental status, hypoxia (PaO 2 /FiO 2 \u2264 250), bilateral lung infiltration, and old age (\u2265 65 yr) were independent risk factors for severe cases (all P < 0.001).", {"entities": []}], ["The area under the ROC curve (0.834 [95% CI, 0.778-0.890]) of the number of risk factors were not significantly different with that of APACHE II score (0.840 [95% CI, 0.790-0.891]) ( P = 0.496).", {"entities": []}], ["The presence of \u2265 2 risk factors had a higher sensitivity, specificity, positive predictive value and negative predictive value than an APACHE II score of \u2265 13.", {"entities": []}], ["As a prediction rule, the presence of \u2265 2 these risk factors is a powerful and easy-to-use predictor of the severity in adult patients hospitalized with pandemic influenza A (H1N1) 2009.", {"entities": [[162, 171, "DISEASE"]]}], ["The prevalence of dietary supplements has increased in Japan, and, as a consequence, the adverse events associated with dietary supplement use have become more prominent.", {"entities": []}], ["Severe adverse events must be reported to the Japanese government via public health centers.", {"entities": []}], ["However, the number of cases reported to the Japanese government is limited.", {"entities": []}], ["To clarify this discrepancy, we conducted an internet questionnaire, and surveyed how consumers, physicians and pharmacists acted when they or their patients developed adverse events due to dietary supplement use.", {"entities": []}], ["This study was completed by 2732 consumers, 515 physicians, and 515 pharmacist via internet surveillance on November 2015.", {"entities": []}], ["Although 8.8% of consumers developed adverse events including diarrhea, constipation, stomachache, headache, and nausea and vomiting, most of them did not report their adverse events to public health centers.", {"entities": [[72, 84, "DISEASE"], [62, 70, "DISEASE"]]}], ["However, some consumers went to hospitals because of adverse events.", {"entities": []}], ["We also surveyed how physicians and pharmacists acted when their patients developed adverse events due to dietary supplement use.", {"entities": []}], ["Most physicians and pharmacists did not report these cases to public health centers because they were unable to definitively prove the cause-and-effect relationship of these adverse events.", {"entities": []}], ["Furthermore, some physicians and pharmacists did not know how or where to report these adverse events.", {"entities": []}], ["We clarified the reasons for the limited number of reports of adverse events to the Japanese government in this survey.", {"entities": []}], ["It is important to encourage not only consumers, but also physicians and pharmacists to report adverse events to public health centers.", {"entities": []}], ["In addition, an analyzing tool of cause-and-effect relationships might be helpful for physicians and pharmacists.", {"entities": []}], ["The online version of this article (doi:10.1186/s12937-017-0239-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Transferrin receptor (TfR) is expressed in most lung cancers and is an indicator of poor prognosis in certain groups of patients.", {"entities": []}], ["In this study, we blocked cell surface TfR to inhibit lung adenocarcinoma (LAC) cell growth in vitro and investigated the associated molecular mechanisms to determine a potential therapeutic target in human LAC.", {"entities": [[59, 73, "DISEASE"], [54, 73, "DISEASE"]]}], ["RNA interference and antibody blocking techniques were used to block the function of TfR in LAC cells, and cell proliferation assays were used to detect the results.", {"entities": []}], ["Affymetrix microarray analysis was conducted using H1299 cells in which TfR was blocked with an antibody to investigate the molecular mechanisms involved.", {"entities": []}], ["The cell proliferation assay demonstrated that H1299 cell proliferation was significantly inhibited after small interfering RNA knockdown or blocking of TfR.", {"entities": []}], ["Mechanistic studies found that 100 genes were altered more than two\u2010fold after TfR was blocked and that blocking TfR was accompanied by decreased expression of the oncogene KRAS.", {"entities": []}], ["Our data provide evidence that blocking TfR could significantly inhibit LAC proliferation by targeting the oncogene KRAS ; therefore, TfR may be a therapeutic target for LAC.", {"entities": []}], ["In addition, our results suggest a new method for blocking the signal from the oncogene KRAS by targeting TfR in LAC.", {"entities": []}], ["The Behavioral Risk Factor Surveillance System (BRFSS) is a network of health-related telephone surveys--conducted by all 50 states, the District of Columbia, and participating US territories\u2014that receive technical assistance from CDC.", {"entities": []}], ["Data users often aggregate BRFSS state samples for national estimates without accounting for state-level sampling, a practice that could introduce bias because the weighted distributions of the state samples do not always adhere to national demographic distributions.", {"entities": []}], ["This article examines six methods of reweighting, which are then compared with key health indicator estimates from the National Health Interview Survey (NHIS) based on 2013 data.", {"entities": []}], ["Compared to the usual stacking approach, all of the six new methods reduce the variance of weights and design effect at the national level, and some also reduce the estimated bias.", {"entities": []}], ["This article also provides a comparison of the methods based on the variances induced by unequal weighting as well as the bias reduction induced by raking at the national level, and recommends a preferred method.", {"entities": []}], ["The new method leads to weighted distributions that more accurately reproduce national demographic characteristics.", {"entities": []}], ["While the empirical results for key estimates were limited to a few health indicators, they also suggest reduction in potential bias and mean squared error.", {"entities": []}], ["To the extent that survey outcomes are associated with these demographic characteristics, matching the national distributions will reduce bias in estimates of these outcomes at the national level.", {"entities": []}], ["To explore what it means for patients to live with chronic obstructive pulmonary disease (COPD) as an incurable and constantly progressing disease.", {"entities": [[51, 88, "DISEASE"]]}], ["Qualitative longitudinal study using narrative and semistructured interviews.", {"entities": []}], ["This paper presents findings of the initial interviews.", {"entities": []}], ["Analysis using grounded theory.", {"entities": []}], ["Lung care clinics and community care in Lower Saxony, Germany.", {"entities": []}], ["17 patients with advanced-stage COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) III/IV).", {"entities": []}], ["Analysis shows that these patients have difficulties accepting their life situation and feel at the mercy of the disease, which could be identified as a core-experienced phenomenon.", {"entities": []}], ["Over a long period of time, patients have only a vague feeling of being ill, caused by uncertain knowledge, slow progress and doubtful attribution of clinical symptoms of the disease (causal conditions).", {"entities": []}], ["As an action strategy, patients try to maintain daily routines for as long as possible after diagnosis.", {"entities": []}], ["Both effective standard and rescue medication, which helps to reduce breathlessness and other symptoms, and the feeling of being faced with one's own responsibility (intervening conditions) support this strategy, whereby patients' own responsibility is too painful to acknowledge.", {"entities": []}], ["As a consequence, patients try to deny the threat to life for a long period of time.", {"entities": []}], ["Frequently, they need to experience facing their own limits, often in the form of an acute crisis, to realise their health situation.", {"entities": []}], ["The experience of the illness is contextualised by a continuous increase in limited mobility and social isolation.", {"entities": []}], ["In order to help patients to improve disease awareness, to accept their life situation and to improve their reduced quality of life, patients may benefit from the early integration of palliative care (PC), considering its multiprofessional patient-centred and team-centred approach.", {"entities": [[201, 203, "GENE"]]}], ["Psychological support and volunteer work, which are relevant aspects of PC, should be appropriate to address psychosocial needs.", {"entities": [[72, 74, "GENE"]]}], ["More research is needed to evaluate how patients could benefit from early PC.", {"entities": [[74, 76, "GENE"]]}], ["Exposure to secondhand smoke (SHS) from burning tobacco causes disease and death in nonsmoking children and adults.", {"entities": []}], ["No risk-free level of SHS exposure exists.", {"entities": []}], ["National Health and Nutrition Examination Survey (NHANES) data from 1999\u20132012 were used to examine SHS exposure among the nonsmoking population aged \u22653 years.", {"entities": []}], ["SHS exposure among nonsmokers was defined as a serum cotinine level (a metabolite of nicotine) of 0.05\u201310 ng/mL.", {"entities": []}], ["SHS exposure was assessed overall and by age, sex, race/ethnicity, poverty level, education, and whether the respondent owned or rented their housing.", {"entities": []}], ["Prevalence of SHS exposure in nonsmokers declined from 52.5% during 1999\u20132000 to 25.3% during 2011\u20132012.", {"entities": []}], ["During this period, declines were observed for all population subgroups, but disparities exist.", {"entities": []}], ["During 2011\u20132012, SHS was highest among: children aged 3\u201311 years (40.6%), non-Hispanic blacks (46.8%), persons living below the poverty level (43.2%), and persons living in rental housing (36.8%).", {"entities": []}], ["Among children aged 3\u201311 years, 67.9% of non-Hispanic blacks were exposed to SHS compared with 37.2% of non-Hispanic whites and 29.9% of Mexican Americans.", {"entities": []}], ["Overall, SHS exposure in the United States has been reduced by half since 1999\u20132000.", {"entities": []}], ["However, 58 million persons were still exposed to SHS during 2011\u20132012, and exposure remains higher among children, non-Hispanic blacks, those living in poverty, and those who rent their housing.", {"entities": []}], ["Eliminating smoking in indoor spaces fully protects nonsmokers from SHS exposure; separating smokers from nonsmokers, cleaning the air and ventilating buildings cannot completely eliminate exposure.", {"entities": []}], ["Continued efforts to promote implementation of comprehensive statewide laws prohibiting smoking in workplaces and public places, smoke-free policies in multiunit housing, and voluntary smoke-free home and vehicle rules are critical to protect nonsmokers from this preventable health hazard in the places they live, work, and gather.", {"entities": []}], ["Tuberculosis (TB) remains a significant global health concern and its diagnosis is challenging due to the limitations in the specificity and sensitivity of the current diagnostic tests.", {"entities": []}], ["Exosomes are bioactive 30\u2013100\u00a0nm vesicles produced by most cell types and are found in almost all human body fluids.", {"entities": []}], ["Exosomal microRNAs (miRNAs) can transfer biological information between cells and tissues and may act as potential biomarkers in many diseases.", {"entities": []}], ["In this pilot study, we assessed the miRNA profile of exosomes released from human monocyte-derived macrophages upon infection with Mycobacterium bovis Bacillus Calmette\u2013Guerin (BCG).", {"entities": []}], ["Human monocytes were obtained from the peripheral blood of three healthy subjects and driven to a monocyte-derived macrophage (MDM) phenotype using standard protocols.", {"entities": []}], ["MDMs were infected with BCG or left uninfected as control.", {"entities": []}], ["72\u00a0h post-infection, exosomes were collected from the cell culture medium, RNA was isolated and RNA-seq performed.", {"entities": []}], ["The raw reads were filtered to eliminate adaptor and primer sequences and the sequences were run against the mature human miRNA sequences available in miRBase.", {"entities": []}], ["MicroRNAs were identified using an E value <0.01.", {"entities": []}], ["miRNA network analysis was performed using the DIANA miRNA tool, miRDB and functional KEGG pathway analysis.", {"entities": []}], ["Infection of MDMs with BCG leads to the release of several exosomal miRNAs.", {"entities": []}], ["These included miR-1224, -1293, -425, -4467, -4732, -484, -5094, -6848-6849, -4488 and -96 all of which were predicted to target metabolism and energy production-related pathways.", {"entities": []}], ["This study provides evidence for the release of specific exosomal miRNAs from BCG-infected MDMs.", {"entities": []}], ["These exosomal miRNAs reflect host-pathogen interaction and subversion of host metabolic processes following infection.", {"entities": []}], ["Human T\u2010lymphotropic virus ( HTLV )\u20101 causes T\u2010cell leukaemia and myelopathy.", {"entities": []}], ["Together with HTLV \u20102, it is endemic in some African nations.", {"entities": []}], ["Seroprevalence data from Malawi are scarce, with no reports on associated disease incidence.", {"entities": []}], ["HTLV seroprevalence and type were tested in 418 healthy mothers from Malawi.", {"entities": []}], ["In addition, we tested the sera of 534 children to investigate mother\u2010to\u2010child transmission.", {"entities": []}], ["To provide context, we conducted a systematic review and meta\u2010analysis of HTLV seroprevalence in African women and children.", {"entities": []}], ["Stored samples from a previous childhood cancer and BBV study were analysed.", {"entities": [[41, 47, "DISEASE"]]}], ["ELISA was used for HTLV screening followed by immunoblot for confirmation and typing.", {"entities": []}], ["Standard methods were used for the systematic review.", {"entities": []}], ["HTLV seroprevalence was 2.6% (11/418) in mothers and 2.2% (12/534) in children.", {"entities": []}], ["Three mothers carried HTLV \u20101 alone, seven had HTLV \u20102 and one was dually infected.", {"entities": []}], ["Three children carried HTLV \u20101 alone, seven had HTLV \u20102 and two were dually infected.", {"entities": []}], ["Only two corresponding mothers of the 12 HTLV \u2010positive children were HTLV positive.", {"entities": []}], ["The systematic review included 66 studies of women and 13 of children conducted in 25 African countries.", {"entities": []}], ["Seroprevalence of HTLV \u20101 varied from 0 to 17% and of HTLV \u20102 from 0 to 4%.", {"entities": []}], ["In contrast to findings from other studies in Africa, the seroprevalence of HTLV \u20102 was higher than that of HTLV \u20101 in Malawi and one of the highest for the African region.", {"entities": []}], ["The lack of mother\u2013child concordance suggests alternative sources of infection among children.", {"entities": []}], ["Our data and analyses contribute to HTLV prevalence mapping in Africa.", {"entities": []}], ["Implicit biases involve associations outside conscious awareness that lead to a negative evaluation of a person on the basis of irrelevant characteristics such as race or gender.", {"entities": []}], ["This review examines the evidence that healthcare professionals display implicit biases towards patients.", {"entities": []}], ["PubMed, PsychINFO, PsychARTICLE and CINAHL were searched for peer-reviewed articles published between 1st March 2003 and 31st March 2013.", {"entities": []}], ["Two reviewers assessed the eligibility of the identified papers based on precise content and quality criteria.", {"entities": []}], ["The references of eligible papers were examined to identify further eligible studies.", {"entities": []}], ["Forty two articles were identified as eligible.", {"entities": []}], ["Seventeen used an implicit measure (Implicit Association Test in fifteen and subliminal priming in two), to test the biases of healthcare professionals.", {"entities": []}], ["Twenty five articles employed a between-subjects design, using vignettes to examine the influence of patient characteristics on healthcare professionals\u2019 attitudes, diagnoses, and treatment decisions.", {"entities": []}], ["The second method was included although it does not isolate implicit attitudes because it is recognised by psychologists who specialise in implicit cognition as a way of detecting the possible presence of implicit bias.", {"entities": []}], ["Twenty seven studies examined racial/ethnic biases; ten other biases were investigated, including gender, age and weight.", {"entities": []}], ["Thirty five articles found evidence of implicit bias in healthcare professionals; all the studies that investigated correlations found a significant positive relationship between level of implicit bias and lower quality of care.", {"entities": []}], ["The evidence indicates that healthcare professionals exhibit the same levels of implicit bias as the wider population.", {"entities": []}], ["The interactions between multiple patient characteristics and between healthcare professional and patient characteristics reveal the complexity of the phenomenon of implicit bias and its influence on clinician-patient interaction.", {"entities": []}], ["The most convincing studies from our review are those that combine the IAT and a method measuring the quality of treatment in the actual world.", {"entities": []}], ["Correlational evidence indicates that biases are likely to influence diagnosis and treatment decisions and levels of care in some circumstances and need to be further investigated.", {"entities": []}], ["Our review also indicates that there may sometimes be a gap between the norm of impartiality and the extent to which it is embraced by healthcare professionals for some of the tested characteristics.", {"entities": []}], ["Our findings highlight the need for the healthcare profession to address the role of implicit biases in disparities in healthcare.", {"entities": []}], ["More research in actual care settings and a greater homogeneity in methods employed to test implicit biases in healthcare is needed.", {"entities": []}], ["Air pollution in Darwin, Northern Australia, is dominated by smoke from seasonal fires in the surrounding savanna that burn during the dry season from April to November.", {"entities": []}], ["Our aim was to study the association between particulate matter less than or equal to 10 microns diameter (PM 10 ) and daily emergency hospital admissions for cardio-respiratory diseases for each fire season from 1996 to 2005.", {"entities": []}], ["We also investigated whether the relationship differed in indigenous Australians; a disadvantaged population sub-group.", {"entities": []}], ["Daily PM 10 exposure levels were estimated for the population of the city from visibility data using a previously validated model.", {"entities": []}], ["We used over-dispersed Poisson generalized linear models with parametric smoothing functions for time and meteorology to examine the association between admissions and PM 10 up to three days prior.", {"entities": []}], ["An interaction between indigenous status and PM 10 was included to examine differences in the impact on indigenous people.", {"entities": []}], ["We found both positive and negative associations and our estimates had wide confidence intervals.", {"entities": []}], ["There were generally positive associations between respiratory disease and PM 10 but not with cardiovascular disease.", {"entities": []}], ["An increase of 10 \u03bcg/m 10 was associated with a 4.81% (95%CI: -1.04%, 11.01%) increase in total respiratory admissions.", {"entities": []}], ["When the interaction between indigenous status and PM 10 was assessed a statistically different association was found between PM 10 and admissions three days later for respiratory infections of indigenous people (15.02%; 95%CI: 3.73%, 27.54%) than for non-indigenous people (0.67%; 95%CI: -7.55%, 9.61%).", {"entities": []}], ["There were generally negative estimates for cardiovascular conditions.", {"entities": []}], ["For non-indigenous admissions the estimated association with total cardiovascular admissions for same day ambient PM 10 and admissions was -3.43% (95%CI: -9.00%, 2.49%) and the estimate for indigenous admissions was -3.78% (95%CI: -13.4%, 6.91%), although ambient PM 10 did have positive (non-significant) associations with cardiovascular admissions of indigenous people two and three days later.", {"entities": []}], ["We observed positive associations between vegetation fire smoke and daily hospital admissions for respiratory diseases that were stronger in indigenous people.", {"entities": []}], ["While this study was limited by the use of estimated rather than measured exposure data, the results are consistent with the currently small evidence base concerning this source of air pollution.", {"entities": []}], ["Articles in the literature on alpha-1 antitrypsin (AAT) deficiency have been interpreted as indicating that AAT deficiency is a rare disease that affects mainly Caucasians (whites) from northern Europe.", {"entities": []}], ["In a recent publication on the worldwide racial and ethnic distribution of AAT deficiency, new data were presented demonstrating that it is also found in various populations of African blacks; Arabs and Jews in the Middle East; and Central, Far East, and Southeast Asians, as well as whites in Australia, Europe, New Zealand, and North America.", {"entities": []}], ["The new data on the prevalence of AAT deficiency in other major racial groups worldwide will affect the standards for the diagnosis of AAT deficiency by the medical community, with the realization that is not a rare disease of whites in northern Europe and immigrants from these countries in the New World.", {"entities": []}], ["In a total population of 4.4 billion in the 58 countries surveyed, there are at least 116 million carriers (those with Pi phenotypes PiMS and PiMZ) and 3.4 million with deficiency allele combinations (phenotypes PiSS, PiSZ, and PiZZ) for the two most prevalent deficiency alleles PiS and PiZ; therefore, the new data suggest that AAT deficiency may be one of the most common serious single-locus genetic diseases in the world.", {"entities": []}], ["Particularly important is the unique susceptibility of AAT-deficient individuals to exposure to chemical and particulate environmental agents.", {"entities": []}], ["Such exposures are known to result in both lung and liver disease as well as other adverse health effects.", {"entities": [[52, 65, "DISEASE"]]}], ["Vitamin D receptor (VDR) gene Fok I polymorphism have been studied in relation to tuberculosis (TB) in many populations and provided inconsistent results.", {"entities": [[82, 94, "DISEASE"], [20, 23, "GENE"]]}], ["In this study, we carried out a meta-analysis to derive a more reliable assessment on Fok I polymorphism and the risk of HIV-negative TB.", {"entities": []}], ["The Embase, PubMed, and Cochrane Library databases were used to undertake a comprehensive systematic literature review of all current published VDR gene FOKI association studies aimed at the risk of TB up to June 30, 2015.", {"entities": [[144, 147, "GENE"]]}], ["Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to measure the strength of the models.", {"entities": []}], ["A total of 14 studies (1,668 cases and 1,893 controls) were retrieved in the meta-analysis.", {"entities": []}], ["The pooled OR was 1.60 (95% = 1.28\u20131.97, P <0.001; I P = 0.141 for heterogeneity) in the best genetic model (recessive model: ff vs. fF+FF).", {"entities": []}], ["In the subgroup analysis by ethnicities, a significantly increased risk was found in the Asian group (OR = 1.82, 95% CI = 1.42\u20132.33, P <0.001; I P = 0.150 for heterogeneity) in the recessive model.", {"entities": []}], ["Similarly, significant associations were also found in the polymerase chain reaction-restriction fragment length polymorphism group, high-quality studies, and the population based or hospital based groups.", {"entities": []}], ["Moderate heterogeneity was found in this study.", {"entities": []}], ["Our results suggested that VDR Fok I polymorphism contributes to increasing the risk of TB in HIV-negative individuals, especially in the Asian region.", {"entities": [[27, 30, "GENE"]]}], ["Further studies on this topic in other races are expected to be conducted in future.", {"entities": []}], ["Desert dermatology describes the cutaneous changes and the diseases affecting those living in the desert.", {"entities": []}], ["Diurnal variation in temperature is high and is characteristic of the deserts.", {"entities": []}], ["The lack of water affects daily activities and impacts dermatological conditions.", {"entities": []}], ["Adaptation to the desert is, therefore, important to survival.", {"entities": []}], ["Infections are the most common conditions seen among this population, and among them, fungal infections are the most common.", {"entities": []}], ["The high incidence of these infections would be accounted for by the poor hygienic conditions due to lack of bathing facilities due to scarcity of water and the consequent sweat retention and overgrowth of cutaneous infective organisms.", {"entities": []}], ["Pigmentary disorders, photodermatoses, leishmaniasis, and skin tumors are found to be more prevalent in this region.", {"entities": [[39, 52, "DISEASE"]]}], ["Desert sweat dermatitis was another specific condition found to have an increased incidence.", {"entities": [[13, 23, "DISEASE"]]}], ["The environment of the desert provides for a wide variety of dermatoses that can result in these regions with few of these dermatoses found in much higher incidence than in other regions.", {"entities": []}], ["Subclinical atherosclerosis has been recently detected in adolescents with a family history of premature atherosclerosis.", {"entities": [[12, 27, "DISEASE"], [105, 120, "DISEASE"]]}], ["However, no studies in the literature have assessed the cardiac autonomic functions of these adolescents.", {"entities": []}], ["The aim of this study was to evaluate the cardiac autonomic functions of adolescents with a family history of premature atherosclerosis compared with those of age- and gender-matched adolescents without a family history of atherosclerosis.", {"entities": [[120, 135, "DISEASE"], [223, 238, "DISEASE"]]}], ["We evaluated the cardiac autonomic functions of 36 adolescents with a family history of premature atherosclerosis (Group 1) and compared them with those of 31 age- and gender-matched adolescents whose parents did not have premature atherosclerosis (Group 2).", {"entities": [[98, 113, "DISEASE"], [232, 247, "DISEASE"]]}], ["Twenty-four-hour time domain (standard deviation of all normal sinus RR intervals [SDNN], standard deviation of the mean of normal RR intervals in each 5-minute segment [SDANN], root-mean-square differences in successive RR intervals) and frequency domain (very low frequency, low frequency, high frequency, low frequency/high frequency) parameters of heart rate variability were used for the evaluation of cardiac autonomic functions.", {"entities": []}], ["There were no differences in the time and frequency domain parameters of heart rate variability between the two groups.", {"entities": []}], ["Heart rate was negatively correlated with SDNN (r\u200a=\u200a-0.278, p \u200a=\u200a0.035), while age was significantly correlated with root-mean-square differences in successive RR intervals, high frequency, low frequency and low frequency/high frequency (r\u200a=\u200a-0.264, -0.370, 0.265 and 0.374, respectively; p <0.05 for all).", {"entities": []}], ["We found that the cardiac autonomic functions of adolescents with a family history of premature atherosclerosis were not different compared with those of adolescents without a positive family history of premature atherosclerosis.", {"entities": [[96, 111, "DISEASE"], [213, 228, "DISEASE"]]}], ["It appears that subclinical atherosclerosis does not reach a critical value such that it can alter cardiac autonomic functions in adolescence.", {"entities": [[28, 43, "DISEASE"]]}], ["Physicians have recognized for more than a century that alcohol use is associated with infections and that alcoholics are especially at risk for pneumonia.", {"entities": [[145, 154, "DISEASE"]]}], ["Clear evidence now indicates that alcohol has a systemic effect on every organ.", {"entities": []}], ["This review first presents a clinical case to describe a patient with immunity issues complicated by alcohol use\u2014a setting familiar to many clinicians.", {"entities": []}], ["This is followed by a description of the molecular mechanisms that explain the secondary immune deficiency produced by alcohol in the host, focusing mostly on the gut and lower respiratory mucosal immunity.", {"entities": []}], ["The goal of this review is to increase awareness of the new mechanisms being investigated to understand how alcohol affects the human immune system and the development of new strategies to attenuate adverse outcomes in the affected population.", {"entities": []}], ["While several recent large randomized trials found clinically relevant effects of acupuncture over no treatment or routine care, blinded trials comparing acupuncture to sham interventions often reported only minor or no differences.", {"entities": []}], ["This raises the question whether (sham) acupuncture is associated with particularly potent nonspecific effects.", {"entities": []}], ["We aimed to investigate the size of nonspecific effects associated with acupuncture interventions.", {"entities": []}], ["MEDLINE, Embase, Cochrane Central Register of Controlled Clinical Trials and reference lists were searched up to April 2010 to identify randomized trials of acupuncture for any condition, including both sham and no acupuncture control groups.", {"entities": []}], ["Data were extracted by one reviewer and verified by a second.", {"entities": []}], ["Pooled standardized mean differences were calculated using a random effects model with the inverse variance method.", {"entities": []}], ["Thirty-seven trials with a total of 5754 patients met the inclusion criteria.", {"entities": []}], ["The included studies varied strongly regarding patients, interventions, outcome measures, methodological quality and effect sizes reported.", {"entities": []}], ["Among the 32 trials reporting a continuous outcome measure, the random effects standardized mean difference between sham acupuncture and no acupuncture groups was -0.45 (95% confidence interval, -0.57, -0.34; I P = 0.25).", {"entities": []}], ["Trials with larger effects of sham over no acupuncture reported smaller effects of acupuncture over sham intervention than trials with smaller nonspecific effects (\u03b2 = -0.39, P = 0.029).", {"entities": []}], ["Sham acupuncture interventions are often associated with moderately large nonspecific effects which could make it difficult to detect small additional specific effects.", {"entities": []}], ["Compared to inert placebo interventions, effects associated with sham acupuncture might be larger, which would have considerable implications for the design and interpretation of clinical trials.", {"entities": []}], ["Long-acting muscarinic antagonists (LAMAs) and short-acting \u03b2 2 -adrenoceptor agonists (SABAs) play important roles in remedy for COPD.", {"entities": []}], ["To propel a translational research for development of bronchodilator therapy, synergistic effects between SABAs with LAMAs were examined focused on Ca Ca ) channels, significantly suppressed the effects of these combined agents with reducing F340/F380.", {"entities": []}], ["In conclusion, combination of SABAs with LAMAs synergistically enhances inhibition of muscarinic contraction via decreasing both Ca Ca channels.", {"entities": []}], ["PKC and K Ca channels may be molecular targets for cross talk between \u03b2 2 -adrenoceptors and muscarinic receptors.", {"entities": []}], ["to develop and assess a serious game on healthy eating and physical activity to promote health and tackle childhood obesity.", {"entities": [[116, 123, "DISEASE"]]}], ["a descriptive, applied and methodological study.For the development of the game, the following steps were taken: conceptualization, pre-production with the development of the game documentation, prototyping, production and assessment of thecomputer and health experts.", {"entities": []}], ["a prototype has been developed up to beta version.", {"entities": []}], ["The game was positively assessed both in terms of gameplay and mechanics, and in relation to the content presented, standing out as a powerful strategy for health promotion.", {"entities": []}], ["The information from the assessment phase contributed to the settings in the software in order to make it available in the future for the target population of this research.", {"entities": []}], ["The greatest advantage of the proposed game is the fact that it is an open educational resource.", {"entities": []}], ["the expert assessments showed that the game has great educational potential and it is considered suitable for future application to the target audience.The serious game can become a technological teaching resource available for use in schools and health facilities, and can also be reused for the production of other educational games by accessing its source code.", {"entities": []}], ["Bronchial epithelial cells (BEC) are primary target for Rhinovirus infection through attaching to cell membrane proteins.", {"entities": []}], ["OM-85, a bacterial extract, improves recovery of asthma and COPD patients after viral infections, but only part of the mechanism was addressed, by focusing on defined immune cells.", {"entities": [[49, 55, "DISEASE"]]}], ["We therefore determined the effect of OM-85 on isolated primary human BEC of controls (n = 8), asthma patients (n = 10) and COPD patients (n = 9).", {"entities": [[95, 101, "DISEASE"]]}], ["BEC were treated with OM-85 alone (24 hours) or infected with Rhinovirus.", {"entities": []}], ["BEC survival was monitored by manual cell counting and Rhinovirus replication by lytic activity.", {"entities": []}], ["Immuno-blotting and ELISA were used to determine the expression of Rhinovirus interacting proteins: intracellular adhesion molecule (ICAM), major histocompatibility complex class II (MHC-2), complement component C1q receptor (C1q-R), inducible T-Cell co-stimulator (ICOS), its ligand ICOSL, and myeloid differentiation primary response gene 88 (Myd88); as well as for signal transducers Erk1/2, p38, JNK mitogen activated protein kinases MAPK), and cAMP.", {"entities": [[266, 270, "GENE"], [345, 350, "GENE"]]}], ["OM-85 significantly reduced Rhinovirus-induced BEC death and virus replication.", {"entities": []}], ["OM-85 significantly increased the expression of virus interacting proteins C1q-R and \u03b2-defensin in all 3 probes and groups, which was prevented by either Erk1/2 MAPK or cAMP inhibition.", {"entities": []}], ["In addition, OM-85 significantly reduced Rhinovirus induced expression of ICAM1 involving p38 MAPK.", {"entities": [[74, 79, "GENE"]]}], ["In BEC OM-85 had no significant effect on the expression of ICOS, ICOSL and MHC-2 membrane proteins nor on the adaptor protein MyD88.", {"entities": [[60, 64, "GENE"], [127, 132, "GENE"]]}], ["The OM-85-induced increased of C1q-R and \u03b2-defensin, both important for antigen presentation and phagocytosis, supports its activity in host cell\u2019s defence against Rhinovirus infection.", {"entities": []}], ["The risk of bacteremia is considered low in children with acute bronchiolitis.", {"entities": [[64, 77, "DISEASE"]]}], ["However the rate of occult bacteremia in infants with RSV infection is not well established.", {"entities": []}], ["The aim was to determine the actual rate and predictive factors of bacteremia in children admitted to hospital due to confirmed RSV acute respiratory illness (ARI), using both conventional culture and molecular techniques.", {"entities": []}], ["A prospective multicenter study (GENDRES-network) was conducted between 2011\u20132013 in children under the age of two admitted to hospital because of an ARI.", {"entities": []}], ["Among those RSV-positive, bacterial presence in blood was assessed using PCR for Meningococcus , Streptococcus pneumoniae , Haemophilus influenzae , Streptococcus pyogenes , Klebsiella pneumoniae , Pseudomonas aeruginosa , Escherichia coli , and Staphylococcus aureus , in addition to conventional cultures.", {"entities": []}], ["66 children with positive RSV respiratory illness were included.", {"entities": []}], ["In 10.6% patients, bacterial presence was detected: H .", {"entities": []}], ["influenzae ( n = 4) and S .", {"entities": []}], ["pneumoniae ( n = 2).", {"entities": []}], ["In those patients with bacteremia, there was a previous suspicion of bacterial superinfection and had received empirical antibiotic treatment 6 out of 7 (85.7%) patients.", {"entities": []}], ["There were significant differences in terms of severity between children with positive bacterial PCR and those with negative results: PICU admission (100% vs. 50%, P- value = 0.015); respiratory support necessity (100% vs. 18.6%, P- value < 0.001); Wood-Downes score (mean = 8.7 vs. 4.8 points, P -value < 0.001); GENVIP scale (mean = 17 vs. 10.1, P- value < 0.001); and length of hospitalization (mean = 12.1 vs. 7.5 days, P- value = 0.007).", {"entities": []}], ["Bacteremia is not frequent in infants hospitalized with RSV respiratory infection, however, it should be considered in the most severe cases.", {"entities": []}], ["The Health Education Impact Questionnaire (heiQ) allows for the evaluation of the effects of education interventions provided to patients with chronic diseases.", {"entities": []}], ["This study describes the process for the cross-cultural adaptation and validation of the heiQ into French (heiQ-Fv).", {"entities": []}], ["We undertook a systematic translation process followed by a validation study based on the secondary analysis of cross-sectional data from a longitudinal study.", {"entities": []}], ["Participants in the validation study were adult patients from primary care clinics in Quebec, Canada, with one or more of the following diseases: diabetes, asthma, chronic obstructive pulmonary disease, cardiovascular disease; or one or more risk factors for these diseases.", {"entities": [[164, 201, "DISEASE"], [156, 162, "DISEASE"]]}], ["Main outcomes of the study were the French version of the heiQ-Fv and the validation analyses that included internal consistency, test-retest reliability, confirmatory factor analysis (CFA) and concomitant validity.", {"entities": []}], ["The validation analysis was conducted on results from 332 participants.", {"entities": []}], ["Cronbach\u2019s alphas (internal consistency) for seven domains of the heiQ-Fv varied from 0.80 to 0.89; one domain scored 0.69.", {"entities": []}], ["The test-retest analysis (n\u2009=\u200950) yielded intra-class correlation coefficients from 0.66 to 0.86.", {"entities": []}], ["The CFA of the eight heiQ domains with the hypothesis of no correlation between the domains yielded a model that did not exhibit acceptable fit values.", {"entities": []}], ["A model with the hypothesis of all domains correlated exhibited acceptable fit values (scaled chi-square\u2009=\u20091210.15, degrees of freedom\u2009=\u2009712, p\u2009<\u20090.001; CFI\u2009=\u20090.98; RMSEA\u2009=\u20090.06; SRMR\u2009=\u20090.065).", {"entities": [[153, 156, "GENE"]]}], ["Results show a moderate correlation (concomitant validity) between five domains of the heiQ-Fv and the Self-Efficacy for Managing Chronic Diseases.", {"entities": []}], ["We also found a moderate to strong correlation between the Emotional Wellbeing domain of the heiQ and the Kessler Psychological Distress Scale (K6) (r\u2009=\u20090.61; 95\u00a0% CI: 0.52 \u20130.69, p\u2009<\u20090.01).", {"entities": []}], ["The heiQ was translated into French using a rigorous translation process; the French-language version showed good psychometric properties.", {"entities": []}], ["Health professionals and researchers in primary care settings may use the heiQ-FV to evaluate the impact of educational programs on patients with chronic diseases.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-015-0254-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There is good evidence for an association between chronic obstructive pulmonary disease (COPD) and depression, but there are few studies on the relationship between COPD and suicidal ideation/suicidal attempts.", {"entities": [[50, 87, "DISEASE"]]}], ["To evaluate the mental health of patients with COPD in Korea and to compare it with that of the general population.", {"entities": []}], ["We analysed data of 15,718 subjects (age \u2a7e40 years) who participated in the 2007\u20132012 Korea National Health and Nutrition Examination Survey.", {"entities": []}], ["COPD was defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for people aged \u2a7e40 years.", {"entities": []}], ["We compared the mental health outcomes of 2,506 patients with COPD (2,355 GOLD stages I and II; 151 GOLD stages III and IV) with those of 13,212 controls.", {"entities": []}], ["Suicidal thoughts were reported by 16.0% of patients in stages I and II, by 23.8% of those in stages III and IV and by 15.7% of controls ( P =0.023).", {"entities": []}], ["Suicidal attempts were reported by 0.6% of patients in stages I and II, by 2.6% of those in stages III and IV and by 1.0% of controls ( P =0.019).", {"entities": []}], ["The crude odds ratio (OR) for suicidal ideation in those in stages III and IV was 1.68 (95% confidence interval (CI), 1.16\u20132.46), and the OR for suicidal attempts in stages III and IV was 2.83 (95% CI, 1.03\u20137.75).", {"entities": []}], ["In multivariate analysis, the OR for suicidal ideation in stages III and IV was 1.67 (95% CI, 1.12\u20132.49) and that for suicidal attempts was 2.94 (95% CI, 1.03\u20138.31).", {"entities": []}], ["GOLD stages III and IV COPD were associated with a marked increase in suicidal behaviour.", {"entities": []}], ["Named entity recognition (NER) is an important task in clinical natural language processing (NLP) research.", {"entities": []}], ["Machine learning (ML) based NER methods have shown good performance in recognizing entities in clinical text.", {"entities": []}], ["Algorithms and features are two important factors that largely affect the performance of ML-based NER systems.", {"entities": []}], ["Conditional Random Fields (CRFs), a sequential labelling algorithm, and Support Vector Machines (SVMs), which is based on large margin theory, are two typical machine learning algorithms that have been widely applied to clinical NER tasks.", {"entities": []}], ["For features, syntactic and semantic information of context words has often been used in clinical NER systems.", {"entities": []}], ["However, Structural Support Vector Machines (SSVMs), an algorithm that combines the advantages of both CRFs and SVMs, and word representation features, which contain word-level back-off information over large unlabelled corpus by unsupervised algorithms, have not been extensively investigated for clinical text processing.", {"entities": []}], ["Therefore, the primary goal of this study is to evaluate the use of SSVMs and word representation features in clinical NER tasks.", {"entities": []}], ["In this study, we developed SSVMs-based NER systems to recognize clinical entities in hospital discharge summaries, using the data set from the concept extration task in the 2010 i2b2 NLP challenge.", {"entities": []}], ["We compared the performance of CRFs and SSVMs-based NER classifiers with the same feature sets.", {"entities": []}], ["Furthermore, we extracted two different types of word representation features (clustering-based representation features and distributional representation features) and integrated them with the SSVMs-based clinical NER system.", {"entities": []}], ["We then reported the performance of SSVM-based NER systems with different types of word representation features.", {"entities": []}], ["Using the same training (N = 27,837) and test (N = 45,009) sets in the challenge, our evaluation showed that the SSVMs-based NER systems achieved better performance than the CRFs-based systems for clinical entity recognition, when same features were used.", {"entities": []}], ["Both types of word representation features (clustering-based and distributional representations) improved the performance of ML-based NER systems.", {"entities": []}], ["By combining two different types of word representation features together with SSVMs, our system achieved a highest F-measure of 85.82%, which outperformed the best system reported in the challenge by 0.6%.", {"entities": []}], ["Our results show that SSVMs is a great potential algorithm for clinical NLP research, and both types of unsupervised word representation features are beneficial to clinical NER tasks.", {"entities": []}], ["Plants that are used as traditional medicine represent a relevant pool for selecting plant candidates that may have anticancer properties.", {"entities": []}], ["In this study, the ethnomedicinal approach was used to select several medicinal plants native to Nigeria, on the basis of their local or traditional uses.", {"entities": []}], ["The collected plants were then evaluated for cytoxicity.", {"entities": []}], ["The antitumor activity of methanolic extracts obtained from 24 of the selected plants, were evaluated in vitro on five human cancer cell lines.", {"entities": [[125, 131, "DISEASE"]]}], ["Results obtained from the plants screened indicate that 18 plant extracts of folk medicine exhibited promising cytotoxic activity against human carcinoma cell lines.", {"entities": [[144, 153, "DISEASE"]]}], ["Erythrophleum suaveolens (Guill.", {"entities": []}], ["Brenan was found to demonstrate potent anti-cancer activity in this study exhibiting IC 50 = 0.2-1.3 \u03bcg/ml.", {"entities": [[44, 50, "DISEASE"]]}], ["Based on the significantly potent activity of some plants extracts reported here, further studies aimed at mechanism elucidation and bio-guided isolation of active anticancer compounds is currently underway.", {"entities": []}], ["Traditional hazards such as poor sanitation currently account for most of Africa\u2019s environmentally related disease burden.", {"entities": []}], ["However, with rapid development absent appropriate safeguards for environment and health, modern environmental health hazards (MEHHs) may emerge as critical contributors to the continent\u2019s disease burden.", {"entities": []}], ["We review recent evidence of human exposure to and health effects from MEHHs, and their occurrence in environmental media and consumer products.", {"entities": []}], ["Our purpose is to highlight the growing significance of these hazards as African countries experience urbanization, industrial growth, and development.", {"entities": []}], ["We reviewed published epidemiologic, exposure, and environmental studies of chemical agents such as heavy metals and pesticides.", {"entities": []}], ["The body of evidence demonstrates ongoing environmental releases of MEHHs and human exposures sometimes at toxicologically relevant levels.", {"entities": []}], ["Several sources of MEHHs in environmental media have been identified, including natural resource mining and processing and automobile exhaust.", {"entities": []}], ["Biomonitoring studies provided direct evidence of human exposure to metals such as mercury and lead and pesticides such as p , p\u2032 -dichlorodiphenyltrichloroethane (DDT) and organophosphates.", {"entities": []}], ["Land and water resource pollution and industrial air toxics are areas of significant data gaps, notwithstanding the presence of several emitting sources.", {"entities": []}], ["Unmitigated MEHH releases and human exposure have implications for Africa\u2019s disease burden.", {"entities": []}], ["For Africans encumbered by conditions such as malnutrition that impair resilience to toxicologic challenges, the burden may be higher.", {"entities": []}], ["A shift in public health policy toward accommodating the emerging diversity in Africa\u2019s environmental health issues is necessary to successfully alleviate the burden of avoidable ill health and premature death for all its communities now and in the future.", {"entities": []}], ["Morbidity and mortality due to viral infections are major health concerns, particularly when individuals are vitamin A deficient.", {"entities": []}], ["Vitamin A deficiency significantly impairs mucosal IgA, a first line of defense against virus at its point of entry.", {"entities": []}], ["Previous reports have suggested that CD11c", {"entities": []}], ["Various international laws and guidelines stress the importance of respecting the developing autonomy of children and involving minors in decision-making regarding treatment and research participation.", {"entities": []}], ["However, no universal agreement exists as to at what age minors should be deemed decision-making competent.", {"entities": []}], ["Minors of the same age may show different levels of maturity.", {"entities": []}], ["In addition, patients deemed rational conversation-partners as a child can suddenly become noncompliant as an adolescent.", {"entities": []}], ["Age, context and development all play a role in decision-making competence.", {"entities": []}], ["In this article we adopt a perspective on competence that specifically focuses on the impact of brain development on the child\u2019s decision-making process.", {"entities": []}], ["We believe that the discussion on decision-making competence of minors can greatly benefit from a multidisciplinary approach.", {"entities": []}], ["We adopted such an approach in order to contribute to the understanding on how to deal with children in decision-making situations.", {"entities": []}], ["Evidence emerging from neuroscience research concerning the developing brain structures in minors is combined with insights from various other fields, such as psychology, decision-making science and ethics.", {"entities": []}], ["Four capacities have been described that are required for (medical) decision-making: (1) communicating a choice; (2) understanding; (3) reasoning; and (4) appreciation.", {"entities": []}], ["Each capacity is related to a number of specific skills and abilities that need to be sufficiently developed to support the capacity.", {"entities": []}], ["Based on this approach it can be concluded that at the age of 12 children can have the capacity to be decision-making competent.", {"entities": []}], ["However, this age coincides with the onset of adolescence.", {"entities": []}], ["Early development of the brain\u2019s reward system combined with late development of the control system diminishes decision-making competence in adolescents in specific contexts.", {"entities": []}], ["We conclude that even adolescents possessing capacities required for decision-making, may need support of facilitating environmental factors.", {"entities": []}], ["This paper intends to offer insight in neuroscientific mechanisms underlying the medical decision-making capacities in minors and to stimulate practices for optimal involvement of minors.", {"entities": []}], ["Developing minors become increasingly capable of decision-making, but the neurobiological development in adolescence affects competence in specific contexts.", {"entities": []}], ["Adequate support should be offered in order to create a context in which minors can make competently make decisions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-017-0869-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although recent studies show an improved survival of children with sickle cell disease in the US and Europe, for adult patients mortality remains high.", {"entities": []}], ["This study was conducted to evaluate the factors associated with mortality in adult patients following the approval of hydroxyurea.", {"entities": []}], ["We first evaluated the association between selected variables and mortality at an academic center (University of North Carolina).", {"entities": []}], ["Data sources were then searched for publications from 1998 to June 2016, with meta-analysis of eligible studies conducted in North America and Europe to evaluate the associations of selected variables with mortality in adult patients.", {"entities": []}], ["Nine studies, combined with the UNC cohort (total n=3257 patients) met the eligibility criteria.", {"entities": []}], ["Mortality was significantly associated with age (per 10-year increase in age) [7 studies, 2306 participants; hazard ratio (HR): 1.28; 95% confidence interval (CI): 1.10\u20131.50], tricuspid regurgitant jet velocity 2.5 m/s or more (5 studies, 1577 participants; HR: 3.03; 95%CI: 2.0\u20134.60), reticulocyte count (3 studies, 1050 participants; HR: 1.05; 95%CI: 1.01\u20131.10), log(N-terminal-pro-brain natriuretic peptide) (3 studies, 800 participants; HR: 1.68; 95%CI: 1.48\u20131.90), and fetal hemoglobin (7 studies, 2477 participants; HR: 0.97; 95%CI: 0.94\u20131.0).", {"entities": [[123, 125, "GENE"], [258, 260, "GENE"], [336, 338, "GENE"], [441, 443, "GENE"], [522, 524, "GENE"], [123, 125, "GENE"], [258, 260, "GENE"], [336, 338, "GENE"], [441, 443, "GENE"], [522, 524, "GENE"], [123, 125, "GENE"], [258, 260, "GENE"], [336, 338, "GENE"], [441, 443, "GENE"], [522, 524, "GENE"], [123, 125, "GENE"], [258, 260, "GENE"], [336, 338, "GENE"], [441, 443, "GENE"], [522, 524, "GENE"], [123, 125, "GENE"], [258, 260, "GENE"], [336, 338, "GENE"], [441, 443, "GENE"], [522, 524, "GENE"]]}], ["This study identifies variables associated with mortality in adult patients with sickle cell disease in the hydroxyurea era.", {"entities": []}], ["Although the etiologies of cardiovascular disease (CVD) are widely understood, the goal of finding a globally effective solution for preventing CVD is unrealistic.", {"entities": []}], ["Therefore, we aimed to conduct a community-based prospective study on the prevention and management of CVD in Korean adults.", {"entities": []}], ["This study was designed to recruit 8,000 healthy adults over the course of 5 years.", {"entities": []}], ["The baseline assessment includes a wide range of established CVD risk factors, including demographic characteristics, medical history, health behaviors, psychological conditions, body size and composition, blood pressure, the augmentation index, carotid ultrasonography, an electrocardiogram, and biochemical indicators, as well as some novel factors, such as social network characteristics, exposure to environmental pollutants, inflammatory markers, hemostatic markers, and immunosenescence markers.", {"entities": []}], ["Annual telephone interviews and follow-up health examinations at 5-year intervals after the baseline assessment are planned to collect information on changes in health status and its determinants.", {"entities": []}], ["Additionally, indirect follow-up using secondary data sources will be conducted to obtain information on health services utilization and death.", {"entities": []}], ["So far, more than 6,000 adults have been enrolled during the first three and a half years, and almost all participants have been tracked by annual telephone follow-up surveys.", {"entities": []}], ["The data have been uploaded to iCReaT, the clinical research information management system of the Korea National Institute of Health.", {"entities": []}], ["This study is aimed to conduct a systematic literature review regarding the associations between psychiatric symptoms, functional impairments, and quality of life in patients with CMT (Charcot\u2013Marie\u2013Tooth).", {"entities": []}], ["The PUBMED, PsycInfo, SCIELO, and LILACS electronic databases were used, and the following search terms were employed: CMT, HMSN (hereditary motor and sensory neuropathy), mental disorder, quality of life, psychiatry, psychiatric, and psychological without the use of time-limit filters.", {"entities": [[159, 169, "DISEASE"]]}], ["According to the adopted inclusion criteria, 20 studies were included and appraised.", {"entities": []}], ["These studies indicated that patients with CMT exhibited an increased trend toward depressive symptoms compared with the general population.", {"entities": []}], ["In addition, CMT patients were exposed to a higher risk of reduced quality of life and significant sleep impairment.", {"entities": []}], ["Considering the comorbidity of CMT with other psychiatric disorders, the heterogeneity of the instruments used to evaluate the psychiatric symptoms compromised the ability to compare the studies examined.", {"entities": []}], ["Our results indicate a need for a systematic evaluation of these conditions to minimize the impairments and decreased quality of life caused by CMT.", {"entities": []}], ["Patients with CMT exhibited an increased trend toward depressive symptoms compared with the general population.", {"entities": []}], ["In addition, CMT patients were exposed to a higher risk of reduced quality of life and significant sleep impairment.", {"entities": []}], ["A medical sensor network can wirelessly monitor vital signs of humans, making it useful for long-term health care without sacrificing patient comfort and mobility.", {"entities": []}], ["For such a network to be viable, its design must protect data privacy and authenticity given that medical data are highly sensitive.", {"entities": []}], ["We identify the unique security challenges of such a sensor network and propose a set of resource-efficient mechanisms to address these challenges.", {"entities": []}], ["Our solution includes (1) a novel two-tier scheme for verifying the authenticity of patient data, (2) a secure key agreement protocol to set up shared keys between sensor nodes and base stations, and (3) symmetric encryption/decryption for protecting data confidentiality and integrity.", {"entities": []}], ["We have implemented the proposed mechanisms on a wireless mote platform, and our results confirm their feasibility.", {"entities": []}], ["SPARCLE is a nine-centre European epidemiological research study examining the relationship of participation and quality of life to impairment and environment (physical, social and attitudinal) in 8\u201312 year old children with cerebral palsy.", {"entities": [[225, 239, "DISEASE"]]}], ["Concepts are adopted from the International Classification of Functioning, Disability and Health which bridges the medical and social models of disability.", {"entities": []}], ["A cross sectional study of children with cerebral palsy sampled from total population databases in 9 European regions.", {"entities": [[41, 55, "DISEASE"]]}], ["Children were visited by research associates in each country who had been trained together.", {"entities": []}], ["The main instruments used were KIDSCREEN, Life-H, Strength and Difficulties Questionnaire, Parenting Stress Index.", {"entities": []}], ["A measure of environment was developed within the study.", {"entities": []}], ["All instruments were translated according to international guidelines.", {"entities": []}], ["The potential for bias due to non response and missing data will be examined.", {"entities": []}], ["After initial analysis using multivariate regression of how the data captured by each instrument relate to impairment and socio-economic characteristics, relationships between the latent traits captured by the instruments will then be analysed using structural equation modelling.", {"entities": []}], ["This study is original in its methods by directly engaging children themselves, ensuring those with learning or communication difficulty are not excluded, and by studying in quantitative terms the crucial outcomes of participation and quality of life.", {"entities": []}], ["Specification and publication of this protocol prior to analysis, which is not common in epidemiology but well established for randomised controlled trials and systematic reviews, should avoid the pitfalls of data dredging and post hoc analyses.", {"entities": []}], ["We wanted to prospectively assess the adverse events and hemodynamic effects associated with an intravenous adenosine infusion in patients with suspected or known coronary artery disease and who were undergoing cardiac MRI.", {"entities": []}], ["One hundred and sixty-eight patients (64 \u00b1 9 years) received adenosine (140 \u00b5g/kg/min) during cardiac MRI.", {"entities": []}], ["Before and during the administration, the heart rate, systemic blood pressure, and oxygen saturation were monitored using a MRI-compatible system.", {"entities": []}], ["We documented any signs and symptoms of potential adverse events.", {"entities": []}], ["In total, 47 out of 168 patients (28%) experienced adverse effects, which were mostly mild or moderate.", {"entities": []}], ["In 13 patients (8%), the adenosine infusion was discontinued due to intolerable dyspnea or chest pain.", {"entities": []}], ["No high grade atrioventricular block, bronchospasm or other life-threatening adverse events occurred.", {"entities": []}], ["The hemodynamic measurements showed a significant increase in the heart rate during adenosine infusion (69.3 \u00b1 11.7 versus 82.4 \u00b1 13.0 beats/min, respectively; p < 0.001).", {"entities": []}], ["A significant but clinically irrelevant increase in oxygen saturation occurred during adenosine infusion (96 \u00b1 1.9% versus 97 \u00b1 1.3%, respectively; p < 0.001).", {"entities": []}], ["The blood pressure did not significantly change during adenosine infusion (systolic: 142.8 \u00b1 24.0 versus 140.9 \u00b1 25.7 mmHg; diastolic: 80.2 \u00b1 12.5 mmHg versus 78.9 \u00b1 15.6, respectively).", {"entities": []}], ["This study confirms the safety of adenosine infusion during cardiac MRI.", {"entities": []}], ["A considerable proportion of all patients will experience minor adverse effects and some patients will not tolerate adenosine infusion.", {"entities": []}], ["However, all adverse events can be successfully managed by a radiologist.", {"entities": []}], ["The increased heart rate during adenosine infusion highlights the need to individually adjust the settings according to the patient, e.g., the number of slices of myocardial perfusion imaging.", {"entities": []}], ["Enterovirus 71 (EV71) is a major pathogen that causes hand, foot and mouth disease (HFMD) as well as neurological complications, such as encephalitis.", {"entities": [[54, 82, "DISEASE"], [69, 82, "DISEASE"], [137, 149, "DISEASE"]]}], ["The chemokines involved in the migration of leukocytes have increasingly been implicated in infectious diseases of the central nervous system.", {"entities": []}], ["Few studies have evaluated the levels of chemokines in HMFD children with EV71-related encephalitis.", {"entities": [[87, 99, "DISEASE"]]}], ["In the present study, we evaluated the cerebrospinal fluid (CSF) levels of the chemokines IL-8, RANTES, MIG, MCP-1 and IP-10 in 99 children with EV71-related encephalitis and 22 children with febrile convulsion (FC).", {"entities": [[158, 170, "DISEASE"]]}], ["We found that the concentrations of IL-8, RANTES, MIG and IP-10 were significantly higher in HFMD children with encephalitis compared to patients with FC.", {"entities": [[112, 124, "DISEASE"]]}], ["Additionally, these four chemokines were dramatically reduced during convalescence.", {"entities": []}], ["Inversely, the level of MCP-1 was lower in encephalitis patients than FC patients and was not significantly reduced during convalescence.", {"entities": [[43, 55, "DISEASE"]]}], ["Additionally, MIG was strongly correlated with IP-10 in encephalitis patients.", {"entities": [[56, 68, "DISEASE"]]}], ["Furthermore, the area under the ROC curve (AUC) of CSF MIG and IP-10 in distinguishing encephalitis from FC were 0.869 and 0.876, and the corresponding sensitivities/specificities were 67.7%/100.0% and 67.7%/95.5%, respectively.", {"entities": [[87, 99, "DISEASE"]]}], ["In conclusion, our results indicate that chemokines play important roles in the pathogenesis of EV71 infection.", {"entities": []}], ["Acute cutaneous neurogenic inflammation initiated by activation of transient receptor potential vanilloid-1 (TRPV 1 ) receptors following intradermal injection of capsaicin is mediated mainly by dorsal root reflexes (DRRs).", {"entities": []}], ["Inflammatory neuropeptides are suggested to be released from primary afferent nociceptors participating in inflammation.", {"entities": []}], ["However, no direct evidence demonstrates that the release of inflammatory substances is due to the triggering of DRRs and how activation of TRPV 1 receptors initiates neurogenic inflammation via triggering DRRs.", {"entities": []}], ["Here we used pharmacological manipulations to analyze the roles of TRPV 1 and neuropeptidergic receptors in the DRR-mediated neurogenic inflammation induced by intradermal injection of capsaicin.", {"entities": []}], ["The degree of cutaneous inflammation in the hindpaw that followed capsaicin injection was assessed by measurements of local blood flow (vasodilation) and paw-thickness (edema) of the foot skin in anesthetized rats.", {"entities": []}], ["Local injection of capsaicin, calcitonin gene-related peptide (CGRP) or substance P (SP) resulted in cutaneous vasodilation and edema.", {"entities": []}], ["Removal of DRRs by either spinal dorsal rhizotomy or intrathecal administration of the GABA A receptor antagonist, bicuculline, reduced dramatically the capsaicin-induced vasodilation and edema.", {"entities": []}], ["In contrast, CGRP- or SP-induced inflammation was not significantly affected after DRR removal.", {"entities": []}], ["Dose-response analysis of the antagonistic effect of the TRPV 1 receptor antagonist, capsazepine administered peripherally, shows that the capsaicin-evoked inflammation was inhibited in a dose-dependent manner, and nearly completely abolished by capsazepine at doses between 30\u2013150 \u03bcg.", {"entities": []}], ["In contrast, pretreatment of the periphery with different doses of CGRP 8\u201337 (a CGRP receptor antagonist) or spantide I (a neurokinin 1 receptor antagonist) only reduced the inflammation.", {"entities": []}], ["If both CGRP and NK 1 receptors were blocked by co-administration of CGRP 8\u201337 and spantide I, a stronger reduction in the capsaicin-initiated inflammation was produced.", {"entities": []}], ["Our data suggest that 1) the generation of DRRs is critical for driving the release of neuropeptides antidromically from primary afferent nociceptors; 2) activation of TRPV 1 receptors in primary afferent nociceptors following intradermal capsaicin injection initiates this process; 3) the released CGRP and SP participate in neurogenic inflammation.", {"entities": []}], ["This study examined whether propofol and aminophylline affect the mobilization of intracellular calcium in human umbilical vein endothelial cells.", {"entities": []}], ["Intracellular calcium was measured using laser scanning confocal microscopy.", {"entities": []}], ["Cultured and serum-starved cells on round coverslips were incubated with propofol or aminophylline for 30 min, and then stimulated with lysophosphatidic acid, propofol and aminophylline.", {"entities": []}], ["The results were expressed as relative fluorescence intensity and fold stimulation.", {"entities": []}], ["Propofol decreased the concentration of intracellular calcium, whereas aminophylline caused increased mobilization of intracellular calcium in a concentration-dependent manner.", {"entities": []}], ["Propofol suppressed the lysophosphatidic acid-induced mobilization of intracellular calcium in a concentration-dependent manner.", {"entities": []}], ["Propofol further prevented the aminophylline-induced increase of intracellular calcium at clinically relevant concentrations.", {"entities": []}], ["However, aminophylline reversed the inhibitory effect of propofol on the elevation of intracellular calcium by lysophosphatidic acid.", {"entities": []}], ["Our results suggest that propofol and aminophylline antagonize each other on the mobilization of intracellular calcium in human umbilical vein endothelial cells at clinically relevant concentrations.", {"entities": []}], ["Serious consideration should be given to how this interaction affects mobilization of intracellular calcium when these two drugs are used together.", {"entities": []}], ["Clinical studies showed the contribution of viral infection to the development of asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["Although mast cells have multiple roles in the pathogenesis of allergic asthma, their role of in the virus-associated pathogenesis of asthma remains unknown.", {"entities": [[63, 78, "DISEASE"], [72, 78, "DISEASE"], [134, 140, "DISEASE"]]}], ["Most respiratory viruses generate double-stranded (ds) RNA during their replication.", {"entities": []}], ["dsRNA provokes innate immune responses.", {"entities": []}], ["We recently showed that an administration of polyinocinic polycytidilic acid (poly IC), a mimetic of viral dsRNA, during allergen sensitization augments airway eosinophilia and hyperresponsiveness in mice via enhanced production of IL-13.", {"entities": [[160, 172, "DISEASE"]]}], ["The effect of poly IC on allergen-induced airway eosinophilia was investigated for mast cell-conserved Kit Airway eosinophilia and IL-13 production were augmented by poly IC in Kit 4 and prostaglandin D 2 are major lipid mediators released from activated mast cells, no their contribution was shown to the dsRNA-induced augmentation of airway eosinophilia.", {"entities": [[49, 61, "DISEASE"], [114, 126, "DISEASE"], [343, 355, "DISEASE"]]}], ["We conclude that mast cells contribute to dsRNA-induced augmentation of allergic airway inflammation without requiring direct activation of mast cells with dsRNA or involvement of leukotriene B 4 or prostaglandin D 2 .", {"entities": []}], ["Data on obesity from the Kingdom of Saudi Arabia (KSA) are nonexistent, making it impossible to determine whether the efforts of the Saudi Ministry of Health are having an effect on obesity trends.", {"entities": [[8, 15, "DISEASE"], [182, 189, "DISEASE"]]}], ["To determine obesity prevalence and associated factors in the KSA, we conducted a national survey on chronic diseases and their risk factors.", {"entities": [[13, 20, "DISEASE"]]}], ["We interviewed 10,735 Saudis aged 15 years or older (51.1% women) through a multistage survey.", {"entities": []}], ["Data on sociodemographic characteristics, health-related habits and behaviors, diet, physical activity, chronic diseases, access to and use of health care, and anthropometric measurements were collected through computer-assisted personal interviews.", {"entities": []}], ["We first compared sociodemographic factors and body mass index between men and women.", {"entities": []}], ["Next, we conducted a sex-specific analysis for obesity and its associated factors using backward elimination multivariate logistic regression models.", {"entities": [[47, 54, "DISEASE"]]}], ["We used SAS 9.3 for the statistical analyses and to account for the complex sampling design.", {"entities": []}], ["Of the 10,735 participants evaluated, 28.7% were obese (body mass index \u226530 kg/m Obesity remains strongly associated with diabetes, hypercholesterolemia, and hypertension in the KSA, although the epidemic\u2019s characteristics differ between men and women.", {"entities": [[158, 170, "DISEASE"], [81, 88, "DISEASE"]]}], ["Chronic smoking is the main risk factor for chronic obstructive pulmonary disease.", {"entities": [[44, 81, "DISEASE"]]}], ["Knowledge on the response to the initial smoke exposures might enhance the understanding of changes due to chronic smoking, since repetitive acute smoke effects may cumulate and lead to irreversible lung damage.", {"entities": []}], ["We investigated acute effects of smoking on inflammation in 16 healthy intermittent smokers in an open randomised cross-over study.", {"entities": []}], ["We compared effects of smoking of two cigarettes on inflammatory markers in exhaled air, induced sputum, blood and urine at 0, 1, 3, 6, 12, 24, 48, 96 and 192 hours and outcomes without smoking.", {"entities": []}], ["All sputum and blood parameters were log transformed and analysed using a linear mixed effect model.", {"entities": []}], ["Significant findings were: Smoking increased exhaled carbon monoxide between 0 and 1 hour, and induced a greater decrease in blood eosinophils and sputum lymphocytes between 0 and 3 hours compared to non-smoking.", {"entities": []}], ["Compared to non-smoking, smoking induced a greater interleukin-8 release from stimulated blood cells between 0 and 3 hours, and a greater increase in sputum lymphocytes and neutrophils between 3 and 12 hours.", {"entities": []}], ["We conclude that besides an increase in inflammation, as known from chronic smoking, there is also a suppressive effect of smoking two cigarettes on particular inflammatory parameters.", {"entities": []}], ["To investigate whether the success rate of ICSI is (1) related to the etiology of infertility or (2) adversely affected by a family history of potential genetic disorders.", {"entities": [[82, 93, "DISEASE"]]}], ["All men with an ICSI indication in our hospital between 1994 and 2005 were included in our cohort study.", {"entities": []}], ["Data on the ICSI process, etiology of infertility, and family history were collected.", {"entities": [[38, 49, "DISEASE"]]}], ["ICSI success rates of infertility subgroups and a subgroup with a positive family history were compared to a group with unknown etiology and a negative family history.", {"entities": [[22, 33, "DISEASE"]]}], ["There was no significant difference in clinical pregnancy or delivery rates between the subgroups.", {"entities": []}], ["Couples achieving a pregnancy underwent significantly more ICSI cycles compared to couples not achieving a pregnancy.", {"entities": []}], ["Our results suggest that the success rate of ICSI treatment is not related to the cause of infertility or a family history positive for potential genetic disorders.", {"entities": [[91, 102, "DISEASE"]]}], ["Life Satisfaction (LS) is an indicator of subjective well-being (SWB) among the elderly, and is directly associated with health and mortality.", {"entities": []}], ["Present study deals with the factors associated with the LS among the rural elderly in Odisha, India.", {"entities": []}], ["A cross-sectional survey using multi-stage random sampling procedure was conducted among elderly (60+ years) in Bargarh district of Odisha.", {"entities": []}], ["The survey was conducted among 310 respondents.", {"entities": []}], ["Hierarchical regression analysis was used to assess the adjusted effect of various socio-economic, demographic, health conditions (physical and mental), social support and effects of multi-morbidity on LS.", {"entities": []}], ["Cognitive health was the most influential factor in determining LS among both men (\u03b2\u2009=\u20090.327) and women (\u03b2\u2009=\u20090.329).", {"entities": []}], ["Individual\u2019s social support also plays an influential role in LS among rural elderly.", {"entities": []}], ["Elderly who are living alone and have any sort of disability and had low score of activities of daily living (ADL) have also reported significantly lower perceived LS for both the genders.", {"entities": []}], ["It is necessary to analyze and identify the major factors which can improve upon the level of LS among the elderly population.", {"entities": []}], ["Better understanding of these factors can help in removing the superfluous anxiety of old age in the mindset of people which is pervading in the society.", {"entities": []}], ["Atopic diseases are a major burden of disease on a global scale.", {"entities": []}], ["Regarding their aetiology, the early years of life are assumed to play a crucial role.", {"entities": []}], ["In addition, there is growing evidence that elucidating the impact of cross-generational effects and epigenetic mechanisms such as DNA methylation can substantially widen the scientific knowledge of the occurrence and progression of these diseases.", {"entities": []}], ["We are thus aiming at following the course of asthma, allergies, and potential risk factors for their occurrence across three generations by establishing a birth cohort in the offspring of an existing population-based cohort.", {"entities": [[46, 52, "DISEASE"]]}], ["2051 young adults who have been recruited in 1995 for Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC) and who have subsequently been followed-up by the Study on Occupational Allergy Risks (SOLAR) are asked bi-annually since 2009 if they conceived a child in the meantime.", {"entities": [[93, 99, "DISEASE"]]}], ["If parenthood is reported, parents are invited to enrol along with their children in the ACROSSOLAR cohort.", {"entities": []}], ["Participation involves completing a questionnaire assessing general and health-related information about the course of the pregnancy and the first year of life of their children.", {"entities": []}], ["Subsequently, the children are followed up until primary school age when asthma and allergies can be diagnosed reliably.", {"entities": [[73, 79, "DISEASE"]]}], ["In addition, DNA for epigenetic analysis will be collected and analysed.", {"entities": []}], ["Longitudinal data analysis techniques will then be used to assess potential associations between early-life exposures and onset of childhood asthma and allergies taking into account epigenetics.", {"entities": [[141, 147, "DISEASE"]]}], ["Birth cohorts are especially suited to elucidate the impact of genetic predisposition, epigenetics, exposures during the first years of life, and gene-environment interactions on the occurrence and progression of asthma and allergies.", {"entities": [[213, 219, "DISEASE"]]}], ["By building upon an existing cohort, ACROSSOLAR offers a unique and cost-effective opportunity to investigate the aetiology of atopic disease in a prospective and cross-generational way.", {"entities": []}], ["Acceptance and Commitment Therapy (ACT) is a form of cognitive behavioural therapy, which may be beneficial for people with chronic pain.", {"entities": []}], ["The approach aims to enhance daily functioning through increased psychological flexibility.", {"entities": []}], ["Whilst the therapeutic model behind ACT appears well suited to chronic pain, there is a need for further research to test its effectiveness in clinical practice, particularly with regards to combining ACT with physical exercise.", {"entities": []}], ["This prospective, two-armed, parallel-group, single-centre randomised controlled trial (RCT) will assess the effectiveness of a combined Exercise and ACT programme, in comparison to supervised exercise for chronic pain.", {"entities": []}], ["One hundred and sixty patients, aged 18 years and over, who have been diagnosed with a chronic pain condition by a physician will be recruited to the trial.", {"entities": []}], ["Participants will be individually randomised to one of two 8-week, group interventions.", {"entities": []}], ["The combined group will take part in weekly psychology sessions based on the ACT approach, in addition to supervised exercise classes led by a physiotherapist.", {"entities": []}], ["The control group will attend weekly supervised exercise classes but will not take part in an ACT programme.", {"entities": []}], ["The primary outcome will be pain interference at 12-week follow-up, measured using the Brief Pain Inventory-Interference Scale.", {"entities": []}], ["Secondary outcomes will include self-reported pain severity, self-perception of change, patient satisfaction, quality of life, depression, anxiety and healthcare utilisation.", {"entities": []}], ["Treatment process measures will include self-efficacy, pain catastrophising, fear avoidance, pain acceptance and committed action.", {"entities": []}], ["Physical activity will be measured using Fitbit Zip To our knowledge, this will be the first RCT to examine whether combining exercise with ACT produces greater benefit for patients with chronic pain, compared to a standalone supervised exercise programme.", {"entities": []}], ["www.ClinicalTrials.gov, ID: NCT03050528 .", {"entities": []}], ["Registered on 13 February 2017.", {"entities": []}], ["The online version of this article (10.1186/s13063-018-2543-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Vitamin D plays an important role in health promotion during adolescence.", {"entities": []}], ["Vitamin D deficiency and insufficiency are common in adolescents worldwide.", {"entities": []}], ["Few data on vitamin D status and risk factors for hypovitaminosis D in Italian adolescents are currently available.", {"entities": []}], ["25-hydroxyvitamin D (25-OH-D) and parathyroid hormone (PTH) levels were evaluated in 427 Italian healthy adolescents (10.0-21.0\u00a0years).", {"entities": [[55, 58, "GENE"]]}], ["We used the following cut-off of 25-OH-D to define vitamin D status: deficiency\u2009<\u200950\u00a0nmol/L; insufficiency 50-75\u00a0nmol/L; sufficiency\u2009\u2265\u200975\u00a0nmol/L.", {"entities": []}], ["Hypovitaminosis D was defined as 25-OH-D levels\u2009<\u200975.0\u00a0nmol/L and severe vitamin D deficiency as 25-OH-D levels\u2009<\u200925.0\u00a0nmol/L.", {"entities": []}], ["We evaluated gender, residence, season of blood withdrawal, ethnicity, weight status, sun exposure, use of sunscreens, outdoor physical activity, and history of fractures as predictors of vitamin D status.", {"entities": []}], ["Enrolled adolescents had a median serum 25-OH-D level of 50.0\u00a0nmol/L, range 8.1-174.7, with 82.2% having hypovitaminosis D. Vitamin D deficiency and insufficiency were detected in 49.9% and 32.3% of adolescents, respectively.", {"entities": []}], ["Among those with deficiency, 38 subjects were severely deficient (38/427, 8.9% of the entire sample).", {"entities": []}], ["Non-white adolescents had a higher prevalence of severe vitamin D deficiency than white subjects (6/17-35.3% vs 32/410-7.8% respectively, p\u2009=\u20090.002).", {"entities": []}], ["Logistic regression showed increased risk of hypovitaminosis D as follows: blood withdrawal taken in winter-spring (Odds ratio (OR) 5.64) compared to summer-fall period; overweight-obese adolescents (OR 3.89) compared to subjects with normal body mass index (BMI); low sun exposure (OR 5.94) compared to moderate-good exposure and regular use of sunscreens (OR 5.89) compared to non regular use.", {"entities": []}], ["Adolescents who performed\u2009<\u20093\u00a0hours/week of outdoor exercise had higher prevalence of hypovitaminosis D. Gender, residence, and history of fractures were not associated with vitamin D status.", {"entities": []}], ["Serum 25-OH-D levels were inversely related to PTH (r\u2009=\u2009-0.387, p\u2009<\u20090.0001) and BMI-SDS (r\u2009=\u2009-0.141, p\u2009=\u20090.007).", {"entities": [[47, 50, "GENE"]]}], ["44/427 (10.3%) adolescents showed secondary hyperparathyroidism.", {"entities": [[34, 63, "DISEASE"], [44, 63, "DISEASE"]]}], ["Italian adolescents have high prevalence of vitamin D deficiency and insufficiency.", {"entities": []}], ["Pediatricians should tackle predictors of vitamin D status, favoring a healthier lifestyle and promoting supplementation in the groups at higher risk of hypovitaminosis D.", {"entities": []}], ["Comorbidity is often mentioned as interfering with \u201coptimal\u201d treatment decisions in diabetes care.", {"entities": []}], ["It is suggested that diabetes-related comorbidity will increase adequate treatment, whereas diabetes-unrelated comorbidity may decrease this process of care.", {"entities": []}], ["We hypothesized that these effects differ according to expected priority of the conditions.", {"entities": []}], ["We evaluated the relationship between comorbidity and treatment intensification in a study of 11,248 type 2 diabetes patients using the GIANTT (Groningen Initiative to Analyse type 2 diabetes Treatment) database.", {"entities": []}], ["We formed a cohort of patients with a systolic blood pressure \u2265140 mmHg (6,820 hypertensive diabetics), and a cohort of patients with an HbA1c \u22657% (3,589 hyperglycemic diabetics) in 2007.", {"entities": []}], ["We differentiated comorbidity by diabetes-related or unrelated conditions and by priority.", {"entities": []}], ["High priority conditions include conditions that are life-interfering, incident or requiring new medication treatment.", {"entities": []}], ["We performed Cox regression analyses to assess association with treatment intensification, defined as dose increase, start, or addition of drugs.", {"entities": []}], ["In both the hypertensive and hyperglycemic cohort, only patients with incident diabetes-related comorbidity had a higher chance of treatment intensification (HR 4.48, 2.33\u20138.62 (p<0.001) for hypertensives; HR 2.37, 1.09\u20135.17 (p\u200a=\u200a0.030) for hyperglycemics).", {"entities": [[158, 160, "GENE"], [206, 208, "GENE"], [158, 160, "GENE"], [206, 208, "GENE"]]}], ["Intensification of hypertension treatment was less likely when a new glucose-regulating drug was prescribed (HR 0.24, 0.06\u20130.97 (p\u200a=\u200a0.046)).", {"entities": [[19, 31, "DISEASE"], [109, 111, "GENE"]]}], ["None of the prevalent or unrelated comorbidity was significantly associated with treatment intensification.", {"entities": []}], ["Diabetes-related comorbidity induced better risk factor treatment only for incident cases, implying that appropriate care is provided more often when complications occur.", {"entities": []}], ["Diabetes-unrelated comorbidity did not affect hypertension or hyperglycemia management, even when it was incident or life-interfering.", {"entities": [[46, 58, "DISEASE"], [62, 75, "DISEASE"]]}], ["Thus, the observed \u201cundertreatment\u201d in diabetes care cannot be explained by constraints caused by such comorbidity.", {"entities": []}], ["Objective To determine if use of paracetamol in early life is an independent risk factor for childhood asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["Design Prospective birth cohort study.", {"entities": []}], ["Setting Melbourne Atopy Cohort Study.", {"entities": []}], ["Participants 620 children with a family history of allergic disease, with paracetamol use prospectively documented on 18 occasions from birth to 2 years of age, followed until age 7 years.", {"entities": []}], ["Main outcome measures The primary outcome was childhood asthma, ascertained by questionnaire at 6 and 7 years.", {"entities": [[56, 62, "DISEASE"]]}], ["Secondary outcomes were infantile wheeze, allergic rhinitis, eczema, and skin prick test positivity.", {"entities": [[42, 59, "DISEASE"], [51, 59, "DISEASE"]]}], ["Results Paracetamol had been used in 51% (295/575) of children by 12 weeks of age and in 97% (556/575) by 2 years.", {"entities": []}], ["Between 6 and 7 years, 80% (495/620) were followed up; 30% (148) had current asthma.", {"entities": [[77, 83, "DISEASE"]]}], ["Increasing frequency of paracetamol use was weakly associated with increased risk of childhood asthma (crude odds ratio 1.18, 95% confidence interval 1.00 to 1.39, per doubling of days of use).", {"entities": [[95, 101, "DISEASE"]]}], ["However, after adjustment for frequency of respiratory infections, this association essentially disappeared (odds ratio 1.08, 0.91 to 1.29).", {"entities": []}], ["Paracetamol use for non-respiratory causes was not associated with asthma (crude odds ratio 0.95, 0.81 to 1.12).", {"entities": [[67, 73, "DISEASE"]]}], ["Conclusions In children with a family history of allergic diseases, no association was found between early paracetamol use and risk of subsequent allergic disease after adjustment for respiratory infections or when paracetamol use was restricted to non-respiratory tract infections.", {"entities": []}], ["These findings suggest that early paracetamol use does not increase the risk of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["The receptor tyrosine kinases (RTKs) TYRO3 , AXL and MERTK (TAM) have well-described oncogenic functions in a number of cancers.", {"entities": [[37, 42, "GENE"], [45, 48, "GENE"], [53, 58, "GENE"]]}], ["Notwithstanding, TAM RTKs are also potent and indispensable inhibitors of inflammation.", {"entities": []}], ["The combined deletion of Axl and Mertk in mice enhances chronic inflammation and autoimmunity, including increased inflammation in the gut and colitis-associated cancer.", {"entities": [[162, 168, "DISEASE"], [25, 28, "GENE"], [33, 38, "GENE"]]}], ["On the other hand, deletion of Tyro3 increases the risk of allergic responses.", {"entities": [[31, 36, "GENE"]]}], ["Therefore, the indiscriminate inhibition of these TAM RTKs could result in undesirable immunological diseases.", {"entities": []}], ["Here we show that AXL , but not MERTK or TYRO3 expression is enhanced in late stage colorectal cancer (CRC) and AXL expression associates with a cell migration gene signature.", {"entities": [[84, 101, "DISEASE"], [95, 101, "DISEASE"], [18, 21, "GENE"], [112, 115, "GENE"], [32, 37, "GENE"], [41, 46, "GENE"], [18, 21, "GENE"], [112, 115, "GENE"]]}], ["Silencing AXL or the inhibition of AXL kinase activity significantly inhibits tumor cell migration and invasion.", {"entities": [[10, 13, "GENE"], [35, 38, "GENE"], [10, 13, "GENE"], [35, 38, "GENE"]]}], ["These results indicate that the selective inhibition of AXL alone might confer sufficient therapeutic benefit in CRC, while preserving at least some of the beneficial, anti-inflammatory effects of MERTK and TYRO3 RTKs.", {"entities": [[56, 59, "GENE"], [197, 202, "GENE"], [207, 212, "GENE"]]}], ["The aim of this study was to assess the efficacy and safety of laparoscopic treatment for adnexal cystic masses that were predicted to be benign in postmenopausal women.", {"entities": []}], ["Postmenopausal women found to have an adnexal cystic mass were retrospectively evaluated with transvaginal ultrasonography, and serum CA-125 levels.", {"entities": []}], ["The selection criteria were adnexal cystic masses greater than 3 cm but less than 10 cm, the masses were in the benign range (4-8) of Sassone's scoring system for transvaginal ultrasonography, and the patients had serum CA-125 levels less than 65 IU/mL.", {"entities": []}], ["Two hundred nineteen women fulfilled the criteria and underwent operative laparoscopy.", {"entities": []}], ["Almost all the masses (99.5%) were accurately predicted to be benign except for one borderline ovarian tumor.", {"entities": []}], ["Two hundreds thirteen (97.3%) women were successfully managed by operative laparoscopy and six (2.7%) required laparotomy.", {"entities": []}], ["For the patients managed by laparoscopy, the mean operative time was 51.3 min; the mean hospital stay was 2.5 days.", {"entities": []}], ["There was no significant morbidity and surgery-related mortality.", {"entities": []}], ["The combination of the Sassone's scoring system for transvaginal ultrasonography and serum CA-125 level can accurately predict benign cystic masses, and operative laparoscopy is technically feasible and safe for the management of adnexal mass in postmenopausal women.", {"entities": []}], ["Repeated exposure to certain low molecular weight (LMW) chemical compounds may result in development of allergic reactions in the skin or in the respiratory tract.", {"entities": []}], ["In most cases, a certain LMW compound selectively sensitize the skin, giving rise to allergic contact dermatitis (ACD), or the respiratory tract, giving rise to occupational asthma (OA).", {"entities": [[94, 112, "DISEASE"], [85, 112, "DISEASE"], [174, 180, "DISEASE"], [102, 112, "DISEASE"], [114, 117, "GENE"]]}], ["To limit occurrence of allergic diseases, efforts are currently being made to develop predictive assays that accurately identify chemicals capable of inducing such reactions.", {"entities": []}], ["However, while a few promising methods for prediction of skin sensitization have been described, to date no validated method, in vitro or in vivo , exists that is able to accurately classify chemicals as respiratory sensitizers.", {"entities": []}], ["Recently, we presented the in vitro based Genomic Allergen Rapid Detection (GARD) assay as a novel testing strategy for classification of skin sensitizing chemicals based on measurement of a genomic biomarker signature.", {"entities": []}], ["We have expanded the applicability domain of the GARD assay to classify also respiratory sensitizers by identifying a separate biomarker signature containing 389 differentially regulated genes for respiratory sensitizers in comparison to non-respiratory sensitizers.", {"entities": []}], ["By using an independent data set in combination with supervised machine learning, we validated the assay, showing that the identified genomic biomarker is able to accurately classify respiratory sensitizers.", {"entities": []}], ["We have identified a genomic biomarker signature for classification of respiratory sensitizers.", {"entities": []}], ["Combining this newly identified biomarker signature with our previously identified biomarker signature for classification of skin sensitizers, we have developed a novel in vitro testing strategy with a potent ability to predict both skin and respiratory sensitization in the same sample.", {"entities": []}], ["Plants of the Lauraceae family are widely used in traditional medicine and are sources of various classes of secondary metabolites.", {"entities": []}], ["Two genera of this family, Beilschmiedia and Endiandra , have been the subject of numerous investigations over the past decades because of their application in traditional medicine.", {"entities": []}], ["They are the only source of bioactive endiandric acid derivatives.", {"entities": []}], ["Noteworthy is that their biosynthesis contains two consecutive non-enzymatic electrocyclic reactions.", {"entities": []}], ["Several interesting biological activities for this specific class of secondary metabolites and other constituents of the two genera have been reported, including antimicrobial, enzymes inhibitory and cytotoxic properties.", {"entities": []}], ["This review compiles information on the structures of the compounds described between January 1960 and March 2015, their biological activities and information on endiandric acid biosynthesis, with 104 references being cited.", {"entities": []}], ["Asthma is a complex heterogeneous disease that has increased in prevalence in many industrialised countries.", {"entities": [[0, 6, "DISEASE"]]}], ["However, the causes of asthma inception remain elusive.", {"entities": [[23, 29, "DISEASE"]]}], ["Consideration of sub-phenotypes of wheezing may reveal important clues to aetiological risk factors.", {"entities": []}], ["Longitudinal phenotypes capturing population heterogeneity in wheezing reports from birth to 7 years were derived using latent class analysis in the Avon Longitudinal Study of Parents and Children (ALSPAC).", {"entities": []}], ["Probability of class membership was used to examine the association between five wheezing phenotypes (transient early, prolonged early, intermediate-onset, late-onset, persistent) and early life risk factors for asthma.", {"entities": [[212, 218, "DISEASE"]]}], ["Phenotypes had similar patterns and strengths of associations with early environmental factors.", {"entities": []}], ["Comparing transient early with prolonged early wheezing showed a similar pattern of association with most exposure variables considered in terms of the direction of the effect estimates but with prolonged early wheezing tending to have stronger associations than transient early wheezing except for parity and day care attendance.", {"entities": []}], ["Associations with early life risk factors suggested that prolonged early wheeze might be a severe form of transient early wheezing.", {"entities": []}], ["Although differences were found in the associations of early life risk factors with individual phenotypes, these did not point to novel aetiological pathways.", {"entities": []}], ["Persistent wheezing phenotype has features suggesting overlap of early and late-onset phenotypes.", {"entities": []}], ["Health technology assessment (HTA) has been continuously used for value-based healthcare decisions over the last decade.", {"entities": [[30, 33, "GENE"]]}], ["Healthcare databases represent an important source of information for HTA, which has seen a surge in use in Western countries.", {"entities": [[70, 73, "GENE"]]}], ["Although HTA agencies have been established in Asia-Pacific region, application and understanding of healthcare databases for HTA is rather limited.", {"entities": [[9, 12, "GENE"], [126, 129, "GENE"], [9, 12, "GENE"], [126, 129, "GENE"]]}], ["Thus, we reviewed existing databases to assess their potential for HTA in Thailand where HTA has been used officially and Japan where HTA is going to be officially introduced.", {"entities": [[67, 70, "GENE"], [89, 92, "GENE"], [134, 137, "GENE"], [67, 70, "GENE"], [89, 92, "GENE"], [134, 137, "GENE"], [67, 70, "GENE"], [89, 92, "GENE"], [134, 137, "GENE"]]}], ["Existing healthcare databases in Thailand and Japan were compiled and reviewed.", {"entities": []}], ["Databases\u2019 characteristics e.g.", {"entities": []}], ["name of database, host, scope/objective, time/sample size, design, data collection method, population/sample, and variables were described.", {"entities": []}], ["Databases were assessed for its potential HTA use in terms of safety/efficacy/effectiveness, social/ethical, organization/professional, economic, and epidemiological domains.", {"entities": [[42, 45, "GENE"]]}], ["Request route for each database was also provided.", {"entities": []}], ["Forty databases\u2013 20 from Thailand and 20 from Japan\u2014were included.", {"entities": []}], ["These comprised of national censuses, surveys, registries, administrative data, and claimed databases.", {"entities": []}], ["All databases were potentially used for epidemiological studies.", {"entities": []}], ["In addition, data on mortality, morbidity, disability, adverse events, quality of life, service/technology utilization, length of stay, and economics were also found in some databases.", {"entities": []}], ["However, access to patient-level data was limited since information about the databases was not available on public sources.", {"entities": []}], ["Our findings have shown that existing databases provided valuable information for HTA research with limitation on accessibility.", {"entities": [[82, 85, "GENE"]]}], ["Mutual dialogue on healthcare database development and usage for HTA among Asia-Pacific region is needed.", {"entities": [[65, 68, "GENE"]]}], ["It has been debated whether children who have experienced early life stress (ELS), such as early caregiver separation show elevated risk for stress-related psychiatric disorders and a multi-symptom psychopathological profile that is not fully reflected in categorical assessments.", {"entities": []}], ["In this study, we investigated dimensional measures of stress-related psychopathology in children in permanent out-of-home care, taking into account potential neuroendocrine interactions.", {"entities": []}], ["In the current study, 25 children who had been placed in permanent out-of-home care before age 3\u00a0(years) and 26 controls (aged 10.6\u00a0\u00b1\u00a01.75\u00a0years) were investigated with categorical (DSM-IV) and dimensional assessments (CBCL) of psychopathology and diurnal salivary cortisol levels were assessed.", {"entities": []}], ["Semi-structured interviews (K-DIPS) revealed no significant group differences in full-scale psychiatric diagnoses, whereas dimensional assessment (CBCL) revealed significant group differences in externalizing and total problem behaviours within the clinical range for children with ELS.", {"entities": []}], ["Only children with ELS showed a combined symptom profile of clinical-range internalizing and externalizing problems.", {"entities": []}], ["Lower morning cortisol values and subsequent flatter decline was found in subjects with ELS children compared to controls, showing group differences in diurnal cortisol secretion.", {"entities": []}], ["Lower morning cortisol values were associated with more problem behaviour in the ELS group.", {"entities": []}], ["Results show that ELS children exhibited increased psychopathological symptom severity and complexity associated with lower morning cortisol levels, which was not fully reflected in categorical assessments.", {"entities": []}], ["This highlights the importance of incorporating dimensional assessments and neurobiological factors into psychopathological evaluations of children in out-of-home care in order to facilitate early identification of children at high risk for stress-related disorders.", {"entities": []}], ["Functionally distinct T-helper (Th) subsets orchestrate immune responses.", {"entities": []}], ["Maintenance of homeostasis through the tight control of inflammatory Th cells is crucial to avoid autoimmune inflammation.", {"entities": []}], ["Activation-Induced Cell Death (AICD) regulates homeostasis of T cells, and it has never been investigated in human Th cells.", {"entities": []}], ["We generated stable clones of inflammatory Th subsets involved in autoimmune diseases, such as Th1, Th17 and Th1/17 cells, from healthy donors (HD) and multiple sclerosis (MS) patients and we measured AICD.", {"entities": [[152, 170, "DISEASE"]]}], ["We find that human Th1 cells are sensitive, whereas Th17 and Th1/17 are resistant, to AICD.", {"entities": []}], ["In particular, Th1 cells express high level of FAS-ligand (FASL), which interacts with FAS and leads to caspases' cleavage and ultimately to cell death.", {"entities": [[47, 50, "GENE"], [87, 90, "GENE"]]}], ["In contrast, low FASL expression in Th17 and Th1/17 cells blunts caspase 8 activation and thus reduces cell death.", {"entities": []}], ["Interestingly, Th cells obtained from healthy individuals and MS patients behave similarly, suggesting that this mechanism could explain the persistence of inflammatory IL-17-producing cells in autoimmune diseases, such as MS, where their generation is particularly substantial.", {"entities": []}], ["Despite the widespread implementation of electronic health records (EHRs), there is growing evidence that racial/ethnic minority patients do not use portals as frequently as non-Hispanic whites to access their EHR information online.", {"entities": []}], ["This differential portal use could be problematic for health care disparities since early evidence links portal use to better outcomes.", {"entities": []}], ["We sought to understand specific barriers to portal use among African American and Latino patients at Kaiser Permanente, which has had a portal in place for over a decade, and broad uptake among the patient population at large.", {"entities": []}], ["We conducted 10 focus groups with 87 participants in 2012 and 2013 among African American and Latino Kaiser Permanente members in the mid-Atlantic, Georgia, and Southern California regions.", {"entities": []}], ["Members were eligible to participate if they were not registered for portal access.", {"entities": []}], ["Focus groups were conducted within each racial/ethnic group, and each included individuals who were older, had a chronic disease, or were parents (as these are the three biggest users of the portal at Kaiser Permanente overall).", {"entities": []}], ["We videotaped each focus group and transcribed the discussion for analysis.", {"entities": []}], ["We used general inductive coding to develop themes for major barriers to portal use, overall and separately by racial/ethnic group.", {"entities": []}], ["We found that lack of support was a key barrier to initiating portal use in our sample\u2014both in terms of technical assistance as well as the fear of the portal eroding existing personal relationships with health care providers.", {"entities": []}], ["This held true across a range of focus groups representing a mix of age, income, health conditions, and geographic regions.", {"entities": []}], ["Our study was among the first qualitative explorations of barriers to portal use among racial/ethnic subgroups.", {"entities": []}], ["Our findings suggest that uniform adoption of portal use across diverse patient groups requires more usable and personalized websites, which may be particularly important for reducing health care disparities.", {"entities": []}], ["This work is particularly important as all health care systems continue to offer and promote more health care features online via portals.", {"entities": []}], ["Emerging technologies now make it possible to genotype hundreds of thousands of genetic variations in individuals, across the genome.", {"entities": []}], ["The study of loci at finer scales will facilitate the understanding of genetic variation at genomic and geographic levels.", {"entities": []}], ["We examined global and chromosomal variations across HapMap populations using 3.7 million single nucleotide polymorphisms to search for the most stratified genomic regions of human populations and linked these regions to ontological annotation and functional network analysis.", {"entities": []}], ["To achieve this, we used five complementary statistical and genetic network procedures: principal component (PC), cluster, discriminant, fixation index (F ST ) and network/pathway analyses.", {"entities": [[109, 111, "GENE"]]}], ["At the global level, the first two PC scores were sufficient to account for major population structure; however, chromosomal level analysis detected subtle forms of population structure within continental populations, and as many as 31 PCs were required to classify individuals into homogeneous groups.", {"entities": [[35, 37, "GENE"]]}], ["Using recommended population ancestry differentiation measures, a total of 126 regions of the genome were catalogued.", {"entities": []}], ["Gene ontology and networks analyses revealed that these regions included the genes encoding oculocutaneous albinism II ( OCA2 ), hect domain and RLD 2 ( HERC2 ), ectodysplasin A receptor ( EDAR ) and solute carrier family 45, member 2 ( SLC45A2 ).", {"entities": [[92, 115, "DISEASE"], [121, 125, "GENE"], [153, 158, "GENE"], [189, 193, "GENE"], [237, 244, "GENE"]]}], ["These genes are associated with melanin production, which is involved in the development of skin and hair colour, skin cancer and eye pigmentation.", {"entities": [[114, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["We also identified the genes encoding interferon-\u03b3 ( IFNG ) and death-associated protein kinase 1 (DAPK1), which are associated with cell death, inflammatory and immunological diseases.", {"entities": [[53, 57, "GENE"], [99, 104, "GENE"]]}], ["An in-depth understanding of these genomic regions may help to explain variations in adaptation to different environments.", {"entities": []}], ["Our approach offers a comprehensive strategy for analysing chromosome-based population structure and differentiation, and demonstrates the application of complementary statistical and functional network analysis in human genetic variation studies.", {"entities": []}], ["A growing body of evidence suggests that a majority of people with celiac disease and on a gluten-free diet can safely consume pure oats in moderate amounts; however, previous studies have indicated that the commercial oat supply in other countries, and in Canada to some extent, is contaminated with other grains.", {"entities": [[67, 81, "DISEASE"]]}], ["This study has confirmed that the commercial oat supply in Canada is heavily contaminated with gluten from other grains.", {"entities": []}], ["Approximately 88% of the oat samples ( n = 133) were contaminated above 20 mg kg", {"entities": []}], ["We summarized the recently published, peer-reviewed literature that examined the impact of investments in social services or investments in integrated models of health care and social services on health outcomes and health care spending.", {"entities": []}], ["Of 39 articles that met criteria for inclusion in the review, 32 (82%) reported some significant positive effects on either health outcomes (N = 20), health care costs (N = 5), or both (N = 7).", {"entities": []}], ["Of the remaining 7 (18%) studies, 3 had non-significant results, 2 had mixed results, and 2 had negative results in which the interventions were associated with poorer health outcomes.", {"entities": []}], ["Our analysis of the literature indicates that several interventions in the areas of housing, income support, nutrition support, and care coordination and community outreach have had positive impact in terms of health improvements or health care spending reductions.", {"entities": []}], ["These interventions may be of interest to health care policymakers and practitioners seeking to leverage social services to improve health or reduce costs.", {"entities": []}], ["Further testing of models that achieve better outcomes at less cost is needed.", {"entities": []}], ["This report identifies mitochondrial DNA (mtDNA) as a target and active mediator that links low-level oxidative stress to inflammatory response in pulmonary epithelial cells.", {"entities": []}], ["Extrusion of mtDNA into the bronchoalveolar lavage fluid occurs as an early event in mice subjected to cigarette smoke injury, concomitantly with the depletion of mtDNA in the lung tissue.", {"entities": []}], ["In cultured lung epithelial cells, prolonged, low-level oxidative stress damages the mtDNA, without any detectable damage to the nuclear DNA.", {"entities": []}], ["In turn, cellular depletion of the mtDNA occurs, together with a transient remodeling of cellular bioenergetics and morphology - all without any detectable impairment in overall cell viability.", {"entities": []}], ["Damaged mtDNA first enters the cytoplasm, where it binds to Z-DNA binding protein 1 (ZBP1) and triggers inflammation via the TANK-binding kinase 1 /interferon regulatory factor 3 signaling pathway.", {"entities": [[85, 89, "GENE"]]}], ["Fragments of the mtDNA are subsequently released into the extracellular space via exosomes.", {"entities": []}], ["MtDNA-containing exosomes are capable of inducing an inflammatory response in na\u00efve (non-oxidatively stressed) epithelial cells.", {"entities": []}], ["In vivo , administration of isolated mtDNA into the in lungs of na\u00efve mice induces the production of pro-inflammatory mediators, without histopathologic evidence of tissue injury.", {"entities": []}], ["We propose that mtDNA-specific damage, and subsequent activation of the ZBP1 pathway, is a mechanism that links prolonged, low-level oxidative stress to autocrine and paracrine inflammation during the early stages of inflammatory lung disease.", {"entities": [[230, 242, "DISEASE"], [72, 76, "GENE"]]}], ["Definitions of healthy ageing include survival to a specific age, being free of chronic diseases, autonomy in activities of daily living, wellbeing, good quality of life, high social participation, only mild cognitive or functional impairment, and little or no disability.", {"entities": []}], ["The working group Epidemiology of Ageing of the German Association of Epidemiology organized a workshop in 2012 with the aim to present different indicators used in German studies and to discuss their impact on health for an ageing middle-European population.", {"entities": []}], ["Workshop presentations focused on prevalence of chronic diseases and multimorbidity, development of healthy life expectancy at the transition to oldest-age, physical activity, assessment of cognitive capability, and functioning and disability in old age.", {"entities": []}], ["The communication describes the results regarding specific indicators for Germany, and hereby contributes to the further development of a set of indicators for the assessment of healthy ageing.", {"entities": []}], ["Little is known about the occurrence and distribution of types of paraneoplastic syndromes (PNS) in patients with lung cancer.", {"entities": [[114, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["Identification of autoimmune PNS is particularly important for discerning them from immune-related adverse events of novel immunotherapies.", {"entities": []}], ["We estimated the occurrence of PNS among patients with lung cancer and compared it with that in the general population.", {"entities": [[55, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["In this registry-based cohort study in Denmark, we identified all patients with incident primary lung cancer between 1997 and 2010, and in a general-population comparison cohort matched on calendar time, sex, age, and residence.", {"entities": [[97, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["Among patients with non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), we estimated prevalence of potential PNS and selected autoimmune conditions and compared their incidence rates with those of equivalent conditions in the general population cohort, using hazard ratios (HRs) adjusted for baseline comorbidity.", {"entities": [[35, 46, "DISEASE"], [70, 81, "DISEASE"], [40, 46, "DISEASE"], [75, 81, "DISEASE"]]}], ["There were 35,319 patients with NSCLC and 6,711 patients with SCLC.", {"entities": []}], ["The incidence rates per 1000 person-years (95% confidence interval) of any potential PNS or selected autoimmune disorders were 135.4 (131.9\u2013139.1) among NSCLC patients and 237.3 (224.4\u2013250.5) among SCLC patients.", {"entities": []}], ["Adjusted HRs for any potential PNS or selected autoimmune disorders were 4.8 (4.7\u20135.0) for NSCLC and 8.2 (7.6\u20138.8) for SCLC.", {"entities": []}], ["Incidence rate of any potential PNS or selected autoimmune disorders among patients with lung cancer was greater than that in the general population and was greater after SCLC than after NSCLC.", {"entities": [[89, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["These results provide context to discerning PNS from adverse effects of novel immunotherapies during the clinical course of NSCLC and SCLC.", {"entities": []}], ["Physical activity, screen viewing, sleep, and homework among children have been independently linked to health outcomes.", {"entities": []}], ["However, few studies have assessed the independent associations between time spent in daily activities and children\u2019s physical and mental health.", {"entities": []}], ["This study describes time spent in four activities among primary school students in Shanghai, and examines the relationship between daily time-use patterns and obesity and mental health.", {"entities": [[160, 167, "DISEASE"]]}], ["The representative sample consists of 17,318 children aged 6\u201311 years in Shanghai.", {"entities": []}], ["Time spent in moderate to vigorous physical activities (MVPA), screen viewing, sleep, and homework was measured by validated questionnaires.", {"entities": []}], ["Logistic regressions were performed.", {"entities": []}], ["We also fitted generalized additive models (GAM) and performed two-objective optimization to minimize the probability of poor mental health and obesity.", {"entities": [[144, 151, "DISEASE"]]}], ["In 2014, 33.7% of children spent \u02c21\u2009hour/day on MVPA, 15.6% spent\u2009\u2265\u20092\u2009hours/day on screen viewing, 12.4% spent \u02c2 9\u2009hours/day on sleep, and 27.2% spent\u2009\u2265\u20092\u2009hours/day on homework.", {"entities": []}], ["The optimization results suggest that considering the 24-hour time limit, children face trade-offs when allocating time.", {"entities": []}], ["A priority should be given to the duration of sleep and MVPA.", {"entities": []}], ["Screen exposure should be minimized to save more time for sleep and other beneficial activities.", {"entities": []}], ["Gene-mapping studies, regularly, rely on examination for Mendelian transmission of marker alleles in a pedigree as a way of screening for genotyping errors and mutations.", {"entities": []}], ["For analysis of family data sets, it is, usually, necessary to resolve or remove the genotyping errors prior to consideration.", {"entities": []}], ["At the Center of Inherited Disease Research (CIDR), to deal with their large-scale data flow, they formalized their data cleaning approach in a set of rules based on PedCheck output.", {"entities": []}], ["We scrutinize via carefully designed simulations that how well CIDR\u2019s data cleaning rules work in practice.", {"entities": []}], ["We found that genotype errors in siblings are detected more often than in parents for less polymorphic SNPs and vice versa for more polymorphic SNPs.", {"entities": []}], ["Through computer simulations, we conclude that some of the CIDR\u2019s rules work poorly in some circumstances, and we suggest a set of modified data cleaning rules that may work better than CIDR\u2019s rules.", {"entities": []}], ["Numerous studies have reported associations between delivery mode and health outcomes in infancy and later life.", {"entities": []}], ["Previous smaller studies indicated a relationship between delivery mode and newborn inflammation potentially constituting a mediating factor.", {"entities": []}], ["We aimed to determine the influence of delivery mode and duration of labor on cord blood concentrations of adiponectin, leptin, and high-sensitivity C-reactive protein (hs-CRP).", {"entities": []}], ["In the Ulm SPATZ Health Study, 934 singleton newborns and their mothers were recruited during their hospital stay in the University Medical Center Ulm, Southern Germany, from 04/2012-05/2013.", {"entities": []}], ["Inflammatory biomarkers were measured by ELISAs (n = 836).", {"entities": []}], ["Delivery mode was analyzed categorically (elective cesarean (reference), active labor delivery: emergency cesarean, assisted vaginal, and spontaneous vaginal); duration of labor continuously.", {"entities": []}], ["Following log-transformation, linear regression was used to estimate geometric means ratios (GMR) adjusted for potential confounders for the effects of delivery mode and duration of labor on each biomarker separately.", {"entities": []}], ["Independent replication was sought in the similarly conducted Ulm Birth Cohort Study recruited from 11/2000-11/2001.", {"entities": []}], ["Individually, active labor delivery modes as well as increasing duration of labor were associated with higher leptin and hs-CRP concentrations.", {"entities": []}], ["After mutual adjustment, the associations with delivery modes were attenuated but those for duration of labor remained statistically significant (GMR (95%CI) 1.10 (1.00; 1.21) and 1.15 (1.04; 1.27) for leptin and hs-CRP per hour of labor, respectively).", {"entities": []}], ["No significant adjusted associations were observed between delivery modes and adiponectin concentrations.", {"entities": []}], ["These findings were replicated in an independent birth cohort study.", {"entities": []}], ["Cord blood leptin and hs-CRP concentrations were associated with duration of labor rather than delivery mode.", {"entities": []}], ["Further research is warranted to investigate these associations with additional cytokines involved in inflammatory response to delineate the inflammatory profile.", {"entities": []}], ["Subsequently, research on determinants of these associations and their role in development of chronic disease is needed.", {"entities": []}], ["On the basis of our recent findings of oncogenic KRAS-induced interleukin-8 (IL-8) overexpression in non-small cell lung cancer, we assessed the clinicopathological and prognostic significances of IL-8 expression and its relationship to KRAS mutations in lung adenocarcinomas.", {"entities": [[116, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["IL-8 expression was examined by quantitative RT\u2013PCR using 136 of surgical specimens from lung adenocarcinoma patients.", {"entities": [[94, 108, "DISEASE"], [89, 108, "DISEASE"]]}], ["The association between IL-8 expression, clinicopathological features, KRAS or EGFR mutation status and survival was analysed.", {"entities": [[79, 83, "GENE"]]}], ["IL-8 was highly expressed in tumours from elderly patients or smokers and in tumours with pleural involvement or vascular invasion.", {"entities": []}], ["In a non-smokers' subgroup, IL-8 level positively correlated with age.", {"entities": []}], ["IL-8 was highly expressed in tumours with KRAS mutations compared with those with EGFR mutations or wild-type EGFR / KRAS .", {"entities": [[82, 86, "GENE"], [110, 114, "GENE"], [82, 86, "GENE"], [110, 114, "GENE"]]}], ["Lung adenocarcinoma patients with high IL-8 showed significantly shorter disease-free survival (DFS) and overall survival (OS) than those with low IL8 .", {"entities": [[5, 19, "DISEASE"], [0, 19, "DISEASE"], [147, 150, "GENE"]]}], ["DFS and OS were significantly shorter in the patients with mutant KRAS /high IL-8 than in those with wild-type KRAS /low IL-8 .", {"entities": []}], ["Cox regression analyses demonstrated that elevated IL-8 expression correlated with unfavourable prognosis.", {"entities": []}], ["Our findings suggest that IL-8 expression is associated with certain clinicopathological features including age and is a potent prognostic marker in lung adenocarcinoma, especially in oncogenic KRAS -driven adenocarcinoma.", {"entities": [[154, 168, "DISEASE"], [207, 221, "DISEASE"], [149, 168, "DISEASE"]]}], ["This study evaluated the effect of antiasthmatic medication on the surface roughness and color stability of dental restorative materials.", {"entities": []}], ["A total of 60 disc-shaped specimens were fabricated from glass ionomer (n = 20), composite resin (n = 20) and feldspathic porcelain (n = 20).", {"entities": []}], ["Each material group was randomly divided into two subgroups (n = 10): (1) control group and (2) test group.", {"entities": []}], ["Control groups of the specimens were kept in artificial saliva.", {"entities": []}], ["Test groups were exposed to salbutamol sulfate (Ventolin Nebules) using an inhaler machine.", {"entities": []}], ["Surface roughness measurements were done using a profilometry and color measurements were done with digital colorimetry at baseline and after inhalation and storing in artificial saliva.", {"entities": []}], ["A two-way analysis of variance (ANOVA) and post-hoc Fisher's least significant difference test were used to compare the change in surface roughness and color.", {"entities": []}], ["The confidence level was set at 95%.", {"entities": []}], ["Inhaler treatment significantly increased the surface roughness and color change of glass ionomer and composite resin materials (p < 0.05), while the surface roughness and color of feldspathic porcelain was not changed after inhaler treatment (p > 0.05).", {"entities": []}], ["The antiasthmatic inhaler medication (salbutamol sulfate) affected the surface roughness and color of composite resin and glass ionomer restorative materials.", {"entities": []}], ["In Germany, routine childhood varicella vaccination was implemented in 2004 with two doses recommended since 2009.", {"entities": []}], ["We used an immunisation information system based on countrywide health insurance claims data to analyse vaccine effectiveness (VE) and factors influencing VE.", {"entities": []}], ["We applied proportional hazard models to estimate VE under various conditions and compared the risk of acquiring varicella among unvaccinated children in regions with high vs low vaccination coverage (VC).", {"entities": []}], ["Among 1.4 million children we identified 29,404 varicella cases over a maximum follow-up of 8 years post-vaccination.", {"entities": []}], ["One-dose VE was 81.9% (95% confidence interval (CI): 81.4\u201382.5), two-dose VE 94.4% (95% CI: 94.2\u201394.6).", {"entities": []}], ["With dose one given 1\u201327 days after measles-containing vaccine (MCV), one-dose VE was 32.2% (95% CI: 10.4\u201348.6), two-dose VE 92.8% (95% CI: 84.8\u201396.6).", {"entities": [[36, 43, "DISEASE"]]}], ["VE was not associated with age at vaccination (11\u201314 vs\u2009\u2265\u200915 months), time since vaccination, or vaccine type.", {"entities": []}], ["Unvaccinated children had a twofold higher risk of acquiring varicella in low VC regions.", {"entities": []}], ["Our system generated valuable data, showing that two-dose varicella vaccination provides good protection for at least 8 years.", {"entities": []}], ["Unvaccinated children benefit from herd effects.", {"entities": []}], ["When the first varicella vaccine dose is given shortly after MCV, a second dose is essential.", {"entities": []}], ["Influenza is a contagious respiratory acute viral disease characterized by a short incubation period, high fever and respiratory and systemic symptoms.", {"entities": [[0, 9, "DISEASE"]]}], ["The burden of influenza is very heavy.", {"entities": [[14, 23, "DISEASE"]]}], ["Indeed, the World Health Organization (WHO) estimates that annual epidemics affect 5-15% of the world's population, causing up to 4-5 million severe cases and from 250,000 to 500,000 deaths.", {"entities": []}], ["In order to design anti-influenza molecules and compounds, it is important to understand the complex replication cycle of the influenza virus.", {"entities": [[24, 33, "DISEASE"], [126, 135, "DISEASE"]]}], ["Replication is achieved through various stages.", {"entities": []}], ["First, the virus must engage the sialic acid receptors present on the free surface of the cells of the respiratory tract.", {"entities": []}], ["The virus can then enter the cells by different routes (clathrin-mediated endocytosis or CME, caveolae-dependent endocytosis or CDE, clathrin-caveolae-independent endocytosis, or macropinocytosis).", {"entities": []}], ["CME is the most usual pathway; the virus is internalized into an endosomal compartment, from which it must emerge in order to release its nucleic acid into the cytosol.", {"entities": []}], ["The ribonucleoprotein must then reach the nucleus in order to begin the process of translation of its genes and to transcribe and replicate its nucleic acid.", {"entities": []}], ["Subsequently, the RNA segments, surrounded by the nucleoproteins, must migrate to the cell membrane in order to enable viral assembly.", {"entities": []}], ["Finally, the virus must be freed to invade other cells of the respiratory tract.", {"entities": []}], ["All this is achieved through a synchronized action of molecules that perform multiple enzymatic and catalytic reactions, currently known only in part, and for which many inhibitory or competitive molecules have been studied.", {"entities": []}], ["Some of these studies have led to the development of drugs that have been approved, such as Amantadine, Rimantadine, Oseltamivir, Zanamivir, Peramivir, Laninamivir, Ribavirin and Arbidol.", {"entities": []}], ["This review focuses on the influenza lifecycle and on the currently available drugs, while potential antiviral compounds for the prevention and treatment of influenza are considered in the subsequent review.", {"entities": [[27, 36, "DISEASE"], [157, 166, "DISEASE"]]}], ["Air pollution can cause respiratory symptoms or exacerbate pre-existing respiratory diseases, especially in children.", {"entities": []}], ["This study looked at the short-term association of air pollution concentrations with Emergency Room (ER) admissions for respiratory reasons in pediatric age (0\u201318 years).", {"entities": []}], ["Daily number of ER admissions in a children\u2019s Hospital, concentrations of urban-background PM 2.5 , NO 2 , O 3 and total aeroallergens (Corylaceae, Cupressaceae, Gramineae, Urticaceae, Ambrosia, Betula) were collected in Turin, northwestern Italy, for the period 1/08/2008 to 31/12/2010 (883\u00a0days).", {"entities": []}], ["The associations between exposures and ER admissions were estimated, at time lags between 0 and 5\u00a0days, using generalized linear Poisson regression models, adjusted for non-meteorological potential confounders.", {"entities": []}], ["In the study period, 21,793 ER admissions were observed, mainly (81\u00a0%) for upper respiratory tract infections.", {"entities": []}], ["Median air pollution concentrations were 22.0, 42.5, 34.1\u00a0\u03bcg/m 2.5 , NO 2 , and O 3 , respectively, and 2.9 grains/m 2 , and by 0.7\u00a0% (95 % CI: 0.1-1.2\u00a0%) one day after a 10 grains/m 2.5 concentrations.", {"entities": []}], ["ER admissions were negatively associated with O 3 and aeroallergen concentrations at some time lags, but these association shifted to the null when meteorological confounders were adjusted for in the models.", {"entities": []}], ["Overall, these findings confirm adverse short-term health effects of air pollution on the risk of ER admission in children and encourage a careful management of the urban environment to health protection.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-3376-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This archival cross-sectional investigation examined the impact of mood, reproductive status (RS), and age on polysomnographic (PSG) measures in women.", {"entities": []}], ["PSG was performed on 73 normal controls (NC) and 64 depressed patients (DP), in the course of studies in menstruating, pregnant, postpartum, and peri- and postmenopausal women.", {"entities": []}], ["A two-factor, between-subjects multivariate analysis of variance (MANOVA) was used to test the main effects of reproductive status (RS: menstrual vs pregnant vs postpartum vs menopausal) and diagnosis (NC vs DP), and their interaction, on PSG measures.", {"entities": []}], ["To further refine the analyses, a two-factor, between subjects MANOVA was used to test the main effects of age (19 to 27 vs 28 to 36 vs 37 to 45 vs 46+ years) and diagnosis on the PSG data.", {"entities": []}], ["Analyses revealed that in DP women, rapid eye movement (REM) sleep percentage was significantly elevated relative to NC across both RS and age.", {"entities": []}], ["Significant differences in sleep efficiency, Stage 1%, and REM density were associated with RS; differences in total sleep time, Stage 2 percentage, and Stage 4 percentage were associated with differences in age.", {"entities": []}], ["Both RS and age were related to differences in sleep latency, Stage 3 percentage, and Delta percentage.", {"entities": []}], ["Finally, wake after sleep onset time, REM percentage, and REM latency did not vary with respect to RS or age.", {"entities": []}], ["Overall, this investigation examined three major variables (mood, RS, and age) that are known to impact sleep in women.", {"entities": []}], ["Of the variables, age appeared to have the greatest impact on PSG sleep measures, reflecting changes occurring across the lifespan.", {"entities": []}], ["Guidelines on immunoprophylaxis for prevention of RSV infection recommend it in preterm babies born before 29 wGA; in babies affected by bronchopulmonary dysplasia or congenital heart defects; and in post-heart transplantation patients.", {"entities": []}], ["On the contrary, immunoprophylaxis is not recommended in preterm babies born between 29 and 35 wGA.", {"entities": []}], ["We evaluated the impact of RSV-related healthcare expenditures in infants in the first 3\u00a0years of life in Italy, Lombardy Region.", {"entities": []}], ["In light of the collected data and considering the cost of a complete palivizumab prophylaxis, extending it to babies 29\u201332 wGA, aged less than 6\u00a0months, appears to be a cost-effective strategy.", {"entities": []}], ["Objectives To test whether bisphosphonate use is related to improved implant survival after total arthroplasty of the knee or hip.", {"entities": []}], ["Design Population based retrospective cohort study.", {"entities": []}], ["Setting Primary care data from the United Kingdom.", {"entities": []}], ["Participants All patients undergoing primary total arthroplasty of the knee (n=18\u2009726) or hip (n=23\u2009269) in 1986-2006 within the United Kingdom\u2019s General Practice Research Database.", {"entities": []}], ["We excluded patients with a history of hip fracture before surgery or rheumatoid arthritis, and individuals younger than 40 years at surgery.", {"entities": [[70, 90, "DISEASE"], [81, 90, "DISEASE"]]}], ["Intervention Bisphosphonate users were classified as patients with at least six prescriptions of bisphosphonates or at least six months of prescribed bisphosphonate treatment with more than 80% adherence before revision surgery.", {"entities": []}], ["Outcome measures Revision arthroplasties occurring after surgery, identified by READ and OXMIS codes.", {"entities": []}], ["Parametric survival models were used to determine effects on implant survival with propensity score adjustment to account for confounding by indication.", {"entities": []}], ["Results Of 41\u2009995 patients undergoing primary hip or knee arthroplasty, we identified 1912 bisphosphonate users, who had a lower rate of revision at five years than non-users (0.93% (95% confidence interval 0.52% to 1.68%) v 1.96% (1.80% to 2.14%)).", {"entities": []}], ["Implant survival was significantly longer in bisphosphonate users than in non-users in propensity adjusted models (hazard ratio 0.54 (0.29 to 0.99); P=0.047) and had an almost twofold increase in time to revision after hip or knee arthroplasty (time ratio 1.96 (1.01 to 3.82)).", {"entities": []}], ["Assuming 2% failure over five years, we estimated that the number to treat to avoid one revision was 107 for oral bisphosphonates.", {"entities": []}], ["Conclusions In patients undergoing lower limb arthroplasty, bisphosphonate use was associated with an almost twofold increase in implant survival time.", {"entities": []}], ["These findings require replication and testing in experimental studies for confirmation.", {"entities": []}], ["Adverse drug events (ADEs) are common in older people and contribute significantly to emergency department (ED) visits, unplanned hospitalisations, healthcare costs, morbidity and mortality.", {"entities": []}], ["Many ADEs are avoidable if attention is directed towards identifying and preventing inappropriate drug use and undesirable drug combinations.", {"entities": []}], ["Tools exist to identify potentially inappropriate prescribing (PIP) in clinical settings, but they are underused.", {"entities": []}], ["Applying PIP assessment tools to population-wide health administrative data could provide an opportunity to assess the impact of PIP on individual patients as well as on the healthcare system.", {"entities": []}], ["This would open new possibilities for interventions to monitor and optimise medication management on a broader, population-level scale.", {"entities": []}], ["The aim of this study is to describe the occurrence of PIP in Ontario's older population (aged 65\u2005years and older), and to assess the health outcomes and health system costs associated with PIP\u2014more specifically, the association between PIP and the occurrence of ED visits, hospitalisations and death, and their related costs.", {"entities": []}], ["This will be done within the framework of a population-based retrospective cohort study using Ontario's large health administrative and population databases.", {"entities": []}], ["Eligible patients aged 66\u2005years and older who were issued at least 1 prescription between 1 April 2003 and 31 March 2014 (approximately 2 million patients) will be included.", {"entities": []}], ["Ethical approval was obtained from the Ottawa Health Services Network Ethical Review Board and from the Bruy\u00e8re Research Institute Ethics Review Board.", {"entities": []}], ["Dissemination will occur via publication, presentation at national and international conferences, and ongoing exchanges with regional, provincial and national stakeholders, including the Ontario Drug Policy Research Network and the Ontario Ministry of Health and Long-Term Care.", {"entities": []}], ["Registered with clinicaltrials.gov (registration number: NCT02555891).", {"entities": []}], ["The interactions among genetic factors related to diseases are called epistasis.", {"entities": []}], ["With the availability of genotyped data from genome-wide association studies, it is now possible to computationally unravel epistasis related to the susceptibility to common complex human diseases such as asthma, diabetes, and hypertension.", {"entities": [[227, 239, "DISEASE"], [205, 211, "DISEASE"]]}], ["However, the difficulties of detecting epistatic interaction arose from the large number of genetic factors and the enormous size of possible combinations of genetic factors.", {"entities": []}], ["Most computational methods to detect epistatic interactions are predictor-based methods and can not find true causal factor elements.", {"entities": []}], ["Moreover, they are both time-consuming and sample-consuming.", {"entities": []}], ["We propose a new and fast Markov Blanket-based method, FEPI-MB (Fast EPistatic Interactions detection using Markov Blanket), for epistatic interactions detection.", {"entities": []}], ["The Markov Blanket is a minimal set of variables that can completely shield the target variable from all other variables.", {"entities": []}], ["Learning of Markov blankets can be used to detect epistatic interactions by a heuristic search for a minimal set of SNPs, which may cause the disease.", {"entities": []}], ["Experimental results on both simulated data sets and a real data set demonstrate that FEPI-MB significantly outperforms other existing methods and is capable of finding SNPs that have a strong association with common diseases.", {"entities": []}], ["FEPI-MB algorithm outperforms other computational methods for detection of epistatic interactions in terms of both the power and sample-efficiency.", {"entities": []}], ["Moreover, compared to other Markov Blanket learning methods, FEPI-MB is more time-efficient and achieves a better performance.", {"entities": []}], ["The many randomized trials of the collaborative care model for improving depression in primary care have not described the implementation and maintenance of this model.", {"entities": []}], ["This paper reports how and the degree to which collaborative care process changes were implemented and maintained for the 75 primary care clinics participating in the DIAMOND Initiative (Depression Improvement Across Minnesota\u2013Offering a New Direction).", {"entities": []}], ["Each clinic was trained to implement seven components of the model and participated in ongoing evaluation and facilitation activities.", {"entities": []}], ["For this study, assessment of clinical process implementation was accomplished via completion of surveys by the physician leader and clinic manager of each clinic site at three points in time.", {"entities": []}], ["The physician leader of each clinic completed a survey measure of the presence of various practice systems prior to and one and two years after implementation.", {"entities": []}], ["Clinic managers also completed a survey of organizational readiness and the strategies used for implementation.", {"entities": []}], ["Survey response rates were 96% to 100%.", {"entities": []}], ["The systems survey confirmed a very high degree of implementation (with large variation) of DIAMOND depression practice systems (mean of 24.4\u2009\u00b1\u200914.6%) present at baseline, 57.0\u2009\u00b1\u200921.0% at one year (P\u2009=\u2009<0.0001), and 55.9\u2009\u00b1\u200921.3% at two years.", {"entities": []}], ["There was a similarly large increase (and variation) in the use of various quality improvement strategies for depression (mean of 29.6\u2009\u00b1\u200928.1% at baseline, 75.1\u2009\u00b1\u200922.3% at one year (P\u2009=\u2009<0.0001), and 74.6\u2009\u00b1\u200923.0% at two years.", {"entities": []}], ["This study demonstrates that under the right circumstances, primary care clinics that are prepared to implement evidence-based care can do so if financial barriers are reduced, effective training and facilitation are provided, and the new design introduces the specific mental models, new care processes, and workers and expertise that are needed.", {"entities": []}], ["Implementation was associated with a marked increase in the number of improvement strategies used, but actual care and outcomes data are needed to associate these changes with patient outcomes and patient-reported care.", {"entities": []}], ["Time is a crucial parameter in the assessment of comorbidities in population-based studies, as it permits to identify more complex disease patterns apart from the pairwise disease associations.", {"entities": []}], ["So far, it has been, either, completely ignored or only, taken into account by assessing the temporal directionality of identified comorbidity pairs.", {"entities": []}], ["In this work, a novel time-analysis framework is presented for large-scale comorbidity studies.", {"entities": []}], ["The disease-history vectors of patients of a regional Spanish health dataset are represented as time sequences of ordered disease diagnoses.", {"entities": []}], ["Statistically significant pairwise disease associations are identified and their temporal directionality is assessed.", {"entities": []}], ["Subsequently, an unsupervised clustering algorithm, based on Dynamic Time Warping, is applied on the common disease trajectories in order to group them according to the temporal patterns that they share.", {"entities": []}], ["The proposed methodology for the temporal assessment of such trajectories could serve as the preliminary basis of a disease prediction system.", {"entities": []}], ["The identification of poor medicinal adherence is difficult because direct observation of medication use is usually impractical.", {"entities": []}], ["Up to 50% of individuals on chronic therapies may not be taking their medication as prescribed.", {"entities": []}], ["This study is one of the first to explore possible risk factors for over-reporting of antihypertensive adherence using electronic medication monitoring.", {"entities": []}], ["The adherence of 286 individuals on single-drug antihypertensive therapy in a large managed care organization was electronically monitored for approximately three months.", {"entities": []}], ["Questionnaires on socioeconomic background, adherence to therapy, health beliefs, and social support before and after adherence monitoring were completed.", {"entities": []}], ["Over-reporting of antihypertensive adherence was assessed by comparing the self-reported frequency of noncompliance with that determined from electronic dosing records.", {"entities": []}], ["Risk factors for over-reporting were identified by contingency table analysis and step-wise logistic regression.", {"entities": []}], ["Although only 21% of participants acknowledged missing doses on one or more days per week, electronic monitoring documented nonadherence at this or a higher level in 42% of participants.", {"entities": []}], ["The following variables were associated with over-reporting: >1 versus 1 daily dose (OR = 2.58; 95% CI = 1.50\u20134.41; p = .0006), lower perceived health risk from nonadherence (OR = 1.35; 95% CI = 1.10\u20131.64; p = .0035), and annual household income of <$15,000 versus >$30,000 (OR = 2.64; 95% CI = 1.13\u20136.18; p = .025).", {"entities": []}], ["Over-reporting of adherence may be affected by factors related to dosing frequency, health beliefs and socioeconomic status.", {"entities": []}], ["This topic deserves further investigation in other patient populations to elucidate possible underlying behavioral explanations.", {"entities": []}], ["Understanding how people of diverse cultural backgrounds have traditionally used plants and animals as medicinal substances during displacements is one of the most important objectives of ethnopharmacological studies.", {"entities": []}], ["An ethnopharmacological survey conducted among migrants living in the Southeast Atlantic Forest remnants (Diadema, S\u00e3o Paulo, Brazil) is presented herein.", {"entities": []}], ["Ethnographical methods were used to select and interview the migrants, and botanical and zoological techniques were employed to collect the indicated resources.", {"entities": []}], ["We interviewed five migrants who described knowledge on 12 animals and 85 plants.", {"entities": []}], ["Only 78 plants were present in Diadema, they belong to 37 taxonomic families; 68 were used exclusively for medicinal purposes, whereas 10 were reported to be toxic and/or presented some restriction of use.", {"entities": []}], ["These taxa were grouped into 12 therapeutic categories (e.g., gastrointestinal disturbances, inflammatory processes or respiratory problems) based on the 41 individual complaints cited by the migrants.", {"entities": []}], ["While the twelve animal species were used by the migrants to treat nine complaints; these were divided into six categories, the largest of which related to respiratory problems.", {"entities": []}], ["None of the animal species and only 57 of the 78 plant species analysed in the present study were previously reported in the pharmacological literature; the popular knowledge concurred with academic findings for 30 of the plants.", {"entities": []}], ["The seven plants [ Impatiens hawkeri W.", {"entities": []}], ["Bull., Artemisia canphorata Vill., Equisetum arvensis L., Senna pendula (Humb.", {"entities": []}], ["Irwin & Barneby, Zea mays L., Fevillea passiflora Vell.", {"entities": []}], ["and Croton fuscescens Spreng)] and the two animals ( Atta sexdens and Periplaneta americana ) that showed maintenance of use among migrants during their displacement in Brazilian territory, have not been studied by pharmacologists yet.", {"entities": []}], ["Thus, they should be highlighted and focused in further pharmacology and phytochemical studies, since the persistence of their uses can be indicative of bioactive potentials.", {"entities": []}], ["Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) are antipyretic analgesics with established adverse effects (AEs); however, only a few studies have compared their AEs simultaneously.", {"entities": []}], ["We aimed to compare the AEs of these medications to confirm the respective frequencies of both rare and major AEs.", {"entities": []}], ["We used a high-quality database for spontaneous adverse drug event reporting in Japan.", {"entities": []}], ["Data were extracted regarding the AEs of acetaminophen and NSAIDs to compare the tendency of the appearance of those AEs between the drugs.", {"entities": []}], ["We also performed a principal component analysis using the AE data to assess the characteristics of major AEs.", {"entities": []}], ["Cutaneous disorders and hepatic disorders were the most common AEs induced by acetaminophen and NSAIDs, with gastrointestinal tract disorders also common with NSAID use.", {"entities": []}], ["Principal component analysis quantitatively showed the tendencies of specific AEs, and it helped demonstrate the characteristics of AEs.", {"entities": []}], ["Acetaminophen and NSAIDs showed different tendencies in the occurrence of AEs.", {"entities": []}], ["Each NSAID was plotted based on the tendency of the appearance of major AEs, and AEs were classified by their likelihood of being pharmacological or idiosyncratic.", {"entities": []}], ["These findings may help clinicians select an appropriate drug for patients considering their backgrounds, instead of choosing merely based on the class of the drug, for example, cyclooxygenase selectivity.", {"entities": []}], ["This selection, based on the characteristic information on AEs occurring in clinical settings, might be more suitable for patients.", {"entities": []}], ["Criteria pollutants have been associated with exacerbation of children\u2019s asthma, but the role of air toxics in relation to asthma is less clear.", {"entities": [[73, 79, "DISEASE"], [123, 129, "DISEASE"]]}], ["Our objective was to evaluate whether exposure to outdoor air toxics in early childhood increased asthma risk or severity.", {"entities": [[98, 104, "DISEASE"]]}], ["Air toxics exposure was estimated using the 2002 National Air toxics Assessment (NATA) and linked to longitudinal data (n=6950) from a representative sample of US children born in 2001 and followed through kindergarten-age in the Early Child Longitudinal Study - Birth Cohort (ECLS-B).", {"entities": []}], ["Overall, 17.7% of 5.5 year-olds had ever been told by a healthcare professional they had asthma, and 6.8% had been hospitalized or visited an emergency room for an asthma attack.", {"entities": [[89, 95, "DISEASE"], [164, 170, "DISEASE"]]}], ["Higher rates of asthma were observed among boys (20.1%), low-income (24.8%), and non-Hispanic black children (30.0%) (p\u22640.05).", {"entities": [[16, 22, "DISEASE"]]}], ["Air toxics exposure was greater for minority race/ethnicity (p<0.0001), low income (p<0.0001), non-rural area (p<0.001).", {"entities": []}], ["Across all analyses, greater air toxics exposure, as represented by total NATA respiratory hazard index, or when limited to respiratory hazard index from onroad mobile sources or diesel PM, was not associated with a greater prevalence of asthma or hospitalizations (p trend >0.05).", {"entities": [[238, 244, "DISEASE"]]}], ["In adjusted logistic regression models, children exposed to the highest respiratory hazard index were not more likely to have asthma compared to those exposed to the lowest respiratory hazard index of total, onroad sources, or diesel PM.", {"entities": [[126, 132, "DISEASE"]]}], ["Early childhood exposure to outdoor air toxics in a national sample has not previously been studied relative to children\u2019s asthma.", {"entities": [[123, 129, "DISEASE"]]}], ["Within the constraints of the study, we found no evidence that early childhood exposure to outdoor air toxics increased risk for asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["As has been previously reported, it is evident that there are environmental justice and disparity concerns for exposure to air toxics and asthma prevalence in US children.", {"entities": [[138, 144, "DISEASE"]]}], ["Sports injury and illness surveillance is the first step in injury and illness prevention, and is important for the protection of both athlete health and performance in major competitions.", {"entities": []}], ["To identify the prevalence, severity nature and causes of athlete injuries and illnesses in the Great Britain Olympic Team (TeamGB) during the Sochi 2014 Winter Olympic Games.", {"entities": []}], ["The observational prospective cohort study followed the Great Britain Injury/Illness Performance Project surveillance methodology and obtained information on injuries and illnesses that occurred during the Games between 30 January and 23 February 2014 in TeamGB athletes (n=56).", {"entities": []}], ["Among the 56 TeamGB athletes, there were 27 injuries and 11 illnesses during the Olympic Games period.", {"entities": []}], ["This equated to 39% sustaining at least one injury and 18% at least one illness, with an incidence of 48.2 injuries and 19.6 illnesses per 100 athletes, respectively.", {"entities": []}], ["Of all injuries and illnesses, 9% and 7%, respectively, resulted in time loss.", {"entities": []}], ["The risk of sustaining an injury was highest for freestyle skiing, skeleton and snowboarding; and lowest for curling, biathlon and Alpine skiing (with no reported injuries); with the lower limb being the most commonly injured location.", {"entities": []}], ["Respiratory system illnesses were most frequently reported overall, and older female athletes were the ones most affected by illness.", {"entities": []}], ["The risk of injury was double the risk of illness for TeamGB athletes.", {"entities": []}], ["Overall, the rate of time-loss issues was low.", {"entities": []}], ["Methodological considerations are important when interpreting data, and prevention strategies should focus on those issues causing the greatest risk, in terms of prevalence and severity, to athlete health and performance.", {"entities": []}], ["mRNA expression profiles provide important insights on a diversity of biological processes involved in rectal carcinoma (RC).", {"entities": [[110, 119, "DISEASE"]]}], ["Our aim was to comprehensively map complex interactions between the mRNA expression patterns and the clinical traits of RC.", {"entities": []}], ["We employed the integrated analysis of five microarray datasets and The Cancer Genome Atlas rectal adenocarcinoma database to identify 2118 consensual differentially expressed genes (DEGs) in RC and adjacent normal tissue samples, and then applied weighted gene co-expression network analysis to parse DEGs and eight clinical traits in 66 eligible RC samples.", {"entities": [[99, 113, "DISEASE"]]}], ["A total of 16 co-expressed gene modules were identified.", {"entities": []}], ["The green-yellow and salmon modules were most appropriate to the pathological stage (R = 0.36) and the overall survival (HR =13.534, P = 0.014), respectively.", {"entities": [[121, 123, "GENE"]]}], ["A diagnostic model of the five pathological stage hub genes (SCG3, SYP, CDK5R2, AP3B2, and RUNDC3A) provided a powerful classification accuracy between localized RC and non-localized RC.", {"entities": [[61, 65, "GENE"], [67, 70, "GENE"], [72, 78, "GENE"], [80, 85, "GENE"], [91, 98, "GENE"]]}], ["We also found increased Secretogranin III (SCG3) expression with higher pathological stage and poorer prognosis in the test and validation set.", {"entities": [[43, 47, "GENE"]]}], ["The increased Homer scaffolding protein 2 (HOMER2) expression with the favorable survival prediction efficiency significantly correlated with the markedly reduced overall survival of RC patients and the higher pathological stage during the test and validation set.", {"entities": [[43, 49, "GENE"]]}], ["Our findings indicate that the SCG3 and HOMER2 mRNA levels should be further evaluated as predictors of pathological stage and survival in patients with RC.", {"entities": [[31, 35, "GENE"], [40, 46, "GENE"]]}], ["Traditional medicine (TM) has been established as a two-edged sword.", {"entities": []}], ["On one edge numerous forms of TM have been proven safe and effective, while on the other edge various modes of TM have been shown to be futile and potentially dangerous.", {"entities": []}], ["Resorting to TM, especially for chronic diseases, is common world-wide and includes Saudi Arabia.", {"entities": []}], ["Most neurological diseases are chronic.", {"entities": []}], ["No data is available on the utilization of TM among patients with neurological disorders.", {"entities": []}], ["We conducted this study to assess for the prevalence, pattern, perception and triggers for TM use by the adult Saudi patients with neurological disorders.", {"entities": []}], ["A survey written in Arabic and comprised of 15 questions was used to collect data on the practice of TM among the neurology patients of King Saud University Ambulatory Clinic.", {"entities": []}], ["The questions in the survey pertain mainly to the frequency of TM practice, its form and the patient\u2019s opinion of this practice.", {"entities": []}], ["The data was collected through a face to face interview by three medical students who were instructed on the survey questions prior to the launch of the study.", {"entities": []}], ["292 patients completed the survey (35.9% males and 64.0% females).", {"entities": []}], ["67% (n = 196) of the sample used TM.", {"entities": []}], ["Cupping or what is commonly known as \u201chojamah\u201d was the most prevalent method (45.4%) followed by herbs, skin cauterization and the Reciting of the Holy Quran (42.3%, 33.7% and 20.4% respectively).", {"entities": []}], ["The prevalence of TM use did not differ across gender (chi-sq = 2.02; p-value = 0.15), level of education (chi-sq = 4.02; p-value = 0.40), health status (chi-sq = 2.29; p-value = 0.68), age groups (chi-sq = 5.12; p-value = 0.16), or perception toward TM (chi-sq = 2.67; p-value = 0.26) in this population.", {"entities": []}], ["The practice of TM is common among the neurology patients of Saudi Arabia.", {"entities": []}], ["Cupping, herbs, and skin cauterization, which can be harmful when wrongly employed, are frequently utilized in this patient population.", {"entities": []}], ["Measures and policies to endorse the appropriate use of TM by Saudi society must be implemented promptly.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-015-0623-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To assess the influence of variable factors such as the size of the airway and the CT imaging parameters such as the reconstruction kernel, field-of-view (FOV), and slice thickness on the automatic measurement of airway dimension.", {"entities": []}], ["An airway phantom was fabricated that contained eleven poly-acryl tubes of various lumen diameters and wall thicknesses.", {"entities": []}], ["The measured density of the poly-acryl wall was 150 HU, and the measured density of the airspace filled with polyurethane foam was -900 HU.", {"entities": []}], ["CT images were obtained using a 16-MDCT (multidetector CT) scanner and were reconstructed with various reconstruction kernels, thicknesses and FOV.", {"entities": []}], ["The luminal radius and wall thickness were measured using in-house software based on the full-width-half-maximum method.", {"entities": []}], ["The measured values as determined by CT and the actual dimensions of the tubes were compared.", {"entities": []}], ["Measurements were most accurate on images reconstructed with use of a standard kernel (mean error: -0.03 \u00b1 0.21 mm for wall thickness and -0.12 \u00b1 0.11 mm for the luminal radius).", {"entities": []}], ["There was no significant difference in accuracy among images with the use of variable slice thicknesses or a variable FOV.", {"entities": []}], ["Below a 1-mm threshold, the measurement failed to represent the change of the real dimensions.", {"entities": []}], ["Measurement accuracy was strongly influenced by the specific reconstruction kernel utilized.", {"entities": []}], ["For accurate measurement, standardization of the imaging protocol and selection of the appropriate anatomic level are essential.", {"entities": []}], ["The T H 2 cytokines, IL-4 and IL-13, play critical roles in inducing allergic lung inflammation and drive the alternative activation of macrophages (AAM).", {"entities": []}], ["Although both cytokines share receptor subunits, IL-4 and IL-13 have differential roles in asthma pathogenesis: IL-4 regulates T H 2 cell differentiation, while IL-13 regulates airway hyperreactivity and mucus production.", {"entities": [[91, 97, "DISEASE"]]}], ["Aside from controlling T H 2 differentiation, the unique contribution of IL-4 signaling via the Type I receptor in airway inflammation remains unclear.", {"entities": []}], ["Therefore, we analyzed responses in mice deficient in gamma c (\u03b3 c ) to elucidate the role of the Type I IL-4 receptor.", {"entities": []}], ["OVA primed CD4 c c c xRAG2 c c in macrophages, however, resulted in reduced YM1 expression.", {"entities": [[11, 14, "GENE"]]}], ["We observed higher T H 2 cytokine levels in the BAL and an altered DC phenotype in the \u03b3 c c- deficient environment.", {"entities": []}], ["These results demonstrate that in absence of the Type I IL-4R, the Type II R can mediate allergic responses in the presence of T H 2 effectors.", {"entities": []}], ["However, the Type I R regulates AAM protein expression in macrophages.", {"entities": []}], ["Performance in primary school is a determinant of children\u2019s educational attainment and their socio-economic position and health inequalities in adulthood.", {"entities": []}], ["We examined the relationship between five common childhood health conditions (asthma symptoms, eczema, general health, frequent respiratory infections, and overweight), health related school absence and family socio-economic status on children\u2019s school performance.", {"entities": [[78, 84, "DISEASE"]]}], ["We used data from 1,865 children in the Dutch PIAMA birth cohort study.", {"entities": []}], ["School performance was measured as the teacher\u2019s assessment of a suitable secondary school level for the child, and the child\u2019s score on a standardized achievement test (Cito Test).", {"entities": []}], ["Both school performance indicators were standardised using Z-scores.", {"entities": []}], ["Childhood health was indicated by eczema, asthma symptoms, general health, frequent respiratory infections, overweight, and health related school absence.", {"entities": [[42, 48, "DISEASE"]]}], ["Children\u2019s health conditions were reported repeatedly between the age of one to eleven.", {"entities": []}], ["School absenteeism was reported at age eleven.", {"entities": []}], ["Highest attained educational level of the mother and father indicated family socio-economic status.", {"entities": []}], ["We used linear regression models with heteroskedasticity-robust standard errors for our analyses with adjustment for sex of the child.", {"entities": []}], ["The health indicators used in our study were not associated with children\u2019s school performance, independently from parental educational level, with the exception of asthma symptoms (-0.03 z-score / -0.04 z-score with Cito Test score after adjusting for respectively maternal and paternal education) and missing more than 5 schooldays due to illness (-0.18 z-score with Cito Test score and -0.17 z-score with school level assessment after adjustment for paternal education).", {"entities": [[165, 171, "DISEASE"]]}], ["The effect estimates for these health indicators were much smaller though than the effect estimates for parental education, which was strongly associated with children\u2019s school performance.", {"entities": []}], ["Children\u2019s school performance was affected only slightly by a number of common childhood health problems, but was strongly associated with parental education.", {"entities": []}], ["Ficus benghalensis L. (Banyan) is a commonly found tree in Eastern Nepal.", {"entities": []}], ["Its different plant parts are used for various neurological ailments.", {"entities": []}], ["This study was performed in mice to see its effects in various neuropharmacological parameters.", {"entities": []}], ["Passive-avoidance (memory), Open-field (anxiety), Pentobarbital-induced Sleep potentiation (sleep), Rota-rod (muscle-co-ordination), Pentylenetetrazol-Induced and Maximal Electroshock Seizure Tests were performed.", {"entities": []}], ["Sample size was calculated using G*Power 3.1.9.2.", {"entities": []}], ["Aqueous root extracts (Soxhlet method) of Ficus benghalensis 100\u00a0mg/kg and 200\u00a0mg/kg with negative and positive controls were used.", {"entities": []}], ["The experimental results were represented as Mean\u2009\u00b1\u2009SD.", {"entities": []}], ["P-value was set at <0.05.", {"entities": []}], ["Oneway analysis of variance (ANOVA) or Mann-Whitney U test was appropriately used.", {"entities": []}], ["Passive-avoidance test showed 200\u00a0mg/kg group spent significantly less.", {"entities": []}], ["Time (0.00s\u2009+\u20090.00s) in shock-zone than Normal Saline-group (9.67\u00a0s\u2009+\u200914.36\u00a0s, P \u2009=\u20090.000) or Diazepam-group (41.07\u00a0s\u2009+\u200988.24\u00a0s, P \u2009=\u20090.000).", {"entities": []}], ["Open-field test showed 200\u00a0mg/kg group spent significantly longer Time (24.77\u00a0s + 12.23\u00a0s) in central-square than either Normal Saline group (15.08\u00a0s\u2009+\u20096.81\u00a0s, P \u2009=\u20090.000) or Diazepam-group (15.32\u00a0s\u2009+\u20095.12\u00a0s, P \u2009=\u20090.000).", {"entities": []}], ["In Rota-rod test, 200\u00a0mg/kg group fell off the rod significantly ( P \u2009=\u20090.000) earlier (33.01\u00a0s\u2009+\u200943.61\u00a0s) than both Normal Saline (>120\u00a0s) and Diazepam (62.07\u00a0s\u2009+\u200943.83\u00a0s) PTZ model showed that 100\u00a0mg/kg significantly ( P \u2009=\u20090.004) delayed seizure-onset (184.40s\u2009+\u200936.36\u00a0s) compared to Normal Saline (101.79\u00a0s\u2009+\u200922.81\u00a0s), however, in MES model 200\u00a0mg/kg significantly ( P \u2009=\u20090.000) prolonged tonic hind-limb extension (17.57\u00a0s + 2.15\u00a0s) compared to Normal Saline (13.55\u00a0s\u2009+\u20092.75\u00a0s) or Phenytoin (00.00s\u2009+\u200900.00s).", {"entities": []}], ["Aerial roots of Ficus benghalensis have memory-enhancing, anxiolytic, musclerelaxant, and seizure-modifying effect.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-016-1413-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Few studies with a limited number of patients have provided indications that cashew-allergic patients may experience severe allergic reactions to minimal amounts of cashew nut.", {"entities": []}], ["The objectives of this multicentre study were to assess the clinical relevance of cashew nut sensitisation, to study the clinical reaction patterns in double-blind placebo-controlled food challenge tests and to establish the amount of cashew nuts that can elicit an allergic reaction.", {"entities": []}], ["A total of 179 children were included (median age 9.0 years; range 2\u201317 years) with cashew nut sensitisation and a clinical history of reactions to cashew nuts or unknown exposure.", {"entities": []}], ["Sensitised children who could tolerate cashew nuts were excluded.", {"entities": []}], ["The study included three clinical visits and a telephone consultation.", {"entities": []}], ["During the first visit, the medical history was evaluated, physical examinations were conducted, blood samples were drawn and skin prick tests were performed.", {"entities": []}], ["The children underwent a double-blind placebo-controlled food challenge test with cashew nut during the second and third visits.", {"entities": []}], ["The study showed that 137 (76.5%) of the sensitised children suspected of allergy to cashew nut had a positive double-blind placebo-controlled food challenge test, with 46% (63) manifesting subjective symptoms to the lowest dose of 1 mg cashew nut protein and 11% (15) developing objective symptoms to the lowest dose.", {"entities": []}], ["Children most frequently had gastro-intestinal symptoms, followed by oral allergy and skin symptoms.", {"entities": []}], ["A total of 36% (49/137) of the children experienced an anaphylactic reaction and 6% (8/137) of the children were treated with epinephrine.", {"entities": []}], ["This prospective study demonstrated a strikingly high percentage of clinical reactions to cashew nut in this third line population.", {"entities": []}], ["Severe allergic reactions, including anaphylaxis requiring epinephrine, were observed.", {"entities": []}], ["These reactions were to minimal amounts of cashew nut, demonstrated the high potency of this allergens.", {"entities": []}], ["www.ncbi.nlm.nih.gov/pubmed NTR3572", {"entities": []}], ["To explore parents\u2019 experiences and perceptions on informational, management and relational continuity of care for children with special health care needs from hospitalization to the first months after discharge to the home.", {"entities": []}], ["Semi-structured interviews and a focus group were carried out to capture parents\u2019 experiences and perceptions.", {"entities": []}], ["Transcripts were analyzed using a directed approach to the qualitative content analysis.", {"entities": []}], ["16 families participated to this study: 13 were involved in interviews (10 face-to-face and 3 by phone) and 3 in a focus group, within 1\u20136 months after discharge from the University Hospital of Bologna (S.Orsola/Malpighi) and from hospitals of Bologna Province.", {"entities": []}], ["To parents of children with special health care needs, the three domains of continuity of care were relevant in a whole but with different key elements during hospitalization, at discharge and after discharge.", {"entities": []}], ["Moreover, empowerment emerged from parents\u2019 narratives as essential to help parents cope with the transition from the hospital setting to the new responsibilities connected with the home care of their child.", {"entities": []}], ["Parent\u2019s perceptions about the family pediatrician concerned his/her centrality in the activation and coordination of the healthcare network.", {"entities": []}], ["Moreover, parents exhibited different attitudes towards involvement in decision making: some wished and expected to be involved, others preferred not to be involved.", {"entities": []}], ["Care coordination for children with special care needs is a complex process that need to be attended to during the hospitalization phase and after discharge to the community.", {"entities": []}], ["The findings of this study may contribute to elucidating the perceptions and experiences of parents with children with special health care needs about the continuity of care from hospital to community care.", {"entities": []}], ["The online version of this article (doi:10.1186/s13052-015-0114-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Introduction .", {"entities": []}], ["An outpatient transoral endoscopic procedure for gastroesophageal reflux disease (GERD) and obesity would be appealing if safe, effective, and durable.", {"entities": [[92, 99, "DISEASE"], [49, 80, "DISEASE"]]}], ["We present the first in human experience with a new system.", {"entities": []}], ["Eight patients with GERD (3) and obesity (5) were selected according to a preapproved study protocol.", {"entities": [[33, 40, "DISEASE"]]}], ["All GERD patients had preprocedure manometry and pH monitoring to document GERD as well as quality of life and symptom questionnaires.", {"entities": []}], ["Obese patients (body mass index >35) underwent a psychological evaluation and tests for comorbidities.", {"entities": []}], ["Under general anesthesia, a procedure was performed at the gastroesophageal junction including mucosal excision, suturing of the excision beds for apposition, and suture knotting.", {"entities": []}], ["One patient with micrognathia could not undergo the required preprocedural passage of a 60 F dilator and was excluded.", {"entities": []}], ["The first 2 GERD patients had incomplete procedures due to instrument malfunction.", {"entities": []}], ["The subsequent 5 subjects had a successfully completed procedure.", {"entities": []}], ["Four patients were treated for obesity and had an average excess weight loss of 30.3% at 2-year follow-up.", {"entities": [[31, 38, "DISEASE"]]}], ["Of these patients, one had an 8-mm outlet at the end of the procedure recognized on video review\u2014a correctable error\u2014and another vomited multiple times postoperatively and loosened the gastroplasty sutures.", {"entities": []}], ["The treated GERD patient had resolution of reflux-related symptoms and is off all antisecretory medications at 2-year follow-up.", {"entities": []}], ["Her DeMeester score was 8.9 at 24 months.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The initial human clinical experience showed promising results for effective and safe GERD and obesity therapy.", {"entities": [[95, 102, "DISEASE"]]}], ["An inverse relationship between allergies with glioma risk has been reported in several but not all epidemiological observational studies.", {"entities": []}], ["We performed an analysis of genetic variants associated with atopy to assess the relationship with glioma risk using Mendelian randomisation (MR), an approach unaffected by biases from temporal variability and reverse causation that might have affected earlier investigations.", {"entities": []}], ["Two-sample MR was undertaken using genome-wide association study data.", {"entities": []}], ["We used single nucleotide polymorphisms (SNPs) associated with atopic dermatitis, asthma and hay fever, IgE levels, and self-reported allergy as instrumental variables.", {"entities": [[63, 80, "DISEASE"], [82, 88, "DISEASE"], [70, 80, "DISEASE"]]}], ["We calculated MR estimates for the odds ratio (OR) for each risk factor with glioma using SNP-glioma estimates from 12,488 cases and 18,169 controls, using inverse-variance weighting (IVW), maximum likelihood estimation (MLE), weighted median estimate (WME) and mode-based estimate (MBE) methods.", {"entities": []}], ["Violation of MR assumptions due to directional pleiotropy were sought using MR-Egger regression and HEIDI-outlier analysis.", {"entities": []}], ["Under IVW, MLE, WME and MBE methods, associations between glioma risk with asthma and hay fever, self-reported allergy and IgE levels were non-significant.", {"entities": [[75, 81, "DISEASE"]]}], ["An inverse relationship between atopic dermatitis and glioma risk was found by IVW (OR 0.96, 95% confidence interval (CI) 0.93\u20131.00, P = 0.041) and MLE (OR 0.96, 95% CI 0.94\u20130.99, P = 0.003), but not by WME (OR 0.96, 95% CI 0.91\u20131.01, P = 0.114) or MBE (OR 0.97, 95% CI 0.92\u20131.02, P = 0.194).", {"entities": [[32, 49, "DISEASE"], [39, 49, "DISEASE"]]}], ["Our investigation does not provide strong evidence for relationship between atopy and the risk of developing glioma, but findings do not preclude a small effect in relation to atopic dermatitis.", {"entities": [[176, 193, "DISEASE"], [183, 193, "DISEASE"]]}], ["Our analysis also serves to illustrate the value of using several MR methods to derive robust conclusions.", {"entities": []}], ["The online version of this article (10.1186/s12916-018-1027-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this systematic literature review was to summarize the current knowledge regarding the prevalence of, time to recovery from, and influence of glucocorticoid dose and duration on glucocorticoid-induced adrenal insufficiency (AI).", {"entities": []}], ["Eligible studies were original research articles, which included adult patients with an indication for glucocorticoids and measured adrenal function following exposure to systemic glucocorticoids.", {"entities": []}], ["Searches were performed in Web of Science and MEDLINE, with further articles identified from reference lists.", {"entities": []}], ["Screening was performed in duplicate.", {"entities": []}], ["Data were extracted for each group of glucocorticoid-exposed patients within eligible studies.", {"entities": []}], ["The reported proportion of patients with AI was summarized as median and inter-quartile range.", {"entities": []}], ["Results were then stratified by daily dose, cumulative dose, duration of exposure and time since last glucocorticoid use.", {"entities": []}], ["The risk of bias within and across studies was considered: for randomised controlled trials risk of bias was assessed using the tool developed by the Cochrane Collaboration.", {"entities": []}], ["Overall, 73 eligible studies were identified out of 673 screened.", {"entities": []}], ["The percentage of patients with AI ranged from 0% to 100% with a median (IQR) = 37.4% (13\u201363%).", {"entities": []}], ["Studies were small\u2014median (IQR) group size 16 (9\u201338)\u2014and heterogeneous in methodology.", {"entities": []}], ["AI persisted in 15% of patients retested 3 years after glucocorticoid withdrawal.", {"entities": []}], ["Results remained widely distributed following stratification.", {"entities": []}], ["AI was demonstrated at <5\u00a0mg prednisolone equivalent dose/day, <4 weeks of exposure, cumulative dose <0.5\u00a0g, and following tapered withdrawal.", {"entities": []}], ["The heterogeneity of studies and variability in results make it difficult to answer the research questions with confidence based on the current literature.", {"entities": []}], ["There is evidence of AI following low doses and short durations of glucocorticoids.", {"entities": []}], ["Hence, clinicians should be vigilant for adrenal insufficiency at all degrees of glucocorticoid exposure.", {"entities": []}], ["The first upsurge of enterovirus D68 (EV-D68), a causative agent of acute respiratory infections (ARIs), in Japan was reported in Osaka City in 2010.", {"entities": []}], ["In this study, which began in 2010, we surveyed EV-D68 in children with ARIs and analyzed sequences of EV-D68 strains detected.", {"entities": []}], ["Real-time PCR of 19 respiratory viruses or subtypes of viruses, including enterovirus, was performed on 2,215 specimens from ARI patients (<10 years of age) collected between November 2010 and December 2015 in Osaka City, Japan.", {"entities": []}], ["EV-D68 was identified in 18 enterovirus-positive specimens ( n = 4 in 2013, n = 1 in 2014, and n = 13 in 2015) by analysis of viral protein 1 (VP1) or VP4 sequences, followed by a BLAST search for similar sequences.", {"entities": []}], ["All EV-D68 strains were detected between June and October (summer to autumn), except for one strain detected in 2014.", {"entities": []}], ["A phylogenetic analysis of available VP1 sequences revealed that the Osaka strains detected in 2010, 2013, and 2015 belonged to distinct clusters (Clades C, A, and B [Subclade B3], respectively).", {"entities": []}], ["Comparison of the 5\u2032 untranslated regions of these viruses showed that Osaka strains in Clades A, B (Subclade B3), and C commonly had deletions at nucleotide positions 681\u2013703 corresponding to the prototype Fermon strain.", {"entities": []}], ["Clades B and C had deletions from nucleotide positions 713\u2013724.", {"entities": []}], ["Since the EV-D68 epidemic in 2010, EV-D68 re-emerged in Osaka City, Japan, in 2013 and 2015.", {"entities": []}], ["Results of this study indicate that distinct clades of EV-D68 contributed to re-emergences of this virus in 2010, 2013, and 2015 in this limited region.", {"entities": []}], ["This study was conducted to evaluate a problem-oriented focused torso bedside ultrasound protocol termed \u201cSonographic Evaluation of Aetiology for Respiratory difficulty, Chest pain, and/or Hypotension\u201d (SEARCH 8Es) for its ability to narrow differential diagnoses and increase physicians\u2019 diagnostic confidence, and its diagnostic accuracy, for patients presenting with dyspnea, chest pain, or symptomatic hypotension.", {"entities": []}], ["This single-center prospective observational study was conducted over 12 months in an emergency department and included 308 patients (184 men and 124 women; mean age, 67.7 \u00b1 19.1 years) with emergent cardiopulmonary symptoms.", {"entities": []}], ["The paired t -test was used to compare the number of differential diagnoses and physician\u2019s level of confidence before and after SEARCH 8Es.", {"entities": []}], ["The overall accuracy of the SEARCH 8Es protocol in differentiating 13 diagnostic entities was evaluated based on concordance (kappa coefficient) with the diagnosis made by the inpatient specialists.", {"entities": []}], ["Sensitivity, specificity, positive predictive value, and negative predictive value were calculated.", {"entities": []}], ["SEARCH 8Es narrows the number of differential diagnoses (2.5 \u00b1 1.5 vs. 1.4 \u00b1 0.7; p < 0.001) and improves physicians\u2019 diagnostic confidence (2.8 \u00b1 0.8 vs. 4.3 \u00b1 0.9; p < 0.001) significantly.", {"entities": []}], ["The overall kappa coefficient value was 0.870 ( p < 0.001), with the overall sensitivity, specificity, positive predictive value, and negative predictive value at 90.9%, 99.0%, 89.7%, and 99.0%, respectively.", {"entities": []}], ["The SEARCH 8Es protocol helps emergency physicians to narrow the differential diagnoses, increase diagnostic confidence and provide accurate assessment of patients with dyspnea, chest pain, or symptomatic hypotension.", {"entities": []}], ["Natural compounds have been used to develop drugs for many decades.", {"entities": []}], ["Vast diversities and minimum side effects make natural compounds a good source for drug development.", {"entities": []}], ["However, the composition and concentrations of natural compounds can vary.", {"entities": []}], ["Despite this inconsistency, half of the Food and Drug Administration (FDA)-approved pharmaceuticals are natural compounds or their derivatives.", {"entities": []}], ["Therefore, it is essential to continuously investigate natural compounds as sources of new pharmaceuticals.", {"entities": []}], ["This review provides comprehensive information and analysis on natural compounds from plants (phytogenic compounds) that may serve as anti-obesity and/or anti-diabetes therapeutics.", {"entities": [[139, 146, "DISEASE"]]}], ["Our growing understanding and further exploration of the mechanisms of action of the phytogenic compounds may afford opportunities for development of therapeutic interventions in metabolic diseases.", {"entities": []}], ["Combination therapy with budesonide and formoterol reduces exacerbations of asthma, which are closely associated with human rhinovirus (RV) infections in both children and adults.", {"entities": [[76, 82, "DISEASE"]]}], ["These data suggest that budesonide and formoterol inhibit virus-induced inflammatory responses of airway epithelial cells.", {"entities": []}], ["To test this hypothesis, bronchial epithelial (BE) cells were obtained from airway brushings of 8 subjects with moderate-to-severe allergic asthma and 9 with neither asthma nor respiratory allergies.", {"entities": [[131, 146, "DISEASE"], [140, 146, "DISEASE"], [166, 172, "DISEASE"]]}], ["Cultured BE cells were incubated for 24 hours with budesonide (1.77 \u03bcM), formoterol (0.1 \u03bcM), both, or neither, and then inoculated with RV-16 (5\u00d710 RV infection induced CXCL10 protein secretion and IFNB1 and IL28 mRNA expression.", {"entities": [[170, 176, "GENE"], [199, 204, "GENE"]]}], ["Drug treatments significantly inhibited secretion of CXCL10 in mock-infected, but not RV-infected, BE cells, and inhibited secretion of TNF\u03b1 under both conditions.", {"entities": [[53, 59, "GENE"]]}], ["Neither budesonide nor formoterol, alone or in combination, significantly affected viral replication, nor did they inhibit RV-induced upregulation of IFNB1 and IL28 mRNA.", {"entities": [[150, 155, "GENE"]]}], ["Overall, RV replication was positively related to CXCL10 secretion and induction of IFNB1 and IL28 mRNA, but the positive relationship between RV RNA and CXCL10 secretion was stronger in normal subjects than in subjects with asthma.", {"entities": [[225, 231, "DISEASE"], [50, 56, "GENE"], [154, 160, "GENE"], [84, 89, "GENE"], [50, 56, "GENE"], [154, 160, "GENE"]]}], ["Budesonide and formoterol can inhibit BE cell inflammatory responses in vitro without interfering with viral replication or production of interferons.", {"entities": []}], ["These effects could potentially contribute to beneficial effects of budesonide/formoterol combination therapy in preventing RV-induced asthma exacerbations.", {"entities": [[135, 141, "DISEASE"]]}], ["The efficiency of antiretroviral therapy (ART) depends on a near-perfect level of patient's adherence.", {"entities": []}], ["Adherence in children poses peculiar challenges.", {"entities": []}], ["The aim of the study was to determine the adherence level and factors influencing adherence among HIV-infected children and adolescents in University of Port Harcourt Teaching Hospital, Nigeria.", {"entities": []}], ["A cross-sectional survey of HIV-infected children and adolescents on ART using self-report by the caregiver/child in the past one month.", {"entities": []}], ["A total of 213 caregivers and their children were interviewed.", {"entities": []}], ["A hundred and sixty-two (76.1%) had adherence rates \u226595%.", {"entities": []}], ["Only 126 (59.2%) were completely (100%) adherent.", {"entities": []}], ["The commonest caregiver-related factors for missing doses were forgetfulness 48(55.2%), travelled 22(25.3%) and drugs finished 16(18.4%), while the child-related factors were refused drugs 10(11.5%), slept 8(9.2%), and vomited 8(9.2%).", {"entities": []}], ["Sixty-eight (31.9%) caregivers reported missing clinic visit and reasons given were travelled 18(26.5%), caregiver ill 12(17.6%) and family problems 9(13.2%).", {"entities": []}], ["Predictors of poor adherence include mother as the primary caregiver (OR 3.32; 95%CI, 1.33-8.67), younger than 5years (OR 2.62; 95%CI, 1.30-5.31) and presence of a co-morbidity (OR 3.97; 95%CI, 1.92-8.33).", {"entities": []}], ["Having a medication reminder strategy (OR 6.34; 95%CI, 3.04-13.31), regular clinic visits (OR 8.55; 95%CI 4.01-18.45) and status disclosure (p = 0.008) predicted a better adherence.", {"entities": []}], ["The caregiver's age (p= 0.11), education (p = 0.86), socioeconomic status (p = 0.89), gender of the child (p = 0.84), type of ART (p = 0.2) and duration of ART (1.0) did not significantly affect adherence.", {"entities": []}], ["Adherence is still suboptimal.", {"entities": []}], ["Since barriers to Paediatric ART adherence are largely caregiver-dependent, identifying and addressing these barriers in each caregiver-child pair will improve adherence and patient outcome.", {"entities": []}], ["Santonin, a powerful anthelmintic drug that was formely used to treat worms, is Artemisia cina 's main constituent.", {"entities": []}], ["However, due to its toxicity to humans, it is no longer in use.", {"entities": []}], ["Kazakhstan is looking to introduce this plant as an anthelmintic drug for veterinary purposes, despite the known toxic properties of the santonin.", {"entities": []}], ["The objective of this study was to develop a fast and specific method for the identification of santonin and its precise quantitation using HPLC-UV in order to avoid unnecessary intoxication, which is paramount for the development of veterinary medicines.", {"entities": []}], ["The results obtained showed that santonin appears at around 5.7 minutes in this very reliable HPLC method.", {"entities": []}], ["The validation of the method was performed by the investigation of parameters such as precision, accuracy, reproducibility and recovery.", {"entities": []}], ["The method was used to identify and quantify santonin in leaves of A .", {"entities": []}], ["scoparia , A .", {"entities": []}], ["foetida , A .", {"entities": []}], ["gmelinni , A .", {"entities": []}], ["schrenkiana , A .", {"entities": []}], ["frigida , A .", {"entities": []}], ["sublesingiana , A terra-albae , and A .", {"entities": []}], ["absinthium from Kazakhstan as well as in three different extracts of leaves of A .", {"entities": []}], ["This study has provided a faster and simpler method for the identification and quantification of this compound in other species of Artemisia of economic importance.", {"entities": []}], ["Evaluating the impact of federally funded research with a broad, methodical, and objective approach is important to ensure that public funds advance the mission of federal agencies.", {"entities": []}], ["We aimed to develop a methodical approach that would yield a broad assessment of National Toxicology Program\u2019s (NTP\u2019s) effectiveness across multiple sectors and demonstrate the utility of the approach through a case study.", {"entities": []}], ["A conceptual model was developed with defined activities, outputs (products), and outcomes (proximal, intermediate, distal) and applied retrospectively to NTP\u2019s research on hexavalent chromium (CrVI).", {"entities": []}], ["Proximal outcomes were measured by counting views of and requests for NTP\u2019s products by external stakeholders.", {"entities": []}], ["Intermediate outcomes were measured by bibliometric analysis.", {"entities": []}], ["Distal outcomes were assessed through Web and LexisNexis searches for documents related to legislation or regulation changes.", {"entities": []}], ["The approach identified awareness of NTP\u2019s work on CrVI by external stakeholders (proximal outcome) and citations of NTP\u2019s research in scientific publications, reports, congressional testimonies, and legal and policy documents (intermediate outcome).", {"entities": []}], ["NTP\u2019s research was key to the nation\u2019s first-ever drinking water standard for CrVI adopted by California in 2014 (distal outcome).", {"entities": []}], ["By applying this approach to a case study, the utility and limitations of the approach were identified, including challenges to evaluating the outcomes of a research program.", {"entities": []}], ["This study identified a broad and objective approach for assessing NTP\u2019s effectiveness, including methodological needs for more thorough and efficient impact assessments in the future.", {"entities": []}], ["Xie Y, Holmgren S, Andrews DMK, Wolfe MS. 2017.", {"entities": []}], ["Evaluating the impact of the U.S. National Toxicology Program: a case study on hexavalent chromium.", {"entities": []}], ["Environ Health Perspect 125:181\u2013188;\u2002http://dx.doi.org/10.1289/EHP21", {"entities": []}], ["Using a single vector targeting strategy, we have generated mice with a combined deficiency of interleukin (IL)-4 and IL-13 to clarify their roles in T helper type 2 (Th2) cell responses.", {"entities": []}], ["Using immunological challenges normally characterized by a Th2-like response, we have compared the responses of the double-deficient mice with those generated by wild-type, IL-4\u2013deficient, and IL-13\u2013deficient mice.", {"entities": []}], ["Using a pulmonary granuloma model, induced with Schistosoma mansoni eggs, we demonstrate that although eosinophil infiltration, immunoglobulin E, and IL-5 production are reduced in the IL-4\u2013deficient mice and IL-13\u2013deficient mice, they are abolished only in the combined absence of both cytokines.", {"entities": []}], ["Furthermore, IL-4/13\u2013deficient animals are severely impaired in their ability to expel the gastrointestinal nematode Nippostrongylus brasiliensis .", {"entities": []}], ["Unexpectedly, N .", {"entities": []}], ["brasiliensis \u2013infected IL-4/13\u2013deficient mice developed elevated IL-5 and eosinophilia, indicating that compensatory mechanisms exist for the expression of IL-5, although serum IgE remained undetectable.", {"entities": [[74, 86, "DISEASE"]]}], ["IL-4/13\u2013deficient mice default to a Th1-like phenotype characterized by the expression of interferon \u03b3 and the production of IgG2a and IgG2b.", {"entities": []}], ["We conclude that IL-4 and IL-13 cooperate to initiate rapid Th2 cell\u2013driven responses, and that although their functions overlap, they perform additive roles.", {"entities": []}], ["Cardiovascular diseases are one of the leading causes of death in the industrialized world.", {"entities": []}], ["Sudden cardiac death is very often the first manifestation of the disease and it occurs in the prehospital setting.", {"entities": []}], ["The determination of the sudden cardiac death phenotype is challenging.", {"entities": []}], ["It requires prospective studies in the community including multiple sources of case ascertainment that help to identify the cause and circumstances of death.", {"entities": []}], ["The aim of the Clinical and Pathological Registry of Tarragona (ReCaPTa) is to study incidence and etiology of Sudden Cardiac Death in the Tarragona region (Catalonia, Spain).", {"entities": []}], ["ReCaPTa is a population-based registry of OHCA using multiple sources of surveillance.", {"entities": []}], ["The population base is 511,662.", {"entities": []}], ["This registry is compiled chronologically in a relational database and it prospectively contains data on all the OHCA attended by the EMS from April 2014 to April 2017.", {"entities": []}], ["ReCaPTa collects data after each emergency medical assistance using an online application including variables of the onset of symptoms.", {"entities": []}], ["A quality control is performed and it permits monitoring the percentage of cases included by the emergency crew.", {"entities": []}], ["Simultaneously, data from the medico-legal autopsies is taken from the Pathology Center of the area.", {"entities": []}], ["All the examination findings following a specific protocol for the sudden death study are entered into the ReCaPTa database by one trained person.", {"entities": []}], ["Survivors admitted to hospital are followed up and their clinical variables are collected in each hospital.", {"entities": []}], ["The primary care researchers analyze the digital clinical records in order to obtain medical background.", {"entities": []}], ["All the available data will be reviewed after an adjudication process with the aim of identifying all cases of sudden cardiac death.", {"entities": []}], ["There is a lack of population-based registries including multiple source of surveillance in the Mediterranean area.", {"entities": []}], ["The ReCaPTa study could provide valuable information to prevent sudden cardiac death and develop new strategies to improve its survival.", {"entities": []}], ["Although continuous positive airway pressure (CPAP) is a highly efficacious treatment for obstructive sleep apnea (OSA), there is a need for alternative treatment options, such as sleep surgeries and mandibular advancement devices (MADs), to overcome the limitations of CPAP.", {"entities": []}], ["This study aimed to analyze the therapeutic outcomes of OSA subjects who were treated with a MAD, and to estimate the clinical impact of MAD as a first-line treatment for OSA.", {"entities": []}], ["Forty-seven patients diagnosed with OSA received an adjustable MAD as an initial treatment.", {"entities": []}], ["Drug-induced sleep endoscopic findings and sleep parameters (both pre-MAD and post-MAD treatment), such as apnea index, oxygen saturation, and degree of daytime sleepiness, were assessed retrospectively.", {"entities": []}], ["The MAD treatment resulted in a significant reduction in apnea\u2013hypopnea index, and also a significant elevation in lowest oxygen saturation.", {"entities": []}], ["Satisfactory results of MAD treatment as a first treatment modality were observed in 27 patients, and a successful outcome was reached in approximately 72% of patients.", {"entities": []}], ["The OSA patients who had lower body mass index and upper airway narrowing at the level of palate and tongue base showed relatively higher rates of a satisfactory outcome even in cases of moderate or severe OSA.", {"entities": []}], ["These results suggest that the use of a MAD may be an alternative treatment option in OSA patients with retropalatal and retroglossal area narrowing regardless of disease severity.", {"entities": []}], ["Additionally, MADs can be recommended as an initial treatment modality, and the effectiveness of MADs in achieving success may not be inferior to CPAP.", {"entities": []}], ["Asthma is characterized by both chronic inflammation and airway remodeling.", {"entities": [[0, 6, "DISEASE"]]}], ["Remodeling - the structural changes seen in asthmatic airways - is pivotal in the pathogenesis of the disease.", {"entities": []}], ["Although significant advances have been made recently in understanding the different aspects of airway remodeling, the exact biology governing these changes remains poorly understood.", {"entities": []}], ["There is broad agreement that, in asthma, increased airway smooth muscle mass, in part due to smooth muscle hyperplasia, is a very significant component of airway remodeling.", {"entities": [[34, 40, "DISEASE"]]}], ["However, significant debate persists on the origins of these airway smooth muscle cells.", {"entities": []}], ["In this review article we will explore the natural history of airway remodeling in asthma and we will discuss the possible contribution of progenitors, stem cells and epithelial cells in mesenchymal cell changes, namely airway smooth muscle hyperplasia seen in the asthmatic airways.", {"entities": [[83, 89, "DISEASE"]]}], ["The incidence of diabetes mellitus is rapidly increasing throughout the world.", {"entities": [[17, 34, "DISEASE"]]}], ["Although the exact cause of the disease is not fully clear, perhaps, genetics, ethnic origin, obesity, age, and lifestyle are considered as few of many contributory factors for the disease pathogenesis.", {"entities": [[94, 101, "DISEASE"]]}], ["In recent years, the disease progression is particularly linked with functional and taxonomic alterations in the gastrointestinal tract microbiome.", {"entities": []}], ["A change in microbial diversity, referred as microbial dysbiosis, alters the gut fermentation profile and intestinal wall integrity and causes metabolic endotoxemia, low-grade inflammation, autoimmunity, and other affiliated metabolic disorders.", {"entities": []}], ["This article aims to summarize the role of the gut microbiome in the pathogenesis of diabetes.", {"entities": []}], ["Additionally, we summarize gut microbial dysbiosis in preclinical and clinical diabetes cases reported in literature in the recent years.", {"entities": []}], ["Airway microvascular leak (MVL) involves the extravasation of proteins from post\u2010capillary venules into surrounding tissue.", {"entities": []}], ["MVL is a cardinal sign of inflammation and an important feature of airway inflammatory diseases such as asthma.", {"entities": [[104, 110, "DISEASE"]]}], ["PGE 2 , a product of COX\u2010mediated metabolism of arachidonic acid, binds to four receptors, termed EP 1\u20134 .", {"entities": []}], ["PGE 2 has a wide variety of effects within the airway, including modulation of inflammation, sensory nerve activation and airway tone.", {"entities": []}], ["However, the effect of PGE 2 on airway MVL and the receptor/s that mediate this have not been described.", {"entities": []}], ["Evans Blue dye was used as a marker of airway MVL, and selective EP receptor agonists and antagonists were used alongside EP receptor\u2010deficient mice to define the receptor subtype involved.", {"entities": []}], ["PGE 2 induced significant airway MVL in mice and guinea pigs.", {"entities": []}], ["A significant reduction in PGE 2 \u2010induced MVL was demonstrated in Ptger2 Ptger4 2 (PF\u201004418948) and EP 4 (ER\u2010819762) receptor antagonists.", {"entities": [[66, 72, "GENE"], [73, 79, "GENE"]]}], ["In a model of allergic asthma, an increase in airway levels of PGE 2 was associated with a rise in MVL; this change was absent in Ptger2 Ptger4 mice.", {"entities": [[14, 29, "DISEASE"], [23, 29, "DISEASE"], [130, 136, "GENE"], [137, 143, "GENE"]]}], ["PGE 2 is a key mediator produced by the lung and has widespread effects according to the EP receptor activated.", {"entities": []}], ["Airway MVL represents a response to injury and under \u2018disease\u2019 conditions is a prominent feature of airway inflammation.", {"entities": []}], ["The data presented highlight a key role for EP 2 and EP 4 receptors in MVL induced by PGE 2.", {"entities": []}], ["The determination of relatedness between individuals in a family is crucial in analysis of common complex diseases.", {"entities": []}], ["We present a method to infer close inter-familial relationships based on SNP genotyping data and provide the relationship coefficient of kinship in Korean families.", {"entities": []}], ["We obtained blood samples from 43 Korean individuals in two families.", {"entities": []}], ["SNP data was obtained using the Affymetrix Genome-wide Human SNP array 6.0 and the Illumina Human 1M-Duo chip.", {"entities": []}], ["To measure the kinship coefficient with the SNP genotyping data, we considered all possible pairs of individuals in each family.", {"entities": []}], ["The genetic distance between two individuals in a pair was determined using the allele sharing distance method.", {"entities": []}], ["The results show that genetic distance is proportional to the kinship coefficient and that a close degree of kinship can be confirmed with SNP genotyping data.", {"entities": []}], ["This study represents the first attempt to identify the genetic distance between very closely related individuals.", {"entities": []}], ["[BMB Reports 2013; 46(6): 305-309]", {"entities": []}], ["Allergic rhinitis is a major chronic respiratory disease and an immunoneuronal disorder.", {"entities": [[9, 17, "DISEASE"]]}], ["We aimed at providing further knowledge on the function of the neural system in nasal allergic reaction.", {"entities": []}], ["Here, a method to assess simultaneously the nasal airflow resistance and the underlying function of autonomic nervous system (ANS) is presented and used during the nasal provocation of allergic and nonallergic subjects.", {"entities": []}], ["Continuous nasal airflow resistance and spectral heart rate variability parameters show in detail the timing and intensity differences in subjects' reactions.", {"entities": []}], ["After the provocation, the nasal airflow resistance of allergic subjects showed a positive trend, whereas LF/HF (Low Frequency/High Frequency) ratio and LF power showed a negative trend.", {"entities": []}], ["This could imply a gradual sympathetic withdrawal in allergic subjects after the allergen provocation.", {"entities": []}], ["The groups differed significantly by these physiological descriptors.", {"entities": []}], ["The proposed method opens entirely new opportunities to research accurately concomitant changes in nasal breathing function and ANS.", {"entities": []}], ["Tungsten trioxide is the second most commonly used semiconducting metal oxide in gas sensors.", {"entities": []}], ["Semiconducting metal oxide (SMOX)-based sensors are small, robust, inexpensive and sensitive, making them highly attractive for handheld portable medical diagnostic detectors.", {"entities": [[28, 32, "GENE"]]}], ["WO 3 is reported to show high sensor responses to several biomarkers found in breath, e.g., acetone, ammonia, carbon monoxide, hydrogen sulfide, toluene, and nitric oxide.", {"entities": []}], ["Modern material science allows WO 3 samples to be tailored to address certain sensing needs.", {"entities": []}], ["Utilizing recent advances in breath sampling it will be possible in the future to test WO 3 -based sensors in application conditions and to compare the sensing results to those obtained using more expensive analytical methods.", {"entities": []}], ["Alpha-1-antitrypsin deficiency (AATD) is a rare hereditary disease that is associated with a higher risk to develop chronic obstructive pulmonary disease and liver cirrhosis.", {"entities": [[116, 153, "DISEASE"], [158, 173, "DISEASE"]]}], ["Previous cross-sectional studies on AATD individuals have shown a relationship between worse St George\u2019s Respiratory Questionnaire (SGRQ) scores and elevated exacerbation rate or high cigarette consumption.", {"entities": []}], ["There is a lack of longitudinal data on the relationship between the exacerbation rate and worsening of SGRQ during disease.", {"entities": []}], ["The aim of this study was to provide not only cross-sectional data but also information about the deterioration in quality of life over a follow-up period up to 7 years (median follow-up period of 3.33 years).", {"entities": []}], ["We investigated questionnaire-based data of the German AATD registry concerning the relationship between SGRQ and exacerbation frequency, smoking history, forced expiratory volume in 1 second (FEV 1 ) and carbon monoxide diffusion capacity (DLCO) first in cross-sectional analysis and later in longitudinal analysis.", {"entities": [[193, 196, "GENE"]]}], ["Eight hundred sixty-eight individuals with protease inhibitor ZZ (PiZZ) genotype with an average age of 52.6\u00b112.8 years had an SGRQ score of 45.7\u00b120.6.", {"entities": []}], ["SGRQ significantly correlated with the exacerbation frequency within the last 2 years ( r =0.464; P <0.001), smoking history ( r =0.233; P <0.001), FEV 1 ( r =\u22120.436; P <0.001), DLCO ( r =\u22120.333; P <0.001), and patients\u2019 age ( r =0.292; P <0.001).", {"entities": [[148, 151, "GENE"]]}], ["Individuals with occupational dust exposure had significantly worse quality of life ( P <0.001).", {"entities": []}], ["Mean annual deterioration of SGRQ in all patients with available follow-up data (n=286) was 1.21\u00b14.45 points per year.", {"entities": []}], ["Univariate and multivariate analysis showed a significant relationship between worsening of SGRQ/year and exacerbation frequency in the follow-up period ( r =0.144; P =0.015).", {"entities": []}], ["Worsening of SGRQ is associated with the exacerbation frequency in individuals with PiZZ AATD.", {"entities": []}], ["Increasing age is associated with poor prognosis in patients with COPD.", {"entities": []}], ["This analysis from the replicate Phase III OTEMTO 2 -agonist, compared to monotherapies and placebo in patients with COPD aged 40 years to <65 years, 65 years to <75 years, 75 years to <85 years, and \u226585 years.", {"entities": []}], ["In these double-blind, parallel-group, active-controlled, multicenter, randomized studies, patients received tiotropium + olodaterol 2.5/5 \u03bcg or 5/5 \u03bcg, tiotropium 5 \u03bcg or 2.5 \u03bcg (TONADO only), olodaterol 5 \u03bcg (TONADO only), or placebo (OTEMTO only).", {"entities": []}], ["This analysis used the approved doses of tiotropium + olodaterol 5/5 \u03bcg, tiotropium 5 \u03bcg, and olodaterol 5 \u03bcg.", {"entities": []}], ["Primary end points at 12 weeks (OTEMTO) or 24 weeks (TONADO) included St George\u2019s Respiratory Questionnaire (SGRQ) total score, forced expiratory volume in 1 second (FEV 1 ) area under the curve from 0 hour to 3 hours (AUC 0\u20133 ) response, and trough FEV 1 response.", {"entities": [[166, 169, "GENE"], [250, 253, "GENE"], [166, 169, "GENE"], [250, 253, "GENE"]]}], ["A total of 1,621 patients were randomized (40 years to <65 years, n=749; 65 years to <75 years, n=674; 75 years to <85 years, n=186; \u226585 years, n=12) in OTEMTO and 5,162 patients (40 years to <65 years, n=2,654; 65 years to <75 years, n=1,967; 75 to <85 years, n=528; \u226585 years, n=13) in TONADO.", {"entities": []}], ["FEV 1 AUC 0\u20133 and trough FEV 1 responses improved with tiotropium + olodaterol 5/5 \u03bcg at 12 weeks and 24 weeks compared to monotherapies or placebo for all age groups.", {"entities": [[0, 3, "GENE"], [25, 28, "GENE"], [0, 3, "GENE"], [25, 28, "GENE"]]}], ["SGRQ scores generally improved with tiotropium + olodaterol 5/5 \u03bcg after 12 weeks in OTEMTO and improved after 24 weeks in all age groups in TONADO.", {"entities": []}], ["In all age groups receiving tiotropium + olodaterol 5/5 \u03bcg compared to monotherapies or placebo, transition dyspnea index scores generally improved, while rescue medication usage improved.", {"entities": []}], ["No differences were noted in relative responses to treatment or safety when using tiotropium + olodaterol 5/5 \u03bcg compared to monotherapies or placebo across all age groups.", {"entities": []}], ["Although the relationship between allergy and cancer has been investigated extensively, the role of allergy in head and neck cancer (HNC) appears less consistent.", {"entities": [[46, 52, "DISEASE"], [125, 131, "DISEASE"]]}], ["It is not clear whether allergies can independently influence the risk of HNC in the presence of known strong environmental risk factors, including consumption of alcohol, betel quid, and cigarette.", {"entities": []}], ["The current paper reports results from: 1) an original hospital-based case-control study, which included 252 incident cases of HNC and 236 controls frequency-matched to cases on sex and age; and 2) a meta-analysis combining the results of the current case-control study and 13 previously published studies (9 cohort studies with 727,569 subjects and 550 HNC outcomes and 5 case-control studies with 4,017 HNC cases and 10,928 controls).", {"entities": []}], ["In the original case-control study, we observed a strong inverse association between allergies and HNC [odds ratio\u200a=\u200a0.41, 95% confidence interval (CI): 0.27\u20130.62].", {"entities": []}], ["The meta-analysis also indicated a statistically significant inverse association between HNC and allergies [meta-relative risk (RR)\u200a=\u200a0.76, 95% CI: 0.63\u20130.91], particularly strong for allergic rhinitis (meta-RR\u200a=\u200a0.55, 95% CI: 0.40\u20130.76).", {"entities": [[184, 201, "DISEASE"], [193, 201, "DISEASE"]]}], ["In addition, the inverse association between allergies and HNC was observed only among men (meta-RR\u200a=\u200a0.67, 95% CI: 0.54\u20130.84) but not among women (meta-RR\u200a=\u200a0.98, 95% CI: 0.81\u20131.18).", {"entities": []}], ["These findings suggest that immunity plays an influential role in the risk of HNC.", {"entities": []}], ["Future studies investigating immune biomarkers, including cytokine profiles and genetic polymorphisms, are warranted to further delineate the relationship between allergies and HNC.", {"entities": []}], ["Understanding the relationship between allergies and HNC may help devise effective strategies to reduce and treat HNC.", {"entities": []}], ["The current study had two aims.", {"entities": []}], ["The primary purpose was to examine the association between serum vitamin D levels and the ergometric evaluation of muscle strength, aerobic capacity, and speed in professional soccer players.", {"entities": []}], ["The secondary aim was to evaluate the effects of the soccer off-season period on serum vitamin D levels.", {"entities": []}], ["Sixty-seven Caucasian male soccer players (age 25.6\u00b16.2 and height 1.81\u00b10.08 m), members of two Greek Superleague Soccer teams and one Football-league championship team participated in this study.", {"entities": []}], ["Exercise performance testing for the determination of squat jump (SJ), countermovement jump (CMJ), 10 (10 m) and 20 meters (20 m) sprint performance, maximal oxygen consumption (VO 2 max), anthropometry, and blood sampling were performed before (pre) and after (post) the six-week off-season period.", {"entities": [[183, 186, "GENE"]]}], ["Analysis of our results showed the following: (a) a significant correlations between serum vitamin D levels and performance parameters in both pre (SJ; P<0.001, CMJ; P<0.001, VO 2 max; P<0.001, 10 m; P<0.001, and 20 m; P<0.001) and post (SJ; P<0.001, CMJ; P<0.001, VO 2 max; P\u200a=\u200a0.006, 10 m; P<0.001, and 20 m; P<0.001) experimental sessions.", {"entities": [[180, 183, "GENE"], [270, 273, "GENE"], [180, 183, "GENE"], [270, 273, "GENE"]]}], ["(b) Vitamin D concentration increased significantly (P<0.001) following the six-week off-season period compared to baseline, while at the same time all measured performance parameters decreased (SJ; P<0.001, CMJ; P<0.001, 10 m; P<0.001, 20 m; P<0.001, VO 2 max; P<0.001).", {"entities": [[257, 260, "GENE"]]}], ["Our findings suggest that vitamin D levels are associated with the ergometric evaluation of muscle strength, as expressed by SJ and CMJ, sprinting capacity, and VO 2 max in professional soccer players, irrespective the levels of performance.", {"entities": [[166, 169, "GENE"]]}], ["Furthermore, our data reaffirm the importance of UVB on serum vitamin D levels.", {"entities": []}], ["Moreover, reductions in exercise training stress may also have beneficial effects on vitamin D levels, suggesting a possible association of its levels and the training-induced stress.", {"entities": []}], ["Our results indicate a possibly bidirectional interaction between soccer performance indices and vitamin D levels.", {"entities": []}], ["This study was aimed to investigate the protective role of baicalin on vascular endothelium exposed to ischemia reperfusion injury and the involved molecular mechanisms.", {"entities": [[103, 111, "DISEASE"]]}], ["Cultured human arterial endothelial cells (HAECs) were exposed to hypoxia/deoxygenation (H/R).", {"entities": []}], ["Cells were also treated with baicalin at serially diluted concentrations.", {"entities": []}], ["Cells were also treated with PKC activator PEP005 or specific siRNA against protein kinase C\u03b4 (PKC\u03b4).", {"entities": []}], ["MTT assay was used to evaluate the cell viabilities.", {"entities": []}], ["Flow cytometry was used to detect cell apoptosis.", {"entities": []}], ["The protein phosphorylation and expression levels were determined by Western blotting.", {"entities": []}], ["PKC\u03b4-siRNA transfection increased cell viabilities and reduced cell apoptosis in HAECs exposed to H/R.", {"entities": []}], ["Baicalin treatment preserved cell viabilities and reduced apoptosis of H/R-exposed HAECs in a concentration-dependent manner.", {"entities": []}], ["Baicalin treatment reduced phosphorylation levels of PKC\u03b4 and p53, as well as the expression levels of active caspase3 and bax in HAECs exposed to H/R.", {"entities": [[123, 126, "GENE"]]}], ["The treatment of PKC activator PEP005 impaired the protective effects of baicalin in increasing cell viabilities and reducing apoptosis in HAECs exposed to H/R.", {"entities": []}], ["Baicalin exerts vascular a protective effect on HAECs exposed to H/R by reducing cell apoptosis.", {"entities": []}], ["The PKC\u03b4/p53 apoptotic signaling pathway was the pharmacological target of baicalin.", {"entities": []}], ["This evidence map describes the volume and focus of Tai Chi research reporting health outcomes.", {"entities": []}], ["Originally developed as a martial art, Tai Chi is typically taught as a series of slow, low-impact movements that integrate the breath, mind, and physical activity to achieve greater awareness and a sense of well-being.", {"entities": []}], ["The evidence map is based on a systematic review of systematic reviews.", {"entities": []}], ["We searched 11 electronic databases from inception to February 2014, screened reviews of reviews, and consulted with topic experts.", {"entities": []}], ["We used a bubble plot to graphically display clinical topics, literature size, number of reviews, and a broad estimate of effectiveness.", {"entities": []}], ["The map is based on 107 systematic reviews.", {"entities": []}], ["Two thirds of the reviews were published in the last five\u00a0years.", {"entities": []}], ["The topics with the largest number of published randomized controlled trials (RCTs) were general health benefits (51 RCTs), psychological well-being (37 RCTs), interventions for older adults (31 RCTs), balance (27 RCTs), hypertension (18 RCTs), fall prevention (15 RCTs), and cognitive performance (11 RCTs).", {"entities": [[221, 233, "DISEASE"]]}], ["The map identified a number of areas with evidence of a potentially positive treatment effect on patient outcomes, including Tai Chi for hypertension, fall prevention outside of institutions, cognitive performance, osteoarthritis, depression, chronic obstructive pulmonary disease, pain, balance confidence, and muscle strength.", {"entities": [[137, 149, "DISEASE"], [243, 280, "DISEASE"], [215, 229, "DISEASE"]]}], ["However, identified reviews cautioned that firm conclusions cannot be drawn due to methodological limitations in the original studies and/or an insufficient number of existing research studies.", {"entities": []}], ["Tai Chi has been applied in diverse clinical areas, and for a number of these, systematic reviews have indicated promising results.", {"entities": []}], ["The evidence map provides a visual overview of Tai Chi research volume and content.", {"entities": []}], ["PROSPERO CRD42014009907 The online version of this article (doi:10.1186/s13643-016-0300-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Depression is highly prevalent in COPD patients, and both diseases are believed to be associated with inflammation.", {"entities": []}], ["The aim of this study was to elucidate the role of the immune system alterations in pathogenesis of depression in COPD patients.", {"entities": []}], ["Blood was collected from patients diagnosed with chronic obstructive pulmonary disease and comorbid depressive symptoms [COPD\u00a0+\u00a0DS, ( N \u00a0=\u00a013)], from individuals with either COPD ( N \u00a0=\u00a016) or recurrent depressive disorder (rDD) alone ( N \u00a0=\u00a015), and from healthy controls ( N \u00a0=\u00a019).", {"entities": [[49, 86, "DISEASE"]]}], ["Surface phenotype expression of T regulatory and T effector cells was analyzed with a flow cytometry, and IL-2, IL-6, IL-8, IFN-\u03b3, IL-17, and neopterin were detected with ELISA.", {"entities": []}], ["We demonstrated that COPD, depression, and COPD with comorbid depression are associated with increased IL-6 levels when compared with healthy controls 42.2\u00a0\u00b1\u00a01.87, 40.9\u00a0\u00b1\u00a02.12, 41.7\u00a0\u00b1\u00a01.31, and 33.2\u00a0\u00b1\u00a01.23\u00a0pg/ml, respectively ( p \u00a0<\u00a00.05).", {"entities": []}], ["A significant increase in neopterin levels was observed both in rDD and COPD patients when compared with controls (15.69\u00a0\u00b1\u00a00.095, 13.98\u00a0\u00b1\u00a00.887 vs. 9.22\u00a0\u00b1\u00a00.466\u00a0nmol/l, p \u00a0<\u00a00.001 and p \u00a0<\u00a00.05, respectively).", {"entities": []}], ["Concentrations of IFN-\u03b3 were significantly increased in COPD\u00a0+\u00a0DS patients when compared with controls (24.3\u00a0\u00b1\u00a01.49 and 17.8\u00a0\u00b1\u00a00.70\u00a0pg/ml, respectively, p \u00a0<\u00a00.05).", {"entities": []}], ["IL-2 levels were highest in COPD\u00a0+\u00a0DS (3.20\u00a0\u00b1\u00a00.389\u00a0pg/ml) and differed significantly when this group was compared with controls (2.20\u00a0\u00b1\u00a00.184\u00a0pg/ml), p \u00a0\u2264\u00a00.05).", {"entities": []}], ["In this study, we demonstrated for the first time that depressive symptoms in COPD patients may be related to inflammatory state as confirmed by increased levels of IL-6 both in COPD and depression and also in COPD with comorbid depressive symptoms, despite the fact that the patients were treated with anti-inflammatory drugs and/or antidepressants.", {"entities": []}], ["We also identified IFN-\u03b3 and IL-2 as putative inflammatory agents associated with depressive symptoms in COPD patients.", {"entities": []}], ["Prospective studies will need to confirm whether measuring IL-2 and IFN-\u03b3 can identify COPD patients at risk of depression.", {"entities": []}], ["These findings suggest that T helper cell 1-derived cellular immune activation may play significant role in developing depressive symptoms in COPD patients.", {"entities": []}], ["The specificity of computed tomography (CT) for subarachnoid haemorrhage (SAH) is very high.", {"entities": []}], ["However, physicians should be aware of rare false positive findings, also referred to as \u201cpseudo-SAH\u201d.", {"entities": []}], ["We present an unusual case in which such a finding was caused by chronic hypoxaemia.", {"entities": []}], ["A 37-year-old male patient presented with headaches.", {"entities": []}], ["His CT-scan showed multiple confluent subarachnoid hyperattenuations, which mimicked SAH.", {"entities": []}], ["However, the headache was chronic and had no features typical for SAH.", {"entities": []}], ["The patient suffered from severe chronic hypoxaemia due to congenital heart failure.", {"entities": []}], ["On CT-angiography diffuse intracranial vessel proliferation was found and laboratory results revealed a highly raised level of haematocrit, which had both probably developed as compensatory mechanisms.", {"entities": []}], ["A combination of these findings explained the subarachnoid hyperdensities.", {"entities": []}], ["Magnetic resonance imaging (MRI) showed no signs of SAH and visualized hypoxaemia in cerebral veins.", {"entities": []}], ["A diagnosis of pseudo-SAH was made.", {"entities": []}], ["The patient\u2019s symptoms were likely due to a secondary headache attributed to hypoxia and/or hypercapnia.", {"entities": []}], ["Therapy was symptomatic.", {"entities": []}], ["Severe chronic hypoxaemia should be recognised as a rare cause of pseudo-SAH.", {"entities": []}], ["Clinical evaluation and MRI help differentiate SAH from pseudo-SAH.", {"entities": []}], ["Two acostatin heterodimers interact together to form an \u03b1\u03b2\u03b2\u03b1 tetramer.", {"entities": []}], ["Disintegrins are a family of small (4\u201314\u2005kDa) proteins that bind to another class of proteins, integrins.", {"entities": []}], ["Therefore, as integrin inhibitors, they can be exploited as anticancer and antiplatelet agents.", {"entities": []}], ["Acostatin, an \u03b1\u03b2 heterodimeric disintegrin, has been isolated from the venom of Southern copperhead ( Agkistrodon contortrix contortrix ).", {"entities": []}], ["The three-dimensional structure of acostatin has been determined by macromolecular crystallography using the molecular-replacement method.", {"entities": []}], ["The asymmetric unit of the acostatin crystals consists of two heterodimers.", {"entities": []}], ["The structure has been refined to an R work and R free of 18.6% and 21.5%, respectively, using all data in the 20\u20131.7\u2005\u00c5 resolution range.", {"entities": []}], ["The structure of all subunits is similar and is well ordered into N-terminal and C-\u00adterminal clusters with four intramolecular disulfide bonds.", {"entities": []}], ["The overall fold consists of short \u03b2-sheets, each of which is formed by a pair of antiparallel \u03b2-strands connected by \u03b2-turns and flexible loops of different lengths.", {"entities": []}], ["Conformational flexibility is found in the RGD loops and in the C-terminal segment.", {"entities": []}], ["The interaction of two N-terminal clusters via two intermolecular disulfide bridges anchors the \u03b1\u03b2 chains of the acostatin dimers.", {"entities": []}], ["The C-terminal clusters of the heterodimer project in opposite directions and form a larger angle between them in comparison with other dimeric disintegrins.", {"entities": []}], ["Extensive interactions are observed between two heterodimers, revealing an \u03b1\u03b2\u03b2\u03b1 acostatin tetramer.", {"entities": []}], ["Further experiments are required to identify whether the \u03b1\u03b2\u03b2\u03b1 acostatin complex plays a functional role in vivo .", {"entities": []}], ["The association between vitamin D and clinical parameters in obstructive lung diseases (OLDs), including COPD and bronchial asthma, was previously investigated.", {"entities": [[124, 130, "DISEASE"]]}], ["As asthma\u2013COPD overlap syndrome (ACOS) is a new clinical entity, the prevalence of vitamin D levels in ACOS is unknown.", {"entities": [[23, 31, "DISEASE"], [3, 9, "DISEASE"]]}], ["Our aim was to assess the levels of circulating vitamin D (25-hydroxyvitamin D [25(OH)D]) in different OLDs, including ACOS patients, and its correlation with clinical parameters.", {"entities": []}], ["A total of 106 men and women (control, n=21; asthma, n=44; COPD, n=21; and ACOS, n=20) were involved in the study.", {"entities": [[45, 51, "DISEASE"]]}], ["All patients underwent detailed clinical examinations; disease control and severity was assessed by disease-specific questionnaires (COPD assessment test, asthma control test, and modified Medical Research Council); furthermore, 25(OH)D levels were measured in all patients.", {"entities": [[155, 161, "DISEASE"]]}], ["The 25(OH)D level was significantly lower in ACOS and COPD groups compared to asthma group (16.86\u00b11.79 ng/mL and 14.27\u00b11.88 ng/mL vs 25.66\u00b11.91 ng/mL).", {"entities": [[78, 84, "DISEASE"]]}], ["A positive correlation was found between 25(OH)D level and forced expiratory volume in 1 second ( r =0.4433; P <0.0001), forced vital capacity (FVC) ( r =0.3741; P =0.0004), forced expiratory flow between 25% and 75% of FVC ( r =0.4179; P <0.0001), and peak expiratory flow ( r =0.4846; P <0.0001) in OLD patient groups.", {"entities": []}], ["Asthma control test total scores and the 25(OH)D level showed a positive correlation in the ACOS ( r =0.4761; P =0.0339) but not in the asthma group.", {"entities": [[0, 6, "DISEASE"], [136, 142, "DISEASE"]]}], ["Higher COPD assessment test total scores correlated with decreased 25(OH)D in ACOS ( r =\u22120.4446; P =0.0495); however, this was not observed in the COPD group.", {"entities": []}], ["Vitamin D deficiency is present in ACOS patients and circulating 25(OH)D level may affect disease control and severity.", {"entities": []}], ["Background .", {"entities": []}], ["In questing for a more refined quantitative research approach, we revisited vector autoregressive (VAR) modeling for the analysis of time series data in the context of the so far poorly explored concept of family dynamics surrounding instable diabetes type 1 (or brittle diabetes).", {"entities": []}], ["We adopted a new approach to VAR analysis from econometrics referred to as the optimized multivariate lag selection process and applied it to a set of raw data previously analyzed through standard approaches.", {"entities": []}], ["We illustrated recurring psychosomatic circles of cause and effect relationships between emotional and somatic parameters surrounding glycemic control of the child's diabetes and the affective states of all family members.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The optimized multivariate lag selection process allowed for more specific, dynamic, and statistically reliable results (increasing R", {"entities": []}], ["Cerebral neocortex development in mammals requires highly orchestrated events involving proliferation, differentiation, and migration of neural progenitors and neurons.", {"entities": []}], ["Rapgef2 and Rapgef6 constitute a unique family of guanine nucleotide exchange factors for Rap1 small GTPase, which is known to play crucial roles in migration of postmitotic neurons.", {"entities": [[0, 7, "GENE"], [12, 19, "GENE"]]}], ["We previously reported that conditional knockout of Rapgef2 in dorsal telencephalon ( Rapgef2 -cKO) resulted in the formation of an ectopic cortical mass (ECM) resembling that of subcortical band heterotopia.", {"entities": [[52, 59, "GENE"], [86, 93, "GENE"], [52, 59, "GENE"], [86, 93, "GENE"]]}], ["Here we show that double knockout of Rapgef6 in Rapgef2 -cKO mice ( Rapgef2/6 -dKO) results in marked enlargement of the ECM.", {"entities": [[37, 44, "GENE"], [48, 55, "GENE"], [68, 75, "GENE"]]}], ["While Rapgef2 -cKO affects late-born neurons only, Rapgef2/6 -dKO affects both early-born and late-born neurons.", {"entities": [[6, 13, "GENE"], [51, 58, "GENE"]]}], ["The Rapgef2 -cKO cortex at embryonic day (E) 15.5, and the Rapgef2/6 -dKO cortex at E13.5 and E15.5 show disruption of the adherens junctions (AJs) on the apical surface, detachment of radial glial cells (RGCs) from the apical surface and disorganization of the radial glial fiber system, which are accompanied by aberrant distribution of RGCs and intermediate progenitors, normally located in the ventricular zone and the subventricular zone, respectively, over the entire cerebral cortex.", {"entities": [[4, 11, "GENE"], [59, 66, "GENE"]]}], ["Moreover, intrauterine transduction of Cre recombinase into the Rapgef2 brains also results in the apical surface AJ disruption and the RGC detachment from the apical surface, both of which are effectively suppressed by cotransduction of the constitutively active Rap1 mutant Rap1", {"entities": [[64, 71, "GENE"]]}], ["Despite the high prevalence of gastroesophageal reflux disease (GERD), its risk factors are still a subject of controversy.", {"entities": [[31, 62, "DISEASE"]]}], ["This is probably due to inadequate distinction between reflux esophagitis (RE) and non-erosive reflux disease (NERD), and is also due to inadequate evaluation of adjacent stomach.", {"entities": [[62, 73, "DISEASE"]]}], ["Our aim is therefore to define background factors of RE and NERD independently, based on the evaluation of Helicobacter pylori infection and gastric atrophy.", {"entities": []}], ["We analyzed 10,837 healthy Japanese subjects (6,332 men and 4,505 women, aged 20\u201387 years) who underwent upper gastrointestinal endoscopy.", {"entities": []}], ["RE was diagnosed as the presence of mucosal break, and NERD was diagnosed as the presence of heartburn and/or acid regurgitation in RE-free subjects.", {"entities": []}], ["Using GERD-free subjects as control, background factors for RE and NERD were separately analyzed using logistic regression to evaluate standardized coefficients (SC), odds ratio (OR), and p -value.", {"entities": []}], ["Of the 10,837 study subjects, we diagnosed 733 (6.8%) as RE and 1,722 (15.9%) as NERD.", {"entities": []}], ["For RE, male gender (SC\u200a=\u200a0.557, OR\u200a=\u200a1.75), HP non-infection (SC\u200a=\u200a0.552, OR\u200a=\u200a1.74), higher pepsinogen I/II ratio (SC\u200a=\u200a0.496, OR\u200a=\u200a1.64), higher BMI (SC\u200a=\u200a0.464, OR\u200a=\u200a1.60), alcohol drinking (SC\u200a=\u200a0.161, OR\u200a=\u200a1.17), older age (SC\u200a=\u200a0.148, OR\u200a=\u200a1.16), and smoking (SC\u200a=\u200a0.129, OR\u200a=\u200a1.14) are positively correlated factors.", {"entities": [[45, 47, "GENE"]]}], ["For NERD, HP infection (SC\u200a=\u200a0.106, OR\u200a=\u200a1.11), female gender (SC\u200a=\u200a0.099, OR\u200a=\u200a1.10), younger age (SC\u200a=\u200a0.099, OR\u200a=\u200a1.10), higher pepsinogen I/II ratio (SC\u200a=\u200a0.099, OR\u200a=\u200a1.10), smoking (SC\u200a=\u200a0.080, OR\u200a=\u200a1.08), higher BMI (SC\u200a=\u200a0.078, OR\u200a=\u200a1.08), and alcohol drinking (SC\u200a=\u200a0.076, OR\u200a=\u200a1.08) are positively correlated factors.", {"entities": [[10, 12, "GENE"]]}], ["Prevalence of RE in subjects with chronic HP infection and successful HP eradication denotes significant difference (2.3% and 8.8%; p <0.0001), whereas that of NERD shows no difference (18.2% and 20.8%; p \u200a=\u200a0.064).", {"entities": [[42, 44, "GENE"], [70, 72, "GENE"], [42, 44, "GENE"], [70, 72, "GENE"]]}], ["Significantly associated factors of NERD are considerably different from those of RE, indicating that these two disorders are pathophysiologically distinct.", {"entities": []}], ["Eradication of Helicobacter pylori may have disadvantageous effects on RE but not on NERD.", {"entities": []}], ["To elucidate the mechanisms of molecular regulations underlying primary dysmenorrhea (PD), we used our previously published mRNA expression profile of uterus from PD syndrome rats to construct protein-protein interactions (PPI) network via STRING Interactome.", {"entities": [[166, 174, "DISEASE"]]}], ["Consequently, 34 subnetworks, including a \u201ccontinent\u201d (Subnetwork 1) and 33 \u201cislands\u201d (Subnetwork 2\u201334) were generated.", {"entities": []}], ["The nodes, with relative expression ratios, were visualized in the PPI networks and their connections were identified.", {"entities": []}], ["Through path and module exploring in the network, the bridges were found from pathways of cellular response to calcium ion, SMAD protein signal transduction, regulation of transcription from RNA polymerase II promoter in response to stress and muscle stretch that were significantly enriched by the up-regulated mRNAs, to the cascades of cAMP metabolic processes and positive regulation of cyclase activities by the down-regulated ones.", {"entities": []}], ["This link is mainly dependent on Fos/Jun - Vip connection.", {"entities": [[43, 46, "GENE"]]}], ["Our data, for the first time, report the PPI network analysis of differentially expressed mRNAs in the uterus of PD syndrome rats, to give insight into screening drugs and find new therapeutic strategies to relieve PD.", {"entities": [[116, 124, "DISEASE"]]}], ["In recent years, the desire to adopt a healthy diet has drawn attention to legume seeds and food products derived from them.", {"entities": []}], ["Mash bean is an important legume crop used in Pakistan however a systematic mapping of the chemical composition of mash bean seeds is lacking.", {"entities": []}], ["Therefore seeds of four mash bean ( Vigna mungo (L.) Hepper, family Leguminoseae ) cultivars (NARC-Mash-1, NARC-Mash-2, NARC-Mash-3, NARC-Mash-97) commonly consumed in Pakistan have been analyzed for their chemical composition, antioxidant potential and biological activities like inhibition of formation of advanced glycation end products (AGE) activity and tyrosinase inhibition activity.", {"entities": []}], ["The investigated cultivars varied in terms of biochemical composition to various extents.", {"entities": []}], ["Mineral composition indicated potassium and zinc in highest and lowest amounts respectively, in all cultivars.", {"entities": []}], ["The amino acid profile in protein of these cultivars suggested cysteine is present in lowest quantity in all cultivars while fatty acid distribution pattern indicated unsaturated fatty acids as major fatty acids in all cultivars.", {"entities": []}], ["All cultivars were found to be rich source of tocopherols and sterols.", {"entities": []}], ["Fourier transform infrared spectroscopy (FTIR) fingerprints of seed flour and extracts indicated major functional groups such as polysaccharides, lipids, amides, amines and amino acids.", {"entities": []}], ["Results indicated that all investigated cultivars possessed appreciable antioxidant potential.", {"entities": []}], ["All cultivars are rich source of protein and possess sufficient content of dietary fiber, a balanced amino acid profile, low saturated fatty acids and antioxidant capacity that rationalizes many traditional uses of seeds of this crop besides its nutritional importance.", {"entities": []}], ["The collected data will be useful for academic and corporate researchers, nutritionists and clinical dieticians as well as consumers.", {"entities": []}], ["If proper attention is paid, it may become an important export commodity and may fetch considerable foreign exchange for Pakistan.", {"entities": []}], ["Whether patient socio-demographic characteristics (age, sex, race/ethnicity, income, and education) are independently associated with failure to receive indicated statin therapy and/or to achieve low density lipoprotein cholesterol (LDL-C) therapy goals are not known.", {"entities": []}], ["We examined socio-demographic factors associated with a) eligibility for statin therapy among those not on statins, and b) achievement of statin therapy goals.", {"entities": []}], ["Adults (21-79 years) participating in the United States (US) National Health and Nutrition Examination Surveys, 1999-2006 were studied.", {"entities": []}], ["Statin eligibility and achievement of target LDL-C was assessed using the US Third Adult Treatment Panel (ATP III) on Treatment of High Cholesterol guidelines.", {"entities": []}], ["Among 6,043 participants not taking statins, 10.4% were eligible.", {"entities": []}], ["Adjusted predictors of statin eligibility among statin non-users were being older, male, poorer, and less educated.", {"entities": []}], ["Hispanics were less likely to be eligible but not using statins, an effect that became non-significant with adjustment for language usually spoken at home.", {"entities": []}], ["Among 537 persons taking statins, 81% were at LDL-C goal.", {"entities": []}], ["Adjusted predictors of goal failure among statin users were being male and poorer.", {"entities": []}], ["These risks were not attenuated by adjustment for healthcare access or utilization.", {"entities": []}], ["Among person's not taking statins, the socio-economically disadvantaged are more likely to be eligible and among those on statins, the socio-economically disadvantaged are less likely to achieve statin treatment goals.", {"entities": []}], ["Further study is needed to identify specific amenable patient and/or physician factors that contribute to these disparities.", {"entities": []}], ["There is growing interest in odonates (damselflies and dragonflies) as model organisms in ecology and evolutionary biology but the development of genomic resources has been slow.", {"entities": []}], ["So far only one draft genome ( Ladona fulva ) and one transcriptome assembly ( Enallagma hageni ) have been published.", {"entities": []}], ["Odonates have some of the most advanced visual systems among insects and several species are colour polymorphic, and genomic and transcriptomic data would allow studying the genomic architecture of these interesting traits and make detailed comparative studies between related species possible.", {"entities": []}], ["Here, we present a comprehensive de novo transcriptome assembly for the blue-tailed damselfly Ischnura elegans (Odonata: Coenagrionidae) built from short-read RNA-seq data.", {"entities": []}], ["The transcriptome analysis in this paper provides a first step towards identifying genes and pathways underlying the visual and colour systems in this insect group.", {"entities": []}], ["Illumina RNA sequencing performed on tissues from the head, thorax and abdomen generated 428,744,100 paired-ends reads amounting to 110 Gb of sequence data, which was assembled de novo with Trinity.", {"entities": []}], ["A transcriptome was produced after filtering and quality checking yielding a final set of 60,232 high quality transcripts for analysis.", {"entities": []}], ["CEGMA software identified 247 out of 248 ultra-conserved core proteins as \u2018complete\u2019 in the transcriptome assembly, yielding a completeness of 99.6%.", {"entities": []}], ["BLASTX and InterProScan annotated 55% of the assembled transcripts and showed that the three tissue types differed both qualitatively and quantitatively in I. elegans .", {"entities": []}], ["Differential expression identified 8,625 transcripts to be differentially expressed in head, thorax and abdomen.", {"entities": []}], ["Targeted analyses of vision and colour functional pathways identified the presence of four different opsin types and three pigmentation pathways.", {"entities": []}], ["We also identified transcripts involved in temperature sensitivity, thermoregulation and olfaction.", {"entities": []}], ["All these traits and their associated transcripts are of considerable ecological and evolutionary interest for this and other insect orders.", {"entities": []}], ["Our work presents a comprehensive transcriptome resource for the ancient insect order Odonata and provides insight into their biology and physiology.", {"entities": []}], ["The transcriptomic resource can provide a foundation for future investigations into this diverse group, including the evolution of colour, vision, olfaction and thermal adaptation.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-15-808) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Single-nucleotide polymorphisms within intron 1 of the FTO (fat mass and obesity-associated) gene are associated with enhanced FTO expression, increased body weight, obesity and type 2 diabetes mellitus (T2DM).", {"entities": [[73, 80, "DISEASE"], [166, 173, "DISEASE"], [185, 202, "DISEASE"], [178, 202, "DISEASE"], [55, 58, "GENE"], [127, 130, "GENE"], [55, 58, "GENE"], [127, 130, "GENE"]]}], ["The N FTO has recently been associated with T2DM.", {"entities": [[6, 9, "GENE"]]}], ["CpG methylation is generally associated with gene silencing.", {"entities": []}], ["In contrast, CpG demethylation generally increases transcription.", {"entities": []}], ["DNA de novo methylation of CpG sites is facilitated by DNA methyltransferases (DNMT) 3A and 3B, whereas DNA maintenance methylation is controlled by DNMT1.", {"entities": [[149, 154, "GENE"]]}], ["MiRNA-29s target all DNMTs and thus reduce DNA CpG methylation.", {"entities": []}], ["Cow\u00b4s milk provides substantial amounts of exosomal miRNA-29s that reach the systemic circulation and target mRNAs of the milk recipient.", {"entities": []}], ["Via DNMT suppression, milk exosomal miRNA-29s may reduce the magnitude of FTO methylation, thereby epigenetically increasing FTO expression in the milk consumer.", {"entities": [[74, 77, "GENE"], [125, 128, "GENE"], [74, 77, "GENE"], [125, 128, "GENE"]]}], ["High lactation performance with increased milk yield has recently been associated with excessive miRNA-29 expression of dairy cow mammary epithelial cells (DCMECs).", {"entities": []}], ["Notably, the galactopoietic hormone prolactin upregulates the transcription factor STAT3, which induces miRNA-29 expression.", {"entities": [[83, 88, "GENE"]]}], ["In a retrovirus-like manner milk exosomes may transfer DCMEC-derived miRNA-29s and bovine FTO mRNA to the milk consumer amplifying FTO expression.", {"entities": [[90, 93, "GENE"], [131, 134, "GENE"], [90, 93, "GENE"], [131, 134, "GENE"]]}], ["There is compelling evidence that obesity, T2DM, prostate and breast cancer, and neurodegenerative diseases are all associated with increased FTO expression.", {"entities": [[62, 75, "DISEASE"], [34, 41, "DISEASE"], [69, 75, "DISEASE"], [142, 145, "GENE"]]}], ["Maximization of lactation performance by veterinary medicine with enhanced miRNA-29s and FTO expression associated with increased exosomal miRNA-29 and FTO mRNA transfer to the milk consumer may represent key epigenetic mechanisms promoting FTO/mTORC1-mediated diseases of civilization.", {"entities": [[89, 92, "GENE"], [152, 155, "GENE"], [241, 244, "GENE"], [89, 92, "GENE"], [152, 155, "GENE"], [241, 244, "GENE"]]}], ["The relationship between asthma and ankylosing spondylitis (AS) is controversial.", {"entities": [[47, 58, "DISEASE"], [25, 31, "DISEASE"], [36, 58, "DISEASE"]]}], ["We examined the risk of asthma among AS patients in a nationwide population.", {"entities": [[24, 30, "DISEASE"]]}], ["We conducted a retrospective cohort study using data from the National Health Insurance (NHI) system of Taiwan.", {"entities": []}], ["The cohort included 5,974 patients newly diagnosed with AS from 2000 to 2010.", {"entities": []}], ["The date of diagnosis was defined as the index date.", {"entities": []}], ["A 4-fold of general population without AS was randomly selected frequency matched by age, gender and the index year.", {"entities": []}], ["The occurrence and hazard ratio (HR) of asthma were estimated by the end of 2011.", {"entities": [[40, 46, "DISEASE"], [33, 35, "GENE"]]}], ["The overall incidence of asthma was 1.74 folds greater in the AS cohort than in the non-AS cohort (8.26 versus 4.74 per 1000 person-years) with a multivariable Cox method measured adjusted HR of 1.54 (95% confidence interval (CI), 1.34\u20131.76).", {"entities": [[25, 31, "DISEASE"], [189, 191, "GENE"]]}], ["The adjusted HR of asthma associated with AS was higher in women (1.59; 95% CI, 1.33\u20131.90), those aged 50\u201364 years (1.66; 95% CI, 1.31\u20132.09), or those without comorbidities (1.82; 95% CI, 1.54\u20132.13).", {"entities": [[19, 25, "DISEASE"], [13, 15, "GENE"]]}], ["Patients with AS are at a higher risk of developing asthma than the general population, regardless of gender and age.", {"entities": [[52, 58, "DISEASE"]]}], ["The pathophysiology needs further investigation.", {"entities": []}], ["The rate of severe outcomes of patients with 2009 pandemic (A/H1N1) influenza (2009pI) hospitalized in non-intensive care units (ICUs) has not been defined thus far.", {"entities": [[68, 77, "DISEASE"]]}], ["This study aims to assess the efficacy of the management of patients with influenza-like illness (ILI) of moderate intermediate severity in an infectious diseases unit (IDU) during the first wave of 2009pI and its influence on the burden of ICUs.", {"entities": [[74, 83, "DISEASE"]]}], ["All patients hospitalized from October 27, 2009, to February 5, 2010, with ILI were included in this prospective observational study.", {"entities": []}], ["The IDU was organized and the staff was trained to provide intermediate care; patients were transferred to the ICU only if they required invasive ventilation, extracorporeal membrane oxygenation, or advanced cardiovascular support.", {"entities": []}], ["Demographic data, clinical presentation, coexisting medical conditions, and laboratory and radiological findings were recorded and analyzed, as well as treatment and outcome data.", {"entities": []}], ["Overall, 108 patients (median age 36 years [IQR 27\u201354], 57.4% males) including 66.7% with \u22651 risk factor for severe influenza, 47.2% with confirmed 2009pI by RT-PCR and 63.9% with pneumonia, were enrolled in the study.", {"entities": [[116, 125, "DISEASE"], [180, 189, "DISEASE"]]}], ["All subjects received intravenous fluids and 83.3% were administered oseltamivir, 96.3% antibacterials, 19.4% oxygen therapy without ventilatory support, and 10.2% non-invasive ventilation.", {"entities": []}], ["A total of 106 (98.1%) subjects were discharged after a 6-day median hospital stay [IQR 4\u20139].", {"entities": []}], ["Two patients (1.9%) were transferred to the ICU.", {"entities": []}], ["There were no deaths.", {"entities": []}], ["These results suggest that the aggressive treatment of patients with moderate intermediate severity 2009 pandemic ILI in non-ICU wards may result in a low rate of severe outcomes and brief hospitalization.", {"entities": []}], ["IDUs, if properly organized for intermediate care, may efficiently provide correct disease management, in addition to complying with infection control requirements, thus reducing the burden of the pandemic on ICUs.", {"entities": []}], ["Further studies are warranted to evaluate the outcome of patients with moderate intermediate 2009pI in different non-ICU settings.", {"entities": []}], ["Defective Rhinovirus induced interferon-\u03b2 and interferon-\u03bb production has been reported in bronchial epithelial cells from asthmatics but the mechanisms of defective interferon induction in asthma are unknown.", {"entities": [[190, 196, "DISEASE"]]}], ["Virus infection can induce interferon through Toll like Receptors (TLR)3, TLR7 and TLR8.", {"entities": [[74, 78, "GENE"], [83, 87, "GENE"]]}], ["The role of these TLRs in interferon induction in asthma is unclear.", {"entities": [[50, 56, "DISEASE"]]}], ["This objective of this study was to measure the type I and III interferon response to TLR in bronchial epithelial cells and peripheral blood cells from atopic asthmatics and non-atopic non-asthmatics.", {"entities": []}], ["Bronchial epithelial cells and peripheral blood mononuclear cells from atopic asthmatic and non-atopic non-asthmatic subjects were stimulated with agonists to TLR3, TLR4 & TLRs7\u20139 and type I and III interferon and pro-inflammatory cytokine, interleukin(IL)-6 and IL-8, responses assessed.", {"entities": [[159, 163, "GENE"], [165, 169, "GENE"]]}], ["mRNA expression was analysed by qPCR.", {"entities": []}], ["Interferon proteins were analysed by ELISA.", {"entities": []}], ["Pro-inflammatory cytokines were induced by each TLR ligand in both cell types.", {"entities": []}], ["Ligands to TLR3 and TLR7/8, but not other TLRs, induced interferon-\u03b2 and interferon-\u03bb in bronchial epithelial cells.", {"entities": [[11, 15, "GENE"]]}], ["The ligand to TLR7/8, but not those to other TLRs, induced only type I interferons in peripheral blood mononuclear cells.", {"entities": []}], ["No difference was observed in TLR induced interferon or pro-inflammatory cytokine production between asthmatic and non-asthmatic subjects from either cell type.", {"entities": []}], ["TLR3 and TLR7/8,, stimulation induced interferon in bronchial epithelial cells and peripheral blood mononuclear cells.", {"entities": [[0, 4, "GENE"]]}], ["Interferon induction to TLR agonists was not observed to be different in asthmatics and non-asthmatics.", {"entities": []}], ["Diagnoses of Type 1 Diabetes Mellitus (T1DM) in Europe appear to be on the rise.", {"entities": []}], ["Therefore it is imperative that researchers understand the potential impact that increases in prevalence could have on the affected individuals as well as on society as a whole.", {"entities": []}], ["Accordingly this study examined the humanistic and economic burden of T1DM in patients relative to those without the condition across a number of health outcomes including health status, work productivity loss, activity impairment, and healthcare resource use.", {"entities": []}], ["Survey data from a large, representative sample of EU adults (The EU National Health and Wellness Survey) were examined.", {"entities": []}], ["Results suggest that overall burden is higher for those diagnosed with T1DM than respondents without diabetes and that burden increases as complications associated with T1DM increase.", {"entities": []}], ["Taken together, these results suggest that treatment strategies for T1DM should balance clinical, humanistic, and economic burden and patients should be educated on the role of complications in disease outcomes.", {"entities": []}], ["CCL5/RANTES, a chemoattractant for myeloid cells, is induced by hepatic ischemia/reperfusion injury (IRI).", {"entities": [[72, 80, "DISEASE"]]}], ["The roles of CCL5 in hepatic IRI were carried out by means of CCL5 immunodepletion, antagonistic competition by Met-CCL5, and treatment with recombinant murine CCL5 (rmCCL5).", {"entities": [[13, 17, "GENE"], [62, 66, "GENE"], [116, 120, "GENE"], [160, 164, "GENE"], [13, 17, "GENE"], [62, 66, "GENE"], [116, 120, "GENE"], [160, 164, "GENE"], [13, 17, "GENE"], [62, 66, "GENE"], [116, 120, "GENE"], [160, 164, "GENE"]]}], ["Depletion or inhibition of CCL5 reduced severity of hepatic IRI, whereas rmCCL5 treatment aggravated liver IRI as manifested in elevated serum alanine aminotransferase (ALT) and tissue myeloperoxidase (MPO) levels.", {"entities": [[27, 31, "GENE"], [202, 205, "GENE"]]}], ["Moreover, IRI severity was reduced in CCL5-knockout (CCL5-KO) mice versus wildtype (WT) mice, with drops in serum ALT level, intrahepatic MPO activity, and histological pathology.", {"entities": [[138, 141, "GENE"]]}], ["Bone marrow transplantion (BMT) studies show that myeloid cells and tissue cells are both required for CCL5-aggravated hepatic IRI.", {"entities": []}], ["The profile of liver-infiltrating leukocyte subsets after hepatic reperfusion identified CD11b+ cells as the only compartment significantly reduced in CCL5-KO mice versus WT controls at early reperfusion phase.", {"entities": []}], ["The role of CCL5 recruiting CD11b+ cells in early reperfusion was validated by in vitro transwell migration assay of murine primary macrophages (broadly characterized by their CD11b expression) in response to liver lysates after early reperfusion.", {"entities": [[12, 16, "GENE"]]}], ["Taken together, our results demonstrate a sequence of early events elicited by CCL5 chemoattracting macrophage that result in inflammatory aggravation of hepatic IRI.", {"entities": [[79, 83, "GENE"]]}], ["Schizophrenia is associated with atopy and increased inflammatory markers.", {"entities": []}], ["We report a population-based longitudinal study of the associations between childhood atopic disorders, subsequent serum inflammatory markers, interleukin 6 (IL-6) and C-reactive protein (CRP), and the risk of psychotic experiences (PEs).", {"entities": [[188, 191, "GENE"]]}], ["PEs were assessed at age 13\u00a0years (n\u00a0=\u00a06785).", {"entities": []}], ["Presence of clinician-diagnosed atopic disorders (asthma and eczema) was determined from parent-completed questionnaires at age 10\u00a0years (n\u00a0=\u00a07814).", {"entities": [[50, 56, "DISEASE"]]}], ["Serum IL-6 and CRP were measured at age 9\u00a0years (n\u00a0=\u00a05076).", {"entities": [[15, 18, "GENE"]]}], ["Logistic regression examined the association between (1) atopy and PEs, (2) inflammatory markers and PEs, and (3) mediating effects of inflammatory markers on the atopy\u2013PEs association.", {"entities": []}], ["Linear regression examined the association between atopy and inflammatory markers.", {"entities": []}], ["Age, gender, social class, ethnicity and body mass index were included as potential confounders.", {"entities": []}], ["At age 10\u00a0years, about 14% of the sample was reported to have asthma, 12% eczema, and 7% both asthma and eczema.", {"entities": [[62, 68, "DISEASE"], [94, 100, "DISEASE"]]}], ["Compared with children with no atopy, risk of PEs at age 13\u00a0years was increased for all of these groups; adjusted odds ratios (95% CI) were, respectively, 1.39 (1.10\u20131.77), 1.33 (1.04\u20131.69), and 1.44 (1.06\u20131.94).", {"entities": []}], ["Atopy was associated with increased serum IL-6 and CRP; however, this did not mediate association between atopy and PEs.", {"entities": [[51, 54, "GENE"]]}], ["Inflammatory markers were not associated with later PEs.", {"entities": []}], ["Childhood atopic disorders increase the risk of psychotic experiences in adolescence.", {"entities": []}], ["Follow-up of these individuals will be useful to determine the effect of atopy and inflammation on different trajectories of early-life PEs.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a debilitating lung disease with a survival of only three to five years from the time of diagnosis.", {"entities": [[11, 29, "DISEASE"], [54, 66, "DISEASE"]]}], ["Due to a paucity of studies, large gaps remain in our understanding of how IPF affects the quality of patients' lives.", {"entities": []}], ["In only one other study did investigators ask patients directly for their perspectives on this topic.", {"entities": []}], ["Further, currently there is no disease-specific instrument to measure health-related quality of life (HRQL) in patients with IPF.", {"entities": []}], ["A carefully constructed measurement instrument, sensitive to underlying change, is needed for use in clinical trials and longitudinal studies of patients with IPF.", {"entities": []}], ["Before developing such an instrument, researchers must improve their understanding of the relevant effects of IPF on patients' lives.", {"entities": []}], ["On a broader scale, to provide the best care for people with IPF, clinicians must appreciate \u2013 from patients' perspectives \u2013 how this disease affects various aspects of their lives.", {"entities": []}], ["We used focus groups and individual in-depth interviews with 20 IPF patients to collect their perspectives on how IPF affects their lives (with a focus on the quality of their lives).", {"entities": []}], ["We then analyzed these perspectives and organized them into a conceptual framework for describing HRQL in patients with IPF.", {"entities": []}], ["Next, we examined how well certain existing measurement instruments \u2013 which have been administered to IPF patients in prior studies \u2013 covered the domains and topics our patients identified.", {"entities": []}], ["In our framework, we identified 12 primary domains: symptoms, IPF therapy, sleep, exhaustion, forethought, employment and finances, dependence, family, sexual relations, social participation, mental and spiritual well-being, mortality.", {"entities": []}], ["Each domain is composed of several topics, which describe how IPF affects patients' lives.", {"entities": []}], ["When we compared the content of our conceptual framework with the existing instruments, we found the coverage of the existing instruments to be inadequate for several reasons, including they may tap general areas of QOL or HRQL but not some areas that appear to be most directly affected by IPF, and they include items that are relevant to symptoms and effects of other respiratory diseases but not IPF.", {"entities": []}], ["Collecting patients' perspectives and developing an organized inventory of the relevant effects of IPF on patients' lives provides valuable information for improving our understanding of the impact of this disease on patients and their loved ones.", {"entities": []}], ["We believe our findings will help alert clinicians and researchers to IPF patients' experiences and concerns.", {"entities": []}], ["Based on the comparison or our conceptual framework with the content of four existing instruments, it would appear that developing an IPF-specific measurement instrument is justified.", {"entities": []}], ["Our conceptual framework for describing health-related quality of life in patients with IPF lays a solid foundation for constructing such an instrument.", {"entities": []}], ["Chemokines (CKs) and chemokine receptors (CKR) promote leukocyte recruitment into cardiac tissue infected by the Trypanosoma cruzi .", {"entities": []}], ["This study investigated the long-term treatment with subantimicrobial doses of doxycycline (Dox) in association, or not, with benznidazole (Bz) on the expression of CK and CKR in cardiac tissue.", {"entities": []}], ["Thirty mongrel dogs were infected, or not, with the Berenice-78 strain of T. cruzi and grouped according their treatments: (i) two months after infection, Dox (50\u2009mg/kg) 2x/day for 12 months; (ii) nine months after infection, Bz (3,5\u2009mg/kg) 2x/day for 60 days; (iii) Dox + Bz; and (iv) vehicle.", {"entities": []}], ["After 14 months of infection, hearts were excised and processed for qPCR analysis of Th1 (CCL2, CCL3, CCL4, CCL5, CXCL9, and CXCL11), Th2 (CCL1, CCL17, CCL24, and CCL26), Th17 (CCL20) CKs, Th1 (CCR5, CCR6, and CXCR3), and Th2/Th17 (CCR3, CCR4, and CCR8) CKR, as well as IL-17.", {"entities": [[90, 94, "GENE"], [96, 100, "GENE"], [102, 106, "GENE"], [108, 112, "GENE"], [114, 119, "GENE"], [125, 131, "GENE"], [139, 143, "GENE"], [145, 150, "GENE"], [152, 157, "GENE"], [163, 168, "GENE"], [177, 182, "GENE"], [194, 198, "GENE"], [200, 204, "GENE"], [210, 215, "GENE"], [232, 236, "GENE"], [238, 242, "GENE"], [248, 252, "GENE"]]}], ["T. cruzi infection increases CCL1, CCL2, CCL4, CCL5, CCL17, CXCL10, and CCR5 expression in the heart.", {"entities": [[29, 33, "GENE"], [35, 39, "GENE"], [41, 45, "GENE"], [47, 51, "GENE"], [53, 58, "GENE"], [60, 66, "GENE"], [72, 76, "GENE"]]}], ["Dox, Bz, or Dox + Bz treatments cause a reversal of CK and CKR and reduce the expression of CCL20, IL-17, CCR6, and CXCR3.", {"entities": [[92, 97, "GENE"], [106, 110, "GENE"], [116, 121, "GENE"]]}], ["Our data reveal an immune modulatory effect of Dox with Bz, during the chronic phase of infection suggesting a promising therapy for cardiac protection.", {"entities": []}], ["Age at menarche is a marker of timing of puberty in females.", {"entities": []}], ["It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality P <5\u00d710 DLK1/WDR25 , MKRN3/MAGEL2 and KCNK9 ) demonstrating parent-of-origin specific associations concordant with known parental expression patterns.", {"entities": [[142, 155, "DISEASE"], [92, 99, "DISEASE"], [149, 155, "DISEASE"], [218, 223, "GENE"]]}], ["Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and gamma-aminobutyric acid-B2 receptor signaling, among novel mechanisms that regulate pubertal timing in humans.", {"entities": []}], ["Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.", {"entities": []}], ["Fraction of exhaled nitric oxide (FeNO) provides information about chronic inflammation in asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["However, its relationship with structural changes in the airways is unknown.", {"entities": []}], ["We aimed to evaluate the correlation between computer-based airway changes and FeNO in patients with asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["The wall area (WA) and airway inner luminal area (Ai) of the third- to sixth-generation bronchi were measured using three-dimensional computed tomography in asthmatic patients.", {"entities": []}], ["Each value was corrected by body surface area (BSA).", {"entities": []}], ["Relationships between FeNO and WA/BSA and Ai/BSA were evaluated.", {"entities": []}], ["Forty-one clinically stable patients with asthma were evaluated.", {"entities": [[42, 48, "DISEASE"]]}], ["FeNO was significantly correlated with WA/BSA of the third-, fourth-, fifth- and sixth-generation bronchi (Spearman correlation coefficient ( \u03c1 )\u2009=\u20090.326, p \u2009=\u20090.041; \u03c1 \u2009=\u20090.356, p \u2009=\u20090.025; \u03c1 \u2009=\u20090.496, p \u2009=\u20090.002; and \u03c1 \u2009=\u20090.529, p \u2009<\u20090.001, respectively).", {"entities": []}], ["The correlation with sixth-generation bronchi was significantly greater than with the third-generation bronchi ( p \u2009=\u20090.047).", {"entities": []}], ["Partial rank correlation analysis indicated FeNO was significantly correlated with WA/BSA of the sixth-generation bronchi, independent from confounding factors of Ai/BSA, age, duration of asthma, dose of inhaled corticosteroid, blood eosinophil percentage, and blood IgE ( \u03c1 \u2009=\u20090.360, p \u2009=\u20090.034).", {"entities": [[188, 194, "DISEASE"]]}], ["In contrast, there was no correlation between FeNO and Ai/BSA.", {"entities": []}], ["FeNO correlates with bronchial wall thickening in asthma patients.", {"entities": [[50, 56, "DISEASE"]]}], ["Measurement of FeNO may be useful to detect airway remodeling in asthma.", {"entities": [[65, 71, "DISEASE"]]}], ["Around 17% of general practitioner (GP) consultations are for musculoskeletal conditions, which will rise as the population ages.", {"entities": []}], ["Patient direct access to physiotherapy provides one solution, yet adoption in the National Health Service (NHS) has been slow.", {"entities": [[107, 110, "GENE"]]}], ["A pilot, pragmatic, non-inferiority, cluster randomised controlled trial (RCT) in general practice and physiotherapy services in the UK.", {"entities": []}], ["Investigate feasibility of a main RCT.", {"entities": []}], ["Adult patients registered in participating practices and consulting with a musculoskeletal problem.", {"entities": []}], ["4 general practices (clusters) randomised to provide GP-led care as usual or the addition of a patient direct access to physiotherapy pathway.", {"entities": []}], ["Process outcomes and exploratory analyses of clinical and cost outcomes.", {"entities": []}], ["Participant-level data were collected via questionnaires at identification, 2, 6 and 12\u2005months and through medical records.", {"entities": []}], ["The study statistician and research nurses were blinded to practice allocation.", {"entities": []}], ["Of 2696 patients invited to complete study questionnaires, 978 participated (intervention group n=425, control arm n=553) and were analysed.", {"entities": []}], ["Participant recruitment was completed in 6\u2005months.", {"entities": []}], ["Follow-up rates were 78% (6\u2005months) and 71% (12\u2005months).", {"entities": []}], ["No evidence of selection bias was observed.", {"entities": []}], ["The direct access pathway was used by 90% of patients in intervention practices needing physiotherapy.", {"entities": []}], ["Some increase in referrals to physiotherapy occurred from one practice, although waiting times for physiotherapy did not increase (28\u2005days before, 26\u2005days after introduction of direct access).", {"entities": []}], ["No safety issues were identified.", {"entities": []}], ["Clinical and cost outcomes were similar in both groups.", {"entities": []}], ["Exploratory estimates of between group effect (using 36-item Short Form Health Survey (SF-36) Physical Component Summary (PCS)) at 6\u2005months was \u22120.28 (95% CI \u22121.35 to 0.79) and at 12\u2005months 0.12 (95% CI \u22121.27 to 1.51).", {"entities": []}], ["A full RCT is feasible and will provide trial evidence about the clinical and cost-effectiveness of patient direct access to physiotherapy.", {"entities": []}], ["ISRCTN23378642 .", {"entities": []}], ["In Cameroon herbs are traditionally used to meet health care needs and plans are on the way to integrate traditional medicine in the health care system, even though the plans have not been put into action yet.", {"entities": []}], ["The country however has a rich biodiversity, with ~8,620 plant species, some of which are commonly used in the treatment of several microbial infections and a range of diseases (malaria, trypanosomiasis, leishmaniasis, diabetes and tuberculosis).", {"entities": [[204, 217, "DISEASE"], [232, 244, "DISEASE"], [178, 185, "DISEASE"], [187, 202, "DISEASE"]]}], ["Our survey consisted in collecting published data from the literature sources, mainly from PhD theses in Cameroonian university libraries and also using the author queries in major natural product and medicinal chemistry journals.", {"entities": []}], ["The collected data includes plant sources, uses of plant material in traditional medicine, plant families, region of collection of plant material, isolated metabolites and type (e.g.", {"entities": []}], ["flavonoid, terpenoid, etc.", {"entities": []}], ["), measured biological activities of isolated compounds, and any comments on significance of isolated metabolites on the chemotaxonomic classification of the plant species.", {"entities": []}], ["This data was compiled on a excel sheet and analysed.", {"entities": []}], ["In this study, a literature survey led to the collection of data on 2,700 secondary metabolites, which have been previously isolated or derived from Cameroonian medicinal plants.", {"entities": []}], ["This represents distinct phytochemicals derived from 312 plant species belonging to 67 plant families.", {"entities": []}], ["The plant species are investigated in terms of chemical composition with respect to the various plant families.", {"entities": []}], ["A correlation between the known biological activities of isolated compounds and the ethnobotanical uses of the plants is also attempted.", {"entities": []}], ["Insight into future direction for natural product search within the Cameroonian forest and Savanna is provided.", {"entities": []}], ["It can be verified that a phytochemical search of active secondary metabolites, which is inspired by knowledge from the ethnobotanical uses of medicinal plants could be very vital in a drug discovery program from plant-derived bioactive compounds.", {"entities": []}], ["Adolescent pregnant women are at greater risk for nutritional deficits, stress, and depression than their adult counterparts, and these risk factors for adverse pregnancy outcomes are likely interrelated.", {"entities": []}], ["This study evaluated the prevalence of nutritional deficits in pregnant teenagers and assessed the associations among micronutrient dietary intake, stress, and depression.", {"entities": []}], ["One hundred and eight pregnant Latina adolescents completed an Automated Self-Administered 24-hour dietary recall (ASA24) in the 2nd trimester.", {"entities": []}], ["Stress was measured using the Perceived Stress Scale and the Prenatal Distress Questionnaire.", {"entities": []}], ["Depressive symptoms were evaluated with the Reynolds Adolescent Depression Scale.", {"entities": []}], ["Social support satisfaction was measured using the Social Support Questionnaire.", {"entities": []}], ["More than 50% of pregnant teenagers had an inadequate intake (excluding dietary supplement) of folate, vitamin A, vitamin E, iron, zinc, calcium, magnesium, and phosphorous.", {"entities": []}], ["Additionally, >20% of participants had an inadequate intake of thiamin, riboflavin, niacin, vitamin B6, vitamin B12, vitamin C, copper, and selenium.", {"entities": []}], ["Prenatal supplement inclusion improved dietary intake for most micronutrients except for calcium, magnesium, and phosphorous, (>50% below the Estimated Average Requirement (EAR)) and for copper and selenium (>20% below the EAR).", {"entities": []}], ["Higher depressive symptoms were associated with higher energy, carbohydrates, and fats, and lower magnesium intake.", {"entities": []}], ["Higher social support satisfaction was positively associated with dietary intake of thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, vitamin C, vitamin E, iron, and zinc.", {"entities": []}], ["The findings suggest that mood and dietary factors are associated and should be considered together for health interventions during adolescent pregnancy for the young woman and her future child.", {"entities": []}], ["It is recognized that IL\u201018 is related to development of asthma, but role of IL\u201018 in asthma remains controversial and confusing.", {"entities": [[57, 63, "DISEASE"], [86, 92, "DISEASE"]]}], ["This is largely due to lack of information on expression of IL\u201018 binding protein (BP) and IL\u201018 receptor (R) in asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["In this study, we found that plasma levels of IL\u201018 and IL\u201018BP were elevated in asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["The ratio between plasma concentrations of IL\u201018 and IL\u201018BP was 1:12.8 in asthma patients.", {"entities": [[75, 81, "DISEASE"]]}], ["We demonstrated that 13\u2010fold more monocytes, 17.5\u2010fold more neutrophils and 4.1\u2010fold more B cells express IL\u201018BP than IL\u201018 in asthmatic blood, suggesting that there is excessive amount of IL\u201018BP to abolish actions of IL\u201018 in asthma.", {"entities": [[229, 235, "DISEASE"]]}], ["We also discovered that more IL\u201018R+ monocytes, neutrophils and B cells are located in asthmatic blood.", {"entities": []}], ["Once injected, IL\u201018 eliminated IL\u201018R+ monocytes in blood, but up\u2010regulated expression of IL\u201018R in lung macrophages of OVA\u2010sensitized mice.", {"entities": []}], ["Our data clearly indicate that the role of IL\u201018 in asthma is very likely to be determined by balance of IL\u201018/IL\u201018BP/IL\u201018R expression in inflammatory cells.", {"entities": [[52, 58, "DISEASE"]]}], ["Therefore, IL\u201018R blocking or IL\u201018BP activity enhancing therapies may be useful for treatment of asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["The fast-moving field of dendritic cell (DC) biology is hard to keep pace with.", {"entities": []}], ["Here we report on advances from the recent Keystone Symposium, \u201cDendritic Cells at the Center of Innate and Adaptive Immunity,\u201d organized in Vancouver, BC on Feb. 1\u20137, 2005 by Anne O'Garra, Jacques Banchereau, and Alan Sher.", {"entities": []}], ["New insights into the molecular mechanisms of DC function and their influence on immune regulation, their role in infectious and autoimmune disease, and new clinical applications are highlighted.", {"entities": []}], ["Pseudomonas aeruginosa is the most common bacterial pathogen in patients with cystic fibrosis (CF).", {"entities": [[78, 93, "DISEASE"]]}], ["Current infection control guidelines aim to prevent transmission via contact and respiratory droplet routes and do not consider the possibility of airborne transmission.", {"entities": []}], ["It was hypothesised that subjects with CF produce viable respirable bacterial aerosols with coughing.", {"entities": []}], ["A cross-sectional study was undertaken of 15 children and 13 adults with CF, 26 chronically infected with P aeruginosa .", {"entities": []}], ["A cough aerosol sampling system enabled fractioning of respiratory particles of different sizes and culture of viable Gram-negative non-fermentative bacteria.", {"entities": []}], ["Cough aerosols were collected during 5 min of voluntary coughing and during a sputum induction procedure when tolerated.", {"entities": []}], ["Standardised quantitative culture and genotyping techniques were used.", {"entities": []}], ["P aeruginosa was isolated in cough aerosols of 25 subjects (89%), 22 of whom produced sputum samples.", {"entities": []}], ["P aeruginosa from sputum and paired cough aerosols were indistinguishable by molecular typing.", {"entities": []}], ["In four cases the same genotype was isolated from ambient room air.", {"entities": []}], ["Approximately 70% of viable aerosols collected during voluntary coughing were of particles \u2a7d3.3 \u03bcm aerodynamic diameter.", {"entities": []}], ["P aeruginosa , Burkholderia cenocepacia , Stenotrophomonas maltophilia and Achromobacter xylosoxidans were cultivated from respiratory particles in this size range.", {"entities": []}], ["Positive room air samples were associated with high total counts in cough aerosols (p\u200a=\u200a0.003).", {"entities": []}], ["The magnitude of cough aerosols was associated with higher forced expiratory volume in 1 s (r\u200a=\u200a0.45, p\u200a=\u200a0.02) and higher quantitative sputum culture results (r\u200a=\u200a0.58, p\u200a=\u200a0.008).", {"entities": []}], ["During coughing, patients with CF produce viable aerosols of P aeruginosa and other Gram-negative bacteria of respirable size range, suggesting the potential for airborne transmission.", {"entities": []}], ["Thousands of genome segments appear to be present in widely varying copy number in different human genomes.", {"entities": []}], ["We developed ways to use increasingly abundant whole genome sequence data to identify the copy numbers, alleles and haplotypes present at most large, multi-allelic CNVs (mCNVs).", {"entities": []}], ["We analyzed 849 genomes sequenced by the 1000 Genomes Project to identify most large (>5 kb) mCNVs, including 3,878 duplications, of which 1,356 appear to have three or more segregating alleles.", {"entities": []}], ["We find that mCNVs give rise to most human gene-dosage variation \u2013 exceeding sevenfold the contribution of deletions and biallelic duplications \u2013 and that this variation in gene dosage generates abundant variation in gene expression.", {"entities": []}], ["We describe \u201crunaway duplication haplotypes\u201d in which genes, including HPR and ORM1 , have mutated to high copy number on specific haplotypes.", {"entities": [[71, 74, "GENE"], [79, 83, "GENE"]]}], ["We describe partially successful initial strategies for analyzing mCNVs via imputation and provide an initial data resource to support such analyses.", {"entities": []}], ["Much evidence has demonstrated that interleukin (IL)-33 plays an important role in rheumatoid arthritis (RA).", {"entities": [[83, 103, "DISEASE"], [94, 103, "DISEASE"]]}], ["However, there have been limited studies about soluble ST2, a receptor for IL-33, in RA.", {"entities": []}], ["The aims of this study were to detect the levels of ST2 in the serum and synovial fluid of RA patients and to reveal the association of these levels with disease activity and the function of ST2 in RA.", {"entities": []}], ["A total of 56 RA patients and 38 age-matched healthy controls were enrolled in this study.", {"entities": []}], ["Synovial fluid samples were collected from another 30 RA patients and 20 osteoarthritis patients.", {"entities": [[73, 87, "DISEASE"]]}], ["Serum and synovial fluid levels of ST2 were measured by ELISA.", {"entities": []}], ["In addition, the levels of ST2 in the serum of RA patients before and after therapy were detected.", {"entities": []}], ["The function of ST2 in RA was revealed by the results of an in vitro cell assay, where recombinant ST2 proteins were used to treat peripheral blood mononuclear cells (PBMCs) and RA synovial fibroblasts (RASFs).", {"entities": []}], ["Serum-soluble ST2 levels were significantly higher in RA patients (127.14 \u00b1 61.43 pg/ml) than those in healthy controls (78.37 \u00b1 41.93 pg/ml, P < 0.01).", {"entities": []}], ["Synovial fluid-soluble ST2 levels (41.90 \u00b1 33.58 pg/ml) were much higher in RA patients than those in osteoarthritis patients (19.71 \u00b1 16.72 pg/ml, P < 0.05).", {"entities": [[102, 116, "DISEASE"]]}], ["RA patients who received effective therapy for 6 months showed decreased serum-soluble ST2 levels (113.01 \u00b1 53.90 pg/ml) compared to baseline (139.59 \u00b1 68.36 pg/ml) ( P = 0.01).", {"entities": []}], ["RA patients with high disease activity had higher serum-soluble ST2 levels (162.02 \u00b1 56.78 pg/ml) than those with low disease activity (94.67 \u00b1 40.27 pg/ml, P = 0.001).", {"entities": []}], ["Soluble ST2 did not affect IL-1\u03b2, IL-6, IL-8, or tumor necrosis factor-\u03b1 (TNF-\u03b1) expression in PBMCs from RA patients.", {"entities": []}], ["However, soluble ST2 ameliorated the expressions of IL-33 and IL-1\u03b2 but not that of IL-6, IL-8, or TNF-\u03b1 in resting RASFs.", {"entities": []}], ["Interestingly, in the RASFs stimulated by TNF-\u03b1 plus IL-1\u03b2, soluble ST2 showed extensive suppressive effects on the expression of IL-6, IL-8, and TNF-\u03b1.", {"entities": []}], ["Elevated levels of ST2 in the serum and synovial fluid were associated with disease activity and ameliorated IL-33 expression and IL-33-induced inflammation in RASFs, suggesting that soluble ST2 might be a potential therapeutic candidate for RA.", {"entities": []}], ["Lysine deacetylases (KDACs) are enzymes that reverse the post-translational modification of lysine acetylation.", {"entities": []}], ["Recently, a series of N-acetylthioureas were synthesized and reported to enhance the activity of KDAC8 with a fluorogenic substrate.", {"entities": []}], ["To determine if the activation was general, we synthesized three of the most potent N-acetylthioureas and measured their effect with peptide substrates and the fluorogenic substrate under multiple reaction conditions and utilizing two enzyme purification approaches.", {"entities": []}], ["No activation was observed for any of the three N-acetylthioureas under any assayed conditions.", {"entities": []}], ["Further characterization of KDAC8 kinetics with the fluorogenic substrate yielded a k cat /K M of 164 \u00b1 17 in the absence of any N-acetylthioureas.", {"entities": []}], ["This catalytic efficiency is comparable to or higher than that previously reported when KDAC8 was activated by the N-acetylthioureas, suggesting that the previously reported activation effect may be due to use of an enzyme preparation that contains a large fraction of inactive enzyme.", {"entities": []}], ["Further characterization with a less active preparation and additional substrates leads us to conclude that N-acetylthioureas are not true activators of KDAC8 and only increase activity if the enzyme preparation is below the maximal basal activity.", {"entities": []}], ["Recent large-scale genetic approaches such as genome-wide association studies have allowed the identification of common genetic variations that contribute to risk architectures of psychiatric disorders.", {"entities": []}], ["However, most of these susceptibility variants are located in noncoding genomic regions that usually span multiple genes.", {"entities": []}], ["As a result, pinpointing the precise variant(s) and biological mechanisms accounting for the risk remains challenging.", {"entities": []}], ["By reviewing recent progresses in genetics, functional genomics and neurobiology of psychiatric disorders, as well as gene expression analyses of brain tissues, here we propose a roadmap to characterize the roles of noncoding risk loci in the pathogenesis of psychiatric illnesses (that is, identifying the underlying molecular mechanisms explaining the genetic risk conferred by those genomic loci, and recognizing putative functional causative variants).", {"entities": []}], ["This roadmap involves integration of transcriptomic data, epidemiological and bioinformatic methods, as well as in vitro and in vivo experimental approaches.", {"entities": []}], ["These tools will promote the translation of genetic discoveries to physiological mechanisms, and ultimately guide the development of preventive, therapeutic and prognostic measures for psychiatric disorders.", {"entities": []}], ["Whether obesity is associated with recurrent venous thromboembolism (VTE) in elderly patients is unknown.", {"entities": [[8, 15, "DISEASE"]]}], ["To examine the association between two obesity measures, the body mass index (BMI) and the waist circumference (WC), and recurrent VTE in elderly patients.", {"entities": [[39, 46, "DISEASE"]]}], ["We studied 986 patients aged \u226565 years with an acute VTE from a prospective multicenter cohort study (09/2009-12/2013).", {"entities": []}], ["The BMI was determined and categorized as <25, 25 to <30, or \u226530 kg/m The mean follow-up was 28 months.", {"entities": []}], ["The 3-year cumulative incidence of recurrent VTE did not vary by BMI and was 17.6% for a BMI <25 kg/m P = 0.09).", {"entities": []}], ["The 3-year cumulative incidence of recurrent VTE did not vary by WC.", {"entities": []}], ["After adjustment, neither the BMI (sub-hazard ratio [SHR] 1.02, 95% confidence interval [CI 0.98\u20131.05]) nor the WC (SHR 1.01, 95% CI 0.99\u20131.02) was associated with recurrent VTE.", {"entities": []}], ["Measures of body weight were not associated with recurrent VTE in our cohort.", {"entities": []}], ["Obesity does not appear to be a predictor of recurrent VTE in the elderly.", {"entities": [[0, 7, "DISEASE"]]}], ["The Social Cognitive Theory (SCT) is a widely used model for developing elementary nutrition education programs; however, few instruments are available to assess the impact of such programs on the main constructs of the SCT.", {"entities": []}], ["The purposes of this study were: 1) to develop and validate a SCT-based survey instrument that focuses on knowledge, behavior, and self-efficacy for fifth grade students; 2) to assess the relationships between knowledge, behavior, and self-efficacy; and 3) to assess knowledge, behavior, and self-efficacy for healthy eating among the fifth grade students.", {"entities": []}], ["A 40-item instrument was developed and validated using content validity and tested among 98 fifth grade students for internal consistency reliability.", {"entities": []}], ["Relationships between knowledge, behavior, and self-efficacy were assessed using Pearson Correlation Coefficients.", {"entities": []}], ["Differences in behavior and knowledge scores between children with high and low self-efficacy were examined using t-test.", {"entities": []}], ["Cronbach\u2019s alphas for self-efficacy (0.70) and behavior (0.71) subscales of the survey were acceptable, although lower for knowledge (0.56).", {"entities": []}], ["Summary scores for self-efficacy and behaviors were positively correlated (r\u2009=\u20090.40, P\u2009=\u20090.0001); however, summary knowledge scores were not associated with self-efficacy (r\u2009=\u20090.02, P\u2009=\u20090.88) or behavior scores (r\u2009=\u20090.14, P\u2009=\u20090.23).", {"entities": []}], ["Participants with high self-efficacy also had significantly higher scores on consuming fruits (P\u2009=\u20090.0009) and dairy products (P\u2009=\u20090.009), eating breakfast (P\u2009=\u20090.008), helping plan family meals (P\u2009=\u20090.0006) and total behaviors for healthy-eating (P\u2009=\u20090.001) compared to those with low self-efficacy.", {"entities": []}], ["In addition, approximately two thirds of the fifth grade students reported that they did not eat any fruits or vegetables or ate them only once on a typical day.", {"entities": []}], ["The developed instrument is a reliable and useful tool to assess SCT-based elementary nutrition education programs, particularly for self-efficacy and behavior.", {"entities": []}], ["Our results also indicated that strategic interventions are necessary to improve dietary behaviors regarding fruit and vegetable consumptions among elementary school students.", {"entities": []}], ["There is increasing interest in finding novel approaches to reduce health disparities in readmissions for acute decompensated heart failure (ADHF).", {"entities": []}], ["Text messaging is a promising platform for improving chronic disease self-management in low-income populations, yet is largely unexplored in ADHF.", {"entities": []}], ["The purpose of this pre-post study was to assess the feasibility and acceptability of a text message\u2013based (SMS: short message service) intervention in a largely African American population with ADHF and explore its effects on self-management.", {"entities": [[108, 111, "GENE"]]}], ["Hospitalized patients with ADHF were enrolled in an automated text message\u2013based heart failure program for 30 days following discharge.", {"entities": []}], ["Messages provided self-care reminders and patient education on diet, symptom recognition, and health care navigation.", {"entities": []}], ["Demographic and cell phone usage data were collected on enrollment, and an exit survey was administered on completion.", {"entities": []}], ["The Self-Care of Heart Failure Index (SCHFI) was administered preintervention and postintervention and compared using sample t tests (composite) and Wilcoxon rank sum tests (individual).", {"entities": []}], ["Clinical data were collected through chart abstraction.", {"entities": []}], ["Of 51 patients approached for recruitment, 27 agreed to participate and 15 were enrolled (14 African-American, 1 White).", {"entities": []}], ["Barriers to enrollment included not owning a personal cell phone (n=12), failing the Mini-Mental exam (n=3), needing a proxy (n=2), hard of hearing (n=1), and refusal (n=3).", {"entities": []}], ["Another 3 participants left the study for health reasons and 3 others had technology issues.", {"entities": []}], ["A total of 6 patients (5 African-American, 1 White) completed the postintervention surveys.", {"entities": []}], ["The mean age was 50 years (range 23-69) and over half had Medicaid or were uninsured (60%, 9/15).", {"entities": []}], ["The mean ejection fraction for those with systolic dysfunction was 22%, and at least two-thirds had a prior hospitalization in the past year.", {"entities": []}], ["Participants strongly agreed that the program was easy to use (83%), reduced pills missed (66%), and decreased salt intake (66%).", {"entities": []}], ["Maintenance (mean composite score 49 to 78, P =.003) and management (57 to 86, P =.002) improved at 4 weeks, whereas confidence did not change (57 to 75, P =.11).", {"entities": []}], ["Of the 6 SCHFI items that showed a statistically significant improvement, 5 were specifically targeted by the texting intervention.", {"entities": []}], ["Over half of ADHF patients in an urban, largely African American community were eligible and interested in participating in a text messaging program following discharge.", {"entities": []}], ["Access to mobile phones was a significant barrier that should be addressed in future interventions.", {"entities": []}], ["Among the participants who completed the study, we observed a high rate of satisfaction and preliminary evidence of improvements in heart failure self-management.", {"entities": []}], ["Increased activity of metalloproteinases may play a role in the initiation and propagation of inflammation in sarcoidosis, and may also be one of the factors responsible for the development of lung fibrosis.", {"entities": [[110, 121, "DISEASE"]]}], ["The aim of this study was to verify whether polymorphisms of MMP2 C-735T, MMP7 A-181G, MMP9 T-1702A and tissue inhibitor of metalloproteinase (TIMP)2 G-418C predispose to sarcoidosis.", {"entities": [[171, 182, "DISEASE"], [61, 65, "GENE"], [74, 78, "GENE"], [87, 91, "GENE"]]}], ["The study included 139 patients with sarcoidosis and 100 healthy subjects.", {"entities": [[37, 48, "DISEASE"]]}], ["MMPs and TIMP2 mRNA were measured in peripheral blood lysate using real-time RT-PCR.", {"entities": [[9, 14, "GENE"]]}], ["DNA for genetic polymorphism was extracted from peripheral blood by GTC method.", {"entities": []}], ["Protein concentrations in peripheral blood lysates were measured by ELISA, and MMP2 and 9 activities in BAL fluid were estimated by gel zymography.", {"entities": [[79, 83, "GENE"]]}], ["TT genotype in MMP9 T-1702A was more frequent in sarcoidosis (p<0.0001, OR=13.71, 95% CI 7.02\u201326.80) and resulted in higher expression of MMP9 mRNA (p<0.0001).", {"entities": [[49, 60, "DISEASE"], [15, 19, "GENE"], [138, 142, "GENE"], [15, 19, "GENE"], [138, 142, "GENE"]]}], ["No differences were found between TT and AT/AA patients in terms of radiological stage, lung function test parameters, activity markers and the presence/absence of L\u00f6fgren syndrome.", {"entities": [[172, 180, "DISEASE"]]}], ["There were no differences in the distribution of MMP2, MMP7 and TIMP2 polymorphisms.", {"entities": [[49, 53, "GENE"], [55, 59, "GENE"], [64, 69, "GENE"]]}], ["Messenger RNAs, as well as protein concentrations of MMP2, 7, 9, and TIMP2 were elevated in patients with sarcoidosis (p<0.0001 for each).", {"entities": [[106, 117, "DISEASE"], [53, 57, "GENE"], [69, 74, "GENE"]]}], ["The TT homozygotes of MMP9 T-1702A genotype may be predisposed to sarcoidosis.", {"entities": [[66, 77, "DISEASE"], [22, 26, "GENE"]]}], ["Elevated MMP2, 7, 9, and TIMP2 mRNAs suggest their inducibility.", {"entities": [[9, 13, "GENE"], [25, 30, "GENE"]]}], ["Acute asthma is a common reason for patients to seek care from ambulance services.", {"entities": [[6, 12, "DISEASE"]]}], ["Although better care of acute asthma can prevent avoidable morbidity and deaths, there has been little research into ambulance clinicians\u2019 adherence to national guidelines for asthma assessment and management and how this might be improved.", {"entities": [[30, 36, "DISEASE"], [176, 182, "DISEASE"]]}], ["Our research aim was to explore paramedics\u2019 attitudes, perceptions and beliefs about prehospital management of asthma, to identify barriers and facilitators to guideline adherence.", {"entities": [[111, 117, "DISEASE"]]}], ["We conducted three focus group interviews of paramedics in a regional UK ambulance trust.", {"entities": []}], ["We used framework analysis supported by NVivo 8 to code and analyse the data.", {"entities": []}], ["Seventeen participants, including paramedics, advanced paramedics or paramedic operational managers at three geographical sites, contributed to the interviews.", {"entities": []}], ["Analysis led to five themes: (1) guidelines should be made more relevant to ambulance service care; (2) there were barriers to assessment; (3) the approach needed to address conflicts between clinicians\u2019 and patients\u2019 expectations; (4) the complexity of ambulance service processes and equipment needed to be taken into account; (5) and finally there were opportunities for improved prehospital education, information, communication, support and care pathways for asthma.", {"entities": [[464, 470, "DISEASE"]]}], ["This qualitative study provides insight into paramedics\u2019 perceptions of the assessment and management of asthma, including why paramedics may not always follow guidelines for assessment or management of asthma.", {"entities": [[105, 111, "DISEASE"], [203, 209, "DISEASE"]]}], ["These findings provide opportunities to strengthen clinical support, patient communication, information transfer between professionals and pathways for prehospital care of patients with asthma.", {"entities": [[186, 192, "DISEASE"]]}], ["An involvement of the immune system has been suggested in Rett syndrome (RTT), a devastating neurodevelopmental disorder related to oxidative stress, and caused by a mutation in the methyl-CpG binding protein 2 gene ( MECP2 ) or, more rarely, cyclin-dependent kinase-like 5 ( CDKL5 ).", {"entities": [[63, 71, "DISEASE"], [218, 223, "GENE"], [276, 281, "GENE"]]}], ["To date, it is unclear whether both mutations may have an impact on the circulating cytokine patterns.", {"entities": []}], ["In the present study, cytokines involved in the Th1-, Th2-, and T regulatory (T-reg) response, as well as chemokines, were investigated in MECP2 - ( MECP2 -RTT) ( n = 16) and CDKL5 -Rett syndrome ( CDKL5 -RTT) ( n = 8), before and after \u03c9 -3 polyunsaturated fatty acids (PUFAs) supplementation.", {"entities": [[187, 195, "DISEASE"], [139, 144, "GENE"], [149, 154, "GENE"], [139, 144, "GENE"], [149, 154, "GENE"], [175, 180, "GENE"], [198, 203, "GENE"], [175, 180, "GENE"], [198, 203, "GENE"]]}], ["A major cytokine dysregulation was evidenced in untreated RTT patients.", {"entities": []}], ["In MECP2 -RTT, a Th2-shifted balance was evidenced, whereas in CDKL5 -RTT both Th1- and Th2-related cytokines (except for IL-4) were upregulated.", {"entities": [[3, 8, "GENE"], [63, 68, "GENE"]]}], ["In MECP2 -RTT, decreased levels of IL-22 were observed, whereas increased IL-22 and T-reg cytokine levels were evidenced in CDKL5 -RTT.", {"entities": [[3, 8, "GENE"], [124, 129, "GENE"]]}], ["Chemokines were unchanged.", {"entities": []}], ["The cytokine dysregulation was proportional to clinical severity, inflammatory status, and redox imbalance.", {"entities": []}], ["Omega-3 PUFAs partially counterbalanced cytokine changes, as well as aberrant redox homeostasis and the inflammatory status.", {"entities": []}], ["RTT is associated with a subclinical immune dysregulation as the likely consequence of a defective inflammation regulatory signaling system.", {"entities": []}], ["In developed countries, health care utilization among immigrant groups differs where the dominant interpretation is unjustified overutilization due to lack of acculturation.", {"entities": []}], ["We investigated utilization of prescribed drugs in native Dutch and various groups of immigrant elderly.", {"entities": []}], ["Cross-sectional study using data from the survey \"Social Position, Health and Well-being of Elderly Immigrants\" (the Netherlands, 2003).", {"entities": []}], ["Ethnicity-matched interviewers conducted the survey among first generation immigrants aged 55 years and older.", {"entities": []}], ["Outcome measure is self-reported use of prescribed drugs.", {"entities": []}], ["Utilization is explained by need, and by enabling and predisposing factors, in particular acculturation; analysis is conducted by multiple logistic regression.", {"entities": []}], ["The study population consisted of immigrants from Turkey (n = 307), Morocco (n = 284), Surinam (n = 308) and the Netherlands Antilles (n = 300), and a native Dutch reference group (n = 304).", {"entities": []}], ["Prevalence of diabetes mellitus (DM), COPD and musculoskeletal disorders was relatively high among immigrant elderly.", {"entities": [[14, 31, "DISEASE"]]}], ["Drug utilization in especially Turkish and Moroccan elderly with DM and COPD was relatively low.", {"entities": []}], ["Drugs use for non-mental chronic diseases was explained by more chronic conditions (OR 2.64), higher age (OR 1.03), and modern attitudes on male-female roles (OR 0.74) and religiosity (OR 0.89).", {"entities": []}], ["Ethnicity specific effects remained only among Turkish elderly (OR 0.42).", {"entities": []}], ["Drugs use for mental health problems was explained by more chronic conditions (OR 1.43), better mental health (OR 0.95) and modern attitudes on family values (OR 0.59).", {"entities": []}], ["Ethnicity specific effects remained only among Moroccan (OR 0.19) and Antillean elderly (OR 0.31).", {"entities": []}], ["Explanation of underutilization of drugs among diseased with diabetes and musculoskeletal disorders are found in number of chronic diseases (OR 0.74 and OR 0.78) and regarding diabetes also in language proficiency (OR 0.66) and modern attitudes on male-female roles (OR 1.69).", {"entities": []}], ["Need and predisposing factors (acculturation) are the strongest determinants for drugs utilization among elderly immigrants.", {"entities": []}], ["Significant drugs underutilization exists among migrants with diabetes and musculoskeletal disorders.", {"entities": []}], ["There are a number of different methods that can be used when estimating the size of the owned cat and dog population in a region, leading to varying population estimates.", {"entities": []}], ["The aim of this study was to conduct a systematic review to evaluate the methods that have been used for estimating the sizes of owned cat and dog populations and to assess the biases associated with those methods.", {"entities": []}], ["A comprehensive, systematic search of seven electronic bibliographic databases and the Google search engine was carried out using a range of different search terms for cats, dogs and population.", {"entities": []}], ["The inclusion criteria were that the studies had involved owned or pet domestic dogs and/or cats, provided an estimate of the size of the owned dog or cat population, collected raw data on dog and cat ownership, and analysed primary data.", {"entities": []}], ["Data relating to study methodology were extracted and assessed for biases.", {"entities": []}], ["Seven papers were included in the final analysis.", {"entities": []}], ["Collection methods used to select participants in the included studies were: mailed surveys using a commercial list of contacts, door to door surveys, random digit dialled telephone surveys, and randomised telephone surveys using a commercial list of numbers.", {"entities": []}], ["Analytical and statistical methods used to estimate the pet population size were: mean number of dogs/cats per household multiplied by the number of households in an area, human density multiplied by number of dogs per human, and calculations using predictors of pet ownership.", {"entities": []}], ["The main biases of the studies included selection bias, non-response bias, measurement bias and biases associated with length of sampling time.", {"entities": []}], ["Careful design and planning of studies is a necessity before executing a study to estimate pet populations.", {"entities": []}], ["The radial artery is increasingly used as a second arterial conduit for myocardial revascularization.", {"entities": []}], ["However, the radial artery is susceptible to vasospasm, which is thought to be the principal cause of graft failure.", {"entities": []}], ["The radial artery is harvested as a skeletonized or a non-skeletonized graft, but the effect of different harvesting technique remains unknown.", {"entities": []}], ["In this study, we compared the early- and mid-term angiographic findings to elucidate its influence on the graft luminal diameter.", {"entities": []}], ["We harvested 39 radial arteries either as a skeletonized ( n \u00a0=\u00a018) or a non-skeletonized graft ( n \u00a0=\u00a021) using an ultrasonic scalpel.", {"entities": []}], ["We constructed a composite straight graft by combining a right internal thoracic artery and a radial artery.", {"entities": []}], ["All the radial artery grafts were sequentially anastomosed to coronary arteries.", {"entities": []}], ["We measured the diameters of the radial arteries before the operation, within 1\u00a0month and 1\u00a0year after the operation.", {"entities": []}], ["At early postoperative period, graft diameter was significantly larger in skeletonized grafts.", {"entities": []}], ["Graft diameter at the point before the first and the second anastomosis was similar in skeletonized grafts, although that was significantly smaller before the second anastomosis in non-skeletonized grafts.", {"entities": []}], ["However, 1\u00a0year after the operation, the graft diameter was comparable and equally reduced after the first anastomosis in both groups.", {"entities": []}], ["Skeletonization with an ultrasonic scalpel increases the luminal diameter of the radial artery graft at early postoperative period, which, however, reduces possibly as adaptation to graft flow 1\u00a0year after the operation.", {"entities": []}], ["OBJECTIVE: T lymphocytes have a central regulatory role in the pathogenesis of asthma.", {"entities": [[79, 85, "DISEASE"]]}], ["The objective of this study was to characterize immunologically the activation stage of asthma and the functional profile of lymphocytes from induced sputum, with particular emphasis on gammadelta T cells.", {"entities": [[88, 94, "DISEASE"]]}], ["METHODS: Induced sputum was collected from 10 patients with acute exacerbation of asthma, and from healthy controls.", {"entities": [[82, 88, "DISEASE"]]}], ["The expression of activation markers on freshly isolated induced sputum lymphocytes and T-cell subsets was analyzed by double immunofluorescent staining and flow cytometry.", {"entities": []}], ["Fas ligand (FasL) was determined by reverse transcriptase-polymerase chain reaction analysis.", {"entities": [[0, 3, "GENE"]]}], ["The phenotype of gammadelta T-cell subpopulations was tested by A13 and BB3 monoclonal antibodies.", {"entities": []}], ["In this context, the functional profile of gammadelta T cells was tested in a chromium releasing test.", {"entities": []}], ["RESULTS: A significantly decreased proportion of alphabeta T cells and an increased proportion of gammadelta T cells, CD56+ cells and CD8+ gammadelta T cells were found in asthma patients compared with healthy controls.", {"entities": [[172, 178, "DISEASE"]]}], ["In asthmatic patients, there is a significantly increased proportion of T cells expressing CD69 and CD25 antigen.", {"entities": [[91, 95, "GENE"]]}], ["After stimulation of gammadelta T cells, an increased expression of intracellular tumour necrosis factor-alpha, interleukin (IL)-4 and IL10 cytokines were found at higher levels than controls.", {"entities": [[135, 139, "GENE"]]}], ["Interferon-gamma was observed at similar levels in asthma patients and healthy controls.", {"entities": [[51, 57, "DISEASE"]]}], ["Freshly isolated T-cell receptor (TCR) gammadelta+ cells exhibited an increased percentage of FasL in our patient group.", {"entities": []}], ["FasL mRNA was detected in TCR gammadelta+ cells before and after IL2 stimulation.", {"entities": [[65, 68, "GENE"]]}], ["TCR gammadelta+ cells were cytotoxic against the K562 cell line.", {"entities": []}], ["This natural killer activity was mediated by the A13-positive subpopulation.", {"entities": []}], ["CONCLUSION: The presence of cytokines producing gammadelta cells in induced sputum of asthmatic patients is consistent with regulatory activities.", {"entities": []}], ["These cells display also cytotoxic function.", {"entities": []}], ["Vitiligo is a common, acquired, pigmentary disorder characterized by loss of melanocytes resulting in white spots.", {"entities": [[0, 8, "DISEASE"]]}], ["This disease carries a lot of social stigma in India.", {"entities": []}], ["To study the clinico-epidemiological profile of vitiligo patients in Kumaun region of Uttarakhand state in India.", {"entities": [[48, 56, "DISEASE"]]}], ["The clinical presentation of vitiligo was examined and analyzed in 762 vitiligo patients attending the Dermatology outdoor of Government Medical College, Haldwani, which is a referral centre for Kumaun region of Uttarakhand state in India.", {"entities": [[29, 37, "DISEASE"], [71, 79, "DISEASE"]]}], ["Male and female patients were found to be affected almost equally.", {"entities": []}], ["It was observed that onset of vitiligo was most common in 0-10 years age group, as evidenced by 336 cases out of 762 cases.", {"entities": [[30, 38, "DISEASE"]]}], ["Acrofacial type of vitiligo (339 cases out of 762) was most commonly observed, followed by vitiligo vulgaris, focal, segmental, mucosal, mixed, and universal vitiligo.", {"entities": [[19, 27, "DISEASE"], [91, 99, "DISEASE"], [158, 166, "DISEASE"]]}], ["The most common site of onset was the lower limbs followed by head and neck, upper limbs, trunk, genitalia, and mucasae.", {"entities": []}], ["Leucotrichia was observed in 33.5%, Koebner's phenomenon in 26.3%, and a positive family history in 19% of the vitiligo patients.", {"entities": [[111, 119, "DISEASE"]]}], ["The other common conditions associated were thyroid disorders (8.9%), diabetes (5.3%), and atopic dermatitis (4.9%).", {"entities": [[91, 108, "DISEASE"], [98, 108, "DISEASE"]]}], ["The study indicates that acrofacial vitiligo is the most common clinical type observed in Kumaun region of Uttarakhand in India.", {"entities": [[36, 44, "DISEASE"]]}], ["Onset of vitiligo is most common in first decade of life.", {"entities": [[9, 17, "DISEASE"]]}], ["Bromodomain-containing protein 2 (Brd2) is a nuclear serine/threonine kinase involved in transcriptional regulation.", {"entities": [[34, 38, "GENE"]]}], ["In 3T3-L1 adipocytes, Brd2 normally co-represses PPAR\u03b3 (peroxisome proliferator-activated receptor gamma) and inhibits adipogenesis.", {"entities": [[22, 26, "GENE"]]}], ["Here, we show that Brd2 over-expression in preadipocytes inhibits their differentiation into adipocytes, while Brd2 knockdown promotes adipogenic differentiation in vitro and forces cells to undergo adipogenesis independent of the MDI (methyisobutylxanthane, dexamethasone and insulin) induction.", {"entities": [[19, 23, "GENE"], [111, 115, "GENE"], [19, 23, "GENE"], [111, 115, "GENE"]]}], ["In this study, the two key transcription factors for adipogenesis, PPAR\u03b3 and C/EBP\u03b1 (CCAAT/enhancer binding protein-\u03b1) were persistently expressed during the differentiation of preadipocytes to mature adipocytes in Brd2 knockdown 3T3-L1 cells, but their expression was inhibited in cells in which Brd2 was overexpressed.", {"entities": [[215, 219, "GENE"], [297, 301, "GENE"], [215, 219, "GENE"], [297, 301, "GENE"]]}], ["To investigate the role of Brd2 in signal transduction we examined the expression of several signaling molecules involved in the regulation of gene expression and cell differentiation by immunoblotting assay.", {"entities": [[27, 31, "GENE"]]}], ["Down-regulation of Brd2 expression in 3T3-L1 cells led to a decrease in extracellular signal-regulated kinase1/2 (ERK1/2) activity and, conversely, the up-regulation of Brd2 leads to increase in ERK1/2 phosphorylation.", {"entities": [[19, 23, "GENE"], [169, 173, "GENE"], [19, 23, "GENE"], [169, 173, "GENE"]]}], ["Nevertheless, changes in Brd2 expression do not affect the activities of JNK and p38 MAPK.", {"entities": [[25, 29, "GENE"]]}], ["In addition, the phosphorylation of Rafs is not affected by changes in Brd2 expression in 3T3-L1 cells.", {"entities": [[71, 75, "GENE"]]}], ["MEK inhibitor UO126 partly restores differentiation of 3T3-L1 cells that overexpress Brd2.", {"entities": [[85, 89, "GENE"]]}], ["In conclusion, these results indicate that Brd2 regulates ERK1/2 activity independently of Raf signaling in 3T3-L1 adipocytes.", {"entities": [[43, 47, "GENE"]]}], ["One of the challenging problems in the etiology of diseases is to explore the relationships between initiation and progression of diseases and abnormalities in local regions of metabolic pathways.", {"entities": []}], ["To gain insight into such relationships, we applied the \u201ck-clique\u201d subpathway identification method to all disease-related gene sets.", {"entities": []}], ["For each disease, the disease risk regions of metabolic pathways were then identified and considered as subpathways associated with the disease.", {"entities": []}], ["We finally built a disease-metabolic subpathway network (DMSPN).", {"entities": []}], ["Through analyses based on network biology, we found that a few subpathways, such as that of cytochrome P450, were highly connected with many diseases, and most belonged to fundamental metabolisms, suggesting that abnormalities of fundamental metabolic processes tend to cause more types of diseases.", {"entities": []}], ["According to the categories of diseases and subpathways, we tested the clustering phenomenon of diseases and metabolic subpathways in the DMSPN.", {"entities": []}], ["The results showed that both disease nodes and subpathway nodes displayed slight clustering phenomenon.", {"entities": []}], ["We also tested correlations between network topology and genes within disease-related metabolic subpathways, and found that within a disease-related subpathway in the DMSPN, the ratio of disease genes and the ratio of tissue-specific genes significantly increased as the number of diseases caused by the subpathway increased.", {"entities": []}], ["Surprisingly, the ratio of essential genes significantly decreased and the ratio of housekeeping genes remained relatively unchanged.", {"entities": []}], ["Furthermore, the coexpression levels between disease genes and other types of genes were calculated for each subpathway in the DMSPN.", {"entities": []}], ["The results indicated that those genes intensely influenced by disease genes, including essential genes and tissue-specific genes, might be significantly associated with the disease diversity of subpathways, suggesting that different kinds of genes within a disease-related subpathway may play significantly differential roles on the diversity of diseases caused by the corresponding subpathway.", {"entities": []}], ["Peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\u03b4 and \u03b3 are nuclear receptors activated by fatty acid metabolites.", {"entities": []}], ["An anti-inflammatory role for these receptors in airway inflammation has been suggested.", {"entities": []}], ["Nasal biopsies were obtained from 10 healthy volunteers and 10 patients with symptomatic allergic rhinitis.", {"entities": [[89, 106, "DISEASE"], [98, 106, "DISEASE"]]}], ["Nasal polyps were obtained from 22 patients, before and after 4 weeks of local steroid treatment (fluticasone).", {"entities": []}], ["Real-time RT-PCR was used for mRNA quantification and immunohistochemistry for protein localization and quantification.", {"entities": []}], ["mRNA expression of PPAR\u03b1, PPAR\u03b2\u03b4, PPAR\u03b3 was found in all specimens.", {"entities": []}], ["No differences in the expression of PPARs were obtained in nasal biopsies from patients with allergic rhinitis and healthy volunteers.", {"entities": [[93, 110, "DISEASE"], [102, 110, "DISEASE"]]}], ["Nasal polyps exhibited lower levels of PPAR\u03b1 and PPAR\u03b3 than normal nasal mucosa and these levels were, for PPAR\u03b3, further reduced following steroid treatment.", {"entities": []}], ["PPAR\u03b3 immunoreactivity was detected in the epithelium, but also found in smooth muscle of blood vessels, glandular acini and inflammatory cells.", {"entities": []}], ["Quantitative evaluation of the epithelial immunostaining revealed no differences between nasal biopsies from patients with allergic rhinitis and healthy volunteers.", {"entities": [[123, 140, "DISEASE"], [132, 140, "DISEASE"]]}], ["In polyps, the PPAR\u03b3 immunoreactivity was lower than in nasal mucosa and further decreased after steroid treatment.", {"entities": []}], ["The down-regulation of PPAR\u03b3, in nasal polyposis but not in turbinates during symptomatic seasonal rhinitis, suggests that PPAR\u03b3 might be of importance in long standing inflammations.", {"entities": [[99, 107, "DISEASE"]]}], ["Aeroallergens are the most common causes of allergy.", {"entities": []}], ["The aim of this study was to determine hypersensitivity to aeroallergens in patients with nasobronchial allergy.", {"entities": []}], ["This retrospective population study included 2254 patients with nasobronchial allergy, from late adolescents to adults.", {"entities": []}], ["Their response to aeroallergens was assessed by skin prick tests.", {"entities": []}], ["More patients had rhinitis (72.7%), than asthma (27.6%).", {"entities": [[18, 26, "DISEASE"], [41, 47, "DISEASE"]]}], ["Although majority of patients were female, allergy is more common in men than in women (p<0.05).", {"entities": []}], ["Both groups of patients had the greatest number of positive skin prick tests for Dermatophagoides pteronyssinus (27.5%) and weed pollens (21.9%), followed by grass (18.3%) and tree pollens (10.1%).", {"entities": []}], ["Ragweed is the most common positive weed pollen in both groups, more in patients with rhinitis (p=0.022).", {"entities": [[86, 94, "DISEASE"]]}], ["The cocksfoot is the most common grass pollen in rhinitis group (15.3%), but meadow grass (12.6%) in asthma patients.", {"entities": [[49, 57, "DISEASE"], [101, 107, "DISEASE"]]}], ["Birch is the most common tree allergen in the both groups.", {"entities": []}], ["More patients with nasobronchial allergy have rhinitis than asthma.", {"entities": [[46, 54, "DISEASE"], [60, 66, "DISEASE"]]}], ["Skin prick tests are usually positive for Dermatophagoides pteronyssinus and weed pollens, followed by grass and tree pollens, and they are more common positive in patients with rhinitis than asthma.", {"entities": [[178, 186, "DISEASE"], [192, 198, "DISEASE"]]}], ["Although COPD is a prevalent disease, it is undertreated, and there are no available data regarding previous treatment of COPD in Brazil.", {"entities": []}], ["This study aimed to determine the appropriateness of maintenance treatment in COPD patients prior to their hospitalization and to identify variables associated with inappropriate treatment.", {"entities": []}], ["This was an observational, cross-sectional, analytical study involving 50 inpatients with COPD at two hospitals in the city of Florian\u00f3polis, Brazil.", {"entities": []}], ["The patients completed a questionnaire on parameters related to the maintenance treatment of COPD.", {"entities": []}], ["Non-pharmacological management and pharmacological treatment were assessed based on the recommendations made by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in 2011 and by the Brazilian National Ministry of Health in the chronic respiratory diseases section of its Caderno de Aten\u00e7\u00e3o B\u00e1sica (CAB, Primary Care Guidebook).", {"entities": []}], ["In most of the patients, the COPD was classified as being severe or very severe.", {"entities": []}], ["Regarding non-pharmacological management, 33% of the patients were smokers, only 32% had been advised to receive the flu vaccine, 28% had received pneumococcal vaccine, and only 6.5% of the patients in the B, C, and D categories received pulmonary rehabilitation.", {"entities": []}], ["Regarding GOLD and CAB recommendations, pharmacological treatment was inappropriate in 50% and 74% of the patients, respectively.", {"entities": []}], ["Based on GOLD recommendations, 38% were undertreated.", {"entities": []}], ["A low level of education, low income, not receiving oxygen therapy, and not receiving the flu vaccine were associated with inappropriate treatment.", {"entities": []}], ["The application of various non-pharmacological management recommendations was unsatisfactory.", {"entities": []}], ["Regarding the GOLD recommendations, the high rate of inappropriate maintenance treatment was mainly due to undertreatment.", {"entities": []}], ["In Brazil, even in severe COPD cases, optimizing treatment to achieve greater benefits continues to be a challenge.", {"entities": []}], ["Embora a DPOC seja uma enfermidade prevalente, ela \u00e9 subtratada, e dados sobre o tratamento pr\u00e9vio s\u00e3o desconhecidos em nosso meio.", {"entities": []}], ["Buscou-se verificar a adequa\u00e7\u00e3o \u00e0s recentes diretrizes no que se refere ao tratamento de manuten\u00e7\u00e3o em pacientes com DPOC antes de sua hospitaliza\u00e7\u00e3o e identificar poss\u00edveis vari\u00e1veis associadas \u00e0 inadequa\u00e7\u00e3o do tratamento.", {"entities": []}], ["Estudo transversal, observacional e anal\u00edtico, que incluiu 50 portadores de DPOC, internados em dois hospitais na cidade de Florian\u00f3polis (SC).", {"entities": []}], ["Aplicou-se um question\u00e1rio sobre par\u00e2metros relacionados ao tratamento de manuten\u00e7\u00e3o da DPOC.", {"entities": []}], ["Avaliou-se o manejo n\u00e3o farmacol\u00f3gico e a adequa\u00e7\u00e3o do tratamento farmacol\u00f3gico \u00e0 terapia preconizada pelo Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 e pelo Caderno de Aten\u00e7\u00e3o B\u00e1sica (CAB) do Minist\u00e9rio da Sa\u00fade do Brasil sobre doen\u00e7as respirat\u00f3rias cr\u00f4nicas.", {"entities": [[102, 106, "GENE"], [176, 180, "GENE"], [102, 106, "GENE"], [176, 180, "GENE"]]}], ["Na maioria dos pacientes, a DPOC foi classificada como grave ou muito grave.", {"entities": []}], ["Em rela\u00e7\u00e3o ao manejo n\u00e3o farmacol\u00f3gico, 33% eram tabagistas, apenas 32% foram orientados a receber vacina\u00e7\u00e3o anti-influenza, 28% receberam vacina anti-pneumoc\u00f3cica, e somente 6,5% dos pacientes nas categorias GOLD B, C e D realizaram reabilita\u00e7\u00e3o respirat\u00f3ria.", {"entities": [[114, 123, "DISEASE"]]}], ["O tratamento farmacol\u00f3gico foi inadequado em 50% e 74% da amostra, respectivamente, em rela\u00e7\u00e3o \u00e0s recomenda\u00e7\u00f5es do GOLD e do CAB.", {"entities": []}], ["Baseado nas recomenda\u00e7\u00f5es do GOLD, 38% eram subtratados.", {"entities": []}], ["Baixa escolaridade, baixa renda, n\u00e3o utiliza\u00e7\u00e3o de oxigenoterapia e aus\u00eancia de vacina\u00e7\u00e3o anti-influenza associaram-se a inadequa\u00e7\u00e3o do tratamento.", {"entities": [[95, 104, "DISEASE"]]}], ["N\u00e3o foram seguidas satisfatoriamente v\u00e1rias recomenda\u00e7\u00f5es do manejo n\u00e3o farmacol\u00f3gico.", {"entities": []}], ["Segundo o GOLD, a elevada inadequa\u00e7\u00e3o do tratamento de manuten\u00e7\u00e3o foi principalmente devida ao subtratamento.", {"entities": []}], ["No Brasil, mesmo nos casos mais graves, a otimiza\u00e7\u00e3o do tratamento da DPOC para se obter benef\u00edcios mais evidentes continua a ser um desafio.", {"entities": []}], ["Respiratory symptoms, either newly reported after the World Trade Center (WTC) disaster on 11 September 2001 (9/11) or increased in severity, have been well documented in WTC-exposed workers and New York City residents.", {"entities": []}], ["However, considerable uncertainty exists over the persistence of symptoms.", {"entities": []}], ["In this study, our goals were to describe trends in post-9/11 respiratory and gastro-esophageal reflux disease (GERD) symptoms in WTC-exposed firefighters and to examine symptom progression in the cohort that completed both year 1 and year 4 questionnaires.", {"entities": []}], ["We analyzed questionnaire responses from 10,378 firefighters in yearly intervals, from 2 October 2001 to 11 September 2005, defining exposure based on arrival time at the WTC site.", {"entities": []}], ["For the cohort of 3,722 firefighters who completed the two questionnaires, we also calculated exposure duration summing months of work at the site.", {"entities": []}], ["In cross-sectional analyses, the prevalence of dyspnea, wheeze, rhinosinusitis, and GERD remained relatively stable, whereas cough and sore throat declined, especially between 1 and 2 years post-9/11.", {"entities": []}], ["We found a dose\u2013response relationship between arrival time and symptoms in all years ( p < 0.01).", {"entities": []}], ["Logistic models of symptoms at year 4 in the cohort demonstrated independent effects of earlier arrival and longer work duration: each additional month of work increased the odds of symptoms 8\u201311%.", {"entities": []}], ["Protracted work exposures increased the odds of respiratory and GERD symptoms 4 years later.", {"entities": []}], ["In most large disasters, exposures may be unavoidable during the rescue phase, but our data strongly suggest the need to minimize additional exposures during recovery and cleanup phases.", {"entities": []}], ["Caveolin-1 (Cav1) is a scaffold protein and pathogen receptor in the mucosa of the gastrointestinal tract.", {"entities": [[12, 16, "GENE"]]}], ["Chronic infection of gastric epithelial cells by Helicobacter pylori ( H. pylori ) is a major risk factor for human gastric cancer (GC) where Cav1 is frequently down-regulated.", {"entities": [[124, 130, "DISEASE"], [132, 134, "GENE"], [142, 146, "GENE"]]}], ["However, the function of Cav1 in H. pylori infection and pathogenesis of GC remained unknown.", {"entities": [[25, 29, "GENE"], [73, 75, "GENE"]]}], ["We show here that Cav1-deficient mice, infected for 11 months with the CagA-delivery deficient H. pylori strain SS1, developed more severe gastritis and tissue damage, including loss of parietal cells and foveolar hyperplasia, and displayed lower colonisation of the gastric mucosa than wild-type B6129 littermates.", {"entities": [[139, 148, "DISEASE"]]}], ["Cav1-null mice showed enhanced infiltration of macrophages and B-cells and secretion of chemokines (RANTES) but had reduced levels of CD25 H. pylori strain G27, were more sensitive to CagA-related cytoskeletal stress morphologies (\u201chumming bird\u201d) compared to AGS cells stably transfected with Cav1 (AGS/Cav1).", {"entities": [[0, 4, "GENE"], [293, 297, "GENE"], [303, 307, "GENE"]]}], ["Infection of AGS/Cav1 cells triggered the recruitment of p120 RhoGTPase-activating protein/deleted in liver cancer-1 (p120RhoGAP/DLC1) to Cav1 and counteracted CagA-induced cytoskeletal rearrangements.", {"entities": [[102, 114, "DISEASE"], [108, 114, "DISEASE"], [17, 21, "GENE"], [138, 142, "GENE"]]}], ["In human GC cell lines (MKN45, N87) and mouse stomach tissue, H. pylori down-regulated endogenous expression of Cav1 independently of CagA.", {"entities": [[9, 11, "GENE"], [112, 116, "GENE"]]}], ["Mechanistically, H. pylori activated sterol-responsive element-binding protein-1 (SREBP1) to repress transcription of the human Cav1 gene from sterol-responsive elements (SREs) in the proximal Cav1 promoter.", {"entities": [[128, 132, "GENE"], [193, 197, "GENE"], [128, 132, "GENE"], [193, 197, "GENE"]]}], ["These data suggested a protective role of Cav1 against H. pylori -induced inflammation and tissue damage.", {"entities": [[42, 46, "GENE"]]}], ["We propose that H. pylori exploits down-regulation of Cav1 to subvert the host's immune response and to promote signalling of its virulence factors in host cells.", {"entities": [[54, 58, "GENE"]]}], ["Infection with the bacterium Helicobacter pylori ( H. pylori ) mainly affects children in the developing countries who are at risk to progress to gastric cancer (GC) as adults after many years of persistent infection, especially with strains which are positive for the oncogenic virulence factor CagA.", {"entities": [[154, 160, "DISEASE"], [162, 164, "GENE"]]}], ["Eradication of H. pylori by antibiotics is a treatment of choice but may also alter the susceptibility to allergies and other tumor types.", {"entities": []}], ["Thus, novel diagnostic or prognostic markers are needed which detect early molecular changes in the stomach mucosa during the transition of chronic inflammation to cancer.", {"entities": [[164, 170, "DISEASE"]]}], ["In our study, we found that the tumor suppressor caveolin-1 (Cav1) is reduced upon infection with H. pylori , and CagA was sufficient but not necessary for this down-regulation.", {"entities": [[61, 65, "GENE"]]}], ["Loss of Cav1 was caused by H. pylori -dependent activation of sterol-responsive element-binding protein-1 (SREBP1), and this event abolished the interaction of Cav1 with p120 RhoGTPase-activating protein/deleted in liver cancer-1 (p120RhoGAP/DLC1), a second bona fide tumor suppressor in gastric tissue.", {"entities": [[215, 227, "DISEASE"], [221, 227, "DISEASE"], [8, 12, "GENE"], [160, 164, "GENE"], [8, 12, "GENE"], [160, 164, "GENE"]]}], ["Conclusively, Cav1 and DLC1 may constitute novel molecular markers in the H. pylori -infected gastric mucosa before neoplastic transformation of the epithelium.", {"entities": [[14, 18, "GENE"], [23, 27, "GENE"]]}], ["Ectromelia virus (ECTV) causes mousepox in mice, a disease very similar to smallpox in humans.", {"entities": [[75, 83, "DISEASE"]]}], ["ECTV and variola virus (VARV), the agent of smallpox, are closely related orthopoxviruses.", {"entities": [[44, 52, "DISEASE"]]}], ["Mousepox is an excellent small animal model to study the genetic and immunologic basis for resistance and susceptibility of humans to smallpox.", {"entities": [[134, 142, "DISEASE"]]}], ["Resistance to mousepox is dependent on a strong polarized type 1 immune response, associated with robust natural killer (NK) cell, cytotoxic T lymphocyte (CTL) and gamma interferon (IFN-\u03b3) responses.", {"entities": []}], ["In contrast, ECTV-susceptible mice generate a type 2 response, associated with weak NK cell, CTL and IFN-\u03b3 responses but robust IL-4 responses.", {"entities": []}], ["Nonetheless, susceptible strains infected with mutant ECTV lacking virus-encoded IFN-\u03b3 binding protein (vIFN-\u03b3bp) (ECTV-IFN-\u03b3bp", {"entities": []}], ["Tobacco smoking continues to be a major preventable cause of death and disease and therefore tobacco control research is extremely important.", {"entities": []}], ["However, research in this area is often hampered by a lack in funding and there is a need for scientometric techniques to display research efforts.", {"entities": []}], ["The present study combines classical bibliometric tools with novel scientometric and visualizing techniques in order to analyse and categorise research in the field of tobacco control.", {"entities": []}], ["All studies related to tobacco control and listed in the ISI database since 1900 were identified by the use of defined search terms.", {"entities": []}], ["Using bibliometric approaches, a continuous increase in qualitative markers such as collaboration numbers or citations were found for tobacco control research.", {"entities": []}], ["The combination with density equalizing mapping revealed a distinct global pattern of research productivity and citation activity.", {"entities": []}], ["Radar chart techniques were used to visualize bi- and multilateral research cooperation and institutional cooperation.", {"entities": []}], ["The present study supplies a first scientometric approach that visualises research activity in the field of tobacco control.", {"entities": []}], ["It provides data that can be used for funding policy and the identification of research clusters.", {"entities": []}], ["Influenza and Influenza-like-illness (ILI) represents a substantial public health problem, but it is difficult to measure the overall burden as many cases do not access health care.", {"entities": []}], ["Community cohorts have the advantage of not requiring individuals to present at hospitals and surgeries and therefore can potentially monitor a wider variety of cases.", {"entities": []}], ["This study reports on the incidence and risk factors for ILI in the UK as measured using Flusurvey, an internet-based open community cohort.", {"entities": []}], ["Upon initial online registration participants were asked background characteristics, and every week were asked to complete a symptoms survey.", {"entities": []}], ["We compared the representativeness of our sample to the overall population.", {"entities": []}], ["We used two case definitions of ILI, which differed in whether fever/chills was essential.", {"entities": []}], ["We calculated ILI incidence week by week throughout the season, and investigated risk factors associated with ever reporting ILI over the course of the season.", {"entities": []}], ["Risk factor analysis was conducted using binomial regression.", {"entities": []}], ["5943 participants joined the survey, and 4532 completed the symptoms survey at least twice.", {"entities": []}], ["Participants who filled in symptoms surveys at least twice filled in a median of nine symptoms surveys over the course of the study.", {"entities": []}], ["46.1% of participants reported at least one episode of ILI, and 6.0% of all reports were positive for ILI.", {"entities": []}], ["Females had slightly higher incidence, and individuals over 65 had the lowest incidence.", {"entities": []}], ["Incidence peaked just before Christmas and declined dramatically during school holidays.", {"entities": []}], ["Multivariate regression showed that, for both definitions of ILI considered, being female, unvaccinated, having underlying health issues, having contact with children, being aged between 35 and 64, and being a smoker were associated with the highest risk of reporting an ILI.", {"entities": []}], ["The use of public transport was not associated with an increased risk of ILI.", {"entities": []}], ["Our results show that internet based surveillance can be used to measure ILI and understand risk factors.", {"entities": []}], ["Vaccination is shown to be linked to a reduced risk of reporting ILI.", {"entities": []}], ["Taking public transport does not increase the risk of reporting ILI.", {"entities": []}], ["Flusurvey and other participatory surveillance techniques can be used to provide reliable information to policy makers in nearly real-time.", {"entities": []}], ["In the general population the prevalence of bipolar and schizophrenia is 0.24% and 1.4% respectively.", {"entities": [[56, 69, "DISEASE"]]}], ["People with schizophrenia and bipolar disorder have a significantly reduced life expectancy, increased rates of unemployment and a fear of stigma leading to reduced self-confidence.", {"entities": [[12, 25, "DISEASE"], [30, 46, "DISEASE"]]}], ["A core outcome set is a standardised collection of items that should be reported in all controlled trials within a research area.", {"entities": []}], ["There are currently no core outcome sets available for use in effectiveness trials involving bipolar or schizophrenia service users managed in a community setting.", {"entities": [[104, 117, "DISEASE"]]}], ["A three-step approach is to be used to concurrently develop two core outcome sets, one for bipolar and one for schizophrenia.", {"entities": [[111, 124, "DISEASE"]]}], ["First, a comprehensive list of outcomes will be compiled through qualitative research and systematic searching of trial databases.", {"entities": []}], ["Focus groups and one-to-one interviews will be completed with service users, carers and healthcare professionals.", {"entities": []}], ["Second, a Delphi study will be used to reduce the lists to a core set.", {"entities": []}], ["The three-round Delphi study will ask service users to score the outcome list for relevance.", {"entities": []}], ["In round two stakeholders will only see the results of their group, while in round three stakeholders will see the results of all stakeholder group by stakeholder group.", {"entities": []}], ["Third, a consensus meeting with stakeholders will be used to confirm outcomes to be included in the core set.", {"entities": []}], ["Following the development of the core set a systematic literature review of existing measures will allow recommendations for how the core outcomes should be measured and a stated preference survey will explore the strength of people\u2019s preferences and estimate weights for the outcomes that comprise the core set.", {"entities": []}], ["A core outcome set represents the minimum measurement requirement for a research area.", {"entities": []}], ["We aim to develop core outcome sets for use in research involving service users with schizophrenia or bipolar managed in a community setting.", {"entities": [[85, 98, "DISEASE"]]}], ["This will inform the wider PARTNERS2 study aims and objectives of developing an innovative primary care-based model of collaborative care for people with a diagnosis of bipolar or schizophrenia.", {"entities": [[180, 193, "DISEASE"]]}], ["Patients are increasingly expected and asked to be involved in health care decisions.", {"entities": []}], ["In this decision-making process, preferences for participation are important.", {"entities": []}], ["In this systematic review we aim to provide an overview the literature related to the congruence between patients\u2019 preferences and their perceived participation in medical decision-making.", {"entities": []}], ["We also explore the direction of mismatched and outline factors associated with congruence.", {"entities": []}], ["A systematic review was performed on patient participation in medical decision-making.", {"entities": []}], ["Medline, PsycINFO, CINAHL, EMBASE and the Cochrane Library databases up to September 2012, were searched and all studies were rigorously critically appraised.", {"entities": []}], ["In total 44 papers were included, they sampled contained 52 different patient samples.", {"entities": []}], ["Mean of congruence between preference for and perceived participation in decision-making was 60% (49 and 70 representing 25 This review suggests that a similar approach to all patients is not likely to meet patients\u2019 wishes, since preferences for participation vary among patients.", {"entities": []}], ["Health care professionals should be sensitive to patients individual preferences and communicate about patients\u2019 participation wishes on a regular basis during their illness trajectory.", {"entities": []}], ["The effect of sepsis on epidermal wound healing has not been previously studied.", {"entities": []}], ["It was hypothesised that epidermal wound healing is disturbed in severe sepsis.", {"entities": []}], ["Blister wounds were induced in 35 patients with severe sepsis and in 15 healthy controls.", {"entities": []}], ["The healing of the wounds was followed up by measuring transepidermal water loss and blood flow in the wound, reflecting the restoration of the epidermal barrier function and inflammation, respectively.", {"entities": []}], ["The first set of suction blisters (early wound) was made within 48 hours of the first sepsis-induced organ failure and the second set (late wound) four days after the first wound.", {"entities": []}], ["In addition, measurements were made on the intact skin.", {"entities": []}], ["The average age of the whole study population was 62 years (standard deviation [SD] 12).", {"entities": []}], ["The mean Acute Physiology and Chronic Health Evaluation II (APACHE II) score on admission was 25 (SD 8).", {"entities": []}], ["The two most common causes of infections were peritonitis and pneumonia.", {"entities": [[62, 71, "DISEASE"], [46, 57, "DISEASE"]]}], ["Sixty-six percent of the patients developed multiple organ failure.", {"entities": []}], ["The decrease in water evaporation from the wound during the first four days was lower in septic patients than in the control subjects (56 g/m P = 0.004).", {"entities": []}], ["On the fourth day, septic patients had significantly higher blood flow in the wound compared with the control subjects (septic patients 110 units versus control subjects 47 units, P = 0.001).", {"entities": []}], ["No difference in transepidermal water loss from the intact skin was found between septic patients and controls.", {"entities": []}], ["Septic patients had higher blood flow in the intact skin on the fourth and on the eighth day of study compared with the controls.", {"entities": []}], ["The restoration of the epidermal barrier function is delayed and wound blood flow is increased in patients with severe sepsis.", {"entities": []}], ["Inflammatory joint diseases are a group of heterogeneous disorders with a variety of different etiologies and disease manifestations.", {"entities": []}], ["However, there are features that are common to all of them: first, the recruitment of various inflammatory cell types that are attracted to involved tissues over the course of the disease process.", {"entities": []}], ["Second, the treatments used in many of these diseases are commonly medications that suppress or alter immune function.", {"entities": []}], ["The demonstration that adenosine has endogenous anti-inflammatory functions and that some of the most commonly used anti-rheumatic medications exert their therapeutic effects through stimulation of adenosine release suggest an important role for purinergic signaling in inflammatory rheumatic disorders.", {"entities": []}], ["Stressful life events are associated with mood disorders in adults in clinical settings.", {"entities": []}], ["Less described in the literature is the association between common life stressors and a wide range of psychopathology in young adolescents.", {"entities": []}], ["This study uses a large non-clinical sample of young adolescents to describe the associations among worry or stress about common life events/difficulties, mental health and substance use.", {"entities": []}], ["Data on lifetime stress or worry about common life events/difficulties (i.e., romantic breakups, family disruption, interpersonal difficulties, and personal stress (health, weight, school work)), symptoms of depression, conduct disorder symptoms, and substance use were collected from 1025 grade 7 students (mean age 12.9 years; 45% male).", {"entities": [[220, 236, "DISEASE"]]}], ["The association between each source of stress and each mental health and substance use indicator was modeled in separate logistic regression analyses.", {"entities": []}], ["The proportion of adolescents reporting worry or stress ranged from 7% for new family to 53% for schoolwork.", {"entities": []}], ["Romantic breakup stress was statistically significantly associated with all the mental health and substance use indicators except illicit drug use.", {"entities": []}], ["Family disruption was statistically significantly associated with depression symptoms, marijuana use, and cigarette use.", {"entities": []}], ["Interpersonal difficulties stress was statistically significantly associated with depression symptoms.", {"entities": []}], ["All sources of personal stress were statistically significantly related to depression symptoms.", {"entities": []}], ["In addition, health-related stress was inversely related to binge drinking.", {"entities": []}], ["Young adolescents may benefit from learning positive coping skills to manage worry or stress about common stressors and in particular, worry or stress related to romantic breakups.", {"entities": []}], ["Appropriate management of mental health symptoms and substance use related to common stressful life events and difficulties may help reduce emerging psychopathology.", {"entities": []}], ["A significant proportion of glaucoma patients present late, particularly in the developing world, and unfortunately, in an advanced stage of the disease.", {"entities": [[28, 36, "DISEASE"]]}], ["They are at imminent danger of losing remaining vision, and may also be afflicted with various socioeconomic and health challenges.", {"entities": []}], ["The encounter with such a patient is typically characterized by anxiety/fear and sometimes hopelessness from the patient's perspective.", {"entities": []}], ["The physician may also feel that they are in a difficult position managing the patient's disease.", {"entities": []}], ["When dealing with such cases, we suggest a holistic, individualized approach taking into account the \u2018biopsychosociospiritual\u2019 (BPSS) profile of each patient.", {"entities": []}], ["The BPSS model takes into account relevant ocular as well as systemic biology (factors such as the mechanism of glaucoma, level of intraocular pressure [IOP], rate of progression, life expectancy, general health), psychological considerations (e.g., fear, depression), socio-economic factors and spiritual/cultural values and beliefs before being able to decide with the patient and their care partner(s) what treatment goals should be and how they can best be approached.", {"entities": [[112, 120, "DISEASE"]]}], ["Treatment for advanced glaucoma can be highly effective, and patients and their care partners should be informed that aggressive IOP lowering to the low teens or even single digits offers the best chance of protecting remaining vision.", {"entities": [[23, 31, "DISEASE"]]}], ["This can be achieved safely and effectively in most cases with trabeculectomy (including an antimetabolite), and in some cases with medical and/or laser therapy.", {"entities": []}], ["Vision rehabilitation and psychosocial support should also be considered in order to optimize remaining vision, replace fear with hope as appropriate, and thus improve the overall quality of life.", {"entities": []}], ["Pseudomonas aeruginosa causes chronic respiratory disease, and the elastase enzyme that it produces increases the permeability of airway epithelial cells owing to the disruption of tight junctions.", {"entities": []}], ["P. aeruginosa is also implicated in prolonged chronic rhinosinusitis.", {"entities": []}], ["However, the effects of P. aeruginosa elastase (PE) against the barrier formed by human nasal epithelial cells (HNECs) remain unknown.", {"entities": []}], ["To investigate the mechanisms involved in the disruption of tight junctions by PE in HNECs, primary cultures of HNECs transfected with human telomerase reverse transcriptase (hTERT-HNECs) were used.", {"entities": []}], ["The hTERT-HNECs were pretreated with inhibitors of various signal transduction pathways, PKC, MAPK, p38MAPK, PI3K, JNK, NF-\u03baB, EGF receptor, proteasome, COX1 and COX2 before treatment with PE.", {"entities": [[127, 130, "GENE"]]}], ["Some cells were pretreated with siRNA and agonist of protease activated receptor-2 (PAR-2) before treatment with PE.", {"entities": []}], ["Expression and structures of tight junctions were determined by Western blotting, real-time PCR, immunostaining and freeze-fracture.", {"entities": []}], ["Transepithelial electrical resistance (TER) was examined as the epithelial barrier function.", {"entities": []}], ["PE treatment transiently disrupted the epithelial barrier and downregulated the transmembrane proteins claudin-1 and -4, occludin, and tricellulin, but not the scaffold PDZ-expression proteins ZO-1 and -2 and adherens junction proteins E-cadherin and \u03b2-catenin.", {"entities": []}], ["The transient downregulation of tight junction proteins was controlled via distinct signal transduction pathways such as the PKC, MAPK, PI3K, p38 MAPK, JNK, COX-1 and -2, and NF-\u03baB pathways.", {"entities": []}], ["Furthermore, treatment with PE transiently decreased PAR-2 expression, which also regulated the expression of the tight junction proteins.", {"entities": []}], ["Treatment with a PAR-2 agonist prevented the downregulation of the tight junction proteins after PE treatment in HNECs.", {"entities": []}], ["PE transiently disrupts tight junctions in HNECs and downregulates PAR-2.", {"entities": []}], ["The transient disruption of tight junctions by PE might occur repeatedly during chronic rhinosinusitis.", {"entities": []}], ["Familial Amyloidotic Polyneuropathy (FAP) is a disorder characterized by the extracellular deposition of fibrillar Transthyretin (TTR) amyloid, with a special involvement of the peripheral nerve.", {"entities": [[37, 40, "GENE"], [130, 133, "GENE"]]}], ["We had previously shown that doxycycline administered for 3 months at 40 mg/Kg/ml in the drinking water, was capable of removing TTR amyloid deposits present in stomachs of old TTR-V30M transgenic mice; the removal was accompanied by a decrease in extracellular matrix remodeling proteins that accompany fibrillar deposition, but not of non-fibrillar TTR deposition and/or markers associated with pre-fibrillar deposits.", {"entities": [[129, 132, "GENE"], [177, 180, "GENE"], [351, 354, "GENE"], [129, 132, "GENE"], [177, 180, "GENE"], [351, 354, "GENE"]]}], ["On the other hand, Tauroursodeoxycholic acid (TUDCA), a biliary acid, administrated to the same mouse model was shown to be effective at lowering deposited non-fibrillar TTR, as well as the levels of markers associated with pre-fibrillar TTR, but only at young ages.", {"entities": [[170, 173, "GENE"], [238, 241, "GENE"], [170, 173, "GENE"], [238, 241, "GENE"]]}], ["In the present work we evaluated different doxycycline administration schemes, including different periods of treatment, different dosages and different FAP TTR V30M animal models.", {"entities": [[153, 156, "GENE"], [157, 160, "GENE"]]}], ["Evaluation included CR staining, immunohistochemistry for TTR, metalloproteinase 9 (MMP-9) and serum amyloid P component (SAP).", {"entities": [[58, 61, "GENE"]]}], ["We determined that a minimum period of 15 days of treatment with a 8 mg/Kg/day dosage resulted in fibril removal.", {"entities": []}], ["The possibility of intermittent treatments was also assessed and a maximum period of 15 days of suspension was determined to maintain tissues amyloid-free.", {"entities": []}], ["Combined cycled doxycycline and TUDCA administration to mice with amyloid deposition, using two different concentrations of both drugs, was more effective than either individual doxycycline or TUDCA, in significantly lowering TTR deposition and associated tissue markers.", {"entities": [[226, 229, "GENE"]]}], ["The observed synergistic effect of doxycycline/TUDCA in the range of human tolerable quantities, in the transgenic TTR mice models prompts their application in FAP, particularly in the early stages of disease.", {"entities": [[115, 118, "GENE"], [160, 163, "GENE"]]}], ["There is conflicting evidence that traffic-related air pollution is a risk factor for allergic conditions.", {"entities": []}], ["Few studies have investigated this in adults.", {"entities": []}], ["In adults, a high proportion of asthma, rhinitis and eczema is triggered by non-allergic factors.", {"entities": [[40, 48, "DISEASE"], [32, 38, "DISEASE"]]}], ["We investigated traffic as a risk factor for allergic versus non-allergic asthma and rhinitis, and eczema, in adults.", {"entities": [[65, 80, "DISEASE"], [85, 93, "DISEASE"], [74, 80, "DISEASE"]]}], ["A questionnaire from 2000 (n = 9319, 18\u201377 years) provided individual data about disease outcome and self-reported traffic exposure.", {"entities": []}], ["Additional exposure assessments were obtained using Geographical Informations Systems (GIS).", {"entities": []}], ["Residential addresses were linked to the national Swedish Road Database and to a pollutant database with modelled annual means of NO x (Nitrogen Oxids).", {"entities": []}], ["Living within 100 m from a road with a traffic intensity of >10 cars/min (24 hour mean) was associated with prevalence of current asthma reported to be triggered by allergic factors (OR = 1.83, 95% CI = 1.23\u20132.72) and with allergic rhinitis (OR = 1.30, 95%CI = (1.05\u20131.61).", {"entities": [[223, 240, "DISEASE"], [232, 240, "DISEASE"], [130, 136, "DISEASE"]]}], ["No relation was seen with asthma or rhinitis triggered by other factors.", {"entities": [[36, 44, "DISEASE"], [26, 32, "DISEASE"]]}], ["Living within 100 m of a road with >10 cars/min was also associated with hand-eczema during the last 12 months (OR = 1.63, 95% CI = 1.19\u20132.23), but not with allergic eczema or diagnosed hand-eczema.", {"entities": []}], ["Consistent results were seen using self-reported traffic, but the associations with NO x were less consistent.", {"entities": []}], ["Exposure to traffic was associated with a higher prevalence of allergic asthma and allergic rhinitis, but not with asthma or rhinitis triggered by non-allergic factors.", {"entities": [[83, 100, "DISEASE"], [63, 78, "DISEASE"], [92, 100, "DISEASE"], [125, 133, "DISEASE"], [72, 78, "DISEASE"], [115, 121, "DISEASE"]]}], ["This difference was suggested by the overall pattern, but only clear using GIS-measured traffic intensity as a proxy for traffic exposure.", {"entities": []}], ["An association was also found with hand-eczema during the last 12 months.", {"entities": []}], ["We suggest that asthma and rhinitis should not be treated as homogenous groups when estimating effects from traffic in adults.", {"entities": [[27, 35, "DISEASE"], [16, 22, "DISEASE"]]}], ["During vascular injury, vascular smooth muscle cells (SMCs) and fibroblasts/myofibroblasts (FBs/MFBs) are exposed to altered luminal blood flow or transmural interstitial flow.", {"entities": []}], ["We investigate the effects of these two types of fluid flows on the phenotypes of SMCs and MFBs and the underlying mechanotransduction mechanisms.", {"entities": []}], ["Exposure to 8 dyn/cm 2 O, \u223c0.05 dyn/cm The results suggest that HSPG-mediated ERK1/2 activation is an important mechanotransduction pathway modulating SMC marker gene expression when SMCs and MFBs are exposed to flow.", {"entities": []}], ["Fluid flow may be involved in vascular remodeling and lesion formation by affecting phenotypes of vascular wall cells.", {"entities": []}], ["This study has implications in understanding the flow-related mechanobiology in vascular lesion formation, tumor cell invasion, and stem cell differentiation.", {"entities": []}], ["Climate change is taking a toll on human health, and some leaders in the public health community have urged their colleagues to give voice to its health implications.", {"entities": []}], ["Previous research has shown that Americans are only dimly aware of the health implications of climate change, yet the literature on issue framing suggests that providing a novel frame - such as human health - may be potentially useful in enhancing public engagement.", {"entities": []}], ["We conducted an exploratory study in the United States of people's reactions to a public health-framed short essay on climate change.", {"entities": []}], ["U.S. adult respondents (n = 70), stratified by six previously identified audience segments, read the essay and were asked to highlight in green or pink any portions of the essay they found \"especially clear and helpful\" or alternatively \"especially confusing or unhelpful.\"", {"entities": []}], ["Two dependent measures were created: a composite sentence-specific score based on reactions to all 18 sentences in the essay; and respondents' general reactions to the essay that were coded for valence (positive, neutral, or negative).", {"entities": []}], ["We tested the hypothesis that five of the six audience segments would respond positively to the essay on both dependent measures.", {"entities": []}], ["There was clear evidence that two of the five segments responded positively to the public health essay, and mixed evidence that two other responded positively.", {"entities": []}], ["There was limited evidence that the fifth segment responded positively.", {"entities": []}], ["Post-hoc analysis showed that five of the six segments responded more positively to information about the health benefits associated with mitigation-related policy actions than to information about the health risks of climate change.", {"entities": []}], ["Presentations about climate change that encourage people to consider its human health relevance appear likely to provide many Americans with a useful and engaging new frame of reference.", {"entities": []}], ["Information about the potential health benefits of specific mitigation-related policy actions appears to be particularly compelling.", {"entities": []}], ["We believe that the public health community has an important perspective to share about climate change, a perspective that makes the problem more personally relevant, significant, and understandable to members of the public.", {"entities": []}], ["Immunoglobulin (Ig)G4-associated cholangitis (IAC) is one of the common organ manifestations of IgG4-related systemic disease (ISD).", {"entities": [[33, 44, "DISEASE"]]}], ["IAC and autoimmune pancreatitis (AIP) may mimic sclerosing cholangitis, cholangiocarcinoma, or pancreatic carcinoma.", {"entities": [[48, 70, "DISEASE"], [95, 115, "DISEASE"], [106, 115, "DISEASE"], [19, 31, "DISEASE"], [59, 70, "DISEASE"], [72, 90, "DISEASE"], [33, 36, "GENE"]]}], ["Diagnosis is based on a combination of clinical, biochemical, radiological, and histological findings.", {"entities": []}], ["To study the clinical presentation of and treatment strategy for IAC, we reviewed clinical, serologic, and imaging characteristics, as well as treatment response, in 39 patients with IAC.", {"entities": []}], ["The majority of patients were men (82%).", {"entities": []}], ["Clinical features on presentation included obstructive jaundice in 26 patients (67%) and abdominal pain in 20 (51%).", {"entities": [[43, 63, "DISEASE"]]}], ["Positive IgG4 immunostaining was seen in 27 patients.", {"entities": []}], ["The median serum IgG4 level before treatment was 769.4\u200amg/dL (range, 309.1\u20131229.7\u200amg/dL).", {"entities": []}], ["After the steroid therapy, the median serum IgG4 level in 23 patients was 247.0\u200amg/dL (range, 139.0\u2013355.0\u200amg/dL).", {"entities": []}], ["Cholangiograms were available in 36 (92%) patients.", {"entities": []}], ["Stenosis of the lower part of the common bile duct was found in 26 of 39 patients.", {"entities": []}], ["Stenosis was diffusely distributed in the intra- and extrahepatic bile ducts in 14 of 39 patients.", {"entities": []}], ["Additionally, strictures of the bile duct were detected in the hilar hepatic lesions in 27 of 39 patients.", {"entities": []}], ["AIP was the most frequent comorbidity (35/39 in this study) of IAC.", {"entities": [[0, 3, "GENE"]]}], ["Other affected organs included eyes (n\u200a=\u200a6), salivary glands (sialadenitis, n\u200a=\u200a10), lymph nodes (mediastinal and axillary, n\u200a=\u200a3), kidneys (n\u200a=\u200a2), and the retroperitoneum (retroperitoneal fibrosis, n\u200a=\u200a2).", {"entities": [[62, 74, "DISEASE"]]}], ["Regarding treatment, 29 patients were treated with steroids, of whom one underwent pancreatoduodenectomy, and one underwent choledochojejunostomy.", {"entities": []}], ["Eight patients were treated with biliary stents.", {"entities": []}], ["The remaining 19 patients took prednisolone alone.", {"entities": []}], ["Eight patients achieved spontaneous resolution.", {"entities": []}], ["Four patients with suspected pancreatic cancer or cholangiocarcinoma underwent surgery, including 2 patients who also received postoperative steroids.", {"entities": [[29, 46, "DISEASE"], [40, 46, "DISEASE"], [50, 68, "DISEASE"]]}], ["All patients were regularly followed up for 9 to 36 months.", {"entities": []}], ["Only 2 patients in the steroids treatment group relapsed to manifest obstructive jaundice and high serum IgG4 levels.", {"entities": [[69, 89, "DISEASE"]]}], ["These 2 patients were treated with steroids and biliary stents, resulting in complete remission.", {"entities": []}], ["We also review the diagnostic and therapeutic management and discuss recent pathophysiological findings, which might aid in understanding the molecular mechanisms contributing to IAC and other manifestations of IgG4-related diseases (IgG4-RD).", {"entities": []}], ["Biomarkers that are more accurate are needed to correctly diagnose IAC and prevent misdiagnoses and unnecessary therapeutic interventions.", {"entities": []}], ["The epidemic of obesity has reached alarming levels in both developing and developed nations.", {"entities": [[16, 23, "DISEASE"]]}], ["Excessive calorie intake and sedentary lifestyle due to technological advancements are the main causal factors for overweight and obesity among the human population.", {"entities": [[130, 137, "DISEASE"]]}], ["Obesity has been associated with a number of co-morbidities such as hypertension, type 2 diabetes mellitus, cardiovascular diseases, and neurodegeneration and dementia.", {"entities": [[68, 80, "DISEASE"], [159, 167, "DISEASE"], [0, 7, "DISEASE"], [89, 106, "DISEASE"], [82, 106, "DISEASE"]]}], ["The progression of neurological disorders in obese subjects has been mainly attributed to neuroinflammation.", {"entities": []}], ["Withania somnifera has been used in numerous Ayurvedic formulations owing to its wide array of health-promoting properties.", {"entities": []}], ["The current study was designed to test the hypothesis whether dry leaf powder of W .", {"entities": []}], ["somnifera has anxiolytic and anti-neuroinflammatory potential in diet-induced obesity.", {"entities": [[78, 85, "DISEASE"]]}], ["Young adult female rats were divided into four groups: low\u00a0fat diet group (LFD) fed with regular chow feed, high\u00a0fat diet group (HFD) fed with diet containing 30% fat by weight, low\u00a0fat diet plus extract group (LFDE) fed with regular chow feed supplemented with dry leaf powder of W .", {"entities": []}], ["somnifera 1\u00a0mg/g of body weight (ASH), and high\u00a0fat diet plus extract group (HFDE) fed with diet containing 30% fat by weight and supplemented with ASH.", {"entities": []}], ["All the animals were kept on respective feeding regimen for 12\u00a0weeks; following which, the animals were tested for their anxiety-like behavior using elevated plus maze test.", {"entities": []}], ["The animals were sacrificed and used to study various inflammatory markers such as GFAP, Iba1, PPAR\u03b3, iNOS, MCP-1, TNF\u03b1, IL-1\u03b2, IL-6, and various markers of NF-\u03baB pathway by Western blotting and quantitative real-time PCR.", {"entities": [[83, 87, "GENE"]]}], ["Serum levels of leptin, insulin and pro-inflammatory cytokines were also assayed.", {"entities": []}], ["ASH\u00a0treated rats showed less anxiety levels as compared to HFD animals.", {"entities": []}], ["At molecular level, ASH ameliorated the HFD-induced reactive gliosis and microgliosis and suppressed the expression of inflammatory markers such as PPAR\u03b3, iNOS, MCP-1, TNF\u03b1, IL-1\u03b2, and IL-6.", {"entities": []}], ["Further, ASH ameliorated leptin and insulin resistance and prevented HFD-induced apoptosis.", {"entities": []}], ["Dry leaf powder of W .", {"entities": []}], ["somnifera may prove to be a potential therapeutic agent to attenuate neuroinflammation associated with obesity and may prevent its co-morbidities.", {"entities": [[103, 110, "DISEASE"]]}], ["Smoking is a leading cause of morbidity and mortality globally.", {"entities": []}], ["There is therefore need to identify relevant factors associated with smoking among adolescents in order to better tailor public health interventions aimed at preventing smoking.", {"entities": []}], ["We used data from the Global Youth Tobacco Survey (GYTS) conducted in 2003 in Punjab, India, on 2014 adolescents of whom 58.9% were males.", {"entities": []}], ["We conducted a weighted logistic regression analysis, adjusting for age and sex, to determine associations between predictor variables and current tobacco smoking status.", {"entities": []}], ["A total of 2014 adolescents participated in the survey in 2003, and of these 58.9% were males.", {"entities": []}], ["Male respondents tended to be older than females (21.2% of males, and 13.1% of females were of age 16 years or above).", {"entities": []}], ["The percent of males and females in the other age groups were: 23.0% and 28.6% for <14 years, 27.3% and 31.0% for 14 years, and 28.4% and 27.0% for 15 years, respectively.", {"entities": []}], ["The following factors were positively associated with smoking: adolescents who received pocket money; adolescents who had parents who smoked, chewed or applied tobacco; adolescents who said that boys or girls who smoke or chew tobacco have more friends; adolescents who said that smoking or chewing tobacco makes boys look less attractive; adolescents who said that there is no difference in weight between smokers and non-smokers; adolescents who said that smoking makes one gain weight; and adolescents who had most or all of their closest friends who smoked.", {"entities": []}], ["The factors that were negatively associated with smoking were: adolescents who said that boys or girls who smoke or chew tobacco have less number of friends; adolescents who said that girls who smoke or chew tobacco are less attractive; and adolescents who had some of their closest friends who smoked.", {"entities": []}], ["The observed associations between current smoking on one hand and peer smoking, and perception that boys who smoke are less attractive on the other, deserve further studies.", {"entities": []}], ["The factors reported in the current study should be considered in the design of public health interventions aimed to reduce adolescent cigarette smoking.", {"entities": []}], ["T lymphocytes (T cells) undergo metabolic reprogramming after activation to provide energy and biosynthetic materials for growth, proliferation and differentiation.", {"entities": []}], ["Distinct T cell subsets, however, adopt metabolic programs specific to support their needs.", {"entities": []}], ["As CD4 T cells coordinate adaptive immune responses while CD8 T cells become cytotoxic effectors, we compared activation-induced proliferation and metabolic reprogramming of these subsets.", {"entities": [[3, 6, "GENE"]]}], ["Resting CD4 and CD8 T cells were metabolically similar and used a predominantly oxidative metabolism.", {"entities": [[8, 11, "GENE"]]}], ["Following activation CD8 T cells proliferated more rapidly.", {"entities": []}], ["Stimulation led both CD4 and CD8 T cells to sharply increase glucose metabolism and adopt aerobic glycolysis as a primary metabolic program.", {"entities": [[21, 24, "GENE"]]}], ["Activated CD4 T cells, however, remained more oxidative and had greater maximal respiratory capacity than activated CD8 T cells.", {"entities": [[10, 13, "GENE"]]}], ["CD4 T cells were also associated with greater levels of ROS and increased mitochondrial content, irrespective of the activation context.", {"entities": [[0, 3, "GENE"]]}], ["CD8 cells were better able, however, to oxidize glutamine as an alternative fuel source.", {"entities": []}], ["The more glycolytic metabolism of activated CD8 T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of cell growth to metabolic inhibition.", {"entities": []}], ["These specific metabolic programs may promote greater growth and proliferation of CD8 T cells and enhance survival in diverse nutrient conditions.", {"entities": []}], ["Helicobacter pylori is a highly successful human bacterium, which is exceptionally equipped to persistently inhabit the human stomach.", {"entities": []}], ["Colonization by this pathogen is associated with gastric disorders ranging from chronic gastritis and peptic ulcers to cancer.", {"entities": [[88, 97, "DISEASE"], [119, 125, "DISEASE"]]}], ["Highly virulent H. pylori strains express the well-established adhesins BabA/B, SabA, AlpA/B, OipA, and HopQ, and a type IV secretion system (T4SS) encoded by the cag pathogenicity island (PAI).", {"entities": []}], ["The adhesins ascertain intimate bacterial contact to gastric epithelial cells, while the T4SS represents an extracellular pilus-like structure for the translocation of the effector protein CagA.", {"entities": []}], ["Numerous T4SS components including CagI, CagL, CagY, and CagA have been shown to target the integrin-\u03b2 1 receptor followed by translocation of CagA across the host cell membrane.", {"entities": []}], ["The interaction of CagA with membrane-anchored phosphatidylserine and CagA-containing outer membrane vesicles may also play a role in the delivery process.", {"entities": []}], ["Translocated CagA undergoes tyrosine phosphorylation in C-terminal EPIYA-repeat motifs by oncogenic Src and Abl kinases.", {"entities": [[100, 103, "GENE"]]}], ["CagA then interacts with an array of host signaling proteins followed by their activation or inactivation in phosphorylation-dependent and phosphorylation-independent fashions.", {"entities": []}], ["We now count about 25 host cell binding partners of intracellular CagA, which represent the highest quantity of all currently known virulence-associated effector proteins in the microbial world.", {"entities": []}], ["Here we review the research progress in characterizing interactions of CagA with multiple host cell receptors in the gastric epithelium, including integrin-\u03b2 1 , EGFR, c-Met, CD44, E-cadherin, and gp130.", {"entities": [[162, 166, "GENE"], [175, 179, "GENE"]]}], ["The contribution of these interactions to H. pylori colonization, signal transduction, and gastric pathogenesis is discussed.", {"entities": []}], ["The objective of this paper is to introduce an efficient algorithm, namely, the mathematically improved learning-self organizing map (MIL-SOM) algorithm, which speeds up the self-organizing map (SOM) training process.", {"entities": []}], ["In the proposed MIL-SOM algorithm, the weights of Kohonen's SOM are based on the proportional-integral-derivative (PID) controller.", {"entities": []}], ["Thus, in a typical SOM learning setting, this improvement translates to faster convergence.", {"entities": []}], ["The basic idea is primarily motivated by the urgent need to develop algorithms with the competence to converge faster and more efficiently than conventional techniques.", {"entities": []}], ["The MIL-SOM algorithm is tested on four training geographic datasets representing biomedical and disease informatics application domains.", {"entities": []}], ["Experimental results show that the MIL-SOM algorithm provides a competitive, better updating procedure and performance, good robustness, and it runs faster than Kohonen's SOM.", {"entities": []}], ["The aim of this cross-sectional in vitro study was to evaluate the mucosal surfaces of healthy maxillary sinuses, explore different forms of bacterial microorganism colonies present on the mucous membrane, and determine a mucosal surface area they occupy.", {"entities": []}], ["Samples of the maxillary sinus mucosa were collected from 30 healthy patients (M = 11; F = 19).", {"entities": []}], ["The material was obtained during the Le Fort I osteotomy performed during corrective jaw surgery.", {"entities": []}], ["The morphological and morphometric analysis of sinus mucosa and bacterial film that was grown on it was performed using scanning electron microscopy (SEM) as well as imaging software.", {"entities": []}], ["Scanning electron microscopy analysis showed the presence of different bacterium and bacteria-like structures in all the analyzed samples.", {"entities": []}], ["In most cases, the bacterial film was mostly composed of diplococci-like and streptococci-like structures on the mucosa of the paranasal sinus.", {"entities": []}], ["In any case, the mucous layer did not cover the whole lining of the evaluated sample.", {"entities": []}], ["Each colony consists of more than 20 single bacterial cells, which has grown in aggregates.", {"entities": []}], ["Under the conditions of normal homeostasis of the body, the maxillary sinuses present diverse bacterial colonization.", {"entities": []}], ["The bacteria are dispersed or concentrated in single microcolonies of the biofilm on the border of the mucous covering the ciliary epithelium.", {"entities": []}], ["There is no uniform layer of the biofilm covering the mucosa of the maxillary sinuses.", {"entities": []}], ["Because the biofilm is detected on healthy individuals sinus mucosa, the clinical question if it may become pathogenic is unclear and require an explanation.", {"entities": []}], ["To elucidate possible independent associations of psychological resources with inflammatory markers, all linked with coronary heart disease (CHD).", {"entities": [[126, 139, "DISEASE"], [117, 139, "DISEASE"]]}], ["In a middle-aged general population ( n \u2009=\u2009944), psychological resources (coping, self-esteem, and sense of coherence (SOC)), a global measure of quality of life (Cantril\u2019s self-anchoring ladder, also called \u201cladder of life\u201d), and psychological risk factors (hopelessness, vital exhaustion, and depressive symptoms) were used in linear regression models to evaluate associations with the inflammatory markers interleukin (IL)-6, C-reactive protein (CRP), and matrix metalloproteinase (MMP)-9.", {"entities": [[449, 452, "GENE"]]}], ["Adjustments were done for age, sex, medical conditions, and cardiovascular risk factors.", {"entities": []}], ["After full adjustments, self-esteem was independently associated with all three biomarkers.", {"entities": []}], ["Ladder of life was associated with IL-6 and log-CRP; coping, vital exhaustion, and depressive symptoms with IL-6; and SOC with MMP-9 ( p \u2009<\u20090.05 for all associations).", {"entities": []}], ["Numerous significant associations of psychological resources and risk factors with IL-6, CRP, and MMP-9 were found in a community-based sample.", {"entities": [[89, 92, "GENE"]]}], ["The associations of psychological resources were mostly independent, while the psychological risk factors seemed preferentially dependent on lifestyle factors as smoking, physical activity, and body mass index (BMI).", {"entities": []}], ["This suggests that the psychological resources\u2019 (in particular self-esteem) protective effects on CHD are linked to inflammatory markers.", {"entities": []}], ["Filaggrin proteins are located in the skin and prevent epidermal water loss and impede the entry of micro-organisms, allergens and chemicals.", {"entities": []}], ["Filaggrin null mutations are strongly associated with ichthyosis vulgaris and atopic dermatitis.", {"entities": [[54, 73, "DISEASE"], [78, 95, "DISEASE"], [85, 95, "DISEASE"]]}], ["The authors aimed to investigate the association between filaggrin null mutations, atopic dermatitis and diabetes.", {"entities": [[83, 100, "DISEASE"], [90, 100, "DISEASE"]]}], ["A random sample of 3335 adults from the general population in Denmark was filaggrin-genotyped for R501X and 2282del4 null-mutations and questioned about atopic dermatitis and diabetes.", {"entities": [[153, 170, "DISEASE"], [160, 170, "DISEASE"]]}], ["Furthermore, two independent study populations of patients with type 1 (n=104) or 2 (n=774) diabetes were genotyped.", {"entities": []}], ["In a crude data analysis, a positive association was detected between the filaggrin null genotype and, respectively, subjects from the general population who reported diabetes (p=0.04) and patients with established type 2 diabetes (p=0.073).", {"entities": []}], ["Adjustment for age and gender resulted in significant associations for patients with type 2 diabetes (p=0.048) and subjects with self-reported diabetes (p=0.032).", {"entities": []}], ["Adult Danes with a filaggrin null genotype had a significantly increased prevalence of self-reported diabetes.", {"entities": []}], ["This finding was replicated when an independent sample of Danish patients with established type 2 diabetes was compared with control subjects from the general population.", {"entities": []}], ["A few studies have suggested the existence of an inverse association between atopic dermatitis and type 1 diabetes.", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"]]}], ["The existence of a specific endotype of asthma that is not driven by sensitisation but rather driven by skin barrier dysfunction was recently suggested.", {"entities": [[40, 46, "DISEASE"]]}], ["It is unknown whether a putative impairment of the skin barrier may increase the propensity to low-grade inflammation in other organs as well.", {"entities": []}], ["Data from a general population study suggested that the prevalence of filaggrin null mutations was higher in adult Danes who reported diabetes than in non-diabetics.", {"entities": []}], ["This finding was replicated when an independent sample of Danish patients with type 2 diabetes was compared with participants from the general population who did not report diabetes and who had normal fasting plasma-glucose and glycated haemoglobin (HbA1c) levels.", {"entities": []}], ["Two independent samples were investigated and showed similar results.", {"entities": []}], ["The question on self-reported diabetes was not validated in the general population allowing for misclassification.", {"entities": []}], ["The medical problem list is an important part of the electronic medical record in development in our institution.", {"entities": []}], ["To serve the functions it is designed for, the problem list has to be as accurate and timely as possible.", {"entities": []}], ["However, the current problem list is usually incomplete and inaccurate, and is often totally unused.", {"entities": []}], ["To alleviate this issue, we are building an environment where the problem list can be easily and effectively maintained.", {"entities": []}], ["For this project, 80 medical problems were selected for their frequency of use in our future clinical field of evaluation (cardiovascular).", {"entities": []}], ["We have developed an Automated Problem List system composed of two main components: a background and a foreground application.", {"entities": []}], ["The background application uses Natural Language Processing (NLP) to harvest potential problem list entries from the list of 80 targeted problems detected in the multiple free-text electronic documents available in our electronic medical record.", {"entities": []}], ["These proposed medical problems drive the foreground application designed for management of the problem list.", {"entities": []}], ["Within this application, the extracted problems are proposed to the physicians for addition to the official problem list.", {"entities": []}], ["The set of 80 targeted medical problems selected for this project covered about 5% of all possible diagnoses coded in ICD-9-CM in our study population (cardiovascular adult inpatients), but about 64% of all instances of these coded diagnoses.", {"entities": []}], ["The system contains algorithms to detect first document sections, then sentences within these sections, and finally potential problems within the sentences.", {"entities": []}], ["The initial evaluation of the section and sentence detection algorithms demonstrated a sensitivity and positive predictive value of 100% when detecting sections, and a sensitivity of 89% and a positive predictive value of 94% when detecting sentences.", {"entities": []}], ["The global aim of our project is to automate the process of creating and maintaining a problem list for hospitalized patients and thereby help to guarantee the timeliness, accuracy and completeness of this information.", {"entities": []}], ["The basophilic granule of blood and marrow cells does not show the brown color reaction with benzidine solutions that is characteristic of the neutrophilic and eosinophilic granules.", {"entities": []}], ["It differs from these types also in other important microchemical and physical particulars.", {"entities": []}], ["The hemic basophil which bears these granules is peculiar from a purely cytological standpoint, while physiologically it appears to be devoid of any functional activity comparable with that of the other granulocytes.", {"entities": []}], ["The peculiarities exhibited seem in every instance, at least for mammalian blood, best explained as evidence that the basophil is a degenerated or degenerating cell.", {"entities": []}], ["It is probably derived from the eosinophilic cells and perhaps in rare cases from those of neutrophilic type.", {"entities": []}], ["Current estimates suggest over 218,000 individuals in Australia are chronically infected with hepatitis B virus.", {"entities": [[94, 103, "DISEASE"]]}], ["The majority of these people are migrants and refugees born in hepatitis B endemic countries, where attitudes towards health, levels of education, and English proficiency can be a barrier to accessing the Australian health care system, and best managing chronic hepatitis B.", {"entities": [[63, 72, "DISEASE"], [262, 271, "DISEASE"]]}], ["This study aimed to assess the knowledge of transmission and consequences of chronic hepatitis B among these patients.", {"entities": [[85, 94, "DISEASE"]]}], ["A prospective study was conducted between May and August 2012.", {"entities": []}], ["Patients with chronic hepatitis B were recruited from three Royal Melbourne Hospital outpatient clinics.", {"entities": [[22, 31, "DISEASE"]]}], ["Two questionnaires were administered.", {"entities": []}], ["Questionnaire 1 , completed during observation of a prospective participants\u2019 consultation, documented information given to the patient by their clinician.", {"entities": []}], ["After the consultation, Questionnaire 2 was administered to assess patient demographics, and overall knowledge of the effect, transmission and treatment of hepatitis B.", {"entities": [[156, 165, "DISEASE"]]}], ["55 participants were recruited.", {"entities": []}], ["93% of them were born overseas, 17% used an interpreter, and the average time since diagnosis was 9.7\u00a0years.", {"entities": []}], ["Results from Questionnaire 1 showed that the clinician rarely discussed many concepts.", {"entities": []}], ["Questionnaire 2 exposed considerable gaps in hepatitis B knowledge.", {"entities": [[45, 54, "DISEASE"]]}], ["Few participants reported a risk of cirrhosis (11%) or liver cancer (18%).", {"entities": [[55, 67, "DISEASE"], [61, 67, "DISEASE"]]}], ["There was a high awareness of transmission routes, with 89% correctly identifying sexual transmission, 93% infected blood, and 85% perinatal transmission.", {"entities": []}], ["However, 25% of participants believed hepatitis B could be spread by sharing food, and over 50% by kissing and via mosquitoes.", {"entities": [[38, 47, "DISEASE"]]}], ["A knowledge score out of 12 was assessed for each participant.", {"entities": []}], ["The average score was 7.5.", {"entities": []}], ["Multivariate analysis found higher knowledge scores among those with a family member also diagnosed with chronic hepatitis B and those routinely seeing the same clinician (p\u2009=\u20090.009 and p\u2009=\u20090.002, respectively).", {"entities": [[113, 122, "DISEASE"]]}], ["This is the largest Australian study assessing knowledge and understanding of the effect, transmission, and treatment of hepatitis B among chronically infected individuals.", {"entities": [[121, 130, "DISEASE"]]}], ["The findings highlight the knowledge gaps and misconceptions held by these patients, and the need to expand education and support initiatives.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2334-14-537) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The human gut microbiome plays a crucial role in the compositional development of gut microbiota.", {"entities": []}], ["Though well documented in western pediatrics population, little is known about how various host conditions affect populations in different geographic locations such as the Indian subcontinent.", {"entities": []}], ["Given the impact of distinct environmental conditions, our study assess the gut bacterial diversity of a small cohort of Indian and Finnish children and investigated the influence of FUT2 secretor status and birth mode on the gut microbiome of these populations.", {"entities": [[183, 187, "GENE"]]}], ["Using multiple profiling techniques, we show that the gut bacterial community structure in 13\u201314-year-old Indian (n\u2009=\u200947) and Finnish (n\u2009=\u200952) children differs significantly.", {"entities": []}], ["Specifically, Finnish children possessed higher Blautia and Bifidobacterium , while genera Prevotella and Megasphaera were predominant in Indian children.", {"entities": []}], ["Our study also demonstrates a strong influence of FUT2 and birth mode variants on specific gut bacterial taxa, influence of which was noticed to differ between the two populations under study.", {"entities": [[50, 54, "GENE"]]}], ["We have recently shown that IL-29 was an important proinflammatory cytokine in pathogenesis of rheumatoid arthritis (RA).", {"entities": [[95, 115, "DISEASE"], [106, 115, "DISEASE"]]}], ["Inflammation also contributes to the pathogenesis of osteoarthritis (OA).", {"entities": [[53, 67, "DISEASE"]]}], ["The aim of this study was to investigate the effect and mechanism of IL-29 on cytokine production and cartilage degradation in OA.", {"entities": []}], ["The mRNA levels of IL-29 and its specific receptor IL-28Ra in peripheral blood mononuclear cells (PBMCs) were significantly increased in OA patients when compared to healthy controls (HC).", {"entities": []}], ["In the serum, IL-29 protein levels were higher in OA patients than those in HC.", {"entities": []}], ["Immunohistochemistry revealed that both IL-29 and IL-28Ra were dramatically elevated in OA synovium compared to HC; synovial fibroblasts (FLS) and macrophages were the main IL-29-producing cells in OA synovium.", {"entities": []}], ["Furthermore, recombinant IL-29 augmented the mRNA expression of IL-1 \u03b2 , IL-6, IL-8, and matrix-metalloproteinase-3 (MMP-3) in OA FLS and increased cartilage degradation when ex vivo OA cartilage explant was coincubated with OA FLS.", {"entities": []}], ["Finally, in OA FLS, IL-29 dominantly activated MAPK and nuclear factor- \u03ba B (NF- \u03ba B), but not Jak-STAT and AKT signaling pathway as examined by western blot.", {"entities": []}], ["In conclusion, IL-29 stimulates inflammation and cartilage degradation by OA FLS, indicating that this cytokine is likely involved in the pathogenesis of OA.", {"entities": []}], ["Despite taking advantage of established learning from other industries, quality improvement initiatives in healthcare may struggle to outperform secular trends.", {"entities": []}], ["The reasons for this are rarely explored in detail, and are often attributed merely to difficulties in engaging clinicians in quality improvement work.", {"entities": []}], ["In a narrative review of the literature, we argue that this focus on clinicians, at the relative expense of managerial staff, has proven counterproductive.", {"entities": []}], ["Clinical engagement is not a universal challenge; moreover, there is evidence that managers\u2014particularly middle managers\u2014also have a role to play in quality improvement.", {"entities": []}], ["Yet managerial participation in quality improvement interventions is often assumed, rather than proven.", {"entities": []}], ["We identify specific factors that influence the coordination of front-line staff and managers in quality improvement, and integrate these factors into a novel model: the model of alignment.", {"entities": []}], ["We use this model to explore the implementation of an interdisciplinary intervention in a recent trial, describing different participation incentives and barriers for different staff groups.", {"entities": []}], ["The extent to which clinical and managerial interests align may be an important determinant of the ultimate success of quality improvement interventions.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a widespread disease, with no curative therapies available.", {"entities": []}], ["Recent findings suggest a key role of NO and sGC-cGMP signaling for the pathogenesis of the disease.", {"entities": []}], ["Previous data suggest a downregulation/inactivation of the cGMP producing soluble guanylate cyclase, and sGC stimulation prevented cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice.", {"entities": [[179, 191, "DISEASE"], [169, 191, "DISEASE"]]}], ["We thus aimed to investigate if the inhibition of the cGMP degrading phosphodiesterase (PDE)5 has similar effects.", {"entities": []}], ["Results were compared to the effects of a PDE 4 inhibitor (cAMP elevating) and a combination of both.", {"entities": []}], ["C57BL6/J mice were chronically exposed to cigarette smoke and in parallel either treated with Tadalafil (PDE5 inhibitor), Piclamilast (PDE4 inhibitor) or both.", {"entities": []}], ["Functional measurements (lung compliance, hemodynamics) and structural investigations (alveolar and vascular morphometry) as well as the heart ratio were determined after 6 months of tobacco smoke exposure.", {"entities": []}], ["In addition, the number of alveolar macrophages in the respective lungs was counted.", {"entities": []}], ["Preventive treatment with Tadalafil, Piclamilast or a combination of both almost completely prevented the development of emphysema, the increase in lung compliance, tidal volume, structural remodeling of the lung vasculature, right ventricular systolic pressure, and right ventricular hypertrophy induced by cigarette smoke exposure.", {"entities": []}], ["Single, but not combination treatment prevented or reduced smoke-induced increase in alveolar macrophages.", {"entities": []}], ["Cigarette smoke-induced emphysema and PH could be prevented by inhibition of the phosphodiesterases 4 and 5 in mice.", {"entities": []}], ["The purpose of this study was to investigate the association between Attention Deficit/Hyperactivity Disorder (ADHD) and various factors using a representative sample of US children in a comprehensive manner.", {"entities": []}], ["This includes variables that have not been previously studied such as watching TV/playing video games, computer usage, family member\u2019s smoking, and participation in sports.", {"entities": []}], ["This was a cross-sectional study of 68,634 children, 5\u201317\u2009years old, from the National Survey of Children\u2019s Health (NSCH, 2007\u20132008).", {"entities": []}], ["We performed bivariate and multivariate logistic regression analyses with ADHD classification as the response variable and the following explanatory variables: sex, race, depression, anxiety, body mass index, healthcare coverage, family structure, socio-economic status, family members\u2019 smoking status, education, computer usage, watching television (TV)/playing video games, participation in sports, and participation in clubs/organizations.", {"entities": []}], ["Approximately 10% of the sample was classified as having ADHD.", {"entities": []}], ["We found depression, anxiety, healthcare coverage, and male sex of child to have increased odds of being diagnosed with ADHD.", {"entities": []}], ["One of the salient features of this study was observing a significant association between ADHD and variables such as TV usage, participation in sports, two-parent family structure, and family members\u2019 smoking status.", {"entities": []}], ["Obesity was not found to be significantly associated with ADHD, contrary to some previous studies.", {"entities": []}], ["The current study uncovered several factors associated with ADHD at the national level, including some that have not been studied earlier in such a setting.", {"entities": []}], ["However, we caution that due to the cross-sectional and observational nature of the data, a cause and effect relationship between ADHD and the associated factors can not be deduced from this study.", {"entities": []}], ["Future research on ADHD should take into consideration these factors, preferably through a longitudinal study design.", {"entities": []}], ["We work on the assumption that four major specialities or sectors of medical laboratory assays, comprising clinical chemistry, haematology, immunology, and microbiology, embraced by genome sequencing techniques, are routinely in use.", {"entities": []}], ["Medical laboratory markers for inflammation serve as model: they are allotted to most fields of medical lab assays including genomics.", {"entities": []}], ["Incessant coding of assays aligns each of them in the long lists of big data.", {"entities": []}], ["As exemplified with the complement gene family, containing C2, C3, C8A, C8B, CFH, CFI, and ITGB2, heritability patterns/risk factors associated with diseases with genetic glitch of complement components are unfolding.", {"entities": [[59, 61, "GENE"], [63, 65, "GENE"], [67, 70, "GENE"], [72, 75, "GENE"], [77, 80, "GENE"], [82, 85, "GENE"], [91, 96, "GENE"]]}], ["The C4 component serum levels depend on sufficient vitamin D whilst low vitamin D is inversely related to IgG1, IgA, and C3 linking vitamin sufficiency to innate immunity.", {"entities": [[121, 123, "GENE"]]}], ["Whole genome sequencing of microbial organisms may distinguish virulent from nonvirulent and antibiotic resistant from nonresistant varieties of the same species and thus can be listed in personal big data banks including microbiological pathology; the big data warehouse continues to grow.", {"entities": []}], ["Postmenopausal osteoporosis (POMP) is a public health problem characterized by decreased bone density and increased fracture risk.", {"entities": [[15, 27, "DISEASE"]]}], ["Over-activated osteoclastogenesis plays a vital role in POMP.", {"entities": []}], ["Here we developed a novel bioactive compound MASM (M19) based on sophocarpine.", {"entities": []}], ["Although it showed no significant effects on osteogenesis and adipogenesis for bone marrow-derived mesenchymal stem cells (BMSCs) in vitro , it could significantly inhibit RANKL/M-CSF induced osteoclastogenesis through suppressing NF- \u03ba B, MAPKs and PI3K/Akt pathways in vitro and ameliorate bone loss in ovariectomized mice in vivo .", {"entities": []}], ["Ribosomal protein s5 (RPS5) has been identified as a target of M19 and regulates PI3K/Akt, NF- \u03ba B and MAPKs pathways in osteoclastogenesis.", {"entities": [[22, 26, "GENE"]]}], ["Overexpressions of RPS5 synergistically inhibited osteoclastogenesis with M19 while silencing RPS5 compromised M19 inhibitory effects on osteoclastogenesis in vitro .", {"entities": [[19, 23, "GENE"], [94, 98, "GENE"], [19, 23, "GENE"], [94, 98, "GENE"]]}], ["Among the three pathways, Akt plays a major role in M19 effects.", {"entities": []}], ["The Akt activator SC 79 partially reversed the inhibitory effects on osteoclastogenesis by M19 and RPS5-knocking-down.", {"entities": []}], ["It indicates that RPS5 serves as a potential candidate target for inhibiting osteoclastogenesis and osteoporosis therapy and M19 is a promising agent for POMP treatment.", {"entities": [[100, 112, "DISEASE"], [18, 22, "GENE"]]}], ["Although human T-lymphotropic virus (HTLV) is transmitted via the same routes as human immunodeficiency virus (HIV), its worldwide seroprevalence differs drastically because HTLV is transmitted mainly via infected cells rather than free virus.", {"entities": []}], ["The sharing of needles and other equipment places people who inject drugs (PWID) at particularly high-risk for such blood-borne diseases.", {"entities": []}], ["To validate the methodology used to process and analyze the dried blood spots (DBS) utilized in the study, dried serum spots (DSS) with dilutions of sera from known HTLV infected individuals were analyzed by ELISA and Western blot.", {"entities": []}], ["DBS collected between 2011 and 2015 from 2,077 PWID in eight German cities recruited by respondent-driven sampling were tested for HTLV-specific antibodies.", {"entities": []}], ["The validation demonstrated that the use of DSS allowed identification of samples with even low titers of HTLV-specific antibodies, although a confirmatory Western blot with an additional venous blood sample would often be required.", {"entities": []}], ["Despite numerous HIV and HCV positive individuals being identified within the study population, none tested positive for HTLV.", {"entities": []}], ["While the HIV and HCV prevalences in German PWID are comparable to those in other European countries, the very low prevalence of HTLV reflects the situation in the general population.", {"entities": []}], ["Chemokine receptor antagonists appear to access two distinct binding sites on different members of this receptor family.", {"entities": []}], ["One class of CCR4 antagonists has been suggested to bind to a site accessible from the cytoplasm while a second class did not bind to this site.", {"entities": [[13, 17, "GENE"]]}], ["In this report, we demonstrate that antagonists representing a variety of structural classes bind to two distinct allosteric sites on CCR4.", {"entities": [[134, 138, "GENE"]]}], ["The effects of pairs of low-molecular weight and/or chemokine CCR4 antagonists were evaluated on CCL17- and CCL22-induced responses of human CCR4", {"entities": [[62, 66, "GENE"], [141, 145, "GENE"], [62, 66, "GENE"], [141, 145, "GENE"]]}], ["Asthma in older adults is frequently underdiagnosed, as reflected by approximately 60% of asthma deaths occurring in people older than age 65.", {"entities": [[0, 6, "DISEASE"], [90, 96, "DISEASE"]]}], ["The present study evaluates the effects of a respiratory exercise program tailored for elderly individuals with asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["We are not aware of any other reports examining breathing exercises in this population.", {"entities": []}], ["Fourteen patients concluded the 16-week respiratory exercise program.", {"entities": []}], ["All the patients were evaluated with regard to lung function, respiratory muscle strength, aerobic capacity, quality of life and clinical presentation.", {"entities": []}], ["After 16 weeks of this open-trial intervention, significant increases in maximum inspiratory pressure and maximum expiratory pressure (27.6% and 20.54%, respectively) were demonstrated.", {"entities": []}], ["Considerable improvement in quality of life was also observed.", {"entities": []}], ["The clinical evaluations and daily recorded-symptoms diary also indicated significant improvements and fewer respiratory symptoms.", {"entities": []}], ["A month after the exercises were discontinued, however, detraining was observed.", {"entities": []}], ["In conclusion, a respiratory exercise program increased muscle strength and was associated with a positive effect on patient health and quality of life.", {"entities": []}], ["Therefore, a respiratory training program could be included in the therapeutic approach in older adults with asthma.", {"entities": [[109, 115, "DISEASE"]]}], ["Kawasaki Disease (KD) is the most common cause of acquired heart disease in children in developed nations.", {"entities": [[59, 72, "DISEASE"]]}], ["The KD etiologic agent is unknown but likely to be a ubiquitous microbe that usually causes asymptomatic childhood infection, resulting in KD only in genetically susceptible individuals.", {"entities": []}], ["KD synthetic antibodies made from prevalent IgA gene sequences in KD arterial tissue detect intracytoplasmic inclusion bodies (ICI) resembling viral ICI in acute KD but not control infant ciliated bronchial epithelium.", {"entities": []}], ["The prevalence of ICI in late-stage KD fatalities and in older individuals with non-KD illness should be low, unless persistent infection is common.", {"entities": []}], ["Lung tissue from late-stage KD fatalities and non-infant controls was examined by light microscopy for the presence of ICI.", {"entities": []}], ["Nucleic acid stains and transmission electron microscopy (TEM) were performed on tissues that were strongly positive for ICI.", {"entities": []}], ["ICI were present in ciliated bronchial epithelium in 6/7 (86%) late-stage KD fatalities and 7/27 (26%) controls ages 9\u201384 years (p\u200a=\u200a0.01).", {"entities": []}], ["Nucleic acid stains revealed RNA but not DNA within the ICI.", {"entities": []}], ["ICI were also identified in lung macrophages in some KD cases.", {"entities": []}], ["TEM of bronchial epithelium and macrophages from KD cases revealed finely granular homogeneous ICI.", {"entities": []}], ["These findings are consistent with a previously unidentified, ubiquitous RNA virus that forms ICI and can result in persistent infection in bronchial epithelium and macrophages as the etiologic agent of KD.", {"entities": []}], ["Knight and colleagues discuss the diagnosis and management of a 35-year-old man with a past history of recurrent cellulitis and otitis media and a two-year history of facial swelling.", {"entities": [[113, 123, "DISEASE"], [128, 140, "DISEASE"]]}], ["Few studies have described patients with foregut dysmotility in inflammatory bowel disease.", {"entities": [[64, 90, "DISEASE"]]}], ["The aim of this case series was to evaluate clinical characteristics of 5 patients with inflammatory bowel disease and symptoms and signs of upper gut dysmotility.", {"entities": [[88, 114, "DISEASE"]]}], ["We describe a series of four patients with Crohn's disease and one with indeterminate colitis who presented with severe symptoms and signs of gastroparesis.", {"entities": [[142, 155, "DISEASE"]]}], ["We reviewed medical records of all cases.", {"entities": []}], ["Gastric emptying of a solid meal was assessed by scintigraphy.", {"entities": []}], ["Small bowel enteroclysis, gastroduodenoscopy and colonoscopy with biopsies were performed to estimate the activity of the disease and to exclude organic obstruction.", {"entities": []}], ["None of the patients had any signs of active inflammation or stricture.", {"entities": []}], ["All of the patients had markedly delayed gastric emptying with a mean t 1/2 of 234 minutes (range 110\u2013380 minutes; normal values 54\u201394 minutes).", {"entities": []}], ["Clinicians should consider impaired gastric emptying when evaluating patients with Crohn's disease and severe symptoms of upper gut dysmotility, which cannot be attributed to active inflammation or organic obstruction of the digestive tract.", {"entities": []}], ["Symptoms in these patients are refractory to various therapeutic interventions including tube feeding and gastric surgery.", {"entities": []}], ["Currently, there is an intensive debate about the regulation of the use of electronic cigarettes (e-cigarettes) in indoor places.", {"entities": []}], ["The aim of this study was to assess the attitudes toward e-cigarette use in indoor workplaces and selected public and private venues among the general population in Barcelona (Spain) in 2013\u20132014.", {"entities": []}], ["This is a cross-sectional study of a representative sample of the population of Barcelona (n\u200a=\u200a736).", {"entities": []}], ["The field work was conducted between May 2013 and February 2014.", {"entities": []}], ["We computed the prevalence and the adjusted odds ratios (OR) derived from multivariable logistic regression models.", {"entities": []}], ["The awareness of e-cigarettes was 82.3%.", {"entities": []}], ["Forty five percent of respondents did not agree with the use of e-cigarettes in public places and 52.3% in workplaces.", {"entities": []}], ["The proportion of disapproval of the use of e-cigarettes in indoor places was higher at 71.5% for schools and 65.8% for hospitals and health care centers; while the prevalence of disapproval of e-cigarette use in homes and cars was lower (18.0% and 32.5%, respectively).", {"entities": [[223, 227, "GENE"]]}], ["Respondents who disagreed on the use of e-cigarettes in indoor workplaces were more likely to be older (OR\u200a=\u200a1.64 and 1.97 for groups 45\u201364 and \u226765 years old, respectively), those with a high educational level (OR\u200a=\u200a1.60), and never and former smokers (OR\u200a=\u200a2.34 and 2.16, respectively).", {"entities": []}], ["Increased scores in the Fagerstr\u00f6m test for cigarette dependence were also related to increased support for their use.", {"entities": []}], ["Based on this population based study, half of the general population of Barcelona does not support the use of e-cigarettes in indoor workplaces and public places, with the percentage reaching 65% for use in schools, hospitals and health care centers.", {"entities": []}], ["Consequently, there is good societal support in Spain for the politicians and legislators to promote policies restricting e-cigarettes use in workplaces and public places, including hospitality venues.", {"entities": []}], ["China has high COPD rates, even among never-regular smokers.", {"entities": []}], ["Little is known about nonrespiratory disease risks, especially vascular morbidity and mortality after developing airflow obstruction (AFO) in Chinese adults.", {"entities": []}], ["We aimed to investigate the prospective association of prevalent AFO with major vascular morbidity and mortality.", {"entities": []}], ["In 2004\u20132008, a nationwide prospective cohort study recruited 512,891 men and women aged 30\u201379 years from 10 diverse localities across China, tracking cause-specific mortality and coded episodes of hospitalization for 9 years.", {"entities": []}], ["Cox regression yielded adjusted HRs for vascular diseases comparing individuals with spirometry-defined prevalent AFO at baseline to those without.", {"entities": []}], ["Of 489,382 participants with no vascular disease at baseline, 6.8% had AFO, with prevalence rising steeply with age.", {"entities": [[32, 48, "DISEASE"]]}], ["Individuals with prevalent AFO had significantly increased vascular mortality (n=1,429, adjusted HR 1.29, 95% CI 1.21\u20131.36).", {"entities": [[97, 99, "GENE"]]}], ["There were also increased risks of hemorrhagic stroke (n=823, HR 1.18, 95% CI 1.09\u20131.27), major coronary events (n=635, HR 1.33, 95% CI 1.22\u20131.45), and heart failure (n=543, HR 2.19, 95% CI 1.98\u20132.41).", {"entities": [[62, 64, "GENE"], [120, 122, "GENE"], [174, 176, "GENE"], [62, 64, "GENE"], [120, 122, "GENE"], [174, 176, "GENE"], [62, 64, "GENE"], [120, 122, "GENE"], [174, 176, "GENE"]]}], ["For each outcome, the risk increased progressively with increasing COPD severity and persisted among never-regular smokers.", {"entities": []}], ["Among adult Chinese, AFO was associated with significantly increased risks of major vascular morbidity and mortality.", {"entities": []}], ["COPD management should be integrated with vascular disease prevention and treatment programs to improve long-term prognosis.", {"entities": [[42, 58, "DISEASE"]]}], ["Cow\u2019s milk allergy (CMA) is thought to affect 2\u20133% of infants.", {"entities": []}], ["The signs and symptoms are nonspecific and may be difficult to objectify, and as the diagnosis requires cow\u2019s milk elimination followed by challenge, often, children are considered cow\u2019s milk allergic without proven diagnosis.", {"entities": []}], ["Because of the consequences, a correct diagnosis of CMA is pivotal.", {"entities": []}], ["Open challenges tend to overestimate the number of children with CMA.", {"entities": []}], ["The only reliable way to diagnose CMA is by double-blind, placebo-controlled challenge (DBPCFC).", {"entities": []}], ["At present, the only proven treatment consists of elimination of cow\u2019s milk protein from the child\u2019s diet and the introduction of formulas based on extensively hydrolysed whey protein or casein; amino acid-based formula is rarely indicated.", {"entities": []}], ["The majority of children will regain tolerance to cow\u2019s milk within the first 5\u00a0years of life.", {"entities": []}], ["Open challenges can be used to reject CMA, but for adequate diagnosis, DBPCFC is mandatory.", {"entities": []}], ["In most children, CMA can be adequately treated with extensively hydrolysed whey protein or casein formulas.", {"entities": []}], ["To assess the diagnostic significance of total IgE in foods, inhalant, and multiple allergies.", {"entities": []}], ["Retrospective review of the laboratory records of patients who presented with clinical suspicion of food or inhalant allergy between January 2013 and December 2014.", {"entities": []}], ["Total IgE level was defined as positive for a value >195\u2009kU/L; and diagnosis was confirmed by the detection of specific IgE (golden standard) for at least one food or inhalant allergen and at least two allergens in multiple allergies.", {"entities": []}], ["A total of 1893 (male ratio = 0.68, mean age = 39.0 \u00b1 19.2 years) patients were included.", {"entities": []}], ["Total IgE had comparable sensitivity (55.8% versus 59.6%) and specificity (83.9% versus 84.4%) in food versus inhalant allergy, respectively, but a superior PPV in inhalant allergy (79.1% versus 54.4%).", {"entities": []}], ["ROC curve analysis showed a better diagnostic value in inhalant allergies (AUC = 0.817 (95% CI = 0.796\u20130.837) versus 0.770 (95% CI = 0.707\u20130.833)).", {"entities": []}], ["In multiple allergies, total IgE had a relatively good sensitivity (78.6%), while negative IgE testing (<195\u2009kU/L) predicted the absence of multiple allergies with 91.5% certitude.", {"entities": []}], ["Conclusion.", {"entities": []}], ["Total IgE assay is not efficient as a diagnostic test for foods, inhalant, or multiple allergies.", {"entities": []}], ["The best strategy should refer to specific IgE testing guided by a comprehensive atopic history.", {"entities": []}], ["The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting \u03b2 2 -agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoterol, flutiform Patients aged \u2265 18 years (N = 202) with mild-to-moderate\u2013severe, persistent asthma for \u2265 6 months prior to screening were included in the study.", {"entities": [[304, 310, "DISEASE"]]}], ["After a screening phase (4\u201310 days), eligible patients were randomized 1:1 to receive fluticasone/formoterol or fluticasone/salmeterol during the 12-week treatment period.", {"entities": []}], ["The primary objective was to demonstrate non-inferiority of fluticasone/formoterol versus fluticasone/salmeterol, measured by pre-dose forced expiratory volume in the first second (FEV 1 ), at week 12.", {"entities": [[181, 184, "GENE"]]}], ["Fluticasone/formoterol was comparable to fluticasone/salmeterol for the primary efficacy endpoint, mean pre-dose FEV 1 at week 12.", {"entities": [[113, 116, "GENE"]]}], ["The new combination was also comparable to fluticasone/salmeterol for change from baseline to week 12 in pre-dose FEV 1 , change from pre-dose FEV 1 at baseline to 2-hour post-dose FEV 1 at week 12 and discontinuations due to lack of efficacy.", {"entities": [[114, 117, "GENE"], [143, 146, "GENE"], [181, 184, "GENE"], [114, 117, "GENE"], [143, 146, "GENE"], [181, 184, "GENE"], [114, 117, "GENE"], [143, 146, "GENE"], [181, 184, "GENE"]]}], ["Importantly, fluticasone/formoterol was superior to fluticasone/salmeterol in time to onset of action throughout the duration of the study.", {"entities": []}], ["The two treatments demonstrated similar results for various other secondary efficacy parameters, including other lung function tests, patient-reported outcomes, rescue medication use, asthma exacerbations and Asthma Quality of Life Questionnaire scores.", {"entities": [[184, 190, "DISEASE"], [209, 215, "DISEASE"]]}], ["Fluticasone/formoterol was well tolerated and had a good safety profile that was similar to fluticasone/salmeterol.", {"entities": []}], ["The results of this study indicate that fluticasone/formoterol is as effective as fluticasone/salmeterol, and has a more rapid onset of action, reflecting the faster bronchodilatory effects of formoterol compared with those of salmeterol.", {"entities": []}], ["If patients perceive the benefits of therapy with fluticasone/formoterol more rapidly than with fluticasone/salmeterol, this could have a positive impact on preference and adherence.", {"entities": []}], ["ClinicalTrials.gov: NCT00476073", {"entities": []}], ["Breast cancer brain metastases (BCBM) are a challenging consequence of advanced BC.", {"entities": [[7, 13, "DISEASE"]]}], ["Nanoparticle agents, including liposomes, have shown enhanced delivery to solid tumors and brain.", {"entities": []}], ["We compared pharmacokinetics (PK) and efficacy of PEGylated liposomal doxorubicin (PLD) with non-liposomal doxorubicin (NonL-doxo) in an intracranial model of BC.", {"entities": []}], ["Athymic mice were inoculated intracerebrally with MDA-MB-231-BR-luciferase-expressing cells.", {"entities": []}], ["Tumor-bearing mice were administered PLD or NonL-doxo at 6mg/kg IV\u00d71 and were euthanized prior to and 0.083, 1, 3, 6, 24, 72 and 96 h post-treatment.", {"entities": []}], ["Samples were processed to measure sum total doxorubicin via HPLC.", {"entities": []}], ["PLD and NonL-doxo were administered IV weekly as single agents (6 mg/kg) or in combination (4.5 mg/kg) with the PARP inhibitor, ABT-888, PO 25 mg/kg/day.", {"entities": []}], ["Efficacy was assessed by survival and bioluminescence.", {"entities": []}], ["Treatment with PLD resulted in approximately 1,500-fold higher plasma and 20-fold higher intracranial tumor sum total doxorubicin AUC compared with NonL-doxo.", {"entities": []}], ["PLD was detected at 96 h; NonL-doxo was undetectable after 24 h in plasma and tumor.", {"entities": []}], ["Median survival of PLD-treated animals was 32 days (d, [CI] 31\u201338), which was significantly longer than controls (26d [CI 25\u201328]; p\u200a=\u200a0.0012) or NonL-doxo treatment (23.5d [CI 18\u201328], p\u200a=\u200a0.0002).", {"entities": []}], ["Combination treatment with PLD/ABT-888 yielded improved survival compared to NonL-doxo/ABT-888 (35d [CI 31\u201338] versus 29.5d [CI 25\u201334]; p\u200a=\u200a0.006).", {"entities": []}], ["PLD provides both PK and efficacy advantage over NonL-doxo in the treatment of an in vivo model of BCBM.", {"entities": []}], ["The results provide preclinical rationale to translate findings into early phase trials of PLD, with or without ABT-888, for patients with BCBM.", {"entities": []}], ["A novel pathway of IgE-B cell differentiation has been identified.", {"entities": []}], ["Engagement of the B cell antigen CD40 by F(ab')2 fragments of monoclonal antibody (mAb) 626.1 in the presence of recombinant interleukin 4 (rIL-4) induced intense IgE synthesis, but modest IgG synthesis, by highly purified human B cells.", {"entities": [[33, 37, "GENE"]]}], ["Surface IgE- B cells isolated by cell sorting were induced to produce IgE by mAb 626.1 and IL-4.", {"entities": []}], ["Thus, IgE synthesis is unlikely to result from expansion of a B cell population precommitted to IgE in vivo.", {"entities": []}], ["A neutralizing anti-IL-6 antibody strongly, but not completely, inhibited the IgE response.", {"entities": []}], ["This indicates that autocrine production of IL-6 plays an important amplification role in IgE synthesis triggered by anti-CD40 mAb and IL- 4.", {"entities": []}], ["Although the exact role played by CD40 in IgE responses in vivo remains to be established, this T cell-independent system represents a useful model to characterize the biochemical and molecular events leading to IgE synthesis in human B cells.", {"entities": [[34, 38, "GENE"]]}], ["Betel nut chewing is associated with type 2 diabetes mellitus (T2DM) in a recent prevalence study in Taiwan.", {"entities": [[44, 61, "DISEASE"], [37, 61, "DISEASE"]]}], ["The present study further investigated its link with the incidence of newly diagnosed T2DM during the years 1992-1996.", {"entities": []}], ["Population-based datasets of a sample of 93,484 out of 256,036 diabetic patients from 66 medical settings using the National Health Insurance scheme covering > 96% of the population, published population prevalence of betel nut chewing and the governmental census of national population were used for calculation of odds ratios, incidence rates and incidence rate ratios between chewers and never-chewers in the male population for the year 1992 to 1996.", {"entities": []}], ["Ever chewers among the diabetic patients were younger, more obese and had higher prevalence of parental diabetes than never-chewers (all p values < 0.001).", {"entities": []}], ["Odds ratios for T2DM for ever chewers vs. never-chewers in the age of < 40, 40-49, 50-59, 60-69 and \u226570 years were 1.06 (0.92-1.23), 1.60 (1.45-1.76), 2.12 (1.88-2.39), 3.58 (3.10-4.13) and 7.14 (5.47-9.31), respectively.", {"entities": []}], ["In 1996, incidence rates (per 100,000 population) in the respective age groups were 19.1, 251.5, 567.3, 721.7 and 971.4 for never-chewers; and were 30.2, 520.9, 2566.9, 11672.8 and 630.3 for ever chewers.", {"entities": []}], ["The respective incidence rate ratios were 1.58, 2.07, 4.52, 16.17 and 0.65.", {"entities": []}], ["The age-specific incidence rates and rate ratios were relatively consistent from 1992 to 1996.", {"entities": []}], ["The differences in obesity and parental diabetes between ever chewers and never-chewers were mostly not statistically significant after age stratification, suggesting the link could not be attributed to these two factors.", {"entities": [[19, 26, "DISEASE"]]}], ["Chewing betel nut is associated with newly diagnosed T2DM, supporting the suggestion that the habit is diabetogenic.", {"entities": []}], ["A cancer diagnosis is 2.9 times more likely to occur during the adolescent and young adult years than in younger children.", {"entities": [[2, 8, "DISEASE"]]}], ["This spike in incidence coincides with a life stage characterised by psychological vulnerability as young people strive to attain numerous, critical developmental milestones.", {"entities": []}], ["The distress young people experience after cancer treatment seriously jeopardises their ability to move into well-functioning adulthood.", {"entities": [[43, 49, "DISEASE"]]}], ["This article presents the protocol of the Recapture Life study, a phase II three-arm randomised controlled trial designed to evaluate the feasibility and efficacy of a new intervention in reducing distress and improving quality of life for adolescent and young adult cancer survivors.", {"entities": [[267, 273, "DISEASE"]]}], ["The novel intervention, \u201cReCaPTure LiFe\u201d will be compared to a both a wait-list, and a peer-support group control.", {"entities": []}], ["Ninety young people aged 15\u201325 years who have completed cancer treatment in the past 1\u20136 months will be recruited from hospitals around Australia.", {"entities": [[56, 62, "DISEASE"]]}], ["Those randomised to receive Recapture Life will participate in six, weekly, 90-minute online group sessions led by a psychologist, involving peer-discussion around cognitive-behavioural coping skills (including: behavioural activation, thought challenging, communication and assertiveness skills training, problem-solving and goal-setting).", {"entities": []}], ["Participants randomised to the peer-support group control will receive non-directive peer support delivered in an identical manner.", {"entities": []}], ["Participants will complete psychosocial measures at baseline, post-intervention, and 12-months post-intervention.", {"entities": []}], ["The primary outcome will be quality of life.", {"entities": []}], ["Secondary outcomes will include depression, anxiety, stress, family functioning, coping, and cancer-related identity.", {"entities": [[93, 99, "DISEASE"]]}], ["This article reviews the empirical rationale for using group-based, online cognitive-behavioural therapy in young people after cancer treatment.", {"entities": [[127, 133, "DISEASE"]]}], ["The potential challenges of delivering skills-based programs in an online modality are highlighted, and the role of both peer and caregiver support in enhancing the effectiveness of this skills-based intervention is also discussed.", {"entities": []}], ["The innovative videoconferencing delivery method Recapture Life uses has the potential to address the geographic and psychological isolation of adolescents and young adults as they move toward cancer survivorship.", {"entities": [[193, 199, "DISEASE"]]}], ["It is expected that teaching AYAs coping skills as they resume their normal lives after cancer may have long-term implications for their quality of life.", {"entities": [[88, 94, "DISEASE"]]}], ["ACTRN12610000717055", {"entities": []}], ["In comparison to genome-wide association studies (GWAS), there has been poor replication of gene expression studies in chronic obstructive pulmonary disease (COPD).", {"entities": [[119, 156, "DISEASE"]]}], ["We performed microarray gene expression profiling on a large sample of resected lung tissues from subjects with severe COPD.", {"entities": []}], ["Comparing 111 COPD cases and 40 control smokers, 204 genes were differentially expressed; none were at significant GWAS loci.", {"entities": []}], ["The top differentially expressed gene was HMGB1 , which interacts with AGER , a known COPD GWAS gene.", {"entities": [[42, 47, "GENE"]]}], ["Differentially expressed genes showed enrichment for putative interactors of the first three identified COPD GWAS genes IREB2, HHIP , and FAM13A , based on gene sets derived from protein and RNA binding studies, RNA-interference, a murine smoking model, and expression quantitative trait locus analyses.", {"entities": [[120, 125, "GENE"], [127, 131, "GENE"], [138, 144, "GENE"]]}], ["The gene module most highly associated for COPD in Weighted Gene Co-Expression Network Analysis (WGCNA) was enriched for B cell pathways, and shared seventeen genes with a mouse smoking model and twenty genes with previous emphysema studies.", {"entities": []}], ["As in other common diseases, genes at COPD GWAS loci were not differentially expressed; however, using a combination of network methods, experimental studies and careful phenotype definition, we found differential expression of putative interactors of these genes, and we replicated previous human and mouse microarray results.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology.", {"entities": [[11, 29, "DISEASE"], [48, 60, "DISEASE"]]}], ["Patients present loss of lung function, dyspnea and dry cough.", {"entities": []}], ["Diagnosis requires compatible radiologic imaging and, in undetermined cases, invasive procedures such as bronchoscopy and surgical lung biopsy.", {"entities": []}], ["The pathophysiological mechanisms of IPF are not completely understood.", {"entities": []}], ["Lung injury with abnormal alveolar epithelial repair is thought to be a major cause for activation of profibrotic pathways in IPF.", {"entities": []}], ["Metabolic signatures might indicate pathological pathways involved in disease development and progression.", {"entities": []}], ["Reliable serum biomarker would help to improve both diagnostic approach and monitoring of drug effects.", {"entities": []}], ["The global metabolic profiles measured by ultra high-performance liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) of ten stable IPF patients were compared to the ones of ten healthy participants.", {"entities": []}], ["The results were validated in an additional study of eleven IPF patients and ten healthy controls.", {"entities": []}], ["We discovered 10 discriminative metabolic features using multivariate and univariate statistical analysis.", {"entities": []}], ["Among them, we identified one metabolite at a retention time of 9.59\u00a0min that was two times more abundant in the serum of IPF patients compared to healthy participants.", {"entities": []}], ["Based on its ion pattern, a lysophosphatidylcholine (LysoPC) was proposed.", {"entities": []}], ["LysoPC is a precursor of lysophosphatidic acid (LPA) \u2013 a known mediator for lung fibrosis with its pathway currently being evaluated as new therapeutic drug target for IPF and other fibrotic diseases.", {"entities": [[48, 51, "GENE"]]}], ["We identified a LysoPC by UHPLC-HRMS as potential biomarker in serum of patients with IPF.", {"entities": []}], ["Further validation studies in a larger cohort are necessary to determine its role in IPF.", {"entities": []}], ["Serum samples from IPF patients have been obtained within the clinical trial NCT02173145 at baseline and from the idiopathic interstitial pneumonia (IIP) cohort study.", {"entities": [[114, 147, "DISEASE"], [138, 147, "DISEASE"]]}], ["The study was approved by the Swiss Ethics Committee, Bern (KEK 002/14 and 246/15 or PB_2016\u201301524).", {"entities": []}], ["The online version of this article (doi: 10.1186/s12931-018-0714-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The major house dust mite allergens Der p 1 and Der p 2 are prevalent inducers of eczema.", {"entities": []}], ["Der p 1 is a cysteine protease disrupting epithelial barriers, whereas Der p 2 functionally mimics the LPS-binding compound MD-2 within the TLR4 complex.", {"entities": [[140, 144, "GENE"]]}], ["In this work, we tested the percutaneous sensitizing capacity of recombinant (r) Der p 1 and Der p 2 in BALB/c mice.", {"entities": []}], ["Mice were sensitized by percutaneous application of low (10 \u03bcg/application) and high dose (100 \u03bcg) rDer p 1 or rDer p 2, or with rDer p 1 followed by rDer p 2.", {"entities": []}], ["Allergen-specific and total IgE antibodies were determined by ELISA.", {"entities": []}], ["Eczema of BALB/c was classified by the itching score and corresponded to erosions.", {"entities": []}], ["Infiltrating immune cells were identified by haematoxylin/eosin and Giemsa staining for eosinophils or mast cells, CD3 staining for T lymphocytes.", {"entities": []}], ["Percutaneous treatments with rDer p 1, but not rDer p 2-induced specific IgG1.", {"entities": []}], ["However, cotreatment with rDer p 1 led to increase in anti-Der p 2 IgG titres.", {"entities": []}], ["Both allergens elicited skin erosions because of scratching, thickening of the epidermis, and eosinophil and T-cell infiltration.", {"entities": []}], ["Our data indicate that recombinant mite allergens in the absence of adjuvant are sufficient for inducing eczema in BALB/c mice.", {"entities": []}], ["As the enzymatic activity of an allergen might be an important cofactor for specific sensitization via the skin, Der p 1 may act as adjuvant for other allergens too.", {"entities": []}], ["The presented mouse model is suitable for investigating the mechanisms of allergic eczema.", {"entities": []}], ["Recently, the genomes of two Mycoplasma fermentans strains, namely M64 and JER, have been completely sequenced.", {"entities": []}], ["Gross comparison indicated that the genome of M64 is significantly bigger than the other strain and the difference is mainly contributed by the repetitive sequences including seven families of simple and complex transposable elements ranging from 973 to 23,778 bps.", {"entities": []}], ["Analysis of these repeats resulted in the identification of a new distinct family of Integrative Conjugal Elements of M. fermentans , designated as ICEF-III.", {"entities": []}], ["Using the concept of \u201creaction connectivity\u201d, the metabolic capabilities in M. fermentans manifested by the complete and partial connected biomodules were revealed.", {"entities": []}], ["A comparison of the reported M. pulmonis , M. arthritidis , M. genitalium , B. subtilis , and E. coli essential genes and the genes predicted from the M64 genome indicated that more than 73% of the Mycoplasmas essential genes are preserved in M. fermentans .", {"entities": []}], ["Further examination of the highly and partly connected reactions by a novel combinatorial phylogenetic tree, metabolic network, and essential gene analysis indicated that some of the pathways (e.g.", {"entities": []}], ["purine and pyrimidine metabolisms) with partial connected reactions may be important for the conversions of intermediate metabolites.", {"entities": []}], ["Taken together, in light of systems and network analyses, the diversity among the Mycoplasma species was manifested on the variations of their limited metabolic abilities during evolution.", {"entities": []}], ["A growing body of evidence suggests that there is a relationship between impaired lung function and the risk of developing diabetes mellitus (DM).", {"entities": [[123, 140, "DISEASE"]]}], ["However, it is not known if this reflects a causal effect of lung function on glucose metabolism.", {"entities": []}], ["To clarify the relationship between lung function and the development of DM, we examined the incidence of newly diagnosed prediabetes (a precursor of DM) among subjects with normal glucose tolerance (NGT) at baseline.", {"entities": []}], ["Primary analysis of an occupational cohort with both cross-sectional and longitudinal data (follow-up duration mean\u00b1SD: 28.4\u00b16.1\u2005months).", {"entities": []}], ["Data were analysed from 1058 men in a cross-sectional study and from 560 men with NGT in a longitudinal study.", {"entities": []}], ["Impaired lung function (per cent predicted value of forced vital capacity (%FVC) or per cent value of forced expiratory volume 1\u2005s/FVC (FEV 1 /FVC ratio)) in relation to the ratio of prediabetes or DM in a cross-sectional study and development of new prediabetes in a longitudinal study.", {"entities": [[136, 139, "GENE"]]}], ["NGT, prediabetes including impaired glucose tolerance (IGT) and increased fasting glucose (IFG) and DM were diagnosed according to 75\u2005g oral glucose tolerance tests.", {"entities": []}], ["%FVC at baseline, but not FEV 1 /FVC ratio at baseline, was significantly associated with the incidences of DM and prediabetes.", {"entities": [[26, 29, "GENE"]]}], ["Among prediabetes, IGT but not IFG was associated with %FVC.", {"entities": []}], ["During follow-up, 102 subjects developed prediabetes among those with NGT.", {"entities": []}], ["A low %FVC, but not FEV 1 /FVC ratio, was predictive of an increased risk for development of IGT, but not of IFG.", {"entities": [[20, 23, "GENE"]]}], ["Low lung volume is associated with an increased risk for the development of prediabetes, especially IGT, in Japanese men.", {"entities": []}], ["Although there is published evidence for an association between chronic obstructive pulmonary disease and DM, prediabetes is not associated with the early stage of COPD.", {"entities": [[64, 101, "DISEASE"]]}], ["The utilization of biomass for power generation has become more prevalent globally.", {"entities": []}], ["To survey the status of evidence concerning resulting health impacts and to depict potential research needs, a scoping-review was conducted.", {"entities": []}], ["Biomass life cycle phases of interest were the conversion and combustion phases.", {"entities": []}], ["Studies from occupational and residential settings were considered.", {"entities": []}], ["The scoping review was conducted systematically, comprising an extensive literature search, a guided screening process, in-duplicate data extraction, and critical appraisal.", {"entities": []}], ["Two reviewers executed most review steps.", {"entities": []}], ["Nine articles of relevance were identified.", {"entities": []}], ["In occupational settings of biomass plants, exposure to endotoxins and fungi might be associated with respiratory disorders.", {"entities": []}], ["An accidental leakage of hydrogen sulfide in biogas plants may lead to fatalities or severe health impacts.", {"entities": []}], ["Living near biomass power plants (and the accompanied odorous air pollution) may result in an increased risk for several symptoms and odor annoyance, mediated by perception about air pollution or an evaluation of a resulting health risk.", {"entities": []}], ["The methodological quality of included studies varied a lot.", {"entities": []}], ["Overall, the body of evidence on the topic is sparse and future high-quality research is strongly recommended.", {"entities": []}], ["To further develop and validate previously published national prescribing appropriateness criteria to assist in identifying drug-related problems (DRPs) for commonly occurring medications and medical conditions in older (\u226565\u2005years old) Australians.", {"entities": []}], ["RAND/UCLA appropriateness method.", {"entities": []}], ["A panel of medication management experts were identified consisting of geriatricians/pharmacologists, clinical pharmacists and disease management advisors to organisations that produce Australian evidence-based therapeutic publications.", {"entities": []}], ["This resulted in a round-one panel of 15 members, and a round-two panel of 12 members.", {"entities": []}], ["Agreement on all criteria.", {"entities": []}], ["Forty-eight prescribing criteria were rated.", {"entities": []}], ["In the first rating round via email, there was disagreement regarding 17 of the criteria according to median panel ratings.", {"entities": []}], ["During a face-to-face second round meeting, discussion resulted in retention of 25 criteria after amendments, agreement for 14 criteria with no changes required and deletion of 9 criteria.", {"entities": []}], ["Two new criteria were added, resulting in a final validated list of 41 prescribing appropriateness criteria.", {"entities": []}], ["Agreement after round two was reached for all 41 criteria, measured by median panel ratings and the amount of dispersion of panel ratings, based on the interpercentile range.", {"entities": []}], ["A set of 41 Australian prescribing appropriateness criteria were validated by an expert panel.", {"entities": []}], ["Use of these criteria, together with clinical judgement and other medication review processes such as patient interview, is intended to assist in improving patient care by efficiently detecting potential DRPs related to commonly occurring medicines and medical conditions in older Australians.", {"entities": []}], ["These criteria may also contribute to the medication management education of healthcare professionals.", {"entities": []}], ["The large geographical gaps in our knowledge of the prevalence and burden of headache disorders include almost all of Eastern Mediterranean Region (EMR).", {"entities": []}], ["We report a nationwide population-based study in Pakistan, an EMR country with the sixth largest population in the world, conducted as a project within the Global Campaign against Headache.", {"entities": []}], ["We surveyed six locations from the four provinces of Pakistan: Punjab, Sindh, Khyber Pakhtunkhwa and Baluchistan.", {"entities": []}], ["We randomly selected and visited rural and urban households in each.", {"entities": []}], ["One adult member (18\u201365 years) of each household, also randomly selected, was interviewed by a trained non-medical interviewer from the same location using a previously-validated structured questionnaire translated into Urdu, the national language.", {"entities": []}], ["We estimated 1-year prevalences of the headache disorders of public-health importance and examined their associations with demographic variables using multivariate analysis.", {"entities": []}], ["There were 4223 participants (mean age 34.4\u2009\u00b1\u200911.0\u00a0years; male 1957 [46.3%], female 2266 [53.7%]; urban 1443 [34.2%], rural 2780 [65.8%]).", {"entities": []}], ["Participation proportion was 89.5%.", {"entities": []}], ["Headache in the previous year was reported by 3233 (76.6% [95% CI: 75.3\u201377.8%]).", {"entities": []}], ["The age- and gender-adjusted 1-year prevalence of migraine was 22.5% [21.2\u201323.8%] (male 18.0% [16.8\u201319.2%], female 26.9% [25.6\u201328.2%]), of tension-type headache (TTH) 44.6% [43.1\u201346.1%] (male 51.2% [49.7\u201352.7%], female 37.9% [36.4\u201339.4%]), of probable medication-overuse headache 0.7% [0.5\u20131.0%] (male 0.7% [0.5\u20131.0%], female 0.8% [0.5\u20131.1%]) and of other headache on \u226515\u00a0days/month 7.4% [6.6\u20138.2%] (male 4.4% [3.8\u20135.0%], female 10.4% [9.5\u201311.3%]).", {"entities": [[50, 58, "DISEASE"]]}], ["Migraine was more prevalent in females by a factor of 3:2 although this association barely survived ( P \u2009=\u20090.039) after correcting for other factors.", {"entities": [[0, 8, "DISEASE"]]}], ["TTH was more prevalent in males by about 4:3 ( P \u2009=\u20090.026).", {"entities": []}], ["All headache and migraine were age-related, peaking in the age group 40\u201349 years; TTH peaked a decade earlier.", {"entities": [[17, 25, "DISEASE"]]}], ["Higher education ( P \u2009=\u20090.004) and income ( P \u2009=\u20090.001) were negatively associated with prevalence of migraine.", {"entities": [[102, 110, "DISEASE"]]}], ["With three quarters of its population affected, headache disorders must be on the public-health agenda of Pakistan.", {"entities": []}], ["Worldwide, these disorders are the third leading cause of disability; information from specific enquiry into the burden attributable to headache disorders in this country is needed to inform health policy and priority-setting, and will be reported soon.", {"entities": []}], ["A design concept of low-cost, simple, fully mechanical model of a mechanically ventilated, passively breathing lung is developed.", {"entities": []}], ["An example model is built to simulate a patient under mechanical ventilation with accurate volumes and compliances, while connected directly to a ventilator.", {"entities": []}], ["The lung is modelled with multiple units, represented by rubber bellows, with adjustable weights placed on bellows to simulate compartments of different superimposed pressure and compliance, as well as different levels of lung disease, such as Acute Respiratory Distress Syndrome (ARDS).", {"entities": [[222, 234, "DISEASE"]]}], ["The model was directly connected to a ventilator and the resulting pressure volume curves recorded.", {"entities": []}], ["The model effectively captures the fundamental lung dynamics for a variety of conditions, and showed the effects of different ventilator settings.", {"entities": []}], ["It was particularly effective at showing the impact of Positive End Expiratory Pressure (PEEP) therapy on lung recruitment to improve oxygenation, a particulary difficult dynamic to capture.", {"entities": []}], ["Application of PEEP therapy is difficult to teach and demonstrate clearly.", {"entities": []}], ["Therefore, the model provide opportunity to train, teach, and aid further understanding of lung mechanics and the treatment of lung diseases in critical care, such as ARDS and asthma.", {"entities": [[176, 182, "DISEASE"]]}], ["Finally, the model's pure mechanical nature and accurate lung volumes mean that all results are both clearly visible and thus intuitively simple to grasp.", {"entities": []}], ["Th17 cells have been reported to produce proinflammatory cytokines like Interleukin-17, IL-22, and regarded as important players in various inflammatory diseases.", {"entities": []}], ["One of the IL-12 cytokine family cytokines, IL-23, composed of p19 and p40 subunit, is known for its potential to promote Th17 development and IL-17 producing, and the IL-23/IL-17 pathway is considered to be potential therapeutic target for autoimmune inflammation responses.", {"entities": []}], ["Knockout mice deficient in either IL-23 or IL-17 related genes can suppress the allergic responses.", {"entities": []}], ["Several IL-23 or IL-17 neutralizing agents are being evaluated in vitro or in vivo to disrupt the IL-23/IL-17 axis.", {"entities": []}], ["Herein, we report that prokaryotically expressed soluble IL-23 receptor cytokine-binding homology region as an endogenous extracellular receptor analogue could be a natural antagonist against IL-23/IL-17 axis.", {"entities": []}], ["We provide evidence that IL23R-CHR can bind to IL-23 in a dose-dependent manner in vitro , and block IL-23 signal by IL23R-CHR reducing the ROR\u03b3t expression, which in turn lowers the expression of IL-17/IL-22, thus protecting naive CD4+ T cells against Th17 development.", {"entities": []}], ["Together, this study indicates the importance of IL-23 pathway in Th17 development and the negative regulation of Th17 development by IL23R-CHR, and highlights the important roles of the soluble receptor extracellular region in the therapeutic strategy of neutralizing IL-23.", {"entities": []}], ["Preconceptional carcinogenesis occurs in animals and is suspected for humans--for example, after occupational metals exposure.", {"entities": []}], ["Several characteristics in animal models, including high frequency and non-Mendelian inheritance patterns, have suggested an epigenetic mechanism, possibly involving hormone changes in offspring.", {"entities": []}], ["To test this hypothesis, we treated male mice with chromium(III) chloride, a preconceptional carcinogen, 2 weeks before mating, in two separate experiments.", {"entities": []}], ["Their 10-week-old offspring showed highly significant increases in average serum corticosterone and glucose, compared with control offspring.", {"entities": []}], ["Average serum levels of insulin-like growth factor 1 (IGF1) showed more modest possible increases.", {"entities": [[54, 58, "GENE"]]}], ["A previous microarray experiment identified hepatic insulin-like growth factor binding protein 1 (IGF BP1) gene expression as consistently changed in correlation with serum corticosterone levels.", {"entities": []}], ["In the present study, hepatic IGF BP1 mRNA correlated with serum IGF1 in male offspring of chromium-treated fathers, but not in controls; serum glucose correlated positively with hepatic IGF BP1 in chromium-group offspring but negatively in controls.", {"entities": [[65, 69, "GENE"]]}], ["These results support the hypothesis that preconceptional exposure effects may alter hormones, metabolism, and control of tissue gene expression, probably through epigenetic mechanisms.", {"entities": []}], ["Risk of neoplasia may be influenced by these changes.", {"entities": []}], ["In the past decades, chronic inflammatory diseases such as psoriasis, atopic dermatitis, asthma, Crohn\u2019s disease and celiac disease were generally regarded as immune-mediated conditions involving activated T-cells and proinflammatory cytokines produced by these cells.", {"entities": [[59, 68, "DISEASE"], [70, 87, "DISEASE"], [117, 131, "DISEASE"], [89, 95, "DISEASE"], [77, 87, "DISEASE"]]}], ["This paradigm has recently been challenged by the finding that mutations and polymorphisms in epithelium-expressed genes involved in physical barrier function or innate immunity, are risk factors of these conditions.", {"entities": []}], ["We used a functional genomics approach to analyze cultured keratinocytes from patients with psoriasis or atopic dermatitis and healthy controls.", {"entities": [[92, 101, "DISEASE"], [105, 122, "DISEASE"], [112, 122, "DISEASE"]]}], ["First passage primary cells derived from non-lesional skin were stimulated with pro-inflammatory cytokines, and expression of a panel of 55 genes associated with epidermal differentiation and cutaneous inflammation was measured by quantitative PCR.", {"entities": []}], ["A subset of these genes was analyzed at the protein level.", {"entities": []}], ["Using cluster analysis and multivariate analysis of variance we identified groups of genes that were differentially expressed, and could, depending on the stimulus, provide a disease-specific gene expression signature.", {"entities": []}], ["We found particularly large differences in expression levels of innate immunity genes between keratinocytes from psoriasis patients and atopic dermatitis patients.", {"entities": [[113, 122, "DISEASE"], [136, 153, "DISEASE"], [143, 153, "DISEASE"]]}], ["Our findings indicate that cell-autonomous differences exist between cultured keratinocytes of psoriasis and atopic dermatitis patients, which we interpret to be genetically determined.", {"entities": [[95, 104, "DISEASE"], [109, 126, "DISEASE"], [116, 126, "DISEASE"]]}], ["We hypothesize that polymorphisms of innate immunity genes both with signaling and effector functions are coadapted, each with balancing advantages and disadvantages.", {"entities": []}], ["In the case of psoriasis, high expression levels of antimicrobial proteins genes putatively confer increased protection against microbial infection, but the biological cost could be a beneficial system gone awry, leading to overt inflammatory disease.", {"entities": [[15, 24, "DISEASE"]]}], ["Pseudomonas aeruginosa is a major opportunistic pathogen in cystic fibrosis (CF) patients and causes a wide range of infections among other susceptible populations.", {"entities": [[60, 75, "DISEASE"]]}], ["Its inherent resistance to many antimicrobials also makes it difficult to treat infections with this pathogen.", {"entities": []}], ["Recent evidence has highlighted the diversity of this species, yet despite this, the majority of studies on virulence and pathogenesis focus on a small number of strains.", {"entities": []}], ["There is a pressing need for a P. aeruginosa reference panel to harmonize and coordinate the collective efforts of the P. aeruginosa research community.", {"entities": []}], ["We have collated a panel of 43 P. aeruginosa strains that reflects the organism's diversity.", {"entities": []}], ["In addition to the commonly studied clones, this panel includes transmissible strains, sequential CF isolates, strains with specific virulence characteristics, and strains that represent serotype, genotype or geographic diversity.", {"entities": []}], ["This focussed panel of P. aeruginosa isolates will help accelerate and consolidate the discovery of virulence determinants, improve our understanding of the pathogenesis of infections caused by this pathogen, and provide the community with a valuable resource for the testing of novel therapeutic agents.", {"entities": []}], ["Schisandrae fructus (SF) has recently been reported to increase skeletal muscle mass and inhibit atrophy in mice.", {"entities": []}], ["We investigated the effect of SF extract on human myotube differentiation and its acting pathway.", {"entities": []}], ["Various concentrations (0.1\u201310 \u03bcg/mL) of SF extract were applied on human skeletal muscle cells in vitro.", {"entities": []}], ["Myotube area and fusion index were measured to quantify myotube differentiation.", {"entities": []}], ["The maximum effect was observed at 0.5 \u03bcg/mL of SF extract, enhancing differentiation up to 1.4-fold in fusion index and 1.6-fold in myotube area at 8 days after induction of differentiation compared to control.", {"entities": []}], ["Phosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 and 70 kDa ribosomal protein S6 kinase, which initiate translation as downstream of mammalian target of rapamycin pathway, was upregulated in early phases of differentiation after SF treatment.", {"entities": []}], ["SF also attenuated dexamethasone-induced atrophy.", {"entities": []}], ["In conclusion, we show that SF augments myogenic differentiation and attenuates atrophy by increasing protein synthesis through mammalian target of rapamycin/70 kDa ribosomal protein S6 kinase and eukaryotic translation initiation factor 4E-binding protein 1 signaling pathway in human myotubes.", {"entities": []}], ["SF can be a useful natural dietary supplement in increasing skeletal muscle mass, especially in the aged with sarcopenia and the patients with disuse atrophy.", {"entities": []}], ["Allergic rhinitis (AR), one of the common diseases of the upper respiratory system, is associated with high risk of nasopharyngeal carcinoma.", {"entities": [[0, 17, "DISEASE"], [131, 140, "DISEASE"], [9, 17, "DISEASE"]]}], ["Biyuanling Granules (BLG), a formulated preparation of traditional Chinese medicine, has been used in China for treatment of AR for more than a decade; however, its exact action against allergic rhinitis and the mechanism involved remain unclear.", {"entities": [[186, 203, "DISEASE"], [195, 203, "DISEASE"]]}], ["In this study, we studied the effects of BLG on allergic rhinitis induced by toluene-2, 4- diisocyanate (TDI) in guinea pigs.", {"entities": [[48, 65, "DISEASE"], [57, 65, "DISEASE"]]}], ["The anti-AR effects of BLG were evaluated by behavior observations, histological examinations of the nasal tissues stained with hematoxylin and eosin staining (H&E), immunohistochemical analyses of pulmonary surfactant associated protein (SP), Bcl-2 Associated X Protei (Bax), tumor necrosis factor (TNF-\u03b1) and vascular cell adhesion molecule-1 (VCAM-1) in the nasal mucosa, and serum tests of interleukin-4 (IL-4) and human SARS-specific immunoglobulin (SIgE) levels.", {"entities": [[271, 274, "GENE"]]}], ["We observed that in the AR-positive animals treated with BLG, the symptom scores were significantly higher ( P < 0.01), the nasal mucosa edemas and inflammatory infiltrates were significantly alleviated ( P < 0.01) and the serum IL-4 and SIgE levels were significantly decreased ( P < 0.05) as compared with the control group.", {"entities": []}], ["Immunohistochemical examinations of the nasal mucosa demonstrated that the expressions of TNF-\u03b1, SP and VCAM-1 were significantly decreased ( P < 0.01), whereas Bax expression was increased in the BLG treatment groups ( P < 0.05).", {"entities": [[161, 164, "GENE"]]}], ["These results indicate that BLG can effectively suppress the TDI-induced AR, and that the protective effects of BLG were associated with reductions of TNF-\u03b1, SP and VCAM-1, and an elevation of Bax, suggesting that BLG exerts its AR-suppressive effects through inhibition of inflammatory response.", {"entities": [[193, 196, "GENE"]]}], ["The endotoxic portion of lipopolysaccharide (LPS), a glycophospholipid Lipid A, initiates the activation of the Toll-like Receptor 4 (TLR4)\u2013myeloid differentiation factor 2 (MD-2) complex, which results in pro-inflammatory immune signaling.", {"entities": [[134, 138, "GENE"]]}], ["To unveil the structural requirements for TLR4\u00b7MD-2-specific ligands, we have developed conformationally restricted Lipid A mimetics wherein the flexible \u03b2GlcN(1\u21926)GlcN backbone of Lipid A is exchanged for a rigid trehalose-like \u03b1GlcN(1\u21941)\u03b1Man scaffold resembling the molecular shape of TLR4\u00b7MD-2-bound E. coli Lipid A disclosed in the X-ray structure.", {"entities": []}], ["A convergent synthetic route toward orthogonally protected \u03b1GlcN(1\u21941)\u03b1Man disaccharide has been elaborated.", {"entities": []}], ["The \u03b1,\u03b1-(1\u21941) linkage was attained by the glycosylation of 2- N -carbamate-protected \u03b1-GlcN-lactol with N -phenyl-trifluoroacetimidate of 2- O -methylated mannose.", {"entities": []}], ["Regioselective acylation with ( R )-3-acyloxyacyl fatty acids and successive phosphorylation followed by global deprotection afforded bis- and monophosphorylated hexaacylated Lipid A mimetics.", {"entities": []}], ["\u03b1GlcN(1\u21941)\u03b1Man-based Lipid A mimetics (\u03b1,\u03b1-GM-LAM) induced potent activation of NF-\u03baB signaling in hTLR4/hMD-2/CD14-transfected HEK293 cells and robust LPS-like cytokines expression in macrophages and dendritic cells.", {"entities": []}], ["Thus, restricting the conformational flexibility of Lipid A by fixing the molecular shape of its carbohydrate backbone in the \u201cagonistic\u201d conformation attained by a rigid \u03b1GlcN(1\u21941)\u03b1Man scaffold represents an efficient approach toward powerful and adjustable TLR4 activation.", {"entities": [[259, 263, "GENE"]]}], ["This study evaluates the association between high-sensitivity cardiac troponin I (hs-cTnI) and T (hs-cTnT) and coronary calcium concentration (CAC) detected by coronary computed tomography (CCT) and evaluated with the Agatston score in patients with suspected coronary artery disease (CAD).", {"entities": []}], ["Patients undergoing CCT during routine clinical care were enrolled\u00a0prospectively.", {"entities": []}], ["CCT was indicated for patients with a low to intermediate pretest probability for CAD.", {"entities": []}], ["Within 24\u00a0h of CCT examination, peripheral blood samples were taken to measure cardiac biomarkers hs-cTnI and hs-cTnT.", {"entities": []}], ["A total of 76 patients were enrolled including\u00a038% without detectable CAC, 36% with an Agatston score from 1 to 100, 17% from 101 to 400, and 9% with values\u00a0\u2265\u00a0400. hs-cTnI was increasing alongside Agatston score and was able to differentiate between different groups of\u00a0Agatston scores.", {"entities": []}], ["Both hs-cTn discriminated values greater than 100 (hs-cTnI, AUC\u00a0=\u00a00.663; p \u00a0=\u00a00.032; hs-cTnT, AUC\u00a0=\u00a00.650; p \u00a0=\u00a00.048).", {"entities": []}], ["In univariate and multivariate logistic regression models, hs-cTnT and hs-cTnI were significantly associated with increased Agatston scores.", {"entities": []}], ["Patients with hs-cTnT\u00a0\u2265\u00a00.02\u00a0\u00b5g/l and hs-cTnI\u00a0\u2265\u00a05.5\u00a0ng/l were more likely to reveal values\u00a0\u2265\u00a0400 (hs-cTnT; OR\u00a0=\u00a013.4; 95% CI 1.545\u2013116.233; p \u00a0=\u00a00.019; hs-cTnI; OR\u00a0=\u00a08.8; 95% CI 1.183\u201365.475; p \u00a0=\u00a00.034).", {"entities": []}], ["The present study shows that the Agatston score was significantly correlated with hs cardiac troponins, both in univariable and multivariable linear regression models.", {"entities": []}], ["Hs-cTnI is able to discriminate between different Agatston values.", {"entities": []}], ["The present\u00a0results might reveal potential cut-off values for hs cardiac troponins regarding different Agatston values.", {"entities": []}], ["Trial registration Cardiovascular Imaging and Biomarker Analyses (CIBER), NCT03074253 https://clinicaltrials.gov/ct2/show/record/NCT03074253", {"entities": []}], ["Sedation is widely used in intensive care unit (ICU) patients to limit the risk of pulmonary barotrauma and to decrease oxygen needs.", {"entities": []}], ["However, adverse effects of cc5128sedation have not been fully evaluated; in particular, effects of benzodiazepine and opiates on microcirculation have not been extensively studied.", {"entities": []}], ["The aim of this study was to evaluate the microcirculatory effects of a sedation protocol commonly prescribed in the ICU.", {"entities": []}], ["Ten non-septic patients under controlled ventilation requiring sedation for therapeutic purposes were enrolled in a prospective observational study conducted in an ICU of a university hospital.", {"entities": []}], ["Sedation was conducted in two successive steps: first, each patient received midazolam (0.1 mg/kg per hour after a bolus of 0.05 mg/kg, then adapted to reach a Ramsay score of between 3 and 5).", {"entities": []}], ["Second, after one hour, sufentanil was added (0.1 \u03bcg/kg per hour after a bolus of 0.1 \u03bcg/kg).", {"entities": []}], ["Arterial pressure, heart rate, cardiac output determined by transthoracic impedance, transcutaneous oxygen (tcPO 2 ) and carbon dioxide (tcPCO 2 ) pressures, and microcirculatory blood flow determined by laser Doppler flowmetry at rest and during a reactive hyperaemia challenge were measured before sedation (NS period), one hour after midazolam infusion (H period), and one hour after midazolam-sufentanil infusion (HS period).", {"entities": []}], ["Arterial pressure decreased in both sedation periods, but heart rate, cardiac output, tcPO 2 , and tcPCO 2 remained unchanged.", {"entities": []}], ["In both sedation periods, microcirculatory changes occurred with an increase in cutaneous blood flow at rest (H period: 207 \u00b1 25 perfusion units [PU] and HS period: 205 \u00b1 25 PU versus NS period: 150 \u00b1 22 PU, p < 0.05), decreased response to ischaemia (variation of blood flow to peak: H period: 97 \u00b1 16 PU and HS period: 73 \u00b1 9 PU versus NS period: 141 \u00b1 14 PU, p < 0.05), and attenuation of vasomotion.", {"entities": []}], ["Sedation with midazolam or a combination of midazolam and sufentanil induces a deterioration of vasomotion and microvascular response to ischaemia, raising the question of whether this effect may further alter tissue perfusion when already compromised, as in septic patients.", {"entities": []}], ["Exacerbations of chronic obstructive pulmonary disease (COPD) are natural events in the progression of the disease, and are characterised by acute worsening of symptoms, especially dyspnoea.", {"entities": [[17, 54, "DISEASE"]]}], ["These heterogeneous events follow increased airway inflammation, often due to infection, and lead to decreased airflow and increased lung hyperinflation relative to stable COPD.", {"entities": []}], ["Although exacerbation frequency generally increases as COPD progresses, some patients experience frequent exacerbations (\u22652 per year) independently of disease severity.", {"entities": []}], ["Exacerbations, especially frequent exacerbations, are associated with impaired health-related quality of life, reduced physical activity and poor disease prognosis.", {"entities": []}], ["The cornerstone of pharmacotherapy for stable COPD is long-acting bronchodilators, including the long-acting \u03b2 2 -agonists (LABAs) and long-acting anti-muscarinic agents (LAMAs) alone or combined with inhaled corticosteroids (ICS).", {"entities": []}], ["While ICS treatment can potentially reduce the risk of exacerbations, clinical studies have demonstrated the efficacy of LABAs and LAMAs in reducing COPD symptoms, primarily by reducing lung hyperinflation secondary to reduced airway resistance.", {"entities": []}], ["Sustained reduction in lung hyperinflation may in turn lessen dyspnoea during an exacerbation.", {"entities": []}], ["Indeed, recent studies suggest that bronchodilators may also reduce the incidence of, or prevent, exacerbations.", {"entities": []}], ["Using data from recent studies, this review explores the evidence and possible mechanisms through which bronchodilators may prevent exacerbations.", {"entities": []}], ["The patterns and determinants of saxagliptin use among patients with type 2 diabetes mellitus (T2DM) are unknown in real-world settings.", {"entities": [[76, 93, "DISEASE"], [69, 93, "DISEASE"]]}], ["We compared the characteristics of T2DM patients who were new initiators of saxagliptin to those who were new initiators of non-dipeptidyl peptidase-4 (DPP-4) inhibitor oral anti-diabetic drugs (OADs) and identified factors associated with saxagliptin use.", {"entities": []}], ["We conducted a cross-sectional study within the Clinical Practice Research Datalink (CPRD), The Health Improvement Network (THIN), US Medicare, and the HealthCore Integrated Research Database (HIRD We identified 64,079 saxagliptin initiators (CPRD: 1,962; THIN: 2,084; US Medicare: 51,976; HIRD In these UK and US data sources, initiation of saxagliptin was associated with prior poor glycemic control, prior OAD use, and diagnoses of hypertension and hyperlipidemia.", {"entities": [[435, 447, "DISEASE"]]}], ["ClinicalTrials.gov identifiers NCT01086280 , NCT01086293 , NCT01086319 , NCT01086306 , and NCT01377935", {"entities": []}], ["Interleukin-33 (IL-33)/IL-33 receptor (IL-33R, ST2) signaling pathway promotes mammary cancer growth and metastasis by inhibiting anti-tumor immunity.", {"entities": [[87, 93, "DISEASE"]]}], ["However, the role of IL-33/IL-33R axis in neoangiogenesis and tumor necrosis is not elucidated.", {"entities": []}], ["Therefore, the aim of this study was to investigate the role of IL-33/IL-33R axis in mammary tumor necrosis.", {"entities": []}], ["Deletion of IL-33R (ST2) gene in BALB/c mice enhanced tumor necrosis and attenuated tumor growth in 4T1 breast cancer model, which was associated with markedly decreased expression of vascular endothelial growth factor (VEGF) and IL-33 in mammary tumor cells.", {"entities": [[104, 117, "DISEASE"], [111, 117, "DISEASE"]]}], ["We next analyzed IL-33, IL-33R and VEGF expression and microvascular density (MVD) in breast tumors from 40 female patients with absent or present tumor necrosis.", {"entities": [[78, 81, "GENE"]]}], ["We found significantly higher expression of IL-33, IL-33R and VEGF in breast cancer tissues with absent tumor necrosis.", {"entities": [[70, 83, "DISEASE"], [77, 83, "DISEASE"]]}], ["Both, IL-33 and IL-33R expression correlated with VEGF expression in tumor cells.", {"entities": []}], ["Further, VEGF expression positively correlated with MVD in perinecrotic zone.", {"entities": [[52, 55, "GENE"]]}], ["Taking together, our data indicate that IL-33/IL-33R pathway is critically involved in mammary tumor growth by facilitating expression of pro-angiogenic VEGF in tumor cells and attenuating tumor necrosis.", {"entities": []}], ["These data add an unidentified mechanism by which IL-33/IL-33R axis facilitates tumor growth.", {"entities": []}], ["Little is known about how neonatal airway epithelial cell phenotype impacts on respiratory disease in later life.", {"entities": []}], ["This study aimed to establish a methodology to culture and characterise neonatal nasal epithelial cells sampled from healthy, non-sedated infants within 48 hours of delivery.", {"entities": []}], ["Nasal epithelial cells were sampled by brushing both nostrils with an interdental brush, grown to confluence and sub-cultured.", {"entities": []}], ["Cultured cells were characterised morphologically by light and electron microscopy and by immunocytochemistry.", {"entities": []}], ["As an exemplar pro-inflammatory chemokine, IL-8 concentrations were measured in supernatants from unstimulated monolayers and after exposure to IL-1\u03b2/TNF-\u03b1 or house dust mite extract.", {"entities": []}], ["Primary cultures were successfully established in 135 (91%) of 149 neonatal samples seeded, with 79% (n \u200a=\u200a 117) successfully cultured to passage 3.", {"entities": []}], ["The epithelial lineage of the cells was confirmed by morphological analysis and immunostaining.", {"entities": []}], ["Constitutive IL-8 secretion was observed and was upregulated by IL-1\u03b2/TNF-\u03b1 or house dust mite extract in a dose dependent manner.", {"entities": []}], ["We describe a safe, minimally invasive method of culturing nasal epithelial cells from neonates suitable for functional cell analysis offering an opportunity to study \u201cna\u00efve\u201d cells that may prove useful in elucidating the role of the epithelium in the early origins of asthma and/or allergic rhinitis.", {"entities": [[283, 300, "DISEASE"], [292, 300, "DISEASE"], [269, 275, "DISEASE"]]}], ["Transforming spatial data from one scale to another is a challenge in geographic analysis.", {"entities": []}], ["As part of a larger, primary study to determine a possible association between travel barriers to pediatric cancer facilities and adolescent cancer mortality across the United States, we examined methods to estimate mortality within zones at varying distances from these facilities: (1) geographic centroid assignment, (2) population-weighted centroid assignment, (3) simple areal weighting, (4) combined population and areal weighting, and (5) geostatistical areal interpolation.", {"entities": [[108, 114, "DISEASE"], [141, 147, "DISEASE"]]}], ["For the primary study, we used county mortality counts from the National Center for Health Statistics (NCHS) and population data by census tract for the United States to estimate zone mortality.", {"entities": []}], ["In this paper, to evaluate the five mortality estimation methods, we employed address-level mortality data from the state of Georgia in conjunction with census data.", {"entities": []}], ["Our objective here is to identify the simplest method that returns accurate mortality estimates.", {"entities": []}], ["The distribution of Georgia county adolescent cancer mortality counts mirrors the Poisson distribution of the NCHS counts for the U.S.", {"entities": [[46, 52, "DISEASE"]]}], ["Likewise, zone value patterns, along with the error measures of hierarchy and fit, are similar for the state and the nation.", {"entities": []}], ["Therefore, Georgia data are suitable for methods testing.", {"entities": []}], ["The mean absolute value arithmetic differences between the observed counts for Georgia and the five methods were 5.50, 5.00, 4.17, 2.74, and 3.43, respectively.", {"entities": []}], ["Comparing the methods through paired t-tests of absolute value arithmetic differences showed no statistical difference among the methods.", {"entities": []}], ["However, we found a strong positive correlation (r\u00a0=\u00a00.63) between estimated Georgia mortality rates and combined weighting rates at zone level.", {"entities": []}], ["Most importantly, Bland\u2013Altman plots indicated acceptable agreement between paired arithmetic differences of Georgia rates and combined population and areal weighting rates.", {"entities": []}], ["This research contributes to the literature on areal interpolation, demonstrating that combined population and areal weighting, compared to other tested methods, returns the most accurate estimates of mortality in transforming small counts by county to aggregated counts for large, non-standard study zones.", {"entities": []}], ["This conceptually simple cartographic method should be of interest to public health practitioners and researchers limited to analysis of data for relatively large enumeration units.", {"entities": []}], ["Asthma is a complex polygenic disease involving the interaction of many genes.", {"entities": [[0, 6, "DISEASE"]]}], ["In this study, we investigated the allergic response in experimental asthma.", {"entities": [[69, 75, "DISEASE"]]}], ["First, we constructed a biological interaction network using the BOND (Biomolecular Object Network Databank) database of literature curated molecular interactions.", {"entities": []}], ["Second, we mapped differentially expressed genes from microarray data onto the network.", {"entities": []}], ["Third, we analyzed the topological characteristics of the modulated genes.", {"entities": []}], ["Fourth, we analyzed the correlation between the topology and biological function using the Gene Ontology classifications.", {"entities": []}], ["Our results demonstrate that nodes with high connectivity (hubs and superhubs) tend to have low levels of change in gene expression.", {"entities": []}], ["The significance of our observations was confirmed by permutation testing.", {"entities": []}], ["Furthermore, our analysis indicates that hubs and superhubs have significantly different biological functions compared with peripheral nodes based on Gene Ontology classification.", {"entities": []}], ["Our observations have important ramifications for interpreting gene expression data and understanding biological responses.", {"entities": []}], ["Thus, our analysis suggests that a combination of differential gene expression plus topological characteristics of the interaction network provides enhanced understanding of the biology in our model of experimental asthma.", {"entities": [[215, 221, "DISEASE"]]}], ["To investigate the relationship between short sleep and obesity among Thai adults.", {"entities": [[56, 63, "DISEASE"]]}], ["Both 4-year longitudinal and cross-sectional analyses of a large national cohort.", {"entities": []}], ["Thai adults residing nationwide from 2005 to 2009.", {"entities": []}], ["Cohort members were enrolled as distance learners at Sukhothai Thammathirat Open University (N=87\u2008134 in 2005 and 60\u2008569 at 2009 follow-up).", {"entities": []}], ["At 2005 baseline, 95% were between 20 and 49\u2005years of age.", {"entities": []}], ["Self-reported sleep duration was categorised as <6, 6, 7, 8 and \u22659\u2005h. For all analyses (2005 and 2009 cross-sectional and 2005\u20132009 longitudinal), we used multinomial logistic regression models to assess the effect of sleep duration on abnormal body size (underweight, overweight-at-risk, obese).", {"entities": []}], ["Results were adjusted for an array of relevant covariates.", {"entities": []}], ["At the last cohort follow-up in 2009, cross-sectional associations linked short sleep (<6\u2005h) and obesity: adjusted ORs (AOR) =1.49, 95% CIs 1.32 to 1.68 for women and AOR=1.36, 95% CI 1.21 to 1.52 for men.", {"entities": [[97, 104, "DISEASE"]]}], ["The earlier cross-sectional baseline results in 2005 were quite similar.", {"entities": []}], ["Longitudinal analysis (2005\u20132009) of 4-year incremental weight gain (5 to <10%, 10 to <20% and 20%+) strongly supported the short sleep\u2013obesity relationship (significant AORs of 1.10, 1.30 and 1.69, respectively).", {"entities": [[136, 143, "DISEASE"]]}], ["The results are internally consistent (2005 and 2009) and longitudinally confirmatory of a short sleep effect on obesity among Thai adults.", {"entities": [[113, 120, "DISEASE"]]}], ["Further research is needed to elucidate causal mechanisms underlying the sleep\u2013obesity relationship.", {"entities": [[79, 86, "DISEASE"]]}], ["The association between sleep duration and obesity for adults is controversial and has rarely been examined in middle-income countries.", {"entities": [[43, 50, "DISEASE"]]}], ["The evidence for a short sleep\u2013obesity effect in adults is mostly based on cross-sectional data.", {"entities": [[31, 38, "DISEASE"]]}], ["This study examines both cross-sectional and longitudinal evidence linking short sleep and obesity among a large national cohort of Thai adults.", {"entities": [[91, 98, "DISEASE"]]}], ["Our cohort study revealed a consistent and substantial association between short sleep and obesity among Thai adults.", {"entities": [[91, 98, "DISEASE"]]}], ["The ORs connecting short sleep to obesity were substantial and significant: 1.36 for men and 1.49 for women in 2009; corresponding ORs were similar in 2005.", {"entities": [[34, 41, "DISEASE"]]}], ["Longitudinal 2004\u20132009 cohort data confirmed a significant short sleep\u2013weight gain relationship with a notable dose\u2013response.", {"entities": []}], ["The strength of this study was the large sample, longitudinal data, involvement of young adults and the opportunity to control for many covariates in the analyses.", {"entities": []}], ["One limitation was the subjective nature of self-reporting sleep duration, a problem noted by many others conducting sleep research.", {"entities": []}], ["WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025.", {"entities": []}], ["We undertook a secondary analysis of data from 30 surveys in low- and middle-income countries, conducted from 2008\u20132015 using the World Health Organization (WHO)/Health Action International (HAI) medicine availability and price survey methodology, to establish a baseline for this target.", {"entities": []}], ["Data for 49 medicines (lowest priced generics and originator brands) to treat cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary diseases (COPD) and central nervous system (CNS) conditions were analysed to determine their availability in healthcare facilities and pharmacies, their affordability for those on low incomes (based on median patient prices of each medicine), and the percentage of medicines that were both available and affordable.", {"entities": []}], ["Affordability was expressed as the number of days\u2019 wages of the lowest-paid unskilled government worker needed to purchase 30 days\u2019 supply using standard treatment regimens.", {"entities": []}], ["Paying more than 1 days\u2019 wages was considered unaffordable.", {"entities": []}], ["In low-income countries, 15.2% and 18.9% of lowest-priced generics met WHO\u2019s target in the public and private sectors, respectively, and 2.6% and 5.2% of originator brands.", {"entities": []}], ["In lower-middle income countries, 23.8% and 23.2% of lowest priced generics, and 0.8% and 1.4% of originator brands, met the target in the public and private sectors, respectively.", {"entities": []}], ["In upper-middle income countries, the situation was better for generics but still suboptimal as 36.0% and 39.4% met the target in public and private sectors, respectively.", {"entities": []}], ["For originator brands in upper-middle income countries, none reached the target in the public sector and 13.7% in the private sector.", {"entities": []}], ["Across the therapeutic groups for lowest priced generics, CVD medicines in low-income countries (11.9%), and CNS medicines in lower-middle (10.2%) and upper-middle income countries (33.3%), were least available and affordable in the public sector.", {"entities": []}], ["In the private sector for lowest priced generics, CNS medicines were least available and affordable in all three country income groups (11.4%, 5.8% and 29.3% in low-, lower-middle and upper-middle income countries respectively).", {"entities": []}], ["This data, which can act as a baseline for the WHO target, shows low availability and/or poor affordability is resulting in few essential NCD medicines meeting the target in low- and middle-income countries.", {"entities": []}], ["In the era of Sustainable Development Goals, and as countries work to achieve Universal Health Coverage, increased commitments are needed by governments to improve the situation through the development of evidence-informed, nationally-contextualised interventions, with regular monitoring of NCD medicine availability, patient prices and affordability.", {"entities": []}], ["The bacterial protein flagellin plays a major role in stimulating mucosal surface innate immune response to bacterial infection and uniquely induces profound cytoprotection against pathogens, chemicals, and radiation.", {"entities": []}], ["This study sought to determine signaling pathways responsible for the flagellin-induced inflammatory and cytoprotective effects on human corneal epithelial cells (HCECs).", {"entities": []}], ["Flagellin purified from Pseudomonas aeruginosa (strain PAK) or live bacteria were used to challenge cultured HCECs.", {"entities": []}], ["The activation of signaling pathways was assessed with Western blot, and the secretion of cytokine/chemokine and production of antimicrobial peptides (AMPs) were measured with ELISA and dot blot, respectively.", {"entities": []}], ["Effects of flagellin on wound healing were assessed in cultured porcine corneas.", {"entities": []}], ["L94A (a site mutation in TLR5 binding region) flagellin and PAK expressing L94A flagellin were unable to stimulate NF-\u03baB activation, but were potent in eliciting EGFR signaling in a TGF-\u03b1\u2013related pathway in HCECs.", {"entities": [[25, 29, "GENE"], [162, 166, "GENE"]]}], ["Concomitant with the lack of NF-\u03baB activation, L94A flagellin was ineffective in inducing IL-6 and IL-8 production in HCECs.", {"entities": []}], ["Surprisingly, the secretion of two inducible AMPs, LL-37 and hBD2, was not affected by L94A mutation.", {"entities": []}], ["Similar to wild-type flagellin, L94A induced epithelial wound closure in cultured porcine cornea through maintaining EGFR-mediated signaling.", {"entities": []}], ["Our data suggest that inflammatory response mediated by NF-\u03baB can be uncoupled from epithelial innate defense machinery (i.e., AMP expression) and major epithelial proliferation/repair pathways mediated by EGFR, and that flagellin and its derivatives may have broad therapeutic applications in cytoprotection and in controlling infection in the cornea and other mucosal tissues.", {"entities": [[206, 210, "GENE"]]}], ["Debate continues as to whether acute bronchodilator responsiveness (BDR) predicts long-term outcomes in COPD.", {"entities": []}], ["Furthermore, there is no consensus on a threshold for BDR.", {"entities": []}], ["At baseline and during the 4-year Understanding Potential Long-term Improvements in Function with Tiotropium (UPLIFT 1 values (criterion C).", {"entities": []}], ["Several outcomes (pre-dose spirometry, exacerbations, St. George's Respiratory Questionnaire [SGRQ] total score) were assessed according to presence or absence of BDR in the treatment groups.", {"entities": []}], ["5783 of 5993 randomized patients had evaluable pre- and post-bronchodilator spirometry at baseline.", {"entities": []}], ["Mean age (SD) was 64 (8) years, with 75% men, mean post-bronchodilator FEV 1 1.33 \u00b1 0.44 L (47.6 \u00b1 12.7% predicted) and 30% current smokers.", {"entities": [[71, 74, "GENE"]]}], ["At baseline, 52%, 66%, and 39% of patients had acute BDR using criterion A, B, and C, respectively.", {"entities": []}], ["The presence of BDR was variable at follow-up visits.", {"entities": []}], ["Statistically significant improvements in spirometry and health outcomes occurred with tiotropium regardless of the baseline BDR or criterion used.", {"entities": []}], ["A large proportion of COPD patients demonstrate significant acute BDR.", {"entities": []}], ["BDR in these patients is variable over time and differs according to the criterion used.", {"entities": []}], ["BDR status at baseline does not predict long-term response to tiotropium.", {"entities": []}], ["Assessment of acute BDR should not be used as a decision-making tool when prescribing tiotropium to patients with COPD.", {"entities": []}], ["Prior descriptions of the psychometric properties of validated knowledge assessment tools designed to determine Emergency medicine (EM) residents understanding of physiologic and clinical concepts related to mechanical ventilation are lacking.", {"entities": []}], ["In this setting, we have performed this study to describe the psychometric and performance properties of a novel knowledge assessment tool that measures EM residents\u2019 knowledge of topics in mechanical ventilation.", {"entities": []}], ["Results from a multicenter, prospective, survey study involving 219 EM residents from 8 academic hospitals in northeastern United States were analyzed to quantify reliability, item difficulty, and item discrimination of each of the 9 questions included in the knowledge assessment tool for 3 weeks, beginning in January 2013.", {"entities": []}], ["The response rate for residents completing the knowledge assessment tool was 68.6% (214 out of 312 EM residents).", {"entities": []}], ["Reliability was assessed by both Cronbach\u2019s alpha coefficient (0.6293) and the Spearman-Brown coefficient (0.6437).", {"entities": []}], ["Item difficulty ranged from 0.39 to 0.96, with a mean item difficulty of 0.75 for all 9 questions.", {"entities": []}], ["Uncorrected item discrimination values ranged from 0.111 to 0.556.", {"entities": []}], ["Corrected item-total correlations were determined by removing the question being assessed from analysis, resulting in a range of item discrimination from 0.139 to 0.498.", {"entities": []}], ["Reliability, item difficulty and item discrimination were within satisfactory ranges in this study, demonstrating acceptable psychometric properties of this knowledge assessment tool.", {"entities": []}], ["This assessment indicates that this knowledge assessment tool is sufficiently rigorous for use in future research studies or for assessment of EM residents for evaluative purposes.", {"entities": []}], ["The protein deacetylase sirtuin-1 (SIRT1) is an antiaging molecule that is decreased in the lung in patients with COPD.", {"entities": [[35, 40, "GENE"]]}], ["Recently, SIRT1 was reported to be detectable in serum, but serum SIRT1 (s120S) levels have not yet been reported in patients with COPD.", {"entities": [[10, 15, "GENE"], [66, 71, "GENE"], [10, 15, "GENE"], [66, 71, "GENE"]]}], ["Serum SIRT1 protein of all samples was measured by Western blot, and the SIRT1 protein band densities were calculated and compared with clinical parameters.", {"entities": [[6, 11, "GENE"], [73, 78, "GENE"], [6, 11, "GENE"], [73, 78, "GENE"]]}], ["Several molecular sizes of SIRT1, including 120\u00a0kDa (actual size) and fragments (102 and 75\u00a0kDa) were quantified by Western blot.", {"entities": [[27, 32, "GENE"]]}], ["Among them, only the 120-kDa s120S was significantly decreased in patients with COPD compared with the control subjects without COPD (s120S ratio in healthy subjects\u00a0= 0.90 \u00b1 0.34 vs\u00a0those with COPD\u00a0= 0.68 \u00b1 0.24; P \u00a0= .014) and was positively correlated with airway obstruction (FEV 1 /FVC, r \u00a0= 0.31 ; P \u00a0= .020); its severity measured by FEV 1 %\u00a0predicted ( r \u00a0= 0.29 ; P \u00a0= .029).", {"entities": [[280, 283, "GENE"], [341, 344, "GENE"], [280, 283, "GENE"], [341, 344, "GENE"]]}], ["s120S also showed\u00a0a positive correlation with BMI ( r \u00a0= 0.36 ; P \u00a0= .0077) and diffusing capacity of the lung per unit volume (the carbon monoxide transfer coefficient: K CO %) ( r \u00a0= 0.32 ; P \u00a0= .025).", {"entities": []}], ["It was also significantly decreased with increasing severity of lung emphysema ( r \u00a0= \u20130.40 ; P \u00a0= .027) and with a clinical history of frequent COPD exacerbations (infrequent vs\u00a0frequent, 0.76 \u00b1 0.20 vs\u00a00.56 \u00b1 0.26 ; P \u00a0= .027).", {"entities": []}], ["SIRT1 was not detected in supernatant of A549 and primary epithelial cells in normal culture conditions.", {"entities": [[0, 5, "GENE"]]}], ["s120S was decreased in the patients with COPD, potentially as reflected by the reduced SIRT1 within cells as a result of oxidative stress, and might be a potential biomarker for certain disease characteristics of COPD.", {"entities": [[87, 92, "GENE"]]}], ["Little is known about the levels of exposure to grass pollen in urban environments.", {"entities": []}], ["We assessed the spatio-temporal variation of grass pollen concentrations and the role of urbanity as a determinant of grass pollen exposure in the Helsinki Metropolitan area.", {"entities": []}], ["We monitored grass pollen concentrations in 2013 at 16 sites during the peak pollen season by using rotorod-type samplers at the breathing height.", {"entities": []}], ["The sites were in the cities of Helsinki and Espoo, Finland, and formed city-specific lines that represented urban-rural gradient.", {"entities": []}], ["The monitoring sites were both visually and based on land use data ranked as high to low (graded 1 to 8) pollen area.", {"entities": []}], ["The lowest grass pollen concentrations were observed in the most urban sites compared to the least urban sites (mean 3.6 vs. 6.8 grains/m", {"entities": []}], ["Atopic asthma is a prevalent respiratory disease that is characterized by inflammation, mucus hypersecretion, and airway hyperresponsiveness.", {"entities": [[7, 13, "DISEASE"]]}], ["The complexity of this heterogeneous disorder has commanded the need to better define asthma phenotypes based on underlying molecular mechanisms of disease.", {"entities": [[86, 92, "DISEASE"]]}], ["Although classically viewed as a type 2-regulated disease, type 17 helper T (Th17) cells are known to be influential in asthma pathogenesis, predominantly in asthmatics with neutrophilia and severe refractory disease.", {"entities": [[120, 126, "DISEASE"]]}], ["Bromodomain and extra-terminal domain (BET) chromatin adaptors serve as immunomodulators by directly regulating Th17 responses and Th17-mediated pathology in murine models of autoimmunity and infection.", {"entities": []}], ["Based on this, we hypothesized that BET proteins may also play an essential role in neutrophil-dominant allergic airway disease.", {"entities": []}], ["Using a murine model of neutrophil-dominant allergic airway disease, we demonstrate that BET inhibition limits pulmonary inflammation and alters the Th17-related inflammatory milieu in the lungs.", {"entities": []}], ["In addition, inhibition of BET proteins improved lung function (specifically quasi-static lung compliance and tissue elastance) and reduced mucus production in airways.", {"entities": []}], ["Overall, these studies show that BET proteins may have a critical role in asthma pathogenesis by altering type 17 inflammation, and thus interfering with BET-dependent chromatin signaling may provide clinical benefits to patients suffering from asthma.", {"entities": [[74, 80, "DISEASE"], [245, 251, "DISEASE"]]}], ["The prevalence of obesity has increased at an alarming rate worldwide.", {"entities": [[18, 25, "DISEASE"]]}], ["Metallic elements are involved in the pathogenesis of obesity and related diseases.", {"entities": [[54, 61, "DISEASE"]]}], ["To date, whether environmental exposure to metallic elements has effects on obesity in children and adolescents is still unclear.", {"entities": [[76, 83, "DISEASE"]]}], ["The aim of the current study was to investigate the association of blood metallic elements with obesity in U.S. children and adolescents.", {"entities": [[96, 103, "DISEASE"]]}], ["This cross-sectional study was performed with 5404 children and adolescents (6\u201319 years, 2745 males and 2659 females) who participated in the US National Health and Nutrition Examination Survey 2011\u20132014.", {"entities": []}], ["Blood lead, mercury, selenium, manganese, copper, and zinc, as well as biochemical parameters including triglyceride (TG), cholesterol, low-density lipoprotein (LDL), and homeostasis model assessment of insulin resistance (HOMA-IR) were assessed for all subjects.", {"entities": [[118, 120, "GENE"]]}], ["Multivariate logistic regression and linear regression were applied to assess associations of metallic elements and overweight, obesity status, and serum metabolites as distinct outcomes adjusted for age, gender, ethnicity, and the poverty income ratio.", {"entities": [[128, 135, "DISEASE"]]}], ["When stratified by age and sex, significant associations were found between the highest quartile of copper concentrations in blood with obesity status (OR = 9.27, 95% CI: 5.43, 15.82, p for trend < 0.001) and cholesterol (OR = 3.08, 95% CI: 1.43, 6.63, p for trend < 0.001).", {"entities": [[136, 143, "DISEASE"]]}], ["The highest concentrations of manganese in the blood was associated with obesity in those aged 6\u201319 years (OR = 2.29, 95% CI: 1.74, 3.02, p for trend < 0.001).", {"entities": [[73, 80, "DISEASE"]]}], ["Moreover, blood mercury and selenium showed positive relationships with cholesterol.", {"entities": []}], ["Further, a negative association existed between blood zinc and obesity.", {"entities": [[63, 70, "DISEASE"]]}], ["The National Health and Nutrition Examination Survey data provide epidemiological evidence that blood metallic elements are positively associated with obesity in children and adolescents.", {"entities": [[151, 158, "DISEASE"]]}], ["However, the underlying mechanisms still need further exploration.", {"entities": []}], ["Human bronchial smooth muscle cells (HBSMC) may regulate airway inflammation by secreting cytokines, chemokines and growth factors.", {"entities": []}], ["The neurotrophins, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), have been shown to be elevated during airway inflammation and evoke airway hyperresponsiveness.", {"entities": [[50, 53, "GENE"], [91, 95, "GENE"]]}], ["We studied if HBSMC may be a source of NGF, BDNF and NT-3, and if so, how inflammatory cytokines may influence their production.", {"entities": [[39, 42, "GENE"], [44, 48, "GENE"]]}], ["Basal and cytokine (IL-1\u03b2, IFN-\u03b3, IL-4)-stimulated neurotrophin expression in HBSMC cultured in vitro was quantified.", {"entities": []}], ["The mRNA expression was quantified by real-time RT-PCR and the protein secretion into the cell culture medium by ELISA.", {"entities": []}], ["We observed a constitutive NGF, BDNF and NT-3 expression.", {"entities": [[27, 30, "GENE"], [32, 36, "GENE"]]}], ["IL-1\u03b2 stimulated a transient increase of NGF, while the increase of BDNF had a later onset and was more sustained.", {"entities": [[41, 44, "GENE"], [68, 72, "GENE"]]}], ["COX-inhibitors (indomethacin and NS-398) markedly decreased IL-1\u03b2-stimulated secretion of BDNF, but not IL-1\u03b2-stimulated NGF secretion.", {"entities": [[90, 94, "GENE"], [121, 124, "GENE"]]}], ["IFN-\u03b3 increased NGF expression, down-regulated BDNF expression and synergistically enhanced IL-1\u03b2-stimulated NGF expression.", {"entities": [[16, 19, "GENE"], [109, 112, "GENE"], [47, 51, "GENE"], [16, 19, "GENE"], [109, 112, "GENE"]]}], ["In contrast, IL-4 had no effect on basal NGF and BDNF expression, but decreased IL-1\u03b2-stimulated NGF expression.", {"entities": [[41, 44, "GENE"], [97, 100, "GENE"], [49, 53, "GENE"], [41, 44, "GENE"], [97, 100, "GENE"]]}], ["NT-3 was not altered by the tested cytokines.", {"entities": []}], ["Taken together, our data indicate that, in addition to the contractile capacity, HBSMC can express NGF, BDNF and NT-3.", {"entities": [[99, 102, "GENE"], [104, 108, "GENE"]]}], ["The expression of these neurotrophins may be differently regulated by inflammatory cytokines, suggesting a dynamic interplay that might have a potential role in airway inflammation.", {"entities": []}], ["Isocyanates are the most significant cause of occupational asthma in our country.", {"entities": [[59, 65, "DISEASE"]]}], ["To evaluate the prevalence of work-related respiratory symptoms and immunologic sensitization to it, we performed a questionnaire survey, allergy skin test, radioallergosorbent test (RAST) to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate and methacholine bronchial challenge test on 23 isocyanate-exposed employees and 9 unexposed controls working in a zipper factory.", {"entities": []}], ["Six employees (26.1%) complained of work-related respiratory symptoms and three symptomatic workers showed significant bronchoconstrictions on TDI-bronchoprovocation test.", {"entities": []}], ["Three (13%) asymptomatic workers had high specific IgE antibodies to TDI-HSA and none of the TDI-sensitive asthmatic workers had specific IgE antibody.", {"entities": []}], ["One of the TDI-sensitive asthmatic workers showed a negative result on the initial methacholine bronchial challenge test, but bronchial hyperresponsiveness developed after the TDI challenge.", {"entities": []}], ["It was suggested that TDI-sensitive asthma was noted in three (13%) of 23 exposed workers and that asymptomatic workers could have high specific IgE antibody.", {"entities": [[36, 42, "DISEASE"]]}], ["Measurement of the changes in bronchial hyperresponsiveness after the TDI challenge could be helpful to diagnose TDI-sensitive asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["Concurrent diseases, multiple pathologies and multimorbidity patterns are topics of increased interest as the world\u2019s population ages.", {"entities": []}], ["To explore the impact of multimorbidity on affected patients and the consequences for health services, we designed a study to describe multimorbidity by sex and life-stage in a large population sample and to assess the association with acute morbidity, area of residency and use of health services.", {"entities": []}], ["A cross-sectional study was conducted in Catalonia (Spain).", {"entities": []}], ["Participants were 1,749,710 patients aged 19+ years (251 primary care teams).", {"entities": []}], ["Primary outcome: Multimorbidity (\u22652 chronic diseases).", {"entities": []}], ["Secondary outcome: Number of new events of each acute disease.", {"entities": []}], ["Other variables: number of acute diseases per patient, sex, age group (19\u201324, 25\u201344, 45\u201364, 65\u201379, and 80+ years), urban/rural residence, and number of visits during 2010.", {"entities": []}], ["Multimorbidity was present in 46.8% (95% CI, 46.7%-46.8%) of the sample, and increased as age increased, being higher in women and in rural areas.", {"entities": []}], ["The most prevalent pair of chronic diseases was hypertension and lipid disorders in patients older than 45 years.", {"entities": [[48, 60, "DISEASE"]]}], ["Infections (mainly upper respiratory infection) were the most common acute diagnoses.", {"entities": []}], ["In women, the highest significant RR of multimorbidity vs. non-multimorbidity was found for teeth/gum disease (aged 19\u201324) and acute upper respiratory infection.", {"entities": []}], ["In men, this RR was only positive and significant for teeth/gum disease (aged 65\u201379).", {"entities": []}], ["The adjusted analysis showed a strongly positive association with multimorbidity for the oldest women (80+ years) with acute diseases and women aged 65\u201379 with 3 or more acute diseases, compared to patients with no acute diseases (OR ranged from 1.16 to 1.99, p < 0.001).", {"entities": []}], ["Living in a rural area was significantly associated with lower probability of having multimorbidity.", {"entities": []}], ["The odds of multimorbidity increased sharply as the number of visits increased, reaching the highest probability in those aged 65\u201379 years.", {"entities": []}], ["Multimorbidity is related to greater use of health care services and higher incidence of acute diseases, increasing the burden on primary care services.", {"entities": []}], ["The differences related to sex and life-stage observed for multimorbidity and acute diseases suggest that further research on multimorbidity should be stratified according to these factors.", {"entities": []}], ["The unprecedented global increase in the use of herbal remedies is set to continue apace well into the foreseeable future.", {"entities": []}], ["This raises important public health concerns, especially as it relates to safety issues including adverse effects and herb-drug interactions.", {"entities": []}], ["Most Western-trained physicians are ignorant of the risks and benefits of this healthcare modality and assessment of acceptance and knowledge would identify appropriate intervention strategies to improve physician-patient communication in this area.", {"entities": []}], ["A cross-sectional survey was done using an interviewer-administered pilot tested de novo questionnaire at six public hospitals in Trinidad between May\u2013July 2004.", {"entities": []}], ["The questionnaire utilized weighed questions to quantify acceptance (maximum score = 14 points) and knowledge (maximum score = 52 points).", {"entities": []}], ["Acceptance and knowledge scores were analyzed using the ANOVA and Tukey's tests.", {"entities": []}], ["Of 192 physicians interviewed, most (60.4%) believed that herbal remedies were beneficial to health.", {"entities": []}], ["Respondents had relatively high acceptance levels (mean = 5.69 \u00b1 0.29 points or 40% of total possible score) and poor knowledge (mean = 7.77 \u00b1 0.56 points or 15% of total possible score).", {"entities": []}], ["Seventy-eight physicians (40.6%) admitted having used herbs in the past, and 60 of these (76.9%) were satisfied with the outcome.", {"entities": []}], ["Although 52 physicians (27.1%) recommended the use of herbs to their patients only 29 (15.1%) were able to identify at least one known herb-drug interaction.", {"entities": []}], ["The use of herbal remedies is relatively high in Trinidad, as throughout the world, and most patients self-medicate with or without the knowledge of their attending physician.", {"entities": []}], ["Surprisingly, we demonstrated relatively high acceptance levels and use of herbs among physicians in Trinidad.", {"entities": []}], ["This interesting scenario of high acceptance levels and poor knowledge creates a situation that demands urgent intervention.", {"entities": []}], ["We recommend educational intervention to narrow the gap between acceptance and knowledge so that physicians would be adequately equipped to communicate with their patients on this modality.", {"entities": []}], ["The integration of herbal medicine into the curriculum of medical schools, continuing education programs and the availability of reputable pharmacopoeias for referencing at public health institutions are useful instruments that can be used to close this gap and promote improved physician-patient communication.", {"entities": []}], ["Recently, a 24-h impedance was used to detect laryngopharyngeal reflux (LPR).", {"entities": []}], ["However, not every case of LPR is pathological.", {"entities": []}], ["Thus, pathological pharyngeal impedance values need to be clearly established to diagnose pathological LPR.", {"entities": []}], ["The aim of our study was to establish pathological 24-h pharyngoesophageal impedance/pH values for the diagnosis of LPR.", {"entities": []}], ["The study was conducted in a tertiary care setting.", {"entities": []}], ["A total of 30 patients who were referred to microlaryngoscopy for a laryngeal pathology that might be caused by LPR were included in this prospective study.", {"entities": []}], ["All patients were off proton-pump inhibitor therapy.", {"entities": []}], ["The 24-h pharyngoesophageal impedance\u2013pH monitoring was performed 1 day before surgery.", {"entities": []}], ["A biopsy of laryngeal tissue was obtained during microlaryngoscopy and was analyzed by immunohistochemistry to detect pepsin.", {"entities": []}], ["The patients were divided into two groups: pepsin negative and pepsin positive (which indicated pathological LPR).", {"entities": []}], ["The results of 24-h multichannel intraluminal impedance\u2013dual-channel pH monitoring were compared between the groups.", {"entities": []}], ["The number of LPR episodes in the pepsin-positive group was analyzed to establish a cutoff value for pathological LPR.", {"entities": []}], ["There were 18 participants in the pepsin-negative group and 12 in the pepsin-positive group.", {"entities": []}], ["The median total pharyngeal refluxes detected were two (0\u20135) in the pepsin-negative group and 14 (6\u201339) in the pepsin-positive group ( P <0.001), although the groups were otherwise homogeneous.", {"entities": []}], ["There was a statistically significant difference in the number of all types of refluxes between groups.", {"entities": []}], ["Six or more pharyngeal refluxes were the cutoff for the presence of pepsin in the laryngeal mucosa and, thereby, for the diagnosis of relevant/pathological LPR.", {"entities": []}], ["Six or more pharyngeal reflux episodes registered during the 24-h impedance/pH monitoring seem to be the cutoff for diagnosing pathological LPR.", {"entities": []}], ["Therefore, it is possible to suggest establishing this value as the pathological impedance value indicating pathological LPR.", {"entities": []}], ["These results must be interpreted with caution due to the small sample size.", {"entities": []}], ["Pain is an enormous problem globally.", {"entities": []}], ["Estimates suggest that 20% of adults suffer from pain globally and 10% are newly diagnosed with chronic pain each year.", {"entities": []}], ["Nevertheless, the problem of pain has primarily been regarded as a medical problem, and has been little addressed by the field of public health.", {"entities": []}], ["Despite the ubiquity of pain, whether acute, chronic or intermittent, public health scholars and practitioners have not addressed this issue as a public health problem.", {"entities": []}], ["The importance of viewing pain through a public health lens allows one to understand pain as a multifaceted, interdisciplinary problem for which many of the causes are the social determinants of health.", {"entities": []}], ["Addressing pain as a global public health issue will also aid in priority setting and formulating public health policy to address this problem, which, like most other chronic non-communicable diseases, is growing both in absolute numbers and in its inequitable distribution across the globe.", {"entities": []}], ["The prevalence, incidence, and vast social and health consequences of global pain requires that the public health community give due attention to this issue.", {"entities": []}], ["Doing so will mean that health care providers and public health professionals will have a more comprehensive understanding of pain and the appropriate public health and social policy responses to this problem.", {"entities": []}], ["Numerous studies have found adverse health effects of acute and chronic exposure to fine particulate matter (PM 2.5 ).", {"entities": []}], ["Air pollution epidemiological studies relying on ground measurements provided by monitoring networks are often limited by sparse and unbalanced spatial distribution of the monitors.", {"entities": []}], ["Studies have found correlations between satellite aerosol optical depth (AOD) and PM 2.5 in some land regions.", {"entities": []}], ["Satellite aerosol data may be used to extend the spatial coverage of PM 2.5 exposure assessment.", {"entities": []}], ["This study was to investigate correlation between PM 2.5 and AOD in the conterminous USA, to derive a spatially complete PM 2.5 surface by merging satellite AOD data and ground measurements based on the potential correlation, and to examine if there is an association of coronary heart disease with PM 2.5 .", {"entities": [[280, 293, "DISEASE"], [271, 293, "DISEASE"]]}], ["Years 2003 and 2004 daily MODIS (Moderate Resolution Imaging Spectrometer) Level 2 AOD images were collated with US EPA PM 2.5 data covering the conterminous USA.", {"entities": []}], ["Pearson's correlation analysis and geographically weighted regression (GWR) found that the relationship between PM 2.5 and AOD is not spatially consistent across the conterminous states.", {"entities": []}], ["The average correlation is 0.67 in the east and 0.22 in the west.", {"entities": []}], ["GWR predicts well in the east and poorly in the west.", {"entities": []}], ["The GWR model was used to derive a PM 2.5 grid surface using the mean AOD raster calculated using the daily AOD data (RMSE = 1.67 \u03bcg/m 2.5 with age-race standardized mortality rates (SMRs) of chronic coronary heart disease found that areas with higher values of PM 2.5 also show high rates of CCHD mortality: = 0.802, posterior 95% Bayesian credible interval (CI) = (0.386, 1.225).", {"entities": [[209, 222, "DISEASE"], [200, 222, "DISEASE"]]}], ["There is a spatial variation of the relationship between PM 2.5 and AOD in the conterminous USA.", {"entities": []}], ["In the eastern USA where AOD correlates well with PM 2.5 , AOD can be merged with ground PM 2.5 data to derive a PM 2.5 surface for epidemiological study.", {"entities": []}], ["The study found that chronic coronary heart disease mortality rate increases with exposure to PM 2.5 .", {"entities": [[38, 51, "DISEASE"], [29, 51, "DISEASE"]]}], ["As health systems find ways to improve quality of care, medical training programs are finding opportunities to prepare learners on principles of quality improvement (QI).", {"entities": []}], ["The impact of QI curricula for medical students as measured by student learning is not well delineated.", {"entities": []}], ["The aim of this study is to evaluate the effectiveness of a QI curriculum for senior medical students as measured by student knowledge and skills.", {"entities": []}], ["This study was an observational study that involved a self-assessment and post-test Quality Improvement Knowledge Application Tool (QIKAT) for intervention and control students.", {"entities": []}], ["A QI curriculum consisting of online modules, live discussions, independent readings and reflective writing, and participation in a mentored QI project was offered to fourth-year medical students completing an honor's elective (intervention group).", {"entities": []}], ["Senior medical students who received the standard QI curriculum only were recruited as controls.", {"entities": []}], ["A total of 22 intervention students and 12 control students completed the self-assessment and QIKAT.", {"entities": []}], ["At baseline, there was no difference between groups in self-reported prior exposure to QI principles.", {"entities": []}], ["Students in the intervention group reported more comfort with their skills in QI overall and in 9 of the 12 domains (p<0.05).", {"entities": []}], ["Additionally, intervention students performed better in each of the three case scenarios (p<0.01).", {"entities": []}], ["A brief QI curriculum for senior medical students results in improved comfort and knowledge with QI principles.", {"entities": []}], ["The strengths of our curriculum include effective use of classroom time and faculty mentorship with reliance on pre-existing online modules and written resources.", {"entities": []}], ["Additionally, the curriculum is easily expandable to larger groups of students and transferable to other institutions.", {"entities": []}], ["Despite the availability of effective prophylactic and therapeutic measures, influenza remains one of the most important infectious disease threats to the human population.", {"entities": [[77, 86, "DISEASE"]]}], ["Every year, seasonal influenza epidemics infect up to 30% of the population; a relevant portion of the ill are hospitalized, and more than a marginal number die.", {"entities": [[21, 30, "DISEASE"]]}], ["In an attempt to reduce the medical, social and economic burden of influenza, vaccines are recommended by many health authorities worldwide.", {"entities": [[67, 76, "DISEASE"]]}], ["However, not all countries have a national program for influenza immunization.", {"entities": [[55, 64, "DISEASE"]]}], ["The main aim of this paper is to list the differences among influenza immunization policies of various countries, highlighting the most important scientific reasons that may have led health authorities to make different decisions.", {"entities": [[60, 69, "DISEASE"]]}], ["The manuscript highlights that national influenza immunization policies can vary significantly from country to country.", {"entities": [[40, 49, "DISEASE"]]}], ["These differences arise from insufficient evidence of the relevance of influenza infection from a clinical, social and economic point of view.", {"entities": [[71, 80, "DISEASE"]]}], ["The lack of precise data on the true frequency and clinical relevance of influenza infection makes it nearly impossible to establish the economic burden of influenza.", {"entities": [[73, 82, "DISEASE"], [156, 165, "DISEASE"]]}], ["Moreover, it remains very difficult to evaluate the efficacy of the different influenza vaccines and whether their use is cost-effective considering the various types of people receiving them and the indirect advantages.", {"entities": [[78, 87, "DISEASE"]]}], ["Disparities among countries will be overcome only when more reliable data regarding all these aspects of influenza infection, particularly those related to the true impact of the disease, are precisely defined.", {"entities": [[105, 114, "DISEASE"]]}], ["Patients with asthma suffer from dyspnea, cough, wheeze in their daily life and this may be by stress and anxiety.", {"entities": [[14, 20, "DISEASE"]]}], ["Massage may promote relaxation and relieve symptom.", {"entities": []}], ["Thus, it is appropriate to explore the effectiveness of massage on symptom in patients with asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["This study was a randomized-controlled trial that was performed in the Immunology and Allergy Clinics of Tabriz University of Medical Sciences, Iran.", {"entities": []}], ["60 children with allergic asthma of 6\u201312 year\u2013old were invited to participate in this study; only 58 of them agreed.", {"entities": [[17, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["They were divided into two groups at random.", {"entities": []}], ["Subjects in the massage therapy group received a 30 minute massage therapy by their parents at home before bedtime every night for 4 weeks in addition to the standard asthma treatment.", {"entities": [[167, 173, "DISEASE"]]}], ["The control group received the standard asthma treatment alone for 4 weeks.", {"entities": [[40, 46, "DISEASE"]]}], ["Both groups were given a diary notes to monitor symptoms.", {"entities": []}], ["The results of this study showed that symptom Scores in massage group were improved significantly compared with control group, and the rate of dyspnea, cough and wheeze in the experimental group than the control group were reduced by approximately 45%, 56% and 52%.", {"entities": []}], ["The findings suggest that massage might reduce anxiety in patient with asthma and may have a beneficial effect on symptoms of asthma, such as dyspnea, cough, and wheeze.", {"entities": [[71, 77, "DISEASE"], [126, 132, "DISEASE"]]}], ["Therefore can be used as a nursing education for parents to improve dyspnea in children with asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["Per a 9 is a major allergen of the American cockroach (CR), which has been recognized as an important cause of imunoglobulin E-mediated type I hypersensitivity worldwide.", {"entities": []}], ["However, it is not neasy to obtain a substantial quantity of this allergen for use in functional studies.", {"entities": []}], ["In the present study, the Per a 9 gene was cloned and expressed in Escherichia coli ( E. coli ) systems.", {"entities": []}], ["It was found that 13/16 (81.3%) of the sera from patients with allergies caused by the American CR reacted to Per a 9, as assessed by enzyme-linked immunosorbent assay, confirming that Per a 9 is a major allergen of CR.", {"entities": []}], ["The induction of the expression of CD63 and CCR3 in passively sensitized basophils (from sera of patients with allergies caused by the American CR) by approximately 4.2-fold indicated that recombinant Per a 9 was functionally active.", {"entities": [[35, 39, "GENE"], [44, 48, "GENE"]]}], ["Three immunoinformatics tools, including the DNASTAR Protean system, Bioinformatics Predicted Antigenic Peptides (BPAP) system and the BepiPred 1.0 server were used to predict the potential B cell epitopes, while Net-MHCIIpan-2.0 and NetMHCII-2.2 were used to predict the T cell epitopes of Per a 9.", {"entities": []}], ["As a result, we predicted 11 peptides (23\u201328, 39\u201346, 58\u201364, 91\u2013118, 131\u2013136, 145\u2013154, 159\u2013165, 176\u2013183, 290\u2013299, 309\u2013320 and 338\u2013344) as potential B cell linear epitopes.", {"entities": []}], ["In T cell prediction, the Per a 9 allergen was predicted to have 5 potential T cell epitope sequences, 119\u2013127, 194\u2013202, 210\u2013218, 239\u2013250 and 279\u2013290.", {"entities": []}], ["The findings of our study may prove to be useful in the development of peptide-based vaccines to combat CR-induced allergies.", {"entities": []}], ["Epidemiological studies have clarified the potential associations between regular aspirin use and cancers.", {"entities": []}], ["However, it remains controversial on whether aspirin use decreases the risk of cancers risks.", {"entities": []}], ["Therefore, we conducted an updated meta-analysis to assess the associations between aspirin use and cancers.", {"entities": []}], ["The PubMed, Embase, and Web of Science databases were systematically searched up to March 2017 to identify relevant studies.", {"entities": []}], ["Relative risks (RRs) with 95% confidence intervals (CIs) were used to assess the strength of associations.", {"entities": []}], ["A total of 218 studies with 309 reports were eligible for this meta-analysis.", {"entities": []}], ["Aspirin use was associated with a significant decrease in the risk of overall cancer (RR\u2009=\u20090.89, 95% CI: 0.87\u20130.91), and gastric (RR\u2009=\u20090.75, 95% CI: 0.65\u20130.86), esophageal (RR\u2009=\u20090.75, 95% CI: 0.62\u20130.89), colorectal (RR\u2009=\u20090.79, 95% CI: 0.74\u20130.85), pancreatic (RR\u2009=\u20090.80, 95% CI: 0.68\u20130.93), ovarian (RR\u2009=\u20090.89, 95% CI: 0.83\u20130.95), endometrial (RR\u2009=\u20090.92, 95% CI: 0.85\u20130.99), breast (RR\u2009=\u20090.92, 95% CI: 0.88\u20130.96), and prostate (RR\u2009=\u20090.94, 95% CI: 0.90\u20130.99) cancers, as well as small intestine neuroendocrine tumors (RR\u2009=\u20090.17, 95% CI: 0.05\u20130.58).", {"entities": [[78, 84, "DISEASE"]]}], ["These findings suggest that aspirin use is associated with a reduced risk of gastric, esophageal, colorectal, pancreatic, ovarian, endometrial, breast, and prostate cancers, and small intestine neuroendocrine tumors.", {"entities": []}], ["The online version of this article (10.1186/s12885-018-4156-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Motivation: Increased availability of various genotyping techniques has initiated a race for finding genetic markers that can be used in diagnostics and personalized medicine.", {"entities": []}], ["Although many genetic risk factors are known, key causes of common diseases with complex heritage patterns are still unknown.", {"entities": []}], ["Identification of such complex traits requires a targeted study over a large collection of data.", {"entities": []}], ["Ideally, such studies bring together data from many biobanks.", {"entities": []}], ["However, data aggregation on such a large scale raises many privacy issues.", {"entities": []}], ["Results: We show how to conduct such studies without violating privacy of individual donors and without leaking the data to third parties.", {"entities": []}], ["The presented solution has provable security guarantees.", {"entities": []}], ["Contact: jaak.vilo@ut.ee Supplementary information: Supplementary data are available at Bioinformatics online.", {"entities": []}], ["It has been shown that inter-individual variation in host response to porcine reproductive and respiratory syndrome (PRRS) has a heritable component, yet little is known about the underlying genetic architecture of gene expression in response to PRRS virus (PRRSV) infection.", {"entities": [[107, 115, "DISEASE"]]}], ["Here, we integrated genome-wide genotype, gene expression, viremia level, and weight gain data to identify genetic polymorphisms that are associated with variation in inter-individual gene expression and response to PRRSV infection in pigs.", {"entities": []}], ["RNA-seq analysis of peripheral blood samples collected just prior to experimental challenge (day 0) and at 4, 7, 11 and 14 days post infection from 44 pigs revealed 6,430 differentially expressed genes at one or more time points post infection compared to the day 0 baseline.", {"entities": []}], ["We mapped genetic polymorphisms that were associated with inter-individual differences in expression at each day and found evidence of cis- acting expression quantitative trait loci ( cis- eQTL) for 869 expressed genes (qval\u2009<\u20090.05).", {"entities": []}], ["Associations between cis -eQTL markers and host response phenotypes using 383 pigs suggest that host genotype-dependent differences in expression of GBP5, GBP6, CCHCR1 and CMPK2 affect viremia levels or weight gain in response to PRRSV infection.", {"entities": [[149, 153, "GENE"], [155, 159, "GENE"], [161, 167, "GENE"], [172, 177, "GENE"]]}], ["Neutrophil elastase, metalloproteinases, and their inhibitors play an important role in the development of chronic obstructive pulmonary disease (COPD), resulting in extensive tissue damage and malfunctioning of the airways.", {"entities": [[107, 144, "DISEASE"]]}], ["Nearly fifty years after the protease-antiprotease imbalance hypothesis has been suggested for the cause of emphysema, it is still appealing, but it does not explain the considerable variation in the clinical expressions of emphysema.", {"entities": []}], ["However, there are many recent research findings to support the imbalance hypothesis as will be shown in this review.", {"entities": []}], ["Although limited, there might be openings for the treatment of the disease.", {"entities": []}], ["Immediate-type hypersensitivity to glucocorticosteroids is rare but well known among allergists.", {"entities": []}], ["Surprisingly, very few reports of glucocorticosteroid hypersensitivity in children exist although glucocorticosteroid treatment is particularly common in this age group.", {"entities": []}], ["We report the case of a 2-year-old boy who developed generalized urticaria, facial angio-oedema, nausea and severe dyspnoea after intravenous application of prednisolone-21-hydrogen succinate.", {"entities": [[65, 74, "DISEASE"]]}], ["Skin prick testing with prednisolone-21-hydrogen succinate elicited a positive result; no reactions were observed to prednisone, betamethasone or dexamethasone.", {"entities": []}], ["While fluorescence enzyme immunoassay analysis revealed no specific IgE antibodies against prednisolone-21-hydrogen succinate, CD63-based basophil activation testing with the culprit drug prednisolone-21-hydrogen succinate was positive.", {"entities": []}], ["In contrast, additional incubation of basophils with prednisone, betamethasone and dexamethasone did not elicit any significant response.", {"entities": []}], ["Hence, we performed an oral provocation test with betamethasone and a titrated intravenous dexamethasone challenge.", {"entities": []}], ["As both drugs were tolerated without any complications they were recommended for future treatment.", {"entities": []}], ["In a child with confirmed immediate-type hypersensitivity to glucocorticosteroids, it is still not possible to predict which glucocorticosteroid might be tolerated by solely relying on clinical history or results of skin and in vitro testing.", {"entities": []}], ["Therefore, incremental glucocorticosteroid challenges under standardized clinical conditions remain necessary in order to facilitate a patient-tailored emergency treatment and to avoid severe reactions to glucocorticosteroids in these patients.", {"entities": []}], ["This paper uses a framework developed for gender and tropical diseases for the analysis of non-communicable diseases and conditions in developing and industrialized countries.", {"entities": []}], ["The framework illustrates that gender interacts with the social, economic and biological determinants and consequences of tropical diseases to create different health outcomes for males and females.", {"entities": []}], ["Whereas the framework was previously limited to developing countries where tropical infectious diseases are more prevalent, the present paper demonstrates that gender has an important effect on the determinants and consequences of health and illness in industrialized countries as well.", {"entities": []}], ["This paper reviews a large number of studies on the interaction between gender and the determinants and consequences of chronic diseases and shows how these interactions result in different approaches to prevention, treatment, and coping with illness.", {"entities": []}], ["Specific examples of chronic diseases are discussed in each section with respect to both developing and industrialized countries.", {"entities": []}], ["Severity scores including the Simplified Acute Physiology Score (SAPS) II and the Sequential Organ Failure Assessment (SOFA) score are used in intensive care units (ICUs) to assess disease severity, predict mortality and in research.", {"entities": []}], ["We aimed to assess the predictive performance of SAPS II and the initial SOFA score for in-hospital and 90-day mortality in a contemporary international cohort.", {"entities": []}], ["This was a post-hoc study of the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) inception cohort study, which included acutely ill adults from ICUs across 11 countries (n = 1034).", {"entities": []}], ["We compared the discrimination of SAPS II and initial SOFA scores, compared the discrimination of SAPS II in our cohort with the original cohort, assessed the calibration of SAPS II customised to our cohort, and compared the discrimination for 90-day mortality vs. in-hospital mortality for both scores.", {"entities": []}], ["Discrimination was evaluated using areas under the receiver operating characteristics curves (AUROC).", {"entities": []}], ["Calibration was evaluated using Hosmer-Lemeshow\u2019s goodness-of-fit \u0108-statistic.", {"entities": []}], ["AUROC for in-hospital mortality was 0.80 (95% confidence interval (CI) 0.77\u20130.83) for SAPS II and 0.73 (95% CI 0.69\u20130.76) for initial SOFA score (P<0.001 for the comparison).", {"entities": []}], ["Calibration of the customised SAPS II for predicting in-hospital mortality was adequate (P = 0.60).", {"entities": []}], ["Discrimination of SAPS II was reduced compared with the original SAPS II validation sample (AUROC 0.80 vs. 0.86; P = 0.001).", {"entities": []}], ["AUROC for 90-day mortality was 0.79 (95% CI 0.76\u20130.82; P = 0.74 for comparison with in-hospital mortality) for SAPS II and 0.71 (95% CI 0.68\u20130.75; P = 0.66 for comparison with in-hospital mortality) for the initial SOFA score.", {"entities": []}], ["The predictive performance of SAPS II was similar for in-hospital and 90-day mortality and superior to that of the initial SOFA score, but SAPS II\u2019s performance has decreased over time.", {"entities": []}], ["Use of a contemporary severity score with improved predictive performance may be of value.", {"entities": []}], ["Tuberculosis (TB) is a serious health concern, particularly in developing countries.", {"entities": []}], ["Various delays, such as patient delay (PD) and healthcare system delay (HSD) in the TB process, are exacerbating the disease burden and increasing the rates of transmission and mortality in various global communities.", {"entities": []}], ["Therefore, the aim of this study is to identify risk factors associated with PD and HSD in TB patients in Tabriz, Iran.", {"entities": []}], ["A cross-sectional study was conducted on 173\u00a0TB patients in Tabriz, Iran from 2012 to 2014.", {"entities": []}], ["Patients were interviewed with a semi-structured questionnaire.", {"entities": []}], ["Frequencies and percentages were reported for patient categories of sex, age, and education.", {"entities": []}], ["The median and interquartile range (IQR) were reported for the time intervals of delays.", {"entities": []}], ["Univariate and multivariate logistic regressions of delay in respect to socio-demographic and clinical variables were performed.", {"entities": []}], ["Statistical significance was set at p \u2009<\u20090.05.", {"entities": []}], ["The median values for delays were 53\u00a0days for HSD (IQR\u2009=\u200973) and 13\u00a0days for PD (IQR\u2009=\u200957).", {"entities": []}], ["Odds ratios (OR) associated with PD were: employed vs. unemployed (OR\u2009=\u20095.86, 95% CI: 1.59 to 21.64); public hospitals vs. private hospitals (OR\u2009=\u20092.64, 95% CI: 1.01 to 6.85); \u2265\u20093 vs. <\u20093 visits to health facilities before correct diagnosis (OR\u2009=\u20092.35, 95% CI: 1.08 to 5.11); and male vs. female (OR\u2009=\u20092.28, 95% CI: 1.29 to 4.39).", {"entities": []}], ["The OR associated with HSD were: \u2265\u20093 vs. <\u20093 visits to health facilities before correct diagnosis (OR\u2009=\u20099.44, 95% CI: 4.50 to 19.82), without vs. with access to TB diagnostic services (OR\u2009=\u20093.56, 95% CI: 1.85 to 6.83), and misdiagnosis as cold or viral infection vs. not (OR\u2009=\u20092.62, 95% CI: 1.40 to 4.91).", {"entities": []}], ["The results provide for an important understanding of the risk factors associated with PD and HSD.", {"entities": []}], ["One of the major recommendations is to provide more TB diagnostic knowledge and tools to primary health providers and correct diagnoses for patients during their initial visit to the health care facilities.", {"entities": []}], ["The knowledge generated from this study will be helpful for prioritizing and developing strategies for minimizing delays, initiating early treatment to TB patients, and improving TB-related training programs and healthcare systems in Tabriz, Iran.", {"entities": []}], ["mHealth is enjoying considerable interest and private investment in the United States.", {"entities": []}], ["A small but growing body of evidence indicates some promise in supporting healthy behavior change and self-management of long-term conditions.", {"entities": []}], ["The unique benefits mobile phones bring to health initiatives, such as direct access to health information regardless of time or location, may create specific issues for the implementation of such initiatives.", {"entities": []}], ["Other issues may be shared with general health information technology developments.", {"entities": []}], ["To determine the important issues facing the implementation of mHealth from the perspective of those within the US health system and those working in mHealth in the United States.", {"entities": []}], ["Semistructured interviews were conducted with 27 key informants from across the health and mHealth sectors in the United States.", {"entities": []}], ["Interviewees were approached directly following an environmental scan of mHealth in the United States or recommendation by those working in mHealth.", {"entities": []}], ["The most common issues were privacy and data security, funding, a lack of good examples of the efficacy and cost effectiveness of mHealth in practice, and the need for more high-quality research.", {"entities": []}], ["The issues are outlined and categorized according to the environment within which they predominantly occur: policy and regulatory environments; the wireless industry; the health system; existing mHealth practice; and research.", {"entities": []}], ["Many of these issues could be addressed by making the most of the current US health reform environment, developing a strategic and coordinated approach, and seeking to improve mHealth practice.", {"entities": []}], ["In animal models, resident memory CD8+ T (Trm) cells assist in respiratory virus elimination but their importance in man has not been determined.", {"entities": []}], ["Here, using experimental human respiratory syncytial virus (RSV) infection, we investigate systemic and local virus-specific CD8+ T-cell responses in adult volunteers.", {"entities": []}], ["Having defined the immunodominance hierarchy, we analyse phenotype and function longitudinally in blood and by serial bronchoscopy.", {"entities": []}], ["Despite rapid clinical recovery, we note surprisingly extensive lower airway inflammation with persistent viral antigen and cellular infiltrates.", {"entities": []}], ["Pulmonary virus-specific CD8+ T cells display a CD69+CD103+ Trm phenotype and accumulate to strikingly high frequencies into convalescence without continued proliferation.", {"entities": []}], ["While these have a more highly differentiated phenotype, they express fewer cytotoxicity markers than in blood.", {"entities": []}], ["Nevertheless, their abundance before infection correlates with reduced symptoms and viral load, implying that CD8+ Trm cells in the human lung can confer protection against severe respiratory viral disease when humoral immunity is overcome.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections.", {"entities": []}], ["Here the authors analyse cellular immune responses of individuals experimentally infected with RSV and reveal the presence of high frequencies of virus- specific resident memory CD8", {"entities": []}], ["To address the role of Toll-like receptor 4 (TLR4) single nucleotide polymorphisms (SNP) in lipopolysaccharide (LPS) recognition, we generated mice that differed only in the sequence of TLR4.", {"entities": [[45, 49, "GENE"], [186, 190, "GENE"], [45, 49, "GENE"], [186, 190, "GENE"]]}], ["We used a bacterial artificial chromosome (BAC) transgenic approach and TLR4/MD-2 knockout mice to specifically examine the role of human TLR4 variants in recognition of LPS.", {"entities": [[72, 76, "GENE"], [138, 142, "GENE"]]}], ["Using in vitro and in vivo assays we found that the expression level rather than the sequence of TLR4 played a larger role in recognition of LPS, especially hypoacylated LPS.", {"entities": [[97, 101, "GENE"]]}], ["Exposure to cold temperatures is, often, a neglected problem in prehospital care.", {"entities": []}], ["One of the leading influences of the overall sensation of cold discomfort is the cooling of the back.", {"entities": []}], ["The aim of this study was to evaluate the effect of a heated ambulance mattress-prototype on body temperatures and thermal comfort in an experimental study.", {"entities": []}], ["Data were collected during four days in November, 2011 inside and outside of a cold chamber.", {"entities": []}], ["All participants (n\u2009=\u200923) participated in two trials each.", {"entities": []}], ["In one trial, they were lying on a stretcher with a supplied heated mattress and in the other trial without a heated mattress.", {"entities": []}], ["Outcomes were back temperature, finger temperature, core body temperature, Cold Discomfort Scale (CDS), four statements from the state-trait anxiety \u2013 inventory (STAI), and short notes of their experiences of the two mattresses.", {"entities": []}], ["Data were analysed both quantitatively and qualitatively.", {"entities": []}], ["A repeated measure design was used to evaluate the effect of the two mattresses.", {"entities": []}], ["A statistical difference between the regular mattress and the heated mattress was found in the back temperature.", {"entities": []}], ["In the heated mattress trial, the statement \u201cI am tense\u201d was fewer whereas the statements \u201cI feel comfortable\u201d, \u201cI am relaxed\u201d and \u201cI feel content\u201d were higher in the heated mattress trial.", {"entities": []}], ["The qualitative analyses of the short notes showed that the heated mattress, when compared to the unheated mattress, was experienced as warm, comfortable, providing security and was easier to relax on.", {"entities": []}], ["Heat supply from underneath the body results in increased comfort and may prevent hypothermia which is important for injured and sick patients in ambulance care.", {"entities": []}], ["Background and Aim.", {"entities": []}], ["Chemokine/receptor axis is a predominant actor of clinical disorders.", {"entities": []}], ["They are key factors of pathogenesis of almost all clinical situations including asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["Correspondingly, CXCL12 is involved in the immune responses.", {"entities": [[17, 23, "GENE"]]}], ["Therefore, this study was designed to explore the association between gene polymorphism at position +801 of CXCL12, known as SDF-1 \u03b1 3\u2032A, and susceptibility to asthma in Iranian patients.", {"entities": [[160, 166, "DISEASE"], [108, 114, "GENE"]]}], ["Material and Methods.", {"entities": []}], ["In this experimental study, samples were taken from 162 asthma patients and 189 healthy controls on EDTA.", {"entities": [[56, 62, "DISEASE"]]}], ["DNA was extracted and analyzed for CXCL12 polymorphisms using PCR-RLFP.", {"entities": [[35, 41, "GENE"]]}], ["The demographic information was also collected in parallel with the experimental part of the study by a questionnaire which was designed specifically for this study.", {"entities": []}], ["Our results indicated a significant difference ( P < 0.0001) between the A/A , A/G , and G/G genotypes and A and G alleles of polymorphisms at position +801 of CXCL12.", {"entities": [[160, 166, "GENE"]]}], ["We also showed an elevated level of CXCL12 circulating level in Iranian asthma patients.", {"entities": [[72, 78, "DISEASE"], [36, 42, "GENE"]]}], ["Conclusion.", {"entities": []}], ["Our findings suggest that SDF-1 \u03b1 3\u2032A (CXCL12) polymorphism plays a role in pathogenesis of asthma.", {"entities": [[92, 98, "DISEASE"], [39, 45, "GENE"]]}], ["It can also be concluded that circulatory level of CXCL12 presumably can be used as one of the pivotal biological markers in diagnosis of asthma.", {"entities": [[138, 144, "DISEASE"], [51, 57, "GENE"]]}], ["Older adults are susceptible to adverse effects from the concurrent use of medications and alcohol.", {"entities": []}], ["The aim of this study was to systematically review the prevalence of concurrent use of alcohol and alcohol-interactive (AI) medicines in older adults and associated adverse outcomes.", {"entities": []}], ["A systematic search was performed using MEDLINE (PubMed), Embase, Scopus and Web of Science (January 1990 to June 2016), and hand searching references of retrieved articles.", {"entities": []}], ["Observational studies reporting on the concurrent use of alcohol and AI medicines in the same or overlapping recall periods in older adults were included.", {"entities": []}], ["Two independent reviewers verified that studies met the inclusion criteria, critically appraised included studies and extracted relevant data.", {"entities": []}], ["A narrative synthesis is provided.", {"entities": []}], ["Twenty studies, all cross-sectional, were included.", {"entities": []}], ["Nine studies classified a wide range of medicines as AI using different medication compendia, thus resulting in heterogeneity across studies.", {"entities": []}], ["Three studies investigated any medication use and eight focused on psychotropic medications.", {"entities": []}], ["Based on the quality assessment of included studies, the most reliable estimate of concurrent use in older adults ranges between 21 and 35%.", {"entities": []}], ["The most reliable estimate of concurrent use of psychotropic medications and alcohol ranges between 7.4 and 7.75%.", {"entities": []}], ["No study examined longitudinal associations with adverse outcomes.", {"entities": []}], ["Three cross-sectional studies reported on falls with mixed findings, while one study reported on the association between moderate alcohol consumption and adverse drug reactions at hospital admission.", {"entities": []}], ["While there appears to be a high propensity for alcohol-medication interactions in older adults, there is a lack of consensus regarding what constitutes an AI medication.", {"entities": []}], ["An explicit list of AI medications needs to be derived and validated prospectively to quantify the magnitude of risk posed by the concurrent use of alcohol for adverse outcomes in older adults.", {"entities": []}], ["This will allow for risk stratification of older adults at the point of prescribing, and prioritise alcohol screening and brief alcohol interventions in high-risk groups.", {"entities": []}], ["The online version of this article (doi:10.1186/s12877-017-0532-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Broad-spectrum antimicrobials kill indiscriminately, a property that can lead to negative clinical consequences and an increase in the incidence of resistance.", {"entities": []}], ["Species-specific antimicrobials that could selectively kill pathogenic bacteria without targeting other species in the microbiome could limit these problems.", {"entities": []}], ["The pathogen genome presents an excellent target for the development of such antimicrobials.", {"entities": []}], ["In this study we report the design and evaluation of species-selective peptide nucleic acid (PNA) antibacterials.", {"entities": []}], ["Selective growth inhibition of B. subtilis , E. coli , K. pnuemoniae and S. enterica serovar Typhimurium in axenic or mixed culture could be achieved with PNAs that exploit species differences in the translation initiation region of essential genes.", {"entities": []}], ["Typhimurium-specific PNA targeting fts Z resulted in elongated cells that were not observed in E. coli , providing phenotypic evidence of the selectivity of PNA-based antimicrobials.", {"entities": []}], ["Analysis of the genomes of E. coli and S .", {"entities": []}], ["Typhimurium gave a conservative estimate of >150 PNA targets that could potentially discriminate between these two closely related species.", {"entities": []}], ["This work provides a basis for the development of a new class of antimicrobial with a tuneable spectrum of activity.", {"entities": []}], ["Type 1 diabetes is caused by the destruction of insulin producing beta cells by the immune system.", {"entities": []}], ["The p110\u03b4 isoform of PI3K is expressed primarily in cells of haematopoietic origin and the catalytic activity of p110\u03b4 is important for the activation of these cells.", {"entities": []}], ["Targeting of this pathway offers an opportunity to reduce immune cell activity without unwanted side effects.", {"entities": []}], ["We have explored the effects of a specific p110\u03b4 isoform inhibitor, IC87114, on diabetogenic T cells both in vitro and in vivo , and find that although pharmacological inhibition of p110\u03b4 has a considerable impact on the production of pro-inflammatory cytokines, it does not delay the onset of diabetes after adoptive transfer of diabetogenic cells.", {"entities": []}], ["Further, we demonstrate that combination treatment with CTLA4-Ig does not improve the efficacy of treatment, but instead attenuates the protective effects seen with CTLA4-Ig treatment alone.", {"entities": []}], ["Our results suggest that decreased IL-10 production by Foxp3", {"entities": [[55, 60, "GENE"]]}], ["Introduction: Workers in the cotton processing industries risk developing obstructive respiratory conditions due to prolonged exposure to cotton dust.", {"entities": []}], ["We noted a tenfold increase in asthma among workers in a Textile Manufacturing Company.", {"entities": [[31, 37, "DISEASE"]]}], ["We determined the prevalence of respiratory obstructive conditions among workers in various sections.", {"entities": []}], ["Methods We conducted a cross sectional analytic study.", {"entities": []}], ["Workers were randomly sampled and data was collected using interviewer-administered questionnaires.", {"entities": []}], ["Respiratory function was assessed using spirometry and chest auscultation.", {"entities": []}], ["A walk through survey was conducted and a checklist was used to capture hazards and control measures in the work place.", {"entities": []}], ["Results A total of 194 workers participated.", {"entities": []}], ["The prevalence of severe respiratory obstruction was 27.8%.", {"entities": []}], ["It was 50.0% among the blowers, 35.3% in waste recovery, 32.5% in carders, 15.0% in spinners and 7.5% among weavers.", {"entities": []}], ["The mean years of exposure between the affected and the non-affected were significantly different (T =2.20; p< 0.05).", {"entities": []}], ["Working in the blowing department was significantly associated with developing respiratory obstruction (OR=3.53; 95% CI= 1.61-7.79) but working in the weaving department was significantly protective (OR 0.16; CI 0.04-0.59).Working in a department for less than 10 years was protective (OR =0.94; 95% CI= 0.48-1.85), but not significant.", {"entities": []}], ["Conclusion Obstructive respiratory conditions are common among textile workers, with those in blowing and waste recovery sections being the most affected.", {"entities": []}], ["We recommended worker rotation every six months, regular spirometric screening employment of a medical officer.", {"entities": []}], ["This study was designed to report factors associated with asthma hospital admission, such as patient characteristics, type of admission and subsequent outcome i.e.", {"entities": [[58, 64, "DISEASE"]]}], ["discharge or death, for the years 2000\u20132005.", {"entities": []}], ["These data are used for health economic models regarding asthma burden in the hospital setting in Australia.", {"entities": [[57, 63, "DISEASE"]]}], ["Data was obtained from the Australian Centre for Asthma Monitoring using their amalgamated dataset from all states and territories.", {"entities": [[49, 55, "DISEASE"]]}], ["Admissions under ICD-10 codes J45 \u2018Asthma\u2019 plus all subcodes, and J46 \u2018acute severe asthma\u2019 were included.", {"entities": [[35, 41, "DISEASE"], [84, 90, "DISEASE"]]}], ["Codes for associated comorbidity at the time of admission were identified, as well as the month of death, age, gender and length and the type of stay.", {"entities": []}], ["Confidence intervals for death rate assumed a binomial distribution because of the rarity of event.", {"entities": []}], ["The total number of all-cause deaths for the 5-year observation period was 289 from 202,739 asthma separations or 0.14% or 143 deaths/100,000 separations and the highest rate was seen in patients over 45 years.", {"entities": [[92, 98, "DISEASE"]]}], ["Acute upper respiratory tract infections were reported in up to 25% of all asthma hospital admissions.", {"entities": [[75, 81, "DISEASE"]]}], ["Length of stay was up to a mean average of 10.2 days in patients who died (SD 15.3).", {"entities": []}], ["In 5 years observation there was 152,758 emergency asthma admissions which contributed greatly to Australian healthcare burden.", {"entities": [[51, 57, "DISEASE"]]}], ["The study demonstrates that emergency admissions dominate asthma care in the hospital setting in Australia, which suggests poor asthma control in some patients with subsequent economic burden.", {"entities": [[58, 64, "DISEASE"], [128, 134, "DISEASE"]]}], ["Asthma-related mortality remains a risk for specific patients in the hospital setting.", {"entities": [[0, 6, "DISEASE"]]}], ["Changes in relative humidity, along with other meteorological factors, accompany ongoing climate change and play a significant role in weather-related health outcomes, particularly among children.", {"entities": []}], ["The purpose of this review is to improve our understanding of the relationship between ambient humidity and child health, and to propose directions for future research.", {"entities": []}], ["A comprehensive search of electronic databases (PubMed, Medline, Web of Science, ScienceDirect, OvidSP and EBSCO host) and review of reference lists, to supplement relevant studies, were conducted in March 2013.", {"entities": []}], ["All identified records were selected based on explicit inclusion criteria.", {"entities": []}], ["We extracted data from the included studies using a pre-designed data extraction form, and then performed a quality assessment.", {"entities": []}], ["Various heterogeneities precluded a formal quantitative meta-analysis, therefore, evidence was compiled using descriptive summaries.", {"entities": []}], ["Out of a total of 3797 identified records, 37 papers were selected for inclusion in this review.", {"entities": []}], ["Among the 37 studies, 35% were focused on allergic diseases and 32% on respiratory system diseases.", {"entities": []}], ["Quality assessment revealed 78% of the studies had reporting quality scores above 70%, and all findings demonstrated that ambient humidity generally plays an important role in the incidence and prevalence of climate-sensitive diseases among children.", {"entities": []}], ["With climate change, there is a significant impact of ambient humidity on child health, especially for climate-sensitive infectious diseases, diarrhoeal diseases, respiratory system diseases, and pediatric allergic diseases.", {"entities": []}], ["However, some inconsistencies in the direction and magnitude of the effects are observed.", {"entities": []}], ["The ratio of the diameter of the pulmonary artery (PA) to the diameter of the aorta (PA:A) on computed tomography (CT) imaging is associated with both COPD exacerbation and pulmonary hypertension.", {"entities": [[183, 195, "DISEASE"], [173, 195, "DISEASE"]]}], ["The mechanisms of PA enlargement in COPD are poorly understood.", {"entities": []}], ["In this retrospective, single center study we evaluated pulmonary function, CT scans, right heart catheterizations, and echocardiography in 88 subjects with mild-to-moderately severe COPD.", {"entities": []}], ["A sensitivity analysis was performed in 43 subjects in whom CT scan and echocardiogram were performed within 50 days of each other.", {"entities": []}], ["To evaluate the association between PA:A ratio and echocardiographic parameters and hemodynamics, we performed simple correlations and multivariable linear regression analysis adjusting for lung function, age, sex, race, and diastolic function.", {"entities": []}], ["All subjects had preserved left ventricular (LV) systolic function (LV ejection fraction 62.7%\u00b15.5%).", {"entities": []}], ["Among them, 56.8% had evidence of diastolic dysfunction.", {"entities": []}], ["There was no association between PA:A ratio and the presence of diastolic dysfunction.", {"entities": []}], ["In a multivariable model, PA:A ratio was associated with right ventricular (RV) chamber size (\u03b2=0.015; P <0.003), RV wall thickness (\u03b2=0.56; P <0.002), and RV function (\u22120.49; P =0.05).", {"entities": []}], ["In the subgroup of subjects with testing within 50 days, the association with RV chamber size persisted (\u03b2=0.017; P =0.04), as did the lack of association with diastolic function.", {"entities": []}], ["PA:A ratio was also associated with elevated PA systolic pressures ( r =0.62; P =0.006) and pulmonary vascular resistance ( r =0.46; P =0.05), but not pulmonary arterial wedge pressure ( r =0.17; P =0.5) in a subset of patients undergoing right heart catheterization.", {"entities": []}], ["In patients with mild-to-moderately severe COPD and preserved LV function, increased PA:A ratio occurs independent of LV diastolic dysfunction.", {"entities": []}], ["Furthermore, the PA:A ratio is associated with right heart structure and function changes, as well as pulmonary hemodynamics.", {"entities": []}], ["These findings indicate that PA:A ratio is a marker of intrinsic pulmonary vascular changes rather than impaired LV filling.", {"entities": []}], ["Neorogioltriol is a tricyclic brominated diterpenoid isolated from the organic extract of the red algae Laurencia glandulifera .", {"entities": []}], ["In the present study, the anti-inflammatory effects of neorogioltriol were evaluated both in vivo using carrageenan-induced paw edema and in vitro on lipopolysaccharide (LPS)-treated Raw264.7 macrophages.", {"entities": []}], ["The in vivo study demonstrated that the administration of 1 mg/kg of neorogioltriol resulted in the significant reduction of carregeenan-induced rat edema.", {"entities": []}], ["In vitro , our results show that neorogioltriol treatment decreased the luciferase activity in LPS-stimulated Raw264.7 cells, stably transfected with the NF-\u03baB-dependent luciferase reporter.", {"entities": []}], ["This effect on NF-\u03baB activation is not mediated through MAPK pathways.", {"entities": []}], ["The inhibition of NF-\u03baB activity correlates with decreased levels of LPS-induced tumor necrosis factor-alpha (TNF\u03b1) present in neorogioltriol treated supernatant cell culture.", {"entities": []}], ["Further analyses indicated that this product also significantly inhibited the release of nitric oxide and the expression of cyclooxygenase-2 (COX-2) in LPS-stimulated Raw264.7 cells.", {"entities": []}], ["These latter effects could only be observed for neorogioltriol concentrations below 62.5 \u03bcM.", {"entities": []}], ["To our knowledge, this is the first report describing a molecule derived from Laurencia glandulifera with anti-inflammatory activity both in vivo and in vitro .", {"entities": []}], ["The effect demonstrated in vitro may be explained by the inhibition of the LPS-induced NF-\u03baB activation and TNF\u03b1 production.", {"entities": []}], ["NO release and COX-2 expression may reinforce this effect.", {"entities": []}], ["Obstructive sleep apnea (OSA) is known to be a risk factor of coronary artery disease.", {"entities": []}], ["The chemotaxis and adhesion of monocytes to the endothelium in the early atherosclerosis is important.", {"entities": [[73, 88, "DISEASE"]]}], ["This study aimed to investigate the effect of intermittent hypoxia, the hallmark of OSA, on the chemotaxis and adhesion of monocytes.", {"entities": []}], ["Peripheral blood was sampled from 54 adults enrolled for suspected OSA.", {"entities": []}], ["RNA was prepared from the isolated monocytes for the analysis of C-C chemokine receptor 2 (CCR2).", {"entities": [[91, 95, "GENE"]]}], ["The effect of intermittent hypoxia on the regulation and function of CCR2 was investigated on THP-1 monocytic cells and monocytes.", {"entities": [[69, 73, "GENE"]]}], ["The mRNA and protein expression levels were investigated by RT/real-time PCR and western blot analysis, respectively.", {"entities": []}], ["Transwell filter migration assay and cell adhesion assay were performed to study the chemotaxis and adhesion of monocytes.", {"entities": []}], ["Monocytic CCR2 gene expression was found to be increased in severe OSA patients and higher levels were detected after sleep.", {"entities": [[10, 14, "GENE"]]}], ["Intermittent hypoxia increased the CCR2 expression in THP-1 monocytic cells even in the presence of TNF-\u03b1 and CRP.", {"entities": [[35, 39, "GENE"], [110, 113, "GENE"]]}], ["Intermittent hypoxia also promoted the MCP-1-mediated chemotaxis and adhesion of monocytes to endothelial cells.", {"entities": []}], ["Furthermore, inhibitor for p42/44 MAPK or p38 MAPK suppressed the activation of monocytic CCR2 expression by intermittent hypoxia.", {"entities": [[90, 94, "GENE"]]}], ["This is the first study to demonstrate the increase of CCR2 gene expression in monocytes of severe OSA patients.", {"entities": [[55, 59, "GENE"]]}], ["Monocytic CCR2 gene expression can be induced under intermittent hypoxia which contributes to the chemotaxis and adhesion of monocytes.", {"entities": [[10, 14, "GENE"]]}], ["Small bowel ischemia following laparoscopy was described recently as a rare fatal complication of the CO 2 pneumoperitoneum.", {"entities": [[12, 20, "DISEASE"]]}], ["Of the 8 cases reported in the surgical literature, 7 were fatal, 1 was not.", {"entities": []}], ["In this report, we describe the first gynecological case.", {"entities": []}], ["A 34-year-old woman who underwent laparoscopy with extensive adhesiolysis and myolysis was re-admitted with an acute abdomen on postoperative day 4.", {"entities": []}], ["Immediate laparotomy revealed acute peritonitis, extensive adhesions, and a 3-cm defect in the small bowel.", {"entities": [[36, 47, "DISEASE"]]}], ["Tissue examination showed ischemic necrosis of edematous, but essentially normal, bowel mucosa.", {"entities": []}], ["The postoperative course was extremely complicated.", {"entities": []}], ["She was discharged after a 2-month hospital stay in the intensive care unit for rehabilitation.", {"entities": []}], ["Data are available on 7 patients (including ours).", {"entities": []}], ["All procedures were described as uneventful.", {"entities": []}], ["The intraabdominal pressure was set at 15 mm Hg when specified.", {"entities": []}], ["Some abdominal pain occurred in all, nausea and vomiting in 4, diarrhea in 2, abdominal distention in 1, fever in none.", {"entities": [[63, 71, "DISEASE"]]}], ["Quick reintervention laparotomy was performed in 2 and delayed in 5 (up to 4 days).", {"entities": []}], ["The CO 2 pneumoperitoneum is a predisposing factor for intestinal ischemia as it reduces cardiac output and splanchnic blood flow.", {"entities": [[66, 74, "DISEASE"]]}], ["However, critical ischemia relies on underlying vasculopathy or an inciting event.", {"entities": [[18, 26, "DISEASE"]]}], ["Patient selection, maintaining intraabdominal pressure at 15 mm Hg or less, and intermittent decompression of the gas represent the best options for preventing this complication.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) patients with mucus hypersecretion tend to demonstrate increased frequency of infective exacerbations and a steeper slope of decline in lung function.", {"entities": []}], ["Enhanced mucociliary clearance with high-frequency chest wall oscillation (HFCWO) devices previously used in cystic fibrosis and bronchiectasis patients may offer the opportunity for community-based, self-managed therapy to improve quality of life and lung function.", {"entities": [[129, 143, "DISEASE"], [109, 124, "DISEASE"]]}], ["A randomized controlled crossover pilot study of HFCWO compared with conventional treatment was conducted in 22 patients with moderate to severe COPD and mucus hypersecretion.", {"entities": []}], ["Patients spent 4 weeks using an HFCWO (SmartVest The patients were elderly with a mean age of 71 (standard deviation [SD] 10) years and were at the upper end of the normal range of body mass index (25 [SD 4.2] kg/m P < 0.05).", {"entities": []}], ["Sputum production showed a declining trend in the HFCWO phase, although not reaching statistical significance.", {"entities": []}], ["The HFCWO device was well tolerated with good reported compliance.", {"entities": []}], ["This pilot study demonstrated that patients with advanced COPD and mucus hypersecretion at increased risk of declining lung function tolerated the HFCWO treatment well, leading to improvement in quality of life and reduced symptoms.", {"entities": []}], ["Endobronchial tuberculosis (EBTB) presenting as right middle lobe syndrome (RMLS) is an uncommon clinical condition.", {"entities": [[54, 74, "DISEASE"], [14, 26, "DISEASE"], [66, 74, "DISEASE"]]}], ["We investigated the clinical characteristics in patients with EBTB presenting as RMLS.", {"entities": []}], ["We retrospectively reviewed the records of 22 patients with EBTB presenting as RMLS who were diagnosed at our hospital from 2003 to 2006.", {"entities": []}], ["Its occurrence was more common in females than males (F, 18; M, 4).", {"entities": []}], ["The mean age was 70.3 \u00b1 8.5 years, and 17 patients were above the age of 65 years.", {"entities": []}], ["Cough with sputum was the most common manifestation and 2 patients were asymptomatic.", {"entities": []}], ["In bronchoscopic analysis, the most common finding was edematous-type EBTB, which was found in 15 patients, followed by actively caseating type in 6 and tumorous type in 1.", {"entities": []}], ["Acid-fast bacilli (AFB) staining for bronchial washing fluid was positive in only 5 patients: 1 with edematous type and 4 with actively caseating type.", {"entities": []}], ["Bronchoscopic biopsy showed chronic granulomatous inflammation in 16 patients.", {"entities": []}], ["Follow-up chest X-ray after treatment showed complete disappearance of the lesion in 2 patients, more than 50% improvement in 5, less than 50% improvement in 5, and no change of lesion in 4.", {"entities": []}], ["Edematous-type EBTB was the most common type of EBTB presenting as RMLS, and it usually occurred in elderly patients.", {"entities": []}], ["Culturing for mycobacterium and histologic examination by bronchoscopy are necessary for proper diagnosis in these patients.", {"entities": []}], ["Tuberculosis (TB) is a major contributor to the global burden of disease and has received considerable attention in recent years, particularly in low- and middle-income countries where it is closely associated with HIV/AIDS.", {"entities": [[0, 12, "DISEASE"]]}], ["Poor adherence to treatment is common despite various interventions aimed at improving treatment completion.", {"entities": []}], ["Lack of a comprehensive and holistic understanding of barriers to and facilitators of, treatment adherence is currently a major obstacle to finding effective solutions.", {"entities": []}], ["The aim of this systematic review of qualitative studies was to understand the factors considered important by patients, caregivers and health care providers in contributing to TB medication adherence.", {"entities": []}], ["We searched 19 electronic databases (1966\u2013February 2005) for qualitative studies on patients', caregivers', or health care providers' perceptions of adherence to preventive or curative TB treatment with the free text terms \u201cTuberculosis AND (adherence OR compliance OR concordance)\u201d.", {"entities": [[224, 236, "DISEASE"]]}], ["We supplemented our search with citation searches and by consulting experts.", {"entities": []}], ["For included studies, study quality was assessed using a predetermined checklist and data were extracted independently onto a standard form.", {"entities": []}], ["We then followed Noblit and Hare's method of meta-ethnography to synthesize the findings, using both reciprocal translation and line-of-argument synthesis.", {"entities": []}], ["We screened 7,814 citations and selected 44 articles that met the prespecified inclusion criteria.", {"entities": []}], ["The synthesis offers an overview of qualitative evidence derived from these multiple international studies.", {"entities": []}], ["We identified eight major themes across the studies: organisation of treatment and care; interpretations of illness and wellness; the financial burden of treatment; knowledge, attitudes, and beliefs about treatment; law and immigration; personal characteristics and adherence behaviour; side effects; and family, community, and household support.", {"entities": []}], ["Our interpretation of the themes across all studies produced a line-of-argument synthesis describing how four major factors interact to affect adherence to TB treatment: structural factors, including poverty and gender discrimination; the social context; health service factors; and personal factors.", {"entities": []}], ["The findings of this study are limited by the quality and foci of the included studies.", {"entities": []}], ["Adherence to the long course of TB treatment is a complex, dynamic phenomenon with a wide range of factors impacting on treatment-taking behaviour.", {"entities": []}], ["Patients' adherence to their medication regimens was influenced by the interaction of a number of these factors.", {"entities": []}], ["The findings of our review could help inform the development of patient-centred interventions and of interventions to address structural barriers to treatment adherence.", {"entities": []}], ["From a systematic review of qualitative research, Munro and coauthors found that a range of interacting factors can lead to patients deciding not to complete their course of tuberculosis treatment.", {"entities": [[174, 186, "DISEASE"]]}], ["Every year nearly nine million people develop tuberculosis\u2014a contagious infection, usually of the lungs\u2014and about two million people die from the disease.", {"entities": [[46, 58, "DISEASE"]]}], ["Tuberculosis is caused by Mycobacterium tuberculosis , bacteria that are spread in airborne droplets when people with active tuberculosis sneeze or cough.", {"entities": [[0, 12, "DISEASE"], [40, 52, "DISEASE"], [125, 137, "DISEASE"]]}], ["Tuberculosis can be cured by taking several strong antibiotics daily for at least six months but many patients fail to complete this treatment because the drugs have unpleasant side-effects and the treatment is complicated.", {"entities": [[0, 12, "DISEASE"]]}], ["In addition, people often feel better soon after starting treatment so they stop taking their tablets before all the bacteria in their body are dead.", {"entities": []}], ["Poor treatment adherence (poor compliance) means that people remain infectious for longer and are more likely to relapse and die.", {"entities": []}], ["It also contributes to the emergence of drug-resistant tuberculosis.", {"entities": [[55, 67, "DISEASE"]]}], ["To help people complete their treatment, the World Health Organization recommends a strategy known as DOTS (directly observed treatment, short course).", {"entities": []}], ["As part of this strategy, a health worker or a tuberculosis treatment supporter\u2014a person nominated by the health worker and the patient\u2014watches the patient take his/her antibiotics.", {"entities": [[47, 59, "DISEASE"]]}], ["Although DOTS has contributed to improved tuberculosis control, better patient compliance is needed to halt the global tuberculosis epidemic.", {"entities": [[42, 54, "DISEASE"], [119, 131, "DISEASE"]]}], ["Treatment adherence is a complex behavioral issue and improving treatment outcomes for tuberculosis (and for other diseases) requires a full understanding of the factors that prevent people taking medicines correctly and those that help them complete their treatment.", {"entities": [[87, 99, "DISEASE"]]}], ["In this study, the researchers have done a systematic review (a study in which the medical literature is surveyed and appraised using defined methods to reach a consensus view on a specific question) of qualitative studies that asked patients, carers, and health workers which factors contributed to adherence to tuberculosis treatment.", {"entities": [[313, 325, "DISEASE"]]}], ["Qualitative studies collect non-quantitative data so, for example, a qualitative study on tuberculosis treatment might ask people how the treatment made them feel whereas a quantitative study might count bacteria in patient samples.", {"entities": [[90, 102, "DISEASE"]]}], ["The researchers searched electronic databases and reference lists for qualitative studies on adherence to tuberculosis treatments and also consulted experts on tuberculosis treatment.", {"entities": [[106, 118, "DISEASE"], [160, 172, "DISEASE"]]}], ["They carefully read the 44 published papers that met their predefined inclusion criteria and then used a method called \u201cmeta-ethnography\u201d to compare the factors (themes) associated with good or bad adherence in the different studies and to synthesize (reach) a consensus view of which factors influence adherence to tuberculosis treatment.", {"entities": [[316, 328, "DISEASE"]]}], ["The researchers identified eight major factors associated with adherence to treatment.", {"entities": []}], ["These included: health service factors such as the organization of treatment and care; social context (family, community and household influences); and the financial burden of treatment.", {"entities": []}], ["Finally, the researchers interpreted the themes that emerged from the studies to build a simple model that proposes that adherence to tuberculosis treatment is influenced by four interacting sets of factors\u2014structural factors (including poverty and gender discrimination), social context factors, health service factors, and personal factors (including attitudes towards treatment and illness).", {"entities": [[134, 146, "DISEASE"]]}], ["The findings of this systematic review of qualitative research on patient adherence to tuberculosis treatment are inevitably limited by the quality and scope of the original research.", {"entities": [[87, 99, "DISEASE"]]}], ["Consequently, further studies into patients' understanding of tuberculosis and its treatment are needed.", {"entities": [[62, 74, "DISEASE"]]}], ["Nevertheless, the findings and the model proposed by the researchers indicate that patients often take their tuberculosis medications under very difficult conditions and that they cannot control many of the factors that prevent them taking their drugs.", {"entities": [[109, 121, "DISEASE"]]}], ["So, although current efforts to improve adherence to tuberculosis treatments emphasize instilling a willingness to take their medications into patients, this systematic review suggests that more must be done to address how factors such as poverty and gender affect treatment adherence and to tailor support systems to patients' needs.", {"entities": [[53, 65, "DISEASE"]]}], ["Most importantly, it indicates that future interventions should involve patients more in the decisions made about their treatment.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0040238 .", {"entities": []}], ["MedlinePlus has an encyclopedia page on tuberculosis (in English and Spanish) See the US National Institute of Allergy and Infectious Disease fact sheet on tuberculosis US Centers for Disease Control and Prevention provide a variety of fact sheets and other information resources on tuberculosis World Health Organization has produced the 2007 Global Tuberculosis Control report (in English with key findings in French and Spanish), information on DOTS (in English, Spanish, French, Russian, Arabic and Chinese), and A Guide for Tuberculosis Treatment Supporters See the brief guide to systematic reviews , published by the British Medical Journal", {"entities": [[40, 52, "DISEASE"], [156, 168, "DISEASE"], [283, 295, "DISEASE"], [351, 363, "DISEASE"], [529, 541, "DISEASE"]]}], ["The American Academy of Pediatrics recently issued guidelines regarding the potential toxic effect of indoor molds.", {"entities": []}], ["We now report another case of an infant with pulmonary hemorrhage whose residential environmental assessment revealed the presence of the toxigenic mold Stachybotrys atra.", {"entities": []}], ["We used a questionnaire to identify environmental factors that could predispose the home to fungal contamination.", {"entities": []}], ["We collected air samples from multiple locations in the home that we felt would reflect areas of relevant exposure.", {"entities": []}], ["Surface samples were collected with a piece of transparent tape for semiquantitative measurement of spores present.", {"entities": []}], ["We classified spores into their respective genera based on shape, size, and color.", {"entities": []}], ["We also measured mycotoxin levels.", {"entities": []}], ["Air sampling revealed significantly elevated total spore counts in the patient's bedroom and in the attic.", {"entities": []}], ["Aspergillus/Penicillium species were predominant.", {"entities": []}], ["Stachybotrys spores were found in the air sampled in the patient's bedroom, as well as from surfaces sampled in the patient's closet and the attic ceiling.", {"entities": []}], ["Additionally, a small patch of Stachybotrys-contaminated area in the closet ceiling was sent for mycotoxin analysis.", {"entities": []}], ["This material proved to be highly toxigenic.", {"entities": []}], ["As the link between the presence of Stachybotrys in the home and pulmonary hemorrhage in infants increases, further efforts should be made to educate physicians, health care providers, and new parents about the potential toxic effects of this mold.", {"entities": []}], ["Pulmonary fibrosis (PF) is a serious progressive lung disease and it originates from inflammation-induced parenchymal injury with excessive extracellular matrix deposition to result in the destruction of the normal lung architecture.", {"entities": [[0, 18, "DISEASE"], [49, 61, "DISEASE"]]}], ["Modified Kushen Gancao Formula ( m KG), derived from traditional Chinese herbal medicine, has a prominent anti-inflammatory effect.", {"entities": []}], ["The present study is to explore the inhibitory effects of m KG on bleomycin (BLM)-induced pulmonary fibrosis in mice.", {"entities": [[90, 108, "DISEASE"], [77, 80, "GENE"]]}], ["m KG significantly decreased pulmonary alveolitis, fibrosis scores, and interleukin-6 (IL-6), interleukin-17 (IL-17), transforming growth factor-\u03b2 (TGF-\u03b2) and hydroxyproline (HYP) levels in lung tissue of mice compared with BLM treatment.", {"entities": [[224, 227, "GENE"]]}], ["It markedly alleviated the increase of HYP content in the lung tissues and pathologic changes of pulmonary fibrosis caused by BLM instillation.", {"entities": [[97, 115, "DISEASE"], [126, 129, "GENE"]]}], ["In conclusion, m KG has an anti-fibrotic effect and might be employed as a therapeutic candidate agent for attenuating pulmonary fibrosis.", {"entities": [[119, 137, "DISEASE"]]}], ["The purpose of this study was to confirm the efficacy and safety of twice-daily glycopyrrolate 15.6 \u00b5g, a long-acting muscarinic antagonist, in patients with stable, symptomatic, chronic obstructive pulmonary disease (COPD) with moderate-to-severe airflow limitation.", {"entities": [[179, 216, "DISEASE"]]}], ["The GEM1 study was a 12-week, multicenter, double-blind, parallel-group, placebo-controlled study that randomized patients with stable, symptomatic COPD with moderate-to-severe airflow limitation to twice-daily glycopyrrolate 15.6 \u00b5g or placebo (1:1) via the Neohaler Of the 441 patients randomized (glycopyrrolate, n=222; placebo, n=219), 96% of patients completed the planned treatment phase.", {"entities": []}], ["Glycopyrrolate demonstrated statistically significant ( P <0.001) improvements in lung function versus placebo.", {"entities": []}], ["Glycopyrrolate showed statistically significant improvement in the transition dyspnea index focal score, St George\u2019s Respiratory Questionnaire total score, COPD Assessment Test score, rescue medication use, and daily total symptom score versus placebo at week 12.", {"entities": []}], ["Safety was comparable between the treatment groups.", {"entities": []}], ["Significant improvement in lung function, dyspnea, COPD symptoms, health status, and rescue medication use suggests that glycopyrrolate is a safe and effective treatment option as maintenance bronchodilator in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation.", {"entities": []}], ["Puerarin is an active component of Pueraria lobata , which is a commonly used Chinese herbal medicine for the treatment of osteoporosis.", {"entities": [[123, 135, "DISEASE"]]}], ["The present study aimed to evaluate the osteoprotective effect of puerarin on glucocorticoid (GC)-induced apoptosis of osteoblasts in vitro .", {"entities": [[94, 96, "GENE"]]}], ["The effects of puerarin on dexamethasone (DEX)-induced cell apoptosis were assessed using enzyme-linked immunosorbent assay and a terminal deoxynucleotidyl transferase dUTP nick-end labeling assay, and found that the viability of hFOB1.19 cells was significantly increased following exposure to between 10 c and cleavage of caspase-3, and treatment with puerarin inhibited the c-Jun N-terminal kinase (JNK) pathway and activated the phosphoinositide 3-kinase (PI3K)/Akt pathway in the hFOB1.19 cells.", {"entities": []}], ["Furthermore, the Akt inhibitor, LY294002, partly eliminated the protective effect of puerarin on DEX-induced apoptosis, and puerarin combined with the JNK inhibitor, SP600125, suppressed DEX-induced apoptosis to a lesser extent than in the cells treated with SP600125 alone.", {"entities": []}], ["These results suggested that the JNK and PI3K/Akt signaling pathways mediate the inhibitory effects of puerarin on apoptosis in the hFOB1.19 cells.", {"entities": []}], ["In conclusion, puerarin prevented DEX-induced apoptosis of hFOB1.19 cells via inhibition of the JNK pathway and activation of the PI3K/Akt signaling pathway in the cells, dependent on the mitochondrial apoptotic pathway.", {"entities": []}], ["These results support puerarin as a promising target in the treatment of GC-induced osteoporosis.", {"entities": [[84, 96, "DISEASE"]]}], ["The aims of our study were to assess the effect of follow-up on the quality of life of colorectal cancer patients and to assess the attitudes of patients towards follow-up as a function of patient characteristics.", {"entities": [[87, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["Patients who had been treated with curative intent were selected from four types of hospitals.", {"entities": []}], ["Eighty-two patients were interviewed using a structured questionnaire, whereas 130 patients received the questionnaire by mail.", {"entities": []}], ["To assess the effect of follow-up on the quality of life, the interviewed patients were randomly allocated to three groups and interviewed at different times in relation to the follow-up visit.", {"entities": []}], ["Analysis did not show an effect of the follow-up visit on quality of life.", {"entities": []}], ["Patients reported a positive attitude towards follow-up: it reassured them, they judged the communication with the physician to be positive, and they experienced only slight nervous anticipation and few other disadvantages.", {"entities": []}], ["Patients reported a strong preference for follow-up, and a large majority would prefer follow-up even if it would not lead to earlier detection of a recurrence.", {"entities": []}], ["Apart from living situation, no patient characteristics were clearly associated with the attitude towards follow-up.", {"entities": []}], ["Implications for clinical practice are discussed.", {"entities": []}], ["Patients with Mycobacterium avium complex (MAC) lung disease (LD) have a heterogeneous prognosis.", {"entities": [[48, 60, "DISEASE"]]}], ["This study aimed to develop and validate a prognostic scoring model for these patients using independent risk factors for survival.", {"entities": []}], ["We retrospectively analyzed the data of patients with MAC-LD from two hospitals (cohort 1, n \u00a0=\u00a0368; cohort 2, n \u00a0=\u00a0118).", {"entities": []}], ["Cohort 1 was evaluated using a multivariate Cox proportional hazards model to identify independent risk factors for overall survival (OS).", {"entities": []}], ["A prognostic scoring model composed of these factors was developed, and cohort 1 was stratified into three groups according to risk using the log-rank test.", {"entities": []}], ["Finally, the prognostic scoring model was validated using the data of cohort 2.", {"entities": []}], ["Seven independent risk factors for OS were selected from cohort 1, including the male sex, age\u00a0\u2265\u00a070\u00a0years, the presence of a malignancy, body mass index <18.5\u00a0kg/m P \u00a0<\u00a00.001), in cohort 1, and 97.2, 82.3, and 45.4%, respectively ( P \u00a0<\u00a00.001), in cohort 2.", {"entities": []}], ["This study is the first to develop and validate a prognostic scoring model for patients with MAC-LD.", {"entities": []}], ["This model may prove useful in clinical settings and practical in estimating the prognosis.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-017-2544-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Health care seeking is a dynamic process that is influenced by socio-demographic, cultural and other factors.", {"entities": []}], ["In Ethiopia, there are limited studies regarding the health seeking behaviour of tuberculosis (TB) suspects and TB patients.", {"entities": [[81, 93, "DISEASE"]]}], ["However, a thorough understanding of patients' motivation and actions is crucial to understanding TB and the treatment of disease.", {"entities": []}], ["Such insights would conceivably help to reduce delay in diagnosis, improve treatment adherence and thereby reduce transmission of TB in the community.", {"entities": []}], ["The objective of this study was to describe and analyze health care seeking among TB suspects and pulmonary TB (PTB) cases in a rural district of the Amhara Region in Ethiopia.", {"entities": []}], ["Study kebeles were randomly selected in a cross-sectional study design.", {"entities": []}], ["House-to-house visits were conducted in which individuals aged 15 years and above in all households of the kebeles were included.", {"entities": []}], ["Subjects with symptoms suggestive of TB were interviewed about their health seeking behaviour, socio-demographic and clinical factors using a semi-structured questionnaire.", {"entities": []}], ["Logistics regression analysis was employed to assess associations between the independent and outcome variables.", {"entities": []}], ["The majority, 787 (78%), TB suspects and 33 (82.5%) PTB cases had taken health care actions for symptoms from sources outside their homes.", {"entities": []}], ["The median delay before the first action was 30 days.", {"entities": []}], ["In logistics regression, women (AOR 0.8, 95% CI 0.6, 0.9) were found to be less likely to visit a medical health provider than men.", {"entities": []}], ["Those with a long duration of cough (AOR 1.5, 95% CI 1.03, 2.1) and those with a previous history of TB (AOR 1.5, 95% CI 1.03, 2.3) were more likely to visit a medical health provider compared to those with a shorter duration of cough and with no history of TB.", {"entities": []}], ["The majority of TB suspects and PTB cases had already taken health care actions for their symptoms at the time of the survey.", {"entities": []}], ["The availability of a simple and rapid diagnostic TB test for use at the lowest level of health care and the involvement of all health providers in case finding activities are imperative for early TB case detection.", {"entities": []}], ["Asthma is a complex chronic inflammatory disease of multifactorial etiology.", {"entities": [[0, 6, "DISEASE"]]}], ["International guidelines increasingly recognize that a standard \u201cone size fits all\u201d approach is no longer an effective approach to achieve optimal treatment outcomes, and a number of disease phenotypes have been proposed for asthma, which has the potential to guide treatment decisions.", {"entities": [[225, 231, "DISEASE"]]}], ["Among the many asthma phenotypes, allergic asthma represents the widest and most easily recognized asthma phenotype, present in up to two-thirds of adults with asthma.", {"entities": [[34, 49, "DISEASE"], [15, 21, "DISEASE"], [43, 49, "DISEASE"], [99, 105, "DISEASE"], [160, 166, "DISEASE"]]}], ["Immunoglobulin E (IgE) production is the primary and key cause of allergic asthma leading to persistent symptoms, exacerbations and a poor quality of life.", {"entities": [[66, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["Therefore, limiting IgE activity upstream could stop the entire allergic inflammation cascade in IgE-mediated allergic asthma.", {"entities": [[110, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["The anti-IgE treatment omalizumab has an accepted place in the management of severe asthma (Global Initiative for Asthma [GINA] step 5) and represents the first (and, currently, only) targeted therapy with a specific target in severe allergic asthma.", {"entities": [[234, 249, "DISEASE"], [84, 90, "DISEASE"], [114, 120, "DISEASE"], [243, 249, "DISEASE"]]}], ["This review summarizes current knowledge of the mechanisms and pathogenesis of severe asthma, examines the actual role of IgE in asthma and the biological rationale for targeting IgE in allergic asthma and reviews the data for the efficacy and safety of omalizumab in the treatment of severe asthma.", {"entities": [[186, 201, "DISEASE"], [86, 92, "DISEASE"], [129, 135, "DISEASE"], [195, 201, "DISEASE"], [292, 298, "DISEASE"]]}], ["Current knowledge of the role of IgE in asthma, extensive clinical trial data and a decade of use in clinical practice has established omalizumab as a safe and effective targeted therapy for the treatment of patients with severe persistent IgE-mediated allergic asthma.", {"entities": [[253, 268, "DISEASE"], [40, 46, "DISEASE"], [262, 268, "DISEASE"]]}], ["Mechanotransduction holds the underlying mechanisms of ventilator-induced lung injury.", {"entities": []}], ["Research on this subject, however, could be difficult for clinicians, especially when results are controversial.", {"entities": []}], ["A recent study by Li and co-workers is used as an example, to explain how to critically read literatures related to basic science and how to understand the limitation of experimental studies.", {"entities": []}], ["Cough in bronchiectasis is associated with significant impairment in health status.", {"entities": [[9, 23, "DISEASE"]]}], ["This study aimed to quantify cough frequency objectively with a cough monitor and investigate its relationship with health status.", {"entities": []}], ["A secondary aim was to identify clinical predictors of cough frequency.", {"entities": []}], ["Fifty-four patients with bronchiectasis were compared with thirty-five healthy controls.", {"entities": [[25, 39, "DISEASE"]]}], ["Objective 24-h cough, health status (cough-specific: Leicester Cough Questionnaire LCQ and bronchiectasis specific: Bronchiectasis Health Questionnaire BHQ), cough severity and lung function were measured.", {"entities": [[91, 105, "DISEASE"], [116, 130, "DISEASE"]]}], ["The clinical predictors of cough frequency in bronchiectasis were determined in a multivariate analysis.", {"entities": [[46, 60, "DISEASE"]]}], ["Objective cough frequency was significantly raised in patients with bronchiectasis compared to healthy controls [geometric mean (standard deviation)] 184.5 (4.0) vs. 20.6 (3.2) coughs/24-h; mean fold-difference (95% confidence interval) 8.9 (5.2, 15.2); p \u00a0<\u00a00.001 and they had impaired health status.", {"entities": [[68, 82, "DISEASE"]]}], ["There was a significant correlation between objective cough frequency and subjective measures; LCQ r \u00a0=\u00a0\u22120.52 and BHQ r \u00a0=\u00a0\u22120.62, both p \u00a0<\u00a00.001.", {"entities": []}], ["Sputum production, exacerbations (between past 2\u00a0weeks to 12\u00a0months) and age were significantly associated with objective cough frequency in multivariate analysis, explaining 52% of the variance ( p \u00a0<\u00a00.001).", {"entities": []}], ["There was no statistically significant association between cough frequency and lung function.", {"entities": []}], ["Cough is a common and significant symptom in patients with bronchiectasis.", {"entities": [[59, 73, "DISEASE"]]}], ["Sputum production, exacerbations and age, but not lung function, were independent predictors of cough frequency.", {"entities": []}], ["Ambulatory objective cough monitoring provides novel insights and should be further investigated as an outcome measure in bronchiectasis.", {"entities": [[122, 136, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s00408-017-0038-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In 2009, the influenza A (H1N1) virus spread rapidly around the world, causing the first pandemic of the 21", {"entities": [[13, 22, "DISEASE"]]}], ["Genome-wide association studies and follow-up meta-analyses in Crohn's disease (CD) and ulcerative colitis (UC) have recently identified 163 disease-associated loci that meet genome-wide significance for these two inflammatory bowel diseases (IBD).", {"entities": [[88, 106, "DISEASE"]]}], ["These discoveries have already had a tremendous impact on our understanding of the genetic architecture of these diseases and have directed functional studies that have revealed some of the biological functions that are important to IBD (e.g.", {"entities": []}], ["autophagy).", {"entities": []}], ["Nonetheless, these loci can only explain a small proportion of disease variance (\u223c14% in CD and 7.5% in UC), suggesting that not only are additional loci to be found but that the known loci may contain high effect rare risk variants that have gone undetected by GWAS.", {"entities": []}], ["To test this, we have used a targeted sequencing approach in 200 UC cases and 150 healthy controls (HC), all of French Canadian descent, to study 55 genes in regions associated with UC.", {"entities": []}], ["We performed follow-up genotyping of 42 rare non-synonymous variants in independent case-control cohorts (totaling 14,435 UC cases and 20,204 HC).", {"entities": []}], ["Our results confirmed significant association to rare non-synonymous coding variants in both IL23R and CARD9 , previously identified from sequencing of CD loci, as well as identified a novel association in RNF186 .", {"entities": [[93, 98, "GENE"], [103, 108, "GENE"], [206, 212, "GENE"]]}], ["With the exception of CARD9 (OR\u200a=\u200a0.39), the rare non-synonymous variants identified were of moderate effect (OR\u200a=\u200a1.49 for RNF186 and OR\u200a=\u200a0.79 for IL23R ).", {"entities": [[22, 27, "GENE"], [124, 130, "GENE"], [149, 154, "GENE"]]}], ["RNF186 encodes a protein with a RING domain having predicted E3 ubiquitin-protein ligase activity and two transmembrane domains.", {"entities": [[0, 6, "GENE"]]}], ["Importantly, the disease-coding variant is located in the ubiquitin ligase domain.", {"entities": []}], ["Finally, our results suggest that rare variants in genes identified by genome-wide association in UC are unlikely to contribute significantly to the overall variance for the disease.", {"entities": []}], ["Rather, these are expected to help focus functional studies of the corresponding disease loci.", {"entities": []}], ["Genetic studies of common diseases have seen tremendous progress in the last half-decade primarily due to recent technologies that enable a systematic examination of genetic markers across the entire genome in large numbers of patients and healthy controls.", {"entities": []}], ["The studies, while identifying genomic regions that influence a person's risk for developing disease, often do not pinpoint the actual gene or gene variants that account for this risk (called a causal gene/variant).", {"entities": []}], ["A prime example of this can be seen with the 163 genetic risk factors that have recently been associated with the chronic inflammatory bowel diseases known as Crohn's disease and ulcerative colitis.", {"entities": [[179, 197, "DISEASE"]]}], ["For less than a handful of these 163 is the causative change in the genetic code known.", {"entities": []}], ["The current study used an approach to directly look at the genetic code for a subset of these and identified a causative change in the genetic code for eight risk factors for ulcerative colitis.", {"entities": [[175, 193, "DISEASE"]]}], ["This finding is particularly important because it directs biological studies to understand the mechanisms that lead to this chronic life-long inflammatory disease.", {"entities": []}], ["Initiatives to raise the quality of care provided to mothers need to be given priority in Sub Saharan Africa (SSA).", {"entities": []}], ["The promotion of clinical practice guidelines (CPGs) is a common strategy, but their implementation is often challenging, limiting their potential impact.", {"entities": []}], ["Through a cross-country perspective, this study explored CPGs for maternal health in Burkina Faso, Ghana, and Tanzania.", {"entities": []}], ["The objectives were to compare factors related to CPG use including their content compared with World Health Organization (WHO) guidelines, their format, and their development processes.", {"entities": []}], ["Perceptions of their availability and use in practice were also explored.", {"entities": []}], ["The overall purpose was to further the understanding of how to increase CPGs' potential to improve quality of care for mothers in SSA.", {"entities": []}], ["The study was a multiple case study design consisting of cross-country comparisons using document review and key informant interviews.", {"entities": []}], ["A conceptual framework to aid analysis and discussion of results was developed, including selected domains related to guidelines' implementability and use by health workers in practice in terms of usability, applicability, and adaptability.", {"entities": []}], ["The study revealed few significant differences in content between the national guidelines for maternal health and WHO recommendations.", {"entities": []}], ["There were, however, marked variations in the format of CPGs between the three countries.", {"entities": []}], ["Apart from the Ghanaian and one of the Tanzanian CPGs, the levels of both usability and applicability were assessed as low or medium.", {"entities": []}], ["In all three countries, the use of CPGs by health workers in practice was perceived to be limited.", {"entities": []}], ["Our cross-country study suggests that it is not poor quality of content or lack of evidence base that constitute the major barrier for CPGs to positively impact on quality improvement in maternal care in SSA.", {"entities": []}], ["It rather emphasises the need to prioritise the format of guidelines to increase their usability and applicability and to consider these attributes together with implementation strategies as integral to their development processes.", {"entities": []}], ["Please cite this paper as: Larcombe et\u00a0al.", {"entities": []}], ["(2012) Factors influencing the assessment of lung function in mice with influenza\u2010induced lung disease.", {"entities": [[72, 81, "DISEASE"], [90, 102, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12034.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 The constant\u2010phase model (CPM) is commonly fit to respiratory system input impedance ( Z rs ) to estimate lung mechanics.", {"entities": [[38, 41, "GENE"]]}], ["Driving signal frequencies and the method of model fitting may influence the results, especially in cases of severe lung disease or under severe bronchoconstriction.", {"entities": [[116, 128, "DISEASE"]]}], ["Objective\u2002 To illustrate the effects of different CPM fits to Z rs data using a mouse model of influenza\u2010induced lung disease.", {"entities": [[95, 104, "DISEASE"], [113, 125, "DISEASE"], [50, 53, "GENE"]]}], ["Methods\u2002 BALB/c mice infected with influenza (or control) were challenged with methacholine.", {"entities": [[35, 44, "DISEASE"]]}], ["The CPM was fitted to Z rs , measured between 0\u00b725 and 19\u00b7625\u2003Hz, using both unweighted and weighted fits.", {"entities": [[4, 7, "GENE"]]}], ["The effect of different lowest frequencies was assessed.", {"entities": []}], ["Results and Conclusions\u2002 For influenza\u2010infected mice, the unweighted fit was poor, and airway resistance ( R aw ) was often biologically impossible.", {"entities": [[29, 38, "DISEASE"]]}], ["The weighted fit provided more realistic estimates of R aw .", {"entities": []}], ["Different model fits and minimal frequencies had little effect on tissue mechanics.", {"entities": []}], ["Background and Objectives.", {"entities": []}], ["Parents' birth weight acts as a predictor for the descendant birth weight, with the correlation more strongly transmitted through maternal line.", {"entities": []}], ["The present research aims to study the correlation between the child's low or increased birth weight, the mother's birth weight, and maternal conditions.", {"entities": []}], ["773 mother-infant binomials were identified with information on both the baby's and the mother's birth weight recorded.", {"entities": []}], ["Group studies were constituted, dividing the sample according to birth weight (<2,500 grams (g) and \u22653,500 grams (g)).", {"entities": []}], ["The length at birth was also studied in children \u226447.5\u2009cm (lower quartile).", {"entities": []}], ["Chi Results.", {"entities": []}], ["The girls were heavier at birth than their mothers, with an average increase at birth weight between the generations of 79\u2009g. The child's birth weight <2,500\u2009g did not show any correlation with maternal birth weight <2,500\u2009g ( Fisher 0.264; Spearman's Rho 0.048; OR 2.1 and OR lower 0.7 ) or with maternal stature below the lower quartile (<157\u2009cm) ( Chi sig 0.323; with Spearman's Rho 0.036; OR 1.5 and OR lower 0.7 ).", {"entities": []}], ["The child's low birth weight (<2,500\u2009g) was lightly correlated with drug use by the mother during pregnancy ( Fisher 0.083; Spearman's Rho 0.080; OR 4.9 and OR lower 1.0 ).", {"entities": []}], ["The child's birth weight <2,500\u2009g showed increased correlation with gestational age lower than 38 weeks and 3 days ( Chi sig 0.002; Spearman's Rho 0.113; OR 3.2 and OR lower 1.5 ).", {"entities": []}], ["The child's weight at birth \u22653,500\u2009g showed strong correlation with maternal weight at birth \u22653,500\u2009g ( Chi sig 0; Spearman's Rho +0.142; OR 0.5 and OR upper 0.7 ).", {"entities": []}], ["It was also revealed that the higher the maternal prepregnancy BMI, the stronger the correlation with child's birth weight \u22653,500\u2009g ((maternal prepregnancy BMI > 25.0 with Chi sig 0.013; Spearman's Rho 0.09; OR 1.54 and OR upper 2.17 ) and (maternal prepregnancy BMI > 30.0 with Chi sig 0 Spearman's Rho 0.137; OR 2.58 and OR upper 4.26 )).", {"entities": []}], ["The child's length at birth in the lower quartile (\u226447.5\u2009cm) showed strong correlation with drug use by the mother during pregnancy ( Chi sig 0.004; Spearman's Rho 0.105; OR 4.3 and OR lower 1.5 ).", {"entities": []}], ["Conclusions.", {"entities": []}], ["The mother's increased weight at birth and the prenatal overweight or obesity were correlated with increased weight and length at birth of the newborn, coupled with the tendency of increasing birth weight between generations of mothers and daughters.", {"entities": [[70, 77, "DISEASE"]]}], ["Also, descendants with smaller length at birth are the children of women with the lowest statures.", {"entities": []}], ["Tissue hypoxia is a consequence of decreased oxygen levels in different inflammatory conditions, many associated with mast cell activation.", {"entities": []}], ["However, the effect of hypoxia on mast cell functions is not well established.", {"entities": []}], ["Here, we have investigated the effect of hypoxia per se on human mast cell survival, mediator secretion, and reactivity.", {"entities": []}], ["Human cord blood derived mast cells were subjected to three different culturing conditions: culture and stimulation in normoxia (21% O 2 ); culture and stimulation in hypoxia (1% O 2 ); or 24 hour culture in hypoxia followed by stimulation in normoxia.", {"entities": []}], ["Hypoxia, per se , did not induce mast cell degranulation, but we observed an increased secretion of IL-6, where autocrine produced IL-6 promoted mast cell survival.", {"entities": []}], ["Hypoxia did not have any effect on A23187 induced degranulation or secretion of cytokines.", {"entities": []}], ["In contrast, cytokine secretion after LPS or CD30 treatment was attenuated, but not inhibited, in hypoxia compared to normoxia.", {"entities": []}], ["Our data suggests that mast cell survival, degranulation and cytokine release are sustained under hypoxia.", {"entities": []}], ["This may be of importance for host defence where mast cells in a hypoxic tissue can react to intruders, but also in chronic inflammations where mast cell reactivity is not inhibited by the inflammatory associated hypoxia.", {"entities": []}], ["Background: When comparing the health of two populations, it is not enough to compare the prevalence of chronic diseases.", {"entities": []}], ["The objective of this study is therefore to propose a metric of health based on domains of functioning to determine whether the English are healthier than the Americans.", {"entities": []}], ["Methods: We analysed representative samples aged 50 to 80 years from the 2008 wave of the Health and Retirement Study (N\u2009=\u200910\u2009349) for the US data, and wave 4 of the English Longitudinal Study of Ageing (N\u2009=\u20099405) for English counterpart data.", {"entities": []}], ["We first calculated the age-standardized disease prevalence of diabetes, hypertension, all heart diseases, stroke, lung disease, cancer and obesity.", {"entities": [[73, 85, "DISEASE"], [140, 147, "DISEASE"], [115, 127, "DISEASE"], [129, 135, "DISEASE"]]}], ["Second, we developed a metric of health using Rasch analyses and the questions and measured tests common to both surveys addressing domains of human functioning.", {"entities": []}], ["Finally, we used a linear additive model to test whether the differences in health were due to being English or American.", {"entities": []}], ["Results: The English have better health than the Americans when population health is assessed only by prevalence of selected chronic health conditions.", {"entities": []}], ["The English health advantage disappears almost completely, however, when health is assessed with a metric that integrates information about functioning domains.", {"entities": []}], ["Conclusions: It is possible to construct a metric of health, based on data directly collected from individuals, in which health is operationalized as domains of functioning.", {"entities": []}], ["Its application has the potential to tackle one of the most intractable problems in international research on health, namely the comparability of health across countries.", {"entities": []}], ["Na\u00efve CD4 H 9 cells are less well-characterized than other T cell subsets, and factors that control their development and function have only recently been identified.", {"entities": [[6, 9, "GENE"]]}], ["It is now clear that T H 9 cells play critical roles in immune-mediated diseases, including allergic airway, autoimmune and inflammatory bowel diseases, and cancer.", {"entities": [[157, 163, "DISEASE"]]}], ["Thus, the promotion or suppression of T H 9 cell differentiation, transcriptional control and function may provide novel treatments for clinical inflammation, autoimmune diseases and tumors.", {"entities": []}], ["High mobility group box 1 (HMGB1) is a nuclear protein that involves the binding with DNA and influences chromatin regulation and transcription.", {"entities": [[27, 32, "GENE"]]}], ["HMGB1 is also a cytokine that can activate monocytes and neutrophils involved in inflammation.", {"entities": [[0, 5, "GENE"]]}], ["In this study, we investigated the role of HMGB1 on cellular activation using human fibroblast cell line WI-38.", {"entities": [[43, 48, "GENE"]]}], ["After treatment with 1, 10, and 100 ng/mL of HMGB1 for 24 h, we did not find obviously cytotoxicity and cellular proliferation of WI-38 cells by MTT and BrdU incorporation assay, respectively.", {"entities": [[45, 50, "GENE"]]}], ["However, we found that treatment with 10 and 100 ng/mL of HMGB1 induced the differentiation of lung fibroblasts into myofibroblasts and myofibroblasts showed higher migration ability through activation of matrix metalloproteinase (MMP)-9 activation.", {"entities": [[58, 63, "GENE"]]}], ["To delineate the mechanism underlying HMGB1-induced cellular migration, we examined HMGB1-induced mitogen activated protein kinases (MAPKs), including extracellular signal related kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 mitogen activated protein kinase (p38) phosphorylation, as well as nuclear factor (NF)-\u03baB nuclear translocation.", {"entities": []}], ["Using specific inhibitors and shRNAs of protein kinases, we observed that repression of ERK, JNK, p38, and NF-\u03baB all inhibited HMGB1-induced cellular differentiation, migration and MMP-9 activation in WI-38 cells.", {"entities": []}], ["In addition, knocking down of RAGE but not TLR2 and TLR4 by shRNAs attenuated HMGB1-induced myofibroblast differentiation and migration.", {"entities": [[43, 47, "GENE"], [52, 56, "GENE"]]}], ["In conclusion, our study demonstrated that HMGB1 induced lung fibroblasts\u2019 differentiation into myofibroblasts and enhanced cell migration through induction of MMP-9 activation and the RAGE-MAPK and NF-\u03baB interaction signaling pathways.", {"entities": [[43, 48, "GENE"]]}], ["Targeting HMGB1 might be a potential therapeutic approach for alleviation of airway remodeling seen in chronic airway inflammatory diseases.", {"entities": [[10, 15, "GENE"]]}], ["Although genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing 2) have been associated with the pathogenesis of Crohn\u2019s disease (CD), little is known regarding the role of wild-type (WT) NOD2 in the gut.", {"entities": [[34, 38, "GENE"], [217, 221, "GENE"], [34, 38, "GENE"], [217, 221, "GENE"]]}], ["To date, most murine studies addressing the role of WT Nod2 have been conducted using healthy (ileitis/colitis-free) mouse strains.", {"entities": [[55, 59, "GENE"]]}], ["Here, we evaluated the effects of Nod2 deletion in a murine model of spontaneous ileitis, i.e.", {"entities": [[34, 38, "GENE"]]}], [", the SAMP1Yit/Fc (SAMP) strain, which closely resembles CD.", {"entities": []}], ["Remarkably, Nod2 deletion improved both chronic cobblestone ileitis (by 50% assessed, as the % of abnormal mucosa at 24 wks of age), as well as acute dextran sodium sulfate (DSS) colitis.", {"entities": [[12, 16, "GENE"]]}], ["Mechanistically, Th2 cytokine production and Th2-transcription factor activation ( i.e.", {"entities": []}], [", STAT6 phosphorylation) were reduced.", {"entities": [[2, 7, "GENE"]]}], ["Microbiologically, the effects of Nod2 deletion appeared independent of fecal microbiota composition and function, assessed by 16S rRNA and metatranscriptomics.", {"entities": [[34, 38, "GENE"]]}], ["Our findings indicate that pharmacological blockade of NOD2 signaling in humans could improve health in Th2-driven chronic intestinal inflammation.", {"entities": [[55, 59, "GENE"]]}], ["Smoking in pregnancy remains a public health challenge.", {"entities": []}], ["Nicotine replacement therapy (NRT) is effective for smoking cessation in non-pregnant people, but because women metabolise nicotine and cotinine much faster in pregnancy, it is unclear whether this will be effective for smoking cessation in pregnancy.", {"entities": []}], ["The NHS Health Technology Assessment Programme (HTA)-funded smoking, nicotine and pregnancy (SNAP) trial will investigate whether or not nicotine replacement therapy (NRT) is effective, cost-effective and safe when used for smoking cessation by pregnant women.", {"entities": [[4, 7, "GENE"], [48, 51, "GENE"]]}], ["Over two years, in 5 trial centres, 1050 pregnant women who are between 12 and 24 weeks pregnant will be randomised as they attend hospital for ante-natal ultrasound scans.", {"entities": []}], ["Women will receive either nicotine or placebo transdermal patches with behavioural support.", {"entities": []}], ["The primary outcome measure is biochemically-validated, self-reported, prolonged and total abstinence from smoking between a quit date (defined before randomisation and set within two weeks of this) and delivery.", {"entities": []}], ["At six months after childbirth self-reported maternal smoking status will be ascertained and two years after childbirth, self-reported maternal smoking status and the behaviour, cognitive development and respiratory symptoms of children born in the trial will be compared in both groups.", {"entities": []}], ["This trial is designed to ascertain whether or not standard doses of NRT (as transdermal patches) are effective and safe when used for smoking cessation during pregnancy.", {"entities": []}], ["Anxiety disorders (ADs) are common with a high rate of medical comorbidities.", {"entities": []}], ["Although the association between ADs and the overall cancer risk remains controversial, patients with ADs were found to be more likely to develop specific cancer types.", {"entities": [[53, 59, "DISEASE"], [155, 161, "DISEASE"]]}], ["Herein, we estimated the risk of developing urological cancers among patients with ADs in a 5-year follow-up period using a population-based database.", {"entities": []}], ["Two study cohorts were identified from the Taiwan Longitudinal Health Insurance Database 2005: patients with ADs, and comparison subjects selected by one-to-one matching for sex, age, and the year of recruitment.", {"entities": []}], ["Follow-up was undertaken to determine whether sampled patients and comparison subjects had developed urological cancers in the subsequent 5\u00a0years.", {"entities": []}], ["We found that urological cancers occurred among 0.54% of patients with ADs and 0.13% of comparison subjects.", {"entities": []}], ["After adjusting for sociodemographic characteristics, medical comorbidities, and alcohol and tobacco use disorder, the stratified Cox proportional hazard regression suggested that patients with ADs were more likely to develop urological cancers relative to comparison subjects (adjusted hazard ratio, 3.67; 95% confidence interval, 2.85\u2009~\u20094.72).", {"entities": []}], ["The adjusted HR for males with ADs was 3.82 (95% CI: 2.79\u2009~\u20095.23) in comparison to males without ADs.", {"entities": [[13, 15, "GENE"]]}], ["In addition, the adjusted HR for females with ADs was 3.47 (95% CI: 2.26\u2009~\u20095.31) than those females without ADs.", {"entities": [[26, 28, "GENE"]]}], ["We concluded that during the 5-year follow-up period, there was a significantly increased risk of urological cancers among patients with ADs.", {"entities": []}], ["To determine the feasibility of a randomised controlled trial (RCT) of rhinothermy for the common cold.", {"entities": [[91, 102, "DISEASE"]]}], ["Open label, randomised, controlled feasibility study.", {"entities": []}], ["Single-centre research institute in New Zealand recruiting participants from the community.", {"entities": []}], ["30 adult participants with symptoms of a common cold, presenting within 48\u2009hours of the onset of symptoms.", {"entities": [[41, 52, "DISEASE"]]}], ["Participants were randomly assigned 2:1 to receive either 35\u2009L/min of 100% humidified air at 41\u00b0C via high flow nasal cannulae, 2\u2009hours per day for up to 5\u2009days (rhinothermy), or vitamin C 250\u2009mg daily for 5\u2009days (control).", {"entities": []}], ["The primary outcome was the proportion of screened candidates who were randomised.", {"entities": []}], ["Secondary outcomes included: proportion of randomised participants who completed the study; modified Jackson scores from randomisation to 10 days after initiation of randomised regimen; time until feeling \u2018a lot better\u2019 compared with study entry; time until resolution of symptoms or symptom score at 10 days postrandomisation; proportion of organisms identified by PCR analysis of nasal swabs taken at baseline; the patterns of use of the rhinothermy device; estimated adherence of the control group; and rhinothermy device tolerability.", {"entities": []}], ["In all 30/79 (38%, 95%\u2009CI 27% to 50%) of potential participants screened for eligibility were randomised.", {"entities": []}], ["Rhinothermy was well tolerated, and all randomised participants completed the study (100%, 95%\u2009CI 88% to 100%).", {"entities": []}], ["The reduction from baseline in the modified Jackson score was greater with rhinothermy compared with control at days 2, 3, 4, 5 and 6, with the maximum difference at day 4 (\u22126.4, 95%\u2009CI \u22129.4 to \u22123.3).", {"entities": []}], ["The substantial clinical benefit threshold for modified Jackson score was a 5-unit change.", {"entities": []}], ["This study shows that an RCT of rhinothermy compared with low-dose vitamin C in the treatment of the common cold is feasible.", {"entities": [[101, 112, "DISEASE"]]}], ["ACTRN12616000470493; Results.", {"entities": []}], ["Maternal enterovirus infections during pregnancy have been linked to an increased risk of type 1 diabetes in the offspring.", {"entities": []}], ["The aim of this study was to evaluate this association in a unique series of pregnant mothers whose child progressed to clinical type 1 diabetes.", {"entities": []}], ["Maternal and in utero enterovirus infections were studied in 171 offspring who presented with type 1 diabetes before the age of 11 years and in 316 control subjects matched for date and place of birth, sex, and HLA-DQ risk alleles for diabetes.", {"entities": []}], ["Acute enterovirus infections were diagnosed by increases in enterovirus IgG and IgM in samples taken from the mother at the end of the first trimester of pregnancy and cord blood samples taken at delivery.", {"entities": []}], ["Signs of maternal enterovirus infection were observed in altogether 19.3% of the mothers of affected children and in 12.0% of the mothers of control children ( P = 0.038).", {"entities": []}], ["This difference was seen in different HLA risk groups and in both sexes of the offspring, and it was unrelated to the age of the child at the diagnosis of diabetes or the age of the mother at delivery.", {"entities": [[38, 41, "GENE"]]}], ["These results suggest that an enterovirus infection during pregnancy is not a major risk factor for type 1 diabetes in childhood but may play a role in some susceptible subjects.", {"entities": []}], ["Asthma is the most common chronic disease of childhood and affects nearly 5 million children.", {"entities": [[0, 6, "DISEASE"]]}], ["The prevalence and severity of childhood asthma have continued to increase over the past decade despite major advances in the recognition and treatment of this condition.", {"entities": [[41, 47, "DISEASE"]]}], ["A comparison of urban and rural children suggests that the etiology of airway disease is multifactorial and that unique exposures and genetic factors contribute to the development of asthma in both settings.", {"entities": [[183, 189, "DISEASE"]]}], ["The most important environmental exposure that distinguishes the rural environment and is known to cause asthma is the organic dusts.", {"entities": [[105, 111, "DISEASE"]]}], ["However, animal-derived proteins, common allergens, and low concentrations of irritants also contribute to the development of airway disease in children and adults living in rural communities.", {"entities": []}], ["A fundamental unanswered question regarding asthma is why only a minority of children who wheeze at an early age develop persistent airway disease that continues throughout their life.", {"entities": [[44, 50, "DISEASE"]]}], ["Although genetic factors are important in the development of asthma, recurrent airway inflammation, presumably mediated by environmental exposures, may result in persistent airway hyperresponsiveness and the development of chronic airway disease.", {"entities": [[61, 67, "DISEASE"]]}], ["Increasing evidence indicates that control of the acute inflammatory response substantially improves airflow and reduces chronic airway remodeling.", {"entities": []}], ["Reducing exposure to agricultural dusts and treatment with anti-inflammatory medication is indicated in most cases of childhood asthma.", {"entities": [[128, 134, "DISEASE"]]}], ["In addition, children with asthma from rural (in comparison to urban) America face multiple barriers that adversely affect their health e.g., more poverty, geographic barriers to health care, less health insurance, and poorer access to health care providers.", {"entities": [[27, 33, "DISEASE"]]}], ["These unique problems must be considered in developing interventions that effectively reduce the morbidity and mortality of asthma in children from rural communities.", {"entities": [[124, 130, "DISEASE"]]}], ["Antibiotic exposure in early life can lead to a significant change of the gut microbiota and may contribute to later onset of inflammatory bowel disease (IBD).", {"entities": [[126, 152, "DISEASE"]]}], ["However, the relationship between early-life antibiotic treatment and IBD is ambiguous, according to contradicting results of epidemiologic studies.", {"entities": []}], ["In the present study, we demonstrated that low-dose penicillin pre-treatment had a unique protective effect against mouse colitis induced by dextran sodium sulfate (DSS).", {"entities": []}], ["Low-dose penicillin also suppressed the expression of pro-inflammatory cytokine IL-17 in various intestinal tissues, and decreased the amount of Th17 cells in small-intestine lamina propria.", {"entities": []}], ["Neither metronidazole nor enrofloxacin had a similar effect.", {"entities": []}], ["We further confirmed that low-dose penicillin could cause specific changes of the gut microbiota, especially the eradication of segmented filamentous bacteria (SFB).", {"entities": []}], ["Mice without SFB inoculation showed no disparity when treated with penicillin or water.", {"entities": []}], ["Taken together, the results showed that low-dose penicillin can achieve a highly specific manipulation of sensitive bacteria and interfere with development of intestinal immune system in early life.", {"entities": []}], ["The study may further indicate the possibility of achieving a favorable immune state among a certain group of patients with IBD, or other autoimmune diseases, by fine-tuning the gut microbiota.", {"entities": []}], ["To evaluate the association between physical activity changes in those aged 11 to 15 years and lung function at age 15 years.", {"entities": []}], ["The original cohort comprised 5,249 hospital-born children during the calendar year of 1993 in Pelotas, Brazil.", {"entities": []}], ["In 2004\u20132005 and 2008\u20132009, all cohort members were sought for follow-up visits.", {"entities": []}], ["Self-reported physical activity was measured at ages 11 and 15 years.", {"entities": []}], ["At the 2008\u20132009 visit, when participants were 15 years old, spirometry was performed.", {"entities": []}], ["Linear regression was used, and all analyses were stratified by sex.", {"entities": []}], ["Of the 5,249 original members of the cohort, 4,325 were located at 15 years of age, and spirometry was performed on 4,010 members.", {"entities": []}], ["Forced expiratory volume in 1 second was not associated with physical activity.", {"entities": []}], ["In girls, those who were active in leisure time in both periods have better percent-predicted forced vital capacity ( \u03b2 = 3.573 [95% confidence interval {CI}: 1.015, 6.130]) and forced expiratory volume in the 6 seconds ( \u03b2 = .095 [95% CI: .021, .168]) than those who were inactive in the two periods.", {"entities": []}], ["Also in girls, those who became active at 15 years of age had higher peak expiratory flow than those who were inactive at 11 and 15 years of age.", {"entities": []}], ["In boys, only those who became inactive in leisure time had worse peak expiratory flow ( \u03b2 = \u2212.180 [95% CI: \u2212.339, \u2212.021]) than boys who were inactive at ages 11 and 15 years.", {"entities": []}], ["Self-reported leisure-time physical activity was associated with better effort-dependent lung function parameters, particularly among girls.", {"entities": []}], ["The hard-shelled mussel ( Mytilus coruscus ) has been used as Chinese traditional medicine for thousands of years; however, to date the ingredients responsible for the various beneficial health outcomes attributed to Mytilus coruscus are still unclear.", {"entities": []}], ["An \u03b1- d -Glucan, called MP-A, was isolated from Mytilus coruscus , and observed to exert anti-inflammatory activity in THP-1 human macrophage cells.", {"entities": []}], ["Specifically, we showed that MP-A treatment inhibited the production of inflammatory markers, including TNF-\u03b1, NO, and PGE2, inducible NOS (iNOS), and cyclooxygenase-2 (COX-2), in LPS-activated THP-1 cells.", {"entities": []}], ["It was also shown to enhance phagocytosis in the analyzed cells, but to severely inhibit the phosphorylation of mitogen-activated protein kinases (MAPKs) and the nuclear translocation of NF-\u03baB P65.", {"entities": []}], ["Finally, MP-A was found to exhibit a high binding affinity for the cell surface receptor TLR4, but a low affinity for TLR2 and dectin-1, via surface plasmon resonance (SPR) analysis.", {"entities": [[89, 93, "GENE"], [118, 122, "GENE"], [168, 171, "GENE"]]}], ["The study indicates that MP-A suppresses LPS-induced TNF-\u03b1, NO and PEG2 production via TLR4/NF-\u03baB/MAPK pathway inhibition, and suggests that MP-A may be a promising therapeutic candidate for diseases associated with TNF-\u03b1, NO, and/or PEG2 overproduction.", {"entities": []}], ["The Breathlessness Intervention Service is a novel service for patients with intractable breathlessness regardless of aetiology.", {"entities": []}], ["It is being evaluated using the Medical Research Council's framework for the evaluation of complex interventions.", {"entities": []}], ["This paper describes the feasibility results of Phase II: a single-blinded fast-track pragmatic randomised controlled trial.", {"entities": []}], ["A single-blinded fast-track pragmatic randomised controlled trial was conducted for patients with chronic obstructive pulmonary disease referred to the service.", {"entities": [[98, 135, "DISEASE"]]}], ["Patients were randomised to either receive the intervention immediately for an eight-week period, or receive the intervention after an eight-week period on a waiting list during which time they received standard care.", {"entities": []}], ["Outcomes examined included: response rates to the trial; response rates to the individual questionnaires and items; comments relating to the trial functioning made during interviews with patients, carers, referrers and service providers; and, researcher fieldwork notes.", {"entities": []}], ["16 of the 20 eligible patients agreed to participate in a recruitment visit (16/20); 14 respondents went on to complete a recruitment visit/baseline interview.", {"entities": []}], ["The majority of those who completed a recruitment visit/baseline interview completed the RCT protocol (13/14); 12 of their carers were recruited and completed the protocol.", {"entities": []}], ["An unblinding rate of 6/25 respondents (patients and carers) was identified.", {"entities": []}], ["Missing data were minimal and only one patient was lost to follow up.", {"entities": []}], ["The fast-track trial methodology proved feasible and acceptable.", {"entities": []}], ["Two of the baseline/outcome measures proved unsuitable: the WHO performance scale and the Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW).", {"entities": []}], ["This study adds to the evidence that fast-track randomised controlled trials are feasible and acceptable in evaluations of palliative care interventions for patients with non-malignant conditions.", {"entities": []}], ["Reasonable response rates and low attrition rates were achieved.", {"entities": []}], ["Further, with adequate preparation of the research and randomisation teams, clinicians, and responders, and effective liaison with the clinicians, single-blinding proved possible.", {"entities": []}], ["Methods were identified to reduce unblinding through careful attention to the type of data collected at unblinded measurement points; the content of interviews should be carefully considered when designing blinded-trial protocols.", {"entities": []}], ["Clinical Trials.gov NCT00711438", {"entities": []}], ["We present the case of a 28-year-old man who presented with chest pain and elevated cardiac biomarkers, with no evidence of acute ischaemia.", {"entities": []}], ["He had a pronounced eosinophilia, abnormal echocardiographic, cardiac MRI and CT findings.", {"entities": [[20, 32, "DISEASE"]]}], ["He underwent transbronchial biopsy of carinal lymph nodes and of lung parenchyma.", {"entities": []}], ["Endomyocardial biopsy yielded an eosinophilic infiltrate.", {"entities": []}], ["He was treated with high dose glucocorticoids and made a rapid recovery.", {"entities": []}], ["Testing for FIP1L1-PDGFRA and other BCR-ABL1 mutations was negative.", {"entities": []}], ["Ultimately, he was diagnosed with eosinophilic granulomatosis with polyangiitis, also known as Churg-Strauss syndrome.", {"entities": [[109, 117, "DISEASE"]]}], ["An immunosuppressive subgroup of neutrophils, low density neutrophils (LDNs) was reported to be closely related to several diseases.", {"entities": []}], ["This study was designed to explore the association between LDNs and advanced lung adenocarcinoma, as well as potential mechanisms.", {"entities": [[82, 96, "DISEASE"], [77, 96, "DISEASE"]]}], ["The expression levels of surface CD molecules on LDNs were different from high density neutrophils (HDNs), consistent with previous studies.", {"entities": []}], ["The ratio of LDNs/HDNs, rather than the percentage of LDNs in peripheral blood mononuclear cells (PBMCs), was significantly higher in lung adenocarcinoma patients than healthy controls.", {"entities": [[139, 153, "DISEASE"], [134, 153, "DISEASE"]]}], ["It was also observed that the ratio decreased when patients received anti-cancer treatments, and increased when disease relapsed.", {"entities": [[74, 80, "DISEASE"]]}], ["Patients harboring positive epidermal growth factor receptor (EGFR) mutation had significantly higher ratios.", {"entities": [[62, 66, "GENE"]]}], ["Both the ratio and the percentage showed positive correlation with CD8+ T cells.", {"entities": []}], ["Although significantly increased TGF-\u03b2 was detected in lung adenocarcinoma patients, relationship between TGF-\u03b2 and LDNs was not obvious.", {"entities": [[60, 74, "DISEASE"], [55, 74, "DISEASE"]]}], ["LDNs and HDNs levels of peripheral blood from 52 lung adenocarcinoma patients and 13 healthy controls were determined by flow cytometry.", {"entities": [[54, 68, "DISEASE"], [49, 68, "DISEASE"]]}], ["Lymphocytes and cytokines were also detected.", {"entities": []}], ["Two kinds of neutrophils with different phenotypes were identified in lung adenocarcinoma patients.", {"entities": [[75, 89, "DISEASE"], [70, 89, "DISEASE"]]}], ["Besides, we found the existence of high ratio of LDNs/HDNs in these patients, which is related to disease prognosis, EGFR mutation and bad immune status.", {"entities": [[117, 121, "GENE"]]}], ["This review focuses on polymer field-effect transistor (PFET) based gas sensor with polymer as the sensing layer, which interacts with gas analyte and thus induces the change of source-drain current (\u0394 I SD ).", {"entities": []}], ["Dependent on the sensing layer which can be semiconducting polymer, dielectric layer or conducting polymer gate, the PFET sensors can be subdivided into three types.", {"entities": []}], ["For each type of sensor, we present the molecular structure of sensing polymer, the gas analyte and the sensing performance.", {"entities": []}], ["Most importantly, we summarize various analyte\u2013polymer interactions, which help to understand the sensing mechanism in the PFET sensors and can provide possible approaches for the sensor fabrication in the future.", {"entities": []}], ["Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder that manifests as pulmonary emphysema, liver cirrhosis and, rarely, as the skin disease panniculitis, and is characterized by low serum levels of AAT, the main protease inhibitor (PI) in human serum.", {"entities": [[148, 160, "DISEASE"], [99, 114, "DISEASE"], [78, 97, "DISEASE"], [135, 147, "DISEASE"], [43, 59, "DISEASE"]]}], ["The prevalence in Western Europe and in the USA is estimated at approximately 1 in 2,500 and 1 : 5,000 newborns, and is highly dependent on the Scandinavian descent within the population.", {"entities": []}], ["The most common deficiency alleles in North Europe are PI Z and PI S, and the majority of individuals with severe AATD are PI type ZZ.", {"entities": []}], ["The clinical manifestations may widely vary between patients, ranging from asymptomatic in some to fatal liver or lung disease in others.", {"entities": [[114, 126, "DISEASE"]]}], ["Type ZZ and SZ AATD are risk factors for the development of respiratory symptoms (dyspnoea, coughing), early onset emphysema, and airflow obstruction early in adult life.", {"entities": []}], ["Environmental factors such as cigarette smoking, and dust exposure are additional risk factors and have been linked to an accelerated progression of this condition.", {"entities": []}], ["Type ZZ AATD may also lead to the development of acute or chronic liver disease in childhood or adulthood: prolonged jaundice after birth with conjugated hyperbilirubinemia and abnormal liver enzymes are characteristic clinical signs.", {"entities": [[66, 79, "DISEASE"]]}], ["Cirrhotic liver failure may occur around age 50.", {"entities": []}], ["In very rare cases, necrotizing panniculitis and secondary vasculitis may occur.", {"entities": [[32, 44, "DISEASE"], [59, 69, "DISEASE"]]}], ["AATD is caused by mutations in the SERPINA1 gene encoding AAT, and is inherited as an autosomal recessive trait.", {"entities": [[35, 43, "GENE"]]}], ["The diagnosis can be established by detection of low serum levels of AAT and isoelectric focusing.", {"entities": []}], ["Differential diagnoses should exclude bleeding disorders or jaundice, viral infection, hemochromatosis, Wilson's disease and autoimmune hepatitis.", {"entities": [[87, 102, "DISEASE"], [125, 145, "DISEASE"], [136, 145, "DISEASE"]]}], ["For treatment of lung disease, intravenous alpha-1-antitrypsin augmentation therapy, annual flu vaccination and a pneumococcal vaccine every 5 years are recommended.", {"entities": [[17, 29, "DISEASE"]]}], ["Relief of breathlessness may be obtained with long-acting bronchodilators and inhaled corticosteroids.", {"entities": []}], ["The end-stage liver and lung disease can be treated by organ transplantation.", {"entities": [[24, 36, "DISEASE"]]}], ["In AATD patients with cirrhosis, prognosis is generally grave.", {"entities": []}], ["To assess the clinical significance of IL-17 in patients with sepsis-induced acute respiratory distress syndrome (ARDS) and to investigate the effects of IL-17 blocking in a mouse model of acute lung injury (ALI).", {"entities": [[104, 112, "DISEASE"]]}], ["Significantly increased IL-17 level was found in patients with sepsis-related ARDS compared to healthy controls, whereas significantly increased plasma IL-17 level was also observed in non-survivors compared to that in survivors.", {"entities": []}], ["According to the data from the mouse ALI model, we found significantly increased IL-17 level in lung tissue lysates, mouse bronchoalveolar lavage fluid (mBALF) and plasma at 6, 12 and 24 h after ALI.", {"entities": []}], ["Histological analyses revealed that reduced sign of pathological changes and lung injury score in the lungs at 48 h after IL-17 blocking antibody administration.", {"entities": []}], ["Reduced level of proinflammatory tumor necrosis factor \u03b1 and increased level of anti-inflammatory factor interleukin-10 were found in both mBALF and plasma.", {"entities": []}], ["Moreover, IL-17 blocking antibody administration attenuated the expression of ROR\u03b3t and activity of PI3K-Akt pathway.", {"entities": []}], ["Increased IL-17 was presented in patients with sepsis-induced ARDS and IL-17 may serve as a biomarker to indicate the severity of ARDS.", {"entities": []}], ["Moreover, IL-17 antibody administration could relieve the ALI symptom by affecting ROR\u03b3t level and PI3K pathway.", {"entities": []}], ["Month-long daytime Ramadan fasting pose s major challenges to multiple sclerosis (MS) patients in Muslim countries.", {"entities": [[62, 80, "DISEASE"]]}], ["Physicians should have practical knowledge on the implications of fasting on MS. We present a summary of database searches (Cochrane Database of Systematic Reviews, PubMed) and a mini-symposium on Ramadan fasting and MS.", {"entities": []}], ["In this symposium, we aimed to review the effect of fasting on MS and suggest practical guidelines on management.", {"entities": []}], ["In general, fasting is possible for most stable patients.", {"entities": []}], ["Appropriate amendment of drug regimens, careful monitoring of symptoms, as well as providing patients with available evidence on fasting and MS are important parts of management.", {"entities": []}], ["Evidence from experimental studies suggests that calorie restriction before disease induction reduces inflammation and subsequent demyelination and attenuates disease severity.", {"entities": []}], ["Fasting does not appear to have unfavorable effects on disease course in patients with mild disability (Expanded Disability Status Scale (EDSS) score \u22643).", {"entities": []}], ["Most experts believed that during fasting (especially in summer), some MS symptoms (fatigue, fatigue perception, dizziness, spasticity, cognitive problems, weakness, vision, balance, gait) might worsen but return to normal levels during feasting.", {"entities": []}], ["There was a general consensus that fasting is not safe for patients: on high doses of anti-convulsants, anti-spastics, and corticosteroids; with coagulopathy or active disease; during attacks; with EDSS score \u22657.", {"entities": []}], ["These data suggest that MS patients should have tailored care.", {"entities": []}], ["Fasting in MS patients is a challenge that is directly associated with the spiritual belief of the patient.", {"entities": []}], ["Asthma is a chronic respiratory disorder which is associated with airway inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["Environmental factors, in association with genetic susceptibility, play a critical role in asthma pathophysiology.", {"entities": [[91, 97, "DISEASE"]]}], ["Inhaled allergens, smoke exposure, indoor and outdoor air pollution are common triggers of asthma symptoms.", {"entities": [[91, 97, "DISEASE"]]}], ["Although the role of diet has clearly established mechanisms in diseases such as cardiovascular disease, type 2 diabetes, and cancer, it is not commonly identified as a causal factor in asthma.", {"entities": [[186, 192, "DISEASE"], [126, 132, "DISEASE"]]}], ["However, some dietary patterns, such as the Western diet, which includes a high intake of refined grains, processed and red meats, and desserts, have pro-inflammatory effects.", {"entities": []}], ["On the contrary, the Mediterranean diet, with high intake of fruits and vegetables has anti-inflammatory properties.", {"entities": []}], ["The influence of food on asthma outcomes is of growing interest, but dietary habits of asthma patients are not commonly investigated in clinical practice.", {"entities": [[25, 31, "DISEASE"], [87, 93, "DISEASE"]]}], ["In this review, we focus on the impact of diet on asthma risk and asthma control.", {"entities": [[50, 56, "DISEASE"], [66, 72, "DISEASE"]]}], ["We also detail the influence of diet on obese patients with asthma.", {"entities": [[60, 66, "DISEASE"]]}], ["Regorafenib (BAY 73-4506, Stivarga\u00ae Bayer HealthCare Pharmaceutical Inc) is an oral multikinase inhibitor with a distinct and wide-ranging profile of tyrosine kinase inhibition, resulting in antiangiogenic and antiproliferative properties in tumors.", {"entities": []}], ["Single-agent regorafenib administered as a 160-mg daily dose for the first 21\u00a0days of a 28-day cycle is approved for use in patients with pretreated metastatic colorectal cancer (mCRC) and gastrointestinal stromal tumor (GIST) progressing on imatinib and sunitinib, following publication of data from the phase III CORRECT and GRID studies respectively.", {"entities": [[189, 219, "DISEASE"], [160, 177, "DISEASE"], [171, 177, "DISEASE"]]}], ["Regorafenib is currently under phase III investigation in patients with hepatocellular carcinoma and is in several phase II studies in patients with gastrointestinal (GI) tumors.", {"entities": [[72, 96, "DISEASE"], [87, 96, "DISEASE"]]}], ["This review describes the clinical development of regorafenib in patients with GI cancers, and highlights the key issues important for the modern day clinical pharmacist who forms part of the multidisciplinary team ensuring safe and effective delivery of the drug to the patient.", {"entities": []}], ["This information is considered of particular importance to the clinical pharmacist for the future development of regorafenib in this treatment setting.", {"entities": []}], ["Several infrequent genetic polymorphisms in the SERPINA1 gene are known to substantially reduce concentration of alpha1-antitrypsin (AAT) in the blood.", {"entities": [[48, 56, "GENE"]]}], ["Since low AAT serum levels fail to protect pulmonary tissue from enzymatic degradation, these polymorphisms also increase the risk for early onset chronic obstructive pulmonary disease (COPD).", {"entities": [[147, 184, "DISEASE"]]}], ["The role of more common SERPINA1 single nucleotide polymorphisms (SNPs) in respiratory health remains poorly understood.", {"entities": [[24, 32, "GENE"]]}], ["We present here an agnostic investigation of genetic determinants of circulating AAT levels in a general population sample by performing a genome-wide association study (GWAS) in 1392 individuals of the SAPALDIA cohort.", {"entities": []}], ["Five common SNPs, defined by showing minor allele frequencies (MAFs) >5%, reached genome-wide significance, all located in the SERPINA gene cluster at 14q32.13.", {"entities": []}], ["The top-ranking genotyped SNP rs4905179 was associated with an estimated effect of \u03b2\u200a=\u200a\u22120.068 g/L per minor allele (P\u200a=\u200a1.20*10 SERPINA1 locus genotyping in 5569 participants with subsequent stepwise conditional analysis, as well as exon-sequencing in a subsample (N\u200a=\u200a410), suggested that AAT serum level is causally determined at this locus by rare (MAF<1%) and low-frequent (MAF 1\u20135%) variants only, in particular by the well-documented protein inhibitor S and Z (PI S, PI Z) variants.", {"entities": [[128, 136, "GENE"], [352, 355, "GENE"], [378, 381, "GENE"], [352, 355, "GENE"], [378, 381, "GENE"]]}], ["Replication of the association of rs4905179 with AAT serum levels in the Copenhagen City Heart Study (N\u200a=\u200a8273) was successful (P<0.0001), as was the replication of its synthetic nature (the effect disappeared after adjusting for PI S and Z, P\u200a=\u200a0.57).", {"entities": []}], ["Extending the analysis to lung function revealed a more complex situation.", {"entities": []}], ["Only in individuals with severely compromised pulmonary health (N\u200a=\u200a397), associations of common SNPs at this locus with lung function were driven by rarer PI S or Z variants.", {"entities": []}], ["Overall, our meta-analysis of lung function in ever-smokers does not support a functional role of common SNPs in the SERPINA gene cluster in the general population.", {"entities": []}], ["Low levels of alpha1-antitrypsin (AAT) in the blood are a well-established risk factor for accelerated loss in lung function and chronic obstructive pulmonary disease.", {"entities": [[129, 166, "DISEASE"]]}], ["While a few infrequent genetic polymorphisms are known to influence the serum levels of this enzyme, the role of common genetic variants has not been examined so far.", {"entities": []}], ["The present genome-wide scan for associated variants in approximately 1400 Swiss inhabitants revealed a chromosomal locus containing the functionally established variants of AAT deficiency and variants previously associated with lung function and emphysema.", {"entities": []}], ["We used dense genotyping of this genetic region in more than 5500 individuals and subsequent conditional analyses to unravel which of these associated variants contribute independently to the phenotype's variability.", {"entities": []}], ["All associations of common variants could be attributed to the rarer functionally established variants, a result which was then replicated in an independent population-based Danish cohort.", {"entities": []}], ["Hence, this locus represents a textbook example of how a large part of a trait's heritability can be hidden in infrequent genetic polymorphisms.", {"entities": []}], ["The attempt to transfer these results to lung function furthermore suggests that effects of common variants in this genetic region in ever-smokers may also be explained by rarer variants, but only in individuals with hampered pulmonary health.", {"entities": []}], ["Myeloid differentiation factor 88 (MyD88) and MyD88-adaptor like (Mal)/Toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) play a critical role in transducing signals downstream of the Toll-like receptor (TLR) family.", {"entities": [[35, 40, "GENE"], [46, 51, "GENE"], [134, 139, "GENE"]]}], ["While genetic ablation of the TLR4/MyD88 signaling axis in mice leads to pulmonary cell death and oxidative stress culminating in emphysema, the involvement of Mal, as well as TLR2 which like TLR4 also signals via MyD88 and Mal, in the pathogenesis of emphysema has not been studied.", {"entities": [[176, 180, "GENE"], [30, 34, "GENE"], [192, 196, "GENE"], [35, 40, "GENE"], [214, 219, "GENE"]]}], ["By employing an in vivo genetic approach, we reveal here that unlike the spontaneous pulmonary emphysema which developed in Tlr4 mice by 6 months of age, the lungs of Tlr2 mice showed no physiological or morphological signs of emphysema.", {"entities": [[85, 104, "DISEASE"], [124, 128, "GENE"], [167, 171, "GENE"]]}], ["A more detailed comparative analysis of the lungs from these mice confirmed that elevated oxidative protein carbonylation levels and increased numbers of alveolar cell apoptosis were only detected in Tlr4 mice, along with up-regulation of NADPH oxidase 3 ( Nox3 ) mRNA expression.", {"entities": [[200, 204, "GENE"], [257, 261, "GENE"]]}], ["With respect to Mal, the architecture of the lungs of Mal mice was normal.", {"entities": []}], ["However, despite normal oxidative protein carbonylation levels in the lungs of emphysema-free Mal mice, these mice displayed increased levels of apoptosis comparable to those observed in emphysematous Tlr4 mice.", {"entities": [[201, 205, "GENE"]]}], ["In conclusion, our data provide in vivo evidence for the non-essential role for TLR2, unlike the related TLR4, in maintaining the normal architecture of the lung.", {"entities": [[80, 84, "GENE"], [105, 109, "GENE"]]}], ["In addition, we reveal that Mal differentially facilitates the anti-apoptotic, but not oxidant suppressive, activities of TLR4 in the lung, both of which appear to be essential for TLR4 to prevent the onset of emphysema.", {"entities": [[122, 126, "GENE"], [181, 185, "GENE"], [122, 126, "GENE"], [181, 185, "GENE"]]}], ["Despite the seemingly insatiable interest in healthcare professional\u2013patient communication, less attention has been paid to the use of non-verbal communication in medical consultations.", {"entities": []}], ["This article considers pharmacists\u2032 and patients\u2032 use of non-verbal communication to interact directly in consultations in which they do not share a common language.", {"entities": []}], ["In total, 12 video-recorded, interpreted pharmacy consultations concerned with a newly prescribed medication or a change in medication were analysed in detail.", {"entities": []}], ["The analysis focused on instances of direct communication initiated by either the patient or the pharmacist, despite the presence of a multilingual pharmacy assistant acting as an interpreter.", {"entities": []}], ["Direct communication was shown to occur through (i) the demonstration of a medical device, (ii) the indication of relevant body parts and (iii) the use of limited English.", {"entities": []}], ["These connections worked to make patients and pharmacists visible to each other and thus to maintain a sense of mutual involvement in consultations within which patients and pharmacists could enact professionally and socially appropriate roles.", {"entities": []}], ["In a multicultural society this work is important in understanding the dynamics involved in consultations in situations in which language is not shared and thus in considering the development of future research and policy.", {"entities": []}], ["SOCS2-deficient T cells more readily produce Th2 cytokines, and SOCS2-deficient mice exhibit exacerbated atopic dermatitis and allergic airway inflammation.", {"entities": [[105, 122, "DISEASE"], [112, 122, "DISEASE"]]}], ["The incidence of allergy and asthma in developed countries is on the increase and this trend looks likely to continue.", {"entities": [[29, 35, "DISEASE"]]}], ["To evaluate the safety and effectiveness of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA) in real-world clinical settings in Japan.", {"entities": [[108, 117, "DISEASE"]]}], ["Paediatric patients with sJIA initiating TCZ between April 2008 and February 2012 and those previously enrolled in clinical trials who initiated TCZ before April 2008 were enrolled in a Japanese registry surveillance programme.", {"entities": []}], ["Safety and effectiveness parameters were collected for 52\u2005weeks.", {"entities": []}], ["Of 417 patients enrolled, mean age was 11.2\u2005years and 48.0% were female.", {"entities": []}], ["TCZ exposure was 407.0 patient-years (PYs).", {"entities": []}], ["Baseline corticosteroid use was higher than in clinical trials.", {"entities": []}], ["Rates of total adverse events (AEs) and serious AEs (SAEs) were 224.3/100 PYs and 54.5/100 PYs, respectively, with SAEs higher than previously reported.", {"entities": []}], ["The most frequent AEs and SAEs were infections and infestations (69.8/100 PYs and 18.2/100 PYs, respectively).", {"entities": []}], ["74 serious infections occurred in 55 patients (18.2/100 PYs); higher than previously reported.", {"entities": []}], ["26 macrophage activation syndrome events were reported in 24 patients (6.4/100 PYs).", {"entities": [[25, 33, "DISEASE"]]}], ["Fever and rash symptoms improved from baseline to week 52 (54.6% to 5.6% and 43.0% to 5.6%, respectively).", {"entities": []}], ["At 4 weeks, 8 weeks and 52\u2005weeks, 90.5%, 96.2% and 99.0% of patients achieved normal C reactive protein levels (<0.3\u2005mg/dL), respectively.", {"entities": []}], ["These first real-world data demonstrated that TCZ was well tolerated, with acceptable safety and effectiveness in patients with sJIA.", {"entities": []}], ["Higher incidences of SAEs and serious infections may be due to differences, such as corticosteroid use and concomitant diseases, between patient populations enrolled in previously reported clinical trials and this study.", {"entities": []}], ["Natural compounds often have complex molecular structures and unknown molecular targets.", {"entities": []}], ["These characteristics make them difficult to analyse using a classical pharmacological approach.", {"entities": []}], ["Curcumin, the main curcuminoid of turmeric, is a complex molecule possessing wide-ranging biological activities, cellular mechanisms and roles in potential therapeutic treatment, including Alzheimer's disease and cancer.", {"entities": [[213, 219, "DISEASE"]]}], ["Here, we investigate the physiological effects and molecular targets of curcumin in Dictyostelium discoideum .", {"entities": []}], ["We show that curcumin exerts acute effects on cell behaviour, reduces cell growth and slows multicellular development.", {"entities": []}], ["We employed a range of structurally related compounds to show the distinct role of different structural groups in curcumin's effects on cell behaviour, growth and development, highlighting active moieties in cell function, and showing that these cellular effects are unrelated to the well-known antioxidant activity of curcumin.", {"entities": []}], ["Molecular mechanisms underlying the effect of curcumin and one synthetic analogue (EF24) were then investigated to identify a curcumin-resistant mutant lacking the protein phosphatase 2A regulatory subunit (PsrA) and an EF24-resistant mutant lacking the presenilin 1 orthologue (PsenB).", {"entities": []}], ["Using in silico docking analysis, we then showed that curcumin might function through direct binding to a key regulatory region of PsrA.", {"entities": []}], ["These findings reveal novel cellular and molecular mechanisms for the function of curcumin and related compounds.", {"entities": []}], ["Summary: To unlock the therapeutic potential of curcumin and related compounds, we employ a tractable model system to characterise their cellular and molecular effects and propose novel targets implicated in disease.", {"entities": []}], ["Direct measurement of exposure to volatile organic compounds (VOCs) via personal monitoring is the most accurate exposure assessment method available.", {"entities": []}], ["However, its wide-scale application to evaluating exposures at the population level is prohibitive in terms of both cost and time.", {"entities": []}], ["Consequently, indirect measurements via a combination of microenvironment concentrations and personal activity diaries represent a potentially useful alternative.", {"entities": []}], ["The aim of this study was to optimize a model of personal exposures (PEs) based on microenvironment concentrations and time/activity diaries and to compare modeled with measured exposures in an independent data set.", {"entities": []}], ["VOC PEs and a range of microenvironment concentrations were collected with active samplers and sorbent tubes.", {"entities": []}], ["Data were supplemented with information collected through questionnaires.", {"entities": []}], ["Seven models were tested to predict PE to VOCs in 75% ( n = 370) of the measured PE data set, whereas the other 25% ( n = 120) was used for validation purposes.", {"entities": []}], ["The best model able to predict PE with independence of measurements was based upon stratified microenvironment concentrations, lifestyle factors, and individual-level activities.", {"entities": []}], ["The proposed model accounts for 40\u201385% of the variance for individual VOCs and was validated for almost all VOCs, showing normalized mean bias and mean fractional bias below 25% and predicting 60% of the values within a factor of 2.", {"entities": []}], ["The models proposed identify the most important non-weather-related variables for VOC exposures; highlight the effect of personal activities, use of solvents, and exposure to environmental tobacco smoke on PE levels; and may assist in the development of specific models for other locations.", {"entities": []}], ["Fish oils (FOs) have anti-inflammatory effects and lower serum triglycerides.", {"entities": [[11, 14, "GENE"]]}], ["This study examined adipose and muscle inflammatory markers after treatment of humans with FOs and measured the effects of \u03c9-3 fatty acids on adipocytes and macrophages in vitro.", {"entities": [[91, 94, "GENE"]]}], ["Insulin-resistant, nondiabetic subjects were treated with Omega-3-Acid Ethyl Esters (4 g/day) or placebo for 12 weeks.", {"entities": []}], ["Plasma macrophage chemoattractant protein 1 (MCP-1) levels were reduced by FO, but the levels of other cytokines were unchanged.", {"entities": []}], ["The adipose (but not muscle) of FO-treated subjects demonstrated a decrease in macrophages, a decrease in MCP-1, and an increase in capillaries, and subjects with the most macrophages demonstrated the greatest response to treatment.", {"entities": []}], ["Adipose and muscle \u03c9-3 fatty acid content increased after treatment; however, there was no change in insulin sensitivity or adiponectin.", {"entities": []}], ["In vitro, M1-polarized macrophages expressed high levels of MCP-1.", {"entities": []}], ["The addition of \u03c9-3 fatty acids reduced MCP-1 expression with no effect on TNF-\u03b1.", {"entities": []}], ["In addition, \u03c9-3 fatty acids suppressed the upregulation of adipocyte MCP-1 that occurred when adipocytes were cocultured with macrophages.", {"entities": []}], ["Thus, FO reduced adipose macrophages, increased capillaries, and reduced MCP-1 expression in insulin-resistant humans and in macrophages and adipocytes in vitro; however, there was no measureable effect on insulin sensitivity.", {"entities": []}], ["Respiratory failure from severe asthma is a potentially reversible, life-threatening condition.", {"entities": [[32, 38, "DISEASE"]]}], ["Poor outcome in this setting is frequently a result of the development of gas-trapping.", {"entities": []}], ["This condition can arise in any mechanically ventilated patient, but those with severe airflow limitation have a predisposition.", {"entities": []}], ["It is important that clinicians managing these types of patients understand that the use of mechanical ventilation can lead to or worsen gas-trapping.", {"entities": []}], ["In this review we discuss the development of this complication during mechanical ventilation, techniques to measure it and strategies to limit its severity.", {"entities": []}], ["We hope that by understanding such concepts clinicians will be able to reduce further the poor outcomes occasionally related to severe asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Hochuekkito, a traditional herbal medicine, is occasionally prescribed in Japan to treat patients with a poor general condition.", {"entities": []}], ["We aimed to examine whether this medicine was beneficial and tolerable for patients with progressed pulmonary Mycobacterium avium complex (MAC) disease.", {"entities": []}], ["This pilot open-label quasi-randomized controlled trial enrolled 18 patients with progressed pulmonary MAC disease who had initiated antimycobacterial treatment over one year ago but were persistently culture-positive or intolerant.", {"entities": []}], ["All patients continued their baseline treatment regimens with (n\u200a=\u200a9) or without (n\u200a=\u200a9) oral Hochuekkito for 24 weeks.", {"entities": []}], ["Baseline characteristics were generally similar between the groups.", {"entities": []}], ["Most patients were elderly (median age 70 years), female, had a low body mass index (<20 kg/m Hochuekkito could be an effective, feasible adjunct to conventional therapy for patients with progressed pulmonary MAC disease.", {"entities": []}], ["Future study is needed to explore this possibility.", {"entities": []}], ["UMIN Clinical Trials Registry UMIN000009920", {"entities": []}], ["Peru is what Peruvian anthropologist Lupe Camino calls the \u201chealth axis\u201d of the old Central Andean culture area stretching from Ecuador to Bolivia.", {"entities": []}], ["In particular in the North of the country the traditional use of medicinal dates back as far as the first millennium B.C.", {"entities": []}], ["Both healers, and the wider population, often buy their medicinal plants in local markets, but there is very little comparative information available about which plants are sold under which vernacular name at any given time, for which indication, and which dosage information and information about side effects is given by vendors.", {"entities": []}], ["For this study we used two traditionally used species groups \u201cHercampuri\u201d Gentianella spec.", {"entities": []}], ["(Gentianaceae) and \u201cPasuchaca\u201d Geranium spec.", {"entities": []}], ["(Geraniaceae .", {"entities": []}], ["), found in the Mercado Aviaci\u00f3n in Lima, as small, clearly circumscribed plant group frequently used to treat symptoms of diabetes as a test case to study the taxonomy, indications, dosage, indicated side effects, and additional species used as admixtures and hypothesized that: 1.", {"entities": []}], ["A wide variety of different species is sold under the same common name, and often several common names exist for one species.", {"entities": []}], ["There is no consistency in the dosage, or a relationship between dosage and species marketed under one name.", {"entities": []}], ["However, there is consistency in the knowledge about usage and side effects.", {"entities": []}], ["Surveys focusing on medicinal plants sold and their properties were conducted at the Mercado Aviaci\u00f3n in Lima in December 2012.", {"entities": []}], ["Vouchers of all specimens were deposited at the National Herbarium of Peru.", {"entities": []}], ["Our surveys in Mercado Aviaci\u00f3n in Lima yielded four species of Gentianella , two of Geranium, and three additional species from three genera used as common additives that were sold as anti-diabetic.", {"entities": []}], ["These results indicate that even in case of only a few plant species, used for a very clearly circumscribed application, patients run a considerable risk when purchasing their remedies in the market.", {"entities": []}], ["The possible side effects in this case are the more serious because diabetes has to be treated long term, and as such the patients are ingesting possible toxic remedies over a long period of time.", {"entities": []}], ["Much more control, and a much more stringent identification of the material sold in public markets, and entering the global supply chain via internet sales, would be needed.", {"entities": []}], ["Infections with human respiratory syncytial virus (HRSV) occur globally in all age groups and can have devastating consequences in young infants.", {"entities": []}], ["We demonstrate that a vaccine based on the extracellular domain (SHe) of the small hydrophobic (SH) protein of HRSV, reduced viral replication in challenged laboratory mice and in cotton rats.", {"entities": []}], ["We show that this suppression of viral replication can be transferred by serum and depends on a functional IgG receptor compartment with a major contribution of Fc\u03b3RI and Fc\u03b3RIII.", {"entities": []}], ["Using a conditional cell depletion method, we provide evidence that alveolar macrophages are involved in the protection by SHe-specific antibodies.", {"entities": []}], ["HRSV-infected cells abundantly express SH on the cell surface and are likely the prime target of the humoral immune response elicited by SHe-based vaccination.", {"entities": []}], ["Finally, natural infection of humans and experimental infection of mice or cotton rats does not induce a strong immune response against HRSV SHe.", {"entities": []}], ["Using SHe as a vaccine antigen induces immune protection against HRSV by a mechanism that differs from the natural immune response and from other HRSV vaccination strategies explored to date.", {"entities": []}], ["Hence, HRSV vaccine candidates that aim at inducing protective neutralizing antibodies or T-cell responses could be complemented with a SHe-based antigen to further improve immune protection.", {"entities": []}], ["Interleukin 17 (IL-17) and its closest relative, IL-17F, have recently drawn much attention in the field of immunology.", {"entities": []}], ["IL-17 and IL-17F are expressed by a distinct type of T cells, T helper 17 cells and certain other lymphocytes.", {"entities": []}], ["These cytokines play key regulatory roles in host defense and inflammatory diseases.", {"entities": []}], ["In this review, we summarize the recent findings in IL-17 biology and the progress towards understanding the regulatory mechanisms of IL-17 expression and signaling mechanisms.", {"entities": []}], ["This knowledge will benefit the development of novel immune modulators that enhance immunity to various infections and reduce inflammatory damage in infected patients.", {"entities": []}], ["Cerebral malaria (CM) is a major cause of death of Plasmodium falciparum infection.", {"entities": [[9, 16, "DISEASE"]]}], ["Misdiagnosis of CM often leads to treatment delay and mortality.", {"entities": []}], ["Conventional brain imaging technologies are rarely applicable in endemic areas.", {"entities": []}], ["Here we address the unmet need for a simple, non-invasive imaging methodology for early diagnosis of CM.", {"entities": []}], ["This study presents the diagnostic and therapeutic monitoring using liposomes containing the FDA-approved fluorescent dye indocyanine green (ICG) in a CM murine model.", {"entities": []}], ["Increased emission intensity of liposomal ICG was demonstrated in comparison with free ICG.", {"entities": []}], ["The Liposomal ICG's emission was greater in the brains of the infected mice compared to na\u00efve mice and drug treated mice (where CM was prevented).", {"entities": []}], ["Histological analyses suggest that the accumulation of liposomal ICG in the cerebral vasculature is due to extensive uptake mediated by activated phagocytes.", {"entities": []}], ["Overall, liposomal ICG offers a valuable diagnostic tool and a biomarker for effectiveness of CM treatment, as well as other diseases that involve inflammation and blood vessel occlusion.", {"entities": []}], ["The roles of EZH2 in various subsets of CD4 Ezh2 in CD4 T cells resulted in reduced numbers of Treg cells in vivo and differentiation in vitro and an increased proportion of memory CD4 T cells in part due to exaggerated production of effector cytokines.", {"entities": [[13, 17, "GENE"], [44, 48, "GENE"], [40, 43, "GENE"], [52, 55, "GENE"], [181, 184, "GENE"], [13, 17, "GENE"], [44, 48, "GENE"], [40, 43, "GENE"], [52, 55, "GENE"], [181, 184, "GENE"], [40, 43, "GENE"], [52, 55, "GENE"], [181, 184, "GENE"]]}], ["Furthermore, we found that both Ezh2- deficient Treg cells and T effector cells were functionally impaired in vivo : Tregs failed to constrain autoimmune colitis and T effector cells neither provided a protective response to T. gondii infection nor mediated autoimmune colitis.", {"entities": []}], ["The dichotomous function of EZH2 in regulating differentiation and senescence in effector and regulatory T cells helps to explain the apparent existing contradictions in literature.", {"entities": [[28, 32, "GENE"]]}], ["Hyperbaric oxygen has been used as a therapy for patients experiencing chronic intestinal syndromes after pelvic radiotherapy for decades, yet the evidence to support the use of this therapy is based almost exclusively on non-randomised studies.", {"entities": []}], ["We aimed to provide conclusive results for the clinical benefits of hyperbaric oxygen in patients with chronic bowel dysfunction after radiotherapy for pelvic malignancies.", {"entities": [[111, 128, "DISEASE"]]}], ["HOT2 was a double-blind, sham-controlled, phase 3 randomised study of patients (\u226518 years) with chronic gastrointestinal symptoms for 12 months or more after radiotherapy and which persisted despite at least 3 months of optimal medical therapy and no evidence of cancer recurrence.", {"entities": [[263, 269, "DISEASE"]]}], ["Participants were stratified by participating hyperbaric centre and randomly assigned (2:1) by a computer-generated list (block size nine or 12) to receive treatment with hyperbaric oxygen therapy or sham.", {"entities": []}], ["Participants in the active treatment group breathed 100% oxygen at 2\u00b74 atmospheres of absolute pressure (ATA) and the control group breathed 21% oxygen at 1\u00b73 ATA; both treatment groups received 90-min air pressure exposures once daily for 5 days per week for a total of 8 weeks (total of 40 exposures).", {"entities": []}], ["Staff at the participating hyperbaric medicine facilities knew the allocated treatment, but patients, clinicians, nurse practitioners, and other health-care professionals associated with patients' care were masked to treatment allocation.", {"entities": []}], ["Primary endpoints were changes in the bowel component of the modified Inflammatory Bowel Disease Questionnaire (IBDQ) score and the IBDQ rectal bleeding score 12 months after start of treatment relative to baseline.", {"entities": []}], ["The primary outcome was analysed in a modified intention-to-treat population, excluding patients who did not provide IBDQ scores within a predetermined time-frame.", {"entities": []}], ["All patients have completed 12 months of follow-up and the final analysis is complete.", {"entities": []}], ["The trial is registered with the ISRCTN registry, number ISRCTN86894066.", {"entities": []}], ["Between Aug 14, 2009, and Oct 23, 2012, 84 participants were randomly assigned: 55 to hyperbaric oxygen and 29 to sham control.", {"entities": []}], ["75 (89%) participants received 40 pressure exposures, all participants returned the IBDQ at baseline, 75 (89%) participants returned the IBDQ at 2 weeks post-treatment, and 79 (94%) participants returned the IBDQ at 12 months post-start of treatment.", {"entities": []}], ["Patients were excluded from analyses of co-primary endpoints if they had missing IBDQ scores for intestinal function or rectal bleeding at baseline or at 12 months.", {"entities": []}], ["In an analysis of 46 participants in the active treatment group and 23 participants in the control group, we found no significant differences in the change of IBDQ bowel component score (median change from baseline to 12 months of 4 (IQR \u22123 to 11) in the treatment group vs 4 (\u22126 to 9) in the sham group; Mann-Whitney U score 0\u00b767, p=0\u00b750).", {"entities": []}], ["In an analysis of 29 participants in the active treatment group and 11 participants in the sham group with rectal bleeding at baseline, we also found no significant differences in the change of IBDQ rectal bleeding score (median change from baseline to 12 months of 3 [1 to 3] in the treatment group vs 1 [1 to 2] in the sham group; U score 1\u00b769, p=0\u00b7092).", {"entities": []}], ["Common adverse events in both groups were eye refractive changes (three [11%] of 28 patients in the control group vs 16 [30%] of 53 patients in the treatment group), increased fatigue (three [11%] vs two [4%]), and ear pain (six [21%] vs 15 [28%]).", {"entities": []}], ["Eight serious adverse events were reported in eight patients: two were reported in two patients in the control group (tonsillitis requiring surgery [grade 3]; recurrent cancer of the vulva [grade 4]) and six serious adverse events were reported in six patients in the treatment group (malignant spinal cord compression requiring surgery [grade 3]; malignant paraortic lymph node involvement requiring surgery [grade 3]; recurrence of vomiting and dehydration [grade 3]; diarrhoea and fever associated with Campylobacter infection [grade 3]; recurrence of abdominal pain, bloating, diarrhoea, and urinary tract infection [grade 3]; aneurysm [grade 4]), none of which were deemed treatment-related.", {"entities": [[118, 129, "DISEASE"], [169, 175, "DISEASE"]]}], ["We found no evidence that patients with radiation-induced chronic gastrointestinal symptoms, including those patients with rectal bleeding, benefit from hyperbaric oxygen therapy.", {"entities": []}], ["These findings contrast with evidence used to justify current practices, and more level 1 evidence is urgently needed.", {"entities": []}], ["Cancer Research UK and National Health Service (NHS) funding to the National Institute of Health Research Biomedical Research Centre at The Royal Marsden and the Institute of Cancer Research.", {"entities": [[0, 6, "DISEASE"], [175, 181, "DISEASE"], [48, 51, "GENE"]]}], ["To date, determinants of respiratory health in First Nations people living on reserves and means of addressing and redressing those determinants have not been well established.", {"entities": []}], ["Hence the Saskatchewan First Nations Lung Health Project (FNLHP) is a new prospective cohort study of aboriginal people being conducted in two First Nations reserves to evaluate potential health determinants associated with respiratory outcomes.", {"entities": []}], ["Using the population health framework (PHF) of Health Canada, instruments designed with the communities, joint ownership of data, and based on the 4-phase concept of the First Nations Regional Longitudinal Health Survey, the project aims to evaluate individual factors, contextual factors , and principal covariates on respiratory outcomes.", {"entities": []}], ["The objective of this report is to clearly describe the methodology of (i) the baseline survey that consists of two components, an interviewer-administered questionnaire and clinical assessment; and (ii) potential intervention programs; and present descriptive results of the baseline data of longitudinal FNLHP.", {"entities": []}], ["The study is being conducted over 5 years (2012\u20132017) in two phases, baseline and longitudinal.", {"entities": []}], ["Baseline survey has been completed and consisted of (i) an interviewer-administered questionnaire-based evaluation of individual and contextual factors of importance to respiratory health (with special focus on chronic bronchitis, chronic obstructive pulmonary disease, asthma and obstructive sleep apnea), and (ii) clinical lung function and allergy tests with the consent of study participants.", {"entities": [[231, 268, "DISEASE"], [270, 276, "DISEASE"], [219, 229, "DISEASE"]]}], ["The address-redress phase consists of potential intervention programs and is currently being rolled out to address-at community level (via green light program and environmental study), and redress-at policy level (via obesity reduction and improved diagnosis and treatment of obstructive sleep apnea) the issues that have been identified by the baseline data.", {"entities": [[218, 225, "DISEASE"]]}], ["Interviewer-administered surveys were conducted in 2012\u20132013 and collected data on 874 individuals living in 406 households from two reserve communities located in Saskatchewan, Canada.", {"entities": []}], ["Four hundred and forty six (51%) females and 428 (49%) males participated in the FNLHP.", {"entities": []}], ["The information from this project will assist in addressing and redressing many of the issues involved including the provision of adequate housing, health lifestyle practices, and in planning for health service delivery.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-015-1137-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Epigenetics is currently one of the hottest topics in basic and biomedical research.", {"entities": []}], ["However, to date, most of the studies have been descriptive in nature, designed to investigate static distribution of various epigenetic modifications in cells.", {"entities": []}], ["Even though tremendous amount of information has been collected, we are still far from the complete understanding of epigenetic processes, their dynamics or even their direct effects on local chromatin and we still do not comprehend whether these epigenetic states are the cause or the consequence of the transcriptional profile of the cell.", {"entities": []}], ["In this review, we try to define the concept of synthetic epigenetics and outline the available genome targeting technologies, which are used for locus-specific editing of epigenetic signals.", {"entities": []}], ["We report early success stories and the lessons we have learned from them, and provide a guide for their application.", {"entities": []}], ["Finally, we discuss existing limitations of the available technologies and indicate possible areas for further development.", {"entities": []}], ["Complex diseases are characterized as being polygenic and multifactorial, so this poses a challenge regarding the search for genes related to them.", {"entities": []}], ["With the advent of high-throughput technologies for genome sequencing, gene expression measurements (transcriptome), and protein-protein interactions, complex diseases have been sistematically investigated.", {"entities": []}], ["Particularly, Protein-Protein Interaction (PPI) networks have been used to prioritize genes related to complex diseases according to its topological features.", {"entities": []}], ["However, PPI networks are affected by ascertainment bias, in which more studied proteins tend to have more connections, degrading the results quality.", {"entities": []}], ["Additionally, methods using only PPI networks can provide only static and non-specific results, since the topologies of these networks are not specific of a given disease.", {"entities": []}], ["The goal of this work is to develop a methodology that integrates PPI networks with disease specific data sources, such as GWAS and gene expression, to find genes more specific of a given complex disease.", {"entities": []}], ["After the integration of PPI networks and gene expression data, the resulting network is used to connect genes related to the disease through the shortest paths that have the greatest concordance between their gene expressions.", {"entities": []}], ["Both case and control expression data are used separately and, at the end, the most altered genes between the two conditions are selected.", {"entities": []}], ["To evaluate the method, schizophrenia was adopted as case study.", {"entities": [[24, 37, "DISEASE"]]}], ["Results show that the proposed method successfully retrieves differentially coexpressed genes in two conditions, while avoiding the bias from literature.", {"entities": []}], ["Moreover we were able to achieve a greater concordance in the selection of important genes from different microarray studies of the same disease and to produce a more specific gene set related to the studied disease.", {"entities": []}], ["Studies have been conducted in developing countries using SMS to communicate with patients to reduce the number of missed appointments and improve retention in treatment, however; very few have been scaled up.", {"entities": [[58, 61, "GENE"]]}], ["One possible reason for this could be that patients or staff are dissatisfied with the method in some way.", {"entities": []}], ["This paper reports a study of patients\u2019 and healthcare workers\u2019 (HCW) views on an mHealth intervention aiming to support retention in antiretroviral therapy (ART) and tuberculosis (TB) treatment in Mozambique.", {"entities": [[167, 179, "DISEASE"]]}], ["The study was conducted at five healthcare centres in Mozambique.", {"entities": []}], ["Automated SMS health promotions and reminders were sent to patients in a RCT.", {"entities": [[10, 13, "GENE"]]}], ["A total of 141 patients and 40 HCWs were interviewed.", {"entities": []}], ["Respondents rated usefulness, perceived benefits, ease of use, satisfaction, and risks of the SMS system using a Likert scale questionnaire.", {"entities": [[94, 97, "GENE"]]}], ["A semi-structured interview guide was followed.", {"entities": []}], ["Interviews were transcribed and thematic analysis was conducted.", {"entities": []}], ["Both patients and HCW found the SMS system useful and reliable.", {"entities": [[32, 35, "GENE"]]}], ["Most highly rated positive effects were reducing the number of failures to collect medication and avoiding missing appointments.", {"entities": []}], ["Patients\u2019 confidence in the system was high.", {"entities": []}], ["Most perceived the system to improve communication between health-care provider and patient and assist in education and motivation.", {"entities": []}], ["The automatic recognition of questions from patients and the provision of appropriate answers (a unique feature of this system) was especially appreciated.", {"entities": []}], ["A majority would recommend the system to other patients or healthcare centres.", {"entities": []}], ["Risks also were mentioned, mostly by HCW, of unintentional disclosure of health status in cases where patients use shared phones.", {"entities": []}], ["The results suggest that SMS technology for HIV and TB should be used to transmit reminders for appointments, medications, motivational texts, and health education to increase retention in care.", {"entities": [[25, 28, "GENE"]]}], ["Measures must be taken to reduce risks of privacy intrusion, but these are not a main obstacle for scaling up systems of this kind.", {"entities": []}], ["Potentially inappropriate prescribing (PIP) in older people is common in primary care and can result in increased morbidity, adverse drug events, hospitalizations and mortality.", {"entities": []}], ["The prevalence of PIP in Ireland is estimated at 36% with an associated expenditure of over \u20ac45 million in 2007.", {"entities": []}], ["The aim of this paper is to describe the application of the Medical Research Council (MRC) framework to the development of an intervention to decrease PIP in Irish primary care.", {"entities": []}], ["The MRC framework for the design and evaluation of complex interventions guided the development of the study intervention.", {"entities": []}], ["In the development stage, literature was reviewed and combined with information obtained from experts in the field using a consensus based methodology and patient cases to define the main components of the intervention.", {"entities": []}], ["In the pilot stage, five GPs tested the proposed intervention.", {"entities": []}], ["Qualitative interviews were conducted with the GPs to inform the development and implementation of the intervention for the main randomised controlled trial.", {"entities": []}], ["The literature review identified PIP criteria for inclusion in the study and two initial intervention components - academic detailing and medicines review supported by therapeutic treatment algorithms.", {"entities": []}], ["Through patient case studies and a focus group with a group of 8 GPs, these components were refined and a third component of the intervention identified - patient information leaflets.", {"entities": []}], ["The intervention was tested in a pilot study.", {"entities": []}], ["In total, eight medicine reviews were conducted across five GP practices.", {"entities": []}], ["These reviews addressed ten instances of PIP, nine of which were addressed in the form of either a dose reduction or a discontinuation of a targeted medication.", {"entities": []}], ["Qualitative interviews highlighted that GPs were receptive to the intervention but patient preference and time needed both to prepare for and conduct the medicines review, emerged as potential barriers.", {"entities": []}], ["Findings from the pilot study allowed further refinement to produce the finalised intervention of academic detailing with a pharmacist, medicines review with web-based therapeutic treatment algorithms and tailored patient information leaflets.", {"entities": []}], ["The MRC framework was used in the development of the OPTI-SCRIPT intervention to decrease the level of PIP in primary care in Ireland.", {"entities": []}], ["Its application ensured that the intervention was developed using the best available evidence, was acceptable to GPs and feasible to deliver in the clinical setting.", {"entities": []}], ["The effectiveness of this intervention is currently being tested in a pragmatic cluster randomised controlled trial.", {"entities": []}], ["Current controlled trials ISRCTN41694007", {"entities": []}], ["Very low birth weight (less than 1500\u00a0g) is associated with increased morbidity and costs of health care in childhood.", {"entities": []}], ["Emerging evidence suggests these infants face a range of health and social problems as young adults.", {"entities": []}], ["We studied all New Zealand very low birth weight infants born in 1986 (when 58\u00a0% were exposed to antenatal corticosteroids) in infancy, with later follow-up at 7 to 8\u00a0years and 23 to 24\u00a0years.", {"entities": []}], ["We now aim to assess the cohort at 26\u201328\u00a0years compared with controls.", {"entities": []}], ["The case sample will comprise a minimum of 250 members of the 1986 New Zealand national very low birth weight cohort (77\u00a0% of survivors).", {"entities": []}], ["Outcomes will be compared with a control group of 100 young adults born at term in 1986.", {"entities": []}], ["Following written informed consent, participants will travel to Christchurch for 2\u00a0days of assessments undertaken by experienced staff.", {"entities": []}], ["Medical assessments include growth measures, vision, respiratory function, blood pressure and echocardiogram, renal function, dental examination and blood tests.", {"entities": []}], ["Cognitive and neuropsychological functioning will be assessed with standard tests, and mental health and social functioning by participant interview.", {"entities": []}], ["A telephone interview will be conducted with a parent or significant other person nominated by the respondent to gain a further perspective on the young person\u2019s health and functioning.", {"entities": []}], ["All those born at less than 28\u00a0weeks\u2019 gestation, plus a random subset of the cohort to a total of 150 cases and 50 controls, will be offered cranial magnetic-resonance imaging.", {"entities": []}], ["Statistical analysis will examine comparison with controls and long-term trajectories for the very low birth weight cohort.", {"entities": []}], ["The research will provide crucial New Zealand data on the young adult outcomes for very low birth weight infants and address gaps in the international literature, particularly regarding cardiovascular, respiratory, visual and neurocognitive outcomes.", {"entities": []}], ["These data will inform future neonatal care, provide evidence-based guidelines for care of preterm graduates transitioning to adult care, and help shape health education and social policies for this high risk group.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12612000995875 .", {"entities": []}], ["Registered 1 October 2012 The online version of this article (doi:10.1186/s12887-015-0413-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hydrocarbon oils are often utilized as adjuvants in vaccines.", {"entities": []}], ["In response to naturally occurring hydrocarbon oils, inflammation is initiated and persists with the continuous recruitment of immune cells such as macrophages and neutrophils.", {"entities": []}], ["However, the mechanism underlying the chronic inflammation in response to hydrocarbon oils is not fully defined.", {"entities": []}], ["In this study, we revealed an essential role of retinoid-related orphan receptor gamma t (ROR\u03b3t) in sustaining the recruitment of macrophages following pristane treatment.", {"entities": []}], ["ROR\u03b3t absence resulted in the incompetent formation of mesenteric oil granulomas which may associate to a reduction in the migration of macrophages into the mesentery during pristane-induced inflammation.", {"entities": []}], ["This is at least partially dependent on the expression of the monocyte chemoattractant protein-1 (MCP-1) in the mesentery and the decrease in the macrophage reservoir in the spleen.", {"entities": []}], ["However, the absence of ROR\u03b3t had no impact on the recruitment of neutrophils to the mesentery after pristane treatment.", {"entities": []}], ["Our data uncovered an important role of ROR\u03b3t in the recruitment of macrophages during hydrocarbon oil-induced chronic inflammation.", {"entities": []}], ["A number of studies have evaluated two functional polymorphisms on p53 Arg72Pro and GSTP1 Ile105Val, in relation to esophageal cancer susceptibility.", {"entities": [[116, 133, "DISEASE"], [127, 133, "DISEASE"], [84, 89, "GENE"]]}], ["However, the results remain conflicting rather than conclusive.", {"entities": []}], ["This meta-analysis on 2919 cases and 4074 controls for p53 Arg72Pro and 1885 cases and 2194 controls for GSTP1 Ile105Val from 13 published case-control studies showed that no significant general main effects for GSTP1 Ile105Val on esophageal cancer risk.", {"entities": [[231, 248, "DISEASE"], [242, 248, "DISEASE"], [105, 110, "GENE"], [212, 217, "GENE"], [105, 110, "GENE"], [212, 217, "GENE"]]}], ["However, we found that the p53 Arg72Pro was associated with an increased risk of esophageal cancer ((Pro/Arg +Pro/Pro) versus Arg/Arg: OR=1.20, 95%CI=1.06-1.36) without any between-study heterogeneity.", {"entities": [[81, 98, "DISEASE"], [92, 98, "DISEASE"]]}], ["In the stratified analysis by ethnicity, we found that the increased esophageal cancer risk associated with p53 Arg72Pro polymorphism was more evident in Asian group ((Pro/Arg +Pro/Pro) versus Arg/Arg: OR=1.35, 95%CI=1.14-1.60, P =0.09 for heterogeneity test), although we still failed to find any significant association between GSTP1 Ile105Val polymorphism and esophageal cancer risk in different ethnicity.", {"entities": [[69, 86, "DISEASE"], [363, 380, "DISEASE"], [80, 86, "DISEASE"], [374, 380, "DISEASE"], [330, 335, "GENE"]]}], ["These results suggest that p53 Arg72Pro polymorphism, but not GSTP1 Ile105Val, may contribute to esophageal cancer development, especially in Asian.", {"entities": [[97, 114, "DISEASE"], [108, 114, "DISEASE"], [62, 67, "GENE"]]}], ["Additional well-designed large studies were required for the validation of this association.", {"entities": []}], ["In the near future, genomics may have a profound impact on the way we think about the common and complex disease asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["Microarray experiments have identified novel candidate genes in animal models of asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["In the near future, genomics may have a profound impact on the way we think about this common and complex disease.", {"entities": []}], ["We need to assess clinical treatments in real-life settings outside of randomised controlled trials (RCTs).", {"entities": []}], ["Pragmatic RCT (pRCT) data can supplement RCTs by providing effectiveness information to support healthcare decisions.", {"entities": []}], ["Electronic health records can facilitate concurrent safety monitoring and data collection without direct patient contact for large randomised study populations in pRCTs.", {"entities": []}], ["The Salford Lung Study is the world's first phase III pRCT in asthma and chronic obstructive pulmonary disease (COPD), which aims to randomise over 7000 patients.", {"entities": [[73, 110, "DISEASE"], [62, 68, "DISEASE"]]}], ["This paper describes the hurdles overcome and the enormous effort and resource required to establish this comparative effectiveness study of a prelicence intervention.", {"entities": []}], ["HZC115151 NCT01706198 NCT01551758", {"entities": []}], ["A hallmark of the diagnosis of chronic obstructive pulmonary disease (COPD) is the measurement of post-bronchodilator (post-BD) airflow obstruction (AO) by spirometry, but spirometry is not enough for the provision of a clinical diagnosis.", {"entities": [[31, 68, "DISEASE"]]}], ["In the majority of previous epidemiological studies, COPD diagnosis has been based on spirometry and a few clinical characteristics.", {"entities": []}], ["The aim of our study was to identify outcomes in patients newly diagnosed with airflow obstruction (AO) based on a diagnostic work-up conducted as part of a population-based cross-sectional study in North-Western Russia.", {"entities": []}], ["Spirometry was performed before (pre-BD) and after BD administration, and AO was defined using the FEV1/FVC <0.70 and FEV1/FVC <lower limit of normal cut-off values.", {"entities": []}], ["Relevant symptoms were recorded.", {"entities": []}], ["Participants with AO identified at baseline were then examined by a pulmonologist, including a clinical examination and second spirometry with BD test.", {"entities": []}], ["Of the 102 participants with post-BD AO in the initial assessment, only 60.8% still had AO identified at the second examination; among these patients, the following final diagnoses were reported: COPD ( n \u2009=\u200941), asthma ( n \u2009=\u20095), asthma\u2013COPD overlap syndrome (ACOS) ( n \u2009=\u20094) and likely ACOS ( n \u2009=\u20095).", {"entities": [[251, 259, "DISEASE"], [213, 219, "DISEASE"], [231, 237, "DISEASE"]]}], ["Of the 65 participants with pre-BD AO, 23.1% had post-BD AO at the second assessment, and these patients had been diagnosed with COPD ( n \u2009=\u200912), asthma ( n \u2009=\u20091), ACOS ( n \u2009=\u20091), likely ACOS ( n \u2009=\u20091).", {"entities": [[146, 152, "DISEASE"]]}], ["Serial spirometric assessments complemented by a comprehensive clinical evaluation are recommended in new epidemiological studies.", {"entities": []}], ["A single lung function test is insufficient to accurately diagnose chronic obstructive pulmonary disease (COPD).", {"entities": [[67, 104, "DISEASE"]]}], ["A team led by Jean-Marie Degryse from the Universit\u00e9 Catholique de Louvain, Belgium, studied patients in Northwestern Russia who showed signs of airflow obstruction, as measured by a spirometer, a medical device that records the amount of air inhaled and exhaled and the speed of breath.", {"entities": []}], ["Among those who initially showed signs of limited lung function, even after treatment with a bronchodilator, a large proportion did not exhibit airflow obstruction on a second spirometry test months later.", {"entities": []}], ["Moreover, not everyone who had confirmed airflow obstruction were diagnosed with COPD when examined by a pulmonologist.", {"entities": []}], ["Some had asthma or asthma-COPD overlap syndrome.", {"entities": [[39, 47, "DISEASE"], [9, 15, "DISEASE"], [19, 25, "DISEASE"]]}], ["The findings point to the need for clinical assessments and follow-up spirometry tests to accurately diagnose and manage COPD.", {"entities": []}], ["We applied physiological and operative severity score for the enumeration of morbidity and mortality (POSSUM) to evaluate overall surgical outcome and investigated the role of gender for early post-operative complications in gastric cancer surgery.", {"entities": [[233, 239, "DISEASE"]]}], ["The data from a total of 357 patients of gastric cancer were analysed by univariate and multivariate analysis.", {"entities": [[49, 55, "DISEASE"]]}], ["Post-operative complications were recorded according to definition of POSSUM.", {"entities": []}], ["Post-operative complications of male and female patients were compared separately.", {"entities": []}], ["The observed to estimated morbidity ratio (O:E) was 1.01.", {"entities": []}], ["Among the pre-operative variables, patient gender was one of the independent risk factors for a higher rate of post-operative complications (risk ratio 1.777, P = 0.024).", {"entities": []}], ["Post-operative complication was significantly higher in female patients.", {"entities": []}], ["Similarly, post-operative length of stay was significantly longer and more severe complications were observed in female patients ( P = 0.03).", {"entities": []}], ["In conclusion, POSSUM system is a valid algorithm for risk-adjusted surgical audit.", {"entities": []}], ["We conclude that a patient's gender influences the early post-operative complications after gastric cancer surgery.", {"entities": [[100, 106, "DISEASE"]]}], ["A detailed understanding on disparity of early post-operative complications between men and women may provide valuable information to improve surgical outcome of gastric cancer.", {"entities": [[170, 176, "DISEASE"]]}], ["However, results of this study need further confirmation by a prospective study involving a larger cohort.", {"entities": []}], ["Apoptosis has recently been proposed to contribute to the pathogenesis of emphysema.", {"entities": []}], ["In order to establish if cell fate plays a role even in end-stage disease we studied 16 lungs (9 smoking-associated and 7 \u03b11antitrypsin (AAT)-deficiency emphysema) from patients who had undergone lung transplantations.", {"entities": []}], ["Six unused donor lungs served as controls.", {"entities": []}], ["Apoptosis was evaluated by TUNEL analysis, single-stranded DNA laddering, electron microscopy and cell proliferation by an immunohistochemical method (MIB1).", {"entities": [[151, 155, "GENE"]]}], ["The role of the transforming growth factor (TGF)-\u03b21 pathway was also investigated and correlated with epithelial cell turnover and with the severity of inflammatory cell infiltrate.", {"entities": []}], ["The apoptotic index (AI) was significantly higher in emphysematous lungs compared to the control group (p \u2264 0.01), particularly if only lungs with AAT-deficiency emphysema were considered (p \u2264 0.01 vs p = 0.09).", {"entities": []}], ["The proliferation index was similar in patients and controls (1.9 \u00b1 2.2 vs 1.7 \u00b1 1.1).", {"entities": []}], ["An increased number of T lymphocytes was observed in AAT-deficiency lungs than smoking-related cases (p \u2264 0.05).", {"entities": []}], ["TGF-\u03b21 expression in the alveolar wall was higher in patients with smoking-associated emphysema than in cases with AAT-deficiency emphysema (p \u2264 0.05).", {"entities": []}], ["A positive correlation between TGF-\u03b2RII and AI was observed only in the control group (p \u2264 0.005, r Our findings suggest that apoptosis of alveolar epithelial cells plays an important role even in end-stage emphysema particularly in AAT-deficiency disease.", {"entities": []}], ["The TGF\u03b2-1 pathway does not seem to directly influence epithelial turnover in end-stage disease.", {"entities": []}], ["Inflammatory cytokine different from TGF-\u03b21 may differently orchestrate cell fate in AAT and smoking-related emphysema types.", {"entities": []}], ["The aims of the study were to assess the impact of both positive (PA) and negative affect (NA) on self-reported oral health-related quality of life and to determine the effect of including affectivity on the relationship between oral health-related quality of life and a set of explanatory variables consisting of oral health status, socio-economic status and dental visiting pattern.", {"entities": []}], ["A random sample of 45\u201354 year-olds from metropolitan Adelaide, South Australia was surveyed by mailed self-complete questionnaire during 2004\u201305 with up to four follow-up mailings of the questionnaire to non-respondents (n = 986 responded, response rate = 44.4%).", {"entities": []}], ["Oral health-related quality of life was measured using OHIP-14 and affectivity using the Bradburn scale.", {"entities": []}], ["Using OHIP-14 and subscales as the dependent variables, regression models were constructed first using oral health status, socio-economic characteristics and dental visit pattern and then adding PA and NA as independent variables, with nested models tested for change in R-squared values.", {"entities": []}], ["PA and NA exhibited a negative correlation of -0.49 (P < 0.01).", {"entities": []}], ["NA accounted for a larger percentage of variance in OHIP-14 scores (3.0% to 7.3%) than PA (1.4% to 4.6%).", {"entities": []}], ["In models that included both PA and NA, PA accounted for 0.2% to 1.1% of variance in OHIP-14 scores compared to 1.8% to 3.9% for NA.", {"entities": []}], ["PA and NA both accounted for additional variance in quality of life scores, but did not substantially diminish the effect of established explanatory variables such as oral health status, socio-economic status and dental visit patterns.", {"entities": []}], ["Limited accessibility to health care may be a barrier to obtaining good care.", {"entities": []}], ["Few studies have investigated the association between access-to-care factors and COPD hospitalizations.", {"entities": []}], ["The objective of this study is to estimate the association between access-to-care factors and health care utilization including hospital/emergency department (ED) visits and primary care physician (PCP) office visits among adults with COPD utilizing a nationally representative survey data.", {"entities": []}], ["We conducted a pooled cross-sectional analysis based upon a bivariate probit model, utilizing datasets from the 2011\u20132012 Behavioral Risk Factor Surveillance System linked with the 2014 Area Health Resource Files among adults with COPD.", {"entities": []}], ["Dichotomous outcomes were hospital/ED visits and PCP office visits.", {"entities": []}], ["Key covariates were county-level access-to-care factors, including the population-weighted numbers of pulmonary care specialists, PCPs, hospitals, rural health centers, and federally qualified health centers.", {"entities": []}], ["Among a total of 9,332 observations, proportions of hospital/ED visits and PCP office visits were 16.2% and 44.2%, respectively.", {"entities": []}], ["Results demonstrated that access-to-care factors were closely associated with hospital/ED visits.", {"entities": []}], ["An additional pulmonary care specialist per 100,000 persons serves to reduce the likelihood of a hospital/ED visit by 0.4 percentage points (pp) ( P =0.028).", {"entities": []}], ["In contrast, an additional hospital per 100,000 persons increases the likelihood of hospital/ED visit by 0.8 pp ( P =0.008).", {"entities": []}], ["However, safety net facilities were not related to hospital utilizations.", {"entities": []}], ["PCP office visits were not related to access-to-care factors.", {"entities": []}], ["Pulmonary care specialist availability was a key factor in reducing hospital utilization among adults with COPD.", {"entities": []}], ["The findings of our study implied that an increase in the availability of pulmonary care specialists may reduce hospital utilizations in counties with little or no access to pulmonary care specialists and that since availability of hospitals increases hospital utilization, directing patients with COPD to pulmonary care specialists may decrease hospital utilizations.", {"entities": []}], ["Infectious diseases and underlying medical conditions common to Africa may affect influenza frequency and severity.", {"entities": [[82, 91, "DISEASE"]]}], ["We conducted a systematic review of published studies on influenza and the following co-infections or co-morbidities that are prevalent in Africa: dengue, malaria, measles, meningococcus, Pneumocystis jirovecii pneumonia (PCP), hemoglobinopathies, and malnutrition.", {"entities": [[164, 171, "DISEASE"], [57, 66, "DISEASE"], [211, 220, "DISEASE"], [155, 162, "DISEASE"]]}], ["Articles were identified except for influenza and PCP.", {"entities": [[36, 45, "DISEASE"]]}], ["Very few studies were from Africa.", {"entities": []}], ["Sickle cell disease, dengue, and measles co-infection were found to increase the severity of influenza disease, though this is based on few studies of dengue and measles and the measles study was of low quality.", {"entities": [[33, 40, "DISEASE"], [162, 169, "DISEASE"], [178, 185, "DISEASE"], [93, 102, "DISEASE"]]}], ["The frequency of influenza was increased among patients with sickle cell disease.", {"entities": [[17, 26, "DISEASE"]]}], ["Influenza infection increased the frequency of meningococcal disease.", {"entities": [[0, 9, "DISEASE"]]}], ["Studies on malaria and malnutrition found mixed results.", {"entities": [[11, 18, "DISEASE"]]}], ["Age-adjusted morbidity and mortality from influenza may be more common in Africa because infections and diseases common in the region lead to more severe outcomes and increase the influenza burden.", {"entities": [[42, 51, "DISEASE"], [180, 189, "DISEASE"]]}], ["However, gaps exist in our knowledge about these interactions.", {"entities": []}], ["Smoking prevalence in remote Australian Aboriginal communities remains extraordinarily high, with rates reported of up to 82%.", {"entities": []}], ["Widespread exposure to environmental tobacco smoke (ETS) is exacerbated by overcrowded housing.", {"entities": []}], ["Implementation of existing smoke-free policies is challenged by the normalization of smoking and a lack of appropriate regulation resources.", {"entities": []}], ["This paper celebrates a grassroots approach to control of environmental tobacco smoke (ETS) in these settings.", {"entities": []}], ["We report on selected findings from a tobacco intervention study in Arnhem Land, Northern Territory in 2007\u20132012.", {"entities": []}], ["In community-level tobacco use surveys at baseline (n = 400 \u2265 16 years), participants reported concern about the constant exposure of non-smokers to tobacco smoke.", {"entities": []}], ["Suggestions for action included restricting smoking in private and public spaces.", {"entities": []}], ["We selected three case studies illustrating management of ETS from observational data during the study\u2019s intervention phase.", {"entities": []}], ["Using a critical realist approach, the context and mechanisms that contributed to specific strategies, or outcomes, were examined in order to develop a hypothesis regarding more effective management of ETS in these environments.", {"entities": []}], ["Our results suggest that in discrete, disadvantaged communities, enhanced local ownership of smoke-free policies and development of implementation strategies at the grassroots level that acknowledge and incorporate cultural contexts can contribute to more effective management of ETS.", {"entities": []}], ["Infection with Helicobacter pylori is associated with severe digestive diseases including chronic gastritis, peptic ulcer disease, and gastric cancer.", {"entities": [[109, 121, "DISEASE"], [98, 107, "DISEASE"], [143, 149, "DISEASE"]]}], ["Successful eradication of this common gastric pathogen in individual patients is known to prevent the occurrence of peptic ulcer disease and gastric cancer.", {"entities": [[116, 128, "DISEASE"], [149, 155, "DISEASE"]]}], ["With half of the world\u2019s population being infected with H, pylori and only few antibiotics result in an effective eradication, a successful antibiotic driven worldwide eradication program seems unlikely.", {"entities": []}], ["In addition, H. pylori eradication is not always beneficial as it has been described that eradication can be associated with an increased frequency of other disorders such as pediatric asthma, inflammatory bowel diseases and Barrett\u2019s Esophagus.", {"entities": [[185, 191, "DISEASE"]]}], ["We have to accept that eradication of this infection is a two-edged sword that is both useful and harmful and we should therefore focus our H. pylori eradication policy toward selectively identify and destroy only the virulent strains.", {"entities": []}], ["In order to still be able to effectively treat H. pylori infections in the future we need an alternative diagnostic/treatment algorithm.", {"entities": []}], ["This would involve a shift towards more precise and enhanced disease predicting diagnosis that tries to identify patients with chance of developing severe diseases such as gastric cancer, rather than the current regime that is geared towards find and destroy all H. pylori .", {"entities": [[180, 186, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) patients often present considerable individual medical burden in their symptoms, limitations, and well-being that complicate medical treatment.", {"entities": []}], ["To improve their overall health status, while reducing the number of exacerbations, a multidisciplinary approach including different elements of care is needed.", {"entities": []}], ["The aim of this study was to evaluate the effects of a remote support program on COPD patients at high risk of experiencing worsening of their disease and other health-related outcomes.", {"entities": []}], ["An observational, multicenter, prospective study aimed at evaluating the impact of a 7-month remote support program on COPD patients in exacerbations control and changes in health status measured with the COPD assessment test (CAT).", {"entities": []}], ["Factors associated with a clinically relevant decrease in CAT were assessed using a logistic regression analysis.", {"entities": []}], ["A total of 114 subjects started the program.", {"entities": []}], ["The majority of the study population were males (81.6\u00a0%), retired (70.2\u00a0%), without academic qualifications or with a low level of education (68.4\u00a0%), and ex-smokers (79.8\u00a0%).", {"entities": []}], ["The mean\u2009\u00b1\u2009SD age was 69.6\u2009\u00b1\u20099.1\u00a0years and the BMI was 27.8\u2009\u00b1\u20095.5 Kg/m p \u2009<\u20090.001] and with being non-compliant [62.5\u00a0% (15/24) of non-compliant vs 34.7\u00a0% (24/69) of compliant patients significantly improved CAT scores; OR\u2009=\u20093.13, 95\u00a0% CI: 1.19\u20138.19; p \u2009=\u20090.021).", {"entities": []}], ["After controlling for the effect of all variables in a multivariable logistic regression model, the only factor that remained significant was baseline CAT score.", {"entities": []}], ["The proportion of smokers in the total population remained constant during the study.", {"entities": []}], ["There was a significant reduction in the number of exacerbations after entering this remote support program with median -1 (IQR: -2, 0), ( p \u2009<\u20090.001).", {"entities": []}], ["The Morisky-Green questionnaire showed an increase of treatment compliance, namely at baseline, 25.8\u00a0% (24/93) of patients were noncompliant while in the end 66.7\u00a0% (16/24) of them became compliant) ( p \u2009=\u20090.053).", {"entities": []}], ["A remote support program for high-risk COPD patients results in an improvement of the patients\u2019 health status, particularly in those with initially poor health status, and it helps to reduce COPD exacerbations.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0304-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Osteopontin (OPN), a secreted protein involved in inflammatory processes and cancer, induces cell adhesion, migration, and activation of inflammatory pathways in various cell types.", {"entities": [[77, 83, "DISEASE"]]}], ["Cells bind OPN via integrins at a canonical RGD region in the full length form as well as to a contiguous cryptic site that some have shown is unmasked upon thrombin or matrix metalloproteinase cleavage.", {"entities": []}], ["Thus, the adhesive capacity of osteopontin is enhanced by proteolytic cleavage that may occur in inflammatory conditions such as obesity, atherosclerosis, rheumatoid arthritis, tumor growth and metastasis.", {"entities": [[138, 153, "DISEASE"], [155, 175, "DISEASE"], [129, 136, "DISEASE"], [166, 175, "DISEASE"]]}], ["Our aim was to inhibit cellular adhesion to recombinant truncated proteins that correspond to the N-terminal cleavage products of thrombin- or matrix metalloproteinase-cleaved OPN in vitro .", {"entities": []}], ["We specifically targeted the cryptic integrin binding site with monoclonal antibodies and antisera induced by peptide immunization of mice.", {"entities": []}], ["HEK 293 cells adhered markedly stronger to truncated OPN proteins than to full length OPN.", {"entities": []}], ["Without affecting cell binding to the full length form, the raised monoclonal antibodies specifically impeded cellular adhesion to the OPN fragments.", {"entities": []}], ["Moreover, we show that the peptides used for immunization were able to induce antisera, which impeded adhesion either to all OPN forms, including the full-length form, or selectively to the corresponding truncated recombinant proteins.", {"entities": []}], ["In conclusion, we developed immunological tools to selectively target functional properties of protease-cleaved OPN forms, which could find applications in treatment and prevention of various inflammatory diseases and cancers.", {"entities": []}], ["Blood is the pipeline of the immune system.", {"entities": []}], ["Assessing changes in transcript abundance in blood on a genome-wide scale affords a comprehensive view of the status of the immune system in health and disease.", {"entities": []}], ["This review summarizes the work that has used this approach to identify therapeutic targets and biomarker signatures in the field of autoimmunity and infectious disease.", {"entities": []}], ["Recent technological and methodological advances that will carry the blood transcriptome research field forward are also discussed.", {"entities": []}], ["To establish the diagnostic accuracy of magnetic resonance imaging (MRI) as an auxiliary means for the diagnosis of oral cancer through a systematic review and meta-analysis.", {"entities": [[121, 127, "DISEASE"]]}], ["An exhaustive search of publications from 1986 to 2016 was performed of Medline, Embase and Cochrane (and related databases), including grey literature.", {"entities": []}], ["Primary diagnostic accuracy studies that assessed oral cancer (target condition) using MRI (index test) were included.", {"entities": [[55, 61, "DISEASE"]]}], ["Diagnostic threshold, sensitivity and meta-regression analyses were performed.", {"entities": []}], ["A meta-analysis was performed using Meta-DiSc\u00ae v. 1.4 software.", {"entities": []}], ["A total of 24 primary studies were assessed, comprising 1,403 oral cancer lesions.", {"entities": [[67, 73, "DISEASE"]]}], ["Nine studies used diffusion-weighted MRI, with a diagnostic odds ratio (DOR) of 30.7 (95% confidence interval [CI]: 12.7\u201374.3) and area under the curve (AUC) of 0.917 (95% CI: 0.915\u20130.918); seven studies used dynamic contrast-enhanced MRI, with a DOR of 48.1 (95%CI: 22.4\u2013103.2) and AUC of 0.936 (95% CI: 0.934\u20130.937); and 13 studies used traditional MRI, with a DOR of 23.9 (95%CI: 13.2\u201343.3) and AUC of 0.894 (95% CI: 0.894\u20130.895).", {"entities": []}], ["Meta-regression analysis indicated that the magnetic field strength may have influenced the heterogeneity of the results obtained (p = 0.0233) using traditional MRI.", {"entities": []}], ["Sensitivity analysis revealed a discrete reduction of inconsistency in some subgroups.", {"entities": []}], ["The three types of MRI assessed exhibited satisfactory accuracy compared to biopsy.", {"entities": []}], ["Considering the relevance of early treatment and screening and that better health care results in improved survival rates and quality of life for oral cancer patients, we suggest the use of MRI as a part of the pre-treatment and monitoring protocol at public health services.", {"entities": [[151, 157, "DISEASE"]]}], ["The assumption that improving housing conditions can lead to improved health may seem a self-evident hypothesis.", {"entities": []}], ["Yet evidence from intervention studies suggests small or unclear health improvements, indicating that further thought is required to refine this hypothesis.", {"entities": []}], ["Articulation of a theory can help avoid a black box approach to research and practice and has been advocated as especially valuable for those evaluating complex social interventions like housing.", {"entities": []}], ["This paper presents a preliminary theory of housing improvement and health based on a systematic review conducted by the authors.", {"entities": []}], ["Following extraction of health outcomes, data on all socio-economic impacts were extracted by two independent reviewers from both qualitative and quantitative studies.", {"entities": []}], ["Health and socio-economic outcome data from the better quality studies ( n \u00a0=\u00a023/34) were mapped onto a one page logic models by two independent reviewers and a final model reflecting reviewer agreement was prepared.", {"entities": []}], ["Where there was supporting evidence of links between outcomes these were indicated in the model.", {"entities": []}], ["Two models of specific improvements (warmth & energy efficiency; and housing led renewal), and a final overall model were prepared.", {"entities": []}], ["The models provide a visual map of the best available evidence on the health and socio-economic impacts of housing improvement.", {"entities": []}], ["The use of a logic model design helps to elucidate the possible pathways between housing improvement and health and as such might be described as an empirically based theory.", {"entities": []}], ["Changes in housing factors were linked to changes in socio-economic determinants of health.", {"entities": []}], ["This points to the potential for longer term health impacts which could not be detected within the lifespan of the evaluations.", {"entities": []}], ["The developed theories are limited by the available data and need to be tested and refined.", {"entities": []}], ["However, in addition to providing one page summaries for evidence users, the theory may usefully inform future research on housing and health.", {"entities": []}], ["\u2022 Theories of health impacts of complex interventions are valuable but poorly developed.", {"entities": []}], ["\u2022 Including socio-economic data may explain why health impacts are observed or not.", {"entities": []}], ["\u2022 A theory of healthy housing improvement was prepared using systematic review data.", {"entities": []}], ["\u2022 Quantitative and qualitative data on health and socio-economic impacts were used.", {"entities": []}], ["\u2022 Warmth, affordability & suitable space provision may mediate health impacts of housing.", {"entities": []}], ["Theories of health impacts of complex interventions are valuable but poorly developed.", {"entities": []}], ["Including socio-economic data may explain why health impacts are observed or not.", {"entities": []}], ["A theory of healthy housing improvement was prepared using systematic review data.", {"entities": []}], ["Quantitative and qualitative data on health and socio-economic impacts were used.", {"entities": []}], ["Warmth, affordability & suitable space provision may mediate health impacts of housing.", {"entities": []}], ["In migraineurs pituitary adenylate cyclase activating peptide1\u201338 (PACAP1\u201338) is a potent migraine provoking substance and the accompanying long lasting flushing suggests degranulation of mast cells.", {"entities": [[90, 98, "DISEASE"]]}], ["Infusion of the closely related vasoactive intestinal peptide (VIP) either induces headache or flushing.", {"entities": [[63, 66, "GENE"]]}], ["This implicates the pituitary adenylate cyclase activating peptide type I receptor (PAC1) to be involved in the pathophysiology of PACAP1\u201338 provoked headaches.", {"entities": []}], ["Here we review studies characterizing the effects of mainly PACAP but also of VIP on cerebral and meningeal arteries and mast cells.", {"entities": [[60, 65, "GENE"], [78, 81, "GENE"]]}], ["PACAP1\u201338, PACAP1\u201327 and VIP dilate cerebral and meningeal arteries from several species including man.", {"entities": [[25, 28, "GENE"]]}], ["In rat cerebral and meningeal arteries the dilation seems to be mediated preferably via vasoactive intestinal peptide receptor type 1 (VPAC1) receptors while, in human, middle meningeal artery dilation induced via vasoactive intestinal peptide receptor type 2 (VPAC2) receptors cannot be ruled out.", {"entities": []}], ["PACAP1\u201338 is a strong degranulator of peritoneal and dural mast cells while PACAP1\u201327 and VIP only have weak effects.", {"entities": [[90, 93, "GENE"]]}], ["More detailed characterization studies suggest that mast cell degranulation is not mediated via the known receptors for PACAP1\u201338 but rather via a still unknown receptor coupled to phospholipase C. It is suggested that PACAP1\u201338 might induce migraine via degranulation of dural mast cells via a yet unknown receptor.", {"entities": [[242, 250, "DISEASE"]]}], ["Each day people are exposed to millions of bioaerosols, including whole microorganisms, which can have both beneficial and detrimental effects.", {"entities": []}], ["The next chapter in understanding the airborne microbiome of the built environment is characterizing the various sources of airborne microorganisms and the relative contribution of each.", {"entities": []}], ["We have identified the following eight major categories of sources of airborne bacteria, viruses, and fungi in the built environment: humans; pets; plants; plumbing systems; heating, ventilation, and air-conditioning systems; mold; dust resuspension; and the outdoor environment.", {"entities": []}], ["Certain species are associated with certain sources, but the full potential of source characterization and source apportionment has not yet been realized.", {"entities": []}], ["Ideally, future studies will quantify detailed emission rates of microorganisms from each source and will identify the relative contribution of each source to the indoor air microbiome.", {"entities": []}], ["This information could then be used to probe fundamental relationships between specific sources and human health, to design interventions to improve building health and human health, or even to provide evidence for forensic investigations.", {"entities": []}], ["To assess the relationship between smoking status and health-related quality of life 1\u2005year after participation in a smoking cessation programme in Taiwan.", {"entities": []}], ["A cohort study of smokers who voluntarily participated in a smoking cessation programme with two follow-up assessments of smoking status via telephone interview, conducted 6\u2005months and 1\u2005year after finishing the smoking cessation programme.", {"entities": []}], ["Hospitals and clinics providing smoking cessation services.", {"entities": []}], ["A total of 3514 participants completed both telephone interviews, which represents a response rate of 64%.", {"entities": []}], ["After the interviews, participants were divided into four groups according to their smoking status: (1) long-term quitters: participants who had quit tobacco use for 1\u2005year; (2) short-term quitters: participants who had been smoking for at least 6\u2005months and then quit tobacco for 6\u2005months after participating in the programme; (3) relapsed smokers: participants who relapsed into tobacco use after ceasing tobacco use for 6\u2005months; and (4) continuing smokers: participants who failed to quit smoking for at least 1\u2005year, despite participating in the programme.", {"entities": []}], ["The Outpatient Smoking Cessation Service of Taiwan provides counselling and pharmacotherapy to individuals seeking to quit smoking.", {"entities": []}], ["The health-related quality of life of the participants was measured using an approved Chinese version of the EuroQol-5D-3L (EQ-5D-3L) descriptive system.", {"entities": []}], ["After controlling for sex, age, education, marital status, job status, monthly income and disease status at baseline, our results revealed that long-term (OR=0.61 (0.48 to 0.77)) and short-term (OR=0.65 (0.54 to 0.79)) quitters experienced less anxiety and depression than did continuing smokers.", {"entities": []}], ["Our study provides evidence to support claims that all quitters, regardless of whether they stop smoking for 6\u2005months or 1\u2005year, have better quality of life with regard to anxiety or depression.", {"entities": []}], ["Rhinoviruses are the major trigger of acute asthma exacerbations and asthmatic subjects are more susceptible to these infections.", {"entities": [[44, 50, "DISEASE"]]}], ["To investigate the underlying mechanisms of this increased susceptibility, we examined virus replication and innate responses to rhinovirus (RV)-16 infection of primary bronchial epithelial cells from asthmatic and healthy control subjects.", {"entities": []}], ["Viral RNA expression and late virus release into supernatant was increased 50- and 7-fold, respectively in asthmatic cells compared with healthy controls.", {"entities": []}], ["Virus infection induced late cell lysis in asthmatic cells but not in normal cells.", {"entities": []}], ["Examination of the early cellular response to infection revealed impairment of virus induced caspase 3/7 activity and of apoptotic responses in the asthmatic cultures.", {"entities": []}], ["Inhibition of apoptosis in normal cultures resulted in enhanced viral yield, comparable to that seen in infected asthmatic cultures.", {"entities": []}], ["Examination of early innate immune responses revealed profound impairment of virus-induced interferon-\u03b2 mRNA expression in asthmatic cultures and they produced >2.5 times less interferon-\u03b2 protein.", {"entities": []}], ["In infected asthmatic cells, exogenous interferon-\u03b2 induced apoptosis and reduced virus replication, demonstrating a causal link between deficient interferon-\u03b2, impaired apoptosis and increased virus replication.", {"entities": []}], ["These data suggest a novel use for type I interferons in the treatment or prevention of virus-induced asthma exacerbations.", {"entities": [[102, 108, "DISEASE"]]}], ["Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of approximately 20%.", {"entities": [[63, 96, "DISEASE"], [87, 96, "DISEASE"], [11, 29, "DISEASE"]]}], ["Progressive and irreversible lung functional impairment leads to chronic respiratory insufficiency with a severely impaired quality of life.", {"entities": []}], ["In the last 2 decades, novel treatments for IPF have been developed as a consequence of an increasing understanding of disease pathogenesis and pathobiology.", {"entities": []}], ["In IPF, injured dysfunctional alveolar epithelial cells promote fibroblast recruitment and proliferation, resulting in scarring of the lung tissue.", {"entities": []}], ["Recently, pirfenidone and nintedanib have been approved for the treatment of IPF, having shown efficacy to slow functional decline and disease progression.", {"entities": []}], ["This article focuses on the pharmacologic characteristics and clinical evidence supporting the use of nintedanib, a potent small-molecule tyrosine kinase inhibitor, as therapy for IPF.", {"entities": []}], ["After introducing the mechanism of action and pharmacokinetics, an overview of the safety and efficacy results from the most recent clinical trials of nintedanib in IPF is presented.", {"entities": []}], ["Decision-making in child and youth mental health (CYMH) care requires recommendations that are developed through an efficient and effective method and are based on credible knowledge.", {"entities": []}], ["Credible knowledge is informed by two sources: scientific evidence, and practice-based evidence, that reflects the \"real world\" experience of service providers.", {"entities": []}], ["Current approaches to developing these recommendations in relation to CYMH will typically include evidence from one source or the other but do not have an objective method to combine the two.", {"entities": []}], ["To this end, a modified version of the Grading Recommendations Assessment, Development and Evaluation (GRADE) approach was pilot-tested, a novel method for the CYMH field.", {"entities": []}], ["GRADE has an explicit methodology that relies on input from scientific evidence as well as a panel of experts.", {"entities": []}], ["The panel established the quality of evidence and derived detailed recommendations regarding the organization and delivery of mental health care for children and youth or their caregivers.", {"entities": []}], ["In this study a modified GRADE method was used to provide precise recommendations based on a specific CYMH question (i.e.", {"entities": []}], ["What is the current credible knowledge concerning the effects of parent-implemented, early intervention with their autistic children?).", {"entities": []}], ["Overall, it appeared that early, parent-implemented interventions for autism result in positive effects that outweigh any undesirable effects.", {"entities": []}], ["However, as opposed to overall recommendations, the heterogeneity of the evidence required that recommendations be specific to particular interventions, based on the questions of whether the benefits of a particular intervention outweighs its harms.", {"entities": []}], ["This pilot project provided evidence that a modified GRADE method may be an effective and practical approach to making recommendations in CYMH, based on credible knowledge.", {"entities": []}], ["Key strengths of the process included separating the assessments of the quality of the evidence and the strength of recommendations, transparency in decision-making, and the objectivity of the methods.", {"entities": []}], ["Most importantly, this method combined the evidence and clinical experience in a more timely, explicit and simple process as compared to previous approaches.", {"entities": []}], ["The strengths, limitations and modifications of the approach as they pertain to CYMH, are discussed.", {"entities": []}], ["No population study has explored the population distribution of adult asthma in the United Arab Emirates (UAE).", {"entities": [[70, 76, "DISEASE"]]}], ["The objective is to estimate asthma prevalence in general population in UAE.", {"entities": [[29, 35, "DISEASE"]]}], ["Using standard European Community Respiratory Health Survey (ECRHS) questionnaires and tools, this is a cross-sectional assessment of a random sample of the population in established quotas of the seven Emirates in the UAE.", {"entities": []}], ["We surveyed 1,220 participants, of which 63.2% were male, and 20.1% were UAE Nationals, with a mean (SD) age of 32.9 (14.1) years.", {"entities": []}], ["Prevalence of individual respiratory symptoms from the ECRHS screening questionnaire in all participants were generally ranging 8 - 10%, while participants 20-44 years presented lower prevalence in all symptoms ( p < 0.05).", {"entities": []}], ["The expected male:female ratio of reported wheezing and asthma attacks and its treatment by age was not observed.", {"entities": [[56, 62, "DISEASE"]]}], ["Participating women reported more individual symptoms than men.", {"entities": []}], ["Overall, there were 15.4% (95% C.I.", {"entities": []}], ["13.5 - 17.5) participants who fulfilled our screening criteria for asthma, while for consistency with ECRHS, there were 12.1% (95% C.I.", {"entities": [[67, 73, "DISEASE"]]}], ["10.4 - 14.1) participants who fulfilled the ECRHS asthma definition, being 9.8% (95% C.I.", {"entities": [[50, 56, "DISEASE"]]}], ["7.8 - 12.2) of those 20-44 years, that is 8.6% of male and 11.8% of female young adults participating.", {"entities": []}], ["We conclude that asthma is common in the UAE, and gender differences are not observed in reported asthma symptoms in young adults.", {"entities": [[17, 23, "DISEASE"], [98, 104, "DISEASE"]]}], ["This being the first population based study exploring the prevalence of asthma and its determinants in the United Arab Emirates based on the ECRHS.", {"entities": [[72, 78, "DISEASE"]]}], ["Human bocavirus (HBoV) is a newly discovered parvovirus and increasing evidences are available to support its role as an etiologic agent in lower respiratory tract infection (LRTI).", {"entities": []}], ["The objective of this study is to assess the impact of HBoV viral load on clinical characteristics in children who were HBoV positive and suffered severe LRTI.", {"entities": []}], ["Lower respiratory tract aspirates from 186 hospitalized children with severe LRTI were obtained by bronchoscopy.", {"entities": []}], ["HBoVs were detected by real-time PCR and other 10 infectious agents were examined using PCR and/or direct fluorescent assay.", {"entities": []}], ["Thirty-one patients (24.6%) were tested positive for HBoV in the respiratory tract aspirates.", {"entities": []}], ["Fifteen samples had a high viral load (>10 We confirmed that HBoV was frequently detected in patients with severe LRTI.", {"entities": []}], ["Wheezing was one of the most common symptoms presented by patients with positive HBoV.", {"entities": []}], ["A high HBoV viral load could be an etiologic agent for LRTI, which led to more severe lower respiratory tract symptom, longer duration of wheezing and hospitalization.", {"entities": []}], ["Equitable access to affordable medicines and diagnostic tests is an integral component of optimal clinical care of patients with asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[140, 177, "DISEASE"], [129, 135, "DISEASE"]]}], ["In Uganda, we lack contemporary data about the availability, cost and affordability of medicines and diagnostic tests essential in asthma and COPD management.", {"entities": [[131, 137, "DISEASE"]]}], ["Data on the availability, cost and affordability of 17 medicines and 2 diagnostic tests essential in asthma and COPD management were collected from 22 public hospitals, 23 private and 85 private pharmacies.", {"entities": [[101, 107, "DISEASE"]]}], ["The percentage of the available medicines and diagnostic tests, the median retail price of the lowest priced generic brand and affordability in terms of the number of days\u2019 wages it would cost the least paid public servant were analysed.", {"entities": []}], ["The availability of inhaled short acting beta agonists (SABA), oral leukotriene receptor antagonists (LTRA), inhaled LABA-ICS combinations and inhaled corticosteroids (ICS) in all the study sites was 75%, 60.8%, 46.9% and 45.4% respectively.", {"entities": []}], ["None of the study sites had inhaled long acting anti muscarinic agents (LAMA) and inhaled long acting beta agonist (LABA)-LAMA combinations.", {"entities": []}], ["Spirometry and peak flow-metry as diagnostic tests were available in 24.4% and 6.7% of the study sites respectively.", {"entities": []}], ["Affordability ranged from 2.2 days\u2019 wages for inhaled salbutamol to 17.1 days\u2019 wages for formoterol/budesonide inhalers and 27.8 days\u2019 wages for spirometry.", {"entities": []}], ["Medicines and diagnostic tests essential in asthma and COPD care are not widely available in Uganda and remain largely unaffordable.", {"entities": [[44, 50, "DISEASE"]]}], ["Strategies to improve access to affordable asthma and COPD medicines and diagnostic tests should be implemented in Uganda.", {"entities": [[43, 49, "DISEASE"]]}], ["Inflammatory cell numbers are important endpoints in clinical studies relying on endobronchial biopsies.", {"entities": []}], ["Assumption-based bidimensional (2D) counting methods are widely used, although theoretically design-based stereologic three-dimensional (3D) methods alone offer an unbiased quantitative tool.", {"entities": []}], ["We assessed the method agreement between 2D and 3D counting designs in practice when applied to identical samples in parallel.", {"entities": []}], ["Biopsies from segmental bronchi were collected from healthy non-smokers (n\u200a=\u200a7) and smokers (n\u200a=\u200a7), embedded and sectioned exhaustively.", {"entities": []}], ["Systematic uniform random samples were immunohistochemically stained for macrophages (CD68) and T-lymphocytes (CD3), respectively.", {"entities": [[86, 90, "GENE"]]}], ["In identical fields of view, cell numbers per volume unit (N V ) were assessed using the physical disector (3D), and profiles per area unit (N A ) were counted (2D).", {"entities": []}], ["For CD68 In both groups, mean CD68 V and N A were significantly different (non-smokers: 0.39 and 0.68, p<0.05; smokers: 0.49 and 1.68, p<0.05).", {"entities": [[4, 8, "GENE"], [30, 34, "GENE"], [4, 8, "GENE"], [30, 34, "GENE"]]}], ["When counting only nucleated CD68 2D counts of cell and nuclear profiles introduce a variable size-dependent bias throughout the measurement range.", {"entities": [[29, 33, "GENE"]]}], ["Because the deviation between the 3D and 2D data was different in the two groups, it precludes establishing a \u2018universal conversion formula\u2019.", {"entities": []}], ["The generation of long-lived antibody-secreting cells (ASC) and memory B cells are critical events for an effective vaccine and the choice of adjuvant can influence these processes.", {"entities": []}], ["Various cellular and molecular mechanism involved in the protease action that determine Th2 responses have been identified.", {"entities": []}], ["However, direct or indirect actions in the regulation of the induction, survival and longevity of ASC in differential compartments remain largely unknown.", {"entities": []}], ["We investigated whether the proteolytic activity of proteins are determinant for the modulation of the memory immune response in mice, promoting the differentiation of memory B cells to terminally differentiated end stage cells.", {"entities": []}], ["Here, we show that the proteolytic activity of Natterins, from the venom of Thalassophryne nattereri Brazilian fish, besides inducing a Th2 response with plasmatic titers of high-affinity antigen-specific IgE over extended periods is sufficient for the generation of signals that contribute to the formation of a survival niche in the spleen, essential for the longevity of the main subtype of ASC with B220", {"entities": []}], ["Excessive alcohol consumption on single occasions among undergraduate students is a major health issue as research has shown this pattern of drinking to be related to maladaptive health and psychosocial outcomes.", {"entities": []}], ["Brief, theory-based interventions targeting motivation and self-control as behavior-change techniques have been identified as effective means to reduce alcohol consumption, but few studies have examined the interactive effects of these components.", {"entities": []}], ["The aim of the present study is to develop a brief theory-based intervention using motivational and self-control intervention techniques to reduce alcohol consumption in undergraduate students.", {"entities": []}], ["The intervention will adopt a factorial design to test the main and interactive effects of the techniques on alcohol consumption.", {"entities": []}], ["Using mental simulations and the strength model of self-control as the theoretical bases of the intervention, the study will adopt a fully randomized 2 (mental simulation: mental simulation vs. control irrelevant visualization exercise) \u00d7 2 (self-control training: challenging Stroop task vs. easy Stroop task) between-participants design.", {"entities": []}], ["Non-abstinent undergraduate students aged 18\u00a0years or older will be eligible to participate in the study.", {"entities": []}], ["Participants will complete an initial survey including self-reported alcohol consumption measures, measures of motivation and self- measures.", {"entities": []}], ["Participants will be randomly allocated to receive either a mental simulation exercise presented in print format or a control irrelevant visualization exercise.", {"entities": []}], ["Thereafter, participants will be randomly assigned to receive a challenging online self-control training exercise or an easy training exercise that has little self-control demand over the course of the next four weeks.", {"entities": []}], ["Four weeks later participants will complete a follow-up alcohol consumption, motivation and self-control measures.", {"entities": []}], ["This study will provide the first evidence for the individual and interactive effects of motivational and self-control training techniques in an intervention to reduce alcohol consumption.", {"entities": []}], ["It will also demonstrate the importance of adopting multiple theoretical perspectives and a factorial design to identify the unique and interactive impact of behavior-change techniques on health behavior.", {"entities": []}], ["The trial is registered with the Australian and New Zealand Clinical Trials Registry, ACTRN12613000573752.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1648-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Early distinction between severe Mycoplasma pneumoniae pneumonia (MPP) and mild MPP is still difficult.", {"entities": [[55, 64, "DISEASE"]]}], ["The aim of this study was to analyze cytokines in bronchoalveolar lavage fluid (BALF) and explore predicting factors of severe MPP in children.", {"entities": []}], ["Retrospective analysis was performed on 150 children with MPP or bronchial foreign body (FB) admitted in our hospital.", {"entities": []}], ["The mRNA levels of IL17A were found significantly lower in severe MPP group comparing with mild MPP group or FB group.", {"entities": [[19, 24, "GENE"]]}], ["However, no significant difference was found in the levels of IL4, IL10 or interferon beta1 (IFN\u03b21) between the two groups.", {"entities": [[62, 65, "GENE"], [67, 71, "GENE"]]}], ["Receiver operator characteristic (ROC) curve analysis showed that IL17A can be used to distinguish severe MPP from mild MPP.", {"entities": [[66, 71, "GENE"]]}], ["These results were confirmed in a validation cohort including 40 MPP children from another hospital.", {"entities": []}], ["IL17A levels were correlated with some clinical characters, such as refractoriness and pleural effusion.", {"entities": [[0, 5, "GENE"]]}], ["Lower IL17A levels were more likely to be found in refractory MPP children or in MPP children with pleural effusion.", {"entities": [[6, 11, "GENE"]]}], ["Moreover, the protein levels of IL17A in BALF were also found greatly decreased in children with severe MPP.", {"entities": [[32, 37, "GENE"]]}], ["Thus, decreased IL17A levels in BALF may be a valuable biomarker to identify severe MPP in children.", {"entities": [[16, 21, "GENE"]]}], ["To evaluate the administration of antipyretics to children with upper respiratory tract infections (URTI) by their parents or guardians without consultation with physicians, and compare epidemiological and clinical characteristics of patients who received antipyretics and of untreated patients.", {"entities": []}], ["A prospective observational study was performed in three pediatric clinics in Zagreb, Croatia, from March to June 2002.", {"entities": []}], ["A total of 171 children aged from 2 to 14 years with symptoms and signs of URTI lasting more than 2 days and fever above 38\u00b0C lasting more than 2 days were included in the study.", {"entities": []}], ["Data were collected on the usage of antipyretics, patients\u2019 demographic and epidemiological characteristics, and clinical signs and symptoms.", {"entities": []}], ["Antipyretics, predominantly paracetamol, were used in 29.8% of patients.", {"entities": []}], ["Their usage was less frequent in children attending day-care centers (49% of treated and 70% of untreated children, P \u2009=\u20090.014) and in children with reiterated URTIs (33.3% of treated and 55.8% of untreated children, P \u2009=\u20090.008).", {"entities": []}], ["However, it was more frequent in children with recent URTIs in the family (33.3% of treated and 7.5% of untreated children, P \u2009<\u20090.001).", {"entities": []}], ["Overall, most clinical signs and symptoms of URTI were notably less pronounced in patients treated with antipyretics.", {"entities": []}], ["Antipyretics use correlated with less pronounced clinical signs and symptoms of infection, which indicates their anti-inflammatory activity, but also with negative effects such as lethargy.", {"entities": []}], ["It is necessary to educate parents on the positive and negative aspects of antipyretics use and on the optimal choice of an antipyretic drug.", {"entities": []}], ["Lower expression of secretoglobin and transferrin has been found in the bronchoalveolar lavage fluid ( BALF ) of a small number of horses with experimentally induced signs of recurrent airway obstruction ( RAO ) compared to healthy controls.", {"entities": []}], ["Secretoglobin and transferrin BALF expression will be similarly decreased in horses with naturally occurring clinical signs of RAO and in horses with experimentally induced clinical signs of RAO as compared to healthy controls and intermediate in horses with inflammatory airway disease ( IAD ).", {"entities": []}], ["Recurrent airway obstruction\u2010affected and control horses were subjected to an experimental hay exposure trial to induce signs of RAO .", {"entities": []}], ["Client\u2010owned horses with a presumptive diagnosis of RAO and controls from the same stable environments were recruited.", {"entities": []}], ["Pulmonary function and BALF were evaluated from control and RAO \u2010affected research horses during an experimental hay exposure trial (n\u00a0=\u00a05 in each group) and from client\u2010owned horses ( RAO \u2010affected horses, n\u00a0=\u00a017; IAD \u2010affected horses, n\u00a0=\u00a019; healthy controls, n\u00a0=\u00a05).", {"entities": []}], ["The concentrations of secretoglobin and transferrin in BALF were assessed using Western blots.", {"entities": []}], ["Naturally occurring and experimentally induced RAO horses had similar decreases in BALF transferrin expression, but secretoglobin expression was most decreased in naturally occurring RAO .", {"entities": []}], ["Secretoglobin and transferrin expression were both lower in BALF of RAO \u2010affected horses than in IAD \u2010affected and control horses.", {"entities": []}], ["Secretoglobin and transferrin expression is decreased in BALF of RAO \u2010affected horses after both experimental and natural exposure.", {"entities": []}], ["Secretoglobin and transferrin likely play clinically relevant roles in the pathophysiology of RAO , and may thus be used as biomarkers of the disease.", {"entities": []}], ["To determine diabetic patients' knowledge and beliefs about the disease and medications that could hinder optimal disease management.", {"entities": []}], ["A cross-sectional survey of 151 type 2 diabetic patients characterizing diabetes knowledge and beliefs about the disease and medications was conducted.", {"entities": []}], ["Mean diabetes duration was 13 years.", {"entities": []}], ["Over half of the patients (56%) believed that normal glucose is \u2264200 mg/dl, 54% reported being able to feel when blood glucose levels are high, 36% thought that they will not always have diabetes, 29% thought that their doctor will cure them of diabetes, one in four (23%) said there is no need to take diabetes medications when glucose levels are normal, and 12% believed they have diabetes only when glucose levels are high.", {"entities": []}], ["Diabetes knowledge and beliefs inconsistent with a chronic disease model of diabetes were prevalent in this sample.", {"entities": []}], ["Suboptimal knowledge and beliefs are potentially modifiable and are logical targets for educational interventions to improve diabetes self-management.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) is an interleukin (IL) 7\u2013like cytokine that triggers dendritic cell\u2013mediated T helper (Th)2 inflammatory responses.", {"entities": [[30, 34, "GENE"]]}], ["TSLP is highly expressed by keratinocytes in skin lesions of patients with atopic dermatitis and is associated with dendritic cell activation in situ, suggesting that TSLP might be a master switch for allergic inflammation at the epithelial cell\u2013dendritic cell interface.", {"entities": [[75, 92, "DISEASE"], [82, 92, "DISEASE"], [0, 4, "GENE"], [167, 171, "GENE"], [0, 4, "GENE"], [167, 171, "GENE"]]}], ["New reports now establish a direct link between TSLP expression and the pathogenesis of atopic dermatitis and asthma in vivo, and begin to reveal the molecular mechanisms underlying TSLP-induced allergic inflammation.", {"entities": [[88, 105, "DISEASE"], [110, 116, "DISEASE"], [95, 105, "DISEASE"], [48, 52, "GENE"], [182, 186, "GENE"]]}], ["Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality worldwide, causing severe respiratory illness in infants and immune compromised patients.", {"entities": []}], ["The ciliated cells of the human airway epithelium have been considered to be the exclusive target of RSV, although recent data have suggested that basal cells, the progenitors for the conducting airway epithelium, may also become infected in vivo .", {"entities": []}], ["Using either mechanical or chemical injury models, we have demonstrated a robust RSV infection of p63", {"entities": []}], ["Angioimmunoblastic T-cell lymphoma (AITL) is a rare, distinct subtype of peripheral T-cell lymphoma, possessing an aggressive course and poor prognosis with no standard therapy.", {"entities": [[26, 34, "DISEASE"], [91, 99, "DISEASE"]]}], ["Twelve patients who have failed at least two initial CHOP or CHOP-like regimens were enrolled in this study and treated with individualized cyclosporine (CsA), prednisone (PDN), and monthly, high-dose intravenous immunoglobulin (HDIVIG).", {"entities": []}], ["The dose of CsA was adjusted individually based on the blood trough concentration of CsA and renal function.", {"entities": []}], ["All patients were examined for response, toxicity and survival.", {"entities": []}], ["The most significant toxicities (\u2265 grade 2) were infection (16.7%), renal insufficiency (8.3%), hypertension (8.3%), diabetes (8.3%) and insomnia (16.7%).", {"entities": [[96, 108, "DISEASE"]]}], ["Discontinuation of treatment occurred in one patient (8.3%) due to grade 3 renal toxicity and subsequent grade 4 pulmonary infection.", {"entities": []}], ["Treatment-related death was not observed.", {"entities": []}], ["The overall response rate was 75.0% (complete response, 33.3%; partial response, 41.7%).", {"entities": []}], ["With a median follow-up of 25.5 months, the median duration of response was 20 months (range, 12 to 49 months) and the median progression-free survival (PFS) was 25.5 months (range, 10 to 56 months).", {"entities": []}], ["The 2-year PFS rate was 81.5%.", {"entities": []}], ["Our findings indicate the combination of CsA, PDN and HDIVIG is an effective salvage regimen for refractory or relapsed AITL with predictable and manageable toxicity.", {"entities": []}], ["Some of the Census Enumeration Areas' (CEA) information may help planning the sample of population studies but it can also be used for some analyses that require information that is more difficult to obtain at the individual or household level, such as income.", {"entities": []}], ["This paper verifies if the income information of CEA can be used as a proxy for household income in a household survey.", {"entities": []}], ["A population-based survey conducted from January to December 2003 obtained data from a probabilistic sample of 1,734 households of Niter\u00f3i, Rio de Janeiro, Brazil.", {"entities": []}], ["Uniform semi-association models were adjusted in order to obtain information about the agreement/disagreement structure of data.", {"entities": []}], ["The distribution of nutritional status categories of the population of Niter\u00f3i according to income quintiles was performed using both CEA- and household-level income measures and then compared using Wald statistics for homogeneity.", {"entities": []}], ["Body mass index was calculated using body mass and stature data measured in the households and then used to define nutritional status categories according to the World Health Organization.", {"entities": []}], ["All estimates and statistics were calculated accounting for the structural information of the sample design and a significance level lower than 5% was adopted.", {"entities": []}], ["The classification of households in the quintiles of household income was associated with the classification of these households in the quintiles of CEA income.", {"entities": []}], ["The distribution of the nutritional status categories in all income quintiles did not differ significantly according to the source of income information (household or CEA) used in the definition of quintiles.", {"entities": []}], ["The structure of agreement/disagreement between quintiles of the household's monthly per capita income and quintiles of the head-of-household's mean nominal monthly income of the CEA, as well as the results produced by these measures when they were associated with the nutritional status of the population, showed that the CEA's income information can be used when income information at the individual or household levels is not available.", {"entities": []}], ["Combustion generated particulate matter is deposited in the respiratory tract and pose a hazard to the lungs through their potential to cause oxidative stress and inflammation.", {"entities": []}], ["We have previously shown that combustion of fuels and chlorinated hydrocarbons produce semiquinone-type radicals that are stabilized on particle surfaces (i.e.", {"entities": []}], ["environmentally persistent free radicals; EPFRs).", {"entities": []}], ["Because the composition and properties of actual combustion-generated particles are complex, heterogeneous in origin, and vary from day-to-day, we have chosen to use surrogate particle systems.", {"entities": []}], ["In particular, we have chosen to use the radical of 2-monochlorophenol (MCP230) as the EPFR because we have previously shown that it forms a EPFR on Cu(II)O surfaces and catalyzes formation of PCDD/F.", {"entities": []}], ["To understand the physicochemical properties responsible for the adverse pulmonary effects of combustion by-products, we have exposed human bronchial epithelial cells (BEAS-2B) to MCP230 or the CuO/silica substrate.", {"entities": []}], ["Our general hypothesis was that the EPFR-containing particle would have greater toxicity than the substrate species.", {"entities": []}], ["Exposure of BEAS-2B cells to our combustion generated particle systems significantly increased reactive oxygen species (ROS) generation and decreased cellular antioxidants resulting in cell death.", {"entities": []}], ["Resveratrol treatment reversed the decline in cellular glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) levels for both types of combustion-generated particle systems.", {"entities": []}], ["The enhanced cytotoxicity upon exposure to MCP230 correlated with its ability to generate more cellular oxidative stress and concurrently reduce the antioxidant defenses of the epithelial cells (i.e.", {"entities": []}], ["reduced GSH, SOD activity, and GPx).", {"entities": []}], ["The EPFRs in MCP230 also seem to be of greater biological concern due to their ability to induce lipid peroxidation.", {"entities": []}], ["These results are consistent with the oxidizing nature of the CuO/silica ultrafine particles and the reducing nature and prolonged environmental and biological lifetimes of the EPFRs in MCP230.", {"entities": []}], ["Patient: Female, 74 Final Diagnosis: Toxic epidermal necrolysis Symptoms: Bullous hemorrhagic lesions Medication: Levoflaxosine Clinical Procedure: Omalizumab therapy Specialty: Allergology Rare disease Toxic epidermal necrolysis (TEN) is characterized by widespread erythematous and bullous lesions on the skin.", {"entities": []}], ["Nowadays, considerable progress has been made in the understanding of its pathogenesis.", {"entities": []}], ["Immunologically it is similar to graft-versus-host disease.", {"entities": []}], ["Therefore, we may propose that TEN is a disorder of cell-mediated immunity.", {"entities": []}], ["Our patient was a 74-year-old white female who had pneumonia and was positive for hepatitis C virus (HCV), and who had been on levofloxacin therapy.", {"entities": [[51, 60, "DISEASE"], [82, 91, "DISEASE"]]}], ["After the first levofloxacin dose, erythematous dusky red macules occurred on her extremities and trunk, and on the following day, confluent purpuric lesions tended to run together over 85% of her body.", {"entities": []}], ["Her biopsy results indicated TEN.", {"entities": []}], ["Laboratory testing for serum ECP (eosinophil cationic peptide) and serum immunoglobulin (Ig) levels were performed, and blister fluid was investigated.", {"entities": []}], ["The patient responded positively to omalizumab treatment and after treatment laboratory tests revealed decreased high sensitive CRP, ECP, IgG1, IgG2, IgG3, IgG4, IgA, and IgM levels.", {"entities": [[128, 131, "GENE"]]}], ["To the best of our knowledge, this is the first case of a patient with HCV who developed cutaneous adverse drug reaction on levofloxacin medication and recovered with omalizumab treatment.", {"entities": []}], ["This is the first documentation of omalizumab treatment of a TEN patient.", {"entities": []}], ["Identification of novel drug-induced toxic nephropathy and acute kidney injury (AKI) biomarkers has been designated as a top priority by the American Society of Nephrology.", {"entities": []}], ["Increasing knowledge in the science of biology and medicine is leading to the discovery of still more new biomarkers and of their roles in molecular pathways triggered by physiological and pathological conditions.", {"entities": []}], ["Concomitantly, the development of the so-called \u201comics\u201d allows the progressive clinical utilization of a multitude of information, from those related to the human genome (genomics) and proteome (proteomics), including the emerging epigenomics, to those related to metabolites (metabolomics).", {"entities": []}], ["In preterm newborns, one of the most important factors causing the pathogenesis and the progression of AKI is the interaction between the individual genetic code, the environment, the gestational age, and the disease.", {"entities": []}], ["By analyzing a small urine sample, metabolomics allows to identify instantly any change in phenotype, including changes due to genetic modifications.", {"entities": []}], ["The role of liquid chromatography-mass spectrometry (LC-MS), proton nuclear magnetic resonance (", {"entities": []}], ["Radix Astragali (RA) is one of the commonly-used traditional Chinese medicines (TCMs) with an immunomodulatory effect confirmed in the clinic.", {"entities": []}], ["In order to better understand the material basis for the therapeutic effects, this study was to investigate the absorbed components and their pharmacokinetic profile after oral administration of RA on cyclophosphamide-induced immunosuppression in Balb/c mice.", {"entities": []}], ["As a result, 51 compounds in RA extract and 31 prototype compounds with nine metabolites were detected in mice plasma by the ultra-fast liquid chromatography (UFLC)-DAD-Q-TOF-MS/MS method.", {"entities": []}], ["The pharmacokinetic parameters of five main constituents, including calycosin-7- O -glucoside, ononin, calycosin, formononetin and astragaloside IV, were obtained using HPLC-MS/MS.", {"entities": []}], ["These results offered useful information for research on the pharmacological mechanism of RA and for its further development.", {"entities": []}], ["There is controversy regarding how comorbidity impacts on colorectal cancer screening, especially in the context of organised programmes.", {"entities": [[58, 75, "DISEASE"], [69, 75, "DISEASE"]]}], ["The aim of this study is to assess the effect of comorbidities on participation in the Barcelona population-based colorectal cancer screening programme (BCCSP).", {"entities": [[114, 131, "DISEASE"], [125, 131, "DISEASE"]]}], ["Cross-sectional study carried out in ten primary care centres involved in the BCCSP.", {"entities": []}], ["Individuals aged 50 to 69, at average risk of colorectal cancer, who were invited to participate in the first round of the faecal immunochemical test-based BCCSP were included (2011\u20132012).", {"entities": [[46, 63, "DISEASE"], [57, 63, "DISEASE"]]}], ["The main variable was participation in the BCCSP.", {"entities": []}], ["Comorbidity was assessed by clinical risk group status.", {"entities": []}], ["Other adjusting variables were age, sex, socioeconomic deprivation, visits to primary care, smoking, alcohol consumption and body mass index.", {"entities": []}], ["Logistic regression models were used to test the association between participation in the programme and potential explanatory variables.", {"entities": []}], ["The results were given as incidence rate ratios (IRR) and their 95% confidence intervals (CI).", {"entities": []}], ["Of the 36,208 individuals included, 17,404 (48%) participated in the BCCSP.", {"entities": []}], ["Participation was statistically significantly higher in women, individuals aged 60 to 64, patients with intermediate socioeconomic deprivation, and patients with more medical visits.", {"entities": []}], ["There was a higher rate of current smoking, high-risk alcohol intake, obesity and individuals in the highest comorbidity categories in the non-participation group.", {"entities": [[70, 77, "DISEASE"]]}], ["In the adjusted analysis, only individuals with multiple minor chronic diseases were more likely to participate in the BCCSP (IRR 1.14; 95% CI [1.06 to 1.22]; p \u00a0<\u00a00.001).", {"entities": []}], ["In contrast, having three or more dominant chronic diseases was associated with lower participation in the screening programme (IRR 0.76; 95% CI [0.65 to 0.89]; p \u00a0=\u00a00.001).", {"entities": []}], ["Having three or more dominant chronic diseases, was associated with lower participation in a faecal immunochemical test-based colorectal cancer screening programme, whereas individuals with multiple minor chronic diseases were more likely to participate.", {"entities": [[126, 143, "DISEASE"], [137, 143, "DISEASE"]]}], ["Further research is needed to explore comorbidity as a cause of non-participation in colorectal cancer screening programmes and which individuals could benefit most from colorectal cancer screening.", {"entities": [[85, 102, "DISEASE"], [170, 187, "DISEASE"], [96, 102, "DISEASE"], [181, 187, "DISEASE"]]}], ["Background : Physical activity plays an important role in individual health at all stages of life.", {"entities": []}], ["However, evidence is lacking regarding the level of moderate to vigorous physical activity (MVPA) and the related factors to insufficient physical activity (IPA).", {"entities": []}], ["Methods : A sample of 1060 students aged 12\u201315 years from nine public junior high schools in China were invited to participate in this study.", {"entities": []}], ["Physical activity was assessed by a modified version of the International Physical Activity Questionnaire.", {"entities": []}], ["Logistic regression was used to assess the factors associated with IPA.", {"entities": []}], ["Results : 30.1% boys and 43.0% girls in our sample did not engage in sufficient physical activity.", {"entities": []}], ["Obesity (OR = 2.2, 95% CI: 1.5\u20132.9) and high socioeconomic status (SES) (OR = 2.4, 95% CI: 1.3\u20134.8) were positively associated with IPA, whereas male sex (OR = 0.7, 95% CI: 0.5\u20130.9), underweight status (OR = 0.5, 95% CI: 0.3\u20130.7), and high family support level for physical activity (OR = 0.7, 95% CI: 0.6\u20130.9) showed inverse associations.", {"entities": []}], ["Age was not associated with IPA.", {"entities": []}], ["Conclusions : IPA appears to be a considerable problem in this sample of Chinese youth.", {"entities": []}], ["Effective interventions to increase physical activity are needed and may include improving family support level for physical activity, especially for girls, the obese and those with high SES.", {"entities": []}], ["To assess the prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in adolescents in the city of Belo Horizonte, Brazil, in 2012 by administering the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire, as well as to compare the observed prevalences with those found in studies performed 10 years earlier and employing the same methodology used here.", {"entities": [[37, 54, "DISEASE"], [46, 54, "DISEASE"], [29, 35, "DISEASE"], [195, 201, "DISEASE"]]}], ["This was a cross-sectional study conducted between May and December of 2012 and involving adolescents in the 13- to 14-year age bracket.", {"entities": []}], ["Participants were randomly selected from among adolescents studying at public schools in Belo Horizonte and completed the ISAAC questionnaire.", {"entities": []}], ["Proportions were calculated in order to assess the prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in the sample as a whole, and the chi-square goodness-of-fit test was used in order to compare the prevalences observed in 2012 with those found in 2002.", {"entities": [[74, 91, "DISEASE"], [83, 91, "DISEASE"], [66, 72, "DISEASE"]]}], ["The prevalences of symptoms of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in 2012 were 19.8%, 35.3%, and 16.3%, respectively, being significantly higher than those found in 2002 (asthma, p = 0.006; allergic rhinitis, p < 0.01; and allergic rhinoconjunctivitis, p = 0.002).", {"entities": [[39, 56, "DISEASE"], [215, 232, "DISEASE"], [48, 56, "DISEASE"], [224, 232, "DISEASE"], [31, 37, "DISEASE"], [196, 202, "DISEASE"]]}], ["The prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis among adolescents in 2012 were found to be high, having increased in comparison with those found 10 years earlier, despite efforts in prevention, diagnosis, and treatment.", {"entities": [[27, 44, "DISEASE"], [36, 44, "DISEASE"], [19, 25, "DISEASE"]]}], ["Avaliar as preval\u00eancias de asma, rinite al\u00e9rgica e rinoconjuntivite al\u00e9rgica em adolescentes da cidade de Belo Horizonte (MG) atrav\u00e9s do question\u00e1rio do International Study of Asthma and Allergies in Childhood no ano de 2012, bem como compar\u00e1-las com aquelas obtidas em estudos realizados 10 anos antes empregando a mesma metodologia.", {"entities": [[176, 182, "DISEASE"]]}], ["Estudo transversal realizado com estudantes de 13-14 anos de idade de escolas p\u00fablicas localizadas no munic\u00edpio, selecionados de forma aleat\u00f3ria simples, entre maio e dezembro de 2012, com a utiliza\u00e7\u00e3o do question\u00e1rio.", {"entities": []}], ["Foram realizados c\u00e1lculos das diferen\u00e7as de propor\u00e7\u00f5es para a an\u00e1lise das preval\u00eancias de asma, rinite al\u00e9rgica e rinoconjuntivite al\u00e9rgica na amostra geral, e o teste de qui-quadrado de ades\u00e3o foi utilizado para a compara\u00e7\u00e3o das preval\u00eancias de 2012 e 2002.", {"entities": []}], ["As preval\u00eancias de sintomas de asma, rinite al\u00e9rgica e rinoconjuntivite al\u00e9rgica em 2012 foram de 19,8%, 35,3% e 16,3%, respectivamente.", {"entities": []}], ["Houve aumentos significativos dessas preval\u00eancias em rela\u00e7\u00e3o ao ano de 2002 (asma, p = 0,006; rinite al\u00e9rgica, p < 0.01; e rinoconjuntivite al\u00e9rgica, p = 0.002).", {"entities": []}], ["Foram evidenciados elevadas taxas de asma, rinite al\u00e9rgica e rinoconjuntivite al\u00e9rgica entre os adolescentes estudados e aumentos dessas preval\u00eancias no intervalo de 10 anos, apesar dos esfor\u00e7os no \u00e2mbito da preven\u00e7\u00e3o, diagn\u00f3stico e tratamento dessas doen\u00e7as.", {"entities": []}], ["Childhood obesity is a concern in Australia and across the world.", {"entities": [[10, 17, "DISEASE"]]}], ["Community-based weight management programs are an important response to address childhood obesity.", {"entities": [[90, 97, "DISEASE"]]}], ["However, the scientific literature suggests that their effectiveness could potentially be enhanced by providing a structured incentive scheme.", {"entities": []}], ["This proposal aims to determine the effectiveness of enhanced goal setting linked to a structured incentive scheme designed to improve the sustained health and wellbeing of overweight/obese children within the context of an existing community-based program.", {"entities": []}], ["This study is a cluster randomized controlled trial delivered within the context of the existing NSW \u201cGo4Fun\u201d program with a 10-week and 6- and 12-month follow-up ( n \u2009=\u200940 sites, 570 participants) that compares the effectiveness of small changes to the program in which children were asked to set goals (supported by text messages) and were given rewards for achieving them (intervention).", {"entities": []}], ["This will be compared to the standard/existing program (control), which did not have the same structured incentive program.", {"entities": []}], ["Data will be collected for all participants at baseline, end of program, and at 6 and 12 months.", {"entities": []}], ["The primary outcome is a mean change in body mass index (BMI) z score at the 12-month follow-up.", {"entities": []}], ["Secondary outcomes include anthropometric measures (body weight, height, and waist circumference) and behavioral measures collected via validated questionnaires.", {"entities": []}], ["A process evaluation (comprising surveys and focus groups) to determine acceptability and sustainability and to inform downstream translation will also be conducted.", {"entities": []}], ["This study will inform policy and program delivery as well as the broader evidence base regarding goal achievement and incentive schemes directed at children\u2019s health-related behaviors and will provide evidence that is likely to be transferrable across a range of health conditions.", {"entities": []}], ["ACTRN12615000558527 registered on 29 May 2015.", {"entities": []}], ["The shift in the prevailing view of alcoholism from a moral paradigm towards a biomedical paradigm is often characterized as a form of biomedicalization.", {"entities": []}], ["We will examine and critique three reasons offered for the claim that viewing alcoholism as a disease is morally problematic.", {"entities": []}], ["The first is that the new conceptualization of alcoholism as a chronic brain disease will lead to individualization, e.g., a too narrow focus on the individual person, excluding cultural and social dimensions of alcoholism.", {"entities": [[71, 84, "DISEASE"]]}], ["The second claim is that biomedicalization will lead to stigmatization and discrimination for both alcoholics and people who are at risk of becoming alcoholics.", {"entities": []}], ["The third claim is that as a result of the biomedical point of view, the autonomy and responsibility of alcoholics and possibly even persons at risk may be unjustly restricted.", {"entities": []}], ["Our conclusion is that the claims against the biomedical conceptualization of alcoholism as a chronic brain disease are neither specific nor convincing.", {"entities": [[102, 115, "DISEASE"]]}], ["Not only do some of these concerns also apply to the traditional moral model; above that they are not strong enough to justify the rejection of the new biomedical model altogether.", {"entities": []}], ["The focus in the scientific and public debate should not be on some massive \u201cbiomedicalization objection\u201d but on the various concerns underlying what is framed in terms of the biomedicalization of alcoholism.", {"entities": []}], ["Krill contains two marine omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), mainly bound in phospholipids.", {"entities": []}], ["Typical products from krill are krill oil and krill meal.", {"entities": []}], ["Fish oils contain EPA and DHA predominantly bound in triglycerides.", {"entities": []}], ["The difference in the chemical binding of EPA and DHA has been suggested to affect their bioavailability, but little is known on bioavailability of EPA and DHA in krill meal.", {"entities": []}], ["This study was undertaken to compare the acute bioavailability of two krill products, krill oil and krill meal, with fish oil in healthy subjects.", {"entities": []}], ["A randomized, single-dose, single-blind, cross-over, active-reference trial was conducted in 15 subjects, who ingested krill oil, krill meal and fish oil, each containing approx.", {"entities": []}], ["1 700\u00a0mg EPA and DHA.", {"entities": []}], ["Fatty acid compositions of plasma triglycerides and phospholipids were measured repeatedly for 72\u00a0hours.", {"entities": []}], ["The primary efficacy analysis was based on the 72\u00a0hour incremental area under the curve (iAUC) of EPA and DHA in plasma phospholipid fatty acids.", {"entities": []}], ["A larger iAUC for EPA and DHA in plasma phospholipid fatty acids was detected after krill oil (mean 89.08\u2009\u00b1\u200933.36% \u00d7 h) than after krill meal (mean 44.97\u2009\u00b1\u200918.07% x h, p\u2009<\u20090.001) or after fish oil (mean 59.15\u2009\u00b1\u200922.22% \u00d7 h, p=0.003).", {"entities": []}], ["Mean iAUC\u2019s after krill meal and after fish oil were not different.", {"entities": []}], ["A large inter-individual variability in response was observed.", {"entities": []}], ["EPA and DHA in krill oil had a higher 72-hour bioavailability than in krill meal or fish oil.", {"entities": []}], ["Our finding that bioavailabilities of EPA and DHA in krill meal and fish oil were not different argues against the interpretation that phospholipids are better absorbed than triglycerides.", {"entities": []}], ["Longer-term studies using a parameter reflecting tissue fatty acid composition, like erythrocyte EPA plus DHA are needed.", {"entities": []}], ["NCT02089165", {"entities": []}], ["Mechanical ventilation is a resource intensive organ support treatment, and historical studies from low-resource settings had reported a high mortality.", {"entities": []}], ["We aimed to study the outcomes in patients receiving mechanical ventilation in a contemporary low-resource setting.", {"entities": []}], ["We prospectively studied the characteristics and outcomes (disease-related, mechanical ventilation-related, and process of care-related) in 237 adults mechanically ventilated for a medical illness at a teaching hospital in southern India during February 2011 to August 2012.", {"entities": []}], ["Vital status of patients discharged from hospital was ascertained on Day 90 or later.", {"entities": []}], ["Mean age of the patients was 40 \u00b1 17 years; 140 (51%) were men.", {"entities": []}], ["Poisoning and envenomation accounted for 98 (41%) of 237 admissions.", {"entities": []}], ["In total, 87 (37%) patients died in-hospital; 16 (7%) died after discharge; 115 (49%) were alive at 90-day assessment; and 19 (8%) were lost to follow-up.", {"entities": []}], ["Weaning was attempted in 171 (72%) patients; most patients (78 of 99 [79%]) failing the first attempt could be weaned off.", {"entities": []}], ["Prolonged mechanical ventilation was required in 20 (8%) patients.", {"entities": []}], ["Adherence to head-end elevation and deep vein thrombosis prophylaxis were 164 (69%) and 147 (62%) respectively.", {"entities": []}], ["Risk of nosocomial infections particularly ventilator-associated pneumonia was high (57.2 per 1,000 ventilator-days).", {"entities": [[65, 74, "DISEASE"]]}], ["Higher APACHE II score quartiles (adjusted HR [95% CI] quartile 2, 2.65 [1.19\u20135.89]; quartile 3, 2.98 [1.24\u20137.15]; quartile 4, 5.78 [2.45\u201313.60]), and new-onset organ failure (2.98 [1.94\u20134.56]) were independently associated with the risk of death.", {"entities": [[43, 45, "GENE"]]}], ["Patients with poisoning had higher risk of reintubation (43% vs. 20%; P = 0.001) and ventilator-associated pneumonia (75% vs. 53%; P = 0.001).", {"entities": [[107, 116, "DISEASE"]]}], ["But, their mortality was significantly lower compared to the rest (24% vs. 44%; P = 0.002).", {"entities": []}], ["The case-mix considerably differs from other settings.", {"entities": []}], ["Mortality in this low-resource setting is similar to high-resource settings.", {"entities": []}], ["But, further improvements in care processes and prevention of nosocomial infections are required.", {"entities": []}], ["Interleukin (IL)-9 is a Th2-derived cytokine with pleiotropic biological effects, which recently has been proposed as a candidate gene for asthma and allergy.", {"entities": [[139, 145, "DISEASE"]]}], ["We aimed to evaluate the therapeutic effect of a neutralizing anti-IL-9 antibody in a mouse model of airway eosinophilic inflammation and compared any such effect with anti-IL-5 treatment.", {"entities": []}], ["OVA-sensitized Balb/c mice were intraperitoneally pretreated with a single dose (100 \u03bcg) of an anti-mouse IL-9 monoclonal antibody (clone D9302C12) or its vehicle.", {"entities": []}], ["A third group was given 50 \u03bcg of a monoclonal anti-mouse IL-5 antibody (TRFK-5) or its vehicle.", {"entities": []}], ["Animals were subsequently exposed to OVA on five days via airways.", {"entities": []}], ["Newly produced eosinophils were labelled using 5-bromo-2'-deoxyuridine (BrdU).", {"entities": []}], ["BrdU U -test was used to determine significant differences between groups.", {"entities": []}], ["Anti-IL-9 significantly reduced bone marrow eosinophilia, primarily by decrease of newly produced (BrdU Our data shows that a single dose of a neutralizing IL-9 antibody is not sufficient to reduce allergen-induced influx of newly produced cells from bone marrow to airways.", {"entities": [[44, 56, "DISEASE"]]}], ["However, in response to allergen, bone marrow cells over-express IL-9.", {"entities": []}], ["This data suggest that IL-9 may participate in the regulation of granulocytopoiesis in allergic inflammation.", {"entities": []}], ["Allergy is a complex disease that is likely to involve dysregulated CD4+ T cell activation.", {"entities": []}], ["Here we propose a novel methodology to gain insight into how coordinated behaviour emerges between disease-dysregulated pathways in response to pathophysiological stimuli.", {"entities": []}], ["Using peripheral blood mononuclear cells of allergic rhinitis patients and controls cultured with and without pollen allergens, we integrate CD4+ T cell gene expression from microarray data and genetic markers of allergic sensitisation from GWAS data at the pathway level using enrichment analysis; implicating the complement system in both cellular and systemic response to pollen allergens.", {"entities": [[44, 61, "DISEASE"], [53, 61, "DISEASE"]]}], ["We delineate a novel disease network linking T cell activation to the complement system that is significantly enriched for genes exhibiting correlated gene expression and protein-protein interactions, suggesting a tight biological coordination that is dysregulated in the disease state in response to pollen allergen but not to diluent.", {"entities": []}], ["This novel disease network has high predictive power for the gene and protein expression of the Th2 cytokine profile ( IL-4, IL-5, IL-10, IL-13 ) and of the Th2 master regulator ( GATA3 ), suggesting its involvement in the early stages of CD4+ T cell differentiation.", {"entities": [[180, 185, "GENE"]]}], ["Dissection of the complement system gene expression identifies 7 genes specifically associated with atopic response to pollen, including C1QR1, CFD, CFP, ITGB2 , ITGAX and confirms the role of C3AR1 and C5AR1.", {"entities": [[144, 147, "GENE"], [149, 152, "GENE"], [154, 159, "GENE"], [162, 167, "GENE"], [193, 198, "GENE"], [203, 208, "GENE"]]}], ["Two of these genes ( ITGB2 and C3AR1) are also implicated in the network linking complement system to T cell activation, which comprises 6 differentially expressed genes.", {"entities": [[21, 26, "GENE"], [31, 36, "GENE"]]}], ["C3AR1 is also significantly associated with allergic sensitisation in GWAS data.", {"entities": [[0, 5, "GENE"]]}], ["We evaluated the profiles of allergic rhino-conjunctivitis and asthma patients annually in Antalya, a Mediterranean coastal city in Turkey.", {"entities": [[44, 58, "DISEASE"], [63, 69, "DISEASE"]]}], ["We evaluated patients\u2019 allergic clinical status, and recorded the climate and pollens in the city center air, investigating any correlation between pollination, climatic conditions and allergic disorders.", {"entities": []}], ["The meteorological conditions and the pollen count/cm SPT positivity for plantago lanceolata, aspergillus fumigatus and d. pteronyssinus was significant in patients younger than 40 years old.", {"entities": []}], ["Pollination levels are consistent from March 2010 to February 2011.", {"entities": []}], ["In Antalya, high levels occur mostly from April to June, thus we performed skin prick tests mostly in May/June (~30%).", {"entities": []}], ["During these months meteorological conditions of the city were windy with low humidity, without rain, and lukewarm temperatures, all of which contribute to high-risk conditions for seasonal allergies.", {"entities": []}], ["The major allergen between April and June was derived from Graminea ; between February and March was Cupressus spp; and between March and June was Pinus spp.", {"entities": []}], ["These results suggest that the pollination is correlated with allergic conditions and thus SPT might be best performed according to the pollen count.", {"entities": []}], ["The airway epithelium may release pro-inflammatory cytokines and chemokines in the asthmatic airway.", {"entities": []}], ["Sphingosine 1-phosphate (S1P) is a bioactive lipid, increased in the airways of asthmatics, that may trigger the release of the potent neutrophil chemoattractant Interleukin-8 (IL-8) by epithelial cells.", {"entities": []}], ["S1P is a ligand for 5 G protein-coupled receptors, S1PR1-5.", {"entities": []}], ["We wished to explore the mechanisms of S1P induced IL-8 secretion with regard to the receptor(s) and downstream signaling events involved.", {"entities": []}], ["Our results indicate that S1P induced IL-8 release is mediated by S1PR2 and the transcription factor NF-\u03baB.", {"entities": [[66, 71, "GENE"]]}], ["Since the Epidermal Growth Factor Receptor (EGFR) and reactive oxygen species (ROS) have been implicated in IL-8 release in response to activation of other G protein-coupled receptors, we examined their importance in S1P induced IL-8 release and established that they are not involved.", {"entities": [[44, 48, "GENE"]]}], ["This study reveals S1PR2 and NF-\u03baB as potential therapeutic targets in neutrophilic airway diseases such as severe asthma.", {"entities": [[115, 121, "DISEASE"], [19, 24, "GENE"]]}], ["During inflammation polymorphonuclear neutrophils (PMNs) traverse venular walls, composed of the endothelium, pericyte sheath and vascular basement membrane.", {"entities": []}], ["Compared to PMN transendothelial migration, little is known about how PMNs penetrate the latter barriers.", {"entities": []}], ["Using mouse models and intravital microscopy, we show that migrating PMNs expand and use the low expression regions (LERs) of matrix proteins in the vascular basement membrane (BM) for their transmigration.", {"entities": []}], ["Importantly, we demonstrate that this remodeling of LERs is accompanied by the opening of gaps between pericytes, a response that depends on PMN engagement with pericytes.", {"entities": []}], ["Exploring how PMNs modulate pericyte behavior, we discovered that direct PMN-pericyte contacts induce relaxation rather than contraction of pericyte cytoskeletons, an unexpected response that is mediated by inhibition of the RhoA/ROCK signaling pathway in pericytes.", {"entities": []}], ["Taking our in vitro results back into mouse models, we present evidence that pericyte relaxation contributes to the opening of the gaps between pericytes and to the enlargement of the LERs in the vascular BM, facilitating PMN extravasation.", {"entities": []}], ["Our study demonstrates that pericytes can regulate PMN extravasation by controlling the size of pericyte gaps and thickness of LERs in venular walls.", {"entities": []}], ["This raises the possibility that pericytes may be targeted in therapies aimed at regulating inflammation.", {"entities": []}], ["Successfully coping with a chronic disease depends significantly on social support, particularly that of a significant other.", {"entities": []}], ["Thus, it depends on the ways of dealing with stress within a couple (dyadic coping).", {"entities": []}], ["In this study, the relationship between dyadic coping and well-being was investigated among couples in which one partner suffers from chronic obstructive pulmonary disease (COPD).", {"entities": [[134, 171, "DISEASE"]]}], ["A total of 43 couples participated.", {"entities": []}], ["They were mailed questionnaires on anxiety and depression (Hospital Anxiety and Depression Scale), quality of life (World Health Organization Quality of Life Questionnaire-BREF), and dyadic coping (Dyadic Coping Inventory).", {"entities": []}], ["Low scores of positive and high scores of negative dyadic coping were associated with poorer quality of life and higher psychological distress among couples.", {"entities": []}], ["Delegated coping (assistance with daily tasks) was higher among partners.", {"entities": []}], ["When estimated by patients, high delegated partner coping (frequent provision of support by partners) and low delegated personal coping (low provision of support by patients) were associated with poorer quality of life for both patient and partner.", {"entities": []}], ["COPD patients suffering from depression were supported more often and attributed deficits in dyadic coping primarily to themselves, whereas partners with higher scores of depression provided higher estimates of both their own negative coping and the negative coping of their partner.", {"entities": []}], ["The higher the patient perceived the imbalance in delegated dyadic coping, the lower the couple\u2019s quality of life.", {"entities": []}], ["More negative and less positive dyadic coping were associated with lower quality of life and higher psychological distress.", {"entities": []}], ["Psychotherapeutic interventions to improve dyadic coping may lead to better quality of life and less psychological distress among COPD patients and their partners.", {"entities": []}], ["Traditionally top-down method was used to identify prognostic features in cancer research.", {"entities": [[74, 80, "DISEASE"]]}], ["That is to say, differentially expressed genes usually in cancer versus normal were identified to see if they possess survival prediction power.", {"entities": [[58, 64, "DISEASE"]]}], ["The problem is that prognostic features identified from one set of patient samples can rarely be transferred to other datasets.", {"entities": []}], ["We apply bottom-up approach in this study: survival correlated or clinical stage correlated genes were selected first and prioritized by their network topology additionally, then a small set of features can be used as a prognostic signature.", {"entities": []}], ["Gene expression profiles of a cohort of 221 hepatocellular carcinoma (HCC) patients were used as a training set, \u2018bottom-up\u2019 approach was applied to discover gene-expression signatures associated with survival in both tumor and adjacent non-tumor tissues, and compared with \u2018top-down\u2019 approach.", {"entities": [[44, 68, "DISEASE"], [59, 68, "DISEASE"]]}], ["The results were validated in a second cohort of 82 patients which was used as a testing set.", {"entities": []}], ["Two sets of gene signatures separately identified in tumor and adjacent non-tumor tissues by bottom-up approach were developed in the training cohort.", {"entities": []}], ["These two signatures were associated with overall survival times of HCC patients and the robustness of each was validated in the testing set, and each predictive performance was better than gene expression signatures reported previously.", {"entities": []}], ["Moreover, genes in these two prognosis signature gave some indications for drug-repositioning on HCC.", {"entities": []}], ["Some approved drugs targeting these markers have the alternative indications on hepatocellular carcinoma.", {"entities": [[80, 104, "DISEASE"], [95, 104, "DISEASE"]]}], ["Using the bottom-up approach, we have developed two prognostic gene signatures with a limited number of genes that associated with overall survival times of patients with HCC.", {"entities": []}], ["Furthermore, prognostic markers in these two signatures have the potential to be therapeutic targets.", {"entities": []}], ["COPD is characterized by persistent and progressive airway inflammation.", {"entities": []}], ["Although neutrophilic airway inflammation is generally accepted to be a major factor in the pathogenesis of COPD, the influence of the agents used for the treatment of COPD on neutrophil functions such as chemotaxis is not fully understood.", {"entities": []}], ["The present study aimed to examine the influence of tiotropium bromide on the production of interleukin (IL)-8 from human airway epithelial cells and lung fibroblasts (LFs) after lipopolysaccharide (LPS) stimulation in vitro.", {"entities": []}], ["BEAS-2B cells, human bronchial epithelial cell line, and LFs, at a concentration of 5 \u00d7 10 Tiotropium bromide at >15 pg/mL inhibited IL-8 production from both BEAS-2B cells and LFs after LPS stimulation.", {"entities": []}], ["Tiotropium bromide also suppressed IL-8 mRNA expression through the inhibition of NF-\u03baB activation and signaling protein, extracellular-signal-regulated kinase 1/2, and c-Jun N-terminal kinase, phosphorylation.", {"entities": []}], ["The present results strongly suggest that tiotropium bromide exerts the inhibitory effect on neutrophilic inflammation through the suppression of IL-8 production from epithelial cells and LFs by interfering with LPS-mediated signaling pathways and thus may contribute to lower cellular inflammation in COPD, which is responsible for favorable modification of the disease.", {"entities": []}], ["The increase in allergic diseases over the past several decades is correlated with changes in the composition and diversity of the intestinal microbiota.", {"entities": []}], ["Microbial-derived signals are critical for instructing the developing immune system and conversely, immune regulation can impact the microbiota.", {"entities": []}], ["Perturbations in the microbiota composition may be especially important during early-life when the immune system is still developing, resulting in a critical window of opportunity for instructing the immune system.", {"entities": []}], ["This review highlights recent studies investigating the role of the microbiome in susceptibility or development of allergic diseases with a focus on animal models that provide insight into the mechanisms and pathways involved.", {"entities": []}], ["Identification of a causal link between reduced microbial diversity or altered microbial composition and increased susceptibility to immune-mediated diseases will hopefully pave the way for better preventive therapies.", {"entities": []}], ["\u2022 Early microbial diversity negatively correlates with susceptibility to allergy.", {"entities": []}], ["\u2022 A \u2018window of opportunity\u2019 in early life can establish immune regulation.", {"entities": []}], ["\u2022 Animal models seek mechanisms linking microbial diversity and allergic disease.", {"entities": []}], ["\u2022 Microbiota-based therapies for preventive treatment regimes are the ultimate goal.", {"entities": []}], ["Early microbial diversity negatively correlates with susceptibility to allergy.", {"entities": []}], ["A \u2018window of opportunity\u2019 in early life can establish immune regulation.", {"entities": []}], ["Animal models seek mechanisms linking microbial diversity and allergic disease.", {"entities": []}], ["Microbiota-based therapies for preventive treatment regimes are the ultimate goal.", {"entities": []}], ["Despite national recommendations, most patients with asthma are not given a written action plan .", {"entities": [[53, 59, "DISEASE"]]}], ["The objectives were to ascertain physicians\u2019 endorsement of potential enablers to providing a written action plan, and the determinants and proportion, of physician-reported use of a written action plan.", {"entities": []}], ["We surveyed 838 family physicians, paediatricians, and emergency physicians in Quebec .", {"entities": []}], ["The mailed questionnaire comprised 102 questions on asthma management, 11 of which pertained to written action plan and promising enablers.", {"entities": [[52, 58, "DISEASE"]]}], ["Physicians also selected a case vignette that best corresponded to their practice and reported their management.", {"entities": []}], ["The survey was completed by 421 (56%) physicians (250 family physicians, 115 paediatricians and 56 emergency physicians); 43 (5.2%) reported providing a written action plan to \u226570% of their asthmatic patients and 126 (30%) would have used a written action plan in the selected vignette.", {"entities": []}], ["Most (>60%) physicians highly endorsed the following enablers: patients requesting a written action plan, adding a blank written action plan to the chart, receiving a copy of the written action plan completed by a consultant, receiving a monetary compensation for its completion, and having another healthcare professional explain the completed written action plan to patients.", {"entities": []}], ["Four determinants were significantly associated with providing a written action plan: being a paediatrician (RR:2.1), treating a child (RR:2.0), aiming for long-term asthma control (RR:2.5), and being aware of national recommendations to provide a written action plan to asthmatic patients (RR:2.9).", {"entities": [[166, 172, "DISEASE"]]}], ["A small minority of Quebec physicians reported providing a written action plan to most of their patients, revealing a huge care gap.", {"entities": []}], ["Several enablers to improve uptake, highly endorsed by physicians, should be prioritised in future implementation efforts.", {"entities": []}], ["Changes to practice organization and doctors\u2019 perceptions should encourage the provision of written action plans for all asthma patients.", {"entities": [[121, 127, "DISEASE"]]}], ["International guidelines state that effective long-term treatment of asthma requires educated self-management, regular reviews and provision of a written action plan (WAP).", {"entities": [[69, 75, "DISEASE"]]}], ["However, many patients have poor asthma control and as few as 30 per cent have a WAP.", {"entities": [[33, 39, "DISEASE"]]}], ["Fabienne Djandji at the Saint-Justine University Central Hospital in Montreal, Canada, and co-workers conducted a survey of 421 doctors to determine their attitudes and provision of WAPs.", {"entities": []}], ["Only 5.2 per cent of respondents provided WAPs to patients; those treating children or aiming for long-term asthma control were more likely to do so.", {"entities": [[108, 114, "DISEASE"]]}], ["The doctors said that incentives to provide WAPs would include requests from patients themselves, being paid to complete WAPs and having extra support from specialists or other health care professionals such as pharmacists.", {"entities": []}], ["Ras guanine nucleotide-releasing protein-4 (RasGRP4) is an evolutionarily conserved calcium-regulated, guanine nucleotide exchange factor and diacylglycerol/phorbol ester receptor.", {"entities": [[44, 51, "GENE"]]}], ["While an important intracellular signaling protein for CD117 in vivo -differentiated splenic CD117", {"entities": []}], ["Novel therapies need to be evaluated in normal clinical practice to allow a true representation of the treatment effectiveness in real-world settings.", {"entities": []}], ["The Salford Lung Study is a pragmatic randomised controlled trial in adult asthma, evaluating the clinical effectiveness and safety of once-daily fluticasone furoate (100\u00a0\u03bcg or 200\u00a0\u03bcg)/vilanterol 25\u00a0\u03bcg in a novel dry-powder inhaler, versus existing asthma maintenance therapy.", {"entities": [[75, 81, "DISEASE"], [249, 255, "DISEASE"]]}], ["The study was initiated before this investigational treatment was licensed and conducted in real-world clinical practice to consider adherence, co-morbidities, polypharmacy, and real-world factors.", {"entities": []}], ["Primary endpoint: Asthma Control Test at week 24; safety endpoints include the incidence of serious pneumonias.", {"entities": [[18, 24, "DISEASE"]]}], ["The study utilises the Salford electronic medical record, which allows near to real-time collection and monitoring of safety data.", {"entities": []}], ["The Salford Lung Study is the world\u2019s first pragmatic randomised controlled trial of a pre-licensed medication in asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["Use of patients\u2019 linked electronic health records to collect clinical endpoints offers minimal disruption to patients and investigators, and also ensures patient safety.", {"entities": []}], ["This highly innovative study will complement standard double-blind randomised controlled trials in order to improve our understanding of the risk/benefit profile of fluticasone furoate/vilanterol in patients with asthma in real-world settings.", {"entities": [[213, 219, "DISEASE"]]}], ["Clinicaltrials.gov, NCT01706198 ; 04 October 2012.", {"entities": []}], ["Malaysia is a country with the intermediate burden of tuberculosis (TB).", {"entities": [[54, 66, "DISEASE"]]}], ["TB is still a public-health problem in Sabah, one of the two states in East Malaysia.", {"entities": []}], ["In 2007, the state of Sabah contributed slightly more than 3,000 of 16,129 new and relapse cases reported in the country.", {"entities": []}], ["It has a notification rate of two and a half times that of the country's.", {"entities": []}], ["Very few studies on TB have been conducted in Sabah, and there is little documentation on the perceptions of TB patients and the community about TB, healthcare-seeking behaviour, and impact of TB on the people of Sabah.", {"entities": []}], ["A qualitative study was conducted in 2006 in seven districts in Sabah to assess the knowledge and perceptions of TB patients and the community about TB, also to know the experiences of healthcare services, and to examine the impact of TB on patients and families.", {"entities": []}], ["Purposive sampling identified 27 TB patients and 20 relatives and community members who were interviewed using a set of questions on knowledge, perceptions about TB, healthcare-seeking behaviour, and impact of TB.", {"entities": []}], ["A further 11 health staff attended informal discussions and feedback sessions.", {"entities": []}], ["Most interviews were taped and later translated.", {"entities": []}], ["Data were analyzed using thematic content analysis.", {"entities": []}], ["Ninety-six percent of the respondents did not know the cause of TB.", {"entities": []}], ["Some thought that TB occurred due to a \u2018tear\u2019 in the body or due to hard work or inflammation while others thought that it occurred due to eating contaminated food or due to sharing utensils or breathing space with TB patients.", {"entities": []}], ["Although the germ theory was not well-known, 98% of the respondents believed that TB was infectious.", {"entities": []}], ["Some patients did not perceive the symptoms they had as those of TB.", {"entities": []}], ["The prevailing practice among the respondents was to seek modern medicine for cure.", {"entities": []}], ["Other forms of treatment, such as traditional medicine, were sought if modern medicine failed to cure the disease.", {"entities": []}], ["TB was still a stigmatizing disease, and the expression of this was in both perceived and enacted ways.", {"entities": []}], ["TB also affected the patients in various aspects of their lives, such as psychosocial, physical, financial and life practices.", {"entities": []}], ["Patients who were farmers complained that they did not recover fully from their disease and were not, thus, able to continue with their previous work.", {"entities": []}], ["Patients changed their life practices, such as not sharing their utensils, had a separate sleeping area, and practised social distancing.", {"entities": []}], ["On the other hand, most health workers were unaware of the effects of TB on their patients and that knowledge of their patients on TB was inadequate.", {"entities": []}], ["There is a need to understand the reasons for the misconceptions about TB and to address the lack of knowledge on TB through health education.", {"entities": []}], ["Patients need to recognize the symptoms of TB early so that prompt treatment can be initiated, and patients need to be convinced of its curability.", {"entities": []}], ["Hookworms survive for several years (5 to 7 years) in the host lumen, inducing a robust but largely ineffective immune response.", {"entities": []}], ["Among the most striking aspects of the immune response to hookworm (as with many other helminths) is the ablation of parasite-specific T cell proliferative response (hyporesponsiveness).", {"entities": []}], ["While the role of the adaptive immune response in human helminth infection has been well investigated, the role of the innate immune responses (e.g., dendritic cells and eosinophils) has received less attention and remains to be clearly elucidated.", {"entities": []}], ["We report on the differentiation/maturation of host dendritic cells in vitro and the eosinophil activation/function associated with human hookworm infection.", {"entities": []}], ["Mature DCs (mDCs) from Necator americanus (Necator) \u2013infected individuals showed an impaired differentiation process compared to the mDCs of non-infected individuals, as evidenced by the differential expression of CD11c and CD14.", {"entities": [[224, 228, "GENE"]]}], ["These same hookworm-infected individuals also presented significantly down-regulated expression of CD86, CD1a, HLA-ABC, and HLA-DR.", {"entities": [[99, 103, "GENE"], [105, 109, "GENE"]]}], ["The lower expression of co-stimulatory and antigen presentation molecules by hookworm-infected\u2013derived mDCs was further evidenced by their reduced ability to induce cell proliferation.", {"entities": []}], ["We also showed that this alternative DC differentiation is partially induced by excreted-secreted hookworm products.", {"entities": []}], ["Conversely, eosinophils from the same individuals showed a highly activated status, with an upregulation of major cell surface markers.", {"entities": []}], ["Antigen-pulsed eosinophils from N. americanus \u2013infected individuals induced significant cell proliferation of autologous PBMCs, when compared to non-infected individuals.", {"entities": []}], ["Chronic N. americanus infection alters the host's innate immune response, resulting in a possible modulation of the maturation process of DCs, a functional change that may diminish their ability for antigen presentation and thus contribute to the ablation of the parasite-specific T cell proliferative response.", {"entities": []}], ["Interestingly, a concomitant upregulation of the major cell surface markers of eosinophils was observed in hookworm-infected individuals, indicative of antigen-specific immune responses, especially antigen presentation.", {"entities": []}], ["We showed that in addition to the postulated role of the eosinophils as effector cells against helminth infection, activated cells may also be recruited to sites of inflammation and contribute to the immune response acting as antigen presenting cells.", {"entities": []}], ["Hookworms survive for several years in the host lumen, inducing a robust but ineffective immune response.", {"entities": []}], ["While the role of the adaptive response in human helminth infection has been well investigated, the role of the innate immune responses remains to be elucidated.", {"entities": []}], ["We report on the development of dendritic cells (DCs) and the role of eosinophils during human hookworm infection.", {"entities": []}], ["DCs from hookworm-infected individuals did not mature in the same manner as DCs from non-infected volunteers.", {"entities": []}], ["Additionally, hookworm-infected individuals have lower expression of costimulatory (CD86) and antigen presenting molecules (CD1a, HLA-ABC, HLA-DR), which was coincident with a reduced ability of the DCs to induce cell proliferation.", {"entities": [[84, 88, "GENE"], [124, 128, "GENE"]]}], ["We also showed that this alternative DC differentiation is partially induced by excreted-secreted hookworm products.", {"entities": []}], ["Conversely, eosinophils from the same individuals showed a highly activated status, with an upregulation of major cell surface markers.", {"entities": []}], ["Moreover, eosinophils from hookworm-infected individuals induced a significant cell proliferation to crude antigen extracts compared to non-infected individuals.", {"entities": []}], ["We show that, while hookworm infection modulates the development of DCs, the major cell surface markers of eosinophils are upregulated.", {"entities": []}], ["Our data suggest that hookworm infection may alter the host's innate immune response, resulting in parasite-impaired DCs and activated, antigen presenting eosinophils.", {"entities": []}], ["The enzyme tartrate resistant acid phosphatase (TRAP, two isoforms 5a and 5b) is highly expressed in alveolar macrophages, but its function there is unclear and potent selective inhibitors of TRAP are required to assess functional aspects of the protein.", {"entities": []}], ["We found higher TRAP activity/expression in lungs of patients with chronic obstructive pulmonary disease (COPD) and asthma compared to controls and more TRAP activity in lungs of mice with experimental COPD or asthma.", {"entities": [[67, 104, "DISEASE"], [116, 122, "DISEASE"], [210, 216, "DISEASE"]]}], ["Stimuli related to asthma and/or COPD were tested for their capacity to induce TRAP.", {"entities": [[19, 25, "DISEASE"]]}], ["Receptor activator of NF-\u03bab ligand (RANKL) and Xanthine/Xanthine Oxidase induced TRAP mRNA expression in mouse macrophages, but only RANKL also induced TRAP activity in mouse lung slices.", {"entities": []}], ["Several Au(III) coordination compounds were tested for their ability to inhibit TRAP activity and [Au(4,4\u2032-dimethoxy-2,2\u2032-bipyridine)Cl 2 ][PF 6 ] (AubipyOMe) was found to be the most potent inhibitor of TRAP5a and 5b activity reported to date (IC50 1.3 and 1.8\u2009\u03bcM respectively).", {"entities": []}], ["AubipyOMe also inhibited TRAP activity in murine macrophage and human lung tissue extracts.", {"entities": []}], ["In a functional assay with physiological TRAP substrate osteopontin, AubipyOMe inhibited mouse macrophage migration over osteopontin-coated membranes.", {"entities": []}], ["In conclusion, higher TRAP expression/activity are associated with COPD and asthma and TRAP is involved in regulating macrophage migration.", {"entities": [[76, 82, "DISEASE"]]}], ["Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal diseases characterized by the excessive and chronic production of mature cells from one or several of the myeloid lineages.", {"entities": []}], ["Recent advances in the biology of MPNs have greatly facilitated their molecular diagnosis since most patients present with mutation(s) in the JAK2, MPL, or CALR genes.", {"entities": [[142, 146, "GENE"], [148, 151, "GENE"], [156, 160, "GENE"]]}], ["Yet the roles played by these mutations in the pathogenesis and main complications of the different subtypes of MPNs are not fully elucidated.", {"entities": []}], ["Importantly, chronic inflammation has long been associated with MPN disease and some of the symptoms and complications can be linked to inflammation.", {"entities": []}], ["Moreover, the JAK inhibitor clinical trials showed that the reduction of symptoms linked to inflammation was beneficial to patients even in the absence of significant decrease in the JAK2 -V617F mutant load.", {"entities": [[183, 187, "GENE"]]}], ["These observations suggested that part of the inflammation observed in patients with JAK2 -mutated MPNs may not be the consequence of JAK2 mutation.", {"entities": [[85, 89, "GENE"], [134, 138, "GENE"], [85, 89, "GENE"], [134, 138, "GENE"]]}], ["The aim of this paper is to review the different aspects of inflammation in MPNs, the molecular mechanisms involved, the role of specific genetic defects, and the evidence that increased production of certain cytokines depends or not on MPN-associated mutations, and to discuss possible nongenetic causes of inflammation.", {"entities": []}], ["Recovery efforts after natural disasters typically focus on physical infrastructure.", {"entities": []}], ["In general less attention is paid to the social infrastructure that might impact the capacity of the community to rebuild.", {"entities": []}], ["We examine perceptions of preparedness and recovery (markers of resilience at the community level) in the wake of Superstorm Sandy with a novel data set that includes a multi-mode survey of twelve neighborhoods severely affected by the storm.", {"entities": []}], ["With these data, we suggest that social resources are associated with beliefs about neighborhood resilience.", {"entities": []}], ["People who live in communities with higher social cohesion (coefficient = .73, p <.001), informal social control (coefficient = .53, p <.001), and social exchange (coefficient = .69, p <.001) are more likely to believe their neighborhoods are well prepared for a disaster.", {"entities": []}], ["Likewise, people living in communities with higher social cohesion (coefficient = .35, p <.01), informal social control (coefficient = .27, p <.05), and social exchange (coefficient = .42, p <.001) are more likely to be confident their neighborhoods will recover quickly from a disaster.", {"entities": []}], ["However, the effects of social resources on beliefs about resilience vary based on neighborhood socioeconomic status (SES) and the impact of the storm.", {"entities": []}], ["Informal social control and social exchange lead to a greater increase in confidence in recovery in low, as compared to high, SES neighborhoods.", {"entities": []}], ["Social resources tend to have more impact on perceptions of recovery in communities less affected by the storm.", {"entities": []}], ["In sum, these findings suggest the potential value of various forms of social intervention to better equip communities to respond when disaster strikes.", {"entities": []}], ["Supplemental Digital Content is available in the text Lung cancer is the third most common cancer in the world and has the highest cancer mortality rate.", {"entities": [[54, 65, "DISEASE"], [59, 65, "DISEASE"], [91, 97, "DISEASE"], [131, 137, "DISEASE"]]}], ["A worldwide increasing trend of lung adenocarcinoma has been noted.", {"entities": [[37, 51, "DISEASE"], [32, 51, "DISEASE"]]}], ["In addition, the identification of epidermal growth factor receptor (EGFR) mutations and the introduction of EGFR inhibitors to successfully treat EGFR mutated non\u2013small cell lung cancers are breakthroughs for lung cancer treatment.", {"entities": [[210, 221, "DISEASE"], [215, 221, "DISEASE"], [69, 73, "GENE"], [109, 113, "GENE"], [147, 151, "GENE"], [69, 73, "GENE"], [109, 113, "GENE"], [147, 151, "GENE"], [69, 73, "GENE"], [109, 113, "GENE"], [147, 151, "GENE"]]}], ["The current study evaluated the incidence and survival of lung cancer using data collected by the Taiwan Cancer Registry between 1996 and 2008.", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"], [105, 111, "DISEASE"]]}], ["The results showed that the most common histologic subtype of lung cancer was adenocarcinoma, followed by squamous cell carcinoma, small cell carcinoma, large cell carcinoma, neuroendocrine tumors, lymphoma, and sarcoma.", {"entities": [[78, 92, "DISEASE"], [62, 73, "DISEASE"], [153, 173, "DISEASE"], [120, 129, "DISEASE"], [142, 151, "DISEASE"], [164, 173, "DISEASE"], [106, 129, "DISEASE"], [212, 219, "DISEASE"], [198, 206, "DISEASE"], [131, 151, "DISEASE"], [67, 73, "DISEASE"]]}], ["Overall, the incidence of lung cancer in Taiwan increased significantly from 1996 to 2008.", {"entities": [[26, 37, "DISEASE"], [31, 37, "DISEASE"]]}], ["An increased incidence was observed for adenocarcinoma, particularly for women, with an annual percentage change of 5.9, whereas the incidence of squamous cell carcinoma decreased.", {"entities": [[40, 54, "DISEASE"], [160, 169, "DISEASE"], [146, 169, "DISEASE"]]}], ["Among the subtypes of lung cancer, the most rapid increase occurred in neuroendocrine tumors with an annual percentage change of 15.5.", {"entities": [[22, 33, "DISEASE"], [27, 33, "DISEASE"]]}], ["From 1996\u20131999 to 2005\u20132008, the 1-year survival of adenocarcinoma increased by 10% for men, whereas the 1-, 3-, and 5-year survivals of adenocarcinoma for women increased by 18%, 11%, and 5%, respectively.", {"entities": [[52, 66, "DISEASE"], [137, 151, "DISEASE"]]}], ["Overall, the incidence of lung cancer has been increasing in Taiwan, although the trends were variable by subtype.", {"entities": [[26, 37, "DISEASE"], [31, 37, "DISEASE"]]}], ["The introduction of targeted therapies was associated with a significantly improved survival for lung adenocarcinoma in Taiwan; however, more studies are needed to explain the rising incidence of lung adenocarcinoma.", {"entities": [[102, 116, "DISEASE"], [201, 215, "DISEASE"], [97, 116, "DISEASE"], [196, 215, "DISEASE"]]}], ["In addition, it is important to investigate the molecular pathogenesis of the various subtypes of lung cancer to develop novel therapeutic agents.", {"entities": [[98, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Asthma is a complex heritable inflammatory disorder of the airways in which the development of clinical disease depends on environmental exposure.", {"entities": [[0, 6, "DISEASE"]]}], ["It has been well established that T helper type 2 (T H 2) lymphocytes and their cytokines have an important role in allergic asthma.", {"entities": [[116, 131, "DISEASE"], [125, 131, "DISEASE"]]}], ["Interleukin (IL)-9, a member of the T H 2 cytokine family, has recently been implicated as an essential factor in determining mucosal immunity and susceptibility to atopic asthma.", {"entities": [[172, 178, "DISEASE"]]}], ["In this review we examine the critical experiments and observations that support this hypothesis.", {"entities": []}], ["We also discuss these results in comparison with the experiments supporting the involvement of other T H 2 cytokines such as IL-4, IL-5 and IL-13.", {"entities": []}], ["The diagnosis of active pulmonary tuberculosis (TB) remains a challenge in clinic, especially for sputum negative pulmonary TB.", {"entities": [[34, 46, "DISEASE"], [24, 46, "DISEASE"]]}], ["Bronchoalveolar lavage fluid (BALF) has higher sensitivity than sputum for detection of Mycobacterium tuberculosis (Mtb).", {"entities": [[102, 114, "DISEASE"]]}], ["However, bronchoscopy is invasive and costly, and not suitable for all patients.", {"entities": []}], ["In order to make TB patients get more benefit from BALF for diagnosis, we explore which indicator might be used to optimize the choice of bronchoscopy.", {"entities": []}], ["A total of 1539 sputum-smear-negative pulmonary TB suspects who underwent bronchoscopy were recruited for evaluation.", {"entities": []}], ["The sensitivity, specificity and accuracy of Mtb detection in sputum and BALF were compared.", {"entities": []}], ["Odds ratios and 95% confidence intervals were used to assess variables that associated with positive acid-fast bacilli (AFB) smear, Mtb culture and nucleic acid amplification test (NAAT) of BALF in sputum-negative and non-sputum-producing pulmonary TB suspects.", {"entities": []}], ["BALF has significantly higher sensitivity (63.4%) than sputum (43.5%) for Mtb detection by culture and NAAT.", {"entities": []}], ["19.7% (122/620) sputum-negative and 40.0% (163/408) non-sputum-producing suspects had positive bacteriological results in BALF.", {"entities": []}], ["Among sputum-negative and non-sputum-producing pulmonary TB suspects, the positivity of Mtb detection in BALF is associated with a younger age, the presence of pulmonary cavities and a positive result of interferon-gamma release assay (IGRA).", {"entities": []}], ["Sputum-negative patients under 35\u00a0years old with positive IGRA and pulmonary cavity had 84.8% positivity of Mtb in BALF.", {"entities": []}], ["Our study indicated that combination of age, the presence of pulmonary cavity, and the result of IGRA is useful to predict the positivity of Mtb detection in BALF among sputum-negative and non-sputum producing pulmonary TB suspects.", {"entities": []}], ["Those who are under 35\u00a0years old, positive for the presence of pulmonary cavity and IGRA, should undergo bronchoscopy to collect BAFL for Mtb tests, as they have the highest possibility to get bacteriologically confirmation of TB.", {"entities": []}], ["The online version of this article (10.1186/s40249-018-0403-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sarcopenia is a condition diagnosed when the patient presents low muscle mass, plus low muscle strength or low physical performance.", {"entities": []}], ["Muscle weakness in the oldest (dynapenia) is a major public health concern because it predicts future all-cause mortality and is associated with falls, disability, cardiovascular mortality and morbidity.", {"entities": []}], ["Grip strength is a simple method for assessment of muscle function in clinical practice.", {"entities": []}], ["To estimate the grip strength and identify factors associated with handgrip strength variation in elderly people with low socioeconomic status.", {"entities": []}], ["Cross-sectional study based on a multidimensional assessment of primary care users that were 60 years or older.", {"entities": []}], ["The sample size was calculated using an estimated prevalence of depression in older adults of 20%.", {"entities": []}], ["A kappa coefficient of 0.6 with a 95% confidence interval was used to generate a conservative sample size of 180 individuals.", {"entities": []}], ["Procedures : tests and scales to assess humor, cognition (MMSE), basic (ADL) and instrumental activities (IADL) of daily living, mobility (Timed Up and Go), strength, height, Body Mass Index (BMI) and social support were applied.", {"entities": []}], ["Questions about falls, chronic diseases and self-rated health (SRH) were also included.", {"entities": []}], ["Statistical Analysis : Mean, standard deviation and statistical tests were used to compare grip strength means by demographic and health factors.", {"entities": []}], ["A multivariate linear model was used to explain the relationship of the predictors with grip strength.", {"entities": []}], ["The group was composed predominantly by women (73%) with a very low level of education (mean 3 years of schooling), mean age of 73.09 (\u00b1 7.05) years old, good mobility and without IADL impairment.", {"entities": []}], ["Mean grip strength of male and female were 31.86Kg (SD 5.55) and 21.69Kg (SD 4.48) [p- 0.0001], respectively.", {"entities": []}], ["Low grip strength was present in 27.7% of women and 39.6% of men.", {"entities": []}], ["As expected, men and younger participants had higher grip strength than women and older individuals.", {"entities": []}], ["In the adjusted model, age (p- 0.03), female sex (p- 0.0001), mobility (p- 0.05), height (p- 0.03) and depression (p- 0.03) were independently associated with low grip strength.", {"entities": []}], ["For every second more in the mobility test, there was a mean decrease of 0.08 Kg in the grip strength.", {"entities": []}], ["Elders with depression had a mean reduction of 1.74Kg in the grip strength in relation to those in the comparison groups.", {"entities": []}], ["There was an average reduction of 8.36Kg in the grip strength of elderly females relative to males.", {"entities": []}], ["For each year of age after 60 years, it was expected an average reduction of 0.11 Kg in the grip strength.", {"entities": []}], ["our results suggest that low grip strength is associated with age, female sex, height, depression and mobility problems in poor elderly.", {"entities": []}], ["Grip strength can be a simple, quick and inexpensive means of stratifying elders\u2019 risk of sarcopenia in the primary care setting.", {"entities": []}], ["Efforts should be made to recognize weaker persons and the conditions associated to low grip strength in order to target early interventions to prevent frailty and disability.", {"entities": []}], ["Endotoxin exposure associated with organic dust exposure has been studied in several industries.", {"entities": []}], ["Coffee cherries that are dried directly after harvest may differ in dust and endotoxin emissions to those that are peeled and washed before drying.", {"entities": []}], ["The aim of this study was to measure personal total dust and endotoxin levels and to evaluate their determinants of exposure in coffee processing factories.", {"entities": []}], ["Using Sidekick Casella pumps at a flow rate of 2l/min, total dust levels were measured in the workers\u2019 breathing zone throughout the shift.", {"entities": []}], ["Endotoxin was analyzed using the kinetic chromogenic Limulus amebocyte lysate assay.", {"entities": []}], ["Separate linear mixed-effects models were used to evaluate exposure determinants for dust and endotoxin.", {"entities": []}], ["Total dust and endotoxin exposure were significantly higher in Robusta than in Arabica coffee factories (geometric mean 3.41mg/m Dust and endotoxin exposure is high, in particular when processing dry pre-processed coffee.", {"entities": []}], ["Minimization of dust emissions and use of efficient dust exhaust systems are important to prevent the development of respiratory system impairment in workers.", {"entities": []}], ["Background: Although many climate-sensitive environmental exposures are related to mortality and morbidity, there is a paucity of estimates of the public health burden attributable to climate change.", {"entities": []}], ["Objective: We estimated the excess current and future public health impacts related to respiratory hospitalizations attributable to extreme heat in summer in New York State (NYS) overall, its geographic regions, and across different demographic strata.", {"entities": []}], ["Methods: On the basis of threshold temperature and percent risk changes identified from our study in NYS, we estimated recent and future attributable risks related to extreme heat due to climate change using the global climate model with various climate scenarios.", {"entities": []}], ["We estimated effects of extreme high apparent temperature in summer on respiratory admissions, days hospitalized, direct hospitalization costs, and lost productivity from days hospitalized after adjusting for inflation.", {"entities": []}], ["Results: The estimated respiratory disease burden attributable to extreme heat at baseline (1991\u20132004) in NYS was 100 hospital admissions, US$644,069 in direct hospitalization costs, and 616 days of hospitalization per year.", {"entities": []}], ["Projections for 2080\u20132099 based on three different climate scenarios ranged from 206\u2013607 excess hospital admissions, US$26\u2013$76 million in hospitalization costs, and 1,299\u20133,744 days of hospitalization per year.", {"entities": []}], ["Estimated impacts varied by geographic region and population demographics.", {"entities": []}], ["Conclusions: We estimated that excess respiratory admissions in NYS due to excessive heat would be 2 to 6 times higher in 2080\u20132099 than in 1991\u20132004.", {"entities": []}], ["When combined with other heat-associated diseases and mortality, the potential public health burden associated with global warming could be substantial.", {"entities": []}], ["Please cite this paper as: Coleman et\u00a0al.", {"entities": []}], ["(2011) Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season.", {"entities": [[79, 88, "DISEASE"], [146, 155, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(6), 404\u2013408.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Data regarding both rates of acute respiratory illness in health care workers and experience with long\u2010term antiviral prophylaxis are sparse.", {"entities": []}], ["Objective\u2002 To determine the efficacy and tolerability of oseltamivir prophylaxis versus seasonal influenza vaccine for the prevention of influenza among health care workers.", {"entities": [[97, 106, "DISEASE"], [137, 146, "DISEASE"]]}], ["Methods\u2002 We conducted a pilot, randomized control study during the 2007/2008 influenza season in a tertiary care setting.", {"entities": [[77, 86, "DISEASE"]]}], ["Adult health care workers 18\u201369\u2003years of age were recruited and randomly assigned in a 4:1 ratio to receive either oseltamivir (Tamiflu Results\u2002 Of 56 adults enrolled, 12 received vaccine and 44 received prophylaxis.", {"entities": []}], ["Incidence of symptomatic laboratory\u2010confirmed influenza was similar for participants in the vaccine and prophylaxis arms (17% and 24%, respectively; P \u2003=\u20030\u00b771).", {"entities": [[46, 55, "DISEASE"]]}], ["Participants who developed an acute respiratory illness during the study period reported working 85% of scheduled work days, and 29% stated that they worked despite feeling miserable because they were too busy to stay home.", {"entities": []}], ["Of 42 participants who initiated oseltamivir prophylaxis, four discontinued it owing to side effects.", {"entities": []}], ["Median duration of oseltamivir prophylaxis was 121\u2003days, with 34 (81%) continuing \u226512\u2003weeks.", {"entities": []}], ["Conclusions\u2002 During an extended season of suboptimal vaccine match, 22% of health care workers receiving antiviral prophylaxis or seasonal influenza vaccine developed symptomatic laboratory\u2010confirmed influenza.", {"entities": [[139, 148, "DISEASE"], [200, 209, "DISEASE"]]}], ["Long\u2010term antiviral prophylaxis against influenza was generally well tolerated with good compliance.", {"entities": [[40, 49, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae family, Orthopneumovirus genus.", {"entities": []}], ["It is the leading cause of acute bronchiolitis and one of the most common causes of infant viral death worldwide, with infection typically occurring as recurrent seasonal epidemics.", {"entities": [[33, 46, "DISEASE"]]}], ["There are two major RSV subtypes, A and B, and multiple genotypes, which can coexist during RSV epidemic season every year and result in different disease severity.", {"entities": []}], ["Recently, new RSV genomic sequences and analysis of RSV genotypes have provided important data for understanding RSV pathogenesis.", {"entities": []}], ["Novel RSV strains do spread rapidly and widely, and a knowledge of viral strain-specific phenotypes may be important in order to include the more virulent strains in future therapeutical options and vaccine development.", {"entities": []}], ["Here we summarize recent literature exploring genetic and molecular aspects related to RSV infection, their impact on the clinical course of the disease and their potential utility in the development of safe and effective preventive and therapeutic strategies.", {"entities": []}], ["Experience with high-frequency oscillatory ventilation (HFOV) after congenital cardiac surgery is limited despite evidence about reduction in pulmonary vascular resistance after the Fontan procedure.", {"entities": []}], ["HFOV is recommended in adults and children with acute respiratory distress syndrome.", {"entities": [[75, 83, "DISEASE"]]}], ["The aim of the present study was to assess associations between commencement of HFOV on the day of surgery and length of mechanical ventilation, length of Intensive Care Unit (ICU) stay and mortality in neonates and infants with respiratory distress following cardiac surgery.", {"entities": []}], ["A logistic regression model was used to develop a propensity score, which accounted for the probability of being switched from conventional mechanical ventilation (CMV) to HFOV on the day of surgery.", {"entities": []}], ["It included baseline characteristics, type of procedure and postoperative variables, and was used to match each patient with HFOV with a control patient, in whom CMV was used exclusively.", {"entities": []}], ["Length of mechanical ventilation, ICU stay and mortality rates were compared in the matched set.", {"entities": []}], ["Overall, 3,549 neonates and infants underwent cardiac surgery from January 2001 through June 2010, 120 patients were switched to HFOV and matched with 120 controls.", {"entities": []}], ["After adjustment for the delay to sternal closure, duration of renal replacement therapy, occurrence of pulmonary hypertension and year of surgery, the probability of successful weaning over time and the probability of ICU delivery over time were significantly higher in patients with HFOV, adjusted hazard ratios and 95% confidence intervals: 1.63, 1.17 to 2.26 ( P = 0.004).", {"entities": [[114, 126, "DISEASE"], [104, 126, "DISEASE"]]}], ["and 1.65, 95% confidence intervals: 1.20 to 2.28 ( P = 0.002) respectively.", {"entities": []}], ["No association was found with mortality.", {"entities": []}], ["When commenced on the day of surgery in neonates and infants with respiratory distress following cardiac surgery, HFOV was associated with shorter lengths of mechanical ventilation and ICU stay than CMV.", {"entities": []}], ["The aim of this study was to investigate the cardiotoxicity and mechanism of particulate matter 2.5 (PM2.5) exposure on offspring rats during pregnancy.", {"entities": []}], ["Wistar rats were used to establish a PM2.5 exposure animal model during pregnancy, and they were divided into a control group, a low-dose group, a middle-dose group, and a high-dose group according to PM2.5 exposure dose.", {"entities": []}], ["The pathological changes of heart tissue, the rate of myocardial cell apoptosis, the levels of LDH, AST, and CM-KB in serum, and the difference in mitochondrial fusion genes (OPA1 and Mfn1) and mitochondrial genes (Drp1 and Fis1) were compared among groups.", {"entities": [[175, 179, "GENE"], [184, 188, "GENE"], [224, 228, "GENE"]]}], ["The arrangement of myocardial fibers in offspring mice of PM2.5 exposure groups became disordered, the shape of some cardiomyocytes became irregular, and some staining darker nuclei appeared.", {"entities": []}], ["The apoptotic rates of myocardium in offspring rats exposed to PM2.5 were (12.61\u00b10.93)% in the low-dose group, (25.14\u00b11.53)% in the middle-dose group, and (30.13\u00b11.50)% in the high-dose group, which were all significantly higher than in the control group (9.12\u00b10.80)% (P<0.05).", {"entities": []}], ["The levels of LDH, AST, and CM-KB and the expression of OPA1, Mfn1, Drp1, and Fis1 in offspring mice of PM2.5 exposure groups increased with the increase of PM2.5 exposure dose, and were significantly higher than that of the control group (P<0.05).", {"entities": [[56, 60, "GENE"], [62, 66, "GENE"], [78, 82, "GENE"]]}], ["The mitochondria of the offspring mice were damaged due to the abnormal expression of mitochondrial fusion/splicing gene by PM2.5 exposure during pregnancy, and the hearts of offspring mice were damaged due to damaged mitochondria.", {"entities": []}], ["As lung function declines rapidly in the early stages of chronic obstructive pulmonary disease (COPD), the effects of bronchodilators in patients with moderate disease and those who have not previously received maintenance therapy are of interest.", {"entities": [[57, 94, "DISEASE"]]}], ["OTEMTO\u00ae 1 and 2 were two replicate, 12-week, Phase III studies investigating the benefit of tiotropium\u2009+\u2009olodaterol on lung function and quality of life in patients with moderate to severe disease.", {"entities": []}], ["Post hoc analyses were performed to assess the benefits for patients according to disease severity and treatment history.", {"entities": []}], ["Four subgroup analyses were performed: Global initiative for chronic Obstructive Lung Disease (GOLD) 2/3, GOLD A/B/C/D, treatment naive/not treatment naive and receiving inhaled corticosteroids (ICS) at baseline/not receiving ICS at baseline.", {"entities": []}], ["Primary end points were change in forced expiratory volume in 1\u00a0s (FEV 1 ) area under the curve from 0 to 3\u00a0h response, change in trough FEV 1 and St George\u2019s Respiratory Questionnaire (SGRQ) total score.", {"entities": [[67, 70, "GENE"], [137, 140, "GENE"], [67, 70, "GENE"], [137, 140, "GENE"]]}], ["Transition Dyspnoea Index (TDI) focal score was a secondary end point, and SGRQ and TDI responder analyses were further end points; all were assessed at 12\u00a0weeks.", {"entities": []}], ["In all subgroups, patients receiving tiotropium\u2009+\u2009olodaterol responded better overall than those receiving tiotropium monotherapy.", {"entities": []}], ["Improvements with tiotropium\u2009+\u2009olodaterol over placebo or tiotropium monotherapy were noted across GOLD 2/3 and GOLD A/B/C/D; however, improvements in SGRQ total score were most evident in the GOLD B subgroup.", {"entities": []}], ["Moreover, lung-function outcomes were generally greater in those patients who had been receiving previous long-acting bronchodilator and/or ICS maintenance treatment.", {"entities": []}], ["These data suggest that tiotropium\u2009+\u2009olodaterol should be considered as a treatment option in patients with moderate COPD who are initiating maintenance therapy, as well as those with more severe disease.", {"entities": []}], ["ClinicalTrials.gov: NCT01964352 and NCT02006732 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0387-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Research on the association between ambient temperature and cerebrovascular morbidity is scarce in China.", {"entities": []}], ["In this study, we applied mixed generalized additive model (MGAM) to daily counts of cerebrovascular disease of Shanghai residents aged 65 years or older from 2007\u20132011, stratified by gender.", {"entities": [[85, 108, "DISEASE"], [60, 64, "GENE"]]}], ["Weighted daily mean temperature up to lags of one week was smoothed by natural cubic spline, and was added into the model to assess both linear and nonlinear effects of temperature.", {"entities": []}], ["We found that when the mean temperature increased by 1\u2009\u00b0C, the male cases of cerebrovascular disease reduced by 0.95% (95% Confidence Interval (CI): 0.80%, 1.10%) or reduced by 0.34% (95% CI: \u22120.68, 1.36%) in conditions of temperature was below or above 27\u2009\u00b0C.", {"entities": [[77, 100, "DISEASE"]]}], ["However, for every 1\u2009\u00b0C increase in temperature, the female cases of cerebrovascular disease increased by 0.34% (95% CI: \u22120.26%, 0.94%) or decreased by 0.92% (95% CI: 0.72, 1.11%) in conditions of temperature was below or above 8\u2009\u00b0C, respectively.", {"entities": [[69, 92, "DISEASE"]]}], ["Temperature and cerebrovascular morbidity is negatively associated in Shanghai.", {"entities": []}], ["MGAM is recommended in assessing the association between environmental hazards and health outcomes in time series studies.", {"entities": [[0, 4, "GENE"]]}], ["IL-33, an IL-1 family member and ligand for the IL-1 receptor-related protein ST2, has been associated with induction of Th2 cytokines such as IL-4, IL-5, and IL-13.", {"entities": []}], ["Here, we report that IL-33 can initiate IL-9 protein secretion in vitro in human CD4+ T cells and basophils isolated from peripheral blood.", {"entities": []}], ["TGF-\u03b2 has been described as a critical factor for IL-9 induction in Th2 cells; however, we found that TGF-\u03b2 also induces co-production of IL-9 in purified, na\u00efve (>99%) CD4", {"entities": [[169, 172, "GENE"]]}], ["This paper reports on the development of an autonomous instrument based on an array of eight resonant microcantilevers for vapor detection.", {"entities": []}], ["The fabricated sensors are label-free devices, allowing chemical and biological functionalization.", {"entities": []}], ["In this work, sensors based on an array of silicon and synthetic diamond microcantilevers are sensitized with polymeric films for the detection of analytes.", {"entities": []}], ["The main advantage of the proposed system is that sensors can be easily changed for another application or for cleaning since the developed gas cell presents removable electrical connections.", {"entities": []}], ["We report the successful application of our electronic nose approach to detect 12 volatile organic compounds.", {"entities": []}], ["Moreover, the response pattern of the cantilever arrays is interpreted via principal component analysis (PCA) techniques in order to identify samples.", {"entities": []}], ["Children with attention-deficit/hyperactivity disorder (ADHD) show a marked temporal variability in their display of symptoms and neuropsychological performance.", {"entities": []}], ["This could be explained in terms of an impaired glial supply of energy to support neuronal activity.", {"entities": []}], ["We pursued one test of the idea with measures of a neurotrophin reflecting glial integrity (S100B) and the influences of 8 cytokines on the metabolism of amino-acids, and of tryptophan/kynurenine to neuroprotective or potentially toxic products that could modulate glial function.", {"entities": [[92, 97, "GENE"]]}], ["Serum samples from 21 medication-na\u00efve children with ADHD, 21 typically-developing controls, 14 medicated children with ADHD and 7 healthy siblings were analysed in this preliminary exploration of group differences and associations.", {"entities": []}], ["There were no marked group differences in levels of S100B, no major imbalance in the ratios of pro- to anti-inflammatory interleukins nor in the metabolism of kynurenine to toxic metabolites in ADHD.", {"entities": [[52, 57, "GENE"]]}], ["However, four trends are described that may be worthy of closer examination in a more extensive study.", {"entities": []}], ["First, S100B levels tended to be lower in ADHD children that did not show oppositional/conduct problems.", {"entities": [[7, 12, "GENE"]]}], ["Second, in medicated children raised interleukin levels showed a trend to normalisation.", {"entities": []}], ["Third, while across all children the sensitivity to allergy reflected increased levels of IL-16 and IL-10, the latter showed a significant inverse relationship to measures of S100B in the ADHD group.", {"entities": [[175, 180, "GENE"]]}], ["Fourthly, against expectations healthy controls tended to show higher levels of toxic 3-hydroxykynurenine (3 HK) than those with ADHD.", {"entities": []}], ["Thus, there were no clear signs (S100B) that the glial functions were compromised in ADHD.", {"entities": [[33, 38, "GENE"]]}], ["However, other markers of glial function require examination.", {"entities": []}], ["Nonetheless there is preliminary evidence that a minor imbalance of the immunological system was improved on medication.", {"entities": []}], ["Finally, if lower levels of the potentially toxic 3 HK in ADHD children were confirmed this could reflect a reduction of normal pruning processes in the brain that would be consistent with delayed maturation (supported here by associations with amino-acid metabolism) and a reduced metabolic source of energy.", {"entities": []}], ["Interleukin-10 (IL-10) has an important anti-inflammatory and immunoregulatory function, and its expression is negatively correlated with the development and severity of allergic rhinitis (AR).", {"entities": [[170, 187, "DISEASE"], [179, 187, "DISEASE"]]}], ["However, the in vivo effects of exogenous IL-10 on AR have not been studied and the mechanisms underlying the effects of IL-10 have not been fully understood.", {"entities": []}], ["Here, we investigated the effects of intranasal administration of recombinant mouse (rm) IL-10 on the expression of Th responses and local IL-10 in a mouse model of AR induced by ovalbumin.", {"entities": []}], ["Administration of rmIL-10 during challenge significantly reduced the number of eosinophils and mast cells, as well as Type 2 helper T (Th2) and Th17 cell related cytokine and transcription factor levels in the nasal mucosa and nasal lavage fluid in AR mice.", {"entities": []}], ["The rmIL-10 treatment significantly inhibited the number of IL-10-positive cells and IL-10 mRNA expression in the nasal mucosa in AR mice.", {"entities": []}], ["Our results show that exogenous IL-10 administrated in challenge phase alleviates nasal allergic inflammation in AR mice, most likely by inhibiting Th2 and Th17 responses.", {"entities": []}], ["It can also inhibit local IL-10 levels in the nasal mucosa.", {"entities": []}], ["Our findings indicate that IL-10 may have the potential as an inhibitor of AR.", {"entities": []}], ["The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, extension study in patients completing 1 of 2 phase 3 randomized, double-blind, controlled, 14-week trials that examined the efficacy and safety of SXB 4.5 g, SXB 6 g, and placebo for treatment of FM.", {"entities": [[86, 94, "DISEASE"], [73, 85, "DISEASE"]]}], ["This extension study comprised an additional 38 weeks of treatment and was carried out at 130 clinical sites in 7 countries.", {"entities": []}], ["Initial entry criteria for the previous 2 double-blind clinical trials required that patients aged \u2265 18 years met the American College of Rheumatology 1990 criteria for FM, had a body mass index (BMI) < 40 kg/m Of the 560 FM patients enrolled in this extension study, 319 (57.0%) completed the study.", {"entities": []}], ["The main reason for early discontinuation was adverse events (AEs; 23.0% of patients).", {"entities": []}], ["Patients were primarily middle-aged (mean 46.9\u2009\u00b1\u200910.8 years), female (91.1%), white (91.4%), with a mean duration of FM symptoms of 9.9\u2009\u00b1\u20098.7 years.", {"entities": []}], ["Serious AEs were experienced by 3.6% of patients.", {"entities": []}], ["The most frequently reported AEs (incidence \u2265 5% at any dose or overall) were nausea, headache, dizziness, nasopharyngitis, vomiting, sinusitis, diarrhea, anxiety, insomnia, influenza, somnolence, upper respiratory tract infection, muscle spasms, urinary tract infection, and gastroenteritis viral.", {"entities": [[174, 183, "DISEASE"], [134, 143, "DISEASE"], [107, 122, "DISEASE"], [145, 153, "DISEASE"], [276, 291, "DISEASE"]]}], ["Maintenance of SXB therapeutic response was demonstrated with continued improvement from controlled-study baseline in pain VAS, Fibromyalgia Impact Questionnaire (FIQ) total scores, and other measures.", {"entities": [[128, 140, "DISEASE"]]}], ["Responder analyses showed that 68.8% of patients achieved \u2265 30% reduction in pain VAS and 69.7% achieved \u2265 30% reduction in FIQ total score at study endpoint.", {"entities": []}], ["The long-term safety profile of SXB in FM patients was similar to that in the previously reported controlled clinical trials.", {"entities": []}], ["Improvement in pain and other FM clinical domains was maintained during long-term use.", {"entities": []}], ["ClinicalTrials.gov NCT00423605 .", {"entities": []}], ["Patients with primary immunodeficiency diseases (PIDD) are at increased risk of infection and may require lifelong immunoglobulin G (IgG) replacement.", {"entities": []}], ["Infection incidence rates were determined for patients with PIDD receiving intravenously administered IgG (IGIV) in a home or hospital outpatient infusion center (HOIC).", {"entities": []}], ["Data were extracted from a large, US-based, employer-sponsored administrative database.", {"entities": []}], ["Patients were eligible for analysis if they had \u22651 inpatient or emergency room claim or \u22652 outpatient claims with a PIDD diagnosis between January 2002 and March 2013, 12\u00a0months of continuous health plan enrollment prior to index date (i.e., first IGIV infusion date), and 6\u00a0months of continuous IGIV at the same site of care after the index date.", {"entities": []}], ["Incidences of pneumonia (bacterial or viral) and bronchitis (all types) within 7\u00a0days of IGIV infusion were retrospectively determined and compared between sites of care.", {"entities": [[14, 23, "DISEASE"], [49, 59, "DISEASE"]]}], ["A total of 1076 patients were included in the analysis; 51 and 49% received IGIV at home and at an HOIC, respectively.", {"entities": []}], ["The event/patient-year of pneumonia was significantly lower in patients receiving IGIV at home compared to an outpatient hospital (0.102 vs. 0.216, p \u00a0=\u00a00.0071).", {"entities": [[26, 35, "DISEASE"]]}], ["Similarly, the event/patient-year of bronchitis was significantly lower among patients infusing at home compared to an HOIC (0.150 vs. 0.288, p \u00a0<\u00a00.0001).", {"entities": [[37, 47, "DISEASE"]]}], ["PIDD patients experienced incidence rates for pneumonia and bronchitis that were lower for patients receiving home-based IGIV treatment versus HOIC-based IGIV treatment.", {"entities": [[46, 55, "DISEASE"], [60, 70, "DISEASE"]]}], ["The lower infection rates in the home setting suggest that infection risk may be an important factor in site of care selection.", {"entities": []}], ["Trauma represents the leading cause of death among young people in industrialized countries.", {"entities": []}], ["Recent clinical and experimental studies have brought increasing evidence for activation of the innate immune system in contributing to the pathogenesis of trauma-induced sequelae and adverse outcome.", {"entities": []}], ["As the \"first line of defense\", the complement system represents a potent effector arm of innate immunity, and has been implicated in mediating the early posttraumatic inflammatory response.", {"entities": []}], ["Despite its generic beneficial functions, including pathogen elimination and immediate response to danger signals, complement activation may exert detrimental effects after trauma, in terms of mounting an \"innocent bystander\" attack on host tissue.", {"entities": []}], ["Posttraumatic ischemia/reperfusion injuries represent the classic entity of complement-mediated tissue damage, adding to the \"antigenic load\" by exacerbation of local and systemic inflammation and release of toxic mediators.", {"entities": [[14, 22, "DISEASE"]]}], ["These pathophysiological sequelae have been shown to sustain the systemic inflammatory response syndrome after major trauma, and can ultimately contribute to remote organ injury and death.", {"entities": [[96, 104, "DISEASE"]]}], ["Numerous experimental models have been designed in recent years with the aim of mimicking the inflammatory reaction after trauma and to allow the testing of new pharmacological approaches, including the emergent concept of site-targeted complement inhibition.", {"entities": []}], ["The present review provides an overview on the current understanding of the cellular and molecular mechanisms of complement activation after major trauma, with an emphasis of emerging therapeutic concepts which may provide the rationale for a \"bench-to-bedside\" approach in the design of future pharmacological strategies.", {"entities": []}], ["Urban air pollution has caused public concern globally because it seriously affects human life.", {"entities": []}], ["Modern monitoring systems providing pollution information with high spatio-temporal resolution have been developed to identify personal exposures.", {"entities": []}], ["However, these systems\u2019 hardware specifications and configurations are usually fixed according to the applications.", {"entities": []}], ["They can be inconvenient to maintain, and difficult to reconfigure and expand with respect to sensing capabilities.", {"entities": []}], ["This paper aims at tackling these issues by adopting the proposed Modular Sensor System (MSS) architecture and Universal Sensor Interface (USI), and modular design in a sensor node.", {"entities": []}], ["A compact MSS sensor node is implemented and evaluated.", {"entities": []}], ["It has expandable sensor modules with plug-and-play feature and supports multiple Wireless Sensor Networks (WSNs).", {"entities": []}], ["Evaluation results show that MSS sensor nodes can easily fit in different scenarios, adapt to reconfigurations dynamically, and detect low concentration air pollution with high energy efficiency and good data accuracy.", {"entities": []}], ["We anticipate that the efforts on system maintenance, adaptation, and evolution can be significantly reduced when deploying the system in the field.", {"entities": []}], ["The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement.", {"entities": [[110, 133, "DISEASE"], [119, 133, "DISEASE"]]}], ["This prospective observational study included 1436 patients with refractory allergic conjunctivitis whose condition had responded poorly to conventional antiallergic drugs and/or topical steroids and/or topical cyclosporine.", {"entities": [[76, 99, "DISEASE"], [85, 99, "DISEASE"]]}], ["All patients received tacrolimus eye drops twice daily during the study period.", {"entities": []}], ["Ten clinical signs and six clinical symptoms were rated on a four-grade scale.", {"entities": []}], ["The primary endpoint was the change from baseline in total clinical signs and symptoms score at the last observation or following 6\u2005months of treatment.", {"entities": []}], ["Total signs and symptoms score significantly decreased after 1\u2005month of treatment (p<0.001).", {"entities": []}], ["Giant papillae and corneal lesions were also reduced by tacrolimus eye drop use (p<0.001).", {"entities": []}], ["The drug proved effective in patients whose condition did not respond well to topical cyclosporine therapy.", {"entities": []}], ["About 50% of all patients using topical steroids were weaned.", {"entities": []}], ["The most common adverse reaction was a transient burning sensation (3.20%).", {"entities": []}], ["Tacrolimus eye drops are highly effective in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement, and may reduce or replace topical steroid use.", {"entities": [[65, 88, "DISEASE"], [74, 88, "DISEASE"]]}], ["UMIN 000008640.", {"entities": []}], ["To compare and evaluate the treatment outcomes of a nurse-led rheumatology clinic and a rheumatologist-led clinic in patients with low disease activity or in remission who are undergoing biological therapy.", {"entities": []}], ["Patients with chronic inflammatory arthritis treated with biological therapy are usually monitored by rheumatologists.", {"entities": [[35, 44, "DISEASE"]]}], ["Nurse-led rheumatology clinics have been proposed in patients with low disease activity or in remission.", {"entities": []}], ["Randomized controlled trial.", {"entities": []}], ["A 12-month follow-up trial was conducted between October 2009 and August 2011, where 107 patients were randomized into two groups with a 6-month follow-up to a nurse-led rheumatology clinic based on person-centred care (intervention group; n\u00a0 =\u00a053) or to a rheumatologist-led clinic (control group; n\u00a0 =\u00a054).", {"entities": []}], ["The hypothesis was that the nurse-led clinic outcomes would not be inferior to those obtained from a rheumatologist-led clinic at the 12-month follow-up.", {"entities": []}], ["The primary outcome was disease activity measured by Disease Activity Score 28.", {"entities": []}], ["A total of 47 patients in the intervention group and 50 in the control group completed the 12-month trial.", {"entities": []}], ["The trial revealed no statistically significant differences between groups in mean change of Disease Activity Score 28, Visual Analogue Scales for pain, the Health Assessment Questionnaire, satisfaction with or confidence in obtaining rheumatology care.", {"entities": []}], ["Patients with stable chronic inflammatory arthritis undergoing biological therapy could be monitored by a nurse-led rheumatology clinic without difference in outcome as measured by the Disease Activity Score 28.", {"entities": [[42, 51, "DISEASE"]]}], ["Expansion of autoreactive follicular helper T (Tfh) cells is tightly restricted to prevent induction of autoantibody-dependent immunological diseases, such as systemic lupus erythematosus (SLE).", {"entities": [[168, 187, "DISEASE"], [159, 187, "DISEASE"]]}], ["Here we show expression of an orphan immune regulator, death receptor 6 (DR6/TNFRSF21), on a population of Tfh cells that are highly expanded in lupus-like disease progression in mice.", {"entities": []}], ["Genome-wide screening reveals an interaction between syndecan-1 and DR6 resulting in immunosuppressive functions.", {"entities": []}], ["Importantly, syndecan-1 is expressed specifically on autoreactive germinal centre (GC) B cells that are critical for maintenance of Tfh cells.", {"entities": [[83, 85, "GENE"]]}], ["Syndecan-1 expression level on GC B cells is associated with Tfh cell expansion and disease progression in lupus-prone mouse strains.", {"entities": [[31, 33, "GENE"]]}], ["In addition, Tfh cell suppression by DR6-specific monoclonal antibody delays disease progression in lupus-prone mice.", {"entities": []}], ["These findings suggest that the DR6/syndecan-1 axis regulates aberrant GC reactions and could be a therapeutic target for autoimmune diseases such as SLE.", {"entities": [[71, 73, "GENE"]]}], ["Germinal centre (GC) reactions are driven by T follicular helper (Tfh) cells and their dysregulation can cause autoimmune disease.", {"entities": [[17, 19, "GENE"]]}], ["Here the authors show that the orphan receptor DR6 is a Tfh cell marker that binds syndecan-1 on GC B cells driving autoimmunity in lupus-prone mice.", {"entities": [[97, 99, "GENE"]]}], ["The enzyme indoleamine 2,3-dioxygenase (IDO) exerts an well established immunosuppressive function in cancer.", {"entities": [[102, 108, "DISEASE"]]}], ["IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it promotes the establishment of peripheral immune tolerance to tumor antigens.", {"entities": []}], ["In the present study, we tested the notion whether IDO itself may be subject to immune responses.", {"entities": []}], ["The presence of naturally occurring IDO-specific CD8 T cells in cancer patients was determined by MHC/peptide stainings as well as ELISPOT.", {"entities": [[64, 70, "DISEASE"]]}], ["Antigen specific cytotoxic T lymphocytes (CTL) from the peripheral blood of cancer patients were cloned and expanded.", {"entities": [[76, 82, "DISEASE"]]}], ["The functional capacity of the established CTL clones was examined by chrome release assays.", {"entities": []}], ["The study unveiled spontaneous cytotoxic T-cell reactivity against IDO in peripheral blood as well as in the tumor microenvironment of different cancer patients.", {"entities": [[145, 151, "DISEASE"]]}], ["We demonstrate that these IDO reactive T cells are indeed peptide specific, cytotoxic effector cells.", {"entities": []}], ["Hence, IDO reactive T cells are able to recognize and kill tumor cells including directly isolated AML blasts as well as IDO-expressing dendritic cells, i.e.", {"entities": []}], ["one of the major immune suppressive cell populations.", {"entities": []}], ["IDO may serve as an important and widely applicable target for anti-cancer immunotherapeutic strategies.", {"entities": [[68, 74, "DISEASE"]]}], ["Furthermore, as emerging evidence suggests that IDO constitutes a significant counter-regulatory mechanism induced by pro-inflammatory signals, IDO-based immunotherapy holds the promise to boost anti-cancer immunotherapy in general.", {"entities": [[200, 206, "DISEASE"]]}], ["The phospholipase A 2 (PLA 2 ) family comprises a group of lipolytic enzymes that typically hydrolyze the sn -2 position of glycerophospholipids to give rise to fatty acids and lysophospholipids.", {"entities": []}], ["The mammalian genome encodes more than 50 PLA 2 s or related enzymes, which are classified into several subfamilies on the basis of their structures and functions.", {"entities": []}], ["From a general viewpoint, the PLA 2 family has mainly been implicated in signal transduction, producing bioactive lipid mediators derived from fatty acids and lysophospholipids.", {"entities": []}], ["Recent evidence indicates that PLA 2 s also contribute to phospholipid remodeling for membrane homeostasis or energy production for fatty acid \u03b2-oxidation.", {"entities": []}], ["Accordingly, PLA 2 enzymes can be regarded as one of the key regulators of the quality of lipids, which I herein refer to as lipoquality .", {"entities": []}], ["Disturbance of PLA 2 -regulated lipoquality hampers tissue and cellular homeostasis and can be linked to various diseases.", {"entities": []}], ["Here I overview the current state of understanding of the classification, enzymatic properties, and physiological functions of the PLA 2 family.", {"entities": []}], ["Differences in minute ventilation between cyclists, pedestrians and other commuters influence inhaled doses of air pollution.", {"entities": []}], ["This study estimates minute ventilation of cyclists, car and bus passengers, as part of a study on health effects of commuters' exposure to air pollutants.", {"entities": []}], ["Thirty-four participants performed a submaximal test on a bicycle ergometer, during which heart rate and minute ventilation were measured simultaneously at increasing cycling intensity.", {"entities": []}], ["Individual regression equations were calculated between heart rate and the natural log of minute ventilation.", {"entities": []}], ["Heart rates were recorded during 280 two hour trips by bicycle, bus and car and were calculated into minute ventilation levels using the individual regression coefficients.", {"entities": []}], ["Minute ventilation during bicycle rides were on average 2.1 times higher than in the car (individual range from 1.3 to 5.3) and 2.0 times higher than in the bus (individual range from 1.3 to 5.1).", {"entities": []}], ["The ratio of minute ventilation of cycling compared to travelling by bus or car was higher in women than in men.", {"entities": []}], ["Substantial differences in regression equations were found between individuals.", {"entities": []}], ["The use of individual regression equations instead of average regression equations resulted in substantially better predictions of individual minute ventilations.", {"entities": []}], ["The comparability of the gender-specific overall regression equations linking heart rate and minute ventilation with one previous American study, supports that for studies on the group level overall equations can be used.", {"entities": []}], ["For estimating individual doses, the use of individual regression coefficients provides more precise data.", {"entities": []}], ["Minute ventilation levels of cyclists are on average two times higher than of bus and car passengers, consistent with the ratio found in one small previous study of young adults.", {"entities": []}], ["The study illustrates the importance of inclusion of minute ventilation data in comparing air pollution doses between different modes of transport.", {"entities": []}], ["Maternal diabetes in pregnancy affects offspring health.", {"entities": []}], ["The impact of parental diabetes on offspring health is unclear.", {"entities": []}], ["We investigated the impact of parental diabetes on the metabolic-health of adult-offspring who did not themselves have diabetes.", {"entities": []}], ["Data from the Generation Scotland: Scottish Family Health Study, a population-based family cohort, were record-linked to subjects\u2019 own diabetes medical records.", {"entities": []}], ["From F 0 -parents, we identified F 1 -offspring of: mothers with diabetes (OMD, n = 409), fathers with diabetes (OFD, n = 468), no parent with diabetes (ONoPD, n = 2489).", {"entities": [[75, 78, "GENE"]]}], ["Metabolic syndrome, body, biochemical measurements and blood-pressures were compared between F 1 -offspring groups by sex.", {"entities": [[10, 18, "DISEASE"]]}], ["A higher proportion of female OMD had metabolic syndrome than female OFD or ONoPD (P<0.0001).", {"entities": [[48, 56, "DISEASE"], [30, 33, "GENE"]]}], ["In female offspring, predictors of metabolic syndrome were: having a mother with diabetes (OR = 1.78, CI 1.03\u20133.07, [reference ONoPD]), body mass index (BMI, OR = 1.21, CI 1.13\u20131.30) and age (OR = 1.03, CI 1.01\u20131.06).", {"entities": [[45, 53, "DISEASE"]]}], ["In male offspring, predictors of metabolic syndrome were: BMI (OR = 1.18, CI 1.09\u20131.29) and percent body-fat (OR = 1.12, CI 1.05\u20131.19).", {"entities": [[43, 51, "DISEASE"]]}], ["In both sexes, OMD had higher blood-pressures than OFD (P<0.0001).", {"entities": [[15, 18, "GENE"]]}], ["In females, OMD had higher glucose (P<0.0001) and percent body-fat (P<0.0001) compared with OFD or ONoPD.", {"entities": [[12, 15, "GENE"]]}], ["OMD and OFD both had increased waist-measurements (P<0.0001), BMI (P<0.0001) and percent body-fat (P<0.0001) compared with ONoPD.", {"entities": [[0, 3, "GENE"]]}], ["Female OMD and OFD had lower HDL-cholesterol levels (P<0.0001) than female ONoPD.", {"entities": [[7, 10, "GENE"]]}], ["Parental diabetes is associated with higher offspring-BMI and body-fat.", {"entities": []}], ["In female offspring, maternal diabetes increased the odds of metabolic syndrome, even after adjusting for BMI.", {"entities": [[71, 79, "DISEASE"]]}], ["Further investigations are required to determine the mechanisms involved.", {"entities": []}], ["Jaun-ointment (JO), also known as Shiunko in Japan, is one of the most popular medicinal formulae used in Korean traditional medicine for the external treatment of skin wound and inflammatory skin conditions.", {"entities": []}], ["Since JO is composed of crude mixture of two herbal extracts (radix of Lithospermum erythrorhizon Siebold & Zucc and Angelica gigas Nakai), those been proved its anti-inflammatory activities in-vitro and in-vivo , JO has been expected as a good alternative treatment option for atopic dermatitis (AD).", {"entities": [[278, 295, "DISEASE"], [285, 295, "DISEASE"]]}], ["However, due to the lack of strategies for the penetrating methods of JO\u2019s various anti-inflammatory elements into the skin, an effective and safe transdermal drug delivery system needs to be determined.", {"entities": []}], ["Here, low-temperature argon plasma (LTAP) was adopted as an ancillary partner of topically applied JO in a mice model of AD and the effectiveness was examined.", {"entities": []}], ["Dorsal skins of NC/Nga mice were challenged with DNCB (2,4-dinitrochlorobenzene) to induce AD.", {"entities": []}], ["AD-like skin lesions were treated with JO alone, or in combination with LTAP.", {"entities": []}], ["Inflammatory activity in the skin tissues was evaluated by histological analysis and several molecular biological tests.", {"entities": []}], ["LTAP enhanced the effect of JO on AD-like skin lesion.", {"entities": []}], ["Topical application of JO partially inhibited the development of DNCB-induced AD, shown by the moderate reduction of eosinophil homing and pro-inflammatory cytokine level.", {"entities": []}], ["Combined treatment of JO and LTAP dramatically inhibited AD phenotypes.", {"entities": []}], ["Interestingly, treatment with JO alone did not affect the activity of nuclear factor (NF)\u03baB/RelA in the skin, but combined treatment of LTAP-JO blocked DCNB-mediated NF\u03baB/RelA activation.", {"entities": []}], ["LTAP markedly enhanced the anti-inflammatory activity of JO on AD-like skin lesions.", {"entities": []}], ["The effect of LTAP may be attributed to enhancement of drug penetration and regulation of NF\u03baB activity.", {"entities": []}], ["Therefore, the combination treatment of JO and LTAP could be a potential strategy for the treatment of AD.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with cognitive impairment, but consequences of this association on a person\u2019s functional limitations are unclear.", {"entities": []}], ["We examined the association between COPD and increased confusion and memory loss (ICML) and functional limitations among adults with COPD.", {"entities": []}], ["We studied adults aged 45 years or older in 21 states who participated in the 2011 Behavioral Risk Factor Surveillance System (n = 102,739).", {"entities": []}], ["Presence of COPD was based on self-reported physician diagnosis.", {"entities": []}], ["ICML was based on self-report that confusion or memory loss occurred more often or worsened during the prior year.", {"entities": []}], ["ICML-associated difficulties were defined as giving up household chores and former activities, decreased ability to work or engage in social activities, or needing help from family or friends during the prior year due to ICML.", {"entities": []}], ["General limitations were defined as needing special equipment as a result of a health condition, having had activity limitations for 2 weeks or more in the prior month, or being unable to work.", {"entities": []}], ["Multivariable models were adjusted for demographics, health behaviors or conditions, and frequent mental distress.", {"entities": []}], ["COPD was reported by 9.3% of adults.", {"entities": []}], ["ICML was greater among those with COPD than among those without COPD (25.8% vs 11%; adjusted prevalence ratio [aPR], 1.48; 95% confidence interval [CI], 1.32%\u20131.66%).", {"entities": []}], ["People with COPD, either with or without ICML, were more likely than those without COPD to report general functional limitations.", {"entities": []}], ["Among people reporting ICML, those with COPD were more likely to report interference with work or social activities than those without COPD (aPR, 1.17; 95% CI, 1.01%\u20131.36%).", {"entities": []}], ["Functional limitations were greater among those with COPD than among those without, and ICML may further affect these limitations.", {"entities": []}], ["Results from our study can inform future studies of self- management and functional limitations for people with COPD.", {"entities": []}], ["In humans, Mammalian Target of Rapamycin (MTOR) encodes a 300\u00a0kDa serine/ threonine protein kinase that is ubiquitously expressed, particularly at high levels in brain.", {"entities": [[42, 46, "GENE"]]}], ["MTOR functions as an integrator of multiple cellular processes, and in so doing either directly or indirectly regulates the phosphorylation of at least 800 proteins.", {"entities": [[0, 4, "GENE"]]}], ["While somatic MTOR mutations have been recognized in tumors for many years, and more recently in hemimegalencephaly, germline MTOR mutations have rarely been described.", {"entities": [[14, 18, "GENE"], [126, 130, "GENE"], [14, 18, "GENE"], [126, 130, "GENE"]]}], ["We report the successful application of family-trio Diagnostic Exome Sequencing (DES) to identify the underlying molecular etiology in two brothers with multiple neurological and developmental lesions, and for whom previous testing was non-diagnostic.", {"entities": [[81, 84, "GENE"]]}], ["The affected brothers, who were 6 and 23\u00a0years of age at the time of DES, presented symptoms including but not limited to mild Autism Spectrum Disorder (ASD), megalencephaly, gross motor skill delay, cryptorchidism and bilateral iris coloboma.", {"entities": [[200, 214, "DISEASE"], [234, 242, "DISEASE"], [69, 72, "GENE"]]}], ["Importantly, we determined that each affected brother harbored the MTOR missense alteration p.E1799K (c.5395G>A).", {"entities": [[67, 71, "GENE"]]}], ["This exact variant has been previously identified in multiple independent human somatic cancer samples and has been shown to result in increased MTOR activation.", {"entities": [[88, 94, "DISEASE"], [145, 149, "GENE"]]}], ["Further, recent independent reports describe two unrelated families in whom p.E1799K co-segregated with megalencephaly and intellectual disability (ID); in both cases, p.E1799K was shown to have originated due to germline mosaicism.", {"entities": [[123, 146, "DISEASE"]]}], ["In the case of the family reported herein, the absence of p.E1799K in genomic DNA extracted from the blood of either parent suggests that this alteration most likely arose due to gonadal mosaicism.", {"entities": []}], ["Further, the p.E1799K variant exerts its effect by a gain-of-function (GOF), autosomal dominant mechanism.", {"entities": []}], ["Herein, we describe the use of DES to uncover an activating MTOR missense alteration of gonadal mosaic origin that is likely to be the causative mutation in two brothers who present multiple neurological and developmental abnormalities.", {"entities": [[31, 34, "GENE"], [60, 64, "GENE"]]}], ["Our report brings the total number of families who harbor MTOR p.E1799K in association with megalencephaly and ID to three.", {"entities": [[58, 62, "GENE"]]}], ["In each case, evidence suggests that p.E1799K arose in the affected individuals due to gonadal mosaicism.", {"entities": []}], ["Thus, MTOR p.E1799K can now be classified as a pathogenic GOF mutation that causes megalencephaly and cognitive impairment in humans.", {"entities": [[6, 10, "GENE"]]}], ["The online version of this article (doi:10.1186/s12881-015-0240-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chromosome/DNA instability could be one of the primary causes of malignant cell transformation.", {"entities": []}], ["The objective of the present study was to evaluate the spontaneous genetic damages in exfoliated cells of buccal mucosa of head and neck cancer (HNC) by counting micronucleus (MN) and binucleated (BN) cells frequencies.", {"entities": [[137, 143, "DISEASE"]]}], ["MN and BN frequencies were significantly increased in HNC patients compared with controls (5.53\u2009\u00b1\u20093.09/1000\u2009cells, 5.63\u2009\u00b1\u20092.99/1000\u2009cells versus 2.36\u2009\u00b1\u20092.11/1000\u2009cells, 3.09\u2009\u00b1\u20091.82/1000\u2009cells, P < 0.001).", {"entities": []}], ["Regarding the gender and the age, the frequencies of the MN and BN were significantly higher than those of controls ( P < 0.01).", {"entities": []}], ["The evaluation of the MN and BN frequencies revealed a significant increase ( P < 0.001) in the cases in relation to the control group after controlling the risk factors (tobacco smoking and chewing and occupational exposure) of HNC.", {"entities": []}], ["Moreover, MN and BN frequencies were significantly increased in smokers and chewers compared with nonsmokers and nonchewers among patients ( P < 0.05).", {"entities": []}], ["MN frequency was significantly ( P = 0.014) different between patients occupationally exposed (6.99\u2009\u00b1\u20093.40/1000 cells) and nonexposed (4.70\u2009\u00b1\u20092.48/1000\u2009cells) among HNC group.", {"entities": []}], ["The logistic regression model illustrated that HNC was significantly associated with frequencies of MN (OR\u2009=\u20098.63, P < 0.0001) and BN (OR\u2009=\u20095.62, P = 0.001).", {"entities": []}], ["Our results suggest that increased chromosome/DNA instabilities may be associated with HNC.", {"entities": []}], ["Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, through the production and release of a large spectrum of pro-angiogenic mediators.", {"entities": []}], ["These may create the specific microenvironment that favours an increased rate of tissue vascularization.", {"entities": []}], ["In this review, we will focus on the immune cell component of the angiogenic process in inflammation and tumour growth.", {"entities": []}], ["As angiogenesis is the result of a net balance between the activities exerted by positive and negative regulators, we will also provide information on some antiangiogenic properties of immune cells that may be utilized for a potential pharmacological use as antiangiogenic agents in inflammation as well as in cancer.", {"entities": [[310, 316, "DISEASE"]]}], ["Influenza-like illness occurs annually worldwide, with peak timing and severity varying seasonally, resulting in significant annual mortality.", {"entities": [[0, 9, "DISEASE"]]}], ["There were three objectives: (1) to describe the epidemiological and clinical features of hospitalised patients with severe acute respiratory infection caused by influenza and other respiratory viruses (ORVs); (2) to report the influenza seasonality in the region and (3) to correlate findings of influenza circulation and immunisation time in Brazil.", {"entities": [[162, 171, "DISEASE"], [228, 237, "DISEASE"], [297, 306, "DISEASE"]]}], ["This study took place in three Brazilian hospitals located in cities with different climatic conditions (Curitiba (south), Rio de Janeiro (south-east) and Fortaleza (north-east)).", {"entities": []}], ["Patients presenting with an acute process with indication for admission consisting of a predefined set of conditions potentially associated with recent influenza infection were enrolled.", {"entities": [[152, 161, "DISEASE"]]}], ["We screened 1666 patients, with 595 meeting the inclusion criteria.", {"entities": []}], ["Influenza viruses and ORVs were detected in 6.5% and 59% of patients, respectively.", {"entities": [[0, 9, "DISEASE"]]}], ["Influenza-positive cases fell into the severe spectrum as compared with those with ORVs (30% vs 11%), but without any difference in mortality rates.", {"entities": [[0, 9, "DISEASE"]]}], ["Epidemiological results revealed variations in the peak time of influenza infections between north-east (Fortaleza) and south (Curitiba) Brazil, basically following the rain period of each region.", {"entities": [[64, 73, "DISEASE"]]}], ["In north-east Brazil, viral circulation was prevalent in the first 4 months of the year, indicating that the vaccination campaign occurred in a postseasonal period, possibly explaining the low effectiveness.", {"entities": []}], ["The active-surveillance model is a valuable tool for investigating respiratory virus impact on hospitalised patients, with influenza-infection monitoring enabling implementation of adequate preventive measures.", {"entities": [[123, 132, "DISEASE"]]}], ["The elucidation of epigenetic alterations in the autism brain has potential to provide new insights into the molecular mechanisms underlying abnormal gene expression in this disorder.", {"entities": []}], ["Given strong evidence that engrailed-2 ( EN-2 ) is a developmentally expressed gene relevant to cerebellar abnormalities and autism, the epigenetic evaluation of this candidate gene was undertaken in 26 case and control post-mortem cerebellar samples.", {"entities": []}], ["Assessments included global DNA methylation, EN-2 promoter methylation, EN-2 gene expression and EN-2 protein levels.", {"entities": []}], ["Chromatin immunoprecipitation was used to evaluate trimethylation status of histone H3 lysine 27 (H3K27) associated with gene downregulation and histone H3 lysine 4 (H3K4) associated with gene activation.", {"entities": []}], ["The results revealed an unusual pattern of global and EN-2 promoter region DNA hypermethylation accompanied by significant increases in EN-2 gene expression and protein levels.", {"entities": []}], ["Consistent with EN-2 overexpression, histone H3K27 trimethylation mark in the EN-2 promoter was significantly decreased in the autism samples relative to matched controls.", {"entities": []}], ["Supporting a link between reduced histone H3K27 trimethylation and increased EN-2 gene expression, the mean level of histone H3K4 trimethylation was elevated in the autism cerebellar samples.", {"entities": []}], ["Together, these results suggest that the normal EN-2 downregulation that signals Purkinje cell maturation during late prenatal and early-postnatal development may not have occurred in some individuals with autism and that the postnatal persistence of EN-2 overexpression may contribute to autism cerebellar abnormalities.", {"entities": []}], ["Exacerbations of COPD are defined clinically by worsening of chronic respiratory symptoms.", {"entities": []}], ["Chronic respiratory symptoms are common in the general population.", {"entities": []}], ["There are no data on the frequency of exacerbation-like events in individuals without spirometric evidence of COPD.", {"entities": []}], ["To determine the occurrence of \u2018exacerbation-like\u2019 events in individuals without airflow limitation, their associated risk factors, healthcare utilisation and social impacts.", {"entities": []}], ["We analysed the cross-sectional data from 5176 people aged 40\u2005years and older who participated in a multisite, population-based study on lung health.", {"entities": []}], ["The study cohort was stratified into spirometrically defined COPD (post-bronchodilator FEV 1 /FVC\u2009<\u20090.7) and non-COPD (post bronchodilator FEV 1 /FVC\u2009\u2265\u20090.7 and without self-reported doctor diagnosis of airway diseases) subgroups and then into those with and without respiratory \u2018exacerbation-like\u2019 events in the past year.", {"entities": [[87, 90, "GENE"], [139, 142, "GENE"], [87, 90, "GENE"], [139, 142, "GENE"]]}], ["Individuals without COPD had half the frequency of \u2018exacerbation-like\u2019 events compared with those with COPD.", {"entities": []}], ["In the non-COPD group, the independent associations with \u2018exacerbations\u2019 included female gender, presence of wheezing, the use of respiratory medications and self-perceived poor health.", {"entities": []}], ["In the non-COPD group, those with exacerbations were more likely than those without exacerbations to have poorer health-related quality of life (12-item Short-Form Health Survey), miss social activities (58.5% vs 18.8%), miss work for income (41.5% vs 17.3%) and miss housework (55.6% vs 16.5%), p<0.01 to <0.0001.", {"entities": []}], ["Events similar to exacerbations of COPD can occur in individuals without COPD or asthma and are associated with significant health and socioeconomic outcomes.", {"entities": [[81, 87, "DISEASE"]]}], ["They increase the respiratory burden in the community and may contribute to the false-positive diagnosis of asthma or COPD.", {"entities": [[108, 114, "DISEASE"]]}], ["Th2-promoting cytokine IL-25 might contribute to bronchial mucosal vascular remodelling in asthma through its receptor expressed by vascular endothelial and vascular smooth muscle cells.", {"entities": [[91, 97, "DISEASE"]]}], ["By utilising a newly established chronic asthma murine model induced by direct exposure of the airways to IL-25 alone, we examined effects of IL-25 on angiogenesis, vascular remodelling and expression of angiogenic factors, compared changes with those in a \u201cclassical\u201d ovalbumin (OVA)-induced murine asthma model.", {"entities": [[41, 47, "DISEASE"], [300, 306, "DISEASE"]]}], ["IL-25 and OVA were intranasally instilled into the airways of BALB/c mice for up to 55\u00a0days.", {"entities": []}], ["Airways vessels and angiogenic factors, including Von Willebrand Factor (vWF), amphiregulin, angiogenin, endothelin-1, transcription factor ERG, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor (IGF-1) and vascular endothelial growth factor (VEGF) in lung sections, homogenates and BAL fluid were detected and quantified by immunostaining or enzyme linked immunosorbent assay (ELISA).", {"entities": [[73, 76, "GENE"], [209, 212, "GENE"]]}], ["An in house assay was also utilised to compare the effects of IL-25 and other Th2-cytokines on angiogenesis by human vascular endothelial cells.", {"entities": []}], ["Repetitive intranasal challenge with IL-25 alone or OVA alone in OVA-presensitised animals significantly increased peribronchial vWF in vitro .", {"entities": [[129, 132, "GENE"]]}], ["The data suggest that chronic exposure of murine airways to IL-25 alone is able to reproduce a local angiogenic milieu.", {"entities": []}], ["Thus, blocking IL-25 may attenuate vascular remodelling and improve outcomes in asthma patients.", {"entities": [[80, 86, "DISEASE"]]}], ["The molecular and cellular etiology of eosinophilic esophagitis (EoE), an emerging tissue-specific allergic disease, involves dysregulated gene expression in esophageal epithelial cells.", {"entities": [[52, 63, "DISEASE"], [39, 63, "DISEASE"]]}], ["Herein, we assessed the esophageal expression of IL-33, an epithelium-derived alarmin cytokine, in patients with EoE.", {"entities": []}], ["IL-33 protein was markedly overexpressed within the nuclei of a subpopulation of basal layer esophageal epithelial cells in patients with active EoE compared to control individuals.", {"entities": []}], ["IL-33 exhibited dynamic expression as levels normalized upon EoE remission.", {"entities": []}], ["IL-33\u2013positive basal epithelial cells expressed E-cadherin and the undifferentiated epithelial cell markers keratin 5 and 14 but not the differentiation marker keratin 4.", {"entities": []}], ["Moreover, the IL-33\u2013positive epithelial cells expressed the epithelial progenitor markers p75 and p63 and lacked the proliferation markers Ki67 and phospho-histone H3.", {"entities": []}], ["Additionally, the IL-33\u2013positive cells had low expression of PCNA.", {"entities": [[61, 65, "GENE"]]}], ["IL-33 expression was detected in ex vivo \u2013cultured primary esophageal epithelial cells in a subpopulation of cells lacking expression of proliferation markers.", {"entities": []}], ["Collectively, we report that IL-33 expression is induced in an undifferentiated, non-dividing esophageal epithelial cell population in patients with active EoE.", {"entities": []}], ["Hypoxic-ischaemic encephalopathy is the main determinant of clinical outcome after cardiac arrest.", {"entities": []}], ["The study was designed to determine long-term neurological and psychological status in cardiac arrest survivors, as well as to compare neuropsychological outcomes between patients treated with mild therapeutic hypothermia (MTH) and patients who did not undergo hypothermia treatment.", {"entities": []}], ["The article describes a single-center, retrospective, observational study on 28 post-cardiac arrest adult patients treated in the cardiac intensive care unit who qualified for MTH vs. 37 control group patients, hospitalized at the same center following cardiac arrest in the preceding years and fulfilling criteria for induced hypothermia, but who were not treated due to unavailability of the method at that time.", {"entities": []}], ["Disability Rating Scale (DRS), Barthel Index and RAND-36 were used to assess performance status and quality of life in both study groups after hospital discharge.", {"entities": []}], ["There were no statistically significant differences in physical functioning found between groups either at the end of hospital treatment or at long-term follow-up (DRS: p\u2009=\u20090.11; Barthel Index: p\u2009=\u20090.83).", {"entities": []}], ["In long-term follow-up, MTH patients showed higher vitality (p\u2009=\u20090.02) and reported fewer complaints on role limitations due to emotional problems (p\u2009=\u20090.04) compared to the control group.", {"entities": []}], ["No significant differences were shown between study groups in terms of physical capacity and independent functioning.", {"entities": []}], ["To conclude, in long-term follow-up, MTH patients showed higher vitality and reported fewer complaints on role limitations due to emotional problems compared to the control group.", {"entities": []}], ["This suggest that MTH helps to preserve global brain function in cardiac arrest survivors.", {"entities": []}], ["However, the results can be biased by a small sample size and variable observation periods.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with high morbidity and mortality.", {"entities": []}], ["COPD is typified by persistent, progressive airflow limitation and a range of respiratory and systemic symptoms such as breathlessness, coughing, wheezing, depression, anxiety, general fatigue, and sleeping difficulties.", {"entities": []}], ["Despite receiving treatment for COPD, many patients suffer from regular symptoms that affect their daily lives and lead to increased morbidity.", {"entities": []}], ["These symptoms vary in severity, frequency, and type, and can occur at any time throughout the 24-h day, with over half of patients with COPD experiencing symptoms in the morning, during the day, and at nighttime.", {"entities": []}], ["Despite the prevalence of symptoms, patient and physician perception of the impact of COPD symptoms on patients\u2019 lives is not always in concordance.", {"entities": []}], ["Dual bronchodilator therapy with a long-acting muscarinic antagonist (LAMA) and long-acting beta agonist (LABA) has the potential to treat the symptoms of COPD in addition to improving lung function.", {"entities": []}], ["This review therefore examines the burden of symptoms experienced throughout the day by patients with COPD and the evidence for combined LAMA/LABA treatment in terms of symptom management.", {"entities": []}], ["As patients with COPD experience varying symptoms throughout the course of their disease, the role of tailoring treatment to the individual needs of the patient is also examined.", {"entities": []}], ["We conclude that the symptoms of COPD are troublesome, variable, can occur during all parts of the 24-h day, and have a substantial impact on patients\u2019 health status and quality of life.", {"entities": []}], ["In order to provide effective, patient-orientated care, patients with COPD should be evaluated on the basis of lung function, the frequency of symptoms, and patient-perceived impact of symptoms on their lives.", {"entities": []}], ["Therapy should be chosen carefully based on individualized assessment, ensuring personalization to the individual needs of the patient.", {"entities": []}], ["Germinal center (GC) B cells cycle between the dark zone (DZ) and light zone (LZ) during antibody affinity maturation.", {"entities": [[17, 19, "GENE"]]}], ["Whether this movement is necessary for GC function has not been tested.", {"entities": [[39, 41, "GENE"]]}], ["Here we show that CXCR4-deficient GC B cells, which are restricted to\u00a0the LZ, are gradually outcompeted by WT cells indicating an essential role for DZ access.", {"entities": [[34, 36, "GENE"]]}], ["Remarkably, the transition between DZ centroblast and LZ centrocyte phenotypes occurred independently of positioning.", {"entities": []}], ["However, CXCR4-deficient cells carried fewer mutations and were overrepresented in the CD73 \u2022 CXCR4-deficient B cells are gradually outcompeted of influenza-induced GCs \u2022 GC B cells transition from the DZ to LZ state according to a cellular program \u2022 DZ access is required for normal somatic hypermutation rates \u2022 The DZ contains a dense network of CXCL12-expressing reticular cells CXCR4-deficient B cells are gradually outcompeted of influenza-induced GCs GC B cells transition from the DZ to LZ state according to a cellular program DZ access is required for normal somatic hypermutation rates The DZ contains a dense network of CXCL12-expressing reticular cells", {"entities": [[147, 156, "DISEASE"], [436, 445, "DISEASE"], [171, 173, "GENE"], [458, 460, "GENE"], [171, 173, "GENE"], [458, 460, "GENE"]]}], ["We previously used a single nucleotide polymorphism (SNP) in the CHRNA5-A3-B4 gene cluster associated with heaviness of smoking within smokers to confirm the causal effect of smoking in reducing body mass index (BMI) in a Mendelian randomisation analysis.", {"entities": []}], ["While seeking to extend these findings in a larger sample we found that this SNP is associated with 0.74% lower body mass index (BMI) per minor allele in current smokers (95% CI -0.97 to -0.51, P \u200a=\u200a2.00\u00d710 higher BMI in never smokers (95% CI +0.18 to +0.52, P \u200a=\u200a6.38\u00d710 P \u200a=\u200a4.95\u00d710 We found that a single nucleotide polymorphism in the CHRNA5-A3-B4 gene cluster, which is known to influence smoking heaviness, is associated with lower body mass index (BMI) in current smokers, but higher BMI in never smokers.", {"entities": []}], ["This difference in effects suggests that the variant influences BMI both via pathways other than smoking, and via the weight-reducing effects of smoking, in opposite directions.", {"entities": []}], ["The overall effect on BMI would therefore be undetectable in an unstratified genome-wide association study, indicating that novel associations may be obscured by hidden population sub-structure.", {"entities": []}], ["The pathogenesis of complex diseases, such as type 1 diabetes (T1D), derives from interactions between host genetics and environmental factors.", {"entities": []}], ["Previous studies have suggested that viral infection plays a significant role in initiation of T1D in genetically predisposed individuals.", {"entities": []}], ["T1D susceptibility loci may therefore be enriched in previously uncharacterized genes functioning in antiviral defense pathways.", {"entities": []}], ["To identify genes involved in antiviral immunity, we performed an image-based high-throughput genetic screen using short hairpin RNAs (shRNAs) against 161 genes within T1D susceptibility loci.", {"entities": []}], ["RAW 264.7 cells transduced with shRNAs were infected with GFP-expressing herpes simplex virus type 1 (HSV-1) and fluorescent microscopy was performed to assess the viral infectivity by fluorescence reporter activity.", {"entities": [[73, 87, "DISEASE"]]}], ["Of the 14 candidates identified with high confidence, two candidates were selected for further investigation, Il27 and Tagap .", {"entities": [[110, 114, "GENE"], [119, 124, "GENE"]]}], ["Administration of recombinant IL-27 during viral infection was found to act synergistically with interferon gamma (IFN-\u03b3) to activate expression of type I IFNs and proinflammatory cytokines, and to enhance the activities of interferon regulatory factor 3 (IRF3).", {"entities": [[256, 260, "GENE"]]}], ["Consistent with a role in antiviral immunity, Tagap-deficient macrophages demonstrated increased viral replication, reduced expression of proinflammatory chemokines and cytokines, and decreased production of IFN-\u03b2.", {"entities": []}], ["Taken together, our unbiased loss-of-function genetic screen identifies genes that play a role in host antiviral immunity and delineates roles for IL-27 and Tagap in the production of antiviral cytokines.", {"entities": [[157, 162, "GENE"]]}], ["The current literature focusing on the effect of obesity and overweight on lung function and fraction of exhaled nitric oxide (FeNO) in children, particularly among healthy children of non-European descent, remains controversial.", {"entities": [[49, 56, "DISEASE"]]}], ["Furthermore, whether the relationship of obesity and overweight with lung function and FeNO in children is modified by atopy is unclear.", {"entities": [[41, 48, "DISEASE"]]}], ["The objective of this study was to examine the effect of excess weight on lung function parameters and FeNO among Asian children, with a particular focus on exploring the potential effect modification by atopy.", {"entities": []}], ["We investigated the effect of excess weight on lung function and FeNO in a population sample of 1,717 children aged 5 to 18 years and explored the potential modifying effect of atopy.", {"entities": []}], ["There were positive associations of body mass index (BMI) z-score with forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ), peak expiratory flow (PEF), and forced expiratory flow at 25\u201375% (FEF 25-75 ) (all P <0.001), after controlling for confounders.", {"entities": [[138, 141, "GENE"]]}], ["The beta coefficient for FEV 1 (0.084) was smaller than that for FVC (0.111).", {"entities": [[25, 28, "GENE"]]}], ["In contrast, a negative association was found between BMI z-score and FEV 1 /FVC ratio ( P <0.001) and FeNO ( P = 0.03).", {"entities": [[70, 73, "GENE"]]}], ["A consistent pattern of association for lung function variables was observed when stratifying by atopy.", {"entities": []}], ["There was a negative association of BMI z-score with FeNO in atopic subjects ( P = 0.006), but not in non-atopic subjects ( P = 0.46).", {"entities": []}], ["Excess weight disproportionately impacts lung volumes and airflow in children from the general population, independent of atopic status.", {"entities": []}], ["Excess weight inversely affects FeNO in atopic but not in non-atopic children.", {"entities": []}], ["Sheep erythrocytes ingested by guinea pig peritoneal macrophages in vitro, and permitted to undergo digestion for various periods, were found after some hours to lose the capacity to induce antibodies while gaining the ability to invoke delayed hypersensitivity.", {"entities": []}], ["These observations may be related to the known predilection of small molecular immunogens to act as good inducers of delayed reactivity and poor stimulators of antibody.", {"entities": []}], ["They may be related also to the activity of mycobacterial adjuvant as a vehicle for the induction of delayed hypersensitivity on the basis that this melange activates macrophages to phagocytose and enzymatically degrade macromolecular antigens rapidly.", {"entities": []}], ["The thesis that small fragments of antigenic molecules may preferentially invoke hypersensitivity can be interpreted on the basis of current concepts of multicellular involvements in immune responses.", {"entities": []}], ["Epidemiologic studies of the respiratory health effects of air pollution are intrinsically difficult because exposure is common, expected effects at concentrations found in developed countries are weak, random misclassification of exposure is common, and the respiratory health indicators have multiple etiologies.", {"entities": []}], ["Exposures to air pollutants also are multidimensional, generally consisting of a mixture of gases and particles.", {"entities": []}], ["In this paper, epidemiologic study designs are described, and their potential for evaluating effects of complex pollutant mixtures are discussed.", {"entities": []}], ["Power to detect the independent effects of individual pollutants in a complex pollutant mixture or to measure their interactions is in general very weak unless the study is specifically designed to test such hypotheses.", {"entities": []}], ["However, with innovative and creative design, the independent and joint effects of multiple pollutants should be estimable in epidemiologic studies.", {"entities": []}], ["Upon contact with allergen, sensitized mast cells release highly active proinflammatory mediators.", {"entities": []}], ["Allergen-mediated mast cell activation is an important mechanism in the pathogenesis of atopic asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["Asthmatic patients are especially susceptible to air pollution.", {"entities": []}], ["Epidemiologic studies found a positive correlation between severity of symptoms among asthmatic patients and the level of particulate matter (PM) in the air.", {"entities": []}], ["Among the constituents of PM are metals and transition metals, which could mediate some of its adverse effects on human health.", {"entities": []}], ["We sought to determine the effect of metal and transition metal ions on allergen-mediated mast cell activation.", {"entities": []}], ["We observed that several metal and transition metal ions activated mast cells and enhanced allergen-mediated mast cell activation.", {"entities": []}], ["Thus, Al(3+), Cd(2+), and Sr(2+) induced release of granule-associated N-acetyl-ss-d-hexosaminidase, and Al(3+) and Ni(2+) enhanced antigen-mediated release.", {"entities": []}], ["Metal and transition metal ions also induced significant secretion of interleukin (IL)-4 and increased antigen-mediated IL-4 secretion in mast cells.", {"entities": []}], ["These effects of metal and transition metal ions on mast cells were observed at concentrations that do not result in direct cytotoxicity and might be relevant for environmental exposure.", {"entities": []}], ["Thus, metals and transition metals could increase the level of allergen-mediated mast cell activation, which might be one of the mechanisms mediating exacerbation of allergen-driven asthma symptoms by air pollution.", {"entities": [[182, 188, "DISEASE"]]}], ["Doxofylline, which differs from theophylline in containing the dioxalane group at position 7, has comparable efficacy to theophylline in the treatment of respiratory diseases, but with an improved tolerability profile and a favorable risk-to-benefit ratio.", {"entities": []}], ["Furthermore, it does not have significant drug\u2013drug interactions as exhibited with theophylline, which make using theophylline more challenging, especially in elderly patients with co-morbidities receiving multiple classes of drug.", {"entities": []}], ["It is now clear that doxofylline also possesses a distinct pharmacological profile from theophylline (no significant effect on any of the known phosphodiesterase isoforms, no significant adenosine receptor antagonism, no direct effect on histone deacetylases, interaction with \u03b2 2 -adrenoceptors) and therefore, should not be considered as just a modified theophylline.", {"entities": []}], ["Randomized clinical trials of doxofylline to investigate the use of this drug to reduce exacerbations and hospitalizations due to asthma or COPD as an alternative to expensive biologics, and certainly as an alternative to theophylline are to be encouraged.", {"entities": [[130, 136, "DISEASE"]]}], ["Appreciable numbers of aspirin-sensitive asthmatic patients have chronic steroid-dependent severe asthmatic symptoms.", {"entities": []}], ["We report four cases of aspirin-sensitive asthmatics who had mild to severe asthmatic symptoms, whose methacholine PC20 level ranged from 0.6 to 22 mg/ml at the first visit.", {"entities": []}], ["The aspirin sensitivity was confirmed by lysine-aspirin bronchoprovocation.", {"entities": []}], ["After anti-asthmatic medications and avoidance of salicylate-containing agents, airway hyperresponsiveness and respiratory symptoms disappeared for two to 30 months.", {"entities": []}], ["These results suggest that early detection and careful avoidance of salicylate-containing agents may have a beneficial effect resulting in the resolution of airway hyperresponsiveness in aspirin-sensitive asthmatic patients.", {"entities": []}], ["Age appropriateness is a major concern of pulmonary delivery devices, in particular of dry powder inhalers (DPIs), since their performance strongly depends on the inspiratory flow manoeuvre of the patient.", {"entities": []}], ["Previous research on the use of DPIs by children focused mostly on specific DPIs or single inspiratory parameters.", {"entities": []}], ["In this study, we investigated the requirements for a paediatric DPI more broadly using an instrumented test inhaler.", {"entities": []}], ["Our primary aim was to assess the impact of airflow resistance on children\u2019s inspiratory flow profiles.", {"entities": []}], ["Additionally, we investigated children\u2019s preferences for airflow resistance and mouthpiece design and how these relate to what may be most suitable for them.", {"entities": []}], ["We tested 98 children (aged 4.7\u201312.6 years), of whom 91 were able to perform one or more correct inhalations through the test inhaler.", {"entities": []}], ["We recorded flow profiles at five airflow resistances ranging from 0.025 to 0.055 kPa", {"entities": []}], ["In 1992, 1998, and 2006, questionnaires were sent to stratified samples of residents aged 18\u201375 years living near petrochemical industries (n = 600\u2013800 people on each occasion) and in a control area (n = 200\u20131,000).", {"entities": []}], ["The aims were to estimate the long-term prevalence and change over time of annoyance caused by industrial odour, industrial noise, and worries about possible health effects, and to identify risk indicators.", {"entities": []}], ["In 2006, 20% were annoyed by industrial odour, 27% by industrial noise (1\u20134% in the control area), and 40\u201350% were worried about health effects or industrial accidents (10\u201320% in the control area).", {"entities": []}], ["Multiple logistic regression analyses revealed significantly lower prevalence of odour annoyance in 1998 and 2006 than in 1992, while industrial noise annoyance increased significantly over time.", {"entities": []}], ["The prevalence of worry remained constant.", {"entities": []}], ["Risk of odour annoyance increased with female sex, worry of health effects, annoyance by motor vehicle exhausts and industrial noise.", {"entities": []}], ["Industrial noise annoyance was associated with traffic noise annoyance and worry of health effects of traffic.", {"entities": []}], ["Health-risk worry due to industrial air pollution was associated with female sex, having children, annoyance due to dust/soot in the air, and worry of traffic air pollution.", {"entities": []}], ["We previously reported that importin 13 (IPO13), a member of the importin-\u03b2 family of nuclear import proteins, regulates nuclear import of the glucocorticoid receptor in airway epithelial cells, IPO13 serves as a potential marker for corneal epithelial progenitor cells, and IPO13 is associated with corneal cell proliferation.", {"entities": [[41, 46, "GENE"], [195, 200, "GENE"], [275, 280, "GENE"], [41, 46, "GENE"], [195, 200, "GENE"], [275, 280, "GENE"], [41, 46, "GENE"], [195, 200, "GENE"], [275, 280, "GENE"]]}], ["Here we investigated the role of IPO13 in the pathogenesis of pterygium and the underlying mechanism including interaction with other cell proliferation\u2013related factors: keratin 17 (K17), a lesional protein and a member of the type I keratins, and c-Jun, a protein of the activator protein-1 complex.", {"entities": [[62, 71, "DISEASE"], [33, 38, "GENE"]]}], ["Tissue samples were collected from primary pterygia, recurrent pterygia, and normal conjunctiva to perform the following experiments: immunohistochemical measurement of IPO13 and K17.", {"entities": [[169, 174, "GENE"]]}], ["Pterygium epithelial cells (PECs) were cultured in keratinocyte serum-free defined medium to examine the expression of IPO13 and K17.", {"entities": [[0, 9, "DISEASE"], [119, 124, "GENE"]]}], ["Lentivirus-mediated silencing and overexpression IPO13 testing was conducted, and K17 alternation was evaluated with western blot and immunostaining.", {"entities": [[49, 54, "GENE"]]}], ["In addition, the translocation of c-Jun (a K17 regulator) was further examined after IPO13 was silenced.", {"entities": [[85, 90, "GENE"]]}], ["IPO13 activity was significantly increased in the basal layer of the epithelium of the pterygium.", {"entities": [[87, 96, "DISEASE"], [0, 5, "GENE"]]}], ["In cultured PECs, overexpression or knockdown of the IPO13 gene increased or decreased PEC proliferation, respectively.", {"entities": [[53, 58, "GENE"]]}], ["IPO13 was colocalized with K17 in the epithelium of the pterygium, and overexpression or knockdown of the IPO13 gene induced upregulation or downregulation of K17 expression in PECs, respectively.", {"entities": [[56, 65, "DISEASE"], [0, 5, "GENE"], [106, 111, "GENE"], [0, 5, "GENE"], [106, 111, "GENE"]]}], ["In addition, silencing of the IPO13 gene blocked nuclear translocation of c-Jun.", {"entities": [[30, 35, "GENE"]]}], ["We provided novel evidence that IPO13 may contribute to the pathogenesis of pterygium via modulation of K17 and c-Jun.", {"entities": [[76, 85, "DISEASE"], [32, 37, "GENE"]]}], ["A new trend among users of new psychoactive substances\u2019 the consumption of \u201cherbal highs\u201d: plant parts containing psychoactive substances.", {"entities": []}], ["Most of the substances extracted from herbs, in old centuries were at the centre of religious ceremonies of ancient civilizations.", {"entities": []}], ["Currently, these herbal products are mainly sold by internet web sites and easily obtained since some of them have no legal restriction.", {"entities": []}], ["We reviewed psychoactive effects and neuropharmacology of the most used \u201cherbal highs\u201d with characterized active principles, with studies reporting mechanisms of action, pharmacological and subjective effects, eventual secondary effects including intoxications and/or fatalities The PubMed database was searched using the following key.words: herbal highs, Argyreia nervosa, Ipomoea violacea and Rivea corymbosa; Catha edulis; Datura stramonium; Piper methysticum; Mitragyna speciosa.", {"entities": []}], ["Psychoactive plants here reviewed have been known and used from ancient times, even if for some of them limited information still exist regarding subjective and neuropharmacological effects and consequent eventual toxicity when plants are used alone or in combination with \u201cclassical\u201d drugs of abuse.", {"entities": []}], ["Some \u201cherbal highs\u201d should be classified as harmful drugs since chronic administration has been linked with addiction and cognitive impairment; for some others taking into consideration only the recent trends of abuse, studies investigating these aspects are lacking.", {"entities": []}], ["Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expression of multiple markers on single cells.", {"entities": []}], ["This data contains invaluable biomedical information on (1) the marker expressions per cell, (2) the variation in such expression across cells, (3) the variability of cell marker expression across samples that (4) may vary systematically between cells collected from donors and patients.", {"entities": []}], ["Current conventional and even advanced data analysis methods for MFC data explore only a subset of these levels.", {"entities": []}], ["The Discriminant Analysis of MultiAspect CYtometry (DAMACY) we present here provides a comprehensive view on health and disease responses by integrating all four levels.", {"entities": []}], ["We validate DAMACY by using three distinct datasets: in vivo response of neutrophils evoked by systemic endotoxin challenge, the clonal response of leukocytes in bone marrow of acute myeloid leukaemia (AML) patients, and the complex immune response in blood of asthmatics.", {"entities": []}], ["DAMACY provided good accuracy 91\u2013100% in the discrimination between health and disease, on par with literature values.", {"entities": []}], ["Additionally, the method provides figures that give insight into the marker expression and cell variability for more in-depth interpretation, that can benefit both physicians and biomedical researchers to better diagnose and monitor diseases that are reflected by changes in blood leukocytes.", {"entities": []}], ["Acute and chronic inflammatory responses in the lung are associated with the accumulation of large quantities of immune and structural cells undergoing apoptosis, which need to be engulfed by phagocytes in a process called \u2018efferocytosis\u2019.", {"entities": []}], ["Apoptotic cell recognition and removal from the lung is mediated predominantly by airway macrophages, though immature dendritic cells and non-professional phagocytes, such as epithelial cells and mesenchymal cells, can also display this function.", {"entities": []}], ["Efficient clearance of apoptotic cells from the airways is essential for successful resolution of inflammation and the return to lung homeostasis.", {"entities": []}], ["Disruption of this process leads to secondary necrosis of accumulating apoptotic cells, release of necrotic cell debris and subsequent uncontrolled inflammatory activation of the innate immune system by the released \u2018damage associated molecular patterns\u2019 (DAMPS).", {"entities": []}], ["To control the duration of the immune response and prevent autoimmune reactions, anti-inflammatory signalling cascades are initiated in the phagocyte upon apoptotic cell uptake, mediated by a range of receptors that recognise specific phospholipids or proteins externalised on, or secreted by, the apoptotic cell.", {"entities": []}], ["However, prolonged activation of apoptotic cell recognition receptors, such as the family of receptor tyrosine kinases Tyro3, Axl and MerTK (TAM), may delay or prevent inflammatory responses to subsequent infections.", {"entities": [[119, 124, "GENE"], [126, 129, "GENE"], [134, 139, "GENE"]]}], ["In this review, we will discuss recent advances in our understanding of the mechanism controlling apoptotic cell recognition and removal from the lung in homeostasis and during inflammation, the contribution of defective efferocytosis to chronic inflammatory lung diseases, such as chronic obstructive pulmonary disease, asthma and cystic fibrosis, and implications of the signals triggered by apoptotic cells in the susceptibility to pulmonary microbial infections.", {"entities": [[282, 319, "DISEASE"], [332, 347, "DISEASE"], [321, 327, "DISEASE"]]}], ["Poverty is a major determinant of population health, but little is known about its role in modifying air pollution effects.", {"entities": []}], ["We set out to examine whether people residing in socially deprived communities are at higher mortality risk from ambient air pollution.", {"entities": []}], ["This study included 209 tertiary planning units (TPUs), the smallest units for town planning in the Special Administrative Region of Hong Kong, China.", {"entities": []}], ["The socioeconomic status of each TPU was measured by a social deprivation index (SDI) derived from the proportions of the population with a ) unemployment, b ) monthly household income < US$250, c ) no schooling at all, d ) one-person household, e ) never-married status, and f ) subtenancy, from the 2001 Population Census.", {"entities": []}], ["TPUs were classified into three levels of SDI: low, middle, and high.", {"entities": []}], ["We performed time-series analysis with Poisson regression to examine the association between changes in daily concentrations of ambient air pollution and daily number of deaths in each SDI group for the period from January 1996 to December 2002.", {"entities": []}], ["We evaluated the differences in pollution effects between different SDI groups using a case-only approach with logistic regression.", {"entities": []}], ["We found significant associations of nitrogen dioxide, sulfur dioxide, particulate matter with aerodynamic diameter < 10 \u03bcm, and ozone with all nonaccidental and cardiovascular mortality in areas of middle or high SDI ( p < 0.05).", {"entities": []}], ["Health outcomes, measured as all nonaccidental, cardiovascular, and respiratory mortality, in people residing in high SDI areas were more strongly associated with SO 2 and NO 2 compared with those in middle or low SDI areas.", {"entities": []}], ["Neighborhood socioeconomic deprivation increases mortality risks associated with air pollution.", {"entities": []}], ["The microorganism\u2013microorganism or microorganism\u2013host interactions are the key strategy to colonize and establish in a variety of different environments.", {"entities": []}], ["These interactions involve all ecological aspects, including physiochemical changes, metabolite exchange, metabolite conversion, signaling, chemotaxis and genetic exchange resulting in genotype selection.", {"entities": []}], ["In addition, the establishment in the environment depends on the species diversity, since high functional redundancy in the microbial community increases the competitive ability of the community, decreasing the possibility of an invader to establish in this environment.", {"entities": []}], ["Therefore, these associations are the result of a co-evolution process that leads to the adaptation and specialization, allowing the occupation of different niches, by reducing biotic and abiotic stress or exchanging growth factors and signaling.", {"entities": []}], ["Microbial interactions occur by the transference of molecular and genetic information, and many mechanisms can be involved in this exchange, such as secondary metabolites, siderophores, quorum sensing system, biofilm formation, and cellular transduction signaling, among others.", {"entities": []}], ["The ultimate unit of interaction is the gene expression of each organism in response to an environmental (biotic or abiotic) stimulus, which is responsible for the production of molecules involved in these interactions.", {"entities": []}], ["Therefore, in the present review, we focused on some molecular mechanisms involved in the microbial interaction, not only in microbial\u2013host interaction, which has been exploited by other reviews, but also in the molecular strategy used by different microorganisms in the environment that can modulate the establishment and structuration of the microbial community.", {"entities": []}], ["Pulmonary bronchogenic cyst in adults is rare and the typical appearance is a sharply circumscribed, round or oval nodule or mass, usually in the medial third of the lungs.", {"entities": []}], ["Bronchial polyps are rare histopathologically distinct nonneoplastic endobronchial lesions and are classified as multiple papillomas, solitary papillomas, and inflammatory polyps.", {"entities": []}], ["We herein report a patient with polypoid endobronchial lung cyst.", {"entities": []}], ["A 68-yr-old woman presented with a discomfort and pain in the right upper chest of four weeks??duration.", {"entities": []}], ["Chest radiography revealed a cystic lesion in the right upper lung.", {"entities": []}], ["Computed tomography revealed a 4\u00d75 cm sized large cyst.", {"entities": []}], ["Neither enlarged mediastinal lymph nodes nor extrabronchial involvements were observed.", {"entities": []}], ["Flexible bronchoscopy revealed a peduncular polyp about 2 cm in length originating from the anterior segment of right upper lung.", {"entities": []}], ["After bronchoscopic removal of polyp, cystic lesion of the right upper lung disappeared.", {"entities": []}], ["Joint hypermobility syndrome/Ehlers\u2013Danlos syndrome hypermobility type (JHS/EDS-HT), is likely the most common systemic heritable connective tissue disorder, and is mostly recognized by generalized joint hypermobility, joint instability complications, minor skin changes and a wide range of satellite features.", {"entities": [[20, 28, "DISEASE"], [43, 51, "DISEASE"], [6, 28, "DISEASE"]]}], ["JHS/EDS-HT is considered an autosomal dominant trait but is still without a defined molecular basis.", {"entities": []}], ["The absence of (a) causative gene(s) for JHS/EDS-HT is likely attributable to marked genetic heterogeneity and/or interaction of multiple loci.", {"entities": []}], ["In order to help in deciphering such a complex molecular background, we carried out a comprehensive immunofluorescence analysis and gene expression profiling in cultured skin fibroblasts from five women affected with JHS/EDS-HT.", {"entities": []}], ["Protein study revealed disarray of several matrix structural components such as fibrillins, tenascins, elastin, collagens, fibronectin, and their integrin receptors.", {"entities": []}], ["Transcriptome analysis indicated perturbation of different signaling cascades that are required for homeostatic regulation either during development or in adult tissues as well as altered expression of several genes involved in maintenance of extracellular matrix architecture and homeostasis (e.g., SPON2 , TGM2 , MMP16 , GPC4 , SULF1 ), cell-cell adhesion (e.g., CDH2 , CHD10 , PCDH9 , CLDN11 , FLG , DSP ), immune/inflammatory/pain responses (e.g., CFD , AQP9 , COLEC12 , KCNQ5 , PRLR ), and essential for redox balance (e.g., ADH1C , AKR1C2 , AKR1C3 , MAOB , GSTM5 ).", {"entities": [[300, 305, "GENE"], [308, 312, "GENE"], [315, 320, "GENE"], [323, 327, "GENE"], [330, 335, "GENE"], [365, 369, "GENE"], [380, 385, "GENE"], [388, 394, "GENE"], [397, 400, "GENE"], [403, 406, "GENE"], [452, 455, "GENE"], [458, 462, "GENE"], [465, 472, "GENE"], [475, 480, "GENE"], [483, 487, "GENE"], [538, 544, "GENE"], [547, 553, "GENE"], [556, 560, "GENE"], [563, 568, "GENE"]]}], ["Our findings provide a picture of the gene expression profile and dysregulated pathways in JHS/EDS-HT skin fibroblasts that correlate well with the systemic phenotype of the patients.", {"entities": []}], ["The \u201cAsthma Control Questionnaire\u201d (ACQ) is a very common questionnaire for assessing asthma control.", {"entities": [[5, 11, "DISEASE"], [86, 92, "DISEASE"]]}], ["This study compares different ACQ versions in a self-monitoring program over a 12-week period combining them with patients' self-measurements of peak expiratory flow (PEF) and forced expiratory volume in one second (FEV1).", {"entities": []}], ["The objective was to test the feasibility of FEV1-self-measurements and to compare ACQ versions regarding possible additional information given by lung function.", {"entities": []}], ["In this prospective multicenter observational study 100 adult asthma patients, recruited at six family practices and two pulmologists' private practices in Germany, completed the ACQ weekly, performing self-measurements of PEF and FEV1.", {"entities": [[62, 68, "DISEASE"]]}], ["Seventy-six patients were included into final analysis with only 3% missing values.", {"entities": []}], ["Scores for all ACQ versions improved significantly (all P -values\u2009<\u20090.05) with reductions of 32% for ACQ5, 31% for ACQ6, 22% for ACQ7-FEV1, and 21% for ACQ7-PEF with high Pearson\u2019s correlation coefficients of all scores ( r between 0.96 and 0.99).", {"entities": []}], ["ACQ7-FEV1 scores were significantly higher than others.", {"entities": []}], ["Separated courses of lung function parameters showed nearly no change, but ACQ5 and ACQ6 as scores for symptoms and reliever medication improved constantly.", {"entities": []}], ["ACQ5 and ACQ6 revealed higher percentages of patients classified as \u201ccontrolled\u201d than ACQ7-scores.", {"entities": []}], ["In conclusion, with only a few missing data points, our results suggest feasibility of FEV1-self-measurements.", {"entities": []}], ["Courses of symptom-related and lung function-related ACQ items differ clearly.", {"entities": []}], ["Our results support the GINA recommendations to consider symptoms and lung function separately.", {"entities": []}], ["FEV1-self-measurements for research purposes may be included with the ACQ, but in clinical practice seem to measure a different domain to symptomatic asthma control.", {"entities": [[150, 156, "DISEASE"]]}], ["Lung function tests taken by patients at home is doable, but yields different information than self-reports of disease control.", {"entities": []}], ["Christoph Werner and colleagues from the Technical University of Munich, Germany, tested the feasibility of collecting lung function data from patients who measured forced expiratory volume in one second by themselves.", {"entities": []}], ["These same patients also completed the Asthma Control Questionnaire (ACQ), which describes symptom severity and medication use.", {"entities": [[39, 45, "DISEASE"]]}], ["Looking at data from 76 participants, the researchers found that people did well measuring forced expiratory volume in one second, but they could not say whether this test was superior to another metric of lung function that considers peak expiratory flow.", {"entities": []}], ["The results also showed that symptom scores and lung function assays seem to capture different aspects of the disease, meaning they\u2019re worth considering separately rather than lumping together in a single test.", {"entities": []}], ["During efferocytosis, phagocytic cells recognize dying cells by receptors binding to ligands specifically exposed on apoptotic cells.", {"entities": []}], ["Multiple phagocytic receptors and some of their signaling pathways have been identified.", {"entities": []}], ["However, the downstream pathways of tethering receptors that secure apoptotic cells remain elusive.", {"entities": []}], ["It is generally assumed that tethering receptors induce signaling to mediate engulfment via interacting with co-receptors or other engulfment receptors located nearby.", {"entities": []}], ["However, it is poorly understood whether co-receptors for tethering receptors exist during efferocytosis, and, if they do, whether they are indispensable for this process.", {"entities": []}], ["Here, we address this issue using glycophosphatidylinositol (GPI)-anchored annexin A5 (Anxa5-GPI), an artificial tethering receptor without a putative co-receptor.", {"entities": [[61, 64, "GENE"], [93, 96, "GENE"]]}], ["Phagocytes expressing Anxa5-GPI exhibited enhanced binding of apoptotic cells, resulting in promoted ingestion of apoptotic cells in a phosphatidylserine-dependent manner.", {"entities": []}], ["Anxa5-GPI-induced phagocytosis of apoptotic cells relied on the known cytoskeletal engulfment machinery but partially depended on the Elmo-Dock-Rac module or the integrin pathway.", {"entities": []}], ["In addition, Anxa5-GPI-mediated efferocytosis provoked anti-inflammatory responses.", {"entities": []}], ["Taken together, our work suggests that co-receptors are dispensable for tethering receptor-induced efferocytosis and that tethering receptors mediate the engulfment of apoptotic cells through multiple engulfment signaling pathways.", {"entities": []}], ["The frequent occurrences of antibiotic-resistant biofilm forming pathogens have become global issue since various measures that had been taken to curb the situation led to failure.", {"entities": []}], ["Euphorbia hirta , is a well-known ethnomedicinal plant of Malaysia with diverse biological activities.", {"entities": []}], ["This plant has been used widely in traditional medicine for the treatment of gastrointestinal, bronchial and respiratory ailments caused by infectious agents.", {"entities": []}], ["In the present study, chemical compositions of methanol extract of E. hirta L. aerial part was analyzed by gas chromatography and gas chromatography coupled to mass spectrometry.", {"entities": []}], ["A relevant in vitro model was developed to assess the potency of the E. hirta extract to inhibit the bacterial biofilm formation as well as to eradicate the established biofilms.", {"entities": []}], ["Besides biofilm, E. hirta extract was also evaluated for the inhibition efficacy on planktonic cells using tetrazolium microplate assay.", {"entities": []}], ["For these purposes, a panel of clinically resistant pathogens and American type culture collection (ATCC) strains were used.", {"entities": []}], ["The methanolic extract of aerial part of E. hirta was predominantly composed of terpenoid (60.5%) which is often regarded as an active entity accountable for the membrane destruction and biofilm cell detachment.", {"entities": []}], ["The highest antibacterial effect of crude E. hirta extract was observed in the clinical isolates of Pseudomonas aeruginosa with minimum inhibitory concentration (MIC) value of 0.062\u00a0mg/ml.", {"entities": []}], ["The extract also displayed potent biofilm inhibition and eradication activity against P. aeruginosa with minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) values of 0.25\u00a0mg/ml and 0.5\u00a0mg/ml, respectively.", {"entities": []}], ["The crude methanol extract of E. hirta has proven to have interesting and potential anti-biofilm properties.", {"entities": []}], ["The findings from this study will also help to establish a very promising anti-infective phytotherapeutical to be exploited in the pharmaceutical industries.", {"entities": []}], ["Thickening of reticular basement membrane, increased airway smooth muscle mass and eosinophilic inflammation are found in adult fatal asthma.", {"entities": [[134, 140, "DISEASE"]]}], ["At the present study the histopathology of fatal paediatric and adolescent asthma is evaluated.", {"entities": [[75, 81, "DISEASE"]]}], ["Post-mortem lung autopsies from 12 fatal asthma cases and 8 non-asthmatic control subjects were examined.", {"entities": [[41, 47, "DISEASE"]]}], ["Thickness of reticular basement membrane (RBM) and percentage of airway smooth muscle (ASM%) mass area were measured and inflammatory cells were counted.", {"entities": [[42, 45, "GENE"]]}], ["Patient records were reviewed for clinical history.", {"entities": []}], ["The age range of the cases was from 0.9 to 19.5\u00a0years, eight were males and five had received inhaled corticosteroids.", {"entities": []}], ["Thickened RBM was detected in majority of the cases without any correlation to treatment delay, age at onset of symptoms or diagnosis.", {"entities": [[10, 13, "GENE"]]}], ["In the large airways ASM was clearly increased in one third of the cases whereas the median ASM% did not differ from that in healthy controls (14.0% vs. 14.0%).", {"entities": []}], ["In small airways no increase of ASM was found, instead mucous plugs were seen in fatal asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["The number of eosinophils, plasmacytoid dendritic cells, macrophages, and B-cells were significantly increased in fatal asthma cases compared with controls and the two latter correlated with the length of the fatal exacerbation.", {"entities": [[120, 126, "DISEASE"]]}], ["The findings highlight the strong presence of eosinophils and mucous plugs even in small airways in children and adolescents with fatal asthma.", {"entities": [[136, 142, "DISEASE"]]}], ["Thickened RBM was obvious in majority of the patients.", {"entities": [[10, 13, "GENE"]]}], ["Contrary to our hypothesis, increased ASM% was detected in only one third of the patients.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is an important differential diagnosis in heart failure (HF).", {"entities": []}], ["However, routine use of spirometry in outpatient HF clinics is not implemented.", {"entities": []}], ["The aim of the present study was to determine the prevalence of both airflow obstruction and non obstructive lung function impairment in patients with HF and to examine the effect of optimal medical treatment for HF on lung function parameters.", {"entities": []}], ["Consecutive patients with HF (ejection fraction (EF)\u2009<\u200945%) and New York Heart Association (NYHA) functional class II-IV at 10 different outpatient heart failure clinics were examined with spirometry at their first visit and after optimal medical treatment for HF was achieved.", {"entities": []}], ["airflow obstruction was classified and graded according to the GOLD 2011 revision.", {"entities": []}], ["Baseline spirometry was performed in 593 included patients and 71 (12%) had a clinical diagnosis of COPD.", {"entities": []}], ["Mean age was 69\u2009\u00b1\u200911\u00a0years and mean EF was 30\u2009\u00b1\u20099%.", {"entities": []}], ["Thirty-two % of the patients were active smokers and 53% were previous smokers.", {"entities": []}], ["Mean FEV 1 and FVC was 77.9\u2009\u00b1\u20091.7% and 85.4\u2009\u00b1\u20091.5% of predicted respectively.", {"entities": [[5, 8, "GENE"]]}], ["Obstructive pattern was observed in 233 (39%) of the patients.", {"entities": []}], ["Of these, 53 patients (9%) had mild disease (GOLD I) and 180 (30%) patients had moderate to very severe disease (GOLD II-IV).", {"entities": []}], ["No difference in spirometric variables was observed following up titration of medication.", {"entities": []}], ["In stable patients with HF airflow obstruction is frequent and severely underdiagnosed.", {"entities": []}], ["Spirometry should be considered in all patients with HF in order to improve diagnosis and treatment for concomitant pulmonary disease.", {"entities": []}], ["The progression of complex diseases, such as diabetes and cancer, is generally a nonlinear process with three stages, i.e., normal state, pre-disease state, and disease state, where the pre-disease state is a critical state or tipping point immediately preceding the disease state.", {"entities": [[58, 64, "DISEASE"]]}], ["Traditional biomarkers aim to identify a disease state by exploiting the information of differential expressions for the observed molecules, but may fail to detect a pre-disease state because there are generally little significant differences between the normal and pre-disease states.", {"entities": []}], ["Thus, it is challenging to signal the pre-disease state, which actually implies the disease prediction.", {"entities": []}], ["In this work, by exploiting the information of differential associations among the observed molecules between the normal and pre-disease states, we propose a temporal differential network based computational method to accurately signal the pre-disease state or predict the occurrence of severe disease.", {"entities": []}], ["The theoretical foundation of this work is the quantification of the critical state using dynamical network biomarkers.", {"entities": []}], ["Considering that there is one stationary Markov process before reaching the tipping point, a novel index, inconsistency score ( I -score), is proposed to quantitatively measure the change of the stationary processes from the normal state so as to detect the onset of pre-disease state.", {"entities": []}], ["In other words, a drastic increase of I -score implies the high inconsistency with the preceding stable state and thus signals the upcoming critical transition.", {"entities": []}], ["This approach is applied to the simulated and real datasets of three diseases, which demonstrates the effectiveness of our method for predicting the deterioration into disease states.", {"entities": []}], ["Both functional analysis and pathway enrichment also validate the computational results from the perspectives of both molecules and networks.", {"entities": []}], ["At the molecular network level, this method provides a computational way of unravelling the underlying mechanism of the dynamical progression when a biological system is near the tipping point, and thus detecting the early-warning signal of the imminent critical transition, which may help to achieve timely intervention.", {"entities": []}], ["Moreover, the rewiring of differential networks effectively extracts discriminatively interpretable features, and systematically demonstrates the dynamical change of a biological system.", {"entities": []}], ["The online version of this article (doi:10.1186/s12967-017-1320-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Interleukin 33 (IL-33), a member of the IL-1 family, is constitutively expressed in epithelial and in endothelial cells at barrier sites, acting as a danger signal and adjuvanting the immune response following tissue damage and infection.", {"entities": []}], ["Originally implicated in allergy, IL-33 is also known to be involved in innate and adaptive immune responses by enhancing natural killer, Th1, and CD4 and CD8 T-cell functions.", {"entities": [[147, 150, "GENE"]]}], ["The nature of the antiviral immune response orchestrated by IL-33 depends on the site of infection, the duration of the disease and the cytokine milieu.", {"entities": []}], ["In this review, we focus on the distinctive contribution of IL-33 as an anti-infective and proinflammatory cytokine in response to cell death and viral infections.", {"entities": []}], ["The dynamic role of IL-33 in the acute and chronic phases of infection with HIV, hepatitis B and C viruses, and with CMV is highlighted.", {"entities": [[81, 90, "DISEASE"]]}], ["This review will also discuss the potential immunotherapeutic and adjuvant roles of IL-33.", {"entities": []}], ["English language, indexed publications in PubMed were searched using combinations of following key words: \u201cinterleukin-33\u201d, \u201cIL-33\u201d, \u201csuppression of tumorigenicity 2\u201d, ST2\u201d, \u201csST2\u201d, \u201cHIV\u201d, \u201cHBV\u201d, \u201cHCV\u201d, \u201cCMV\u201d, \u201cHPV\u201d, \u201cimmunotherapy\u201d and \u201cvaccine\u201d.", {"entities": []}], ["Except for seminal studies, only articles published between 2010 and 2016 were included.", {"entities": []}], ["\u2022 IL-33, a guardian of barriers, acts as an alarmin and as an enhancer of immune responses following injury or infection.", {"entities": []}], ["\u2022 sST2, the IL-33 decoy receptor, is considered as a biomarker for allergies, cardiac conditions and infections.", {"entities": []}], ["\u2022 IL-33 has immunotherapeutic and/or adjuvant potential.", {"entities": []}], ["IL-33, a guardian of barriers, acts as an alarmin and as an enhancer of immune responses following injury or infection.", {"entities": []}], ["sST2, the IL-33 decoy receptor, is considered as a biomarker for allergies, cardiac conditions and infections.", {"entities": []}], ["IL-33 has immunotherapeutic and/or adjuvant potential.", {"entities": []}], ["Apart from reducing the acid secretion, omeprazole inhibits activation of the nuclear factor-\u03baB, release of inflammatory cytokines, and chemotaxis of neutrophils.", {"entities": []}], ["These mechanisms prompted us to evaluate antineuropathic effect of omeprazole in the chronic constriction injury (CCI)-induced rat model of neuropathic pain and LPS mediated ROS-induced U-87 cells.", {"entities": []}], ["Omeprazole at 50\u2009mg/kg/day/oral for 14\u2009days significantly reduced the intensity of neuropathic pain estimated as paw withdrawal latency, withdrawal pressure threshold and restored the motor nerve conduction velocity in the constricted nerve, when compared with respective groups.", {"entities": []}], ["The histological findings revealed the protective effect of omeprazole against the CCI-induced damage.", {"entities": []}], ["Omeprazole significantly decreased the levels of tumor necrosis factor (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2) and interleukin-6 (IL-6) as compared to their respective control groups.", {"entities": []}], ["It also reduced the oxidative stress by up regulating the SOD, catalase activity and decreasing MDA content.", {"entities": []}], ["Similarly, in-vitro study , LPS mediated ROS-induced U-87 cells, omeprazole reduced the oxidative stress as well as the release of TNF-\u03b1, IL-1\u03b2 and IL-6.", {"entities": []}], ["Altogether, these results suggest that, neuroprotective effect of omeprazole is mediated through preventing release of proinflammatory cytokines, augmenting endogenous anti-oxidant defense system, and maintain the structural integrity of sciatic nerve from the CCI-induced structural damage and inflammatory changes.", {"entities": []}], ["Psoriasis vulgaris is one of the most prevalent chronic, inflammatory skin disorders.", {"entities": [[0, 9, "DISEASE"]]}], ["Patients with psoriasis have excess risk of essential hypertension.", {"entities": [[54, 66, "DISEASE"], [44, 66, "DISEASE"], [14, 23, "DISEASE"]]}], ["Masked hypertension (MH), defined as normal office blood pressure (BP) with elevated ambulatory BP (ABPM), has been drawing attention recently due to its association with increased risk of developing sustained hypertension, cardiovascular morbidity, and mortality.", {"entities": [[7, 19, "DISEASE"], [210, 222, "DISEASE"]]}], ["The aim of this study was to investigate the prevalence of MH in psoriatic patients.", {"entities": []}], ["On hundred and ten middle-aged, normotensive, non-obese patients with psoriasis vulgaris and 110 age- and sex-matched normotensive controls were included in the study.", {"entities": [[70, 79, "DISEASE"]]}], ["ABPM was performed in all participants over a 24-h period.", {"entities": []}], ["The clinical severity of the disease was determined according to current indexes.", {"entities": []}], ["The prevalence of MH among subjects with psoriasis vulgaris was 31.8% and increased compared to control subjects ( p <0.01).", {"entities": [[41, 50, "DISEASE"]]}], ["Predictors of MH in patients with psoriasis vulgaris were detected as male sex, smoking, obesity-related anthropometric measures, and disease activity.", {"entities": [[34, 43, "DISEASE"], [89, 96, "DISEASE"]]}], ["Male sex, waist circumference, and diffuse psoriatic involvement were detected as independent predictors of MH.", {"entities": []}], ["MH is prevalent in patients with psoriasis vulgaris.", {"entities": [[33, 42, "DISEASE"]]}], ["Assessment with ABPM and close follow-up for development of hypertension is reasonable.", {"entities": [[60, 72, "DISEASE"]]}], ["Immunotherapy by sublingual administration of allergens provides high patient compliance and has emerged as an alternative to subcutaneous immunotherapy for the treatment of IgE-associated allergic diseases.", {"entities": []}], ["However, sublingual immunotherapy (SLIT) can cause adverse events.", {"entities": []}], ["Development of allergen delivery systems enabling more efficient delivery and hence lower allergen load might reduce the adverse events.", {"entities": []}], ["In the present study, we have investigated neutral and cationic liposomes as delivery systems of ovalbumin (OVA), as a model allergen, in an OVA-induced allergic airway inflammation model.", {"entities": []}], ["We investigated the liposome carriers\u2019 ability to improve tolerance induction of antigens compared to the corresponding dose of free OVA.", {"entities": []}], ["Mice were treated sublingually over 2 weeks with free or liposome encapsulated OVA followed by intraperitoneal injections and intranasal challenge.", {"entities": []}], ["Mice sublingually treated with OVA-liposomes showed a significant reduction of airway eosinophilia and splenocyte proliferation in comparison to free OVA.", {"entities": [[86, 98, "DISEASE"]]}], ["A similar nonsignificant pattern was seen for OVA-specific IgE antibodies.", {"entities": []}], ["In addition, reduced levels of interferon-\u03b3 and interleukin-5 were observed in spleen cell culture supernatants from OVA-liposome-treated mice compared to the sham-treated group.", {"entities": []}], ["In conclusion, in vivo efficacy data showed that prophylactic SLIT with OVA-liposomes is significantly more effective in preventing allergic inflammation than the corresponding dose of free OVA.", {"entities": []}], ["Background : Smoking reduction remains a pivotal issue in public health policy, but quit rates obtained with traditional quit-smoking therapies remain disappointingly low.", {"entities": []}], ["Tobacco Harm Reduction (THR), aiming at less harmful ways of consuming nicotine, may provide a more effective alternative.", {"entities": []}], ["One promising candidate for THR are electronic cigarettes (e-cigs).", {"entities": []}], ["The aim of this study was to investigate the efficacy of second-generation e-cigs both in terms of acute craving-reduction in the lab and in terms of smoking reduction and experienced benefits/complaints in an eight-month Randomized Controlled Trial (RCT).", {"entities": []}], ["Design : RCT with three arms.", {"entities": []}], ["Methods : Participants ( N = 48) unwilling to quit smoking were randomized into two e-cig groups and one control group.", {"entities": []}], ["During three lab sessions (over two months) participants, who had been abstinent for four hours, vaped/smoked for five minutes, after which we monitored the effect on craving and withdrawal symptoms.", {"entities": []}], ["eCO and saliva cotinine levels were also measured.", {"entities": []}], ["In between lab sessions, participants in the e-cig groups could use e-cigs or smoke ad libitum , whereas the control group could only smoke.", {"entities": []}], ["After the lab sessions, the control group also received an e-cig.", {"entities": []}], ["The RCT included several questionnaires, which repeatedly monitored the effect of ad libitum e-cig use on the use of tobacco cigarettes and the experienced benefits/complaints up to six months after the last lab session.", {"entities": []}], ["Results : From the first lab session on, e-cig use after four hours of abstinence resulted in a reduction in cigarette craving which was of the same magnitude as when a cigarette was smoked, while eCO was unaffected.", {"entities": []}], ["After two months, we observed that 34% of the e-cig groups had stopped smoking tobacco cigarettes, versus 0% of the control group (difference p < 0.01).", {"entities": []}], ["After five months, the e-cig groups demonstrated a total quit-rate of 37%, whereas the control group showed a quit rate of 38% three months after initiating e-cig use.", {"entities": []}], ["At the end of the eight-month study, 19% of the e-cig groups and 25% of the control group were totally abstinent from smoking, while an overall reduction of 60% in the number of cigarettes smoked per day was observed (compared to intake).", {"entities": []}], ["eCO levels decreased, whereas cotinine levels were the same in all groups at each moment of measurement.", {"entities": []}], ["Reported benefits far outweighed the reported complaints.", {"entities": []}], ["Conclusion : In a series of controlled lab sessions with e-cig na\u00efve tobacco smokers, second generation e-cigs were shown to be immediately and highly effective in reducing abstinence induced cigarette craving and withdrawal symptoms, while not resulting in increases in eCO.", {"entities": []}], ["Remarkable (>50 pc) eight-month reductions in, or complete abstinence from tobacco smoking was achieved with the e-cig in almost half (44%) of the participants.", {"entities": [[16, 18, "GENE"]]}], ["The impact of high physician workload and job stress on quality and outcomes of healthcare delivery is not clear.", {"entities": []}], ["Our study explored whether high workload and job stress were associated with lower performance in general practices in the Netherlands.", {"entities": []}], ["Secondary analysis of data from 239 general practices, collected in practice visits between 2003 to 2006 in the Netherlands using a comprehensive set of measures of practice management.", {"entities": []}], ["Data were collected by a practice visitor, a trained non-physician observer using patients questionnaires, doctors and staff.", {"entities": []}], ["For this study we selected five measures of practice performance as outcomes and six measures of GP workload and job stress as predictors.", {"entities": []}], ["A total of 79 indicators were used out of the 303 available indicators.", {"entities": []}], ["Random coefficient regression models were applied to examine associations.", {"entities": []}], ["Workload and job stress are associated with practice performance.", {"entities": []}], ["Workload : Working more hours as a GP was associated with more positive patient experiences of accessibility and availability (b = 0.16).", {"entities": []}], ["After list size adjustment, practices with more GP-time per patient scored higher on GP care (b = 0.45).", {"entities": []}], ["When GPs provided more than 20 hours per week per 1000 patients, patients scored over 80% on the Europep questionnaire for quality of GP care.", {"entities": []}], ["Job stress : High GP job stress was associated with lower accessibility and availability (b = 0.21) and insufficient practice management (b = 0.25).", {"entities": []}], ["Higher GP commitment and more satisfaction with the job was associated with more prevention and disease management (b = 0.35).", {"entities": []}], ["Providing more time in the practice, and more time per patient and experiencing less job stress are all associated with perceptions by patients of better care and better practice performance.", {"entities": []}], ["Workload and job stress should be assessed by using list size adjusted data in order to realise better quality of care.", {"entities": []}], ["Organisational development using this kind of data feedback could benefit both patients and GP.", {"entities": []}], ["Genome-wide association studies (GWAS) and candidate gene studies in ulcerative colitis (UC) have identified 18 susceptibility loci.", {"entities": [[69, 87, "DISEASE"]]}], ["We conducted a meta-analysis of 6 UC GWAS, comprising 6,687 cases and 19,718 controls, and followed-up the top association signals in 9,628 cases and 12,917 controls.", {"entities": []}], ["We identified 29 additional risk loci (P<5\u00d710 IL1R2, IL8RA/B, IL7R, IL12B, DAP, PRDM1, JAK2, IRF5, GNA12 and LSP1 .", {"entities": [[46, 51, "GENE"], [62, 66, "GENE"], [68, 73, "GENE"], [80, 85, "GENE"], [87, 91, "GENE"], [93, 97, "GENE"], [99, 104, "GENE"], [109, 113, "GENE"]]}], ["The total number of confirmed inflammatory bowel disease (IBD) risk loci is now 99, including a minimum of 28 shared association signals between Crohn\u2019s disease (CD) and UC.", {"entities": [[30, 56, "DISEASE"]]}], ["It has been hypothesized that by coupling magnetic particles to inhaled therapeutics, the ability to target specific lung regions (eg, only acinar deposition), or even more so specific points in the lung (eg, tumor targeting), can be substantially improved.", {"entities": []}], ["Although this method has been proven feasible in seminal in vivo studies, there is still a wide gap in our basic understanding of the transport phenomena of magnetic particles in the pulmonary acinar regions of the lungs, including particle dynamics and deposition characteristics.", {"entities": []}], ["Here, we present computational fluid dynamics-discrete element method simulations of magnetically loaded microdroplet carriers in an anatomically inspired, space-filling, multi-generation acinar airway tree.", {"entities": []}], ["Breathing motion is modeled by kinematic sinusoidal displacements of the acinar walls, during which droplets are inhaled and exhaled.", {"entities": []}], ["Particle dynamics are governed by viscous drag, gravity, and Brownian motion as well as the external magnetic force.", {"entities": []}], ["In particular, we examined the roles of droplet diameter and volume fraction of magnetic material within the droplets under two different breathing maneuvers.", {"entities": []}], ["Our results indicate that by using magnetic-loaded droplets, 100% of the particles that enter are deposited in the acinar region.", {"entities": []}], ["This is consistent across all particle sizes investigated (ie, 0.5\u20133.0 \u00b5m).", {"entities": []}], ["This is best achieved through a deep inhalation maneuver combined with a breath-hold.", {"entities": []}], ["Particles are found to penetrate deep into the acinus and disperse well, while the required amount of magnetic material is maintained low (<2.5%).", {"entities": []}], ["Although particles in the size range of ~90\u2013500 nm typically show the lowest deposition fractions, our results suggest that this feature could be leveraged to augment targeted delivery.", {"entities": []}], ["Psoriasis is a multifactorial inflammatory skin disease characterized by increased proliferation of keratinocytes, activation of immune cells and susceptibility to metabolic syndrome.", {"entities": [[0, 9, "DISEASE"], [174, 182, "DISEASE"], [43, 55, "DISEASE"]]}], ["Systems biology approach makes it possible to reveal novel important factors in the pathogenesis of the disease.", {"entities": []}], ["Protein-protein, protein-DNA, merged (containing both protein-protein and protein-DNA interactions) and chemical-protein interaction networks were constructed consisting of differentially expressed genes (DEG) between lesional and non-lesional skin samples of psoriatic patients and/or the encoded proteins.", {"entities": []}], ["DEGs were determined by microarray meta-analysis using MetaOMICS package.", {"entities": []}], ["We used STRING for protein-protein, CisRED for protein-DNA and STITCH for chemical-protein interaction network construction.", {"entities": []}], ["General network-, cluster- and motif-analysis were carried out in each network.", {"entities": []}], ["Many DEG-coded proteins (CCNA2, FYN, PIK3R1, CTGF, F3) and transcription factors (AR, TFDP1, MEF2A, MECOM) were identified as central nodes, suggesting their potential role in psoriasis pathogenesis.", {"entities": [[176, 185, "DISEASE"], [25, 30, "GENE"], [32, 35, "GENE"], [37, 43, "GENE"], [45, 49, "GENE"], [51, 53, "GENE"], [86, 91, "GENE"], [93, 98, "GENE"], [100, 105, "GENE"]]}], ["CCNA2, TFDP1 and MECOM might play role in the hyperproliferation of keratinocytes, whereas FYN may be involved in the disturbed immunity in psoriasis.", {"entities": [[140, 149, "DISEASE"], [0, 5, "GENE"], [7, 12, "GENE"], [17, 22, "GENE"], [91, 94, "GENE"]]}], ["AR can be an important link between inflammation and insulin resistance, while MEF2A has role in insulin signaling.", {"entities": [[79, 84, "GENE"]]}], ["A controller sub-network was constructed from interlinked positive feedback loops that with the capability to maintain psoriatic lesional phenotype.", {"entities": []}], ["Analysis of chemical-protein interaction networks detected 34 drugs with previously confirmed disease-modifying effects, 23 drugs with some experimental evidences, and 21 drugs with case reports suggesting their positive or negative effects.", {"entities": []}], ["In addition, 99 unpublished drug candidates were also found, that might serve future treatments for psoriasis.", {"entities": [[100, 109, "DISEASE"]]}], ["The transcription factor PLZF (promyelocytic leukemia zinc finger; zbtb16 ) is essential for nearly all of the unique characteristics of NKT cells including their rapid and potent response to antigen.", {"entities": [[45, 53, "DISEASE"], [67, 73, "GENE"]]}], ["In the immune system, zbtb16 expression is only found in innate cells.", {"entities": [[22, 28, "GENE"]]}], ["Conventional T cells that ectopically express PLZF spontaneously acquire an activated, effector phenotype.", {"entities": []}], ["Activation induced expression of lineage defining transcription factors such as T-bet, FoxP3, ROR\u03b3t, GATA3 and others is essential for na\u00efve T cell differentiation into effector T cells.", {"entities": [[87, 92, "GENE"], [101, 106, "GENE"]]}], ["In this study, we used sensitive genetic-based approaches to assess the induction of PLZF expression in non-innate T cells by T cell receptor (TCR)-mediated activation.", {"entities": []}], ["Surprisingly, we found that PLZF was stably repressed in non-innate T cells and that TCR-mediated signaling was not sufficient to induce PLZF in conventional T cells.", {"entities": []}], ["The inactivated state of PLZF was stably maintained in mature T cells, even under inflammatory conditions imposed by bacterial infection.", {"entities": []}], ["Collectively, our data show that, in contrast to multiple recent reports, PLZF expression is highly specific to innate T cells and cannot be induced in conventional T cells via TCR-mediated activation or inflammatory challenge.", {"entities": []}], ["Early life infection has been implicated in the aetiology of many chronic diseases, most often through proxy measures.", {"entities": []}], ["Data on ten infectious symptoms were collected by parental questionnaire when children were 6\u00a0months old as part of the Avon Longitudinal Study of Parents and Children, United Kingdom.", {"entities": []}], ["A latent class analysis was used to identify patterns of infection and their relationship to five factors commonly used as proxies: sex, other children in the home, maternal smoking, breastfeeding and maternal education.", {"entities": []}], ["A total of 10,032 singleton children were included in the analysis.", {"entities": []}], ["Five classes were identified with differing infectious disease patterns and children were assigned to the class for which they had a highest probability of membership based on their infectious symptom profile: \u2018general infection\u2019 (n\u00a0=\u00a01,252, 12.5%), \u2018gastrointestinal\u2019 (n\u00a0=\u00a01,902, 19.0%), \u2018mild respiratory\u2019 (n\u00a0=\u00a03,560, 35.5%), \u2018colds/ear ache\u2019 (n\u00a0=\u00a0462, 4.6%) and \u2018healthy\u2019 (n\u00a0=\u00a02,856, 28.5%).", {"entities": []}], ["Females had a reduced risk of being in all infectious classes, other children in the home were associated with an increased risk of being in the \u2018general infection\u2019, \u2018mild respiratory\u2019 or \u2018colds/ear ache\u2019 class.", {"entities": []}], ["Breastfeeding reduced the risk of being in the \u2018general infection\u2019 and \u2018gastrointestinal\u2019 classes whereas maternal smoking increased the risk of membership.", {"entities": []}], ["Higher maternal education was associated with an increased risk of being in the \u2018mild respiratory\u2019 group.", {"entities": []}], ["Other children in the home had the greatest association with infectious class membership.", {"entities": []}], ["Latent class analysis provided a flexible method of investigating the relationship between multiple symptoms and demographic and lifestyle factors.", {"entities": []}], ["While deaths are thought to be rare in community Australian sport, there is no systematic reporting so the frequency and leading causes of death is unknown.", {"entities": []}], ["The aim of this study was to describe the frequency and cause of deaths associated with community-level Australian Football (AF), based on insurance-claims records.", {"entities": []}], ["Retrospective review of prospectively collected insurance-claims for death in relation to community-level AF activities Australia-wide from 2004 to 2013.", {"entities": []}], ["Eligible participants were aged 15+ years, involved in an Australian football club as players, coaches, umpires or supporting roles.", {"entities": []}], ["Details were extracted for: year of death, level of play, age, sex, anatomical location of injury, and a descriptive narrative of the event.", {"entities": []}], ["Descriptive data are presented for frequency of cases by subgroups.", {"entities": []}], ["From 26,749 insurance-claims relating to AF, 31 cases were in relation to a death.", {"entities": []}], ["All fatalities were in males.", {"entities": []}], ["The initial event occurred during on-field activities of players (football matches or training) in 16 cases.", {"entities": []}], ["The remainder occurred to people outside of on-field football activity (n = 8), or non-players (n = 7).", {"entities": []}], ["Road trauma (n = 8) and cardiac conditions (n = 7) were the leading identifiable causes, with unconfirmed and other causes (including collapsed or not yet determined) comprising 16 cases.", {"entities": []}], ["Although rare, fatalities do occur in community AF to both players and people in supporting roles, averaging 3 per year in this setting alone.", {"entities": []}], ["A systematic, comprehensive approach to data collection is urgently required to better understand the risk and causes of death in participants of AF and other sports.", {"entities": []}], ["Patients with chronic asthma have thicker intrapulmonary airways measured on high resolution computed tomography (HRCT).", {"entities": [[22, 28, "DISEASE"]]}], ["We determined whether the presence of lower airway bacteria was associated with increased airway wall thickness.", {"entities": []}], ["In 56 patients with stable severe asthma, sputum specimens obtained either spontaneously or after induction with hypertonic saline were cultured for bacteria and thoracic HRCT scans obtained.", {"entities": [[34, 40, "DISEASE"]]}], ["Wall thickness (W T ) and area (W A ) expressed as a ratio of airway diameter (D) and total area, respectively, were measured at five levels.", {"entities": []}], ["Positive bacterial cultures were obtained in 29 patients, with H. influenzae, P. aeruginosa and S. aureus being the commonest strains.", {"entities": []}], ["Logistic regression analysis showed that this was associated with the duration of asthma and the exacerbations during the past year.", {"entities": [[82, 88, "DISEASE"]]}], ["In airways > 2 mm, there was no significant difference in W A (67.5 \u00b1 5.4 vs 66.4 \u00b1 5.4) and W T /D (21.6 \u00b1 2.7 vs 21.3 \u00b1 2.4) between the culture negative versus positive groups.", {"entities": []}], ["Similarly, in airways (\u2264 2 mm), there were no significant differences in these parameters.", {"entities": []}], ["The ratio of \u221awall area to P i was negatively correlated with FEV 1 % predicted (p < 0.05).", {"entities": [[62, 65, "GENE"]]}], ["Bacterial colonization of the lower airways is common in patients with chronic severe asthma and is linked to the duration of asthma and having had exacerbations in the past year, but not with an increase in airway wall thickness.", {"entities": [[86, 92, "DISEASE"], [126, 132, "DISEASE"]]}], ["Surgical patients are at risk for preventable adverse drug events (ADEs) during hospitalization.", {"entities": []}], ["Usually, preventable ADEs are measured as an outcome parameter of quality of pharmaceutical care.", {"entities": []}], ["However, process measures such as QIs are more efficient to assess the quality of care and provide more information about potential quality improvements.", {"entities": []}], ["To assess the quality of pharmaceutical care of medication-related processes in surgical wards with quality indicators, in order to detect targets for quality improvements.", {"entities": []}], ["For this observational cohort study, quality indicators were composed, validated, tested, and applied on a surgical cohort.", {"entities": []}], ["Three surgical wards of an academic hospital in the Netherlands (Academic Medical Centre, Amsterdam) participated.", {"entities": []}], ["Consecutive elective surgical patients with a hospital stay longer than 48 hours were included from April until June 2009.", {"entities": []}], ["To assess the quality of pharmaceutical care, the set of quality indicators was applied to 252 medical records of surgical patients.", {"entities": []}], ["Thirty-four quality indicators were composed and tested on acceptability and content- and face-validity.", {"entities": []}], ["The selected 28 candidate quality indicators were tested for feasibility and \u2018sensitivity to change\u2019.", {"entities": []}], ["This resulted in a final set of 27 quality indicators, of which inter-rater agreements were calculated (kappa 0.92 for eligibility, 0.74 for pass-rate).", {"entities": []}], ["The quality of pharmaceutical care was assessed in 252 surgical patients.", {"entities": []}], ["Nearly half of the surgical patients passed the quality indicators for pharmaceutical care (overall pass rate 49.8%).", {"entities": []}], ["Improvements should be predominantly targeted to medication care related processes in surgical patients with gastro-intestinal problems (domain pass rate 29.4%).", {"entities": []}], ["This quality indicator set can be used to measure quality of pharmaceutical care and detect targets for quality improvements.", {"entities": []}], ["With these results medication safety in surgical patients can be enhanced.", {"entities": []}], ["Genome-wide association studies (GWAS) have identified a large number of disease-associated SNPs, but in few cases the functional variant and the gene it controls have been\u00a0identified.", {"entities": []}], ["To systematically identify candidate regulatory variants, we sequenced ENCODE cell lines and used public ChIP-seq data to look for transcription factors binding preferentially to one allele.", {"entities": []}], ["We found 9962 candidate regulatory SNPs, of which 16\u00a0% were rare and showed evidence of larger functional effect than common ones.", {"entities": []}], ["Functionally rare variants may explain divergent GWAS results between populations and are candidates for a partial explanation of the missing heritability.", {"entities": []}], ["The majority of allele-specific variants (96\u00a0%) were specific to a cell type.", {"entities": []}], ["Furthermore, by examining GWAS loci we found >400 allele-specific candidate SNPs, 141 of which were highly relevant in our cell types.", {"entities": []}], ["Functionally validated SNPs support identification of an SNP in SYNGR1 which may expose to the risk of rheumatoid arthritis and primary biliary cirrhosis, as well as an SNP in the last intron of COG6 exposing to the risk of psoriasis.", {"entities": [[103, 123, "DISEASE"], [224, 233, "DISEASE"], [128, 153, "DISEASE"], [114, 123, "DISEASE"], [64, 70, "GENE"], [195, 199, "GENE"]]}], ["We propose that by repeating the ChIP-seq experiments of 20 selected transcription factors in three to ten people, the most common polymorphisms can be interrogated for allele-specific binding.", {"entities": []}], ["Our strategy may help to remove the current bottleneck in functional annotation of the genome.", {"entities": []}], ["The online version of this article (doi:10.1007/s00439-016-1654-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives .", {"entities": []}], ["To examine the association between maternal leisure time physical activity and mode of delivery.", {"entities": []}], ["Study Design .", {"entities": []}], ["Population-based multicentre cohort.", {"entities": []}], ["From the Danish Dystocia Study, we included 2,435 nulliparous women, who delivered a singleton infant in cephalic presentation at term after spontaneous onset of labor in 2004-2005.", {"entities": []}], ["We analysed mode of delivery according to self-reported physical activity at four stages, that is, the year before pregnancy and during first, second, and third trimester, in logistic regression models.", {"entities": []}], ["Further, we combined physical activity measures at all four stages in one variable for a proportional odds model for cumulative logits.", {"entities": []}], ["Main Outcome Measures .", {"entities": []}], ["Mode of delivery (emergency caesarean section; vacuum extractor; spontaneous vaginal delivery).", {"entities": []}], ["The odds of emergency caesarean section decreased with increasing levels of physical activity with statistically significant trends at all four time stages except the third trimester.", {"entities": []}], ["This tendency was confirmed in the proportional odds model showing 28% higher odds of a more complicated mode of delivery among women with a low activity level compared to moderately active women.", {"entities": []}], ["Conclusions .", {"entities": []}], ["We found increasing leisure time physical activity before and during pregnancy associated with a less complicated delivery among low-risk, nulliparous women.", {"entities": []}], ["Airway remodeling is a key characteristic of chronic asthma, particularly in patients with a fixed airflow limitation.", {"entities": [[53, 59, "DISEASE"]]}], ["The mechanisms underlying airway remodeling are poorly understood, and no therapeutic option is available.", {"entities": []}], ["The Wnt/\u03b2-catenin signaling pathway is involved in various physiological and pathological processes, including fibrosis and smooth muscle hypertrophy.", {"entities": []}], ["In this study, we investigated the roles of Wnt/\u03b2-catenin signaling in airway remodeling in patients with asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["Wnt7a mRNA expression was prominent in induced sputum from patients with asthma compared with that from healthy controls.", {"entities": [[73, 79, "DISEASE"], [0, 5, "GENE"]]}], ["Next, we induced a chronic asthma mouse model with airway remodeling features, including subepithelial fibrosis and airway smooth muscle hyperplasia.", {"entities": [[27, 33, "DISEASE"]]}], ["Higher expression of Wnt family proteins and \u03b2-catenin was detected in the lung tissue of mice with chronic asthma compared to control mice.", {"entities": [[108, 114, "DISEASE"]]}], ["Blocking \u03b2-catenin expression with a specific siRNA attenuated airway inflammation and airway remodeling.", {"entities": []}], ["Decreased subepithelial fibrosis and collagen accumulation in the \u03b2-catenin siRNA-treated mice was accompanied by reduced expression of transforming growth factor-\u03b2.", {"entities": []}], ["We further showed that suppressing \u03b2-catenin in the chronic asthma model inhibited smooth muscle hyperplasia by downregulating the tenascin C/platelet-derived growth factor receptor pathway.", {"entities": [[60, 66, "DISEASE"]]}], ["Taken together, these findings demonstrate that the Wnt/\u03b2-catenin signaling pathway is highly expressed and regulates the development of airway remodeling in chronic asthma.", {"entities": [[166, 172, "DISEASE"]]}], ["Infections caused by bacteria in the airway preferentially induce a Th17 response.", {"entities": []}], ["However the mechanisms involved in the regulation of CD4 T cells responses in the lungs are incompletely understood.", {"entities": [[53, 56, "GENE"]]}], ["Here we have investigated the mechanisms involved in the regulation of Th17 differentiation in the lungs in response to immunization with LPS as adjuvant.", {"entities": []}], ["Our data shows that both Myd88 and TRIF are necessary for Th17 induction.", {"entities": [[25, 30, "GENE"]]}], ["This distinctive fate determination can be accounted for by the pattern of inflammatory cytokines induced by airway administration of LPS.", {"entities": []}], ["We identified the production of IL-1\u03b2 and IL-6 by small macrophages and IL-23 by alveolar dendritic cells, favoring Th17 responses, and IL-10 repressing IFN-\u03b3 production.", {"entities": []}], ["Furthermore, we show that exogenous IL-1\u03b2 can drastically alter Th1 responses driven by influenza and lymphocytic choriomeningitis virus infection models and induce IL-17 production.", {"entities": [[88, 97, "DISEASE"], [102, 130, "DISEASE"]]}], ["Thus the precision of the lung immune responses to potential threats is orchestrated by the cytokine microenvironment, can be repolarized and targeted therapeutically by altering the cytokine milieu.", {"entities": []}], ["These results indicate how the development of Th17 responses in the lung are regulated by the cytokines produced by lung dendritic cells and macrophages in response to intranasal immunization with LPS adjuvant.", {"entities": []}], ["The aim of the study was to examine basal hypothalamic-pituitary-adrenal (HPA) axis activity and to determine associations of various covariates (gender, sleep-wake rhythm, demographic, academic, life style and health-related characteristics) with altered daily salivary cortisol profiles in late adolescence.", {"entities": []}], ["The total analytic sample consisted of 903 Croatian secondary school students aged 18 - 21 years (median 19 years).", {"entities": []}], ["Salivary cortisol was sampled at home at three time points over the course of one week and its concentrations were measured by using the enzyme immunoassay.", {"entities": []}], ["In comparison to males, female students had a higher cortisol awakening response (CAR) (median 4.69, IQR 10.46 and median 3.03, IQR 8.94, respectively; P < 0.001), a steeper (\u201chealthier\u201d) diurnal cortisol slope (DCS) (median 0.51, IQR 0.55 and median 0.44, IQR 0.51, respectively; P = 0.001), and a greater area under curve with respect to ground (AUC G ) (median 206.79, IQR 111.78 and median 191.46, IQR 104.18, respectively; P < 0.001).", {"entities": []}], ["Those students who woke-up earlier and were awake longer, had a higher CAR (P < 0.001), a flatter (\u201cless healthy\u201d) DCS (P < 0.001), and a greater AUCG (P < 0.001), than students who woke-up later and were awake shorter.", {"entities": []}], ["Less consistent but still significant predictors of salivary cortisol indexes were age, school behaviour, friendship, diet healthiness and drug abuse.", {"entities": []}], ["Gender and sleep-wake up rhythm were major determinants of the altered daily salivary cortisol profiles in late adolescence.", {"entities": []}], ["The predictive power of other covariates, although less clear, has a potential for identifying vulnerable subgroups such as male drug users and females without a best friend.", {"entities": []}], ["Tumor necrosis factor alpha (TNF-\u03b1), a central mediator of the inflammatory response, is released from basophilic cells and other cells in response to a variety of proinflammatory stimuli.", {"entities": []}], ["Vialinin A is a potent inhibitor of TNF-\u03b1 production and is released from RBL-2H3 cells.", {"entities": []}], ["Ubiquitin-specific peptidase 5 (USP5), a deubiquitinating enzyme, was identified as a target molecule of vialinin A and its enzymatic activity was inhibited by vialinin A.", {"entities": [[32, 36, "GENE"]]}], ["Here we report production of TNF-\u03b1 is decreased in USP5 siRNA-knockdown RBL-2H3 cells, compared with control cells.", {"entities": [[51, 55, "GENE"]]}], ["The finding of the present study strongly suggests that USP5 is one of the essential molecules for the production of TNF-\u03b1 in RBL-2H3.", {"entities": [[56, 60, "GENE"]]}], ["Introduction : To improve work participation in individuals with a chronic illness, insight into the role of work-related factors in the association between health and sick leave is needed.", {"entities": []}], ["The aim of this study was to gain insight into the contribution of work limitations, work characteristics, and work adjustments to the association between health and sick leave in employees with a chronic illness.", {"entities": []}], ["Methods : All employees with a chronic illness, between 15 and 65\u00a0years of age (n\u00a0=\u00a07,748) were selected from The Netherlands Working Conditions Survey.", {"entities": []}], ["The survey included questions about perceived health, working conditions, and sick leave.", {"entities": []}], ["Block-wise multivariate linear regression analyses were performed and, in different blocks, limitations at work, work characteristics, and work adjustments were added to the model of perceived health status.", {"entities": []}], ["Changes in regression coefficient (B) (%) were calculated for the total group and for sub-groups per chronic illness.", {"entities": []}], ["Results : When work limitations were added to the model, the B between health and sick leave decreased by 18% (5.0 to 4.1).", {"entities": []}], ["Adding work characteristics did not decrease the association between health and sick leave, but the B between work limitations and sick leave decreased by 14%, (5.3 to 4.5).", {"entities": []}], ["When work adjustments were added to the model, the Bs between sick leave and work limitations and work characteristics changed from 4.5 to 3.4 for work limitations and from 2.1 to 1.9 for temporary contract and from \u22120.8 to \u22121.0 for supervisor support.", {"entities": []}], ["Conclusions : The association between health and sick leave was explained by limitations at work, work characteristics, and work adjustments.", {"entities": []}], ["Paying more attention to work limitations, characteristics and adjustments offers opportunities to reduce the negative consequences of chronic illness.", {"entities": []}], ["Patients with gastroesophageal reflux disease (GERD) present with comorbid complications with implications for healthcare utilization.", {"entities": [[14, 45, "DISEASE"]]}], ["To date, little is known about the effects of GERD treatment with a proton-pump inhibitor (PPI) on patients\u2019 subsequent healthcare utilization for acute respiratory infections (ARIs).", {"entities": []}], ["This population-based study compared ARI episodes captured through outpatient visits, one year before and one year after GERD patients received PPI treatment.", {"entities": []}], ["We used retrospective data from the Longitudinal Health Insurance Database 2005 in Taiwan, comparing 21,486 patients diagnosed with GERD from 2010 to 2012 with 21,486 age-sex matched comparison patients without GERD.", {"entities": []}], ["Annual ARI episodes represented by ambulatory care visits for ARI (visits during a 7-day period bundled into one episode), were compared between the patient groups during the 1-year period before and after the index date (date of GERD diagnosis for study patients, first ambulatory visit in the same year for their matched comparison counterpart).", {"entities": []}], ["Multiple regression analysis using a difference-in-difference approach was performed to estimate the adjusted association between GERD treatment and the subsequent annual ARI rate.", {"entities": []}], ["We found that the mean annual ARI episode rate among GERD patients reduced by 11.4%, from 4.39 before PPI treatment, to 3.89 following treatment (mean change = -0.5 visit, 95% confidence interval (CI) = (-0.64, -0.36)).", {"entities": []}], ["In Poisson regression analysis, GERD treatment showed an independent association with the annual ARI rate, showing a negative estimate (with p <0.001).", {"entities": []}], ["The study suggests that GERD treatment with PPIs may help reduce healthcare visits for ARIs, highlighting the importance of treatment-seeking by GERD patients and compliance with treatment.", {"entities": []}], ["The Global Initiative defines COPD for chronic obstructive lung disease as an entirely preventable and treatable disease characterized by sputum production, bacterial colonisation, neutrophilic bronchial airway inflammation and poor health status.", {"entities": [[47, 71, "DISEASE"], [59, 71, "DISEASE"]]}], ["The World Health Organization (WHO) estimates that COPD will become the fourth-most common cause of death worldwide, just behind ischemic heart disease, cerebrovascular disease and HIV/AIDS, by 2030.", {"entities": [[129, 151, "DISEASE"], [153, 176, "DISEASE"], [138, 151, "DISEASE"]]}], ["The aim of this study was to determine the main structure feature of sputum potentially pathogenic microorganisms in subjects with COPD during the clinical stable state.", {"entities": []}], ["We employed a molecular genetics-based investigation of the bacteria community, including DNA isolation, PCR amplification and DGGE profiling.", {"entities": []}], ["PCR-denaturing gradient gel electrophoresis (DGGE) with universal primers targeting the V3 region of the 16S rRNA gene was employed to characterize the overall COPD patient sputum microbiota composition, and some excised gel bands were cloned for sequencing.", {"entities": []}], ["Real-time PCR was further utilized to quantitatively analyze the subpopulation of microbiota using group-specific primers targeting Streptococcus pneumoniae , Klebsiella pneumoniae , Pseudomonas aeruginosa .", {"entities": []}], ["The DGGE profiles of two groups displayed significant differences between COPD and healthy groups ( P \u2009<\u20090.05).", {"entities": []}], ["Real-time PCR revealed significant increases of Streptococcus pneumoniae , Klebsiella pneumoniae and Pseudomonas aeruginosa ( P \u2009<\u20090.05) in the COPD group compared with the healthy group.", {"entities": []}], ["This study revealed strong relationship between alterations of sputum microbiota and COPD.", {"entities": []}], ["By determining the content of several types of bacteria, we can provide evidence to aid in the diagnosis and treatment of COPD.", {"entities": []}], ["Tumor necrosis factor alpha (TNF- \u03b1 ) is a potent proinflammatory cytokine that plays a significant role in the pathogenesis of asthma by inducing hyperresponsiveness and airway remodeling.", {"entities": [[128, 134, "DISEASE"]]}], ["TNF- \u03b1 diminishes the L-type voltage dependent Ca \u03b1 , pointing out that this cytokine might be present in Ser-S. We observed that a small-molecule inhibitor of TNF- \u03b1 (SMI-TNF) and a TNF- \u03b1 receptor 1 (TNFR1) antagonist (WP9QY) reversed ICa decrease induced by Ser-S in NS myocytes, confirming the former hypothesis.", {"entities": []}], ["U0126 (a blocker of ERK 1/2 kinase) also reverted the decrease in ICa.", {"entities": []}], ["Neither cycloheximide (a protein synthesis inhibitor) nor actinomycin D (a transcription inhibitor) showed any effect on the TNF- \u03b1 -induced ICa reduction.", {"entities": []}], ["We found that Ca V 1.2 and Ca V 1.3 mRNA and proteins were expressed in tracheal myocytes and that sensitization did not modify them.", {"entities": []}], ["In cardiac myocytes, ERK 1/2 phosphorylates two sites of the L-VDCC, augmenting or decreasing ICa; we postulate that, in guinea pig tracheal smooth muscle, TNF- \u03b1 diminishes ICa probably by phosphorylating the L-VDCC site that reduces its activity through the ERK1/2 MAP kinase pathway.", {"entities": []}], ["Abnormal immune responses are believed to be highly relevant in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[84, 121, "DISEASE"]]}], ["Dendritic cells provide a critical checkpoint for immunity by their capacity to both induce and suppress immunity.", {"entities": []}], ["Although evident that cigarette smoke, the primary cause of COPD, significantly influences dendritic cell functions, little is known about the roles of dendritic cells in the pathogenesis of COPD.", {"entities": []}], ["The extent of dendritic cell infiltration in COPD tissue specimens was determined using immunohistochemical localization of CD83+ cells (marker of matured myeloid dendritic cells), and CD1a+ cells (Langerhans cells).", {"entities": []}], ["The extent of tissue infiltration with Langerhans cells was also determined by the relative expression of the CD207 gene in COPD versus control tissues.", {"entities": [[110, 115, "GENE"]]}], ["To determine mechanisms by which dendritic cells accumulate in COPD, complimentary studies were conducted using monocyte-derived human dendritic cells exposed to cigarette smoke extract (CSE), and dendritic cells extracted from mice chronically exposed to cigarette smoke.", {"entities": []}], ["In human COPD lung tissue, we detected a significant increase in the total number of CD83+ cells, and significantly higher amounts of CD207 mRNA when compared with control tissue.", {"entities": [[134, 139, "GENE"]]}], ["Human monocyte-derived dendritic cells exposed to CSE (0.1-2%) exhibited enhanced survival in vitro when compared with control dendritic cells.", {"entities": []}], ["Murine dendritic cells extracted from mice exposed to cigarette smoke for 4 weeks, also demonstrated enhanced survival compared to dendritic cells extracted from control mice.", {"entities": []}], ["Acute exposure of human dendritic cells to CSE induced the cellular pro-survival proteins heme-oxygenase-1 (HO-1), and B cell lymphoma leukemia-x(L) (Bcl-xL), predominantly through oxidative stress.", {"entities": [[126, 134, "DISEASE"], [135, 143, "DISEASE"]]}], ["Although activated human dendritic cells conditioned with CSE expressed diminished migratory CCR7 expression, their migration towards the CCR7 ligand CCL21 was not impaired.", {"entities": [[93, 97, "GENE"], [138, 142, "GENE"], [93, 97, "GENE"], [138, 142, "GENE"], [150, 155, "GENE"]]}], ["These data indicate that COPD is associated with increased numbers of cells bearing markers associated with Langerhans cells and mature dendritic cells, and that cigarette smoke promotes survival signals and augments survival of dendritic cells.", {"entities": []}], ["Although CSE suppressed dendritic cell CCR7 expression, migration towards a CCR7 ligand was not diminished, suggesting that reduced CCR7-dependent migration is unlikely to be an important mechanism for dendritic cell retention in the lungs of smokers with COPD.", {"entities": [[39, 43, "GENE"], [76, 80, "GENE"], [132, 136, "GENE"], [39, 43, "GENE"], [76, 80, "GENE"], [132, 136, "GENE"]]}], ["Cystic fibrosis (CF) is a fatal genetic disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene that primarily affects the lungs and the digestive system, and the current drug treatment is mainly able to alleviate symptoms.", {"entities": [[32, 48, "DISEASE"], [116, 120, "GENE"]]}], ["To improve disease management for CF, we considered the repurposing of approved drugs and hypothesized that specific microRNA (miRNA) transcription factors (TF) gene networks can be used to generate feed-forward loops (FFLs), thus providing treatment opportunities on the basis of disease specific FFLs.", {"entities": [[157, 159, "GENE"]]}], ["Comprehensive database searches revealed significantly enriched TFs and miRNAs in CF and CFTR gene networks.", {"entities": [[89, 93, "GENE"]]}], ["The target genes were validated using ChIPBase and by employing a consensus approach of diverse algorithms to predict miRNA gene targets.", {"entities": []}], ["STRING analysis confirmed protein-protein interactions (PPIs) among network partners and motif searches defined composite FFLs.", {"entities": []}], ["Using information extracted from SM2miR and Pharmaco-miR, an in silico drug repurposing pipeline was established based on the regulation of miRNA/TFs in CF/CFTR networks.", {"entities": []}], ["In human airway epithelium, a total of 15 composite FFLs were constructed based on CFTR specific miRNA/TF gene networks.", {"entities": [[83, 87, "GENE"]]}], ["Importantly, nine of them were confirmed in patient samples and CF epithelial cells lines, and STRING PPI analysis provided evidence that the targets interacted with each other.", {"entities": []}], ["Functional analysis revealed that ubiquitin-mediated proteolysis and protein processing in the endoplasmic reticulum dominate the composite FFLs, whose major functions are folding, sorting, and degradation.", {"entities": []}], ["Given that the mutated CFTR gene disrupts the function of the chloride channel, the constructed FFLs address mechanistic aspects of the disease and, among 48 repurposing drug candidates, 26 were confirmed with literature reports and/or existing clinical trials relevant to the treatment of CF patients.", {"entities": [[23, 27, "GENE"]]}], ["The construction of FFLs identified promising drug repurposing candidates for CF and the developed strategy may be applied to other diseases as well.", {"entities": []}], ["The online version of this article (doi:10.1186/s13073-014-0094-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We studied the effects of various chemokines including neutrophil- activating peptide 2 (NAP-2), beta-thromboglobulin (beta-TG), platelet factor 4 (PF-4), melanoma growth stimulating activity (GRO), gamma interferon-induced protein (IP-10), regulated on activation, normal T expressed and secreted (RANTES), macrophage inflammatory protein 1 alpha (MIP-1 alpha), MIP-1 beta, and monocyte chemotactic protein 1 (MCP-1) on Immunoglobulin (IgE) and IgG4 production by human B cells.", {"entities": [[155, 163, "DISEASE"]]}], ["None of these chemokines with or without interleukin (IL-4), anti-CD40 or -CD58 monoclonal antibody (mAb), induced IgE and IgG4 production by B cells from nonatopic donors.", {"entities": []}], ["However, RANTES and MIP-1 alpha selectively enhanced IgE and IgG4 production induced by IL-4 plus anti- CD40 or -CD58 mAb without affecting production of IgM, IgG1, IgG2, IgG3, IgA1, or IgA2, whereas other chemokines failed to do so.", {"entities": [[104, 108, "GENE"]]}], ["Enhancement of IgE and IgG4 production by RANTES and MIP-1 alpha was specifically blocked by anti-RANTES mAb and anti-MIP-1 alpha antibody (Ab), respectively, whereas anti-IL-5 mAb, anti-IL-6 mAb, anti-IL-10 Ab, anti-IL-13 Ab, and anti-tumor necrosis factor-alpha mAb failed to do so.", {"entities": []}], ["Purified surface IgE positive (slgE4) and slgG4+ B cells generated either in vitro or in vivo spontaneously produced IgE and IgG4, respectively, whereas sIgE- and sIgG4- B cells failed to do so.", {"entities": []}], ["RANTES and MIP-1 alpha enhanced spontaneous IgE and IgG4 production in slgE+ and slgG4- B cells, respectively, whereas neither RANTES nor MIP- 1 alpha did so in sIgE- or sIgG4- B cells.", {"entities": []}], ["Purified sIgE4+ and sIgG4+, but not sIgE- or sIgG4- B cells, generated in vitro and in vivo expressed receptors for RANTES and MIP-1 alpha, whereas they failed to express receptors for other chemokines.", {"entities": []}], ["These findings indicate that RANTES and MIP-1 alpha enhance IgE and IgG4 production by directly stimulating sIgE+ and sIgG4+ B cells.", {"entities": []}], ["Polymorphism of the Duffy Antigen Receptor for Chemokines (DARC) is associated with susceptibility to and the severity of Plasmodium vivax malaria in humans.", {"entities": [[139, 146, "DISEASE"], [59, 63, "GENE"]]}], ["P. vivax uses DARC to invade erythrocytes.", {"entities": [[14, 18, "GENE"]]}], ["Individuals lacking DARC are \u2018resistant\u2019 to P. vivax erythrocytic infection.", {"entities": [[20, 24, "GENE"]]}], ["However, susceptibility to P. vivax in DARC+ individuals is reported to vary between specific DARC genotypes.", {"entities": [[39, 43, "GENE"], [94, 98, "GENE"]]}], ["We hypothesized that the natural acquisition of antibodies to P. vivax blood stages may vary with the host genotype and the level of DARC expression.", {"entities": [[133, 137, "GENE"]]}], ["Furthermore, high parasitemia has been reported to effect the acquisition of immunity against pre-erythrocytic parasites.", {"entities": []}], ["We investigated the correlation between host DARC genotypes and the frequency and magnitude of antibodies against P. vivax erythrocytic stage antigens.", {"entities": [[45, 49, "GENE"]]}], ["We assessed the frequencies and magnitudes of antibody responses against P. vivax and P. falciparum sporozoite and erythrocytic antigens in Colombian donors from malaria-endemic regions.", {"entities": [[162, 169, "DISEASE"]]}], ["The frequency and level of naturally-acquired antibodies against the P. vivax erythrocytic antigens merozoite surface protein 1 (PvMSP1) and Duffy binding protein (PvDBP) varied with the host DARC genotypes.", {"entities": [[192, 196, "GENE"]]}], ["Donors with one negative allele (FY*B/FY*Bnull and FY*A/FY*Bnull) were more likely to have anti-PvMSP1 and anti-PvDBP antibodies than those with two positive alleles (FY*B/FY*B and FY*A/FY*B).", {"entities": []}], ["The lower IgG3 and IgG1 components of the total IgG response may account for the decreased responses to P. vivax erythrocytic antigens with FY*A/FY*B and FY*B/FY*B genotypes.", {"entities": []}], ["No such association was detected with P. falciparum erythrocytic antigens, which does not use DARC for erythrocyte invasion.", {"entities": [[94, 98, "GENE"]]}], ["Individuals with higher DARC expression, which is associated with higher susceptibility to P. vivax infection, exhibited low frequencies and magnitudes of P. vivax blood-stage specific antibody responses.", {"entities": [[24, 28, "GENE"]]}], ["This may indicate that one of the primary mechanisms by which P. vivax evades host immunity is through DARC indirectly down-regulating humoral responses against erythrocytic invasion and development.", {"entities": [[103, 107, "GENE"]]}], ["Dietary approaches to preventing Helicobacter pylori ( H. pylori )-associated gastric carcinogenesis are widely accepted because surrounding break-up mechanisms are mandatory for cancer prevention, however, eradication alone has been proven to be insufficient.", {"entities": [[179, 185, "DISEASE"]]}], ["Among these dietary interventions, omega-3-polyunsaturated-fatty acids (\u03c9-3 PUFAs) are often the first candidate selected.", {"entities": []}], ["However, there was no trial of fatty acids in preventing H. pylori -associated carcinogenesis and inconclusive results have been reported, likely based on inconsistent dietary administration.", {"entities": []}], ["In this study, we developed an H. pylori initiated-, high salt diet promoted-gastric tumorigenesis model and conducted a comparison between wild-type (WT) and Fat -1-transgenic (TG)-mice.", {"entities": [[178, 180, "GENE"]]}], ["Gross and pathological lesions in mouse stomachs were evaluated at 16, 24, 32, and 45 weeks after H. pylori infection, and the underlying molecular changes to explain the cancer preventive effects were investigated.", {"entities": [[171, 177, "DISEASE"]]}], ["Significant changes in: i) ameliorated gastric inflammations at 16 weeks of H. pylori infection, ii) decreased angiogenic growth factors at 24 weeks, iii) attenuated atrophic gastritis and tumorigenesis at 32 weeks, and iv) decreased gastric cancer at 45 weeks were all noted in Fat- 1-TG-mice compared to WT-mice.", {"entities": [[175, 184, "DISEASE"], [166, 184, "DISEASE"], [242, 248, "DISEASE"]]}], ["While an increase in the expression of Cyclooxygenase (COX)-2, and reduced expression of the tumor suppressive 15-PGDH were observed in WT-mice throughout the experimental periods, the expression of Hydroxyprostaglandin dehydrogenase (15-PGDH) was preserved in Fat-1- TG-mice.", {"entities": []}], ["Using a comparative protein array, attenuated expressions of proteins implicated in proliferation and inflammation were observed in Fat -1-TG-mice compared to WT-mice.", {"entities": []}], ["Conclusively, long-term administration of \u03c9-3 PUFAs can suppress H. pylori -induced gastric tumorigenesis through a dampening of inflammation and reduced proliferation in accordance with afforded rejuvenation.", {"entities": []}], ["The current paradigm suggests that structural homology of allergenic proteins to microbial (particularly helminths) or human proteins underlie their allergenic nature.", {"entities": []}], ["To examine systematically the structural relationships among allergens and proteins of pathogens (helminths, protozoans, fungi and bacteria) as they relate to allergenicity, we compared the amino acid sequence of 499 molecularly-defined allergens with the predicted proteomes of fifteen known pathogens, including Th2 inducing helminths and Th1-inducing protozoans, and humans using a variety of bioinformatic tools.", {"entities": []}], ["Allergenicity was assessed based on IgE prevalences using publicly accessible databases and the literature.", {"entities": []}], ["We found multiple homologues of common allergens among proteins of helminths, protozoans, fungi and humans, but not of bacteria.", {"entities": []}], ["In contrast, 187 allergens showed no homology with any of the microbial genera studied.", {"entities": []}], ["Interestingly, allergens without homologues or those with limited levels of sequence conservation were the most allergenic displaying high IgE prevalences in the allergic population.", {"entities": []}], ["There was an inverse relationship between allergenicity and amino acid conservation levels with either parasite, including helminth, or human proteins.", {"entities": []}], ["Our results suggest that allergenicity may be associated with the relative \u201cuniqueness\u201d of an antigen, i.e.", {"entities": []}], ["immunogenicity, while similarity would lead to immunological tolerance.", {"entities": []}], ["To assess directly the effects of various risk factors on lung cancer incidence among never smokers, large prospective studies are needed.", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["In a cohort of 1.2 million UK women without prior cancer, half (634,039) reported that they had never smoked.", {"entities": [[50, 56, "DISEASE"]]}], ["Mean age at recruitment was 55 (SD5) years, and during 14 (SD3) years of follow\u2010up, 0.2% (1,469) of these never smokers developed lung cancer.", {"entities": [[130, 141, "DISEASE"], [135, 141, "DISEASE"]]}], ["Cox regression was used to estimate relative risks (RRs) of lung cancer for 34 potential risk factors, of which 31 were nonsignificant ( p \u2009>\u20090.05).", {"entities": [[60, 71, "DISEASE"], [65, 71, "DISEASE"]]}], ["The remaining three risk factors were associated with a significantly increased incidence of lung cancer in never smokers: non\u2010white vs .", {"entities": [[93, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["white ethnicity (RR\u2009=\u20092.34, 95% CI 1.55\u20133.52, p \u2009<\u20090.001), asthma requiring treatment vs .", {"entities": [[59, 65, "DISEASE"]]}], ["not (RR\u2009=\u20091.32, 1.10\u20131.58, p \u2009=\u20090.003) and taller stature (height\u2009\u2265\u2009165 cm vs .", {"entities": []}], ["<160 cm: RR\u2009=\u20091.16, 1.03\u20131.32, p \u2009=\u20090.02).", {"entities": []}], ["There was little association with other sociodemographic, anthropometric or hormonal factors, or with dietary intakes of meat, fish, fruit, vegetables and fiber.", {"entities": []}], ["The findings were not materially affected by restricting the analyses to adenocarcinomas, the most common histological type among never smokers.", {"entities": []}], ["What's new?", {"entities": []}], ["What causes lung cancer in people who don't smoke?", {"entities": [[12, 23, "DISEASE"], [17, 23, "DISEASE"]]}], ["Because it's rare, researchers have a hard time teasing out exactly what factors contribute.", {"entities": []}], ["Thanks to the Million Women Study, these authors were able to collect data from more than 634,000 women who had never smoked, of whom 1469 (0.2%) developed lung cancer.", {"entities": [[156, 167, "DISEASE"], [161, 167, "DISEASE"]]}], ["They analyzed 34 different characteristics, including lifestyle, medical, and socioeconomic factors, in relation to lung cancer status.", {"entities": [[116, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["Of the 34 risk factors, 3 showed a statistical connection with lung cancer: non\u2010white race, taller stature, and asthma requiring treatment.", {"entities": [[63, 74, "DISEASE"], [112, 118, "DISEASE"], [68, 74, "DISEASE"]]}], ["CD8+ T cell response is important in the response to viral infections; this response though is regulated by inhibitory receptors.", {"entities": []}], ["Expression of inhibitory receptors has been positively correlated with CD8+ T cell exhaustion; the consequent effect of simultaneous blockade of these inhibitory receptors on CD8+ T cell response in viral infections have been studied, however, the role of individual blockade of receptor-ligand pair is unclear.", {"entities": []}], ["2B4/CD48 interaction is involved in CD8+T cell regulation, its signal transducer SAP (signaling lymphocyte activation molecule (SLAM)-associated protein) is required for stimulatory function of 2B4/CD244 on lymphocytes hence, we analyzed 2B4/CD244 (natural killer cell receptor) and SAP (signaling lymphocyte activation molecule(SLAM)-associated protein) on total CD8+ and HTLV-1 specific CD8+T cells in HTLV-1 infection and the effect of blockade of interaction with ligand CD48 on HTLV-1 specific CD8+ T cell function.", {"entities": [[4, 8, "GENE"], [475, 479, "GENE"]]}], ["We observed a high expression of 2B4/CD244 on CD8+ T cells relative to uninfected and further upregulation on HTLV-1 specific CD8+ T cells.", {"entities": []}], ["2B4+ CD8+ T cells exhibited more of an effector and terminally differentiated memory phenotype.", {"entities": []}], ["Blockade of 2B4/CD48 interaction resulted in improvement in function via perforin expression and degranulation as measured by CD107a surface mobilization on HTLV-1 specific CD8+ T cells.", {"entities": []}], ["In the light of these findings, we thus propose an inhibitory role for 2B4/CD48 interaction on CD8+T cell function.", {"entities": []}], ["This study investigates the role of Smad3 signalling for the T-helper2 (Th2) cytokine homeostasis in normal lungs and in a mouse model of asthma.", {"entities": [[138, 144, "DISEASE"], [36, 41, "GENE"]]}], ["We used mice deficient for Smad3, a central part of the major signal transduction pathway for TGF-\u03b2 and other related cytokines, and a mouse model for allergic asthma with ovalbumin (OVA) as the antigen.", {"entities": [[151, 166, "DISEASE"], [160, 166, "DISEASE"], [27, 32, "GENE"]]}], ["Compared to wild type mice, naive (unmanipulated) Smad3-/- mice exhibited significantly increased levels of proinflammatory cytokines and IL-4 as well as the Th2 associated transcription factor GATA-3 in the lung tissue and bronchoalveolar lavage (BAL).", {"entities": []}], ["In the asthma model, mucin secretion and airway hyperresponsiveness (AHR) after allergen exposure was significantly increased in the Smad3-/- mice as compared to wild type (WT) mice.", {"entities": [[7, 13, "DISEASE"], [69, 72, "GENE"]]}], ["IL-4 levels in Smad3-/- were similar to those encountered in WT mice but IL-13 levels were decreased in the airways of OVA sensitized Smad3-/- mice compared to corresponding WT mice.", {"entities": []}], ["The results indicate that a lack of Smad3 dependent signalling in the normal state will lead to an increase in the GATA-3 levels and as a result of this the levels of IL-4 increase.", {"entities": [[36, 41, "GENE"]]}], ["However, the lack of Smad3 also seems to inhibit expression of some cytokines, especially IL-13.", {"entities": [[21, 26, "GENE"]]}], ["Our results also indicate that in the inflammatory state TGF-\u03b2 or related cytokines functions to counterbalance the effects of IL-4 rather than to critically regulate its expression.", {"entities": []}], ["The knowledge on viral respiratory infections in nursing home (NH) residents and their caregivers is limited.", {"entities": []}], ["The purpose of the present study was to assess and compare the incidence of acute respiratory infections (ARI) in nursing home (NH) residents and staff, to identify viruses involved in ARI and to correlate viral etiology with clinical manifestations of ARI.", {"entities": []}], ["The prospective surveillance study was accomplished in a medium-sized NH in Slovenia (central Europe).", {"entities": []}], ["Ninety NH residents and 42 NH staff were included.", {"entities": []}], ["Nasopharyngeal swabs were collected from all participants at enrollment (December 5th, 2011) and at the end of the study (May 31st, 2012), and from each participant that developed ARI within this timeframe.", {"entities": []}], ["Molecular detection of 15 respiratory viruses in nasopharyngeal swab samples was performed.", {"entities": []}], ["The weekly incidence rate of ARI in NH residents and NH staff correlated; however, it was higher in staff members than in residents (5.9 versus 3.8/1,000 person-days, P \u2009=\u20090.03), and was 2.5 (95\u00a0% CI: 1.36\u20134.72) times greater in residents without dementia than in residents with dementia.", {"entities": [[247, 255, "DISEASE"], [279, 287, "DISEASE"]]}], ["Staff members typically presented with upper respiratory tract involvement, whereas in residents lower respiratory tract infections predominated.", {"entities": []}], ["Respiratory viruses were detected in 55/100 ARI episodes.", {"entities": []}], ["In residents, influenza A virus, respiratory syncytial virus, and human metapneumovirus were detected most commonly, whereas in NH staff rhinovirus and influenza A virus prevailed.", {"entities": [[14, 23, "DISEASE"], [152, 161, "DISEASE"]]}], ["38/100 ARI episodes (30/56 in residents, 8/44 in staff) belonged to one of three outbreaks (caused by human metapneumovirus, influenza A virus and respiratory syncytial virus, respectively).", {"entities": [[125, 134, "DISEASE"]]}], ["NH residents had higher chances for virus positivity within outbreak than HN staff (OR\u2009=\u20097.4, 95\u00a0% CI: 1.73\u201331.48, P \u2009<\u20090.01).", {"entities": []}], ["ARI are common among NH residents and staff, and viruses were detected in a majority of the episodes of ARI.", {"entities": []}], ["Many ARI episodes among NH residents were outbreak cases and could be considered preventable.", {"entities": []}], ["The study was registered on the 1 NCT01486160 ).", {"entities": []}], ["Vitamin D deficiency has been associated with a high number of health outcomes, and its role on the immune system has been deeply investigated in recent years, although poor data are still available on vitamin D status in orthopedic infections including those of prosthetic implants.", {"entities": []}], ["We focused on preoperative values of 25(OH)D in selected groups of patients with septic (Group A) or aseptic (Group B) prosthetic loosening, infective bone disease such as septic arthritis and osteomyelitis (Group C) and other orthopedic pathologies (Group D) to evaluate differences in the vitamin D status.", {"entities": [[172, 188, "DISEASE"], [193, 206, "DISEASE"], [151, 163, "DISEASE"], [179, 188, "DISEASE"]]}], ["A high prevalence of vitamin D deficiency was recorded among the study population (16.5\u2009\u00b1\u20095.4\u00a0ng/mL, mean\u2009\u00b1\u2009SD).", {"entities": []}], ["Interestingly, all patients with an infection presented a higher 25(OH)D concentration (17.7\u2009\u00b1\u20095.3\u00a0ng/mL) in respect to uninfected ones (15.1\u2009\u00b1\u20095.6\u00a0ng/mL).", {"entities": []}], ["Significantly higher levels of 25(OH)D were observed in patients with prosthetic joint infection (18.5\u2009\u00b1\u20096.5\u00a0ng/mL), when compared with those presenting an aseptic loosening (13.6\u2009\u00b1\u20099.4\u00a0ng/mL).", {"entities": []}], ["Deficiency in vitamin D levels have been found in orthopaedic patients.", {"entities": []}], ["Prosthetic joint infections seems to be associated to higher values of vitamin D in respect to other bone infections or to other orthopaedic conditions requiring surgery.", {"entities": []}], ["More studies are needed to improve the knowledge on vitamin D status in these patients and to better clarify the role of vitamin D in relation to osteoarticular infections.", {"entities": []}], ["Sphingolipids are a diverse class of signaling molecules implicated in many important aspects of cellular biology, including growth, differentiation, apoptosis, and autophagy.", {"entities": []}], ["Autophagy and apoptosis are fundamental physiological processes essential for the maintenance of cellular and tissue homeostasis.", {"entities": []}], ["There is great interest into the investigation of sphingolipids and their roles in regulating these key physiological processes as well as the manifestation of several disease states.", {"entities": []}], ["With what is known to date, the entire scope of sphingolipid signaling is too broad, and a single review would hardly scratch the surface.", {"entities": []}], ["Therefore, this review attempts to highlight the significance of sphingolipids in determining cell fate (e.g.", {"entities": []}], ["apoptosis, autophagy, cell survival) in the context of the healthy lung, as well as various respiratory diseases including acute lung injury, acute respiratory distress syndrome, bronchopulmonary dysplasia, asthma, chronic obstructive pulmonary disease, emphysema, and cystic fibrosis.", {"entities": [[215, 252, "DISEASE"], [169, 177, "DISEASE"], [269, 284, "DISEASE"], [207, 213, "DISEASE"]]}], ["We present an overview of the latest findings related to sphingolipids and their metabolites, provide a short introduction to autophagy and apoptosis, and then briefly highlight the regulatory roles of sphingolipid metabolites in switching between cell survival and cell death.", {"entities": []}], ["Finally, we describe functions of sphingolipids in autophagy and apoptosis in lung homeostasis, especially in the context of the aforementioned diseases.", {"entities": []}], ["Inhaled therapy is the cornerstone of asthma management in that it optimizes the delivery of the medication to the site of action.", {"entities": [[38, 44, "DISEASE"]]}], ["The effectiveness of inhaled therapy is affected by the correct choice of the device and proper inhalation technique.", {"entities": []}], ["In fact, this influences the drug delivery and distribution along the bronchial tree, including the most peripheral airways.", {"entities": []}], ["In this context, accumulating evidence supports the contribution of small airways in asthma, and these have become an important target of treatment.", {"entities": [[85, 91, "DISEASE"]]}], ["In reality, the \u201cideal inhaler\u201d does not exist, and not all inhalers are the same.", {"entities": []}], ["Advances in technology has highlighted these differences, and have led to the design of new devices and the development of formulations characterized by extrafine particles that facilitate the distribution and deposition of the drug particles along the respiratory tract.", {"entities": []}], ["In addition, efforts have been made to implement adherence to chronic treatment, which translates into clinical benefit.", {"entities": []}], ["Taken together, the optimal control of asthma depends on the drug that is selected, the device that is employed and the removal of factors that reduce patient\u2019s adherence to therapy.", {"entities": [[39, 45, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s12325-015-0201-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The human lysosomal cysteine proteases are a family of 11 proteases whose members include cathepsins B, C, H, L, and S. The biology of these proteases was largely ignored for decades because of their lysosomal location and the belief that their function was limited to the terminal degradation of proteins.", {"entities": []}], ["In the past 10 years, this view has changed as these proteases have been found to have specific functions within cells.", {"entities": []}], ["This review highlights some of these functions, specifically their roles in matrix remodeling and in regulating the immune response, and their relationship to lung diseases.", {"entities": []}], ["Cough is the most frequent reason for consultation with a family doctor, or with a general or respiratory physician.", {"entities": []}], ["Treatment options are limited and a recent meta-analysis concluded that over-the-counter remedies are ineffective and there is increasing concern about their use in children.", {"entities": []}], ["Endogenous inflammatory mediators such as prostaglandin E 2 (PGE 2 ) and bradykinin (BK), which are often elevated in respiratory disease states, are also known to cause cough by stimulating airway sensory nerves.", {"entities": []}], ["However, how this occurs is not understood.", {"entities": []}], ["We hypothesised that the transient receptor potential (TRP) channels, TRPA1 and TRPV1, may have a role as \u2018common effectors\u2019 of tussive responses to these agents.", {"entities": [[70, 75, "GENE"], [80, 85, "GENE"]]}], ["We have employed a range of in vitro imaging and isolated tissue assays in human, murine and guinea pig tissue and an in vivo cough model to support this hypothesis.", {"entities": []}], ["Using calcium imaging we demonstrated that PGE 2 and BK activated isolated guinea pig sensory ganglia and evoked depolarisation (activation) of vagal sensory nerves, which was inhibited by TRPA1 and TRPV1 blockers (JNJ17203212 and HC-030031).", {"entities": [[189, 194, "GENE"], [199, 204, "GENE"]]}], ["These data were confirmed in vagal sensory nerves from TRPA1 and TRPV1 gene deleted mice.", {"entities": [[55, 60, "GENE"], [65, 70, "GENE"]]}], ["TRPV1 and TRPA1 blockers partially inhibited the tussive response to PGE 2 and BK with a complete inhibition obtained in the presence of both antagonists together in a guinea pig conscious cough model.", {"entities": [[0, 5, "GENE"], [10, 15, "GENE"]]}], ["This study identifies TRPA1 and TRPV1 channels as key regulators of tussive responses elicited by endogenous and exogenous agents, making them the most promising targets currently identified in the development of anti-tussive drugs.", {"entities": [[22, 27, "GENE"], [32, 37, "GENE"]]}], ["Various inhaled corticosteroids (ICSs) are available to control the symptoms of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["Although beclomethasone dipropionate (BDP) and budesonide (BUD) are one of the oldest ICSs, their wide availability and low cost make them attractive options in developing countries.", {"entities": []}], ["Due to lack of consensus on which of the two drugs is better for controlling mild persistent asthma, we undertook this study to compare the efficacy of these two drugs by measuring the change in percentage predicted forced expiratory volume in one second (FEV 1 ) from baseline in children with mild persistent asthma.", {"entities": [[93, 99, "DISEASE"], [311, 317, "DISEASE"], [256, 259, "GENE"]]}], ["A double-blind, randomized, parallel group study was conducted in children 7-15 yr of age with newly diagnosed asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["Of the 85 cases of mild persistent asthma, 42 received BUD while 43 received BDP at a dose of 400 \u00b5g/day using pressurized metered-dose inhaler with valved spacer for two months.", {"entities": [[35, 41, "DISEASE"]]}], ["The outcomes measured were change in FEV 1 , symptom scores and side effects.", {"entities": [[37, 40, "GENE"]]}], ["There was a significant ( P < 0.05) improvement in FEV 1 in BUD group (98.43 \u00b1 4.63%) than in BDP group (95.65 \u00b1 5.66%) at the end of two months of treatment.", {"entities": [[51, 54, "GENE"]]}], ["The mean symptom scores in BUD group (0.28 \u00b1 1.22) and BDP group (0.43 \u00b1 1.52) were comparable after two months.", {"entities": []}], ["No side effects were seen in either group.", {"entities": []}], ["FEV 1 was significantly greater in BUD group than BDP group.", {"entities": [[0, 3, "GENE"]]}], ["Improvement in symptoms and incidence of side effects were similar.", {"entities": []}], ["Our findings indicate that both BDP and BUD can be used effectively in the management of children with mild persistent asthma.", {"entities": [[119, 125, "DISEASE"]]}], ["[CTRI No: CTRI/2013/03/003495].", {"entities": []}], ["Objective: Complementary and alternative medicine (CAM) is increasingly utilized in adults and children for treatment of various conditions.", {"entities": []}], ["Studies on CAM in diabetes have mainly focused on the adult population and its application in children has not been well established.", {"entities": []}], ["The aim of this study was to examine the prevalence and characteristics of CAM use in Turkish children with type 1 diabetes mellitus (T1DM).", {"entities": [[108, 132, "DISEASE"], [115, 132, "DISEASE"]]}], ["Methods: The information was acquired by a questionnaire completed by a face-to-face interview with the parents of children with T1DM.", {"entities": []}], ["Results: A total of 195 subjects (mean age: 14.02\u00b14.7 years; F/M: 103/92) were included in this survey.", {"entities": []}], ["Use of CAM was reported in 85 subjects (43.6%).", {"entities": []}], ["Herbal medicines were used in 64 subjects (75.3%).", {"entities": []}], ["Sixty-nine subjects (81.2%) did not inform the diabetes specialist about CAM use.", {"entities": []}], ["Thirty-eight subjects (44.7%) evaluated CAM as efficacious.", {"entities": []}], ["Only 3 subjects (3.5%) interrupted the insulin injections to use CAM.", {"entities": []}], ["No relationships were found between CAM use and parental education or insulin dose.", {"entities": []}], ["There were significant correlations between CAM use and higher family income (p=0.027), urban residence (p=0.05), presence of complications (p=0.03), dissatisfaction with medical therapy (p=0.034) and prior CAM use among parents (p=0.001).", {"entities": []}], ["Conclusion: CAM use is a frequent practice among diabetic children, which is usually not shared with their physicians and sometimes leads to cessation of medical treatment.", {"entities": []}], ["Conflict of interest: None declared.", {"entities": []}], ["Probiotics are living microorganisms that, when administered in adequate amounts, confer health benefits on the host.", {"entities": []}], ["Because probiotics are not marketed as pharmaceuticals, they are commercially available without rigorous scientific documentation of their efficacy for many health-related claims.", {"entities": []}], ["Results from existing clinical trials are both confusing and controversial.", {"entities": []}], ["The evidence base is relatively limited, includes studies with varied designs, assesses multiple probiotic preparations across discrepant disease states, and provides conflicting results.", {"entities": []}], ["Recent advances in the delineation of probiotics' mechanisms of action offer the opportunity to construct a more logical framework within which future trials are designed.", {"entities": []}], ["Protective athletic mouthguards (PAM) produce oral mucosal injuries and may be associated with other systemic conditions.", {"entities": []}], ["With wear, PAM become contaminated by a range of microorganisms.", {"entities": []}], ["The number of microorganisms in PAM can be reduced by daily use of an antimicrobial solution.", {"entities": []}], ["Study Type: Case series.", {"entities": []}], ["Sixty-two division I football player volunteers were divided into 4 groups, using PAM for varying lengths of time before surrendering them for microbial analysis.", {"entities": []}], ["One group had their PAM soaked in an antimicrobial solution between uses.", {"entities": []}], ["The PAM were analyzed qualitatively and quantitatively for bacteria, yeasts, and fungi, using previously accepted methods.", {"entities": []}], ["The 62 football players surrendered a total of 81 PAM for microbial analysis.", {"entities": []}], ["The PAM yielded 154 gram-positive cocci, 150 gram-positive bacilli, 21 gram-negative cocci, 31 gram-negative bacilli, 22 yeasts, and 107 molds.", {"entities": []}], ["The most common species of gram-positive cocci were Staphylococcus spp.", {"entities": []}], ["and Micrococcus spp.", {"entities": []}], ["Only 3 PAM (4%) were positive for Staphylococcus aureus .", {"entities": []}], ["The most common species of gram-positive bacilli were Brevibacterium spp.", {"entities": []}], ["and Cellulomonas spp.", {"entities": []}], ["The most common species of yeasts were Candida parapsilosis and Rhodotorula mucilaginosa , while the most common species of mold were Cochliobolus spp.", {"entities": []}], ["and Penicillium chrysogenum .", {"entities": []}], ["Soaking the PAM in an antimicrobial solution between uses substantially reduced the numbers of microorganisms.", {"entities": []}], ["Substantial microbial contamination of PAM occurs with use.", {"entities": []}], ["The microbial load can be reduced by soaking in an antimicrobial solution between uses.", {"entities": []}], ["Clinical Relevance: PAM are contaminated by microorganisms that have the potential to produce oral and systemic diseases.", {"entities": []}], ["They should be sanitized daily and changed when they become sharp and/or jagged.", {"entities": []}], ["Interleukin-4 (IL-4) produced from Th2 cells modulates both innate and adaptive immune responses.", {"entities": []}], ["It is a common belief that wild animals possess better immunity against diseases than domestic and laboratory animals; however, the immune system of wild animals is not fully explored yet.", {"entities": []}], ["Therefore, a comparative study was designed to explore the wildlife immunity through characterisation of IL-4 cDNA of nilgai, a wild ruminant, and Indian buffalo, a domestic ruminant.", {"entities": []}], ["Total RNA was extracted from peripheral blood mononuclear cells of nilgai and Indian buffalo and reverse transcribed into cDNA.", {"entities": []}], ["Respective cDNA was further cloned and sequenced.", {"entities": []}], ["Sequences were analysed in silico and compared with their homologues available at GenBank.", {"entities": []}], ["The deduced 135 amino acid protein of nilgai IL-4 is 95.6% similar to that of Indian buffalo.", {"entities": []}], ["N-linked glycosylation sequence, leader sequence, Cysteine residues in the signal peptide region, and 3\u2032 UTR of IL-4 were found to be conserved across species.", {"entities": []}], ["Six nonsynonymous nucleotide substitutions were found in Indian buffalo compared to nilgai amino acid sequence.", {"entities": []}], ["Tertiary structure of this protein in both species was modeled, and it was found that this protein falls under 4-helical cytokines superfamily and short chain cytokine family.", {"entities": []}], ["Phylogenetic analysis revealed a single cluster of ruminants including both nilgai and Indian buffalo that was placed distinct from other nonruminant mammals.", {"entities": []}]]